PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Grane, VA; Brunner, JF; Endestad, T; Aasen, IES; Kropotov, J; Knight, RT; Solbakk, AK				Grane, Venke Arntsberg; Brunner, Jan Ferenc; Endestad, Tor; Aasen, Ida Emilia S.; Kropotov, Juri; Knight, Robert Thomas; Solbakk, Anne-Kristin			ERP Correlates of Proactive and Reactive Cognitive Control in Treatment-Naive Adult ADHD (vol 11, e0159833, 2016)	PLOS ONE			English	Correction														Endestad, Tor/0000-0002-4403-6887				Grane VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159833	1	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163404	10.1371/journal.pone.0163404	http://dx.doi.org/10.1371/journal.pone.0163404			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631088	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900149
J	Kaluzny, J; Purta, P; Poskin, Z; Rogers, JD; Fawzi, AA				Kaluzny, Joel; Purta, Patryk; Poskin, Zach; Rogers, Jeremy D.; Fawzi, Amani A.			Ex Vivo Confocal Spectroscopy of Autofluorescence in Age-Related Macular Degeneration	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; BRUCHS MEMBRANE; MORPHOMETRIC-ANALYSIS; HUMAN RPE; LIPOFUSCIN; FLUORESCENCE; DISEASE; DRUSEN; EYES	Purpose We investigated the autofluorescence (AF) signature of the microscopic features of retina with age-related macular degeneration (AMD) using 488 nm excitation. Methods The globes of four donors with AMD and four age-matched controls were embedded in paraffin and sectioned through the macula. Sections were excited using a 488 nm argon laser, and the AF emission was captured using a laser scanning confocal microscope (496-610 nm, 6 nm resolution). The data cubes were then analyzed to compare peak emission spectra between the AMD and the controls. Microscopic features, including individual lipofuscin and melanolipofuscin granules, Bruch's Membrane, as well macroscopic features, were considered. Results Overall, the AMD eyes showed a trend of blue-shifted emission peaks compared with the controls. These differences were statistically significant when considering the emission of the combined RPE/Bruch's Membrane across all the tissue cross-sections (p = 0.02). Conclusions The AF signatures of ex vivo AMD RPE/BrM show blue-shifted emission spectra (488 nm excitation) compared with the control tissue. The magnitude of these differences is small (similar to 4 nm) and highlights the potential challenges of detecting these subtle spectral differences in vivo.	[Kaluzny, Joel; Purta, Patryk; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Poskin, Zach; Rogers, Jeremy D.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.; Rogers, JD (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	jdrogers5@wisc.edu; amani.fawzi@northwestern.edu	fawzi, amani/AAA-9199-2021; Rogers, Jeremy/A-4572-2008	fawzi, amani/0000-0002-9568-3558; Rogers, Jeremy/0000-0003-3049-2803	National Institutes of Health [NIH-EY021470]; Illinois Society for the Prevention of Blindness; Edwin and Dorothy Gamewell Professorship, Retina Research Foundation; National Cancer Institute (Northwestern University) [NCI-CCSG-P30-CA060553]; NCI CCSG [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Society for the Prevention of Blindness; Edwin and Dorothy Gamewell Professorship, Retina Research Foundation; National Cancer Institute (Northwestern University); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (http://www.nih.gov/; NIH-EY021470; AAF), Illinois Society for the Prevention of Blindness (http://www.eyehealthillinois.org/; JK), and the Edwin and Dorothy Gamewell Professorship, Retina Research Foundation (http://retinaresearchfnd.org/; JDR), National Cancer Institute (http://www.cancer.gov/; NCI-CCSG-P30-CA060553; Northwestern University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Confocal microscopy was performed at the Northwestern University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center.	Ach T, 2012, BRIT J OPHTHALMOL, V96, P1141, DOI 10.1136/bjophthalmol-2012-301547; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Biesemeier A, 2011, EXP EYE RES, V93, P29, DOI 10.1016/j.exer.2011.04.004; Bourg-Heckly G, 2008, IN VIVO ENDOSCOPIC A; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cucio CA, 2010, J LIPID RES, V51, P451, DOI [10.1194/jlr.R002238, DOI 10.1194/JLR.R002238]; Cummings TJ., 2013, OPHTHALMIC PATHOLOGY; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Feldman TB, 2015, ANAL BIOANAL CHEM, V407, P1075, DOI 10.1007/s00216-014-8353-z; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; Hussain AA, 2011, INVEST OPHTH VIS SCI, V52, P4459, DOI 10.1167/iovs.10-6678; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kamei M, 1999, INVEST OPHTH VIS SCI, V40, P2367; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Marmorstein AD, 2002, INVEST OPHTH VIS SCI, V43, P2435; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; NEWSOME DA, 1987, CURR EYE RES, V6, P1211, DOI 10.3109/02713688709025231; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Rocha R, 2008, PHOTOMED LASER SURG, V26, P329, DOI 10.1089/pho.2007.2208; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Schweitzer D, 2009, OPHTHALMOLOGE, V106, P714, DOI 10.1007/s00347-009-1975-4; Schweitzer D, 2012, INVEST OPHTH VIS SCI, V53, P3376, DOI 10.1167/iovs.11-8970; SISKEN JE, 1989, METHOD CELL BIOL, V30, P113; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Thiberville L, 2007, AM J RESP CRIT CARE, V175, P22, DOI 10.1164/rccm.200605-684OC; VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407; vonRuckmann A, 1997, INVEST OPHTH VIS SCI, V38, P478; Warburton S, 2005, MOL VIS, V11, P1122; Warburton S, 2007, MOL VIS, V13, P318; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107	46	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162869	10.1371/journal.pone.0162869	http://dx.doi.org/10.1371/journal.pone.0162869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631087	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900089
J	Kolarevic, S; Aborgiba, M; Kracun-Kolarevic, M; Kostic, J; Simonovic, P; Simic, V; Miloskovic, A; Reischer, G; Farnleitner, A; Gacic, Z; Milacic, R; Zuliani, T; Vidmar, J; Pergal, M; Piria, M; Paunovic, M; Vukovic-Gacic, B				Kolarevic, Stoimir; Aborgiba, Mustafa; Kracun-Kolarevic, Margareta; Kostic, Jovana; Simonovic, Predrag; Simic, Vladica; Miloskovic, Aleksandra; Reischer, Georg; Farnleitner, Andreas; Gacic, Zoran; Milacic, Radmila; Zuliani, Tea; Vidmar, Janja; Pergal, Marija; Piria, Marina; Paunovic, Momir; Vukovic-Gacic, Branka			Evaluation of Genotoxic Pressure along the Sava River	PLOS ONE			English	Article							DNA-DAMAGE; COMET ASSAY; POTENTIAL VALUE; UNIO-PICTORUM; WATER; FRESH; HEMOCYTES; EXPOSURE; REPAIR; LYMPHOCYTES	In this study we have performed a comprehensive genotoxicological survey along the 900 rkm of the Sava River. In total, 12 sites were chosen in compliance with the goals of GLOBAQUA project dealing with the effects of multiple stressors on biodiversity and functioning of aquatic ecosystems. The genotoxic potential was assessed using a complex battery of bioassays performed in prokaryotes and aquatic eukaryotes (freshwater fish). Battery comprised evaluation of mutagenicity by SOS/umuC test in Salmonella typhimurium TA1535/pSK1002. The level of DNA damage as a biomarker of exposure (comet assay) and biomarker of effect (micronucleus assay) and the level of oxidative stress as well (Fpg-modified comet assay) was studied in blood cells of bleak and spirlin (Alburnus alburnus/Alburnoides bipunctatus respectively). Result indicated differential sensitivity of applied bioassays in detection of genotoxic pressure. The standard and Fpg-modified comet assay showed higher potential in differentiation of the sites based on genotoxic potential in comparison with micronucleus assay and SOS/umuC test. Our data represent snapshot of the current status of the river which indicates the presence of genotoxic potential along the river which can be traced to the deterioration of quality of the Sava River by communal and industrial wastewaters. The major highlight of the study is that we have provided complex set of data obtained from a single source (homogeneity of analyses for all samples).	[Kolarevic, Stoimir; Aborgiba, Mustafa; Vukovic-Gacic, Branka] Univ Belgrade, Fac Biol, Chair Microbiol, Ctr Genotoxicol & Ecogenotoxicol, Belgrade, Serbia; [Kracun-Kolarevic, Margareta; Paunovic, Momir] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Belgrade, Serbia; [Kostic, Jovana; Gacic, Zoran] Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia; [Simonovic, Predrag] Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia; [Simic, Vladica; Miloskovic, Aleksandra] Univ Kragujevac, Fac Sci, Kragujevac, Serbia; [Reischer, Georg; Farnleitner, Andreas] TU Wien, Inst Chem Engn, Res Grp Environm Microbiol & Mol Ecol, Interuniv Cooperat Ctr Water & Hlth, Vienna, Austria; [Milacic, Radmila; Zuliani, Tea; Vidmar, Janja] Jozef Stefan Inst, Dept Environm Sci, Ljubljana, Slovenia; [Pergal, Marija] Univ Belgrade, Inst Chem Technol & Met, Belgrade, Serbia; [Piria, Marina] Univ Zagreb, Fac Agr, Zagreb, Croatia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; University of Kragujevac; Technische Universitat Wien; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Belgrade; University of Zagreb	Kolarevic, S (corresponding author), Univ Belgrade, Fac Biol, Chair Microbiol, Ctr Genotoxicol & Ecogenotoxicol, Belgrade, Serbia.	stoimirk@bio.bg.ac.rs	Simonovic, Predrag/AAK-9577-2020; Paunović, Momir/H-9177-2019; Milošković, Aleksandra/AAQ-6464-2021; Reischer, Georg Hubert/N-6381-2017; Kostic-Vukovic, Jovana/K-8699-2019; Zuliani, Tea/ABH-6516-2020; Zuliani, Tea/AAE-7372-2022; Piria, Marina/L-8228-2019	Simonovic, Predrag/0000-0002-4819-4962; Paunović, Momir/0000-0002-6432-1191; Reischer, Georg Hubert/0000-0002-3962-8685; Zuliani, Tea/0000-0002-8367-876X; Simic, Vladica/0000-0001-6787-9783; Vidmar, Janja/0000-0003-0336-6561; Kolarevic, Stoimir/0000-0002-6938-8803; Miloskovic, Aleksandra/0000-0003-2407-7099; Piria, Marina/0000-0001-6324-9282; Kostic-Vukovic, Jovana/0000-0002-6608-1013; Kracun-Kolarevic, Margareta/0000-0002-8885-2456; Pergal, Marija/0000-0001-6078-2006; Vukovic-Gacic, Branka/0000-0001-8767-1912; Farnleitner, Andreas/0000-0002-0542-5425	European Community [603629-ENV-2013-6.2.1]; Ministry of Education, Science and Technological Development of the Republic of Serbia	European Community(European Commission); Ministry of Education, Science and Technological Development of the Republic of Serbia	This research received financial support of the European Community's Seventh Framework Programme, Grant agreement 603629-ENV-2013-6.2.1. (Globaqua). This study represents a part of activities within the Projects funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia and bilateral project Serbia and Austria: Implementation of Microbial Source Tracking (MST) method for assessment of faecal pollution in the Sava River and relation (potential relationship) to the presence of genotoxic agents.	Aborgiba M, 2016, SCI TOTAL ENVIRON, V540, P358, DOI 10.1016/j.scitotenv.2015.03.120; Akcha F, 2003, MUTAT RES-GEN TOX EN, V534, P21, DOI 10.1016/S1383-5718(02)00244-9; Pereira CSA, 2010, ARCH ENVIRON CON TOX, V58, P112, DOI 10.1007/s00244-009-9330-y; [Anonymous], 2000, 13829 ISOCD; Bahlmann A., 2015, JOINT DANUBE SURVEY, P277; Bailey CR, 2004, BIOASSESSMENT FRESHW, P145; Beliaeff B, 2002, ENVIRON TOXICOL CHEM, V21, P1316, DOI 10.1002/etc.5620210629; Bervoets L, 2003, ENVIRON POLLUT, V126, P9, DOI 10.1016/S0269-7491(03)00173-8; Buckalew DW, 2006, J ENVIRON MANAGE, V80, P191, DOI 10.1016/j.jenvman.2005.08.024; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Deutschmann B, 2015, JOINT DANUBE SURVEY, P296; Dixon DR, 2002, MUTAGENESIS, V17, P495, DOI 10.1093/mutage/17.6.495; Dragun Z, 2015, HANDB ENVIRON CHEM, V31, P123, DOI 10.1007/978-3-662-44034-6_6; Dragun Z, 2009, ENVIRON MONIT ASSESS, V159, P99, DOI 10.1007/s10661-008-0615-9; Duthie SJ, 2002, MUTAGENESIS, V17, P211, DOI 10.1093/mutage/17.3.211; EC, 2003, EUROPEAN COMMISSION; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Gacic Z, 2014, ENVIRON POLLUT, V191, P145, DOI 10.1016/j.envpol.2014.04.024; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Hartmann A, 1997, TOXICOL LETT, V90, P183, DOI 10.1016/S0378-4274(96)03847-7; Jha AN, 2008, MUTAGENESIS, V23, P207, DOI 10.1093/mutage/gen014; Kallqvist T, 2008, WATER RES, V42, P2146, DOI 10.1016/j.watres.2007.11.026; Kapetanovic D, 2015, HANDB ENVIRON CHEM, V31, P201, DOI 10.1007/978-3-662-44034-6_9; Kirschner A., 2015, JOINT DANUBE SURVEY, P155; Kittinger C, 2013, SCI TOTAL ENVIRON, V447, P424, DOI 10.1016/j.scitotenv.2013.01.015; Kittinger C, 2015, WATER-SUI, V7, P1959, DOI 10.3390/w7051959; Klobucar GIV, 2003, AQUAT TOXICOL, V64, P15, DOI 10.1016/S0166-445X(03)00009-2; Klobucar GIV, 2012, CHEMOSPHERE, V87, P62, DOI 10.1016/j.chemosphere.2011.11.060; Kolarevic S, 2016, SCI TOTAL ENVIRON, V540, P377, DOI 10.1016/j.scitotenv.2015.06.061; Kolarevic S, 2013, CHEMOSPHERE, V93, P243, DOI 10.1016/j.chemosphere.2013.04.073; Kopjar N, 2008, FOLIA ZOOL, V57, P120; Krca S, 2007, ENVIRON TOXICOL CHEM, V26, P2620, DOI 10.1897/07-227.1; Marijic VF, 2013, SCI TOTAL ENVIRON, V463, P772, DOI 10.1016/j.scitotenv.2013.06.041; Marijic VF, 2012, WATER AIR SOIL POLL, V223, P4769, DOI 10.1007/s11270-012-1233-2; Merciai R, 2014, ECOTOX ENVIRON SAFE, V107, P154, DOI 10.1016/j.ecoenv.2014.05.006; Milacic R, 2010, ENVIRON MONIT ASSESS, V163, P263, DOI 10.1007/s10661-009-0832-x; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Navarro-Ortega A, 2016, SCI TOTAL ENVIRON, V503, P3; OLIVE PL, 1993, RADIAT RES, V136, P130, DOI 10.2307/3578650; Pavlica M, 2015, ENVIRON MONIT ASSESS, V177, P85; Petkovsek SA, 2012, ENVIRON MONIT ASSESS, V184, P2647, DOI 10.1007/s10661-011-2141-4; Recio L, 2012, ENVIRON MOL MUTAGEN, V53, P101, DOI 10.1002/em.20694; Scancar J, 2015, HANDB ENVIRON CHEM, V31, P95, DOI 10.1007/978-3-662-44034-6_5; Simic V, 2015, HANDB ENVIRON CHEM, V31, P453, DOI 10.1007/978-3-662-44034-6_17; Simonovic P, 2015, HANDB ENVIRON CHEM, V31, P361, DOI 10.1007/978-3-662-44034-6_14; Smital T, 2015, HANDB ENVIRON CHEM, V31, P177, DOI 10.1007/978-3-662-44034-6_8; Straser A, 2011, ARCH TOXICOL, V85, P1617, DOI 10.1007/s00204-011-0716-z; Sunjog K, 2014, ENVIRON TOXICOL PHAR, V37, P967, DOI 10.1016/j.etap.2014.03.010; Sunjog K, 2013, ANAL BIOANAL CHEM, V405, P4879, DOI 10.1007/s00216-013-6909-y; Sunjog K, 2012, SCI WORLD J, DOI 10.1100/2012/351074; Usero J, 1997, ENVIRON INT, V23, P291, DOI 10.1016/S0160-4120(97)00030-5; Uysal K, 2009, ENVIRON MONIT ASSESS, V157, P355, DOI 10.1007/s10661-008-0540-y; Visvardis EE, 1997, MUTAT RES-DNA REPAIR, V383, P71, DOI 10.1016/S0921-8777(96)00047-X; Vukovic Z, 2011, J SERB CHEM SOC, V76, P795, DOI 10.2298/JSC100420067V; Vukovic-Gacic B, 2015, HANDB ENVIRON CHEM, V31, P437, DOI 10.1007/978-3-662-44034-6_16; Vukovic-Gacic B, 2014, HYDROBIOLOGIA, V735, P221, DOI 10.1007/s10750-013-1513-x; Zegura B, 2009, CHEMOSPHERE, V75, P1453, DOI 10.1016/j.chemosphere.2009.02.041	57	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162450	10.1371/journal.pone.0162450	http://dx.doi.org/10.1371/journal.pone.0162450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631093	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900049
J	Kuznetsova, IS; Labutina, EV; Hunter, N				Kuznetsova, Irina S.; Labutina, Elena V.; Hunter, Nezahat			Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948-2004	PLOS ONE			English	Article							CANCER INCIDENCE; WORKERS; MORTALITY; PLUTONIUM; LUNG	Incidence of all types of lymphatic and hematopoietic cancers, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiplemyeloma, acute and chronicmyeloid leukemia (AML and CML respectively), chronic lymphocytic leukemia (CLL) and other forms of leukemia have been studied in a cohort of 22,373 workers employed at the Mayak Production Association (PA) main facilities during 536,126 person-years of follow-up from the start of employment between 1948 and 1982 to the end of 2004. Risk assessment was performed for both external gamma-radiation and internal alpha-exposure of red bone marrow due to incorporated Pu-239 using Mayak Workers Dosimetry System 2008 taking into account non-radiation factors. The incidence of leukemia excluding CLL showed a non-linear dose response relationship for external gamma exposure with exponential effect modifiers based on time since exposure and age at exposure. Among the major subtypes of leukemia, the excess risk of AML was the highest within the first 2-5 years of external exposure (ERR per Gy: 38.40; 90% CI: 13.92-121.4) and decreased substantially thereafter, but the risks remained statistically significant (ERR per Gy: 2.63; 90% CI: 0.07-12.55). In comparison, excess CML first occurred 5 years after exposure and decreased about 10 years after exposure, although the association was not statistically significant (ERR per Gy: 1.39; 90% CI: -0.22-7.32). The study found no evidence of an association between leukemia and occupational exposure to internal plutonium ERR per Gy 2.13; 90% CI: < 0-9.45). There was also no indication of any relationship with either external gamma or internal plutonium radiation exposure for either incidence of Hodgkin or non-Hodgkin lymphoma or multiplemyeloma.	[Kuznetsova, Irina S.; Labutina, Elena V.] SUBI, Ozyorsk, Chelyabinsk Reg, Russia; [Hunter, Nezahat] Ctr Radiat Chem & Environm Hazards CRCE, PHE, Chilton, Oxon, England	Southern Urals Biophysics Institute	Kuznetsova, IS (corresponding author), SUBI, Ozyorsk, Chelyabinsk Reg, Russia.	Kuznetsova@subi.su	Kuznetsova, Irina S./L-5569-2019; Kuznetsova, Irina S/D-3847-2019	Kuznetsova, Irina S./0000-0002-1214-295X; Kuznetsova, Irina S/0000-0002-1214-295X	European Commission though EC-SOLO project under EC SEVENTH FRAMEWORK PROGRAMME THEME: Radiation Protection Quantification of Risks for Low and Protracted Exposures [CP-IP: 249675]	European Commission though EC-SOLO project under EC SEVENTH FRAMEWORK PROGRAMME THEME: Radiation Protection Quantification of Risks for Low and Protracted Exposures	This work was supported by the European Commission though EC-SOLO project (CP-IP: 249675) under EC SEVENTH FRAMEWORK PROGRAMME THEME: Radiation Protection Quantification of Risks for Low and Protracted Exposures.	Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Daniels RD, 2013, OCCUP ENVIRON MED, V70, P41, DOI 10.1136/oemed-2012-100906; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; Hunter N, 2013, BRIT J CANCER, V109, P1989, DOI 10.1038/bjc.2013.543; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Krestinina LY, 2013, BRIT J CANCER, V109, P2886, DOI 10.1038/bjc.2013.614; Labutina EV, 2013, HEALTH PHYS, V105, P165, DOI 10.1097/HP.0b013e31828f57df; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Preston DL, 1998, EPICURE RELEASE 2 10; Richardson DB, 2007, AM J EPIDEMIOL, V166, P1015, DOI 10.1093/aje/kwm176; Richardson DB, 2009, AM J EPIDEMIOL, V169, P969, DOI 10.1093/aje/kwp018; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Sokolnikov ME, 2013, INT J CANCER, V123, P905; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, SOURC EFF ION RAD UN; Vasilenko EK, AAHP SPEC SESS HLTH; *WHO, 1977, INT CLASS DIS INJ CA	19	22	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162710	10.1371/journal.pone.0162710	http://dx.doi.org/10.1371/journal.pone.0162710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631102	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900069
J	Moreno-Dominguez, R; Cascales-Minana, B; Ferrer, J; Diez, JB				Moreno-Dominguez, Rafael; Cascales-Minana, Borja; Ferrer, Javier; Diez, Jose B.			Acrostichum, a Pioneering Fern of Floodplain Areas from the Late Oligocene Sarinena Formation of the Iberian Peninsula	PLOS ONE			English	Article							MANGROVE FERN; CAINOZOIC FERNS; SOIL-SALINITY; EBRO BASIN; DISTURBANCES; VEGETATION; SPAIN; WATER	Acrostichum is considered today an opportunistic fern in disturbed areas, which indicates the first stages of colonisation of such zones. However, in the fossil record, Acrostichum appears related to fluvio-lacustrine environments, freshwater marshes and mangrove deposits. We report here for first time fossil evidence of Acrostichum that reveals a pioneering behaviour of this fern in the colonisation of perturbed communities in Europe, which corroborates previous assumptions about the paleobiology of Acrostichum. Plant remains were collected from the Chattian (late Oligocene) La Val fossil site (Estadilla, Huesca, northeastern Spain) belonging to the Sarinena Formation, which mainly embraces crevasse splays, levees and floodplain deposits. Evidence shows that Acrostichum grew within the levee's vegetal community or close to/on the river banks as well as on floodplain areas and closer to/on the shores of ephemeral ponds. But most importantly, the observed co-existence of Equisetum and Acrostichum remains in the same beds indicates that such strata represent short-lived inundated terrains, e.g., floodplains where the water table was temporarily stagnant. Evidence shows wetland environments dominated by pioneering taxa, implying a pioneering role for Acrostichum during the late Oligocene in the Iberian Peninsula.	[Moreno-Dominguez, Rafael; Ferrer, Javier] Univ Zaragoza, Area Paleontol, Dept Ciencias Tierra, E-50009 Zaragoza, Spain; [Cascales-Minana, Borja] Univ Liege, PPP, Dept Geol, Allee 6 Aout,B18 Sart Tilman, B-4000 Liege, Belgium; [Diez, Jose B.] Univ Vigo, Dpto Geociencias Marinas & Ordenac Terr, Campus Lagoas Marcosende, Vigo 36200, Spain	University of Zaragoza; University of Liege; Universidade de Vigo	Moreno-Dominguez, R (corresponding author), Univ Zaragoza, Area Paleontol, Dept Ciencias Tierra, E-50009 Zaragoza, Spain.; Cascales-Minana, B (corresponding author), Univ Liege, PPP, Dept Geol, Allee 6 Aout,B18 Sart Tilman, B-4000 Liege, Belgium.	noctubre7@gmail.com; bcascales@ulg.ac.be	Diez, Jose B./L-1004-2014	Diez, Jose B./0000-0001-5739-7270; MORENO-DOMINGUEZ, RAFAEL/0000-0002-3602-3410	Marie Curie COFUND Project - University of Liege [600405]; Marie Curie COFUND Postdoctoral Fellowship from the University of Liege [600405]	Marie Curie COFUND Project - University of Liege; Marie Curie COFUND Postdoctoral Fellowship from the University of Liege	This work has been funded by a Marie Curie COFUND Project - University of Liege (grant number: 600405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jose Francisco Lisa Blanco for his assistance during fieldworks. We also thank Arsenio Munoz (University of Zaragoza) for his helpful comments about the sedimentary structures. The constructive comments provided by the two anonymous referees are also acknowledged. This work has been funded by a Marie Curie COFUND Postdoctoral Fellowship from the University of Liege (BCM, grant number: 600405).	Alvarez Ramis C., 1987, B I GEOL MINER ESPAN, V98, P349; Alvarez Ramis C., 1986, B SOC HIST NATURAL B, V30, P83; alvarez-Rami C, 1982, ACTA GEOL HISP, V17, P5; Alvarez-Ramis C, 1995, C PALEONTOLOGIA, V47, P193; Arenas C., 2004, GEOLOG A ESPA A, P343; ARENES J., 1951, BOL R SOC ESPANOLA HIST NAT SEC GEOL, V49, P73; Arenes J., 1956, REV GEN BOT, V63, P347; Arnold C. A., 1963, CONTRIBUTIONS MUSEUM, V18, P205; AWASTHI N, 1996, PALEOBOTANIST, V43, P83; Bataller JR, 1950, ANALES ESC PERITOS A, V9, P3; Bauza-Rullan J, 1961, ESTUD GEOL, V17, P161; Bonde SD, 2002, REV PALAEOBOT PALYNO, V120, P285, DOI 10.1016/S0034-6667(02)00081-7; BUNT JS, 1982, AUST J BOT, V30, P401, DOI 10.1071/BT9820401; COLLENETTE I S, 1991, Fern Gazette, V14, P57; Collinson ME, 2002, REV PALAEOBOT PALYNO, V119, P51, DOI 10.1016/S0034-6667(01)00129-4; Collinson ME, 2001, BRITTONIA, V53, P173, DOI 10.1007/BF02812700; Depape G., 1931, B I CATALANA HIST NA, V31, P194; Dufour S, 2010, GEOMORPHOLOGIE, P371; Fernandez Marron M.T, 1971, THESIS U MADRID SPAI; Fliche P., 1908, BUTLLETI I CATALANA, V7, P77; Massini JLG, 2006, INT J PLANT SCI, V167, P909; Massini JLG, 2011, REV PALAEOBOT PALYNO, V164, P211, DOI 10.1016/j.revpalbo.2010.12.003; Garcia-Massini JL, 2010, PALAEONTOL ELECTRON, V13, p16A; Hamer JMM, 2007, PALAEOGEOGR PALAEOCL, V247, P220, DOI 10.1016/j.palaeo.2006.10.016; Hirst J. P. P., 1983, THESIS; Husby CE, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr022; Jarzen DM, 2009, GRANA, V48, P136, DOI 10.1080/00173130902797188; Luzon A, 2005, SEDIMENT GEOL, V177, P19, DOI 10.1016/j.sedgeo.2005.01.013; Luzon A, 1998, GEOGACETA, V24, P195; Martin-Closas C, 2004, GEOBIOS-LYON, V37, P65, DOI 10.1016/j.geobios.2003.01.006; MARTINCLOSAS C, 1995, GEOBIOS, V18, P287, DOI DOI 10.1016/S0016-6995(95)80175-8; MEDINA E, 1990, BOT GAZ, V151, P41, DOI 10.1086/337803; NAIMAN R. J., 2001, RIVER ECOLOGY MANAGE, P289, DOI DOI 10.1007/978-1-4612-1652-0_12; Nichols G.J., 2009, SEDIMENTOLOGY STRATI; Nooteboom HP, 2012, FLORA MALESIANA 2, V4, P137; Pardo G., 1989, REV SOC GEOL ESPAN, V2, P199; Sanz de Siria A., 1992, TREB MUS GEOL BARCEL, V2, P269; Sharpe JM, 2010, WETL ECOL MANAG, V18, P57, DOI 10.1007/s11273-009-9148-4; Siti Nurfazilah Abdul Rahman, 2010, [湿地科学, Wetland Science], V8, P48; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; SPICER RA, 1989, ADV BOT RES, V16, P95; Srivastava G., 2014, SPECIAL PUBLICATION, V5, P283; TAYLOR FJ, 1986, BLUMEA, V31, P271; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Ukpong, 1997, MANGROVES SALT MARSH, V1, P211, DOI [10.1023/A:1009952700317, DOI 10.1023/A:1009952700317]; Vicente-Castells JV, 1965, RECERCA FLORA EOCENI, P3; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74	47	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162334	10.1371/journal.pone.0162334	http://dx.doi.org/10.1371/journal.pone.0162334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631099	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900039
J	Ansari, MA; Fatima, Z; Hameed, S				Ansari, Moiz A.; Fatima, Zeeshan; Hameed, Saif			Anticandidal Effect and Mechanisms of Monoterpenoid, Perillyl Alcohol against Candida albicans	PLOS ONE			English	Article							CELL-WALL INTEGRITY; CANCER-CELLS; CALCINEURIN; VIRULENCE; STRESS; TOLERANCE; INSIGHTS; GROWTH; MITOCHONDRIAL; MORPHOGENESIS	This study explored the antifungal potential of perillyl alcohol (PA), a natural monoterpene alcohol, against most prevalent human fungal pathogen C. albicans, its clinical isolates and four non-albicans species of Candida. To resolve the potential mechanisms, we used whole genome transcriptome analyses of PA treated Candida cells to examine the affected cellular circuitry of this pathogen. The transcriptome data revealed a link between calcineurin signaling and PA as among the several categories of PA responsive genes the down regulation of calcineurin signaling gene CNB1 was noteworthy which was also confirmed by both molecular docking and susceptibility assays. We observed that PA treated Candida phenocopied compromised calcineurin pathway stress responses and turned sensitive to alkaline pH, ionic, membrane, salinity, endoplasmic reticulum and serum stresses. Indispensability of functional calcineurin was further confirmed as calcineurin mutant was hypersensitive to PA while constitutively expressed calcineurin strain remained resistant. We explored that PA leads to perturbed membrane integrity as depicted through depleted ergosterol levels and disrupted pH homeostasis. Moreover, PA caused cell wall damage which was evident from hypersensitivity against cell wall perturbing agents (congo red, cal-coflour white), SEM and enhanced rate of cell sedimentation. Furthermore, PA inhibited potential virulence traits including morphological transition, biofilm formation and displayed diminished capacity to adhere both to the polystyrene surface and buccal epithelial cells. The study also revealed that PA leads to cell cycle arrest and mitochondrial dysfunction in C. albicans. Together, the present study provides enough evidence for furtherwork on PA so that better strategies could be employed to treat Candida infections.	[Ansari, Moiz A.; Fatima, Zeeshan; Hameed, Saif] Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, Manesar, India		Fatima, Z; Hameed, S (corresponding author), Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, Manesar, India.	drzeeshanfatima@gmail.com; saifhameed@yahoo.co.in		ANSARI, MOIZ/0000-0002-4817-0119	Science and Engineering Research Board (SERB), New Delhi [SR/FT/LS-12/2012]	Science and Engineering Research Board (SERB), New Delhi	S.H. is thankful for the financial assistance in the form of Young Scientist award (SR/FT/LS-12/2012) from Science and Engineering Research Board (SERB), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2003, INT J RADIAT ONCOL, V57, P813, DOI 10.1016/S0360-3016(03)00737-5; Andaluz E, 2006, MOL MICROBIOL, V59, P1452, DOI 10.1111/j.1365-2958.2005.05038.x; [Anonymous], 2008, M27A3 NAT COMM CLIN; Ansari M.A., 2013, MICROBIAL PATHOGENS, V1, P1189, DOI DOI 10.1155/2014/895193; Ansari MA, 2016, MICROB PATHOGENESIS, V98, P140, DOI 10.1016/j.micpath.2016.07.004; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Bader T, 2006, INFECT IMMUN, V74, P4366, DOI 10.1128/IAI.00142-06; Belanger J T, 1998, Altern Med Rev, V3, P448; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Chen HG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123176; Chen TC, 2014, MOL CANCER THER, V13, P1181, DOI 10.1158/1535-7163.MCT-13-0882; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Ciudad T, 2004, MOL MICROBIOL, V53, P1177, DOI 10.1111/j.1365-2958.2004.04197.x; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; de Castro Patricia Alves, 2014, PLoS One, V9, pe103957, DOI 10.1371/journal.pone.0103957; Desai JV, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0005-2014; Gerontides AS, 1999, GENE DEV, V13, P798; Hameed Saif, 2013, Int J Microbiol, V2013, P240209, DOI 10.1155/2013/240209; Heilmann CJ, 2013, EUKARYOT CELL, V12, P254, DOI 10.1128/EC.00278-12; Islahudin F, 2013, ANTIMICROB AGENTS CH, V57, P3889, DOI 10.1128/AAC.00478-13; KAUR S, 1988, BIOCHIM BIOPHYS ACTA, V972, P277, DOI 10.1016/0167-4889(88)90202-9; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P167, DOI 10.1128/AAC.01385-13; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Manzoor Nikhat, 2002, Indian Journal of Experimental Biology, V40, P785; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Meadows SM, 2002, J GASTROINTEST CANC, V32, P125, DOI 10.1385/IJGC:32:2-3:125; Mielniczki-Pereira AA, 2011, TOXICOL LETT, V207, P104, DOI 10.1016/j.toxlet.2011.08.023; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Noble SM, 2013, CURR OPIN MICROBIOL, V16, P708, DOI 10.1016/j.mib.2013.09.006; Ofir A, 2010, EUKARYOT CELL, V9, P1311, DOI 10.1128/EC.00038-10; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Rizvi SMD, 2013, EXCLI J, V12, P831; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Saibabu V, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/823539; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sarkar S, 2014, CURR MOL MED, V14, P125, DOI 10.2174/1566524013666131118110827; Singh S, 2016, ARCH MICROBIOL, V198, P459, DOI 10.1007/s00203-016-1205-9; Singh Shweta, 2015, Infez Med, V23, P211; Tanwar Jyoti, 2014, Interdiscip Perspect Infect Dis, V2014, P541340, DOI 10.1155/2014/541340; Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13; Tournu H, 2005, CURR DRUG TARGETS, V6, P909, DOI 10.2174/138945005774912690; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Yeruva L, 2010, ANTI-CANCER DRUG, V21, P1, DOI 10.1097/CAD.0b013e32832a68ad; Yu QL, 2014, FEMS YEAST RES, V14, P1037, DOI 10.1111/1567-1364.12194; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008; Zoric N, 2013, CURR DRUG TARGETS, V14, P992, DOI 10.2174/13894501113149990167	54	31	34	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162465	10.1371/journal.pone.0162465	http://dx.doi.org/10.1371/journal.pone.0162465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627759	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600035
J	Iwasaki, K; Takamura, Y; Nishida, T; Sawada, A; Iwao, K; Shinmura, A; Kunimatsu-Sanuki, S; Yamamoto, T; Tanihara, H; Sugiyama, K; Nakazawa, T; Inatani, M				Iwasaki, Kentaro; Takamura, Yoshihiro; Nishida, Takashi; Sawada, Akira; Iwao, Keiichiro; Shinmura, Ayano; Kunimatsu-Sanuki, Shiho; Yamamoto, Tetsuya; Tanihara, Hidenobu; Sugiyama, Kazuhisa; Nakazawa, Toru; Inatani, Masaru			Comparing Trabeculectomy Outcomes between First and Second Operated Eyes: A Multicenter Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; STRIPPING ENDOTHELIAL KERATOPLASTY; PSEUDOPHAKIC EYES; GRAFT-SURVIVAL; AQUEOUS-HUMOR; RISK-FACTORS; MITOMYCIN-C; FAILURE; PHACOEMULSIFICATION; PHACOTRABECULECTOMY	Objective To compare surgical outcomes between the first and second operated eyes in patients who underwent trabeculectomy in both eyes. Methods This retrospective clinical cohort study at five clinical centers in Japan included 84 patients with open-angle glaucoma who underwent primary trabeculectomy in both eyes. The primary outcome was surgical success or failure, with failure being defined according to three criteria: <20% reduction of the preoperative intraocular pressure (IOP), or Criterion A, IOP >21 mmHg; CriterionB, IOP > 18 mmHg; or CriterionC, IOP > 15 mmHg. Cases of reoperation, a loss of light perception vision, or hypotony were also considered as "failures". Results There were no significant differences in success rate for any of the three criteria between the first and second operated eyes. For patients whose first trabeculectomy was successful, when the second trabeculectomy was performed >= 2 months after the first, the survival curves for all three criteria for the second trabeculectomy were significantly worse than those for patients waiting a shorter interval between trabeculectomies (Criterion A, 52.0% vs 83.6%, P = 0.0031; CriterionB, 51.5% vs 80.4%, P = 0.026; CriterionC, 51.1% vs 80.4%, P = 0.048). In multivariable analyses, a longer interval between trabeculectomies was a significant prognostic factor for surgical failure (Criterion A, P = 0.0055; CriterionB, P = 0.0023; CriterionC, P = 0.027). However, no dependency on the interval between trabeculectomies was found among patients whose first trabeculectomy failed. Conclusions If the first trabeculectomy is successful, a long interval before the second trabeculectomy increases the risk of surgical failure in the second eye. This result has clinical implications for developing surgical strategies for patients with bilateral glaucoma.	[Iwasaki, Kentaro; Takamura, Yoshihiro; Inatani, Masaru] Univ Fukui, Dept Ophthalmol, Fac Med Sci, Fukui, Japan; [Nishida, Takashi; Sawada, Akira; Yamamoto, Tetsuya] Gifu Univ, Dept Ophthalmol, Grad Sch Med, Gifu, Japan; [Iwao, Keiichiro; Tanihara, Hidenobu] Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Kumamoto, Japan; [Shinmura, Ayano; Sugiyama, Kazuhisa] Kanazawa Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kunimatsu-Sanuki, Shiho; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan	University of Fukui; Gifu University; Kumamoto University; Kanazawa University; Tohoku University	Inatani, M (corresponding author), Univ Fukui, Dept Ophthalmol, Fac Med Sci, Fukui, Japan.	inatani@u-fukui.ac.jp	Sawada, Akira/ABE-1846-2021; NISHIDA, TAKASHI/ABC-7887-2021	NISHIDA, TAKASHI/0000-0002-8312-6623; Iwao, Keiichiro/0000-0002-4102-9374	JSPS KAKENHI, Japan [15K15630]; Grants-in-Aid for Scientific Research [26293375] Funding Source: KAKEN	JSPS KAKENHI, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15K15630, Japan.	Alvarenga LS, 2004, AM J OPHTHALMOL, V138, P200, DOI 10.1016/j.ajo.2004.02.058; Anshu A, 2012, OPHTHALMOLOGY, V119, P1982, DOI 10.1016/j.ophtha.2012.04.031; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Carreno E, 2011, J OPHTHALMIC INFLAMM, V1, P43, DOI 10.1007/s12348-010-0012-8; DIESTELHORST M, 1991, GRAEF ARCH CLIN EXP, V229, P274, DOI 10.1007/BF00167883; Hitchings R, 1998, ARCH OPHTHALMOL-CHIC, V116, P241; Inoue T, CLIN EXPT OPHTHALMOL, V42, P334; Iverson SM, 2015, BRIT J OPHTHALMOL, V99, P1477, DOI 10.1136/bjophthalmol-2014-306547; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Iwao K, 2009, GRAEF ARCH CLIN EXP, V247, P1095, DOI 10.1007/s00417-009-1051-4; JOSEPH JP, 1989, ARCH OPHTHALMOL-CHIC, V107, P69, DOI 10.1001/archopht.1989.01070010071030; Jung Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136869; Kleinmann G, 2002, OPHTHALMIC SURG LAS, V33, P102; Lochhead J, 2003, BRIT J OPHTHALMOL, V87, P850, DOI 10.1136/bjo.87.7.850; Mietz H, 2002, OPHTHALMOLOGY, V109, P992, DOI 10.1016/S0161-6420(02)01014-X; Ogata-Iwao M, 2013, ACTA OPHTHALMOL, V91, pe500, DOI 10.1111/aos.12133; Ramulu PY, 2007, OPHTHALMOLOGY, V114, P2265, DOI 10.1016/j.ophtha.2007.02.005; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; THOMAS R, 1989, AUST NZ J OPHTHALMOL, V17, P217, DOI 10.1111/j.1442-9071.1989.tb00524.x; Yu JG, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6521567; Zhu XJ, 2015, INVEST OPHTH VIS SCI, V56, P5566, DOI 10.1167/iovs.15-16531	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162569	10.1371/journal.pone.0162569	http://dx.doi.org/10.1371/journal.pone.0162569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622906	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000040
J	Pingel, S; Passon, SG; Pausewang, KS; Blatzheim, AK; Pizarro, C; Tuleta, I; Gliem, M; Issa, PC; Schahab, N; Nickenig, G; Skowasch, D; Schaefer, CA				Pingel, Simon; Passon, Sebastian Gorgonius; Pausewang, Kristin Solveig; Blatzheim, Anna Katharina; Pizarro, Carmen; Tuleta, Izabela; Gliem, Martin; Issa, Peter Charbel; Schahab, Nadjib; Nickenig, Georg; Skowasch, Dirk; Schaefer, Christian Alexander			Pseudoxanthoma Elasticum - Also a Lung Disease? The Respiratory Affection of Patients with Pseudoxanthoma Elasticum	PLOS ONE			English	Article							ECTOPIC MINERALIZATION; CALCIFICATION; DISORDERS	Background Pseudoxanthoma elasticum (PXE) is an autosomal-recessive mineralisation disorder caused by loss of function mutations in the ABCC6 Gen. Histological findings and data of an autopsy of a PXE-patient suggest a possible pulmonal calcification. So far, there exists no clinical data whether PXE patients actually are at high risk of developing pulmonary disorder. Methods In a cross-sectional study, 35 PXE patients and 15 healthy controls underwent a pulmonary function testing, including spirometry, body plethysmography and carbon monoxide diffusing test. Additionally, PXE patients completed a COPD-Assessment-Test (CAT). Results We observed in PXE patients normal values for predicted vital capacity (VC%; 96.0 +/- 13.0%), predicted total lung capacity (TLC%; 98.2 +/- 12.0%) and predicted forced expiration volume (FEV1%; 102.5 +/- 15.6%), whereas compared to healthy controls the PXE group showed significant diminished values for carbon monoxide diffusing capacity (DLCO, 7.2 +/- 1.4 mmol/min/kPa vs. 8.6 +/- 1.5 mmol/min/kPa; p = 0.008) and predicted carbon monoxide diffusing capacity (DLCO%; 79.7 +/- 11.5% vs. 87.2 +/- 6.6%; p = 0.008). 11/35 (31.4%) PXE patients showed pathological DLCO% values under 75% (68.5%+/- 5.4%). Conclusion PXE patients demonstrated a regular lung function testing, but nevertheless they had impaired CO diffusing parameters, which might be associated with a preclinical state of an interstitial lung disease and a risk for restrictive ventilation disorders.	[Pingel, Simon; Passon, Sebastian Gorgonius; Pausewang, Kristin Solveig; Blatzheim, Anna Katharina; Pizarro, Carmen; Tuleta, Izabela; Schahab, Nadjib; Nickenig, Georg; Skowasch, Dirk; Schaefer, Christian Alexander] Univ Bonn, Dept Internal Med 2, Bonn, North Rhine Wes, Germany; [Gliem, Martin; Issa, Peter Charbel] Univ Bonn, Dept Ophthalmol, Bonn, North Rhine Wes, Germany	University of Bonn; University of Bonn	Pingel, S (corresponding author), Univ Bonn, Dept Internal Med 2, Bonn, North Rhine Wes, Germany.	simon.pingel@ukb.uni-bonn.de	Issa, Peter Charbel/O-2580-2019; Issa, Peter Charbel/E-8935-2018	Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673				Bodolay E, 2005, RHEUMATOLOGY, V44, P656, DOI 10.1093/rheumatology/keh575; Campens L, 2013, ARTERIOSCL THROM VAS, V33, P2646, DOI 10.1161/ATVBAHA.113.301901; Finger RP, 2009, RETINA-J RET VIT DIS, V29, P1496, DOI 10.1097/IAE.0b013e3181aade47; Gliem M, 2014, AM J OPHTHALMOL, V158, P198, DOI 10.1016/j.ajo.2014.04.005; JACKSON A, 1980, HISTOPATHOLOGY, V4, P607, DOI 10.1111/j.1365-2559.1980.tb02956.x; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Kornet L, 2004, ULTRASOUND MED BIOL, V30, P1041, DOI 10.1016/j.ultrasmedbio.2004.06.004; Leftheriotis Georges, 2013, Frontiers in Genetics, V4, P4, DOI 10.3389/fgene.2013.00004; Li QL, 2014, MATRIX BIOL, V33, P23, DOI 10.1016/j.matbio.2013.06.003; Marconi B, 2015, INTRACTABLE RARE DIS, V4, P113, DOI 10.5582/irdr.2015.01014; Miki K, 2007, MED MOL MORPHOL, V40, P172, DOI 10.1007/s00795-007-0368-5; Roach E Steve, 2015, Handb Clin Neurol, V132, P215, DOI 10.1016/B978-0-444-62702-5.00015-9; Uitto J, 2014, EXPERT OPIN ORPHAN D, V2, P567, DOI 10.1517/21678707.2014.908702; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360; Yamamoto N, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P716	16	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162337	10.1371/journal.pone.0162337	http://dx.doi.org/10.1371/journal.pone.0162337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622520	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000025
J	Cho, JS; Fang, TC; Reynolds, TL; Sofia, DJ; Hamann, S; Burkly, LC				Cho, John S.; Fang, Terry C.; Reynolds, Taylor L.; Sofia, Daniel J.; Hamann, Stefan; Burkly, Linda C.			PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; INTERFERON; EXPRESSION; THERAPY; SKIN; SCLERODERMA; ACTIVATION; RESPONSES; ASSOCIATION	Systemic sclerosis (SSc) is a chronic autoimmune disorder that can result in extensive tissue damage in the skin and, in advanced cases, internal organs. Vasculopathy, aberrant immune activation, and tissue fibrosis are three hallmarks of the disease that have been identified, with vasculopathy and aberrant immunity being amongst the earliest events. However, a mechanistic link between these processes has not been established. Here, we have identified a novel role of platelet derived growth factor-BB (PDGF-BB)/PDGFR beta activation in combination with dermal injury induced by bleomycin as a driver of early, aberrant expression of interferon stimulatory genes (ISGs) and inflammatory monocyte infiltration. Activation of PDGFR beta in combination with bleomycin-induced dermal injury resulted in increased dermal thickness, vascular density, monocyte/macrophage infiltration, and exacerbation of tissue injury. Many of these features were dependent on IFNAR-signaling, and an increase in the number of interferon-beta (IFN-beta) producing monocytes cells was found in the skin lesions. Taken together, these results identify a novel link between PDGFR beta activation, and Type I IFN-driven vascular maintenance and monocyte/macrophage cell recruitment, and provide a potential explanation linking key features of SSc that were previously thought to be unrelated.	[Cho, John S.; Fang, Terry C.; Burkly, Linda C.] Biogen, Immunol Res, Cambridge, MA 02142 USA; [Reynolds, Taylor L.; Sofia, Daniel J.; Hamann, Stefan] Biogen, Translat Sci Pathol, Cambridge, MA USA	Biogen; Biogen	Cho, JS; Burkly, LC (corresponding author), Biogen, Immunol Res, Cambridge, MA 02142 USA.	johncho@outlook.com; linda.burkly@biogen.com			Biogen	Biogen(Biogen)	This study was funded by Biogen. The funder provided support in the form of salaries for authors [JC, TF, TR, DS, SH, and LB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; [Anonymous], 2011, DIGITAL ISCHEMIC NEC, V2, P6, DOI [10.4292/wjgpt.v2.i1.6, DOI 10.4292/WJGPT.V2.I1.6]; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Barth PG, 1999, ACTA NEUROPATHOL, V98, P212, DOI 10.1007/s004010051071; Beyer C, 2010, ARTHRITIS RHEUM-US, V62, P2831, DOI 10.1002/art.27647; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Distler O, 2004, CIRC RES, V95, P109, DOI 10.1161/01.RES.0000134644.89917.96; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Fang F, 2013, J IMMUNOL, V191, P2956, DOI 10.4049/jimmunol.1300376; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; GAY S, 1989, J INVEST DERMATOL, V92, P301, DOI 10.1111/1523-1747.ep12276895; Gordon JK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0721-3; ISHIKAWA O, 1992, J RHEUMATOL, V19, P1202; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; KLARESKOG L, 1990, ARTHRITIS RHEUM, V33, P1534, DOI 10.1002/art.1780331011; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Maurer B, 2014, ANN RHEUM DIS, V73, P1880, DOI 10.1136/annrheumdis-2013-203535; Maurer B, 2013, ANN RHEUM DIS, V72, P2039, DOI 10.1136/annrheumdis-2013-203729; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Solans R, 2004, CLIN EXP RHEUMATOL, V22, P625; Tahara H, 2007, INTERNAL MED, V46, P473, DOI 10.2169/internalmedicine.46.6328; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; Wu MH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00266; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162758	10.1371/journal.pone.0162758	http://dx.doi.org/10.1371/journal.pone.0162758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618690	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100049
J	Desjardins, D; Liu, YY; Crosson, CE; Ablonczy, Z				Desjardins, Danielle; Liu, Yueying; Crosson, Craig E.; Ablonczy, Zsolt			Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; ENDOTHELIAL GROWTH-FACTOR; INDUCED VASCULAR LEAKAGE; IN-VIVO; 14-YEAR INCIDENCE; OCULAR DISEASE; RETINOPATHY; VEGF; HDAC6; MICROTUBULES	In diabetic individuals, macular edema is a major cause of vision loss. This condition is refractory to insulin therapy and has been attributed to metabolic memory. The retinal pigment epithelium (RPE) is central to maintaining fluid balance in the retina, and this function is compromised by the activation of advanced glycation end-product receptors (RAGE). Here we provide evidence that acute administration of the RAGE agonist, glycated-albumin (gAlb) or vascular endothelial growth factor (VEGF), increased histone deacetylase (HDAC) activity in RPE cells. The administration of the class I/II HDAC inhibitor, trichostatin-A (TSA), suppressed gAlb-induced reductions in RPE transepithelial resistance (in vitro) and fluid transport (in vivo). Systemic TSA also restored normal RPE fluid transport in rats with subchronic hyperglycemia. Both gAlb and VEGF increased HDAC activity and reduced acetyl-a-tubulin levels. Tubastatin-A, a relatively specific antagonist of HDAC6, inhibited gAlb-induced changes in RPE cell resistance. These data are consistent with the idea that RPE dysfunction following exposure to gAlb, VEGF, or hyperglycemia is associated with increased HDAC6 activity and decreased acetyl-a-tubulin. Therefore, we propose inhibiting HDAC6 in the RPE as a potential therapy for preserving normal fluid homeostasis in the hyperglycemic retina.	[Desjardins, Danielle; Liu, Yueying; Crosson, Craig E.; Ablonczy, Zsolt] Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	Medical University of South Carolina	Ablonczy, Z (corresponding author), Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA.	ablonczy@musc.edu			National Institutes of Health [EY019065, EY021368, UL1 TR000062, T32 HL7260-37, F30 EY025465]; Ola B. Williams Foundation; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY021368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ola B. Williams Foundation; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (nih.gov): EY019065 (ZA), EY021368 (CEC), UL1 TR000062 (DD), T32 HL7260-37 (DD), F30 EY025465 (DD); The Ola B. Williams Foundation (http://academicdepartments.musc.edu/foundation, CEC); and an unrestricted grant to the Department of Ophthalmology, Medical University of South Carolina, from Research to Prevent Blindness, New York, NY (http://www.rpbusa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Ablonczy Z, 2014, FASEB J, V28, P2369, DOI 10.1096/fj.13-248021; Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Zapata MA, 2010, BRIT J OPHTHALMOL, V94, P1230, DOI 10.1136/bjo.2009.171702; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Bordin M, 2004, MOL CANCER RES, V2, P692; Boulton M, 1998, BRIT J OPHTHALMOL, V82, P561, DOI 10.1136/bjo.82.5.561; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chan N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120587; Chen E, 2010, CURR MED RES OPIN, V26, P1587, DOI 10.1185/03007995.2010.482503; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Dahrouj M, 2015, EXP EYE RES, V137, P50, DOI 10.1016/j.exer.2015.06.004; Dahrouj M, 2014, INVEST OPHTH VIS SCI, V55, P2269, DOI 10.1167/iovs.13-13334; Dai Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/486386; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Desjardins DM, 2016, INVEST OPHTH VIS SCI, V57, P2706, DOI 10.1167/iovs.15-18397; Edelman JL, 2005, EXP EYE RES, V80, P249, DOI 10.1016/j.exer.2004.09.013; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; FERRIS FL, 1993, JAMA-J AM MED ASSOC, V269, P1290, DOI 10.1001/jama.269.10.1290; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Glotfelty LG, 2014, AM J PHYSIOL-CELL PH, V307, pC245, DOI 10.1152/ajpcell.00336.2013; Gupta N, 2013, OPEN OPHTHALMOL J, V7, P4, DOI 10.2174/1874364101307010004; He SK, 2013, MOL VIS, V19, P665; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kakehashi A, 2008, DIABETES RES CLIN PR, V79, P438, DOI 10.1016/j.diabres.2007.10.018; Khan S, 2015, EXP MOL PATHOL, V98, P230, DOI 10.1016/j.yexmp.2015.01.003; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ma WC, 2007, INVEST OPHTH VIS SCI, V48, P1355, DOI 10.1167/iovs.06-0738; Majumdar G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-709; Marmor MF, 1999, DOC OPHTHALMOL, V97, P239, DOI 10.1023/A:1002192829817; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; NEI N, FACTS DIAB EYE DIS 2; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Prevention CfdCa, 2014, NAT DIAB STAT REP ES; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; Romero-Aroca P, 2011, WORLD J DIABETES, V2, P98, DOI 10.4239/wjd.v2.i6.98; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Stewart MW, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0510-4; Sugimoto M, 2013, AM J PATHOL, V183, P987, DOI 10.1016/j.ajpath.2013.05.017; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Wells JA, 1996, BRIT J OPHTHALMOL, V80, P363, DOI 10.1136/bjo.80.4.363; Xie MY, 2014, MOL VIS, V20, P1411; Yokoi M, 2005, BRIT J OPHTHALMOL, V89, P673, DOI 10.1136/bjo.2004.055053; Zhong Q, 2010, J CELL BIOCHEM, V110, P1306, DOI 10.1002/jcb.22644	60	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162596	10.1371/journal.pone.0162596	http://dx.doi.org/10.1371/journal.pone.0162596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617745	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100031
J	Liberman, MC; Epstein, MJ; Cleveland, SS; Wang, HB; Maison, SF				Liberman, M. Charles; Epstein, Michael J.; Cleveland, Sandra S.; Wang, Haobing; Maison, Stephane F.			Toward a Differential Diagnosis of Hidden Hearing Loss in Humans	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; COCHLEAR NERVE DEGENERATION; HAIR CELL LOSS; NOISE EXPOSURE; NEUROPATHY; TINNITUS; FIBERS; AGE; SYNAPTOPATHY; INJURY	Recent work suggests that hair cells are not the most vulnerable elements in the inner ear; rather, it is the synapses between hair cells and cochlear nerve terminals that degenerate first in the aging or noise-exposed ear. This primary neural degeneration does not affect hearing thresholds, but likely contributes to problems understanding speech in difficult listening environments, and may be important in the generation of tinnitus and/or hyperacusis. To look for signs of cochlear synaptopathy in humans, we recruited college students and divided them into low-risk and high-risk groups based on self-report of noise exposure and use of hearing protection. Cochlear function was assessed by otoacoustic emissions and click-evoked electrocochleography; hearing was assessed by behavioral audiometry and word recognition with or without noise or time compression and reverberation. Both groups had normal thresholds at standard audiometric frequencies, however, the high-risk group showed significant threshold elevation at high frequencies (10-16 kHz), consistent with early stages of noise damage. Electrocochleography showed a significant difference in the ratio between the waveform peaks generated by hair cells (Summating Potential; SP) vs. cochlear neurons (Action Potential; AP), i.e. the SP/AP ratio, consistent with selective neural loss. The high-risk group also showed significantly poorer performance on word recognition in noise or with time compression and reverberation, and reported heightened reactions to sound consistent with hyperacusis. These results suggest that the SP/AP ratio may be useful in the diagnosis of "hidden hearing loss" and that, as suggested by animal models, the noise-induced loss of cochlear nerve synapses leads to deficits in hearing abilities in difficult listening situations, despite the presence of normal thresholds at standard audiometric frequencies.	[Liberman, M. Charles; Maison, Stephane F.] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA; [Liberman, M. Charles; Wang, Haobing; Maison, Stephane F.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Liberman, M. Charles; Maison, Stephane F.] Harvard Program Speech & Hearing Biosci & Technol, Boston, MA 02115 USA; [Epstein, Michael J.; Cleveland, Sandra S.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Commun Sci & Disorders, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Northeastern University	Maison, SF (corresponding author), Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA.; Maison, SF (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.; Maison, SF (corresponding author), Harvard Program Speech & Hearing Biosci & Technol, Boston, MA 02115 USA.	stephane_maison@meei.harvard.edu		Maison, Stephane/0000-0003-2813-6439; Epstein, Michael/0000-0002-8290-4403	NIDCD [R01 DC00188, P30 DC 05209]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000188] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIDCD R01 DC00188 and NIDCD P30 DC 05209 (https://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas JP, 2014, NOISE HEALTH, V16, P306, DOI 10.4103/1463-1741.140511; Badri R, 2011, J ACOUST SOC AM, V129, P852, DOI 10.1121/1.3523476; Bohne BA, 2000, AM J OTOL, V21, P505; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Chambers AR, 2016, NEURON, V89, P867, DOI 10.1016/j.neuron.2015.12.041; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Ferraro JA, 1997, AUDIOL NEURO-OTOL, V2, P241, DOI 10.1159/000259251; Ferraro JA, 2006, J AM ACAD AUDIOL, V17, P45, DOI 10.3766/jaaa.17.1.6; Fried M P, 1976, Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol, V82, P285; Fujioka M, 2015, TRENDS NEUROSCI, V38, P139, DOI 10.1016/j.tins.2014.12.004; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; JOHNSSON LG, 1974, ANN OTO RHINOL LARYN, V83, P294, DOI 10.1177/000348947408300303; JOHNSSON LG, 1976, ANN OTO RHINOL LARYN, V85, P725, DOI 10.1177/000348947608500603; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; KIANG N. Y., 1960, ANN OTOL RHINOL AND LARYNGOL, V69, P448; Kim JS, 2005, OTOLARYNG HEAD NECK, V133, P619, DOI 10.1016/j.otohns.2005.06.012; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liberman LD, 2015, JARO-J ASSOC RES OTO, V16, P205, DOI 10.1007/s10162-015-0510-3; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lobarinas E, 2013, HEARING RES, V302, P113, DOI 10.1016/j.heares.2013.03.012; Lopez-Poveda EA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00124; MICHALEWSKI HJ, 1980, ELECTROEN CLIN NEURO, V48, P351, DOI 10.1016/0013-4694(80)90271-0; NADOL JB, 1987, ANN OTO RHINOL LARYN, V96, P449, DOI 10.1177/000348948709600420; NIKIFORIDIS GC, 1993, EAR HEARING, V14, P423, DOI 10.1097/00003446-199312000-00008; Noffsinger D, 1994, J Am Acad Audiol, V5, P231; Oates P, 1997, J ACOUST SOC AM, V102, P3597, DOI 10.1121/1.420148; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Santarelli R, 2009, JARO-J ASSOC RES OTO, V10, P545, DOI 10.1007/s10162-009-0181-z; Schaette R, 2014, HEARING RES, V311, P63, DOI 10.1016/j.heares.2013.12.004; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; SCHMIEDT RA, 1984, J ACOUST SOC AM, V76, P1293, DOI 10.1121/1.391446; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Slater J, 2015, BEHAV BRAIN RES, V291, P244, DOI 10.1016/j.bbr.2015.05.026; Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Suzuki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24907; Valero MD, 2016, HEARING RES, V332, P29, DOI 10.1016/j.heares.2015.11.005; Vermiglio AJ, 2012, J AM ACAD AUDIOL, V23, P779, DOI 10.3766/jaaa.23.10.4; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wilson R H, 1994, J Am Acad Audiol, V5, P269; WOELLNER R C, 1955, Trans Am Acad Ophthalmol Otolaryngol, V59, P147; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7	56	325	351	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162726	10.1371/journal.pone.0162726	http://dx.doi.org/10.1371/journal.pone.0162726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618300	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100045
J	Zhuo, CJ; Ma, XL; Qu, HR; Wang, LN; Jia, F; Wang, CL				Zhuo, Chuanjun; Ma, Xiaolei; Qu, Hongru; Wang, Lina; Jia, Feng; Wang, Chunli			Schizophrenia Patients Demonstrate Both Inter-Voxel Level and Intra-Voxel Level White Matter Alterations	PLOS ONE			English	Article							DIFFUSION-TENSOR; HUMAN BRAIN; DEPENDENCE; INTEGRITY	Fractional anisotropy (FA) and mean diffusivity (MD) are the most frequently used metrics to investigate white matter impairments in mental disorders. However, these two metrics are derived from intra-voxel analyses and only reflect the diffusion properties solely within the voxel unit. Local diffusion homogeneity (LDH) is a newly developed inter-voxel metric which quantifies the local coherence of water molecule diffusion in a model-free manner. In this study, 94 schizophrenia patients and 91 sex-and age-matched healthy controls underwent diffusion tensor imaging (DTI) examinations. White matter integrity was assessed by FA, MD and LDH. Group differences in these metrics were compared using tract-based spatial statistics (TBSS). Compared with healthy controls, schizophrenia patients exhibited reduced FA and increased MD in the corpus callosum, cingulum, internal capsule, fornix and widespread superficial white matter in the frontal, parietal, occipital and temporal lobes. We also found decreased LDH in the corpus callosum, cingulum, internal capsule and fornix in schizophrenia. Our findings suggest that both intra-voxel and inter-voxel diffusion metrics are able to detect impairments in the anisotropic white matter regions, and intra-voxel diffusion metrics could detect additional impairments in the widespread isotropic white matter regions in schizophrenia.	[Zhuo, Chuanjun; Wang, Lina; Jia, Feng; Wang, Chunli] Tianjin Anding Hosp, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China; [Zhuo, Chuanjun] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin 300052, Peoples R China; [Zhuo, Chuanjun] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin 300052, Peoples R China; [Zhuo, Chuanjun; Ma, Xiaolei; Qu, Hongru] Tianjin Anning Hosp, Tianjin 300300, Peoples R China; [Zhuo, Chuanjun] Wenzhou Seventh peoples Hosp, Wenzhou 325000, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, CL (corresponding author), Tianjin Anding Hosp, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China.	iamdoforyou@163.com			National Basic Research Program of China (973 program) [2011CB707801]; Natural Science Foundation of China [81501451, 91332113, 81271551]; Tianjin Key Technology RD Program [14ZCZDSY00018]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Key Technology RD Program	This study was supported by grants from the National Basic Research Program of China (973 program, 2011CB707801), Natural Science Foundation of China (81501451, 91332113 and 81271551) and Tianjin Key Technology R&D Program (14ZCZDSY00018).	Abdul-Rahman MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018652; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bihel E, 2011, STROKE, V42, P1412, DOI 10.1161/STROKEAHA.110.596650; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Gong GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066366; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kunimatsu N, 2012, PSYCHIAT RES-NEUROIM, V201, P136, DOI 10.1016/j.pscychresns.2011.07.010; Kyriakopoulos M, 2008, EUR PSYCHIAT, V23, P255, DOI 10.1016/j.eurpsy.2007.12.004; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Nazeri A, 2013, NEUROPSYCHOPHARMACOL, V38, P1954, DOI 10.1038/npp.2013.93; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Rosenberger G, 2012, BRAIN IMAGING BEHAV, V6, P417, DOI 10.1007/s11682-012-9152-9; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280	21	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162656	10.1371/journal.pone.0162656	http://dx.doi.org/10.1371/journal.pone.0162656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618693	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100039
J	Gaudry, M; Bartoli, JM; Bal, L; Giorgi, R; De Masi, M; Magnan, PE; Piquet, P				Gaudry, Marine; Bartoli, Jean-Michel; Bal, Laurence; Giorgi, Roch; De Masi, Mariangela; Magnan, Pierre-Edouard; Piquet, Philippe			Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis	PLOS ONE			English	Article							SHEAR-STRESS; ANGIOPLASTY; EXPERIENCE; DISEASE; SURGERY; IMPLANTATION; DURABILITY; PATHOLOGY; OUTCOMES	Background Carotid arterystenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy(CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and anatomical predictive factors for in-stent restenosis. Methods We performed a retrospective monocentric study. We included all patients who underwent CAS for post-CEA restenosis at our institution from July 1997 to November 2013. The primary endpoints were the technical success, the presence of in-stent restenosis > 50% or occlusion, either symptomatic or asymptomatic, during the follow-up period, and risk factors for restenosis. The secondary endpoints were early and late morbidity and mortality (TIA, stroke, myocardial infarction, or death). Results A total of 153 CAS procedures were performed for post-CEA restenosis, primarily because of asymptomatic lesions (137/153). The technical success rate was 98%. The 30-day perioperative stroke and death rate was 2.6% (two TIAs and two minor strokes), and rates of 2.2% (3/137) and 6.2% (1/16) were recorded for asymptomatic and symptomatic patients, respectively. The average follow-up time was 36 months (range, 6-171 months). In-stent restenosis or occlusion was observed in 16 patients (10.6%). Symptomatic restenosis was observed in only one patient. We found that young age (P = 0.002), stenosis > 85% (P = 0.018), and a lack of stent coverage of the common carotid artery(P = 0.006) were independent predictors of in-stent restenosis. Conclusion We identified new risk factors for in-stent restenosis that were specific to this population, and we propose a technical approach that may reduce this risk.	[Gaudry, Marine; Bal, Laurence; De Masi, Mariangela; Magnan, Pierre-Edouard; Piquet, Philippe] Hop La Timone, APHM, Dept Vasc Surg, F-13005 Marseille, France; [Bartoli, Jean-Michel] Hop La Timone, APHM, Dept Radiol, F-13005 Marseille, France; [Giorgi, Roch] Aix Marseille Univ, SESSTIM, INSERM, IRD, Marseille, France; [Giorgi, Roch] Hop La Timone, APHM, Serv Biostat & Technol Informat & Commun, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gaudry, M (corresponding author), Hop La Timone, APHM, Dept Vasc Surg, F-13005 Marseille, France.	marine.gaudry@ap-hm.fr	GIORGI, Roch/A-6438-2009; gaudry, marine/AAF-3790-2019	GIORGI, Roch/0000-0001-6135-3078; gaudry, marine/0000-0001-9717-475X; De Masi, Mariangela/0000-0003-4779-8112				AbuRahma AF, 2002, J ENDOVASC THER, V9, P566, DOI 10.1583/1545-1550(2002)009<0566:EPCRRS>2.0.CO;2; AbuRahma AF, 2001, J VASC SURG, V34, P831, DOI 10.1067/mva.2001.118591; AbuRahma AF, 2008, J VASC SURG, V48, P589, DOI 10.1016/j.jvs.2008.04.004; AbuRahma AF, 2010, J VASC SURG, V52, P1180, DOI 10.1016/j.jvs.2010.06.074; AbuRahma AF, 2009, J VASC SURG, V50, P1031, DOI 10.1016/j.jvs.2009.06.051; Arquizan C, 2011, STROKE, V42, P1015, DOI 10.1161/STROKEAHA.110.589309; Attigah N, 2010, ANN VASC SURG, V24, P190, DOI 10.1016/j.avsg.2009.07.002; Bekelis K, 2013, BRIT J SURG, V100, P440, DOI 10.1002/bjs.9027; Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis, 1991, THE NEW ENGLAND JOUR, V325, P445, DOI 10.1056/NEJM199108153250701; Cho JS, 2004, J VASC SURG, V39, P155, DOI 10.1016/j.jvs.2003.07.003; de Borst GJ, 2007, J VASC SURG, V45, P118, DOI 10.1016/j.jvs.2006.09.013; de Borst GJ, 2008, J VASC SURG, V47, P363, DOI 10.1016/j.jvs.2007.10.002; Dorigo W, 2013, EUR J VASC ENDOVASC, V45, P437, DOI 10.1016/j.ejvs.2013.01.029; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Fokkema M, 2015, ANN SURG, V261, P598, DOI 10.1097/SLA.0000000000000799; Giannoglou GD, 2010, EUROINTERVENTION, V6, pJ16, DOI 10.4244/EIJV6SUPJA4; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Khan MA, 2003, AM J CARDIOL, V92, P895, DOI 10.1016/S0002-9149(03)00912-3; Koskinas KC, 2012, J AM COLL CARDIOL, V59, P1337, DOI 10.1016/j.jacc.2011.10.903; LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; Lattimer CR, 1997, BRIT J SURG, V84, P1206; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Midy D, 2011, EUR J VASC ENDOVASC, V42, P742, DOI 10.1016/j.ejvs.2011.08.008; Mousa AY, 2015, J ENDOVASC THER, V22, P449, DOI 10.1177/1526602815581597; O'Hara PJ, 2001, J VASC SURG, V34, P5, DOI 10.1067/mva.2001.115601; RENSING BJ, 1993, CIRCULATION, V88, P975, DOI 10.1161/01.CIR.88.3.975; Setacci C, 2003, J ENDOVASC THER, V10, P1031, DOI 10.1583/1545-1550(2003)010<1031:DOIRAC>2.0.CO;2; Shankar JJS, 2012, NEURORADIOLOGY, V54, P1347, DOI 10.1007/s00234-012-1031-y; Simonetti G, 2009, RADIOL MED, V114, P95, DOI 10.1007/s11547-008-0326-x; Simonetti G, 2009, EUR RADIOL, V19, P982, DOI 10.1007/s00330-008-1207-3; Toma N, 2003, J NEUROSURG, V98, P199, DOI 10.3171/jns.2003.98.1.0199; Touze E, 2009, STROKE, V40, pE683, DOI 10.1161/STROKEAHA.109.562041; Valentine RJ, 1999, J VASC SURG, V30, P436, DOI 10.1016/S0741-5214(99)70070-4; Van Laanen J, 2008, J CARDIOVASC SURG, V49, P743; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Wasser K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022683; Willfort-Ehringer A, 2003, J ENDOVASC THER, V10, P636, DOI 10.1583/1545-1550(2003)010<0636:HOCSAP>2.0.CO;2; Zhou W, 2006, J VASC SURG, V43, P305, DOI [10.1016/j.jvs.2005.10.040, DOI 10.1016/J.JVS.2005.10.040]	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161716	10.1371/journal.pone.0161716	http://dx.doi.org/10.1371/journal.pone.0161716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611997	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900026
J	Luu, HM; Klink, C; Niessen, W; Moelker, A; van Walsum, T				Ha Manh Luu; Klink, Camiel; Niessen, Wiro; Moelker, Adriaan; van Walsum, Theo			Non-Rigid Registration of Liver CT Images for CT-Guided Ablation of Liver Tumors	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION	CT-guided percutaneous ablation for liver cancer treatment is a relevant technique for patients not eligible for surgery and with tumors that are inconspicuous on US imaging. The lack of real-time imaging and the use of a limited amount of CT contrast agent make targeting the tumor with the needle challenging. In this study, we evaluate a registration framework that allows the integration of diagnostic pre-operative contrast enhanced CT images and intra-operative non-contrast enhanced CT images to improve image guidance in the intervention. The liver and tumor are segmented in the pre-operative contrast enhanced CT images. Next, the contrast enhanced image is registered to the intra-operative CT images in a two-stage approach. First, the contrast-enhanced diagnostic image is non-rigidly registered to a non-contrast enhanced image that is conventionally acquired at the start of the intervention. In case the initial registration is not sufficiently accurate, a refinement step is applied using non-rigid registration method with a local rigidity term. In the second stage, the intra-operative CT-images that are used to check the needle position, which often consist of only a few slices, are registered rigidly to the intra-operative image that was acquired at the start of the intervention. Subsequently, the diagnostic image is registered to the current intra-operative image, using both transformations, this allows the visualization of the tumor region extracted from pre-operative data in the intra-operative CT images containing needle. The method is evaluated on imaging data of 19 patients at the Erasmus MC. Quantitative evaluation is performed using the Dice metric, mean surface distance of the liver border and corresponding landmarks in the diagnostic and the intra-operative images. The registration of the diagnostic CT image to the initial intra-operative CT image did not require a refinement step in 13 cases. For those cases, the resulting registration had a Dice coefficient for the livers of 91.4%, a mean surface distance of 4.4 mm and a mean distance between corresponding landmarks of 4.7 mm. For the three cases with a refinement step, the registration result significantly improved (p < 0.05) compared to the result of the initial non rigid registration method (DICE of 90.3% vs 71.3% and mean surface distance of 5.1 mm vs 11.3 mm and mean distance between corresponding landmark of 6.4 mm vs 10.2 mm). The registration of the preoperative data with the needle image in 16 cases yielded a DICE of 90.1% and a mean surface distance of 5.2 mm. The remaining three cases with DICE smaller than 80% were classified as unsuccessful registration. The results show that this is promising tool for liver image registration in interventional radiology.	[Ha Manh Luu; Niessen, Wiro; van Walsum, Theo] Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Dr Molewaterpl 50-60, Rotterdam, Netherlands; [Ha Manh Luu; Niessen, Wiro; van Walsum, Theo] Erasmus MC, Dept Med Informat, Dr Molewaterpl 50-60, Rotterdam, Netherlands; [Klink, Camiel; Moelker, Adriaan] Erasmus MC, Dept Radiol, Dr Molewaterpl 50-60, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luu, HM (corresponding author), Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Dr Molewaterpl 50-60, Rotterdam, Netherlands.; Luu, HM (corresponding author), Erasmus MC, Dept Med Informat, Dr Molewaterpl 50-60, Rotterdam, Netherlands.	l.manhha@erasmusmc.nl		Niessen, Wiro/0000-0002-5822-1995; van Walsum, Theo/0000-0001-8257-7759	ITEA project, Benefit [13031]	ITEA project, Benefit	The work was supported by ITEA project 13031, Benefit (https://itea3.org/project/benefit.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Stefan Klein for his kind introduction in Elastix software required for this study. This work was supported by ITEA project 13031, Benefit.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Archip N, 2007, LECT NOTES COMPUT SC, V4792, P969; Elhawary H, 2010, ACAD RADIOL, V17, P1334, DOI 10.1016/j.acra.2010.06.004; Garrean S, 2008, AM J SURG, V195, P508, DOI 10.1016/j.amjsurg.2007.06.024; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Kim KW, 2011, AM J ROENTGENOL, V196, pW565, DOI 10.2214/AJR.10.5122; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lange T, 2009, EXPT COMP LANDMARK B; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Luu HM, 2015, MED PHYS, V42, P5559, DOI 10.1118/1.4927790; Maes F, 2003, P IEEE, V91, P1699, DOI 10.1109/JPROC.2003.817864; Pereira PL, 2007, EUR RADIOL, V17, P2062, DOI 10.1007/s00330-007-0587-0; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Rieder C, 2012, AUTOMATIC ALIGNMENT, V8316; Rieder C, 2010, COMPUT GRAPH FORUM, V29, P1093, DOI 10.1111/j.1467-8659.2009.01665.x; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Staring M, 2007, MED PHYS, V34, P4098, DOI 10.1118/1.2776236; Weihusen A, 2007, PROC SPIE, V6509, DOI 10.1117/12.709503; Xie YQ, 2011, MED PHYS, V38, P5351, DOI 10.1118/1.3633902	20	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161600	10.1371/journal.pone.0161600	http://dx.doi.org/10.1371/journal.pone.0161600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611780	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900023
J	Honda, H; Fujimoto, M; Miyamoto, S; Ishikawa, N; Serada, S; Hattori, N; Nomura, S; Kohno, N; Yokoyama, A; Naka, T				Honda, Hiromi; Fujimoto, Minoru; Miyamoto, Shintaro; Ishikawa, Nobuhisa; Serada, Satoshi; Hattori, Noboru; Nomura, Shintaro; Kohno, Nobuoki; Yokoyama, Akihito; Naka, Tetsuji			Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma	PLOS ONE			English	Article							EPITHELIAL-CELLS; HUMAN-SERUM; PERIOSTIN; ALPHA-2-GLYCOPROTEIN; DIFFERENTIATION; EXPRESSION; BIOMARKER; ALPHA(2)-GLYCOPROTEIN; ROLES; IL-13	Background Asthma is a chronic inflammatory disease of airways, but an ideal biomarker that accurately reflects ongoing airway inflammation has not yet been established. The aim of this study was to examine the potential of sputum leucine-rich alpha-2 glycoprotein (LRG) as a new biomarker for airway inflammation in asthma. Methods We obtained induced sputum samples from patients with asthma (N = 64) and healthy volunteers (N = 22) and measured LRG concentration by sandwich enzyme-linked immunosorbent assay (ELISA). Ovalbumin (OVA)-induced asthma model mice were used to investigate the mechanism of LRG production during airway inflammation. The LRG concentrations in the bronchoalveolar lavage fluid (BALF) obtained from mice were determined by ELISA and mouse lung sections were stained with anti-LRG antibody and periodic acid-Schiff (PAS) reagent. Results Sputum LRG concentrations were significantly higher in patients with asthma than in healthy volunteers (p = 0.00686). Consistent with patients' data, BALF LRG levels in asthma model mice were significantly higher than in control mice (p = 0.00013). Immunohistochemistry of lung sections from asthma model mice revealed that LRG was intensely expressed in a subpopulation of bronchial epithelial cells, which corresponded with PAS-positive mucus producing cells. Conclusion These findings suggest that sputum LRG is a promising biomarker of local inflammation in asthma.	[Honda, Hiromi; Fujimoto, Minoru; Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Ibaraki, Osaka, Japan; [Miyamoto, Shintaro; Yokoyama, Akihito] Kochi Univ, Dept Haematol & Resp Med, Nankoku, Kochi, Japan; [Ishikawa, Nobuhisa] Hiroshima Prefectural Hosp, Dept Resp Med, Minami Ku, Hiroshima, Japan; [Hattori, Noboru; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Minami Ku, Hiroshima, Japan; [Nomura, Shintaro] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Shiga, Japan; [Naka, Tetsuji] Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol ICAM Tech, Div Translat Res, Nankoku, Kochi, Japan	Kochi University; Hiroshima University; Kochi University	Fujimoto, M; Naka, T (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Ibaraki, Osaka, Japan.; Naka, T (corresponding author), Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol ICAM Tech, Div Translat Res, Nankoku, Kochi, Japan.	mfujimoto@nibiohn.go.jp; tnaka@nibiohn.go.jp	Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037; Serada, Satoshi/0000-0001-6948-9009; Naka, Tetsuji/0000-0002-1269-3997; FUJIMOTO, MINORU/0000-0002-6390-8863	Japanese Ministry of Education, Culture, Sports, Science and Technology [22591101]; Ministry of Health, Labour and Welfare of Japan [H24-bio-ippan-002]; Japan Agency for Medical Research and Development [15ek0109045h0002]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by the Grant-in-Aid for Scientific Research (C) (22591101) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Grant-in-Aid for Scientist from the Ministry of Health, Labour and Welfare of Japan (H24-bio-ippan-002) and the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (15ek0109045h0002).	Atsuta J, 1999, AM J RESP CELL MOL, V20, P643, DOI 10.1165/ajrcmb.20.4.3265; Bobolea I, 2015, ALLERGY, V70, P540, DOI 10.1111/all.12580; Boero S, 2010, J ASTHMA, V47, P381, DOI 10.3109/02770901003759410; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fujimoto M, 2015, ARTHRITIS RHEUMATOL, V67, P2056, DOI 10.1002/art.39164; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Ishikawa N, 2011, RESPIRATION, V82, P10, DOI 10.1159/000324539; Kanehara M, 2008, PULM PHARMACOL THER, V21, P874, DOI 10.1016/j.pupt.2008.09.003; Kanoh S, 2011, CLIN EXP ALLERGY, V41, P1747, DOI 10.1111/j.1365-2222.2011.03852.x; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Li W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0218-2; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Paggiaro PL, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00000302; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Simpson JL, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0230-4; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Takemoto N, 2015, ONCOTARGET, V6, P11009, DOI 10.18632/oncotarget.3557; Wadsworth SJ, 2011, J ASTHMA ALLERGY, V4, P77, DOI 10.2147/JAA.S15081; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; ZUHDI AM, 2000, AM J RESP CELL MOL B, V22, P253	30	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162672	10.1371/journal.pone.0162672	http://dx.doi.org/10.1371/journal.pone.0162672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611322	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900149
J	Lee, H; Kim, Y; Jeong, JH; Ryu, JH; Kim, WY				Lee, Hani; Kim, Yonghwan; Jeong, Ji Hye; Ryu, Jae-Ha; Kim, Woo-Young			ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; BRONCHIAL EPITHELIAL-CELLS; REPLICATION STRESS; IN-VIVO; S-PHASE; CARCINOGENESIS; P53; ACTIVATION; GENOTOXICITY; PREVENTION	Among the many stilbenoids found in a variety of berries, resveratrol and pterostilbene are of particular interest given their potential for use in cancer therapeutics and prevention. We purified four stilbenoids from R. undulatum and found that pterostilbene inhibits cancer cell proliferation more efficiently than rhapontigenin, piceatannol and resveratrol. To investigate the underlying mechanism of this superior action of pterostilbene on cancer cells, we utilized a reverse-phase protein array followed by bioinformatic analysis and found that the ATM/CHK pathway is modified by pterostilbene in a lung cancer cell line. Given that ATM/CHK signaling requires p53 for its biological effects, we hypothesized that p53 is required for the anticancer effect of pterostilbene. To test this hypothesis, we used two molecularly defined precancerous human bronchial epithelial cell lines, HBECR and HBECR/p53i, with normal p53 and suppressed p53 expression, respectively, to represent premalignant states of squamous lung carcinogenesis. Pterostilbene inhibited the cell cycle more efficiently in HBECR cells compared to HBECR/p53i cells, suggesting that the presence of p53 is required for the action of pterostilbene. Pterostilbene also activated ATM and CHK1/2, which are upstream of p53, in both cell lines, though pterostilbene-induced senescence was dependent on the presence of p53. Finally, pterostilbene more effectively inhibited p53-dependent cell proliferation compared to the other three stilbenoids. These results strongly support the potential chemopreventive effect of pterostilbene on p53-positive cells during early carcinogenesis.	[Lee, Hani; Jeong, Ji Hye; Ryu, Jae-Ha; Kim, Woo-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea; [Kim, Yonghwan] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea	Sookmyung Women's University; Sookmyung Women's University	Kim, WY (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea.; Kim, Y (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea.	yhkim@sookmyung.ac.kr; wykim@sookmyung.ac.kr			National Research Foundation (NRF) of Korea grant - Korea government, Bio & Medical Technology Development Program, Basic Science Research Program [NRF-2012M3A9B6055466, NRF-2015R1D1A1A01056594]; MSIP [2011-0030074]	National Research Foundation (NRF) of Korea grant - Korea government, Bio & Medical Technology Development Program, Basic Science Research Program; MSIP	This work was supported by National Research Foundation (NRF) of Korea grant funded by the Korea government, Bio & Medical Technology Development Program, Basic Science Research Program and MSIP (NRF-2012M3A9B6055466, NRF-2015R1D1A1A01056594 and 2011-0030074, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2013, NUTR CANCER, V65, P1, DOI 10.1080/01635581.2013.785012; Athar M, 2011, CURR PHARM DESIGN, V17, P631, DOI 10.2174/138161211795222595; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong GZ, 2015, PHYTOTHER RES, V29, P1605, DOI 10.1002/ptr.5442; Dubinett SM, 2013, J CLIN ONCOL, V31, P4169, DOI 10.1200/JCO.2013.51.2400; Duthie SJ, 2007, MOL NUTR FOOD RES, V51, P665, DOI 10.1002/mnfr.200600257; Dutta C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006944; Erol A, 2011, CELL CYCLE, V10, P3239, DOI 10.4161/cc.10.19.17460; Estrela JM, 2013, CRIT REV CL LAB SCI, V50, P65, DOI 10.3109/10408363.2013.805182; Ferguson LR, 2015, SEMIN CANCER BIOL, V35, pS5, DOI 10.1016/j.semcancer.2015.03.005; Fox JT, 2012, P NATL ACAD SCI USA, V109, P5423, DOI 10.1073/pnas.1114278109; Garcia-Escudero V, 2010, MOL THER, V18, P394, DOI 10.1038/mt.2009.268; Glade MJ, 1997, NUTRITION, V13, P595, DOI 10.1016/S0899-9007(97)00127-5; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Hecht SS, 2009, NAT REV CANCER, V9, P476, DOI 10.1038/nrc2674; Heggie SJ, 2003, J NUTR, V133, p3837S, DOI 10.1093/jn/133.11.3837S; Hong WK, 2005, LUNG CANCER-J IASLC, V49, pS50, DOI 10.1016/S0169-5002(05)80093-5; Hong WK, 2003, GYNECOL ONCOL, V88, pS56, DOI 10.1006/gyno.2002.6685; Hsiao PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105342; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kelloff GJ, 2000, CANCER EPIDEM BIOMAR, V9, P127; Khuri FR, 2002, CANCER EPIDEM BIOMAR, V11, p1244S; Kim WY, 2009, CANCER RES, V69, P7439, DOI 10.1158/0008-5472.CAN-08-3792; Leone S, 2012, INT J CANCER, V131, pE173, DOI 10.1002/ijc.27358; Leone S, 2010, CANCER LETT, V295, P167, DOI 10.1016/j.canlet.2010.02.022; Leung HY, 2009, BRIT J NUTR, V102, P1462, DOI 10.1017/S0007114509990481; Lin VCH, 2012, J AGR FOOD CHEM, V60, P6399, DOI 10.1021/jf301499e; LIPPMAN SM, 1993, CHEST, V103, pS15, DOI 10.1378/chest.103.1_Supplement.15S; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030; McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mitrut P, 2009, ROM J MORPHOL EMBRYO, V50, P429; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Nambiar D, 2011, MUTAT RES-REV MUTAT, V728, P139, DOI 10.1016/j.mrrev.2011.07.005; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Riviere C, 2012, NAT PROD REP, V29, P1317, DOI 10.1039/c2np20049j; Robles AI, 2002, ONCOGENE, V21, P6898, DOI 10.1038/sj.onc.1205563; Rodin SN, 2005, SEMIN CANCER BIOL, V15, P103, DOI 10.1016/j.semcancer.2004.08.005; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soria JC, 2003, LANCET ONCOL, V4, P659, DOI 10.1016/S1470-2045(03)01244-0; Stopper H, 2005, MUTAT RES-FUND MOL M, V574, P139, DOI 10.1016/j.mrfmmm.2005.01.029; Tsao AS, 2004, CA-CANCER J CLIN, V54, P150, DOI 10.3322/canjclin.54.3.150; van Zandwijk N, 2005, EUR J CANCER, V41, P1990, DOI 10.1016/j.ejca.2005.05.011; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	28	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162335	10.1371/journal.pone.0162335	http://dx.doi.org/10.1371/journal.pone.0162335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612029	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900078
J	Mehta, S; Das, M; Laxmeshwar, C; Jonckheere, S; Thi, SS; Isaakidis, P				Mehta, Salil; Das, Mrinalini; Laxmeshwar, Chinmay; Jonckheere, Sylvie; Thi, Sein Sein; Isaakidis, Petros			Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India	PLOS ONE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; MULTIDRUG-RESISTANT; XDR-TB; EFFICACY; SAFETY; TOLERABILITY; METAANALYSIS; REGIMENS	Background Patients on linezolid-containing drug-resistant TB (DR-TB) regimen often develop adverse-events, particularly peripheral and optic neuropathy. Programmatic data and experiences of linezolid-associated optic neuropathy from high DR-TB burden settings are lacking. The study aimed to determine the frequency of and risk-factors associated with linezolid-associated optic neuropathy and document the experiences related to treatment/care of DR-TB patients on linezolid-containing regimens. Methods This was a retrospective cohort study using routine clinical and laboratory data in Medecins Sans Frontieres (MSF) HIV/DR-TB clinic in collaboration with Lilavati Hospital & Research Center, Mumbai, India. All DR-TB patients on linezolid-containing treatment regimens were included in the study and underwent routine evaluations for systemic and/or ocular complaints. Ophthalmological evaluation by a consultant ophthalmologist included visual-acuity screening, slit-lamp examination and dilated fundus examination. Results During January 2013-April 2016, 86 of 136 patients (with/without HIV co-infection) initiated linezolid-containing DR-TB treatment. The median age of these 86 patients was 25 (20-35) years and 47% were males. 20 percent of them had HIV co-infection. Of 86, 24 (27.9%) had at least one episode of ocular complaints (the majority blurred-vision) and among them, five (5.8%) had optic neuropathy. Patients received appropriate treatment and improvements were observed. None of the demographic/clinical factors were associated with optic neuropathy in Poissons ormultivariate binary logistic-regression models. Discussion This is the first report focusing on optic neuropathy in a cohort of complex DR-TB patients, including patients co-infected with HIV, receiving linezolid-containing regimens. In our study, one out of four patients on linezolid had at least one episode of ocular complaints; therefore, systematic monitoring of patients by primary physicians/nurses, and access to specialized diagnostic-services by specialists are needed. As linezolid will be increasingly added to treatment regimens of DR-TB patients, programmes should allocate adequate resources for early diagnosis, prevention and management of this disabling adverse event.	[Mehta, Salil] Lilavati Hosp & Res Ctr, Dept Ophthalmol, Bombay, Maharashtra, India; [Das, Mrinalini; Laxmeshwar, Chinmay; Jonckheere, Sylvie; Thi, Sein Sein; Isaakidis, Petros] Med Sans Frontieres, Bombay, Maharashtra, India; [Isaakidis, Petros] Med Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg	Doctors Without Borders	Das, M (corresponding author), Med Sans Frontieres, Bombay, Maharashtra, India.	msfocb-delhi-epi@brussels.msf.org	Mehta, Salil/ABG-1687-2020	Mehta, Salil/0000-0003-4175-459X; Laxmeshwar, Chinmay/0000-0003-1561-3857; Isaakidis, Petros/0000-0002-7881-1554				Agrawal R, 2015, OCUL IMMUNOL INFLAMM, V23, P90, DOI 10.3109/09273948.2013.874447; Alcala L, 2003, ANTIMICROB AGENTS CH, V47, P416, DOI 10.1128/AAC.47.1.416-417.2003; Cleveland KO, 2009, CLIN INFECT DIS, V49, P645, DOI 10.1086/603592; Han J, 2013, J NEURO-OPHTHALMOL, V33, P316, DOI 10.1097/WNO.0b013e31829b4265; Hughes J, 2015, EUR RESPIR J, V46, P271, DOI 10.1183/09031936.00188114; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Javaheri M, 2007, BRIT J OPHTHALMOL, V91, P111, DOI 10.1136/bjo.2006.102541; Joshi L, 2009, CLIN INFECT DIS, V48, pe73, DOI 10.1086/597298; Karuppannasamy D, 2014, INDIAN J OPHTHALMOL, V62, P497, DOI 10.4103/0301-4738.118451; Kho RC, 2011, J NEURO-OPHTHALMOL, V31, P121, DOI 10.1097/WNO.0b013e318205a148; Kiuchi K, 2009, JPN J OPHTHALMOL, V53, P420, DOI 10.1007/s10384-009-0678-3; Kulkarni K, 2005, BRIT J OPHTHALMOL, V89, P1664, DOI 10.1136/bjo.2005.074237; Lee E, 2003, CLIN INFECT DIS, V37, P1389, DOI 10.1086/379012; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; McKinley SH, 2005, J NEURO-OPHTHALMOL, V25, P18, DOI 10.1097/00041327-200503000-00005; Rucker JC, 2006, NEUROLOGY, V66, P595, DOI 10.1212/01.wnl.0000201313.24970.b8; Saijo T, 2005, AM J OPHTHALMOL, V139, P1114, DOI 10.1016/j.ajo.2004.11.047; Schecter GF, 2010, CLIN INFECT DIS, V50, P49, DOI 10.1086/648675; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; Tang SJ, 2015, EUR RESPIR J, V45, P161, DOI 10.1183/09031936.00035114; Udwadia ZF, 2010, EUR RESPIR J, V35, P936, DOI 10.1183/09031936.00132009; Zhang X, 2015, J THORAC DIS, V7, P603, DOI 10.3978/j.issn.2072-1439.2015.03.10	23	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162138	10.1371/journal.pone.0162138	http://dx.doi.org/10.1371/journal.pone.0162138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611434	Green Published, gold			2022-12-27	WOS:000383255900046
J	Sauter, A; Koehler, T; Fingerle, AA; Brendel, B; Richter, V; Rasper, M; Rummeny, EJ; Noel, PB; Munzel, D				Sauter, Andreas; Koehler, Thomas; Fingerle, Alexander A.; Brendel, Bernhard; Richter, Vivien; Rasper, Michael; Rummeny, Ernst J.; Noel, Peter B.; Muenzel, Daniela			Ultra Low Dose CT Pulmonary Angiography with Iterative Reconstruction	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; IMAGE QUALITY; COMPUTED-TOMOGRAPHY; ABDOMINAL CT; RADIATION; REDUCTION; EMBOLISM; ALGORITHM; CHEST; IMPACT	Objective Evaluation of a new iterative reconstruction algorithm (IMR) for detection/rule-out of pulmonary embolism (PE) in ultra-low dose computed tomography pulmonary angiography (CTPA). Methods Lower dose CT data sets were simulated based on CTPA examinations of 16 patients with pulmonary embolism (PE) with dose levels (DL) of 50%, 25%, 12.5%, 6.3% or 3.1% of the original tube current setting. Original CT data sets and simulated low-dose data sets were reconstructed with three reconstruction algorithms: the standard reconstruction algorithm "filtered back projection" (FBP), the first generation iterative reconstruction algorithm iDose and the next generation iterative reconstruction algorithm "Iterative Model Reconstruction" (IMR). In total, 288 CTPA data sets (16 patients, 6 tube current levels, 3 different algorithms) were evaluated by two blinded radiologists regarding image quality, diagnostic confidence, detectability of PE and contrast-to-noise ratio (CNR). Results iDose and IMR showed better detectability of PE than FBP. With IMR, sensitivity for detection of PE was 100% down to a dose level of 12.5%. iDose and IMR showed superiority to FBP regarding all characteristics of subjective (diagnostic confidence in detection of PE, image quality, image noise, artefacts) and objective image quality. The minimum DL providing acceptable diagnostic performance was 12.5% (= 0.45 mSv) for IMR, 25% (= 0.89 mSv) for iDose and 100% (= 3.57 mSv) for FBP. CNR was significantly (p < 0.001) improved by IMR compared to FBP and iDose at all dose levels. Conclusion By using IMR for detection of PE, dose reduction for CTPA of up to 75% is possible while maintaining full diagnostic confidence. This would result in a mean effective dose of approximately 0.9 mSv for CTPA.	[Sauter, Andreas; Fingerle, Alexander A.; Rasper, Michael; Rummeny, Ernst J.; Noel, Peter B.; Muenzel, Daniela] Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany; [Koehler, Thomas; Brendel, Bernhard] Philips GmbH, Innovat Technol, Res Labs, Hamburg, Germany; [Richter, Vivien] Univ Klinikum Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Noel, Peter B.] Tech Univ Munich, Lehrstuhl Biomed Phys, Dept Phys, Garching, Germany; [Noel, Peter B.] Tech Univ Munich, Inst Med Tech, Garching, Germany	Technical University of Munich; Philips; Philips Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; Technical University of Munich	Sauter, A (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany.	andreas.sauter@tum.de	Sauter, Andreas/AAM-6986-2020	Sauter, Andreas/0000-0003-4394-862X; Noel, Peter/0000-0002-9671-6171				Astani SA, 2014, NUCL MED COMMUN, V35, P704, DOI 10.1097/MNM.0000000000000114; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chen MY, 2013, INT J CARDIOVAS IMAG, V29, P1167, DOI 10.1007/s10554-013-0190-1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; EVANS SH, 1989, CLIN RADIOL, V40, P45, DOI 10.1016/S0009-9260(89)80021-2; Henes FOG, 2012, J THORAC IMAG, V27, P113, DOI 10.1097/RTI.0b013e31820b8696; Huda W, 1997, RADIOLOGY, V203, P417, DOI 10.1148/radiology.203.2.9114097; Itatani R, 2013, CLIN RADIOL, V68, pE128, DOI 10.1016/j.crad.2012.10.014; Kalra MK, 2005, RADIOLOGY, V237, P303, DOI 10.1148/radiol.2371041227; Kligerman S, 2013, J THORAC IMAG, V28, P49, DOI 10.1097/RTI.0b013e31825412b2; Lambert L, 2015, ACTA RADIOL, V56, P517, DOI 10.1177/0284185114533683; Laqmani A, 2013, ROFO-FORTSCHR RONTG, V185, P749, DOI 10.1055/s-0033-1335577; MacKenzie JD, 2007, AM J ROENTGENOL, V189, P1371, DOI 10.2214/AJR.07.2686; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Mayo J, 2013, AM J ROENTGENOL, V200, P522, DOI 10.2214/AJR.12.9928; Mehta DB B., 2011, EFFECT ITERATIVE REC; Muenzel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107843; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Noel PB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.033501; Noel PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081141; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Oda S, 2011, ACAD RADIOL, V18, P991, DOI 10.1016/j.acra.2011.03.007; Parker Louise, 2013, Arch Dis Child Educ Pract Ed, V98, P239, DOI 10.1136/archdischild-2013-305274; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; Schoepf UJ, 2004, RADIOLOGY, V230, P329, DOI 10.1148/radiol.2302021489; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Szucs-Farkas Z, 2014, EUR RADIOL, V24, P1868, DOI 10.1007/s00330-014-3208-8; Takahashi EA, 2013, RADIOL RES PRACT, V2013, DOI 10.1155/2013/482403; Waaijer A, 2007, RADIOLOGY, V242, P832, DOI 10.1148/radiol.2423051191; Willemink MJ, 2014, J COMPUT ASSIST TOMO, V38, P815, DOI 10.1097/RCT.0000000000000128; Zabic S, 2013, MED PHYS, V40, DOI 10.1118/1.4789628	32	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162716	10.1371/journal.pone.0162716	http://dx.doi.org/10.1371/journal.pone.0162716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611830	Green Published, gold			2022-12-27	WOS:000383255900154
J	Su, Q; Gu, YQ; Yu, B; Yu, F; He, HY; Zhang, Q; Meng, G; Wu, HM; Du, HM; Liu, L; Shi, HB; Xia, Y; Guo, XY; Liu, X; Li, CL; Bao, X; Liu, FF; Fang, LY; Yang, HJ; Sun, SM; Wang, X; Zhou, M; Jia, QY; Zhao, HL; Song, K; Niu, KJ				Su, Qian; Gu, Yeqing; Yu, Bin; Yu, Fei; He, Haiyan; Zhang, Qing; Meng, Ge; Wu, Hongmei; Du, Huanmin; Liu, Li; Shi, Hongbin; Xia, Yang; Guo, Xiaoyan; Liu, Xing; Li, Chunlei; Bao, Xue; Liu, Fangfang; Fang, Liyun; Yang, Huijun; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Niu, Kaijun			Association between Serum Ferritin Concentrations and Depressive Symptoms among Chinese Adults: A Population Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study	PLOS ONE			English	Article							MAJOR DEPRESSION; IRON STATUS; METABOLIC SYNDROME; DISORDERS; RISK; PREVALENCE; GENDER; AXIS	Depressive symptoms have become the most important global public health issue. Iron plays an important role in brain function, cognition, and behavior, and its impacts on depressive symptoms may be multifactorial with both positive and negative effects. Previous observational studies focusing on the association between iron status and depressive symptoms showed inconsistent results. Ferritin is a ubiquitous intracellular protein that can store and release iron and is widely used as a clinical biomarker to evaluate iron status. We performed a cross-sectional study to examine the relationship between serum ferritin and depressive symptoms among 3,839 subjects who were from the Tianjin Chronic Low-grade Systemic Inflammation and Health (TCLSIHealth) cohort. Depressive symptoms were assessed using the Chinese version of 20-item self-rating Depression Scale (SDS) with 4 cutoffs (40, 45, 48 and 50) to indicate elevated depressive symptoms (40 was the primary cut-off). The prevalence of depressive symptoms was 36.5%, 17.6%, 11.0% and 7.0% for SDS >= 40, >= 45, >= 48 and >= 50, respectively. With the primary cut-off point of 40, multiple potential confounding factors were adjusted and the odds ratios (95% confidence interval) of having elevated depressive symptoms by quartiles of serum ferritin concentrations were 1.00 (reference), 1.10 (0.91, 1.34), 0.81 (0.66, 1.01) and 1.02 (0.81, 1.28) for the first, second, third and fourth quartile, respectively (P for trend = 0.76). Similar relations were observed with the use of other cut-offs as a definition of depressive symptoms. In conclusion, there is no significant relationship between serum ferritin concentrations and depressive symptoms among Chinese adults.	[Su, Qian; Gu, Yeqing; Yu, Bin; Yu, Fei; He, Haiyan; Meng, Ge; Wu, Hongmei; Du, Huanmin; Xia, Yang; Guo, Xiaoyan; Liu, Xing; Li, Chunlei; Bao, Xue; Liu, Fangfang; Fang, Liyun; Yang, Huijun; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Su, Qian; Gu, Yeqing; Yu, Bin; Yu, Fei; He, Haiyan; Meng, Ge; Wu, Hongmei; Du, Huanmin; Xia, Yang; Guo, Xiaoyan; Liu, Xing; Li, Chunlei; Bao, Xue; Liu, Fangfang; Fang, Liyun; Yang, Huijun; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Zhang, Qing; Liu, Li; Shi, Hongbin; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Niu, Kaijun] Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Yu, Bin] Tianjin Med Univ, Inst Psychol, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Collaborat Innovat Ctr Noncommunicable Dis, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Niu, KJ (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.; Niu, KJ (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China.; Niu, KJ (corresponding author), Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China.; Niu, KJ (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Noncommunicable Dis, Tianjin, Peoples R China.	niukaijun@tmu.edu.cn	Xia, Yang/AAW-9116-2021; Gu, Yeqing/S-3103-2017; Yu, Bin/AAV-1606-2020	Xia, Yang/0000-0001-8783-1592; Yu, Bin/0000-0002-8978-5144; Niu, Kaijun/0000-0002-8772-2481	National Natural Science Foundation of China [81673166, 81372118, 81372467, 81302422]; key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; National Science and Technology Support Program [2012BAI02B02]; Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund [2014-071]; Technologies development program of Beichen District of Tianjin [bcws2013-21, bcws2014-05]; technologies project of Tianjin Binhai New Area [2013-02-04, 2013-02-06]; Science Foundation of Tianjin Medical University [2010KY28, 2013KYQ24]; Ministry of Education [GW2014-5]; National Training Programs of Innovation and Entrepreneurship for Undergraduates, China [201510062013]; Key Laboratory of Public Health Safety (Fudan University)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key technologies R&D program of Tianjin; National Science and Technology Support Program; Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund; Technologies development program of Beichen District of Tianjin; technologies project of Tianjin Binhai New Area; Science Foundation of Tianjin Medical University; Ministry of Education; National Training Programs of Innovation and Entrepreneurship for Undergraduates, China; Key Laboratory of Public Health Safety (Fudan University)	This study was supported by grants from the National Natural Science Foundation of China (No. 81673166, 81372118, 81372467 and 81302422), the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), the National Science and Technology Support Program (No. 2012BAI02B02), 2012 Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund (No. 2014-071), the Technologies development program of Beichen District of Tianjin (No. bcws2013-21 and bcws2014-05), the technologies project of Tianjin Binhai New Area (No. 2013-02-04 and 2013-02-06), the Science Foundation of Tianjin Medical University (No. 2010KY28 and 2013KYQ24), the Key Laboratory of Public Health Safety (Fudan University), Ministry of Education (No. GW2014-5), and the National Training Programs of Innovation and Entrepreneurship for Undergraduates (No. 201510062013), China.	ACHTE K, 1986, PSYCHOPATHOLOGY, V19, P210, DOI 10.1159/000285157; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Armony-Sivan R, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/521431; BARTFAY WJ, 1995, CAN J CARDIOL, V11, P305; Baune BT, 2006, INT PSYCHOGERIATR, V18, P437, DOI 10.1017/S1041610205002759; Baune BT, 2010, ACTA PSYCHIAT SCAND, V121, P135, DOI 10.1111/j.1600-0447.2009.01435.x; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2005, J NEUROSCI RES, V79, P254, DOI 10.1002/jnr.20324; Bhattacharya R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-10; Bland RC, 1997, CAN J PSYCHIAT, V42, P367, DOI 10.1177/070674379704200403; Bradvik L, 2008, ACTA PSYCHIAT SCAND, V117, P185, DOI 10.1111/j.1600-0447.2007.01136.x; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088; Huang TL, 2007, PSYCHIAT RES, V152, P277, DOI 10.1016/j.psychres.2005.07.038; Hunt JR, 1999, BEHAV MED, V25, P62, DOI 10.1080/08964289909595738; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074168; Liu XL, 2015, ROUT ADV RISK MANAGE, V4, P1; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lozoff B, 1988, Adv Pediatr, V35, P331; MAES M, 1993, PSYCHIAT RES, V49, P11, DOI 10.1016/0165-1781(93)90027-E; Maes M, 1995, J AFFECT DISORDERS, V36, P29, DOI 10.1016/0165-0327(95)00049-6; MAES M, 1993, BIOL PSYCHIAT, V34, P690, DOI 10.1016/0006-3223(93)90042-C; MAES M, 1993, AM J PSYCHIAT, V150, P1189; Maes M, 1996, J AFFECT DISORDERS, V40, P23, DOI 10.1016/0165-0327(96)00038-9; MAES M, 1993, PSYCHIAT RES, V49, P151, DOI 10.1016/0165-1781(93)90102-M; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Popa T A, 2012, J Med Life, V5, P414; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Rangan AM, 1998, J AM COLL NUTR, V17, P351, DOI 10.1080/07315724.1998.10718774; Shariatpanaahi MV, 2007, EUR J CLIN NUTR, V61, P532, DOI 10.1038/sj.ejcn.1602542; Shiotani I, 2002, J CARDIOVASC RISK, V9, P153, DOI 10.1097/00043798-200206000-00004; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; Sun SM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/412386; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van West Dirk, 1999, Neuro Endocrinol Lett, V20, P11; Xu L, 2004, ARCH MED RES, V35, P301, DOI 10.1016/j.arcmed.2004.04.006; Yi S, 2011, PSYCHIAT RES, V189, P368, DOI 10.1016/j.psychres.2011.03.009; Yip R, 2002, J NUTR, V132, p802S, DOI 10.1093/jn/132.4.802S; Zhu L, 2016, J AFFECT DISORDERS, V190, P98, DOI 10.1016/j.jad.2015.09.074; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162682	10.1371/journal.pone.0162682	http://dx.doi.org/10.1371/journal.pone.0162682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611581	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900151
J	Xia, K; Li, YD; Sun, J; Liang, XL				Xia, Kai; Li, Yudong; Sun, Jing; Liang, Xinle			Comparative Genomics of Acetobacterpasteurianus Ab3, an Acetic Acid Producing Strain Isolated from Chinese Traditional Rice Vinegar Meiguichu	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ACETOBACTER-PASTEURIANUS; BACTERIAL; GENES; RESISTANCE; DIVERSITY; PROTEOME; PROGRAM; SEARCH; SENSOR	Acetobacter pasteurianus, an acetic acid resistant bacterium belonging to alpha-proteobacteria, has been widely used to produce vinegar in the food industry. To understand the mechanism of its high tolerance to acetic acid and robust ability of oxidizing ethanol to acetic acid (> 12%, w/v), we described the 3.1 Mb complete genome sequence (including 0.28M plasmid sequence) with a G+ C content of 52.4% of A. pasteurianus Ab3, which was isolated from the traditional Chinese rice vinegar (Meiguichu) fermentation process. Automatic annotation of the complete genome revealed 2,786 protein-coding genes and 73 RNA genes. The comparative genome analysis among A. pasteurianus strains revealed that A. pasteurianus Ab3 possesses many unique genes potentially involved in acetic acid resistance mechanisms. In particular, two-component systems or toxin-antitoxin systems may be the signal pathway and modulatory network in A. pasteurianus to cope with acid stress. In addition, the large numbers of unique transport systems may also be related to its acid resistance capacity and cell fitness. Our results provide new clues to understanding the underlying mechanisms of acetic acid resistance in Acetobacter species and guiding industrial strain breeding for vinegar fermentation processes.	[Xia, Kai; Li, Yudong; Sun, Jing; Liang, Xinle] Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou 310018, Peoples R China	Zhejiang Gongshang University	Liang, XL (corresponding author), Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou 310018, Peoples R China.	dbiot@mail.zjgsu.edu.cn	li, yu/HGL-9518-2022; Li, Yudong/GSN-4036-2022; li, Yu/HCI-9086-2022		National Nature and Science Foundation of China [3117175]; Nature and Science Foundation of Zhejiang Province [LY15C200006, LY14C060001]; Youth Foundation of Zhejiang Gongshang University	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation of Zhejiang Province; Youth Foundation of Zhejiang Gongshang University	The work was financially supported by National Nature and Science Foundation of China (3117175) and Nature and Science Foundation of Zhejiang Province (LY15C200006) to XL, and Youth Foundation of Zhejiang Gongshang University to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was financially supported by grants from the National Nature and Science Foundation of China (31171745 to X. Liang) and the Nature and Science Foundation of the Zhejiang Province (LY15C200006 to X. Liang, and LY14C060001 to Y. Li).	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andres-Barrao C, 2012, J PROTEOMICS, V75, P1701, DOI 10.1016/j.jprot.2011.11.027; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brito PH, 2013, GENOME BIOL EVOL, V5, P16, DOI 10.1093/gbe/evs122; Bustamante P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112226; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Gao R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003927; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gullo M, 2008, INT J FOOD MICROBIOL, V125, P46, DOI 10.1016/j.ijfoodmicro.2007.11.076; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Haruta S, 2006, INT J FOOD MICROBIOL, V109, P79, DOI 10.1016/j.ijfoodmicro.2006.01.015; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iida A, 2009, MICROBIOL-SGM, V155, P3021, DOI 10.1099/mic.0.028613-0; Illeghems K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-526; Ishikawa M, 2010, J BIOSCI BIOENG, V110, P69, DOI 10.1016/j.jbiosc.2009.12.012; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Laermann V, 2013, MOL MICROBIOL, V88, P1194, DOI 10.1111/mmi.12251; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Marcus EA, 2013, HELICOBACTER, V18, P363, DOI 10.1111/hel.12055; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakano S, 2006, APPL ENVIRON MICROB, V72, P497, DOI 10.1128/AEM.72.1.497-505.2006; Nakano S, 2008, INT J FOOD MICROBIOL, V125, P54, DOI 10.1016/j.ijfoodmicro.2007.05.015; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Sakurai K, 2013, J BIOSCI BIOENG, V115, P32, DOI 10.1016/j.jbiosc.2012.07.017; Shi JY, 2014, LECT NOTES ELECTR EN, V249, P417, DOI 10.1007/978-3-642-37916-1_43; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trcek J, 2006, APPL MICROBIOL BIOT, V70, P366, DOI 10.1007/s00253-005-0073-z; Trcek J, 2015, ANN MICROBIOL, V65, P1287, DOI 10.1007/s13213-014-0966-0; Trcek J, 2015, APPL MICROBIOL BIOT, V99, P6215, DOI 10.1007/s00253-015-6762-3; Wang Z, 2015, APPL BIOCHEM BIOTECH, V177, P1573, DOI 10.1007/s12010-015-1838-1; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Yamada Y, 2008, INT J FOOD MICROBIOL, V125, P15, DOI 10.1016/j.ijfoodmicro.2007.11.077; Yamada Y, 2012, J GEN APPL MICROBIOL, V58, P397, DOI 10.2323/jgam.58.397; Zeng XM, 2013, FEMS MICROBIOL LETT, V347, P83, DOI 10.1111/1574-6968.12221; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	47	11	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162172	10.1371/journal.pone.0162172	http://dx.doi.org/10.1371/journal.pone.0162172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611790	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900050
J	Xu, JM; Chen, X; Yu, SQ; Su, Y; Zhu, WY				Xu, Jumei; Chen, Xue; Yu, Shuiqing; Su, Yong; Zhu, Weiyun			Effects of Early Intervention with Sodium Butyrate on Gut Microbiota and the Expression of Inflammatory Cytokines in Neonatal Piglets	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; INTESTINAL MICROBIOTA; GENE-EXPRESSION; DOWN-REGULATION; PIGS; INHIBITION; DISEASE; HEALTH; COLON	Butyrate in the gut of animals has potential properties including regulating the innate immune, modulating the lipid metabolism, and protecting gut healthy. So far, only limited information on the impact of butyrate on the neonatal is available. This study aimed to investigate effects of oral administration of sodium butyrate (SB) on gut microbiota and the expression of inflammatory cytokine in neonatal piglets. Ten litters of crossbred newborn piglets were randomly allocated to the SB and control (CO) groups, each group consisted of five litters (replicates). Piglets in the SB group were orally administrated with 7 to 13 ml sodium butyrate solution (150 mmol/l) per day from the age of 1 to 7 days, respectively; piglets in the CO group were treated with the same dose of physiological saline. On days 8 and 21 (of age), gut digesta and tissues were collected for the analysis of microbiota, butyrate concentration and gene expression of inflammatory cytokine. Results showed that there was no difference in the butyrate concentration in the gut of piglets on days 8 and 21 between two groups. Real-time PCR assay showed that SB had no effect on the numbers of total bacteria in the stomach, ileum, and colon. MiSeq sequencing of the V3-V4 region of the 16S rRNA gene revealed that SB increased the richness in the stomach and colon, and the diversity of colonic microbiota on day 8 (P < 0.05). Genera Acinetobacter, Actinobacillus, Facklamia, Globicatella, Kocuria, Rothia, unclassified Leptotrichiaceae, unclassified Neisseriaceae, and unclassified Prevotellaceae in the stomach were increased in relative abundance by SB treatment, whereas the abundances of Lactobacillus decreased on day 8 (P < 0.05). At the genus and operational taxonomic unit (OTU) levels, SB had low impact on bacterial community in the ileum and colon on days 8 and 21. SB treatment decreased the expression of IL-6, IL-8, IFN-gamma, IL-10, TGF-alpha, and histone deacetylase 1 (HDAC1) in the ileum of piglets on day 8 (P < 0.05). SB treatment down-regulated the expression of IL-8, IFN-gamma, and IL-1 beta on day 21 (P < 0.05). Correlation analysis on the combined datasets revealed some potential relationships between gut microbiota and the expression of inflammatory cytokines. The results show that early intervention with sodium butyrate can modulate the ileum inflammatory cytokine in neonatal piglets with low impact on intestinal microbial structure, which suggests oral administration of SB may have a benefit role in the health of neonatal piglets.	[Xu, Jumei; Chen, Xue; Yu, Shuiqing; Su, Yong; Zhu, Weiyun] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Su, Y (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Nanjing 210095, Jiangsu, Peoples R China.	yong.su@njau.edu.cn			National Natural Science Foundation of China [31572414]; National Basic Research Program of China [2012CB124705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research has received funding from the National Natural Science Foundation of China (31572414) and National Basic Research Program of China (2012CB124705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has received funding from the National Natural Science Foundation of China (31572414) and National Basic Research Program of China (2012CB124705).	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; BEUTLER B, 1993, CRIT CARE MED, V21, pS423; Biagi G, 2007, J ANIM SCI, V85, P1184, DOI 10.2527/jas.2006-378; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chinese Science and Technology Committee, 1988, REG ADM AFF EXP AN; Conroy ME, 2009, CURR OPIN ALLERGY CL, V9, P197, DOI 10.1097/ACI.0b013e32832b3f1d; Fang L, 2014, LIVEST SCI, V170, P116, DOI 10.1016/j.livsci.2014.10.004; Feng ZM, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0434; FRANKLIN ST, 1991, J DAIRY SCI, V74, P2507, DOI 10.3168/jds.S0022-0302(91)78428-2; GALFI P, 1990, ACTA VET HUNG, V38, P3; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; HENDRIX WF, 1978, J ANIM SCI, V47, P1281, DOI 10.2527/jas1978.4761281x; Hou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119505; Huang C, 2015, J NUTR, V145, P2774, DOI 10.3945/jn.115.217406; Inman CF, 2010, CLIN EXP IMMUNOL, V160, P431, DOI 10.1111/j.1365-2249.2010.04090.x; Ivarsson E, 2014, ANIMAL, V8, P1777, DOI 10.1017/S1751731114001827; Kalliomaki M., 2002, Current Drug Targets - Infectious Disorders, V2, P193; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li GL, 2014, J NUTR, V144, P1887, DOI 10.3945/jn.114.198531; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Lin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111950; Liu LM, 2012, J EXP ZOOL PART B, V318B, P224, DOI 10.1002/jez.b.22440; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Mikkelsen LL, 2004, APPL ENVIRON MICROB, V70, P3485, DOI 10.1128/AEM.70.6.3485-3492.2004; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; RALPH P, 1992, J IMMUNOL, V148, P808; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Saavedra JM, 2012, GASTROENTEROL CLIN N, V41, P717, DOI 10.1016/j.gtc.2012.08.001; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Sun CQ, 1998, CHEM-BIOL INTERACT, V113, P117, DOI 10.1016/S0009-2797(98)00025-8; Sun Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00877; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tudela CV, 2015, BRIT J NUTR, V113, P610, DOI 10.1017/S0007114514004231; Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P1006, DOI 10.1128/AEM.72.2.1006-1012.2006; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wostmann BS., 1996, GERMFREE GNOTOBIOTIC, P101; Zhang HS, 2016, ARCH BIOCHEM BIOPHYS, V598, P50, DOI 10.1016/j.abb.2016.03.031; Zhou LP, 2016, ANAEROBE, V38, P61, DOI 10.1016/j.anaerobe.2015.12.009	59	55	65	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162461	10.1371/journal.pone.0162461	http://dx.doi.org/10.1371/journal.pone.0162461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611998	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900104
J	Liu, WY; Meijer, K; Delbressine, JM; Willems, PJ; Franssen, FME; Wouters, EFM; Spruit, MA				Liu, Wai-Yan; Meijer, Kenneth; Delbressine, Jeannet M.; Willems, Paul J.; Franssen, Frits M. E.; Wouters, Emiel F. M.; Spruit, Martijn A.			Reproducibility and Validity of the 6-Minute Walk Test Using the Gait Real-Time Analysis Interactive Lab in Patients with COPD and Healthy Elderly	PLOS ONE			English	Article							TREADMILL; DISTANCE; HALLWAY; SPEED	Background The 6-minute walk test (6MWT) in a regular hallway is commonly used to assess functional exercise capacity in patients with chronic obstructive pulmonary disease (COPD). However, treadmill walking might provide additional advantages over overground walking, especially if virtual reality and self-paced treadmill walking are combined. Therefore, this study aimed to assess the reproducibility and validity of the 6MWT using the Gait Real-time Analysis Interactive Lab (GRAIL) in patients with COPD and healthy elderly. Methodology/Results Sixty-one patients with COPD and 48 healthy elderly performed two 6MWTs on the GRAIL. Patients performed two overground 6MWTs and healthy elderly performed one overground test. Differences between consecutive 6MWTs and the test conditions (GRAIL vs. overground) were analysed. Patients walked further in the second overground test (24.8 m, 95% CI 15.2-34.4 m, p < 0.001) and in the second GRAIL test (26.8 m, 95% CI 13.9-39.6 m). Healthy elderly improved their second GRAIL test (49.6 m, 95% CI 37.0-62.3 m). The GRAIL 6MWT was reproducible (intra-class coefficients = 0.65-0.80). The best GRAIL 6-minute walk distance (6MWD) in patients was shorter than the best overground 6MWD (-27.3 +/- 49.1 m, p < 0.001). Healthy elderly walked further on the GRAIL than in the overground condition (23.6 +/- 41.4 m, p < 0.001). Validity of the GRAIL 6MWT was assessed and intra-class coefficient values ranging from 0.74-0.77 were found. Conclusion The GRAIL is a promising system to assess the 6MWD in patients with COPD and healthy elderly. The GRAIL 6MWD seems to be more comparable to the 6MWDs assessed overground than previous studies on treadmills have reported. Furthermore, good construct validity and reproducibility were established in assessing the 6MWD using the GRAIL in patients with COPD and healthy elderly.	[Liu, Wai-Yan; Delbressine, Jeannet M.; Franssen, Frits M. E.; Wouters, Emiel F. M.; Spruit, Martijn A.] CIRO, Dept Res & Educ, Horn, Netherlands; [Liu, Wai-Yan; Meijer, Kenneth; Willems, Paul J.] Maastricht Univ, Med Ctr, Dept Human Movement Sci, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Franssen, Frits M. E.; Wouters, Emiel F. M.] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Liu, WY (corresponding author), CIRO, Dept Res & Educ, Horn, Netherlands.; Liu, WY (corresponding author), Maastricht Univ, Med Ctr, Dept Human Movement Sci, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	waiyanliu@ciro-horn.nl	Delbressine, Jeannet/AAE-2339-2022; Meijer, Kenneth/A-8573-2014; Franssen, Frits M.E./B-6988-2018; Franssen, Frits M.E./L-3334-2019; Wouters, Emiel/ABD-6200-2021	Meijer, Kenneth/0000-0001-8236-8754; Franssen, Frits M.E./0000-0002-1633-6356; Franssen, Frits M.E./0000-0002-1633-6356; Liu, Wai-Yan/0000-0003-1379-958X				Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Andrianopoulos V, 2014, RESP PHYSIOL NEUROBI, V190, P40, DOI 10.1016/j.resp.2013.10.002; Annegarn J, 2012, J AM MED DIR ASSOC, V13, P284, DOI 10.1016/j.jamda.2011.01.002; Antonelli-Incalzi R, 2007, DEMENT GERIATR COGN, V23, P264, DOI 10.1159/000100773; Bansal V, 2008, CHEST, V133, P1155, DOI 10.1378/chest.07-2823; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Almeida FG, 2009, RESP CARE, V54, P1712; Elazzazi A, 2012, J GERIATR PHYS THER, V35, P2, DOI 10.1519/JPT.0b013e31821c91b1; Etnier JL, 2001, MED SCI SPORT EXER, V33, P1620, DOI 10.1097/00005768-200110000-00002; Hellstrom K, 2009, CLIN REHABIL, V23, P1136, DOI 10.1177/0269215509342329; Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Janaudis-Ferreira T, 2010, PHYSIOTHERAPY, V96, P234, DOI 10.1016/j.physio.2009.11.015; Plotnik M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0002-z; Singh SJ, 2014, EUR RESPIR J, V44, P1447, DOI 10.1183/09031936.00150414; Sloot LH, 2014, GAIT POSTURE, V39, P939, DOI 10.1016/j.gaitpost.2013.12.005; Sloot LH, 2014, GAIT POSTURE, V39, P478, DOI 10.1016/j.gaitpost.2013.08.022; Spruit MA, 2008, LANCET, V371, P12, DOI 10.1016/S0140-6736(08)60048-3; Stevens D, 1999, AM J RESP CRIT CARE, V160, P1540, DOI 10.1164/ajrccm.160.5.9808139; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067	24	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162444	10.1371/journal.pone.0162444	http://dx.doi.org/10.1371/journal.pone.0162444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607426	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600045
J	Zhou, WW; Wu, LM; Xie, J; Su, TW; Jiang, L; Jiang, YR; Cao, YA; Liu, JM; Ning, G; Wang, WQ				Zhou, Weiwei; Wu, Luming; Xie, Jing; Su, Tingwei; Jiang, Lei; Jiang, Yiran; Cao, Yanan; Liu, Jianmin; Ning, Guang; Wang, Weiqing			Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma	PLOS ONE			English	Article							ADRENAL CUSHINGS-SYNDROME; CATALYTIC SUBUNIT; SOMATIC MUTATIONS; GENE-EXPRESSION; TUMORS; PRKACA; HYPERPLASIA	The association of pathological features of cortisol-producing adrenocortical adenomas (ACAs) with somatic driver mutations and their molecular classification remain unclear. In this study, we explored the association between steroidogenic acute regulatory protein ( StAR) expression and the driver mutations activating cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling to identify the pathological markers of ACAs. Immunohistochemical staining for StAR and mutations in the protein kinase cAMP-activated catalytic subunit alpha (PRKACA), protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A) and guanine nucleotide binding protein, alpha stimulating (GNAS) genes were examined in 97 ACAs. The association of StAR expression with the clinical and mutational features of the ACAs was analyzed. ACAs with mutations in PRKACA, GNAS, and PRKAR1A showed strong immunopositive staining for StAR. The concordance between high StAR expression and mutations activating cAMP/PKA signaling in the ACAs was 99.0%. ACAs with high expression of StAR had significantly smaller tumor volume (P < 0.001) and higher urinary cortisol per tumor volume (P = 0.032) than those with low expression of StAR. Our findings suggest that immunohistochemical staining for StAR is a reliable pathological approach for the diagnosis and classification of ACAs with cAMP/PKA signaling-activating mutations.	[Zhou, Weiwei; Wu, Luming; Su, Tingwei; Jiang, Lei; Jiang, Yiran; Cao, Yanan; Liu, Jianmin; Ning, Guang; Wang, Weiqing] Shanghai Jiao Tong Univ, Shanghai Key Lab Endocrine Tumors, Dept Endocrine & Metab Dis,Rui Jin Hosp, Shanghai Natl Clin Ctr Endocrine & Metab Dis,Sch, Shanghai, Peoples R China; [Xie, Jing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Ning, Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Endocrine Tumors, Dept Endocrine & Metab Dis,Rui Jin Hosp, Shanghai Natl Clin Ctr Endocrine & Metab Dis,Sch, Shanghai, Peoples R China.	wqingw61@163.com		Cao, Yanan/0000-0002-3848-7040	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Natural Science Foundation of China grants [81400779, 81130016, 81522032]; Chinese Society of Endocrinology [13050890474]; Shanghai Municipal commission of Health and Family Planning [2013SY016]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Natural Science Foundation of China grants(National Natural Science Foundation of China (NSFC)); Chinese Society of Endocrinology; Shanghai Municipal commission of Health and Family Planning	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), Natural Science Foundation of China grants (No. 81400779, 81130016 and 81522032), Chinese Society of Endocrinology (13050890474), Shanghai Municipal commission of Health and Family Planning (2013SY016).	Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Bertherat J, 2003, CANCER RES, V63, P5308; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Calebiro D, 2015, EUR J ENDOCRINOL, V173, pM99, DOI 10.1530/EJE-15-0353; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; De Venanzi A, 2014, CURR OPIN ENDOCRINOL, V21, P177, DOI 10.1097/MED.0000000000000061; Di Dalmazi G, 2014, J CLIN ENDOCR METAB, V99, pE2093, DOI 10.1210/jc.2014-2152; Duan K, 2015, J CLIN PATHOL, V68, P175, DOI 10.1136/jclinpath-2014-202612; Espiard S, 2014, HORM METAB RES, V46, P869, DOI 10.1055/s-0034-1385908; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Horvath A, 2006, J CLIN ENDOCR METAB, V91, P584, DOI 10.1210/jc.2005-1301; Jiang XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6809; Lacroix A, 2015, LANCET, V386, P913, DOI 10.1016/S0140-6736(14)61375-1; Lefrancois-Martinez AM, 2011, J BIOL CHEM, V286, P32976, DOI 10.1074/jbc.M111.218016; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; Stratakis CA, 2014, J CLIN ENDOCR METAB, V99, P3629, DOI 10.1210/jc.2014-3295; Thiel A, 2015, EUR J ENDOCRINOL, V172, P677, DOI 10.1530/EJE-14-1113; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162606	10.1371/journal.pone.0162606	http://dx.doi.org/10.1371/journal.pone.0162606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606678	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600069
J	Lee, SW; Baek, SH; Ahn, SY; Na, KY; Chae, DW; Chin, HJ; Kim, S				Lee, Sung Woo; Baek, Seon Ha; Ahn, Shin Young; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong			The Effects of Pre-Existing Hyponatremia and Subsequent-DevelopingAcute Kidney Injury on In-Hospital Mortality: A Retrospective Cohort Study	PLOS ONE			English	Article							HEART-FAILURE; PRIMARY-CARE; DIAGNOSIS; HYPERNATREMIA; OUTCOMES; CHILDREN; MILD	Background and Objectives Both hyponatremia and acute kidney injury (AKI) are common and harmful in hospitalized patients. However, their combined effects on patient mortalityhave been little studied. Methods We retrospectively enrolled 19191 adult patients who were admitted for 1 year. Pre-existing hyponatremia was defined as a serum sodium level < 135 mmol/L on the first measurement of their admission. AKI was defined as a rise in serum creatinine by >= 26.5 mu mol/L or >= 1.5 times of the baseline value of creatinine during the hospital stay. Results The prevalence of pre-existing hyponatremia was 8.2%. During a median 6.0 days of hospital stay, the incidence rates of AKI and in-hospital patient mortality were 5.1% and 0.9%, respectively. Pre-existing hyponatremia independently predicted AKI development and in-hospital mortality (adjusted hazard ratio [HR] 1.300, P = 0.004; HR 2.481, P = 0.002, respectively). Pre-existing hyponatremia and subsequent development of AKI increased in-hospital mortality by 85 times, compared to the patients with normonatremia and no AKI. In subgroup analysis, the AKI group showed higher rates of de novo hypernatremia than the non-AKI group during the admission. De novo hypernatremia, which might be associated with over-correction of hyponatremia, increased in-hospital mortality(HR 3.297, P < 0.001), and patients with AKI showed significantly higher rates of de novo hypernatremia than patients without AKI (16.2% vs. 1.4%, P < 0.001, respectively). Conclusion Pre-existing hyponatremia may be associated with the development of AKI in hospitalized patients, and both hyponatremia and hospital-acquired AKI could have a detrimental effect on short termpatient mortality, which might be related to the inappropriate correction of hyponatremia in AKI patients.	[Lee, Sung Woo; Baek, Seon Ha; Na, Ki Young; Chae, Dong-Wan] Seoul Natl Univ, Postgrad Sch, Dept Internal Med, Seoul, South Korea; [Lee, Sung Woo] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Baek, Seon Ha; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Ahn, Shin Young] Korea Univ, Guro Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	sejoong2@snu.ac.kr	Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962	Korean Society of Nephrology [06-2014-151]; SNUBH Research Fund [02-2014-058]	Korean Society of Nephrology; SNUBH Research Fund	This study was supported by the Young Investigator Research Grant (no 06-2014-151) from the Korean Society of Nephrology (Kyowa Hakko Kirin 2014) and was supported by grant no 02-2014-058 from the SNUBH Research Fund. The sponsors of this study played no role in its design, or in the collection, analysis, or interpretation of data, or the writing of the report. Kyowa Hakko Kirin www.kyowakirin.com/kr/, SNUBH Research Fund www.snubh.org/.	Adams D, 2011, J NEPHROL, V24, P749, DOI 10.5301/JN.2011.6410; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Aronson D, 2014, EUR J HEART FAIL, V16, P49, DOI 10.1093/eurjhf/hft123; Bodonyi-Kovacs G, 2008, CLIN EXP NEPHROL, V12, P74, DOI 10.1007/s10157-007-0021-6; Braam B, 2014, NAT REV NEPHROL, V10, P48, DOI 10.1038/nrneph.2013.250; Chang TI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111373; Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Doi K, 2012, KIDNEY INT, V82, P1114, DOI 10.1038/ki.2012.266; Durand F, 2016, AM J KIDNEY DIS, V67, P318, DOI 10.1053/j.ajkd.2015.09.013; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elmi G, 2014, EUR J INTERN MED, V25, pE45, DOI 10.1016/j.ejim.2014.03.013; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Grams ME, 2015, AM J KIDNEY DIS, V66, P591, DOI 10.1053/j.ajkd.2015.02.337; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Hackworth WA, 2009, LIVER INT, V29, P1071, DOI 10.1111/j.1478-3231.2009.01982.x; Hoorn EJ, 2013, AM J KIDNEY DIS, V62, P139, DOI 10.1053/j.ajkd.2012.09.019; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Lameire N, 2010, SEMIN NEPHROL, V30, P534, DOI 10.1016/j.semnephrol.2010.09.002; Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140674; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liborio AB, 2012, BRAZ J INFECT DIS, V16, P558, DOI 10.1016/j.bjid.2012.08.015; Madsen CM, 2016, OSTEOPOROSIS INT, V27, P397, DOI 10.1007/s00198-015-3423-4; McGregor TL, 2016, AM J KIDNEY DIS, V67, P384, DOI 10.1053/j.ajkd.2015.07.019; Mehta RL, 2011, CONTRIB NEPHROL, V174, P200, DOI 10.1159/000329410; Nigwekar SU, 2013, AM J KIDNEY DIS, V62, P755, DOI 10.1053/j.ajkd.2013.02.367; Prats-Puig A, 2015, THROMB HAEMOSTASIS, V114, P727, DOI 10.1160/TH15-01-0037; RIIKONEN P, 1992, PEDIATR HEMAT ONCOL, V9, P365, DOI 10.3109/08880019209016609; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626; Saepudin S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0082-5; Shum HP, 2016, J CRIT CARE, V31, P82, DOI 10.1016/j.jcrc.2015.09.017; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162990	10.1371/journal.pone.0162990	http://dx.doi.org/10.1371/journal.pone.0162990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622451	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000072
J	Peterson, BA; Haak, DC; Nishimura, MT; Teixeira, PJPL; James, SR; Dangl, JL; Nimchuk, ZL				Peterson, Brenda A.; Haak, David C.; Nishimura, Marc T.; Teixeira, Paulo J. P. L.; James, Sean R.; Dangl, Jeffery L.; Nimchuk, Zachary L.			Genome-Wide Assessment of Efficiency and Specificity in CRISPR/Cas9 Mediated Multiple Site Targeting in Arabidopsis	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATIONS; RNA; MUTAGENESIS; CAS9; VISUALIZATION; PEPTIDES; TALENS	Simultaneous multiplex mutation of large gene families using Cas9 has the potential to revolutionize agriculture and plant sciences. The targeting of multiple genomic sites at once raises concerns about the efficiency and specificity in targeting. The model Arabidopsis thaliana is widely used in basic plant research. Previous work has suggested that the Cas9 off-target rate in Arabidopsis is undetectable. Here we use deep sequencing on pooled plants simultaneously targeting 14 distinct genomic loci to demonstrate thatmultiplex targeting in Arabidopsis is highly specific to on-target sites with no detectable off-target events. In addition, chromosomal translocations are extremely rare. The high specificity of Cas9 in Arabidopsis makes this a reliable method for cleanmutant generation with no need to enhance specificity or adopt alternate Cas9 variants.	[Peterson, Brenda A.; James, Sean R.; Dangl, Jeffery L.; Nimchuk, Zachary L.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA; [Dangl, Jeffery L.; Nimchuk, Zachary L.] Univ North Carolina Chapel Hill, Carolina Ctr Genome Sci, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Dangl, Jeffery L.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Nishimura, Marc T.; Teixeira, Paulo J. P. L.; Dangl, Jeffery L.] Univ North Carolina Chapel Hill, Howard Hughes Med Inst, Chapel Hill, NC USA; [Peterson, Brenda A.; James, Sean R.; Nimchuk, Zachary L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Haak, David C.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nimchuk, ZL (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA.; Nimchuk, ZL (corresponding author), Univ North Carolina Chapel Hill, Carolina Ctr Genome Sci, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA.; Nimchuk, ZL (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	zackn@email.unc.edu	Teixeira, Paulo/C-1546-2013	Teixeira, Paulo/0000-0002-0776-5044; Haak, David/0000-0002-3692-3152; Nishimura, Marc Tad/0000-0003-4666-6900	University of North Carolina at Chapel Hill; Virginia Tech; Pew Latin American Fellows Program in the Biomedical Sciences [00026198]; National Science Foundation-Division of Integrated Organismal Systems [IOS-1455607]; Howard Hughes Medical Institute - HHMI; Gordon and Betty Moore Foundation [GBMF3030]; UNC; Howard HughesMedical Institute; Gordon and BettyMoore Foundation [GBMF3030]; NSF-IOS [IOS-1455607]; HHMI; Direct For Biological Sciences [1257373, 1455607] Funding Source: National Science Foundation	University of North Carolina at Chapel Hill; Virginia Tech; Pew Latin American Fellows Program in the Biomedical Sciences; National Science Foundation-Division of Integrated Organismal Systems(National Science Foundation (NSF)); Howard Hughes Medical Institute - HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); UNC; Howard HughesMedical Institute(Howard Hughes Medical Institute); Gordon and BettyMoore Foundation(Gordon and Betty Moore Foundation); NSF-IOS(National Science Foundation (NSF)); HHMI(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by start up funds from University of North Carolina at Chapel Hill to ZLN; start up funds from Virginia Tech to ZLN and DCH; the Pew Latin American Fellows Program in the Biomedical Sciences (00026198 to PJPLT), http://www.pewtrusts.org/en/projects/pew-latin-american-fellows; National Science Foundation-Division of Integrated Organismal Systems (IOS-1455607 to ZLN), http://www.nsf.gov/div/index.jsp?div=IOS; and Howard Hughes Medical Institute, supported by the HHMI and the Gordon and Betty Moore Foundation (GBMF3030 to JLD), https://www.hhmi.org/programs/biomedical-research/investigator-program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: start-up funds from Virginia Tech (DCH and ZLN) and UNC (ZLN), the Howard HughesMedical Institute, supported by the HHMI and the Gordon and BettyMoore Foundation (GBMF3030, JLD), and The Pew Latin American Fellows Program in the Biomedical Sciences (00026198-PJPLT). Additional support was provided by the NSF-IOS (IOS-1455607) to ZLN.	Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fernandez A, 2013, J EXP BOT, V64, P5263, DOI 10.1093/jxb/ert248; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jun J, 2010, PLANT PHYSIOL, V154, P1721, DOI 10.1104/pp.110.163683; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lozano-Juste J, 2014, TRENDS PLANT SCI, V19, P284, DOI 10.1016/j.tplants.2014.02.014; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Meng L, 2012, P NATL ACAD SCI USA, V109, P1760, DOI 10.1073/pnas.1119864109; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; O'Geen H, 2015, CURR OPIN CHEM BIOL, V29, P72, DOI 10.1016/j.cbpa.2015.10.001; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	32	85	90	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162169	10.1371/journal.pone.0162169	http://dx.doi.org/10.1371/journal.pone.0162169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622539	Green Published, gold			2022-12-27	WOS:000383681000015
J	Tumbarello, DA; Andrews, MR; Brenton, JD				Tumbarello, David A.; Andrews, Melissa R.; Brenton, James D.			SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells	PLOS ONE			English	Article							EXPRESSION ANALYSIS; MESOTHELIAL CELLS; IN-VITRO; PROTEIN; ADHESION; IDENTIFICATION; BINDING; GENE; BETA-IG-H3; MICE	TGFBI has been shown to sensitize ovarian cancer cells to the cytotoxic effects of paclitaxel via an integrin receptor-mediated mechanism that modulates microtubule stability. Herein, we determine that TGFBI localizes within organized fibrillar structures in mesothelial-derived ECM. We determined that suppression of SPARC expression by shRNA decreased the deposition of TGFBI in mesothelial-derived ECM, without affecting its overall protein expression or secretion. Conversely, overexpression of SPARC increased TGFBI deposition. A SPARC-YFP fusion construct expressed by the Met5a cell line co-localized with TGFBI in the cell-derived ECM. Interestingly, in vitro produced SPARC was capable of precipitating TGFBI from cell lysates dependent on an intact SPARC carboxy-terminus with in vitro binding assays verifying a direct interaction. The last 37 amino acids of SPARC were shown to be required for the TGFBI interaction while expression of a SPARC-YFP construct lacking this region (aa 1-256) did not interact and co-localize with TGFBI in the ECM. Furthermore, ovarian cancer cells have a reduced motility and decreased response to the chemotherapeutic agent paclitaxel when plated on ECM derived from mesothelial cells lacking SPARC compared to control mesothelial-derived ECM. In conclusion, SPARC regulates the fibrillar ECM deposition of TGFBI through a novel interaction, subsequently influencing cancer cell behavior.	[Tumbarello, David A.; Brenton, James D.] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge, England; [Andrews, Melissa R.] Univ St Andrews, MBSB, Sch Med, St Andrews, Fife, Scotland; [Tumbarello, David A.] Univ Southampton, Biol Sci, Southampton, Hants, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of St Andrews; University of Southampton	Tumbarello, DA (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge, England.; Tumbarello, DA (corresponding author), Univ Southampton, Biol Sci, Southampton, Hants, England.	D.A.Tumbarello@soton.ac.uk	Brenton, James D/B-3174-2008	Brenton, James D/0000-0002-5738-6683; Tumbarello, David/0000-0002-5169-0561; Andrews, Melissa/0000-0001-5960-5619	Cancer Research UK [A15601]; University of Cambridge; Cancer Research UK [15601] Funding Source: researchfish; Healthway [22905] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Healthway	Funding for this project was provided by Cancer Research UK, grant number A15601 (which supported JDB and DAT) and the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bradshaw AD, 2009, J CELL COMMUN SIGNAL; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brown TJ, 1999, GYNECOL ONCOL, V75, P25, DOI 10.1006/gyno.1999.5552; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042413; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Gardi NL, 2014, CLIN CANCER RES, V20, P87, DOI 10.1158/1078-0432.CCR-13-2063; Golembieski WA, 2002, J NEURO-ONCOL, V60, P213, DOI 10.1023/A:1021167211131; Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4; Huynh MH, 2004, CELL TISSUE RES, V317, P313, DOI 10.1007/s00441-004-0933-3; IruelaArispe ML, 1996, DEV DYNAM, V207, P171, DOI 10.1002/(SICI)1097-0177(199610)207:2<171::AID-AJA5>3.0.CO;2-E; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; Martinek N, 2008, J CELL SCI, V121, P1671, DOI 10.1242/jcs.021931; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Mok SC, 1996, ONCOGENE, V12, P1895; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Paley PJ, 2000, GYNECOL ONCOL, V78, P336, DOI 10.1006/gyno.2000.5894; Phelps SLB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.047; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2007, MOL CANCER RES, V5, P1015, DOI 10.1158/1541-7786.MCR-07-0001; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Stein WD, 2004, CANCER RES, V64, P2805, DOI 10.1158/0008-5472.CAN-03-3383; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Wong FH, 2009, INT J ONCOL, V34, P117, DOI 10.3892/ijo_00000135; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Yuan C, 2004, PROTEIN EXPRES PURIF, V35, P39, DOI 10.1016/j.pep.2003.12.020; Yusuf N, 2014, GYNECOL ONCOL, V134, P356, DOI 10.1016/j.ygyno.2014.04.009; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zutter MM, 2007, ADV EXP MED BIOL, V608, P87	52	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162698	10.1371/journal.pone.0162698	http://dx.doi.org/10.1371/journal.pone.0162698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622658	gold, Green Published, Green Accepted			2022-12-27	WOS:000383681000048
J	van Adrichem, EJ; de Zande, SCV; Dekker, R; Verschuuren, EAM; Dijkstra, PU; van der Schans, CP				van Adrichem, Edwin J.; de Zande, Saskia C. van; Dekker, Rienk; Verschuuren, Erik A. M.; Dijkstra, Pieter U.; van der Schans, Cees P.			Perceived Barriers to and Facilitators of Physical Activity in Recipients of Solid Organ Transplantation, a Qualitative Study	PLOS ONE			English	Article							EXERCISE PARTICIPATION; OF-LIFE; DETERMINANTS; MOTIVATIONS; CAPACITY; PEOPLE	Background Sufficient physical activity is important for solid organ transplant recipients (heart, lung, liver, kidney). However, recipients do not meet the recommended amount or required type of physical activity. The perceived barriers to and facilitators of physical activity in this population are largely unknown. Methods Semi-structured in depth interviews were conducted with solid organ transplant recipients in order to explore experienced barriers and facilitators. Qualitative methodology with thematic line-by-line analysis was used for analysis, and derived themes were classified into personal and environmental factors. Results The most important indicated barriers were physical limitations, insufficient energy level, fear, and comorbidities. The most frequently mentioned facilitators included motivation, coping, consequences of (in) activity, routine/habit, goals/goal priority, and responsibility for the transplanted organ. Neutral factors acting as a barrier or facilitator were self-efficacy and expertise of personnel. A comparison of barriers and facilitators between transplant recipient groups yielded no overt differences. Conclusion Several personal and environmental factors were indicated that should be considered in intervention development to increase physical activity behavior in solid organ transplant recipients.	[van Adrichem, Edwin J.; de Zande, Saskia C. van; van der Schans, Cees P.] Hanze Univ Appl Sci, Res Grp Hlth Ageing Allied Hlth Care & Nursing, Groningen, Netherlands; [van Adrichem, Edwin J.; Dekker, Rienk; Dijkstra, Pieter U.; van der Schans, Cees P.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [van Adrichem, Edwin J.; Verschuuren, Erik A. M.] Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands; [Dekker, Rienk] Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, Groningen, Netherlands; [Verschuuren, Erik A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands; [Dijkstra, Pieter U.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Adrichem, EJ (corresponding author), Hanze Univ Appl Sci, Res Grp Hlth Ageing Allied Hlth Care & Nursing, Groningen, Netherlands.; van Adrichem, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.; van Adrichem, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands.	e.j.van.adrichem@pl.hanze.nl	van Adrichem, Edwin J./AAS-1271-2020	van de Zande, Saskia/0000-0002-3063-0260; van der Schans, Cees P/0000-0003-4728-4082; Verschuuren, Erik/0000-0002-6807-6744				Bossola M, 2014, BLOOD PURIFICAT, V38, P24, DOI 10.1159/000363599; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Clarke AL, 2015, NEPHROL DIAL TRANSPL, V30, P1885, DOI 10.1093/ndt/gfv208; Cleary K, 2015, PHYSIOTHER THEOR PR, V31, P337, DOI 10.3109/09593985.2015.1004770; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Delgado C, 2012, NEPHROL DIAL TRANSPL, V27, P1152, DOI 10.1093/ndt/gfr404; Didsbury M, 2013, TRANSPLANTATION, V95, P679, DOI 10.1097/TP.0b013e31827a3d3e; Dontje ML, 2014, CLIN TRANSPLANT, V28, P394, DOI 10.1111/ctr.12325; Evangelista Lorraine S, 2005, J Cardiovasc Nurs, V20, P334; Frith J, 2010, J HEPATOL, V52, P112, DOI 10.1016/j.jhep.2009.10.010; GODIN G, 1990, SPORTS MED, V10, P103, DOI 10.2165/00007256-199010020-00004; Goodman Eric D, 2004, Nephrol Nurs J, V31, P23; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Langer D, 2012, AM J TRANSPLANTATION; Langer D, 2009, J HEART LUNG TRANSPL, V28, P572, DOI 10.1016/j.healun.2009.03.007; Masala D, 2012, TRANSPL P, V44, P1346, DOI 10.1016/j.transproceed.2012.01.123; Mathur S, 2014, AM J TRANSPLANT, V14, P2235, DOI 10.1111/ajt.12874; Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5; Kulak CAM, 2012, CURR OSTEOPOROS REP, V10, P48, DOI 10.1007/s11914-011-0083-y; Morton J. M., 1999, Journal of Heart and Lung Transplantation, V18, P52, DOI 10.1016/S1053-2498(99)80073-4; Myers Jonathan, 2003, J Cardiopulm Rehabil, V23, P100; Nielens H, 2001, NEPHROL DIAL TRANSPL, V16, P134, DOI 10.1093/ndt/16.1.134; Oman RF, 1998, AM J HEALTH PROMOT, V12, P154, DOI 10.4278/0890-1171-12.3.154; Pender N.J., 2002, HLTH PROMOTION NURSI, V4, P1; Pirenne J, 2004, AM J TRANSPLANT, V4, P554, DOI 10.1111/j.1600-6143.2004.00363.x; Pope C, 2006, QUALITATIVE RES HLTH, V3rd; Ritchie J., 2013, QUALITATIVE RES PRAC; Sanchez Zoila V, 2007, Prog Transplant, V17, P324; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Slapak Maurice, 2005, Ann Transplant, V10, P24; Thorpe O, 2012, J CARDIOPULM REHABIL, V32, P359, DOI 10.1097/HCR.0b013e318262d7df; Tierney S, 2011, INT J NURS STUD, V48, P1234, DOI 10.1016/j.ijnurstu.2011.03.003; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van Adrichem EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142641; van Adrichem EJ, 2015, PHYS THER, V95, P720, DOI 10.2522/ptj.20140001; van den Ham ECH, 2005, AM J TRANSPLANT, V5, P1957, DOI 10.1111/j.1600-6143.2005.00944.x; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Wang XN, 1999, AM J RESP CRIT CARE, V160, P57, DOI 10.1164/ajrccm.160.1.9805092; Williams TJ, 2012, COMPR PHYSIOL, V2, P1937, DOI 10.1002/cphy.c110021; Yates BC, 2003, RES NURS HEALTH, V26, P459, DOI 10.1002/nur.10108; Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410	44	36	36	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162725	10.1371/journal.pone.0162725	http://dx.doi.org/10.1371/journal.pone.0162725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622291	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000051
J	Chang, SJ; Hung, SY; Liu, YL; Jiang, SH				Chang, Shu-Jun; Hung, Shih-Yen; Liu, Yan-Lin; Jiang, Shiang-Huei			Construction of Taiwanese Adult Reference Phantoms for Internal Dose Evaluation	PLOS ONE			English	Article							ABSORBED FRACTIONS	In the internal dose evaluation, the specific absorbed fraction (SAF) and S-value are calculated from the reference phantom based on Caucasian data. The differences in height and weight between Caucasian and Asian may lead to inaccurate dose estimation. In this study, we developed the Taiwanese reference phantoms. 40 volunteers were recruited. Magnetic resonance images (MRI) were obtained, and the contours of 15 organs were drawn. The Taiwanese reference man (TRM) and Taiwanese reference woman (TRW) were constructed. For the SAF calculation, the differences in the self-absorption SAF (self-SAF) between the TRM, TRW, and Oak Ridge National Laboratory (ORNL) adult phantom were less than 10% when the difference in organ mass was less than 20%. The average SAF from liver to pancreas of TRM was 38% larger than that of the ORNL adult phantom, and the result of TRW was 2.02 times higher than that of the ORNL adult phantom. For the S-value calculation, the ratios of TRW and ORNL adult phantom ranged from 0.91 to 1.57, and the ratios of TRM and ORNL adult phantom ranged from 1.04 to 2.29. The SAF and S-value results were dominantly affected by the height, weight, organ mass, and geometric relationship between organs. By using the TRM and TRW, the accuracy of internal dose evaluation can be increased for radiation protection and nuclear medicine.	[Chang, Shu-Jun; Liu, Yan-Lin; Jiang, Shiang-Huei] Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu, Taiwan; [Chang, Shu-Jun] Inst Nucl Energy Res, Atom Energy Council, Div Hlth Phys, Taoyuan, Taiwan; [Hung, Shih-Yen] Chi Mei Med Ctr, Tainan, Taiwan; [Hung, Shih-Yen] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan	National Tsing Hua University; Institute of Nuclear Energy Research - Taiwan; Chi Mei Hospital; Central Taiwan University Science & Technology	Chang, SJ (corresponding author), Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu, Taiwan.; Chang, SJ (corresponding author), Inst Nucl Energy Res, Atom Energy Council, Div Hlth Phys, Taoyuan, Taiwan.	shujchang@iner.gov.tw						Chang SJ, 2015, RADIAT PROT DOSIM, V167, P247, DOI 10.1093/rpd/ncv255; Clairand I, 2000, PHYS MED BIOL, V45, P2771, DOI 10.1088/0031-9155/45/10/304; Cristy M, 1980, ORNLTM367; Cristy M., 1987, REPORT ORNLTM 8381; Cristy M, 2007, ORNLTM2007; ICRP, 2003, USITC PUBL; International Atomic Energy Agency (IAEA), 1998, COMP AN PHYS MET CHA; International Commission on Radiological Protection (ICRP), 1975, ICRP PUBL, V23; Kim J, 2010, RADIAT MEAS, V45, P103, DOI 10.1016/j.radmeas.2009.07.002; Liu YL, 2014, J BIOMED BIOTECHNOL; Ministry of Health and Welfare, 2008, HLTH NAT HLTH INS AN; Park S, 2008, RADIAT PROT DOSIM, V130, P186, DOI 10.1093/rpd/ncm487; Park S, 2006, RADIAT PROT DOSIM, V121, P257, DOI 10.1093/rpd/nc1042; Qiu R, 2008, HEALTH PHYS, V95, P716, DOI 10.1097/01.HP.0000318889.50519.56; Ryman JC, 1996, ORNL MATH PHANTOM SE; Sato K, 2007, RADIAT PROT DOSIM, V123, P337, DOI 10.1093/rpd/ncl101; Sieper J, 2012, COMP 2 REFERAL STRAT; SNYDER WS, 1969, J NUCL MED, V10, P7; Snyder WS, 1975, ABSORBED DOSE PER UN; Stabin M, 1995, ORNLTM12907; Stabin MG, 2005, J NUCL MED, V46, P1023; Wu J, 2012, RADIAT PROT DOSIM, V152, P119, DOI 10.1093/rpd/ncs204; X-5 Monte Carlo Team, 2003, LAUR031987 LANL X 5; Yamauchi M, 2005, MED PHYS, V32, P85, DOI 10.1118/1.1829248	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162359	10.1371/journal.pone.0162359	http://dx.doi.org/10.1371/journal.pone.0162359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618708	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100019
J	Ban, HS; Xu, X; Jang, K; Kim, I; Kim, BK; Lee, K; Won, M				Ban, Hyun Seung; Xu, Xuezhen; Jang, Kusik; Kim, Inhyub; Kim, Bo-Kyung; Lee, Kyeong; Won, Misun			A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER-CELL METABOLISM; HIF-1 INHIBITOR; EXPRESSION; PATHWAY; TARGET; PROBES; LW6	We previously reported that hypoxia-inducible factor (HIF)-1 inhibitor LW6, an aryloxyacety-lamino benzoic acid derivative, inhibits malate dehydrogenase 2 (MDH2) activity during the mitochondrial tricarboxylic acid (TCA) cycle. In this study, we present a novel MDH2 inhibitor compound 7 containing benzohydrazide moiety, which was identified through structure-based virtual screening of chemical library. Similar to LW6, compound 7 inhibited MDH2 activity in a competitive fashion, thereby reducing NADH level. Consequently, compound 7 reduced oxygen consumption and ATP production during the mitochondrial respiration cycle, resulting in increased intracellular oxygen concentration. Therefore, compound 7 suppressed the accumulation of HIF-1 alpha and expression of its target genes, vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT1). Moreover, reduction in ATP content activated AMPK, thereby inactivating ACC and mTOR the downstream pathways. As expected, compound 7 exhibited significant growth inhibition of human colorectal cancer HCT116 cells. Compound 7 demonstrated substantial anti-tumor efficacy in an in vivo xenograft assay using HCT116 mouse model. Taken together, a novel MDH2 inhibitor, compound 7, suppressed HIF-1 alpha accumulation via reduction of oxygen consumption and ATP production, integrating metabolism into anti-cancer efficacy in cancer cells.	[Ban, Hyun Seung] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Daejeon, South Korea; [Ban, Hyun Seung] Univ Sci & Technol, Biomol Sci, Daejeon, South Korea; [Xu, Xuezhen; Jang, Kusik; Lee, Kyeong] Dongguk Univ Seoul, Coll Pharm, Goyang, South Korea; [Kim, Inhyub; Kim, Bo-Kyung; Won, Misun] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Kim, Inhyub; Won, Misun] Univ Sci & Technol, Funct Genom, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Dongguk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Lee, K (corresponding author), Dongguk Univ Seoul, Coll Pharm, Goyang, South Korea.; Won, M (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea.; Won, M (corresponding author), Univ Sci & Technol, Funct Genom, Daejeon, South Korea.	kaylee@donggkuk.edu; misun@kribb.re.kr	Ban, Hyun Seung/F-9526-2014	Ban, Hyun Seung/0000-0002-2698-6037	Korea National Research Foundation (NRF) [2015M3A9A8032460]; National Research Foundation (NRF) [2015M3A9A8032460, 2014R1A2A2A01005455]; Health Technology RD [HI13C2162]; KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology [KGM4751612]	Korea National Research Foundation (NRF); National Research Foundation (NRF); Health Technology RD; KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology	This work was supported by grant 2015M3A9A8032460 by Korea National Research Foundation (NRF) (https://ernd.nrf.re.kr) to MW, grant 2014R1A2A2A01005455 by National Research Foundation (NRF) (https://ernd.nrf.re.kr) to KL, grant HI13C2162 by Health Technology R&D (https://www.htdream.kr) to MW, and grant KGM4751612 by KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology (https://www.kribb.re.kr) to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Research Foundation (NRF) grants (2014R1A2A2A01005455, 2015M3A9A8032460), Health Technology R&D grant (HI13C2162) and KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology.	Akbay EA, 2014, GENE DEV, V28, P479, DOI 10.1101/gad.231233.113; Ban HS, 2016, EXPERT OPIN THER PAT, V26, P309, DOI 10.1517/13543776.2016.1146252; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gaude E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-10; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Israel M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-70; Jung EJ, 2011, J LIPID RES, V52, P1617, DOI 10.1194/jlr.M015263; Kim S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-299; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Lee K, 2013, ANGEW CHEM INT EDIT, V52, P10286, DOI 10.1002/anie.201304987; Lee K, 2010, BIOCHEM PHARMACOL, V80, P982, DOI 10.1016/j.bcp.2010.06.018; Liu Q, 2013, PROSTATE, V73, P1028, DOI 10.1002/pros.22650; Lo YW, 2015, J CELL MOL MED, V19, P744, DOI 10.1111/jcmm.12388; Naik R, 2014, J MED CHEM, V57, P9522, DOI 10.1021/jm501241g; Naik R, 2012, J MED CHEM, V55, P10564, DOI 10.1021/jm301419d; Piao W, 2013, ANGEW CHEM INT EDIT, V52, P13028, DOI 10.1002/anie.201305784; Quintero M, 2004, EJSO-EUR J SURG ONC, V30, P465, DOI 10.1016/j.ejso.2004.03.008; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Schlichtholz B, 2005, PANCREAS, V30, P99, DOI 10.1097/01.mpa.0000153326.69816.7d; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsui KH, 2013, J MOL ENDOCRINOL, V51, P131, DOI 10.1530/JME-13-0090; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	31	26	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162568	10.1371/journal.pone.0162568	http://dx.doi.org/10.1371/journal.pone.0162568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611801	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900127
J	Chebon, LJ; Ngalah, BS; Ingasia, LA; Juma, DW; Muiruri, P; Cheruiyot, J; Opot, B; Mbuba, E; Imbuga, M; Akala, HM; Bulimo, W; Andagalu, B; Kamau, E				Chebon, Lorna J.; Ngalah, Bidii S.; Ingasia, Luicer A.; Juma, Dennis W.; Muiruri, Peninah; Cheruiyot, Jelagat; Opot, Benjamin; Mbuba, Emmanuel; Imbuga, Mabel; Akala, Hoseah M.; Bulimo, Wallace; Andagalu, Ben; Kamau, Edwin			Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites	PLOS ONE			English	Article							IN-VIVO SELECTION; ARTEMETHER-LUMEFANTRINE; DRUG-RESISTANCE; LINKAGE DISEQUILIBRIUM; MALARIA TRANSMISSION; TEMPORAL TRENDS; POPULATION; CLEARANCE; DIVERSITY; CHILDREN	Genetically determined artemisinin resistance in Plasmodium falciparum has been described in Southeast Asia. The relevance of recently described Kelch 13-propellermutations for artemisinin resistance in Sub-Saharan Africa parasites is still unknown. Southeast Asia parasites have low genetic diversity compared to Sub-Saharan Africa, where parasites are highly genetically diverse. This study attempted to elucidate whether genetics provides a basis for discovering molecular markers in response to artemisinin drug treatment in P. falciparum in Kenya. The genetic diversity of parasites collected pre- and post-introduction of artemisinin combination therapy (ACT) in western Kenya was determined. A panel of 12 microsatellites and 91 single nucleotide polymorphisms (SNPs) distributed across the P. falciparum genome were genotyped. Parasite clearance rates were obtained for the post-ACT parasites. The 12 microsatellites were highly polymorphic with post-ACT parasites being significantly more diverse compared to pre- ACT (p < 0.0001). The median clearance half-life was 2.55 hours for the post-ACT parasites. Based on SNP analysis, 15 of 90 post-ACT parasites were single-clone infections. Analysis revealed 3 SNPs that might have some causal association with parasite clearance rates. Further, genetic analysis using Bayesian tree revealed parasites with similar clearance phenotypes were more closely genetically related. With further studies, SNPs described here and genetically determined response to artemisinin treatment might be useful in tracking artemisinin resistance in Kenya.	[Chebon, Lorna J.; Ngalah, Bidii S.; Ingasia, Luicer A.; Juma, Dennis W.; Muiruri, Peninah; Cheruiyot, Jelagat; Opot, Benjamin; Akala, Hoseah M.; Bulimo, Wallace; Andagalu, Ben; Kamau, Edwin] Kenya Med Res Inst KEMRI, Walter Reed Project, US Army Med Res Directorate Kenya, Dept Emerging & Infect Dis, Kisumu, Kenya; [Chebon, Lorna J.; Ngalah, Bidii S.; Muiruri, Peninah; Imbuga, Mabel] Jomo Kenyatta Univ Agr & Technol, Coll Hlth Sci, Inst Trop Med & Infect Dis, Nairobi, Kenya; [Mbuba, Emmanuel] Ifakara Hlth Inst, Bagamoyo, Tanzania	Kenya Medical Research Institute; Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); Jomo Kenyatta University of Agriculture & Technology; Ifakara Health Institute	Kamau, E (corresponding author), Kenya Med Res Inst KEMRI, Walter Reed Project, US Army Med Res Directorate Kenya, Dept Emerging & Infect Dis, Kisumu, Kenya.	edwin.kamau.mil@mail.mil	Bulimo, Wallace/B-1982-2014; Mbuba, Emmanuel/ABQ-7945-2022	Bulimo, Wallace/0000-0001-8475-0586; Mbuba, Emmanuel/0000-0003-0157-1780; Akala, Hoseah/0000-0001-8584-2706; Chebon, Lorna/0000-0001-7236-8750	Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System Operations	Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System Operations	This work was supported by the Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System Operations. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-254; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Anderson TJC, 2010, P ROY SOC B-BIOL SCI, V277, P2531, DOI 10.1098/rspb.2010.0196; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 2009, WORLD MAL REP 2009; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Gatei W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-353; Hamed K, 2012, EXPERT REV ANTI-INFE, V10, P645, DOI [10.1586/eri.12.51, 10.1586/ERI.12.51]; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Haubold B, 1998, GENETICS, V150, P1341; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; Iwagami M, 2009, MALAR J; Kamau E, 2014, JOURNAL OF INFECTIOU; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058; Malmberg M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-103; Malmberg M, 2013, J INFECT DIS, V207, P842, DOI 10.1093/infdis/jis747; Mbogo GW, 2014, AM J TROP MED HYG, V91, P54, DOI 10.4269/ajtmh.13-0647; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nwakanma DC, 2014, J INFECT DIS, V209, P1126, DOI 10.1093/infdis/jit618; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Ogutu BR, 2005, TROP MED INT HEALTH, V10, P484, DOI 10.1111/j.1365-3156.2005.01415.x; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okombo J, 2014, INT J PARASITOL-DRUG, V4, P152, DOI 10.1016/j.ijpddr.2014.07.003; Pandey R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1024; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pollitt LC, 2015, EVOL APPL, V8, P296, DOI 10.1111/eva.12194; Rambaut A., 2014, FIGTREE V 1 4 2 MOL; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; SOUZA V, 1992, P NATL ACAD SCI USA, V89, P8389, DOI 10.1073/pnas.89.17.8389; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tanner M, 1999, Trans R Soc Trop Med Hyg, V93 Suppl 1, P1, DOI 10.1016/S0035-9203(99)90319-X; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; Vardo-Zalik AM, 2013, AM J TROP MED HYG, V88, P29, DOI 10.4269/ajtmh.2012.12-0308; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; WHO, 2015, N ENGL J MED; Zhong D, 2007, AM J TROP MED HYG, V77, P1043, DOI 10.4269/ajtmh.2007.77.1043; Zwang J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-114	71	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162524	10.1371/journal.pone.0162524	http://dx.doi.org/10.1371/journal.pone.0162524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611315	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900123
J	Cheng, WJ; Ma, LY; Yang, TJ; Liang, JL; Zhang, Y				Cheng, Wenjun; Ma, Luyao; Yang, Tiejun; Liang, Jiali; Zhang, Yan			Joint Lung CT Image Segmentation: A Hierarchical Bayesian Approach	PLOS ONE			English	Article								Accurate lung CT image segmentation is of great clinical value, especially when it comes to delineate pathological regions including lung tumor. In this paper, we present a novel framework that jointly segments multiple lung computed tomography (CT) images via hierarchical Dirichlet process (HDP). In specifics, based on the assumption that lung CT images from different patients share similar image structure (organ sets and relative positioning), we derive a mathematical model to segment them simultaneously so that shared information across patients could be utilized to regularize each individual segmentation. Moreover, compared to many conventional models, the algorithm requires little manual involvement due to the nonparametric nature of Dirichlet process (DP). We validated proposed model upon clinical data consisting of healthy and abnormal (lung cancer) patients. We demonstrate that, because of the joint segmentation fashion, more accurate and consistent segmentations could be obtained.	[Cheng, Wenjun; Ma, Luyao; Yang, Tiejun] Taizhou Municipal Hosp, Dept Med Imaging, 381 East Zhongshan Rd, Taizhou 318000, Peoples R China; [Liang, Jiali; Zhang, Yan] China Jiliang Univ, Coll Opt & Elect Technol, Xueyuan St 258, Hangzhou 310018, Peoples R China	Taizhou University; China Jiliang University	Zhang, Y (corresponding author), China Jiliang Univ, Coll Opt & Elect Technol, Xueyuan St 258, Hangzhou 310018, Peoples R China.	05A0402032@cjlu.edu.cn						Farahani FV, 2015, 2015 IEEE CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P47; FERGUSON TS, 1973, THE ANNALS OF STATIS, P209, DOI DOI 10.1214/A0S/1176342360; HOFFMAN EA, 1983, J APPL PHYSIOL, V55, P935, DOI 10.1152/jappl.1983.55.3.935; Jbabdi S, 2009, NEUROIMAGE, V44, P373, DOI 10.1016/j.neuroimage.2008.08.044; MacEachern SN, 1998, J COMPUT GRAPH STAT, V7, P223, DOI 10.2307/1390815; Mesanovic N., 2011, 18 INT C SYSTEMS SIG, P395, DOI 1016/j.compmedimag.2008.04.005; ONOMA DP, 2012, BIOM IM ISBI 2012 9, P1260; Orbanz P, 2008, INT J COMPUT VISION, V77, P25, DOI 10.1007/s11263-007-0061-0; Pu J, 2008, COMPUT MED IMAG GRAP, V32, P452, DOI 10.1016/j.compmedimag.2008.04.005; Sun SH, 2012, IEEE T MED IMAGING, V31, P449, DOI 10.1109/TMI.2011.2171357; Sun Shanhui, 2011, 4 INT WORKSH PULM IM; Tan YQ, 2013, MED PHYS, V40, DOI 10.1118/1.4793409; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P924, DOI 10.1109/TMI.2002.803121; Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050	15	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162211	10.1371/journal.pone.0162211	http://dx.doi.org/10.1371/journal.pone.0162211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611188	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900057
J	Gallo, S; Gili, M; Lombardo, G; Rossetti, A; Rosso, A; Dentelli, P; Togliatto, G; Deregibus, MC; Taverna, D; Camussi, G; Brizzi, MF				Gallo, Sara; Gili, Maddalena; Lombardo, Giusy; Rossetti, Alberto; Rosso, Arturo; Dentelli, Patrizia; Togliatto, Gabriele; Deregibus, Maria Chiara; Taverna, Daniela; Camussi, Giovanni; Brizzi, Maria Felice			Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; TGF-BETA; RENAL FIBROSIS; HORIZONTAL TRANSFER; MICROVESICLES; MIR-21; COMPLICATIONS; DISEASE; INJURY; CLASSIFICATION	Extracellular vesicles (EVs) that are derived from stem cells are proving to be promising therapeutic options. We herein investigate the therapeutic potential of EVs that have been derived from different stem cell sources, bone-marrow (MSC) and human liver (HLSC), on mesangial cells (MCs) exposed to hyperglycaemia. By expressing a dominant negative STAT5 construct (Delta NSTAT5) in HG-cultured MCs, we have demonstrated that miR-21 expression is under the control of STAT5, which translates into Transforming Growth Factor beta (TGF beta) expression and collagen production. A number of approaches have been used to show that both MSC-and HLSC-derived EVs protect MCs from HG-induced damage via the transfer of miR-222. This resulted in STAT5 down-regulation and a decrease in miR-21 content, TGF beta expression and matrix protein synthesis within MCs. Moreover, we demonstrate that changes in the balance between miR-21 and miR-100 in the recipient cell, which are caused by the transfer of EV cargo, further contribute to providing beneficial effects. Interestingly, these effects were only detected in HG-cultured cells. Finally, it was found that HG reduced the expression of the nuclear encoded mitochondrial electron transport chain (ETC) components, CoxIV. It is worth noting that EV administration can rescue CoxIV expression in HG-cultured MCs. These results thus demonstrate that both MSC-and HLSC-derived EVs transfer the machinery needed to preserve MCs from HG-mediated damage. This occurs via the horizontal transfer of functional miR-222 which directly interferes with damaging cues. Moreover, our data indicate that the release of EV cargo into recipient cells provides additional therapeutic advantages against harmful mitochondrial signals.	[Gallo, Sara; Gili, Maddalena; Lombardo, Giusy; Rossetti, Alberto; Rosso, Arturo; Dentelli, Patrizia; Togliatto, Gabriele; Deregibus, Maria Chiara; Camussi, Giovanni; Brizzi, Maria Felice] Univ Turin, Dept Med Sci, Turin, Italy; [Taverna, Daniela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Camussi, G; Brizzi, MF (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giovanni.camussi@unito.it; mariafelice.brizzi@unito.it	Brizzi, Maria Felice/J-7882-2016; Camussi, Giovanni/J-7624-2016; Togliatto, Gabriele/K-5668-2016	Camussi, Giovanni/0000-0003-2795-232X; Togliatto, Gabriele/0000-0002-3123-7823	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 12890, IG 17630]; Ministero dell'Istruzione, Universita e Ricerca (MIUR)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by grants obtained by GC and MFB from the Associazione Italiana per la Ricerca sul Cancro (AIRC) projects IG 12890 and IG 17630 and by grants obtained by MFB from Ministero dell'Istruzione, Universita e Ricerca (MIUR) ex 60%.	Ahmadi M, 2015, CELL MOL BIOL, V61, P100; Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007; Brizzi MF, 2004, FASEB J, V18, P1249, DOI 10.1096/fj.03-1053fje; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Bussolati B, 1999, AM J PATHOL, V154, P623, DOI 10.1016/S0002-9440(10)65307-2; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Dentelli P, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28758; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Feuermann Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085123; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gili M, 2013, ENDOCRINE, V44, P557, DOI 10.1007/s12020-013-9936-8; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Granata A, 2016, EUR J INTERN MED, V30, P1, DOI 10.1016/j.ejim.2016.02.019; Haneda M, 2015, CLIN EXP NEPHROL, V19, P1, DOI 10.1007/s10157-014-1057-z; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Iavello A, 2016, INT J MOL MED, V37, P958, DOI 10.3892/ijmm.2016.2488; Iliopoulos D, 2011, EUR J IMMUNOL, V41, P1754, DOI 10.1002/eji.201040646; Kholia S, 2016, VASCUL PHARM; Lai JY, 2015, J AM SOC NEPHROL, V26, P805, DOI 10.1681/ASN.2013121274; Lombardo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25689; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Ning L, 2014, AM J PATHOL, V184, P1683, DOI 10.1016/j.ajpath.2014.02.006; Osipova J, 2014, J CLIN ENDOCR METAB, V99, pE1661, DOI 10.1210/jc.2013-3868; Pinatel EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084859; Pugliese G, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-59; Qi R, 2014, RENAL FAILURE, V36, P589, DOI 10.3109/0886022X.2014.882713; Quesenberry PJ, 2014, STEM CELLS DEV, V23, P1429, DOI 10.1089/scd.2013.0594; Ratajczak MZ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0087-4; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Togliatto G, 2016, INT J OBESITY, V40, P102, DOI 10.1038/ijo.2015.123; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215; Zhang L, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0103-3; Zhang NJ, 2014, ONCOL REP, V32, P1409, DOI 10.3892/or.2014.3389; Zhang N, 2015, ONCOL REP, V33, P1493, DOI 10.3892/or.2015.3710; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhu HL, 2013, J CLIN IMMUNOL, V33, P1100, DOI 10.1007/s10875-013-9896-z	50	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162417	10.1371/journal.pone.0162417	http://dx.doi.org/10.1371/journal.pone.0162417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611075	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900095
J	Liu, XW; Sun, HY; Feike, T; Zhang, XY; Shao, LW; Chen, SY				Liu, Xiuwei; Sun, Hongyong; Feike, Til; Zhang, Xiying; Shao, Liwei; Chen, Suying			Assessing the Impact of Air Pollution on Grain Yield of Winter Wheat - A Case Study in the North China Plain	PLOS ONE			English	Article							PHOTOSYNTHETICALLY ACTIVE RADIATION; MODELING CANOPY PHOTOSYNTHESIS; ATMOSPHERIC AEROSOL; GLOBAL RADIATION; DIRECT COMPONENT; SOLAR-RADIATION; CROP PRODUCTION; USE EFFICIENCY; CLIMATE-CHANGE; REGIONAL HAZE	The major wheat production region of China the North China Plain (NCP) is seriously affected by air pollution. In this study, yield of winter wheat (Triticum aestivum L.) was analyzed with respect to the potential impact of air pollution index under conditions of optimal crop management in the NCP from 2001 to 2012. Results showed that air pollution was especially serious at the early phase of winter wheat growth significantly influencing various weather factors. However, no significant correlations were found between final grain yield and the weather factors during the early growth phase. In contrast, significant correlations were found between grain yield and total solar radiation gap, sunshine hour gap, diurnal temperature range and relative humidity during the late growing phase. To disentangle the confounding effects of various weather factors, and test the isolated effect of air pollution induced changes in incoming global solar radiation on yield under ceteris paribus conditions, crop model based scenario-analysis was conducted. The simulation results of the calibrated Agricultural Production Systems Simulator (APSIM) model indicated that a reduction in radiation by 10% might cause a yield reduction by more than 10%. Increasing incident radiation by 10% would lead to yield increases of (only) 7%, with the effects being much stronger during the late growing phase compared to the early growing phase. However, there is evidence that APSIM overestimates the effect of air pollution induced changes on radiation, as it does not consider the changes in radiative properties of solar insulation, i.e. the relative increase of diffuse over direct radiation, which may partly alleviate the negative effects of reduced total radiation by air pollution. Concluding, the present study could not detect a significantly negative effect of air pollution on wheat yields in the NCP.	[Liu, Xiuwei; Sun, Hongyong; Zhang, Xiying; Shao, Liwei; Chen, Suying] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Peoples R China; [Liu, Xiuwei] Texas A&M AgriLife Res & Extens Ctr, Uvalde, TX USA; [Feike, Til] Inst Strategies & Technol Assessment, Fed Res Ctr Cultivated Plants, JKI, Kleinmachnow, Germany	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Peoples R China.	xyzhang@sjziam.ac.cn	sun, hongyong/AAF-5679-2020	Feike, Til/0000-0002-1978-9473; Sun, Hongyong/0000-0002-5132-7738	Special Fund for Agro-scientific Research in China [201203077, 201303133]; Hebei ST Project [14227007D]	Special Fund for Agro-scientific Research in China; Hebei ST Project	This study was supported by the Special Fund for Agro-scientific Research in China (201203077 and 201303133) and Hebei S&T Project (14227007D).; This study was supported by the Special Fund for Agro-scientific Research in China (201203077 and 201303133) and Hebei S&T Project (14227007D). Special appreciation is extended to Dr. Xuejun Dong for his help in improving the English writing of this paper.	Akitsu T, 2015, AGR FOREST METEOROL, V209, P59, DOI 10.1016/j.agrformet.2015.04.026; Alton PB, 2007, GLOBAL CHANGE BIOL, V13, P776, DOI 10.1111/j.1365-2486.2007.01316.x; Andreae MO, 2008, ATMOS ENVIRON, V42, P6335, DOI 10.1016/j.atmosenv.2008.01.030; Anwar MR, 2007, FIELD CROP RES, V104, P139, DOI 10.1016/j.fcr.2007.03.020; Asseng S, 2000, EUR J AGRON, V12, P37, DOI 10.1016/S1161-0301(99)00044-1; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Bodin P, 2012, GEOSCI MODEL DEV, V5, P535, DOI 10.5194/gmd-5-535-2012; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; Chameides WL, 1999, P NATL ACAD SCI USA, V96, P13626, DOI 10.1073/pnas.96.24.13626; Che HZ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022322; Chen C, 2010, CLIMATIC CHANGE, V100, P559, DOI 10.1007/s10584-009-9690-3; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coe H, 2011, SCIENCE, V331, P1273, DOI 10.1126/science.1203019; Cogliani E, 2001, ATMOS ENVIRON, V35, P2871, DOI 10.1016/S1352-2310(01)00071-1; Gao W, 2003, AGR FOREST METEOROL, V120, P141, DOI 10.1016/j.agrformet.2003.08.026; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Jing X, 2010, ATMOS CHEM PHYS, V10, P8205, DOI 10.5194/acp-10-8205-2010; Kolar P, 2014, THEOR APPL CLIMATOL, V117, P707, DOI 10.1007/s00704-013-1037-3; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Li WG, 2011, THEOR APPL CLIMATOL, V104, P473, DOI 10.1007/s00704-010-0360-1; Liu N, 2015, CROP PROT, V74, P150, DOI 10.1016/j.cropro.2015.05.001; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Massie ST, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004620; MCCREE KJ, 1972, AGR METEOROL, V10, P443, DOI 10.1016/0002-1571(72)90045-3; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Moan J., 2001, RAD HOME OUTDOORS WO, P69; Moschini RC, 1999, PLANT DIS, V83, P381, DOI 10.1094/PDIS.1999.83.4.381; MOTT KA, 1991, PLANT CELL ENVIRON, V14, P509, DOI 10.1111/j.1365-3040.1991.tb01521.x; Munz S, 2014, AGR FOREST METEOROL, V195, P152, DOI 10.1016/j.agrformet.2014.05.009; Niyogi D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020915; Norris JR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007794; Roderick ML, 1999, AGR FOREST METEOROL, V95, P169, DOI 10.1016/S0168-1923(99)00028-3; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P231, DOI 10.1016/0168-1923(86)90061-4; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P217, DOI 10.1016/0168-1923(86)90060-2; Streets DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026471; Sun H, 2013, INT J PLANT PROD, V7, P117; Sun HY, 2015, EUR J AGRON, V70, P48, DOI 10.1016/j.eja.2015.07.001; Sun HY, 2014, AGRON J, V106, P281, DOI 10.2134/agronj2013.0309; Sun YL, 2012, ATMOS ENVIRON, V51, P250, DOI 10.1016/j.atmosenv.2012.01.013; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Wang E, 2003, SOL BETT ENV P 11 AU; Wang FX, 2014, INT J CLIMATOL, V34, P343, DOI 10.1002/joc.3690; Wang J, 2015, FIELD CROP RES, V176, P1, DOI 10.1016/j.fcr.2015.02.014; Wang YW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054004; Wang YW, 2013, CLIM RES, V56, P11, DOI 10.3354/cr01139; Wang YW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016753; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Xiao DP, 2016, FRONT EARTH SCI-PRC, V10, P444, DOI 10.1007/s11707-015-0534-3; Xiao DP, 2014, EUR J AGRON, V52, P112, DOI 10.1016/j.eja.2013.09.020; Zhang TY, 2013, INT J CLIMATOL, V33, P699, DOI 10.1002/joc.3463; Zhang XY, 2012, ATMOS CHEM PHYS, V12, P779, DOI 10.5194/acp-12-779-2012; Zhang XY, 2013, EUR J AGRON, V50, P52, DOI 10.1016/j.eja.2013.05.005; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zheng B., 2014, THE APSIM WHEAT MODU	56	7	8	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162655	10.1371/journal.pone.0162655	http://dx.doi.org/10.1371/journal.pone.0162655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612146	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900144
J	Martin, OMF; Etheve, L; Launay, G; Martin, J				Martin, Olivier M. F.; Etheve, Loic; Launay, Guillaume; Martin, Juliette			Implication of Terminal Residues at Protein-Protein and Protein-DNA Interfaces	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; COMPLEXES; PRINCIPLES; PREDICTION; REGIONS; CHAINS; DOMAIN	Terminal residues of protein chains are charged and more flexible than other residues since they are constrained only on one side. Do they play a particular role in protein-protein and protein-DNA interfaces? To answer this question, we considered large sets of non-redundant protein-protein and protein-DNA complexes and analyzed the status of terminal residues and their involvement in interfaces. In protein-protein complexes, we found that more than half of terminal residues (62%) are either modified by attachment of a tag peptide (10%) or have missing coordinates in the analyzed structures (52%). Terminal residues are almost exclusively located at the surface of proteins (94%). Contrary to charged residues, they are not over or under-represented in protein-protein interfaces, but strongly prefer the peripheral region of interfaces when present at the interface (83% of terminal residues). The almost exclusive location of terminal residues at the surface of the proteins or in the rim regions of interfaces explains that experimental methods relying on tail hybridization can be successfully applied without disrupting the complexes under study. Concerning conformational rearrangement in protein-protein complexes, despite their expected flexibility, terminal residues adopt similar locations between the free and bound forms of the docking benchmark. In protein-DNA complexes, N-terminal residues are twice more frequent than C-terminal residues at interfaces. Both N-terminal and C-terminal residues are under-represented in interfaces, in contrast to positively charged residues, which are strongly favored. When located in protein-DNA interfaces, terminal residues prefer the periphery. N-terminal and C-terminal residues thus have particular properties with regard to interfaces, which cannot be reduced to their charged nature.	[Martin, Olivier M. F.; Etheve, Loic; Launay, Guillaume; Martin, Juliette] Univ Lyon, CNRS, UMR 5086, MMSB, 7 Passage Vercors, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Martin, J (corresponding author), Univ Lyon, CNRS, UMR 5086, MMSB, 7 Passage Vercors, F-69367 Lyon, France.	juliette.martin@ibcp.fr	Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016; Martin, Olivier M. F./P-8253-2019	Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885; Martin, Olivier M. F./0000-0003-3661-7208; Etheve, Loic/0000-0003-4896-0791; Launay, Guillaume/0000-0003-0177-8706	Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir) [ANR-11-BINF-003]	Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir)(French National Research Agency (ANR))	This work was funded by Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir) (grant numbers: ANR-11-BINF-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir); Grant numbers: ANR-11-BINF-003. We thank Raphael Guerois for providing data regarding the InterEvol dataset.	Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Block P, 2006, PROTEINS, V65, P607, DOI 10.1002/prot.21104; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Christopher JA, 1996, J MOL BIOL, V257, P175, DOI 10.1006/jmbi.1996.0154; Coulocheri SA, 2007, BIOCHIMIE, V89, P1291, DOI 10.1016/j.biochi.2007.07.020; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; De la Pena M, 2007, EMBO J, V26, P4913, DOI 10.1038/sj.emboj.7601912; Faure G, 2012, NUCLEIC ACIDS RES, V40, pD847, DOI 10.1093/nar/gkr845; Horton JR, 2006, NUCLEIC ACIDS RES, V34, P939, DOI 10.1093/nar/gkj484; Hubbard SJ, NACCESS COMPUTER PRO; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Kuttner YY, 2012, J MOL BIOL, V415, P419, DOI 10.1016/j.jmb.2011.11.009; Laio A, 2006, PROTEINS, V62, P17, DOI 10.1002/prot.20712; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Martin J, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-7; Mezei M, 2015, ALGORITHMS, V8, P92, DOI 10.3390/a8020092; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pal D, 2000, BIOPOLYMERS, V53, P467, DOI 10.1002/(SICI)1097-0282(200005)53:6<467::AID-BIP3>3.0.CO;2-9; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reverter D, 2000, NAT STRUCT BIOL, V7, P322, DOI 10.1038/74092; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Schneider B, 2014, NUCLEIC ACIDS RES, V42, P3381, DOI 10.1093/nar/gkt1273; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; THORNTON JM, 1983, J MOL BIOL, V167, P443, DOI 10.1016/S0022-2836(83)80344-1; Toth-Petroczy A, 2009, J AM CHEM SOC, V131, P15084, DOI 10.1021/ja9052784; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; vanPouderoyen G, 1997, EMBO J, V16, P6044, DOI 10.1093/emboj/16.19.6044; Vreven T, 2015, J MOL BIOL, V427, P3031, DOI 10.1016/j.jmb.2015.07.016; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	45	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162143	10.1371/journal.pone.0162143	http://dx.doi.org/10.1371/journal.pone.0162143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611671	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900048
J	Ricci, L; Taffoni, F; Formica, D				Ricci, Luca; Taffoni, Fabrizio; Formica, Domenico			On the Orientation Error of IMU: Investigating Static and Dynamic Accuracy Targeting Human Motion	PLOS ONE			English	Article							ATTITUDE ESTIMATION; CALIBRATION; SENSORS	The accuracy in orientation tracking attainable by using inertial measurement units (IMU) when measuring human motion is still an open issue. This study presents a systematic quantification of the accuracy under static conditions and typical human dynamics, simulated by means of a robotic arm. Two sensor fusion algorithms, selected from the classes of the stochastic and complementary methods, are considered. The proposed protocol implements controlled and repeatable experimental conditions and validates accuracy for an extensive set of dynamic movements, that differ in frequency and amplitude of the movement. We found that dynamic performance of the tracking is only slightly dependent on the sensor fusion algorithm. Instead, it is dependent on the amplitude and frequency of the movement and a major contribution to the error derives from the orientation of the rotation axis w.r.t. the gravity vector. Absolute and relative errors upper bounds are found respectively in the range [0.7 degrees divided by 8.2 degrees]and [1.0 degrees divided by 10.3 degrees]. Alongside dynamic, static accuracy is thoroughly investigated, also with an emphasis on convergence behavior of the different algorithms. Reported results emphasize critical issues associated with the use of this technology and provide a baseline level of performance for the human motion related application.	[Ricci, Luca; Taffoni, Fabrizio; Formica, Domenico] Univ Campus Biomed Roma, Dept Engn, Unit Biomed Robot & Biomicrosyst, Via Alvaro del Portillo 21, I-00128 Rome, Italy	University Campus Bio-Medico - Rome Italy	Formica, D (corresponding author), Univ Campus Biomed Roma, Dept Engn, Unit Biomed Robot & Biomicrosyst, Via Alvaro del Portillo 21, I-00128 Rome, Italy.	d.formica@unicampus.it	Taffoni, Fabrizio/AAC-2572-2019; Formica, Domenico/G-9403-2011	Taffoni, Fabrizio/0000-0003-3215-1375; Formica, Domenico/0000-0003-0240-1265	Ministry of Education, University and Research under "FIRB\Futuro in Ricerca" research program (TOUM project) [RBFR086HEW]	Ministry of Education, University and Research under "FIRB\Futuro in Ricerca" research program (TOUM project)	This work was funded by the Italian Ministry of Education, University and Research under the "FIRB\Futuro in Ricerca" research program (TOUM project, no. RBFR086HEW).	Bachmann BYER, 2007, IEEE ROBOTICS AUTOMA; Barralon P, 2005, P ANN INT IEEE EMBS, P2447, DOI 10.1109/IEMBS.2005.1616963; Bergamini E, 2014, SENSORS-BASEL, V14, P18625, DOI 10.3390/s141018625; Brodie M., 2008, SPORTS TECHNOL, V1, P17, DOI [10.1080/19346182.2008.9648447, DOI 10.1080/19346182.2008.9648447, DOI 10.1002/JST.6]; Brodie MA, 2008, COMPUT METHOD BIOMEC, V11, P641, DOI 10.1080/10255840802326736; Campolo D, 2009, ADV ROBOTICS, V23, P955, DOI 10.1163/156855309X443052; Cooper G, 2009, J BIOMECH, V42, P2678, DOI 10.1016/j.jbiomech.2009.08.004; Crassidis JL, 2007, J GUID CONTROL DYNAM, V30, P12, DOI 10.2514/1.22452; Cutti AG, 2006, SIMPLE TEST ASSESS S, P5912; Cutti AG, 2010, MED BIOL ENG COMPUT, V48, P17, DOI 10.1007/s11517-009-0545-x; de Vries WHK, 2010, J BIOMECH, V43, P1983, DOI 10.1016/j.jbiomech.2010.03.007; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; Godwin A, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000109; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Lebel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118361; Lebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079945; Luinge HJ, 2007, J BIOMECH, V40, P78, DOI 10.1016/j.jbiomech.2005.11.011; Madgwick SOH, 2011, INT C REHAB ROBOT; Mahony R, 2008, IEEE T AUTOMAT CONTR, V53, P1203, DOI 10.1109/TAC.2008.923738; Mann KA, 1989, FREQUENCY SPECTRUM A, P304; Picerno P, 2011, GAIT POSTURE, V33, P373, DOI 10.1016/j.gaitpost.2010.12.006; Ricci L, 2014, SENSORS-BASEL, V14, P1057, DOI 10.3390/s140101057; Roetenberg D., INERTIAL MAGNETIC SE; Roetenberg D, 2007, IEEE T BIO-MED ENG, V54, P883, DOI 10.1109/TBME.2006.889184; Sabatini AM, 2002, MED BIOL ENG COMPUT, V2005, P43; Sabatini AM, 2011, SENSORS-BASEL, V11, P9182, DOI 10.3390/s111009182; Tian Y, 2013, IEEE T NEUR SYS REH, V21, P254, DOI 10.1109/TNSRE.2012.2205706; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8	28	42	42	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161940	10.1371/journal.pone.0161940	http://dx.doi.org/10.1371/journal.pone.0161940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612100	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900040
J	Selby, MJ; Engelhardt, JJ; Johnston, RJ; Lu, LS; Han, MH; Thudium, K; Yao, DP; Quigley, M; Valle, J; Wang, CY; Chen, B; Cardarelli, PM; Blanset, D; Korman, AJ				Selby, Mark J.; Engelhardt, John J.; Johnston, Robert J.; Lu, Li-Sheng; Han, Minhua; Thudium, Kent; Yao, Dapeng; Quigley, Michael; Valle, Jose; Wang, Changyu; Chen, Bing; Cardarelli, Pina M.; Blanset, Diann; Korman, Alan J.			Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; REGULATORY T; PD-1 BLOCKADE; PROGRAMMED DEATH-1; ANTITUMOR-ACTIVITY; CTLA-4; CELLS; CANCER; ANTIBODY; STIMULATION	The monoclonal antibodies ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) have shown remarkable antitumor activity in an increasing number of cancers. When combined, ipilimumab and nivolumab have demonstrated superior activity in patients with metastatic melanoma (CHECKMATE-067). Here we describe the preclinical development strategy that predicted these clinical results. Synergistic antitumor activity in mouse MC38 and CT26 colorectal tumor models was observed with concurrent, but not sequential CTLA-4 and PD1 blockade. Significant antitumor activity was maintained using a fixed dose of anti-CTLA-4 antibody with decreasing doses of anti-PD-1 antibody in the MC38 model. Immunohistochemical and flow cytometric analyses confirmedthat CD3(+) T cells accumulated at the tumor margin and infiltrated the tumor mass in response to the combination therapy, resulting in favorable effector and regulatory T-cell ratios, increased pro-inflammatory cytokine secretion, and activation of tumor-specific T cells. Similarly, in vitro studies with combined ipilimumab and nivolumab showed enhanced cytokine secretion in superantigen stimulation of human peripheral blood lymphocytes and in mixed lymphocyte response assays. In a cynomolgus macaque toxicology study, dose-dependent immune-related gastrointestinal inflammation was observed with the combination therapy; this response had not been observed in previous single agent cynomolgus studies. Together, these in vitro assays and in vivo models comprise a preclinical strategy for the identification and development of highly effective antitumor combination immunotherapies.	[Selby, Mark J.; Engelhardt, John J.; Johnston, Robert J.; Lu, Li-Sheng; Han, Minhua; Thudium, Kent; Yao, Dapeng; Quigley, Michael; Valle, Jose; Wang, Changyu; Chen, Bing; Cardarelli, Pina M.; Blanset, Diann; Korman, Alan J.] Bristol Myers Squibb, Redwood City, CA 94063 USA	Bristol-Myers Squibb	Korman, AJ (corresponding author), Bristol Myers Squibb, Redwood City, CA 94063 USA.	alan.korman@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	The studies described in this manuscript were sponsored by Bristol-Myers Squibb. The funder provided support in the form of salaries for all authors (MJS JJE RJJ LL MH KT DY MQ JV CW BC PMC DB AJK) and was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the Authors' Contributions section. In addition, the funder provided support in the form of salaries to individuals listed in the Acknowledgements section (LW MS IC CB).	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Antonia S., 2016, LANCET ONCOL; Brahmer JR, 2015, FUTURE ONCOL, V11, P1307, DOI 10.2217/fon.15.52; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Dasari A, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3563; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hellman MD, 2016, J CLIN ONCOL S, V34; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Keler T, 2003, J IMMUNOL, V171, P6251, DOI 10.4049/jimmunol.171.11.6251; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; LEBELBINAY S, 1995, EUR J IMMUNOL, V25, P2340, DOI 10.1002/eji.1830250833; Li B, 2009, CLIN CANCER RES, V15, P1623, DOI 10.1158/1078-0432.CCR-08-1825; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ngiow SF, 2015, CANCER RES, V75, P3800, DOI 10.1158/0008-5472.CAN-15-1082; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ueha S, 2015, CANCER IMMUNOL RES, V3, P631, DOI 10.1158/2326-6066.CIR-14-0190; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Walker LSK, 2015, TRENDS IMMUNOL, V36, P63, DOI 10.1016/j.it.2014.12.001; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_supll.9505; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	56	145	156	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161779	10.1371/journal.pone.0161779	http://dx.doi.org/10.1371/journal.pone.0161779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610613	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900029
J	Shin, MH; Lee, SR; Kim, MK; Shin, CY; Lee, DH; Chung, JH				Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho			Activation of Peroxisome Proliferator-Activated Receptor Alpha Improves Aged and UV-Irradiated Skin by Catalase Induction	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HUMAN DERMAL FIBROBLASTS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ULTRAVIOLET; INFLAMMATION; MECHANISMS; MODULATION; RESPONSES; EPIDERMIS	Peroxisome proliferator-activated receptor alpha (PPAR alpha) is a nuclear hormone receptor involved in the transcriptional regulation of lipid metabolism, fatty acid oxidation, and glucose homeostasis. Its activation stimulates antioxidant enzymes such as catalase, whose expression is decreased in aged human skin. Here we investigated the expression of PPAR alpha in aged and ultraviolet (UV)-irradiated skin, and whether PPAR alpha activation can modulate expressions of matrix metalloproteinase (MMP)-1 and procollagen through catalase regulation. We found that PPAR alpha mRNA level was significantly decreased in intrinsically aged and photoaged human skin as well as in UV-irradiated skin. A PPAR alpha activator, Wy14643, inhibited UV-induced increase of MMP-1 and decrease of procollagen expression and caused marked increase in catalase expression. Furthermore, production of reactive oxygen species (ROS) was suppressed by Wy14643 in UV-irradiated and aged dermal fibroblasts, suggesting that the PPAR alpha activation-induced upregulation of catalase leads to scavenging of ROS produced due to UV irradiation or aging. PPAR alpha knockdown decreased catalase expression and abolished the beneficial effects of Wy14643. Topical application of Wy14643 on hairless mice restored catalase activity and prevented MMP-13 and inflammatory responses in skin. Our findings indicate that PPAR alpha activation triggers catalase expression and ROS scavenging, thereby protecting skin from UV-induced damage and intrinsic aging.	[Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho] Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Seoul, South Korea; [Chung, Jin Ho] Seoul Natl Univ, Inst Aging, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, DH; Chung, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.; Lee, DH; Chung, JH (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.; Lee, DH; Chung, JH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Seoul, South Korea.; Chung, JH (corresponding author), Seoul Natl Univ, Inst Aging, Seoul, South Korea.	ivymed27@snu.ac.kr; jhchung@snu.ac.kr	Lee, Dong Hun/AAS-6021-2021		Korea Research Foundation; Basic Science Research program through the National Research Foundation (NRF) of Korea [2009-2-E00032]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0089]	Korea Research Foundation(National Research Foundation of Korea); Basic Science Research program through the National Research Foundation (NRF) of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of Korea Research Foundation and Basic Science Research program through the National Research Foundation (NRF) of Korea (2009-2-E00032) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C0089).	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Briganti S, 2013, EXP DERMATOL, V22, P41, DOI 10.1111/exd.12066; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Ghosh AK, 2004, ARTHRITIS RHEUM-US, V50, P1305, DOI 10.1002/art.20104; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gupta M, 2015, ARCH DERMATOL RES, V307, P767, DOI 10.1007/s00403-015-1571-1; Hatano Y, 2010, J ALLERGY CLIN IMMUN, V125, P160, DOI 10.1016/j.jaci.2009.06.049; Howroyd P, 2004, TOXICOL PATHOL, V32, P591, DOI 10.1080/01926230490515283; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; Inoue I, 1998, LIFE SCI, V63, P135, DOI 10.1016/S0024-3205(98)00249-5; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jeon Y, 2014, BIOCHEM BIOPH RES CO, V450, P1553, DOI 10.1016/j.bbrc.2014.07.026; Kawaguchi Y, 1996, ARCH DERMATOL RES, V288, P39, DOI 10.1007/BF02505041; Kim JK, 2012, EXP DERMATOL, V21, P211, DOI 10.1111/j.1600-0625.2011.01435.x; Kippenberger S, 2001, J INVEST DERMATOL, V117, P1430, DOI 10.1046/j.0022-202x.2001.01537.x; Kwok HH, 2012, BIOCHEM PHARMACOL, V84, P532, DOI 10.1016/j.bcp.2012.05.023; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Lee YM, 2011, ARCH DERMATOL RES, V303, P727, DOI 10.1007/s00403-011-1153-9; Li JL, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-32; Meissner M, 2011, CLIN EXP DERMATOL, V36, P911, DOI 10.1111/j.1365-2230.2011.04125.x; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Naderi-Hachtroudi L, 2002, ARCH DERMATOL, V138, P1473, DOI 10.1001/archderm.138.11.1473; Park MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076820; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Rhie GE, 2001, J INVEST DERMATOL, V117, P1212, DOI 10.1046/j.0022-202x.2001.01469.x; Rhie GE, 2001, MOL CELLS, V11, P399; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Seo JY, 2001, J INVEST DERMATOL, V116, P915, DOI 10.1046/j.1523-1747.2001.01358.x; Sheu MY, 2002, J INVEST DERMATOL, V118, P94, DOI 10.1046/j.0022-202x.2001.01626.x; Shin MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061696; Shin MH, 2012, MECH AGEING DEV, V133, P92, DOI 10.1016/j.mad.2012.01.006; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; SMITH WL, 1994, ANN NY ACAD SCI, V714, P136, DOI 10.1111/j.1749-6632.1994.tb12037.x; Staumont-Salle D, 2008, J ALLERGY CLIN IMMUN, V121, P962, DOI 10.1016/j.jaci.2007.12.1165; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575; Zhang GY, 2010, J PLAST RECONSTR AES, V63, P1209, DOI 10.1016/j.bjps.2009.06.032	47	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162628	10.1371/journal.pone.0162628	http://dx.doi.org/10.1371/journal.pone.0162628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611371	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900137
J	Abramson, CI; Dinges, CW; Wells, H				Abramson, Charles I.; Dinges, Christopher W.; Wells, Harrington			Operant Conditioning in Honey Bees (Apis mellifera L.): The Cap Pushing Response	PLOS ONE			English	Article							STING EXTENSION REFLEX; PROBOSCIS EXTENSION; DECISION-MAKING; LEARNED NONUSE; MEMORY; REPRESENTATIONS; MECHANISMS; PARADIGM; BEHAVIOR; NEURONS	The honey bee has been an important model organism for studying learning and memory. More recently, the honey bee has become a valuable model to understand perception and cognition. However, the techniques used to explore psychological phenomena in honey bees have been limited to only a few primary methodologies such as the proboscis extension reflex, sting extension reflex, and free flying target discrimination-tasks. Methods to explore operant conditioning in bees and other invertebrates are not as varied as with vertebrates. This may be due to the availability of a suitable response requirement. In this manuscript we offer a new method to explore operant conditioning in honey bees: the cap pushing response (CPR). We used the CPR to test for difference in learning curves between novel auto-shaping and more traditional explicit-shaping. The CPR protocol requires bees to exhibit a novel behavior by pushing a cap to uncover a food source. Using the CPR protocol we tested the effects of both explicit-shaping and auto-shaping techniques on operant conditioning. The goodness of fit and lack of fit of these data to the Rescorla-Wagner learning-curve model, widely used in classical conditioning studies, was tested. The model fit well to both control and explicit-shaping results, but only for a limited number of trials. Learning ceased rather than continuing to asymptotically approach the physiological most accurate possible. Rate of learning differed between shaped and control bee treatments. Learning rate was about 3 times faster for shaped bees, but for all measures of proficiency control and shaped bees reached the same level. Auto-shaped bees showed one-trial learning rather than the asymptotic approach to a maximal efficiency. However, in terms of return-time, the auto-shaped bees' learning did not carry over to the covered-well test treatments.	[Abramson, Charles I.; Dinges, Christopher W.] Oklahoma State Univ, Lab Comparat Psychol & Behav Biol, Stillwater, OK 74078 USA; [Wells, Harrington] Univ Tulsa, Dept Biol, Tulsa, OK 74104 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Tulsa	Abramson, CI (corresponding author), Oklahoma State Univ, Lab Comparat Psychol & Behav Biol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu		, Charles/0000-0001-8961-3089	Chilean grant agency Conicyt - PAI; Pontificia Universidad Catolica de Valparaiso Chile; National Science Foundation [DBI 1560389, OISE 1545803, GRF 1144467]; Div Of Biological Infrastructure [1560389] Funding Source: National Science Foundation	Chilean grant agency Conicyt - PAI; Pontificia Universidad Catolica de Valparaiso Chile; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by grants from the Chilean grant agency Conicyt - PAI, the Pontificia Universidad Catolica de Valparaiso Chile, and National Science Foundation grants, DBI 1560389, OISE 1545803, and GRF 1144467. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by grants from the Chilean grant agency Conicyt-PAI, the Pontificia Universidad Catolica de Valparaiso Chile, and National Science Foundation grants DBI 1560389, OISE 1545803, and GRF 1144467. We would like to thank Ms. Solange Elizabeth Huaiquil for her assistance in Chile.	Abramson C. I., 1990, INVERTEBRATE LEARNIN; Abramson C. I., 1994, PRIMER INVERTEBRATE; Abramson Charles I., 2011, P25; Abramson CI, 2010, ETHOLOGY, V116, P843, DOI 10.1111/j.1439-0310.2010.01796.x; Abramson CI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.12201; Abramson CI, 2004, ENVIRON ENTOMOL, V33, P378, DOI 10.1603/0046-225X-33.2.378; Abramson CI, 2001, J ENTOMOL SCI, V36, P78, DOI 10.18474/0749-8004-36.1.78; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; ABRAMSON CI, 1997, RES DEV COMP PSY, P55; Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Avargues-Weber A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1907; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ballester BR, 2015, INT C VIRT REH ICVR; Barron AB, 2016, P NATL ACAD SCI USA, V113, P4900, DOI 10.1073/pnas.1520084113; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brembs B, 2003, CURR OPIN NEUROBIOL, V13, P710, DOI 10.1016/j.conb.2003.10.002; Cakmak I, 2009, ANIM BEHAV, V77, P1273, DOI 10.1016/j.anbehav.2009.01.032; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; Cordoba SA, 2011, ANN BOT-LONDON, V108, P919, DOI 10.1093/aob/mcr196; Craig DPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101262; Deisig N, 2001, LEARN MEMORY, V8, P70, DOI 10.1101/lm.8.2.70; Dennett D. C., 1987, OXFORD COMPANION MIN, P383; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; Dukas R, 2009, VIENNA SER THEOR BIO, P147; ETIENNE AS, 1984, HUM DEV, V27, P309, DOI 10.1159/000272924; Field Matt, 2008, Curr Drug Abuse Rev, V1, P263; Frings H, 1941, J EXP ZOOL, V88, P65, DOI 10.1002/jez.1400880106; Geddes LH, 2013, LEARN MEMORY, V20, P399, DOI 10.1101/lm.030825.113; Giovanetti M, 2011, B INSECTOL, V64, P77; Giray T, 2015, ANIM BEHAV, V100, P144, DOI 10.1016/j.anbehav.2014.11.018; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; Gomez JC, 2005, TRENDS COGN SCI, V9, P118, DOI 10.1016/j.tics.2005.01.004; Jenkins H. M., 1979, 1 CENTURY EXPT PSYCH; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kisch J, 1999, BEHAV BRAIN RES, V99, P93, DOI 10.1016/S0166-4328(98)00076-X; Lee VL, 2011, BEYOND BEHAV; LORD C, 2001, DIVISION BEHAV SOCIA; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; NUNEZ JA, 1970, ACTA PHYSIOL LAT AM, V20, P140; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Ballester BR, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0178-x; Sall F, 1996, JMP IN SPSS; Scheiner R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.04; Schwarzel M, 2006, CELL MOL LIFE SCI, V63, P989, DOI 10.1007/s00018-006-6024-8; Seeley T., 1995, WISDOM HIVE SOCIAL P; Skinner B. F., 1953, SCI HUMAN BEHAV; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sokolowski MBC, 2010, J NEUROSCI METH, V188, P235, DOI 10.1016/j.jneumeth.2010.02.013; Sokolowski MBC, 2010, J EXP ANAL BEHAV, V93, P81, DOI 10.1901/jeab.2010.93-81; Stepanov II, 2008, J MATH PSYCHOL, V52, P313, DOI 10.1016/j.jmp.2008.08.001; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; VARESCHI E, 1971, Z VERGL PHYSIOL, V75, P143; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Zhang SW, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00088	67	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162347	10.1371/journal.pone.0162347	http://dx.doi.org/10.1371/journal.pone.0162347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626797	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600030
J	de Cosio, FG; Jiwani, SS; Sanhueza, A; Soliz, PN; Becerra-Posada, F; Espinal, MA				de Cosio, Federico G.; Jiwani, Safia S.; Sanhueza, Antonio; Soliz, Patricia N.; Becerra-Posada, Francisco; Espinal, Marcos A.			Late Maternal Deaths and Deaths from Sequelae of Obstetric Causes in the Americas from 1999 to 2013: A Trend Analysis	PLOS ONE			English	Article								Background Data on maternal deaths occurring after the 42 days postpartum reference time is scarce; the objective of this analysis is to explore the trend and magnitude of late maternal deaths and deaths from sequelae of obstetric causes in the Americas between 1999 and 2013, and to recommend including these deaths in the monitoring of the Sustainable Development Goals (SDGs). Methods Exploratory data analysis enabled analyzing the magnitude and trend of late maternal deaths and deaths from sequelae of obstetric causes for seven countries of the Americas: Argentina, Brazil, Canada, Colombia, Cuba, Mexico and the United States. A Poisson regression model was developed to compare trends of late maternal deaths and deaths from sequelae of obstetric causes between two periods of time: 1999 to 2005 and 2006 to 2013; and to estimate the relative increase of these deaths in the two periods of time. Findings The proportion of late maternal deaths and deaths from sequelae of obstetric causes ranged between 2.40% (CI 0.85% - 5.48%) and 18.68% (CI 17.06% - 20.47%) in the seven countries. The ratio of late maternal deaths and deaths from sequelae of obstetric causes per 100,000 live births has increased by two times in the region of the Americas in the period 2006-2013 compared to the period 1999-2005. The regional relative increase of late maternal death was 2.46 (p<0.0001) times higher in the second period compared to the first. Interpretation Ascertainment of late maternal deaths and deaths from sequelae of obstetric causes has improved in the Americas since the early 2000's due to improvements in the quality of information and the obstetric transition. Late and obstetric sequelae maternal deaths should be included in the monitoring of the SDGs as well as in the revision of the International Classification of Diseases' 11th version (ICD-11).	[de Cosio, Federico G.; Jiwani, Safia S.; Sanhueza, Antonio; Soliz, Patricia N.; Becerra-Posada, Francisco; Espinal, Marcos A.] Pan Amer Hlth Org, Washington, DC 20037 USA	Pan American Health Organization	Jiwani, SS (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	sjiwani1@jhu.edu						[Anonymous], 1997, Revista Panamericana de Salud Publica/Pan American Journal of Public Health, V1, P481; [Anonymous], REV PANAMERICANA SAL; Donoso E, 2012, REV MED CHILE, V140, P1253, DOI 10.4067/S0034-98872012001000003; Grove J, 2015, LANCET, V386, P1511, DOI 10.1016/S0140-6736(15)00517-6; Hill K, 2006, LANCET, P1311; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Torres LM, 2014, SALUD PUBLICA MEXICO, V56, P333; McCaw-Binns AM, 2015, INT J GYNECOL OBSTET, V128, P62, DOI 10.1016/j.ijgo.2014.07.023; Ramos S, 2007, B WORLD HEALTH ORGAN, V85, P615, DOI 10.2471/BLT.06.032334; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sliwa K, 2016, LANCET, V387, P2072, DOI 10.1016/S0140-6736(16)30391-9; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Szwarcwald CL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00125313; Turner Linda A, 2002, Chronic Dis Can, V23, P22; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wilmoth JR, 2014, STAT POLITICS POLICY, V3; You D, 2015, LANCET, V386, P2256	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0160642	10.1371/journal.pone.0160642	http://dx.doi.org/10.1371/journal.pone.0160642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626277	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600001
J	Feng, Y; Zhou, JH; Li, ZH; Jiang, Y; Zhou, Y				Feng, Yuan; Zhou, Jihong; Li, Zhanhua; Jiang, Ying; Zhou, Ying			Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study	PLOS ONE			English	Article							IN-VITRO; PATHWAY; STRESS; IMMUNOTHERAPY; ACTIVATION; PERIFOSINE; APOPTOSIS; FUTURE	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively targets cancer cells. The present preclinical study investigated the anti-cancer efficiency of ONC201, a first-in-class small molecule TRAIL inducer, in lung cancer cells. We showed that ONC201 was cytotoxic and anti-proliferative in both established (A549 and H460 lines) and primary human lung cancer cells. It was yet non-cytotoxic to normal lung epithelial cells. Further, ONC201 induced exogenous apoptosis activation in lung cancer cells, which was evidenced by TRAIL/death receptor-5 (DR5) induction and caspase-8 activation. The caspase-8 inhibitor or TRAIL/DR5 siRNA knockdown alleviated ONC201' s cytotoxicity against lung cancer cells. Molecularly, ONC201 in-activated Akt-S6K1 and Erk signalings in lung cancer cells, causing Foxo3a nuclear translocation. For the in vivo studies, intraperitoneal injection of ONC201 at well-tolerated doses significantly inhibited xenografted A549 tumor growth in severe combined immunodeficient (SCID) mice. Further, ONC201 administration induced TRAIL/DR5 expression, yet inactivated Akt-S6K1 and Erk in tumor tissues. These results of the study demonstrates the potent anti-lung cancer activity by ONC201.	[Feng, Yuan; Zhou, Jihong; Li, Zhanhua] Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Resp Med, Nanning, Peoples R China; [Jiang, Ying] Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Neurol, Nanning, Peoples R China; [Zhou, Ying] Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Oncol, Nanning, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine	Feng, Y (corresponding author), Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Resp Med, Nanning, Peoples R China.	fengyugx360@163.com			Scientific grant of Guangxi University of Traditional Chinese Medicine [2014-081]	Scientific grant of Guangxi University of Traditional Chinese Medicine	This work was supported by the Scientific grant of Guangxi University of Traditional Chinese Medicine (2014-081, to YF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143082; Allen JE, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0346-9; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Bagci-Onder T, 2013, ONCOGENE, V32, P2818, DOI 10.1038/onc.2012.304; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen W, 2015, CA CANC J CLIN; Creelan BC, 2014, CANCER CONTROL, V21, P80, DOI 10.1177/107327481402100112; Endo Greer Yoshimi, 2016, Sci Signal, V9, pfs1, DOI 10.1126/scisignal.aad7955; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fu M, 2016, BIOCHEM BIOPHYS RES; Horn L, 2016, ONCOLOGIST, V21, P910, DOI 10.1634/theoncologist.2015-0523; Ishizawa J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4380; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Keith RL, 2013, NAT REV CLIN ONCOL, V10, P334, DOI 10.1038/nrclinonc.2013.64; Kline CLB, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4374; Liang Y, 2000, CANCER RES, V60, P1009; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lv HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145195; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Rosell R, 2015, NAT REV CLIN ONCOL, V12, P75, DOI 10.1038/nrclinonc.2014.225; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Shen J, 2016, BIOCHEM BIOPH RES CO, V473, P1170, DOI 10.1016/j.bbrc.2016.04.035; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner J, 2014, ONCOTARGET, V5, P12728, DOI 10.18632/oncotarget.2890; Wu W, 2006, MOL ENDOCRINOL, V20, P2304, DOI 10.1210/me.2006-0131; Yang L, 2016, AM J CLIN EXP IMMUNO, V5, P1; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang JL, 2015, TUMOR BIOL, V36, P5699, DOI 10.1007/s13277-015-3244-2; Zhu YR, 2014, BIOCHEM BIOPH RES CO, V451, P112, DOI 10.1016/j.bbrc.2014.07.077	32	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162133	10.1371/journal.pone.0162133	http://dx.doi.org/10.1371/journal.pone.0162133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626799	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600021
J	Han, J; Thamilarasan, SK; Natarajan, S; Park, JI; Chung, MY; Nou, IS				Han, Jeongsukhyeon; Thamilarasan, Senthil Kumar; Natarajan, Sathishkumar; Park, Jong-In; Chung, Mi-Young; Nou, Ill-Sup			De Novo Assembly and Transcriptome Analysis of Bulb Onion (Allium cepa L.) during Cold Acclimation Using Contrasting Genotypes	PLOS ONE			English	Article							RNA-SEQ DATA; MOLECULAR CHARACTERIZATION; STRESS TOLERANCE; GENE-EXPRESSION; BRASSICA-RAPA; SSR MARKERS; ARABIDOPSIS; DROUGHT; PROTEIN; RESPONSES	Bulb onion (Allium cepa) is the second most widely cultivated and consumed vegetable crop in the world. During winter, cold injury can limit the production of bulb onion. Genomic resources available for bulb onion are still very limited. To date, no studies on heritably durable cold and freezing tolerance have been carried out in bulb onion genotypes. We applied high-throughput sequencing technology to cold (2 degrees C), freezing (-5 and -15 degrees C), and control (25 degrees C)-treated samples of cold tolerant (CT) and cold susceptible (CS) genotypes of A. cepa lines. A total of 452 million paired-end reads were de novo assembled into 54,047 genes with an average length of 1,331 bp. Based on similarity searches, these genes were aligned with entries in the public non-redundant (nr) database, as well as KEGG and COG database. Differentially expressed genes (DEGs) were identified using log(10) values with the FPKM method. Among 5,167DEGs, 491 genes were differentially expressed at freezing temperature compared to the control temperature in both CT and CS libraries. The DEG results were validated with qRT-PCR. We performed GO and KEGG pathway enrichment analyses of all DEGs and iPath interactive analysis found 31 pathways including those related to metabolism of carbohydrate, nucleotide, energy, cofactors and vitamins, other amino acids and xenobiotics biodegradation. Furthermore, a large number of molecular markers were identified from the assembled genes, including simple sequence repeats (SSRs) 4,437 and SNP substitutions of transition and transversion types of CT and CS. Our study is the first to provide a transcriptome sequence resource for Allium spp. with regard to cold and freezing stress. We identified a large set of genes and determined their DEG profiles under cold and freezing conditions using two different genotypes. These data represent a valuable resource for genetic and genomic studies of Allium spp.	[Han, Jeongsukhyeon; Thamilarasan, Senthil Kumar; Natarajan, Sathishkumar; Park, Jong-In; Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea; [Chung, Mi-Young] Sunchon Natl Univ, Dept Agr Educ, Sunchon, Jeonnam, South Korea	Sunchon National University; Sunchon National University	Nou, IS (corresponding author), Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea.	nis@sunchon.ac.kr	Thamilarasan, Senthil Kumar/AAX-5643-2021	Thamilarasan, Senthil Kumar/0000-0003-3691-5838; Natarajan, Sathishkumar/0000-0002-9001-8495	Golden Seed Project (Center for Horticultural Seed Development) [213003-04-4-SB110]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS)	Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)	This research was supported by Golden Seed Project (Center for Horticultural Seed Development, No. 213003-04-4-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).; This research was supported by Golden Seed Project (Center for Horticultural Seed Development, No. 213003-04-4-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Arasan SKT, 2013, INDIAN J EXP BIOL, V51, P522; Bahorun T, 2004, J SCI FOOD AGR, V84, P1553, DOI 10.1002/jsfa.1820; Bogdanovic J, 2008, EUR BIOPHYS J BIOPHY, V37, P1241, DOI 10.1007/s00249-008-0260-9; Brewster J. L., 2008, Onions and other vegetable alliums, P1, DOI 10.1079/9781845933999.0001; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Ciereszko I, 2001, BIOCHEM J, V354, P67, DOI 10.1042/0264-6021:3540067; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Duangjit J, 2013, THEOR APPL GENET, V126, P2093, DOI 10.1007/s00122-013-2121-x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan Xueying, 2014, BMC Res Notes, V7, P493, DOI 10.1186/1756-0500-7-493; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Haq NU, 2013, PLANT MOL BIOL REP, V31, P1230, DOI 10.1007/s11105-013-0588-x; Harwood S, 1996, BIOTECHNOL SOFTW I J, V13, P22; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Hwang I, 2014, GENOMICS, V104, P194, DOI 10.1016/j.ygeno.2014.07.008; Jung Yujin, 2014, Plant Breeding and Biotechnology, V2, P1, DOI 10.9787/PBB.2014.2.1.001; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RF, 2009, PROG NAT SCI-MATER, V19, P667, DOI 10.1016/j.pnsc.2008.06.030; Manoharan RK, 2016, MOLECULES, V21, DOI 10.3390/molecules21020217; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; McCallum J, 2006, THEOR APPL GENET, V112, P958, DOI 10.1007/s00122-005-0199-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Rapacz M, 2002, PHYSIOL PLANTARUM, V115, P236, DOI 10.1034/j.1399-3054.2002.1150209.x; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Slimestad R, 2007, J AGR FOOD CHEM, V55, P10067, DOI 10.1021/jf0712503; Takagi T, 2003, J BIOL CHEM, V278, P14174, DOI 10.1074/jbc.M212101200; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thamilarasan SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-422; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wallis JG, 1997, PLANT MOL BIOL, V35, P323, DOI 10.1023/A:1005886210159; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910	60	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161987	10.1371/journal.pone.0161987	http://dx.doi.org/10.1371/journal.pone.0161987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627679	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600016
J	Mori, K; Moteki, H; Miyagawa, M; Nishio, S; Usami, S				Mori, Kentaro; Moteki, Hideaki; Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi			Social Health Insurance-Based Simultaneous Screening for 154 Mutations in 19 Deafness Genes Efficiently Identified Causative Mutations in Japanese Hearing Loss Patients	PLOS ONE			English	Article							VARIANTS	Sensorineural hearing loss is one of the most common neurosensory disorders in humans. The incidence of SNHL is estimated to be 1 in 500-1000 newborns. In more than half of these patients, the hearing loss is associated with genetic causes. In Japan, genetic testing for the patients with SNHL using the Invader assay to screen for 46 mutations in 13 deafness genes was approved by the Ministry of Health, Labour and Welfare for inclusion in social health insurance coverage in 2012. Furthermore, from August 2015, this genetic testing has been expanded to screen for 154 mutations in 19 deafness genes using targeted genomic enrichment with massively parallel DNA sequencing combined with the Invader assay and TaqMan genotyping. For this study we analyzed 717 unrelated Japanese hearing loss patients. The total allele frequency of 154 mutations in 19 deafness genes was 32.64% (468/1434) and the total numbers of cases associated with at least one mutation was 44.07% (316/717). Among these, we were able to diagnose 212 (30%) patients, indicating that the present screening could efficiently identify causative mutations in hearing loss patients. It is noteworthy that 27 patients (3.8%) had coexistent multiple mutations in different genes. Five of these 27 patients (0.7%, 5/717 overall) were diagnosed with genetic hearing loss affected by concomitant with responsible mutations in more than two different genes. For patients identified with multiple mutations in different genes, it is necessary to consider that several genes might have an impact on their phenotypes.	[Mori, Kentaro; Moteki, Hideaki; Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otolaryngol, Matsumoto, Nagano, Japan; [Moteki, Hideaki; Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otolaryngol, Matsumoto, Nagano, Japan.; Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health, Labour and Welfare of Japan Scientific Research Grant [H25-Kankaku-Ippan-002]; Japan Agency for Medical Research and Development [15dk0310011h0003]; Ministry of Education, Science and Culture of Japan [15H02565]	Health, Labour and Welfare of Japan Scientific Research Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was grant aided by a Health, Labour and Welfare of Japan Scientific Research Grant (H25-Kankaku-Ippan-002), Japan Agency for Medical Research and Development (15dk0310011h0003), and a Grant-in-Aid for Scientific Research (A) (15H02565) from the Ministry of Education, Science and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2001, AM J MED GENET, V103, P334, DOI 10.1002/1096-8628(20011101)103:4<334::AID-AJMG1574>3.0.CO;2-F; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Gazzo AM, 2016, NUCLEIC ACIDS RES, V44, pD900, DOI 10.1093/nar/gkv1068; Huang SS, 2013, MITOCHONDRION, V13, P791, DOI 10.1016/j.mito.2013.05.004; Huang SS, 2013, INT J PEDIATR OTORHI, V77, P379, DOI 10.1016/j.ijporl.2012.11.031; Lu SY, 2009, CLIN GENET, V75, P480, DOI 10.1111/j.1399-0004.2008.01138.x; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moteki H, 2015, ANN OTO RHINOL LARYN, V124, p177S, DOI 10.1177/0003489415575045; Nishio S, 2015, ANN OTO RHINOL LARYN, V124, p49S, DOI 10.1177/0003489415575059; Nishio SY, 2015, GENET TEST MOL BIOMA, V19, P209, DOI 10.1089/gtmb.2014.0252; Sakuma N, 2016, J HUM GENET, V61, P253, DOI 10.1038/jhg.2015.143; Shearer AE, 2015, OTOLARYNG HEAD NECK, V153, P175, DOI 10.1177/0194599815591156; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688	18	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162230	10.1371/journal.pone.0162230	http://dx.doi.org/10.1371/journal.pone.0162230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627659	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600025
J	Schneider, J; Valentini, A; Dejean, T; Montarsi, F; Taberlet, P; Glaizot, O; Fumagalli, L				Schneider, Judith; Valentini, Alice; Dejean, Tony; Montarsi, Fabrizio; Taberlet, Pierre; Glaizot, Olivier; Fumagalli, Luca			Detection of Invasive Mosquito Vectors Using Environmental DNA (eDNA) from Water Samples	PLOS ONE			English	Article							AEDES-ALBOPICTUS; DIPTERA-CULICIDAE; 1ST REPORT; IDENTIFICATION; FUTURE; KOREICUS; BIOLOGY; SURVEILLANCE; DEGRADATION; TEMPERATURE	Repeated introductions and spread of invasive mosquito species (IMS) have been recorded on a large scale these last decades worldwide. In this context, members of the mosquito genus Aedes can present serious risks to public health as they have or may develop vector competence for various viral diseases. While the Tiger mosquito (Aedes albopictus) is a well-known vector for e.g. dengue and chikungunya viruses, the Asian bush mosquito (Ae. j. japonicus) and Ae. koreicus have shown vector competence in the field and the laboratory for a number of viruses including dengue, West Nile fever and Japanese encephalitis. Early detection and identification is therefore crucial for successful eradication or control strategies. Traditional specific identification and monitoring of different and/or cryptic life stages of the invasive Aedes species based on morphological grounds may lead to misidentifications, and are problematic when extensive surveillance is needed. In this study, we developed, tested and applied an environmental DNA (eDNA) approach for the detection of three IMS, based on water samples collected in the field in several European countries. We compared real-time quantitative PCR (qPCR) assays specific for these three species and an eDNA metabarcoding approach with traditional sampling, and discussed the advantages and limitations of these methods. Detection probabilities for eDNA-based approaches were in most of the specific comparisons higher than for traditional survey and the results were congruent between both molecular methods, confirming the reliability and efficiency of alternative eDNA-based techniques for the early and unambiguous detection and surveillance of invasive mosquito vectors. The ease of water sampling procedures in the eDNA approach tested here allows the development of large-scale monitoring and surveillance programs of IMS, especially using citizen science projects.	[Schneider, Judith; Fumagalli, Luca] Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Biophore, CH-1015 Lausanne, Switzerland; [Valentini, Alice; Dejean, Tony] Savoie Technol, SPYGEN, F-73370 Le Bourget Du Lac, France; [Montarsi, Fabrizio] Ist Zooprofilatt Sperimentale Venezie, Viale Univ 10, I-35020 Padua, Italy; [Taberlet, Pierre] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Taberlet, Pierre] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Glaizot, Olivier] Museum Zool, Pl Riponne 6, CH-1014 Lausanne, Switzerland; [Glaizot, Olivier] Univ Lausanne, Dept Ecol & Evolut, Biophore, CH-1015 Lausanne, Switzerland	University of Lausanne; IZS delle Venezie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Lausanne	Fumagalli, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Biophore, CH-1015 Lausanne, Switzerland.	luca.fumagalli@unil.ch	valentini, alice/S-2040-2019; Glaizot, Olivier/B-8627-2012; Valentini, Alice/AFS-1389-2022	Glaizot, Olivier/0000-0001-9116-3355; Valentini, Alice/0000-0001-5829-5479; Fumagalli, Luca/0000-0002-6648-2570; Schneider, Judith/0000-0003-2663-6130				Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; De Jong L, 2009, ACTA TROP, V112, P266, DOI 10.1016/j.actatropica.2009.08.008; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; ECDC, 2016, VECTORNET A EUROPEAN; ECDC, 2012, GUIDELINES FOR THE S; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Engdahl C, 2014, MOL ECOL RESOUR, V14, P478, DOI 10.1111/1755-0998.12202; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Herder JE, 2014, CONTRACT NO REPORT 2; Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Marcantonio M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1340-9; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Robson HLA, 2016, MOLECULAR ECOLOGY RE; Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142; Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Simberloff D, 2001, ENCYCLOPEDIA OF BIOL; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suter T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1010-3; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020; Versteirt V, 2015, MOL ECOL RESOUR, V15, P449, DOI 10.1111/1755-0998.12318; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Werner D, 2016, PARASITOL RES, V115, P1331, DOI 10.1007/s00436-015-4848-6; WHO, 2013, REGIONAL FRAMEWORK F; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Williamson M., 1996, BIOL INVASIONS; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	79	49	52	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162493	10.1371/journal.pone.0162493	http://dx.doi.org/10.1371/journal.pone.0162493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626642	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600038
J	Lin, PL; Yu, YW; Chung, RH				Lin, Peng-Lin; Yu, Ya-Wen; Chung, Ren-Hua			Pathway Analysis Incorporating Protein-Protein Interaction Networks Identified Candidate Pathways for the Seven Common Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAMMALIAN ZINC TRANSPORTER; NF-KAPPA-B; SUSCEPTIBILITY LOCI; BIOLOGICAL PATHWAYS; GENE INTERACTIONS; SET; HYPERTENSION; INFLAMMATION; EPISTASIS	Pathway analysis has become popular as a secondary analysis strategy for genome-wide association studies (GWAS). Most of the current pathway analysis methods aggregate signals from the main effects of single nucleotide polymorphisms (SNPs) in genes within a pathway without considering the effects of gene-gene interactions. However, gene-gene interactions can also have critical effects on complex diseases. Protein-protein interaction (PPI) networks have been used to define gene pairs for the gene-gene interaction tests. Incorporating the PPI information to define gene pairs for interaction tests within pathways can increase the power for pathway-based association tests. We propose a pathway association test, which aggregates the interaction signals in PPI networks within a pathway, for GWAS with case-control samples. Gene size is properly considered in the test so that genes do not contribute more to the test statistic simply due to their size. Simulation studies were performed to verify that the method is a valid test and can have more power than other pathway association tests in the presence of gene-gene interactions within a pathway under different scenarios. We applied the test to the Wellcome Trust Case Control Consortium GWAS datasets for seven common diseases. The most significant pathway is the chaperones modulate interferon signaling pathway for Crohn's disease (p-value = 0.0003). The pathway modulates interferon gamma, which induces the JAK/STAT pathway that is involved in Crohn's disease. Several other pathways that have functional implications for the seven diseases were also identified. The proposed test based on gene-gene interaction signals in PPI networks can be used as a complementary tool to the current existing pathway analysis methods focusing on main effects of genes. An efficient software implementing the method is freely available at http://puppi.sourceforge.net.	[Lin, Peng-Lin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Yu, Ya-Wen; Chung, Ren-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan	Chung, RH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan.	rchung@nhri.org.tw	Chung, Ren-Hua/AAB-8364-2019		National Health Research Institutes [PH-105-PP-10]; Ministry of Science and Technology [MOST 104-2221-E-400-004-MY2]; Medical Research Council [G1001799, MR/N01104X/1] Funding Source: researchfish; MRC [G1001799, MR/N01104X/1] Funding Source: UKRI	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RHC received the funding from the National Health Research Institutes (http://www.nhri.org.tw) with grant number PH-105-PP-10 and from the Ministry of Science and Technology (http://www.most.gov.tw) with grant number MOST 104-2221-E-400-004-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Babron MC, 2015, ANN HUM GENET, V79, P380, DOI 10.1111/ahg.12113; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cassim B, 2009, RHEUMATOLOGY, V48, P490, DOI 10.1093/rheumatology/kep016; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen F, 1999, CLIN CHEM, V45, P7; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Chung RH, 2015, GENET EPIDEMIOL, V39, P20, DOI 10.1002/gepi.21850; Chung RH, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P238, DOI 10.1109/CIBCB.2013.6595415; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Harrison C, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3805; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Jin Lv, 2014, Genomics Proteomics & Bioinformatics, V12, P210, DOI 10.1016/j.gpb.2014.10.002; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARAISKOS C, 2011, GUT               S1, V60, DOI DOI 10.1136/GUT.2011.239301.304; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Lage K, 2014, BBA-MOL BASIS DIS, V1842, P1971, DOI 10.1016/j.bbadis.2014.05.028; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Leiserson MDM, 2013, CURR OPIN GENET DEV, V23, P602, DOI 10.1016/j.gde.2013.09.003; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S15; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Park YS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-267; Pattin KA, 2009, EXPERT REV PROTEOMIC, V6, P647, DOI 10.1586/EPR.09.86; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schoenhagen P, 2001, J AM COLL CARDIOL, V38, P297, DOI 10.1016/S0735-1097(01)01374-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang YT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1620-3; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	78	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162910	10.1371/journal.pone.0162910	http://dx.doi.org/10.1371/journal.pone.0162910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622767	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000068
J	Gross, KS; Brandner, DD; Martinez, LA; Olive, MF; Meisel, RL; Mermelstein, PG				Gross, Kellie S.; Brandner, Dieter D.; Martinez, Luis A.; Olive, M. Foster; Meisel, Robert L.; Mermelstein, Paul G.			Opposite Effects of mGluR1a and mGluR5 Activation on Nucleus Accumbens Medium Spiny Neuron Dendritic Spine Density	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; FEMALE SEXUAL RECEPTIVITY; GROUP-I; INTRACELLULAR CALCIUM; DEPENDENT MECHANISM; SIGNALING PATHWAYS; PREFRONTAL CORTEX; BINDING PROTEIN; ESTRADIOL; DISTINCT	The group I metabotropic glutamate receptors (mGluR1a and mGluR5) are important modulators of neuronal structure and function. Although these receptors share common signaling pathways, they are capable of having distinct effects on cellular plasticity. We investigated the individual effects of mGluR1a or mGluR5 activation on dendritic spine density in medium spiny neurons in the nucleus accumbens (NAc), which has become relevant with the potential use of group I mGluR based therapeutics in the treatment of drug addiction. We found that systemic administration of mGluR subtype-specific positive allosteric modulators had opposite effects on dendritic spine densities. Specifically, mGluR5 positive modulation decreased dendritic spine densities in the NAc shell and core, but was without effect in the dorsal striatum, whereas increased spine densities in the NAc were observed with mGluR1a positive modulation. Additionally, direct activation of mGluR5 via CHPG administration into the NAc also decreased the density of dendritic spines. These data provide insight on the ability of group I mGluRs to induce structural plasticity in the NAc and demonstrate that the group I mGluRs are capable of producing not just distinct, but opposing, effects on dendritic spine density.	[Gross, Kellie S.; Brandner, Dieter D.; Martinez, Luis A.; Meisel, Robert L.; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Gross, Kellie S.; Meisel, Robert L.; Mermelstein, Paul G.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Brandner, Dieter D.; Mermelstein, Paul G.] Univ Minnesota, Med Scientist Training Program, Minneapolis, MN 55455 USA; [Olive, M. Foster] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Arizona State University; Arizona State University-Tempe	Mermelstein, PG (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.; Mermelstein, PG (corresponding author), Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA.; Mermelstein, PG (corresponding author), Univ Minnesota, Med Scientist Training Program, Minneapolis, MN 55455 USA.	pmerm@umn.edu	Brandner, Dieter/AGR-7106-2022	Brandner, Dieter/0000-0001-7278-4391; Olive, Foster/0000-0002-2517-0351	National Institutes of Health [DA035008, AA013852, DA024355];  [DA007234];  [GM08244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471, T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035008, T32DA007234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA035008 to PGM and RLM, and AA013852 and DA024355 to MFO. KSG was supported by DA007234; DDB was supported by GM08244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benquet P, 2002, J NEUROSCI, V22, P9679; Besheer J, 2009, J NEUROSCI, V29, P9582, DOI 10.1523/JNEUROSCI.2366-09.2009; Bonsi P, 2008, NEUROPHARMACOLOGY, V55, P392, DOI 10.1016/j.neuropharm.2008.05.020; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Chaban V, 2011, J NEUROSCI RES, V89, P1707, DOI 10.1002/jnr.22718; Christensen A, 2011, J NEUROSCI, V31, P17583, DOI 10.1523/JNEUROSCI.3030-11.2011; Dewing P, 2007, J NEUROSCI, V27, P9294, DOI 10.1523/JNEUROSCI.0592-07.2007; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Huang GZ, 2012, NEURON, V74, P801, DOI 10.1016/j.neuron.2012.03.035; Kuo J, 2009, ENDOCRINOLOGY, V150, P1369, DOI 10.1210/en.2008-0994; LaCrosse AL, 2015, CNS NEUROL DISORD-DR, V14, P476, DOI 10.2174/1871527314666150429112849; Loweth JA, 2014, NAT NEUROSCI, V17, P73, DOI 10.1038/nn.3590; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; Mitrano DA, 2007, J COMP NEUROL, V500, P788, DOI 10.1002/cne.21214; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peterson BM, 2015, BRAIN STRUCT FUNCT, V220, P2415, DOI 10.1007/s00429-014-0794-9; Poisik OV, 2003, J NEUROSCI, V23, P122; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Staffend NA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00014; Thandi S, 2002, J NEUROCHEM, V83, P1139, DOI 10.1046/j.1471-4159.2002.01217.x; Tuscher JJ, 2016, J NEUROSCI, V36, P1483, DOI 10.1523/JNEUROSCI.3135-15.2016; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Valenti O, 2002, J CELL PHYSIOL, V191, P125, DOI 10.1002/jcp.10081; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Wang XS, 2013, ADDICT BIOL, V18, P40, DOI 10.1111/j.1369-1600.2011.00432.x; Wilkerson JR, 2014, CELL REP, V7, P1589, DOI 10.1016/j.celrep.2014.04.035; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210	36	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162755	10.1371/journal.pone.0162755	http://dx.doi.org/10.1371/journal.pone.0162755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618534	gold, Green Submitted, Green Published			2022-12-27	WOS:000383653100047
J	Cao, Z; Tong, XZ; Xia, WH; Chen, L; Zhang, XY; Yu, BB; Yang, Z; Tao, J				Cao, Zheng; Tong, Xinzhu; Xia, Wenhao; Chen, Long; Zhang, Xiaoyu; Yu, Bingbo; Yang, Zhen; Tao, Jun			CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; REENDOTHELIALIZATION CAPACITY; VASCULAR REPAIR; SHEAR-STRESS; IN-VITRO; ANGIOGENESIS; CXCR7; PROLIFERATION; RECEPTOR; PATHWAY	Coronary artery disease (CAD) is characterized by insufficient vasculogenic response to ischemia, which is typically accompanied by dysfunction of endothelial outgrowth cells (EOCs). CXC chemokine receptor 7 (CXCR7) is a key modulator of the neovascularization of EOCs to perfusion defect area. However, the mechanism underlying the role of EOCs in CAD-related abnormal vasculogenesis is still not clear. Here, we investigated the alteration of EOCs-related vasculogenic capacity in patients with CAD and its potential mechanism. Compared with EOCs isolated from healthy subjects, EOCs from CAD patients showed an impaired vasculogenic function in vitro. CXCR7 expression of EOCs from CAD patients was downregulated. Meanwhile, the phosphorylation of extracellular signal-regulated kinase (ERK), downstream of CXCR7 signaling, was also reduced. CXCR7 expression introduced by adenovirus increased the phosphorylation of ERK, which was parallel to improved function of EOCs. The enhanced adhesion and vasculogenesis of EOCs can be blocked by short interfering RNA (siRNA) against CXCR7 and ERK inhibitor PD098059. Therefore, our study demonstrates that the upregulation of CXCR7 signaling contributes to increased vasculogenic capacity of EOCs from CAD patients, indicating that CXCR7 signaling may be a novel therapeutic vasculogenic target for CAD.	[Cao, Zheng; Tong, Xinzhu] Hubei Univ Med, Taihe Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China; [Tong, Xinzhu; Xia, Wenhao; Chen, Long; Zhang, Xiaoyu; Yu, Bingbo; Yang, Zhen; Tao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou, Guangdong, Peoples R China	Hubei University of Medicine; Sun Yat Sen University	Yang, Z; Tao, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou, Guangdong, Peoples R China.	yangzhen10710710@163.com; taojungz123@163.com			973 program [2013CB531200]; National Natural Science Foundation of China [31530023, 31370941, 81500205, 31270992]	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the grants from the 973 program (2013CB531200), National Natural Science Foundation of China (31530023 and 31370941), and National Natural Science Foundation of China (81500205 and 31270992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barclay GR, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt114; Bertelsen LB, 2014, EXP GERONTOL, V58, P132, DOI 10.1016/j.exger.2014.07.021; Caiado F, 2011, BIOMATERIALS, V32, P7096, DOI 10.1016/j.biomaterials.2011.06.022; Chen L, 2010, CARDIOVASC RES, V88, P462, DOI 10.1093/cvr/cvq207; Chung ES, 2015, EUR HEART J, V36, P2228, DOI 10.1093/eurheartj/ehv254; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Gao JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16382; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kim SW, 2016, INT J CARDIOL, V203, P498, DOI 10.1016/j.ijcard.2015.10.110; Kitta Y, 2009, J AM COLL CARDIOL, V53, P323, DOI 10.1016/j.jacc.2008.08.074; Lamping K, 2007, CIRC RES, V100, P1243, DOI 10.1161/01.RES.0000268193.46418.d1; Lee SH, 2015, STEM CELLS, V33, P1490, DOI 10.1002/stem.1938; Liu CS, 2005, CIRC RES, V97, P135, DOI 10.1161/01.RES.0000174612.90094.fd; Lu AZ, 2015, CELL BIOL INT, V39, P484, DOI 10.1002/cbin.10405; Lu ZY, 2014, BIOCHEM BIOPH RES CO, V446, P25, DOI 10.1016/j.bbrc.2014.02.027; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miquerol L, 2015, CIRC RES, V116, P1765, DOI 10.1161/CIRCRESAHA.116.306476; Pelliccia F, 2010, JACC-CARDIOVASC INTE, V3, P78, DOI 10.1016/j.jcin.2009.10.020; Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Tokgozoglu L, 2011, ATHEROSCLEROSIS, V219, P851, DOI 10.1016/j.atherosclerosis.2011.08.045; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Wegiel B, 2010, CIRCULATION, V121, P537, DOI 10.1161/CIRCULATIONAHA.109.887695; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Xia WH, 2012, HYPERTENSION, V59, P1225, DOI 10.1161/HYPERTENSIONAHA.111.179820; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Yang Z, 2012, J MOL CELL CARDIOL, V52, P1155, DOI 10.1016/j.yjmcc.2012.01.019; Zaccone V, 2015, EUR REV MED PHARMACO, V19, P4047; Zhang XY, 2014, HYPERTENSION, V63, P383, DOI 10.1161/HYPERTENSIONAHA.113.02273; Zhang ZS, 2015, CELL BIOCHEM FUNCT, V33, P80, DOI 10.1002/cbf.3093; Zheng ST, 2011, MOL BIOL REP, V38, P865, DOI 10.1007/s11033-010-0178-z	36	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161255	10.1371/journal.pone.0161255	http://dx.doi.org/10.1371/journal.pone.0161255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612090	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900014
J	Chadi, S; Polyte, J; Lefevre, L; Castille, J; Ehanno, A; Laubier, J; Jaffrezic, F; Le Provost, F				Chadi, Sead; Polyte, Jacqueline; Lefevre, Lucas; Castille, Johan; Ehanno, Aude; Laubier, Johann; Jaffrezic, Florence; Le Provost, Fabienne			Phenotypic and Molecular Alterations in the Mammary Tissue of R-Spondin1 Knock-Out Mice during Pregnancy	PLOS ONE			English	Article							WNT/BETA-CATENIN; WNT RECEPTORS; LGR5; DIFFERENTIATION; MORPHOGENESIS; ENDOCYTOSIS; ACTIVATION; PROTEINS; ADULT; CELLS	R-spondin1 (Rspo1) is a member of a secreted protein family which has pleiotropic functions in development and stem cell growth. Rspo1 knock-out mice are sex-reversed, but some remain sub-fertile, so they fail to nurse their pups. A lack of Rspo1 expression in the mammary gland results in an absence of duct side-branching development and defective alveolar formation. The aim of this study was to characterize the phenotypic and molecular alterations of mammary gland due to Rspo1 knock-out. Using the transcriptional profiling of mammary tissues, we identified misregulated genes in the mammary gland of Rspo1 knock-out mice during pregnancy. A stronger expression of mesenchymal markers was observed, without modifications to the structure of mammary epithelial tissue. Mammary epithelial cell immunohistochemical analysis revealed a persistence of virgin markers, which signify a delay in cell differentiation. Moreover, serial transplantation experiments showed that Rspo1 is associated with a regenerative potential of mammary epithelial cell control. Our finding also highlights the negatively regulated expression of Rspo1's partners, Lgr4 and RNF43, in the mammary gland during pregnancy. Moreover, we offer evidence that Tgf-beta signalling is modified in the absence of Rspo1. Taken together, our results show an abrupt halt or delay to mammary development during pregnancy due to the loss of a further differentiated function.	[Chadi, Sead; Polyte, Jacqueline; Lefevre, Lucas; Castille, Johan; Ehanno, Aude; Laubier, Johann; Jaffrezic, Florence; Le Provost, Fabienne] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Le Provost, F (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France.	Fabienne.LeProvost@jouy.inra.fr		Lefevre, Lucas/0000-0003-0925-7411	INRA Animal Genetic Division [ANR-09-GENM-009-Genidov]	INRA Animal Genetic Division	Support was provided by ANR-09-GENM-009-Genidov, INRA Animal Genetic Division.	Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Cai CG, 2014, GENE DEV, V28, P2205, DOI 10.1101/gad.245142.114; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chadi S, 2009, BIOCHEM BIOPH RES CO, V390, P1040, DOI 10.1016/j.bbrc.2009.10.104; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; DANIEL CW, 1973, EXPERIENTIA, V29, P1420, DOI 10.1007/BF01922854; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; DEOME KB, 1959, CANCER RES, V19, P515; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harburg G, 2014, STEM CELL REP, V3, P385, DOI 10.1016/j.stemcr.2014.07.007; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Locke D, 2007, CELL TISSUE RES, V328, P97, DOI 10.1007/s00441-006-0301-6; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stelwagen K, 2014, J MAMMARY GLAND BIOL, V19, P131, DOI 10.1007/s10911-013-9309-1; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Team RDC, 2012, R LANG ENV STAT COMP; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416; Zhu WT, 2012, BIOSYSTEMS, V109, P403, DOI 10.1016/j.biosystems.2012.04.004	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162566	10.1371/journal.pone.0162566	http://dx.doi.org/10.1371/journal.pone.0162566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611670	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900126
J	Hernandez-Montilla, MC; Martinez-Morales, MA; Vanegas, GP; de Jong, BHJ				Hernandez-Montilla, Mariana C.; Angel Martinez-Morales, Miguel; Posada Vanegas, Gregorio; de Jong, Bernardus H. J.			Assessment of Hammocks (Petenes) Resilience to Sea Level Rise Due to Climate Change in Mexico	PLOS ONE			English	Article							TROPICAL-FOREST; VULNERABILITY; STABILITY	There is a pressing need to assess resilience of coastal ecosystems against sea level rise. To develop appropriate response strategies against future climate disturbances, it is important to estimate the magnitude of disturbances that these ecosystems can absorb and to better understand their underlying processes. Hammocks (petenes) coastal ecosystems are highly vulnerable to sea level rise linked to climate change; their vulnerability is mainly due to its close relation with the sea through underground drainage in predominantly karstic soils. Hammocks are biologically importantbecause of their high diversity and restricted distribution. This study proposes a strategy to assess resilience of this coastal ecosystem when high-precision data are scarce. Approaches and methods used to derive ecological resilience maps of hammocks are described and assessed. Resilience models were built by incorporating and weighting appropriate indicators of persistence to assess hammocks resilience against flooding due to climate change at "Los Petenes Biosphere Reserve", in the Yucatan Peninsula, Mexico. According to the analysis, 25% of the study area is highly resilient (hot spots), whereas 51% has low resilience (cold spots). The most significant hot spot clusters of resilience were located in areas distant to the coastal zone, with indirect tidal influence, and consisted mostly of hammocks surrounded by basin mangrove and floodplain forest. This study revealed thatmulti-criteria analysis and the use of GIS for qualitative, semi-quantitative and statistical spatial analyses constitute a powerful tool to develop ecological resilience maps of coastal ecosystems that are highly vulnerable to sea level rise, even when high-precision data are not available. This method can be applied in other sites to help develop resilience analyses and decision-making processes for management and conservation of coastal areas worldwide.	[Hernandez-Montilla, Mariana C.; Angel Martinez-Morales, Miguel] El Colegio Frontera Sur, Dept Conservac Biodiversidad, Campeche, Campeche, Mexico; [Posada Vanegas, Gregorio] Univ Autonoma Campeche, Inst Ecol Pesquerias & Oceanog Golfo Mexico, Campeche, Campeche, Mexico; [de Jong, Bernardus H. J.] El Colegio Frontera Sur, Dept Ciencias Sustentabilidad, Campeche, Campeche, Mexico	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR)	Martinez-Morales, MA (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodiversidad, Campeche, Campeche, Mexico.	mmartinez@ecosur.mx	de Jong, Ben HJ/GYV-3632-2022		Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [481804]; CONACYT	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MCHM received funding from Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) for this work. Register number 481804. The scholarship and the grant allowed the study design, data analysis, and the preparation of the manuscript. Information about the CONACYT Scholarship and Grant Program is available on the Web at: http://www.conacyt.mx/index.php/becas-y-posgrados and http://www.conacyt.mx/index.php/becas-mixtas.	Acosta Lugo E. D, 2010, PLAN CONSERVACION EC; Anderson KE, 2009, COASTAL SENSITIVITY; AOML/NOAA, 2006, ESC SAFF SIMPS HUR; Borrini-Feyerabend G., 2013, GOVERNANCE PROTECTED; Brand F, 2005, 09489452 LEIPZ HALLE; Brand FS, 2007, ECOL SOC, V12; Brown K, 2012, CLIMATE CHANGE CRISI, P37, DOI DOI 10.4324/9780203146118; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Church J.A., 2013, CLIMATE CHANGE 2013, P1137, DOI [10.1017/CBO9781107415324.026, DOI 10.1017/CBO9781107415324.026, DOI 10.1017/CB09781107415324.026]; Cintron G, 1984, METHODS STUDYING MAN; CONANP, 2006, PROGR CONS MAN RES B; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Eakin H, 2006, ANNU REV ENV RESOUR, V31, P365, DOI 10.1146/annurev.energy.30.050504.144352; Eastman JR, 2009, IDRISI KILIMANJARO G; Espadas C, 2009, ATLAS ESCENARIOS CAM; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Koyoc-Ramirez LG, 2015, ACTA BOT MEX, V110, P89; Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004; Gunderson L. H., 2002, Panarchy: understanding transformations in human and natural systems; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Herrera-Silveira J, 2010, MANUAL PRACTICO REHA; Hodgson D, 2015, TRENDS ECOL EVOL, V30, P503, DOI 10.1016/j.tree.2015.06.010; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Homogeneous A, 2012, NEXTMAP WORLD 30 MET; INEGI, 2013, CART US SUEL VEG 5; Karl TR., 2008, SYNTH ASSESS PROD, P164; Kates RW., 1985, CLIMATE IMPACT ASSES; Lehner B, 2006, HYDROSHEDS TECHNICAL; Torres-Castro IL, 2009, REV BIOL TROP, V57, P141; Lopez R, 2003, LANDSCAPE ATLAS ECOL; Ludwig D., 1997, CONSERV ECOL, V1, P1; March IJ, 2011, SERIE ESTRATEGIAS AD; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McGarigal K., 1994, SPATIAL PATTERN ANAL; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Nerheim S., 2008, 6 US EU BALT INT S O, DOI [10.1109/BALTIC.2008.4625543, DOI 10.1109/BALTIC.2008.4625543]; Nimmo DG, 2015, TRENDS ECOL EVOL, V30, P516, DOI 10.1016/j.tree.2015.07.008; NOAA, 2013, HIST HURR TRACKS V4; Order JK, 1995, GEOGR ANAL, V27, P286, DOI [10.1111/j.1538-4632.1995.tb00912.x, DOI 10.1111/J.1538-4632.1995.TB00912.X]; Ortiz-Perez M. A., 1999, INVESTIGACIONES GEOG, V39, P68; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Posada G, 2010, INT C COAST ENG SHAN, P2156; Posada G, 2010, 16 C NAC OC ENS BAJ; Ramieri E., 2011, ETC CCA TECH PAP, V1, P1; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Sanchez OS, 1999, GLOBAL ECOL BIOGEOGR, V8, P29, DOI 10.1046/j.1365-2699.1999.00317.x; Schott T., 2012, SAFFIR SIMPSON HURRI; SEMARNAT-INECC, 2012, QUINT COM NAC ANT CO; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; The Nature Conservancy (TNC), 2011, GUIA EL PROGR AD CAM; Tighe ML, 2012, VALIDATION NEW 30 ME; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Yanez-Arancibia A., 1996, CARACTERIZACION ECOL	55	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162637	10.1371/journal.pone.0162637	http://dx.doi.org/10.1371/journal.pone.0162637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611802	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900141
J	Kang, KB; Kim, HJ; Park, JH; Shin, YS				Kang, Kyu-Bok; Kim, Hyun-Jung; Park, Jae-Hong; Shin, Young-Soo			Comparison of Dorsal and Volar Percutaneous Approaches in Acute Scaphoid Fractures: A Meta-Analysis	PLOS ONE			English	Article							CENTRAL SCREW PLACEMENT; WAIST FRACTURES; FIXATION; REDUCTION; INSERTION	The dorsal approach allows better central screw placement along the long axis of the scaphoid compared with the volar approach in managing acute scaphoid fractures. However, it is unclear whether the dorsal approach leads to better clinical outcomes than the volar approach. This meta-analysis compared clinical outcomes, including the incidence of nonunion, postoperative complications, overall functional outcome, postoperative pain, grip strength, and range of wrist motion, between the dorsal and volar percutaneous approaches for the management of acute scaphoid fractures. Seven studies met the criteria for inclusion in the meta-analysis. The proportion of patients who developed nonunion (OR 0.74, 95% CI: 0.21 to 2.54; P = 0.63) and postoperative complications (OR 1.05, 95% CI: 0.45 to 2.44; P = 0.91) did not differ significantly between the dorsal and volar approaches. Both approaches also led to similar results in terms of overall functional outcome (95% CI: -0.39 to 0.22; P = 0.57), postoperative pain (95% CI: -0.52 to 0.46; P = 0.92), grip strength (95% CI: -4.56 to 1.02; P = 0.21), flexion (95% CI: -2.86 to 1.13; P = 0.40), extension (95% CI: -1.17 to 2.67; P = 0.44), and radial deviation (95% CI: -1.94 to 2.58; P = 0.78). However, ulnar deviation (95% CI: -7.48 to 0.05; P = 0.05) was significantly greater with the volar approach. Thus, orthopedic surgeons need to master both the dorsal and volar percutaneous approaches because not all acute scaphoid fractures can be dealt with completely with one approach.	[Kang, Kyu-Bok; Park, Jae-Hong; Shin, Young-Soo] Vet Hlth Serv Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Kim, Hyun-Jung] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Veterans Health Service Medical Center; Korea University; Korea University Medicine (KU Medicine)	Shin, YS (corresponding author), Vet Hlth Serv Med Ctr, Dept Orthoped Surg, Seoul, South Korea.	sysoo3180@naver.com						Adamany DC, 2008, J HAND SURG-AM, V33A, P327, DOI 10.1016/j.jhsa.2007.12.006; Bedi A, 2007, J HAND SURG-AM, V32A, P326, DOI 10.1016/j.jhsa.2007.01.002; BOTTE MJ, 1988, J HAND SURG-AM, V13A, P216, DOI 10.1016/S0363-5023(88)80051-0; Bushnell BD, 2007, J HAND SURG-AM, V32A, P827, DOI 10.1016/j.jhsa.2007.04.003; Chan KW, 2004, J HAND SURG-AM, V29A, P74, DOI 10.1016/j.jhsa.2003.09.002; COONEY WP, 1980, CLIN ORTHOP RELAT R, P90; Dias JJ, 2005, J BONE JOINT SURG AM, V87A, P2160, DOI 10.2106/JBJS.D.02305; Dodds SD, 2006, J HAND SURG-AM, V31A, P405, DOI 10.1016/j.jhsa.2005.09.014; Drac P, 2010, ACTA CHIR ORTHOP TR, V77, P143; Drac P, 2014, BIOMED PAP, V158, P277, DOI 10.5507/bp.2012.060; Gehrmann Sebastian V, 2014, GMS Interdiscip Plast Reconstr Surg DGPW, V3, pDoc10, DOI 10.3205/iprs000051; Griffin D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4483; Gurbuz Y, 2012, ACTA ORTHOP TRAUMATO, V46, P339, DOI 10.3944/AOTT.2012.2816; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ibrahim T, 2011, J HAND SURG-AM, V36A, P1759, DOI 10.1016/j.jhsa.2011.08.033; Jeon IH, 2009, J HAND SURG-AM, V34A, P228, DOI 10.1016/j.jhsa.2008.10.016; Jester A, 2005, J HAND SURG-BRIT EUR, V30B, P23, DOI 10.1016/j.jhsb.2004.08.008; Kamineni S, 1999, J HAND SURG-BRIT EUR, V24B, P85, DOI 10.1016/S0266-7681(99)90043-8; Leventhal EL, 2009, J HAND SURG-AM, V34A, P677, DOI 10.1016/j.jhsa.2009.01.011; Levitz S, 2005, J HAND SURG-AM, V30A, P543, DOI 10.1016/j.jhsa.2004.12.014; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McCallister WV, 2003, J BONE JOINT SURG AM, V85A, P72, DOI 10.2106/00004623-200301000-00012; McQueen MM, 2008, J BONE JOINT SURG BR, V90B, P66, DOI 10.1302/0301-620X.90B1.19767; Meermans G, 2008, J HAND SURG-EUR VOL, V33E, P791, DOI 10.1177/1753193408092785; Meermans G, 2014, J BONE JOINT SURG AM, V96A, P1369, DOI 10.2106/JBJS.L.01729; Meermans G, 2012, CLIN ORTHOP RELAT R, V470, P1673, DOI 10.1007/s11999-011-2218-y; Meermans G, 2011, J HAND SURG-AM, V36A, P1669, DOI [10.1016/j.jhsa2011.06.023, 10.1016/j.jhsa.2011.06.023]; Menapace KA, 2001, J HAND SURG-AM, V26A, P883, DOI 10.1053/jhsu.2001.27755; Parajuli NP, 2012, KATHMANDU U MED J, V9, P267; Polsky MB, 2002, ORTHOPEDICS, V25, P817; Shen LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125247; Shin Alexander Y, 2004, Tech Hand Up Extrem Surg, V8, P87, DOI 10.1097/01.bth.0000129884.78204.a5; Slade JF, 2008, J HAND SURG-EUR VOL, V33E, P350, DOI 10.1177/1753193408090121; Slade JF, 2001, ORTHOP CLIN N AM, V32, P247, DOI 10.1016/S0030-5898(05)70247-9; Slade JF, 2005, HAND CLIN, V21, P427, DOI 10.1016/j.hcl.2005.03.004; Soubeyrand M, 2009, J HAND SURG-AM, V34A, P1838, DOI 10.1016/j.jhsa.2009.07.012; Suh Nina, 2010, Hand (N Y), V5, P345, DOI 10.1007/s11552-010-9276-6; Wells G.A., NEWCASTLE OTTAWA SCA	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162779	10.1371/journal.pone.0162779	http://dx.doi.org/10.1371/journal.pone.0162779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611594	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900164
J	Kim, MN; Kim, JO; Lee, SM; Park, H; Lee, J; Rim, KS; Hwang, SG; Kim, NK				Kim, Mi Na; Kim, Jung Oh; Lee, Seung Min; Park, Hana; Lee, Juho; Rim, Kyu Sung; Hwang, Seong Gyu; Kim, Nam Keun			Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							MICRORNA-RELATED GENES; BLADDER-CANCER; POOR-PROGNOSIS; OVARIAN-CANCER; RISK-FACTORS; BIOGENESIS; EXPRESSION; DROSHA; ADENOCARCINOMA; POLYMORPHISMS	Single-nucleotide polymorphisms (SNPs) in microRNA machinery genes might affect microRNA processing and subsequently impact tumorigenesis. The aim of this study was to investigate the associations between SNPs in microRNA machinery genes and hepatocellular carcinoma (HCC) in a Korean population. Genotyping of six SNPs in microRNA machinery genes was performed using blood samples from 147 patients with HCC and 209 healthy control subjects. None of the six SNPs in microRNA machinery genes were significantly associated with HCC development. However, among the models for six polymorphic loci-DICER (rs3742330 and rs13078), DROSHA (rs10719 and rs6877842), RAN (rs14035) and XPO5 (rs11077)-one allele combination (A-A-T-C-C-C) showed synergistic effects in terms of an increased risk of HCC development (odds ratio = 8.881, 95% confidence interval [CI] = 1.889-41.750; P = 0.002). Multivariate Cox proportional hazard regression analysis showed a significant survival benefit for the DICER rs3742330 GG compared with the AA type (hazard ratio [HR], 0.314; 95% CI, 0.135-0.730; P = 0.007) and for the RAN rs14035 CT compared with the CC genotype (HR, 0.587; 95% CI, 0.349-0.987; P = 0.044). Although we found no direct association between DICER (rs3742330 and rs13078), DROSHA (rs10719 and rs6877842), RAN (rs14035) or XPO5 (rs11077) polymorphisms and HCC risk, we demonstrated that DICER (rs3742330) and RAN (rs14035) were associated with the survival of HCC patients. Future studies with larger samples are needed to determine associations of SNPs in microRNA machinery genes with HCC risk and prognosis.	[Kim, Mi Na; Park, Hana; Lee, Juho; Rim, Kyu Sung; Hwang, Seong Gyu] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea; [Kim, Jung Oh; Lee, Seung Min; Kim, Nam Keun] CHA Univ, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea; [Kim, Jung Oh; Kim, Nam Keun] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Hwang, SG (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea.; Kim, NK (corresponding author), CHA Univ, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea.; Kim, NK (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam, South Korea.	sghwang@cha.ac.kr; nkkim@cha.ac.k		Kim, Jung Oh/0000-0002-4171-2034	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058653]; Ministry of Education [2015R1D1A1A09057432]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Ministry of Education	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01058653), and by the Ministry of Education 2015R1D1A1A09057432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cho SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131125; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Gu J, 2005, PHARMACOGENOMICS, V6, P575, DOI 10.2217/14622416.6.6.575; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Honma K, 2009, INT J GEN MED, V2, P243; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Kitagawa N, 2013, CANCER SCI, V104, P543, DOI 10.1111/cas.12126; Leaderer D, 2011, INT J MOL EPIDEMIOL, V2, P9; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murphy D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-92; Papachristou DJ, 2012, HISTOPATHOLOGY, V60, pE28, DOI 10.1111/j.1365-2559.2012.04192.x; Papachristou DJ, 2012, CANCER INVEST, V30, P172, DOI 10.3109/07357907.2011.633293; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Valencak J, 2011, J DERMATOL SCI, V64, P185, DOI 10.1016/j.jdermsci.2011.08.011; Wang JB, 2012, MUTAGENESIS, V27, P779, DOI 10.1093/mutage/ges052; Woo IS, 2008, APOPTOSIS, V13, P1223, DOI 10.1007/s10495-008-0247-0; Wu JF, 2011, MED ONCOL, V28, P804, DOI 10.1007/s12032-010-9520-5; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Xie Y, 2015, ONCOTARGETS THER, V8, P567, DOI 10.2147/OTT.S79150; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yang PW, 2014, ANN SURG ONCOL, V21, pS601, DOI 10.1245/s10434-014-3709-3	33	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162279	10.1371/journal.pone.0162279	http://dx.doi.org/10.1371/journal.pone.0162279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611467	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900072
J	Bai, XM; Xia, F; Lee, I; Zhang, J; Ning, ZL				Bai, Xiaomei; Xia, Feng; Lee, Ivan; Zhang, Jun; Ning, Zhaolong			Identifying Anomalous Citations for Objective Evaluation of Scholarly Article Impact	PLOS ONE			English	Article							SELF-CITATION; INDEX	Evaluating the impact of a scholarly article is of great significance and has attracted great attentions. Although citation-based evaluation approaches have been widely used, these approaches face limitations e.g. in identifying anomalous citations patterns. This negligence would inevitably cause unfairness and inaccuracy to the article impact evaluation. In this study, in order to discover the anomalous citations and ensure the fairness and accuracy of research outcome evaluation, we investigate the citation relationships between articles using the following factors: collaboration times, the time span of collaboration, citing times and the time span of citing to weaken the relationship of Conflict of Interest (COI) in the citation network. Meanwhile, we study a special kind of COI, namely suspected COI relationship. Based on the COI relationship, we further bring forward the COIRank algorithm, an innovative scheme for accurately assessing the impact of an article. Our method distinguishes the citation strength, and utilizes PageRank and HITS algorithms to rank scholarly articles comprehensively. The experiments are conducted on the American Physical Society (APS) dataset. We find that about 80.88% articles contain contributed citations by coauthors in 26,366 articles and 75.55% articles among these articles are cited by the authors belonging to the same affiliation, indicating COI and suspected COI should not be ignored for evaluating impact of scientific papers objectively. Moreover, our experimental results demonstrate COIRank algorithm significantly outperforms the state-of-art solutions. The validity of our approach is verified by using the probability of Recommendation Intensity.	[Bai, Xiaomei; Xia, Feng; Zhang, Jun; Ning, Zhaolong] Dalian Univ Technol, Sch Software, Dalian 116621, Peoples R China; [Lee, Ivan] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA, Australia	Dalian University of Technology; University of South Australia	Xia, F (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116621, Peoples R China.	f.xia@ieee.org	Xia, Feng/Y-2859-2019; Lee, Ivan/F-4131-2013; Ning, Zhaolong/ABI-3626-2022	Xia, Feng/0000-0002-8324-1859; Lee, Ivan/0000-0002-2826-6367; Ning, Zhaolong/0000-0002-7870-5524				Bai XM, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P9, DOI 10.1145/2872518.2889383; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ioannidis JPA, 2015, J PSYCHOSOM RES, V78, P7, DOI 10.1016/j.jpsychores.2014.11.008; Jiang X, 2012, P 21 ACM INT C INFOR, P714; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krell F.T., 2014, EUR SCI ED, V40, P36; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; Liu ZR, 2014, PROC INT C TOOLS ART, P493, DOI 10.1109/ICTAI.2014.80; Pandita Ramesh, 2015, Journal of Information Management, V3, P42, DOI 10.1633/JISTaP.2015.3.2.4; Rad AE, 2012, ACAD RADIOL, V19, P455, DOI 10.1016/j.acra.2011.11.013; Sayyadi H., 2009, SIAM INT C DAT MIN 2, P533; Valenzuela Marco, 2015, AAAI WORKSH SCHOL BI; Walker D, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/06/P06010; Wang S., 2014, P 2014 SIAM INT C DA, P749, DOI DOI 10.1137/1.9781611973440.86; Wang Y., 2013, PROC AAAI C ARTIF IN, P933, DOI DOI 10.1609/AAAI.V27I1.8627; Xia F, 2014, IEEE T EMERG TOP COM, V2, P364, DOI 10.1109/TETC.2014.2356505; Xiaojun Wan, 2014, Journal of the Association for Information Science and Technology, V65, P1929, DOI 10.1002/asi.23083; Yao LY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06663; Zeng A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036101; Zhang CT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01023; Zhou D, 2007, IEEE DATA MINING, P739, DOI 10.1109/ICDM.2007.57; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033	26	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162364	10.1371/journal.pone.0162364	http://dx.doi.org/10.1371/journal.pone.0162364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606817	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000383255600041
J	Chang, YF; Chang, CS; Wang, MW; Wu, CF; Chen, CY; Chang, HJ; Kuo, PH; Wu, CH				Chang, Yin-Fan; Chang, Chin-Sung; Wang, Mei-Wen; Wu, Chun-Feng; Chen, Chuan-Yu; Chang, Hsuan-Jui; Kuo, Po-Hsiu; Wu, Chih-Hsing			Effects of Age and Body Mass Index on Thoracolumbar Spine X-Ray for Diagnosing Osteoporosis in Elderly Women: Tianliao Old People (TOP) Study 07	PLOS ONE			English	Article							VERTEBRAL FRACTURE ASSESSMENT; BONE-MINERAL DENSITY; RISK; HIP; POPULATION; PREVALENCE; NUTRITION; OBESITY; WEIGHT; BURDEN	Purpose The aim of this study was to determine the effects of diagnostic discordance with or without a thoracolumbar spine lateral view X-ray in patients with osteoporosis. Methods We randomly enrolled 368 women over 65 years old (74.3 +/- 6.0 years) from Tianliao Township in 2009 (response rate: 75.7%). A diagnosis of osteoporosis was confirmed using one of these criteria: (1) a history of non-traumatic fracture, (2) vertebral fractures based on a thoracolumbar spine lateral view X-ray, or (3) a bone mineral density T-score <=-2.5 for the total hip, the femoral neck, the lumbar spine, or all 3 sites. The prevalence of osteoporosis in three groups was compared based on Model I (criteria 1+2) vs. Model II (criteria 1+3) vs. Model III (criteria 1+2+3). The role of thoracolumbar X-ray reflected by the diagnostic discordance of osteoporosis between Models II and III was evaluated. Results The overall prevalence of osteoporosis was 78.3%(Model III, age-standardized 78.1%). The diagnostic discordance was 17.4% in the 368 participants. A logistic regression model showed that age was negatively associated with diagnostic discordance (odds ratio [OR] = 0.93, 95% confidence interval [CI]: 0.88-0.98, p < 0.05), but body mass index was positively associated (OR = 1.07, 95% CI: 1.00-1.15, p < 0.05). Conclusions A thoracolumbar spine lateral view X-ray should be added for women >= 65 years old or with a body mass index >= 25 kg/m(2) to minimize the diagnostic discordance in osteoporosis, especially in highly endemic regions.	[Chang, Yin-Fan; Chang, Chin-Sung; Wu, Chih-Hsing] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan; [Wang, Mei-Wen] Tainan Hosp, Dept Radiol, Dept Hlth, Xinhua Branch, Tainan, Taiwan; [Wu, Chun-Feng] Kuo Gen Hosp, Dept Family Med, Tainan, Taiwan; [Chen, Chuan-Yu] Dynasty clin, Tainan, Taiwan; [Chang, Hsuan-Jui] Changhua Christian Hosp, Dept Family Med, Changhua, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Changhua Christian Hospital; National Taiwan University; National Taiwan University	Wu, CH (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan.	paulo@mail.ncku.edu.tw		Kuo, Po-Hsiu/0000-0003-0365-3587	National Cheng Kung University Hospital [NCKUH-9901020]	National Cheng Kung University Hospital	Financial support for this study was partially provided by grant NCKUH-9901020 from National Cheng Kung University Hospital. The funders had a role in data collection and reagents.	Bow CH, 2012, OSTEOPOROSIS INT, V23, P879, DOI 10.1007/s00198-011-1627-9; Chang CS, 2013, J CLIN DENSITOM, V16, P204, DOI 10.1016/j.jocd.2012.03.008; Choi YJ, 2012, J BONE MINER RES, V27, P1879, DOI 10.1002/jbmr.1635; Edwards BJ, 2007, CLIN ORTHOP RELAT R, P226, DOI 10.1097/BLO.0b013e3180534269; El Maghraoui A, 2013, BONE, V52, P176, DOI 10.1016/j.bone.2012.09.023; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Gallacher SJ, 2007, OSTEOPOROSIS INT, V18, P185, DOI 10.1007/s00198-006-0211-1; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Howat I, 2007, CLIN ENDOCRINOL, V67, P923, DOI 10.1111/j.1365-2265.2007.02988.x; Iki M, 2001, OSTEOPOROSIS INT, V12, P529, DOI 10.1007/s001980170073; International Osteoporosis Foundation, FRACT AR WARN SIGNS; International Osteoporosis Foundation, POSTFR CAR GAP; Jager PL, 2010, CAN ASSOC RADIOL J, V61, P194, DOI 10.1016/j.carj.2009.12.012; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lin YC, 2011, ASIA PAC J CLIN NUTR, V20, P283; Mpalaris V, 2015, OBES REV, V16, P225, DOI 10.1111/obr.12244; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Port L, 2003, OSTEOPOROSIS INT, V14, P780, DOI 10.1007/s00198-003-1452-x; Schousboe JT, 2008, J CLIN DENSITOM, V11, P92, DOI 10.1016/j.jocd.2007.12.008; Setting Committee of the WHO Western Pacific Region IASO & IOTF, 2000, AS PAC PERSP RED OB; Shao CJ, 2009, BONE, V44, P125, DOI 10.1016/j.bone.2008.09.004; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; TROISI RJ, 1991, AM J CLIN NUTR, V53, P1104, DOI 10.1093/ajcn/53.5.1104; Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757; van den Berg M, 2011, MATURITAS, V70, P74, DOI 10.1016/j.maturitas.2011.06.006; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Writing Group for the ISCD Position Development Conference, 2004, J Clin Densitom, V7, P7; Wu CH, 2014, J CLIN DENSITOM, V17, P150, DOI 10.1016/j.jocd.2013.06.002; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534	39	65	66	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161773	10.1371/journal.pone.0161773	http://dx.doi.org/10.1371/journal.pone.0161773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606706	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600010
J	Diaz, SA; Martin, SR; Howell, SA; Grainger, M; Moon, RW; Green, JL; Holder, AA				Diaz, Suraya A.; Martin, Stephen R.; Howell, Steven A.; Grainger, Munira; Moon, Robert W.; Green, Judith L.; Holder, Anthony A.			The Binding of Plasmodium falciparum Adhesins and Erythrocyte Invasion Proteins to Aldolase Is Enhanced by Phosphorylation	PLOS ONE			English	Article							HOST-CELL INVASION; MALARIA PARASITE INVASION; TOXOPLASMA-GONDII; ANONYMOUS PROTEIN; CYTOPLASMIC DOMAIN; MEROZOITE PROTEINS; APICOMPLEXAN PARASITES; ACTIN POLYMERIZATION; GLIDING MOTILITY; MOTOR COMPLEX	Aldolase has been implicated as a protein coupling the actomyosin motor and cell surface adhesins involved in motility and host cell invasion in the human malaria parasite Plasmodium falciparum. It binds to the cytoplasmic domain (CTD) of type 1 membrane proteins of the thrombospondin-related anonymous protein (TRAP) family. Other type 1 membrane proteins located in the apical organelles of merozoites, the form of the parasite that invades red blood cells, including apical membrane antigen 1 (AMA1) and members of the erythrocyte binding ligand (EBL) and reticulocyte binding homologue (RH) protein families have been implicated in host cell binding and invasion. Using a direct binding method we confirm that TRAP and merozoite TRAP (MTRAP) bind aldolase and show that the interaction is mediated by more than just the C-terminal six amino acid residues identified previously. Single amino acid substitutions in the MTRAP CTD abolished binding to aldolase. The CTDs of AMA1 and members of the EBL and RH protein families also bound to aldolase. MTRAP competed with AMA1 and RH4 for binding to aldolase, indicating overlapping binding sites. MTRAP CTD was phosphorylated in vitro by both calcium dependent kinase 1 (CDPK1) and protein kinase A, and this modification increased the affinity of binding to aldolase by ten-fold. Phosphorylation of the CTD of members of the EBL and RH protein families also increased their affinity for aldolase in some cases. To examine whether or not MTRAP expressed in asexual blood stage parasites is phosphorylated, it was tagged with GFP, purified and analysed, however no phosphorylation was detected. We propose that CTD binding to aldolase may be dynamically modulated by phosphorylation, and there may be competition for aldolase binding between different CTDs. The use and efficiency of alternate invasion pathways may be determined by the affinity of adhesins and cell invasion proteins for aldolase, in addition to their host ligand specificity.	[Diaz, Suraya A.; Grainger, Munira; Moon, Robert W.; Green, Judith L.; Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, Malaria Parasitol Lab, Mill Hill, London NW7 1AA, England; [Martin, Stephen R.] Francis Crick Inst, Mill Hill Lab, Struct Biol Sci Technol Platform, Mill Hill, London NW7 1AA, England; [Howell, Steven A.] Francis Crick Inst, Mill Hill Lab, Mass Spectrometry Sci Technol Platform, Mill Hill, London NW7 1AA, England; [Diaz, Suraya A.] Natl Univ Ireland, Ctr Chromosome Biol, Biosci Res Bldg, Galway, Ireland; [Moon, Robert W.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England	Ollscoil na Gaillimhe-University of Galway; University of London; London School of Hygiene & Tropical Medicine	Holder, AA (corresponding author), Francis Crick Inst, Mill Hill Lab, Malaria Parasitol Lab, Mill Hill, London NW7 1AA, England.	tony.holder@crick.ac.uk	Moon, Robert/AAF-9808-2019; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Moon, Robert/0000-0002-9070-4292; Green, Judith/0000-0001-6825-9404	Francis Crick Institute from Cancer Research UK; UK Medical Research Council [U117532067]; Wellcome Trust; European Community [242095]; Portuguese FCT; MRC [MR/M021157/1, MC_U117532067] Funding Source: UKRI; Medical Research Council [MR/M021157/1, MC_U117532067] Funding Source: researchfish; The Francis Crick Institute [10097, 10015] Funding Source: researchfish	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Portuguese FCT(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute (https://www.crick.ac.uk/) which receives its core funding from Cancer Research UK (http://www.cancerresearchuk.org), the UK Medical Research Council (http://www.mrc.ac.uk/), and the Wellcome Trust (http://www.wellcome.ac.uk). In addition, this research was supported by the UK Medical Research Council (U117532067 to AAH) and the European Community's FP7 grant agreement 242095 to AAH (EviMalar; http://www.evimalar.org). SAD was in receipt of a Portuguese FCT Studentship (http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; AIKAWA M, 1981, J CELL BIOL, V91, P55, DOI 10.1083/jcb.91.1.55; Akhouri RR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-63; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Buscaglia CA, 2007, PROTEINS, V66, P528, DOI 10.1002/prot.21266; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chattopadhyay R, 2003, J BIOL CHEM, V278, P25977, DOI 10.1074/jbc.M300865200; Dawn A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004520; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Diaz SA, 2014, MOL BIOCHEM PARASIT, V197, P9, DOI 10.1016/j.molbiopara.2014.09.006; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Dvorin JD, 2010, MOL MICROBIOL, V75, P990, DOI 10.1111/j.1365-2958.2009.07040.x; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Engelberg K, 2013, BIOCHEM J, V452, P457, DOI 10.1042/BJ20121694; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Goo YK, 2013, EXP PARASITOL, V135, P42, DOI 10.1016/j.exppara.2013.06.002; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Jacot D, 2014, CELL MICROBIOL, V16, P1518, DOI 10.1111/cmi.12307; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Lasonder E, 2015, PROTEOMICS, V15, P2716, DOI 10.1002/pmic.201400508; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Nemetski SM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0834-9; Pal-Bhowmick I, 2012, MBIO, V3, DOI 10.1128/mBio.00292-12; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Riglar DT, 2016, J CELL SCI, V129, P228, DOI 10.1242/jcs.177741; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; RUSSELL DG, 1983, PARASITOLOGY, V87, P199, DOI 10.1017/S0031182000052562; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tham WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005343; Thompson J, 2004, MOL BIOCHEM PARASIT, V134, P225, DOI 10.1016/j.molbiopara.2003.12.003; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Uchime O, 2012, EUKARYOT CELL, V11, P615, DOI 10.1128/EC.00039-12; WALSH TP, 1977, BIOCHEM J, V165, P165, DOI 10.1042/bj1650165; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Yusuf NA, 2015, J BIOL CHEM, V290, P12147, DOI 10.1074/jbc.M115.637694	56	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161850	10.1371/journal.pone.0161850	http://dx.doi.org/10.1371/journal.pone.0161850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607074	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600013
J	Nakazono, H; Ogata, K; Kuroda, T; Tobimatsu, S				Nakazono, Hisato; Ogata, Katsuya; Kuroda, Tsuyoshi; Tobimatsu, Shozo			Phase and Frequency-Dependent Effects of Transcranial Alternating Current Stimulation on Motor Cortical Excitability	PLOS ONE			English	Article							OSCILLATORY ACTIVITY; CORTICOMUSCULAR COHERENCE; NEURONAL POPULATIONS; SENSORIMOTOR CORTEX; BRAIN OSCILLATIONS; ALPHA; SYNCHRONIZATION; PERFORMANCE; POTENTIALS; NETWORK	Transcranial alternating current stimulation (tACS) can entrain ongoing brain oscillations and modulate the motor system in a frequency-dependent manner. Recent animal studies have demonstrated that the phase of a sinusoidal current also has an important role in modulation of neuronal activity. However, the phase effects of tACS on the human motor system are largely unknown. Here, we systematically investigated the effects of tACS phase and frequency on the primary motor cortex (M1) by using motor evoked potentials (MEPs) with transcranial magnetic stimulation (TMS). First, we compared the phase effects (90 degrees, 180 degrees, 270 degrees or 360 degrees) of 10 and 20 Hz tACS on MEPs. The 20 Hz tACS significantly increased M1 excitability compared with the 10 Hz tACS at 90 degrees phase only. Second, we studied the 90 degrees phase effect on MEPs at different tACS frequencies (5, 10, 20 or 40 Hz). The 20 vs. 10 Hz difference was again observed, but the 90 degrees phase in 5 and 40 Hz tACS did not influence M1 excitability. Third, the 90 degrees phase effects of 10 and 20 Hz tACS were compared with sham stimulation. The 90 degrees phase of 20 Hz tACS enhanced MEP amplitudes compared with sham stimulation, but there was no significant effect of 10 Hz tACS. Taken together, we assume that the differential 90 degrees phase effects on 20 Hz and 10 Hz tACS can be attributed to the neural synchronization modulated by tACS. Our results further underline that phase and frequency are the important factors in the effects of tACS on M1 excitability.	[Nakazono, Hisato; Ogata, Katsuya; Tobimatsu, Shozo] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Clin Neurophysiol, Fukuoka, Japan; [Kuroda, Tsuyoshi] Shizuoka Univ, Fac Informat, Shizuoka, Japan	Kyushu University; Shizuoka University	Nakazono, H (corresponding author), Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Clin Neurophysiol, Fukuoka, Japan.	nakazono@med.kyushu-u.ac.jp	Kuroda, Tsuyoshi/H-8369-2019; l_l, CuteBlock/L-4348-2018	l_l, CuteBlock/0000-0002-7559-9615; Nakazono, Hisato/0000-0002-5076-8953	 [15J03164];  [15K21195];  [15H05875]; Grants-in-Aid for Scientific Research [15H05871] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS KAKENHI 15J03164 to HN, and a Grant-in-Aid for JSPS KAKENHI 15K21195 to TK, and a Grant-in-Aid for Scientific Research on Innovative Areas MEXT KAKENHI 15H05875 to ST.	Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cancelli A, 2015, BRAIN STIMUL, V8, P555, DOI 10.1016/j.brs.2015.01.398; Cecere R, 2015, CURR BIOL, V25, P231, DOI 10.1016/j.cub.2014.11.034; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Feurra M, 2013, J NEUROSCI, V33, P17483, DOI 10.1523/JNEUROSCI.1414-13.2013; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Keil J, 2014, J NEUROPHYSIOL, V111, P513, DOI 10.1152/jn.00387.2013; Krause V, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00004; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Kutchko KM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003304; Lepage JF, 2008, J NEUROSCI METH, V175, P17, DOI 10.1016/j.jneumeth.2008.07.021; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; Mitchell WK, 2007, J PHYSIOL-LONDON, V583, P567, DOI 10.1113/jphysiol.2007.134031; Muller NG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143533; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Nielsen J. F., 1996, CLIN NEUROPHYSIOL, V101, P404; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Pollok B, 2015, BEHAV BRAIN RES, V293, P234, DOI 10.1016/j.bbr.2015.07.049; Raco V, 2014, BRAIN STIMUL, V7, P823, DOI 10.1016/j.brs.2014.08.005; Reato D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00687; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Reimer J, 2010, J NEUROSCI, V30, P11506, DOI 10.1523/JNEUROSCI.5947-09.2010; Riecke L, 2015, BRAIN STIMUL, V8, P777, DOI 10.1016/j.brs.2015.04.004; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Schulz H, 2014, CEREB CORTEX, V24, P1708, DOI 10.1093/cercor/bht024; Schutter DJLG, 2011, BRAIN STIMUL, V4, P97, DOI 10.1016/j.brs.2010.07.002; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Tamura Y, 2005, EUR J NEUROSCI, V21, P2555, DOI 10.1111/j.1460-9568.2005.04096.x; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Turi Z, 2013, RESTOR NEUROL NEUROS, V31, P275, DOI 10.3233/RNN-120297; van Elswijk G, 2010, J NEUROSCI, V30, P4481, DOI 10.1523/JNEUROSCI.2794-09.2010; Voss U, 2014, NAT NEUROSCI, V17, P810, DOI 10.1038/nn.3719; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Wach C, 2013, BEHAV BRAIN RES, V241, P1, DOI 10.1016/j.bbr.2012.11.038; Wetmore DZ, 2004, J PHYSIOL-LONDON, V555, P831, DOI 10.1113/jphysiol.2003.048918; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316	61	37	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162521	10.1371/journal.pone.0162521	http://dx.doi.org/10.1371/journal.pone.0162521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607431	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600055
J	Liu, XY; Chen, Q				Liu, Xinyu; Chen, Qun			An Algorithm for the Mixed Transportation Network Design Problem	PLOS ONE			English	Article							GLOBAL OPTIMIZATION METHOD; VARIATIONAL INEQUALITY CONSTRAINTS; STOCHASTIC USER EQUILIBRIUM; ROAD NETWORK; MATHEMATICAL PROGRAMS; HEURISTIC ALGORITHMS; SENSITIVITY-ANALYSIS; TRAFFIC ASSIGNMENT; RESERVE CAPACITY; SIGNAL CONTROL	This paper proposes an optimization algorithm, the dimension-down iterative algorithm (DDIA), for solving a mixed transportation network design problem (MNDP), which is generally expressed as a mathematical programming with equilibrium constraint (MPEC). The upper level of the MNDP aims to optimize the network performance via both the expansion of the existing links and the addition of new candidate links, whereas the lower level is a traditionalWardrop user equilibrium (UE) problem. The idea of the proposed solution algorithm (DDIA) is to reduce the dimensions of the problem. A group of variables (discrete/continuous) is fixed to optimize another group of variables (continuous/discrete) alternately; then, the problem is transformed into solving a series of CNDPs (continuous network design problems) and DNDPs (discrete network design problems) repeatedly until the problem converges to the optimal solution. The advantage of the proposed algorithm is that its solution process is very simple and easy to apply. Numerical examples show that for the MNDP without budget constraint, the optimal solution can be found within a few iterations with DDIA. For the MNDP with budget constraint, however, the result depends on the selection of initial values, which leads to different optimal solutions (i.e., different local optimal solutions). Some thoughts are given on how to derive meaningful initial values, such as by considering the budgets of new and reconstruction projects separately.	[Liu, Xinyu; Chen, Qun] Cent S Univ, Sch Traff & Transportat Engn, Changsha 410075, Hunan, Peoples R China; [Liu, Xinyu] Foshan Univ, Sch Business & Law, Foshan 528000, Peoples R China	Central South University; Foshan University	Chen, Q (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha 410075, Hunan, Peoples R China.	chenqun631@csu.edu.cn	Chen, Qun/HGD-0868-2022		Science and Technology Project of Hunan Province, China [2015ZK3003]; Research Fund for Young Scholars of Central South University [2014JSJJ015]	Science and Technology Project of Hunan Province, China; Research Fund for Young Scholars of Central South University	This work was supported by the Science and Technology Project of Hunan Province, China [grant number 2015ZK3003, http://61.187.87.49/pms-hn/, QC] and the Research Fund for Young Scholars of Central South University [grant number 2014JSJJ015, http://www.csu.edu.cn/, QC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Science and Technology Project of Hunan Province, China [grant number 2015ZK3003] and the Research Fund for Young Scholars of Central South University [grant number 2014JSJJ015].	ABDULAAL M, 1979, TRANSPORT RES B-METH, V13, P19, DOI 10.1016/0191-2615(79)90004-3; Allsop R. E., 1974, P 6 INT S TRANSP TRA, V6, P345; Cantarella GE, 2006, EUR J OPER RES, V175, P1682, DOI 10.1016/j.ejor.2005.02.034; CHEN MY, 1991, TRANSPORT SCI, V25, P215, DOI 10.1287/trsc.25.3.215; Chiou SW, 2005, TRANSPORT RES B-METH, V39, P361, DOI 10.1016/j.trb.2004.05.001; Chiou SW, 1999, TRANSPORT SCI, V33, P279, DOI 10.1287/trsc.33.3.279; Connors RD, 2007, TRANSPORT RES B-METH, V41, P593, DOI 10.1016/j.trb.2006.11.003; Dimitriou L, 2008, LECT NOTES COMPUT SC, V4974, P669; Drezner Z, 2003, TRANSPORT RES A-POL, V37, P241, DOI 10.1016/S0965-8564(02)00014-9; Drezner Z, 1997, TRANSPORT SCI, V31, P386, DOI 10.1287/trsc.31.4.386; Farvaresh H, 2013, NETW SPAT ECON, V13, P67, DOI 10.1007/s11067-012-9173-3; FRIESZ TL, 1990, MATH PROGRAM, V48, P265, DOI 10.1007/BF01582259; FRIESZ TL, 1992, TRANSPORT SCI, V26, P18, DOI 10.1287/trsc.26.1.18; Friesz TL, 1985, CIVIL ENG SYSTEM, V2, P142; Gallo M, 2010, EUR J OPER RES, V201, P144, DOI 10.1016/j.ejor.2009.02.026; Gao ZY, 2005, TRANSPORT RES B-METH, V39, P479, DOI 10.1016/j.trb.2004.06.004; Gao ZY, 2004, TRANSPORT RES B-METH, V38, P235, DOI 10.1016/S0191-2615(03)00011-0; Gao ZY, 2002, TRANSPORT RES B-METH, V36, P313, DOI 10.1016/S0191-2615(01)00005-4; Haas I, 2016, TRANSPORTMETRICA A, V12, P43, DOI 10.1080/23249935.2015.1094680; Leblanc L. J., 1975, Transportation Science, V9, P183, DOI 10.1287/trsc.9.3.183; Li CM, 2012, TRANSPORT RES B-METH, V46, P1144, DOI 10.1016/j.trb.2012.05.003; Liu C, 2001, MODERN TRANSPORTATIO; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; MARCOTTE P, 1986, MATH PROGRAM, V34, P142, DOI 10.1007/BF01580580; Marcotte P., 1992, Annals of Operations Research, V34, P163, DOI 10.1007/BF02098178; Meng Q, 2001, TRANSPORT RES B-METH, V35, P83, DOI 10.1016/S0191-2615(00)00016-3; Mokhtar S.B., 1979, NONLINEAR PROGRAMMIN; Patriksson M, 2008, TRANSPORT RES B-METH, V42, P843, DOI 10.1016/j.trb.2008.05.001; POORZAHEDY H, 1982, TRANSPORT RES B-METH, V16, P45, DOI 10.1016/0191-2615(82)90040-6; Poorzahedy H, 2005, TRANSPORTATION, V32, P251, DOI 10.1007/s11116-004-8246-7; Poorzahedy H, 2007, EUR J OPER RES, V182, P578, DOI 10.1016/j.ejor.2006.07.038; Riemann R, 2015, TRANSPORT RES C-EMER, V58, P1, DOI 10.1016/j.trc.2015.06.022; Sheffi Y., 1985, URBAN TRANSPORTATION; Solanki RS, 1998, TRANSPORT RES B-METH, V32, P127, DOI 10.1016/S0191-2615(97)00020-9; Sumalee A, 2006, TRANSPORT RES REC, P81, DOI 10.3141/1964-10; Sumalee A, 2007, TRANSPORTMETRICA, V3, P41, DOI 10.1080/18128600708685667; SUWANSIRIKUL C, 1987, TRANSPORT SCI, V21, P254, DOI 10.1287/trsc.21.4.254; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Wang DZW, 2010, TRANSPORT RES B-METH, V44, P482, DOI 10.1016/j.trb.2009.10.003; Wang SA, 2013, TRANSPORT RES B-METH, V50, P42, DOI 10.1016/j.trb.2013.01.006; Wong SC, 1997, TRANSPORT RES B-METH, V31, P397, DOI 10.1016/S0191-2615(97)00002-7; Wu J, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/686272; YANG H, 1994, TRANSPORT RES B-METH, V28, P463, DOI 10.1016/0191-2615(94)90015-9; YANG H, 1994, TRANSPORT RES B-METH, V28, P123, DOI 10.1016/0191-2615(94)90021-3; YANG H, 1995, TRANSPORT RES A-POL, V29, P125, DOI 10.1016/0965-8564(94)E0007-V; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016	48	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162618	10.1371/journal.pone.0162618	http://dx.doi.org/10.1371/journal.pone.0162618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626803	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600048
J	Morell, C; Bort, A; Vara-Ciruelos, D; Ramos-Torres, A; Altamirano-Dimas, M; Diaz-Laviada, I; Rodriguez-Henche, N				Morell, Cecilia; Bort, Alicia; Vara-Ciruelos, Diana; Ramos-Torres, Agata; Altamirano-Dimas, Manuel; Diaz-Laviada, Ines; Rodriguez-Henche, Nieves			Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells	PLOS ONE			English	Article							ANDROGEN DEPRIVATION THERAPY; MEMBRANE-PROTEINS; TUMOR-CELLS; MONITORING AUTOPHAGY; LYSOSOME BIOGENESIS; DANON-DISEASE; CYCLIC-AMP; PROGRESSION; CARCINOMA; TARGET	Neuroendocrine (NE) prostate cancer (PCa) is a highly aggressive subtype of prostate cancer associated with resistance to androgen ablation therapy. In this study, we used LNCaP prostate cancer cells cultured in a serum-free medium for 6 days as a NE model of prostate cancer. Serum deprivation increased the expression of NE markers such as neuron-specific enolase (NSE) and beta III tubulin (beta III tub) and decreased the expression of the androgen receptor protein in LNCaP cells. Using cDNA microarrays, we compared gene expression profiles of NE cells and non-differentiated LNCaP cells. We identified up-regulation of 155 genes, among them LAMP2, a lysosomal membrane protein involved in lysosomal stability and autophagy. We then confirmedup-regulation of LAMP2 in NE cells by qRT-PCR, Western blot and confocal microscopy assays, showing that mRNA up-regulation correlated with increased levels of LAMP2 protein. Subsequently, we determined autophagy activity in NE cells by assessing the protein levels of SQSTM/p62 and LC3 by Western blot and LC3 and Atg5 mRNAs content by qRT-PCR. The decreased levels of SQSTM/p62 was accompanied by an enhanced expression of LC3 and ATG5, suggesting activation of autophagy in NE cells. Blockage of autophagy with 1 mu MAKT inhibitor IV, or by silencing Beclin 1 and Atg5, prevented NE cell differentiation, as revealed by decreased levels of the NE markers. In addition, AKT inhibitor IV as well as Beclin1 and Atg5 kwockdown attenuated LAMP2 expression in NE cells. On the other hand, LAMP2 knockdown by siRNA led to a marked blockage of autophagy, prevention of NE differentiation and decrease of cell survival. Taken together, these results suggest that LAMP2 overexpression assists NE differentiation of LNCaP cells induced by serum deprivation and facilitates autophagy activity in order to attain the NE phenotype and cell survival. LAMP2 could thus be a potential biomarker and potential target for NE prostate cancer.	[Morell, Cecilia; Bort, Alicia; Ramos-Torres, Agata; Diaz-Laviada, Ines; Rodriguez-Henche, Nieves] Univ Alcala De Henares, Sch Med & Hlth Sci, Biochem & Mol Biol Unit, Dept Syst Biol, Alcala De Henares, Spain; [Vara-Ciruelos, Diana] Univ Dundee, Coll Life Sci, Cell Signalling & Immunol, Dundee, Scotland; [Altamirano-Dimas, Manuel] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	Universidad de Alcala; University of Dundee	Rodriguez-Henche, N (corresponding author), Univ Alcala De Henares, Sch Med & Hlth Sci, Biochem & Mol Biol Unit, Dept Syst Biol, Alcala De Henares, Spain.	nieves.rhenche@uah.es	Vara-Ciruelos, Diana/K-6919-2017; Vara-Ciruelos, Diana/S-3077-2019; Rodriguez-Henche, Nieves/K-6828-2017; Bueno, Bort/AAC-1242-2019; Diaz-Laviada, Ines/I-2838-2015	Vara-Ciruelos, Diana/0000-0002-9508-2648; Vara-Ciruelos, Diana/0000-0002-9508-2648; Rodriguez-Henche, Nieves/0000-0001-9798-359X; Bueno, Bort/0000-0003-1490-5823; Diaz-Laviada, Ines/0000-0001-9704-4373; Morell Pucci, Maria Cecilia/0000-0002-9759-855X	University of Alcala [PI2005/063]; Spanish Ministry of Economy and Competitiveness [BFU2012-31444]; Junta de Comunidades Castilla-LaMancha; European Commission FEDER Funds [POII11-0159-0054]; Comunidad de Madrid [S2010-BMD2308]; Fundacion Tatiana Perez de Guzman el Bueno [Patrocinio 2013-001]	University of Alcala; Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Comunidades Castilla-LaMancha(Junta de Comunidades de Castilla-La Mancha); European Commission FEDER Funds(European Commission); Comunidad de Madrid(Comunidad de Madrid); Fundacion Tatiana Perez de Guzman el Bueno	This work was supported by the University of Alcala (Grant no PI2005/063) to ART; the Spanish Ministry of Economy and Competitiveness (Grant no BFU2012-31444); Junta de Comunidades Castilla-LaMancha and European Commission FEDER Funds (Grant no POII11-0159-0054); Comunidad de Madrid (Grant S2010-BMD2308); and the Fundacion Tatiana Perez de Guzman el Bueno (Grant no Patrocinio 2013-001) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Lilian Puebla for English assistance and Isabel Trabado and Pilar Rubio for technical assistance. This research has been supported by the University of Alcala (Grant no PI2005/063); the Spanish Ministry of Economy and Competitiveness (Grant no BFU2012-31444); Junta de Comunidades Castilla-LaMancha and European Commission FEDER Funds (Grant no POII11-0159-0054); Comunidad de Madrid (Grant S2010-BMD2308); and the Fundacion Tatiana Perez de Guzman el Bueno (Grant no Patrocinio 2013-001). AB: is supported by grant from Fundacion Tatiana Perez de Guzman el Bueno. ART: is supported by grant from University of Alcala.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Chang PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088556; Cox ME, 1999, CANCER RES, V59, P3821; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Cussenot O, 1996, J UROLOGY, V155, P1340, DOI 10.1016/S0022-5347(01)66261-X; Damaghi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9752; Deeble PD, 2001, MOL CELL BIOL, V21, P8471, DOI 10.1128/MCB.21.24.8471-8482.2001; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Endo Y, 2015, ACTA NEUROPATHOL, V129, P391, DOI 10.1007/s00401-015-1385-4; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Farrow JM, 2014, NAT REV UROL, V11, P508, DOI 10.1038/nrurol.2014.196; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Furuta K, 2001, AM J PATHOL, V159, P449, DOI 10.1016/S0002-9440(10)61716-6; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Gutierrez-Canas I, 2005, PROSTATE, V63, P44, DOI 10.1002/pros.20173; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Hvamstad T, 2003, EUR UROL, V44, P215, DOI 10.1016/S0302-2838(03)00257-4; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Isshiki S, 2002, J UROLOGY, V167, P512, DOI 10.1016/S0022-5347(01)69075-X; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Morell C, 2016, PROSTATE CANCER P D, V19, P248, DOI 10.1038/pcan.2016.19; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Noguchi M, 2014, BBA-REV CANCER, V1846, P342, DOI 10.1016/j.bbcan.2014.07.013; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Rick FG, 2015, UROL ONCOL-SEMIN ORI, V33, P270, DOI 10.1016/j.urolonc.2014.11.006; Saad F, 2015, UROLOGY, V86, P852, DOI 10.1016/j.urology.2015.07.034; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saha T, 2012, AUTOPHAGY, V8, P1643, DOI 10.4161/auto.21654; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Sauer CG, 2006, PROSTATE, V66, P227, DOI 10.1002/pros.20338; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2009, AM J TRANSL RES, V1, P148; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Terry S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00060; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; Wyatt AW, 2015, EMBO MOL MED, V7, P878, DOI 10.15252/emmm.201303701; Xie SZ, 2004, PROSTATE, V60, P61, DOI 10.1002/pros.20048; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhu YZ, 2014, PROSTATE, V74, P1086, DOI 10.1002/pros.22819	62	28	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162977	10.1371/journal.pone.0162977	http://dx.doi.org/10.1371/journal.pone.0162977			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627761	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600071
J	Savalli, C; Resende, B; Gaunet, F				Savalli, Carine; Resende, Briseida; Gaunet, Florence			Eye Contact Is Crucial for Referential Communication in Pet Dogs	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOGS; GESTURAL COMMUNICATION; HUMANS; ATTENTION; CHIMPANZEE; OWNERS; STATE; CUES; MIND	Dogs discriminate human direction of attention cues, such as body, gaze, head and eye orientation, in several circumstances. Eye contact particularly seems to provide information on human readiness to communicate; when there is such an ostensive cue, dogs tend to follow human communicative gestures more often. However, little is known about how such cues influence the production of communicative signals (e.g. gaze alternation and sustained gaze) in dogs. In the current study, in order to get an unreachable food, dogs needed to communicate with their owners in several conditions that differ according to the direction of owners' visual cues, namely gaze, head, eyes, and availability to make eye contact. Results provided evidence that pet dogs did not rely on details of owners' direction of visual attention. Instead, they relied on the whole combination of visual cues and especially on the owners' availability to make eye contact. Dogs increased visual communicative behaviors when they established eye contact with their owners, a different strategy compared to apes and baboons, that intensify vocalizations and gestures when human is not visually attending. The difference in strategy is possibly due to distinct status: domesticated vs wild. Results are discussed taking into account the ecological relevance of the task since pet dogs live in human environment and face similar situations on a daily basis during their lives.	[Savalli, Carine] Univ Fed Sao Paulo, Dept Publ Policies & Collect Hlth, Santos, SP, Brazil; [Resende, Briseida] Univ Sao Paulo, Dept Expt Psychol, Sao Paulo, SP, Brazil; [Gaunet, Florence] Aix Marseille Univ, Lab Psychol Cognit, Marseille, France	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; UDICE-French Research Universities; Aix-Marseille Universite	Savalli, C (corresponding author), Univ Fed Sao Paulo, Dept Publ Policies & Collect Hlth, Santos, SP, Brazil.	carine.savalli@unifesp.br	Savalli, Carine/AAN-4137-2021; Resende, Briseida/F-1898-2013	Savalli, Carine/0000-0001-7388-7616; Resende, Briseida/0000-0001-5932-0189				Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Bard KA, 2014, ANNU REV ANTHROPOL, V43, P183, DOI 10.1146/annurev-anthro-102313-030223; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Benjamini Y, 2001, ANN STAT, V29, P1165; Bentosela M, 2008, BEHAV PROCESS, V78, P464, DOI 10.1016/j.beproc.2008.03.004; Bourjade M, 2014, ANIM BEHAV, V87, P121, DOI 10.1016/j.anbehav.2013.10.019; Brauer J, 2013, ANIM COGN, V16, P351, DOI 10.1007/s10071-012-0576-9; Brauer J, 2004, APPL ANIM BEHAV SCI, V88, P299, DOI 10.1016/j.applanim.2004.03.004; Brauer J., 2014, SOCIAL DOG BEHAV COG; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Canteloup C, 2015, ANIM COGN, V18, P875, DOI 10.1007/s10071-015-0856-2; Duranton C, 2013, THESIS, P13; Fragaszy DM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0410; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gaunet F, 2008, ANIM COGN, V11, P475, DOI 10.1007/s10071-008-0138-3; Gaunet F, 2014, ANIM COGN, V17, P1137, DOI 10.1007/s10071-014-0746-z; Gaunet F, 2011, ANIM COGN, V14, P849, DOI 10.1007/s10071-011-0418-1; Gaunet F, 2010, ANIM COGN, V13, P311, DOI 10.1007/s10071-009-0279-z; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hattori Y, 2010, ANIM COGN, V13, P87, DOI 10.1007/s10071-009-0248-6; Hobaiter C, 2014, CURR BIOL, V24, P1596, DOI 10.1016/j.cub.2014.05.066; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; HOLLANDER M, 1998, NONPARAMETRIC STAT M; Hopkins WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079338; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Jaeggi AV, 2013, EVOL ANTHROPOL, V22, P186, DOI 10.1002/evan.21364; Kaminski J, 2013, ANIM COGN, V16, P385, DOI 10.1007/s10071-012-0579-6; Kaminski J, 2012, DEVELOPMENTAL SCI, V15, P222, DOI 10.1111/j.1467-7687.2011.01120.x; Kaminski J, 2009, BEHAVIOUR, V146, P979, DOI 10.1163/156853908X395530; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Legerstee M, 2003, COGNITIVE DEV, V18, P91, DOI 10.1016/S0885-2014(02)00165-X; LEHRMAN DS, 1953, Q REV BIOL, V28, P337, DOI 10.1086/399858; Liszkowski U, 2011, J COGN EDUC PSYCHOL, V10, P32, DOI 10.1891/1945-8959.10.1.32; Marshall-Pescini S, 2013, ANIM COGN, V16, P933, DOI 10.1007/s10071-013-0627-x; McKinley J, 2000, ANIM COGN, V3, P13, DOI 10.1007/s100710050046; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Ohkita M, 2016, BEHAV PROCESS, V125, P96, DOI 10.1016/j.beproc.2016.02.013; Passalacqua C, 2011, ANIM BEHAV, V82, P1043, DOI 10.1016/j.anbehav.2011.07.039; Perez-Guisado J, 2009, J ANIM VET ADV, V8, P336; Pitteri E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108176; RESENDE BD, 2008, DEVELOPMENTAL SCI, V11, P812; Savalli C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108003; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Topal J., 2014, SOCIAL DOG BEHAV COG; Udell MAR, 2011, LEARN BEHAV, V39, P289, DOI 10.3758/s13420-011-0034-6; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Whiten A, 2000, COGNITIVE SCI, V24, P477; Yamamoto M, 2011, J VET BEHAV, V6, P4, DOI 10.1016/j.jveb.2010.10.002	57	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162161	10.1371/journal.pone.0162161	http://dx.doi.org/10.1371/journal.pone.0162161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626933	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600022
J	Savige, J; Storey, H; Cheong, HI; Kang, HG; Park, E; Hilbert, P; Persikov, A; Torres-Fernandez, C; Ars, E; Torra, R; Hertz, JM; Thomassen, M; Shagam, L; Wang, DM; Wang, YY; Flinter, F; Nagel, M				Savige, Judith; Storey, Helen; Cheong, Hae Il; Kang, Hee Gyung; Park, Eujin; Hilbert, Pascale; Persikov, Anton; Torres-Fernandez, Carmen; Ars, Elisabet; Torra, Roser; Hertz, Jens Michael; Thomassen, Mads; Shagam, Lev; Wang, Dongmao; Wang, Yanyan; Flinter, Frances; Nagel, Mato			X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations	PLOS ONE			English	Article							BASEMENT-MEMBRANE NEPHROPATHY; COL4A5 COLLAGEN GENE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BENIGN FAMILIAL HEMATURIA; IV COLLAGEN; COL4A3/COL4A4 MUTATIONS; NATURAL-HISTORY; RENAL-FAILURE; PCR; IDENTIFICATION	Alport syndrome results from mutations in the COL4A5 (X-linked) or COL4A3/COL4A4 (recessive) genes. This study examined 754 previously-unpublished variants in these genes from individuals referred for genetic testing in 12 accredited diagnostic laboratories worldwide, in addition to all published COL4A5, COL4A3 and COL4A4 variants in the LOVD databases. It also determined genotype-phenotype correlations for variants where clinical data were available. Individuals were referred for genetic testing where Alport syndrome was suspected clinically or on biopsy (renal failure, hearing loss, retinopathy, lamellated glomerular basement membrane), variant pathogenicity was assessed using currently-accepted criteria, and variants were examined for gene location, and age at renal failure onset. Results were compared using Fisher's exact test (DNA Stata). Altogether 754 new DNA variants were identified, an increase of 25%, predominantly in people of European background. Of the 1168 COL4A5 variants, 504 (43%) were missense mutations, 273 (23%) splicing variants, 73 (6%) nonsense mutations, 169 (14%) short deletions and 76 (7%) complex or large deletions. Only 135 of the 432 Gly residues in the collagenous sequence were substituted (31%), which means that fewer than 10% of all possible variants have been identified. Both missense and nonsense mutations in COL4A5 were not randomly distributed but more common at the 70 CpG sequences (p<10(-41) and p<0.001 respectively). Gly>Ala substitutions were underrepresented in all three genes (p<0.0001) probably because of an association with a milder phenotype. The average age at end-stage renal failure was the same for all mutations in COL4A5 (24.4 +/- 7.8 years), COL4A3 (23.3 +/- 9.3) and COL4A4 (25.4 +/- 10.3) (COL4A5 and COL4A3, p = 0.45; COL4A5 and COL4A4, p = 0.55; COL4A3 and COL4A4, p = 0.41). For COL4A5, renal failure occurred sooner with non-missense than missense variants (p<0.01). For the COL4A3 and COL4A4 genes, age at renal failure occurred sooner with two non-missense variants (p = 0.08, and p = 0.01 respectively). Thus DNA variant characteristics that predict age at renal failure appeared to be the same for all three Alport genes. Founder mutations (with the pathogenic variant in at least 5 apparently-unrelated individuals) were not necessarily associated with a milder phenotype. This study illustrates the benefits when routine diagnostic laboratories share and analyse their data.	[Savige, Judith; Wang, Dongmao; Wang, Yanyan] Univ Melbourne, Melbourne Hlth & Northern Hlth, Melbourne, Vic, Australia; [Storey, Helen] Guys & St Thomas Hosp, Mol Genet Lab, London, England; [Cheong, Hae Il; Kang, Hee Gyung; Park, Eujin] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul, South Korea; [Hilbert, Pascale] Inst Pathol & Genet, Dept Mol Biol, Gosselles, Belgium; [Persikov, Anton] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Torres-Fernandez, Carmen] Mol Genet Ctr GENETAQ, Malaga, Spain; [Ars, Elisabet; Torra, Roser] Univ Autonoma Barcelona, Fundacio Puigvert, REDINREN, Mol Biol Lab, Barcelona, Spain; [Ars, Elisabet; Torra, Roser] Univ Autonoma Barcelona, Fundacio Puigvert, REDINREN, Dept Nephrol, Barcelona, Spain; [Hertz, Jens Michael; Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Shagam, Lev] Pirogov Russian Med Univ, Inst Pediat, Moscow, Russia; [Flinter, Frances] Guys & St Thomas Hosp, Dept Genet, London, England; [Nagel, Mato] Ctr Nephrol & Metab Med, D-02943 Weisswasser, Germany	University of Melbourne; Guy's & St Thomas' NHS Foundation Trust; Seoul National University (SNU); Seoul National University Hospital; Princeton University; Autonomous University of Barcelona; Fundacio Puigvert; Autonomous University of Barcelona; Fundacio Puigvert; University of Southern Denmark; Odense University Hospital; Pirogov Russian National Research Medical University; Guy's & St Thomas' NHS Foundation Trust	Savige, J (corresponding author), Univ Melbourne, Melbourne Hlth & Northern Hlth, Melbourne, Vic, Australia.	jasavige@unimelb.edu.au	Ars, Elisabet/AAM-8454-2021; Park, Eujin/AAZ-5931-2020; Hertz, Jens Michael/H-6269-2014; Torra, Roser/A-9983-2008	Ars, Elisabet/0000-0002-4118-4358; Park, Eujin/0000-0002-4413-468X; Hertz, Jens Michael/0000-0003-0087-4739; Storey, Helen/0000-0002-2214-6444; Torra, Roser/0000-0001-8714-2332	US Alport Foundation; Australian Alport Foundation; Korean government through the Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea [HI12C0014]	US Alport Foundation; Australian Alport Foundation; Korean government through the Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea	JS received seed funding to establish the Alport mutation databases from the US Alport Foundation and the Australian Alport Foundation ($USD 10,000 and $AUD 20,000 respectively). HIC, HGK and EP received funding from the Korean government through the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea ($USD142,000) (HI12C0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrondel C, 2004, KIDNEY INT, V65, P2030, DOI 10.1111/j.1523-1755.2004.00622.x; Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248; Barker DF, 1996, AM J HUM GENET, V58, P1157; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Barker DF, 2001, AM J MED GENET, V98, P148, DOI 10.1002/1096-8628(20010115)98:2<148::AID-AJMG1024>3.0.CO;2-W; Barker DF, 1997, HUM GENET, V99, P681, DOI 10.1007/s004390050429; Buzza M, 2001, KIDNEY INT, V60, P480, DOI 10.1046/j.1523-1755.2001.060002480.x; Chatterjee R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076360; Crockett DK, 2010, HUM MUTAT, V31, pE1652, DOI 10.1002/humu.21312; Dagher Hayat, 2002, Hum Mutat, V20, P321, DOI 10.1002/humu.9065; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; FEINGOLD J, 1985, KIDNEY INT, V27, P672, DOI 10.1038/ki.1985.63; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Grunfeld J P, 1997, Rev Prat, V47, P1566; GUO CY, 1995, J CLIN INVEST, V95, P1832, DOI 10.1172/JCI117862; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; KNEBELMANN B, 1992, AM J HUM GENET, V51, P135; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; Lemmink HH, 1997, HUM MUTAT, V9, P477; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; Malone AF, 2014, KIDNEY INT, V86, P1253, DOI 10.1038/ki.2014.305; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martin P, 1998, J AM SOC NEPHROL, V9, P2291; Mencarelli MA, 2015, J MED GENET, V52, P163, DOI 10.1136/jmedgenet-2014-102822; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Mohammad M, 2014, PEDIATR NEPHROL, V29, P481, DOI 10.1007/s00467-013-2682-6; Ozen S, 2001, PEDIATR NEPHROL, V16, P874, DOI 10.1007/s004670100673; Pierides A, 2013, HIPPOKRATIA, V17, P207; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Plant KE, 1999, HUM MUTAT, V13, P124, DOI 10.1002/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z; Renieri A, 1996, AM J HUM GENET, V58, P1192; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Savige J, 2003, KIDNEY INT, V64, P1169, DOI 10.1046/j.1523-1755.2003.00234.x; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Storey H, 2013, J AM SOC NEPHROL, V24, P1945, DOI 10.1681/ASN.2012100985; Tan R, 2010, CLIN J AM SOC NEPHRO, V5, P34, DOI 10.2215/CJN.01030209; van der Loop FTL, 2000, KIDNEY INT, V58, P1870, DOI 10.1046/j.1523-1755.2000.00358.x; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Wang YY, 2004, KIDNEY INT, V65, P786, DOI 10.1111/j.1523-1755.2004.00453.x; Webb BD, 2014, CLIN GENET, V86, P155, DOI 10.1111/cge.12247; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; ZHOU J, 1993, KIDNEY INT, V43, P722, DOI 10.1038/ki.1993.103	48	47	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161802	10.1371/journal.pone.0161802	http://dx.doi.org/10.1371/journal.pone.0161802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627812	Green Published, gold			2022-12-27	WOS:000383680600009
J	Shokoohi, M; Karamouzian, M; Mirzazadeh, A; Haghdoost, A; Rafierad, AA; Sedaghat, A; Sharifi, H				Shokoohi, Mostafa; Karamouzian, Mohammad; Mirzazadeh, Ali; Haghdoost, AliAkbar; Rafierad, Ali-Ahmad; Sedaghat, Abbas; Sharifi, Hamid			HIV Knowledge, Attitudes, and Practices of Young People in Iran: Findings of a National Population-Based Survey in 2013	PLOS ONE			English	Article							HEALTH; STIGMA; AFRICA	Introduction The evidence is mixed on the HIV knowledge, attitude, and practices of youth in Iran. The aim of the current study was to assess knowledge, attitudes, and practices of Iranian youth towards HIV through a national survey. Materials and Methods Through a cross-sectional study with multistage cluster sampling, we administered a pilot-tested standard questionnaire to assess the levels of HIV knowledge, attitudes and practices of individuals aged 15-29 years old. Participants were recruited from 13 provinces in Iran and consisted of 2456 men and 2412 women. Results Only 37.3% of the participants had a high knowledge score. Most participants knew the main routes of HIV transmission; however, misconceptions existed about the transmission of HIV through mosquito bites across all age groups (31.7% correct response). Positive levels of attitude wereobserved among 20.7% of the participants. Most participants believed that people living with HIV (PLHIV) should be supported (88.3%) while only 46.3% were ready to share a table with them. Among those aged 19-29 years old, the main source of HIV information was mass media (69.1%), only 13.1% had ever tested for HIV, around 20.8% had ever had extramarital sex (31.7% male vs. 9.6% female), 1.8% ever injected drugs (2.9% male vs. and 0.7% female). Among sexually active subjects in this age group, only 21.8% (26.1% male vs. 7.1% female) were consistent condom users. Conclusions The findings showed that Iranian youth and young adults have relatively insufficient overall knowledge and negative attitudes about HIV and PLHIV. Novel strategies involving schools and youth's networks could be employed to deliver a culturally sensitive sexual health program.	[Shokoohi, Mostafa; Karamouzian, Mohammad; Mirzazadeh, Ali; Rafierad, Ali-Ahmad; Sharifi, Hamid] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran; [Shokoohi, Mostafa; Karamouzian, Mohammad; Mirzazadeh, Ali; Rafierad, Ali-Ahmad; Sharifi, Hamid] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Shokoohi, Mostafa] Univ Western Ontario, Schulich Sch Med & Dent, Epidemiol & Biostat, London, ON, Canada; [Karamouzian, Mohammad] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada; [Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran; [Sedaghat, Abbas] Minist Hlth & Med Educ, CDC, Tehran, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Western University (University of Western Ontario); University of British Columbia; University of California System; University of California San Francisco; Kerman University of Medical Sciences; Ministry of Health & Medical Education (MOHME)	Karamouzian, M (corresponding author), Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran.; Karamouzian, M (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran.; Karamouzian, M (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada.	Karamouzian.m@ubc.alumni.ca	Haghdoost, Ali Akbar/C-2823-2009; Karamouzian, Mohammad/C-9277-2018; Sharifi, Hamid/B-5493-2019; Mirzazadeh, Ali/AAJ-5907-2021	Haghdoost, Ali Akbar/0000-0003-4628-4849; Karamouzian, Mohammad/0000-0002-5631-4469; Sharifi, Hamid/0000-0002-9008-7618; Mirzazadeh, Ali/0000-0002-0478-3220; Shokoohi, Mostafa/0000-0002-3810-752X	Ministry of Health of Iran	Ministry of Health of Iran	The survey was financially supported by the Ministry of Health of Iran in 2013. However, the authors received no funding for this specific paper.	Askarian M, 2004, J HOSP INFECT, V58, P292, DOI 10.1016/j.jhin.2004.07.004; Askarian M, 2009, ARCH IRAN MED, V12, P48; Behjati Ardekani M, 2005, IRAN J PEDIATR, V15, P321; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Farahani Farideh Khalaj Abadi, 2012, J Reprod Infertil, V13, P101; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Gao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044881; Ghabili Kamyar, 2008, AIDS Res Ther, V5, P15, DOI 10.1186/1742-6405-5-15; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Haghdoost A. A., 2011, Iranian Journal of Epidemiology, V6, P8; Haghdoost AA, 2013, IRAN RED CRESCENT ME, V15, P500, DOI 10.5812/ircmj.7673; Haroun D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149920; Hedayati-Moghaddam M. R., 2008, Eastern Mediterranean Health Journal, V14, P1321; Kakoko DC, 2006, AIDS CARE, V18, P554, DOI 10.1080/09540120500259779; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Karamouzian M, 2014, J ADOLESCENT HEALTH, V55, P149, DOI 10.1016/j.jadohealth.2014.04.009; Khajehkazemi R, 2013, SEX TRANSM INFECT, V89, P29, DOI 10.1136/sextrans-2013-051204; Martin RJ, 2016, SUBST ABUS, V37, P488, DOI 10.1080/08897077.2016.1142922; Mazloumi MS, 2006, ZAHEDAN J RES MED SC, V8, P53; Montazeri A, 2005, PATIENT EDUC COUNS, V57, P199, DOI 10.1016/j.pec.2004.05.014; Mosavi SA, 2014, J ADOLESCENT HEALTH, V55, P107, DOI 10.1016/j.jadohealth.2013.11.029; Nasirian M, 2016, INT J HEALTH POLICY, V5, P5, DOI 10.15171/ijhpm.2015.146; Nasirian M, 2012, J RES HEALTH SCI, V12, P81; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2015, ISL REP IR AIDS PROG; O'Byrne P, 2014, NURS INQ, V21, P20, DOI 10.1111/nin.12014; ROSS CE, 1994, J HEALTH SOC BEHAV, V35, P161, DOI 10.2307/2137363; Roudsari H. R. Sadeghipour, 2006, Eastern Mediterranean Health Journal, V12, P862; Shoveller J, 2009, SEX TRANSM INFECT, V85, P397, DOI 10.1136/sti.2008.035568; Statistical Center of Iran, 2011, SEL FIND 2011 NAT PO; Taheri JB, 2009, J DENT SCH, V26, P303; Taj SS, 2005, ANN MILITARY HLTH SC, V3, P565; Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17; Tehrani F. Ramezani, 2008, Eastern Mediterranean Health Journal, V14, P142; Terry Paul E, 2005, Int Q Community Health Educ, V24, P29, DOI 10.2190/F5VV-JPNE-71AT-8FUH; Tulloch HE, 2012, J IMMIGR MINOR HEALT, V14, P132, DOI 10.1007/s10903-011-9480-7; UNAIDS, 2015, ALL ENDADOLESCENTAID; UNAIDS, 2014, THE GAP REP; USAID, 2012, DEM HLTH SURV TOOLK; Wood K, 2002, PROMOTING YOUNG PEOP	40	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161849	10.1371/journal.pone.0161849	http://dx.doi.org/10.1371/journal.pone.0161849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626638	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600011
J	Tian, W; Yuan, JF; Yang, D; Zhang, LJ				Tian, Wei; Yuan, Jiangfan; Yang, Dong; Zhang, Lanjing			Descriptive Analysis on the Impacts of Universal Zero-Markup Drug Policy on a Chinese Urban Tertiary Hospital	PLOS ONE			English	Article							PRESCRIBING ERRORS; MEDICINES; PROVINCE; IMPLEMENTATION; INPATIENTS; WORKLOAD	Background Universal Zero-Markup Drug Policy (UZMDP) mandates no price mark-ups on any drug dispensed by a healthcare institution, and covers the medicines not included in the China's National Essential Medicine System. Five tertiaryhospitals in Beijing, China implemented UZMDP in 2012. Its impacts on these hospitals are unknown. We described the effects of UZMDP on a participating hospital, Jishuitan Hospital, Beijing, China (JST). Methods This retrospective longitudinal study examined the hospital-level data of JST and city-level data of tertiaryhospitals of Beijing, China (BJT) 2009-2015. Rank-sum tests and join-point regression analyses were used to assess absolute changes and differences in trends, respectively. Results In absolute terms, after the UZDMP implementation, there were increased annual patient-visits and decreased ratios of medicine-to-healthcare-charges(RMOH) in JST outpatient and inpatient services; however, in outpatient service, physician work-days decreased and physician- workload and inflation-adjusted per-visit healthcare charges increased, while the inpatient physician work-days increased and inpatient mortality-ratereduced. Interestingly, the decreasing trend in inpatient mortality-ratewas neutralized after UZDMP implementation. Compared with BJT and under influence of UZDMP, JST outpatient and inpatient services both had increasing trends in annual patient-visits (annual percentage changes[APC] = 8.1% and 6.5%, respectively) and decreasing trends in RMOH (APC = -4.3% and -5.4%,respectively), while JST outpatient services had increasing trend in inflation-adjusted per-visit healthcare charges (APC = 3.4%) and JST inpatient service had decreasing trend in inflation-adjusted per-visit medicine-charges (APC = -5.2%). Conclusion Implementation of UZMDP seems to increase annual patient- visits, reduce RMOH and have different impacts on outpatient and inpatient services in a Chinese urban tertiary hospital.	[Tian, Wei] Jishuitan Hosp, Dept Spine Surg, Beijing, Peoples R China; [Yuan, Jiangfan] Jishuitan Hosp, Off Patient Phys Relationship, Beijing, Peoples R China; [Yang, Dong] Jishuitan Hosp, Off Performance Management, Beijing, Peoples R China; [Zhang, Lanjing] Univ Med Ctr Princeton, Dept Pathol, Plainsboro, NJ 08536 USA; [Zhang, Lanjing] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Zhang, Lanjing] Rutgers State Univ, RobertWood Johnson Med Sch, Dept Pathol, New Brunswick, NJ 08854 USA; [Zhang, Lanjing] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zhang, LJ (corresponding author), Univ Med Ctr Princeton, Dept Pathol, Plainsboro, NJ 08536 USA.; Zhang, LJ (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.; Zhang, LJ (corresponding author), Rutgers State Univ, RobertWood Johnson Med Sch, Dept Pathol, New Brunswick, NJ 08854 USA.; Zhang, LJ (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA.	ljzhang@hotmail.com	Zhang, Lanjing/GZB-0260-2022; Zhang, Lanjing/AGY-7838-2022	Zhang, Lanjing/0000-0001-5436-887X				BIHM, 2013, BRIEFINGS ON THE HEA; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Elliott DJ, 2014, JAMA INTERN MED, V174, P786, DOI 10.1001/jamainternmed.2014.300; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Gong YH, 2016, HEALTH POLICY PLANN, V31, P21, DOI 10.1093/heapol/czv008; Gong YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103242, 10.1371/journal.pone.0095597]; Kee F, 1999, BRIT MED J, V318, P1381, DOI 10.1136/bmj.318.7195.1381; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Ma XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140568; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Michtalik HJ, 2013, JAMA INTERN MED, V173, P375, DOI 10.1001/jamainternmed.2013.1864; NBSC, 2015, ANN STAT STAT CHIN; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Ross S, 2013, BMJ QUAL SAF, V22, P97, DOI 10.1136/bmjqs-2012-001175; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wang J, 2013, CHINA PHARM, V23, P2982, DOI DOI 10.6039/J.ISSN.1001-0408.2012.32.03; Wang JY, 2015, INDIAN J PHARMACOL, V47, P535, DOI 10.4103/0253-7613.165192; Xu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138948; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yi HM, 2015, HEALTH AFFAIR, V34, P1391, DOI 10.1377/hlthaff.2014.1114; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang X, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006471; Zhou ZL, 2015, J ASIAN PUBLIC POLIC, V8, P102, DOI 10.1080/17516234.2015.1005561; Zhou ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121630	28	13	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162795	10.1371/journal.pone.0162795	http://dx.doi.org/10.1371/journal.pone.0162795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627811	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600054
J	Didiano, TJ; Johnson, MTJ; Duval, TP				Didiano, Teresa J.; Johnson, Marc T. J.; Duval, Tim P.			Disentangling the Effects of Precipitation Amount and Frequency on the Performance of 14 Grassland Species	PLOS ONE			English	Article							EXTREME PRECIPITATION; GAS-EXCHANGE; ROOT DISTRIBUTIONS; RAINFALL REGIMES; CLIMATE EXTREMES; ECOSYSTEM; DROUGHT; RESPONSES; EVENTS; PRODUCTIVITY	Climate change is causing shifts in the amount and frequency of precipitation in many regions, which is expected to have implications for plant performance. Most research has examined the impacts of the amount of precipitation on plants rather than the effects of both the amount and frequency of precipitation. To understand how climate-driven changes in precipitation can affect grassland plants, we asked: (i) How does the amount and frequency of precipitation affect plant performance? (ii) Do plant functional groups vary in their response to variable precipitation? To answer these questions we grew 14 monocot and eudicot grassland species and conducted a factorial manipulation of the amount (70 vs 90mm/month) and frequency (every 3, 15, or 30 days) of precipitation under rainout shelters. Our results show that both the amount and frequency of precipitation impact plant performance, with larger effects on eudicots than monocots. Above-and below-ground biomass were affected by the amount of precipitation and/or the interaction between the amount and frequency of precipitation. Above-ground biomass increased by 21-30% when the amount of precipitation was increased. When event frequency was decreased from 3 to 15 or 30 days, below-ground biomass generally decreased by 18-34% in the 70 mm treatment, but increased by 33-40% in the 90 mm treatment. Changes in stomatal conductance were largely driven by changes in event frequency. Our results show that it is important to consider changes in both the amount and frequency of precipitation when predicting how plant communities will respond to variable precipitation.	[Didiano, Teresa J.; Duval, Tim P.] Univ Toronto Mississauga, Dept Geog, Mississauga, ON, Canada; [Johnson, Marc T. J.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga	Didiano, TJ (corresponding author), Univ Toronto Mississauga, Dept Geog, Mississauga, ON, Canada.	teresa.didiano@gmail.com		Duval, Tim/0000-0002-7494-2709	Natural Sciences and Engineering Research Council Canadian Graduate Scholarship; Ontario Graduate Scholarship; University of Toronto Mississauga Department of Geography Graduate Expansion Fund; Natural Sciences and Engineering Research Council; NSERC CGS-M; OGS; University of Toronto Mississauga Dept. of Geography Graduate Expansion Fund; NSERC	Natural Sciences and Engineering Research Council Canadian Graduate Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); University of Toronto Mississauga Department of Geography Graduate Expansion Fund; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS-M(Natural Sciences and Engineering Research Council of Canada (NSERC)); OGS(Ontario Graduate Scholarship); University of Toronto Mississauga Dept. of Geography Graduate Expansion Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	TJD: Natural Sciences and Engineering Research Council Canadian Graduate Scholarship, Ontario Graduate Scholarship, and University of Toronto Mississauga Department of Geography Graduate Expansion Fund, MTJJ: Natural Sciences and Engineering Research Council Discovery grants, and TPD: Natural Sciences and Engineering Research Council Discovery grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S. Ariano, M. Harris, S. Homewood, A. Maglalang, M. Malone, D. Radu, C. Soden, P. Vora, H. Wilson, V. Yip, and S. Zamora for assistance in setting up and maintaining the field experiment. Technical assistance was provided by P. Rudz. T.J.D was supported by an NSERC CGS-M, OGS, and University of Toronto Mississauga Dept. of Geography Graduate Expansion Fund. The project was supported by NSERC Discovery grants to M.T.J.J. and T.P.D.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Cao ZH, 2009, J APPL METEOROL CLIM, V48, P1955, DOI 10.1175/2009JAMC2055.1; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; D'Odorico P, 2010, BIOSCIENCE, V60, P898, DOI 10.1525/bio.2010.60.11.6; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Dijkstra FA, 2012, OECOLOGIA, V170, P799, DOI 10.1007/s00442-012-2336-6; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Edenhofer O., 2014, CONTRIBUTION WORKING; Evans SE, 2013, ECOSYSTEMS, V16, P20, DOI 10.1007/s10021-012-9593-4; Evans SE, 2011, J ECOL, V99, P1500, DOI 10.1111/j.1365-2745.2011.01864.x; Fay PA, 2002, INT J PLANT SCI, V163, P549, DOI 10.1086/339718; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Fry EL, 2014, PLANT SOIL, V381, P351, DOI 10.1007/s11104-014-2137-2; Halekoh U, 2014, J STAT SOFTW, V59, P1; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; KNAPP AK, 1993, ECOLOGY, V74, P113, DOI 10.2307/1939506; KNAPP AK, 1984, OECOLOGIA, V65, P35, DOI 10.1007/BF00384460; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2015, OECOLOGIA, V177, P949, DOI 10.1007/s00442-015-3233-6; Kuznetsova A., 2014, LMERTEST TESTS LINEA; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; R Core Team, 2014, R A LANGUAGE AND ENV; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Robinson TMP, 2013, OIKOS, V122, P727, DOI 10.1111/j.1600-0706.2012.20655.x; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; SALA OE, 1992, ECOLOGY, V73, P1175, DOI 10.2307/1940667; SALA OE, 1982, OECOLOGIA, V53, P301, DOI 10.1007/BF00389004; Schneider AC, 2014, INT J PLANT SCI, V175, P702, DOI 10.1086/676304; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Shi Z, 2014, BIOGEOSCIENCES, V11, P621, DOI 10.5194/bg-11-621-2014; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Sun GW, 1997, J VEG SCI, V8, P587, DOI 10.2307/3237211; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; TURNER CL, 1995, INT J PLANT SCI, V156, P216, DOI 10.1086/297243; Weaver JE, 1954, NORTHAMERICAN PRAIRI; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Westra S, 2014, REV GEOPHYS, V52, P522, DOI 10.1002/2014RG000464; Wilcox KR, 2015, GLOBAL CHANGE BIOL, V21, P335, DOI 10.1111/gcb.12673; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3; Zeppel MJB, 2014, BIOGEOSCIENCES, V11, P3083, DOI 10.5194/bg-11-3083-2014; Zhang YG, 2013, J GEOPHYS RES-BIOGEO, V118, P148, DOI 10.1029/2012JG002136	52	25	26	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162310	10.1371/journal.pone.0162310	http://dx.doi.org/10.1371/journal.pone.0162310			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622497	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000023
J	Iyoda, T; Nagamine, Y; Nakane, Y; Tokita, Y; Akari, S; Otsuka, K; Fujita, M; Itagaki, K; Takizawa, Y; Orita, H; Owaki, T; Taira, J; Hayashi, R; Kodama, H; Fukai, F				Iyoda, Takuya; Nagamine, Yumi; Nakane, Yoshitomi; Tokita, Yuya; Akari, Shougo; Otsuka, Kazuki; Fujita, Motomichi; Itagaki, Keisuke; Takizawa, You-ichi; Orita, Hiroaki; Owaki, Toshiyuki; Taira, Jyunichi; Hayashi, Ryo; Kodama, Hiroaki; Fukai, Fumio			Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim	PLOS ONE			English	Article							BREAST-CANCER CELLS; FUNCTIONAL-ROLE; FIBRONECTIN; RESISTANCE; COMBINATION; INTEGRIN; ADHESION; EXPRESSION; OVEREXPRESSION; DOXORUBICIN	The acquisition of drug resistance mediated by the interaction of tumor cells with the extracellular matrix (ECM), commonly referred to as cell adhesion-mediated drug resistance (CAM-DR), has been observed not only in hematopoietic tumor cells but also in solid tumor cells. We have previously demonstrated that a 22-mer peptide derived from fibronectin, FNIII14, can inhibit cell adhesion through the inactivation of beta 1 integrin; when coadministered with cytarabine, FNIII14 completely eradicates acute myelogenous leukemia by suppressing CAM-DR. In this study, we show that our FNIII14 peptide also enhances chemotherapy efficacy in solid tumors. Coadministration of FNIII14 synergistically enhances the cytotoxicity of doxorubicin and aclarubicin in mammary tumor and melanoma cells, respectively. The solid tumor cell chemosensitization induced by FNIII14 is dependent upon the upregulation and activation of the pro-apoptotic protein, Bim. Furthermore, the metastasis of tumor cells derived from ventrally transplanted mammary tumor grafts is suppressed by the coadministration of FNIII14 and doxorubicin. These results suggest that the coadministration of our FNIII14 peptide with chemotherapy could achieve efficient solid tumor eradication by increasing chemosensitivity and decreasing metastasis. The major causes of tumor recurrence are the existence of chemotherapy-resistant primary tumor cells and the establishment of secondary metastatic lesions. As such, coadministering FNIII14 with anti-cancer drugs could provide a promising new approach to improve the prognosis of patients with solid tumors.	[Iyoda, Takuya; Nagamine, Yumi; Nakane, Yoshitomi; Tokita, Yuya; Akari, Shougo; Otsuka, Kazuki; Fujita, Motomichi; Itagaki, Keisuke; Takizawa, You-ichi; Orita, Hiroaki; Owaki, Toshiyuki; Fukai, Fumio] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba, Japan; [Iyoda, Takuya; Fukai, Fumio] Tokyo Univ Sci, Res Inst Sci & Technol, Translat Res Ctr, Noda, Chiba, Japan; [Taira, Jyunichi; Hayashi, Ryo; Kodama, Hiroaki] Saga Univ, Dept Biochem, Fac Sci & Engn, Saga, Saga, Japan	Tokyo University of Science; Tokyo University of Science; Saga University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba, Japan.; Fukai, F (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Translat Res Ctr, Noda, Chiba, Japan.	fukai@rs.noda.tus.ac.jp		Taira, Junichi/0000-0002-8438-865X	Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency [5010010052A]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency, JST [5010010052A]	Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency; Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency, JST	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency (Grant#5010010052A/www.jst.go.jp/tt/EN/univ-ip/a-step.html).; This research was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (#5010010052A) from Japan Science and Technology Agency, JST.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Buchheit CL, 2015, CELL DEATH DIFFER, V22, P1275, DOI 10.1038/cdd.2014.209; Canpinar H, 2008, TURK J MED SCI, V38, P97; DREWINKO B, 1976, CANCER TREAT REP, V60, P1619; Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416; Fukai F, 2000, CELL MOL BIOL, V46, P145; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Fukazawa H, 2004, MOL CANCER THER, V3, P1281; Garcia R, 2006, CELL CYCLE, V5, P2820, DOI 10.4161/cc.5.23.3535; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; HAMADA H, 1988, J BIOL CHEM, V263, P1454; Kamiya S, BIOCHEMISTRY, V41, P3270; Kato R, 2002, CLIN CANCER RES, V8, P2455; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Li HY, 2013, CANCER BIOTHER RADIO, V28, P115, DOI 10.1089/cbr.2012.1268; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Marchesin V, 2015, J CELL BIOL, V211, P339, DOI 10.1083/jcb.201506002; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Morozevich GE, 2006, BIOCHEMISTRY-MOSCOW+, V71, P489, DOI 10.1134/S000629790605004X; NAITO M, 1988, J BIOL CHEM, V263, P11887; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Nakagawa Y, 2014, INT J ONCOL, V44, P1376, DOI 10.3892/ijo.2014.2265; Nam JM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3454; Nista A, 1997, INT J CANCER, V72, P133, DOI 10.1002/(SICI)1097-0215(19970703)72:1<133::AID-IJC19>3.0.CO;2-K; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park HK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-431; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Sanchez-Ruderisch H, 2011, CELL DEATH DIFFER, V18, P806, DOI 10.1038/cdd.2010.148; Savry A, 2013, NEOPLASIA, V15, P49, DOI 10.1593/neo.121074; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Yan HJ, 2012, DIGEST DIS SCI, V57, P3160, DOI 10.1007/s10620-012-2400-4; Yang MC, 2015, CELL CYCLE, V22	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162525	10.1371/journal.pone.0162525	http://dx.doi.org/10.1371/journal.pone.0162525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622612	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000036
J	Macia, E; Gueye, L; Duboz, P				Macia, Enguerran; Gueye, Lamine; Duboz, Priscilla			Hypertension and Obesity in Dakar, Senegal	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TO-HEIGHT RATIO; CARDIOVASCULAR-DISEASE; ARTERIAL-HYPERTENSION; WAIST CIRCUMFERENCE; OLDER-ADULTS; PREVALENCE; HEALTH; RISK; AWARENESS	Background Cardiovascular disease is a major public health problem in many sub-Saharan African countries, but data on the main cardiovascular risk factors-hypertension and obesity-are almost nonexistent in Senegal. The aims of this study were therefore (i) to report the prevalence, awareness, treatment and control of hypertension among adults in Dakar, (ii) to assess the prevalence of general and central obesity, and (iii) to analyze the association between hypertension and general and central obesity. Methods A cross-sectional survey was carried out in 2015 on a representative sample of 1000 dwellers of the Senegalese capital aged 20-90. Results The overall prevalence of hypertensionwas 24.7%. Among hypertensive respondents, 28.4% were aware of their condition; 16.0% were on antihypertensive medication; 4.9% had controlled blood pressure. The frequency of doctor visits was a significant predictor of awareness (OR = 2.16; p<0.05) and treatment (OR = 2.57; p<0.05) of hypertension. The prevalence of underweight, overweight and general obesity were 12.6%, 19.2% and 9.7% respectively. The prevalence of central obesity was 26% by WC and 39.8% by WHtR. General obesity and central obesity by WHtR significantly predicted HTN among men and women, but not central obesity by WC. Conclusions This study has demonstrated a high prevalence of hypertension in Dakar and a high prevalence of obesity among women-particularlyamong older women. The awareness, treatment, and effective control of hypertension are unacceptably low. The blood pressure of women with general obesity, and men with central obesity, in the community should be monitored regularly to limit the burden of cardiovascular disease in Senegal.	[Macia, Enguerran; Gueye, Lamine] Univ Bamako, UMI Environm 3189, Fac Med Pharm & Odontostomatol,CNRS, Sante,Soc,Univ Cheikh Anta Diop,CNRST Burkina Fas, Dakar, Senegal; [Duboz, Priscilla] Aix Marseille Univ, UMR Anthropol Droit Eth & Sante 7268, CNRS, EFS,Sect Nord,Fac Med, CS 80011, Marseille 15, France	University Cheikh Anta Diop Dakar; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Macia, E (corresponding author), Univ Bamako, UMI Environm 3189, Fac Med Pharm & Odontostomatol,CNRS, Sante,Soc,Univ Cheikh Anta Diop,CNRST Burkina Fas, Dakar, Senegal.	enguerranmacia@gmail.com			National Center for Scientific Research, France (PEPS "Ecological Health")	National Center for Scientific Research, France (PEPS "Ecological Health")	The authors received funding for this research from the National Center for Scientific Research, France (PEPS "Ecological Health"; http://www.cnrs.fr/inee/outils/PEPS2014.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Asmar R, 2010, BLOOD PRESS MONIT, V15, P49, DOI 10.1097/MBP.0b013e3283354b11; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Brundtland GH, 2002, WORLD HLTH REPORT 20; Campbell NRC, 2015, CARDIOVASC J AFR, V26, P152; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cohen E., 2012, THESIS; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Desabie J., 1963, REVUE DE STATISTIQUE, V11, P5; Duboz P, 2015, MED SANTE TROP, V25, P165, DOI 10.1684/mst.2015.0450; Duboz P, 2014, J HUM HYPERTENS, V28, P489, DOI 10.1038/jhh.2013.142; ELBAGIR M, 1990, J HUM HYPERTENS, V4, P621; Foulds HJA, 2012, J HYPERTENS, V30, P359, DOI 10.1097/HJH.0b013e32834f0b86; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Golaz V, 2012, POPULATION SOC, P491; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kwan GF, 2015, CIRCULATION, V132, P1217, DOI 10.1161/CIRCULATIONAHA.115.019226; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Macia E, 2015, Bull Soc Pathol Exot, V108, P49, DOI 10.1007/s13149-014-0369-2; Macia E, 2010, OBES REV, V11, P691, DOI 10.1111/j.1467-789X.2010.00749.x; Macia E, 2015, SANTE SOC AFRIQUE OU, P241; Macia E, 2015, AGEING SOC, V35, P405, DOI 10.1017/S0144686X13000792; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Marie A., 1997, AFRIQUE INDIVIDUS, P53; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Nwankwo T, 2013, NCHS DATA BRIEF, V133, P1; Ogah OS, 2013, HEART, V99, P1390, DOI 10.1136/heartjnl-2012-303227; Organization WH, 2016, GLOBAL STATUS REPORT; Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Reddy KS, 1998, CIRCULATION, V97, P596; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Seck SM, 2015, MED SANTE TROP, V25, P160, DOI 10.1684/mst.2015.0452; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Unwin N, 2001, HEALTH POLICY PLANN, V16, P351, DOI 10.1093/heapol/16.4.351; WANG SA, 2014, PLOS BIOL, V12, DOI DOI 10.1371/JOURNAL.PONE.0114424; Ware LJ, 2014, NUTR METAB CARDIOVAS, V24, P900, DOI 10.1016/j.numecd.2014.02.005; Ware LJ, 2016, J CLIN HYPERTENS, V18, P396, DOI 10.1111/jch.12768; WHO, 2003, DIET NUTR PREVENTION, V916; WHO Regional Office for Africa, 2006, HLTH PEOPL AFR REG H; World Health Organization, 2000, WHO TECHN REP SER, V894; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.307; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	59	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161544	10.1371/journal.pone.0161544	http://dx.doi.org/10.1371/journal.pone.0161544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622534	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000006
J	Wang, L; Zhang, Y; Wang, ZW; Gong, N; Kweon, TD; Vo, B; Wang, CR; Zhang, XL; Chung, JY; Alachkar, A; Liang, XM; Luo, DZ; Civelli, O				Wang, Lien; Zhang, Yan; Wang, Zhiwei; Gong, Nian; Kweon, Tae Dong; Vo, Benjamin; Wang, Chaoran; Zhang, Xiuli; Chung, Jae Yoon; Alachkar, Amal; Liang, Xinmiao; Luo, David Z.; Civelli, Olivier			The Antinociceptive Properties of the Corydalis yanhusuo Extract	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DOPAMINE D2 RECEPTORS; NEUROPATHIC PAIN; FORMALIN TEST; ISOQUINOLINE ALKALOIDS; NUCLEUS-ACCUMBENS; SCIATIC-NERVE; RATS; MICE; STIMULATION	Corydalis yanhusuo. W.T. extracts (YHS) are widely used for the treatment of pain and inflammation. There are a few studies that assessed the effects of YHS in pain assays; however, none of these studies has systematically compared its activities in the different pain animal modes namely: acute, inflammatory and chronic pain. Furthermore, little is known about the mechanism of YHS activity in these assays. The aim of this study was to systematically evaluate the antinociceptive properties of YHS by testing it in four standardized pain assays and to investigate its mechanism. YHS antinociceptive properties were analyzed in the tail flick, the formalin paw licking, the von Frey filament and the hot box assays after spinal nerve ligation, which monitors acute nociceptive, persistent inflammatory and chronic neuropathic pain, respectively. YHS pharmacological profile was determined by screening it against a battery of G-protein coupled receptors and its mechanism of action was studied using knock-out mice. Our study shows that YHS, at a non-sedative dose, increases the tail flick latency in the tail flick assay without resulting in development of tolerance. YHS also decreases paw licking time in the formalin assay. Further, YHS increases paw withdraw threshold and latency in the von Frey filament and the hot box assays, respectively. In vitro, YHS exhibits prominent dopamine receptor antagonistic properties. In dopamine D2 receptor knockout mice, its antinociceptive effects are attenuated in acute and neuropathic pain but not inflammatory pain assays. Our results therefore indicate that YHS effectively attenuates acute, inflammatory and neuropathic pain, without causing tolerance. The effects on acute and neuropathic pain, but not inflammatory pain, are at least partially mediated through dopamine D2 receptor antagonism. Since YHS is a dietary supplement commercially available in the United States, our data suggest that it might be a candidate for alternative pain treatment.	[Wang, Lien; Zhang, Yan; Wang, Zhiwei; Chung, Jae Yoon; Alachkar, Amal; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Gong, Nian; Kweon, Tae Dong; Vo, Benjamin; Luo, David Z.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA; [Wang, Chaoran; Zhang, Xiuli; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Liaoning, Peoples R China; [Civelli, Olivier] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Civelli, Olivier] Univ Calif Irvine, Dev & Cell Biol, Irvine, CA 92617 USA; [Zhang, Yan] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Chung, Jae Yoon] Wonkwang Univ, Dept Anesthesiol & Pain Med, Sanbon Hosp, Gunpo, Gyeonggi, South Korea	University of California System; University of California Irvine; University of California System; University of California Irvine; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of California System; University of California Irvine; University of California System; University of California Irvine; Shanghai Jiao Tong University; Wonkwang University	Civelli, O (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.; Civelli, O (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA.; Civelli, O (corresponding author), Univ Calif Irvine, Dev & Cell Biol, Irvine, CA 92617 USA.	ocivelli@uci.edu	Civelli, Olivier/A-8392-2012		National Institutes of Health grant [DA024746]; Center for Autism Research and Translation (CART); William & Nancy Thompson Family Foundation; Key Program of National Natural Science Foundation of China [21135005, 81402806]; Major Project of National High Technology Research and Development Program of China [2012AA020203]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Autism Research and Translation (CART); William & Nancy Thompson Family Foundation; Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Institutes of Health grant DA024746 and Eric L. and Lila D. Nelson Chair in Neuropharmacology awared to OC. This work is also supported by the Center for Autism Research and Translation (CART), which is supported by the William & Nancy Thompson Family Foundation. The recipient is OC. This work was also supported by the Key Program of National Natural Science Foundation of China 21135005 awarded to XL and 81402806 awarded to YZ and the Major Project of National High Technology Research and Development Program of China 2012AA020203 awarded to XL.	Almanza A, 2015, PHARMACOL BIOCHEM BE, V137, P119, DOI 10.1016/j.pbb.2015.08.013; Ansah OB, 2007, EXP NEUROL, V205, P536, DOI 10.1016/j.expneurol.2007.03.010; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BARASI S, 1985, EUR J PHARMACOL, V117, P287, DOI 10.1016/0014-2999(85)90001-9; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Chinese Pharmacopoeia Commission, 2015, PHARM PEOPL REP CHIN; Choi JG, 2012, KOREAN J PHYSIOL PHA, V16, P387, DOI 10.4196/kjpp.2012.16.6.387; Cobacho N, 2014, BRAIN RES BULL, V106, P62, DOI 10.1016/j.brainresbull.2014.06.003; Crofford LJ, 2010, NAT REV RHEUMATOL, V6, P191, DOI 10.1038/nrrheum.2010.24; Dang YH, 2011, EUR J PHARMACOL, V657, P97, DOI 10.1016/j.ejphar.2011.01.064; Ding B, 2007, J PHARMACEUT BIOMED, V45, P219, DOI 10.1016/j.jpba.2007.06.009; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Gao X, 2001, EUR J PHARMACOL, V418, P73, DOI 10.1016/S0014-2999(01)00930-X; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hu JY, 1999, ACTA PHARMACOL SIN, V20, P715; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Kim HJ, 2015, J MED FOOD, V18, P909, DOI 10.1089/jmf.2014.3346; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kim SO, 2013, J MED FOOD, V16, P511, DOI 10.1089/jmf.2012.2648; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; LIU QS, 1992, LIFE SCI, V51, P1485; Liu XH, 2010, ARCH PHARM RES, V33, P981, DOI 10.1007/s12272-010-0702-7; Lu Ziming, 2012, Zhongguo Zhong Yao Za Zhi, V37, P235; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma ZZ, 2008, MOLECULES, V13, P2303, DOI 10.3390/molecules13092303; MAGNUSSON O, 1986, NEUROPHARMACOLOGY, V25, P187, DOI 10.1016/0028-3908(86)90040-7; Mansikka H, 2005, BRAIN RES, V1052, P82, DOI 10.1016/j.brainres.2005.06.021; Moradi M, 2015, BEHAV BRAIN RES, V292, P508, DOI 10.1016/j.bbr.2015.07.007; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Nagasaki H, 2009, EUR J PHARMACOL, V602, P194, DOI 10.1016/j.ejphar.2008.10.068; Nishiyama Y, 2010, J NAT MED-TOKYO, V64, P9, DOI 10.1007/s11418-009-0356-2; Pasquinucci L, 2012, LIFE SCI, V90, P66, DOI 10.1016/j.lfs.2011.10.024; Qiu ZhiChun, 2009, Progress in Modern Biomedicine, V9, P4518; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Taylor BK, 2003, BRAIN RES, V987, P135, DOI 10.1016/S0006-8993(03)03318-3; Viisanen H, 2012, BRAIN RES BULL, V89, P133, DOI 10.1016/j.brainresbull.2012.08.002; Wang C, 2010, ANAL BIOANAL CHEM, V396, P1731, DOI 10.1007/s00216-009-3409-1; Weizman T, 2003, EUR J PHARMACOL, V478, P155, DOI 10.1016/j.ejphar.2003.08.049; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Wu HW, 2014, MOLECULES, V19, P11487, DOI 10.3390/molecules190811487; [张先洪 ZHANG Xian-hong], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P449; Zhang Y, 2014, CURR BIOL, V24, P117, DOI 10.1016/j.cub.2013.11.039; Zhang Y, 2012, NEUROCHEM RES, V37, P410, DOI 10.1007/s11064-011-0627-7	47	34	37	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162875	10.1371/journal.pone.0162875	http://dx.doi.org/10.1371/journal.pone.0162875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622550	Green Published, gold			2022-12-27	WOS:000383681000065
J	Lee, K; Goh, GYS; Wong, MA; Klassen, TL; Taubert, S				Lee, Kayoung; Goh, Grace Ying Shyen; Wong, Marcus Andrew; Klassen, Tara Leah; Taubert, Stefan			Gain-of-Function Alleles in Caenorhabditis elegans Nuclear Hormone Receptor nhr-49 Are Functionally Distinct	PLOS ONE			English	Article							C. ELEGANS; MEDIATOR SUBUNIT; BILE-ACID; LIGAND; POLYKETIDES; HNF4-ALPHA; METABOLISM; LONGEVITY; COMPLEX; BINDING	Nuclear hormone receptors (NHRs) are transcription factors that regulate numerous physiological and developmental processes and represent important drug targets. NHR-49, an ortholog of Hepatocyte Nuclear Factor 4 (HNF4), has emerged as a key regulator of lipid metabolism and life span in the nematode worm Caenorhabditis elegans. However, many aspects of NHR-49 function remain poorly understood, including whether and how it regulates individual sets of target genes and whether its activity is modulated by a ligand. A recent study identified three gain-of-function (gof) missen semutations in nhr-49 (nhr-49(et7), nhr-49 (et8), and nhr-49(et13), respectively). These substitutions all affect the ligand-binding domain (LBD), which is critical for ligand binding and protein interactions. Thus, these alleles provide an opportunity to test how three specific residues contribute to NHR-49 dependent gene regulation. We used computational and molecular methods to delineate how the semutations alter NHR-49 activity. We find that despite originating from a screen favoring the activation of specific NHR-49 targets, all three gof alleles cause broad upregulation of NHR-49 regulated genes. Interestingly, nhr-49(et7) and nhr-49(et8) exclusively affect nhr-49 dependent activation, whereas the nhr-49(et13) surprisingly affects both nhr-49 mediated activation and repression, implicating the affected residue as dually important. We also observed phenotypic non-equivalence of these alleles, as they unexpectedly caused a long, short, and normal life span, respectively. Mechanistically, the gof substitutions altered neither protein interactions with the repressive partner NHR-66 and the coactivator MDT-15 nor the subcellular localization or expression of NHR-49. However, in silico structural modeling revealed that NHR-49 likely interacts with small molecule ligands and that the missensemutations might alter ligand binding, providing a possible explanation for increased NHR-49 activity. In sum, our findings indicate that the three nhr-49 gof alleles are non-equivalent, and highlight the conserved V411 residue affected by et13 as critical for gene activation and repression alike.	[Lee, Kayoung; Taubert, Stefan] Univ British Columbia, Grad Program Med Genet, Vancouver, BC, Canada; [Lee, Kayoung; Goh, Grace Ying Shyen; Wong, Marcus Andrew; Taubert, Stefan] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Lee, Kayoung; Goh, Grace Ying Shyen; Wong, Marcus Andrew; Taubert, Stefan] Univ British Columbia, Child & Family Res Inst, Vancouver, BC, Canada; [Goh, Grace Ying Shyen; Taubert, Stefan] Univ British Columbia, Grad Program Cell & Dev Biol, Vancouver, BC, Canada; [Klassen, Tara Leah] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Taubert, Stefan] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Taubert, S (corresponding author), Univ British Columbia, Grad Program Med Genet, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Child & Family Res Inst, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Grad Program Cell & Dev Biol, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	taubert@cmmt.ubc.ca	Taubert, Stefan/A-8104-2015	Taubert, Stefan/0000-0002-2432-7257	Canadian Institute of Health Research (CIHR) [MOP-93713]; Natural Sciences and Engineering Council of Canada (NSERC) [RGPIN 386398-13]; Centre of Molecular Medicine and Therapeutics (CMMT); Canadian Foundation for Innovation (CFI); British Columbia Knowledge Development Fund (BCKDF) [CFI32952]; NSERC Alexander Graham Bell Canada Graduate Scholarships-Master's (CGS M) scholarship; Child and Family Research Institute (CFRI); CFRI summer studentship; Canada Research Chair; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre of Molecular Medicine and Therapeutics (CMMT); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); British Columbia Knowledge Development Fund (BCKDF); NSERC Alexander Graham Bell Canada Graduate Scholarships-Master's (CGS M) scholarship; Child and Family Research Institute (CFRI); CFRI summer studentship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Canadian Institute of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html; funding # MOP-93713 to ST), the Natural Sciences and Engineering Council of Canada (NSERC; http://www.nserc-crsng.gc.ca; funding # RGPIN 386398-13 to ST), the Centre of Molecular Medicine and Therapeutics (CMMT; http://www.cmmt.ubc.ca), and the Canadian Foundation for Innovation (CFI) and the British Columbia Knowledge Development Fund (BCKDF; computational modeling infrastructure to TLK, CFI32952). KL was supported by an NSERC Alexander Graham Bell Canada Graduate Scholarships-Master's (CGS M) scholarship, GYSG by a Child and Family Research Institute (CFRI; http://www.cfri.ca) graduate scholarship, MW by a CFRI summer studentship, and ST by a Canada Research Chair (http://www.chairschaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all Taubert lab members for critical discussions, and Shirley Chen for help with experiments. We also thank Dr. Marc Pilon (University of Goteborg, Sweden) for the strains QC120, QC121, and QC126 and Dr. Arjumand Ghazi (University of Pittsburgh, PA, USA) for the pnhr-49::nhr-49::gfp plasmid. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Antebi Adam, 2015, WormBook, P1, DOI 10.1895/wormbook.1.64.2; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; BRENNER S, 1974, GENETICS, V77, P71; Chamoli M, 2014, AGING CELL; Chianese G, 2016, J ORG CHEM, V81, P5135, DOI 10.1021/acs.joc.6b00695; Chiang JYL, 2009, EXPERT OPIN DRUG MET, V5, P137, DOI [10.1517/17425250802707342 , 10.1517/17425250802707342]; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Festa C, 2013, MAR DRUGS, V11, P2314, DOI 10.3390/md11072314; Folick A, 2015, SCIENCE, V347, P83, DOI 10.1126/science.1258857; Goh GYS, 2014, AGING CELL, V13, P70, DOI 10.1111/acel.12154; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Heestand BN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003651; Hou NS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00143; Kaestner KH, 2010, HEPATOLOGY, V51, P376, DOI 10.1002/hep.23487; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lee D, 2005, J ANTIBIOT, V58, P615, DOI 10.1038/ja.2005.84; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Magner DB, 2013, CELL METAB, V18, P212, DOI 10.1016/j.cmet.2013.07.007; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mikolas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058462; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Park D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002519; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Piskacek M, 2015, MOL BIOSYST, V11, P844, DOI 10.1039/c4mb00672k; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Van Gilst MR, 2005, P NATL ACAD SCI USA, P102; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu WJ, 2015, J MOL GRAPH MODEL, V57, P76, DOI 10.1016/j.jmgm.2015.01.009; Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	53	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162708	10.1371/journal.pone.0162708	http://dx.doi.org/10.1371/journal.pone.0162708			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618178	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100044
J	Rishi, P; Raka, N; Rishi, E				Rishi, Pukhraj; Raka, Neha; Rishi, Ekta			Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naive Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series	PLOS ONE			English	Article							ARTERY-OCCLUSION; OPTIC NEUROPATHY; INJECTION; MEMBRANE	Background To study potential ischemic effects of intravitreal Bevacizumab (IVB) on unaffected retina in treatment-naive eyes with macular edema secondary to branch retinal vein occlusion (BRVO) and contralateral eyes secondary to systemic absorption. Methods and Findings Prospective, interventional series included 27 treatment-naive eyes with BRVO and macular edema. Exclusion criteria: Eyes with diabetic retinopathy, glaucoma, vasculitides, papilledema or systemic neurologic condition. Subjects underwent complete ophthalmological examination including fluoroscein angiography (FA), optical coherence tomography (OCT) and multifocal electroretinogram (mf-ERG). All subjects received single 1.25 mg/0.05ml IVB injection. Two observers measured all parameters; inter-observer agreements were expressed as kappa values. Paired t-test was used to compare values at baseline and follow-up. The statistical analysis was done using SPSS for Windows, Version 14.0. (Chicago, SPSS Inc.) Presenting mean CFT (central foveal thickness) was 499.5(+/-229.7) mu m, mean BCVA (best corrected visual acuity) was 0.64(+/-0.41) logMAR. At last follow-up, mean CFT was 267.9(+/-159.3) mu m (P<0.001), 95% CI [127.18, 422.32]; mean BCVA was 0.28(+/-0.24) logMAR. Respectively, mean N1 and P1 amplitudes of mfERG in 'unaffected quadrant' at presentation were -6.10(+/-4.00) nV/deg(2) and 17.17(+/-11.54) nV/deg(2); and -5.33(+/-1.30) nV/deg(2) and 15.29(+/-4.69) nV/deg(2) at final follow-up (P = 0.631 and 0.197, respectively), (95% CIs [-0.93, 1.42] and [-4.22, 1.08] respectively). In fundus quadrant of fellow eyes corresponding to unaffected quadrant in treated eyes, mean N1 and P1 amplitudes at presentation were -5.39(+/-1.56) nV/deg(2) and 15.89(+/-3.89) nV/deg(2); and -5.39(+/-1.90) nV/deg(2) and 15.9(+/-5.52) nV/deg(2) (P = 0.380 and 0.208), (95% CIs [-0.57, 1.28] and [-4.1, 1.1]) at last follow-up, respectively. Limitations: This study analysed the effects with a single injection of bevacizumab. However, whether ischemic adverse effects will emerge with repeated IVB injections as a consequence of cumulative dosing needs further investigation. The setting of our study being a tertiarycare centre, the numbers of fresh BRVO cases without prior intervention were limited. Thus, the limitations of our study include a small sample size with a small follow-up period. No major ocular/systemic adverse event was observed in the study period. Conclusion No evidence of progressive ischaemia attributable to single bevacizumab treatment was observed in this study. However, a larger prospective study involving subjects with cumulative dosing of bevacizumab and a longer follow-up could provide a better understanding of the potential ischaemic effects of bevacizumab or other anti-VEGF agents.	[Rishi, Pukhraj; Raka, Neha; Rishi, Ekta] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India		Rishi, P (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India.	docrishi@yahoo.co.in	Rishi, Pukhraj/AAZ-5296-2020					Ameri H, 2007, INVEST OPHTH VIS SCI, V48, P5708, DOI 10.1167/iovs.07-0731; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campbell RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4203; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chen E, 2009, OPHTHAL SURG LAS IM, V40, P68, DOI 10.3928/15428877-20090101-04; Chu YK, 2013, RETINA-J RET VIT DIS, V33, P2110, DOI 10.1097/IAE.0b013e3182899205; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Ganssauge M, 2009, GRAEF ARCH CLIN EXP, V247, P1707, DOI 10.1007/s00417-009-1184-5; Goel Neha, 2011, International Ophthalmology, V31, P39, DOI 10.1007/s10792-010-9390-z; Hasegawa S, 2001, INVEST OPHTH VIS SCI, V42, P298; Hosseini H, 2009, J NEURO-OPHTHALMOL, V29, P160, DOI 10.1097/WNO.0b013e3181a58fd1; Hvarfner C, 2006, RETINA-J RET VIT DIS, V26, P292, DOI 10.1097/00006982-200603000-00007; Ikeda F, 2010, JPN J OPHTHALMOL, V54, P423, DOI 10.1007/s10384-010-0841-x; Ikeda Jun, 2004, Nippon Ganka Gakkai Zasshi, V108, P84; Isola V, 2013, CLIN OPHTHALMOL, V7, P455, DOI 10.2147/OPTH.S30156; Kim KS, 2008, ACTA OPHTHALMOL, V86, DOI 10.1111/j.1755-3768.2008.01175.x; Mathew R, 2010, CLIN OPHTHALMOL, V4, P1159, DOI 10.2147/OPTH.S13592; Ohshima A, 2001, JPN J OPHTHALMOL, V45, P516, DOI 10.1016/S0021-5155(01)00374-4; Pai SA, 2007, AM J OPHTHALMOL, V143, P601, DOI 10.1016/j.ajo.2006.12.037; PARODI MB, 1995, INT OPHTHALMOL, V19, P25, DOI 10.1007/BF00156415; Pece A, 2011, BRIT J OPHTHALMOL, V95, P56, DOI 10.1136/bjo.2009.174060; Pieramici Dante J, 2008, Ophthalmology, V115, pe47, DOI 10.1016/j.ophtha.2008.06.021; Rabena MD, 2007, RETINA-J RET VIT DIS, V27, P419, DOI 10.1097/IAE.0b013e318030e77e; Rouvas AA, 2008, GRAEFES ARCH CLIN EX, V247, P1707; Saxena Sandeep, 1997, Indian Journal of Ophthalmology, V45, P125; Wildberger H, 2002, KLIN MONATSBL AUGENH, V219, P254, DOI 10.1055/s-2002-30653; Yokoyama K, 2008, ACTA OPHTHALMOL, V86, P927, DOI 10.1111/j.1755-3768.2008.01187.x; 1991, OPHTHALMOLOGY S, V98, P807	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162533	10.1371/journal.pone.0162533	http://dx.doi.org/10.1371/journal.pone.0162533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618696	gold, Green Submitted, Green Published			2022-12-27	WOS:000383653100029
J	Younes, F; Halawi, G; Jabbour, H; El Osta, N; Karam, L; Hajj, A; Khabbaz, LR				Younes, Farah; Halawi, Ghinwa; Jabbour, Hicham; El Osta, Nada; Karam, Latife; Hajj, Aline; Khabbaz, Lydia Rabbaa			Internet Addiction and Relationships with Insomnia, Anxiety, Depression, Stress and Self-Esteemin University Students: A Cross-Sectional Designed Study	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; KOREAN ADOLESCENTS; SUICIDAL IDEATION; COLLEGE-STUDENTS; SEVERITY INDEX; SCALES DASS; DSM-V; SYMPTOMS; HEALTH; PERSONALITY	Background and Aims Internet addiction (IA) could be a major concern in university medical students aiming to develop into health professionals. The implications of this addiction as well as its association with sleep, mood disorders and self-esteem can hinder their studies, impact their long-termcareer goals and have wide and detrimental consequences for society as a whole. The objectives of this study were to: 1) Assess potential IA in university medical students, as well as factors associated with it; 2) Assess the relationships between potential IA, insomnia, depression, anxiety, stress and self-esteem. Methods Our study was a cross-sectional questionnaire-based survey conducted among 600 students of three faculties: medicine, dentistry and pharmacy at Saint-Joseph University. Four validated and reliable questionnaires were used: the Young Internet Addiction Test, the Insomnia Severity Index, the Depression Anxiety Stress Scales (DASS 21), and the Rosenberg Self Esteem Scale (RSES). Results The average YIAT score was 30 +/- 18.474; Potential IA prevalence rate was 16.8% (95% confidence interval: 13.81-19.79%) and it was significantly different between males and females (p-value = 0.003), with a higher prevalence in males (23.6% versus 13.9%). Significant correlations were found between potential IA and insomnia, stress, anxiety, depression and self-esteem (p-value < 0.001); ISI and DASS sub-scores were higher and self-esteem lower in students with potential IA. Conclusions Identifying students with potential IA is important because this addiction often coexists with other psychological problems. Therefore, interventions should include not only IA management but also associated psychosocial stressors such as insomnia, anxiety, depression, stress, and self-esteem.	[Younes, Farah; Halawi, Ghinwa; Karam, Latife; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Anesthesia & Crit Care, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Fac Med, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Dept Publ Hlth, Fac Med, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Dept Prosthodont, Fac Med Dent, Beirut, Lebanon; [El Osta, Nada] Univ Auvergne, Clermont Univ, CROC EA4847, Ctr Rech Odontol Clin, BP 10448, F-63000 Clermont Ferrand, France; [Karam, Latife] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Pharm, Beirut, Lebanon; [Younes, Farah; Karam, Latife; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Med, Beirut, Lebanon	Universite Clermont Auvergne (UCA)	Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon.; Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Med, Beirut, Lebanon.	lydia.khabbaz@usj.edu.lb	EL OSTA, Nada/GRS-4789-2022					Alpaslan AH, 2015, PSYCHIAT RES, V226, P224, DOI 10.1016/j.psychres.2014.12.052; An J, 2014, J ADDICT MED, V8, P282, DOI 10.1097/ADM.0000000000000026; [Anonymous], 2016, SOCIAL NETWORKING RE; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bremer J, 2005, CHILD ADOL PSYCH CL, V14, P405, DOI 10.1016/j.chc.2005.02.003; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Carli V, 2013, PSYCHOPATHOLOGY, V46, P1, DOI 10.1159/000337971; Cho YW, 2014, J CLIN NEUROL, V10, P210, DOI 10.3988/jcn.2014.10.3.210; Choueiry N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149643; Christakis DA, 2009, ARCH PEDIAT ADOL MED, V163, P959, DOI 10.1001/archpediatrics.2009.162; Creemers DHM, 2012, J BEHAV THER EXP PSY, V43, P638, DOI 10.1016/j.jbtep.2011.09.006; Dalbudak E, 2014, PSYCHIAT RES, V219, P577, DOI 10.1016/j.psychres.2014.02.032; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Durkee T, 2012, ADDICTION, V107, P2210, DOI 10.1111/j.1360-0443.2012.03946.x; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Fernandez-Villa T, 2015, ADICCIONES, V27, P265; Fischer A, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.365; Floros G, 2014, CYBERPSYCH BEH SOC N, V17, P672, DOI 10.1089/cyber.2014.0182; Floros G, 2014, ADDICT BEHAV, V39, P1839, DOI 10.1016/j.addbeh.2014.07.031; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Garaigordobil M, 2008, PSICOTHEMA, V20, P114; Gellis LA, 2014, BEHAV THER, V45, P806, DOI 10.1016/j.beth.2014.05.002; Holden C, 2010, SCIENCE, V327, P935, DOI 10.1126/science.327.5968.935; Internet World Stats, 2016, INT US WORLD DISTR W; Khazaal Y, 2008, CYBERPSYCHOL BEHAV, V11, P703, DOI 10.1089/cpb.2007.0249; Kim EJ, 2008, EUR PSYCHIAT, V23, P212, DOI 10.1016/j.eurpsy.2007.10.010; Kim JH, 2010, J ADOLESCENCE, V33, P215, DOI 10.1016/j.adolescence.2009.03.012; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Lin IH, 2014, COMPR PSYCHIAT, V55, P504, DOI 10.1016/j.comppsych.2013.11.012; Liu TC, 2011, J CLIN PSYCHIAT, V72, P836, DOI 10.4088/JCP.10m06057; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Moksnes UK, 2012, SCAND J PSYCHOL, V53, P483, DOI 10.1111/sjop.12021; Naseri L, 2015, IRAN J PSYCHIATRY BE, V9, DOI 10.17795/ijpbs-421; Ni XL, 2009, CYBERPSYCHOL BEHAV, V12, P327, DOI 10.1089/cpb.2008.0321; Ortega-Montiel J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2112-8; Park SK, 2008, ADOLESCENCE, V43, P895; Pies Ronald, 2009, Psychiatry (Edgmont), V6, P31; Pujazon-Zazik M, 2010, AM J MENS HEALTH, V4, P77, DOI 10.1177/1557988309360819; ROSENBERG M, 1962, J PSYCHIAT RES, V1, P135, DOI 10.1016/0022-3956(62)90004-3; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Siomos KE, 2008, CYBERPSYCHOL BEHAV, V11, P653, DOI 10.1089/cpb.2008.0088; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Tavernier R, 2014, CHRONOBIOL INT, V31, P232, DOI 10.3109/07420528.2013.843541; Taylor R, 2005, CLIN J PAIN, V21, P91, DOI 10.1097/00002508-200501000-00011; Thomas SJ, 2014, BEHAV SLEEP MED, V12, P169, DOI 10.1080/15402002.2013.778202; Tsai CC, 2003, CYBERPSYCHOL BEHAV, V6, P649, DOI 10.1089/109493103322725432; van den Eijnden RJJM, 2010, J ABNORM CHILD PSYCH, V38, P77, DOI 10.1007/s10802-009-9347-8; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; White K, 2015, AM J MED SCI, V350, P290, DOI 10.1097/MAJ.0000000000000554; Widyanto L, 2011, CYBERPSYCH BEH SOC N, V14, P141, DOI 10.1089/cyber.2010.0151; Wildt BTT, 2007, PSYCHIAT PRAX, V34, pS318, DOI 10.1055/s-2007-970973; Young K, 1999, Cyberpsychol Behav, V2, P475, DOI 10.1089/cpb.1999.2.475; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K. S, 1998, CAUGHT NET RECOGNIZE; Young KS, 2004, CYBERPSYCHOL BEHAV, V7, P105, DOI 10.1089/109493104322820174; Young KS, 1996, PSYCHOL REP, V79, P899, DOI 10.2466/pr0.1996.79.3.899	62	167	168	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161126	10.1371/journal.pone.0161126	http://dx.doi.org/10.1371/journal.pone.0161126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618306	gold, Green Submitted, Green Published			2022-12-27	WOS:000383653100005
J	Arnold, MD; Gruber, C; Flokova, K; Miersch, O; Strnad, M; Novak, O; Wasternack, C; Hause, B				Arnold, Monika D.; Gruber, Cornelia; Flokova, Kristyna; Miersch, Otto; Strnad, Miroslav; Novak, Ondrej; Wasternack, Claus; Hause, Bettina			The Recently Identified Isoleucine Conjugate of cis-12-Oxo-Phytodienoic Acid Is Partially Active in cis-12-Oxo-Phytodienoic Acid-Specific Gene Expression of Arabidopsis thaliana	PLOS ONE			English	Article							ALLENE-OXIDE-CYCLASE; 12-OXO-PHYTODIENOIC ACID; JASMONIC ACID; SEED; OXYLIPINS; OPR3; CYCLOPENTENONES; BIOSYNTHESIS; ACCUMULATION; GERMINATION	Oxylipins of the jasmonate family are active as signals in plant responses to biotic and abiotic stresses as well as in development. Jasmonic acid (JA), its precursor cis-12-oxo-phytodienoic acid (OPDA) and the isoleucine conjugate of JA (JA-Ile) are the most prominent members. OPDA and JA-Ile have individual signalling properties in several processes and differ in their pattern of gene expression. JA-Ile, but not OPDA, is perceived by the SCFCOI1-JAZ co-receptor complex. There are, however, numerous processes and genes specifically induced by OPDA. The recently identified OPDA-Ile suggests that OPDA specific responses might be mediated upon formation of OPDA-Ile. Here, we tested OPDA-Ile-induced gene expression in wild type and JA-deficient, JA-insensitive and JA-Ile-deficient mutant background. Tests on putative conversion of OPDA-Ile during treatments revealed only negligible conversion. Expression of two OPDA-inducible genes, GRX480 and ZAT10, by OPDA-Ile could be detected in a JA-independent manner in Arabidopsis seedlings but less in flowering plants. The data suggest a bioactivity in planta of OPDA-Ile.	[Arnold, Monika D.; Gruber, Cornelia; Hause, Bettina] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany; [Flokova, Kristyna; Miersch, Otto; Strnad, Miroslav; Novak, Ondrej; Wasternack, Claus] Inst Expt Bot AS CR, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Olomouc, Czech Republic; [Flokova, Kristyna; Miersch, Otto; Strnad, Miroslav; Novak, Ondrej; Wasternack, Claus] Palacky Univ, Olomouc, Czech Republic; [Miersch, Otto; Wasternack, Claus] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Leibniz Institut fur Pflanzenbiochemie	Hause, B (corresponding author), Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany.	bhause@ipb-halle.de	Strnad, Miroslav/H-1858-2014; NOVAK, Ondrej/F-7031-2014; Floková, Kristýna/K-2888-2014	Strnad, Miroslav/0000-0002-2806-794X; NOVAK, Ondrej/0000-0003-3452-0154; Flokova, Kristyna/0000-0002-5558-0669	Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165]; Czech Science Foundation [GA14-34792 S]; Ministry of Education, Youth and Sports of the Czech Republic [LO1204]; Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/20.0165]	Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness - European Social Fund; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness-European Social Fund	This study was funded by the Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness - European Social Fund (project CZ.1.07/2.3.00/20.0165), by the Czech Science Foundation (No. GA14-34792 S) and the Ministry of Education, Youth and Sports of the Czech Republic (the National Program for Sustainability I, No. LO1204) to KF, ON, MS and CW.; The authors thank Eva Hirnerova and Gerd Balcke for excellent assistance related to hormone analyses. We are grateful for financial support by the Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness-European Social Fund (project CZ.1.07/2.3.00/20.0165), by the Czech Science Foundation (No. GA14-34792 S) and the Ministry of Education, Youth and Sports of the Czech Republic (the National Program for Sustainability I, No. LO1204) to K.F., O.N., M.S. and C.W.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Balcke GU, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-47; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bosch M, 2014, PLANT PHYSIOL, V166, P396, DOI 10.1104/pp.114.237388; Chehab EW, 2011, PLANT PHYSIOL, V156, P770, DOI 10.1104/pp.111.174169; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dave A, 2016, J EXP BOT, V67, P2277, DOI 10.1093/jxb/erw028; Dave A, 2011, PLANT CELL, V23, P583, DOI 10.1105/tpc.110.081489; Dueckershoff K, 2008, BBA-PROTEINS PROTEOM, V1784, P1975, DOI 10.1016/j.bbapap.2008.09.003; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Flokova K, 2016, PHYTOCHEMISTRY, V122, P230, DOI 10.1016/j.phytochem.2015.11.012; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Goetz S, 2012, PLANT PHYSIOL, V158, P1715, DOI 10.1104/pp.111.192658; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KRAMELL R, 1988, TETRAHEDRON, V44, P5791, DOI 10.1016/S0040-4020(01)81437-X; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Park SW, 2013, P NATL ACAD SCI USA, V110, P9559, DOI 10.1073/pnas.1218872110; De Leon IP, 2012, MOL PLANT PATHOL, V13, P960, DOI 10.1111/j.1364-3703.2012.00806.x; Savchenko TV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P362, DOI 10.1134/S0006297914040051; Savchenko T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28304; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stelmach BA, 1998, PHYTOCHEMISTRY, V47, P539, DOI 10.1016/S0031-9422(97)00547-5; Stenzel I, 2012, J EXP BOT, V63, P6125, DOI 10.1093/jxb/ers261; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Stitz M, 2011, PLANT PHYSIOL, V157, P341, DOI 10.1104/pp.111.178582; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Stumpe M, 2010, NEW PHYTOL, V188, P740, DOI 10.1111/j.1469-8137.2010.03406.x; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C., 2015, NEW BIOTECHNOL; Yamamoto Y, 2015, PHYTOCHEMISTRY, V116, P48, DOI 10.1016/j.phytochem.2015.03.008; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; ZIMMERMAN DC, 1978, LIPIDS, V13, P313, DOI 10.1007/BF02533720	40	14	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162829	10.1371/journal.pone.0162829	http://dx.doi.org/10.1371/journal.pone.0162829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611078	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900173
J	Condello, G; Capranica, L; Stager, J; Forte, R; Falbo, S; Di Baldassarre, A; Segura-Garcia, C; Pesce, C				Condello, Giancarlo; Capranica, Laura; Stager, Joel; Forte, Roberta; Falbo, Simone; Di Baldassarre, Angela; Segura-Garcia, Cristina; Pesce, Caterina			Physical Activity and Health Perception in Aging: Do Body Mass and Satisfaction Matter? A Three-Path Mediated Link	PLOS ONE			English	Article							QUALITY-OF-LIFE; 6 EUROPEAN COUNTRIES; OLDER-ADULTS; MUSCLE MASS; EXERCISE; DISSATISFACTION; VALIDATION; NUTRITION; OBESITY; IMAGE	Although ageing people could benefit from healthy diet and physical activity to maintain health and quality of life, further understandings of the diet-and physical activity-related mechanisms that may cause changes in health and quality of life perception are necessary. The purpose of the study was to investigate the effect of eating attitudes, body mass and image satisfaction, and exercise dependence in the relationship between physical activity and health and quality of life perception in older individuals. Hundred and seventy-nine late middle-aged, (55-64 yrs), young-old (65-74 yrs), and old (75-84 yrs) senior athletes (n = 56), physically active (n = 58) or sedentary adults (n = 65) were submitted to anthropometric evaluations (body mass, height) and self-reportedquestionnaires: Body Image Dimensional Assessment, Exercise Dependence Scale, Eating Attitude Test, and Short Form Health Survey (Physical Component Summary [PCS] and Mental Component Summary [MCS] of and health and quality of life perception). Senior athletes, physically active, and sedentary participants subgroups differed (P<0.05) from each other in body mass index (BMI) and several components of body image and exercise dependence. Senior athletes showed, compared to their sedentary counterparts, further differences (P<0.05) in eating attitudes and in both PCS and MCS. Mediation analysis showed that the relationship between physical activity habit and MCS, but not PCS, was indirectly explained by a serial mediation chain composed of objective BMI and subjective body image (dis) satisfaction. Findings confirm the relevant role of physically active life habits for older individuals to perceive good physical and mental health. The novelty of the three-path mediated link between physical activity level and mental health perception suggests that the beneficial effect of a physically active lifestyle on weight control can positively impinge on the cognitive-emotional dimension of mental health by ensuring the maintenance, also at older age, of a satisfactory body image.	[Condello, Giancarlo; Capranica, Laura; Forte, Roberta; Falbo, Simone; Pesce, Caterina] Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy; [Stager, Joel] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Di Baldassarre, Angela] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy; [Segura-Garcia, Cristina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Foro Italico University of Rome; Indiana University System; Indiana University Bloomington; G d'Annunzio University of Chieti-Pescara; Magna Graecia University of Catanzaro	Condello, G (corresponding author), Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy.	giancarlo.condello@gmail.com	C, Segura-Garcia/I-8978-2014; Di Baldassarre, Angela/D-5402-2014; Laura, Capranica/AFW-3460-2022; Condello, Giancarlo/AAC-8365-2020	C, Segura-Garcia/0000-0002-5756-3045; Di Baldassarre, Angela/0000-0002-4473-4909; Condello, Giancarlo/0000-0001-5092-3258; Pesce, Caterina/0000-0002-4245-3898; Capranica, Laura/0000-0003-3073-7655	Ministero dell'Istruzione, dell'Universita e della Ricerca [2010KL2Y73]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (2010KL2Y73) ADB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Backmand H, 2010, INT J SPORTS MED, V31, P751, DOI 10.1055/s-0030-1255109; Baker J, 2010, EUR REV AGING PHYS A, V7, P3, DOI 10.1007/s11556-009-0054-9; Borg C, 2008, GERIATR NURS, V29, P48, DOI 10.1016/j.gerinurse.2007.05.002; Bratland-Sanda S, 2013, EUR J SPORT SCI, V13, P499, DOI 10.1080/17461391.2012.740504; Centers for Disease Control and Prevention, 2016, THE HEALTH EFFECTS O; Chan JSY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00097; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Dahl AK, 2013, EPIDEMIOL REV, V35, P22, DOI 10.1093/epirev/mxs002; Dionigi R., 2002, World Leisure Journal, V44, P4; Drewnowski A, 2001, J GERONTOL A-BIOL, V56, P89, DOI 10.1093/gerona/56.suppl_2.89; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Egorov AY, 2013, J BEHAV ADDICT, V2, P199, DOI 10.1556/JBA.2.2013.4.2; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2156-9; Eisele M, 2015, BRIT J GEN PRACT, V65, pE716, DOI 10.3399/bjgp15X687337; European Commission, 2014, SPECIAL EUROBAROMETE; European Commission, 2013, EU JOINT PROGRAMMING; Forte R, 2015, INT J ENV RES PUB HE, V12, P11328, DOI 10.3390/ijerph120911328; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gariballa S, 2011, HANDBOOK OF BEHAVIOR, FOOD AND NUTRITION, P3099, DOI 10.1007/978-0-387-92271-3_192; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Han TS, 2013, BEST PRACT RES CL EN, V27, P509, DOI 10.1016/j.beem.2013.04.012; Hausenblas HA, 2006, PSYCHOL HEALTH, V21, P33, DOI 10.1080/14768320500105270; Hausenblas HA, 2002, PSYCHOL HEALTH, V17, P387, DOI 10.1080/0887044022000004894; Hayes AF, 2013, INTRO MEDIATION MODE, P85; Hogan S, 2012, J WOMEN AGING, V24, P329, DOI 10.1080/08952841.2012.708589; Jankowski GS, 2016, J HEALTH PSYCHOL, V21, P550, DOI 10.1177/1359105314531468; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Konig HH, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-143; Landolfi E, 2013, SPORTS MED, V43, P111, DOI 10.1007/s40279-012-0013-x; Layte R, 2013, J AM GERIATR SOC, V61, pS299, DOI 10.1111/jgs.12198; Leow MKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067138; Mangweth-Matzek B, 2014, CURR OPIN PSYCHIATR, V27, P431, DOI 10.1097/YCO.0000000000000102; Marshall Catherine, 2012, Can J Diet Pract Res, V73, pe241, DOI 10.3148/73.2.2012.e241; McCabe MP, 2004, J PSYCHOSOM RES, V56, P675, DOI 10.1016/S0022-3999(03)00129-6; Mura Gioia, 2013, Clin Pract Epidemiol Ment Health, V9, P125, DOI 10.2174/1745017901309010125; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Netuveli G, 2008, BRIT MED BULL, V85, P113, DOI 10.1093/bmb/ldn003; Office of Disease Prevention and Health Promotion, 2016, HLTH PEOPL 2020; Office of Disease Prevention and health Promotion, 2016, HEALTHY PEOPLE 2020; Osness WH, 1996, FUNCTIONAL FITNESS A, P32; Pan CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17301; Piacentini MF, 2009, CONT SPORT LEISURE E, P227; Prakash RS, 2015, ANNU REV PSYCHOL, V66, P769, DOI 10.1146/annurev-psych-010814-015249; Rejeski WJ, 2001, J GERONTOL A-BIOL, V56, P23, DOI 10.1093/gerona/56.suppl_2.23; Rosenbloom Christine, 2006, Holist Nurs Pract, V20, P161; Roy M, 2015, J AGING HEALTH, V27, P220, DOI 10.1177/0898264314546715; Rutten A, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-14; Sallinen J, 2008, J SPORT MED PHYS FIT, V48, P190; Segura-Garcia C, 2012, EAT WEIGHT DISORD-ST, V17, pE219, DOI 10.3275/8271; Shroff H. P., 2009, HDB ASSESSMENT METHO, P115; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Spirduso WW, 2005, PHYS DIMENSIONS AGIN, P233; Svantesson Ulla, 2015, J Clin Med Res, V7, P585, DOI 10.14740/jocmr2021w; Thompson D, 2015, EXERC SPORT SCI REV, V43, P67, DOI 10.1249/JES.0000000000000039; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Tiggemann M, 2013, BODY IMAGE, V10, P624, DOI 10.1016/j.bodyim.2013.07.003; Ware J, 1998, HOW TO SCORE THE SF, P97; World Health Organisation, 2011, GLOBAL STRATEGY ON D; Wroblewski AP, 2011, PHYSICIAN SPORTSMED, V39, P172, DOI 10.3810/psm.2011.09.1933; Young BW, 2011, PSYCHOL SPORT EXERC, V12, P168, DOI 10.1016/j.psychsport.2010.09.004	63	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160805	10.1371/journal.pone.0160805	http://dx.doi.org/10.1371/journal.pone.0160805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611689	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900010
J	Powell, MK; Benkova, K; Selinger, P; Dogosi, M; Lunackova, IK; Koutnikova, H; Lastikova, J; Roubickova, A; Spurkova, Z; Laclova, L; Eis, V; Sach, J; Heneberg, P				Powell, Marta K.; Benkova, Kamila; Selinger, Pavel; Dogosi, Marek; Lunackova, Iva Kinkorova; Koutnikova, Hana; Lastikova, Jarmila; Roubickova, Alena; Spurkova, Zuzana; Laclova, Lucie; Eis, Vaclav; Sach, Josef; Heneberg, Petr			Opportunistic Infections in HIV-Infected Patients Differ Strongly in Frequencies and Spectra between Patients with Low CD4(+) Cell Counts Examined Postmortem and Compensated Patients Examined Antemortem Irrespective of the HAART Era	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; AIDS-DEFINING ILLNESSES; POSITIVE PATIENTS; VIRUS-INFECTION; AUTOPSIED PATIENTS; CHANGING PATTERNS; NECROPSY FINDINGS; DEATH; MORTALITY; BACTEREMIA	Objective AIDS-related mortality has changed dramatically with the onset of highly active antiretroviral therapy (HAART), which has even allowed compensated HIV-infected patients to withdraw from secondary therapy directed against opportunistic pathogens. However, in recently autopsied HIV-infected patients, we observed that associations with a broad spectrum of pathogens remain, although detailed analyses are lacking. Therefore, we focused on the possible frequency and spectrum shifts in pathogens associated with autopsied HIV-infected patients. Design We hypothesized that the pathogens frequency and spectrum changes found in HIV-infected patients examined postmortem did not recapitulate the changes found previously in HIV-infected patients examined antemortem in both the pre-and post-HAART eras. Because this is the first comprehensive study originating from Central and Eastern Europe, we also compared our data with those obtained in the West and Southwest Europe, USA and Latin America. Methods We performed autopsies on 124 HIV-infected patients who died from AIDS or other co-mor-bidities in the Czech Republic between 1985 and 2014. The pathological findings were retrieved from the full postmortem examinations and autopsy records. Results We collected a total of 502 host-pathogen records covering 82 pathogen species, a spectrum that did not change according to patients' therapy or since the onset of the epidemics, which can probably be explained by the fact that even recently deceased patients were usually decompensated (in 95% of the cases, the last available CD4(+) cell count was falling below 200 cells*mu l-1) regardless of the treatment they received. The newly identified pathogen taxa in HIV-infected patients included Acinetobacter calcoaceticus, Aerococcus viridans and Escherichia hermannii. We observed a very limited overlap in both the spectra and frequencies of the pathogen species found postmortem in HIV-infected patients in Europe, the USA and Latin America. Conclusions The shifts documented previously in compensated HIV-infected patients examined antemortem in the post-HAART era are not recapitulated in mostly decompensated HIV-infected patients examined postmortem.	[Powell, Marta K.; Eis, Vaclav; Sach, Josef; Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Powell, Marta K.; Benkova, Kamila; Selinger, Pavel; Dogosi, Marek; Lunackova, Iva Kinkorova; Koutnikova, Hana; Lastikova, Jarmila; Roubickova, Alena; Spurkova, Zuzana; Laclova, Lucie] Na Bulovce Hosp, Pathol Anat Dept, Prague, Czech Republic; [Selinger, Pavel; Laclova, Lucie] Charles Univ Prague, Fac Med 2, Dept Forens Med, Prague, Czech Republic; [Dogosi, Marek] Charles Univ Prague, Fac Med 1, Dept Forens Med & Toxicol, Prague, Czech Republic; [Lunackova, Iva Kinkorova] Biopticka Lab Sro, Plzen, Czech Republic; [Eis, Vaclav; Sach, Josef] Teaching Hosp Kralovske Vinohrady, Dept Pathol, Prague, Czech Republic	Charles University Prague; Bulovka University Hospital; Charles University Prague; Charles University Prague; University Hospital Vinohrady	Heneberg, P (corresponding author), Charles Univ Prague, Fac Med 3, Prague, Czech Republic.	petr.heneberg@lf3.cuni.cz	Powell, Marta/E-1317-2017; Heneberg, Petr/C-1881-2012; Walmsley, Alena/G-7471-2018	Powell, Marta/0000-0002-3277-0873; Heneberg, Petr/0000-0002-0703-951X; Walmsley, Alena/0000-0001-7316-6472	Charles University in Prague [UNCE 204015, PRVOUK P31/2012, GAUK 235215, 260276/SVV/2016]; Czech Science Foundation [15-03834Y]	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Charles University in Prague projects UNCE 204015, PRVOUK P31/2012, GAUK 235215 and 260276/SVV/2016, and by the Czech Science Foundation project 15-03834Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P703, DOI 10.1128/JCM.15.4.703-713.1982; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Cox JA, 2010, AIDS REV, V12, P183; Cury PM, 2003, PATHOL RES PRACT, V199, P811, DOI 10.1078/0344-0338-00500; Dang AT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-153; Eza D, 2006, PATHOL RES PRACT, V202, P767, DOI 10.1016/j.prp.2006.07.005; Garcia-Jardon M, 2010, TROP DOCT, V40, P81, DOI 10.1258/td.2010.090465; Guerra I, 2001, PATHOL RES PRACT, V197, P165, DOI 10.1078/0344-0338-00028; Guimaraes LC, 2012, REV INST MED TROP SP, V54, P89, DOI 10.1590/S0036-46652012000200006; HARVEY RL, 1991, REV INFECT DIS, V13, P139; Hofman P, 1999, PATHOL RES PRACT, V195, P209, DOI 10.1016/S0344-0338(99)80037-5; HUI AN, 1984, HUM PATHOL, V15, P670; Iroezindu M. O., 2013, Journal of AIDS and Clinical Research, P002; Ives NJ, 2001, J INFECTION, V42, P134, DOI 10.1053/jinf.2001.0810; Katano H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-229; Li P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0870-7; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Manfredi R, 1997, Infez Med, V5, P23; Martinelli F, 1999, J CLIN MICROBIOL, V37, P2042, DOI 10.1128/JCM.37.6.2042-2044.1999; MCKENZIE R, 1991, MEDICINE, V70, P326, DOI 10.1097/00005792-199109000-00004; MICHALANY J, 1987, ANN PATHOL, V7, P15; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; MOHAR A, 1992, AIDS, V6, P467, DOI 10.1097/00002030-199205000-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PILLAY D, 1993, AIDS, V7, P969, DOI 10.1097/00002030-199307000-00010; Popescu GA, 2004, EMERG INFECT DIS, V10, P1335, DOI 10.3201/eid1007.030567; Razeq JH, 1999, EMERG INFECT DIS, V5, P838, DOI 10.3201/eid0506.990622; Soriano V, 2000, AIDS, V14, P282; Tong YQ, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.18138; Uh Y, 2002, J KOREAN MED SCI, V17, P113, DOI 10.3346/jkms.2002.17.1.113; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; WILKES MS, 1988, LANCET, V2, P85	34	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162704	10.1371/journal.pone.0162704	http://dx.doi.org/10.1371/journal.pone.0162704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611681	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900152
J	Prabhu, SB; Rathore, DK; Nair, D; Chaudhary, A; Raza, S; Kanodia, P; Sopory, S; George, A; Rath, S; Bal, V; Tripathi, R; Ramji, S; Batra, A; Aggarwal, KC; Chellani, HK; Arya, S; Agarwal, N; Mehta, U; Natchu, UCM; Wadhwa, N; Bhatnagar, S				Prabhu, Savit B.; Rathore, Deepak K.; Nair, Deepa; Chaudhary, Anita; Raza, Saimah; Kanodia, Parna; Sopory, Shailaja; George, Anna; Rath, Satyajit; Bal, Vineeta; Tripathi, Reva; Ramji, Siddharth; Batra, Aruna; Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha; Agarwal, Nidhi; Mehta, Umesh; Natchu, Uma Chandra Mouli; Wadhwa, Nitya; Bhatnagar, Shinjini			Comparison of Human Neonatal and Adult Blood Leukocyte Subset Composition Phenotypes	PLOS ONE			English	Article							CORD-BLOOD; IMMUNE-RESPONSE; CYTOKINE RESPONSES; EARLY-LIFE; T-CELLS; DISEASE; VACCINE; SYSTEM; PREDOMINANT; LYMPHOCYTES	The human peripheral leukocyte subset composition depends on genotype variation and pre-natal and post-natal environmental influence diversity. We quantified this composition in adults and neonates, and compared the median values and dispersal ranges of various subsets in them. We confirmed higher frequencies of monocytes and regulatory T cells (Tregs), similar frequencies of neutrophils, and lower frequencies of CD8 T cells, NKT cells, B1 B cells and gamma-delta T cells in neonatal umbilical cord blood. Unlike previous reports, we found higher frequencies of eosinophils and B cells, higher CD4:CD8 ratios, lower frequencies of T cells and iNKT cells, and similar frequencies of CD4 T cells and NK cells in neonates. We characterized monocyte subsets and dendritic cell (DC) subsets in far greater detail than previously reported, using recently described surface markers and gating strategies and observed that neonates had lower frequencies of patrolling monocytes and lower myeloid dendritic cell (mDC):plasmacytoid DC (pDC) ratios. Our data contribute to South Asian reference values for these parameters. We found that dispersal ranges differ between different leukocyte subsets, suggesting differential determination of variation. Further, some subsets were more dispersed in adults than in neonates suggesting influences of postnatal sources of variation, while some show the opposite pattern suggesting influences of developmental process variation. Together, these data and analyses provide interesting biological possibilities for future exploration.	[Prabhu, Savit B.; Rathore, Deepak K.; Nair, Deepa; Chaudhary, Anita; Raza, Saimah; Sopory, Shailaja; Rath, Satyajit; Bal, Vineeta; Natchu, Uma Chandra Mouli; Wadhwa, Nitya; Bhatnagar, Shinjini] Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Faridabad, Haryana, India; [Prabhu, Savit B.; Kanodia, Parna; George, Anna; Rath, Satyajit; Bal, Vineeta] Natl Inst Immunol, New Delhi, India; [Tripathi, Reva] Maulana Azad Med Coll, Dept Obstet & Gynecol, New Delhi, India; [Ramji, Siddharth] Maulana Azad Med Coll, Dept Neonatol, New Delhi, India; [Batra, Aruna] Vardhman Mahavir Med Coll, Dept Obstet & Gynecol, New Delhi, India; [Batra, Aruna; Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha] Safdarjang Hosp, New Delhi, India; [Aggarwal, Kailash C.; Chellani, Harish K.; Arya, Sugandha] Vardhman Mahavir Med Coll, Dept Pediat, New Delhi, India; [Agarwal, Nidhi] Gurgaon Civil Hosp, Dept Obstet & Gynecol, Gurgaon, India; [Mehta, Umesh] Gurgaon Civil Hosp, Dept Pediat, Gurgaon, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Maulana Azad Medical College; Maulana Azad Medical College; Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Prabhu, SB (corresponding author), Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Faridabad, Haryana, India.; Prabhu, SB (corresponding author), Natl Inst Immunol, New Delhi, India.	savit@thsti.res.in		Prabhu, Savit/0000-0003-3486-8951; bhatnagar, shinjini/0000-0003-1703-5296	Department of Biotechnology, Government of India [BT/PR12849/MED/15/35/2009, BT/PR14420/Med/29/213/2010, BT/PR-14592/BRB/10/858/2010, BT/MB/01/THSTI-ChBC/2009, BT/PR14723/MED/15/44/2010]; Department of Science and Technology, Government of India [SR/SO/HS-0005/2011, EMR/2015/001074, SB/SO/HS/210/2013]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported in part by grants from the Department of Biotechnology (to AG # BT/PR12849/MED/15/35/2009; to VB # BT/PR14420/Med/29/213/2010; to SR # BT/PR-14592/BRB/10/858/2010; to SB BT/MB/01/THSTI-ChBC/2009; and to UCMN # BT/PR14723/MED/15/44/2010), and from the Department of Science and Technology, Government of India (to VB # SR/SO/HS-0005/2011 and #EMR/2015/001074; to SR # SB/SO/HS/210/2013). The National Institute of Immunology and the Translational Health Science and Technology Institute are supported by the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants from the Department of Biotechnology (to A.G. # BT/PR12849/MED/15/35/2009; to V.B. # BT/PR14420/Med/29/213/2010; to S.R. # BT/PR-14592/BRB/10/858/2010; to S.B. BT/MB/01/THSTI-ChBC/2009; and to U.C.M.N. # BT/PR14723/MED/15/44/2010), and from the Department of Science and Technology, Government of India (to V.B. # SR/SO/HS-0005/2011 and # EMR/2015/001074; to S.R. # SB/SO/HS/210/2013). The National Institute of Immunology and the Translational Health Science and Technology Institute are supported by the Department of Biotechnology, Government of India.	BECK R, 1994, IMMUNOL CELL BIOL, V72, P440, DOI 10.1038/icb.1994.65; Bienemann K, 2011, SCAND J IMMUNOL, V74, P406, DOI 10.1111/j.1365-3083.2011.02591.x; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Casanova JL, 2015, CELL, V160, P13, DOI 10.1016/j.cell.2014.12.029; D'Arena G, 1998, HAEMATOLOGICA, V83, P197; Darmochwal-Kolarz D, 2004, IMMUNOL LETT, V91, P71, DOI 10.1016/j.imlet.2003.11.006; Drohan L, 2004, HUM IMMUNOL, V65, P1356, DOI 10.1016/j.humimm.2004.09.011; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/erv.12.134, 10.1586/ERV.12.134]; Hoffman R, 2013, HEMATOLOGY DIAGNOSIS; Huang E, 2014, J IMMUNOL, V193, P13, DOI 10.4049/jimmunol.1303410; Juretic E, 2000, IMMUNOBIOLOGY, V202, P421, DOI 10.1016/S0171-2985(00)80101-1; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Kollmann TR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00081; Labuda LA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095241, DOI 10.1371/J0URNAL.P0NE.0095241]; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Lalor MK, 2009, J INFECT DIS, V199, P795, DOI 10.1086/597069; MacGillivray DM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00434; Majumder PP, 2013, EUR J HUM GENET, V21, P1000, DOI 10.1038/ejhg.2012.278; Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Musha N, 1998, CLIN EXP IMMUNOL, V113, P220; Obata Y, 2015, IMMUNOL CELL BIOL, V93, P226, DOI 10.1038/icb.2014.114; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Paparo L, 2014, NUTRIENTS, V6, P4706, DOI 10.3390/nu6114706; Pedraza-Sanchez S, 2013, CLIN VACCINE IMMUNOL, V20, P962, DOI 10.1128/CVI.00609-12; Rathore DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123589; Sohlberg E, 2011, IMMUNOLOGY, V133, P41, DOI 10.1111/j.1365-2567.2011.03407.x; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; van Gent R, 2009, CLIN IMMUNOL, V133, P95, DOI 10.1016/j.clim.2009.05.020; Worku S, 1997, T ROY SOC TROP MED H, V91, P618, DOI 10.1016/S0035-9203(97)90051-1; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11	35	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162242	10.1371/journal.pone.0162242	http://dx.doi.org/10.1371/journal.pone.0162242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610624	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900068
J	Nick, JA; Caceres, SM; Kret, JE; Poch, KR; Strand, M; Faino, AV; Nichols, DP; Saavedra, MT; Taylor-Cousar, JL; Geraci, MW; Burnham, EL; Fessler, MB; Suratt, BT; Abraham, E; Moss, M; Malcolm, KC				Nick, Jerry A.; Caceres, Silvia M.; Kret, Jennifer E.; Poch, Katie R.; Strand, Matthew; Faino, Anna V.; Nichols, David P.; Saavedra, Milene T.; Taylor-Cousar, Jennifer L.; Geraci, Mark W.; Burnham, Ellen L.; Fessler, Michael B.; Suratt, Benjamin T.; Abraham, Edward; Moss, Marc; Malcolm, Kenneth C.			Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							ACUTE LUNG INJURY; BRONCHOALVEOLAR LAVAGE FLUID; NEUTROPHIL APOPTOSIS; CIGARETTE-SMOKING; BLOOD NEUTROPHILS; CLINICAL-OUTCOMES; INFLUENZA-VIRUS; LIPOPOLYSACCHARIDE; ARDS; SUSCEPTIBILITY	Acute Respiratory Distress Syndrome (ARDS) severity may be influenced by heterogeneity of neutrophil activation. Interferon-stimulated genes (ISG) are a broad gene family induced by Type I interferons, often as a response to viral infections, which evokes extensive immunomodulation. We tested the hypothesis that over-or under-expression of immunomodulatory ISG by neutrophils is associated with worse clinical outcomes in patients with ARDS. Genome-wide transcriptional profiles of circulating neutrophils isolated from patients with sepsis-induced ARDS (n = 31) and healthy controls (n = 19) were used to characterize ISG expression. Hierarchical clustering of expression identified 3 distinct subject groups with Low, Mid and High ISG expression. ISG accounting for the greatest variability in expression were identified (MX1, IFIT1, and ISG15) and used to analyze a prospective cohort at the Colorado ARDS Network site. One hundred twenty ARDS patients from four urban hospitals were enrolled within 72 hours of initiation of mechanical ventilation. Circulating neutrophils were isolated from patients and expression of ISG determined by PCR. Samples were stratified by standard deviation from the mean into High (n = 21), Mid, (n = 82) or Low (n = 17) ISG expression. Clinical outcomes were compared between patients with High or Low ISG expression to those with Mid-range expression. At enrollment, there were no differences in age, gender, co-existing medical conditions, or type of physiologic injury between cohorts. After adjusting for age, race, gender and BMI, patients with either High or Low ISG expression had significantly worse clinical outcomes than those in the Mid for number of 28-day ventilator-and ICU-free days (P = 0.0006 and 0.0004), as well as 90-day mortality and 90-day home with unassisted breathing (P = 0.02 and 0.004). These findings suggest extremes of ISG expression by circulating neutrophils from ARDS patients recovered early in the syndrome are associated with poorer clinical outcomes.	[Nick, Jerry A.; Caceres, Silvia M.; Poch, Katie R.; Saavedra, Milene T.; Taylor-Cousar, Jennifer L.; Malcolm, Kenneth C.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Nichols, David P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Strand, Matthew; Faino, Anna V.] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Nick, Jerry A.; Saavedra, Milene T.; Taylor-Cousar, Jennifer L.; Geraci, Mark W.; Burnham, Ellen L.; Moss, Marc; Malcolm, Kenneth C.] Univ Colorado, Denver Sch Med, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA; [Kret, Jennifer E.] St Louis Cty Dept Publ Hlth, Berkeley, MO USA; [Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Suratt, Benjamin T.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Abraham, Edward] Wake Forest Sch Med, Off Dean, Winston Salem, NC USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Vermont; Wake Forest University	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.; Malcolm, KC (corresponding author), Univ Colorado, Denver Sch Med, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA.	malcolmk@njhealth.org	, Ben/L-5749-2019; Strand, Matt/AAU-3762-2021; Fessler, Michael B/C-6323-2019	Strand, Matt/0000-0002-9083-5989; Fessler, Michael B/0000-0002-8262-8613; Nichols, David/0000-0001-8611-7960; Malcolm, Kenneth/0000-0002-8097-6059	NIH [R01HL090991, P01 HL068743, Z01 ES102005]; NIH NHLBI ARDS Network; Cystic Fibrosis Foundation [NICK14G0]; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NHLBI ARDS Network; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Rebecca Runyon Bryan Chair for Cystic Fibrosis; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by NIH R01HL090991 JAN, NIH P01 HL068743 MBS, NIH Z01 ES102005 (Intramural Research Program, NIEHS) MBS, NIH NHLBI ARDS Network MM, Cystic Fibrosis Foundation (NICK14G0) JAN and Rebecca Runyon Bryan Chair for Cystic Fibrosis.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bellingan G, 2014, LANCET RESP MED, V2, P98, DOI 10.1016/S2213-2600(13)70259-5; Bode JG, 2007, ARCH BIOCHEM BIOPHYS, V462, P254, DOI 10.1016/j.abb.2007.03.033; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brukman A, 2006, J VIROL, V80, P6345, DOI 10.1128/JVI.00554-06; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Buckley JM, 2006, J LEUKOCYTE BIOL, V80, P731, DOI 10.1189/jlb.0506312; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Gao L, 2009, AM J PHYSIOL-LUNG C, V296, pL713, DOI 10.1152/ajplung.90269.2008; Golpon HA, 2004, AM J RESP CELL MOL, V31, P595, DOI 10.1165/rcmb.2004-0008OC; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Halminen M, 1997, PEDIATR RES, V41, P647, DOI 10.1203/00006450-199705000-00008; HASLETT C, 1985, AM J PATHOL, V119, P101; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Iribarren C, 2000, CHEST, V117, P163, DOI 10.1378/chest.117.1.163; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kangelaris KN, 2012, CHEST, V141, P1160, DOI 10.1378/chest.11-1766; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022; Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12; Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Lesur O, 2000, CRIT CARE MED, V28, P3814, DOI 10.1097/00003246-200012000-00010; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Malcolm KC, 2003, J BIOL CHEM, V278, P15693, DOI 10.1074/jbc.M212033200; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Malcolm KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021958; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; MARTIN TR, 1991, AM REV RESPIR DIS, V144, P254, DOI 10.1164/ajrccm/144.2.254; Mascellino MT, 2001, J MED MICROBIOL, V50, P49, DOI 10.1099/0022-2615-50-1-49; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Metzger DW, 2013, J IMMUNOL, V191, P2047, DOI 10.4049/jimmunol.1301152; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Morris AE, 2007, CHEST, V131, P342, DOI 10.1378/chest.06-1709; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Parker D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003951; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramilo O, 2009, CELL HOST MICROBE, V6, P199, DOI 10.1016/j.chom.2009.08.007; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SELLERS TF, 1961, J EXP MED, V114, P237, DOI 10.1084/jem.114.2.237; Silva E, 2007, INTENSIVE CARE MED; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wright HJ, 2008, J IMMUNOL, V181, P5775, DOI 10.4049/jimmunol.181.8.5775; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; 2004, NAT REV GENET, V5, P229, DOI DOI 10.1038/NRG1297	76	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162490	10.1371/journal.pone.0162490	http://dx.doi.org/10.1371/journal.pone.0162490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606687	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600050
J	Elchaninov, A; Fatkhudinov, T; Usman, N; Kananykhina, E; Arutyunyan, I; Makarov, A; Bolshakova, G; Goldshtein, D; Sukhikh, G				Elchaninov, Andrey; Fatkhudinov, Timur; Usman, Natalia; Kananykhina, Evgeniya; Arutyunyan, Irina; Makarov, Andrey; Bolshakova, Galina; Goldshtein, Dmitry; Sukhikh, Gennady			Molecular Survey of Cell Source Usage during Subtotal Hepatectomy-Induced Liver Regeneration in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; GENE-EXPRESSION; WEAK INDUCER; INJURY; APOPTOSIS; RECEPTOR; INTACT; EXTENT	Proliferation of hepatocytes is known to be the main process in the hepatectomy-induced liver regrowth; however, in cases of extensive loss it may be insufficient for complete recovery unless supported by some additional sources e.g. mobilization of undifferentiated progenitors. The study was conducted on rat model of 80% subtotal hepatectomy; the objective was to evaluate contributions of hepatocytes and resident progenitor cells to the hepatic tissue recovery via monitoring specific mRNA and/or protein expression levels for a panel of genes implicated in growth, cell differentiation, angiogenesis, and inflammation. Some of the genes showed distinctive temporal expression patterns, which were loosely associated with two waves of hepatocyte proliferation observed at 2 and 7 days after the surgery. Focusing on genes implicated in regulation of the progenitor cell activity, we came across slight increases in expression levels for Sox9 and two genes encoding tumor necrosis factor-like cytokine TWEAK (Tnfsf12) and its receptor Fn14 (Tnfrsf12a). At the same time, no increase in numbers of cytokeratin 19-positive (CK19(+)) cells was observed in periportal areas, and no CK19+ cells were found in hepatic plates. Since CK19 is thought to be a specific marker of both cholangiocytes and the hepatic progenitor cells, the data indicate a lack of activation of the resident progenitor cells during recovery of hepatic tissue after 80% subtotal hepatectomy. Thus, proliferation of hepatocytes invariably makes the major contribution to the hepatic tissue recovery, although in the cases of subtotal loss this contribution is distinctively modulated. In particular, induction of Sox9 and TWEAK/Fn14 regulatory pathways, conventionally attributed to progenitor cell activation, may incidentally stimulate mitotic activity of hepatocytes.	[Elchaninov, Andrey; Fatkhudinov, Timur; Usman, Natalia; Kananykhina, Evgeniya; Arutyunyan, Irina; Makarov, Andrey; Sukhikh, Gennady] Minist Healthcare Russian Federat, Res Ctr Obstet Gynecol & Perinatol, 4 Oparina St, Moscow 117997, Russia; [Elchaninov, Andrey; Fatkhudinov, Timur; Usman, Natalia; Kananykhina, Evgeniya; Arutyunyan, Irina; Makarov, Andrey; Bolshakova, Galina] Sci Res Inst Human Morphol, 3 Tsurupa St, Moscow 117418, Russia; [Elchaninov, Andrey; Usman, Natalia; Makarov, Andrey] Pirogov Russian Natl Res Med Univ, Minist Healthcare Russian Federat, 1 Ostrovitianov St, Moscow 117997, Russia; [Goldshtein, Dmitry] Med Genet Res Ctr, 1 Moskvorechie St, Moscow 115478, Russia	Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Pirogov Russian National Research Medical University; Research Centre for Medical Genetics	Fatkhudinov, T (corresponding author), Minist Healthcare Russian Federat, Res Ctr Obstet Gynecol & Perinatol, 4 Oparina St, Moscow 117997, Russia.; Fatkhudinov, T (corresponding author), Sci Res Inst Human Morphol, 3 Tsurupa St, Moscow 117418, Russia.	fatkhudinov@gmail.com	Makarov, Andrey V/A-4130-2014; Arutyunyan, Irina V/A-5939-2014; Fatkhudinov, Timur Kh/A-5871-2014; Bolshakova, Galina B/A-5771-2014; Kananykhina, Evgeniya Y/A-8228-2014; Goldshtein, Dmitry/AAK-8313-2021; Elchaninov, Andrey V./B-5320-2013	Makarov, Andrey V/0000-0003-2133-2293; Arutyunyan, Irina V/0000-0002-4344-8943; Fatkhudinov, Timur Kh/0000-0002-6498-5764; Bolshakova, Galina B/0000-0002-9669-0821; Kananykhina, Evgeniya Y/0000-0002-9779-2918; Elchaninov, Andrey V./0000-0002-2392-4439; Suhih, Gennadii Tihonovic/0000-0002-7712-1260	Russian Foundation for Basic Research [14-04-01224]; Russian Presidential Grant for Young Scientists [14.120.14.6239]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Presidential Grant for Young Scientists	This work was supported by Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng; Agreement 14-04-01224 of 26 December 2013, TF) and the Russian Presidential Grant for Young Scientists (https://grants.extech.ru/;. 14.120.14.6239 of 3 February 2014, AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026; Chen YM, 2014, LIVER INT, V34, P976, DOI 10.1111/liv.12496; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Dalgetty DM, 2009, AM J PHYSIOL-GASTR L, V297, pG241, DOI 10.1152/ajpgi.00138.2009; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Eshkenazy Rony, 2014, Hepatobiliary Surg Nutr, V3, P303, DOI 10.3978/j.issn.2304-3881.2014.09.08; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Karaca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083987; KONO S, 1992, BIOCHEM BIOPH RES CO, V186, P991, DOI 10.1016/0006-291X(92)90844-B; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Masson S, 1999, LIVER, V19, P312, DOI 10.1111/j.1478-3231.1999.tb00055.x; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2014, EXPERT REV GASTROENT, V8, P897, DOI 10.1586/17474124.2014.934358; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2005, J BIOL CHEM, V280, P2562, DOI 10.1074/jbc.M412372200; Ninomiya M, 2010, AM J TRANSPLANT, V10, P1580, DOI 10.1111/j.1600-6143.2010.03150.x; Panis Y, 1998, J SURG RES, V79, P103, DOI 10.1006/jsre.1998.5400; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Scotte M, 1997, CYTOKINE, V9, P859, DOI 10.1006/cyto.1997.0273; Sowa JP, 2008, WORLD J GASTROENTERO, V14, P7093, DOI 10.3748/wjg.14.7093; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEINBREN K, 1965, BRIT J EXP PATHOL, V46, P413; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030675	38	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162613	10.1371/journal.pone.0162613	http://dx.doi.org/10.1371/journal.pone.0162613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631110	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900059
J	Andritschke, D; Dilling, S; Emmenlauer, M; Welz, T; Schmich, F; Misselwitz, B; Ramo, P; Rottner, K; Kerkhoff, E; Wada, T; Penninger, JM; Beerenwinkel, N; Horvath, P; Dehio, C; Hardt, WD				Andritschke, Daniel; Dilling, Sabrina; Emmenlauer, Mario; Welz, Tobias; Schmich, Fabian; Misselwitz, Benjamin; Ramo, Pauli; Rottner, Klemens; Kerkhoff, Eugen; Wada, Teiji; Penninger, Josef M.; Beerenwinkel, Niko; Horvath, Peter; Dehio, Christoph; Hardt, Wolf-Dietrich			A Genome-Wide siRNA Screen Implicates Spire1/2 in SipA-Driven Salmonella Typhimurium Host Cell Invasion	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION; EFFECTOR PROTEINS; DEPENDENT MECHANISM; EMBRYO FIBROBLASTS; ACTIN NUCLEATORS; RHO GTPASES; RNAI SCREEN; SOPE; MEMBRANE	Salmonella Typhimurium (S. Tm) is a leading cause of diarrhea. The disease is triggered by pathogen invasion into the gut epithelium. Invasion is attributed to the SPI-1 type 3 secretion system (T1). T1 injects effector proteins into epithelial cells and thereby elicits rearrangements of the host cellular actin cytoskeleton and pathogen invasion. The T1 effector proteins SopE, SopB, SopE2 and SipA are contributing to this. However, the host cell factors contributing to invasion are still not completely understood. To address this question comprehensively, we used Hela tissue culture cells, a genome-wide siRNA library, a modified gentamicin protection assay and S. Tm-SipA, a sopBsopE2sopE mutant which strongly relies on the T1 effector protein SipA to invade host cells. We found that S. TmSipA invasion does not elicit membrane ruffles, nor promote the entry of non-invasive bacteria "in trans". However, SipA-mediated infection involved the SPIRE family of actin nucleators, besides well-established host cell factors (WRC, ARP2/3, RhoGTPases, COPI). Stage-specific follow-up assays and knockout fibroblasts indicated that SPIRE1 and SPIRE2 are involved in different steps of the S. Tm infection process. Whereas SPIRE1 interferes with bacterial binding, SPIRE2 influences intracellular replication of S. Tm. Hence, these two proteins might fulfill non-redundant functions in the pathogen-host interaction. The lack of co-localization hints to a short, direct interaction between S. Tm and SPIRE proteins or to an indirect effect.	[Andritschke, Daniel; Dilling, Sabrina; Misselwitz, Benjamin; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Emmenlauer, Mario; Ramo, Pauli; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Welz, Tobias; Kerkhoff, Eugen] Univ Regensburg, Dept Neurol, DE-93040 Regensburg, Germany; [Schmich, Fabian; Beerenwinkel, Niko] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Schmich, Fabian; Beerenwinkel, Niko] SIB, CH-4058 Basel, Switzerland; [Misselwitz, Benjamin] Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Dept Cell Biol, D-38124 Braunschweig, Germany; [Wada, Teiji] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Horvath, Peter] ETH, Light Microscopy Ctr, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Zurich; University Zurich Hospital; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Hardt, WD (corresponding author), ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Penninger, Josef M/I-6860-2013; Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016; Misselwitz, Benjamin/L-7193-2016; Rottner, Klemens/AAE-5030-2020	Penninger, Josef M/0000-0002-8194-3777; Dehio, Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052; Misselwitz, Benjamin/0000-0002-8719-5175; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Rottner, Klemens/0000-0003-4244-4198	SystemsX.ch; Swiss Initiative in Systems Biology [51RT-0_126008, 51RTP0_151029]; Swiss National Science Foundation [310030_153074/1]; SyBIT, the IT project of SystemsX	SystemsX.ch; Swiss Initiative in Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SyBIT, the IT project of SystemsX	This project was funded in part by SystemsX.ch, the Swiss Initiative in Systems Biology, RTD grants 51RT-0_126008 (InfectX) and 51RTP0_151029 (TargetInfectX), evaluated by the Swiss National Science Foundation and Swiss National Science Foundation grant 310030_153074/1 to WDH. Further support was received from SyBIT, the IT project of SystemsX.	Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Bauch A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-468; Birmingham CL, 2005, INFECT IMMUN, V73, P1204, DOI 10.1128/IAI.73.2.1204-1208.2005; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972; COWIE A, 1986, MOL CELL BIOL, V6, P4344, DOI 10.1128/MCB.6.12.4344; Davidson AC, 2015, MBIO, V6, DOI 10.1128/mBio.02253-14; Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GONG S, 1990, VIROLOGY, V178, P81, DOI 10.1016/0042-6822(90)90381-Z; Hanisch J, 2011, CELL HOST MICROBE, V9, P273, DOI 10.1016/j.chom.2011.03.009; Hanisch J, 2010, CELL MICROBIOL, V12, P84, DOI 10.1111/j.1462-5822.2009.01380.x; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hayward RD, 2002, TRENDS CELL BIOL, V12, P15, DOI 10.1016/S0962-8924(01)02183-3; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphreys D, 2013, P NATL ACAD SCI USA, V110, P16880, DOI 10.1073/pnas.1311680110; Humphreys D, 2012, CELL HOST MICROBE, V11, P129, DOI 10.1016/j.chom.2012.01.006; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kerkhoff E, 2011, EUR J CELL BIOL, V90, P922, DOI 10.1016/j.ejcb.2010.10.011; Kreibich S, 2015, CELL HOST MICROBE, V18, P527, DOI 10.1016/j.chom.2015.10.015; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuhbacher A, 2015, MBIO, V6, DOI 10.1128/mBio.00598-15; Lagal V, 2014, J CELL SCI, V127, P328, DOI 10.1242/jcs.130161; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Meier R, 2014, GENOME WIDE SIRNA SC, P809; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pleiser S, 2014, EUR J CELL BIOL, V93, P225, DOI 10.1016/j.ejcb.2013.11.001; Pleiser S, 2010, GENE EXPR PATTERNS, V10, P345, DOI 10.1016/j.gep.2010.08.001; Prager R, 2000, INT J MED MICROBIOL, V290, P605; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Ramo P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1162; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Santos AJM, 2013, J CELL SCI, V126, P2990, DOI 10.1242/jcs.115253; Schlumberger MC, 2007, MOL MICROBIOL, V65, P741, DOI 10.1111/j.1365-2958.2007.05823.x; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schmich F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0783-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; TAKEUCHI A, 1967, AM J PATHOL, V50, P109; Tittel J, 2015, J BIOL CHEM, V290, P6428, DOI 10.1074/jbc.M114.602672; Truong D, 2013, CELL MICROBIOL, V15, P2051, DOI 10.1111/cmi.12173; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Vonaesch P, 2014, CELL MICROBIOL, V16, P1723, DOI 10.1111/cmi.12333; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	87	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161965	10.1371/journal.pone.0161965	http://dx.doi.org/10.1371/journal.pone.0161965			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627128	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000383680600014
J	Hull, V; Zhang, JD; Huang, JY; Zhou, SQ; Vina, A; Shortridge, A; Li, RG; Liu, DA; Xu, WH; Ouyang, ZY; Zhang, HM; Liu, JG				Hull, Vanessa; Zhang, Jindong; Huang, Jinyan; Zhou, Shiqiang; Vina, Andres; Shortridge, Ashton; Li, Rengui; Liu, Dian; Xu, Weihua; Ouyang, Zhiyun; Zhang, Hemin; Liu, Jianguo			Habitat Use and Selection by Giant Pandas	PLOS ONE			English	Article							WILDLIFE HABITAT; SPACE-USE; NATURE-RESERVE; DYNAMICS; RANGE; CHINA; TRACKING; IMPACTS; MODELS	Animals make choices about where to spend their time in complex and dynamic landscapes, choices that reveal information about their biology that in turn can be used to guide their conservation. Using GPS collars, we conducted a novel individual-based analysis of habitat use and selection by the elusive and endangered giant pandas (Ailuropoda melanoleuca). We constructed spatial autoregressive resource utilization functions (RUF) to model the relationship between the pandas' utilization distributions and various habitat characteristics over a continuous space across seasons. Results reveal several new insights, including use of a broader range of habitat characteristics than previously understood for the species, particularly steep slopes and non-forest areas. We also used compositional analysis to analyze habitat selection (use with respect to availability of habitat types) at two selection levels. Pandas selected against low terrain position and against the highest clumped forest at the at-home range level, but no significant factors were identified at the within-home range level. Our results have implications for modeling and managing the habitat of this endangered species by illustrating how individual pandas relate to habitat and make choices that differ from assumptions made in broad scale models. Our study also highlights the value of using a spatial autoregressive RUF approach on animal species for which a complete picture of individual-level habitat use and selection across space is otherwise lacking.	[Hull, Vanessa; Zhang, Jindong; Vina, Andres; Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Zhang, Jindong] China West Normal Univ, Key Lab Southwest China Wildlife Resources Conser, Minist Educ, Nanchong, Peoples R China; [Huang, Jinyan; Zhou, Shiqiang; Li, Rengui; Liu, Dian; Zhang, Hemin] CCRCGP, Wolong Nat Reserve, Chengdu, Sichuan, Peoples R China; [Shortridge, Ashton] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA; [Xu, Weihua; Ouyang, Zhiyun] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Michigan State University; China West Normal University; Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Hull, V (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	hullvane@msu.edu	Liu, Jianguo/G-5211-2015; Shiqiang, Zhou/G-1331-2019	Liu, Jianguo/0000-0001-6344-0087; Shiqiang, Zhou/0000-0002-5537-3205; Vina, Andres/0000-0001-6240-6610	National Science Foundation (NSF); National Aeronautics and Space Administration (NASA); Michigan AgBioResearch; Michigan State University Distinguished Fellowship Program; William W. and Evelyn M. Taylor International Engagement Program; National Natural Science Foundation of China [40901289, 41571517]; State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences [SKLURE2008-1]; Giant Panda International Collaboration Fund [SD0631, SD1113]; Direct For Biological Sciences [1340812] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Michigan AgBioResearch; Michigan State University Distinguished Fellowship Program; William W. and Evelyn M. Taylor International Engagement Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences; Giant Panda International Collaboration Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We gratefully acknowledge the following funding sources: National Science Foundation (NSF), the National Aeronautics and Space Administration (NASA), Michigan AgBioResearch, the Michigan State University Distinguished Fellowship Program, the William W. and Evelyn M. Taylor International Engagement Program, the National Natural Science Foundation of China (40901289, 41571517), the State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (SKLURE2008-1), and the Giant Panda International Collaboration Fund (Grant SD0631; SD1113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; An L, 2006, BIODIVERS CONSERV, V15, P2343, DOI 10.1007/s10531-004-1064-6; An L, 2014, ANN ASSOC AM GEOGR, V104, P723, DOI 10.1080/00045608.2014.910085; Bailey T, 1995, INTERACTIVE SPATIAL; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Bearer S, 2008, BIOL CONSERV, V141, P385, DOI 10.1016/j.biocon.2007.10.009; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Bradbury M, 2014, POPUL ENVIRON, V36, P73, DOI 10.1007/s11111-014-0203-6; Calenge C, 2011, ANALYSIS OF HABITAT; Chen XD, 2010, CONSERV BIOL, V24, P1469, DOI 10.1111/j.1523-1739.2010.01551.x; Chen XD, 2009, BIOL CONSERV, V142, P1740, DOI 10.1016/j.biocon.2009.03.012; Connor T, 2016, INTEGR ZOOL, V11, P295, DOI 10.1111/1749-4877.12197; Cumming GS, 2012, DIVERS DISTRIB, V18, P1057, DOI 10.1111/j.1472-4642.2012.00908.x; Durnin ME, 2004, J WILDLIFE MANAGE, V68, P987, DOI 10.2193/0022-541X(2004)068[0987:EOROGP]2.0.CO;2; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hu Jinchu, 2004, P137; Huang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1268-z; Hull V, 2015, J MAMMAL, V96, P230, DOI 10.1093/jmammal/gyu031; Hull V, 2014, URSUS, V25, P148, DOI 10.2192/URSUS-D-13-00011.1; Hull V, 2014, J NAT CONSERV, V22, P256, DOI 10.1016/j.jnc.2014.02.003; Hull V, 2011, BIOL CONSERV, V144, P3028, DOI 10.1016/j.biocon.2011.09.007; Jenness J., 2012, LAND FACET CORRIDOR; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Linderman MA, 2006, ECOL APPL, V16, P452, DOI 10.1890/1051-0761(2006)016[0452:IEONAH]2.0.CO;2; Liu J., 2016, PANDAS AND PEOPLE CO; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1023/A:1022101026466; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2015, SCIENCE, V348, P642, DOI 10.1126/science.348.6235.642-a; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; Liu XH, 2005, J WILDLIFE MANAGE, V69, P1623, DOI 10.2193/0022-541X(2005)69[1623:GPHSIF]2.0.CO;2; Liu XH, 2011, ECOL MODEL, V222, P645, DOI 10.1016/j.ecolmodel.2010.10.012; Manly B.F., 2002, RESOURCE SELECTION B; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; McGarigal K., 2015, FRAGSTATS HELP PIEEJ; Miller CS, 2010, INTEGR ZOOL, V5, P378, DOI 10.1111/j.1749-4877.2010.00216.x; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Morrison ML., 2006, WILDLIFE HABITAT REL; Nie YG, 2012, ANIM BEHAV, V84, P39, DOI 10.1016/j.anbehav.2012.03.026; Pan W., 2001, CHANCE LASTING SURVI; R Development Core Team, 2005, R LANG ENV STAT COMP; Ran Jiang-Hong, 2003, Acta Ecologica Sinica, V23, P2253; Ran Jianghong, 2004, Acta Theriologica Sinica, V24, P277; REID DG, 1991, J APPL ECOL, V28, P228, DOI 10.2307/2404127; Rogerson P., 2001, STATISTICAL METHODS; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schaller GB, 1985, THE GIANT PANDAS OF; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; State Forestry Administration of China, 2015, THE FOURTH NATIONAL; Swaisgood RR, 2010, BIOL LETTERS, V6, P143, DOI 10.1098/rsbl.2009.0786; TAYLOR AH, 1993, AM J BOT, V80, P375, DOI 10.2307/2445383; Taylor AH, 2004, FOREST ECOL MANAG, V200, P347, DOI 10.1016/j.foreco.2004.07.007; Tuanmu MN, 2011, J BIOGEOGR, V38, P1510, DOI 10.1111/j.1365-2699.2011.02479.x; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Vina A, 2008, REMOTE SENS ENVIRON, V112, P2160, DOI 10.1016/j.rse.2007.09.012; Vina A, 2011, AMBIO, V40, P274, DOI 10.1007/s13280-010-0098-0; Vina A, 2010, BIOL CONSERV, V143, P1960, DOI 10.1016/j.biocon.2010.04.046; Wang Xuezhi, 2008, Acta Ecologica Sinica, V28, P821; Witt CM, 2015, SCIENCE, V347, pS50; Xu WH, 2006, DIVERS DISTRIB, V12, P610, DOI 10.1111/j.1366-9516.2006.00236.x; Yang W, 2015, ASCE-ASME J RISK U B, V1, DOI 10.1115/1.4029751; Yu E, 2007, P NATL ACAD SCI USA, V104, P20629, DOI 10.1073/pnas.0707267104; Zhang ZJ, 2014, INTEGR ZOOL, V9, P46, DOI 10.1111/1749-4877.12030	68	29	38	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162266	10.1371/journal.pone.0162266	http://dx.doi.org/10.1371/journal.pone.0162266			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627805	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600027
J	Khalil, MA; Hrabeta, J; Groh, T; Prochazka, P; Doktorova, H; Eckschlager, T				Khalil, Mohamed Ashraf; Hrabeta, Jan; Groh, Tomas; Prochazka, Pavel; Doktorova, Helena; Eckschlager, Tomas			Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; HISTONE DEACETYLASE; COLON-CANCER; MARKER CD133; INITIATING CELLS; PROSTATE-CANCER; EXPRESSION; TUMORS; PATHWAY; CHEMORESISTANCE	Valproic acid (VPA) is a well-known antiepileptic drug that exhibits antitumor activities through its action as a histone deacetylase inhibitor. CD133 is considered to be a cancer stem cell marker in several tumors including neuroblastoma. CD133 transcription is strictly regulated by epigenetic modifications. We evaluated the epigenetic effects of treatment with 1mM VPA and its influence on the expression of CD133 in four human neuroblastoma cell lines. Chemoresistance and cell cycle of CD133+ and CD133- populations were examined by flow cytometry. We performed bisulfite conversion followed by methylation-sensitive high resolution melting analysis to assess the methylation status of CD133 promoters P1 and P3. Our results revealed that VPA induced CD133 expression that was associated with increased acetylation of histones H3 and H4. On treatment with VPA and cytostatics, CD133+ cells were mainly detected in the S and G2/M phases of the cell cycle and they showed less activated caspase-3 compared to CD133-cells. UKF-NB-3 neuroblastoma cells which express CD133 displayed higher colony and neurosphere formation capacities when treated with VPA, unlike IMR-32 which lacks for CD133 protein. Induction of CD133 in UKF-NB-3 was associated with increased expression of phosphorylated Akt and pluripotency transcription factors Nanog, Oct-4 and Sox2. VPA did not induce CD133 expression in cell lines with methylated P1 and P3 promoters, where the CD133 protein was not detected. Applying the demethylating agent 5-aza-2'-deoxycytidine to the cell lines with methylated promoters resulted in CD133 re-expression that was associated with a drop in P1 and P3 methylation level. In conclusion, CD133 expression in neuroblastoma can be regulated by histone acetylation and/or methylation of its CpG promoters. VPA can induce CD133+ cells which display high proliferation potential and low sensitivity to cytostatics in neuroblastoma. These results give new insight into the possible limitations to use VPA in cancer therapy.	[Khalil, Mohamed Ashraf; Hrabeta, Jan; Doktorova, Helena; Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Khalil, Mohamed Ashraf; Hrabeta, Jan; Doktorova, Helena; Eckschlager, Tomas] Univ Hosp Motol, Prague, Czech Republic; [Groh, Tomas] Fac Sci, Dept Biochem, Prague, Czech Republic; [Prochazka, Pavel] Acad Sci, Inst Expt Med, Prague, Czech Republic; [Prochazka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Eckschlager, T (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic.; Eckschlager, T (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	tomas.eckschlager@lfmotol.cuni.cz		Abdel-Rahman, Mohamed Ashraf khalil/0000-0003-4280-0607; Doktorova, Helena/0000-0002-5748-8807	Grant Agency of Czech Republic [P301/12/1734]; project Grant Agency Charles University in Prague [620612, 635712/2012]; Ministry of Health of the Czech Republic [00064203]; Charles University in Prague, project GA UK grant [620612, 635712/2012];  [GA CR P301/12/1734]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); project Grant Agency Charles University in Prague; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University in Prague, project GA UK grant; 	This work was funded by Grant Agency of Czech Republic (www.gacr.cz) P301/12/1734, project Grant Agency Charles University in Prague (www.cuni.cz/UK-33.html) grants No 620612 and 635712/2012, and the Ministry of Health of the Czech Republic (www.mzcr.cz) for conceptual development of research organization 00064203 (University Hospital Motol, Prague, Czech Republic).; This work was supported by grant GA CR P301/12/1734 and by Charles University in Prague, project GA UK grant No 620612 and 635712/2012. Support also came from the Ministry of Health of the Czech Republic for conceptual development of research organization 00064203 (University Hospital Motol, Prague, Czech Republic).	Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Barrantes-Freer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130519; Boudadi E, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-11; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Burba I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022158; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1155/2010/479364; Chen CL, 2006, J PHARMACOL EXP THER, V319, P533, DOI 10.1124/jpet.106.106658; CINATL J, 1990, Journal of Cancer Research and Clinical Oncology, V116, P9; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Ellis L, 2013, ONCOTARGET, V4, P2225, DOI 10.18632/oncotarget.1314; Feng JM, 2012, CANCER BIOL THER, V13, P1396, DOI 10.4161/cbt.22000; Feng JT, 2015, CELL ADHES MIGR, V9, P495, DOI 10.1080/19336918.2015.1112486; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Groh T, 2015, INT J ONCOL, V47, P343, DOI 10.3892/ijo.2015.2996; Groh T, 2012, NEUROENDOCRINOL LETT, V33, P16; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hammerle B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076761; Han L, 2013, ACTA PHARM SIN B, V3, P65, DOI 10.1016/j.apsb.2013.02.006; Higuchi A, 2015, LAB INVEST, V95, P26, DOI 10.1038/labinvest.2014.132; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hrebackova J, 2010, CURR DRUG TARGETS, V11, P361, DOI 10.2174/138945010790711923; Irollo E, 2013, AM J TRANSL RES, V5, P563; Kamijo T, 2012, PEDIATR RES, V71, P511, DOI 10.1038/pr.2011.54; Kaneko Y, 2015, CANCER SCI, V106, P840, DOI 10.1111/cas.12677; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Khalil MA, 2012, NEOPLASMA, V59, P737, DOI 10.4149/neo_2012_093; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Koyama-Nasu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053710; Kretsovali A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/184154; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee HZ, 2015, CLIN CANCER RES, V21, P2666, DOI 10.1158/1078-0432.CCR-14-3119; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Donovan N, 2003, CLIN CANCER RES, V9, P738; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pezzolo A, 2011, CELL RES, V21, P1470, DOI 10.1038/cr.2011.38; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Poljakova J, 2014, ONCOL REP, V31, P1928, DOI 10.3892/or.2014.2999; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Ross RA, 2003, CANCER LETT, V197, P35, DOI 10.1016/S0304-3835(03)00079-X; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi GL, 2011, J CELL PHYSIOL, V226, P3190, DOI 10.1002/jcp.22679; Shin JH, 2013, J NEURO-ONCOL, V115, P333, DOI 10.1007/s11060-013-1234-z; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tong QS, 2008, WORLD J PEDIATR, V4, P58, DOI 10.1007/s12519-008-0012-z; Vangipuram SD, 2010, PEDIATR BLOOD CANCER, V54, P361, DOI 10.1002/pbc.22351; de Tudela MVP, 2010, J NEUROCHEM, V113, P819, DOI 10.1111/j.1471-4159.2010.06648.x; Wakao Shohei, 2012, Cells, V1, P1045, DOI 10.3390/cells1041045; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wheler JJ, 2014, CANCER CHEMOTH PHARM, V73, P495, DOI 10.1007/s00280-014-2384-1; Wu CP, 2014, HEAD NECK-J SCI SPEC, V36, P1279, DOI 10.1002/hed.23447; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	66	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162916	10.1371/journal.pone.0162916	http://dx.doi.org/10.1371/journal.pone.0162916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627801	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600063
J	Lian, S; Cho, WK; Kim, SM; Choi, H; Kim, KH				Lian, Sen; Cho, Won Kyong; Kim, Sang-Min; Choi, Hoseong; Kim, Kook-Hyung			Time-Course Small RNA Profiling Reveals Rice miRNAs and Their Target Genes in Response to Rice Stripe Virus Infection	PLOS ONE			English	Article							ORYZA-SATIVA; NUCLEOTIDE-SEQUENCE; CODING STRATEGY; DRAFT SEQUENCE; MICRORNA; ARABIDOPSIS; IDENTIFICATION; SEGMENT-3; PLANTS; SIRNAS	It has been known that many microRNAs (miRNAs) are involved in the regulation for the plant development and defense mechanism by regulating the expression of the target gene. Several previous studies has demonstrated functional roles of miRNAs in antiviral defense mechanisms. In this study, we employed high-throughput sequencing technology to identify rice miRNAs upon rice stripe virus (RSV) infection at three different time points. Six libraries from mock and RSV-infected samples were subjected for small RNA sequencing. Bioinformatic analyses revealed 374 known miRNAs and 19 novel miRNAs. Expression of most identified miRNAs was not dramatically changed at 3 days post infection (dpi) and 7 dpi by RSV infection. However, many numbers of miRNAs were up-regulated in mock and RSV-infected samples at 15 dpi by RSV infection. Moreover, expression profiles of identified miRNAs revealed that only few numbers of miRNAs were strongly regulated by RSV infection. In addition, 15 resistance genes were targets of six miRNAs suggesting that those identified miRNAs and 15 NBS-LRR resistance genes might be involved in RSV infection. Taken together, our results provide novel insight into the dynamic expression profiles of rice miRNAs upon RSV infection and clues for the understanding of the regulatory roles of miRNAs via time-course.	[Lian, Sen] Qingdao Agr Univ, Coll Crop Protect & Agron, Qingdao 266109, Shandong, Peoples R China; [Cho, Won Kyong; Kim, Sang-Min; Choi, Hoseong; Kim, Kook-Hyung] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea; [Cho, Won Kyong; Kim, Sang-Min; Choi, Hoseong; Kim, Kook-Hyung] Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Seoul 08826, South Korea; [Kim, Sang-Min] Natl Inst Crop Sci, Rural Dev Adm, Crop Fdn Res Div, Wonju 55365, South Korea	Qingdao Agricultural University; Seoul National University (SNU); Seoul National University (SNU); Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Kim, KH (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea.; Kim, KH (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Plant Genom & Breeding Inst, Seoul 08826, South Korea.	kookkim@snu.ac.kr	Cho, Won Kyong/I-5098-2012	Cho, Won Kyong/0000-0002-8416-5173	Next-Generation BioGreen 21 Program [PJ01101301]; Rural Development Administration (RDA); Vegetable Breeding Research Center through Agriculture Research Center program from the Ministry for Food, Agriculture and Rural Affairs, Republic of Korea [710001-05]; Brain Korea 21 Plus Project	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Vegetable Breeding Research Center through Agriculture Research Center program from the Ministry for Food, Agriculture and Rural Affairs, Republic of Korea; Brain Korea 21 Plus Project	This research was supported in part by grants from the Next-Generation BioGreen 21 Program (No. PJ01101301), Rural Development Administration (RDA) and the Vegetable Breeding Research Center (No. 710001-05) through Agriculture Research Center program from the Ministry for Food, Agriculture and Rural Affairs, Republic of Korea. SL and WKC were supported by research fellowships from the Brain Korea 21 Plus Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by grants from the Next-Generation BioGreen 21 Program (No. PJ01101301), Rural Development Administration (RDA) and the Vegetable Breeding Research Center (No. 710001-05) through Agriculture Research Center program from the Ministry for Food, Agriculture and Rural Affairs, Republic of Korea. SL and WKC were supported by research fellowships from the Brain Korea 21 Plus Project.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Branscheid A, 2010, MOL PLANT MICROBE IN, V23, P915, DOI 10.1094/MPMI-23-7-0915; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cho WK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136736; Choi H, 2013, PLANT PATHOLOGY J, V29, P99, DOI 10.5423/PPJ.NT.09.2012.0142; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116175; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046443; HAYANO Y, 1990, VIROLOGY, V177, P372, DOI 10.1016/0042-6822(90)90493-B; He DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21376; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; KAKUTANI T, 1991, J GEN VIROL, V72, P465, DOI 10.1099/0022-1317-72-2-465; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y, 2014, PLANT PHYSIOL, V164, P1077, DOI 10.1104/pp.113.230052; Lu YD, 2008, PLANT CELL REP, V27, P1571, DOI 10.1007/s00299-008-0584-z; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Shiba T, 2016, J ECO ENTOMOL; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; TAKAHASHI M, 1993, J GEN VIROL, V74, P769, DOI 10.1099/0022-1317-74-4-769; TORIYAMA S, 1994, J GEN VIROL, V75, P3569, DOI 10.1099/0022-1317-75-12-3569; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang HC, 2016, PLANT PHYSIOL, V170, P2365, DOI 10.1104/pp.15.01283; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yang J, 2015, PLOS ONE, V11; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	58	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162319	10.1371/journal.pone.0162319	http://dx.doi.org/10.1371/journal.pone.0162319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626631	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600029
J	Gao, CH; Wang, JZ; Li, C; Zhang, W; Liu, GX				Gao, Chunhai; Wang, Jinzhu; Li, Chong; Zhang, Wei; Liu, Guoxia			A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population	PLOS ONE			English	Article							DNA-REPAIR GENES; LUNG-CANCER RISK; ENVIRONMENT INTERACTION; NER PATHWAY; SUSCEPTIBILITY; DAMAGE; XRCC1	Single nucleotide polymorphisms of XPA gene have been studied in several cancers such as rs10817938, rs2808668. However, the role of XPA polymorphisms in patients with oral squamous cell carcinoma (OSCC) remains unclear. Thus, we analyzed the association of XPA polymorphisms with OSCC risk, clinicopathological characteristics and prognosis in the present study. TaqMan genotyping was used to evaluate the frequency of rs10817938, rs2808668 polymorphisms in OSCC patients. The prognostic significance of these polymorphisms was evaluated using Kaplan-Meier curves, Log-Rank analyses, and the Cox proportional hazard model. Luciferase reporterassay, RT-PCR and western blot were used to determine whether rs10817938 could influence transcription activity and XPA expression. The results showed that individuals carrying TC and CC genotypes had significantly greater risk of developing OSCC (OR = 1.42, 95% CI 1.04-1.93; OR = 2.75, 95% CI 1.32-5.71, respectively) when compared with wild-type TT genotype at rs10817938. OSCC patients with C allele at rs10817938 were more susceptible to lymph metastases, poor pathological differentiation and late TNM stage (OR = 1.67, 95% CI 1.17-2.37; OR = 1.64, 95% CI 1.182.28; OR = 1.54, 95% CI 1.11-2.14; respectively). A significant gene-environment interaction between smoking and CC genotype at rs10817938 was observed (COR = 3.60, 95% CI 1.20-10.9) and data also showed that OSCC patients with CC genotype and C allele had worse survival (p<0.001 for both). The T to C substitution at rs10817938 significantly decreased transcription activity of XPA gene, XPA mRNA and protein were also decreased in individuals with C allele at rs10817938. In addition, no significant association of rs2808668 polymorphism with OSCC risk, prognosis could be observed. In conclusion, the present study showed that XPA rs10817938 polymorphism is a functional SNP in vitro and in vivo and a biomarker for poor prognosis in OSCC patients.	[Gao, Chunhai; Wang, Jinzhu] Linyi Peoples Hosp, Dept Clin Lab, Linyi, Shandong, Peoples R China; [Li, Chong; Liu, Guoxia] Jinan Stomatol Hosp, Jinan, Shandong, Peoples R China; [Zhang, Wei] Linyi Peoples Hosp, Dept Rehabil, Linyi, Shandong, Peoples R China		Liu, GX (corresponding author), Jinan Stomatol Hosp, Jinan, Shandong, Peoples R China.	runninglgx@163.com						ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Butkiewicz D, 2001, CARCINOGENESIS, V22, P593, DOI 10.1093/carcin/22.4.593; Camenisch U, 2008, ADV EXP MED BIOL, V637, P28; Cancela MD, 2010, HEAD NECK-J SCI SPEC, V32, P357, DOI 10.1002/hed.21193; Ding DP, 2012, INT J CANCER, V131, P488, DOI 10.1002/ijc.26391; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Guo W, 2008, J CANCER RES CLIN, V134, P263, DOI 10.1007/s00432-007-0283-0; Han W, 2012, CANCER-AM CANCER SOC, V118, P594, DOI 10.1002/cncr.26220; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hua RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087057; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Larsen LK, 2002, BIOCHEM J, V366, P767, DOI 10.1042/BJ20011821; Liu J, 2016, ONCOTARGET; Liu J, 2012, MOL BIOL REP, V39, P6791, DOI 10.1007/s11033-012-1504-4; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lou YQ, 2014, TUMOR BIOL, V35, P6607, DOI 10.1007/s13277-014-1824-1; Markopoulos AK, 2012, OPEN DENT J, V6, P126, DOI 10.2174/1874210601206010126; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Mei CR, 2014, THORAC CANCER, V5, P232, DOI 10.1111/1759-7714.12073; Miyashita H, 2001, ONCOL REP, V8, P1133; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Palli D, 2004, EUR J CANCER, V40, P2474, DOI 10.1016/j.ejca.2004.07.012; Rafiq R, 2016, TUMOUR BIOL; Ruiz-Cosano J, 2013, J BUON, V18, P486; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Spitz MR, 2001, CANCER RES, V61, P1354; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; Sun YN, 2015, INT J CLIN EXP PATHO, V8, P11615; Thoma BS, 2003, MOL CARCINOGEN, V38, P1, DOI 10.1002/mc.10143; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang BC., 2016, ONCOTARGET; Wang Y, 2007, CLIN CANCER RES, V13, P3753, DOI 10.1158/1078-0432.CCR-06-1911; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu XF, 2003, CARCINOGENESIS, V24, P505, DOI 10.1093/carcin/24.3.505; Zhao FL, 2015, INT J CLIN EXP PATHO, V8, P11579; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036293	40	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0160801	10.1371/journal.pone.0160801	http://dx.doi.org/10.1371/journal.pone.0160801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622501	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000003
J	Best, J; Verhulst, S; Syn, WK; Lagaisse, K; van Hul, N; Heindryckx, F; Sowa, JP; Peeters, L; Van Vlierberghe, H; Leclercq, IA; Canbay, A; Dolle, L; van Grunsven, LA				Best, Jan; Verhulst, Stefaan; Syn, Wing-Kin; Lagaisse, Kimberly; van Hul, Noemi; Heindryckx, Femke; Sowa, Jan-Peter; Peeters, Liesbeth; Van Vlierberghe, Hans; Leclercq, Isabelle A.; Canbay, Ali; Dolle, Laurent; van Grunsven, Leo A.			Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; LIVER PROGENITOR CELLS; MURINE MODEL; INJURY; PROLIFERATION; CHOLANGIOCYTES; LIPOSOMES; APOPTOSIS; CIRRHOSIS; LIGATION	Chronic cholangiopathies, such as primary and secondary sclerosing cholangitis, are progressive disease entities, associated with periportal accumulation of inflammatory cells, encompassing monocytes and macrophages, peribiliary extracellular matrix (ECM) deposition and ductular reaction (DR). This study aimed to elucidate the relevance of macrophages in the progression of chronic cholangiopathies through macrophage depletion in a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) mouse model. One group of mice received a single i.p. injection of Clodronate encapsulated liposomes (CLOLipo) at day 7 of a 14 day DDC treatment, while control animals were co-treated with PBSLipo instead. Mice were sacrificed after 7 or respectively 14 days of treatment for immunohistochemical assessment of macrophage recruitment (F4/80), ECM deposition (Sirius Red, Laminin) and DR (CK19). Macrophage depletion during a 14 day DDC treatment resulted in a significant inhibition of ECM deposition. Porto-lobular migration patterns of laminin-rich ECM and ductular structures were significantly attenuated and a progression of DR was effectively inhibited by macrophage depletion. CLOLipo co-treatment resulted in a confined DR to portal regions without amorphous cell clusters. This study suggests that therapeutic options selectively directed towards macrophages might represent a feasible treatment for chronic cholestatic liver diseases.	[Best, Jan; Verhulst, Stefaan; Lagaisse, Kimberly; Peeters, Liesbeth; Dolle, Laurent; van Grunsven, Leo A.] Vrije Univ Brussel, Dept Basic Biomed Sci, Liver Cell Biol Lab, Brussels, Belgium; [Best, Jan; Sowa, Jan-Peter; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Syn, Wing-Kin] Inst Hepatol, Fdn Liver Res, London, England; [Syn, Wing-Kin] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC USA; [van Hul, Noemi; Leclercq, Isabelle A.] UCL, IREC, Lab Hepatogastroenterol, Brussels, Belgium; [Heindryckx, Femke; Van Vlierberghe, Hans] Univ Ghent, Dept Gastroenterol & Hepatol, Ghent, Belgium; [Syn, Wing-Kin] Ralph H Johnson Veteran Affairs Med Ctr, Gastroenterol Sect, Charleston, SC USA	Vrije Universiteit Brussel; University of Duisburg Essen; University of London; University College London; Medical University of South Carolina; Universite Catholique Louvain; Ghent University	van Grunsven, LA (corresponding author), Vrije Univ Brussel, Dept Basic Biomed Sci, Liver Cell Biol Lab, Brussels, Belgium.	lvgrunsv@vub.ac.be	Van Hul, Noemi/AAB-7985-2020; Verhulst, Stefaan/AAH-7603-2020; Sowa, Jan-Peter/AAQ-6318-2020; van Grunsven, Leo/E-5839-2010; Verhulst, Stefaan/ABD-2923-2020; Canbay, Ali/AAL-9620-2020; Best, Jan/AAG-2350-2020; Syn, Wing-Kin/AAB-8406-2020	Verhulst, Stefaan/0000-0001-6566-6071; van Grunsven, Leo/0000-0002-0990-7034; Best, Jan/0000-0003-2074-0930; Heindryckx, Femke/0000-0002-1987-7676; Van Hul, Noemi/0000-0003-1410-8808; Canbay, Ali/0000-0001-6069-7899	Brustem: Impulse program (Brussels Government) [2011-IP-LS-104-Brustem]; Flemish Government Agency for Innovation by Science and Technology [IWT/SB/121548]; Interuniversity Attraction Poles (IAP)-phase VII (Federal Science Policy-BELSPO) [P7/47]; Research Foundation Flanders (FWO) [G.0333.13N]; Foundation for Liver Research, UK; Deutsche Forschungsgemeinschaft (DFG) [267/4-1, 267/6-1, 267/8-1]; Wilhelm Laupitz Foundation; NICHD;  [FWO G.0348.13N]	Brustem: Impulse program (Brussels Government); Flemish Government Agency for Innovation by Science and Technology; Interuniversity Attraction Poles (IAP)-phase VII (Federal Science Policy-BELSPO); Research Foundation Flanders (FWO)(FWO); Foundation for Liver Research, UK; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); 	This work was supported by the following sources of funding. JB: Brustem: Impulse program 2011-IP-LS-104-Brustem (Brussels Government); SV: Flemish Government Agency for Innovation by Science and Technology, IWT/SB/121548; LD, LvG, NvH, KL & IAL: Interuniversity Attraction Poles (IAP)-phase VII-contract P7/47 (Federal Science Policy-BELSPO), and Brustem: Impulse program 2011-IP-LS-104-Brustem (Brussels Government). HVV, LvG & LD: Research Foundation Flanders (FWO, grant: G.0333.13N); LvG & LD: (FWO G.0348.13N); WKS: Foundation for Liver Research, UK; AC: Deutsche Forschungsgemeinschaft (DFG, grants 267/4-1; 267/6-1 and 267/8-1) and the Wilhelm Laupitz Foundation.; We thank Danielle Blyweert, Tom Schouteet, Bill Roskams, Nathalie Eysackers, Jie Mei, Christophe Empsen, Jan Martin Schlattjan and Svenja Sydor for their excellent technical assistance and we express our sincerest thanks to Jean-Marc Lazou and Kris Deromfor their administrative assistance. The TROMA-III antibody developed by Rolf Kemler was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA52242.	Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767; Alpini G, 2002, HEPATOLOGY, V35, P1256, DOI 10.1053/jhep.2002.33541; Alvaro D, 2000, J HEPATOL, V33, P333, DOI 10.1016/S0168-8278(00)80377-3; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Bogert PT, 2007, CURR OPIN GASTROEN, V23, P299, DOI 10.1097/MOG.0b013e3280b079fb; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brown AC, 2017, FOOD CHEM TOXICOL, V107, P472, DOI 10.1016/j.fct.2016.07.001; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Chang ML, 2005, WORLD J GASTROENTERO, V11, P4167; Desmet VJ, 2009, HEPATOLOGY, V50, P333, DOI 10.1002/hep.23152; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Hirschfield GM, 2013, CLIN LIVER DIS, V17, P147, DOI 10.1016/j.cld.2012.12.002; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Lazaridis KN, 2008, J GASTROINTEST SURG, V12, P417, DOI 10.1007/s11605-007-0344-3; Lazaridis KN, 2015, MAYO CLIN PROC, V90, P791, DOI 10.1016/j.mayocp.2015.03.017; LeSage G, 1996, GASTROENTEROLOGY, V111, P1633, DOI 10.1016/S0016-5085(96)70027-6; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Mendes F, 2010, NAT REV GASTRO HEPAT, V7, P611, DOI 10.1038/nrgastro.2010.155; Mousa HS, 2016, AUTOIMMUN REV, V15, P870, DOI 10.1016/j.autrev.2016.07.003; Nayagam JS, 2016, WORLD J HEPATOL, V8, P265, DOI 10.4254/wjh.v8.i5.265; POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551; Priester Sally, 2010, World J Gastrointest Pathophysiol, V1, P30, DOI 10.4291/wjgp.v1.i2.30; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Scheuer PJ, 1998, MAYO CLIN PROC, V73, P179; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Svegliati-Baroni G, 2008, LIVER INT, V28, P1052, DOI 10.1111/j.1478-3231.2008.01825.x; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Van Hul N, 2011, AM J PATHOL, V179, P1839, DOI 10.1016/j.ajpath.2011.06.042; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wagner M., 2016, F1000RESEARCH, V5	36	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162286	10.1371/journal.pone.0162286	http://dx.doi.org/10.1371/journal.pone.0162286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618307	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100015
J	Nikkhoo, N; Cumby, N; Gulak, PG; Maxwell, KL				Nikkhoo, Nasim; Cumby, Nichole; Gulak, P. Glenn; Maxwell, Karen L.			Rapid Bacterial Detection via an All-Electronic CMOS Biosensor	PLOS ONE			English	Article							ION-SELECTIVE ELECTRODES; LABEL-FREE DETECTION; COLI O157/H7; STATE; VIRULENCE	The timely and accurate diagnosis of infectious diseases is one of the greatest challenges currently facing modern medicine. The development of innovative techniques for the rapid and accurate identification of bacterial pathogens in point-of-care facilities using low-cost, portable instruments is essential. We have developed a novel all-electronic biosensor that is able to identify bacteria in less than ten minutes. This technology exploits bacteriocins, protein toxins naturally produced by bacteria, as the selective biological detection element. The bacteriocins are integrated with an array of potassium-selective sensors in Complementary Metal Oxide Semiconductor technology to provide an inexpensive bacterial biosensor. An electronic platform connects the CMOS sensor to a computer for processing and real-time visualization. We have used this technology to successfully identify both Gram-positive and Gram-negative bacteria commonly found in human infections.	[Nikkhoo, Nasim; Gulak, P. Glenn] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Cumby, Nichole; Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Cumby, Nichole] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Gulak, PG (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.; Maxwell, KL (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.	gulak@eecg.toronto.edu; karen.maxwell@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480	Canadian Institutes of Health Research (CIHR) [MOP-62796, XNE86943]; NSERC [RGPIN -36580-09]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Canadian Institutes of Health Research (CIHR) operating grant to KLM (MOP-62796), a CIHR Emerging Team Grant to KLM and PGG (XNE86943) and an NSERC grant to PGG (RGPIN -36580-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, CLIN MICROBIOL REV, V27, P631, DOI 10.1128/CMR.00120-13; Baffone W, 2003, INT J FOOD MICROBIOL, V89, P31, DOI 10.1016/S0168-1605(03)00102-8; Bakker E, 2002, ANAL CHEM, V74, p420A, DOI 10.1021/ac022086f; Bausells J, 1999, SENSORS ACTUATORS B, V57; BENEDETTI H, 1991, J MOL BIOL, V217, P429, DOI 10.1016/0022-2836(91)90747-T; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; BOURDINEAUD JP, 1990, P NATL ACAD SCI USA, V87, P1037, DOI 10.1073/pnas.87.3.1037; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; CDC, 2013, ANTIBIOTIC RESISTANC; Chan KY, 2013, BIOSENS BIOELECTRON, V41, P532, DOI 10.1016/j.bios.2012.09.016; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; de la Rica R, 2009, ANAL CHEM, V81, P3830, DOI 10.1021/ac9001854; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gasparyan VK, 2013, ANAL CHIM ACTA, V766, P83, DOI 10.1016/j.aca.2012.12.015; Glynn Barry, 2006, V345, P97; Hu JB, 2016, TRAC-TREND ANAL CHEM, V76, P102, DOI 10.1016/j.trac.2015.11.004; Joung CK, 2013, BIOSENS BIOELECTRON, V44, P210, DOI 10.1016/j.bios.2013.01.024; Lai CZ, 2009, J SOLID STATE ELECTR, V13, P123, DOI 10.1007/s10008-008-0579-2; Ligler FS, 2007, ANAL SCI, V23, P5, DOI 10.2116/analsci.23.5; Maalouf R, 2007, ANAL CHEM, V79, P4879, DOI 10.1021/ac070085n; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Michalska AJ, 2004, ANAL CHEM, V76, P2031, DOI 10.1021/ac0353132; MOSS SD, 1975, ANAL CHEM, V47, P2238, DOI 10.1021/ac60363a005; Mouffouk F, 2011, BIOSENS BIOELECTRON, V26, P3517, DOI 10.1016/j.bios.2011.01.037; Narsaiah K, 2012, J FOOD SCI TECH MYS, V49, P383, DOI 10.1007/s13197-011-0437-6; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Ohk SH, 2013, FOOD MICROBIOL, V33, P166, DOI 10.1016/j.fm.2012.09.013; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2620, DOI 10.1128/AEM.61.7.2620-2623.1995; Pitt TL, METHODS MOL BIOL, P5; PRESSLER U, 1986, J BIOL CHEM, V261, P2654; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Summers WC, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P5; Tripathi SM, 2012, BIOSENS BIOELECTRON, V35, P308, DOI 10.1016/j.bios.2012.03.006; WENDT L, 1970, J BACTERIOL, V104, P1236, DOI 10.1128/JB.104.3.1236-1241.1970; World Health Organization, 2004, WORLD HLTH REP 2004; Zourob Mohammed, 2008, P139, DOI 10.1007/978-0-387-75113-9_8	38	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162438	10.1371/journal.pone.0162438	http://dx.doi.org/10.1371/journal.pone.0162438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618185	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100024
J	Sharma, P; Dahiya, S; Balaji, V; Kanga, A; Panda, P; Das, R; Dhanraju, A; Mendiratta, DK; Sood, S; Das, BK; Kapil, A				Sharma, Priyanka; Dahiya, Sushila; Balaji, Veeraraghavan; Kanga, Anil; Panda, Preetilata; Das, Rashna; Dhanraju, Anbumani; Mendiratta, Deepak Kumar; Sood, Seema; Das, Bimal Kumar; Kapil, Arti			Typhoidal Salmonellae: Use of Multi-Locus Sequence Typing to Determine Population Structure	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE; TYPHI; STRAINS; RESISTANCE; DIVERSITY; SEROTYPES; NUMBER; FEVER; INDIA	Enteric fever is an invasive infection predominantly caused by Salmonella enterica serovars Typhi and Paratyphi A. The pathogens have evolved from other nontyphoidal salmonellaeto become invasive and host restricted. Emergence of antimicrobial resistance in typhoidal salmonellae in some countries is a major therapeutic concern as the travelers returning from endemic countries carry resistant strains to non endemic areas. In order to understand the epidemiology and to design disease control strategies molecular typing of the pathogen is very important. We performed Multilocus Sequence Typing (MLST) of 251 S. Typhi and 18 S. Paratyphi strains isolated from enteric fever patients from seven centers across India during 2010-2013 to determine the population structure and prevalence of MLST sequence types in India. MLST analysis revealed the presence of five sequence types (STs) of typhoidal salmonellae in India namely ST1, ST2 and ST3 for S. Typhi and ST85 and ST129 for S. Paratyphi A. S. Typhi strains showed monophyletic lineage and clustered in to 3 Sequence Types-ST1, ST2 and ST3 and S. Paratyphi A isolates segregated in two sequence types ST85 and ST129 respectively. No association was found between antimicrobial susceptibility and sequence types. This study found ST1 as the most prevalent sequence type of S. Typhi in India followed by ST2, which is in concordance with previous studies and MLST database. In addition a rare sequence type ST3 has been found which is reported for the first time from the Indian subcontinent. Amongst S. Paratyphi A, the most common sequence type is ST129 as also reported from other parts of world. This distribution and prevalence suggest the common spread of the sequence types across the globe and these findings can help in understanding the disease distribution.	[Sharma, Priyanka; Dahiya, Sushila; Sood, Seema; Das, Bimal Kumar; Kapil, Arti] All India Inst Med Sci, New Delhi, India; [Balaji, Veeraraghavan] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Kanga, Anil] Indira Gandhi Med Coll, Shimla, India; [Panda, Preetilata] Maharaja Krishna Chandra Gajapati Med Coll, Brahmapur, Orissa, India; [Das, Rashna] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Shillong, Meghalaya, India; [Dhanraju, Anbumani] Sri Ramachandra Med Coll & Res Inst, Madras, Tamil Nadu, India; [Mendiratta, Deepak Kumar] Mahatma Gandhi Inst Med Sci, Wardha, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Christian Medical College & Hospital (CMCH) Vellore; Indira Gandhi Medical College & Hospital Shimla; North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS); Sri Ramachandra Institute of Higher Education & Research; Mahatma Gandhi Institute of Medical Sciences, Sevagram	Kapil, A (corresponding author), All India Inst Med Sci, New Delhi, India.	akapilmicro@gmail.com	Dahiya, Sushila/GOG-9170-2022	Veeraraghavan, Balaji/0000-0002-8662-4257; Sharma, priyanka/0000-0002-8853-1126	ICMR (Indian Council of Medical Research), India [5/3/3/13/2008-ECD I]	ICMR (Indian Council of Medical Research), India(Indian Council of Medical Research (ICMR))	The study was funded by ICMR (Indian Council of Medical Research), India, Grant No: 5/3/3/13/2008-ECD I, URL:http://www.icmr.nic.in/.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Capoor Malini R., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1170; Clinical and Laboratory Standards Institute, 2015, M10025 CLSI S; Collee JG, 1996, MACKIE MCCARTNEY PRA; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Dahiya S, 2013, INDIAN J MED RES, V137, P957; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gokul BN, 2010, EMERG INFECT DIS, V16, P1170, DOI 10.3201/eid1607.091643; Grimont PA, 2007, ANTIGENIC FORMULAE S, V9th; Kadhiravan T, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-37; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; Martinez-Gamboa A, 2015, INT MICROBIOL, V18, P99, DOI 10.2436/20.1501.01.239; Mohanty S, 2006, EPIDEMIOL INFECT, V134, P961, DOI 10.1017/S0950268805005844; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nusch-Inderbinen M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0948-2; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Renuka K, 2004, MICROB DRUG RESIST, V10, P146, DOI 10.1089/1076629041310028; Sabat AJ, 2013, EUROSURVEILLANCE, V24, P18; Saikia KK, 2011, INDIAN J MED MICROBI, V29, P158, DOI 10.4103/0255-0857.81800; Saikia KK, 2012, INDIAN J MED RES, V136, P855; Sankar S, 2013, MOL DIAGN THER, V17, P257, DOI 10.1007/s40291-013-0034-7; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Zhang HF, 2011, CROAT MED J, V52, P688, DOI 10.3325/cmj.2011.52.688	32	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162530	10.1371/journal.pone.0162530	http://dx.doi.org/10.1371/journal.pone.0162530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618626	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100028
J	Song, QJ; Weng, XG; Cai, DJ; Zhang, W; Wang, JF				Song, Quan-Jiang; Weng, Xiao-Gang; Cai, Dong-Jie; Zhang, Wang; Wang, Jiu-Feng			Forsythoside A Inhibits BVDV Replication via TRAF2-Dependent CD28-4-1BB Signaling in Bovine PBMCs	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; T-CELL FUNCTION; CYTOKINE RESPONSES; FAMILY-MEMBERS; TNFR FAMILY; 4-1BB; COSTIMULATION; ACTIVATION; INFECTION; CALVES	Bovine viral diarrhea virus (BVDV), the causative agent of bovine viral diarrhea/mucosal disease (BVD/MD), is an important pathogen of cattle and other wild animals throughout the world. BVDV infection typically leads to an impaired immune response in cattle. In the present study, we investigated the effect of Forsythoside A (FTA) on BVDV infection of bovine peripheral blood mononuclear cells (PBMCs). We found that Forsythoside A could not only promote proliferation of PBMCs and T cells activation but also inhibit the replication of BVDV as well as apoptosis induced by BVDV. FTA treatment could counteract the BVDV-induced overproduction of IFN-gamma to maintain the immune homeostasis in bovine PBMCs. At same time, FTA can enhance the secretion of IL-2. What's more, BVDV promotes the expression of CD28, 4-1BB and TRAF-2, which can be modulated by FTA. Our data suggest that FTA protects PBMCs from BVDV infection possibly via TRAF2-dependent CD28-4-1BB signaling, which may activate PBMCs in response to BVDV infection. Therefore, this aids in the development of an effective adjuvant for vaccines against BVDV and other specific FTA-based therapies for preventing BVDV infection.	[Song, Quan-Jiang; Cai, Dong-Jie; Zhang, Wang; Wang, Jiu-Feng] China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China; [Weng, Xiao-Gang] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China	China Agricultural University; Northeast Agricultural University - China	Wang, JF (corresponding author), China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China.	jiufeng_wang@hotmail.com						Aschermann S, 2010, CLIN EXP IMMUNOL, V160, P161, DOI 10.1111/j.1365-2249.2009.04081.x; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Beyersdorf N, 2015, IMMUNOTARGETS THER, V4, P111, DOI 10.2147/ITT.S61647; Biburger M, 2014, ADV IMMUNOL, V124, P67, DOI 10.1016/B978-0-12-800147-9.00003-0; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Brodersen BW, 1999, VIRAL IMMUNOL, V12, P323, DOI 10.1089/vim.1999.12.323; Cao JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077922; Chase CCL, 2013, BIOLOGICALS, V41, P52, DOI 10.1016/j.biologicals.2012.09.009; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng L, 2015, INT IMMUNOPHARMACOL, V28, P494, DOI 10.1016/j.intimp.2015.07.011; Cho HC, 2015, GUT LIVER; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dawicki W, 2004, J IMMUNOL, V173, P5944, DOI 10.4049/jimmunol.173.10.5944; Degen Winfried G J, 2003, Expert Rev Vaccines, V2, P327, DOI 10.1586/14760584.2.2.327; Dumitriu IE, 2012, CIRC RES, V110, P857, DOI 10.1161/CIRCRESAHA.111.261933; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Glew EJ, 2003, J GEN VIROL, V84, P1771, DOI 10.1099/vir.0.18964-0; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Hirao LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024250; Hou L, 1998, VIRAL IMMUNOL, V11, P233, DOI 10.1089/vim.1998.11.233; HOUE H, 1995, VET CLIN N AM-FOOD A, V11, P521, DOI 10.1016/S0749-0720(15)30465-5; Huang CK, 2014, NEUROCHEM RES, V40, P1; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Karcher EL, 2008, VET IMMUNOL IMMUNOP, V124, P50, DOI 10.1016/j.vetimm.2008.01.006; Ko HC, 2005, J ETHNOPHARMACOL, V102, P418, DOI 10.1016/j.jep.2005.06.029; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li HW, 2011, PHYTOTHER RES, V25, P338, DOI 10.1002/ptr.3260; Lim HS, 2015, J IMMUNOL, V195, P5432, DOI 10.4049/jimmunol.1500707; Lin FC, 2014, CYTOKINE GROWTH F R, V25, P369, DOI 10.1016/j.cytogfr.2014.07.015; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Martinez-Forero I, 2013, J IMMUNOL, V190, P6694, DOI 10.4049/jimmunol.1203010; Mbanwi AN, 2014, SEMIN IMMUNOL, V26, P210, DOI 10.1016/j.smim.2014.05.001; McPherson AJ, 2012, J BIOL CHEM, V287, P23010, DOI 10.1074/jbc.M112.350538; Nobuhiro N, 2009, PLOS PATHOG, V5, P15332; Oh HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126765; Palomares RA, 2014, VET RES COMMUN, V38, P329, DOI 10.1007/s11259-014-9613-2; Pedrera M, 2009, J COMP PATHOL, V141, P52, DOI 10.1016/j.jcpa.2009.03.004; Polak MP, 2000, COMP IMMUNOL MICROB, V23, P141, DOI 10.1016/S0147-9571(99)00060-0; POTGIETER LND, 1995, VET CLIN N AM-FOOD A, V11, P501, DOI 10.1016/S0749-0720(15)30464-3; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Rhodes SG, 1999, J GEN VIROL, V80, P1673, DOI 10.1099/0022-1317-80-7-1673; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Ridpath JF, 2006, VIRUS RES, V118, P62, DOI 10.1016/j.virusres.2005.11.014; Ridpath JF, 2013, BIOLOGICALS, V41, P14, DOI 10.1016/j.biologicals.2012.07.003; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Sercan O, 2010, J IMMUNOL, V184, P2855, DOI 10.4049/jimmunol.0902708; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Turin L, 2012, J VET MED SCI, V74, P1397, DOI 10.1292/jvms.12-0011; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wang XF, 2013, J VIRAL HEPATITIS, V20, P27, DOI 10.1111/jvh.12061; Whitmire JK, 2007, J IMMUNOL, V179, P1190, DOI 10.4049/jimmunol.179.2.1190; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Zhang FJ, 2014, J ANIM SCI, V92, P3026, DOI 10.2527/jas.2013-6932; Zhang G, 1996, J GEN VIROL, V77, P1677, DOI 10.1099/0022-1317-77-8-1677; Zhuge ZY, 2010, PLOS ONE, V7, P1	64	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162791	10.1371/journal.pone.0162791	http://dx.doi.org/10.1371/journal.pone.0162791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617959	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100053
J	Abubakari, A; Jahn, A				Abubakari, Abdulai; Jahn, Albrecht			Maternal Dietary Patterns and Practices and Birth Weight in Northern Ghana	PLOS ONE			English	Article							CHILD UNDERNUTRITION; PREGNANT-WOMEN; MICRONUTRIENTS; ASSOCIATION; ORIGINS; DISEASE; HEALTH	Background Adequate maternal nutrition is a key factor for achieving good pregnancy outcomes. Moreover, inadequate dietary intake during pregnancy is considered an important contributor to maternal malnutrition in developing countries. Although some studies have examined the effect of the entire diet on birth outcome, most studies have been very narrow because they considered the effect of single nutrient. The single nutrient approach is a major setback because usually several nutrient deficiencies are more likely to occur than single deficiencies especially in low-income settings. Objectives The main aim of this study was to investigate the association between maternal dietary patterns, and practices and birth weight in Northern Ghana. Participant Settings A facility-based cross-sectional survey was performed in two districts in the Northern Region of Ghana. The selected districts were the Tamale Metropolis and Savelugu-Nanton District. These districts were purposively sampled to represent a mix of urban, peri-urban and rural populations, therefore ensuring that the distribution in social groups of the study population was similar to the entire population of the region. In all, 578 mothers who were drawing antenatal and postnatal care services were interviewed using a questionnaire, which asked the mothers about their frequency of consumption of individual foods per week since they became pregnant or when they were pregnant. Statistical Analysis We determined dietary patterns by applying a factor analysis with a varimax rotation using STATA. Multivariate analysis was used to establish association between maternal factors and dietary patterns. Logistic regression was used to assess the association between dietary practices and patterns and birth weight. Results Women who ate outside the home twice a week (OR = 1.6 & 95% CI; 1.1-2.45, P; 0.017) and those who practiced 'pica' (OR = 1.7 & 95% CI; 1.16-2.75, P; 0.008) had increased odds for low birth. Two dietary patterns were identified-namely 'health conscious' and 'non-health conscious'. Health conscious diet (OR = 0.23 95% CI 0.12-0.45 per standard deviation change in scores, P; < 0.0001) and dietary diversity score (OR = 0.10 95% CI 0.04-0.13 per standard deviation change in scores, P; < 0.0001) showed a protective effect for low birth weight respectively after adjusting for gestational age. Conclusion Mothers who practiced good nutrition such as consuming foods across and within the various food groups were less likely to have low birth weight babies. Our findings buttress the importance of optimal nutrition during pregnancy.	[Abubakari, Abdulai] Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana; [Abubakari, Abdulai; Jahn, Albrecht] Heidelberg Univ, Inst Publ Hlth, Fac Med, Heidelberg, Germany	University for Development Studies; Ruprecht Karls University Heidelberg	Abubakari, A (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana.; Abubakari, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Fac Med, Heidelberg, Germany.	abubakariabdulai@yahoo.com		Abubakari, Abdulai/0000-0002-7906-9419				Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Abubakari A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135641; Addo AA, 2006, AFR NUTR EP C 15 18; Ahmad Muhammad Owais, 2011, J Ayub Med Coll Abbottabad, V23, P77; Ali Fatima, 2014, J Ayub Med Coll Abbottabad, V26, P506; Annan R. A., 2015, African Journal of Food, Agriculture, Nutrition and Development, V15, P9838; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arkkola T, 2008, PUBLIC HEALTH NUTR, V11, P176, DOI 10.1017/S1368980007000420; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Black RE, 2001, BRIT J NUTR, V85, pS193, DOI 10.1079/BJN2000314; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Colon-Ramos U, 2015, NUTRIENTS, V7, P1318, DOI 10.3390/nu7021318; Cuco G, 2006, EUR J CLIN NUTR, V60, P364, DOI 10.1038/sj.ejcn.1602324; Dixon LB, 2008, J AM DIET ASSOC, V108, P1837, DOI 10.1016/j.jada.2008.08.020; Fall CHD, 2003, J NUTR, V133, p1747S, DOI 10.1093/jn/133.5.1747S; FAO, 2012, GUID MEAS HOUS IND D; FAO & WHO, 1996, PREP US FOOD BAS DIE; Federman D G, 1997, Conn Med, V61, P207; Ghana Demographic and Health Survey, 2010, STUD FAMILY PLANN, V41, P307; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Godfrey K M, 2001, Public Health Nutr, V4, P611; Haider BA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S19; Hanley B, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003338; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Institute of Medicine (IOM), 1990, NUTR PREGN 1; Khoushabi F, 2014, OPEN J OBSTET GYNECO, V2014, DOI [10.4236/ojog.2014.411090, DOI 10.4236/OJOG.2014.411090]; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; Kish L, 1965, SURVEY SAMPLING; Knudsen VK, 2008, EUR J CLIN NUTR, V62, P463, DOI 10.1038/sj.ejcn.1602745; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Lee SE, 2013, PUBLIC HEALTH NUTR, V16, P1340, DOI 10.1017/S1368980012004417; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Northstone K, 2008, EUR J CLIN NUTR, V62, P931, DOI 10.1038/sj.ejcn.1602789; Nti Christina A, 2008, Nutr Res Pract, V2, P35, DOI 10.4162/nrp.2008.2.1.35; Quarshie K, 2006, AFR NUTR EP C 2006 1; Rainville AJ, 1998, J AM DIET ASSOC, V98, P293, DOI 10.1016/S0002-8223(98)00069-8; Ramlal RT, 2015, NUTRIENTS, V7, P584, DOI 10.3390/nu7010584; Rasmussen KM, 2010, OBSTET GYNECOL, V116, P1191, DOI 10.1097/AOG.0b013e3181f60da7; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Rush D, 2001, J Health Popul Nutr, V19, pS217; Saaka M, 2012, INT J CHILD HEALTH N, V1, P148, DOI 10.6000/1929-4247.2012.01.02.6; The Vanuatu National Statistics Office, 2009, NAT POP HOUS CENS AN, V2; Thompson JMD, 2010, BRIT J NUTR, V103, P1665, DOI 10.1017/S0007114509993606; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2010, INT STAT CLASS DIS R; Wolff Cindy Brattan, 1995, Nutrition and Health (Bicester), V10, P121; World Bank and International Monetry Fund, 2012, FOOD PRIC NUTR MILL	52	38	40	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162285	10.1371/journal.pone.0162285	http://dx.doi.org/10.1371/journal.pone.0162285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611597	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900073
J	Adachi, S; Nakano, H; Odajima, H; Motomura, C; Yoshioka, Y				Adachi, Satoshi; Nakano, Hiroshi; Odajima, Hiroshi; Motomura, Chikako; Yoshioka, Yukiko			Lung Sounds in Children before and after Respiratory Physical Therapy for Right Middle Lobe Atelectasis	PLOS ONE			English	Article								Background Chest auscultation is commonly performed during respiratory physical therapy (RPT). However, the changes in breath sounds in children with atelectasis have not been previously reported. The aim of this study was to clarify the characteristics of breath sounds in children with atelectasis using acoustic measurements. Method The subjects of this study were 13 children with right middle lobe atelectasis (3-7 years) and 14 healthy children (3-7 years). Lung sounds at the bilateral fifth intercostal spaces on the midclavicular line were recorded. The right-to-left ratio (R/L ratio) and the expiration to inspiration ratio (E/I ratio) of the breath sound sound pressure were calculated separately for three octave bands (100-200 Hz, 200-400 Hz, and 400-800 Hz). These data were then compared between the atelectasis and control groups. In addition, the same measurements were repeated after treatment, including RPT, in the atelectasis group. Result Before treatment, the inspiratory R/L ratios for all the frequency bands were significantly lower in the atelectasis group than in the control group, and the E/I ratios for all the frequency bands were significantly higher in the atelectasis group than in the control group. After treatment, the inspiratory R/L ratios of the atelectasis group did not increase significantly, but the E/I ratios decreased for all the frequency bands and became similar to those of the control group. Conclusion Breath sound attenuation in the atelectatic area remained unchanged even after radiographical resolution, suggesting a continued decrease in local ventilation. On the other hand, the elevated E/I ratio for the atelectatic area was normalized after treatment. Therefore, the differences between inspiratory and expiration sound intensities may be an important marker of atelectatic improvement in children.	[Adachi, Satoshi; Yoshioka, Yukiko] Fukuoka Natl Hosp, Natl Hosp Org, Dept Rehabil, Fukuoka, Japan; [Nakano, Hiroshi] Fukuoka Natl Hosp, Natl Hosp Org, Dept Pulmonol, Fukuoka, Japan; [Odajima, Hiroshi; Motomura, Chikako] Fukuoka Natl Hosp, Natl Hosp Org, Dept Pediat, Fukuoka, Japan		Adachi, S (corresponding author), Fukuoka Natl Hosp, Natl Hosp Org, Dept Rehabil, Fukuoka, Japan.	fadachi@csf.ne.jp						Adachi S, 2010, JAPANESE J PEDIAT IN, V8, P17; BILLIG DM, 1972, AM J DIS CHILD, V123, P96, DOI 10.1001/archpedi.1972.02110080074002; Collins J, 2007, CHEST RADIOLOGY ESSE, P156; Ellermeier W, 2001, J ACOUST SOC AM, V109, P1464, DOI 10.1121/1.1350402; GAVRIELY N, 1994, EUR RESPIR J, V7, P35, DOI 10.1183/09031936.94.07010035; JESTEADT W, 1977, J ACOUST SOC AM, V61, P169, DOI 10.1121/1.381278; KRAMAN SS, 1983, AM REV RESPIR DIS, V128, P622; Marques A, 2014, RESP CARE, V59, P765, DOI 10.4187/respcare.02765; Nakano H, 1994, Nihon Kyobu Shikkan Gakkai Zasshi, V32, P1142; Pasterkamp H, 1997, MED BIOL ENG COMPUT, V35, P103, DOI 10.1007/BF02534138; Pasterkamp H, 1996, AM J RESP CRIT CARE, V153, P1087, DOI 10.1164/ajrccm.153.3.8630549; PLOYSONGSANG Y, 1982, AM REV RESPIR DIS, V126, P413; REDDING GJ, 1984, PEDIATR CLIN N AM, V31, P891; Rossi M, 2000, EUR RESPIR REV, V10, P611; Sekerel BE, 2004, J ASTHMA, V41, P411, DOI 10.1081/JAS-120033983; Shirota K, 2001, CLIN PHARM THERAPY, V11, P377; SHYKOFF BE, 1988, AM REV RESPIR DIS, V137, P872, DOI 10.1164/ajrccm/137.4.872; Sovijarvi A., 2000, EUR RESP REV, V10, P597; Sovijû±rvi ARA., 2000, EUR RESPIR REV, V10, P591	19	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162538	10.1371/journal.pone.0162538	http://dx.doi.org/10.1371/journal.pone.0162538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611433	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900124
J	Dunning, J; Kennedy, SB; Antierens, A; Whitehead, J; Ciglenecki, I; Carson, G; Kanapathipillai, R; Castle, L; Howell-Jones, R; Pardinaz-Solis, R; Grove, J; Scott, J; Lang, T; Olliaro, P; Horby, PW				Dunning, Jake; Kennedy, Stephen B.; Antierens, Annick; Whitehead, John; Ciglenecki, Iza; Carson, Gail; Kanapathipillai, Rupa; Castle, Lyndsey; Howell-Jones, Rebecca; Pardinaz-Solis, Raul; Grove, Jennifer; Scott, Janet; Lang, Trudie; Olliaro, Piero; Horby, Peter W.		RAPIDE-BCV Trial Team	Experimental Treatment of Ebola Virus Disease with Brincidofovir	PLOS ONE			English	Article							CMX001; INFECTIONS; EFFICACY	Background The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be prioritised for clinical evaluation in patients with Ebola virus disease (EVD) during the West African epidemic. Methods and Findings In this single-armphase 2 trial conducted in Liberia, patients with laboratory-confirmed EVD (two months of age or older, enrolment bodyweight >= 50 kg) received oral brincidofovir 200 mg as a loading dose on day 0, followed by 100 mg brincidofovir on days 3, 7, 10, and 14. Bodyweight-adjusted dosing was used for patients weighing <50 kg at enrolment. The primary outcome was survival at Day 14 after the first dose of brincidofovir. Four patients were enrolled between 01 January 2015 and 31 January 2015. The trial was stopped following the decision by the manufacturer to terminate their program of development of brincidofovir for EVD. No Serious Adverse Reactions or Suspected Unexpected Serious Adverse Reactions were identified. All enrolled subjects died of an illness consistent with EVD. Conclusions Due to the small sample size it was not possible to determine the efficacy of brincidofovir for the treatment of EVD. The premature termination of the trial highlights the need to establish better practices for preclinical in-vitro and animal screening of therapeutics for potentially emerging epidemic infectious diseases prior to their use in patients.	[Dunning, Jake; Carson, Gail; Castle, Lyndsey; Howell-Jones, Rebecca; Pardinaz-Solis, Raul; Grove, Jennifer; Lang, Trudie; Olliaro, Piero; Horby, Peter W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Kennedy, Stephen B.] Univ Liberia, PIRE, Africa Ctr, Monrovia, Liberia; [Antierens, Annick; Kanapathipillai, Rupa] Med Sans Frontieres, Operat Ctr, Brussels, Belgium; [Whitehead, John] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Ciglenecki, Iza] Med Sans Frontieres, Operat Ctr, Geneva, Switzerland; [Scott, Janet] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Olliaro, Piero] UNICEF, UNDP, World Bank, WHO Special Programme Res & Training Trop Dis, Geneva, Switzerland	University of Oxford; Doctors Without Borders; Lancaster University; Doctors Without Borders; University of Liverpool; The World Bank; World Health Organization	Horby, PW (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	peter.horby@ndm.ox.ac.uk	Dunning, Jake/U-7181-2019; Scott, Janet T/K-3769-2013; Leligdowicz, Aleksandra/Q-2494-2016	Dunning, Jake/0000-0002-4035-4562; Horby, Peter/0000-0002-9822-1586; Castle, Lyndsey/0000-0002-9756-6064; Scott, Janet/0000-0001-8030-5223; Lang, Trudie/0000-0003-2273-5975; Merson, Laura/0000-0002-4168-1960; Leligdowicz, Aleksandra/0000-0001-6055-4644	Wellcome Trust of Great Britain [106491/Z/14/Z, 089275/Z/09/Z]; EU FP7 project PREPARE [602525]; Medical Research Council [MC_PC_15001] Funding Source: researchfish; MRC [MC_UU_12014/8, MC_PC_15001] Funding Source: UKRI	Wellcome Trust of Great Britain(Wellcome Trust); EU FP7 project PREPARE; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust of Great Britain (grant number 106491/Z/14/Z and 089275/Z/09/Z) and by the EU FP7 project PREPARE (602525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Barry M, 2015, CLIN INFECT DIS, V60, P1821, DOI 10.1093/cid/civ202; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Chimerix I, 2015, CHIMERIX FOCUSING EF; Cooper B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001815; Fitzpatrick G, 2015, J INFECT DIS, DOI [10.1093/infdis/jiv304, DOI 10.1093/INFDIS/JIV304PMID:26002981]; Florescu DF, 2015, CLIN INFECT DIS, V61, P969, DOI 10.1093/cid/civ395; Florescu DF, 2014, EXPERT REV ANTI-INFE, V12, P1171, DOI 10.1586/14787210.2014.948847; Florescu DF, 2012, BIOL BLOOD MARROW TR, V18, P731, DOI 10.1016/j.bbmt.2011.09.007; Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334; Lanier R, 2010, VIRUSES-BASEL, V2, P2740, DOI 10.3390/v2122740; Liddell AM, 2015, ANN INTERN MED, V163, P81, DOI 10.7326/M15-0530; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Magee WC, 2005, ANTIMICROB AGENTS CH, V49, P3153, DOI 10.1128/AAC.49.8.3153-3162.2005; Marty FM, 2013, NEW ENGL J MED, V369, P1227, DOI 10.1056/NEJMoa1303688; McMullan LK, 2016, ANTIVIR RES, V125, P71, DOI 10.1016/j.antiviral.2015.10.010; Painter W, 2012, ANTIMICROB AGENTS CH, V56, P2726, DOI 10.1128/AAC.05983-11; Qin EQ, 2015, CLIN INFECT DIS, V61, P491, DOI 10.1093/cid/civ319; Qureshi Adnan I, 2015, J Vasc Interv Neurol, V8, pS4; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Trost LC, 2015, ANTIVIR RES, V117, P115, DOI 10.1016/j.antiviral.2015.02.007; WHO, 2016, PONT EB THER VACC 20; World Health Organization, CAT PRIOR DRUGS CONS	23	60	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162199	10.1371/journal.pone.0162199	http://dx.doi.org/10.1371/journal.pone.0162199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611077	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000383255900056
J	Guensch, DP; Yu, J; Nadeshalingam, G; Fischer, K; Shearer, J; Friedrich, MG				Guensch, Dominik P.; Yu, Janelle; Nadeshalingam, Gobinath; Fischer, Kady; Shearer, Jane; Friedrich, Matthias G.			Evidence for Acute Myocardial and Skeletal Muscle Injury after Serial Transthoracic Shocks in Healthy Swine	PLOS ONE			English	Article							ACID-BINDING PROTEIN; CARDIOVASCULAR-MAGNETIC-RESONANCE; DEFIBRILLATION; RECOVERY; ELECTROPORATION; CARDIOVERSION; MEMBRANE	Background Previous serological studies have shown controversial results whether defibrillation or cardioversion can cause myocardial injury. Cardiovascular Magnetic Resonance (CMR) can be used to detect myocardial edema, hyperemia and capillary leak as features of acute myocardial injury. The aim of this study was to assess for myocardial and skeletal muscle injury in swine following transthoracic shocks. Methods Seventeen anaesthetized swine were examined, with 11 undergoing five synchronized transthoracic shocks (200J). Myocardial and skeletal muscle injury were assessed at baseline and up to 5h post-shock employing T1 mapping, T2 mapping, early and late gadolinium enhancement. Serologic markers (cFABP, TnI, CK, and CK-MB) and myocardial tissue were assessed by standard histology methods. Results In myocardial regions within the shock path, T1 and T2 were significantly increased compared to remote myocardium in the same animals. The early gadolinium enhancement ratio between the left-ventricular myocardium and the right pectoral muscle was also increased compared to control animals. After the shocks cFABP and CK were significantly elevated. After shock application, the regions identified as abnormal by CMR showed significantly increased interstitial and myocardial cell areas in histological analysis. This increased cell area suggests significant cellular and interstitial edema. Conclusion Our pilot study data indicate that serial defibrillator shocks lead to acute skeletal muscle and myocardial injury. CMR is a useful tool to detect and localize myocardial and skeletal muscle injury early after transthoracic shocks in vivo. In the future the technique could potentially be used as an additional tool for quality control such as verifying insufficient local shock application in non-responders after cardioversion or to develop safer shock forms.	[Guensch, Dominik P.; Yu, Janelle; Nadeshalingam, Gobinath; Fischer, Kady; Friedrich, Matthias G.] Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada; [Guensch, Dominik P.; Fischer, Kady] Univ Bern, Univ Hosp Bern, Dept Anaesthesiol & Pain Therapy, Inselspital, Bern, Switzerland; [Guensch, Dominik P.] Univ Bern, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Inselspital, Bern, Switzerland; [Friedrich, Matthias G.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Friedrich, Matthias G.] McGill Univ, Dept Radiol, Montreal, PQ, Canada; [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	Universite de Montreal; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; McGill University; McGill University; University of Calgary	Guensch, DP (corresponding author), Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada.; Guensch, DP (corresponding author), Univ Bern, Univ Hosp Bern, Dept Anaesthesiol & Pain Therapy, Inselspital, Bern, Switzerland.; Guensch, DP (corresponding author), Univ Bern, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Inselspital, Bern, Switzerland.	dominik.guensch@gmail.com	; Friedrich, Matthias/H-8474-2015	Gunsch, Dominik/0000-0003-4127-4086; Friedrich, Matthias/0000-0003-1204-5647; Fischer, Kady/0000-0002-7765-4550	Montreal Heart Institute Foundation; Canadian Foundation for Innovation; Fonds de Recherche Sante Quebec	Montreal Heart Institute Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche Sante Quebec	Funding was provided by the Montreal Heart Institute Foundation, the Canadian Foundation for Innovation and the Fonds de Recherche Sante Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiti MA, 2009, PACE, V32, P800, DOI 10.1111/j.1540-8159.2009.02370.x; Allan JJ, 1997, J AM COLL CARDIOL, V30, P1052, DOI 10.1016/S0735-1097(97)00260-X; Azzazy HME, 2006, CLIN CHEM, V52, P19, DOI 10.1373/clinchem.2005.056143; Berg MD, 2008, PEDIATR CRIT CARE ME, V9, P429, DOI 10.1097/PCC.0b013e318172e9f8; Bunai Yasuo, 2003, Leg Med (Tokyo), V5 Suppl 1, pS302, DOI 10.1016/S1344-6223(02)00156-6; Daidoji H, 2012, J CARD FAIL, V18, P556, DOI 10.1016/j.cardfail.2012.04.006; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; del Rey Sanchez JM, 2002, REV ESP CARDIOL, V55, P227; Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Gissel H, 2005, ANN NY ACAD SCI, V1066, P272, DOI 10.1196/annals.1363.024; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Kellman P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-2; Mazove OL, 2006, KARDIOLOGIYA, V46, P43; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Santos Elizabete Silva dos, 2006, Arq Bras Cardiol, V86, P191; Skulec R, 2006, RESUSCITATION, V70, P423, DOI 10.1016/j.resuscitation.2006.02.003; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; TOVAR O, 1992, AM J PHYSIOL, V263, pH1128, DOI 10.1152/ajpheart.1992.263.4.H1128; Vogel U, 1998, INTENS CARE MED, V24, P743, DOI 10.1007/s001340050656; Wang YT, 2012, AM J PHYSIOL-HEART C, V303, pH439, DOI 10.1152/ajpheart.01121.2011	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162245	10.1371/journal.pone.0162245	http://dx.doi.org/10.1371/journal.pone.0162245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611090	Green Published, gold			2022-12-27	WOS:000383255900069
J	Huang, ZR; Tsai, CL; Huang, YY; Shiue, CY; Tzen, KY; Yen, RF; Hsin, LW				Huang, Zih-Rou; Tsai, Chia-Ling; Huang, Ya-Yao; Shiue, Chyng-Yann; Tzen, Kai-Yuan; Yen, Ruoh-Fang; Hsin, Ling-Wei			A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2	PLOS ONE			English	Article							BETA-CELL MASS; ALPHA-DIHYDROTETRABENAZINE; PARKINSONS-DISEASE; 2 ISOFORMS; RAT-BRAIN; BINDING; VMAT2; PET; RADIOLIGAND; C-11-(+)-ALPHA-DIHYDROTETRABENAZINE	In the early 1990s, 9-(+)-C-11-dihydrotetrabenazine (9-(+)-C-11-DTBZ) was shown to be a useful positron emission tomography (PET) imaging agent for various neurodegenerative disorders. Here, we described the radiosynthesis and evaluation of the 9-(+)-C-11-DTBZ analog, 10-(+)-C-11-DTBZ, as a vesicular monoamine transporter2 (VMAT2) imaging agent and compare it with 9-(+)-C-11-DTBZ. 10-(+)-C-11-DTBZ was obtained by C-11-MeI methylation with its 10 hydroxy precursor in the presence of 5 M NaOH. It had a slightly better average radiochemical yield of 35.3 +/- 3.6% (decay-corrected to end of synthesis (EOS)) than did 9-(+)-C-11-DTBZ (30.5 +/- 2.3%). MicroPET studies showed that 10-(+)-C-11-DTBZ had a striatum-to-cerebellum ratio of 3.74 +/- 0.21 at 40 min post-injection, while the ratio of 9-(+)-C-11-DTBZ was 2.50 +/- 0.33. This indicated that 10-(+)-C-11-DTBZ has a higher specific uptake in VMAT2-rich brain regions, and 10-(+)-C-11-DTBZ may be a potential VMAT2 radioligand. Our experiment is the first study of 10-(+)-C-11-DTBZ to include dynamic brain distribution in rat brains.	[Huang, Zih-Rou; Hsin, Ling-Wei] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Tsai, Chia-Ling; Huang, Ya-Yao; Shiue, Chyng-Yann; Tzen, Kai-Yuan; Yen, Ruoh-Fang] Natl Taiwan Univ Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan; [Shiue, Chyng-Yann; Yen, Ruoh-Fang; Hsin, Ling-Wei] Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan; [Shiue, Chyng-Yann] Triserv Gen Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan; [Hsin, Ling-Wei] Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Tri-Service General Hospital; National Taiwan University	Hsin, LW (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan.	lwhsin@ntu.edu.tw	Huang, Ya-Yao/AAR-9221-2020	Huang, Ya-Yao/0000-0002-3460-7922; YEN, RUOH-FANG/0000-0003-1648-6482; TZEN, KAI-YUAN/0000-0002-5657-8579	 [NSC98-2320-B-002-028-MY3]		Support was provided by NSC98-2320-B-002-028-MY3.	Anlauf M, 2003, J HISTOCHEM CYTOCHEM, V51, P1027, DOI 10.1177/002215540305100806; Blesa J, 2010, NEUROBIOL DIS, V38, P456, DOI 10.1016/j.nbd.2010.03.006; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Boileau I, 2010, SYNAPSE, V64, P417, DOI 10.1002/syn.20743; Chang CC, 2015, EUR J NEUROL, V22, P845, DOI 10.1111/ene.12672; Chen JJ, 2012, CLIN THER, V34, P1487, DOI 10.1016/j.clinthera.2012.06.010; Collantes M, 2008, REV ESP MED NUCL, V27, P103; DASILVA JN, 1993, APPL RADIAT ISOTOPES, V44, P1487, DOI 10.1016/0969-8043(93)90103-H; Deng AF, 2014, AAPS J, V16, P592, DOI 10.1208/s12248-014-9584-9; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Freyberg Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10652; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; Harris PE, 2008, J MOL MED, V86, P5, DOI 10.1007/s00109-007-0242-x; KILBOURN M, 1995, EUR J PHARMACOL, V278, P249, DOI 10.1016/0014-2999(95)00162-E; Kilbourn MR, 2010, NUCL MED BIOL, V37, P869, DOI 10.1016/j.nucmedbio.2010.06.001; Kilbourn MR, 2010, NUCL MED BIOL, V37, P3, DOI 10.1016/j.nucmedbio.2009.08.013; Kilbourn MR, 2004, NUCL MED BIOL, V31, P591, DOI 10.1016/j.nucmedbio.2004.02.003; Koeppe RA, 2005, J NUCL MED, V46, P936; Koeppe RA, 1999, J CEREBR BLOOD F MET, V19, P1376, DOI 10.1097/00004647-199912000-00011; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; Kumar A, 2014, BIOORG MED CHEM LETT, V24, P5663, DOI 10.1016/j.bmcl.2014.10.070; Li XM, 2014, ARCH PHARM, V347, P313, DOI 10.1002/ardp.201300307; Penthala NR, 2013, BIOORG MED CHEM LETT, V23, P3342, DOI 10.1016/j.bmcl.2013.03.092; Piel M, 2014, J MED CHEM, V57, P9232, DOI 10.1021/jm5001858; Quincoces G, 2008, REV ESP MED NUCL, V27, P13; Simpson NR, 2006, NUCL MED BIOL, V33, P855, DOI 10.1016/j.nucmedbio.2006.07.002; Singhal T, 2011, MOL IMAGING BIOL, V13, P973, DOI 10.1007/s11307-010-0406-x; Souza F, 2006, J CLIN INVEST, V116, P1506, DOI 10.1172/JCI27645; Tong JC, 2008, SYNAPSE, V62, P873, DOI 10.1002/syn.20573; Zhu L, 2009, BIOORG MED CHEM LETT, V19, P5026, DOI 10.1016/j.bmcl.2009.07.048	30	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161295	10.1371/journal.pone.0161295	http://dx.doi.org/10.1371/journal.pone.0161295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612194	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900015
J	Jang, MK; Lee, S; Jung, MH				Jang, Min-Kyung; Lee, Sunwoo; Jung, Myeong Ho			RNA-Seq Analysis Reveals a Negative Role of KLF16 in Adipogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ADIPOCYTE DIFFERENTIATION; GAMMA EXPRESSION; FAMILY	In this study, we performed high throughput RNA sequencing at the preadipocyte (D0) and differentiated adipocyte (D7) stages of primary brown preadipocyte differentiation in order to characterize the transcriptional events regulating differentiation and function. Compared to the preadipocyte stage (D0), 6,668 genes were identified as differentially expressed genes (DEGs) with a fold change of >= 2.0 at the differentiated adipocyte stage (D7). Several adipogenic genes including peroxisome proliferator-activated receptor-gamma (PPAR.) and CCAAT/enhancer-binding protein-alpha (C/EBP alpha), and Kruppel-like factor (KLF) family genes were differentially expressed at D0 and D7. Since KLF16 gene expression was downregulated at day 7 and its adipogenic function has not been characterized, we investigated its role in adipogenesis. Knockdown of KLF16 stimulated the differentiation of both brown and 3T3-L1 preadipocytes, and led to increased PPAR. expression. However, overexpression of KLF16 had opposite effects. Furthermore, KLF16 downregulated PPAR. expression in brown adipocytes and inhibited its promoter activity. These results indicate that KLF16 inhibits adipogenesis through downregulation of PPAR. expression.	[Jang, Min-Kyung; Jung, Myeong Ho] Pusan Natl Univ, Sch Korean Med, Div Longev & Biofunct Med, Yangsan, Gyeongnam, South Korea; [Lee, Sunwoo] GenomicWorks, Daejeon, South Korea	Pusan National University	Jung, MH (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Longev & Biofunct Med, Yangsan, Gyeongnam, South Korea.	jung0603@pusan.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C1310]; GenomicWorks	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; GenomicWorks	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1310). GenomicWorks provided support in the form of salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Brey CW, 2009, INT J BIOL SCI, V5, P622; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Jang MK, 2014, BIOCHEM BIOPH RES CO, V454, P58, DOI 10.1016/j.bbrc.2014.10.028; Kimura H, 2014, GENE, V534, P169, DOI 10.1016/j.gene.2013.10.065; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Yao YX, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003295; Zhang ZW, 2013, ACTA BIOCH BIOPH SIN, V45, P280, DOI 10.1093/abbs/gmt010	17	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162238	10.1371/journal.pone.0162238	http://dx.doi.org/10.1371/journal.pone.0162238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611969	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900065
J	Kim, DK; Beaven, MA; Kulinski, JM; Desai, A; Bandara, G; Bai, Y; Prussin, C; Schwartz, LB; Komarow, H; Metcalfe, DD; Olivera, A				Kim, Do-Kyun; Beaven, Michael A.; Kulinski, Joseph M.; Desai, Avanti; Bandara, Geethani; Bai, Yun; Prussin, Calman; Schwartz, Lawrence B.; Komarow, Hirsh; Metcalfe, Dean D.; Olivera, Ana			Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis	PLOS ONE			English	Article							FC-EPSILON-RI; PARKINSONS-DISEASE; MAST-CELLS; DIAGNOSTIC-CRITERIA; OXIDATIVE DAMAGE; CANCER-CELLS; ROS; ACTIVATION; STRESS; MUTATION	Neoplastic accumulation of mast cells in systemic mastocytosis (SM) associates with activating mutations in the receptor tyrosine kinase KIT. Constitutive activation of tyrosine kinase oncogenes has been linked to imbalances in oxidant/antioxidant mechanisms in other myeloproliferative disorders. However, the impact of KIT mutations on the redox status in SM and the potential therapeutic implications are not well understood. Here, we examined the regulation of reactive oxygen species (ROS) and of the antioxidant protein DJ-1 (PARK-7), which increases with cancer progression and acts to lessen oxidative damage to malignant cells, in relationship with SM severity. ROS levels were increased in both indolent (ISM) and aggressive variants of the disease (ASM). However, while DJ-1 levels were reduced in ISM with lower mast cell burden, they rose in ISM with higher mast cell burden and were significantly elevated in patients with ASM. Studies on mast cell lines revealed that activating KIT mutations induced constant ROS production and consequent DJ-1 oxidation and degradation that could explain the reduced levels of DJ-1 in the ISM population, while IL-6, a cytokine that increases with disease severity, caused a counteracting transcriptional induction of DJ-1 which would protect malignant mast cells from oxidative damage. A mouse model of mastocytosis recapitulated the biphasic changes in DJ-1 and the escalating IL-6, ROS and DJ-1 levels as mast cells accumulate, findings which were reversed with anti-IL-6 receptor blocking antibody. Our findings provide evidence of increased ROS and a biphasic regulation of the antioxidant DJ-1 in variants of SM and implicate IL-6 in DJ-1 induction and expansion of mast cells with KIT mutations. We propose consideration of IL-6 blockade as a potential adjunctive therapy in the treatment of patients with advanced mastocytosis, as it would reduce DJ-1 levels making mutation-positive mast cells vulnerable to oxidative damage.	[Kim, Do-Kyun; Kulinski, Joseph M.; Desai, Avanti; Bandara, Geethani; Bai, Yun; Prussin, Calman; Komarow, Hirsh; Metcalfe, Dean D.; Olivera, Ana] NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Virginia Commonwealth University	Olivera, A (corresponding author), NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ana.olivera@nih.gov			Division of Intramural Research Programs within NIAID, NIH [AI001206]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001206, ZIAAI000249] Funding Source: NIH RePORTER	Division of Intramural Research Programs within NIAID, NIH; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research Programs within NIAID, NIH (AI001206). Dr. Do-Kyun Kim was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1175).	Akin C, 2014, IMMUNOL ALLERGY CLIN, V34, P207, DOI 10.1016/j.iac.2014.02.003; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bauer G, 2014, ANTICANCER RES, V34, P1467; Brockow K, 2005, CLIN IMMUNOL, V115, P216, DOI 10.1016/j.clim.2005.01.011; Brockow K, 2002, J ALLERGY CLIN IMMUN, V109, P82, DOI 10.1067/mai.2002.120524; Brockow K, 2010, CHEM IMMUNOL ALLERGY, V95, P110, DOI 10.1159/000315946; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Chan EC, 2013, EXP HEMATOL, V41, P870, DOI 10.1016/j.exphem.2013.05.005; Chan JYH, 2015, PHARMACOL THERAPEUT, V156, P69, DOI 10.1016/j.pharmthera.2015.09.005; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Demehri S, 2006, EXP HEMATOL, V34, P284, DOI 10.1016/j.exphem.2005.11.015; FRIEDMAN BS, 1989, AM J MED, V87, P649; Gangemi S, 2015, ALLERGY, V70, P436, DOI 10.1111/all.12571; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; GRANERUS G, 1983, J INVEST DERMATOL, V80, P410, DOI 10.1111/1523-1747.ep12555351; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hartmann K, 2013, J ALLERGY CLIN IMMUN, V132, P232, DOI 10.1016/j.jaci.2012.11.008; He XY, 2011, J DIGEST DIS, V12, P131, DOI 10.1111/j.1751-2980.2011.00488.x; Hoermann G, 2014, ALLERGY, V69, P810, DOI 10.1111/all.12409; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Horny HP, 2008, MASTOCYTOSIS; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Jayavelu AK, 2016, LEUKEMIA, V30, P473, DOI 10.1038/leu.2015.234; Kim DK, 2013, J ALLERGY CLIN IMMUN, V131, P1653, DOI 10.1016/j.jaci.2012.10.012; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim SJ, 2012, FREE RADICAL BIO MED, V53, P936, DOI 10.1016/j.freeradbiomed.2012.05.035; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kristensen T, 2013, J MOL DIAGN, V15, P355, DOI 10.1016/j.jmoldx.2012.12.003; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matsui T, 2000, BIOCHEM BIOPH RES CO, V276, P742, DOI 10.1006/bbrc.2000.3545; Mayado A, 2016, LEUKEMIA, V30, P124, DOI 10.1038/leu.2015.176; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ooe H, 2006, NEUROSCI LETT, V406, P165, DOI 10.1016/j.neulet.2006.06.067; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Schumann C, 2016, MOL PHARMACEUT, V13, P2070, DOI 10.1021/acs.molpharmaceut.6b00205; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Siegel AM, 2013, J ALLERGY CLIN IMMUN, V132, P1388, DOI 10.1016/j.jaci.2013.08.045; Sly LM, 2008, J IMMUNOL, V181, P3850, DOI 10.4049/jimmunol.181.6.3850; Smrz D, 2013, J IMMUNOL METHODS, V390, P52, DOI 10.1016/j.jim.2013.01.008; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Teodosio C, 2013, J ALLERGY CLIN IMMUN, V131, P1213, DOI 10.1016/j.jaci.2012.12.674; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trivedi R, 2016, EUR J PHARMACOL, V784, P99, DOI 10.1016/j.ejphar.2016.04.014; Tsuboi Y, 2008, FEBS LETT, V582, P2643, DOI 10.1016/j.febslet.2008.06.043; TSUJIMURA T, 1994, BLOOD, V83, P2619; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162831	10.1371/journal.pone.0162831	http://dx.doi.org/10.1371/journal.pone.0162831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611333	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900175
J	McCann, J; Schneeweiss, GM; Stuessy, TF; Villasenor, JL; Weiss-Schneeweiss, H				McCann, Jamie; Schneeweiss, Gerald M.; Stuessy, Tod F.; Villasenor, Jose L.; Weiss-Schneeweiss, Hanna			The Impact of Reconstruction Methods, Phylogenetic Uncertainty and Branch Lengths on Inference of Chromosome Number Evolution in American Daisies (Melampodium, Asteraceae)	PLOS ONE			English	Article							CHARACTER-STATE RECONSTRUCTION; KARYOTYPE EVOLUTION; DISCRETE CHARACTERS; BAYESIAN-ESTIMATION; LIKELIHOOD APPROACH; DNA-SEQUENCES; MODEL; POLYPLOIDY; SPECIATION; TREES	Chromosome number change (polyploidy and dysploidy) plays an important role in plant diversification and speciation. Investigating chromosome number evolution commonly entails ancestral state reconstruction performed within a phylogenetic framework, which is, however, prone to uncertainty, whose effects on evolutionary inferences are insufficiently understood. Using the chromosomally diverse plant genus Melampodium (Asteraceae) as model group, we assess the impact of reconstruction method (maximum parsimony, maximum likelihood, Bayesian methods), branch length model (phylograms versus chrono-grams) and phylogenetic uncertainty (topological and branch length uncertainty) on the inference of chromosome number evolution. We also address the suitability of the maximum clade credibility (MCC) tree as single representative topology for chromosome number reconstruction. Each of the listed factors causes considerable incongruence among chromosome number reconstructions. Discrepancies between inferences on the MCC tree from those made by integrating over a set of trees are moderate for ancestral chromosome numbers, but severe for the difference of chromosome gains and losses, a measure of the directionality of dysploidy. Therefore, reliance on single trees, such as the MCC tree, is strongly discouraged and model averaging, taking both phylogenetic and model uncertainty into account, is recommended. For studying chromosome number evolution, dedicated models implemented in the program CHROMEVOL and ordered maximum parsimony may be most appropriate. Chromosome number evolution in Melampodium follows a pattern of bidirectional dysploidy (starting from x = 11 to x = 9 and x = 14, respectively) with no prevailing direction.	[McCann, Jamie; Schneeweiss, Gerald M.; Stuessy, Tod F.; Weiss-Schneeweiss, Hanna] Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, A-1030 Vienna, Austria; [Stuessy, Tod F.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Herbarium, 318 W 12th Ave, Columbus, OH 43210 USA; [Villasenor, Jose L.] Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Tercer Circuito S-N Ciudad Univ Delegac Coyoacan, Mexico City 04510, DF, Mexico	University of Vienna; University System of Ohio; Ohio State University; Universidad Nacional Autonoma de Mexico	Schneeweiss, GM (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, A-1030 Vienna, Austria.	gerald.schneeweiss@univie.ac.at	Villasenor, Jose Luis/R-9719-2019; Schneeweiss, Hanna/B-4011-2013; Schneeweiss, Gerald M./B-4344-2013; McCann, Jamie/AAP-9923-2020	Schneeweiss, Gerald M./0000-0003-2811-3317; McCann, Jamie/0000-0003-2310-4462; Schneeweiss, Hanna/0000-0002-9530-6808	Austrian Science Fund (FWF) [P18201, P25131]; Hertha-Firnberg postdoctoral fellowship [T-218]; Austrian Science Fund (FWF) [P 25131] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Hertha-Firnberg postdoctoral fellowship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF; http://www.fwf.ac.at) grant numbers P18201 (to T.F.S.) and P25131 (to H.W.S.), Hertha-Firnberg postdoctoral fellowship T-218 (to H.W.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bakker FT, 2000, AM J BOT, V87, P727, DOI 10.2307/2656859; Beardsley PM, 2004, AM J BOT, V91, P474, DOI 10.3732/ajb.91.3.474; Bloch C, 2009, MOL PHYLOGENET EVOL, V53, P220, DOI 10.1016/j.ympev.2009.02.021; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bremer K, 1997, P NATL ACAD SCI USA, V94, P9188, DOI 10.1073/pnas.94.17.9188; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CANNE JM, 1983, RHODORA, V85, P355; Chacon J, 2014, SYST BOT, V39, P415, DOI 10.1600/036364414X680852; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; Cusimano N, 2014, TAXON, V63, P721, DOI 10.12705/634.14; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duchene S, 2015, J EXP ZOOL PART B, V324, P517, DOI 10.1002/jez.b.22638; Enke N, 2008, TAXON, V57, P756, DOI 10.1002/tax.573008; Escudero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085266; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Glick L, 2014, MOL BIOL EVOL, V31, P1914, DOI 10.1093/molbev/msu122; Goldblatt P, 1997, ANN MO BOT GARD, V84, P285, DOI 10.2307/2400005; Grant V., 1981, PLANT SPECIATION; Hansen AK, 2006, SYST BOT, V31, P138, DOI 10.1600/036364406775971769; Heled J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-221; Hennequin S, 2010, MOL PHYLOGENET EVOL, V55, P47, DOI 10.1016/j.ympev.2010.01.001; Hipp AL, 2007, EVOLUTION, V61, P2175, DOI 10.1111/j.1558-5646.2007.00183.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Jang TS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-136; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kagale S, 2014, PLANT CELL, V26, P2777, DOI 10.1105/tpc.114.126391; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KEIL DJ, 1988, AM J BOT, V75, P652, DOI 10.2307/2444199; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Litsios G, 2012, SYST BIOL, V61, P533, DOI 10.1093/sysbio/syr124; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Maddison WP, 2011, MESQUITE MODULAR SYS; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pellicer J, 2014, NEW PHYTOL, V201, P1484, DOI 10.1111/nph.12617; Pirie MD, 2012, TAXON, V61, P652, DOI 10.1002/tax.613013; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2013, R LANG ENV STAT COMP; Rice A, 2015, NEW PHYTOL, V206, P19, DOI 10.1111/nph.13191; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royer-Carenzi M, 2013, MATH BIOSCI, V242, P95, DOI 10.1016/j.mbs.2012.12.003; Samuel R, 2003, AM J BOT, V90, P496, DOI 10.3732/ajb.90.3.496; Schneeweiss GM, 2013, MOL PHYLOGENET EVOL, V69, P634, DOI 10.1016/j.ympev.2013.07.015; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Sousa A, 2015, BOT J LINN SOC, V177, P15, DOI 10.1111/boj.12231; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Stuessy T.F., 2014, PLANT SYSTEMATICS OR; STUESSY TF, 1971, AM J BOT, V58, P732, DOI 10.2307/2441471; Stuessy TF, 2011, TAXON, V60, P436, DOI 10.1002/tax.602013; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turner B. L., 1996, Phytologia, V81, P348; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Weiss-Schneeweiss H, 2013, CYTOGENET GENOME RES, V140, P137, DOI 10.1159/000351727; Weiss-Schneeweiss H., 2013, PHYS STRUCTURE BEHAV, V2, P209, DOI DOI 10.1007/978-3-7091-1160-4_13; Weiss-Schneeweiss H, 2012, EVOLUTION, V66, P211, DOI 10.1111/j.1558-5646.2011.01424.x; Weiss-Schneeweiss H, 2009, INT J PLANT SCI, V170, P1168, DOI 10.1086/605876; Xiang QY, 2008, J SYST EVOL, V46, P349, DOI 10.3724/SP.J.1002.2008.08056; Yamane K, 2003, AM J BOT, V90, P339, DOI 10.3732/ajb.90.3.339; Yang Z, 2014, Molecular Evolution: A Statistical Approach, P1, DOI 10.1093/acprof:oso/9780199602605.001.0001; [No title captured]	84	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162299	10.1371/journal.pone.0162299	http://dx.doi.org/10.1371/journal.pone.0162299			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611687	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900074
J	Yan, XD; Liu, JF; Ye, ZX; Huang, JH; He, F; Xiao, W; Hu, XY; Luo, ZJ				Yan, Xiaodong; Liu, Juanfang; Ye, Zhengxu; Huang, Jinghui; He, Fei; Xiao, Wei; Hu, Xueyu; Luo, Zhuojing			CaMKII-Mediated CREB Phosphorylation Is Involved in Ca2+-Induced BDNF mRNA Transcription and Neurite Outgrowth Promoted by Electrical Stimulation	PLOS ONE			English	Article							PROTEIN-KINASE-II; NERVE GROWTH-FACTOR; ACTIVITY-DEPENDENT EXPRESSION; LONG-TERM POTENTIATION; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; PC12 CELLS; CALCIUM-CHANNELS; AXON REGENERATION; GENE-EXPRESSION	Electrical stimulation (ES)-triggered up-regulation of brain-derived neurotrophic factor (BDNF) and neurite outgrowth in cultured rat postnatal dorsal root ganglion neurons (DRGNs) is calcium (Ca2+)-dependent. The effects of increased Ca2+ on BDNF up-regulation and neurite outgrowth remain unclear. We showed here that ES increased phosphorylation of the cAMP-response element binding protein (CREB). Blockade of Ca2+ suppressed CREB phosphorylation and neurite outgrowth. Down-regulation of phosphorylated (p)-CREB reduced BDNF transcription and neurite outgrowth triggered by ES. Furthermore, blockade of calmodulin-dependent protein kinase II (CaMKII) using the inhibitors KN93 or KN62 reduced p-CREB, and specific knockdown of the CaMKII alpha or CaMKII beta subunit was sufficient to suppress p-CREB. Recombinant BDNF or hyperforin reversed the effects of Ca2+ blockade and CaMKII knockdown. Taken together, these data establish a potential signaling pathway of Ca2+-CaMKII-CREB in neuronal activation. To our knowledge, this is the first report of the mechanisms of Ca2+-dependent BDNF transcription and neurite outgrowth triggered by ES. These findings might help further investigation of complex molecular signaling networks in ES-triggered nerve regeneration in vivo.	[Yan, Xiaodong; Ye, Zhengxu; Huang, Jinghui; Xiao, Wei; Hu, Xueyu; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Yan, Xiaodong] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian 710038, Peoples R China; [Liu, Juanfang] Fourth Mil Med Univ, Dept Clin Aerosp Med, Xian 710032, Peoples R China; [He, Fei] Fourth Mil Med Univ, Basic Unit, Dept Hereditary & Dev, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Hu, XY; Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	huxueyu@fmmu.edu.cn; zjluo@fmmu.edu.cn			National Natural Science Foundation of China [30770571, 81401001, 81101352]; Elite Talent Cultivation Programme of Tangdu hospital [20125087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Elite Talent Cultivation Programme of Tangdu hospital	This work was supported by the National Natural Science Foundation of China (No. 30770571, 81401001 and 81101352, ZL) and Elite Talent Cultivation Programme of Tangdu hospital (No. 20125087, XH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support in part from the National Natural Science Foundation of China (No. 30770571, 81401001, and 81101352) and the Elite Talent Cultivation Programme of Tangdu hospital (No. 20125087). We thank Dan Geng, Lifeng Lan, Wei Hu, Li Liang, and Ruichen Wang for technical support.	Bangaru MLY, 2015, NEUROSCIENCE, V300, P116, DOI 10.1016/j.neuroscience.2015.05.007; Barat E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041793; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P1370, DOI 10.1111/acer.12104; Buchholz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122946; Chang YJ, 2013, BBA-GEN SUBJECTS, V1830, P4130, DOI 10.1016/j.bbagen.2013.04.007; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gibon J, 2013, INT J NEUROPSYCHOPH, V16, P189, DOI 10.1017/S146114571100188X; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Guo Y, 2012, EXP CELL RES, V318, P2004, DOI 10.1016/j.yexcr.2012.04.015; Heiser JH, 2013, J NEUROCHEM, V127, DOI 10.1111/jnc.12376; Heist EK, 1998, CELL CALCIUM, V23, P103; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hu Y, 2014, J MOL NEUROSCI, V53, P600, DOI 10.1007/s12031-013-0226-y; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951; Juretic N, 2012, CELL PHYSIOL BIOCHEM, V29, P919, DOI 10.1159/000188068; Kohn J, 1999, J NEUROSCI, V19, P5393; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Krizsan-Agbas D, 2003, EUR J NEUROSCI, V18, P2760, DOI 10.1111/j.1460-9568.2003.03029.x; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Leuner K, 2013, HIPPOCAMPUS, V23, P40, DOI 10.1002/hipo.22052; Li Y, 2014, NEUROCHEM INT, V75, P96, DOI 10.1016/j.neuint.2014.06.004; Lichvarova L, 2012, GEN PHYSIOL BIOPHYS, V31, P473, DOI 10.4149/gpb_2012_054; Ma TC, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582460; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Masse T, 1997, J NEUROSCI, V17, P924; Mishra S, 2005, J BIOL CHEM, V280, P37536, DOI 10.1074/jbc.M504971200; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Morales S, 2007, AM J PHYSIOL-CELL PH, V292, pC553, DOI 10.1152/ajpcell.00096.2006; Morgado-Valle C, 1998, CELL TISSUE RES, V291, P217, DOI 10.1007/s004410050992; Mullen LM, 2012, BRAIN RES, V1430, P25, DOI 10.1016/j.brainres.2011.10.054; Nagendran T, 2011, NEUROSCIENCE, V199, P548, DOI 10.1016/j.neuroscience.2011.09.048; Nomura T, 1997, BRAIN RES, V766, P129, DOI 10.1016/S0006-8993(97)00535-0; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Riquelme D, 2011, ANTIOXID REDOX SIGN, V14, P1245, DOI 10.1089/ars.2010.3238; Roehm PC, 2008, MOL CELL NEUROSCI, V37, P376, DOI 10.1016/j.mcn.2007.10.014; Saito A, 2013, GENES CELLS, V18, P533, DOI 10.1111/gtc.12054; Sakagami H, 2005, EUR J NEUROSCI, V22, P2697, DOI 10.1111/j.1460-9568.2005.04463.x; Sato T, 2008, INVEST OPHTH VIS SCI, V49, P4641, DOI 10.1167/iovs.08-2049; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Takeshita M, 2011, CHEM RES TOXICOL, V24, P1845, DOI 10.1021/tx200160g; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tashima K, 1996, J NEUROCHEM, V66, P57; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007; Ulmann L, 2009, NEUROSCIENCE, V159, P514, DOI 10.1016/j.neuroscience.2009.01.018; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang WJ, 2011, CELL MOL NEUROBIOL, V31, P459, DOI 10.1007/s10571-010-9639-0; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wood M, 2006, BIOELECTROMAGNETICS, V27, P328, DOI 10.1002/bem.20214; Wood MD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046003; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yan XD, 2014, NEUROCHEM RES, V39, P129, DOI 10.1007/s11064-013-1197-7; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2; Zhang HY, 2014, BBA-MOL CELL RES, V1843, P2967, DOI 10.1016/j.bbamcr.2014.09.010; Zhao LX, 2003, J NEUROSCI, V23, P4228	72	52	54	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162784	10.1371/journal.pone.0162784	http://dx.doi.org/10.1371/journal.pone.0162784			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611779	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900166
J	Yanaihara, N; Noguchi, Y; Saito, M; Takenaka, M; Takakura, S; Yamada, K; Okamoto, A				Yanaihara, Nozomu; Noguchi, Yukiko; Saito, Misato; Takenaka, Masataka; Takakura, Satoshi; Yamada, Kyosuke; Okamoto, Aikou			MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; CANCER-CELLS; AMPLIFICATION; ONCOMIRS; NETWORK; DEFINES; PLAYERS; FAMILY	Previous studies have identified microRNA (miRNA) involvement in human cancers. This study aimed to elucidate potential clinical and biological associations of ovarian cancer-related miRNA gene expression profiles in high-grade serous carcinoma (HGSC) and ovarian clear cell carcinoma (OCCC). Accordingly, we investigated 27 patients with ovarian cancer (12 HGSC and 15 OCCC cases) using quantitative real-time reverse transcription polymerase chain reaction to determine the cancer-related miRNA expressions. Gene Cluster 3.0 was used for hierarchical clustering analysis, and differentially expressed miRNAs between HGSC and OCCC were identified by the class comparison analysis using BRB-Array Tools. An unsupervised hierarchical clustering analysis identified two distinct miRNA expression clusters, with histological subtype-related significant differences in the associations between clusters and clinicopathological features. A comparison of miRNA expression in HGSCs and OCCCs identified five miRNAs (miR-132, miR-9, miR-126, miR-34a, and miR-21), with OCCCs demonstrating a statistically higher expression. Further investigation of the biological significance of miR-9 overexpression in OCCC revealed that miR-9 inhibition reduced the cell invasion ability and upregulated E-cadherin expression. Using a luciferase reporter assay, we further demonstrated the direct binding of miR-9 to E-cadherin. Global cancer-related miRNA expression analysis identified statistically unique profiles that could discriminate ovarian cancer histotypes. In OCCC, miR-9 overexpression may affect pathogenesis by targeting E-cadherin, thereby inducing an epithelial-mesenchymal transition. Therefore, miR-9 may be a promising therapeutic target strategy for OCCC.	[Yanaihara, Nozomu; Noguchi, Yukiko; Saito, Misato; Takenaka, Masataka; Yamada, Kyosuke; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Takakura, Satoshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Obstet & Gynecol, Saitama, Japan	Jikei University; Dokkyo Medical University	Yanaihara, N (corresponding author), Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan.	yanazou@jikei.ac.jp			Japan Society for the Promotion of Science KAKENHI [25462615, 25462616, JP16K11159]; Jikei University Research Fund for Graduate Students	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Jikei University Research Fund for Graduate Students	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25462615(NY), 25462616(ST), and JP16K11159 (NY) (https://www.jsps.go.jp/j-grantsinaid/) and The Jikei University Research Fund for Graduate Students (YN)(http://j-net.jikei.ac.jp/similar to daigakuin/H24jyoseikinsaitaku.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calura E, 2013, CLIN CANCER RES, V19, P4114, DOI 10.1158/1078-0432.CCR-13-0360; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Chen X, 2015, SCI REP-UK, V5, DOI [10.1038/srep15744, 10.1038/srep17031]; Dalmay T, 2006, ONCOGENE, V25; Davidson B, 2014, GYNECOL ONCOL, V133, P640, DOI 10.1016/j.ygyno.2014.03.575; Elgaaen BV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-80; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hirata Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-799; Ho CM, 2010, INT J GYNECOL CANCER, V20, P1490, DOI 10.1111/IGC.0b013e3181e68a4d; Huang HN, 2014, HUM PATHOL, V45, P2318, DOI 10.1016/j.humpath.2014.07.020; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jang SG, 2014, INT J GYNECOL CANCER, V24, P1558, DOI 10.1097/IGC.0000000000000267; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lu MH, 2012, CLIN CANCER RES, V18, P6416, DOI 10.1158/1078-0432.CCR-12-0832; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Okamoto A, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5507; Okamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116977; Parikh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3977; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reshmi G, 2008, FEBS LETT, V582, P4113, DOI 10.1016/j.febslet.2008.11.011; Rotkrua P, 2011, INT J CANCER, V129, P2611, DOI 10.1002/ijc.25923; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Song Y, 2014, ONCOTARGET, V5, P11669, DOI 10.18632/oncotarget.2581; Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302; Sun Y, 2015, J PATHOL, V235, P25, DOI 10.1002/path.4443; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yanaihara N, 2016, MOL CARCINOGEN, V55, P832, DOI 10.1002/mc.22325; Yanaihara N, 2013, CLIN CHEM, V59, P1811, DOI 10.1373/clinchem.2012.198176; Yanaihara N, 2012, INT J ONCOL, V41, P1094, DOI 10.3892/ijo.2012.1533; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020	40	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162584	10.1371/journal.pone.0162584	http://dx.doi.org/10.1371/journal.pone.0162584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612152	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900130
J	Kandeel, A; Dawson, P; Labib, M; Said, M; El-Refai, S; El-Gohari, A; Talaat, M				Kandeel, Amr; Dawson, Patrick; Labib, Manal; Said, Mayar; El-Refai, Samir; El-Gohari, Amani; Talaat, Maha			Morbidity, Mortality, and Seasonality of Influenza Hospitalizations in Egypt, November 2007-November 2014	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; A H1N1 VIRUS; PREGNANT-WOMEN; INFECTIONS; SURVEILLANCE; CHILDREN; EPIDEMICS; DISEASE; ILLNESS; BURDEN	Background Influenza typically comprises a substantial portion of acute respiratory infections, a leading cause of mortality worldwide. However, influenza epidemiology data are lacking in Egypt. We describe seven years of Egypt's influenza hospitalizations from a multi-site influenza surveillance system. Methods Syndromic case definitions identified individuals with severe acute respiratory infection (SARI) admitted to eight hospitals in Egypt. Standardized demographic and clinical data were collected. Nasopharyngeal and oropharyngeal swabs were tested for influenza using real-time reverse transcription polymerase chain reaction and typed as influenza A or B, and influenza A specimens subtyped. Results From November 2007-November 2014, 2,936/17,441 (17%) SARI cases were influenza-positive. Influenza-positive patients were more likely to be older, female, pregnant, and have chronic condition(s) (all p<0.05). Among them, 53 (2%) died, and death was associated with older age, five or more days from symptom onset to hospitalization, chronic condition(s), and influenza A (all p<0.05). An annual seasonal influenza pattern occurred from July-June. Each season, the proportion of the season's influenza-positive cases peaked during November-May (19-41%). Conclusions In Egypt, influenza causes considerable morbidity and mortality and influenza SARI hospitalization patterns mirror those of the Northern Hemisphere. Additional assessment of influenza epidemiology in Egypt may better guide disease control activities and vaccine policy.	[Kandeel, Amr; Labib, Manal; El-Refai, Samir; El-Gohari, Amani] Egypt Minist Hlth, Cairo, Egypt; [Dawson, Patrick; Said, Mayar; Talaat, Maha] US Naval Med Res Unit 3, Cairo, Egypt; [Dawson, Patrick; Talaat, Maha] US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Dawson, P (corresponding author), US Naval Med Res Unit 3, Cairo, Egypt.; Dawson, P (corresponding author), US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt.	ptd2103@cumc.columbia.edu			Global Emerging Infections Surveillance Program (GEIS) [GEIS847705.821000.25GB.E0018]; U.S. Centers for Disease Control and Prevention	Global Emerging Infections Surveillance Program (GEIS); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded through the Global Emerging Infections Surveillance Program (GEIS) GEIS847705.821000.25GB.E0018 and by the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2015, VIRULENCE, V6, P6, DOI 10.4161/21505594.2014.992662; Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Al-Awaidy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144186; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P161; [Anonymous], AV CAND VACC VIR POT; Azziz-Baumgartner E, 2012, B WHO, V90; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; El Kholy AA, 2014, J INFECT DEV COUNTR, V8, P1285, DOI 10.3855/jidc.4682; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Gomaa M. R., 2014, J INFECT DIS; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Khattab A, 2013, ASIAN PAC J TROP MED, V6, P693, DOI 10.1016/S1995-7645(13)60120-0; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCKINNEY WP, 1990, ARCH INTERN MED, V150, P213, DOI 10.1001/archinte.150.1.213; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Periolo N, 2015, J CLIN VIROL, V64, P52, DOI 10.1016/j.jcv.2015.01.009; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Rowlinson E, 2013, J INFECT DIS, V208, pS189, DOI 10.1093/infdis/jit457; Schluger NW, ACUTE RESP INFECT MA; Schroedl A, 2010, EMERG INFECT DIS, V16, P161, DOI 10.3201/eid1601.090560; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Tamfum JJM, 2012, J INFECT DIS, V206, pS36, DOI 10.1093/infdis/jis537; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; U.S. Centers for Disease Control and Prevention, 2005, SEAS INFL VACC EFF; U.S. Centers for Disease Control and Prevention International Emerging Infections Program (IEIP): Thailand, DESCR CLIN PNEUM; U.S. Central Intelligence Agency, EG WORLD FACTB; United Nations Development Program, HUM DEV REP 2014; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, PAHO CDC GEN PROT IN; World Health Organization, GLOB EP SURV STAND I; World Health Organization, INT SURV REC HUM INF; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, WORLD HLTH STAT 2014; World Health Organization (WHO), WHO GLOB TECHN CONS; World Lung Foundation, INFLUENZA	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161301	10.1371/journal.pone.0161301	http://dx.doi.org/10.1371/journal.pone.0161301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607330	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255600004
J	Dasgupta, SK; Le, A; Da, Q; Cruz, M; Rumbaut, RE; Thiagarajan, P				Dasgupta, Swapan K.; Anhquyen Le; Da, Qi; Cruz, Miguel; Rumbaut, Rolando E.; Thiagarajan, Perumal			Wdr1-Dependent Actin Reorganization in Platelet Activation	PLOS ONE			English	Article							TALIN HEAD DOMAIN; INTEGRIN ACTIVATION; INTERACTING PROTEIN-1; FILAMENT DYNAMICS; VINCULIN-BINDING; STRUCTURAL BASIS; IIB-IIIA; COFILIN; FIBRINOGEN; ADHESION	In resting platelets, the integrin alpha IIb beta 3 is present in a low-affinity "bent" state. During platelet aggregation, intracytoplasmic signals induce conformational changes (inside-out signaling) that result in a "swung-out" conformation competent to bind ligands such as fibrinogen. The cytoskeleton plays an essential role in alpha IIb beta 3 activation. We investigated the role of the actin interacting protein Wdr1 in alpha IIb beta 3 activation. Wdr1-hypomorphic mice had a prolonged bleeding time (> 10 minutes) compared to that of wild-type mice (2.1 +/- 0.7 minutes). Their platelets had impaired aggregation to collagen and thrombin. In a FeCl3 induced carotid artery thrombosis model, vessel occlusion in Wdr1-hypomorphic mice was prolonged significantly compared to wild-type mice (9.0 +/- 10.5 minutes versus 5.8 +/- 12.6 minutes (p = 0.041). Activation-induced binding of JON/A (a conformation-specific antibody to activated alpha IIb beta 3) was significantly less in Wdr1-hypomorphic platelets at various concentrations of collagen, indicating impaired inside-out activation of alpha IIb beta 3, despite a normal calcium response. Actin turnover, assessed by measuring F-actin and G-actin ratios during collagen- and thrombin-induced platelet aggregation, was highly impaired in Wdr1-hypomorphic platelets. Furthermore, talin failed to redistribute and translocate to the cytoskeleton following activation in Wdr1-hypomorphic platelets. These studies show that Wdr1 is essential for talin-induced activation of alpha IIb beta 3 during platelet activation.	[Dasgupta, Swapan K.; Anhquyen Le; Thiagarajan, Perumal] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Da, Qi; Cruz, Miguel; Rumbaut, Rolando E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dasgupta, Swapan K.; Anhquyen Le; Da, Qi; Cruz, Miguel; Rumbaut, Rolando E.; Thiagarajan, Perumal] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dasgupta, SK (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Dasgupta, SK (corresponding author), Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA.	swapand@bcm.edu		Thiagarajan, Perumal/0000-0003-2186-7036; Rumbaut, Rolando/0000-0002-8486-1013	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institutes of Health [HL 116524]; American Heart Association; Gulf Cost Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116524] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002551] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gulf Cost Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by grants from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (to PT and RR), grants from National Institutes of Health (HL 116524 to RR and PT), a grant from the American Heart Association (to SKD) and a grant from Gulf Cost Blood Center.	Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Ciobanasu C, 2015, NAT PROTOC, V10, P75, DOI 10.1038/nprot.2014.200; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Coller BS, 2015, J THROMB HAEMOST, V13, pS17, DOI 10.1111/jth.12915; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Dasgupta SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084649; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Fox JEB, 2001, THROMB HAEMOSTASIS, V86, P198; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; Hemmings L, 1996, J CELL SCI, V109, P2715; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; LEFEBVRE P, 1993, EUR J CELL BIOL, V62, P194; Luxenburg C, 2015, NAT CELL BIOL, V17, P592, DOI 10.1038/ncb3146; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Morowski M, 2013, BLOOD, V121, P4938, DOI 10.1182/blood-2012-10-461459; MUGURUMA M, 1990, BIOCHEM BIOPH RES CO, V171, P1217, DOI 10.1016/0006-291X(90)90815-5; O'Neill EE, 2002, PROTEOMICS, V2, P288, DOI 10.1002/1615-9861(200203)2:3<288::AID-PROT288>3.0.CO;2-0; Okada K, 1999, J CELL SCI, V112, P1553; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Srinivasan S, 2015, J BIOL CHEM, V290, P25129, DOI 10.1074/jbc.M115.650978; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xue B, 2013, EUR J CELL BIOL, V92, P316, DOI 10.1016/j.ejcb.2013.10.012	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162897	10.1371/journal.pone.0162897	http://dx.doi.org/10.1371/journal.pone.0162897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627652	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600061
J	O'Rourke, M; Cullen, CL; Auderset, L; Pitman, KA; Achatz, D; Gasperini, R; Young, KM				O'Rourke, Megan; Cullen, Carlie L.; Auderset, Loic; Pitman, Kimberley A.; Achatz, Daniela; Gasperini, Robert; Young, Kaylene M.			Evaluating Tissue-Specific Recombination in a Pdgfr alpha-CreER(T2) Transgenic Mouse Line	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PERIPHERAL NERVOUS-SYSTEM; HEMATOPOIETIC STEM-CELLS; ALPHA-POSITIVE CELLS; PDGF-A; BONE-MARROW; OLIGODENDROCYTE LINEAGE; CNS DEMYELINATION; PROGENITOR CELLS; BETA-RECEPTORS	In the central nervous system (CNS) platelet derived growth factor receptor alpha (PDGFR alpha) is expressed exclusively by oligodendrocyte progenitor cells (OPCs), making the Pdgfr alpha promoter an ideal tool for directing transgene expression in this cell type. Two Pdgfr alpha-CreER(T2) mouse lines have been generated for this purpose which, when crossed with cre-sensitive reporter mice, allow the temporally restricted labelling of OPCs for line-age- tracing studies. These mice have also been used to achieve the deletion of CNS-specific genes from OPCs. However the ability of Pdgfr alpha-CreER(T2) mice to induce cre-mediated recombination in PDGFR alpha(+) cell populations located outside of the CNS has not been examined. Herein we quantify the proportion of PDGFR alpha(+) cells that become YFP-labelled following Tamoxifen administration to adult Pdgfr alpha-CreER(T2):: Rosa26-YFP transgenic mice. We report that the vast majority (>90%) of PDGFR alpha(+) OPCs in the CNS, and a significant proportion of PDGFR alpha(+) stromal cells within the bone marrow (similar to 38%) undergo recombination and become YFP-labelled. However, only a small proportion of the PDGFR alpha(+) cell populations found in the sciatic nerve, adrenal gland, pituitary gland, heart, gastrocnemius muscle, kidney, lung, liver or intestine become YFP-labelled. These data suggest that Pdgfr alpha-CreER(T2) transgenic mice can be used to achieve robust recombination in OPCs, while having a minimal effect on most PDGFR alpha(+) cell populations outside of the CNS.	[O'Rourke, Megan; Cullen, Carlie L.; Auderset, Loic; Pitman, Kimberley A.; Achatz, Daniela; Gasperini, Robert; Young, Kaylene M.] Univ Tasmania, Menzies Inst Med Res, Liverpool St, Hobart, Tas 7000, Australia; [Gasperini, Robert] Univ Tasmania, Sch Med, Liverpool St, Hobart, Tas 7000, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania	Young, KM (corresponding author), Univ Tasmania, Menzies Inst Med Res, Liverpool St, Hobart, Tas 7000, Australia.	kaylene.young@utas.edu.au	Pitman, Kimberley/O-4843-2017; Cullen, Carlie/J-7706-2014	Pitman, Kimberley/0000-0003-3198-9336; Cullen, Carlie/0000-0001-6929-6258; Young, Kaylene/0000-0002-1686-3463	National Health and Medical Research Council [1045240, 1066025]; Multiple Sclerosis Research Australia [15-054]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia	We thank our colleagues at the University of Tasmania for their constructive feedback and suggestions for improvement. This research was supported by the National Health and Medical Research Council (grant numbers 1045240 and 1066025) and Multiple Sclerosis Research Australia (15-054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues at the University of Tasmania for their constructive feedback and suggestions for improvement. This research was supported by the National Health and Medical Research Council (grant numbers 1045240 and 1066025) and Multiple Sclerosis Research Australia (15-054).	Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002; Auderset L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155878; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; BOWENPOPE DF, 1982, J BIOL CHEM, V257, P5161; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Chang M, 2008, PEDIATR RES, V64, P240, DOI 10.1203/PDR.0b013e318180e47a; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Contreras O, 2016, CELL TISSUE RES, V364, P647, DOI 10.1007/s00441-015-2343-0; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; ECCLESTON PA, 1993, DEV BIOL, V155, P459, DOI 10.1006/dbio.1993.1044; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; GLENN K, 1982, J BIOL CHEM, V257, P5172; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; Hayes BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092925; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kurahashi M, 2014, AM J PHYSIOL-CELL PH, V307, pC561, DOI 10.1152/ajpcell.00080.2014; Kurahashi M, 2013, AM J PHYSIOL-GASTR L, V304, pG823, DOI 10.1152/ajpgi.00001.2013; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura M, 1997, ANN SURG, V226, P35, DOI 10.1097/00000658-199707000-00005; Noseda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7930; Ntokou A, 2015, AM J PHYSIOL-LUNG C, V309, pL942, DOI 10.1152/ajplung.00272.2014; Oishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056641; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Parretta E, 2008, J IMMUNOL, V180, P7230, DOI 10.4049/jimmunol.180.11.7230; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Seyed-Razavi Y, 2013, AM J PHYSIOL-LUNG C, V305, pL635, DOI 10.1152/ajplung.00092.2013; Soriano P, 1997, DEVELOPMENT, V124, P2691; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162858	10.1371/journal.pone.0162858	http://dx.doi.org/10.1371/journal.pone.0162858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626928	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600058
J	Li, ZY; Zeng, JW; Jin, W; Long, W; Lan, WZ; Yang, X				Li, Zhouyue; Zeng, Junwen; Jin, Wei; Long, Wen; Lan, Weizhong; Yang, Xiao			Time-Course of Changes in Choroidal Thickness after Complete Mydriasis Induced by Compound Tropicamide in Children	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CENTRAL SEROUS CHORIORETINOPATHY; AXIAL LENGTH; FORM DEPRIVATION; HEALTHY-SUBJECTS; MYOPIC DEFOCUS; YOUNG-ADULTS; HUMAN EYES; ACCOMMODATION; FLUCTUATIONS	Purpose The aim of this study was to investigate the time-course of changes in choroidal thickness (ChT) following complete mydriasis induced by compound tropicamide. Methods ChT was measured by OCT with the enhanced-depth imaging technique (Spectralis HRA+ OCT, Heidelberg Engineering, Germany) at nine locations of the fundus: subfoveal ChT (SFChT) and ChT at 1 mm and 3 mm from the fovea in four quadrants. Mydriasis was induced with compound tropicamide (0.5% tropicamide plus 0.5% phenylephrine hydrochloride, three doses at 5-minute intervals). Measurements were conducted prior to the instillation and at 0, 30, and 60 min following complete mydriasis. Results at different time-points were compared using repeated-measures ANOVA to investigate the time-course of the changes. Results Thirty-nine subjects (mean age 11.9 +/- 2 years; 16 males and 23 females) were enrolled in the study. Compound tropicamide resulted in a statistically significant decrease in SFChT at 0, 30, and 60 min after complete mydriasis, as compared to baseline (-5 +/- 4 mu m, -12 +/- 4 mu m, and -13 +/- 4 mu m, respectively; all P<0.0001). No significant changes were detected in the parafoveal choroid except at 1 mm temporal (T-1mm) and nasal (N-1mm) to the fovea at 30 and 60 min (T-1mm: -6 +/- 4 mu m and -7 +/- 5 mu mat 30 and 60 min; N-1mm: -6 +/- 4 mu m and -7 +/- 5 mu m at 30 and 60 min, respectively; all P< 0.0001). Repeated-measures ANOVA showed a significant interaction between the time after complete mydriasis and the effect of the mydriasis agent. Conclusions Complete mydriasis induced by compound tropicamide led to choroidal thinning, and the magnitude varied over time.	[Li, Zhouyue; Zeng, Junwen; Jin, Wei; Long, Wen; Lan, Weizhong; Yang, Xiao] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Lan, Weizhong] Aier Eye Hosp Grp, Optometry & Visual Sci Inst, Changsha, Hunan, Peoples R China	Sun Yat Sen University	Lan, WZ; Yang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; Lan, WZ (corresponding author), Aier Eye Hosp Grp, Optometry & Visual Sci Inst, Changsha, Hunan, Peoples R China.	13725458845@139.com; yangxiao3366@gmail.com		Lan, Weizhong/0000-0002-3829-7415	National Natural Science Foundation of China, China [81170871]; Science and Technology Program of Guangdong Province, China [2013B020400003]; Science and Technology Program of Guangzhou, China [15570001, 11BPP2Xaa2060017]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province, China; Science and Technology Program of Guangzhou, China	This work was supported by grants from National Natural Science Foundation of China, China (grant no.: 81170871), Science and Technology Program of Guangdong Province, China (2013B020400003) and Science and Technology Program of Guangzhou, China (15570001), and Science and Technology Program of Guangzhou, China (11BPP2Xaa2060017).	Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Brown JS, 2009, INVEST OPHTH VIS SCI, V50, P5, DOI 10.1167/iovs.08-1779; Chakraborty R, 2013, OPTOMETRY VISION SCI, V90, P1187, DOI 10.1097/OPX.0000000000000035; Chakraborty R, 2012, EXP EYE RES, V103, P47, DOI 10.1016/j.exer.2012.08.002; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Cheung SW, 2009, CLIN EXP OPTOM, V92, P476, DOI 10.1111/j.1444-0938.2009.00419.x; Chia A, 2014, AM J OPHTHALMOL, V157, P451, DOI 10.1016/j.ajo.2013.09.020; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Drexler W, 1998, INVEST OPHTH VIS SCI, V39, P2140; Drexler W, 1997, VISION RES, V37, P2789, DOI 10.1016/S0042-6989(97)00066-7; Fitzgerald MEC, 2002, EXP EYE RES, V74, P561, DOI 10.1006/exer.2002.1142; Gardner DJ, 2015, OPTOMETRY VISION SCI, V92, P579, DOI 10.1097/OPX.0000000000000573; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Gupta B, 2011, OPHTHALMOLOGICA, V225, P207, DOI 10.1159/000324050; Harb E, 2015, AM J OPHTHALMOL, V160, P62, DOI 10.1016/j.ajo.2015.04.018; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kara N, 2014, J OCUL PHARMACOL TH, V30, P366, DOI 10.1089/jop.2013.0093; Khambhiphant B, 2015, INT OPHTHALMOL, V35, P853, DOI 10.1007/s10792-015-0063-9; Kim M, 2012, OPTOMETRY VISION SCI, V89, P1150, DOI 10.1097/OPX.0b013e318264f657; Lin T, 1996, CURR EYE RES, V15, P453, DOI 10.3109/02713689609000756; Mallen EAH, 2006, INVEST OPHTH VIS SCI, V47, P1251, DOI 10.1167/iovs.05-1086; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Nickla DL, 2012, EXP EYE RES, V102, P93, DOI 10.1016/j.exer.2012.07.002; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Portney L.G., 2008, FDN CLIN RES APPL PR, DOI [10.1016/j.ophtha.2008.10.020, DOI 10.1016/J.OPHTHA.2008.10.020]; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P3103, DOI 10.1167/iovs.15-16446; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; Sander BP, 2014, EXP EYE RES, V128, P181, DOI 10.1016/j.exer.2014.10.003; Sander Beata P., 2016, ARVO; Sizmaz S, 2013, BRIT J OPHTHALMOL, V97, P601, DOI 10.1136/bjophthalmol-2012-302393; Stone RA, 2004, INVEST OPHTH VIS SCI, V45, P63, DOI 10.1167/iovs.03-0294; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tong L, 2009, OPHTHALMOLOGY, V116, P572, DOI 10.1016/j.ophtha.2008.10.020; Vural AD, 2014, RETINA-J RET VIT DIS, V34, P1223, DOI 10.1097/IAE.0000000000000043; Yuvaci I, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/981274	39	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162468	10.1371/journal.pone.0162468	http://dx.doi.org/10.1371/journal.pone.0162468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622495	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000033
J	Rydberg, DM; Holm, L; Engqvist, I; Fryckstedt, J; Lindh, JD; Stiller, CO; Asker-Hagelberg, C				Rydberg, Diana M.; Holm, Lennart; Engqvist, Ida; Fryckstedt, Jessica; Lindh, Jonatan D.; Stiller, Carl-Olav; Asker-Hagelberg, Charlotte			Adverse Drug Reactions in a Tertiary Care Emergency MedicineWard - Prevalence, Preventability and Reporting	PLOS ONE			English	Article							REACTION-RELATED ADMISSIONS; HOSPITAL ADMISSIONS; RISK-FACTORS; FREQUENCY; EVENTS; METAANALYSIS; DEFINITIONS; COST	Purpose To identify the prevalence and preventability of adverse drug reactions (ADRs) in an emergency ward setting in a tertiaryhospital in Sweden and to what extent the detected ADRs were reported to the Medical Product Agency (MPA). Methods In this prospective cross sectional observational study, 706 patients admitted to one of the Emergency Wards, at the Karolinska University Hospital in Solna, Stockholm during September 2008 - September 2009, were included. The electronic patient records were reviewed for patients' demographic parameters, prevalence of possible ADRs and assessment of their preventability. In addition, the extent of formal and required ADR reporting to national registers was studied. Results Approximately 40 percent of the patient population had at least one possible ADR (n = 284). In themultivariable regression model, age and number of drugs were significantly associated with risk of presenting with an ADR (p<0.01 and p<0.001, respectively). Sex was not identified as a significant predictor of ADRs (p = 0.27). The most common ADRs were cardiovascular, followed by electrolyte disturbances, and hemorrhage. In 18 percent of the patient population ADRs were the reason for admission or had contributed to admission and 24% of these ADRs were assessed as preventable. The under-reporting of ADRs to the MPA was 99%. Conclusions ADRs are common in Emergency Medicine in tertiarycare in Sweden, but under-reporting of ADRs is substantial. The most frequent ADRs are caused by cardiovascular drugs, and significantly associated with age and number of drugs. However, only a minority of the detected serious ADRs contributing to admission could have been avoided by increased risk awareness.	[Rydberg, Diana M.; Stiller, Carl-Olav; Asker-Hagelberg, Charlotte] Karolinska Inst, Dept Med Solna, Clin Pharmacol, Stockholm, Sweden; [Rydberg, Diana M.; Stiller, Carl-Olav] Karolinska Univ, Hosp Solna, Clin Pharmacol Drug Safety & Evaluat Sect, Stockholm, Sweden; [Holm, Lennart; Asker-Hagelberg, Charlotte] Med Prod Agcy, Uppsala, Sweden; [Engqvist, Ida; Fryckstedt, Jessica] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Emergency Med,Dept Med, Stockholm, Sweden; [Lindh, Jonatan D.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Lindh, Jonatan D.] Karolinska Univ, Huddinge Hosp, Dept Clin Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Medical Products Agency; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Rydberg, DM (corresponding author), Karolinska Inst, Dept Med Solna, Clin Pharmacol, Stockholm, Sweden.; Rydberg, DM (corresponding author), Karolinska Univ, Hosp Solna, Clin Pharmacol Drug Safety & Evaluat Sect, Stockholm, Sweden.	diana.rydberg@ki.se		Fryckstedt, Jessica/0000-0003-4944-8909	Health Care Division of Stockholm County Council; Swedish foundation of Clinical Pharmacology and Pharmacotherapy	Health Care Division of Stockholm County Council(Stockholm County Council); Swedish foundation of Clinical Pharmacology and Pharmacotherapy	The study was funded by a public funder, the Health Care Division of Stockholm County Council. DR was partly funded by a grant offered by the Swedish foundation of Clinical Pharmacology and Pharmacotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern F, 2014, EMERG MED J, V31, P24, DOI 10.1136/emermed-2012-201945; Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Backstrom M, 2004, PHARMACOEPIDEM DR S, V13, P483, DOI 10.1002/pds.962; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Beijer HJM, 2002, PHARM WORLD SCI, V24, P46, DOI 10.1023/A:1015570104121; Benard-Laribiere A, 2015, FUND CLIN PHARMACOL, V29, P106, DOI 10.1111/fcp.12088; Brvar Miran, 2009, BMC Clin Pharmacol, V9, P8, DOI 10.1186/1472-6904-9-8; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Ekman E, 2009, EUR J CLIN PHARMACOL, V65, P43, DOI 10.1007/s00228-008-0564-9; Eudra Vigilance Expert Working Group (EV-EWG), 2015, IMPORTANTMEDICAL EV; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Fryckstedt Jessica, 2008, Lakartidningen, V105, P894; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Hellden A, 2009, DRUG AGING, V26, P595, DOI 10.2165/11315790-000000000-00000; Hopf Y, 2008, PHARM WORLD SCI, V30, P854, DOI 10.1007/s11096-008-9240-5; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Kanjanarat P, 2003, AM J HEALTH-SYST PH, V60, P1750, DOI 10.1093/ajhp/60.17.1750; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Kongkaew C, 2013, PHARMACOTHERAPY, V33, P827, DOI 10.1002/phar.1287; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Lagnaoui R, 2000, EUR J CLIN PHARMACOL, V56, P181, DOI 10.1007/s002280050738; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leendertse AJ, 2010, DRUG SAFETY, V33, P233, DOI 10.2165/11319030-000000000-00000; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lovborg H, 2012, EUR J CLIN PHARMACOL, V68, P1183, DOI 10.1007/s00228-012-1237-2; Mjorndal T, 2002, PHARMACOEPIDEM DR S, V11, P65, DOI 10.1002/pds.667; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Muehlberger N, 1997, PHARMACOEPIDEM DR S, V6, pS71, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; Olivier P, 2002, DRUG SAFETY, V25, P1035, DOI 10.2165/00002018-200225140-00005; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Paul Esbjorn, 2008, Lakartidningen, V105, P2338; Pedros C, 2014, EUR J CLIN PHARMACOL, V70, P361, DOI 10.1007/s00228-013-1630-5; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Ruiter R, 2012, DRUG AGING, V29, P225, DOI 10.2165/11599430-000000000-00000; SBU, 2009, 193 SBU; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A; Wiffen P, 2002, BANDOLIER EXTRA  JUN, DOI [10.1111/j.1365-2125.2006.02698.x, DOI 10.1111/J.1365-2125.2006.02698.X]; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	42	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162948	10.1371/journal.pone.0162948	http://dx.doi.org/10.1371/journal.pone.0162948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622270	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000071
J	Arias, D; Taylor, L; Ofori-Atta, A; Bradley, EH				Arias, Daniel; Taylor, Lauren; Ofori-Atta, Angela; Bradley, Elizabeth H.			Prayer Camps and Biomedical Care in Ghana: Is Collaboration in Mental Health Care Possible?	PLOS ONE			English	Article							SERVICES; HALLUCINATIONS; DISORDERS; SYSTEMS; PEOPLE	Background Experts have suggested that intersectoral partnerships between prayer camps and biomedical care providers may be an effective strategy to address the overwhelming shortage of mental health care workers in Africa and other low-income settings. Nevertheless, previous studies have not explored whether the prayer camp and biomedical staff beliefs and practices provide sufficient common ground to enable cooperative relationships. Therefore, we sought to examine the beliefs and practices of prayer camp staff and the perspective of biomedical care providers, with the goal of characterizing interest in-and potential for-intersectoral partnership between prayer camp staff and biomedical care providers. Methods We conducted 50 open-ended, semi-structured interviews with prophets and staff at nine Christian prayer camps in Ghana, and with staff within Ghana's three public psychiatric hospitals. We used the purposive sampling method to recruit participants and the constant comparative method for qualitative data analysis. Results Prayer camp staff expressed interest in collaboration with biomedical mental health care providers, particularly if partnerships could provide technical support introducing medications in the prayer camp and address key shortcomings in their infrastructure and hygienic conditions. Nevertheless, challenges for collaboration were apparent as prayer camp staff expressed strong beliefs in a spiritual rather than biomedical explanatory model for mental illness, frequently used fasting and chained restraints in the course of treatment, and endorsed only short-termuse of medication to treat mental illness-expressing concerns that long-termmedication regimens masked underlying spiritual causes of illness. Biomedical providers were skeptical about the spiritual interpretations of mental illness held by faith healers, and were concerned by the use of chains, fasting, and the lack of adequate living facilities for patients in prayer camps; many, however, expressed interest in engaging with prayer camps to expand access to clinical care for patients residing in the camps. Conclusions The findings demonstrate that biomedical care providers are interested in engaging with prayer camps. Key areas where partnerships may best improve conditions for patients at prayer camps include collaborating on creating safe and secure physical spaces and delivering medication for mental illness to patients living in prayer camps. However, while prayer camp staff are willing to engage biomedical knowledge, deeply held beliefs and routine practices of faith and biomedical healers are difficult to reconcile Additional discussion is needed to find the common ground on which the scarce resources for mental health care in Ghana can collaborate most effectively.	[Arias, Daniel] Yale Univ, Yale Coll, New Haven, CT USA; [Taylor, Lauren] Harvard Divin Sch, Cambridge, MA USA; [Ofori-Atta, Angela] Univ Ghana, Sch Med & Dent, Accra, Ghana; [Bradley, Elizabeth H.] Yale Univ, Yale Sch Publ Hlth, New Haven, CT 06520 USA	Yale University; Harvard University; University of Ghana; Yale University	Bradley, EH (corresponding author), Yale Univ, Yale Sch Publ Hlth, New Haven, CT 06520 USA.	elizabeth.bradley@yale.edu						Ae-Ngibise K, 2010, INT REV PSYCHIATR, V22, P558, DOI 10.3109/09540261.2010.536149; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P40, DOI 10.1111/j.1600-0447.1999.tb10693.x; [Anonymous], 1992, MOD LANG J, DOI [DOI 10.2307/330063, 10.2307/330063]; Asamoah MK, 2014, MENT HEALTH RELIG CU, V17, P601, DOI 10.1080/13674676.2013.871628; Badcock JC, 2012, NEUROSCI BIOBEHAV R, V36, P431, DOI 10.1016/j.neubiorev.2011.07.010; Barke A, 2011, SOC PSYCH PSYCH EPID, V46, P1191, DOI 10.1007/s00127-010-0290-3; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Carey B., 2015, NY TIMES, P9; Central Intelligence Agency, 2014, WORLD FACTBOOK; Crawford T.A., 2004, MENTAL HLTH RELIG CU, V7, P131, DOI [DOI 10.1080/13674670310001602463, https://doi.org/10.1080/13674670310001602463]; Curry L., 2015, MIXED METHODS HLTH S; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Daar AS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24589; Doku V C K, 2012, Ghana Med J, V46, P241; Edwards J, 2014, LANCET, V383, P15, DOI 10.1016/S0140-6736(13)62717-8; Estrin James, 2013, NY TIMES; Glaser B. G, 1967, DISCOVERY GROUNDED T, DOI [10.2307/2575405, DOI 10.2307/2575405]; Gureje O, 2006, SOC PSYCH PSYCH EPID, V41, P44, DOI 10.1007/s00127-005-0001-7; Human Rights Watch, 2012, DEATH SENT AB PERS M; International Gallup, 2012, GLOB IND REL ATH; Jack H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057940; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Kilonzo GP, 1998, SOC SCI MED, V47, P419, DOI 10.1016/S0277-9536(97)10127-7; Luhrmann TM, 2015, BRIT J PSYCHIAT, V206, P41, DOI 10.1192/bjp.bp.113.139048; Miles MB, 1984, QUALITATIVE DATA ANA, P1; Ofori-Atta A, 2010, AFR J PSYCHIATRY, V13, P99; Patel V, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7956; Pierre JM, 2010, HARVARD REV PSYCHIAT, V18, P22, DOI 10.3109/10673220903523706; Read U M, 2012, Ghana Med J, V46, P29; Read U, 2012, TRANSCULT PSYCHIATRY, V49, P438, DOI 10.1177/1363461512447070; Read UM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-13; Roberts M, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-16; United Nations Human Rights Council, 2013, GHAN CRIM JUST MENT; United Nations Human Rights Council, 2014, REP SPEC RAPP TORT O; United Nations Human Rights Council, 2015, GHAN UN RIGHTS EXP F; World Health Organization, 2013, MENT HLTH ACT PLAN 2; World Health Organization, 2011, WHO AIMS REP MENT HL	37	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162305	10.1371/journal.pone.0162305	http://dx.doi.org/10.1371/journal.pone.0162305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618551	Green Published, gold			2022-12-27	WOS:000383653100017
J	Koo, HJ; Do, KH; Lee, JB; Alblushi, S; Lee, SM				Koo, Hyun Jung; Do, Kyung-Hyun; Lee, Jung Bok; Alblushi, Sania; Lee, Sang Min			Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CLINICAL-FEATURES; OUTCOMES; PREVALENCE; DIAGNOSIS; SMOKING; COPD	Purpose Patients with combined pulmonary fibrosis and emphysema (CPFE) have been suggested to have an increased risk of lung cancer. We conducted a systematic review of all published data and performed a meta-analysis to define the characteristics of lung cancer that develops in CPFE. Method We searched Pubmed, Embase, and Cochrane to find original articles about lung cancer and CPFE published prior to September 2015. All titles/abstracts were reviewed by two radiologists to identify articles that used predefined selection criteria. Summary estimates were generated using a random-effect model and odds ratios (ORs) to develop squamous cell carcinoma (SqCC) were calculated. Kaplan-Meier survival curves were obtained for the survival of patients with CPFE and non-CPFE. Results Nine original articles that assessed 620 patients were included in this review. In the pooled data, patients were older age (70.4 years), almost all were heavy smokers (53.5 pack years), and males were predominant (92.6%). SqCC was the most common type (42.3%), followed by adenocarcinoma (34.4%). Compared with lung cancer population with an otherwise normal lung, the OR to develop SqCC in CPFE was 9.06 (95% CI, 6.08-13.5). The ORs in CPFE compared with lung cancers that developed in lungs with fibrosis or emphysema were also higher. The median survival for CPFE patients with lung cancer (19.5 months) was significantly shorter than in non-CPFE (53.1 months). Conclusions Lung cancer in CPFE, most commonly SqCC, presents in elderly heavy smokers with a male predominance. The median survival for CPFE patients with lung cancer is 19.5 months.	[Koo, Hyun Jung; Do, Kyung-Hyun; Lee, Sang Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Koo, Hyun Jung; Do, Kyung-Hyun; Lee, Sang Min] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Lee, Jung Bok] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Epidemiol & Biostat, Seoul, South Korea; [Alblushi, Sania] Matern & Childrens Hosp, Dammam, Saudi Arabia	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Do, KH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Do, KH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	dokh@amc.seoul.kr		Koo, Hyun Jung/0000-0001-5640-3835				Arends LR, 2008, STAT MED, V27, P4381, DOI 10.1002/sim.3311; Cottin V, 2005, AM J RESP CRIT CARE, V172, P1605; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Fujiwara A, 2013, THORAC CANCER, V4, P354, DOI 10.1111/1759-7714.12023; Fukui M, 2016, SURG TODAY, V46, P341, DOI 10.1007/s00595-015-1234-z; Girard N, 2014, J THORAC ONCOL, V9, P1162, DOI 10.1097/JTO.0000000000000209; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Kitaguchi Y, 2010, RESPIROLOGY, V15, P265, DOI 10.1111/j.1440-1843.2009.01676.x; Kumagai S, 2014, EUR J CARDIO-THORAC, V46, pE113, DOI 10.1093/ejcts/ezu384; Kwak N, 2014, RESP MED, V108, P524, DOI 10.1016/j.rmed.2013.11.013; Loganathan RS, 2006, CHEST, V129, P1305, DOI 10.1378/chest.129.5.1305; Mimae T, 2015, ANN SURG ONCOL, V22, pS1371, DOI 10.1245/s10434-015-4577-1; Minegishi Y, 2014, LUNG CANCER, V85, P258, DOI 10.1016/j.lungcan.2014.05.016; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Portillo K, 2012, PULM MED, V2012, DOI 10.1155/2012/867870; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Usui K, 2011, RESPIROLOGY, V16, P326, DOI 10.1111/j.1440-1843.2010.01907.x; WIGGINS J, 1990, RESP MED, V84, P365, DOI 10.1016/S0954-6111(08)80070-4; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	22	34	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161437	10.1371/journal.pone.0161437	http://dx.doi.org/10.1371/journal.pone.0161437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618692	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100009
J	Zhang, Z; Li, M; Chen, FX; Li, LX; Liu, J; Li, Z; Ji, R; Zuo, XL; Li, YQ				Zhang, Zhen; Li, Ming; Chen, Feixue; Li, Lixiang; Liu, Jun; Li, Zhen; Ji, Rui; Zuo, Xiuli; Li, Yanqing			Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo	PLOS ONE			English	Article							STROMAL CELLS; BONE-MARROW; THERAPY; DELIVERY; CANCER; GROWTH; METASTASIS; ANTIBODIES; MIGRATION; APOPTOSIS	Introduction Mesenchymal stem cells (MSCs) can serve as vehicles for therapeutic genes. However, little is known about MSC behavior in vivo. Here, we demonstrated that probe-based confocal laser endomicroscopy (pCLE) can be used to track MSCs in vivo and individually monitor tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) gene expression within carcinomas. Methods Isolated BALB/c nu/nu mice MSCs (MSCs) were characterized and engineered to co-express the TRAIL and enhanced green fluorescent protein (EGFP) genes. The number of MSCs co-expressing EGFP and TRAIL (TRAIL-MSCs) at tumor sites was quantified with pCLE in vivo, while their presence was confirmedusing immunofluorescence (IF) and quantitative polymerase chain reaction (qPCR). The therapeutic effects of TRAIL-MSCs were evaluated by measuring the volumes and weights of subcutaneous HT29-derived xenograft tumors. Results Intravital imaging of the subcutaneous xenograft tumors revealed that BALB/c mice treated with TRAIL-MSCs exhibited specific cellular signals, whereas no specific signals were observed in the control mice. The findings from the pCLE images were consistent with the IF and qPCR results. Conclusion The pCLE results indicated that endomicroscopy could effectively quantify injected MSCs that homed to subcutaneous xenograft tumor sites in vivo and correlated well with the therapeutic effects of the TRAIL gene. By applying pCLE for the in vivo monitoring of cellular trafficking, stem cell-based anticancer gene therapeutic approaches might be feasible and attractive options for individualized clinical treatments.	[Zhang, Zhen; Li, Ming; Chen, Feixue; Liu, Jun; Li, Zhen; Ji, Rui; Zuo, Xiuli; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Zhang, Zhen; Li, Lixiang] Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Jinan, Peoples R China	Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China.	liyanqing@sdu.edu.cn	Li, Zhen/AFK-5293-2022; Li, Zhen/HHM-3328-2022; Li, Zhen/AAH-2515-2022	Li, Zhen/0000-0002-9783-169X; 	National Natural Science Foundation of China [81330012, 81300284]; Shandong Province Science and Technology Committee [2013GSF11833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Science and Technology Committee	This study was funded by the National Natural Science Foundation of China (grant numbers 81330012 and 81300284) and the Shandong Province Science and Technology Committee (grant number 2013GSF11833). They are 81300284 to R.J, 81330012 and 2013GSF11833 to Y.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China (grant numbers 81330012 and 81300284) and the Shandong Province Science and Technology Committee (grant number 2013GSF11833).	Altmeyer A, 2011, IN VIVO, V25, P1; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Atreya R, 2014, NAT MED, V20, P313, DOI 10.1038/nm.3462; Barczewska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074658; Belmar-Lopez C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-139; Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; Bipat S, 2012, NETH J MED, V70, P26; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duiker EW, 2006, EUR J CANCER, V42, P2233, DOI 10.1016/j.ejca.2006.03.018; Dwyer RM, 2010, HUM GENE THER, V21, P1506, DOI 10.1089/hum.2010.135; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Goetz M, 2013, ENDOSCOPY, V45, P469, DOI 10.1055/s-0032-1326361; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Grisendi G, 2010, CANCER RES, V70, P3718, DOI 10.1158/0008-5472.CAN-09-1865; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Jarrett Monica, 2003, J Spec Pediatr Nurs, V8, P81, DOI 10.1111/j.1088-145X.2003.00081.x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Ju SH, 2007, RADIOLOGY, V245, P206, DOI 10.1148/radiol.2443061290; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Khalil PN, 2007, GASTROENTEROLOGY, V132, P944, DOI 10.1053/j.gastro.2006.12.029; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, P1975, DOI DOI 10.1093/JNCI/DJV048; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Li M, 2015, INFLAMM BOWEL DIS, V21, P2068, DOI 10.1097/MIB.0000000000000458; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Millard SM, 2013, BIOESSAYS, V35, P173, DOI 10.1002/bies.201200087; Morgan B, 2011, NAT REV CLIN ONCOL, V8, P517, DOI 10.1038/nrclinonc.2011.62; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Mueller LP, 2011, CANCER GENE THER, V18, P229, DOI 10.1038/cgt.2010.68; Oh Y, 2015, J CONTROL RELEASE, V220, P671, DOI 10.1016/j.jconrel.2015.09.014; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Ruan J, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-309; Ruan J, 2011, INT J NANOMED, V6, P425, DOI 10.2147/IJN.S16498; Sathornsumetee S, 2006, ANTI-CANCER DRUG, V17, P1003, DOI 10.1097/01.cad.0000231473.00030.1f; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stoff-Khalili MA, 2007, BREAST CANCER RES TR, V105, P157, DOI 10.1007/s10549-006-9449-8; Tummala S, 2016, DRUG DELIV, V23, P1773, DOI 10.3109/10717544.2015.1084400; Wang Z, 2009, NANOSCALE RES LETT, V4, P593, DOI 10.1007/s11671-009-9292-z; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	50	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162700	10.1371/journal.pone.0162700	http://dx.doi.org/10.1371/journal.pone.0162700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617958	gold, Green Submitted, Green Published			2022-12-27	WOS:000383653100043
J	Fleckenstein, J; Jelden, M; Kremp, S; Jagoda, P; Stroeder, J; Khreish, F; Ezziddin, S; Buecker, A; Rube, C; Schneider, GK				Fleckenstein, Jochen; Jelden, Michael; Kremp, Stephanie; Jagoda, Philippe; Stroeder, Jonas; Khreish, Fadi; Ezziddin, Samer; Buecker, Arno; Ruebe, Christian; Schneider, Guenther K.			The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LOCALLY ADVANCED NSCLC; PET; DELINEATION; DISEASE; SCANS	Objective The study was designed to evaluate diffusion-weighted magnetic resonance imaging (DWI) vs. PET-CT of the thorax in the determination of gross tumor volume (GTV) in radiotherapy planning of non-small-cell lung cancer (NSCLC). Materials and Methods Eligible patients with NSCLC who were supposed to receive definitive radio(chemo) therapy were prospectively recruited. For MRI, a respiratory gated T2-weighted sequence in axial orientation and non-gatedDWI (b = 0, 800, 1,400 and apparent diffusion coefficient map [ADC]) were acquired on a 1.5 Tesla scanner. Primary tumors were delineated on FDGPET/CT (stGTV) and DWI images (dwGTV). The definition of stGTV was based on the CT and visually adapted to the FDG-PET component if indicated (e.g., in atelectasis). For DWI, dwGTV was visually determined and adjusted for anatomical plausibility on T2w sequences. Beside a statistical comparison of stGTV and dwGTB, spatial agreementwas determined with the "Hausdorff-Distance" (HD) and the "Dice Similarity Coefficient" (DSC). Results Fifteen patients (one patient with two synchronous NSCLC) were evaluated. For 16 primary tumors with UICC stages I (n = 4), II (n = 3), IIIA (n = 2) and IIIB (n = 7) mean values for dwGTV were significantly larger than those of stGTV (76.6 +/- 84.5 ml vs. 66.6 +/- 75.2 ml, p<0.01). The correlation of stGTV and dwGTV was highly significant (r = 0.995, p<0.001). Yet, some considerable volume deviations between these two methods were observed (median 27.5%, range 0.4-52.1%). An acceptable agreement between dwGTV and stGTV regarding the spatial extent of primary tumors was found (average HD: 2.25 +/- 0.7 mm; DC 0.68 +/- 0.09). Conclusion The overall level of agreement between PET-CT and MRI based GTV definition is acceptable. Tumor volumes may differ considerably in single cases. DWI-derived GTVs are significantly, yet modestly, larger than their PET-CT based counterparts. Prospective studies to assess the safety and efficacy of DWI-based radiotherapy planning in NSCLC are warranted.	[Fleckenstein, Jochen; Jelden, Michael; Kremp, Stephanie; Ruebe, Christian] Univ Saarland, Med Ctr, Dept Radiotherapy & Radiat Oncol, Homburg, Germany; [Jagoda, Philippe; Stroeder, Jonas; Schneider, Guenther K.] Univ Saarland, Med Ctr, Dept Diagnost & Intervent Radiol, Homburg, Germany; [Khreish, Fadi; Ezziddin, Samer; Buecker, Arno] Univ Saarland, Med Ctr, Dept Nucl Med, Homburg, Germany	Saarland University; Saarland University; Saarland University	Fleckenstein, J (corresponding author), Univ Saarland, Med Ctr, Dept Radiotherapy & Radiat Oncol, Homburg, Germany.	jochen.fleckenstein@uks.eu	Ezziddin, Samer/E-8406-2014	Ezziddin, Samer/0000-0003-4110-3375; Stroeder, Jonas/0000-0001-8498-6134				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Chen W, 2010, MAGN RESON IMAGING, V28, P613, DOI 10.1016/j.mri.2010.02.009; De Ruysscher D, 2012, LUNG CANCER, V75, P141, DOI 10.1016/j.lungcan.2011.07.018; De Ruysscher D, 2010, J CLIN ONCOL, V28, P5301, DOI 10.1200/JCO.2010.30.3271; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Everitt S, 2010, CANCER-AM CANCER SOC, V116, P5030, DOI 10.1002/cncr.25392; Fleckenstein J, 2016, STRAHLENTHER ONKOL, V192, P75, DOI 10.1007/s00066-015-0900-9; Fleckenstein J, 2011, INT J RADIAT ONCOL, V81, pE283, DOI 10.1016/j.ijrobp.2011.01.020; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Konert T, 2015, RADIOTHER ONCOL, V116, P27, DOI 10.1016/j.radonc.2015.03.014; Liao ZXX, 2010, INT J RADIAT ONCOL, V76, P775, DOI 10.1016/j.ijrobp.2009.02.032; McCloskey P, 2013, EUR J CANCER, V49, P1555, DOI 10.1016/j.ejca.2012.12.023; Ohba Y, 2009, J THORAC CARDIOV SUR, V138, P439, DOI 10.1016/j.jtcvs.2008.12.026; Ohno Y, 2011, RADIOLOGY, V261, P605, DOI 10.1148/radiol.11110281; Palma D, 2012, INT J RADIAT ONCOL, V82, P1149, DOI 10.1016/j.ijrobp.2011.03.005; Schaefer A, 2013, EUR J NUCL MED MOL I, V40, P1233, DOI 10.1007/s00259-013-2407-x; Sommer G, 2012, EUR RADIOL, V22, P2859, DOI 10.1007/s00330-012-2542-y; Ung YC, 2011, J THORAC ONCOL, V6, P86, DOI 10.1097/JTO.0b013e3181fc7687; Wu LM, 2012, J SURG RES, V178, P304, DOI 10.1016/j.jss.2012.03.074; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	21	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162816	10.1371/journal.pone.0162816	http://dx.doi.org/10.1371/journal.pone.0162816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612171	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900170
J	Lei, Y; Hu, TT; Song, XF; Nie, H; Chen, M; Chen, WX; Zhou, Z; Zhang, DZ; Hu, HD; Hu, P; Ren, H				Lei, Yu; Hu, Tingting; Song, Xiaofei; Nie, Hong; Chen, Min; Chen, Weixian; Zhou, Zhi; Zhang, Dazhi; Hu, Huaidong; Hu, Peng; Ren, Hong			Production of Autoantibodies in Chronic Hepatitis B Virus Infection Is Associated with the Augmented Function of Blood CXCR5(+)CD4(+) T Cells	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; IL-21; DIFFERENTIATION; SEROCONVERSION; PATHOGENESIS; EXPRESSION; EXPANSION; HBV	T follicular helper cells (Tfh) provide help to B cells to support their activation, expansion and differentiation. However, the role of Tfh cells in chronic HBV infection is poorly defined. The aim of this research was to examine the function of Tfh cells and whether they are involved in HBV related disease. Blood CXCR5(+)CD4(+) T cells and B cells in 85 patients with chronic HBV infection (HBV patients) and health controls (HC) were examined by flow cytometry. The molecule expression in blood CXCR5(+)CD4(+) T cells was detected by realtime PCR. Blood CXCR5(+)CD4(+) T cells and B cells were co-cultured and the production of Ig and cytokines was detected by ELISA. Autoantibodies were detected by indirect immunofluorescence and immunospot assay. We found that blood CXCR5(+)CD4(+) T cells in patients with chronic HBV infection (HBV patients) expressed higher level of activation related molecules and cytokines than that from health controls (HC). In HBV patients, the frequency of blood CXCR5(+)CD4(+) T cells was significantly correlated with serum ALT and AST. We also found that blood CXCR5(+)CD4(+) T cells from HBV patients could induce B cells to secret higher level of immunoglobulin than that from HC. Several autoantibodies, including ANA, ss-A, ss-B, Scl-70, Jo-1, ect, were indeed positive in 65% HBV patients. Among HBV patients, expression of function related molecules was significantly higher in blood CXCR5(+)CD4(+) T cells from patients with autoantibodies than that without autoantibodies. Our research indicated that blood CXCR5(+)CD4(+) T cells from HBV patients were over activated and show augmented capacity to help B cells for antibody secreting, which might correlated with liver inflammation and the production of autoantibodies in extrahepatic manifestations.	[Lei, Yu; Hu, Tingting; Song, Xiaofei; Chen, Min; Zhou, Zhi; Zhang, Dazhi; Hu, Huaidong; Hu, Peng; Ren, Hong] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis,Minist Educ, Inst Viral Hepatitis,Key Lab Mol Biol Infect Dis, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China; [Nie, Hong; Chen, Weixian] Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University	Hu, P; Ren, H (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis,Minist Educ, Inst Viral Hepatitis,Key Lab Mol Biol Infect Dis, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China.	hp_cq@163.com; renhong0531@vip.sina.com			National Natural Science Foundation of China [30930082, 31000397, 81171561]; National Science and Technology Major Project of China [2008ZX10002-006, 2012ZX1002007001, 2012ZX09303001-001]; Key Project of Chongqing Science and Technology Commission [cstc2012gg-yyjsB10007]; Chongqing Post-doctor grant [XM20120016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Key Project of Chongqing Science and Technology Commission; Chongqing Post-doctor grant	This work was supported by the National Natural Science Foundation of China http://www.nsfc.gov.cn/, [grant numbers 30930082 to HongRen, 31000397 to Yu Lei, 81171561 to Peng Hu], the National Science and Technology Major Project of China http://www.nmp.gov.cn [grant numbers 2008ZX10002-006, 2012ZX1002007001, 2012ZX09303001-001 to Hong Ren], the Key Project of Chongqing Science and Technology Commission http://www.cqwsjsw.gov.cn/ [grant number cstc2012gg-yyjsB10007 to Hong Ren], Chongqing Post-doctor grant http://www.cqhrss.gov.cn/ [grant number XM20120016 to Yu Lei].	Amarapurkar Deepak N, 2002, Ann Hepatol, V1, P192; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cacoub P, 2005, J HEPATOL, V43, P764, DOI 10.1016/j.jhep.2005.05.029; Cacoub P, 2009, RHEUM DIS CLIN N AM, V35, P125, DOI 10.1016/j.rdc.2009.03.006; Chen M, 2008, J INFECT DIS, V198, P1643, DOI 10.1086/593065; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Han Steven-Huy B, 2004, Clin Liver Dis, V8, P403, DOI 10.1016/j.cld.2004.02.003; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hu TT, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-54; Kakimi K, 2001, J IMMUNOL, V167, P6701, DOI 10.4049/jimmunol.167.12.6701; Li YY, 2013, HEPATOLOGY, V58, P1277, DOI 10.1002/hep.26489; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma SW, 2012, J HEPATOL, V56, P775, DOI 10.1016/j.jhep.2011.10.020; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wang LF, 2015, HEPATOLOGY, V61, P627, DOI 10.1002/hep.27306; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	33	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162241	10.1371/journal.pone.0162241	http://dx.doi.org/10.1371/journal.pone.0162241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612199	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900067
J	Lin, Y; Krogh-Andersen, K; Pelletier, J; Marcotte, H; Ostenson, CG; Hammarstrom, L				Lin, Yin; Krogh-Andersen, Kasper; Pelletier, Julien; Marcotte, Harold; Ostenson, Claes-Goran; Hammarstrom, Lennart			Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; LACTOCOCCUS-LACTIS; INSULIN-RESISTANCE; GLUCOSE; INCRETIN; RELEASE; GLP-1; EXPRESSION; GLYCEMIA; PLASMA	Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by intestinal cells and stimulates insulin secretion from the pancreas in a glucose-dependent manner. Exogenously supplied GLP-1 analogues are used in the treatment of type 2 diabetes. An anti-diabetic effect of Lactobacillus in lowering plasma glucose levels and its use as a vehicle for delivery of protein and antibody fragments has been shown previously. The aim of this study was to employ lactobacilli as a vehicle for in situ production and delivery of GLP-1 analogue to normalize blood glucose level in diabetic GK (Goto-Kakizaki) rats. In this study, we designed pentameric GLP-1 (5xGLP-1) analogues which were both expressed in a secreted form and anchored to the surface of lactobacilli. Intestinal trypsin sites were introduced within 5xGLP-1, leading to digestion of the pentamer into an active monomeric form. The E. coli-produced 5xGLP-1 peptides delivered by intestinal intubation to GK rats resulted in a significant improvement of glycemic control demonstrated by an intraperitoneal glucose tolerance test. Meanwhile, the purified 5xGLP-1 (trypsin-digested) from the Lactobacillus cultures stimulated insulin secretion from HIT-T15 cells, similar to the E. coli-produced 5xGLP-1 peptides. When delivered by gavage to GK rats, non-expressor L. paracasei significantly lowered the blood glucose level but 5xGLP-1 expression did not provide an additional anti-diabetic effect, possibly due to the low levels produced. Our results indicate that lactobacilli themselves might be used as an alternative treatment method for type 2 diabetes, but further work is needed to increase the expression level of GLP-1 by lactobacilli in order to obtain a significant insulinotropic effect in vivo.	[Lin, Yin; Krogh-Andersen, Kasper; Marcotte, Harold; Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, SE-14186 Stockholm, Sweden; [Pelletier, Julien; Ostenson, Claes-Goran] M1 03 Karolinska Univ Hosp, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hammarstrom, L (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, SE-14186 Stockholm, Sweden.	lennart.hammarstrom@ki.se	Marcotte, Harold/P-9375-2017	Marcotte, Harold/0000-0002-7168-349X	Novo Nordisk Foundation [53101003]; China Scholarship Council; Swedish Research Council; Swedish Diabetes Association	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); China Scholarship Council(China Scholarship Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association	This work was funded by a grant from the Novo Nordisk Foundation, grant number: 53101003 (http://www.novonordiskfonden.dk/en/content/foundations-grants). YL was financially supported by the China Scholarship Council, www.csc.edu.cn. CGO was Funded by Swedish Research Council, www.vr.se, and Swedish Diabetes Association, www.sdf.se. The Novo Nordisk foundation and other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo-Felix E, 2003, INT J SYST EVOL MICR, V53, P67, DOI 10.1099/ijs.0.02325-0; Agarwal P, 2014, PHARM RES-DORDR, V31, P3404, DOI 10.1007/s11095-014-1430-3; Akash MSH, 2013, CURR DIABETES REV, V9, P387, DOI 10.2174/15733998113099990069; Andersen KK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-126; Araujo Francisca, 2012, J Diabetes Sci Technol, V6, P1486; Arulmozhi DK, 2006, EUR J PHARM SCI, V28, P96, DOI 10.1016/j.ejps.2006.01.003; Bond Aaron, 2006, Proc (Bayl Univ Med Cent), V19, P281; Burcelin R, 1999, METABOLISM, V48, P252, DOI 10.1016/S0026-0495(99)90043-4; Chae SY, 2008, BIOCONJUGATE CHEM, V19, P334, DOI 10.1021/bc700292v; Chaikomin R, 2005, AM J PHYSIOL-ENDOC M, V289, pE504, DOI 10.1152/ajpendo.00099.2005; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Martin MC, 2011, APPL ENVIRON MICROB, V77, P2174, DOI 10.1128/AEM.02690-10; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Duan FF, 2015, DIABETES, V64, P1794, DOI 10.2337/db14-0635; Fehmann HC, 1997, INSULINOTROPIC GUT H; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Gunaydin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096409; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hsieh FC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-35; Hui HX, 2002, EUR J ENDOCRINOL, V146, P863, DOI 10.1530/eje.0.1460863; Joseph JW, 2000, DIABETOLOGIA, V43, P1319, DOI 10.1007/s001250051529; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Kumar V, 2014, ROBBINS COTRAN PATHO; Kuo P, 2008, REGUL PEPTIDES, V146, P1, DOI 10.1016/j.regpep.2007.09.032; Levy JC, 2006, DIABETIC MED, V23, P14, DOI 10.1111/j.1464-5491.2006.01833e.x; Lin CH, 2014, BRIT J NUTR, V111, P1712, DOI 10.1017/S0007114513003656; Marcotte H, 2006, J APPL MICROBIOL, V100, P256, DOI 10.1111/j.1365-2672.2005.02786.x; Mathiesen G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-425; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Muller C, 2015, MOL MED, V21, P969, DOI 10.2119/molmed.2015.00267; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Nauck MA, 1999, DIABETOLOGIA, V42, P373, DOI 10.1007/s001250051165; Nguyen HN, 2011, BIOMATERIALS, V32, P2673, DOI 10.1016/j.biomaterials.2010.12.044; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; OSTENSON CG, 1986, MOL CELL ENDOCRINOL, V45, P215, DOI 10.1016/0303-7207(86)90150-4; Panwar H, 2013, DIABETES-METAB RES, V29, P103, DOI 10.1002/dmrr.2376; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Shirazi R, 2013, P NATL ACAD SCI USA, V110, P16199, DOI 10.1073/pnas.1306799110; Simon MC, 2015, DIABETES CARE, V38, P1827, DOI 10.2337/dc14-2690; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Steinert RE, 2009, CLIN PHARMACOL THER, V86, P644, DOI 10.1038/clpt.2009.159; SUZUKI S, 1989, ENDOCRINOLOGY, V125, P3109, DOI 10.1210/endo-125-6-3109; Tabuchi M, 2003, BIOSCI BIOTECH BIOCH, V67, P1421, DOI 10.1271/bbb.67.1421; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Yassin K, 2011, Int J Biomed Sci, V7, P131; Youn YS, 2008, EUR J PHARM BIOPHARM, V68, P667, DOI 10.1016/j.ejpb.2007.07.009; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x	50	15	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162733	10.1371/journal.pone.0162733	http://dx.doi.org/10.1371/journal.pone.0162733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610615	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900159
J	Mariani, E; Frabetti, F; Tarozzi, A; Pelleri, MC; Pizzetti, F; Casadei, R				Mariani, Elisa; Frabetti, Flavia; Tarozzi, Andrea; Pelleri, Maria Chiara; Pizzetti, Fabrizio; Casadei, Raffaella			Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression	PLOS ONE			English	Article							REFERENCE MAP; INSIGHTS; GENOMICS; PROTEIN; INVOLVEMENT; MICRORNAS; EVOLUTION; PEPTIDES; INVASION; PATHWAYS	The understanding of the genetic basis of the Parkinson's disease (PD) and the correlation between genotype and phenotype has revolutionized our knowledge about the pathogenetic mechanisms of neurodegeneration, opening up exciting new therapeutic and neuroprotective perspectives. Genomic knowledge of PD is still in its early stages and can provide a good start for studies of the molecular mechanisms that underlie the gene expression variations and the epigenetic mechanisms that may contribute to the complex and characteristic phenotype of PD. In this study we used the software TRAM (Transcriptome Mapper) to analyse publicly available microarray data of a total of 151 PD patients and 130 healthy controls substantia nigra (SN) samples, to identify chromosomal segments and gene loci differential expression. In particular, we separately analyzed PD patients and controls data from post-mortemsnap-frozen SN whole tissue and from laser microdissected midbrain dopamine (DA) neurons, to better characterize the specific DA neuronal expression profile associated with the late-stage Parkinson's condition. The default "Map" mode analysis resulted in 10 significantly over/under-expressed segments, mapping on 8 different chromosomes for SN whole tissue and in 4 segments mapping on 4 different chromosomes for DA neurons. In conclusion, TRAM software allowed us to confirm the deregulation of some genomic regions and loci involved in key molecular pathways related to neurodegeneration, as well as to provide new insights about genes and non-coding RNA transcripts not yet associated with the disease.	[Mariani, Elisa; Tarozzi, Andrea; Casadei, Raffaella] Univ Bologna, Dept Life Qual Studies, Rimini, Italy; [Frabetti, Flavia; Pelleri, Maria Chiara; Pizzetti, Fabrizio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy	University of Bologna; University of Bologna	Casadei, R (corresponding author), Univ Bologna, Dept Life Qual Studies, Rimini, Italy.	r.casadei@unibo.it	Casadei, Raffaella/K-1730-2015	Casadei, Raffaella/0000-0001-9595-8577; PIZZETTI, FABRIZIO/0000-0002-7712-0209	"Fondazione Del Monte di Bologna e Ravenna" grant [542bis/2012]	"Fondazione Del Monte di Bologna e Ravenna" grant	This work was supported by a "Fondazione Del Monte di Bologna e Ravenna" grant to AT, FF and RC, Grant number 542bis/2012, http://fondazionedelmonte.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research was supported by a "Fondazione Del Monte di Bologna e Ravenna" grant. We are grateful to Dr. Kay Sonntag for kindly providing us the raw data of their study [16]. The Authors wish to thank Dr. Francesca Biondi for helping with the English revision of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellucci A, 2016, NEUROPATH APPL NEURO, V42, P77, DOI 10.1111/nan.12297; Belovari T, 2015, BOSNIAN J BASIC MED, V15, P33, DOI 10.17305/bjbms.2015.251; Bonifati V., 2000, MADAME CURIE BIOSCIE; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Caracausi M, 2016, HIPPOCAMPUS, V26, P13, DOI 10.1002/hipo.22483; Caracausi M, 2014, NEUROGENETICS, V15, P267, DOI 10.1007/s10048-014-0419-8; Cardoso AL, 2016, CURR OPIN PHARMACOL, V26, P1, DOI 10.1016/j.coph.2015.09.001; Coppede F, 2012, SCI WORLD J, DOI 10.1100/2012/489830; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; DelleDonne A, 2008, ARCH NEUROL-CHICAGO, V65, P1074, DOI 10.1001/archneur.65.8.1074; Depboylu C, 2011, J NEUROPATH EXP NEUR, V70, P125, DOI 10.1097/NEN.0b013e31820805b9; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; Durrenberger PF, 2012, ACTA NEUROPATHOL, V124, P893, DOI 10.1007/s00401-012-1027-z; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; Foroud T, 2006, EUR J HUM GENET, V14, P1106, DOI 10.1038/sj.ejhg.5201666; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Guo XB, 2011, WORLD J GASTROENTERO, V17, P1895, DOI 10.3748/wjg.v17.i14.1895; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hill-Burns EM, 2013, PHARMACOGENOMICS J, V13, P530, DOI 10.1038/tpj.2012.38; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Lenzi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-121; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Marei HES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028420; Marques SCF, 2011, PROG NEURO-PSYCHOPH, V35, P348, DOI 10.1016/j.pnpbp.2010.08.008; Mollereau B, 2016, BRAIN RES, V1648, P603, DOI 10.1016/j.brainres.2016.02.033; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Moran LB, 2008, ACTA NEUROPATHOL, V115, P471, DOI 10.1007/s00401-007-0309-3; Mullin S, 2015, BRIT MED BULL, V114, P39, DOI 10.1093/bmb/ldv022; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nemeth BC, 2014, WORLD J GASTROENTERO, V20, P9128, DOI 10.3748/wjg.v20.i27.9128; Nowack A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029560; Pelleri MC, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0063-z; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Pontius J., 2003, NCBI HDB, P1; Pribiag H, 2014, NEUROPHARMACOLOGY, V78, P13, DOI 10.1016/j.neuropharm.2013.06.008; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Schulte C, 2011, APPL CLIN GENET, V4, P67, DOI 10.2147/TACG.S11639; Siangphoe U, 2015, JAIDS-J ACQ IMM DEF, V70, P479, DOI 10.1097/QAI.0000000000000800; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Soreq L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003517; Stark AK, 2004, CELL TISSUE RES, V318, P81, DOI 10.1007/s00441-004-0972-9; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; TANAKA H, 1991, NEUROLOGY, V41, P719, DOI 10.1212/WNL.41.5.719; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Tomasetto C, 2000, GASTROENTEROLOGY, V118, P70, DOI 10.1016/S0016-5085(00)70415-X; Vernier P, 2004, ANN NY ACAD SCI, V1035, P231, DOI 10.1196/annals.1332.015; Watt AD, 2015, J ALZHEIMERS DIS, V44, P1131, DOI 10.3233/JAD-142286; Wilson C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00381; Zawada WM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0189-z; Zhang R, 2015, J NEURO-ONCOL, V121, P63, DOI 10.1007/s11060-014-1607-y; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	68	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161567	10.1371/journal.pone.0161567	http://dx.doi.org/10.1371/journal.pone.0161567			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611585	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900021
J	Naraballobh, W; Trakooljul, N; Murani, E; Brunner, R; Krischek, C; Janisch, S; Wicke, M; Ponsuksili, S; Wimmers, K				Naraballobh, Watcharapong; Trakooljul, Nares; Murani, Eduard; Brunner, Ronald; Krischek, Carsten; Janisch, Sabine; Wicke, Michael; Ponsuksili, Siriluck; Wimmers, Klaus			Transient Shifts of Incubation Temperature Reveal Immediate and Long-Term Transcriptional Response in Chicken Breast Muscle Underpinning Resilience and Phenotypic Plasticity	PLOS ONE			English	Article							MEAT QUALITY; EGGSHELL TEMPERATURE; GROWTH; GENE; EMBRYOS; PERFORMANCE; DISRUPTION; EXPRESSION; TOLERANCE; TISSUE	Variations in egg incubation temperatures can have acute or long-term effects on gene transcription in avian species. Altered gene expression may, in turn, affect muscle traits in poultry and indirectly influence commercial production. To determine how changes in eggshell temperature affect gene expression, incubation temperatures were varied [36.8 degrees C (low), 37.8 degrees C (control), 38.8 degrees C (high)] at specific time periods reflecting two stages of myogenesis [embryonic days (ED) 7-10 and 10-13]. Gene expression was compared between interventions and matching controls by microarrays in broiler breast muscle at ED10 or ED13 and post-hatch at day 35. Early (ED7-10) high incubation temperature (H10 Delta C) resulted in 1370 differentially expressed genes (DEGs) in embryos. Ingenuity pathway analysis revealed temporary activation of cell maintenance, organismal development, and survival ability genes, but these effects were not maintained in adults. Late high incubation temperature (ED10-13) (H13 Delta C) had slightly negative impacts on development of cellular components in embryos, but a cumulative effect was observed in adults, in which tissue development and nutrition metabolism were affected. Early low incubation temperature (L10 Delta C) produced 368 DEGs, most of which were down-regulated and involved in differentiation and formation of muscle cells. In adults, this treatment down-regulated pathways of transcriptional processes, but up-regulated cell proliferation. Late low temperature incubation (L13 Delta C) produced 795 DEGs in embryos, and activated organismal survival and post-transcriptional regulation pathways. In adults this treatment activated cellular and organ development, nutrition and small molecule activity, and survival rate, but deactivated size of body and muscle cells. Thermal interventions during incubation initiate immediate and delayed transcriptional responses that are specific for timing and direction of treatment. Interestingly, the transcriptional response to transiently decreased incubation temperature, which did not affect the phenotypes, prompts compensatory effects reflecting resilience. In contrast, higher incubation temperature triggers gene expression and has long-term effects on the phenotype. These mechanisms of considerable phenotypic plasticity contribute to the biodiversity and broaden the basis for managing poultry populations.	[Naraballobh, Watcharapong; Trakooljul, Nares; Murani, Eduard; Brunner, Ronald; Ponsuksili, Siriluck; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany; [Krischek, Carsten] Fdn Univ Vet Med, Inst Food Qual & Food Safety, D-30173 Hannover, Germany; [Janisch, Sabine; Wicke, Michael] Univ Gottingen, Dept Anim Sci, Qual Food Anim Origin, D-37037 Gottingen, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); University of Veterinary Medicine Hannover, Foundation; University of Gottingen	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	naraballobh, watcharapong/HIR-1593-2022; Wimmers, Klaus/AAF-9434-2020	Trakooljul, Nares/0000-0002-3214-2498; Wimmers, Klaus/0000-0002-9523-6790	German Research Foundation (DFG) [WE 4079/4-1, WI 1754/15-1, WI 2072/9-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG www.dfg.de; WE 4079/4-1, WI 1754/15-1, WI 2072/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA A, 1993, MOL CELL BIOL, V13, P7153, DOI 10.1128/MCB.13.11.7153; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cooper GM., 2000, CELL MOL APPROACH, P63; Cordova G, 2015, J CELL BIOCHEM, V116, P1880, DOI 10.1002/jcb.25143; Du WG, 2015, BIOL REV, V90, P19, DOI 10.1111/brv.12089; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Hadad Yair, FEATHERLESS FEATHERE; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Janisch S, 2015, POULTRY SCI, V94, P2581, DOI 10.3382/ps/pev239; Jia CX, 2010, AUK, V127, P926, DOI 10.1525/auk.2010.09254; Joseph NS, 2006, POULTRY SCI, V85, P932, DOI 10.1093/ps/85.5.932; Krischek C, 2013, BRIT POULTRY SCI, V54, P5, DOI 10.1080/00071668.2013.763901; Krischek C, 2016, MOL REPROD DEV, V83, P71, DOI 10.1002/mrd.22596; LILL A, 1979, CONDOR, V81, P225, DOI 10.2307/1367621; Lourens A, 2005, POULTRY SCI, V84, P914, DOI 10.1093/ps/84.6.914; Loyau T, 2015, ANIMAL, V9, P76, DOI 10.1017/S1751731114001931; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MILLER JB, 1986, J CELL BIOL, V103, P2197, DOI 10.1083/jcb.103.6.2197; MILLER JB, 1987, TRENDS NEUROSCI, V10, P325, DOI 10.1016/0166-2236(87)90089-0; Naraballobh W, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2671-9; Oster M, 2014, ACTA PHYSIOL, V210, P202, DOI 10.1111/apha.12192; Piestun Y, 2009, POULTRY SCI, V88, P2677, DOI 10.3382/ps.2009-00231; Piestun Y, 2009, J APPL PHYSIOL, V106, P233, DOI 10.1152/japplphysiol.91090.2008; Pinchuck S, 2011, EFFECT THERMAL MANIP, P44; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Seaberg B, 2015, MOL CELL BIOL, V35, P1238, DOI 10.1128/MCB.01071-14; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Um M, 2001, MOL CELL BIOL, V21, P2435, DOI 10.1128/MCB.21.7.2435-2448.2001; Wang Qiong, 2007, Yichuan, V29, P1089, DOI 10.1360/yc-007-1089; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Werner C, 2008, ARCH TIERZUCHT, V51, P11; Yamauchi J, 1997, BIOCHEM BIOPH RES CO, V234, P406, DOI 10.1006/bbrc.1997.6653; Yang XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117607; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x	38	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162485	10.1371/journal.pone.0162485	http://dx.doi.org/10.1371/journal.pone.0162485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611643	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900113
J	Ramachandran, GK; Yong, WP; Yeow, CH				Ramachandran, Gokula Krishnan; Yong, Wei Peng; Yeow, Chen Hua			Identification of Gastric Cancer Biomarkers Using H-1 Nuclear Magnetic Resonance Spectrometry	PLOS ONE			English	Article							BREAST-CANCER; IN-VIVO; GLYCOGEN-METABOLISM; MR SPECTROSCOPY; CERVICAL-CANCER; PROTON; CELLS; 2D; 3D; MICROENVIRONMENT	Existing gastric cancer diagnosing methods were invasive, hence, a reliable non-invasive gastric cancer diagnosing method is needed. As a starting point, we used H-1 NMR for identifying gastric cancer biomarkers using a panel of gastric cancer spheroids and normal gastric spheroids. We were able to identify 8 chemical shift biomarkers for gastric cancer spheroids. Our data suggests that the cancerous and non-cancerous spheroids significantly differ in the lipid composition and energy metabolism. These results encourage the translation of these biomarkers into in-vivo gastric cancer detection methodology using MRI-MS.	[Ramachandran, Gokula Krishnan; Yeow, Chen Hua] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Yong, Wei Peng] Singapore NCIS, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore	National University of Singapore; National University of Singapore	Yeow, CH (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore.	bieych@nus.edu.sg	Yong, Wei-Peng/Y-7260-2018; Yeow, Raye Chen-Hua/AAA-3635-2020	Yong, Wei-Peng/0000-0003-4404-3777; Yeow, Raye Chen-Hua/0000-0002-6210-4548; Ramachandran, Gokula Krishnan/0000-0001-5365-4348	MOE Academic research fund (AcRF) Tier-1 grant [R397-000-143-133]	MOE Academic research fund (AcRF) Tier-1 grant	This research is funded by the MOE Academic research fund (AcRF) Tier-1 grant (R397-000-143-133) awarded to YCH at National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research is funded by the MOE Academic research fund (AcRF) Tier-1 grant (R397-000143-133) awarded to YCH at National University of Singapore, Singapore.	Alonso AP, 2010, PLANT PHYSIOL, V153, P915, DOI 10.1104/pp.110.155713; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bellis AD, 2013, BIOTECHNOL BIOENG, V110, P563, DOI 10.1002/bit.24718; BIANCHI E, 1965, J ORG CHEM, V30, P754, DOI 10.1021/jo01014a024; Bolan P. J., 2003, MAGNETIC RESONANCE M, V50, P1; Bolan PJ, 2005, BREAST CANCER RES, V7, P149, DOI 10.1186/bcr1202; Bondock S, 2008, EUR J MED CHEM, V43, P2122, DOI 10.1016/j.ejmech.2007.12.009; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Busse A, 2013, CLIN EXP METASTAS, V30, P781, DOI 10.1007/s10585-013-9578-5; CARY PD, 1978, EUR J BIOCHEM, V89, P475, DOI 10.1111/j.1432-1033.1978.tb12551.x; Chitcholtan K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-38; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; FLORIAN CL, 1995, CANCER RES, V55, P420; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Gillies RJ, 2005, ANNU REV BIOMED ENG, V7, P287, DOI 10.1146/annurev.bioeng.7.060804.100411; Grande S, 2011, NMR BIOMED, V24, P68, DOI 10.1002/nbm.1557; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Heerschap A, 1997, ANTICANCER RES, V17, P1455; HERS HG, 1976, ANNU REV BIOCHEM, V45, P167, DOI 10.1146/annurev.bi.45.070176.001123; Hong YQ, 2013, MICROBIOL-SGM, V159, P2316, DOI 10.1099/mic.0.069823-0; Huang YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08390; Ivascu A, 2007, INT J ONCOL, V31, P1403; Jacobs MA, 2004, J MAGN RESON IMAGING, V19, P68, DOI 10.1002/jmri.10427; Jayalakshmi K, 2011, NMR BIOMED, V24, P335, DOI 10.1002/nbm.1594; Jordan B.F., 2005, NMR BIOMED, V18, P430; Jordan NF, 2005, NMR BIOMED, V18, P430, DOI 10.1002/nbm.977; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Karnjanapratum S, 2012, INT J BIOL MACROMOL, V51, P720, DOI 10.1016/j.ijbiomac.2012.07.006; Kennedy J.P., 1967, J MACROMOL SCI CHEM, V1, P345, DOI [10.1080/10601326708053976, DOI 10.1080/10601326708053976]; Kilonda A, 2003, ARKIVOC, P3, DOI 10.3998/ark.5550190.0004.402; Klein A., 1988, EUROPEAN JOURNAL OF, V171, P643; Kojima H, 2013, GLYCOCONJUGATE J, V30, P257, DOI 10.1007/s10719-012-9436-8; LAMBLIN G, 1991, BIOCHEM J, V275, P199, DOI 10.1042/bj2750199; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; LIN JK, 1992, FOOD CHEM TOXICOL, V30, P695, DOI 10.1016/0278-6915(92)90165-H; LIN JK, 1983, FOOD CHEM TOXICOL, V21, P143, DOI 10.1016/0278-6915(83)90228-4; Lin R. Z., 2008, BIOTECHNOL J, V3, P139; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Mahon MM, 2004, NMR BIOMED, V17, P1, DOI 10.1002/nbm.830; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; Meisamy S, 2004, RADIOLOGY, V233, P424, DOI 10.1148/radiol.2332031285; Muncey HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-496; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Odeh F., 2012, DRUG DELIV, V19, P1; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Pore Y., 2008, DIG J NANOMATER BIOS, V3, P293; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Radermacher KA, 2012, NMR BIOMED, V25, P514, DOI 10.1002/nbm.1765; Razzak Md, 2015, INT J ORG CHEM, V5, P264; Rugge M., 2006, WORLD J GASTROENTERO, V12, P23; RUIZCABELLO J, 1992, NMR BIOMED, V5, P226, DOI 10.1002/nbm.1940050506; Saito K, 2008, ANTICANCER RES, V28, P1899; Schiavoni G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00090; SOWERS LC, 1988, J BIOL CHEM, V263, P14794; Steindl C., 2005, CARBOHYD RES, P340; Stenman K, 2011, BIOMARK INSIGHTS, V6, P39, DOI 10.4137/BMI.S6794; Teneberg S, 2004, GLYCOBIOLOGY, V14, P187, DOI 10.1093/glycob/cwh015; Ting Y ., 2009, J BIOL CHEM, V284, P21526, DOI [10.1074/jbc.M109.014761, DOI 10.1074/JBC.M109.014761]; Umbehr M, 2009, EUR UROL, V55, P575, DOI 10.1016/j.eururo.2008.10.019; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vissers MCM, 2014, BIOCHEM SOC T, V42, P945, DOI 10.1042/BST20140118; VLIEGENTHART JFG, 1981, PURE APPL CHEM, V53, P45, DOI 10.1351/pac198153010045; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yokota H, 2007, J MAGN RESON IMAGING, V25, P992, DOI 10.1002/jmri.20902; Yong J. K., 1989, J KOSOMBE, V10, P285; Yu GL, 2002, CARBOHYD RES, V337, P433, DOI 10.1016/S0008-6215(02)00009-5; Zietkowski D, 2013, NMR BIOMED, V26, P1096, DOI 10.1002/nbm.2923; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	73	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162222	10.1371/journal.pone.0162222	http://dx.doi.org/10.1371/journal.pone.0162222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611679	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900061
J	Sprigg, N; O'Connor, R; Woodhouse, L; Krishnan, K; England, TJ; Connell, LA; Walker, MF; Bath, PM				Sprigg, Nikola; O'Connor, Rebecca; Woodhouse, Lisa; Krishnan, Kailash; England, Timothy J.; Connell, Louise A.; Walker, Marion F.; Bath, Philip M.			Granulocyte Colony Stimulating Factor and Physiotherapy after Stroke: Results of a Feasibility Randomised Controlled Trial: Stem Cell Trial of Recovery EnhanceMent after Stroke-3 (STEMS-3 ISRCTN16714730)	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; THERAPY; METAANALYSIS; EFFICACY; DONORS; SCALE	Background Granulocyte-colony stimulating factor (G-CSF) mobilises endogenous haematopoietic stem cells and enhances recovery in experimental stroke. Recovery may also be dependent on an enriched environment and physical activity. G-CSF may have the potential to enhance recovery when used in combination with physiotherapy, in patients with disability late after stroke. Methods A pilot 2 x 2 factorial randomised (1:1) placebo-controlled trial of G-CSF (double-blind), and/or a 6 week course of physiotherapy, in 60 participants with disability (mRS > 1), at least 3 months after stroke. Primary outcome was feasibility, acceptability and tolerability. Secondary outcomes included death, dependency, motor function and quality of life measured 90 and 365 days after enrolment. Results Recruitment to the trial was feasible and acceptable; of 118 screened patients, 92 were eligible and 32 declined to participate. 60 patients were recruited between November 2011 and July 2013. All participants received some allocated treatment. Although 29 out of 30 participants received all 5 G-CSF/placebo injections, only 7 of 30 participants received all 18 therapy sessions. G-CSF was well tolerated but associated with a tendency to more adverse events than placebo (16 vs 10 patients, p = 0.12) and serious adverse events (SAE) (9 vs 3, p = 0.10). On average, patients received 14 (out of 18 planned) therapy sessions, interquartile range [12, 17]. Only a minority (23%) of participants completed all physiotherapy sessions, a large proportion of sessions (114 of 540, 21%) were cancelled due to patient (94, 17%) and therapist factors (20, 4%). No significant differences in functional outcomes were detected in either the G-CSF or physiotherapy group at day 90 or 365. Conclusions Delivery of G-CSF is feasible in chronic stroke. However, the study failed to demonstrate feasibility for delivering additional physiotherapy sessions late after stroke therefore a definitive study using this trial design is not supported. Future work should occur earlier after stroke, alongside on-going clinical rehabilitation.	[Sprigg, Nikola; O'Connor, Rebecca; Woodhouse, Lisa; Krishnan, Kailash; Bath, Philip M.] Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham, England; [England, Timothy J.] Univ Nottingham, Div Med Sci & GEM, Nottingham, England; [Walker, Marion F.] Univ Nottingham, Div Rehabil & Ageing, Nottingham, England; [Connell, Louise A.] Univ Cent Lancashire, Sch Hlth, Preston, Lancs, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Central Lancashire	Sprigg, N (corresponding author), Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham, England.	nikola.sprigg@nottingham.ac.uk	Connell, Louise/C-9133-2016; England, Timothy J/AAD-3100-2021; Bath, Philip/F-9020-2011	Connell, Louise/0000-0002-0629-2919; England, Timothy J/0000-0001-5330-8584; Bath, Philip/0000-0003-2734-5132; Woodhouse, Lisa/0000-0002-4472-1999; Krishnan, Kailash/0000-0002-6486-3783	NIHR Research for Patient Benefit [PB-PG-0909-19113]; Medical Research Council [G0501997] Funding Source: researchfish; National Institute for Health Research [PB-PG-0909-19113, NF-SI-0512-10092] Funding Source: researchfish; MRC [G0501997] Funding Source: UKRI	NIHR Research for Patient Benefit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	STEMS3 is funded by NIHR Research for Patient Benefit (PB-PG-0909-19113), http://www.nihr.ac.uk/funding/research-for-patient-benefit.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Health and Technology Assessment Programme, NIHR, NHS or the Department of Health.	Allen R, 2013, INT J STROKE, V8, P12; Anderlini P, 2009, CURR OPIN HEMATOL, V16, P35, DOI 10.1097/MOH.0b013e328319913c; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Aziz N, 2009, THERAPY BASED REHABI, V2009; Bath PMW, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub4; Brockmann F, 2013, TRANSFUS MED HEMOTH, V40, P258, DOI 10.1159/000354093; Brown E, 2007, MED DICT REGULATORY, P168, DOI [10.1002/9780470059210.CH13, DOI 10.1002/9780470059210.CH13]; Byl NN, 2008, NEUROREHAB NEURAL RE, V22, P494, DOI 10.1177/1545968308317431; Cavallaro AM, 2000, BONE MARROW TRANSPL, V25, P85, DOI 10.1038/sj.bmt.1702072; Chollet F, 2014, J NEUROL, V261, P1461, DOI 10.1007/s00415-013-7172-z; Clarke J, 2009, NEUROREHAB NEURAL RE, V23, P886, DOI 10.1177/1545968309341067; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; England TJ, 2009, BRAIN RES REV, V62, P71, DOI 10.1016/j.brainresrev.2009.09.002; Floel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019767; Floel A, 2010, NEUROBIOL DIS, V37, P243, DOI 10.1016/j.nbd.2009.05.027; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraser C, 2002, NEURON, V34, P831, DOI 10.1016/S0896-6273(02)00705-5; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Legg L, 2004, LANCET, V363, P352; Logan PA, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18290; MAHONEY F I, 1965, Md State Med J, V14, P61; Mead GE, 2013, JAMA-J AM MED ASSOC, V310, P1066, DOI 10.1001/jama.2013.107828; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; NUDO RJ, 2003, PHYS MED REHABILITAT, V14, P57; Pafford RN, 2015, STROKE, V46; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Sackley CM, 1990, CLIN REHABIL, V4, P301; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Sprigg N, 2009, J NEUROL SCI, V285, P3, DOI 10.1016/j.jns.2009.04.040; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; van Vliet P, 2015, PHYSIOTHERAPY S1, V101; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Wagner DC, 2014, STROKE, V45, P623, DOI 10.1161/STROKEAHA.113.003812; Walsh K, 2007, BRIT J PSYCHIAT, V190, P142, DOI 10.1192/bjp.bp.106.023960; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	42	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161359	10.1371/journal.pone.0161359	http://dx.doi.org/10.1371/journal.pone.0161359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610616	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000383255900016
J	Ssengooba, W; Respeito, D; Mambuque, E; Blanco, S; Bulo, H; Mandomando, I; de Jong, BC; Cobelens, FG; Garcia-Basteiro, AL				Ssengooba, Willy; Respeito, Durval; Mambuque, Edson; Blanco, Silvia; Bulo, Helder; Mandomando, Inacio; de Jong, Bouke C.; Cobelens, Frank G.; Garcia-Basteiro, Alberto L.			Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HIV; TRANSMISSION; BURDEN; INDIA; TB	Introduction Early diagnosis and initiation to appropriate treatment is vital for tuberculosis (TB) control. The XpertMTB/ RIF (Xpert) assay offers rapid TB diagnosis and quantitative estimation of bacterial burden through Cycle threshold (Ct) values. We assessed whether the Xpert Ct value is associated with delayed TB diagnosis as a potential monitoring tool for TB control programme performance. Materials and Methods This analysis was nested in a prospective study under the routine TB surveillance procedures of the National TB Control Program in Manhica district, Maputo province, Mozambique. Presumptive TB patients were tested using smear microscopy and Xpert. We explored the association between Xpert Ct values and self-reporteddelay of Xpert-positive TB patients as recorded at the time of diagnosis enrolment. Patients with > 60 days of TB symptoms were considered to have long delays. Results Of 1,483 presumptive TB cases, 580 were diagnosed as TB of whom 505 (87.0%) were due to pulmonary TB and 302 (94.1%) were Xpert positive. Ct values (range, 9.7-46.4) showed a multimodal distribution. The median (IQR) delay was 30 (30-45) days. Ct values showed no correlation with delay (R-2 = 0.001, p = 0.621), nor any association with long delays: adjusted odds ratios (AOR) (95% confidence interval [CI]) comparing to > 28 cycles 0.99 (0.50-1.96; p = 0.987) for 23-28 cycles, 0.93 (0.50-1.74; p = 0.828) for 16-22 cycles; 1.05 (0.47-2.36; p = 0.897) for < 16 cycles. Being HIV-negative (AOR [95% CI]), 2.05 (1.193.51, p = 0.009) and rural residence 1.74 (1.08-2.81, p = 0.023), were independent predictors of long delays. Conclusion Xpert Ct values were not associated with patient delay for TB diagnosis and cannot be used as an indicator of TB control program performance.	[Ssengooba, Willy; Cobelens, Frank G.; Garcia-Basteiro, Alberto L.] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Ssengooba, Willy; Cobelens, Frank G.; Garcia-Basteiro, Alberto L.] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Acad Med Ctr, Amsterdam, Netherlands; [Ssengooba, Willy; Blanco, Silvia; Garcia-Basteiro, Alberto L.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Ssengooba, Willy] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Respeito, Durval; Mambuque, Edson; Blanco, Silvia; Bulo, Helder; Mandomando, Inacio; Garcia-Basteiro, Alberto L.] Ctr Invest Saude Manhica, Maputo, Mozambique; [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [de Jong, Bouke C.] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Cobelens, Frank G.] KNCV TB Fdn, The Hague, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Makerere University; Centro de Investigacao em Saude de Manhica; Institute of Tropical Medicine (ITM); KNCV Tuberculosis Foundation	Ssengooba, W (corresponding author), Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands.; Ssengooba, W (corresponding author), Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Acad Med Ctr, Amsterdam, Netherlands.; Ssengooba, W (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.; Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	willyssengooba@gmail.com	Ssengooba, Willy/ABE-2168-2020; Mandomando, Inacio/ABD-8007-2020; de Jong, Bouke/A-3636-2013	Ssengooba, Willy/0000-0002-1643-110X; Mandomando, Inacio/0000-0002-1078-2187; de Jong, Bouke/0000-0002-1017-4675	European Union	European Union(European Commission)	This work was supported by the Erasmus Mundus Joint Doctorate Program of the European Union through a training grant to WS.; This work was supported by the Erasmus Mundus Joint Doctorate Program of the European Union through a training grant to WS. We thank all study participants in the district of Manhica for their participation in the study and the National Control Program (Dr Ivan Manhica, Luis Faife) and Health Services of the district (Fausta Temba) for their support. The authors wish to thank the CISM laboratory & health care staff, as well as data clerks involved in the study	Arinaminpathy N, 2015, NATURE, V528, pS60, DOI 10.1038/nature16045; Belkina TV, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0624-y; Buregyeya E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-586; Cohen GM, 2014, JAIDS-J ACQ IMM DEF, V67, pE88, DOI 10.1097/QAI.0000000000000309; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Garcia-Basteiro AL, 2015, EUR RESPIR J, V45, P547, DOI 10.1183/09031936.00145714; Garcia-Basteiro AL, 2014, LANCET, V383, P215, DOI 10.1016/S0140-6736(14)60069-6; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Hanrahan CF, 2014, AM J RESP CRIT CARE, V189, P1426, DOI 10.1164/rccm.201312-2140OC; Lawn SD, 2011, AIDS, V25, P2190, DOI 10.1097/QAD.0b013e32834cda4e; Lin X, 2008, INT J TUBERC LUNG D, V12, P288; Lopez-Varela E, 2016, EUR RESPIR J, V47, P1003, DOI 10.1183/13993003.01454-2015; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-393; Makwakwa L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-132; Marino S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004804; Ngamvithayapong J, 2001, INT J TUBERC LUNG D, V5, P1013; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Sendagire I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014459; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Takarinda KC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1437-7; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; WHO, GLOB TUB REP 2014; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0	28	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162833	10.1371/journal.pone.0162833	http://dx.doi.org/10.1371/journal.pone.0162833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611466	Green Published, gold			2022-12-27	WOS:000383255900176
J	Savastio, S; Cadario, F; Genoni, G; Bellomo, G; Bagnati, M; Secco, G; Picchi, R; Giglione, E; Bona, G				Savastio, Silvia; Cadario, Francesco; Genoni, Giulia; Bellomo, Giorgio; Bagnati, Marco; Secco, Gioel; Picchi, Raffaella; Giglione, Enza; Bona, Gianni			Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; D SUPPLEMENTATION; INSULIN-RESISTANCE; GLUCOSE-METABOLISM; ONSET; PREVALENCE; D-3; ASSOCIATION; CALCITRIOL; DISEASE	Background Vitamin D (25OHD) effects on glycemic control are unclear in children and adolescents with type 1 diabetes. Aims of this study were to investigate 25OHD status among children with T1DM and its relationship with insulin sensitivity and glycemic status. Subjects and Methods A cross sectional study was carried out between 2008-2014. A total of 141 patients had a T1DM >12 months diagnosis and were enrolled in the present study. Of these 35 (24.8%) were migrants and 106 (75.2%) Italians (T2). We retrospectively analyzed data at the onset of the disease (T0)( 64 subjects) and 12-24 months before the last visit (T1,124 subjects). Fasting glucose, glycated hemoglobin (HbA1c), 25OHD levels and daily insulin requirement were evaluated and Cholecalciferol 1000 IU/day supplementation for the management of vitamin D insufficiency (<75 nmol/L) was systematically added. Results A generalized 25OHD insufficiency was found at each study time, particularly in migrants. At T0, the 25OHD levels were inversely related to diabetic keto-acidosis (DKA) severity (p<0.05). At T1 and T2, subjects with 25OHD <= 25nmol/L (10 ng/mL) showed higher daily insulin requirement (p<0.05) and HbA1c values (p<0.01) than others vitamin D status. The 25OHD levels were negatively related with HbA1c (p<0.001) and daily insulin dose (p<0.05) during follow up. There was a significant difference in 25OHD ( p<0.01) between subjects with different metabolic control ( HbA1c <7.5%, 7.5-8%,>8%), both at T1 and T2. In supplemented subjects, we found a significant increase in 25OHD levels (p<0.0001) and decrease of HbA1c (p<0.001) between T1 and T2, but this was not significant in the migrants subgroup. Multivariate regression analysis showed a link between HbA1c and 25OHD levels (p<0.001). Conclusions Children with T1DM show a generalized 25OHD deficiency that impact on metabolic status and glycemic homeostasis. Vitamin D supplementation improves glycemic control and should be considered as an additional therapy.	[Savastio, Silvia; Cadario, Francesco; Genoni, Giulia; Picchi, Raffaella; Giglione, Enza; Bona, Gianni] Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy; [Cadario, Francesco] IRCAD, Novara, Italy; [Bellomo, Giorgio; Bagnati, Marco] Univ Piemonte Orientale, Cent Lab Maggiore della Carita Hosp, Novara, Italy; [Secco, Gioel] Osped Santi Antonio & Biagio & Cesare Arrigo, Div Cardiol, Alessandria, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo	Savastio, S (corresponding author), Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy.	savastio.silvia@gmail.com	Cadario, Francesco/AAA-1240-2019; Secco, Gioel Gabrio/AAC-7522-2022; Savastio, Silvia/AAC-6475-2022	Secco, Gioel Gabrio/0000-0002-9998-7049; Savastio, Silvia/0000-0002-5867-3246; Cadario, Francesco/0000-0001-8808-834X	Ministry of Health [RF-2010-2304835]	Ministry of Health	The paper is part of a project (RF-2010-2304835) funded by the Ministry of Health. The grant had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The paper is part of a project (RF-2010-2304835) funded by the Ministery of Health. The grant had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Al-Timimi DJ, 2013, J CLIN DIAGN RES, V7, P2686, DOI 10.7860/JCDR/2013/6712.3733; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Barengolts E, 2013, ENDOCR PRACT, V19, P497, DOI 10.4158/EP12263.RA; Bener A, 2009, ACTA DIABETOL, V46, P183, DOI 10.1007/s00592-008-0071-6; Bergman P, 2013, PLOS ONE, P8; Billaudel B, 1998, DIABETES METAB, V24, P344; Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]; Bock G, 2011, DIABETES-METAB RES, V27, P942, DOI 10.1002/dmrr.1276; BOURLON PM, 1999, J ENDOCRINOL, V160, P87, DOI DOI 10.1677/JOE.0.1600087; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Cadario F, 2015, PLOS ONE, P10; Cadario F, 2014, ACTA DIABETOL, V51, P263, DOI 10.1007/s00592-013-0514-6; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dutta D, 2013, INDIAN J MED RES, V138, P853; Feng RN, 2015, DIABETES RES CLIN PR, V108, pE71, DOI 10.1016/j.diabres.2014.12.008; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Franchi B, 2014, EUR J PEDIATR, V173, P477, DOI 10.1007/s00431-013-2204-3; Gabbay MAL, 2012, ARCH PEDIAT ADOL MED, V166, P601, DOI 10.1001/archpediatrics.2012.164; Greer RM, 2007, MED J AUSTRALIA, V187, P59, DOI 10.5694/j.1326-5377.2007.tb01130.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2008, CURR DIABETES REP, V8, P393, DOI 10.1007/s11892-008-0068-0; Huynh T, 2009, PEDIATR DIABETES, V10, P38, DOI 10.1111/j.1399-5448.2008.00439.x; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Kostoglou-Athanassiou I, 2013, THER ADV ENDOCRINOL, V4, P122, DOI 10.1177/2042018813501189; Liu Y, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0434-5; Martin CA, 2016, NUTRITION, V32, P21, DOI 10.1016/j.nut.2015.07.007; Nwosu BU, 2012, J PEDIATR ENDOCR MET, V25, P181, DOI 10.1515/jpem-2011-0403; Nwosu BU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099646; Ordooei M, 2014, MINERVA PEDIAT; Ou HY, 2011, EUR J CLIN INVEST, V41, P1195, DOI 10.1111/j.1365-2362.2011.02525.x; Pitocco D, 2006, DIABETIC MED, V23, P920, DOI 10.1111/j.1464-5491.2006.01921.x; Raab J, 2014, DIABETOLOGIA, V57, P902, DOI 10.1007/s00125-014-3181-4; Ryu OH, 2014, ENDOCR J, V61, P167, DOI 10.1507/endocrj.EJ13-0356; SERGEEV IN, 1995, ENDOCRINOLOGY, V136, P2852, DOI 10.1210/en.136.7.2852; Strobel F, 2014, HORM METAB RES, V46, P54, DOI 10.1055/s-0033-1358453; Tunc O, 2011, J PEDIATR ENDOCR MET, V24, P1037, DOI 10.1515/JPEM.2011.213; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579; Zittermann Armin, 2014, Adv Exp Med Biol, V810, P106	44	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162554	10.1371/journal.pone.0162554	http://dx.doi.org/10.1371/journal.pone.0162554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607348	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600064
J	Aghakhanyan, G; Bonanni, P; Randazzo, G; Nappi, S; Tessarotto, F; De Martin, L; Frijia, F; De Marchi, D; De Masi, F; Kuppers, B; Lombardo, F; Caramella, D; Montanaro, D				Aghakhanyan, Gayane; Bonanni, Paolo; Randazzo, Giovanna; Nappi, Sara; Tessarotto, Federica; De Martin, Lara; Frijia, Francesca; De Marchi, Daniele; De Masi, Francesco; Kuppers, Beate; Lombardo, Francesco; Caramella, Davide; Montanaro, Domenico			From Cortical and Subcortical Grey Matter Abnormalities to Neurobehavioral Phenotype of Angelman Syndrome: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; BASAL GANGLIA; MOUSE MODEL; DEFICITS; BRAIN; ORIENTATION; INVOLVEMENT; EXPRESSION; CIRCUITS; EPILEPSY	Angelman syndrome (AS) is a rare neurogenetic disorder due to loss of expression of maternal ubiquitin-protein ligase E3A (UBE3A) gene. It is characterized by severe developmental delay, speech impairment, movement or balance disorder and typical behavioral uniqueness. Affected individuals show normal magnetic resonance imaging (MRI) findings, although mild dysmyelination may be observed. In this study, we adopted a quantitative MRI analysis with voxel-based morphometry(FSL-VBM) method to investigate disease-related changes in the cortical/subcortical grey matter (GM) structures. Since 2006 to 2013 twenty-six AS patients were assessed by our multidisciplinary team. From those, sixteen AS children with confirmed maternal 15q11-q13 deletions (mean age 7.7 +/- 3.6 years) and twenty-one age-matched controls were recruited. The developmental delay and motor dysfunction were assessed using Bayley III and Gross Motor Function Measure (GMFM). Principal component analysis (PCA) was applied to the clinical and neuropsychological datasets. High-resolution T1-weighted images were acquired and FSL-VBM approach was applied to investigate differences in the local GM volume and to correlate clinical and neuropsychological changes in the regional distribution of GM. We found bilateral GM volume loss in AS compared to control children in the striatum, limbic structures, insular and orbito-frontal cortices. Voxel-wise correlation analysis with the principal components of the PCA output revealed a strong relationship with GM volume in the superior parietal lobule and precuneus on the left hemisphere. The anatomical distribution of cortical/subcortical GM changes plausibly related to several clinical features of the disease and may provide an importantmorphological underpinning for clinical and neurobehavioral symptoms in children with AS.	[Aghakhanyan, Gayane; Frijia, Francesca; De Marchi, Daniele; Lombardo, Francesco; Montanaro, Domenico] Fdn CNR Reg Toscana G Monasterio, Unit Neuroradiol, Pisa, Italy; [Bonanni, Paolo; Randazzo, Giovanna; Nappi, Sara; Tessarotto, Federica; De Martin, Lara] E Medea Sci Inst, Epilepsy & Clin Neurophysiol Unit, Conegliano, TV, Italy; [De Masi, Francesco; Kuppers, Beate] Univ Hosp Pisa, Div Anesthesiol & Intens Care, Pisa, Italy; [Caramella, Davide] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Diagnost & Intervent Radiol, Pisa, Italy	IRCCS Eugenio Medea; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa	Montanaro, D (corresponding author), Fdn CNR Reg Toscana G Monasterio, Unit Neuroradiol, Pisa, Italy.	domont@ftgm.it	Montanaro, Domenico/AAB-9718-2022; Montanaro, Domenico/K-5938-2016; Caramella, Davide/AAI-6802-2020; Aghakhanyan, Gayane/AAC-7691-2022; bonanni, paolo/T-7360-2017	Montanaro, Domenico/0000-0002-9895-7016; Caramella, Davide/0000-0002-9951-2916; Aghakhanyan, Gayane/0000-0001-5152-497X; bonanni, paolo/0000-0002-9448-9059; Frijia, Francesca/0000-0003-3802-326X	Italian Ministry of Health; Organization of Angelman Syndrome	Italian Ministry of Health(Ministry of Health, Italy); Organization of Angelman Syndrome	This research was partially supported by the Italian Ministry of Health granted to PB (RC 2015) and the Organization of Angelman Syndrome, (Organizzazione Sindrome di Angelman - http://www.sindromediangelman.org).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersen W H, 2001, Logoped Phoniatr Vocol, V26, P2, DOI 10.1080/140154301300109044; Andersson J.L.R., 2007, TR07JA1 FMRIB; Barkovich AJ, 1997, EPILEPSIA, V38, P1255; Bayley N., 2019, BAYLEY SCALES INFANT; Biraben A, 2004, NEUROLOGY, V63, P73, DOI 10.1212/01.WNL.0000132840.40838.13; Bouilleret V, 2005, J NUCL MED, V46, P540; Bruinsma CF, 2015, J CLIN INVEST, V125, P4305, DOI 10.1172/JCI83541; Castro-Gago M, 2010, EUR J PAEDIATR NEURO, V14, P292, DOI 10.1016/j.ejpn.2009.07.007; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cummings Jeffrey L., 2008, CONCISE GUIDE NEUROP; Dan B, 2004, ANN NY ACAD SCI, V1030, P599, DOI 10.1196/annals.1329.070; Dan B, 2001, CLIN NEUROPHYSIOL, V112, P1618, DOI 10.1016/S1388-2457(01)00618-6; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Gentile JK, 2010, J DEV BEHAV PEDIATR, V31, P592, DOI 10.1097/DBP.0b013e3181ee408e; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guerrini R, 1996, ANN NEUROL, V40, P39, DOI 10.1002/ana.410400109; Guerrini Renzo, 2003, Paediatr Drugs, V5, P647, DOI 10.2165/00148581-200305100-00001; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harbord M, 2001, J CLIN NEUROSCI, V8, P421, DOI 10.1054/jocn.2000.0753; Hart H, 2008, DEV MED CHILD NEUROL, V50, P564, DOI 10.1111/j.1469-8749.2008.03035.x; Harting I, 2009, EUR J PAEDIATR NEURO, V13, P271, DOI 10.1016/j.ejpn.2008.04.005; Hayrapetyan V, 2014, EUR J NEUROSCI, V39, P1018, DOI 10.1111/ejn.12442; Jackowski AP, 2012, REV BRAS PSIQUIATR, V34, P207, DOI 10.1590/S1516-44462012000200014; Jana NR, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/710943; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; Judson MC, 2014, J COMP NEUROL, V522, P1874, DOI 10.1002/cne.23507; Kara S, 2010, AM J NEURORADIOL, V31, P1602, DOI 10.3174/ajnr.A2133; Karnath HO, 1997, PHILOS T ROY SOC B, V352, P1411, DOI 10.1098/rstb.1997.0127; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lichtenberger EO, 2005, MENT RETARD DEV D R, V11, P197, DOI 10.1002/mrdd.20076; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Peters SU, 2011, DEV MED CHILD NEUROL, V53, P361, DOI 10.1111/j.1469-8749.2010.03838.x; Riday TT, 2012, J CLIN INVEST, V122, P4544, DOI 10.1172/JCI61888; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Sahoo T, 2006, J MED GENET, V43, P512, DOI 10.1136/jmg.2005.036913; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Thompson RJ, 2003, J AUTISM DEV DISORD, V33, P171, DOI 10.1023/A:1022991410822; Tiwari VN, 2012, NEUROIMAGE, V59, P349, DOI 10.1016/j.neuroimage.2011.07.067; Wild B, 2003, BRAIN, V126, P2121, DOI 10.1093/brain/awg226; Williams CA, 2005, AM J MED GENET, V2006, P413; Williams CA, 2010, AM J MED GENET C, V154C, P432, DOI 10.1002/ajmg.c.30278; Wilson BJ, 2011, PEDIATR NEUROL, V44, P350, DOI 10.1016/j.pediatrneurol.2010.12.002; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162817	10.1371/journal.pone.0162817	http://dx.doi.org/10.1371/journal.pone.0162817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626634	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600056
J	Rittig, N; Bach, E; Thomsen, HH; Pedersen, SB; Nielsen, TS; Jorgensen, JO; Jessen, N; Moller, N				Rittig, Nikolaj; Bach, Ermina; Thomsen, Henrik Holm; Pedersen, Steen Bonlykke; Nielsen, Thomas Sava; Jorgensen, Jens O.; Jessen, Niels; Moller, Niels			Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOCYTE LIPOLYSIS; METABOLISM; INSULIN; GLUCOSE; PROTEIN; MODEL; ALPHA; TOOL	Background Lipolysis is accelerated during the acute phase of inflammation, a process being regulated by pro-inflammatory cytokines (e.g. TNF-alpha), stress-hormones, and insulin. The intracellular mechanisms remain elusive and we therefore measured pro-and anti-lipolytic signaling pathways in adipocytes after in vivo endotoxin exposure. Methods Eight healthy, lean, male subjects were investigated using a randomized cross over trial with two interventions: i) bolus injection of saline (Placebo) and ii) bolus injection of lipopolysaccharide endotoxin (LPS). A H-3-palmitate tracer was used to measure palmitate rate of appearance (Ra-palmitate) and indirect calorimetry was performed to measure energy expenditures and lipid oxidation rates. A subcutaneous abdominal fat biopsy was obtained during both interventions and subjected to western blotting and qPCR quantifications. Results LPS caused a mean increase in serum free fatty acids (FFA) concentrations of 90% (CI-95%: 37-142, p = 0.005), a median increase in Ra-palmitate of 117% (CI-95%: 77-166, p<0.001), a mean increase in lipid oxidation of 49% (CI-95%: 1-96, p = 0.047), and a median increase in energy expenditure of 28% (CI-95%: 16-42, p = 0.001) compared with Placebo. These effects were associated with increased phosphorylation of hormone sensitive lipase (pHSL) at ser(650) in adipose tissue (p = 0.03), a trend towards elevated pHSL at ser(552) (p = 0.09) and cAMP-dependent protein kinase A (PKA) phosphorylation of perilipin 1 (PLIN1) (p = 0.09). Phosphatase and tensin homolog (PTEN) also tended to increase (p = 0.08) while phosphorylation of Akt at Thr(308) tended to decrease ( p = 0.09) during LPS compared with Placebo. There was no difference between protein or mRNA expression of ATGL, G0S2, and CGI-58. Conclusion LPS stimulated lipolysis in adipose tissue and is associated with increased pHSL and signs of increased PLIN1 phosphorylation combined with a trend toward decreased insulin signaling. The combination of these mechanisms appear to be the driving forces behind the increased lipolysis observed in the early stages of acute inflammation and sepsis.	[Rittig, Nikolaj; Bach, Ermina; Thomsen, Henrik Holm; Pedersen, Steen Bonlykke; Jorgensen, Jens O.; Jessen, Niels; Moller, Niels] Aarhus Univ Hosp, Dept Internal Med & Endocrinol MEA, Norrebrogade 44, DK-8000 Aarhus C, Denmark; [Rittig, Nikolaj; Bach, Ermina; Thomsen, Henrik Holm; Pedersen, Steen Bonlykke; Jorgensen, Jens O.; Jessen, Niels; Moller, Niels] Aarhus Univ Hosp, Med Res Lab, Norrebrogade 44, DK-8000 Aarhus C, Denmark; [Jessen, Niels] Aarhus Univ Hosp, Inst Clin Med, Res Lab Biochem Pathol, Norrebrogade 44, DK-8000 Aarhus C, Denmark; [Nielsen, Thomas Sava] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Blegdamsvej 3b 6-6-30, DK-2200 Copenhagen N, Denmark	Aarhus University; Aarhus University; Aarhus University; Novo Nordisk Foundation; University of Copenhagen	Rittig, N (corresponding author), Aarhus Univ Hosp, Dept Internal Med & Endocrinol MEA, Norrebrogade 44, DK-8000 Aarhus C, Denmark.; Rittig, N (corresponding author), Aarhus Univ Hosp, Med Res Lab, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	nikolaj.rittig@clin.au.dk	Moller, Niels/E-5091-2011; Thomsen, Henrik Holm/GPS-9009-2022; Pedersen, Steen B./AAB-3331-2019; Thomsen, Henrik Holm/AAP-1389-2021; Jorgensen, Jens Otto Lunde/O-8003-2019; Jessen, Niels/E-1731-2011	Moller, Niels/0000-0001-5627-7322; Thomsen, Henrik Holm/0000-0003-0522-0320; Pedersen, Steen B./0000-0002-7838-8063; Thomsen, Henrik Holm/0000-0003-0522-0320; Jessen, Niels/0000-0001-5613-7274; Nielsen, Thomas Svava/0000-0002-9457-8000; Rittig, Nikolaj/0000-0001-9938-2181; Bach, Ermina/0000-0002-7649-5658	Aarhus University (Denmark); Danish Council for Strategic Research [0603-00479B]; Lundbeck foundation [R83-A8172]; NNF Center for Basic Metabolic Research [Treebak Group] Funding Source: researchfish	Aarhus University (Denmark); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck foundation(Lundbeckfonden); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	This work was financially supported by Aarhus University (Denmark), the Danish Council for Strategic Research (grant no. 0603-00479B), and the Lundbeck foundation (R83-A8172).; This work was financially supported by Aarhus University (Denmark), the Danish Council for Strategic Research (grant no. 0603-00479B), and the Lundbeck foundation (R83-A8172).	Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; ASKANAZI J, 1980, ANN SURG, V191, P40, DOI 10.1097/00000658-198001000-00008; Bach E, 2015, J CLIN ENDOCR METAB, V100, P578, DOI 10.1210/jc.2014-2489; BLOESCH D, 1993, J CLIN ENDOCR METAB, V77, P1156, DOI 10.1210/jc.77.5.1156; Buhl M, 2013, J CLIN ENDOCR METAB, V98, P2090, DOI 10.1210/jc.2012-3836; CAHILL GF, 1976, CLIN ENDOCRINOL META, V5, P397, DOI 10.1016/S0300-595X(76)80028-X; Calvano SE, 2012, SURG INFECT, V13, P293, DOI 10.1089/sur.2012.155; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FONG YM, 1990, J CLIN INVEST, V85, P1896, DOI 10.1172/JCI114651; FORSE RA, 1987, ANN SURG, V206, P744, DOI 10.1097/00000658-198712000-00010; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Ilias I, 2014, J CRITICAL CARE, V29, p[e1135, 1130]; JENSEN MD, 1990, AM J PHYSIOL, V258, pE103, DOI 10.1152/ajpendo.1990.258.1.E103; Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; LONNQVIST F, 1993, BRIT J PHARMACOL, V110, P929; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P636, DOI 10.1210/jc.2014-2608; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; MOLLER N, 1990, METABOLISM, V39, P1309, DOI 10.1016/0026-0495(90)90189-J; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; NORDENSTROM J, 1982, ANN SURG, V196, P221, DOI 10.1097/00000658-198208000-00016; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; RICHELSEN B, 1991, METABOLISM, V40, P990, DOI 10.1016/0026-0495(91)90078-B; Rittig N, 2015, CLIN NUTR; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Sugawara K, 2003, TOHOKU J EXP MED, V199, P171, DOI 10.1620/tjem.199.171; Wellhoener P, 2011, HORM METAB RES, V43, P754, DOI 10.1055/s-0031-1287854; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003	34	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162167	10.1371/journal.pone.0162167	http://dx.doi.org/10.1371/journal.pone.0162167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627109	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600023
J	Ding, YY; Wang, ZH; Zhang, X; Teng, Z; Gao, CX; Qian, BH; Wang, LL; Feng, JJ; Wang, JH; Zhao, CY; Guo, CJ; Pan, W				Ding, Yingying; Wang, Zhihong; Zhang, Xi; Teng, Zheng; Gao, Caixia; Qian, Baohua; Wang, Lili; Feng, Jiaojiao; Wang, Jinhong; Zhao, Chunyan; Guo, Cunjiu; Pan, Wei			Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ENTEROVIRUS 71; MOUTH-DISEASE; MONOCLONAL-ANTIBODY; VIRUS; HAND; FOOT; EPIDEMIC; EPITOPE; IDENTIFICATION	Coxsackievirus A16 (CA16) is one of the major causative agents of hand, foot, and mouth disease worldwide. The non-neutralizing antibody response that targets CA16 VP1 remains poorly elucidated. In the present study, antibody responses against CA16 VP1 in Shanghai blood donors and Shanxi individuals were analyzed by ELISA and inhibitory ELISA using five CA16 VP1 antigens: VP1(1-297), VP1(41-297), VP1(1-60), VP1(45-58) and VP1(61-297). The correlation coefficients for most of the reactions against each of the five antigens and the inhibition of the anti-CA16 VP1 antibody response produced by the various antigens were higher in Shanghai blood donors compared to those in Shanxi individuals. VP1(1-297) and VP1(41-297) strongly inhibited the anti-CA16 VP1 response in serum samples from both populations, while VP1(45-58) and VP1(61-297) intermediately and weakly inhibited the anti-CA16 VP1 response, respectively, in only Shanghai group. A specific type of inhibition (anti-CA16 VP1 was completely inhibited by both VP1(1-60) and VP1(41-297)) characterized by high neutralizing antibody titers was identified and accounted for 71.4% of the strongly reactive samples from the Shanghai group. These results indicate that the Shanghai blood donors exhibited a consistent and specific antibody response, while the Shanxi individuals showed an inconsistent and non-specific antibody response. These findings may improve the understanding of host humoral immunity against CA16 and help to identify an effective approach for seroepide-miological surveillance and specific diagnosis of CA16 infection based on normal and competitive ELISA.	[Ding, Yingying; Gao, Caixia; Wang, Lili; Feng, Jiaojiao; Wang, Jinhong; Zhao, Chunyan; Pan, Wei] Second Mil Med Univ, Sch Basic Med, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China; [Wang, Zhihong; Guo, Cunjiu] Shanxi Med Coll, Affiliated Hosp 2, Dept Clin Lab, Taiyuan, Peoples R China; [Zhang, Xi; Teng, Zheng] Shanghai Municipal Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Shanghai, Peoples R China; [Qian, Baohua] Second Mil Med Univ, Dept Blood Transfus, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Shanxi Medical University; Shanghai Center for Disease Control & Prevention; Naval Medical University	Pan, W (corresponding author), Second Mil Med Univ, Sch Basic Med, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China.	pwpanwei@126.com	wang, lili/HDL-7210-2022; ding, yy/HHS-9589-2022		National Natural Science Foundation of China [30872405, 30972632]; Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases [2009ZX10004-105]; Chinese National Key Special Project for Major New Drug Discovery [2011ZX09506-001]; National 863 Project [2014AA021403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases; Chinese National Key Special Project for Major New Drug Discovery; National 863 Project(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/), grant number: No. 30872405 and 30972632 to WP; Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases (http://www.nmp.gov.cn/), grant number: 2009ZX10004-105 to WP; Chinese National Key Special Project for Major New Drug Discovery (http://www.nmp.gov.cn/), grant number: 2011ZX09506-001 to WP and the National 863 Project (http://program.most.gov.cn/), grant number: 2014AA021403 to WP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; BLOMBERG J, 1974, LANCET, V2, P112; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Cao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018477; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Cifuente JO, 2013, J VIROL, V87, P7637, DOI 10.1128/JVI.03519-12; daSilva EE, 1996, EMERG INFECT DIS, V2, P231, DOI 10.3201/eid0203.960312; Ding YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10636; Gao CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21979; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hirota J, 2012, CLIN VACCINE IMMUNOL, V19, P277, DOI 10.1128/CVI.05382-11; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Jiang LP, 2015, VACCINE, V33, P6596, DOI 10.1016/j.vaccine.2015.10.104; Jiang SHH, 2008, DNA CELL BIOL, V27, P423, DOI 10.1089/dna.2007.0708; Ke YY, 2006, J COMPUT CHEM, V27, P1556, DOI 10.1002/jcc.20460; Kiener TK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002895; Kirk K, 2012, VACCINE, V30, P7105, DOI 10.1016/j.vaccine.2012.09.030; Li C, 2007, CURR MED CHEM, V14, P847, DOI 10.2174/092986707780363032; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Plevka P, 2012, ACTA CRYSTALLOGR D, V68, P1217, DOI 10.1107/S0907444912025772; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sharma N, 2013, CLIN VACCINE IMMUNOL, V20, P9, DOI 10.1128/CVI.00516-12; Shi JP, 2013, VACCINE, V31, P2130, DOI 10.1016/j.vaccine.2013.02.051; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yang H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-137; Zhang PP, 2013, GENE, V524, P347, DOI 10.1016/j.gene.2013.03.126; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206	42	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162820	10.1371/journal.pone.0162820	http://dx.doi.org/10.1371/journal.pone.0162820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622652	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000059
J	Hoenen, C; Gustin, A; Birck, C; Kirchmeyer, M; Beaume, N; Felten, P; Grandbarbe, L; Heuschling, P; Heurtaux, T				Hoenen, Claire; Gustin, Audrey; Birck, Cindy; Kirchmeyer, Melanie; Beaume, Nicolas; Felten, Paul; Grandbarbe, Luc; Heuschling, Paul; Heurtaux, Tony			Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant	PLOS ONE			English	Article							NF-KAPPA-B; FAMILIAL PARKINSONS-DISEASE; NORMAL MOUSE-BRAIN; NEURODEGENERATIVE DISEASES; SIGNALING PATHWAYS; ACTIVATES MICROGLIA; THERAPEUTIC TARGET; OXIDATIVE STRESS; THP-1 CELLS; MUTATION	Parkinson's disease (PD) is histologically described by the deposition of alpha-synuclein, whose accumulation in Lewy bodies causes dopaminergic neuronal death. Although most of PD cases are sporadic, point mutations of the gene encoding the alpha-synuclein protein cause inherited forms of PD. There are currently six known point mutations that result in familial PD. Oxidative stress and neuroinflammation have also been described as early events associated with dopaminergic neuronal degeneration in PD. Though it is known that microglia are activated by wild-type alpha-synuclein, little is known about its mutated forms and the signaling cascades responsible for this microglial activation. The present study was designed to investigate consequences of wild-type and mutant alpha-synuclein (A53T, A30P and E46K) exposure on microglial reactivity. Interestingly, we described that alpha-synuclein-induced microglial reactivity appeared to be peptide-dependent. Indeed, the A53T protein activated more strongly microglia than the wild-type alpha-synuclein and othermutants. This A53T-induced microglial reactivity mechanism was found to depend on phosphorylation mechanisms mediated by MAPKs and on successive NFkB/AP-1/Nrf2 pathways activation. These results suggest that the microgliosis intensity during PD might depend on the type of alpha-synuclein protein implicated. Indeed, mutated forms are more potent microglial stimulators than wild-type alpha-synuclein. Based on these data, anti-inflammatory and antioxidant therapeutic strategies may be valid in order to reduce microgliosis but also to subsequently slow down PD progression, especially in familial cases.	[Hoenen, Claire; Gustin, Audrey; Birck, Cindy; Kirchmeyer, Melanie; Beaume, Nicolas; Felten, Paul; Grandbarbe, Luc; Heuschling, Paul; Heurtaux, Tony] Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Neurobiol Lab, 7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg	University of Luxembourg	Heurtaux, T (corresponding author), Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Neurobiol Lab, 7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg.	tony.heurtaux@uni.lu		HEURTAUX, Tony/0000-0002-1709-5312; Birck, Cindy/0000-0002-0763-7544	National Research Fund of Luxembourg; University of Luxembourg	National Research Fund of Luxembourg(Luxembourg National Research Fund); University of Luxembourg	This work was financed through grants from the National Research Fund of Luxembourg and the University of Luxembourg.	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Ahmad R, 2014, CELL PHYSIOL BIOCHEM, V34, P929, DOI 10.1159/000366310; Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Aravalli RN, 2008, J NEUROIMMUNE PHARM, V3, P5, DOI 10.1007/s11481-007-9097-8; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Barrett PJ, 2015, BRAIN RES, V1628, P247, DOI 10.1016/j.brainres.2015.06.002; Beraud D, 2013, J NEUROIMMUNE PHARM, V8, P94, DOI 10.1007/s11481-012-9401-0; Bliederhaeuser C, 2016, ACTA NEUROPATHOL, V131, P379, DOI 10.1007/s00401-015-1504-2; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Campa VM, 2005, INFLAMM RES, V54, P328, DOI 10.1007/s00011-005-1359-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; de Medeiros MC, 2014, J APPL ORAL SCI, V22, P185, DOI 10.1590/1678-775720130593; DebRoy A, 2014, J BIOL CHEM, V289, P24188, DOI 10.1074/jbc.M114.570051; Delgado M, 2008, GLIA, V56, P1091, DOI 10.1002/glia.20681; Durrenberger PF, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/214714; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Heurtaux T, 2010, J NEUROCHEM, V114, P576, DOI 10.1111/j.1471-4159.2010.06783.x; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Korlipara LVP, 2002, INT REV NEUROBIOL, V53, P283; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0; Lee SB, 2009, BIOCHEM BIOPH RES CO, V381, P39, DOI 10.1016/j.bbrc.2009.02.002; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Losciuto S, 2012, J NEUROSCI METH, V207, P59, DOI 10.1016/j.jneumeth.2012.03.010; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Mahul-Mellier AL, 2015, CELL DEATH DIFFER, V22, P2107, DOI 10.1038/cdd.2015.79; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin FL, 2004, PROTEIN PEPTIDE LETT, V11, P229, DOI 10.2174/0929866043407138; McGeer PL, 2001, ADV NEUROL, V86, P83; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Pfeiffer RF, 2016, PARKINSONISM RELAT D, V22, pS119, DOI 10.1016/j.parkreldis.2015.09.004; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pradhan S, 2013, EXP NEUROL, V241, P148, DOI 10.1016/j.expneurol.2012.12.008; Reish HEA, 2015, J PARKINSON DIS, V5, P1, DOI 10.3233/JPD-140491; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Rojanathammanee L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-44; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Sahay S, 2015, J BIOL CHEM, V290, P7804, DOI 10.1074/jbc.M114.598607; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Stefanis L, 2012, CSH PERSPECT BIOL, V4; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tichauer J, 2007, NEUROIMMUNOMODULAT, V14, P168, DOI 10.1159/000110642; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Totterdell S, 2005, NEUROSCIENCE, V135, P907, DOI 10.1016/j.neuroscience.2005.06.047; Totterdell S, 2004, BRAIN RES, V1004, P61, DOI 10.1016/j.brainres.2003.10.072; Vivekanantham S, 2015, INT J NEUROSCI, V125, P717, DOI 10.3109/00207454.2014.982795; Wang QQ, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0042-0; Wilkaniec A, 2013, NEUROCHEM INT, V62, P776, DOI 10.1016/j.neuint.2013.02.004; Wilkinson K, 2012, INT J ALZHEIMERS DIS, V2012, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	85	86	88	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162717	10.1371/journal.pone.0162717	http://dx.doi.org/10.1371/journal.pone.0162717			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622765	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000050
J	Yom-Din, S; Hollander-Cohen, L; Aizen, J; Boehm, B; Shpilman, M; Golan, M; Hurvitz, A; Degani, G; Levavi-Sivan, B				Yom-Din, Svetlana; Hollander-Cohen, Lian; Aizen, Joseph; Boehm, Benjamin; Shpilman, Michal; Golan, Matan; Hurvitz, Avshalom; Degani, Gad; Levavi-Sivan, Berta			Gonadotropins in the Russian Sturgeon: Their Role in Steroid Secretion and the Effect of Hormonal Treatment on Their Secretion	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; LINKED-IMMUNOSORBENT-ASSAY; TROUT ONCORHYNCHUS-MYKISS; PITUITARY-GONADAL AXIS; RAINBOW-TROUT; LUTEINIZING-HORMONE; REPRODUCTIVE-CYCLE; ALPHA-SUBUNIT; ACIPENSER-GUELDENSTAEDTII	In the reproduction process of male and female fish, pituitary derived gonadotropins (GTHs) play a key role. To be able to specifically investigate certain functions of Luteinizing (LH) and Follicle stimulating hormone (FSH) in Russian sturgeon (Acipenser gueldenstaedtii; st), we produced recombinant variants of the hormones using the yeast Pichia pastoris as a protein production system. We accomplished to create in vitro biologically active heterodimeric glycoproteins consisting of two associated alpha- and beta-subunits in sufficient quantities. Three dimensional modelling of both GTHs was conducted in order to study the differences between the two GTHs. Antibodies were produced against the unique beta-subunit of each of the GTHs, in order to be used for immunohistochemical analysis and to develop an ELISA for blood and pituitary hormone quantification. This detection technique revealed the specific localization of the LH and FSH cells in the sturgeon pituitary and pointed out that both cell types are present in substantially higher numbers in mature males and females, compared to immature fish. With the newly attained option to prevent cross-contamination when investigating on the effects of GTH administration, we compared the steroidogeneic response (estradiol and 11-Keto testosterone (11-KT) in female and males, respectively) of recombinant stLH, stFSH, and carp pituitary extract in male and female sturgeon gonads at different developmental stages. Finally, we injected commercially available gonadotropin releasing hormones analog (GnRH) to mature females, and found a moderate effect on the development of ovarian follicles. Application of only testosterone (T) resulted in a significant increase in circulating levels of 11-KT whereas the combination of GnRH + T did not affect steroid levels at all. The response pattern for estradiol demonstrated a similar situation. FSH levels showed significant increases when GnRH + T was administered, while no changes were present in LH levels.	[Yom-Din, Svetlana; Hollander-Cohen, Lian; Aizen, Joseph; Boehm, Benjamin; Shpilman, Michal; Golan, Matan; Levavi-Sivan, Berta] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-76100 Rehovot, Israel; [Hurvitz, Avshalom; Degani, Gad] MIGAL Galilee Technol Ctr, POB 831, IL-10200 Kiryat Shmona, Israel	Hebrew University of Jerusalem	Levavi-Sivan, B (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-76100 Rehovot, Israel.	berta.sivan@mail.huji.ac.il	Aizen, Joseph/Y-1122-2019	Aizen, Joseph/0000-0002-2018-7322; Golan, Matan/0000-0003-4861-5912; Yom, Sue/0000-0002-0779-7476; Levavi-Sivan, Berta/0000-0002-0183-9524	European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant [642893 - IMPRESS]; Binational Agricultural Research and Development Fund [BARD IS-420209]	European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant; Binational Agricultural Research and Development Fund	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement no 642893 - IMPRESS and from the Binational Agricultural Research and Development Fund (BARD IS-420209).	Aizen J, 2007, GEN COMP ENDOCR, V153, P323, DOI 10.1016/j.ygcen.2007.04.004; Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Aizen J, 2012, GEN COMP ENDOCR, V178, P28, DOI 10.1016/j.ygcen.2012.04.002; Alavi SMH, 2012, FISH PHYSIOL BIOCHEM, V38, P1655, DOI 10.1007/s10695-012-9662-9; Barannikova IA, 2004, J FISH BIOL, V64, P1330, DOI 10.1111/j.0022-1112.2004.00395.x; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P427, DOI 10.1023/A:1007382724251; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Cao H, 2009, MOL CELL ENDOCRINOL, V303, P34, DOI 10.1016/j.mce.2009.01.015; Chauvigne F, 2016, COMP BIOCHEM PHYS A, V191, P35, DOI 10.1016/j.cbpa.2015.09.015; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; CHEN F, 1992, MOL ENDOCRINOL, V6, P914, DOI 10.1210/me.6.6.914; CRIM LW, 1979, GEN COMP ENDOCR, V37, P192, DOI 10.1016/0016-6480(79)90107-2; Crossin GT, 2010, J FISH BIOL, V76, P112, DOI 10.1111/j.1095-8649.2009.02479.x; CUISSET B, 1995, FISH PHYSIOL BIOCHEM, V14, P313, DOI 10.1007/BF00004069; CUISSET B, 1994, COMP BIOCHEM PHYS C, V108, P229, DOI 10.1016/1367-8280(94)90035-3; Doroshov SI, 1997, ENVIRON BIOL FISH, V48, P265, DOI 10.1023/A:1007336802423; Erbel PJA, 1999, EUR J BIOCHEM, V260, P490, DOI 10.1046/j.1432-1327.1999.00188.x; Erbel PJA, 2000, BIOCHEMISTRY-US, V39, P6012, DOI 10.1021/bi992786n; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fares F, 2006, BBA-GEN SUBJECTS, V1760, P560, DOI 10.1016/j.bbagen.2005.12.022; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; GIELEN JT, 1984, GEN COMP ENDOCR, V56, P457, DOI 10.1016/0016-6480(84)90088-1; GIELEN JT, 1983, CELL TISSUE RES, V233, P377, DOI 10.1007/BF00238304; Golan M, 2015, ENDOCRINOLOGY, V156, P4163, DOI 10.1210/en.2015-1150; Golan M, 2013, GEN COMP ENDOCR, V192, P126, DOI 10.1016/j.ygcen.2013.04.032; Guzman JM, 2015, GEN COMP EN IN PRESS; Holland JW, 2002, J ENDOCRINOL, V175, P261, DOI 10.1677/joe.0.1750261; Holland LZ, 2000, DEV BIOL, V226, P18, DOI 10.1006/dbio.2000.9810; Holland MCH, 2002, GEN COMP ENDOCR, V129, P178, DOI 10.1016/S0016-6480(02)00532-4; Holmes RL., 1974, PITUITARY GLAND COMP; HUANG JN, 1993, J BIOL CHEM, V268, P9311; Hurvitz A, 2005, GEN COMP ENDOCR, V140, P61, DOI 10.1016/j.ygcen.2004.09.019; Hurvitz A, 2007, AQUACULTURE, V270, P158, DOI 10.1016/j.aquaculture.2007.05.020; Hurvitz A, 2008, CYBIUM, V32, P283; Jarvis P.L., 2004, STURGEONS PADDLEFISH; Kamei H, 2003, GEN COMP ENDOCR, V134, P244, DOI 10.1016/S0016-6480(03)00259-4; Kasuto H, 2005, GEN COMP ENDOCR, V140, P222, DOI 10.1016/j.ygcen.2004.10.016; KAWAUCHI H, 1989, FISH PHYSIOL BIOCHEM, V7, P29, DOI 10.1007/BF00004687; Ko H, 2007, J MOL ENDOCRINOL, V38, P99, DOI 10.1677/jme.1.02163; Kobayashi M, 2010, GEN COMP ENDOCR, V167, P379, DOI 10.1016/j.ygcen.2010.01.003; Levavi-Sivan B, 2004, BIOL REPROD, V70, P1545, DOI 10.1095/biolreprod.103.021998; Levavi-Sivan B, 2004, AQUACULTURE, V229, P419, DOI 10.1016/S0044-8486(03)00349-1; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Levavi-Sivan B, 2006, BIOL REPROD, V75, P642, DOI 10.1095/biolreprod.106.051540; Levavi-Sivan B, 2008, CYBIUM, V32, P17; LEVAVIZERMONSKY B, 1986, GEN COMP ENDOCR, V62, P89, DOI 10.1016/0016-6480(86)90097-3; Lo A, 1998, GEN COMP ENDOCR, V111, P334, DOI 10.1006/gcen.1998.7117; Lokman PM, 2002, GEN COMP ENDOCR, V129, P1, DOI 10.1016/S0016-6480(02)00562-2; Mateos J, 2002, COMP BIOCHEM PHYS B, V132, P75, DOI 10.1016/S1096-4959(01)00535-8; Meiri I, 2000, FUNCTIONAL EXPRESSIO, P488; Moberg GP, 1995, AQUACULTURE, V135, P27, DOI 10.1016/0044-8486(95)01004-1; Moles G, 2012, GEN COMP ENDOCR, V176, P70, DOI 10.1016/j.ygcen.2011.12.029; Moles G, 2011, BIOL REPROD, V84, P1171, DOI 10.1095/biolreprod.110.086470; Mylonas CC, 2001, REV FISH BIOL FISHER, V10, P463; Pavlick RJ, 1997, GEN COMP ENDOCR, V105, P218, DOI 10.1006/gcen.1996.6823; PELISSERO C, 1988, FISH PHYSIOL BIOCHEM, V5, P109, DOI 10.1007/BF01875699; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Prat F, 1996, BIOL REPROD, V54, P1375, DOI 10.1095/biolreprod54.6.1375; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Shimizu A, 2012, GEN COMP ENDOCR, V178, P463, DOI 10.1016/j.ygcen.2012.07.003; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Sower SA, 2015, ENDOCRINOLOGY, V156, P3026, DOI 10.1210/en.2014-1797; SUZUKI K, 1988, GEN COMP ENDOCR, V71, P459, DOI 10.1016/0016-6480(88)90275-4; SWANSON P, 1989, FISH PHYSIOL BIOCHEM, V7, P169, DOI 10.1007/BF00004704; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Zenkevics H, 2000, ACTA BIOCHIM POL, V47, P815, DOI 10.18388/abp.2000_3999; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zmora N, 2007, J ENDOCRINOL, V194, P407, DOI 10.1677/JOE-07-0171	69	24	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162344	10.1371/journal.pone.0162344	http://dx.doi.org/10.1371/journal.pone.0162344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622546	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000026
J	Nunes-de-Almeida, CHL; Assis, CL; Feio, RN; Toledo, LF				Nunes-de-Almeida, Carlos H. L.; Assis, Clodoaldo L.; Feio, Renato N.; Toledo, Luis Felipe			Redescription of the Advertisement Call of Five Species of Thoropa (Anura, Cycloramphidae), Including Recordings of Rare and Endangered Species	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; AMPHIBIA; FROGS; LEPTODACTYLIDAE; EVOLUTION; HYLIDAE; SIGNALS	Frogs of the genus Thoropa comprise six endemic Brazilian species on the Eastern side of the country. Little is known about their natural history, especially about their acoustic communication. Therefore, aiming to provide an overview of their vocalizations, we analyzed and redescribed male advertisement calls of three living and two possibly extinct species. The smaller species, T. petropolitana and T. lutzi, produce simple calls (one single note) with a higher frequency range than the remaining larger ones. On the other hand, the larger species present complex calls, with more than one note: T. megatympanum calls have three notes, T. taophora calls have four notes, and T. miliaris calls varies from three to six notes. Population snout-vent length negatively correlated with peak of dominant frequency as expected. However, highlighted differences between two populations of T. lutzi, which could indicate need of further taxonomic evaluation of those lineages. Peculiar morphology, such as the absence of vocal sacs and slits, may have contributed to their call variation and highly banded frequency structure. If the observed population differences reflect species-level differences, T. lutzi may be classified as a critically endangered species, as T. petropolitana. Furthermore, we provided a suggestion to an unusual behavior in frogs: calling with the mouth open in the smaller species of the genus.	[Nunes-de-Almeida, Carlos H. L.; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, LaHNAB, Campinas, SP, Brazil; [Assis, Clodoaldo L.; Feio, Renato N.] Univ Fed Vicosa, Dept Biol Anim, Museu Zool Joao Moojen, Vicosa, MG, Brazil; [Nunes-de-Almeida, Carlos H. L.] Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade Estadual de Campinas	Nunes-de-Almeida, CHL (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, LaHNAB, Campinas, SP, Brazil.; Nunes-de-Almeida, CHL (corresponding author), Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil.	nunesdealmeida.carlos@gmail.com	Feio, Renato/AAD-8127-2020; de Almeida, Carlos Henrique Luz Nunes/D-6903-2014; Toledo, Luís Felipe/I-4017-2012; Assis, Clodoaldo/AAC-2477-2020	Feio, Renato/0000-0002-3607-2896; de Almeida, Carlos Henrique Luz Nunes/0000-0001-7898-7819; Toledo, Luís Felipe/0000-0002-4929-9598; Assis, Clodoaldo/0000-0001-5009-2706	Sao Paulo Research Foundation (FAPESP) [2014/23388-7, 2013/09964-2]; National Council for Scientific and Technological Development (CNPq) [405285/2013-2, 302589/2013-9, 306732/2015-7]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by: Sao Paulo Research Foundation (FAPESP) #2014/23388-7 Luis Felipe Toledo; National Council for Scientific and Technological Development (CNPq) #405285/2013-2 Luis Felipe Toledo; National Council for Scientific and Technological Development (CNPq) #302589/2013-9 Luis Felipe Toledop; National Council for Scientific and Technological Development (CNPq) #306732/2015-7 Renato Neves Feio; Coordination for the Improvement of Higher Education Personnel (CAPES)-Mr. Carlos Henrique Luz Nunes-de-Almeida; and Sao Paulo Research Foundation (FAPESP) #2013/09964-2 Mr. Carlos Henrique Luz Nunes-de-Almeida.	ABE AS, 1991, ZOOL ANZ, V227, P313; AMIET J-L, 1989, Alytes (Paris), V8, P99; BOKERMANN WERNER C. A., 1965, AN ACAD BRASIL CIENC, V37, P525; CARAMASCHI U, 1984, Revista Brasileira de Zoologia, V2, P139; Caramaschi U, 2000, FAUNA AMEACADA EXTIN; Cochran D. M., 1938, Proceedings of the Biological Society of Washington, V51, P41; COCROFT RB, 1988, P BIOL SOC WASH, V101, P209; De Andrade FS, 2013, ZOOTAXA, V3608, P389, DOI 10.11646/zootaxa.3608.5.7; De Carvalho TR, 2013, ZOOTAXA, V3701, P207, DOI 10.11646/zootaxa.3701.2.5; de Miranda-Ribeiro A., 1923, REV MUS PAUL, V13, P825; de Toledo Luis Felipe, 2009, South American Journal of Herpetology, V4, P25, DOI 10.2994/057.004.0104; DOE-Diario Oficial do Estado do Rio Grande do Sul, 2014, TAX FAUN SILV EST RI, V173; DOSP-Diario Oficial do Estado de Sao Paulo, 2014, LIST OF ESP FAUN AM, V1,124, P25; DOU-Diario Oficial da Uniao, 2014, LIST NAC OF ESP FAUN, P121; Erdtmann L, 2009, ETHOLOGY, V115, P801, DOI 10.1111/j.1439-0310.2009.01673.x; Feio RN, 2002, THESIS; Forti LR, 2016, PEERJ, V4, DOI 10.7717/peerj.2014; Forti Lucas R., 2012, Herpetology Notes, V5, P187; Frost DR, AMPHIBIAN SPECIES WO; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Giaretta Ariovaldo Antonio, 2004, Biota Neotrop., V4, P1, DOI 10.1590/S1676-06032004000200008; Goicoechea N, 2010, ZOOL SCR, V39, P141, DOI 10.1111/j.1463-6409.2009.00413.x; Grenat PR, 2013, AMPHIBIA-REPTILIA, V34, P471, DOI 10.1163/15685381-00002902; Gridi-Papp M, 2008, J ACOUST SOC AM, V123, P2895, DOI 10.1121/1.2897001; HADDAD C.F.B., 2013, GUIA ANFIBIOS MATA A; Heyer W.R., 1988, P245; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Kaefer IL, 2012, BEHAVIOUR, V149, P15, DOI 10.1163/156853912X623757; Magalhaes FD, 2014, HERPETOLOGICA, V70, P77; Muralidhar P, 2014, MOL ECOL, V23, P453, DOI 10.1111/mec.12592; Nali RC, 2014, SALAMANDRA, V50, P181; Neves Feio Renato, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P41; Nunes-De-Almeida CHL, 2012, ZOOTAXA, P43; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Passamani M, 2007, ESPECIES FAUNA AMEAC; Pauly GB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P708, DOI 10.1086/504613; PELOSO PL, 2014, B AM MUS NAT HIST, V386, P1, DOI DOI 10.1206/834.1; Preininger D, 2016, HERPETOL J, V26, P187; Robillard T, 2006, CLADISTICS, V22, P533, DOI 10.1111/j.1096-0031.2006.00118.x; Rodel MO, 2004, TROP ZOOL, V17, P201; Rodel MO, 2002, SALAMANDRA, V38, P213; SAZIMA I, 1971, Ciencia e Cultura (Sao Paulo), V23, P647; Smith MJ, 2003, COPEIA, P750, DOI 10.1643/HA02-133.1; Spix J.B., 1824, MAXIMILIANI HUBSCHMA, P1; Toledo Luis F., 2015, Acta Ethologica, V18, P87; Toledo LF, 2007, ZOOTAXA, P57, DOI 10.11646/zootaxa.1658.1.4; Wandolleck B, 1907, ZOOLOGISCHEN ANTHOPO, V11, P1; Wells DK, 2010, ECOLOGY BEHAV AMPHIB; Wollenberg KC, 2007, MOL PHYLOGENET EVOL, V45, P14, DOI 10.1016/j.ympev.2007.06.024; Wycherley J, 2002, BIOL J LINN SOC, V77, P355, DOI 10.1046/j.1095-8312.2002.00104.x	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162617	10.1371/journal.pone.0162617	http://dx.doi.org/10.1371/journal.pone.0162617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617833	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100032
J	Piskacek, M; Havelka, M; Rezacova, M; Knight, A				Piskacek, Martin; Havelka, Marek; Rezacova, Martina; Knight, Andrea			The 9aaTAD Transactivation Domains: From Gal4 to p53	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION DOMAINS; CREB-BINDING PROTEIN; KIX DOMAIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; IN-VITRO; COACTIVATOR; YEAST; CBP; MEDIATOR	The family of the Nine amino acid Transactivation Domain, 9aaTAD family, comprises currently over 40 members. The 9aaTAD domains are universally recognized by the transcriptional machinery from yeast to man. We had identified the 9aaTAD domains in the p53, Msn2, Pdr1 and B42 activators by our prediction algorithm. In this study, their competence to activate transcription as small peptides was proven. Not surprisingly, we elicited immense 9aaTAD divergence in hundreds of identified orthologs and numerous examples of the 9aaTAD species' convergence. We found unforeseen similarity of the mammalian p53 with yeast Gal4 9aaTAD domains. Furthermore, we identified artificial 9aaTAD domains generated accidentally by others. From an evolutionary perspective, the observed easiness to generate 9aaTAD transactivation domains indicates the natural advantage for spontaneous generation of transcription factors from DNA binding precursors.	[Piskacek, Martin; Havelka, Marek; Rezacova, Martina] Masaryk Univ Brno, Dept Pathol Physiol, Lab Canc Biol & Genet, Fac Med, Kamenice 5, Brno 62500, Czech Republic; [Knight, Andrea] Masaryk Univ Brno, Dept Pathol Physiol, Gamma Delta Cell Lab T, Fac Med, Kamenice 5, Brno 62500, Czech Republic	Masaryk University Brno; Masaryk University Brno	Piskacek, M (corresponding author), Masaryk Univ Brno, Dept Pathol Physiol, Lab Canc Biol & Genet, Fac Med, Kamenice 5, Brno 62500, Czech Republic.	Piskacek@med.muni.cz	Piskacek, Martin/I-4280-2016	Piskacek, Martin/0000-0002-6283-1542; Knight, Andrea/0000-0001-7291-7975	Ministry of Health of the Czech Republic [NT14310, 15-32935A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by Ministry of Health of the Czech Republic NT14310 (M.P.) and 15-32935A (A.K.).	Aguilar X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098575; Arai M, 2010, FEBS LETT, V584, P4500, DOI 10.1016/j.febslet.2010.10.024; Bates CA, 2011, BIOPOLYMERS, V95, P17, DOI 10.1002/bip.21548; Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Cook PR, 2011, J MOL BIOL, V409, P384, DOI 10.1016/j.jmb.2011.04.003; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; FASSLER JS, 1989, MOL CELL BIOL, V9, P5602, DOI 10.1128/MCB.9.12.5602; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Frangioni JV, 2000, NAT BIOTECHNOL, V18, P1080, DOI 10.1038/80280; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Han Y, 2000, J BIOL CHEM, V275, P14979, DOI 10.1074/jbc.275.20.14979; Hong JY, 2011, PHYTOCHEMISTRY, V72, P27, DOI 10.1016/j.phytochem.2010.10.005; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Jeong CJ, 2001, BIOCHEMISTRY-US, V40, P9421, DOI 10.1021/bi010011k; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Klein J, 2003, J BIOL CHEM, V278, P6779, DOI 10.1074/jbc.M212514200; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lallet S, 2006, MOL MICROBIOL, V62, P438, DOI 10.1111/j.1365-2958.2006.05363.x; Langlois C, 2012, J AM CHEM SOC, V134, P1715, DOI 10.1021/ja208999e; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lindert U, 2009, MOL CELL BIOL, V29, P6283, DOI 10.1128/MCB.00847-09; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Lu XY, 2000, P NATL ACAD SCI USA, V97, P1988, DOI 10.1073/pnas.040573197; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Majmudar CY, 2009, ANGEW CHEM INT EDIT, V48, P7021, DOI 10.1002/anie.200902669; Matsushita A, 2013, PLANT J, V73, P302, DOI 10.1111/tpj.12035; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Piskacek M., 2009, NATURE PRECEDINGS, DOI [10.1038/npre.2009.3984.1, DOI 10.1038/NPRE.2009.3984.1]; Piskacek M, 2009, NATURE PRECEDINGS, DOI [10.1038/npre.2009.3939.1, DOI 10.1038/NPRE.2009.3939.1]; Piskacek M., 2009, NAT PRECED, DOI [10.1038/npre.2009.3488.2, DOI 10.1038/NPRE.2009.3488.2]; Piskacek M, 2015, MOL BIOSYST, V11, P844, DOI 10.1039/c4mb00672k; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Pomerantz WC, 2012, ACS CHEM BIOL, V7, P1345, DOI 10.1021/cb3002733; Ptashne M, 2014, J BIOL CHEM, V289, P5417, DOI 10.1074/jbc.X114.547323; Qiu YJ, 2015, PLANT CELL, V27, P1409, DOI 10.1105/tpc.114.136093; RUDEN DM, 1991, NATURE, V350, P250, DOI 10.1038/350250a0; Sadeh A, 2012, J CELL SCI, V125, P3333, DOI 10.1242/jcs.096446; SAKURAI H, 1993, P NATL ACAD SCI USA, V90, P8382, DOI 10.1073/pnas.90.18.8382; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Shekhawat UKS, 2011, MOL BIOL REP, V38, P4023, DOI 10.1007/s11033-010-0521-4; Suzuki Y, 1992, Mol Cell Biol, V12, P4806; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Wang NK, 2014, P NATL ACAD SCI USA, V111, P12061, DOI 10.1073/pnas.1406033111; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	64	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162842	10.1371/journal.pone.0162842	http://dx.doi.org/10.1371/journal.pone.0162842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618436	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100056
J	Wang, L; Zhao, MC; Shi, ZR; Feng, ZS; Guo, WW; Yang, S; Liu, LP; Li, GX				Wang, Le; Zhao, Mengchuan; Shi, Zhongren; Feng, Zhishan; Guo, Weiwei; Yang, Shuo; Liu, Lanping; Li, Guixia			A GeXP-Based Assay for Simultaneous Detection of Multiple Viruses in Hospitalized Children with Community Acquired Pneumonia	PLOS ONE			English	Article							TRANSCRIPTION-PCR ASSAY; RESPIRATORY VIRUSES; EPIDEMIOLOGY	The GeXP-based assay has recently been developed for simultaneous detection of multiple pathogens. So far, the application of the GeXP assay to test larger clinical samples has hardly been reported. Community-acquired pneumonia (CAP) is the leading cause of death in children worldwide and a substantial proportion of childhood CAP is caused by viruses. Rapid and accurate diagnosis of virus infection is important for the clinical management of CAP. In this study, we explored the GeXP assay for simultaneous detection of 20 types/subtypes of viruses in hospitalized children with CAP. A total of 1699 nasopharyngeal swabs were prospectively collected and viral nucleic acid was extracted and assayed. Using viral genomic DNA or RNA as template, we showed that at the concentration of 10(4) copies of DNA or RNA of each virus/mu l, all 20 target viruses were simultaneously identified by the GeXP assay. Fifteen control microorganisms, in contrast, failed to be amplified by the assay. About 65% of cases tested in this study had viral infection, with patients aged <3 years having a 70% positive rate, significantly higher than that in patients aged > 3 years (40%). The most frequently detected virus was RSV followed by PIV3, HRV, ADV and HBoV. Seasonal distribution analysis revealed that RSV was the most predominant in autumn and winter, while in spring and summer PIV3 and RSV were the most frequently identified with similar positive percentages. One hundred twenty randomly-chosen samples tested by the GeXP assay were re-evaluated by mono-RT-PCR, the results showed 97.5% diagnosis agreement between these 2 methods. Our findings suggest that the GeXP assay could be a valuable diagnostic tool for virus infection in pediatric patients with CAP.	[Wang, Le; Shi, Zhongren; Feng, Zhishan; Guo, Weiwei; Yang, Shuo; Liu, Lanping; Li, Guixia] Childrens Hosp Hebei Prov, Pediat Res Inst, Shijiazhuang 050031, Peoples R China; [Zhao, Mengchuan] Hebei Med Univ, Grad Sch, Shijiazhuang 050000, Peoples R China; [Li, Guixia] Childrens Hosp Hebei Prov, Dept Lab Med, Shijiazhuang 050031, Peoples R China	Hebei Medical University	Liu, LP; Li, GX (corresponding author), Childrens Hosp Hebei Prov, Pediat Res Inst, Shijiazhuang 050031, Peoples R China.; Li, GX (corresponding author), Childrens Hosp Hebei Prov, Dept Lab Med, Shijiazhuang 050031, Peoples R China.	LLp19620901@163.com; hbetlgx@126.com			Science and Technology Support Program of Hebei Province, China [15277705D]	Science and Technology Support Program of Hebei Province, China	Support for this study was provided by the Science and Technology Support Program of Hebei Province, China. Grant Number: 15277705D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cantais A, 2014, J CLIN VIROL, V60, P402, DOI 10.1016/j.jcv.2014.05.006; Chen KP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1422-1; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; He Li-xian, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P649; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Rhedin S, 2015, THORAX, V70, P847, DOI 10.1136/thoraxjnl-2015-206933; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Wolf DG, 2010, J PEDIATR-US, V156, P115, DOI 10.1016/j.jpeds.2009.07.014; Zhang YF, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0590-6	19	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162411	10.1371/journal.pone.0162411	http://dx.doi.org/10.1371/journal.pone.0162411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627439	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600033
J	Creanga, AA; Odhiambo, GA; Odera, B; Odhiambo, FO; Desai, M; Goodwin, M; Laserson, K; Goldberg, H				Creanga, Andreea A.; Odhiambo, George Awino; Odera, Benjamin; Odhiambo, Frank O.; Desai, Meghna; Goodwin, Mary; Laserson, Kayla; Goldberg, Howard			Pregnant Women's Intentions and Subsequent Behaviors Regarding Maternal and Neonatal Service Utilization: Results from a Cohort Study in Nyanza Province, Kenya	PLOS ONE			English	Article							FACILITY-BASED DELIVERY; OF-THE-LITERATURE; PLANNED BEHAVIOR; DEVELOPING-COUNTRIES; HOME DELIVERY; CARE; BARRIERS; HEALTH; METAANALYSIS; CHILDBIRTH	Higher use of maternal and neonatal health (MNH) services may reduce maternal and neonatal mortality in Kenya. This study aims to: 1) prospectively explore women's intentions to use MNH services (antenatal care, delivery in a facility, postnatal care, neonatal care) at < 20 and 30-35 weeks' gestation and their actual use of these services; 2) identify predictors of intention-behavior discordance among women with positive service use intentions; 3) examine associations between place of delivery, women's reasons for choosing it, and birthing experiences. We used data from a 2012-2013 population-based cohort of pregnant women in the Demographic Surveillance Site in Nyanza province, Kenya. Of 1,056 women completing the study (89.1% response rate), 948 had live-births and 22 stillbirths, and they represent our analytic sample. Logistic regression analysis identified predictors of intention-behavior discordance regarding delivery in a facility and use of postnatal and neonatal care. At < 20 and 30-35 weeks' gestation, most women intended to seek MNH services (>= 93.9% and >= 87.5%, respectively, for all services assessed). Actual service use was high for antenatal (98.1%) and neonatal (88.5%) care, but lower for delivery in a facility (76.9%) and postnatal care (51.8%). Woman's age > 35 and high-school education were significant predictors of intention-behavior discordance regarding delivery in a facility; several delivery-related factors were significantly associated with intention-behavior discordance regarding use of postnatal and neonatal care. Delivery facilities were chosen based on proximity to women's residence, affordability, and service quality; among women who delivered outside a health facility, 16.3% could not afford going to a facility. Good/very good birth experiences were reported by 93.6% of women who delivered in a facility and 32.6% of women who did not. We found higher MNH service utilization than previously documented in Nyanza province. Further increasing the number of facility deliveries and use of postnatal care may improve MNH in Kenya.	[Creanga, Andreea A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Creanga, Andreea A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA; [Odhiambo, George Awino; Odera, Benjamin; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Desai, Meghna; Laserson, Kayla] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Goodwin, Mary; Goldberg, Howard] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Laserson, Kayla] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Creanga, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Creanga, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA.	acreanga@jhu.edu			US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the US Centers for Disease Control and Prevention; authors have received no funding to prepare the manuscript.	Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, KENYA COUNTRY STAT; Audo M O, 2005, East Afr Med J, V82, P547; Bell J, 2003, BIRTH-ISS PERINAT C, V30, P227, DOI 10.1046/j.1523-536X.2003.00252.x; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Conner M, 1998, J APPL SOC PSYCHOL, V28, P1429, DOI 10.1111/j.1559-1816.1998.tb01685.x; Conner M., 1996, PREDICTING HLTH BEHA; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; Doctor HV, 2012, REPROD HEALTH MATTER, V20, P104, DOI 10.1016/S0968-8080(12)39615-8; Dogba M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-7; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Iyengar SD, 2008, J PERINATOL, V28, pS23, DOI 10.1038/jp.2008.174; Izugbara CO, 2009, PUBLIC HEALTH REP, V124, P585, DOI 10.1177/003335490912400416; Kenya National Bureau of Statistics Nairobi Kenya and MEASURE DHS ICF Macro Calverton Maryland USA, 2009, NAIR KEN MEASURE DHS; Loundon I, 1992, DEATH CHILD BIRTH IN; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Mwangome FK, 2012, RURAL REMOTE HEALTH, V12; Nair M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004749; Ono M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-214; Ouma PO, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-1; Oyerinde K, 2012, J COMMUN MED HLTH ED, V2, P1, DOI DOI 10.4172/2161-0711.1000149; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120; RANDALL DM, 1994, BRIT J SOC PSYCHOL, V33, P405, DOI 10.1111/j.2044-8309.1994.tb01037.x; Seljeskog Line, 2006, Afr J Reprod Health, V10, P66; Sheeran P, 1998, BRIT J SOC PSYCHOL, V37, P231, DOI 10.1111/j.2044-8309.1998.tb01167.x; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Sorensen BL, 2011, AFR J REPROD HEALTH, V15, P2; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Bank, 2014, KEN COUNTR EST	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162017	10.1371/journal.pone.0162017	http://dx.doi.org/10.1371/journal.pone.0162017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622496	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000013
J	Konduru, K; Shurtleff, AC; Bradfute, SB; Nakamura, S; Bavari, S; Kaplan, G				Konduru, Krishnamurthy; Shurtleff, Amy C.; Bradfute, Steven B.; Nakamura, Siham; Bavari, Sina; Kaplan, Gerardo			Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge	PLOS ONE			English	Article							RESPIRATORY-TRACT IMMUNIZATION; NONHUMAN-PRIMATES; VIRUS GLYCOPROTEIN; HEMORRHAGIC-FEVER; PARTICLES PROTECT; VACCINE; ANTIBODY; REPLICATION; RESPONSES; IMMUNITY	Ebola virus (EBOV), a member of the Filoviridae that can cause severe hemorrhagic fever in humans and nonhuman primates, poses a significant threat to the public health. Currently, there are no licensed vaccines or therapeutics to prevent and treat EBOV infection. Several vaccines based on the EBOV glycoprotein (GP) are under development, including vectored, virus-like particles, and protein-based subunit vaccines. We previously demonstrated that a subunit vaccine containing the extracellular domain of the Ebola ebolavirus (EBOV) GP fused to the Fc fragment of human IgG1 (EBOVgp-Fc) protected mice against EBOV lethal challenge. Here, we show that the EBOVgp-Fc vaccine formulated with QS-21, alum, or polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose (poly-ICLC) adjuvants induced strong humoral immune responses in guinea pigs. The vaccinated animals developed anti-GP total antibody titers of approximately 10(5)-10(6) and neutralizing antibody titers of approximately 103 as assessed by a BSL-2 neutralization assay based on vesicular stomatitis virus (VSV) pseudotypes. The poly-ICLC formulated EBOVgp-Fc vaccine protected all the guinea pigs against EBOV lethal challenge performed under BSL-4 conditions whereas the same vaccine formulated with QS-21 or alum only induced partial protection. Vaccination with a mucin-deleted EBOVgp-Fc construct formulated with QS-21 adjuvant did not have a significant effect in anti-GP antibody levels and protection against EBOV lethal challenge compared to the full-length GP construct. The bulk of the humoral response induced by the EBOVgp-Fc vaccine was directed against epitopes outside the EBOV mucin region. Our findings indicate that different adjuvants can eliciting varying levels of protection against lethal EBOV challenge in guinea pigs vaccinated with EBOVgp-Fc, and suggest that levels of total anti-GP antibodies elicit by protein-based GP subunit vaccines do not correlate with protection. Our data further support the development of Fc fusions of GP as a candidate vaccine for human use.	[Konduru, Krishnamurthy; Nakamura, Siham; Kaplan, Gerardo] Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Shurtleff, Amy C.; Bradfute, Steven B.; Bavari, Sina] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Bradfute, Steven B.] Univ New Mexico, Albuquerque, NM 87131 USA	US Food & Drug Administration (FDA); University of New Mexico	Konduru, K (corresponding author), Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	krishnamurthy.konduru@fda.hhs.gov	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635; kaplan, gerardo/0000-0003-3303-7259	CBER/FDA from National Institutes of Allergy and Infectious Disease (NIH) [IAA Y1-AI-0664-01]; Defense Threat Reduction Agency (DTRA) [IAA 11005IA-3333-Basic]; FDA; USAMRIID; FDA-U.S. Department of Energy	CBER/FDA from National Institutes of Allergy and Infectious Disease (NIH); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); FDA(United States Department of Health & Human Services); USAMRIID; FDA-U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Interagency Agreements (IAAs) with CBER/FDA (GK) from the National Institutes of Allergy and Infectious Disease (NIH IAA Y1-AI-0664-01) and the Defense Threat Reduction Agency (DTRA IAA 11005IA-3333-Basic) and intramural funds from FDA (GK) and USAMRIID (SB). SN was supported by an appointment to a Research Participation Program administered by the Oak Ridge Institute for Science and Education through a FDA-U.S. Department of Energy interagency agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Barrette RW, 2011, INFECT GENET EVOL, V11, P1514, DOI 10.1016/j.meegid.2011.06.017; Bradfute SB, 2011, VIRUSES-BASEL, V3, P982, DOI 10.3390/v3070982; Bradfute SB, 2011, HUM VACCINES, V7, P701, DOI 10.4161/hv.7.6.15398; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 2007, J VIROL, V81, P6379, DOI 10.1128/JVI.00105-07; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Cenciarelli Orlando, 2015, Int J Microbiol, V2015, P769121, DOI 10.1155/2015/769121; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; DiNapoli JM, 2010, VACCINE, V29, P17, DOI 10.1016/j.vaccine.2010.10.024; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feldmann H, 2001, J GEN VIROL, V82, P2839, DOI 10.1099/0022-1317-82-12-2839; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Guyre PM, 1997, CANCER IMMUNOL IMMUN, V45, P146, DOI 10.1007/s002620050418; Halfmann P, 2009, J VIROL, V83, P3810, DOI 10.1128/JVI.00074-09; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Heeney JL, 2015, NATURE, V527, P453, DOI 10.1038/527453a; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Konduru K, 2011, VACCINE, V29, P2968, DOI 10.1016/j.vaccine.2011.01.113; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Olson Sarah H, 2012, Emerg Health Threats J, V5, DOI 10.3402/ehtj.v5i0.9134; Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Schmidt SR, 2009, IDRUGS, V12, P284; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Shurtleff AC, 2011, EXPERT OPIN DRUG DIS, V6, P233, DOI 10.1517/17460441.2011.554815; Spengler JR, 2016, EMERG INFECT DIS, V22, P956, DOI [10.32032/eid2206.160021, 10.3201/eid2206.160021]; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Volchkov VE, 2005, ADV VIRUS RES, V64, P359, DOI 10.1016/S0065-3527(05)64011-0; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2004, VACCINE, V22, P3495, DOI 10.1016/j.vaccine.2004.01.063; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083	64	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162446	10.1371/journal.pone.0162446	http://dx.doi.org/10.1371/journal.pone.0162446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622456	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000032
J	Paramelle, D; Peng, T; Free, P; Fernig, DG; Lim, S; Tomczak, N				Paramelle, David; Peng, Tao; Free, Paul; Fernig, David G.; Lim, Sierin; Tomczak, Nikodem			Specific Internalisation of Gold Nanoparticles into Engineered Porous Protein Cages via Affinity Binding	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; VIRUS-BASED NANOPARTICLES; DRUG-DELIVERY; FERRITIN; ENCAPSULATION; APOFERRITIN; FABRICATION; SCAFFOLD; DESIGN; CORES	Porous protein cages are supramolecular protein self-assemblies presenting pores that allow the access of surrounding molecules and ions into their core in order to store and transport them in biological environments. Protein cages' pores are attractive channels for the internalisation of inorganic nanoparticles and an alternative for the preparation of hybrid bioinspired nanoparticles. However, strategies based on nanoparticle transport through the pores are largely unexplored, due to the difficulty of tailoring nanoparticles that have diameters commensurate with the pores size and simultaneously displaying specific affinity to the cages' core and low non-specific binding to the cages' outer surface. We evaluated the specific internalisation of single small gold nanoparticles, 3.9 nm in diameter, into porous protein cages via affinity binding. The E2 protein cage derived from the Geobacillus stearothermophilus presents 12 pores, 6 nm in diameter, and an empty core of 13 nm in diameter. We engineered the E2 protein by site-directed mutagenesis with oligohistidine sequences exposing them into the cage's core. Dynamic light scattering and electron microscopy analysis show that the structures of E2 protein cages mutated with bis-or penta-histidine sequences are well conserved. The surface of the gold nanoparticles was passivated with a self-assembled monolayer made of a mixture of short peptidols and thiolated alkane ethylene glycol ligands. Such monolayers are found to provide thin coatings preventing non-specific binding to proteins. Further functionalisation of the peptide coated gold nanoparticles with Ni2+ nitrilotriacetic moieties enabled the specific binding to oligohistidine tagged cages. The internalisation via affinity binding was evaluated by electron microscopy analysis. From the various mutations tested, only the penta-histidine mutated E2 protein cage showed repeatable and stable internalisation. The present work overcomes the limitations of currently available approaches and provides a new route to design tailored and well-controlled hybrid nanoparticles.	[Paramelle, David; Free, Paul; Tomczak, Nikodem] ASTAR, Inst Mat Res & Engn, Singapore, Singapore; [Peng, Tao; Lim, Sierin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore, Singapore; [Fernig, David G.] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England; [Lim, Sierin] Nanyang Technol Univ, NTU Northwestern Inst Nanomed, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Liverpool; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Paramelle, D; Tomczak, N (corresponding author), ASTAR, Inst Mat Res & Engn, Singapore, Singapore.; Lim, S (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore, Singapore.; Lim, S (corresponding author), Nanyang Technol Univ, NTU Northwestern Inst Nanomed, Singapore, Singapore.	paramelled@imre.a-star.edu.sg; SLim@ntu.edu.sg; tomczakn@imre.a-star.edu.sg	Lim, Sierin/G-6109-2010; Free, Paul/AAW-7885-2021; Fernig, David G/A-3590-2008; Paramelle, David/B-8026-2008	Lim, Sierin/0000-0001-7455-6771; Free, Paul/0000-0002-6231-6989; Fernig, David G/0000-0003-4875-4293; Paramelle, David/0000-0002-5388-9339	Agency for Science, Technology and Research (A*STAR); Institute of Materials Research and Engineering (IMRE) [IMRE/11-1C0215-OOE]; North West Cancer Research; Cancer and Polio Research Fund; Ministry of Education Academic Research Fund Tier 1 [RG33/07]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Institute of Materials Research and Engineering (IMRE); North West Cancer Research; Cancer and Polio Research Fund; Ministry of Education Academic Research Fund Tier 1	DP, PF and NT are grateful for financial support by the Agency for Science, Technology and Research (A*STAR), and the Institute of Materials Research and Engineering (IMRE) (Grant number IMRE/11-1C0215-OOE). DGF was funded by the North West Cancer Research, and the Cancer and Polio Research Fund. TP and SL were funded by the Ministry of Education Academic Research Fund Tier 1 (RG33/07).	Algar WR, 2011, BIOCONJUGATE CHEM, V22, P825, DOI 10.1021/bc200065z; Aniagyei SE, 2008, J MATER CHEM, V18, P3763, DOI 10.1039/b805874c; Blum AS, 2006, NANOTECHNOLOGY, V17, P5073, DOI 10.1088/0957-4484/17/20/006; Bronstein LM, 2011, SMALL, V7, P1609, DOI 10.1002/smll.201001992; Chen WH, 2012, BIOMATERIALS, V33, P7895, DOI 10.1016/j.biomaterials.2012.07.016; Chen XY, 2012, AUST J CHEM, V65, P266, DOI 10.1071/CH11432; Dai Q, 2014, ANGEW CHEM INT EDIT, V53, P5093, DOI 10.1002/anie.201309464; Dalmau M, 2008, BIOTECHNOL BIOENG, V101, P654, DOI 10.1002/bit.21988; Daniel MC, 2010, ACS NANO, V4, P3853, DOI 10.1021/nn1005073; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u; Estrada LPH, 2015, BIOMATER SCI-UK, V3, P787, DOI 10.1039/c5bm00052a; Fan RL, 2010, SMALL, V6, P1483, DOI 10.1002/smll.201000457; Free P, 2012, AUST J CHEM, V65, P275, DOI 10.1071/CH11429; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Jolley C, 2011, NANOSCALE, V3, P1004, DOI 10.1039/c0nr00378f; Jolley CC, 2010, CHEM MATER, V22, P4612, DOI 10.1021/cm100657w; Jutz G, 2015, CHEM REV, V115, P1653, DOI 10.1021/cr400011b; Kale A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/4/045603; Kasyutich O, 2010, J AM CHEM SOC, V132, P3621, DOI 10.1021/ja910918b; Keyes JD, 2011, J NANOPART RES, V13, P2563, DOI 10.1007/s11051-010-0149-2; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; Lee LA, 2009, NANO RES, V2, P349, DOI 10.1007/s12274-009-9033-8; Li F, 2014, SMALL, V10, P230, DOI 10.1002/smll.201301393; Li K, 2012, NANOSCALE, V4, P188, DOI 10.1039/c1nr11132a; Li T, 2012, J MATER CHEM, V22, P14458, DOI 10.1039/c2jm30633f; Lim S, 2013, IFMBE P, P321; Ma YJ, 2012, ADV DRUG DELIVER REV, V64, P811, DOI 10.1016/j.addr.2012.01.005; Octeau V, 2009, ACS NANO, V3, P345, DOI 10.1021/nn800771m; Okuda M, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/41/415601; Paramelle D, 2015, ADV HEALTHC MATER, V4, P911, DOI 10.1002/adhm.201400730; Peng T, 2014, SMALL, V10, P3131, DOI 10.1002/smll.201303516; Peng T, 2011, BIOMACROMOLECULES, V12, P3131, DOI 10.1021/bm2005438; Pieters BJGE, 2016, CHEM SOC REV, V45, P24, DOI 10.1039/c5cs00157a; Pokorski JK, 2011, MOL PHARMACEUT, V8, P29, DOI 10.1021/mp100225y; Qiu HJ, 2013, ACS APPL MATER INTER, V5, P782, DOI 10.1021/am3022366; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Ren DM, 2012, ADV FUNCT MATER, V22, P3170, DOI 10.1002/adfm.201200052; Ren DM, 2011, SMALL, V7, P1051, DOI 10.1002/smll.201002242; San BH, 2012, J MATER CHEM, V22, P1774, DOI 10.1039/c1jm14581a; Swift J, 2009, LANGMUIR, V25, P5219, DOI 10.1021/la8040743; van Rijn P, 2011, J MATER CHEM, V21, P16735, DOI 10.1039/c1jm11433f; Vieweger M, 2011, ACS NANO, V5, P7324, DOI 10.1021/nn202184x; Xie H, 2009, SMALL, V5, P1036, DOI 10.1002/smll.200801106; Zhen ZP, 2013, ACS NANO, V7, P4830, DOI 10.1021/nn305791q	48	2	2	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162848	10.1371/journal.pone.0162848	http://dx.doi.org/10.1371/journal.pone.0162848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622533	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000064
J	Rosato, M; Kovarik, A; Garilleti, R; Rossello, JA				Rosato, Marcela; Kovarik, Ales; Garilleti, Ricardo; Rossello, Josep A.			Conserved Organisation of 45S rDNA Sites and rDNA Gene Copy Number among Major Clades of Early Land Plants	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; GENOME SIZE; X-CHROMOSOME; EVOLUTION; DIVERSITY; REPEAT; LOCUS; UNIT; 5S; RECOMBINATION	Genes encoding ribosomal RNA (rDNA) are universal key constituents of eukaryotic genomes, and the nuclear genome harbours hundreds to several thousand copies of each species. Knowledge about the number of rDNA loci and gene copy number provides information for comparative studies of organismal and molecular evolution at various phylogenetic levels. With the exception of seed plants, the range of 45S rDNA locus (encoding 18S, 5.8S and 26S rRNA) and gene copy number variation within key evolutionary plant groups is largely unknown. This is especially true for the three earliest land plant lineages Marchantiophyta (liverworts), Bryophyta (mosses), and Anthocerotophyta (hornworts). In this work, we report the extent of rDNA variation in early land plants, assessing the number of 45S rDNA loci and gene copy number in 106 species and 25 species, respectively, of mosses, liverworts and hornworts. Unexpectedly, the results show a narrow range of ribosomal locus variation (one or two 45S rDNA loci) and gene copies not present in vascular plant lineages, where a wide spectrum is recorded. Mutation analysis of whole genomic reads showed higher (3-fold) intragenomic heterogeneity of Marchantia polymorpha (Marchantiophyta) rDNA compared to Physcomitrella patens (Bryophyta) and two angiosperms(Arabidopsis thaliana and Nicotiana tomentosifomis) suggesting the presence of rDNA pseudogenes in its genome. No association between phylogenetic position, taxonomic adscription and the number of rDNA loci and gene copy number was found. Our results suggest a likely evolutionary rDNA stasis during land colonisation and diversification across 480 myr of bryophyte evolution. We hypothesise that strong selection forces may be acting against ribosomal gene locus amplification. Despite showing a predominant haploid phase and infrequent meiosis, overall rDNA homogeneity is not severely compromised in bryophytes.	[Rosato, Marcela; Rossello, Josep A.] Univ Valencia, ICBiBE Unidad Asociada CSIC, Jardin Bot, C Quart 80, E-46008 Valencia, Spain; [Kovarik, Ales] Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic; [Garilleti, Ricardo] Univ Valencia, Fac Farm, Dept Bot, E-46100 Burjassot, Spain; [Rossello, Josep A.] Carl Faust Fdn, Marimurtra Bot Garden, POB 112, E-17300 Blanes, Catalonia, Spain	University of Valencia; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Valencia	Rossello, JA (corresponding author), Univ Valencia, ICBiBE Unidad Asociada CSIC, Jardin Bot, C Quart 80, E-46008 Valencia, Spain.; Rossello, JA (corresponding author), Carl Faust Fdn, Marimurtra Bot Garden, POB 112, E-17300 Blanes, Catalonia, Spain.	rossello@uv.es	Garilleti, Ricardo/A-2862-2014; Kovarik, Ales/H-1952-2014	Garilleti, Ricardo/0000-0002-5977-2908; Kovarik, Ales/0000-0003-2896-0698	Spanish Ministry of Science and Innovation [CGL2010-22347-C02-01, CGL2010-15693/BOS]; Catalan Government [2009SGR608]; Czech Scientific Foundation [P501/12/G090]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Czech Scientific Foundation(Grant Agency of the Czech Republic)	This work was supported by funds from the Spanish Ministry of Science and Innovation (Projects CGL2010-22347-C02-01 and CGL2010-15693/BOS), the Catalan Government (Consolidated Research Group 2009SGR608) and the Czech Scientific Foundation (P501/12/G090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainard JD, 2013, GENOME, V56, P431, DOI 10.1139/gen-2013-0041; Bainard JD, 2013, MOL PHYLOGENET EVOL, V68, P619, DOI 10.1016/j.ympev.2013.04.008; Bennett MD, 2012, PLANT DNA C VALUES D; Berrie GK, 1958, T BRIT BRYOL SOC, V3, P422, DOI [10.1179/006813858804829451, DOI 10.1179/006813858804829451]; Berrie GK, 1958, T BRIT BRYOL SOC, V3, P427, DOI [DOI 10.1179/006813858804829334, 10.1179/006813858804829334]; Caperta AD, 2002, J CELL SCI, V115, P2839; Capesius I, 1997, PLANT MOL BIOL, V33, P559, DOI 10.1023/A:1005740031313; Clark J, 2016, NEW PHYTOL, V210, P1072, DOI 10.1111/nph.13833; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; DUBCOVSKY J, 1995, GENETICS, V140, P1367; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Fojtova M, 2015, PLANT MOL BIOL, V87, P591, DOI 10.1007/s11103-015-0299-9; Fritsch R, 1982, REGNUM VEG, V108, P1; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fujisawa M, 2003, CHROMOSOME RES, V11, P695, DOI 10.1023/A:1025941206391; Garcia S, 2012, CHROMOSOMA, V121, P389, DOI 10.1007/s00412-012-0368-7; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Hein N, 2012, SENESCENCE, P171; Hilger HH, 2013, BRYOPHYTE PHYLOGENY; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; INGLE J, 1975, PLANT PHYSIOL, V55, P496, DOI 10.1104/pp.55.3.496; Jovet-Ast S, 1969, REVUE BRYOL LICHEN, V36, P673; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kovarik A, 2012, BOT J LINN SOC, V170, P459, DOI 10.1111/j.1095-8339.2012.01280.x; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P716, DOI 10.1093/nar/gkg155; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; LEE M, 1988, ANNU REV PLANT PHYS, V39, P413, DOI 10.1146/annurev.arplant.39.1.413; Lim KY, 2000, CHROMOSOMA, V109, P161; Liu Y, 2013, MOL PHYLOGENET EVOL, V66, P1089, DOI 10.1016/j.ympev.2012.12.006; Marcon AB, 2005, ANN BOT-LONDON, V95, P271, DOI 10.1093/aob/mci022; Matyasek R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-722; MCADAM SV, 1982, J BRYOL, V12, P233, DOI 10.1179/jbr.1982.12.2.233; MCADAM SV, 1981, J BRYOL, V11, P591, DOI 10.1179/jbr.1981.11.4.591; Milyutina IA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1485, DOI 10.1134/S0006297915110103; Murray B.G., 2013, PLANT GENOME DIVERSI, P231, DOI DOI 10.1007/978-3-7091-1160-4_; Nakayama S, 2001, CHROMOSOME RES, V9, P469, DOI 10.1023/A:1011676328165; NEWTON ME, 1988, J BRYOL, V15, P303, DOI 10.1179/jbr.1988.15.2.303; NEWTON ME, 1971, T BRIT BRYOL SOC, V6, P244, DOI 10.1179/006813871804146364; NEWTON ME, 1986, J BRYOL, V14, P43, DOI 10.1179/jbr.1986.14.1.43; NEWTON ME, 1975, J BRYOL, V8, P365, DOI 10.1179/jbr.1975.8.3.365; Newton ME, 1983, NEW MANUAL BRYOLOGY, V1, P117; Newton ME, 1984, EXPT BIOL BRYOPHYTES, P65; Nieto Feliner G., 2012, PLANT GENOME DIVERSI, VVol. 1, P171, DOI [10.1007/978-3-7091-1130-7_12, DOI 10.1007/978-3-7091-1130-7_12]; Orzechowska M, 2010, J BRYOL, V32, P113, DOI 10.1179/037366810X12578498136075; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; PRUITT RE, 1986, J MOL BIOL, V187, P169, DOI 10.1016/0022-2836(86)90226-3; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Ramsay HP, 1983, NEW MANUAL BRYOLOGY, V1, P151; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, P NATL ACAD SCI USA, V101, P14818, DOI 10.1073/pnas.0405817101; RENZAGLIA KS, 1995, AM J BOT, V82, P18, DOI 10.2307/2445781; Rosato M, 2008, ANN BOT-LONDON, V102, P15, DOI 10.1093/aob/mcn055; Rosato M, 2009, FOLIA GEOBOT, V44, P423, DOI 10.1007/s12224-009-9048-7; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schwarzacher T., 2000, PRACTICAL SITU HYBRI; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Smith AJE., 1978, ADV BOT RES, V6, P195; Sone T, 1999, PLANT MOL BIOL, V41, P679, DOI 10.1023/A:1006398419556; SRIVASTAVA AK, 1991, BIOCHIMIE, V73, P631, DOI 10.1016/0300-9084(91)90042-Y; Temsch EM, 2010, PRESLIA, V82, P63; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Voglmayr H, 2000, ANN BOT-LONDON, V85, P531, DOI 10.1006/anbo.1999.1103; Wang W, 2015, CHROMOSOMA, DOI [10.1007/s00412-015-0556-3, DOI 10.1007/S00412-015-0556]; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Wicke S, 2011, MOL PHYLOGENET EVOL, V61, P321, DOI 10.1016/j.ympev.2011.06.023; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Zhong XB, 1996, PLANT MOL BIOL REP, V14, P232, DOI 10.1007/BF02671658	77	27	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162544	10.1371/journal.pone.0162544	http://dx.doi.org/10.1371/journal.pone.0162544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622766	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000039
J	Tourki, B; Mateo, P; Morand, J; Elayeb, M; Godin-Ribuot, D; Marrakchi, N; Belaidi, E; Messadi, E				Tourki, Bochra; Mateo, Philippe; Morand, Jessica; Elayeb, Mohamed; Godin-Ribuot, Diane; Marrakchi, Naziha; Belaidi, Elise; Messadi, Erij			Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion	PLOS ONE			English	Article							EXPERIMENTAL HEART-FAILURE; LIMITS INFARCT SIZE; GUANYLYL CYCLASE-A; ISOLATED RAT-HEART; PROTEIN-KINASE-C; NITRIC-OXIDE; PLATELET-AGGREGATION; CARDIOMYOCYTE DEATH; KAPPA-B; RECEPTOR	Cardiac ischemia is one of the leading causes of death worldwide. It is now well established that natriuretic peptides can attenuate the development of irreversible ischemic injury during myocardial infarction. Lebetin 2 (L2) is a new discovered peptide isolated from Macrovipera lebetina venom with structural similarity to B-type natriuretic peptide (BNP). Our objectives were to define the acute cardioprotective actions of L2 in isolated Langendorff-perfused rat hearts after regional or global ischemia-reperfusion (IR). We studied infarct size, left ventricular contractile recovery, survival protein kinases and mitochondrial permeability transition pore (mPTP) opening in injured myocardium. L2 dosage was determined by preliminary experiments at its ability to induce cyclic guanosine monophosphate (cGMP) release without changing hemodynamic effects in normoxic hearts. L2 was found to be as effective as BNP in reducing infarct size after the induction of either regional or global IR. Both peptides equally improved contractile recovery after regional IR, but only L2 increased coronary flow and reduced severe contractile dysfunction after global ischemia. Cardioprotection afforded by L2 was abolished after isatin or 5-hydroxydecanote pretreatment suggesting the involvement of natriuretic peptide receptors and mitochondrial K-ATP (mitoK(ATP)) channels in the L2-induced effects. L2 also increased survival protein expression in the reperfused myocardium as evidenced by phosphorylation of signaling pathways PKC epsilon/ERK/GSK3 beta and PI3K/Akt/eNOS. IR induced mitochondrial pore opening, but this effect was markedly prevented by L2 treatment. These data show that L2 has strong cardioprotective effect in acute ischemia through stimulation of natriuretic peptide receptors. These beneficial effects are mediated, at least in part, by mitoK(ATP) channel opening and downstream activated survival kinases, thus delaying mPTP opening and improving IR-induced mitochondrial dysfunction.	[Tourki, Bochra; Elayeb, Mohamed; Marrakchi, Naziha; Messadi, Erij] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Venins & Biomol Therapeut LR11 IPT08, Tunis, Tunisia; [Tourki, Bochra; Elayeb, Mohamed; Marrakchi, Naziha; Messadi, Erij] Univ Tunis El Manar, Inst Pasteur Tunis, Plateformede Physiol & Physiopathol Cardiovasc P2, Tunis, Tunisia; [Tourki, Bochra] Univ Carthage Tunis, Bizerte, Tunisia; [Mateo, Philippe] Univ Paris 11, Fac Pharm, UMR S 1180, Lab Signalisat & Physiopathol Cardiovasc, Paris, France; [Morand, Jessica; Godin-Ribuot, Diane; Belaidi, Elise] Univ Grenoble Alpes, Fac Pharm, Inserm U1042, Lab Hypoxie & Physiopathol Cardiaque, Grenoble, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Messadi, E (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Venins & Biomol Therapeut LR11 IPT08, Tunis, Tunisia.; Messadi, E (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Plateformede Physiol & Physiopathol Cardiovasc P2, Tunis, Tunisia.	erij.messadi@pasteur.rns.tn	Belaidi, Elise/AAC-9050-2019; Godin-Ribuot, Diane/B-6945-2014	Belaidi, Elise/0000-0003-4589-1612; Godin-Ribuot, Diane/0000-0001-7589-932X	Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Tunis; Ministere de l'Enseignement Superieur et de la Recherche de Tunisie; Pasteur Institutes Network; INSERM	Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Tunis; Ministere de l'Enseignement Superieur et de la Recherche de Tunisie; Pasteur Institutes Network; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Reseau International des Instituts Pasteur (RIIP), the Institut Pasteur de Tunis, INSERM and the Ministere de l'Enseignement Superieur et de la Recherche de Tunisie. B. Tourki was supported by a grant-in-aid from the Pasteur Institutes Network.	Abdallah Y, 2005, CARDIOVASC RES, V66, P123, DOI 10.1016/j.cardiores.2005.01.007; Argaud L, 2004, CARDIOVASC RES, V61, P115, DOI 10.1016/j.cardiores.2003.11.003; Barbouche R, 1998, TOXICON, V36, P1939, DOI 10.1016/S0041-0101(98)00118-4; Barbouche R, 1996, FEBS LETT, V392, P6, DOI 10.1016/0014-5793(96)00774-0; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bibli SI, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/986813; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breivik L, 2015, PEPTIDES, V66, P43, DOI 10.1016/j.peptides.2015.01.011; Burley DS, 2007, BRIT J PHARMACOL, V152, P855, DOI 10.1038/sj.bjp.0707409; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Burley DS, 2007, HEART FAIL REV, V12, P279, DOI 10.1007/s10741-007-9029-y; Burley DS, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0402-4; Chandrakala AN, 2012, AM J PHYSIOL-CELL PH, V302, pC165, DOI 10.1152/ajpcell.00116.2011; Chen HH, 2000, J AM COLL CARDIOL, V36, P1706, DOI 10.1016/S0735-1097(00)00911-6; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; Chen HT, 2008, ACTA PHARMACOL SIN, V29, P931, DOI 10.1111/j.1745-7254.2008.00824.x; Costello-Boerrigter LC, 2010, CIRC-HEART FAIL, V3, P412, DOI 10.1161/CIRCHEARTFAILURE.109.916114; D'Souza SP, 2003, AM J PHYSIOL-HEART C, V284, pH1592, DOI 10.1152/ajpheart.00902.2002; D'Souza SP, 2003, HEART, V89, P707, DOI 10.1136/heart.89.7.707; El Andalousi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076183; Evangelista JSAM, 2008, TOXICON, V52, P737, DOI 10.1016/j.toxicon.2008.08.014; Gomez L, 2006, AM J TRANSPLANT, V6, P487, DOI 10.1111/j.1600-6143.2005.01219.x; Gomez L, 2005, AM J PHYSIOL-HEART C, V289, pH2153, DOI 10.1152/ajpheart.00165.2005; Ha KC, 2006, REGUL PEPTIDES, V133, P13, DOI 10.1016/j.regpep.2005.09.015; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; HELLER R, 1995, AGENT ACTION SUPPL, V45, P177; Huang YY, 2016, ANN BIOMED ENG, V44, P432, DOI 10.1007/s10439-015-1389-1; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Inserte J, 2000, CARDIOVASC RES, V45, P351, DOI 10.1016/S0008-6363(99)00371-5; Inserte J, 2011, J MOL CELL CARDIOL, V50, P903, DOI 10.1016/j.yjmcc.2011.02.013; Izumi T, 2001, J CLIN INVEST, V108, P203, DOI 10.1172/JCI12088; Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kawakami R, 2004, CIRCULATION, V110, P3306, DOI 10.1161/01.CIR.0000147829.78357.C5; Kiemer AK, 2002, BIOCHEM BIOPH RES CO, V295, P1068, DOI 10.1016/S0006-291X(02)00807-0; Kim SY, 2011, CARDIOVASC RES, V92, P307, DOI 10.1093/cvr/cvr219; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; Lochner A, 2009, CARDIOVASC J AFR, V20, P43; Luo ZY, 1997, ANN THORAC SURG, V64, P993, DOI 10.1016/S0003-4975(97)00715-7; Lyu T, 2014, INT HEART J, V55, P8, DOI 10.1536/ihj.13-109; Manivasagam S, 2016, MOL CELL ENDOCRINOL, V433, P117, DOI 10.1016/j.mce.2016.06.010; Prendes MGM, 2014, J PHYSIOL BIOCHEM, V70, P791, DOI 10.1007/s13105-014-0347-y; Marrakchi N, 2001, HAEMOSTASIS, V31, P207; Medvedev A, 2005, BRAIN RES, V1042, P119, DOI 10.1016/j.brainres.2005.02.051; Messadi E, 2014, J CARDIOVASC PHARM, V63, P274, DOI 10.1097/FJC.0000000000000045; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Nakanishi M, 2005, HYPERTENSION, V46, P441, DOI 10.1161/01.HYP.0000173420.31354.ef; Pagel-Langenickel I, 2007, J MOL MED, V85, P797, DOI 10.1007/s00109-007-0183-4; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Pasdois P, 2007, J MOL CELL CARDIOL, V42, P631, DOI 10.1016/j.yjmcc.2006.12.014; Ren B, 2010, TRANSPL P, V42, P4496, DOI 10.1016/j.transproceed.2010.09.163; Ren BH, 2007, CLIN CHIM ACTA, V377, P83, DOI 10.1016/j.cca.2006.08.027; Rose RA, 2010, CURR OPIN INVEST DR, V11, P349; Sangawa K, 2004, ANN THORAC SURG, V77, P233, DOI 10.1016/S0003-4975(03)01493-0; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; Shi SJ, 2003, AM J PHYSIOL-RENAL, V285, pF694, DOI 10.1152/ajprenal.00097.2003; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; St Pierre L, 2006, BIOCHIMIE, V88, P1923, DOI 10.1016/j.biochi.2006.06.014; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Sun YG, 2009, BIOL PHARM BULL, V32, P1545, DOI 10.1248/bpb.32.1545; Taimor G, 2000, CARDIOVASC RES, V45, P588, DOI 10.1016/S0008-6363(99)00272-2; Takahashi N, 2003, HYPERTENS RES, V26, P847, DOI 10.1291/hypres.26.847; Talha S, 2013, J APPL PHYSIOL, V114, P172, DOI 10.1152/japplphysiol.00239.2012; Tong HY, 2000, CIRC RES, V87, P309, DOI 10.1161/01.RES.87.4.309; Verdouw PD, 1998, CARDIOVASC RES, V39, P121, DOI 10.1016/S0008-6363(98)00069-8; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Vink S, 2012, TOXICON, V59, P434, DOI 10.1016/j.toxicon.2010.12.001; Wu B, 2009, TOHOKU J EXP MED, V219, P107, DOI 10.1620/tjem.219.107; Yang XM, 2006, BASIC RES CARDIOL, V101, P311, DOI 10.1007/s00395-006-0587-2; YOSHIMURA M, 1991, CIRCULATION, V84, P1581, DOI 10.1161/01.CIR.84.4.1581; Zhang Y, 2004, J CARDIOVASC PHARM, V43, P227, DOI 10.1097/00005344-200402000-00010	73	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162632	10.1371/journal.pone.0162632	http://dx.doi.org/10.1371/journal.pone.0162632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618302	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100035
J	Cassimere, EK; Mauvais, C; Denicourt, C				Cassimere, Erica K.; Mauvais, Claire; Denicourt, Catherine			p27(Kip1) Is Required to Mediate a G1 Cell Cycle Arrest Downstream of ATM following Genotoxic Stress	PLOS ONE			English	Article							KINASE INHIBITOR P27(KIP1); DNA-DAMAGE; DEPENDENT KINASES; MICE LACKING; PROTEIN; DEGRADATION; PROTEOLYSIS; GROWTH; P27; IDENTIFICATION	The DNA damage response (DDR) is a coordinated signaling network that ensures the maintenance of genome stability under DNA damaging stress. In response to DNA lesions, activation of the DDR leads to the establishment of cell cycle checkpoints that delay cell-cycle progression and allow repair of the defects. The tumor suppressor p27(Kip1) is a cyclinCDK inhibitor that plays an important role in regulating quiescence in a variety of tissues. Several studies have suggested that p27(Kip1) also plays a role in the maintenance of genomic integrity. Here we demonstrate that p27(Kip1) is essential for the establishment of a G1 checkpoint arrest after DNA damage. We also uncovered that ATM phosphorylates p27(Kip1) on a previously uncharacterized residue (Ser-140), which leads to its stabilization after induction of DNA double-strand breaks. Inhibition of this stabilization by replacing endogenous p27(Kip1) with a Ser-140 phospho-mutant (S140A) significantly sensitized cells to IR treatments. Our findings reveal a novel role for p27(Kip1) in the DNA damage response pathway and suggest that part of its tumor suppressing functions relies in its ability to mediate a G1 arrest after the induction of DNA double strand breaks.	[Cassimere, Erica K.; Mauvais, Claire; Denicourt, Catherine] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Cassimere, Erica K.] Texas Southern Univ, Dept Biol, Houston, TX 77004 USA	University of Texas System; University of Texas Health Science Center Houston; Texas Southern University	Denicourt, C (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Catherine.Denicourt@uth.tmc.edu		Denicourt, Catherine/0000-0001-8721-0163	Suzan G. Komen postdoctoral fellowship; University of Texas Health Science Center at Houston McGovern Medical School institutional funds	Suzan G. Komen postdoctoral fellowship; University of Texas Health Science Center at Houston McGovern Medical School institutional funds	This work was supported by a Suzan G. Komen postdoctoral fellowship to E.C. and by The University of Texas Health Science Center at Houston McGovern Medical School institutional funds to C.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Cuadrado M, 2009, CANCER RES, V69, P8726, DOI 10.1158/0008-5472.CAN-09-0729; Deckbar D, 2010, CANCER RES, V70, P4412, DOI 10.1158/0008-5472.CAN-09-3198; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Loubat A, 1999, ONCOGENE, V18, P3324, DOI 10.1038/sj.onc.1202668; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Munshi A, 2005, METH MOLEC MED, V110, P21; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; StCroix B, 1996, NAT MED, V2, P1204; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162806	10.1371/journal.pone.0162806	http://dx.doi.org/10.1371/journal.pone.0162806			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611996	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900169
J	Gao, XL; Wei, JJ; Lei, H; Xu, PC; Cowling, BJ; Li, YG				Gao, Xiaolei; Wei, Jianjian; Lei, Hao; Xu, Pengcheng; Cowling, Benjamin J.; Li, Yuguo			Building Ventilation as an Effective Disease Intervention Strategy in a Dense Indoor Contact Network in an Ideal City	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; RESIDENTIAL BUILDINGS; AEROSOL TRANSMISSION; SPREAD; INFECTION; INFLUENZA; SMALLPOX; EPIDEMICS; PATTERNS; PREVENT	Emerging diseases may spread rapidly through dense and large urban contact networks, especially they are transmitted by the airborne route, before new vaccines can be made available. Airborne diseases may spread rapidly as people visit different indoor environments and are in frequent contact with others. We constructed a simple indoor contact model for an ideal city with 7 million people and 3 million indoor spaces, and estimated the probability and duration of contact between any two individuals during one day. To do this, we used data from actual censuses, social behavior surveys, building surveys, and ventilation measurements in Hong Kong to define eight population groups and seven indoor location groups. Our indoor contact model was integrated with an existing epidemiological Susceptible, Exposed, Infectious, and Recovered (SEIR) model to estimate disease spread and with the Wells-Riley equation to calculate local infection risks, resulting in an integrated indoor transmission network model. This model was used to estimate the probability of an infected individual infecting others in the city and to study the disease transmission dynamics. We predicted the infection probability of each sub-population under different ventilation systems in each location type in the case of a hypothetical airborne disease outbreak, which is assumed to have the same natural history and infectiousness as smallpox. We compared the effectiveness of controlling ventilation in each location type with other intervention strategies. We conclude that increasing building ventilation rates using methods such as natural ventilation in classrooms, offices, and homes is a relatively effective strategy for airborne diseases in a large city.	[Gao, Xiaolei; Wei, Jianjian; Lei, Hao; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Xu, Pengcheng] Chinese Acad Sci, Inst Appl Math, Acad Math & Syst Sci, Beijing, Peoples R China; [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; University of Hong Kong; World Health Organization	Wei, JJ (corresponding author), Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	wei.jianjian.88@gmail.com	Cowling, Benjamin John/C-4263-2009; GAO, Caroline X/AAU-7989-2021; Lei, Hao/ACB-5046-2022; Xu, Pengcheng/J-1429-2012; Li, Yuguo/A-9469-2010; Wei, Jianjian/AAW-4145-2021; Wei, Jianjian/F-7788-2011	Cowling, Benjamin John/0000-0002-6297-7154; GAO, Caroline X/0000-0002-0987-2759; Lei, Hao/0000-0002-1850-7040; Xu, Pengcheng/0000-0001-8651-208X; Li, Yuguo/0000-0002-2281-4529; Wei, Jianjian/0000-0001-8859-8462	Research Grants Council [17205014]; National Natural Science Foundation of China [51278440]; General Research Fund grant from RGC [17205014]; NSFC grant [51278440]	Research Grants Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Research Fund grant from RGC; NSFC grant(National Natural Science Foundation of China (NSFC))	LY received a General Research Fund grant from The Research Grants Council (17205014) and a grant from National Natural Science Foundation of China (51278440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by a General Research Fund grant from RGC (17205014) and an NSFC grant (51278440).	Allard F, 1998, NATURAL VENTILATION; ANDERSON R M, 1991; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015; Chao CYH, 2001, BUILD ENVIRON, V36, P999, DOI 10.1016/S0360-1323(00)00057-3; Chao CYH, 2001, ATMOS ENVIRON, V35, P1585, DOI 10.1016/S1352-2310(00)00458-1; Chen SC, 2006, INDOOR AIR, V16, P469, DOI 10.1111/j.1600-0668.2006.00443.x; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Eubank S, 2006, DIMACS SER DISCRET M, V70, P181; Feldmann H, 2011, NEW ENGL J MED, V364, P1561, DOI 10.1056/NEJMe1102671; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Gammaitoni L, 1997, EMERG INFECT DIS, V3, P335, DOI 10.3201/eid0303.970310; Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a; Gao XL, 2016, SCI TOTAL ENVIRON, V569, P373, DOI 10.1016/j.scitotenv.2016.06.179; Gao XL, 2009, INDOOR BUILT ENVIRON, V18, P205, DOI 10.1177/1420326X09104141; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Lee SC, 2000, CHEMOSPHERE, V41, P109, DOI 10.1016/S0045-6535(99)00396-3; Leech JA, 2002, J EXPO ANAL ENV EPID, V12, P427, DOI 10.1038/sj.jea.7500244; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Li YG, 2004, AM J EPIDEMIOL, V160, P719, DOI 10.1093/aje/kwh273; Liao CM, 2008, EPIDEMIOL INFECT, V136, P299, DOI 10.1017/S0950268807008631; Lin Guoji, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35 Suppl, P66; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Noakes CJ, 2009, J R SOC INTERFACE, V6, pS791, DOI 10.1098/rsif.2009.0305.focus; Qian H, 2009, BUILD ENVIRON, V44, P1651, DOI 10.1016/j.buildenv.2008.11.002; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wells W.F, 1955, AIRBORNE CONTAGION A, P423; World Health Organization, 2008, The global burden of disease: 2004 update; Xie X., 2008, THESIS, P196; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	49	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162481	10.1371/journal.pone.0162481	http://dx.doi.org/10.1371/journal.pone.0162481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611368	Green Published, gold			2022-12-27	WOS:000383255900111
J	Germain, N; Viltart, O; Loyens, A; Bruchet, C; Nadin, K; Wolowczuk, I; Estour, B; Galusca, B				Germain, Natacha; Viltart, Odile; Loyens, Anne; Bruchet, Celine; Nadin, Katia; Wolowczuk, Isabelle; Estour, Bruno; Galusca, Bogdan			Interleukin-7 Plasma Levels in Human Differentiate Anorexia Nervosa, Constitutional Thinness and Healthy Obesity	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; PEPTIDE YY; FEMALE ADOLESCENTS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; IMMUNE-SYSTEM; GROWTH-FACTOR; GHRELIN; APPETITE	Introduction Interleukin-7 (IL-7) is a cytokine involved in energy homeostasis as demonstrated in rodents. Anorexia nervosa is characterized by restrained eating behavior despite adaptive orexigenic regulation profile including high ghrelin plasma levels. Constitutional thinness is a physiological condition of resistance to weight gain with physiological anorexigenic profile including high Peptide YY plasma level. Healthy obesity can be considered as a physiological state of resistance to weight loss with opposite appetite regulating profile to constitutional thinness including low Peptide YY plasma level. No studies in IL-7 are yet available in those populations. Therefore we evaluated circadian plasma levels of IL-7 in anorexia nervosa compared to constitutional thinness, healthy obese and control females. Materials and Methods 10 restrictive-type anorexia nervosa women, 5 bingeing/purging anorexia nervosa woman, 5 recovered restrictive anorexia nervosa women, 4 bulimic females, 10 constitutional thinness women, 7 healthy obese females, and 10 normalweight women controls were enrolled in this cross-sectional study, performed in endocrinology unit and academic laboratory. Twelve-point circadian profiles of plasma IL-7 levels were measured in each subject. Results 24h mean IL-7 plasma levels (pg/ml, mean +/- SEM) were decreased in restrictive-type anorexia nervosa (123.4 +/- 14.4, p<0.0037), bingeing/purging anorexia nervosa (24.2 +/- 5.6, p<0.001), recovered restrictive anorexia nervosa (64.2 +/- 16.1, p = 0.01) and healthy obese patients (51 +/- 3.2, p<0.001) compared to controls (187.7 +/- 28.6). Bulimic patients (197.4 +/- 42.7) and constitutional thinness patients (264.3 +/- 35.8) were similar to controls. Conclusions Low IL-7 is part of the adaptive profile in restrictive-type anorexia nervosa, confirming its difference with constitutional thinness. Healthy obesity, with low IL-7, is once again in mirror image of constitutional thinness with normal high IL-7.	[Germain, Natacha; Bruchet, Celine; Nadin, Katia; Estour, Bruno; Galusca, Bogdan] CHU St Etienne, Div Endocrinol Diabet Metab & Eating Disorders, St Etienne, France; [Germain, Natacha; Bruchet, Celine; Nadin, Katia; Estour, Bruno; Galusca, Bogdan] TAPE Eating Disorders Addict & Extreme Bodyweight, EA 7423, St Etienne, France; [Viltart, Odile; Loyens, Anne] Univ Lille, INSERM, CHU Lille,Neurosci & Canc, UMR S 1172,JPArc Jean Pierre AUBERT Res Ctr, F-59000 Lille, France; [Wolowczuk, Isabelle] Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,U1019,UMR8204,CIIL, F-59000 Lille, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Germain, N (corresponding author), CHU St Etienne, Div Endocrinol Diabet Metab & Eating Disorders, St Etienne, France.; Germain, N (corresponding author), TAPE Eating Disorders Addict & Extreme Bodyweight, EA 7423, St Etienne, France.	natacha.germain@chu-st-etienne.fr		wolowczuk, isabelle/0000-0001-6692-6904				ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923; [Anonymous], 1994, NUTR REV, V52, P213; Balligand JL, 1998, EUR J ENDOCRINOL, V138, P415, DOI 10.1530/eje.0.1380415; Benedict C, 2007, BRAIN BEHAV IMMUN, V21, P1058, DOI 10.1016/j.bbi.2007.04.004; Brambilla F, 2001, PSYCHIAT RES, V103, P107, DOI 10.1016/S0165-1781(01)00283-9; Carolan E, 2015, J IMMUNOL; Challet E, 2015, DIABETES OBES METAB, V17, P76, DOI 10.1111/dom.12516; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Galusca B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122040; Galusca B, 2012, J CLIN ENDOCR METAB, V97, P2012, DOI 10.1210/jc.2011-3396; Germain N, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.17; Germain N, 2009, PSYCHONEUROENDOCRINO, V34, P413, DOI 10.1016/j.psyneuen.2008.10.001; Germain N, 2007, AM J CLIN NUTR, V85, P967, DOI 10.1093/ajcn/85.4.967; Germain N, 2010, J CLIN ENDOCR METAB, V95, P3057, DOI 10.1210/jc.2009-2196; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Kahl KG, 2004, PSYCHONEUROENDOCRINO, V29, P13, DOI 10.1016/S0306-4530(02)00131-2; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Labrecque N, 2015, J BIOL RHYTHM, V30, P277, DOI 10.1177/0748730415577723; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lee M, 2015, DIABETOLOGIA, V58, P2361, DOI 10.1007/s00125-015-3684-7; Lucas R, 2013, CYTOKINE, V64, P310, DOI 10.1016/j.cyto.2013.05.025; Lucas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040351; Macia L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009953; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; MORRISSEY PJ, 1989, J EXP MED, V169, P707, DOI 10.1084/jem.169.3.707; Nakai Y, 1999, J CLIN ENDOCR METAB, V84, P1226, DOI 10.1210/jc.84.4.1226; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nova E, 2002, BRIT J NUTR, V88, P183, DOI 10.1079/BJN2002608; Ostlund RE, 1996, J CLIN ENDOCR METAB, V81, P3909, DOI 10.1210/jc.81.11.3909; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Rallon NI, 2011, JAIDS-J ACQ IMM DEF, V58, P436, DOI 10.1097/QAI.0b013e318231de37; Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453; Saidijam M, 2014, INDIAN J MED RES, V140, P238; Stock S, 2005, J CLIN ENDOCR METAB, V90, P2161, DOI 10.1210/jc.2004-1251; Tani A, 2014, J INFLAMM RES, V7, P1, DOI 10.2147/JIR.S52728; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161890	10.1371/journal.pone.0161890	http://dx.doi.org/10.1371/journal.pone.0161890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611669	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900035
J	Goh, S; Ngugi, D; Lizundia, R; Hostettler, I; Woods, K; Ballingall, K; MacHugh, ND; Morrison, WI; Weir, W; Shiels, B; Werling, D				Goh, Shan; Ngugi, Daniel; Lizundia, Regina; Hostettler, Isabel; Woods, Kerry; Ballingall, Keith; MacHugh, Niall D.; Morrison, W. Ivan; Weir, Willie; Shiels, Brian; Werling, Dirk			Identification of Theileria lestoquardi Antigens Recognized by CD8(+) T Cells	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT OVINE THEILERIOSIS; SCHIZONT-INFECTED CELLS; II DRB1 LOCUS; TROPICAL THEILERIOSIS; TISSUE-CULTURE; PARVA; SHEEP; ANNULATA; RESPONSES	As part of an international effort to develop vaccines for Theileria lestoquardi, we undertook a limited screen to test T. lestoquardi orthologues of antigens recognised by CD8(+) T lymphocyte responses against T. annulata and T. parva in cattle. Five MHC defined sheep were immunized by live T. lestoquardi infection and their CD8(+) T lymphocyte responses determined. Thirteen T. lestoquardi orthologues of T. parva and T. annulata genes, previously shown to be targets of CD8(+) T lymphocyte responses of immune cattle, were expressed in autologous fibroblasts and screened for T cell recognition using an IFN gamma assay. Genes encoding T. lestoquardi antigens Tl8 (putative cysteine proteinase, 349 aa) or Tl9 (hypothetical secreted protein, 293 aa) were recognise by T cells from one animal that displayed a unique MHC class I genotype. Antigenic 9-mer peptide epitopes of Tl8 and Tl9 were identified through peptide scans using CD8(+) T cells from the responding animal. These experiments identify the first T. lestoquardi antigens recognised by CD8(+) T cell responses linked to specific MHC class I alleles.	[Goh, Shan; Ngugi, Daniel; Lizundia, Regina; Werling, Dirk] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, Hatfield AL9 7TA, Herts, England; [Hostettler, Isabel] Univ Bern, Vetsuisse Fac, Inst Parasitol, Laenggassstr 122, CH-3012 Bern, Switzerland; [Woods, Kerry] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Laenggassstr 122, CH-3012 Bern, Switzerland; [Ballingall, Keith] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [MacHugh, Niall D.; Morrison, W. Ivan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Weir, Willie; Shiels, Brian] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	University of London; University of London Royal Veterinary College; University of Bern; University of Bern; Moredun Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow	Goh, S (corresponding author), Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	sgoh@rvc.ac.uk	Goh, Shan/A-7261-2010; Werling, Dirk/F-5555-2013; Ballingall, Keith/T-1262-2019	Goh, Shan/0000-0002-9028-0303; Werling, Dirk/0000-0001-5411-4044; Shiels, Brian/0000-0001-7595-2514; Weir, William/0000-0001-8648-666X	EU Seventh Framework Programme for Research (FP7) [245145-PIROVAC]	EU Seventh Framework Programme for Research (FP7)	The work was funded by the EU Seventh Framework Programme for Research (FP7), grant number 245145-PIROVAC, http://www.theileria.org/pirovac/. The funder had no role in study design, data collection and interpretation, or the decision to submit work for publication.	Abdigoudarzi M, 2013, J ARTHROPOD-BORNE DI, V7, P164; Ahmed BM, 2013, VACCINE, V31, P4775, DOI 10.1016/j.vaccine.2013.08.004; Ali AM, 2008, VACCINE, V26, pG17, DOI 10.1016/j.vaccine.2008.10.009; Bakheit MA, 2006, PARASITOL RES, V100, P161, DOI 10.1007/s00436-006-0255-3; Bakheit M, 2006, ANN NY ACAD SCI, V1081, P463, DOI 10.1196/annals.1373.065; Ballingall KT, 2011, TISSUE ANTIGENS, V77, P546, DOI 10.1111/j.1399-0039.2011.01637.x; Ballingall KT, 2010, IMMUNOGENETICS, V62, P31, DOI 10.1007/s00251-009-0410-y; El Hussein AM, 1993, SUD J VET RES, V12, P51; El-Imam A. H., 2015, Jordan Journal of Biological Sciences (JJBS), V8, P165; EMERY DL, 1980, IMMUNOLOGY, V40, P229; GODDEERIS BM, 1986, EUR J IMMUNOL, V16, P1243, DOI 10.1002/eji.1830161010; Graham SP, 2008, INFECT IMMUN, V76, P685, DOI 10.1128/IAI.01244-07; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; Hall R, 1999, TROP MED INT HEALTH, V4, pA78, DOI 10.1046/j.1365-3156.1999.00454.x; Hansen AM, 2014, IMMUNOGENETICS, V66, P705, DOI 10.1007/s00251-014-0802-5; HAWA NJ, 1981, VET PARASITOL, V9, P91, DOI 10.1016/0304-4017(81)90026-1; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Hibbs AR, 2004, CONFOCAL MICROSCOPY; HOOSHMANDRAD P, 1993, PARASITOL RES, V79, P195, DOI 10.1007/BF00931892; HOOSHMANDRAD P, 1985, DEV BIOLOGICALS, V62, P119; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Leemans I, 1997, VET PARASITOL, V69, P9, DOI 10.1016/S0304-4017(96)01098-9; Leemans I, 2001, PARASITOL RES, V87, P768, DOI 10.1007/s004360100388; Macdonald IK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001149; Machugh ND, 2008, PARASITE IMMUNOL, V30, P385, DOI 10.1111/j.1365-3024.2008.01038.x; MacHugh ND, 2011, INFECT IMMUN, V79, P2059, DOI 10.1128/IAI.01285-10; MacHugh ND, 2009, EUR J IMMUNOL, V39, P2459, DOI 10.1002/eji.200939227; MCKEEVER DJ, 1994, P NATL ACAD SCI USA, V91, P1959, DOI 10.1073/pnas.91.5.1959; Miltiadou D, 2005, IMMUNOGENETICS, V57, P499, DOI 10.1007/s00251-005-0008-y; Morrison WI, 2009, PARASITOLOGY, V136, P1415, DOI 10.1017/S0031182009990916; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Razmi G, 2013, J PARASITOL, V99, P77, DOI 10.1645/GE-3202.1; Seitzer U, 2008, VACCINE, V26, pG24, DOI 10.1016/j.vaccine.2008.10.039; Seitzer U, 2010, PARASITOL RES, V106, P1085, DOI 10.1007/s00436-010-1747-8; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; Shkap V, 2003, VET PARASITOL, V115, P247, DOI 10.1016/S0304-4017(03)00214-0; Shkap V, 2007, TRENDS PARASITOL, V23, P420, DOI 10.1016/j.pt.2007.07.003; Sparagano OAE, 2006, ANN NY ACAD SCI, V1081, P505, DOI 10.1196/annals.1373.075; Svitek N, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-50; Taha KM, 2011, PARASITOL RES, V109, P1525, DOI 10.1007/s00436-011-2428-y; Taha KM, 2010, PARASITOL RES, V107, P1009, DOI 10.1007/s00436-010-1968-x; Taracha ELN, 1997, J IMMUNOL, V159, P4539; Walker JG, 2014, VET PARASITOL, V199, P206, DOI 10.1016/j.vetpar.2013.11.008; Woods KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003346; Zakian A, 2014, VET PARASITOL, V203, P322, DOI 10.1016/j.vetpar.2014.04.007; Zia-ur-Rehman, 2010, PAK J ZOOL, V42, P639	46	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162571	10.1371/journal.pone.0162571	http://dx.doi.org/10.1371/journal.pone.0162571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611868	Green Published, Green Accepted, gold			2022-12-27	WOS:000383255900128
J	Thi, HTH; Choi, SW; Kim, YM; Kim, HY; Hong, S				Huyen Trang Ha Thi; Choi, Seo-Won; Kim, Young-Mi; Kim, Hye-Youn; Hong, Suntaek			Protein Tyrosine Phosphatase N2 Is a Positive Regulator of Lipopolysaccharide Signaling in Raw264.7 Cell through Derepression of Src Tyrosine Kinase	PLOS ONE			English	Article							NF-KAPPA-B; FAMILY KINASES; INFLAMMATION; ACTIVATION; DEPHOSPHORYLATION; MACROPHAGES; INHIBITION; EXPRESSION; ALPHA; MICE	T cell protein tyrosine phosphatase N2 (PTPN2) is a phosphotyrosine-specific nonreceptor phosphatase and is ubiquitously expressed in tissues. Although PTPN2 functions as an important regulator in different signaling pathways, it is still unclear what is specific target protein of PTPN2 and how is regulated in lipopolysaccharide (LPS)-induced inflammatory signaling pathway. Here, we found that PTPN2 deficiency downregulated the expression of LPS-mediated pro-inflammtorycytokine genes. Conversely, overexpression of PTPN2 in Raw264.7 cells enhanced the expression and secretion of those cytokines. The activation of MAPK and NF-kappa B signaling pathways by LPS was reduced in PTPN2-knockdowned cells and ectopic expression of PTPN2 reversed these effects. Furthermore, we found that PTNP2 directly interacted with Src and removed the inhibitory Tyr527 phosphorylation of Src to enhance the activatory phosphorylation of Tyr416 residue. These results suggested that PTPN2 is a positive regulator of LPS-induced inflammatory response by enhancing the activity of Src through targeting the inhibitory phosphor-tyrosine527 of Src.	[Huyen Trang Ha Thi; Choi, Seo-Won; Kim, Young-Mi; Kim, Hye-Youn; Hong, Suntaek] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Canc Cell Biol Lab, Inchon, South Korea	Gachon University	Hong, S (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Canc Cell Biol Lab, Inchon, South Korea.	sthong@gachon.ac.kr	Kim, Hye Youn/K-3590-2016		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A1A2004620]; Gil Medical Center, Gachon University [FRD2014-9]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Gil Medical Center, Gachon University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education (2012R1A1A2004620) and by Gil Medical Center, Gachon University (FRD2014-9).	Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Choi YH, 2014, DRUG DES DEV THER, V8, P1941, DOI 10.2147/DDDT.S71957; Curnow SJ, 2004, J IMMUNOL, V173, P5290, DOI 10.4049/jimmunol.173.8.5290; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Frazier WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050071; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Lee HS, 2007, J IMMUNOL, V179, P7001, DOI 10.4049/jimmunol.179.10.7001; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Moron B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073703; Ren JL, 2009, CELL SIGNAL, V21, P378, DOI 10.1016/j.cellsig.2008.10.011; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Shrivastava P, 2004, BLOOD, V103, P1425, DOI 10.1182/blood-2003-03-0716; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162724	10.1371/journal.pone.0162724	http://dx.doi.org/10.1371/journal.pone.0162724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611995	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900156
J	Yi, B; Chen, L; Sa, RN; Zhong, RQ; Xing, H; Zhang, HF				Yi, Bao; Chen, Liang; Sa, Renna; Zhong, Ruqing; Xing, Huan; Zhang, Hongfu			Transcriptome Profile Analysis of Breast Muscle Tissues from High or Low Levels of Atmospheric Ammonia Exposed Broilers (Gallus gallus)	PLOS ONE			English	Article							ANTI-MYOSTATIN ANTIBODY; AFFECTS PERFORMANCE; GROWTH-PERFORMANCE; GENETIC-PARAMETERS; POULTRY HOUSES; LAYER HOUSES; CHICKENS; HYPERAMMONEMIA; EMISSIONS; DUST	Atmospheric ammonia is a common problem in poultry industry. High concentrations of aerial ammonia cause great harm to broilers' health and production. For the consideration of human health, the limit exposure concentration of ammonia in houses is set at 25 ppm. Previous reports have shown that 25 ppm is still detrimental to livestock, especially the gastrointestinal tract and respiratory tract, but the negative relationship between ammonia exposure and the tissue of breastmuscle of broilers is still unknown. In the present study, 25 ppm ammonia in poultry houses was found to lower slaughter performance and breast yield. Then, high-throughput RNA sequencing was utilized to identify differentially expressed genes in breastmuscle of broiler chickens exposed to high (25 ppm) or low (3 ppm) levels of atmospheric ammonia. The transcriptome analysis showed that 163 genes (fold change >= 2 or <= 0.5; P-value < 0.05) were differentially expressed between Ammonia25 (treatment group) and Ammonia3 (control group), including 96 down-regulated and 67 up-regulated genes. qRT-PCR analysis validated the transcriptomic results of RNA sequencing. Gene Ontology (GO) functional annotation analysis revealed potential genes, processes and pathways with putative involvement in growth and development inhibition of breastmuscle in broilers caused by aerial ammonia exposure. This study facilitates understanding of the genetic architecture of the chicken breastmuscle transcriptome, and has identified candidate genes for breastmuscle response to atmospheric ammonia exposure.	[Yi, Bao; Chen, Liang; Sa, Renna; Zhong, Ruqing; Xing, Huan; Zhang, Hongfu] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhang, HF (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	zhanghongfu@caas.cn		Yi, Bao/0000-0003-0295-3035	National Natural Science Foundation of China [31601979]; National Key Research and Development Program of China [2016YFD0500501]; Agricultural Science and Technology Innovation Program [ASTIP-IAS07]; National Science and Technology Support Program in China [2012BAD39B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Agricultural Science and Technology Innovation Program; National Science and Technology Support Program in China	This research was supported by the National Natural Science Foundation of China (31601979), National Key Research and Development Program of China (2016YFD0500501), the Agricultural Science and Technology Innovation Program (ASTIP-IAS07) and National Science and Technology Support Program (2012BAD39B01) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASHHADANI EH, 1985, POULTRY SCI, V64, P2056, DOI 10.3382/ps.0642056; ANDERSON DP, 1964, AVIAN DIS, V8, P369, DOI 10.2307/1587967; Beker A, 2004, J APPL POULTRY RES, V13, P5, DOI 10.1093/japr/13.1.5; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Berri C, 2001, POULTRY SCI, V80, P833, DOI 10.1093/ps/80.7.833; CARLILE FS, 1984, WORLD POULTRY SCI J, V40, P99, DOI 10.1079/WPS19840008; CAVENY DD, 1981, POULTRY SCI, V60, P513, DOI 10.3382/ps.0600513; CHARLES D. R., 1966, BRIT POULTRY SCI, V7, P189, DOI 10.1080/00071668608415623; David B, 2015, ANIMALS-BASEL, V5, P886, DOI 10.3390/ani5030389; Dawkins MS, 2004, NATURE, V427, P342, DOI 10.1038/nature02226; DEATON JW, 1982, POULTRY SCI, V61, P1815, DOI 10.3382/ps.0611815; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Homidan AA, 2003, WORLD POULTRY SCI J, V59, P340, DOI 10.1079/WPS20030021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JOHNSON RW, 1991, POULTRY SCI, V70, P1132, DOI 10.3382/ps.0701132; Juri R, 2016, NUCL ACIDS RES; Kim YS, 2007, POULTRY SCI, V86, P1196, DOI 10.1093/ps/86.6.1196; Kim YS, 2006, POULTRY SCI, V85, P1062, DOI 10.1093/ps/85.6.1062; Koerkamp PWGG, 1998, BRIT POULTRY SCI, V39, P379, DOI 10.1080/00071669888935; Koerkamp PWGG, 1998, J AGR ENG RES, V70, P79, DOI 10.1006/jaer.1998.0275; Kristensen HH, 2000, WORLD POULTRY SCI J, V56, P235, DOI 10.1079/WPS20000018; Le Bihan-Duval E, 1999, POULTRY SCI, V78, P822, DOI 10.1093/ps/78.6.822; Miles DM, 2004, POULTRY SCI, V83, P1650, DOI 10.1093/ps/83.10.1650; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ni JQ, 2012, ENVIRON SCI POLICY, V22, P25, DOI 10.1016/j.envsci.2012.06.001; Nkukwana TT, 2014, LIVEST SCI, V161, P139, DOI 10.1016/j.livsci.2014.01.001; OYETUNDE OOF, 1978, CAN VET J, V19, P187; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012; REECE FN, 1980, POULTRY SCI, V59, P486, DOI 10.3382/ps.0590486; Reece FN, 1980, POULTRY SCI, V59; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Ritz CW, 2004, J APPL POULTRY RES, V13, P684, DOI 10.1093/japr/13.4.684; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Salarpour A, 2015, J ANIM PHYSIOL AN N, V99, P237, DOI 10.1111/jpn.12235; Salim HM, 2014, WORLD POULTRY SCI J, V70, P839, DOI 10.1017/S0043933914000890; Stern RA, 2015, ANIMAL, V9, P992, DOI 10.1017/S1751731115000117; Wang YM, 2010, J ANIM VET ADV, V9, P2802, DOI 10.3923/javaa.2010.2802.2806; Wathes CM, 1997, BRIT POULTRY SCI, V38, P14, DOI 10.1080/00071669708417936; Wei FX, 2015, GENET MOL RES, V14, P3160, DOI 10.4238/2015.April.10.27; WHYTE RT, 1993, WORLD POULTRY SCI J, V49, P139, DOI 10.1079/WPS19930012; Yahav S, 2004, ANIM RES, V53, P289, DOI 10.1051/animres:2004015; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zerehdaran S, 2004, POULTRY SCI, V83, P521, DOI 10.1093/ps/83.4.521; Zhang JZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123596	47	17	21	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162631	10.1371/journal.pone.0162631	http://dx.doi.org/10.1371/journal.pone.0162631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611572	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900138
J	DeJonge, RE; Liu, XP; Deig, CR; Heller, S; Koehler, KR; Hashino, E				DeJonge, Rachel E.; Liu, Xiao-Ping; Deig, Christopher R.; Heller, Stefan; Koehler, Karl R.; Hashino, Eri			Modulation of Wnt Signaling Enhances Inner Ear Organoid Development in 3D Culture	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; OTIC PLACODE INDUCTION; SEMICIRCULAR CANAL FORMATION; FGF; MOUSE; FATE; DIFFERENTIATION; CATENIN; XENOPUS; MORPHOGENESIS	Stem cell-derived inner ear sensory epithelia are a promising source of tissues for treating patients with hearing loss and dizziness. We recently demonstrated how to generate inner ear sensory epithelia, designated as inner ear organoids, from mouse embryonic stem cells (ESCs) in a self-organizing 3D culture. Here we improve the efficiency of this culture system by elucidating how Wnt signaling activity can drive the induction of otic tissue. We found that a carefully timed treatment with the potent Wnt agonist CHIR99021 promotes induction of otic vesicles-a process that was previously self-organized by unknown mechanisms. The resulting otic-like vesicles have a larger lumen size and contain a greater number of Pax8/Pax2-positive otic progenitor cells than organoids derived without the Wnt agonist. Additionally, these otic-like vesicles give rise to large inner ear organoids with hair cells whose morphological, biochemical and functional properties are indistinguishable from those of vestibular hair cells in the postnatal mouse inner ear. We conclude that Wnt signaling plays a similar role during inner ear organoid formation as it does during inner ear development in the embryo.	[DeJonge, Rachel E.; Deig, Christopher R.; Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [DeJonge, Rachel E.; Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Liu, Xiao-Ping] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Otolaryngol, Boston, MA USA; [Liu, Xiao-Ping] Harvard Med Sch, Boston, MA 02115 USA; [Heller, Stefan] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Palo Alto, CA 94305 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Stanford University	Koehler, KR; Hashino, E (corresponding author), Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA.; Koehler, KR; Hashino, E (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	krkoehle@iupui.edu; ehashino@iupui.edu		Koehler, Karl/0000-0002-0685-538X; Moore, Rachel/0000-0002-6281-0821	National Institute of Health [R01 DC013294]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013294] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a National Institute of Health grant R01 DC013294 (to EH).	Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Ai ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150936; Brown AS, 2015, DEV BIOL, V399, P177, DOI 10.1016/j.ydbio.2015.01.001; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Forristall CA, 2014, DEV DYNAM, V243, P1262, DOI [10.1002/DVDY.24116, 10.1002/dvdy.24116]; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Freyer L, 2010, DEV DYNAM, V239, P1708, DOI 10.1002/dvdy.22308; Geng RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148339; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hans S, 2007, DEVELOPMENT, V134, P2449, DOI 10.1242/dev.000448; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Jansson L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00066; Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Koehler KR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-82; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; McCarroll MN, 2012, DEVELOPMENT, V139, P2740, DOI 10.1242/dev.076075; Munnamalai V, 2013, SEMIN CELL DEV BIOL, V24, P480, DOI 10.1016/j.semcdb.2013.03.008; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Noda T, 2012, DEV BIOL, V362, P83, DOI 10.1016/j.ydbio.2011.11.019; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Park BY, 2008, DEV BIOL, V324, P108, DOI 10.1016/j.ydbio.2008.09.009; Phillips BT, 2004, DEVELOPMENT, V131, P923, DOI 10.1242/dev.00978; Rakowiecki S, 2013, DEVELOPMENT, V140, P1730, DOI 10.1242/dev.092882; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Sai XR, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00019; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Shi FX, 2014, J NEUROSCI, V34, P6470, DOI 10.1523/JNEUROSCI.4305-13.2014; St-Jeannet JP, 2014, DEV BIOL, V389, P13, DOI 10.1016/j.ydbio.2014.02.011; Stevens CB, 2003, DEV BIOL, V261, P149, DOI 10.1016/S0012-1606(03)00297-5; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Wright KD, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0083-8	39	36	39	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162508	10.1371/journal.pone.0162508	http://dx.doi.org/10.1371/journal.pone.0162508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607106	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600053
J	Kim, S; Sundaresan, V; Zhou, L; Kahveci, T				Kim, Sebo; Sundaresan, Varsha; Zhou, Lei; Kahveci, Tamer			Integrating Domain Specific Knowledge and Network Analysis to Predict Drug Sensitivity of Cancer Cell Lines	PLOS ONE			English	Article							PHASE-I SAFETY; KINASE INHIBITOR; PHARMACOKINETICS; TRIAL	One of fundamental challenges in cancer studies is that varying molecular characteristics of different tumor types may lead to resistance to certain drugs. As a result, the same drug can lead to significantly different results in different types of cancer thus emphasizing the need for individualized medicine. Individual prediction of drug response has great potential to aid in improving the clinical outcome and reduce the financial costs associated with prescribing chemotherapy drugs to which the patient's tumor might be resistant. In this paper we develop a network based classifier (NBC) method for predicting sensitivity of cell lines to anticancer drugs from transcriptome data. In the literature, this strategy has been used for predicting cancer types. Here, we extend it to estimate sensitivity of cells from different tumor types to various anticancer drugs. Furthermore, we incorporate domain specific knowledge such as the use of apoptotic gene list and clinical dose information in our method to impart biological significance to the prediction. Our experimental results suggest that our network based classifier (NBC) method outperforms existing classifiers in estimating sensitivity of cell lines for different drugs.	[Kim, Sebo; Kahveci, Tamer] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL 32611 USA; [Sundaresan, Varsha; Zhou, Lei] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kim, S; Kahveci, T (corresponding author), Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL 32611 USA.	sebkim@cise.ufl.edu; tamer@cise.ufl.edu			National Science Foundation (NSF) [1262451]; NSF [1262451]; NIH [R01GM106174]; UF Informatics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106174] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UF Informatics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This paper is partially funded by National Science Foundation (NSF) under award number 1262451. This funding from NSF is the only source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is partially funded by NSF under award number 1262451 (TK) NIH R01GM106174 (LZ) and an award from UF Informatics Institute (TK&LZ).	Ay A, 2014, CANCER INFORM, V13, P15, DOI 10.4137/CIN.S14025; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2010, CLIN CANCER RES, V16, P4876, DOI 10.1158/1078-0432.CCR-10-0748; Berlow N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-239; BLANEY SM, 1993, CANCER RES, V53, P1032; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Chabot GG, 1997, CLIN PHARMACOKINET, V33, P245, DOI 10.2165/00003088-199733040-00001; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Cunningham P., 2007, UCDCSI20074, DOI [10.1145/3459665, DOI 10.1145/3459665]; DeAngelo DJ, 2013, LEUKEMIA, V27, P1628, DOI 10.1038/leu.2013.38; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; Deng YM, 2014, MOL CLIN ONCOL, V2, P116, DOI 10.3892/mco.2013.190; Drucker H, 1997, ADV NEUR IN, V9, P155; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Heewon Park, 2014, ROBUST PREDICTION AN; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; Murphy Kevin P., 2006, NAIVE BAYES CLASSIFI; O'Neil BH, 2011, J CLIN ONCOL, V29, P2350, DOI 10.1200/JCO.2010.33.9432; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rokach L., 2005, DATA MIN KNOWL DISC; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Urruticoechea A, 2010, CURR PHARM DESIGN, V16, P3, DOI 10.2174/138161210789941847; WIERNIK PH, 1987, CANCER RES, V47, P2486; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yufang Qin, 2015, NETWORK FLOW BASED M; Zhang NQ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004498; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162173	10.1371/journal.pone.0162173	http://dx.doi.org/10.1371/journal.pone.0162173			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607242	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600024
J	Vaccaro, L; Izquierdo, F; Magnet, A; Hurtado, C; Salinas, MB; Gomes, TS; Angulo, S; Salso, S; Pelaez, J; Tejeda, MI; Alhambra, A; Gomez, C; Enriquez, A; Estirado, E; Fenoy, S; del Aguila, C				Vaccaro, Lucianna; Izquierdo, Fernando; Magnet, Angela; Hurtado, Carolina; Salinas, Mireya B.; Gomes, Thiago Santos; Angulo, Santiago; Salso, Santiago; Pelaez, Jesus; Tejeda, Maria Isabel; Alhambra, Almudena; Gomez, Carmen; Enriquez, Ana; Estirado, Eva; Fenoy, Soledad; del Aguila, Carmen			First Case of Legionnaire's Disease Caused by Legionella anisa in Spain and the Limitations on the Diagnosis of Legionella non-pneumophila Infections (vol 11, e0159726, 2016)	PLOS ONE			English	Correction													Magnet, Angela/G-5325-2013; Arias, Fernando Izquierdo/AAE-3073-2019; del Aguila, Carmen/A-6063-2016; Díaz-Parreño, Santiago Angulo/L-3035-2014	Magnet, Angela/0000-0002-8642-4343; Arias, Fernando Izquierdo/0000-0003-0367-007X; del Aguila, Carmen/0000-0003-0063-7899; 				Vaccaro L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159726	1	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162934	10.1371/journal.pone.0162934	http://dx.doi.org/10.1371/journal.pone.0162934			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607064	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600073
J	Zadravec, P; Mareckova, L; Petrokova, H; Hodnik, V; Nanut, MP; Anderluh, G; Strukelj, B; Maly, P; Berlec, A				Zadravec, Petra; Mareckova, Lucie; Petrokova, Hana; Hodnik, Vesna; Nanut, Milica Perisic; Anderluh, Gregor; Strukelj, Borut; Maly, Petr; Berlec, Ales			Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; ESCHERICHIA-COLI INFECTIONS; SURFACE DISPLAY; GROWTH; INHIBITION; ANTIBODIES; TRANSPORT; PROTEINS; SCAFFOLD; STRAINS	Infections with shiga toxin-producing bacteria, like enterohemorrhagic Escherichia coli and Shigella dysenteriae, represent a serious medical problem. No specific and effective treatment is available for patients with these infections, creating a need for the development of new therapies. Recombinant lactic acid bacterium Lactococcus lactis was engineered to bind Shiga toxin by displaying novel designed albumin binding domains (ABD) against Shiga toxin 1 B subunit (Stx1B) on their surface. Functional recombinant Stx1B was produced in Escherichia coli and used as a target for selection of 17 different ABD variants (named S1B) from the ABD scaffold-derived high-complex combinatorial library in combination with a five-round ribosome display. Two most promising S1Bs (S1B22 and S1B26) were characterized into more details by ELISA, surface plasmon resonance and microscale thermophoresis. Addition of S1Bs changed the subcellular distribution of Stx1B, completely eliminating it from Golgi apparatus most likely by interfering with its retrograde transport. All ABD variants were successfully displayed on the surface of L. lactis by fusing to the Usp45 secretion signal and to the peptidoglycan-binding C terminus of AcmA. Binding of Stx1B by engineered lactococcal cells was confirmed using flow cytometry and whole cell ELISA. Lactic acid bacteria prepared in this study are potentially useful for the removal of Shiga toxin from human intestine.	[Zadravec, Petra; Nanut, Milica Perisic; Strukelj, Borut; Berlec, Ales] Jozef Stefan Inst, Dept Biotechnol, Jamova 39, SI-1000 Ljubljana, Slovenia; [Zadravec, Petra; Strukelj, Borut] Univ Ljubljana, Fac Pharm, Chair Pharmaceut Biol, Askerceva 7, SI-1000 Ljubljana, Slovenia; [Mareckova, Lucie; Petrokova, Hana; Maly, Petr] BIOCEV Res Ctr, Inst Biotechnol CAS, Lab Ligand Engn, Vvi, Prumyslova 595, Vestec 25250, Czech Republic; [Hodnik, Vesna; Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Jamnikarjeva 101, Ljubljana 1000, Slovenia; [Hodnik, Vesna; Anderluh, Gregor] Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Ljubljana; National Institute of Chemistry - Slovenia	Berlec, A (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova 39, SI-1000 Ljubljana, Slovenia.	ales.berlec@ijs.si	Berlec, Aleš/AAG-5922-2019; Marečková, Lucie/G-9720-2014; Anderluh, Gregor/C-6905-2014; Petroková, Hana/AAN-2763-2021; Petrokova, Hana/H-2563-2014; Malý, Petr/H-5962-2014	Berlec, Aleš/0000-0002-8095-6998; Marečková, Lucie/0000-0002-8300-2305; Anderluh, Gregor/0000-0002-9916-8465; Malý, Petr/0000-0001-8118-0581; Perisic Nanut, Milica/0000-0003-2314-2733	Slovenian Research Agency [P4-0127]; Slovene human resources development and scholarship fund; ERDF [BIOCEV CZ.1.05/1.1.00/02.0109]; Academy of Sciences of the Czech Republic [SAZU-16-01]; Slovenian Academy of Sciences and Arts [SAZU-16-01];  [RVO: 86652036]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovene human resources development and scholarship fund; ERDF(European Commission); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Slovenian Academy of Sciences and Arts; 	This work was supported by Slovenian Research Agency grant P4-0127, by Slovene human resources development and scholarship fund, by Bilateral mobility project between Academy of Sciences of the Czech Republic and Slovenian Academy of Sciences and Arts (No. SAZU-16-01) and by BIOCEV CZ.1.05/1.1.00/02.0109 from the ERDF and the institutional research concept RVO: 86652036.	Ahmad JN, 2012, PROTEINS, V80, P774, DOI 10.1002/prot.23234; ASHKENAZI S, 1989, J CLIN MICROBIOL, V27, P1145, DOI 10.1128/JCM.27.6.1145-1150.1989; Berlec A, 2013, APPL MICROBIOL BIOT, V97, P4333, DOI 10.1007/s00253-013-4722-3; Berlec A, 2011, APPL ENVIRON MICROB, V77, P1292, DOI 10.1128/AEM.02102-10; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Keir LS, 2012, DRUG DES DEV THER, V6, P195, DOI 10.2147/DDDT.S25757; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Kuchar M, 2014, PROTEINS, V82, P975, DOI 10.1002/prot.24472; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lindholm A, 2004, APPL ENVIRON MICROB, V70, P2061, DOI 10.1128/AEM.70.4.2061-2071.2004; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Mareckova L, 2015, PROTEIN CELL, V6, P774, DOI 10.1007/s13238-015-0194-9; Melton-Celsa AR, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0013-2013; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mohsin M, 2015, INT J MED MICROBIOL, V305, P20, DOI 10.1016/j.ijmm.2014.10.003; Neri P, 2011, VACCINE, V29, P5340, DOI 10.1016/j.vaccine.2011.05.093; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Ogawa M, 2001, INT J FOOD MICROBIOL, V68, P135, DOI 10.1016/S0168-1605(01)00465-2; Oneda H, 1999, J BIOCHEM-TOKYO, V126, P905, DOI 10.1093/oxfordjournals.jbchem.a022533; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Pinyon RA, 2004, J INFECT DIS, V189, P1547, DOI 10.1086/383417; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Ravnikar M, 2010, APPL ENVIRON MICROB, V76, P6928, DOI 10.1128/AEM.00190-10; Reissbrodt R, 2009, FEMS MICROBIOL LETT, V290, P62, DOI 10.1111/j.1574-6968.2008.01405.x; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Skrlec K, 2015, TRENDS BIOTECHNOL, V33, P408, DOI 10.1016/j.tibtech.2015.03.012; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Zadravec P, 2015, BIOENGINEERED, V6, P179, DOI 10.1080/21655979.2015.1040956; Zadravec P, 2015, APPL ENVIRON MICROB, V81, P2098, DOI 10.1128/AEM.03694-14; Zadravec P, 2014, PROTEIN ENG DES SEL, V27, P21, DOI 10.1093/protein/gzt059	41	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162625	10.1371/journal.pone.0162625	http://dx.doi.org/10.1371/journal.pone.0162625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606705	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255600070
J	Begashaw, B; Tessema, F; Gesesew, HA				Begashaw, Bayu; Tessema, Fasil; Gesesew, Hailay Abrha			Health Care Seeking Behavior in Southwest Ethiopia	PLOS ONE			English	Article							COMMUNITY; SERVICES; EQUITY; TUBERCULOSIS; PERCEPTIONS; FACILITIES; TRANSITION; DISTANCE; AFRICA; CROSS	Background Rural and urban populations have disparate socio-demographic and economic characteristics, which have an influence on equity and their health seeking behavior. We examined and compared the health care seeking behavior for perceived morbidity between urban and rural households in Southwest Ethiopia. Methods Analytic cross-sectional study was conducted among urban and rural households living in Esera district of Southwest Ethiopia. A random sample of 388 head of households (126 urban and 262 rural) were selected. A pretested and structured questionnaire was used for data collection with face-to-face interview. In addition to descriptive methods, binary logistic regression was used to identify factors associated with health seeking behavior at p value of less than 0.05. Results Of the sample household heads, 377 (97.2%) (119 urban and 258 rural) were successfully interviewed. Among these, 58.4% (95% CI, 53.3-63.3%) of the households sought care from modern health care that was lower among rural (48.1%) than urban (80.7%) households. The prevalence of self-treatment was 35.3% in urban and 46.1% in rural households. Among the factors considered for modern health care utilization, higher monthly income (AOR, 5.6; 95% CI, 2.04-15.4), perceived severity of disease (AOR, 2.5; 95% CI, 1.1-5.8), acute duration of disease (AOR, 8.9; 95% CI, 2.4-33.3) and short distance from health facilities (AOR, 3; 95% CI, 1.2-8.4) among rural and being married (AOR, 11.3; 95% CI, 1.2-110.2) and perceived severity of disease (AOR, 6.6; 95% CI, 1.1-10.9) among urban households showed statistically significant association. Conclusions The general health seeking behavior of households on perceived morbidity was satisfactory but lower in rural compared to urban households. Self-medication was also widely practiced in the study area. The findings signal the need to work more on accessibility and promotion of healthcare seeking behavior especially among rural households.	[Begashaw, Bayu] Mizan Tepi Univ, Dept Publ Hlth, Mizan Teferi, Snnpr, Ethiopia; [Tessema, Fasil; Gesesew, Hailay Abrha] Jimma Univ, Dept Epidemiol, Jimma, Oromiya, Ethiopia; [Gesesew, Hailay Abrha] Flinders Univ S Australia, Discipline Publ Hlth, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia	Jimma University; Flinders University South Australia	Gesesew, HA (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Oromiya, Ethiopia.; Gesesew, HA (corresponding author), Flinders Univ S Australia, Discipline Publ Hlth, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia.	hailushepi@gmail.com	Bekele, Bayu Begashaw/R-9348-2017; Gesesew, Hailay/AAF-6486-2020	Bekele, Bayu Begashaw/0000-0001-8590-4874; Gesesew, Hailay/0000-0002-3531-4400	Jimma University	Jimma University	The project was granted by Jimma University. BB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleyne GAO, 2000, B WORLD HEALTH ORGAN, V78, P76; Amare B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-752; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; [Anonymous], 2013, EUR SCI J, V9, P151; Bahrami MA, 2014, INT J MED SCI PUBLIC, V3, P651, DOI DOI 10.5455/IJMSPH.2013.250620131; Bakeera SK, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-25; Berhane Y, 2008, SCAND J PUBLIC HEALT, V36, P436, DOI 10.1177/1403494808089064; Bourne P. A., 2009, International Journal of Collaborative Research on Internal Medicine and Public Health (IJCRIMPH), V1, P101; Chenge MF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-173; Cronin T, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.130.3078; Ghose B, 2014, ASIA PEERJ PREPRINTS, V2; Girma F, 2011, ETHIOP J HEALTH SCI, V21, P85; Gotsadze G, 2005, HEALTH POLICY PLANN, V20, P232, DOI 10.1093/heapol/czi029; Grand JL, 1987, SOCIAL JUSTICE RES, V1, P257, DOI [10.1007/BF01047663, DOI 10.1007/BF01047663]; Klein T, 2007, AFR SPECTR, V42, P461; McLaren ZM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0541-1; Mebratie AD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004020; Mesganaw Fantahun, 2003, Ethiopian Journal of Health Development, V17, P141; Nawal D, LANCET, V381, pS97; Okwaraji YB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-476; Oni T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-575; Pemunta NV, 2012, ARTS SOCIAL SCI J, V2012, P1; Phrasisombath K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-37; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P93, DOI 10.1079/PHN200180; Ribera JM, 2011, MED ANTHROPOL Q, V25, P103, DOI 10.1111/j.1548-1387.2010.01139.x; Smaje C, 1997, SOC SCI MED, V45, P485, DOI 10.1016/S0277-9536(96)00380-2; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; van der Hoeven M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-31; Wagstaff A, 2001, J MED ETHICS, V27, P262, DOI 10.1136/jme.27.4.262; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454; Zhang TH, 2007, HEALTH POLICY, V81, P155, DOI 10.1016/j.healthpol.2005.12.009	33	36	36	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161014	10.1371/journal.pone.0161014	http://dx.doi.org/10.1371/journal.pone.0161014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626804	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600003
J	Chousterman, BG; Pirracchio, R; Guidet, B; Aegerter, P; Mentec, H				Chousterman, Benjamin G.; Pirracchio, Romain; Guidet, Bertrand; Aegerter, Philippe; Mentec, Herve		CUB-REA Network	Impact of Resident Rotations on Critically Ill Patient Outcomes: Results of a French Multicenter Observational Study	PLOS ONE			English	Article							JULY EFFECT IMPACT; LENGTH-OF-STAY; SURGICAL OUTCOMES; AMERICAN-COLLEGE; CARDIAC-SURGERY; END CHANGEOVER; ACADEMIC CYCLE; MORTALITY; CARE; ADMISSION	Purpose The impact of resident rotation on patient outcomes in the intensive care unit (ICU) has been poorly studied. The aim of this study was to address this question using a large ICU database. Methods We retrospectively analyzed the French CUB-REA database. French residents rotate every six months. Two periods were compared: the first (POST) and fifth (PRE) months of the rotation. The primary endpoint was ICU mortality. The secondary endpoints were the length of ICU stay (LOS), the number of organ supports, and the duration of mechanical ventilation (DMV). The impact of resident rotation was explored using multivariate regression, classification tree and random forest models. Results 262,772 patients were included between 1996 and 2010 in the database. The patient characteristics were similar between the PRE (n = 44,431) and POST (n = 49,979) periods. Multivariate analysis did not reveal any impact of resident rotation on ICU mortality(OR = 1.01, 95% CI = 0.94; 1.07, p = 0.91). Based on the classification trees, the SAPS II and the number of organ failures were the strongest predictors of ICU mortality. In the less severe patients (SAPS II< 24), the POST periodwas associated with increased mortality(OR = 1.65, 95% CI = 1.17-2.33, p = 0.004). After adjustment, no significant association was observed between the rotation period and the LOS, the number of organ supports, or the DMV. Conclusion Resident rotation exerts no impact on overall ICU mortality at French teaching hospitals but might affect the prognosis of less severe ICU patients. Surveillance should be reinforced when treating those patients.	[Chousterman, Benjamin G.; Mentec, Herve; CUB-REA Network] Ctr Hosp Victor Dupouy, Serv Reanimat Polyvalente, Argenteuil, France; [Pirracchio, Romain] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, PRES Sorbonne Paris Cite,Serv Anesthesie Reanimat, Paris, France; [Pirracchio, Romain] PRES Sorbonne Paris Cite, INSERM 1153, Equipe ECSTRA, Ctr Rech Epidemiol, Paris, France; [Pirracchio, Romain] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Guidet, Bertrand] Hop St Antoine, AP HP, Serv Reanimat Med, Paris, France; [Aegerter, Philippe] Hop Ambroise Pare, AP HP, Dept Informat Hosp & Sante Publ, Unite Rech Clin, Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Chousterman, BG (corresponding author), Ctr Hosp Victor Dupouy, Serv Reanimat Polyvalente, Argenteuil, France.	bchouster@gmail.com	AEGERTER, Philippe/AAY-6003-2021; Misset, Benoit/P-7817-2018	AEGERTER, Philippe/0000-0002-9156-5028; Chousterman, Benjamin Glenn/0000-0002-9592-7014; Misset, Benoit/0000-0001-6466-0065				Aegerter P, 1998, REV EPIDEMIOL SANTE, V46, P226; Anderson Kane L, 2009, Am J Orthop (Belle Mead NJ), V38, P606; Averbukh Yelena, 2014, J Grad Med Educ, V6, P65, DOI 10.4300/JGME-D-13-00014.1; AYLIN P, 1994, BRIT MED J, V309, P1690, DOI 10.1136/bmj.309.6970.1690; Bakaeen FG, 2009, ANN THORAC SURG, V88, P70, DOI 10.1016/j.athoracsur.2009.04.022; Barry WA, 2003, J GEN INTERN MED, V18, P639, DOI 10.1046/j.1525-1497.2003.20605.x; Bohl DD, 2014, J ARTHROPLASTY, V29, P1332, DOI 10.1016/j.arth.2014.02.008; Bohl DD, 2014, SPINE, V39, P603, DOI 10.1097/BRS.0000000000000196; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREIMAN L, 2009, RANDOM FORESTS CLASS; BUCHWALD D, 1989, ARCH INTERN MED, V149, P765, DOI 10.1001/archinte.149.4.765; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dhaliwal AS, 2008, AM J SURG, V196, P720, DOI 10.1016/j.amjsurg.2008.07.005; DiBiase LM, 2014, INFECT CONT HOSP EP, V35, P321, DOI 10.1086/675284; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Finkielman JD, 2004, CRIT CARE MED, V32, P1161, DOI 10.1097/01.CCM.0000126151.56590.99; Galbois A, 2014, CRIT CARE MED, V42, P1666, DOI 10.1097/CCM.0000000000000321; Garcia S, 2009, SOUTH MED J, V102, P602, DOI 10.1097/SMJ.0b013e3181a2f8ca; Glick SM, 2012, ANN INTERN MED, V156, P167, DOI 10.7326/0003-4819-156-2-201201170-00020; Harring TR, 2013, J SURG RES, V182, P1, DOI 10.1016/j.jss.2012.08.008; Hennessey PT, 2013, LARYNGOSCOPE, V123, P1889, DOI 10.1002/lary.23884; Jarrett MP, 2012, ANN INTERN MED, V156, P168, DOI 10.7326/0003-4819-156-2-201201170-00022; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103; Jena AB, 2013, CIRCULATION, V128, P2754, DOI 10.1161/CIRCULATIONAHA.113.004074; Karipineni F, 2013, J SURG EDUC, V70, P669, DOI 10.1016/j.jsurg.2013.04.012; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; McDonald RJ, 2012, J NEUROSURG, V116, P157, DOI 10.3171/2011.8.JNS11324; Nicolas K, 2014, ENDOCR PRACT, V20, P919, DOI 10.4158/EP13406.CR; Phillips DP, 2010, J GEN INTERN MED, V25, P774, DOI 10.1007/s11606-010-1356-3; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ravi P, 2014, CAN J SURG, V57, P82, DOI 10.1503/cjs.002713; Riguzzi C, 2014, WEST J EMERG MED, V15, P88, DOI 10.5811/westjem.2013.10.18123; Ripley B.D., 2014, CLASSIFICATION REGRE; Shuhaiber JH, 2008, ANN THORAC SURG, V86, P123, DOI 10.1016/j.athoracsur.2008.03.041; Song H, 2014, 14113 HARV BUS SCH; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Warraich HJ, 2014, BOSTON GLOBE; Wright M, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.23249; Yaghoubian A, 2010, J SURG EDUC, V67, P157, DOI 10.1016/j.jsurg.2010.04.003; Young JQ, 2011, ANN INTERN MED, V155, P309, DOI 10.7326/0003-4819-155-5-201109060-00354	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162552	10.1371/journal.pone.0162552	http://dx.doi.org/10.1371/journal.pone.0162552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627449	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600042
J	Avva, SVSP; Hart, CM				Avva, S. V. Satya Prakash; Hart, Craig M.			Characterization of the Drosophila BEAF-32A and BEAF-32B Insulator Proteins	PLOS ONE			English	Article							CHROMATIN-BOUNDARY-ELEMENT; CHROMOSOMAL DOMAINS; IN-VIVO; GENE; TRANSCRIPTION; MELANOGASTER; EXPRESSION; IDENTIFICATION; BINDING; GENOME	Data implicate the Drosophila 32 kDa Boundary Element-Associated Factors BEAF-32A and BEAF-32B in both chromatin domain insulator element function and promoter function. They might also function as an epigenetic memory by remaining bound to mitotic chromosomes. Both proteins are made from the same gene. They differ in their N-terminal 80 amino acids, which contain single DNA-binding BED fingers. The remaining 200 amino acids are identical in the two proteins. The structure and function of the middle region of 120 amino acids is unknown, while the C-terminal region of 80 amino acids has a putative leucine zipper and a BESS domain and mediates BEAF-BEAF interactions. Here we report a further characterization of BEAF. We show that the BESS domain alone is sufficient to mediate BEAF-BEAF interactions, although the presence of the putative leucine zipper on at least one protein strengthens the interactions. BEAF-32B is sufficient to rescue a null BEAF mutation in flies. Using mutant BEAF-32B rescue transgenes, we show that the middle region and the BESS domain are essential. In contrast, the last 40 amino acids of the middle region, which is poorly conserved among Drosophila species, is dispensable. Deleting the putative leucine zipper results in a hypomorphicmutant BEAF-32B protein. Finally, we document the dynamics of BEAF-32A-EGFP and BEAF-32B-mRFP during mitosis in embryos. A subpopulation of both proteins appears to remain on mitotic chromosomes and also on the mitotic spindle, while much of the fluorescence is dispersed during mitosis. Differences in the dynamics of the two proteins are observed in syncytial embryos, and both proteins show differences between syncytial and later embryos. This characterization of BEAF lays a foundation for future studies into molecular mechanisms of BEAF function.	[Avva, S. V. Satya Prakash; Hart, Craig M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Hart, CM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	chart4@lsu.edu	Hart, Craig/B-4832-2016	Hart, Craig/0000-0002-9870-991X	NSF grant from Division of Molecular and Cellular Biosciences [1244100]; Louisiana Board of Regents PFund grant [LEQSF-EPS(2012)-PFUND-274]; Div Of Molecular and Cellular Bioscience [1244100] Funding Source: National Science Foundation	NSF grant from Division of Molecular and Cellular Biosciences; Louisiana Board of Regents PFund grant; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grant 1244100 from the Division of Molecular and Cellular Biosciences (http://www.nsf.gov) and Louisiana Board of Regents PFund grant LEQSF-EPS(2012)-PFUND-274 (http://www.regents.la.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Bhaskar V, 2002, GENE, V299, P173, DOI 10.1016/S0378-1119(02)01058-2; Buchenau P, 1997, J CELL BIOL, V137, P291, DOI 10.1083/jcb.137.2.291; BUCHENAU P, 1993, J CELL SCI, V106, P189; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cuvier O, 1998, MOL CELL BIOL, V18, P7478, DOI 10.1128/MCB.18.12.7478; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Delattre M, 2002, INT J DEV BIOL, V46, P167; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Follmer NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003135; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gilbert MK, 2006, GENETICS, V173, P1365, DOI 10.1534/genetics.106.056002; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Maeda RK, 2007, CURR OPIN GENET DEV, V17, P394, DOI 10.1016/j.gde.2007.08.002; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pathak RU, 2007, MOL CELL BIOL, V27, P4796, DOI 10.1128/MCB.00305-07; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Roy S, 2007, GENETICS, V176, P801, DOI 10.1534/genetics.106.068056; Roy S, 2007, MOL GENET GENOMICS, V277, P273, DOI 10.1007/s00438-006-0187-8; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Yang JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2469; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	48	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162906	10.1371/journal.pone.0162906	http://dx.doi.org/10.1371/journal.pone.0162906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622635	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000067
J	Morgado, FN; Schubach, AO; Pimentel, MI; Lyra, MR; Vasconcellos, ECF; Valete-Rosalino, CM; Conceicao-Silva, F				Morgado, Fernanda N.; Schubach, Armando O.; Pimentel, Maria Ines; Lyra, Marcelo R.; Vasconcellos, Erica C. F.; Valete-Rosalino, Claudia M.; Conceicao-Silva, Fatima			Is There Any Difference between the In Situ and Systemic IL-10 and IFN-gamma Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?	PLOS ONE			English	Article							RIO-DE-JANEIRO; SPOROTHRIX-SCHENCKII; DENDRITIC CELLS; IMMUNE-RESPONSE; NITRIC-OXIDE; PEPTIDE-POLYSACCHARIDE; BETA-GLUCAN; T-CELLS; LEISHMANIASIS; INFECTION	Fungus of the Sporothrix schenckii complex can produce skin lesions in humans, commonly lymphocutaneous (LC) and fixed (F) forms of sporotrichosis. Some authors have suggested that clinical forms are influenced by differences in virulence and genetic profile of isolates. But little is known about the role of immune response in determining the clinical outcome of sporotrichosis. To verify the profile of systemic and in situ IFN-gamma and IL-10 expression in sporotrichosis patients, and consequently to detect any difference between the two compartments and/or clinical presentation, we quantified the number of IFN-gamma and IL-10 producer peripheral blood mononuclear cells stimulated with S. schenckii antigen (Ss-Ag) by Elispot, and quantified cytokines expression by in situ immunohistochemistry in the same patient. Three groups were formed: 1-LC (n = 9); 2-F (n = 10); 3-healthy individuals (n = 14). All sporotrichosis patients produced high amounts of systemic IFN-gamma when compared to uninfected individuals. No differences were observed between LC and F groups. Regarding in situ IL-10 expression, a difference between LC and F groups was observed: LC lesions presented higher amounts of IL-10 than F lesions differently from systemic IL-10 which showed similarities. Our data suggests that LC lesions present higher IL-10 expression which could be related to regulatory mechanisms for compensating the tissue injury, however favoring fungal persistence in the lesions. Surprisingly, there were no differences in systemic and in situ IFN-gamma expression between CL and F patients, although it was significantly higher expressed in these patients than in healthy individuals.	[Morgado, Fernanda N.; Conceicao-Silva, Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil; [Schubach, Armando O.; Pimentel, Maria Ines; Lyra, Marcelo R.; Vasconcellos, Erica C. F.; Valete-Rosalino, Claudia M.] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, VigiLeish Serv Infectol, Rio De Janeiro, RJ, Brazil; [Valete-Rosalino, Claudia M.] Univ Fed Rio de Janeiro, Fac Med, Dept Otorrinolaringol Oftalmol, Rio De Janeiro, RJ, Brazil; [Morgado, Fernanda N.] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, RJ, Brazil; [Valete-Rosalino, Claudia M.] Univ Nova Lisboa, IHMT, Lisbon, Portugal	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Conceicao-Silva, F (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil.	fconcei@ioc.fiocruz.br	Morgado, Fernanda/O-3577-2017; Morgado, Fernanda N/K-2527-2013; Valete-Rosalino, Cláudia Maria/AAR-4293-2021; Morgado, Fernanda/AAV-4435-2021	Morgado, Fernanda/0000-0002-7188-251X; Morgado, Fernanda N/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X	Instituto Oswaldo Cruz-Fundacao Oswaldo Cruz; Instituto Nacional de Infectologia Evandro Chagas-Fundacao Oswaldo Cruz; Programa de Excelencia em Pesquisa-Instituto Oswaldo Cruz-Fundacao Oswaldo Cruz-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [402557/2011-5]; Acoes Estrategicas para o Desenvolvimento e Fortalecimento dos Laboratorios Credenciados e das Areas de Apoio a Pesquisa do Instituto Oswaldo Cruz-Fundacao para o desenvolvimento Cientifico e Tecnologico em Saude [IOC-008-FIO-15]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E26/111.230/2014]; CNPq; FAPERJ	Instituto Oswaldo Cruz-Fundacao Oswaldo Cruz; Instituto Nacional de Infectologia Evandro Chagas-Fundacao Oswaldo Cruz; Programa de Excelencia em Pesquisa-Instituto Oswaldo Cruz-Fundacao Oswaldo Cruz-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Acoes Estrategicas para o Desenvolvimento e Fortalecimento dos Laboratorios Credenciados e das Areas de Apoio a Pesquisa do Instituto Oswaldo Cruz-Fundacao para o desenvolvimento Cientifico e Tecnologico em Saude; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Instituto Oswaldo Cruz-Fundacao Oswaldo Cruz, obtained by FCS; Instituto Nacional de Infectologia Evandro Chagas-Fundacao Oswaldo Cruz, obtained by AOS; Programa de Excelencia em Pesquisa-Instituto Oswaldo Cruz-Fundacao Oswaldo Cruz-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (402557/2011-5), obtained by FCS; Acoes Estrategicas para o Desenvolvimento e Fortalecimento dos Laboratorios Credenciados e das Areas de Apoio a Pesquisa do Instituto Oswaldo Cruz-Fundacao para o desenvolvimento Cientifico e Tecnologico em Saude (IOC-008-FIO-15), obtained by FCS; and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (E26/111.230/2014), obtained by FCS. AOS is a recipient of fellowships from CNPq and FAPERJ. CMVR is a recipient of FAPERJ fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegranci P, 2013, MYCOPATHOLOGIA, V176, P57, DOI 10.1007/s11046-013-9663-y; Almeida-Paes R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003094; Barros MBD, 2004, CLIN INFECT DIS, V38, P529, DOI 10.1086/381200; Brito MMS, 2007, MED MYCOL, V45, P721, DOI 10.1080/13693780701625131; Carlos IZ, 2009, MYCOPATHOLOGIA, V168, P1, DOI 10.1007/s11046-009-9190-z; Carlos IZ, 2003, SCAND J IMMUNOL, V57, P214, DOI 10.1046/j.1365-3083.2003.01175.x; Carlos IZ, 1998, MYCOPATHOLOGIA, V144, P9, DOI 10.1023/A:1006964516334; CONCEICAOSILVA F, 1990, CLIN EXP IMMUNOL, V79, P221, DOI 10.1111/j.1365-2249.1990.tb05182.x; Oliveira MME, 2011, MYCOPATHOLOGIA, V172, P257, DOI 10.1007/s11046-011-9437-3; Fernandes KSS, 2008, IMMUNOLOGY, V123, P469, DOI 10.1111/j.1365-2567.2007.02712.x; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Ferraz R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0799-x; Galhardo MCG, 2002, INT J DERMATOL, V41, P114, DOI 10.1046/j.1365-4362.2002.01381_2.x; Maia DCG, 2016, MYCOPATHOLOGIA, V181, P207, DOI 10.1007/s11046-015-9966-2; Ghosh S, 2010, FEMS IMMUNOL MED MIC, V60, P63, DOI 10.1111/j.1574-695X.2010.00717.x; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; HEARN VM, 1990, J GEN MICROBIOL, V136, P1525, DOI 10.1099/00221287-136-8-1525; Koga T, 2002, MED MYCOL, V40, P111, DOI 10.1080/mmy.40.2.111.114; Koga T, 2001, EUR J DERMATOL, V11, P527; Lefevre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012828; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lopes-Bezerra LM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00243; Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009; Maia DCG, 2006, MYCOPATHOLOGIA, V161, P11, DOI 10.1007/s11046-005-0142-y; Maretti-Mira AC, 2011, ACTA TROP, V119, P160, DOI 10.1016/j.actatropica.2011.05.009; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Martinez-Alvarez JA, 2014, REV IBEROAM MICOL, V31, P62, DOI 10.1016/j.riam.2013.09.015; Morgado FN, 2008, BRIT J DERMATOL, V158, P50, DOI 10.1111/j.1365-2133.2007.08255.x; Morgado FN, 2011, MED MYCOL, V49, P612, DOI 10.3109/13693786.2011.552532; Nascimento RC, 2005, FEMS IMMUNOL MED MIC, V43, P241, DOI 10.1016/j.femsim.2004.08.004; Nisini R, 2007, J LEUKOCYTE BIOL, V82, P1136, DOI 10.1189/jlb.0307160; Rodrigues AM, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.33; Rodrigues AM, 2013, MED MYCOL, V51, P405, DOI 10.3109/13693786.2012.719648; Sassa MF, 2009, IMMUNOLOGY, V128, P301, DOI 10.1111/j.1365-2567.2009.03118.x; Schubach A, 2008, CURR OPIN INFECT DIS, V21, P129, DOI 10.1097/QCO.0b013e3282f44c52; Schubach TMP, 2001, MED MYCOL, V39, P147, DOI 10.1080/mmy.39.1.147.149; Schubach TMP, 2004, J AM VET MED ASSOC, P224; Tachibana T, 1999, MED MYCOL, V37, P397, DOI 10.1046/j.1365-280X.1999.00239.x; Uenotsuchi T, 2006, INT IMMUNOL, V18, P1637, DOI 10.1093/intimm/dxl097; Ursini Francesco, 2015, Case Rep Rheumatol, V2015, P614504, DOI 10.1155/2015/614504; Zhang X., 2012, IEEE SPRING C ENG TE, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0052514	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162764	10.1371/journal.pone.0162764	http://dx.doi.org/10.1371/journal.pone.0162764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622513	Green Published, gold			2022-12-27	WOS:000383681000054
J	Paula, DP; Linard, B; Crampton-Platt, A; Srivathsan, A; Timmermans, MJTN; Sujii, ER; Pires, CSS; Souza, LM; Andow, DA; Vogler, AP				Paula, Debora P.; Linard, Benjamin; Crampton-Platt, Alex; Srivathsan, Amrita; Timmermans, Martijn J. T. N.; Sujii, Edison R.; Pires, Carmen S. S.; Souza, Lucas M.; Andow, David A.; Vogler, Alfried P.			Uncovering Trophic Interactions in Arthropod Predators through DNA Shotgun-Sequencing of Gut Contents	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PREY DNA; MITOCHONDRIAL GENOMES; PCR PRIMERS; BIODIVERSITY; ECOLOGY; ENHANCE; SAMPLES; BIAS	Characterizing trophic networks is fundamental to many questions in ecology, but this typically requires painstaking efforts, especially to identify the diet of small generalist predators. Several attempts have been devoted to develop suitable molecular tools to determine predatory trophic interactions through gut content analysis, and the challenge has been to achieve simultaneously high taxonomic breadth and resolution. General and practical methods are still needed, preferably independent of PCR amplification of barcodes, to recover a broader range of interactions. Here we applied shotgun-sequencing of the DNA from arthropod predator gut contents, extracted from four common coccinellid and dermapteran predators co-occurring in an agroecosystem in Brazil. By matching unassembled reads against six DNA reference databases obtained from public databases and newly assembled mitogenomes, and filtering for high overlap length and identity, we identified prey and other foreign DNA in the predator guts. Good taxonomic breadth and resolution was achieved (93% of prey identified to species or genus), but with low recovery of matching reads. Two to nine trophic interactions were found for these predators, some of which were only inferred by the presence of parasitoids and components of the microbiome known to be associated with aphid prey. Intraguild predation was also found, including among closely related ladybird species. Uncertainty arises from the lack of comprehensive reference databases and reliance on low numbers of matching reads accentuating the risk of false positives. We discuss caveats and some future prospects that could improve the use of direct DNA shotgun-sequencing to characterize arthropod trophic networks.	[Paula, Debora P.; Sujii, Edison R.; Pires, Carmen S. S.; Souza, Lucas M.] Embrapa Genet Resources & Biotechnol, Parque Estacao Biol, Brasilia, DF, Brazil; [Paula, Debora P.; Linard, Benjamin; Crampton-Platt, Alex; Srivathsan, Amrita; Timmermans, Martijn J. T. N.; Vogler, Alfried P.] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London, England; [Crampton-Platt, Alex] UCL, Dept Genet Evolut & Environm, Fac Life Sci, Gower St, London, England; [Srivathsan, Amrita] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Srivathsan, Amrita; Timmermans, Martijn J. T. N.; Vogler, Alfried P.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Timmermans, Martijn J. T. N.] Middlesex Univ, Dept Nat Sci, Hendon Campus, London, England; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Natural History Museum London; University of London; University College London; National University of Singapore; Imperial College London; Middlesex University; University of Minnesota System; University of Minnesota Twin Cities	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Parque Estacao Biol, Brasilia, DF, Brazil.; Paula, DP (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London, England.	debora.pires@embrapa.br	Sujii, Edison Ryoiti/H-7715-2015; de Souza, Lucas Machado/J-8621-2012	Sujii, Edison Ryoiti/0000-0002-0702-0181; Linard, Benjamin/0000-0002-5555-898X; Crampton-Platt, Alex/0000-0002-8096-615X; Machado de Souza, Lucas/0000-0001-8589-9534	NERC (GB) [NE/M021955]; EMBRAPA; Natural History Museum; Biodiversity Initiative	NERC (GB)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Natural History Museum; Biodiversity Initiative	This work was supported by NERC (GB), NE/M021955 to Alfried Volgler; EMBRAPA, No grant number, to Debora Pires Paula; and the Natural History Museum, Biodiversity Initiative to Alfried Vogler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andujar C, 2015, MOL ECOL, V24, P3603, DOI 10.1111/mec.13195; Brooke M. M., 1946, JOUR NATION MALARIA SOC, V5, P45; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Clare EL, 2014, MOL ECOL, V23, P3633, DOI 10.1111/mec.12519; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Crampton-Platt A, 2015, MOL BIOL EVOL, V32, P2302, DOI 10.1093/molbev/msv111; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Elton C., 1927, ANIMAL ECOLOGY; Evans EW, 2011, BIOCONTROL, V56, P597, DOI 10.1007/s10526-011-9374-6; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Geoghegan IE, 1998, EUR J ENTOMOL, V95, P571; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lo N, 2006, BIOL TERMITES MODERN, P27; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mollot G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093740; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Murray DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124671; Paula DP, 2015, MOL ECOL RESOUR, V15, P880, DOI 10.1111/1755-0998.12364; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosenheim JA, 1999, ECOL APPL, V9, P409, DOI 10.1890/1051-0761(1999)009[0409:IOGPOA]2.0.CO;2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Sicsu PR, 2013, THESIS; Srivathsan A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0150-4; Srivathsan A, 2015, MOL ECOL RESOUR, V15, P250, DOI 10.1111/1755-0998.12302; Sunderland K.D., 2005, P299, DOI 10.1007/1-4020-2625-0_6; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4	57	39	42	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161841	10.1371/journal.pone.0161841	http://dx.doi.org/10.1371/journal.pone.0161841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622637	gold, Green Published, Green Accepted			2022-12-27	WOS:000383681000008
J	Fan, DY; Li, YF; Zhao, LY; Li, ZP; Huang, LL; Yan, X				Fan, Dongying; Li, Yanfang; Zhao, Lingyun; Li, Zhengpeng; Huang, Lili; Yan, Xia			Study on Interactions between the Major Apple Valsa Canker Pathogen Valsa mali and Its Biocontrol Agent Saccharothrix yanglingensis Hhs.015 Using RT-qPCR	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; VAR. MALI; QUANTIFICATION; ARABIDOPSIS; RESISTANCE; PECTINASES; SYSTEM; GROWTH; PLANTS	The mechanism of biocontrol agent Saccharothrix yanglingensis Hhs.015 action against Valsa mali, a major apple Valsa canker pathogen, was examined using a novel, sensitive (minimum detection limit 100 pg/mu L) and reliably RT-qPCR technique. Prior to lesion formation, total concentration of V. mali in the bark showed a significant decrease (p<0.05) after 24 h of Hhs.015 treatment. This was more pronounced at 48 and 96 h post treatment. After lesion formation, levels of V. mali remained constant at the boundary between infected and uninfected bark tissues, although the relative expansion rate of the lesion was significantly reduced (p<0.05). Gene expression levels of endo-polygalacturonase, a marker for fungal pathogenicity, were sharply reduced while host induced resistance callose synthase levels increased significantly (p<0.05) at the boundary bark at 9 d after Hhs.015 treatment. The results showed that biocontrol agent Hhs.015 prevented infection of V. mali by inhibiting pathogen growth, down-regulating pathogenicity factor expression and inducing a high level of host resistance.	[Fan, Dongying; Li, Yanfang; Zhao, Lingyun; Li, Zhengpeng; Huang, Lili; Yan, Xia] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Fan, Dongying; Li, Yanfang; Zhao, Lingyun; Yan, Xia] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Li, Zhengpeng; Huang, Lili] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Huang, LL; Yan, X (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Yan, X (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Huang, LL (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	huanglili@nwsuaf.edu.cn; yania@nwsuaf.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [31101476]; Science Technology Research and Development Program of Shaanxi province [2013K01-45]; Science and technology planning project of Yangling demonstration zone [2014NY-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Research and Development Program of Shaanxi province; Science and technology planning project of Yangling demonstration zone	This work was supported by the National Natural Science Foundation of China (31101476), Science Technology Research and Development Program of Shaanxi province (2013K01-45), and Science and technology planning project of Yangling demonstration zone (2014NY-41).	Aidemark M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-27; Ananda K, 2002, CAN J MICROBIOL, V48, P871, DOI 10.1139/W02-080; Baric S, 2011, EUR J PLANT PATHOL, V129, P455, DOI 10.1007/s10658-010-9706-x; Bisognin C, 2008, PHYTOPATHOLOGY, V98, P153, DOI 10.1094/PHYTO-98-2-0153; Bohm J, 1999, J PHYTOPATHOL, V147, P409, DOI 10.1111/j.1439-0434.1999.tb03842.x; Brunner K, 2009, ANAL BIOANAL CHEM, V395, P1385, DOI 10.1007/s00216-009-3083-3; Castillo UF, 2002, MICROBIOL-SGM, V148, P2675, DOI 10.1099/00221287-148-9-2675; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Daniels B, 2012, EUR J PLANT PATHOL, V134, P821, DOI 10.1007/s10658-012-0058-6; Elad Y, 1999, EUR J PLANT PATHOL, V105, P177, DOI 10.1023/A:1008753629207; Gachon C, 2004, PLANT PHYSIOL BIOCH, V42, P367, DOI 10.1016/j.plaphy.2004.04.001; Gao ZuoPeng, 2009, Acta Phytophylacica Sinica, V36, P410; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gummadi SN, 2003, PROCESS BIOCHEM, V38, P987, DOI 10.1016/S0032-9592(02)00203-0; Gusberti M, 2012, PLANT DIS, V96, P1791, DOI 10.1094/PDIS-12-11-1058-RE; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hernandez-Suarez M., 2011, American Journal of Agricultural and Biological Sciences, V6, P189, DOI 10.3844/ajabssp.2011.189.195; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; Ingle CA, 1996, P NATL ACAD SCI USA, V93, P12926, DOI 10.1073/pnas.93.23.12926; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Keer JT, 2003, J MICROBIOL METH, V53, P175, DOI 10.1016/S0167-7012(03)00025-3; Lee DH, 2007, PLANT PATHOLOGY J, V23, P37, DOI 10.5423/PPJ.2007.23.2.037; Leisova L, 2006, J MICROBIOL METH, V67, P446, DOI 10.1016/j.mimet.2006.04.018; Li WL, 2012, PLANT CELL REP, V31, P905, DOI 10.1007/s00299-011-1211-y; Miles LA, 2012, BIOCONTROL, V57, P697, DOI 10.1007/s10526-012-9442-6; Musetti R, 2010, PHYTOPATHOLOGY, V100, P390, DOI 10.1094/PHYTO-100-4-0390; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pirselova B, 2013, ACTA PHYSIOL PLANT, V35, P635, DOI 10.1007/s11738-012-1103-y; Rezzonico F, 2005, MOL PLANT MICROBE IN, V18, P991, DOI 10.1094/MPMI-18-0991; TAMURA O, 1982, Annals of the Phytopathological Society of Japan, V48, P490, DOI 10.3186/jjphytopath.48.490; Tewoldemedhin YT, 2011, EUR J PLANT PATHOL, V129, P637, DOI 10.1007/s10658-010-9728-4; Wang CX, 2014, TOXINS, V6, P1139, DOI 10.3390/toxins6031139; Wang Lei, 2009, Acta Phytopathologica Sinica, V39, P549; Wang XL, 2014, ECOL EVOL, V4, P1369, DOI 10.1002/ece3.1030; Yan X, 2012, ANTON LEEUW INT J G, V101, P141, DOI 10.1007/s10482-011-9631-9; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6	39	4	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162174	10.1371/journal.pone.0162174	http://dx.doi.org/10.1371/journal.pone.0162174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611855	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900051
J	Kletting, P; Schuchardt, C; Kulkarni, HR; Shahinfar, M; Singh, A; Glatting, G; Baum, RP; Beer, AJ				Kletting, Peter; Schuchardt, Christiane; Kulkarni, Harshad R.; Shahinfar, Mostafa; Singh, Aviral; Glatting, Gerhard; Baum, Richard P.; Beer, Ambros J.			Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for Lu-177-Labeled PSMA-Targeting Peptides	PLOS ONE			English	Article							MEMBRANE ANTIGEN PSMA; PROSTATE-CANCER; IN-VITRO; DOSIMETRY; LU-177-OCTREOTATE; SOFTWARE	In molecular radiotherapy with Lu-177-labeled prostate specific membrane antigen (PSMA) peptides, kidney and/or salivary glands doses limit the activity which can be administered. The aim of this work was to investigate the effect of the ligand amount and injected activity on the tumor-to-normaltissue biologically effective dose (BED) ratio for Lu-177-labeled PSMA peptides. For this retrospective study, a recently developed physiologically based pharmacokinetic model was adapted for PSMA targeting peptides. General physiological parameters were taken from the literature. Individual parameters were fitted to planar gamma camera measurements (Lu-177-PSMA I&T) of five patients with metastasizing prostate cancer. Based on the estimated parameters, the pharmacokinetics of tumor, salivary glands, kidneys, total body and red marrow was simulated and time-integrated activity coefficients were calculated for different peptide amounts. Based on these simulations, the absorbed doses and BEDs for normal tissue and tumor were calculated for all activities leading to a maximal tolerable kidney BED of 10 Gy(2.5)/cycle, a maximal salivary gland absorbed dose of 7.5 Gy/cycle and a maximal red marrow BED of 0.25 Gy(15)/cycle. The fits yielded coefficients of determination > 0.85, acceptable relative standard errors and low parameter correlations. All estimated parameters were in a physiologically reasonable range. The amounts (for 2(5)-2(9) nmol) and pertaining activities leading to a maximal tumor dose, considering the defined maximal tolerable doses to organs of risk, were calculated to be 272 +/- 253 nmol (452 +/- 420 mu g) and 7.35 +/- 5.1 GBq. Using the actually injected amount (235 +/- 155 mu g) and the same maximal tolerable doses, the potential improvement for the tumor BED was 1-3 fold. The results suggest that currently given amounts for therapy are in the appropriate order of magnitude for many lesions. However, for lesions with high binding site density or lower perfusion, optimizing the peptide amount and activity might improve the tumor-to-kidney and tumor-to-salivary glands BED ratio considerably.	[Kletting, Peter; Beer, Ambros J.] Univ Ulm, Dept Nucl Med, Ulm, Germany; [Schuchardt, Christiane; Kulkarni, Harshad R.; Shahinfar, Mostafa; Singh, Aviral; Baum, Richard P.] Zent Klin Bad Berka, THERANOST Ctr Mol Radiotherapy & Mol Imaging PET, Bad Berka, Germany; [Glatting, Gerhard] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Med Radiat Phys Radiat Protect, Mannheim, Germany	Ulm University; Zentralklinik Bad Berka; Ruprecht Karls University Heidelberg	Kletting, P (corresponding author), Univ Ulm, Dept Nucl Med, Ulm, Germany.	peter.kletting@uniklinik-ulm.de	Beer, Ambros J./AAA-5539-2022; Glatting, Gerhard/ABF-2506-2020	Beer, Ambros J./0000-0001-9042-7806; Glatting, Gerhard/0000-0001-7916-1576; Kletting, Peter/0000-0003-3654-3667	Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG KL 2742/2-1, BE 4393/1-1, GL 236/11-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	The authors gratefully acknowledge grants by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG KL 2742/2-1, BE 4393/1-1 and GL 236/11-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone R, 2005, J NUCL MED, V46, p99S; Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; Baum R., 2015, NUKLEARMEDIZINER, V38, P145, DOI [10.1055/s-0035-1549991, DOI 10.1055/S-0035-1549991]; Baum RP, 2016, J NUCL MED, V57, P1006, DOI 10.2967/jnumed.115.168443; Ben Jemaa A, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-171; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Breau RH, 2013, CUAJ-CAN UROL ASSOC, V7, P189, DOI 10.5489/cuaj.1338; BUBECK B, 1993, SEMIN NUCL MED, V23, P73, DOI 10.1016/S0001-2998(05)80064-9; Cremonesi M, 2010, Q J NUCL MED MOL IM, V54, P37; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; DALE RG, 1985, BRIT J RADIOL, V58, P515, DOI 10.1259/0007-1285-58-690-515; Delker A, 2016, EUR J NUCL MED MOL I, V43, P42, DOI 10.1007/s00259-015-3174-7; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Hardiansyah D, 2016, EUR J NUCL MED MOL I, V43, P871, DOI 10.1007/s00259-015-3248-6; Hindorf C, 2010, EUR J NUCL MED MOL I, V37, P1238, DOI 10.1007/s00259-010-1422-4; Hobbs RF, 2013, Q J NUCL MED MOL IM, V57, P79; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Kabasakal L, 2015, EUR J NUCL MED MOL I, V42, P1976, DOI 10.1007/s00259-015-3125-3; Kal HB, 2003, INT J RADIAT ONCOL, V57, P1116, DOI 10.1016/S0360-3016(03)01455-X; Kletting P, 2013, MED PHYS, V40, DOI 10.1118/1.4820367; Kletting P, 2016, J NUCL MED, V57, P503, DOI 10.2967/jnumed.115.164699; Kletting P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127934; Kletting P, 2012, MED PHYS, V39, P5708, DOI 10.1118/1.4747266; Kletting P, 2009, Z MED PHYS, V19, P200, DOI 10.1016/j.zemedi.2009.05.003; Konijnenberg M, 2011, Q J NUCL MED MOL IM, V55, P44; Kratochwil C, 2015, J NUCL MED, V56, P293, DOI 10.2967/jnumed.114.147181; Luczynska E, 2015, MED SCI MONITOR, V21, P153, DOI 10.12659/MSM.891401; O'Keefe DS, 2004, PROSTATE, V58, P200, DOI 10.1002/pros.10319; Pfestroff A, 2015, EUR J NUCL MED MOL I, V42, P1971, DOI 10.1007/s00259-015-3186-3; Sabet A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-82; Schuchardt Christiane, 2013, Recent Results Cancer Res, V194, P519, DOI 10.1007/978-3-642-27994-2_30; Schuler E, 2016, ACTA ONCOL, V55, P68, DOI 10.3109/0284186X.2015.1027001; Schwenzer NF, 2008, NMR BIOMED, V21, P598, DOI 10.1002/nbm.1231; Siegel JA, 1999, J NUCL MED, V40, p37S; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Stabin MG, 2005, J NUCL MED, V46, P1023; Strigari L, 2014, EUR J NUCL MED MOL I, V41, P1976, DOI 10.1007/s00259-014-2824-5; TROYER JK, 1995, INT J CANCER, V62, P552, DOI 10.1002/ijc.2910620511; Wang XN, 2011, MOL CANCER THER, V10, P1728, DOI 10.1158/1535-7163.MCT-11-0191; Weineisen M, 2015, J NUCL MED, V56, P1169, DOI 10.2967/jnumed.115.158550; Weineisen M, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0063-1; Winter G, 2014, ANNUAL CONGRESS EANM, P200; Zechmann CM, 2014, EUR J NUCL MED MOL I, V41, P1280, DOI 10.1007/s00259-014-2713-y	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162303	10.1371/journal.pone.0162303	http://dx.doi.org/10.1371/journal.pone.0162303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611841	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900076
J	Li, L; Li, CR; Zhong, H; Tao, YJ; Yuan, YS; Pan, CW				Li, Lan; Li, Cairui; Zhong, Hua; Tao, Yijin; Yuan, Yuansheng; Pan, Chen-Wei			Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population	PLOS ONE			English	Article							YUNNAN MINORITY EYE; PREVALENCE	Purpose We aim to assess the longitudinal association between baseline estimated cerebrospinal fluid pressure (CSFP) and 5-year incident primaryopen angle glaucoma (POAG) in a population-based sample of Bai Chinese living in rural China. Methods Among the 2133 Bai Chinese aged 50 years or older who had participated in the baseline examination of the Yunnan Minority Eye Study, 1520 (71.3%) attended the follow-up examination after five years and 1485 were at risk of developing POAG. Participants underwent comprehensive ophthalmic examinations at both baseline and follow-up surveys. CSFP in mmHg was estimated as 0.55 x body mass index (kg/m2) + 0.16 x diastolic blood pressure (mmHg)-0.18 x age (years)-1.91. Glaucoma was defined using the International Society of Geographical and Epidemiological Ophthalmology Classification criteria. Multivariate logistic regression models were established to determine the association between baseline CSFP and incident POAG. Results After a mean follow-up time of 5 years, 19 new cases of POAG were detected, with an incidence rate of 1.3% (95% confidence interval, 0.7-1.9%). In multivariate logistic regression analysis, after adjusting for age, gender, education, intraocular pressure, central corneal thickness, hypertension and diabetes, no significant associations, nor any trends, were evident between baseline estimated CSFP and incident POAG. The association between estimated CSFP per mmHg increase in baseline and 5-year incidence of POAG was also nonsignificant, with adjusted relative risk of 0.96 (P = 0.11) in multivariate analysis. Conclusions This longitudinal cohort study does not support previously observed cross-sectional association between estimated CSFP and POAG in population-based studies.	[Li, Lan] First Hosp Kunming, Dept Ophthalmol, Kunming, Peoples R China; [Li, Cairui] Dali Univ, Affiliated Hosp, Dali, Peoples R China; [Zhong, Hua; Tao, Yijin; Yuan, Yuansheng] Kunming Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Kunming, Peoples R China; [Pan, Chen-Wei] Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China	Dali University; Kunming Medical University; Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613	National Natural Science Foundation of China [81460085, 81160121, 81371016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China under grant No. 81460085, No. 81160121 and No. 81371016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China under grant No. 81460085, No. 81160121 and No. 81371016.	Baskaran M, 2015, JAMA OPHTHALMOL, V133, P874, DOI 10.1001/jamaophthalmol.2015.1110; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2011, ACTA OPHTHALMOL, V89, P505, DOI 10.1111/j.1755-3768.2010.01915.x; Killer HE, 2009, J GLAUCOMA, V18, P172, DOI 10.1097/IJG.0b013e31819aa4f9; Lee SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148412; Li J, 2012, INVEST OPHTH VIS SCI, V53, P4498, DOI 10.1167/iovs.12-9429; Li L, 2015, CORNEA, V34, P1564, DOI 10.1097/ICO.0000000000000637; Marek B, 2014, BRIT J OPHTHALMOL, V98, P721, DOI 10.1136/bjophthalmol-2013-303884; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P4621, DOI 10.1167/iovs.13-11950; Promelle V, 2016, ACTA RADIOL OPEN, V5, DOI 10.1177/2058460115624275; Roy CU, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0082151; Siaudvytyte L, 2015, EYE, V29, P1242, DOI 10.1038/eye.2015.127; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wang Ningli, 2013, J Glaucoma, V22 Suppl 5, pS11, DOI 10.1097/IJG.0b013e31829349a2; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wilensky J T, 1991, Trans Am Ophthalmol Soc, V89, P757; Yang DY, 2014, INVEST OPHTH VIS SCI, V55, P3067, DOI 10.1167/iovs.13-13657; Yang Y, 2010, MED HYPOTHESES, V74, P31, DOI 10.1016/j.mehy.2009.08.024; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P3221, DOI 10.1167/iovs.11-9306	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162862	10.1371/journal.pone.0162862	http://dx.doi.org/10.1371/journal.pone.0162862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611879	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900181
J	Zaw, KK; Ohnmar, M; Hlaing, MM; Oo, YTN; Win, SS; Htike, MMT; Aye, PP; Shwe, S; Htwe, MT; Thein, ZM				Zaw, Ko-Ko; Ohnmar, Mya; Hlaing, Moh-Moh; Oo, Yin-Thet-Nu; Win, Swe-Swe; Htike, Maung-Maung-Than; Aye, Phyu-Phyu; Shwe, Sein; Htwe, Moe-Thida; Thein, Zaw-Moe			Betel Quid and Oral Potentially Malignant Disorders in a Periurban Township in Myanmar	PLOS ONE			English	Article							ARECA NUT; EPIDEMIOLOGY; TOBACCO	This study aims to describe betel quid chewing practice and compare oral potentially malignant disorders between chewers and non-chewers of betel quid among residents in Dagon Myothit (East) Township, Myanmar. The study used a cross-sectional design conducted with a representative sample of 542 adults aged 18 years and above in the township. The trained interviewers collected data using a pretested structured questionnaire. On-site oral examination was done for suspected oral lesions. The mean age of the respondents was 45 years and 59% were women. Fifty-two percent of the respondents were currently in the habit of chewing betel quids (72% of men and 39% of women). Among 284 current betel quid chewers, 240 (85%) chewed betel quids together with tobacco. Out of 284 current betel quid chewers, 24 (8.5%) were found to have oral potentially malignant disorders; out of 258 betel quid non-chewers, only 1 (0.4%) was found to have oral potentially malignant disorders. This highlights the growing importance of smokeless tobacco use as public health problem.	[Zaw, Ko-Ko; Ohnmar, Mya; Hlaing, Moh-Moh; Oo, Yin-Thet-Nu] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Win, Swe-Swe; Shwe, Sein; Htwe, Moe-Thida; Thein, Zaw-Moe] Univ Dent Med, Yangon, Myanmar; [Htike, Maung-Maung-Than] Minist Hlth, Int Hlth Div, Nayphyitaw, Myanmar; [Aye, Phyu-Phyu] Dept Publ Hlth, Nayphyitaw, Myanmar		Zaw, KK (corresponding author), Dept Med Res Lower Myanmar, Yangon, Myanmar.	zawkzaw@gmail.com	Zaw, Ko-Ko/HGF-2385-2022; Thein, Zaw/AAU-6039-2020		Department of Medical Research;  [200630868]	Department of Medical Research; 	This work was supported by grant number 200630868 and the Department of Medical Research, http://www.dmrlm.gov.mm/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Floraa MS, WHO S E ASIA J PUBLI, V169; Gupta A, 2007, ACTA CYTOL, V51, P788, DOI 10.1159/000325843; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Mazahir S, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-10; Ministry of Information, ENC MYANM CD ROM; Patton LL, 2008, J AM DENT ASSOC, V139, P896, DOI 10.14219/jada.archive.2008.0276; Rahman M, 2006, BEHAV RISK FACTORS N; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; WHO, 2011, NONC DIS RISK FACT S; WHO IARC, 1985, IARC MON EV CARC RIS, V37, P1	14	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162081	10.1371/journal.pone.0162081	http://dx.doi.org/10.1371/journal.pone.0162081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611195	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900044
J	Clausen, AN; Aupperle, RL; Sisante, JFV; Wilson, DR; Billinger, SA				Clausen, Ashley N.; Aupperle, Robin L.; Sisante, Jason-Flor V.; Wilson, David R.; Billinger, Sandra A.			Pilot Investigation of PTSD, Autonomic Reactivity, and Cardiovascular Health in Physically Healthy Combat Veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; WORLD-WAR-II; VIETNAM VETERANS; RATE-VARIABILITY; PHYSIOLOGICAL-RESPONSES; ENDOTHELIAL FUNCTION; AEROBIC EXERCISE; BRACHIAL-ARTERY	Posttraumatic stress disorder (PTSD), and combat-related PTSD in particular, has been associated with increased rates of cardiovascular disease, and cardiovascular-related death. However, less research has examined possible factors that may link PTSD to poorer cardiovascular health in combat veteran populations. The current pilot study investigated whether psychological symptomology and autonomic reactivity to emotional scripts would relate to poorer cardiovascular health in combat veterans without a current diagnosis of cardiovascular disease. Male veterans (N = 24), who served in combat since Operation Iraqi Freedom, completed a semi-structured interview and self-report measures to assess psychological symptomology. Autonomic reactivity, measured using heart rate variability (HRV; low to high frequency ratio), was obtained during script-driven imagery of emotional memories. Cardiovascular health was assessed using flow-mediated dilation (FMD) of the brachial artery. Correlational analyses and discriminant analysis were used to assess the relationship between psychological symptoms (PTSD, depression, anger, as measured via self-report), autonomic reactivity to emotional scripts (HRV), and FMD. Overall, veterans in the current study showed poor cardiovascular health despite their relatively young age and lack of behavioral risk factors, with 15/24 exhibiting impaired FMD (FMD < 5%). Psychological symptomology was not associated with FMD; whereas autonomic reactivity to emotional (compared to neutral) scripts was found to relate to FMD. Autonomic reactivity to negative scripts correctly classified 76.5% of veterans as having impaired versus normative FMD. Results from this pilot study highlight the importance of cardiovascular screening with combat veterans despite psychological diagnosis. Results also support the need for longitudinal research assessing the use of autonomic reactivity to emotionally valenced stimuli as a potential risk factor for poorer cardiovascular health.	[Clausen, Ashley N.; Aupperle, Robin L.] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA; [Clausen, Ashley N.; Aupperle, Robin L.] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Sisante, Jason-Flor V.; Wilson, David R.; Billinger, Sandra A.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA	University of Tulsa; Laureate Institute for Brain Research, Inc.; University of Kansas; University of Kansas Medical Center	Clausen, AN (corresponding author), Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA.; Clausen, AN (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	aclausen@laureateinstitute.org	Clausen, Ashley N/W-5627-2019; Aupperle, Robin/AAU-8550-2020	Clausen, Ashley N/0000-0002-1773-7733; 	University of Missouri-Kansas City's Women's Council Graduate Assistant; Department of Psychology at the University of Missouri-Kansas City; University of Missouri Research Board; Heartland Institute for Clinical and Translational Research [UL1TR000001]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K01HD067318, T32HD057850]; Georgia Holland Endowment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH108707] Funding Source: NIH RePORTER	University of Missouri-Kansas City's Women's Council Graduate Assistant; Department of Psychology at the University of Missouri-Kansas City; University of Missouri Research Board; Heartland Institute for Clinical and Translational Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Georgia Holland Endowment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was partially supported by the University of Missouri-Kansas City's Women's Council Graduate Assistant Funding, and start-up funds from the Department of Psychology at the University of Missouri-Kansas City, and the University of Missouri Research Board and Heartland Institute for Clinical and Translational Research (UL1TR000001), awarded to Dr. Robin Aupperle. Dr. Sandra Billinger was supported in part by K01HD067318 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. JFS was supported in part by T32HD057850 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The KU Research in Exercise and Cardiovascular Health laboratory space was supported by the Georgia Holland Endowment Fund. The authors report no relationship with the industry.	American Psychiatric Association, 2000, DIAGN STAT MAN 4 TEX; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Babor T.F., 1992, AUDIT ALCOHOL USE DI; Beck AT., 1996, MANUAL BECK DEPRESSI; Bedi US, 2007, J NATL MED ASSOC, V99, P642; Billinger SA, 2016, INT J NEUROSCI, P1; Billinger SA, 2012, J NEUROL PHYS THER, V36, P159, DOI 10.1097/NPT.0b013e318274d082; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Boscarino JA, 1999, ANN BEHAV MED, V21, P227, DOI 10.1007/BF02884839; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Buckley TC, 2004, J TRAUMA STRESS, V17, P163, DOI 10.1023/B:JOTS.0000022623.01190.f0; Carney Robert M, 2009, Cleve Clin J Med, V76 Suppl 2, pS13, DOI 10.3949/ccjm.76.s2.03; Christopher M, 2004, CLIN PSYCHOL REV, V24, P75, DOI 10.1016/j.cpr.2003.12.003; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Cohen H, 2000, SEMIN ARTHRITIS RHEU, V29, P217, DOI 10.1016/S0049-0172(00)80010-4; Cohen H, 1997, BIOL PSYCHIAT, V41, P627, DOI 10.1016/S0006-3223(96)00525-2; Cohen H, 2001, BRIT J PSYCHIAT, V179, P167, DOI 10.1192/bjp.179.2.167; Cohen H, 1998, BIOL PSYCHIAT, V44, P1054, DOI 10.1016/S0006-3223(97)00475-7; Cooper DC, 2010, PSYCHOSOM MED, V72, P122, DOI 10.1097/PSY.0b013e3181cdbfc0; COX DA, 1989, CIRCULATION, V80, P458, DOI 10.1161/01.CIR.80.3.458; Dalli E, 2002, REV ESP CARDIOL, V55, P928, DOI 10.1016/S0300-8932(02)76731-6; Elder GH, 1997, AM J PSYCHIAT, V154, P330; Friedman Matthew J., 1995, P507; Grenon SM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003010; Guthikonda S, 2007, ARTERIOSCL THROM VAS, V27, P1172, DOI 10.1161/ATVBAHA.106.131011; Harris KF, 2003, PSYCHOSOM MED, V65, P402, DOI 10.1097/01.PSY.0000035720.08842.9F; Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Klabunde R. E., 2005, CARDIOVASCULAR PHYSL, V2nd; Kluding PM, 2015, PHYS THER, V95, P223, DOI 10.2522/ptj.20140108; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; LEUNG WH, 1993, LANCET, V341, P1496, DOI 10.1016/0140-6736(93)90634-S; Lindauer RTL, 2006, PSYCHOSOM MED, V68, P33, DOI 10.1097/01.psy.0000188566.35902.e7; Moravec Christine S, 2008, Cleve Clin J Med, V75 Suppl 2, pS35; Narita K, 2008, PSYCHONEUROENDOCRINO, V33, P305, DOI 10.1016/j.psyneuen.2007.11.013; Narita K, 2007, INT PSYCHOGERIATR, V19, P947, DOI 10.1017/S1041610206004571; O'Toole BI, 2008, J PSYCHOSOM RES, V64, P33, DOI 10.1016/j.jpsychores.2007.07.006; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Orr SP, 1998, J TRAUMA STRESS, V11, P155, DOI 10.1023/A:1024421502881; ORR SP, 1990, J CONSULT CLIN PSYCH, V58, P329, DOI 10.1037/0022-006X.58.3.329; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Pagani M, 2001, AUTON NEUROSCI-BASIC, V90, P76, DOI 10.1016/S1566-0702(01)00270-3; Page WF, 2001, MIL MED, V166, P803, DOI 10.1093/milmed/166.9.803; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; PITMAN RK, 1990, J ABNORM PSYCHOL, V99, P49, DOI 10.1037/0021-843X.99.1.49; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rausch SM, 2006, INT J STRESS MANAGE, V13, P273, DOI DOI 10.1037/1072-5245.13.3.273; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solter V, 2002, CROAT MED J, V43, P685; Stillman AN, 2013, PSYCHOSOM MED, V75, P537, DOI 10.1097/PSY.0b013e31829a0ae3; Tan G, 2011, APPL PSYCHOPHYS BIOF, V36, P27, DOI 10.1007/s10484-010-9141-y; Tarvainen MP, 2009, IEEE ENG MED BIO, P1, DOI 10.1109/IEMBS.2009.5332678; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Violanti J.M., 2006, INT J STRESS MANAGE, V13, P541, DOI DOI 10.1037/1072-5245.13.4.541; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Walczewska J, 2011, EUR HEART J, V32, P730, DOI 10.1093/eurheartj/ehq354; Wentworth BA, 2013, CARDIOL REV, V21, P16, DOI 10.1097/CRD.0b013e318265343b; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; World Health Organization, 1992, INT STAT CLASS DIS R; Xhyheri B, 2012, PROG CARDIOVASC DIS, V55, P321, DOI 10.1016/j.pcad.2012.09.001; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	76	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162547	10.1371/journal.pone.0162547	http://dx.doi.org/10.1371/journal.pone.0162547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27607181	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600063
J	Hall, TG; Yu, Y; Eathiraj, S; Wang, YX; Savage, RE; Lapierre, JM; Schwartz, B; Abbadessa, G				Hall, Terence G.; Yu, Yi; Eathiraj, Sudharshan; Wang, Yunxia; Savage, Ronald E.; Lapierre, Jean-Marc; Schwartz, Brian; Abbadessa, Giovanni			Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; 8P11 MYELOPROLIFERATIVE SYNDROME; TIGHT-BINDING INHIBITORS; CANCER-CELL-LINES; SOLID TUMORS; TYROSINE KINASE; GENE FUSIONS; INTRAHEPATIC CHOLANGIOCARCINOMA; THERAPEUTIC TARGETS; SELECTIVE INHIBITOR	Dysregulation of Fibroblast Growth Factor Receptor (FGFR) signaling through amplifications, mutations, and gene fusions has been implicated in a broad array of cancers (e.g. liver, gastric, ovarian, endometrial, and bladder). ARQ 087 is a novel, ATP competitive, small molecule, multi-kinase inhibitor with potent in vitro and in vivo activity against FGFR addicted cell lines and tumors. Biochemically, ARQ 087 exhibited IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3. In cells, inhibition of FGFR2 auto-phosphorylation and other proteins downstream in the FGFR pathway (FRS2 alpha, AKT, ERK) was evident by the response to ARQ 087 treatment. Cell proliferation studies demonstrated ARQ 087 has anti-proliferative activity in cell lines driven by FGFR dysregulation, including amplifications, fusions, and mutations. Cell cycle studies in cell lines with high levels of FGFR2 protein showed a positive relationship between ARQ 087 induced G1 cell cycle arrest and subsequent induction of apoptosis. In addition, ARQ 087 was effective at inhibiting tumor growth in vivo in FGFR2 altered, SNU-16 and NCI-H716, xenograft tumor models with gene amplifications and fusions. ARQ 087 is currently being studied in a phase 1/2 clinical trial that includes a sub cohort for intrahepatic cholangiocarcinoma patients with confirmed FGFR2 gene fusions (NCT01752920).	[Hall, Terence G.; Yu, Yi; Eathiraj, Sudharshan; Wang, Yunxia; Savage, Ronald E.; Lapierre, Jean-Marc; Schwartz, Brian; Abbadessa, Giovanni] ArQule Inc, Burlington, MA 01803 USA		Hall, TG (corresponding author), ArQule Inc, Burlington, MA 01803 USA.	thall@arqule.com		Schwartz, Brian/0000-0003-2632-6351	ArQule, Inc.	ArQule, Inc.	Funding for this work was provided by ArQule, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Syed M., 2010, US Patent Application, Patent No. [12/649,573, 12649573]; Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; ARMSTRONG E, 1992, CANCER RES, V52, P2004; Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Borad MJ, 2015, CURR OPIN GASTROEN, V31, P264, DOI 10.1097/MOG.0000000000000171; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Capelletti M, 2014, CLIN CANCER RES, V20, P6551, DOI 10.1158/1078-0432.CCR-14-1337; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chase A, 2007, BLOOD, V110, P3729, DOI 10.1182/blood-2007-02-074286; Chase A, 2013, HAEMATOL-HEMATOL J, V98, P103, DOI 10.3324/haematol.2012.066407; Churi CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115383; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Eathiraj S, 2011, J BIOL CHEM, V286, P20677, DOI 10.1074/jbc.M110.213736; Finch PW, 2006, JNCI-J NATL CANCER I, V98, P812, DOI 10.1093/jnci/djj228; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Graham RP, 2014, HUM PATHOL, V45, P1630, DOI 10.1016/j.humpath.2014.03.014; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; Kelleher FC, 2013, CARCINOGENESIS, V34, P2198, DOI 10.1093/carcin/bgt254; Kim ST, 2014, MOL CANCER THER, V13, P2527, DOI 10.1158/1535-7163.MCT-14-0255; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Konecny GE, 2015, LANCET ONCOL, V16, P686, DOI 10.1016/S1470-2045(15)70159-2; Kumar BVSS, 2013, CURR PHARM DESIGN, V19, P687, DOI 10.2174/138161213804581963; Lemieux S, 2013, ANTI-CANCER AGENT ME, V13, P748, DOI 10.2174/18715206113139990080; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Lewin J, 2015, J CLIN ONCOL, V33, P3372, DOI 10.1200/JCO.2015.62.7380; Liang G, 2013, CYTOKINE GROWTH F R, V24, P467, DOI 10.1016/j.cytogfr.2013.05.002; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mathur A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098515; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Nakamura H, 2015, NAT GENET, V47, P1003, DOI 10.1038/ng.3375; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; Papadopoulos KP, 2015, J CLIN ONCOL S, V33, P2545; Parker BC, 2014, J PATHOL, V232, P4, DOI 10.1002/path.4297; Parker BC, 2013, CHIN J CANCER, V32, P594, DOI 10.5732/cjc.013.10178; Rizvi S, 2014, SEMIN LIVER DIS, V34, P456, DOI 10.1055/s-0034-1394144; Ross JS, 2014, ONCOLOGIST, V19, P235, DOI 10.1634/theoncologist.2013-0352; Sia D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7087; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Tabernero J, 2015, J CLIN ONCOL, V33, P3401, DOI 10.1200/JCO.2014.60.7341; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Zaid TM, 2013, CLIN CANCER RES, V19, P809, DOI 10.1158/1078-0432.CCR-12-2736; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	57	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162594	10.1371/journal.pone.0162594	http://dx.doi.org/10.1371/journal.pone.0162594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627808	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600045
J	Madsen, JS; Riber, L; Kot, W; Basfeld, A; Burmolle, M; Hansen, LH; Sorensen, SJ				Madsen, Jonas Stenlokke; Riber, Leise; Kot, Witold; Basfeld, Alrun; Burmolle, Mette; Hansen, Lars Hestbjerg; Sorensen, Soren Johannes			Type 3 Fimbriae Encoded on Plasmids Are Expressed from a Unique Promoter without Affecting Host Motility, Facilitating an Exceptional Phenotype That Enhances Conjugal Plasmid Transfer	PLOS ONE			English	Article							CYCLIC DI-GMP; BIOFILM FORMATION; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; GENE-EXPRESSION; H-NS; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; NUCLEOTIDE-SEQUENCE; PSEUDOMONAS	Horizontal gene transfer (HGT), the transmission of genetic material to a recipient that is not the progeny of the donor, is fundamental in bacterial evolution. HGT is often mediated by mobile genetic elements such as conjugative plasmids, which may be in conflict with the chromosomal elements of the genome because they are independent replicons that may petition their own evolutionary strategy. Here we study differences between type 3 fimbriae encoded on wild type plasmids and in chromosomes. Using known and newly characterized plasmids we show that the expression of type 3 fimbriae encoded on plasmids is systematically different, as MrkH, a c-di-GMP dependent transcriptional activator is not needed for strong expression of the fimbriae. MrkH is required for expression of type 3 fimbriae of the Klebsiella pneumoniae chromosome, where from the fimbriae operon (mrkABCDF) of plasmids is believed to have originated. We find that mrkABCDFs of plasmids are highly expressed via a unique promoter that differs from the original Klebsiella promoter resulting in fundamental behavioral consequences. Plasmid associated mrkABCDFs did not influence the swimming behavior of the host, that hereby acquired an exceptional phenotype being able to both actively swim (planktonic behavior) and express biofilm associated fimbriae (sessile behavior). We show that this exceptional phenotype enhances the conjugal transfer of the plasmid.	[Madsen, Jonas Stenlokke; Riber, Leise; Kot, Witold; Basfeld, Alrun; Burmolle, Mette; Hansen, Lars Hestbjerg; Sorensen, Soren Johannes] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Kot, Witold; Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark; [Basfeld, Alrun] Max Planck Inst Biochem, Max Planck Res Grp Chromosome Org & Dynam, Martinsried, Germany	University of Copenhagen; Aarhus University; Max Planck Society	Hansen, LH (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.; Hansen, LH (corresponding author), Aarhus Univ, Dept Environm Sci, Aarhus, Denmark.	lhha@envs.au.dk	Kot, Witold/M-2170-2014; Sørensen, Søren J/J-5015-2014; Kot, Witold/N-3747-2017; Sørensen, Søren Johannes/N-2120-2019; Burmølle, Mette/L-8002-2014	Kot, Witold/0000-0002-0188-4587; Sørensen, Søren J/0000-0001-6227-9906; Kot, Witold/0000-0002-0188-4587; Sørensen, Søren Johannes/0000-0001-6227-9906; Burmølle, Mette/0000-0003-1870-632X; Madsen, Jonas Stenlokke/0000-0003-4830-1796; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Riber, Leise/0000-0003-4793-6095	Danish Council for Independent Research grant [11106571]; Danish Innovation Consortium grant; Lundbeck Foundation grant [R93-A8499]; Villum Fonden [00010098] Funding Source: researchfish	Danish Council for Independent Research grant; Danish Innovation Consortium grant; Lundbeck Foundation grant; Villum Fonden(Villum Fonden)	This work was supported by The Danish Council for Independent Research grant 11106571, Danish Innovation Consortium grant 11804520 and Lundbeck Foundation grant R93-A8499. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Aarestrup FM, 1998, APMIS, V106, P745, DOI 10.1111/j.1699-0463.1998.tb00222.x; ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Burmolle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041259; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; DUGUID JP, 1959, J GEN MICROBIOL, V21, P271, DOI 10.1099/00221287-21-1-271; FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001; Garcia J, 2005, BIOCHEM J, V388, P755, DOI 10.1042/BJ20050002; GERLACH GF, 1988, J BACTERIOL, V170, P3547, DOI 10.1128/jb.170.8.3547-3553.1988; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guyer MS, 1981, IDENTIFICATION OF A; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hansen LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019912; Hansen LH, 1997, GENE, V186, P167, DOI 10.1016/S0378-1119(96)00688-9; Hansen LH, 1998, CURR MICROBIOL, V36, P341, DOI 10.1007/s002849900320; Huang YJ, 2006, BIOCHEM BIOPH RES CO, V350, P537, DOI 10.1016/j.bbrc.2006.09.070; Huang YJ, 2009, RES MICROBIOL, V160, P71, DOI 10.1016/j.resmic.2008.10.009; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; KORHONEN TK, 1983, J BACTERIOL, V155, P860, DOI 10.1128/JB.155.2.860-865.1983; Kurihara S, 2011, J BIOL CHEM, V286, P10185, DOI 10.1074/jbc.M110.176032; Landini P, 2002, J BACTERIOL, V184, P1522, DOI 10.1128/JB.184.6.1522-1529.2002; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; LEVINS RICHARD, 1968; Madsen JS, 2015, APPL ENVIRON MICROB, V81, P8414, DOI 10.1128/AEM.02628-15; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Miller JH., 1972, EXPERIMENTS IN MOLEC; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Papagiannitsis CC, 2013, J ANTIMICROB CHEMOTH, V68, P2259, DOI 10.1093/jac/dkt196; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Ren DW, 2014, MICROB ECOL, V68, P146, DOI 10.1007/s00248-013-0315-z; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 1989, MOLECULAR CLONING A; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; van Ditmarsch D, 2013, CELL REP, V4, P697, DOI 10.1016/j.celrep.2013.07.026; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079038; Zienkiewicz M, 2007, ANTIMICROB AGENTS CH, V51, P1164, DOI 10.1128/AAC.00772-06	63	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162390	10.1371/journal.pone.0162390	http://dx.doi.org/10.1371/journal.pone.0162390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627107	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600032
J	Pils, S; Promberger, R; Springer, S; Joura, E; Ott, J				Pils, Sophie; Promberger, Regina; Springer, Stephanie; Joura, Elmar; Ott, Johannes			Decreased Ovarian Reserve Predicts Inexplicability of Recurrent Miscarriage? A Retrospective Analysis	PLOS ONE			English	Article							OOCYTE QUALITY; HORMONE; COUPLES; LEVEL	Objective To evaluate anti-Mullerian hormone, basal follicle stimulating hormone, luteinizing hormone, estradiol, and female age in women with recurrent miscarriage and to compare women with explained and idiopathic recurrent miscarriage. Design Retrospective cohort study. Setting University hospital, tertiary care center. Patients Women with recurrent miscarriage (78 explained, 66 idiopathic). Intervention(s) None. Main Outcome Measures(s) Anti-Mullerian hormone, basal follicle stimulating hormone, luteinizing hormone, estradiol, and age. Results Anti-Mullerian hormone and estradiol were significantly lower in women with idiopathic recurrent miscarriage (median 1.2 ng/ml, IQR 0.6-2.1, and median 36.5 pg/ml, IQR 25.8-47.3, respectively) than in women with explained recurrent miscarriage (median 2.0 ng/ml, IQR 1.1-2.7, and median 42.5 pg/ml, IQR 32.8-59.8, respectively; p<0.05). Optimized cutoff values for the prediction of idiopathic recurrent miscarriage were <39.5 pg/ml for estradiol (sensitivity: 63.3%, 95% CI: 50.9-75.1; specificity: 56.4%, 95% CI: 44.7-67.6) and <1.90 ng/ml for anti-Mullerian hormone (sensitivity: 72.7%, 95% CI: 60.4-83.0; specificity: 52.6%, 95% CI: 40.9-64.0). Conclusion Idiopathic recurrent miscarriage was associated with lower basal estradiol and anti-Mullerian hormone levels compared to explained recurrent miscarriage.	[Pils, Sophie; Springer, Stephanie; Joura, Elmar; Ott, Johannes] Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Promberger, Regina] St John God Hosp Eisenstadt, Dept Obstet & Gynecol, Burgenland, Austria	Medical University of Vienna	Ott, J (corresponding author), Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria.	johannes.ott@meduniwien.ac.at	Ott, Johannes/AAD-1700-2019	Ott, Johannes/0000-0002-2761-5262				Amanvermez R, 2016, INT J FERTIL STERIL, V9, P411; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; [Anonymous], 2002, INT J GYNECOL OBSTET, V78, P179; [Anonymous], 2015, Obstet Gynecol, V125, P268, DOI 10.1097/01.AOG.0000459864.68372.ec; Atasever M, 2016, FERTIL STER IN PRESS; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; Ebner T, 2006, HUM REPROD, V21, P2022, DOI 10.1093/humrep/del127; Guerif F, 2009, ANN ENDOCRINOL-PARIS, V70, P230, DOI 10.1016/j.ando.2009.03.007; Jeve Yadava B, 2014, J Hum Reprod Sci, V7, P159, DOI 10.4103/0974-1208.142475; Ljunger E, 2005, ACTA OBSTET GYN SCAN, V84, P1103, DOI 10.1111/j.0001-6349.2005.00882.x; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Robberecht C, 2012, PRENATAL DIAG, V32, P933, DOI 10.1002/pd.3936; Saravelos SH, 2014, OBSTET GYN CLIN N AM, V41, P157, DOI 10.1016/j.ogc.2013.10.008; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; Tempfer CB, 2006, FERTIL STERIL, V86, P145, DOI 10.1016/j.fertnstert.2005.12.035; TONER JP, 1991, FERTIL STERIL, V55, P784; Van den Berg MMJ, 2014, OBSTET GYN CLIN N AM, V41, P145, DOI 10.1016/j.ogc.2013.10.010	19	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161606	10.1371/journal.pone.0161606	http://dx.doi.org/10.1371/journal.pone.0161606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627119	gold, Green Submitted, Green Published			2022-12-27	WOS:000383680600005
J	Dillon, G; Hussain, R; Loxton, D; Khan, A				Dillon, Gina; Hussain, Rafat; Loxton, Deborah; Khan, Asad			Rurality and Self-Reported Health in Women with a History of Intimate Partner Violence	PLOS ONE			English	Article							MENTAL-HEALTH; PHYSICAL HEALTH; SOCIAL SUPPORT; DOMESTIC VIOLENCE; ABUSIVE PARTNERS; HELP-SEEKING; LOW-INCOME; AUSTRALIA; CONSEQUENCES; SURVIVORS	Objective To investigate differences in self-reported health among Australian women with a history of intimate partner violence (IPV) in relation to rurality of residence. Methods Data were drawn from six survey waves of the Australian Longitudinal Study on Women's Health 1973-78 birth cohort. Self-reported general and mental health scores derived from the SF-36 scale were compared for women with a history of IPV living in metropolitan, regional and rural areas. Multivariable generalised estimating equations were constructed adjusting for income hardship, number of children, education, social support, age and marital status. Results Women with a history of IPV living in regional and rural areas had no significant differences in self-reported general health scores compared to their metropolitan counterparts. Rural women affected by IPV had slightly better self-reported mental health than equivalent women living in metropolitan or regional areas. The socio-demographic factors with the strongest association with self-reported health were income, education, social support, and number of children. Conclusions Women in regional and rural areas were no more disadvantaged, in terms of self-reported general health or mental health, than IPV affected women living in major cities in Australia.	[Dillon, Gina] Univ New England, Sch Rural Med, Armidale, NSW 2351, Australia; [Hussain, Rafat] Australian Natl Univ, ANU Sch Med, Canberra, ACT 0200, Australia; [Hussain, Rafat] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT 0200, Australia; [Loxton, Deborah] Univ Newcastle, Res Ctr Generat Hlth & Ageing, Callaghan, NSW 2308, Australia; [Khan, Asad] Univ Queensland, Sch Hlth & Rehabil Serv, Brisbane, Qld 4072, Australia	University of New England; Australian National University; Australian National University; University of Newcastle; University of Queensland	Hussain, R (corresponding author), Australian Natl Univ, ANU Sch Med, Canberra, ACT 0200, Australia.; Hussain, R (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT 0200, Australia.	Rafat.Hussain@anu.edu.au	Khan, Asad/N-7481-2019; Hussain, Rafat/H-1950-2016; Khan, Asad/F-8739-2010	Khan, Asad/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Dillon, Gina/0000-0001-6367-9709	Australian Government Department of Health; Department of Industry, Innovation, Science, Research and Tertiary Education, Commonwealth Government of Australia	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Department of Industry, Innovation, Science, Research and Tertiary Education, Commonwealth Government of Australia	This work was supported in part by the Australian Government Department of Health, which funds the ALSWH. The funders had no role in this particular analysis, decision to publish, or preparation of the manuscript.; The research on which this paper is based was conducted as part of the Australian Longitudinal Study on Women's Health, at the University of Newcastle and the University of Queensland. This work was supported in part by the Australian Government Department of Health, which funds the ALSWH. The funders had no role in this particular analysis, decision to publish, or preparation of the manuscript. The authors also acknowledge the contribution made by the Collaborative Research Network for Mental Health and Wellbeing in Rural Communities, based at the University of New England, and supported by the Department of Industry, Innovation, Science, Research and Tertiary Education, Commonwealth Government of Australia.	ABS (Australian Bureau of Statistics), 2013, REM STRUCT AUSTR BUR; Alston, 1997, AUSTR SOCIAL WORK, V50, P15, DOI [10.1080/03124079708415203, DOI 10.1080/03124079708415203]; Australian Longitudinal Study for Womens Health (ALSWH), 2014, AUSTR LONG STUD WOM; Beeble ML, 2009, J CONSULT CLIN PSYCH, V77, P718, DOI 10.1037/a0016140; Blandy, 2011, HOMELESSNESS PREVENT; Bonomi AE, 2006, AM J PREV MED, V30, P458, DOI 10.1016/j.amepre.2006.01.015; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Bybee D, 2005, AM J COMMUN PSYCHOL, V36, P85, DOI 10.1007/s10464-005-6234-5; Carlson BE, 2002, VIOLENCE AGAINST WOM, V8, P720, DOI 10.1177/10778010222183251; Casanueva C, 2008, J FAM VIOLENCE, V23, P413, DOI 10.1007/s10896-008-9167-6; Cerulli C, 2012, J FAM VIOLENCE, V27, P773, DOI 10.1007/s10896-012-9469-6; Coker AL, 2000, AM J PREV MED, V19, P316, DOI 10.1016/S0749-3797(00)00239-7; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Coker AL, 2003, PREV MED, V37, P259, DOI 10.1016/S0091-7435(03)00122-1; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Dillon G, 2015, ADV MENTAL HLTH, P1; Dillon G, 2015, HLTH SERVICE U UNPUB; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Dobson, 2011, RURAL REMOTE REGIONA; Dobson AJ, 2015, INT J EPIDEMIOL, V44, DOI 10.1093/ije/dyv110; Duckett S., 2013, ACCESS ALL AREAS NEW; Eby KK, 2004, J FAM VIOLENCE, V19, P221, DOI 10.1023/B:JOFV.0000032632.59865.8e; Ford-Gilboe M, 2009, SOC SCI MED, V68, P1021, DOI 10.1016/j.socscimed.2009.01.003; George Amanda, 2014, LANDSCAPES VIOLENCE; Goodkind JR, 2003, VIOLENCE AGAINST WOM, V9, P347, DOI 10.1177/1077801202250083; Goodman LA, 2009, TRAUMA VIOLENCE ABUS, V10, P306, DOI 10.1177/1524838009339754; Graham ML, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-47; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harding HG, 2009, J FAM VIOLENCE, V24, P75, DOI 10.1007/s10896-008-9211-6; Harvey Desley J, 2007, Rural Remote Health, V7, P823; Holton S, 2010, J REPROD INFANT PSYC, V28, P223, DOI 10.1080/02646830903487359; Hou JA, 2011, J FAM VIOLENCE, V26, P81, DOI 10.1007/s10896-010-9343-3; Jonas HA, 2000, AUST NZ J PUBL HEAL, V24, P185, DOI 10.1111/j.1467-842X.2000.tb00140.x; Letourneau NL, 2007, J FAM VIOLENCE, V22, P649, DOI 10.1007/s10896-007-9099-6; Levendosky A. A., 2000, VIOLENCE WOMAN, V6, P247, DOI [10.1177/10778010022181831, DOI 10.1177/10778010022181831]; Liang B, 2005, AM J COMMUN PSYCHOL, V36, P71, DOI 10.1007/s10464-005-6233-6; Loxton D, 2003, 7 NAT RUR HLTH C HOB; Loxton D, 2006, VIOLENCE AGAINST WOM, V12, P715, DOI 10.1177/1077801206291483; Loxton D, 2006, J INTERPERS VIOLENCE, V21, P1092, DOI 10.1177/0886260506290290; Miller PG, 2010, AUST J RURAL HEALTH, V18, P110, DOI 10.1111/j.1440-1584.2010.01133.x; Mitchell MD, 2006, J CLIN PSYCHOL, V62, P1503, DOI 10.1002/jclp.20305; NRHA (National Rural Health Alliance), 2011, AUSTR HLTH SYST NEED; Phillips A, 2009, AUST J RURAL HEALTH, V17, P2, DOI 10.1111/j.1440-1584.2008.01029.x; Scheffer Lindgren M.S., 2008, J PSYCHIATR MENT HLT, V15, P219, DOI DOI 10.1111/J.1365-2850.2007.01215.X; Scott, 2013, INT J RURAL CRIMINOL, V2, P3, DOI [10.18061/1811/58849, DOI 10.18061/1811/58849]; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Sutherland CA, 2001, VIOLENCE AGAINST WOM, V7, P1122, DOI 10.1177/10778010122183775; Swanberg JE, 2005, TRAUMA VIOLENCE ABUS, V6, P286, DOI 10.1177/1524838005280506; Vives-Cases C, 2011, J PUBLIC HEALTH-UK, V33, P15, DOI 10.1093/pubmed/fdq101; Ware J.E., 2000, SF 36 HLTH SURVEY MA; WESNET, 2000, DOM VIOL REG AUSTR L; Woods SJ, 2008, J MIDWIFERY WOM HEAL, V53, P538, DOI 10.1016/j.jmwh.2008.07.004; Ziersch AM, 2009, AUST NZ J PUBL HEAL, V33, P7, DOI 10.1111/j.1753-6405.2009.00332.x	55	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162380	10.1371/journal.pone.0162380	http://dx.doi.org/10.1371/journal.pone.0162380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622559	Green Submitted, gold, Green Published			2022-12-27	WOS:000383681000027
J	Lee, JY; Hwang, S; Oh, SY; Park, KA; Oh, SY				Lee, Ju-Yeun; Hwang, Sungsoon; Oh, Shin Yeop; Park, Kyung-Ah; Oh, Sei Yeul			Postoperative Change in Ocular Torsion in Intermittent Exotropia: Relationship with Postoperative Surgical Outcomes	PLOS ONE			English	Article							EYE; STRABISMUS	The aim of this study was to determine whether objective ocular torsion in intermittent exotropia (IXT) changes after recession surgery, and to evaluate the relationship between change in ocular torsion and clinical parameters in IXT. Sixty patients between 3 and 14 years of age underwent lateral rectus (LR) recession for IXT. Digital fundus photographs were obtained from both eyes of each subject and the disc-foveal angle (ocular torsion) was calculated using image software. We compared the preoperative and postoperative amount of ocular torsion, and analyzed the correlation between the difference in ocular torsion (DOC) and clinical parameters including age, duration of strabismus, stereoacuity, amount of preoperative exodeviation, and mean dose response. We categorized the patients according to DOC value: positive DOC value as group 1, and negative DOC value as group 2. A correlation between ocular torsion dominance and fixation preference was also investigated using the Kappa test. The mean ocular torsion was 15.8 +/- 4.6 degrees preoperatively and 13.7 +/- 5.1 degrees postoperatively. Compared with preoperative values, the mean ocular torsion showed a significant decrease after LR recession (p< 0.001), and a greater preoperative ocular torsion was significantly associated with the amount of DOC (r = 0.37, p< 0.001). Degree of stereopsis, mean dose-response, and postoperative exodeviation were significantly different between group 1 (positive DOC) and group 2 (negative DOC) (p< 0.001, 0.030, and 0.001 respectively). The Kappa test showed that there was a significant correlation between the dominance of ocular torsion and fixation preference (p = 0.020). Therefore, change in ocular torsion after LR recession can be a useful supplementary indicator for evaluating the degree of fusional control and for predicting postoperative surgical response in IXT.	[Lee, Ju-Yeun; Hwang, Sungsoon; Oh, Shin Yeop; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu						BIXENMAN WW, 1982, OPHTHALMOLOGY, V89, P58; DUKEELDER S, 1973, SYSTEM OPHTHALMOLOGY; Graf EW, 2002, VISION RES, V42, P1185, DOI 10.1016/S0042-6989(02)00047-0; Guyton DL., 1983, AM ORTHOPT J, V33, P7, DOI 10.1080/0065955X.1983.11981591; Harrad R, 2015, EYE, V29, P234, DOI 10.1038/eye.2014.282; Jampolsky A, 1978, S STRAB T NEW ORL AC, P244; Jethani J, 2010, INDIAN J OPHTHALMOL, V58, P417, DOI 10.4103/0301-4738.67060; Kushner BJ, 2009, OPHTHALMOLOGY, V116, P2001, DOI 10.1016/j.ophtha.2009.03.047; Lee DH, 2004, J KOREAN OPHTHALMOL, V45, P797; Lee J, 2015, INT J OPHTHALMOL-CHI, V8, P569, DOI 10.3980/j.issn.2222-3959.2015.03.24; Lefevre F, 2007, J FR OPHTALMOL, V30, P598, DOI 10.1016/S0181-5512(07)89664-1; OLIVIER P, 1982, AM J OPHTHALMOL, V93, P30, DOI 10.1016/0002-9394(82)90694-8; Philips PH, 1999, CLIN STRABISMUS MANA, P52; Schotthoefer EO, 2007, CURR OPIN OPHTHALMOL, V18, P361, DOI 10.1097/ICU.0b013e32827038f2; Shin KH, 2013, AM J OPHTHALMOL, V155, P177, DOI 10.1016/j.ajo.2012.07.011; 이현주, 2005, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V46, P1684	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162819	10.1371/journal.pone.0162819	http://dx.doi.org/10.1371/journal.pone.0162819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622574	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000058
J	Lopes, CS; Daifalla, N; Das, B; da Silva, VD; Campos-Neto, A				Lopes, Carolina S.; Daifalla, Nada; Das, Bikul; da Silva, Valdo Dias; Campos-Neto, Antonio			CD271+Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum	PLOS ONE			English	Article							BONE-MARROW; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; LATENT LEISHMANIASIS; SURFACE-MARKERS; STROMAL CELLS; HOST-CELL; DONOVANI; CD271	Visceral leishmaniasis (VL) is a serious and fatal disease. Therapeutic drugs are toxic and non-sterilizing. The etiological agents Leishmania infantum and Leishmania donovani cause active and asymptomatic diseases. Effective drugs to treat VL exist but unfortunately, post-treatment relapses are common. Little is known why drugs are non-sterilizing or how these intracellular pathogens can escape treatment. Here, using a murine model of VL we found that CD271+/Sca1+ bone marrow mesenchymal stem cells (BM-MSCs) are readily infected in vitro and in vivo by L. infantum. Because BM-MSCs express potent drug efflux pumps, e.g., ABCG2 it is possible that this unique intracellular infectious niche could allow L. infantum to escape anti-parasite drugs.	[Lopes, Carolina S.; Daifalla, Nada; Das, Bikul; Campos-Neto, Antonio] Forsyth Inst, Cambridge, MA USA; [Lopes, Carolina S.; da Silva, Valdo Dias] Triangulo Mineiro Fed Univ, Inst Biol & Nat Sci, Dept Biochem Pharmacol Physiol & Mol Biol, Uberaba, MG, Brazil	Harvard University; Forsyth Institute; Universidade Federal do Triangulo Mineiro	Campos-Neto, A (corresponding author), Forsyth Inst, Cambridge, MA USA.	acampos@forsyth.org	Das, Bikul/ABF-9292-2020; Daifalla, Nada/E-6005-2017	Daifalla, Nada/0000-0001-7895-9586	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship awarded to CSL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Allahverdiyev AM, 2011, AM J TROP MED HYG, V85, P535, DOI 10.4269/ajtmh.2011.11-0037; Alvarez-Viejo M, 2015, WORLD J STEM CELLS, V7, P470, DOI 10.4252/wjsc.v7.i2.470; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Beamer G, 2014, AM J PATHOL, V184, P3170, DOI 10.1016/j.ajpath.2014.08.024; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Campos-Neto A, 2003, INFECT IMMUN, V71, P5065, DOI 10.1128/IAI.71.9.5065-5076.2003; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Das B, 2008, NEOPLASIA, V10, P1105, DOI 10.1593/neo.08466; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gallacher L, 2000, BLOOD, V95, P2813, DOI 10.1182/blood.V95.9.2813.009k20_2813_2820; Gangneux JP, 2005, J EUKARYOT MICROBIOL, V52, P489, DOI 10.1111/j.1550-7408.2005.00055.x; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kuci S, 2010, HAEMATOL-HEMATOL J, V95, P651, DOI 10.3324/haematol.2009.015065; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Watson JT, 2013, CELLS TISSUES ORGANS, V197, P496, DOI 10.1159/000348794	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162927	10.1371/journal.pone.0162927	http://dx.doi.org/10.1371/journal.pone.0162927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622907	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000069
J	Selasi, GN; Nicholas, A; Jeon, H; Na, SH; Il Kwon, H; Kim, YJ; Heo, ST; Oh, MH; Lee, JC				Selasi, Gati Noble; Nicholas, Asiimwe; Jeon, Hyejin; Na, Seok Hyeon; Il Kwon, Hyo; Kim, Yoo Jeong; Heo, Sang Taek; Oh, Man Hwan; Lee, Je Chul			Differences in Biofilm Mass, Expression of Biofilm-Associated Genes, and Resistance to Desiccation between Epidemic and Sporadic Clones of Carbapenem-Resistant Acinetobacter baumannii Sequence Type 191	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANCE; ABIOTIC SURFACES; EUKARYOTIC CELLS; DRY SURFACES; STRAINS; ATTACHMENT; PATHOGEN; IMIPENEM; SURVIVAL	Understanding the biology behind the epidemicity and persistence of Acinetobacter baumannii in the hospital environment is critical to control outbreaks of infection. This study investigated the contributing factors to the epidemicity of carbapenem-resistant A. baumannii (CRAB) sequence type (ST) 191 by comparing the differences in biofilm formation, expression of biofilm-associated genes, and resistance to desiccation between major epidemic (n = 16), minor epidemic (n = 12), and sporadic (n = 12) clones. Biofilm mass was significantly greater in the major epidemic than the minor epidemic and sporadic clones. Major and minor epidemic clones expressed biofilm-associated genes, abaI, bap, pgaABCD, and csuA/BABCDE, higher than the sporadic clones in sessile conditions. The csuC, csuD, and csuE genes were more highly expressed in the major epidemic than minor epidemic clones. Interestingly, minor epidemic clones expressed more biofilm-associated genes than the major epidemic clone under planktonic conditions. Major epidemic clones were more resistant to desiccation than minor epidemic and sporadic clones on day 21. In conclusion, the epidemic CRAB ST191 clones exhibit a higher capacity to form biofilms, express the biofilm-associated genes under sessile conditions, and resist desiccation than sporadic clones. These phenotypic and genotypic characteristics of CRAB ST191 may account for the epidemicity of specific CRAB ST191 clones in the hospital.	[Selasi, Gati Noble; Nicholas, Asiimwe; Jeon, Hyejin; Na, Seok Hyeon; Il Kwon, Hyo; Kim, Yoo Jeong; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Daegu, South Korea; [Heo, Sang Taek] Jeju Natl Univ, Dept Internal Med, Sch Med, Jeju, South Korea; [Oh, Man Hwan] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea	Kyungpook National University; Jeju National University; Dankook University	Lee, JC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Daegu, South Korea.	leejc@knu.ac.kr		Na, Seok Hyeon/0000-0002-8550-9150; Heo, Sang Taek/0000-0001-8947-5069; Gati, Noble Selasi/0000-0002-4229-2908; Asiimwe, Nicholas/0000-0003-0484-4481	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C0257]	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI14C0257).	Alvarez-Fraga L, 2016, VIRULENCE, V7, P443, DOI 10.1080/21505594.2016.1145335; Cevahir N, 2008, J MICROBIOL IMMUNOL, V41, P513; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; De Gregorio E, 2015, NEW MICROBIOL, V38, P251; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Huttner A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-31; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Kuo HY, 2012, INT J ANTIMICROB AG, V39, P33, DOI 10.1016/j.ijantimicag.2011.08.016; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Luo TL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00182; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; Martins N, 2015, ANTIMICROB AGENTS CH, V59, P698, DOI 10.1128/AAC.02415-14; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Ralston A., 2008, NATURE ED, V1, P216; Rao RS, 2008, INDIAN J MED MICROBI, V26, P333; Richmond GE, 2016, MBIO, V7, DOI 10.1128/mBio.00430-16; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Samuelsen O, 2011, CLIN MICROBIOL INFEC, V17, P1811, DOI 10.1111/j.1469-0691.2011.03532.x; Selasi GN, 2015, INFECT GENET EVOL, V36, P1, DOI 10.1016/j.meegid.2015.09.001; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Wroblewska MM, 2008, FEMS IMMUNOL MED MIC, V53, P140, DOI 10.1111/j.1574-695X.2008.00403.x	33	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162576	10.1371/journal.pone.0162576	http://dx.doi.org/10.1371/journal.pone.0162576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622249	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000041
J	Feng, WC; Liu, MY; Chen, DG; Yiu, R; Fang, FC; Lei, BF				Feng, Wenchao; Liu, Mengyao; Chen, Daniel G.; Yiu, Rossana; Fang, Ferric C.; Lei, Benfang			Contemporary Pharyngeal and Invasive emm1 and Invasive emm12 Group A Streptococcus Isolates Exhibit Similar In Vivo Selection for CovRS Mutants in Mice	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; HYALURONIC-ACID CAPSULE; VIRULENCE FACTORS; UNITED-STATES; DISEASE; INFECTION; CLONE; EPIDEMIOLOGY; EXPRESSION; PHENOTYPE	Group A Streptococcus (GAS) causes diverse infections ranging from common pharyngitis to rare severe invasive infections. Invasive GAS isolates can have naturalmutations in the virulence regulator CovRS, which result in enhanced expression of multiple virulence genes, suppressed the expression of the protease SpeB, and increased virulence. It is believed that CovRS mutations arise during human infections with GAS carrying wild-type CovRS and are not transmissible. CovRS mutants of invasive GAS of the emm1 genotype arise readily during experimental infection in mice. It is possible that invasive GAS arises from pharyngeal GAS through rare genetic mutations that confer the capacity of mutated GAS to acquire covRS mutations during infection. The objective of this study was to determine whether contemporary pharyngeal emm1 GAS isolates have a reduced propensity to acquire CovRS mutations in vivo compared with invasive emm1 GAS and whether emm3, emm12, and emm28 GAS acquire CovRS mutants in mouse infection. The propensity of invasive and pharyngeal emm1 and invasive emm3, emm12, and emm28 SpeB(A+) isolates to acquire variants with the SpeB(A-) phenotype was determined during subcutaneous infection of mice. The majority of both invasive and pharyngeal emm1 SpeB(A+) isolates and two of three emm12 isolates, but not emm3 and emm28 isolates, were found to acquire SpeB(A-) variants during skin infection in mice. All analyzed SpeB(A-) variants of emm1 and emm12 GAS from the mouse infection acquired covRS mutations and produced more platelet-activating factor acetylhydrolase SsE. Thus, contemporary invasive and pharyngeal emm1 GAS isolates and emm12 GAS have a similar capacity to acquire covRS mutations in vivo. The rarity of severe invasive infections caused by GAS does not appear to be attributable to a reduced ability of pharyngeal isolates to acquire CovRS mutations.	[Feng, Wenchao; Liu, Mengyao; Chen, Daniel G.; Lei, Benfang] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA; [Yiu, Rossana; Fang, Ferric C.] Harborview Med Ctr, Clin Microbiol Lab, Seattle, WA USA; [Yiu, Rossana; Fang, Ferric C.] Univ Washington, Sch Med, Seattle, WA 98195 USA	Montana State University System; Montana State University Bozeman; Harborview Medical Center; University of Washington; University of Washington Seattle	Lei, BF (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA.	blei@montana.edu		Fang, Ferric/0000-0002-3243-110X; Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI095704, AI097703, GM110732]; Montana University System Research Initiative [51040-MUSRI2015-03]; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095704, R21AI097703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana University System Research Initiative; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants AI095704, AI097703, and GM110732 from the National Institutes of Health, Montana University System Research Initiative 51040-MUSRI2015-03, and the Montana State Agricultural Experimental Station.	Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cockerill FR, 1997, JAMA-J AM MED ASSOC, V277, P38, DOI 10.1001/jama.277.1.38; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Flores AR, 2014, J INFECT DIS, V209, P1520, DOI 10.1093/infdis/jit674; Friaes A, 2015, MBIO, V6, DOI 10.1128/mBio.01780-15; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; KATZ AR, 1992, CLIN INFECT DIS, V14, P298, DOI 10.1093/clinids/14.1.298; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li JQ, 2014, INFECT IMMUN, V82, P1579, DOI 10.1128/IAI.01458-13; Li JQ, 2013, INFECT IMMUN, V81, P974, DOI 10.1128/IAI.01218-12; Liu GH, 2013, INFECT IMMUN, V81, P3128, DOI 10.1128/IAI.00398-13; Liu GL, 2015, IEEE VTS VEH TECHNOL; Liu MY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002624; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Miller EW, 2015, MOL MICROBIOL, V98, P473, DOI 10.1111/mmi.13136; Miyoshi-Akiyama T, 2006, J INFECT DIS, V193, P1677, DOI 10.1086/504263; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen RJ, 2015, INFECT IMMUN, V83, P4750, DOI 10.1128/IAI.00989-15; Shea PR, 2011, P NATL ACAD SCI USA, V108, P5039, DOI 10.1073/pnas.1016282108; Stetzner ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129417; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Turner Claire E, 2015, mBio, V6, pe00622, DOI 10.1128/mBio.00622-15; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Zhu H, 2009, INFECT IMMUN, V77, P5225, DOI 10.1128/IAI.00636-09; Zhu LC, 2015, MBIO, V6, DOI 10.1128/mBio.01378-15	46	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162742	10.1371/journal.pone.0162742	http://dx.doi.org/10.1371/journal.pone.0162742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611332	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900162
J	da Silva, FRC; Cibulski, SP; Daudt, C; Weber, MN; Guimaraes, LLB; Streck, AF; Mayer, FQ; Roehe, PM; Canal, CW				da Silva, Flavio R. C.; Cibulski, Samuel P.; Daudt, Cintia; Weber, Matheus N.; Guimaraes, Lorena L. B.; Streck, Andre F.; Mayer, Fabiana Q.; Roehe, Paulo M.; Canal, Cludio W.			Novel Bovine Papillomavirus Type Discovered by Rolling-Circle Amplification Coupled with Next-Generation Sequencing	PLOS ONE			English	Article							TEAT PAPILLOMATOSIS; COMPLETE GENOMES; REPLICATION; CLASSIFICATION; IDENTIFICATION; CLONING; MODELS; CATTLE	Currently, fifteen bovine papillomavirus (BPV) types have been identified and classified into four genera: Deltapapillomavirus, Epsilonpapillomavirus, Dyoxipapillomavirus, and Xipapillomavirus. Here, the complete genome sequence of a new BPV type (BPV 04AC14) recovered from a papillomatous lesion is reported. The genome is 7,282 bp in length and exhibits the classic genetic organization and motifs of the members of Papillomaviridae. Maximum likelihood phylogenetic analyses revealed that BPV 04AC14 clusters with members of the Xipapillomavirus genus. The nucleotide sequence of the L1 capsid protein of the novel BPV is closely related to its counterpart, BPV3, with which it shares 79% similarity. These findings suggest that this virus is a new BPV type of the Xipapillomavirus genus.	[da Silva, Flavio R. C.; Cibulski, Samuel P.; Daudt, Cintia; Weber, Matheus N.; Guimaraes, Lorena L. B.; Canal, Cludio W.] Univ Fed Rio Grande do Sul, Fac Vet, Lab Virol, Porto Alegre, RS, Brazil; [da Silva, Flavio R. C.] Univ Fed Acre Rio Branco, Ctr Ciencias Biol & Nat, Acre, Brazil; [Streck, Andre F.] Univ Caxias Sul, Caxias Do Sul, RS, Brazil; [Mayer, Fabiana Q.] Fundacao Estadual Pesquisa Agr, IPVDF, Lab Biol Mol, Eldorado Do Sul, RS, Brazil; [Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Lab Virol, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Acre (UFAC); Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul	Canal, CW (corresponding author), Univ Fed Rio Grande do Sul, Fac Vet, Lab Virol, Porto Alegre, RS, Brazil.	claudio.canal@ufrgs.br	Mayer, Fabiana Q/K-2279-2015; Cibulski, Samuel P/G-5190-2017; MAYER, FABIANA QUOOS/AAV-2264-2020; Weber, Matheus/B-2956-2019; Canal, Cláudio W./J-7253-2012; ROEHE, PAULO MICHEL/K-1208-2012	Mayer, Fabiana Q/0000-0002-9324-8536; MAYER, FABIANA QUOOS/0000-0002-9324-8536; Canal, Cláudio W./0000-0002-0621-243X; ROEHE, PAULO MICHEL/0000-0002-2370-7661; Weber, Matheus/0000-0001-8282-6778; Streck, Andre Felipe/0000-0002-4798-0777; Cibulski, Samuel/0000-0003-0503-8692	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Acre (FAPAC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Acre (FAPAC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Acre (FAPAC) supported this study. CWC and PMR are CNPq productivity research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Batista MVA, 2013, VET J, V197, P368, DOI 10.1016/j.tvjl.2013.01.019; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Borzacchiello G, 2008, VET RES, V39, DOI 10.1051/vetres:2008022; Bravo Ignacio G., 2015, Evolution Medicine and Public Health, P32, DOI 10.1093/emph/eov003; Bravo IG, 2010, TRENDS MICROBIOL, V18, P432, DOI 10.1016/j.tim.2010.07.008; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; Dezen D, 2010, RES VET SCI, V88, P436, DOI 10.1016/j.rvsc.2009.10.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Hatama S, 2008, J GEN VIROL, V89, P158, DOI 10.1099/vir.0.83334-0; Hatama S, 2011, ARCH VIROL, V156, P1281, DOI 10.1007/s00705-011-0970-7; JACKSON ME, 1991, MOL CARCINOGEN, V4, P382, DOI 10.1002/mc.2940040510; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Liu XF, 2010, J VIROL, V84, P4264, DOI 10.1128/JVI.02214-09; LU JZJ, 1993, J VIROL, V67, P7131, DOI 10.1128/JVI.67.12.7131-7139.1993; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; Maeda Y, 2007, VET MICROBIOL, V121, P242, DOI 10.1016/j.vetmic.2006.12.015; Munday JS, 2010, VET PATHOL, V47, P254, DOI 10.1177/0300985809358604; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Ogawa T, 2007, J GEN VIROL, V88, P1934, DOI 10.1099/vir.0.82794-0; PATEL KR, 1987, J GEN VIROL, V68, P2117, DOI 10.1099/0022-1317-68-8-2117; Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Rijsewijk FAM, 2011, ARCH VIROL, V156, P1097, DOI 10.1007/s00705-011-0971-6; Scase T, 2010, EQUINE VET J, V42, P738, DOI 10.1111/j.2042-3306.2010.00311.x; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomita Y, 2007, VIRUS GENES, V35, P243, DOI 10.1007/s11262-006-0055-y; Tozato CC, 2013, BRAZ J MICROBIOL, V44, P905, DOI 10.1590/S1517-83822013005000057; Van Doorslaer K, 2007, J GEN VIROL, V88, P1484, DOI 10.1099/vir.0.82615-0; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zhu W, 2012, ARCH VIROL, V157, P85, DOI 10.1007/s00705-011-1140-7	44	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162345	10.1371/journal.pone.0162345	http://dx.doi.org/10.1371/journal.pone.0162345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606703	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600040
J	He, XY; Singh, PK; Dreisigacker, S; Singh, S; Lillemo, M; Duveiller, E				He, Xinyao; Singh, Pawan K.; Dreisigacker, Susanne; Singh, Sukhwinder; Lillemo, Morten; Duveiller, Etienne			Dwarfing Genes Rht-B1b and Rht-D1b Are Associated with Both Type I FHB Susceptibility and Low Anther Extrusion in Two Bread Wheat Populations	PLOS ONE			English	Article							FUSARIUM-HEAD-BLIGHT; QUANTITATIVE TRAIT LOCI; TRITICUM-AESTIVUM L; WINTER-WHEAT; POLLEN PRODUCTION; GREEN-REVOLUTION; EUROPEAN WHEAT; PLANT HEIGHT; RESISTANCE; QTLS	It has been well documented that dwarfing genes Rht-B1b and Rht-D1b are associated with Type I susceptibility to Fusarium head blight (FHB) in wheat; but the underlying mechanism has not been well delineated. Anther extrusion (AE) has also been related to Type I resistance for initial FHB infection, where high AE renders FHB resistance. In this study, two doubled haploid populations were used to investigate the impact of the two dwarfing genes on FHB resistance and AE, and to elucidate the role of AE in Rht-mediated FHB susceptibility. Both populations were derived by crossing the FHB susceptible cultivar 'Ocoroni F86' (Rht-B1a/Rht-D1b) with an FHB resistant variety (Rht-B1b/Rht-D1a), which was 'TRAP#1/BOW//Taigu derivative' in one population (the TO population) and 'Ivan/Soru# 2' in the other (the IO population). Field experiments were carried out from 2010 to 2012 in El Batan, Mexico, where spray inoculation was adopted and FHB index, plant height (PH), and AE were evaluated, with the latter two traits showing always significantly negative correlations with FHB severity. The populations were genotyped with the DArTseq GBS platform, the two dwarfing genes and a few SSRs for QTL analysis, and the results indicated that Rht-B1b and Rht-D1b collectively accounted for 0-41% of FHB susceptibility and 13-23% of reduced AE. It was also observed that three out of the four AE QTL in the TO population and four out of the five AE QTL in the IO population were associated with FHB resistance. Collectively, our results demonstrated the effects of Rht-B1b and Rht-D1b on Type I FHB susceptibility and reducing AE, and proposed that their impacts on Type I FHB susceptibility may partly be explained by their effects on reducing AE. The implication of the relationship between the two dwarfing genes and AE for hybrid wheat breeding was also discussed.	[He, Xinyao; Singh, Pawan K.; Dreisigacker, Susanne; Singh, Sukhwinder; Duveiller, Etienne] Int Maize & Wheat Improvement Ctr CIMMYT, Apdo Postal 6-641, Mexico City 06600, DF, Mexico; [He, Xinyao; Lillemo, Morten] Norwegian Univ Life Sci, Dept Plant Sci, POB 5003, NO-1432 As, Norway	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Norwegian University of Life Sciences	Singh, PK (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Apdo Postal 6-641, Mexico City 06600, DF, Mexico.	pk.singh@cgiar.org	Lillemo, Morten/H-9406-2019	Lillemo, Morten/0000-0002-8594-8794; Singh, Pawan/0000-0003-4610-3120	CGIAR Research Program on Wheat; 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro); CGIAR scholarship by the Research Council of Norway, through NFR project [208340/H30]	CGIAR Research Program on Wheat(CGIAR); 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro); CGIAR scholarship by the Research Council of Norway, through NFR project(CGIAR)	This work was supported by CGIAR Research Program on Wheat and 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro). Xinyao He was financially supported by a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support by the CGIAR Research Program on Wheat and 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro) is gratefully acknowledged. The first author was financially supported by a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30-Breeding for Fusarium resistance in wheat. The authors are grateful to Prof. Asmund Bjornstad, Norwegian University of Life Sciences, for his kind instruction on AE phenotyping, and to Francisco Lopez, Javier Segura and Nerida Lozano for technical assistance.	ATASHIRANG G, 1978, CROP SCI, V18, P267, DOI 10.2135/cropsci1978.0011183X001800020018x; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Buerstmayr H, 2013, RAUMBERG GUMPENSTEIN, P69; Buerstmayr M, 2015, THEOR APPL GENET, V128, P1519, DOI 10.1007/s00122-015-2527-8; Buerstmayr M, 2012, THEOR APPL GENET, V125, P1751, DOI 10.1007/s00122-012-1951-2; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; COUTURE L, 1982, CAN J PLANT SCI, V62, P29, DOI 10.4141/cjps82-004; DEVRIES AP, 1972, EUPHYTICA, V21, P185, DOI 10.1007/BF00036759; Draeger R, 2007, THEOR APPL GENET, V115, P617, DOI 10.1007/s00122-007-0592-3; Dreisigacker S, 2011, P 21 INT TRIT MAPP I, P105; Duveiller E, 2014, MYCOTOXIN REDUCTION IN GRAIN CHAINS, P220; Emrich K, 2008, THEOR APPL GENET, V117, P65, DOI 10.1007/s00122-008-0753-z; Gilbert J, 2013, CAN J PLANT PATHOL, V35, P149, DOI 10.1080/07060661.2013.772921; Graham S, 2009, J PHYTOPATHOL, V157, P580, DOI 10.1111/j.1439-0434.2008.01524.x; He XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158052; He XY, 2014, EUPHYTICA, V195, P383, DOI 10.1007/s10681-013-1002-3; He XY, 2013, THEOR APPL GENET, V126, P2655, DOI 10.1007/s00122-013-2163-0; He XY, 2013, EUR J PLANT PATHOL, V136, P123, DOI 10.1007/s10658-012-0146-7; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hilton AJ, 1999, PLANT PATHOL, V48, P202, DOI 10.1046/j.1365-3059.1999.00339.x; Holzapfel J, 2008, THEOR APPL GENET, V117, P1119, DOI 10.1007/s00122-008-0850-z; JOHNSON JW, 1973, CROP SCI, V13, P92, DOI 10.2135/cropsci1973.0011183X001300010029x; JOPPA LR, 1968, CROP SCI, V8, P487, DOI 10.2135/cropsci1968.0011183X000800040028x; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kubo K, 2013, J PHYTOPATHOL, V161, P308, DOI 10.1111/jph.12060; Langer SM, 2014, PLANT BREEDING, V133, P433, DOI 10.1111/pbr.12192; Li HH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1424-5; Liu SY, 2013, THEOR APPL GENET, V126, P2485, DOI 10.1007/s00122-013-2149-y; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Lu QX, 2013, THEOR APPL GENET, V126, P317, DOI 10.1007/s00122-012-1981-9; Lu QX, 2011, CROP SCI, V51, P2430, DOI 10.2135/cropsci2010.12.0671; Lv C, 2014, CROP J, V2, P70, DOI 10.1016/j.cj.2013.10.004; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2008, CROP SCI, V48, P2115, DOI 10.2135/cropsci2008.02.0107; Miedaner T, 2011, MOL BREEDING, V28, P647, DOI 10.1007/s11032-010-9516-z; Osman M, 2015, EUPHYTICA, V205, P521, DOI 10.1007/s10681-015-1425-0; Pugh GW, 1933, J AGRIC RES, V46, P0771; Saville RJ, 2012, J EXP BOT, V63, P1271, DOI 10.1093/jxb/err350; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Skinnes H, 2010, PLANT BREEDING, V129, P149, DOI 10.1111/j.1439-0523.2009.01731.x; Skinnes H, 2008, CEREAL RES COMMUN, V36, P223, DOI 10.1556/CRC.36.2008.Suppl.B.19; Srinivasachary, 2008, THEOR APPL GENET, V116, P1145, DOI 10.1007/s00122-008-0742-2; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Stack R. W., 1994, VISUAL SCALE ESTIMAT, P1095; STRANGE RN, 1971, PHYSIOL PLANT PATHOL, V1, P141, DOI 10.1016/0048-4059(71)90023-3; STRANGE RN, 1974, PHYSIOL PLANT PATHOL, V4, P277, DOI 10.1016/0048-4059(74)90015-0; STRANGE RN, 1978, T BRIT MYCOL SOC, V70, P201, DOI 10.1016/S0007-1536(78)80031-X; Van Ooijen J, 2009, MAPQTL 6 SOFTWARE MA, V64; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Voss HH, 2008, PLANT BREEDING, V127, P333, DOI 10.1111/j.1439-0523.2008.01518.x; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328	55	12	12	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162499	10.1371/journal.pone.0162499	http://dx.doi.org/10.1371/journal.pone.0162499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606928	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000383255600052
J	Hung, TH; Lay, CJ; Tseng, CW; Tsai, CC; Tsai, CC				Hung, Tsung-Hsing; Lay, Chorng-Jang; Tseng, Chih-Wei; Tsai, Chih-Chun; Tsai, Chen-Chi			The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Followup Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SPONTANEOUS BACTERIAL PERITONITIS; HEPATORENAL-SYNDROME; HOSPITAL MORTALITY; FAILURE; DIAGNOSIS; NORADRENALINE; TERLIPRESSIN; DIALYSIS; CRITERIA	Renal function impairment (RFI) contributes to poor prognosis in cirrhotic patients. However, there have been no studies that seek to identify the effect of different types of RFI on the mortality of cirrhotic patients. We used the National Health Insurance Database, derived from the Taiwan National Health Insurance Program, to identify 44365 cirrhotic patients between January 1, 2007 and December 31, 2007. RFI was identified in 2832 cirrhotic patients, including 1075 with acute renal failure (ARF) (169 with hepatorenal syndrome, HRS; 906 with non-hepatorenal syndrome, NHRS), 705 with chronic kidney disease (CKD), and 1052 with end stage renal disease (ESRD). After Cox proportional hazard regression analysis adjusted by gender, age, and comorbid disorders, the 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortality hazard ratios (HR) compared to the non-RFI group were: (ARF) 5.19 (4.70-5.74), 3.23 (2.76-3.77), 1.51 (1.26-1.81), and 1.35 (1.13-1.61), respectively; (CKD) 2.70 (2.30-3.18), 2.03 (1.66-2.49), 1.60 (1.34-1.90), and 1.26 (1.06-1.49), respectively; and (ESRD) 1.42 (1.17-1.72), 1.62 (1.35-1.94), 1.90 (1.68-2.15), and 1.67 (1.48-1.89), respectively. Compared to NHRS, the 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortalityHRs of HRS were 1.03 (0.80-1.32), 2.13 (1.46-3.11), 1.58 (0.90-2.75), and 2.51 (1.41-4.48), respectively, in cirrhotic patients with ARF. These results indicate the effects of CKD and ESRD on the mortality of cirrhotic patients are distributed equally in every survival stage, whereas the effect of ARF appears only in the early stage. Compared to NHRS, HRS contributes to a higher mortality risk at the late survival stage.	[Hung, Tsung-Hsing; Tseng, Chih-Wei] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Gastroenterol, Dept Med, Chiayi, Taiwan; [Hung, Tsung-Hsing; Lay, Chorng-Jang; Tseng, Chih-Wei; Tsai, Chen-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lay, Chorng-Jang; Tsai, Chen-Chi] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Infect Dis, Dept Med, Chiayi, Taiwan; [Tsai, Chih-Chun] Tamkang Univ, Dept Math, Tamsui, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tamkang University	Tsai, CC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Tsai, CC (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Infect Dis, Dept Med, Chiayi, Taiwan.	antibody_1@msn.com	Tseng, Chih-Wei/AAP-8291-2020	Tseng, Chih-Wei/0000-0002-6951-4646				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Angeli P, 2015, GUT, V64, P1616, DOI 10.1136/gutjnl-2014-307526; Angeli P, 2015, GUT, V64, P531, DOI 10.1136/gutjnl-2014-308874; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Cholongitas E, 2009, EUR J GASTROEN HEPAT, V21, P744, DOI 10.1097/MEG.0b013e328308bb9c; de Carvalho GC, 2012, ANN HEPATOL, V11, P90; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Ghosh S, 2013, LIVER INT, V33, P1187, DOI 10.1111/liv.12179; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gluud LL, 2010, HEPATOLOGY, V51, P576, DOI 10.1002/hep.23286; Hartleb M, 2012, WORLD J GASTROENTERO, V18, P3035, DOI 10.3748/wjg.v18.i24.3035; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; HSU HC, 1983, CANCER-AM CANCER SOC, V52, P1825, DOI 10.1002/1097-0142(19831115)52:10<1825::AID-CNCR2820521011>3.0.CO;2-M; Hung TH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000079; Hung TH, 2012, CLIN GASTROENTEROL H, V10, P677, DOI 10.1016/j.cgh.2012.02.026; Karvellas CJ, 2015, CRIT CARE CLIN, V31, P737, DOI 10.1016/j.ccc.2015.06.009; KELLER F, 1995, RENAL FAILURE, V17, P135, DOI 10.3109/08860229509026250; Maiwall R, 2015, HEPATOL INT, V9, P627, DOI 10.1007/s12072-015-9653-x; Martin-Llahi M, 2011, GASTROENTEROLOGY, V140, P488, DOI 10.1053/j.gastro.2010.07.043; Nadkarni GN, 2016, HEPATOL INT, V10, P525, DOI 10.1007/s12072-016-9706-9; Nassar AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107466; Piano S, 2013, J HEPATOL, V59, P482, DOI 10.1016/j.jhep.2013.03.039; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Singh V, 2012, J HEPATOL, V56, P1293, DOI 10.1016/j.jhep.2012.01.012; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162987	10.1371/journal.pone.0162987	http://dx.doi.org/10.1371/journal.pone.0162987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631098	gold, Green Submitted, Green Published			2022-12-27	WOS:000383706900109
J	Choi, YB; Yi, ES; Kang, JM; Lee, JW; Yoo, KH; Kim, YJ; Sung, KW; Koo, HH				Choi, Young Bae; Yi, Eun Sang; Kang, Ji-Man; Lee, Ji Won; Yoo, Keon Hee; Kim, Yae-Jean; Sung, Ki Woong; Koo, Hong Hoe			Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High- Risk or Recurrent Solid Tumors	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ZOSTER-VIRUS INFECTION; CLOSTRIDIUM-DIFFICILE; FUNGAL-INFECTIONS; CANCER; RESCUE; RECIPIENTS; TRIAL; NEUROBLASTOMA; EPIDEMIOLOGY	We retrospectively analyzed infectious complications during tandem high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) in children and adolescents with high-risk or recurrent solid tumors. A total of 324 patients underwent their first HDCT/auto- SCT between October 2004 and September 2014, and 283 of them proceeded to their second HDCT/auto-SCT (a total of 607 HDCT/auto-SCTs). During the early transplant period of 607 HDCT/auto-SCTs (from the beginning of HDCT to day 30 post-transplant), bacteremia, urinary tract infection (UTI), respiratory virus infection, and varicella zoster virus (VZV) reactivation occurred in 7.1%, 2.3%, 13.0%, and 2.5% of HDCT/auto-SCTs, respectively. The early transplant period of the second HDCT/auto-SCT had infectious complications similar to the first HDCT/auto-SCT. During the late transplant period of HDCT/auto-SCT (from day 31 to 1 year post-transplant), bacteremia, UTI, and VZV reactivation occurred in 7.5%, 2.5%, and 3.9% of patients, respectively. Most infectious complications in the late transplant period occurred during the first 6 months post-transplant. There were no invasive fungal infections during the study period. Six patients died from infectious complications (4 from bacterial sepsis and 2 from respiratory virus infection). Our study suggests that infectious complications are similar following second and first HDCT/auto-SCT in children.	[Choi, Young Bae] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea; [Yi, Eun Sang; Kang, Ji-Man; Lee, Ji Won; Yoo, Keon Hee; Kim, Yae-Jean; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Yi, Eun Sang; Kang, Ji-Man; Lee, Ji Won; Yoo, Keon Hee; Kim, Yae-Jean; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Sung, KW (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea.; Sung, KW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.	kwsped@skku.edu		Yi, Eun Sang/0000-0001-8214-2106	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C1521]; Astellas Pharma Korea, Inc.	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Astellas Pharma Korea, Inc.	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (No. HI13C1521) and by Astellas Pharma Korea, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CD, 2013, BIOL BLOOD MARROW TR, V19, P1502, DOI 10.1016/j.bbmt.2013.07.022; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Auner HW, 2002, ANN HEMATOL, V81, P374, DOI 10.1007/s00277-002-0484-1; Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Barton TD, 2001, CLIN INFECT DIS, V32, P391, DOI 10.1086/318491; Berman JN, 2006, BONE MARROW TRANSPL, V37, P73, DOI 10.1038/sj.bmt.1705191; Bilgrami S, 1999, BONE MARROW TRANSPL, V23, P469, DOI 10.1038/sj.bmt.1701594; Burke MJ, 2007, PEDIATR BLOOD CANCER, V49, P196, DOI 10.1002/pbc.21182; Costa PD, 2014, BRAZ J INFECT DIS, V18, P591, DOI 10.1016/j.bjid.2014.05.012; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; GOODMAN JL, 1992, NEW ENGL J MED, V326, P845, DOI 10.1056/NEJM199203263261301; KESSINGER A, 1991, BLOOD, V77, P211; KLUMPP TR, 1995, J CLIN ONCOL, V13, P1323, DOI 10.1200/JCO.1995.13.6.1323; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lee SH, 2008, BONE MARROW TRANSPL, V42, P385, DOI 10.1038/bmt.2008.181; Leung TF, 2000, BONE MARROW TRANSPL, V25, P167, DOI 10.1038/sj.bmt.1702119; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Pinana JL, 2014, ANN HEMATOL, V93, P299, DOI 10.1007/s00277-013-1872-4; Mossad SB, 1996, BONE MARROW TRANSPL, V18, P265; Oliveira AL, 2007, BONE MARROW TRANSPL, V39, P775, DOI 10.1038/sj.bmt.1705677; Science M, 2014, PEDIATR BLOOD CANCER, V61, P393, DOI 10.1002/pbc.24847; Son MH, 2013, J KOREAN MED SCI, V28, P220, DOI 10.3346/jkms.2013.28.2.220; Srinivasan A, 2014, TRANSPL INFECT DIS, V16, P90, DOI 10.1111/tid.12165; Stram DO, 1996, J CLIN ONCOL, V14, P2417, DOI 10.1200/JCO.1996.14.9.2417; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Sung KW, 2013, BONE MARROW TRANSPL, V48, P68, DOI 10.1038/bmt.2012.86; Sung KW, 2012, J NEURO-ONCOL, V107, P335, DOI 10.1007/s11060-011-0745-8; Weaver CH, 1997, BONE MARROW TRANSPL, V19, P671, DOI 10.1038/sj.bmt.1700713; WIMPERIS JZ, 1991, BONE MARROW TRANSPL, V8, P363	29	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162178	10.1371/journal.pone.0162178	http://dx.doi.org/10.1371/journal.pone.0162178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627440	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600024
J	Gunes, P; Canberk, S; Onenerk, M; Erkan, M; Gursan, N; Kilinc, E; Kilicoglu, GZ				Gunes, Pembegul; Canberk, Sule; Onenerk, Mine; Erkan, Murat; Gursan, Nilufer; Kilinc, Emine; Kilicoglu, Gamze Zeynep			A Different Perspective on Evaluating the Malignancy Rate of the Non-Diagnostic Category of the Bethesda System for Reporting Thyroid Cytopathology: A Single Institute Experience and Review of the Literature	PLOS ONE			English	Review							FINE-NEEDLE-ASPIRATION; ULTRASONOGRAPHIC FINDINGS; NODULES; BIOPSY; MANAGEMENT; CYTOLOGY; DILEMMA; ACCURACY; LESIONS	Objective To determine the malignancy rate in the non-diagnostic (ND) category of the Bethesda System for Reporting Thyroid Cytopathology (BSRTC) based on a different approach in relation to histopathology diagnoses. Study Design All ND fine needle aspirations (FNAs) that were performed under ultrasound guidance by an interventional radiologist with rapid on-site evaluation were included in the study. Slides were reevaluated to identify the cause of inadequacy as "qualitative" or "quantitative." The malignancy rate of the ND category was assessed. Nodule/patient characteristics were compared between benign and malignant cases within the study cohort. Results The study cohort consisted of 192 ND aspirations. Overall there were 156 (81.3%) women and 36 (18.7%) men with a mean age of 50.6 years (range 24-82 years). The malignancy rate was 4.7%. None of the nodules (size, consistency, and number) or patient characteristics (gender and age) were found to be predictive of malignancy. Conclusion The malignancy rate of the ND category was high when compared to BSRTC predictions, but at the low end of the reported malignancy rates in the literature. Our results revealed that cyto-histopathologic correlation and method of malignancy rate estimation could have an effect on a wide range of reported malignancy rates. Furthermore, patient/nodule dependent factors were not statistically found to be predictive of malignancy.	[Gunes, Pembegul; Canberk, Sule; Onenerk, Mine; Erkan, Murat; Gursan, Nilufer; Kilinc, Emine] Haydarpasa Numune Educ & Res Hosp, Dept Pathol, Istanbul, Turkey; [Kilicoglu, Gamze Zeynep] Haydarpasa Numune Educ & Res Hosp, Dept Intervent Radiol, Istanbul, Turkey; [Canberk, Sule] Acibadem Univ, Dept Pathol, Div Cytopathol, Acibadem Pathol Lab, Istanbul, Turkey	Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Numune Training & Research Hospital; Acibadem University	Canberk, S (corresponding author), Haydarpasa Numune Educ & Res Hosp, Dept Pathol, Istanbul, Turkey.; Canberk, S (corresponding author), Acibadem Univ, Dept Pathol, Div Cytopathol, Acibadem Pathol Lab, Istanbul, Turkey.	sule.canberk@acibadem.com	Canberk, Sule/AAM-8781-2020; KILICOGLU, Zeynep Gamze/AAN-3039-2021; Canberk, Sule/AAL-5645-2020; Önenerk Men, Ayşe Mine/GXN-2179-2022	Canberk, Sule/0000-0002-3736-1323; KILICOGLU, Zeynep Gamze/0000-0002-5358-0526; Önenerk Men, Ayşe Mine/0000-0003-0724-0544				Al Maqbali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049078; Baloch Z, 2003, DIAGN CYTOPATHOL, V29, P203, DOI 10.1002/dc.10361; Baloch ZW, 2008, DIAGN CYTOPATHOL, V36, P425, DOI 10.1002/dc.20830; Choi YS, 2012, ANN SURG ONCOL, V19, P2304, DOI 10.1245/s10434-012-2288-4; Chow LS, 2001, THYROID, V11, P1147, DOI 10.1089/10507250152740993; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Deandrea M, 2010, THYROID, V20, P1077, DOI 10.1089/thy.2010.0015; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; GOELLNER JR, 1987, ACTA CYTOL, V31, P587; HAMBURGER JI, 1989, ARCH PATHOL LAB MED, V113, P1035; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Le AR, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0063-9; MacDonald L, 1996, ACTA CYTOL, V40, P423; MCHENRY CR, 1993, AM SURGEON, V59, P415; Moon HJ, 2012, WORLD J SURG, V36, P586, DOI 10.1007/s00268-011-1397-8; Piana S, 2011, CYTOPATHOLOGY, V22, P164, DOI 10.1111/j.1365-2303.2010.00777.x; Renshaw AA, 2011, AM J CLIN PATHOL, V135, P750, DOI 10.1309/AJCP8FX5CLPISSSK; Richards ML, 2008, AM J SURG, V196, P398, DOI 10.1016/j.amjsurg.2007.10.017; Rosario PW, 2015, THYROID, V25, P1115, DOI 10.1089/thy.2015.0253; Schmidt T, 1997, SOUTHERN MED J, V90, P1183, DOI 10.1097/00007611-199712000-00004; Seningen JL, 2012, DIAGN CYTOPATHOL, V40, pE27, DOI 10.1002/dc.21566; Simsek GG, 2013, ENDOCR PATHOL, V24, P57, DOI 10.1007/s12022-013-9238-y; Tabaqchali MA, 2000, ANN ROY COLL SURG, V82, P149; Ucler R, 2015, DIAGN CYTOPATHOL, V43, P622, DOI 10.1002/dc.23289; WALFISH PG, 1976, CAN MED ASSOC J, V115, P35; Woo SH, 2015, WORLD J SURG, V39, P1721, DOI 10.1007/s00268-015-3013-9; Yang GCH, 2001, THYROID, V11, P581, DOI 10.1089/105072501750302895; Yang J, 2007, CANCER CYTOPATHOL, V111, P306, DOI 10.1002/cncr.22955; Yoon JH, 2010, ANN SURG ONCOL, V17, P2147, DOI 10.1245/s10434-010-0992-5	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162745	10.1371/journal.pone.0162745	http://dx.doi.org/10.1371/journal.pone.0162745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627674	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600052
J	Noh, JY; Park, JK; Lee, DH; Yuk, SS; Kwon, JH; Lee, SW; Lee, JB; Park, SY; Choi, IS; Song, CS				Noh, Jin-Yong; Park, Jae-Keun; Lee, Dong-Hun; Yuk, Seong-Su; Kwon, Jung-Hoon; Lee, Sang-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon			Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals ( DIVA)	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; AVIAN INFLUENZA-VIRUS; GP5 PROTEIN; IMMUNOGENICITY; ANTIBODIES; BIRDS; SERA; H7	Highly pathogenic avian influenza (HPAI) and Newcastle disease (ND) are considered as the most devastating poultry infections, owing to their worldwide distribution and economical threat. Vaccines have been widely used to control these diseases in the poultry industry in endemic countries. However, vaccination policy without differentiating infected animals from vaccinated animals (DIVA) makes the virus surveillance difficult. In this study, we developed a bivalent virus-like particle (VLP) vaccine that is composed of the hemagglutinin (HA) and matrix 1 (M1) proteins of the H5N1 HPAI virus (HPAIV) and a chimeric protein containing the ectodomain of the ND virus (NDV) fusion (F) protein fused with the cytoplasmic and transmembrane domains of the HPAIV HA protein. A single immunization of chickens with the chimeric VLP vaccine induced high levels of hemagglutination inhibition (HI) antibody titers against H5N1 HPAI virus and anti-NDV antibody detected in ELISA and protected chickens against subsequent lethal HPAIV and NDV infections. Furthermore, we could easily perform DIVA test using the commercial NP-cELISA tests against HPAIV and HI assay against NDV. These results strongly suggest that utilization of chimeric VLP vaccine in poultry species would be a promising strategy for the better control of HPAI and ND simultaneously.	[Noh, Jin-Yong; Park, Jae-Keun; Lee, Dong-Hun; Yuk, Seong-Su; Kwon, Jung-Hoon; Lee, Sang-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea; [Park, Jae-Keun] NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lee, Dong-Hun] USDA ARS, Southeast Poultry Res Lab, Athens, GA 30613 USA	Konkuk University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA)	Song, CS (corresponding author), Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea.	songcs@konkuk.ac.kr	노, 진용/ABC-9303-2020; Youk, Sungsu/AAC-2316-2019	노, 진용/0000-0003-4824-2335; Youk, Sungsu/0000-0002-3106-3712; Park, Jaekeun/0000-0002-4506-8127	Animal Disease Management Technology Development Program, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea [313013-3]	Animal Disease Management Technology Development Program, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	This research was supported by the Animal Disease Management Technology Development Program (Grant No. 313013-3), Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; BEACH JR, 1948, J AM VET MED ASSOC, V112, P85; Brown C, 1999, VET PATHOL, V36, P125, DOI 10.1354/vp.36-2-125; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Deo VK, 2015, MOL PHARMACEUT, V12, P839, DOI 10.1021/mp500860x; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Kim SH, 2014, VACCINE, V32, P4428, DOI 10.1016/j.vaccine.2014.06.061; Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15; Lee DH, 2014, CLIN EXP VACCINE RES, V3, P133, DOI 10.7774/cevr.2014.3.2.133; Lee DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058186; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Liu QF, 2015, J VIROL, V89, P7401, DOI 10.1128/JVI.00031-15; Lv LS, 2014, J VET SCI, V15, P209, DOI 10.4142/jvs.2014.15.2.209; McLaws M, 2015, EPIDEMIOL INFECT, V143, P1632, DOI 10.1017/S0950268814002623; Park JK, 2014, CLIN VACCINE IMMUNOL, V21, P360, DOI 10.1128/CVI.00636-13; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Shafer AL, 1998, AVIAN DIS, V42, P28, DOI 10.2307/1592573; Shen HF, 2013, VIRUS RES, V178, P430, DOI 10.1016/j.virusres.2013.09.009; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; Suarez DL, 2012, AVIAN DIS, V56, P836, DOI 10.1637/10207-041512-Review.1; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; TOYODA T, 1988, J VIROL, V62, P4427, DOI 10.1128/JVI.62.11.4427-4430.1988; Tretyakova I, 2013, VIROLOGY, V442, P67, DOI 10.1016/j.virol.2013.03.027; Wang W, 2012, VACCINE, V30, P7072, DOI 10.1016/j.vaccine.2012.09.048; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WHO, 2015, CUM NUMB CONF HUM CA; Xue CY, 2014, ARCH VIROL, V159, P3043, DOI 10.1007/s00705-014-2178-0	35	13	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162946	10.1371/journal.pone.0162946	http://dx.doi.org/10.1371/journal.pone.0162946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626934	gold, Green Published			2022-12-27	WOS:000383680600067
J	Toh, YF; Yew, SM; Chan, CL; Na, SL; Lee, KW; Hoh, CC; Yee, WY; Ng, KP; Kuan, CS				Toh, Yue Fen; Yew, Su Mei; Chan, Chai Ling; Na, Shiang Ling; Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan; Ng, Kee Peng; Kuan, Chee Sian			Genome Anatomy of Pyrenochaeta unguis-hominis UM 256, a Multidrug Resistant Strain Isolated from Skin Scraping	PLOS ONE			English	Article							CANDIDA-ALBICANS; TRANSPOSABLE ELEMENTS; FILAMENTOUS FUNGI; RIBOSOMAL DNA; PROTEIN; IDENTIFICATION; ANNOTATION; SEQUENCE; GENES; VISUALIZATION	Pyrenochaeta unguis-hominis is a rare human pathogen that causes infection in human skin and nail. P. unguis-hominis has received little attention, and thus, the basic biology and pathogenicity of this fungus is not fully understood. In this study, we performed in-depth analysis of the P. unguis-hominis UM 256 genome that was isolated from the skin scraping of a dermatitis patient. The isolate was identified to species level using a comprehensive multilocus phylogenetic analysis of the genus Pyrenochaeta. The assembled UM 256 genome has a size of 35.5 Mb and encodes 12,545 putative genes, and 0.34% of the assembled genome is predicted transposable elements. Its genomic features propose that the fungus is a heterothallic fungus that encodes a wide array of plant cell wall degrading enzymes, peptidases, and secondary metabolite biosynthetic enzymes. Antifungal drug resistance genes including MDR, CDR, and ERG11/CYP51 were identified in P. unguis-hominis UM 256, which may confer resistance to this fungus. The genome analysis of P. unguis-hominis provides an insight into molecular and genetic basis of the fungal lifestyles, understanding the unrevealed biology of antifungal resistance in this fungus.	[Toh, Yue Fen; Yew, Su Mei; Chan, Chai Ling; Na, Shiang Ling; Ng, Kee Peng; Kuan, Chee Sian] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan] Codon Genom SB, Seri Kembangan, Selangor Darul, Malaysia	Universiti Malaya	Kuan, CS (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	cs_sam85@yahoo.com.my			University of Malaya; High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/MED/31]; Codon Genomics SB	University of Malaya(Universiti Malaya); High Impact Research MoE Grant from the Ministry of Education Malaysia; Codon Genomics SB	This project was funded by University of Malaya research grants. This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia. Codon Genomics SB provided support in the form of salaries for authors KWL, CCH and WYY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amselem J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1347-1; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Aragona M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-313; Bagut ET, 2012, VET MICROBIOL, V160, P413, DOI 10.1016/j.vetmic.2012.06.011; Baldo A, 2012, MYCOSES, V55, P218, DOI 10.1111/j.1439-0507.2011.02081.x; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; Biely P, 2012, BIOTECHNOL ADV, V30, P1575, DOI 10.1016/j.biotechadv.2012.04.010; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Burmester A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r7; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; Chan CL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2200-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00197; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; DABOUSSI MJ, 1994, GENETICA, V93, P49, DOI 10.1007/BF01435239; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Dickman MB, 1999, FUNGAL GENET BIOL, V26, P99, DOI 10.1006/fgbi.1999.1118; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; ENGLISH MP, 1980, BRIT J DERMATOL, V103, P91, DOI 10.1111/j.1365-2133.1980.tb15843.x; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gao L, 2007, MYCOL RES, V111, P87, DOI 10.1016/j.mycres.2006.07.019; Gostincar C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-549; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Infantino A, 2014, PLANT PATHOL; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jousson O, 2004, GENE, V339, P79, DOI 10.1016/j.gene.2004.06.024; Kempken F, 1998, BIOESSAYS, V20, P652, DOI 10.1002/(SICI)1521-1878(199808)20:8&lt;652::AID-BIES8&gt;3.0.CO;2-K; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khan Z, 2011, J MED MICROBIOL, V60, P842, DOI 10.1099/jmm.0.029520-0; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kuan CS, 2015, DNA RES, V22, P219, DOI 10.1093/dnares/dsv007; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leach MD, 2012, EUKARYOT CELL, V11, P98, DOI 10.1128/EC.05238-11; Lechenne B, 2007, MICROBIOL-SGM, V153, P905, DOI 10.1099/mic.0.2006/003335-0; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levic J, 2012, ROM AGRIC RES, V29, P339; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Monod M, 2005, MICROBIOL-SGM, V151, P145, DOI 10.1099/mic.0.27484-0; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Monod M, 2008, MYCOPATHOLOGIA, V166, P285, DOI 10.1007/s11046-008-9105-4; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Oh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042868; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093560; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PUNITHALINGAM E, 1975, T BRIT MYCOL SOC, V64, P539, DOI 10.1016/S0007-1536(75)80163-X; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santana MF., 2015, SCI J GENETICS GEN T, V1, P12, DOI [10.17352/sjggt.000003, DOI 10.17352/SJGGT.000003]; Saupe SJ, 2000, CURR OPIN MICROBIOL, V3, P608, DOI 10.1016/S1369-5274(00)00148-X; Schrettl M, 2007, DISTINCT ROLES INTRA; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Verkley GJM, 2010, REV IBEROAM MICOL, V27, P22, DOI 10.1016/j.riam.2009.09.001; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yew SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104352; Yew SM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00158-13; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Ying Y, 2013, MICROB DRUG RESIST, V19, P266, DOI 10.1089/mdr.2012.0204; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhao ZT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-6	87	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162095	10.1371/journal.pone.0162095	http://dx.doi.org/10.1371/journal.pone.0162095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626635	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600020
J	Alcaino, J; Bravo, N; Cordova, P; Marcoleta, AE; Contreras, G; Barahona, S; Sepulveda, D; Fernandez-Lobato, M; Baeza, M; Cifuentes, V				Alcaino, Jennifer; Bravo, Natalia; Cordova, Pamela; Marcoleta, Andres E.; Contreras, Gabriela; Barahona, Salvador; Sepulveda, Dionisia; Fernandez-Lobato, Maria; Baeza, Marcelo; Cifuentes, Victor			The Involvement of Mig1 from Xanthophyllomyces dendrorhous in Catabolic Repression: An Active Mechanism Contributing to the Regulation of Carotenoid Production	PLOS ONE			English	Article							ASTAXANTHIN BIOSYNTHESIS PATHWAY; YEAST SACCHAROMYCES-CEREVISIAE; PHAFFIA-RHODOZYMA; GLUCOSE REPRESSION; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL REGULATION; ASPERGILLUS-NIDULANS; SYNTHASE GENE; BETA-CAROTENE	The red yeast X. dendrorhous is one of the few natural sources of astaxanthin, a carotenoid used in aquaculture for salmonid fish pigmentation and in the cosmetic and pharmaceutical industries for its antioxidant properties. Genetic control of carotenogenesis is well characterized in this yeast; however, little is known about the regulation of the carotenogenesis process. Several lines of evidence have suggested that carotenogenesis is regulated by catabolic repression, and the aim of this work was to identify and functionally characterize the X. dendrorhous MIG1 gene encoding the catabolic repressor Mig1, which mediates transcriptional glucose-dependent repression in other yeasts and fungi. The identified gene encodes a protein of 863 amino acids that demonstrates the characteristic conserved features of Mig1 proteins, and binds in vitro to DNA fragments containing Mig1 boxes. Gene functionality was demonstrated by heterologous complementation in a S. cerevisiae mig1(-) strain; several aspects of catabolic repression were restored by the X. dendrorhous MIG1 gene. Additionally, a X. dendrorhous mig1-mutant was constructed and demonstrated a higher carotenoid content than the wild-type strain. Most important, the mig1(-) mutation alleviated the glucose-mediated repression of carotenogenesis in X. dendrorhous: the addition of glucose to mig1(-) and wild-type cultures promoted the growth of both strains, but carotenoid synthesis was observed only in the mutant strain. Transcriptomic and RT-qPCR analyses revealed that several genes were differentially expressed between X. dendrorhous mig1(-) and the wild-type strain when cultured with glucose as the sole carbon source. The results obtained in this study demonstrate that catabolic repression in X. dendrorhous is an active process in which the identified MIG1 gene product plays a central role in the regulation of several biological processes, including carotenogenesis.	[Alcaino, Jennifer; Bravo, Natalia; Cordova, Pamela; Contreras, Gabriela; Barahona, Salvador; Sepulveda, Dionisia; Baeza, Marcelo; Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Lab Genet, Santiago, Chile; [Marcoleta, Andres E.] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Cantoblanco, Spain	Universidad de Chile; Universidad de Chile; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Cifuentes, V (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Lab Genet, Santiago, Chile.	vcifuentes@uchile.cl	Lobato, Maria Fernandez/F-1338-2016; /C-6686-2008; Alcaino, Jennifer/H-4576-2012	Lobato, Maria Fernandez/0000-0003-0778-7443; Alcaino, Jennifer/0000-0001-8984-0943; Contreras, Gabriela/0000-0002-5637-3004; Marcoleta Caldera, Andres Esteban/0000-0003-2950-7510	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1140504]; Mejoramiento de la Calidad y la Equidad en la Educacion Superior (MECESUP) [2-UCH0604]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21110252]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Mejoramiento de la Calidad y la Equidad en la Educacion Superior (MECESUP); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funding was provided by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1140504 (http://www.conicyt.cl/fondecyt/); Mejoramiento de la Calidad y la Equidad en la Educacion Superior (MECESUP) 2-UCH0604 (http://www.mecesup.cl/) NB; and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) 21110252 (http://www.conicyt.cl/becas-conicyt/) PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Alcaino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096626; Alcaino J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-169; Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Alvarez V, 2006, FUNGAL GENET BIOL, V43, P261, DOI 10.1016/j.fgb.2005.12.004; AN GH, 1989, APPL ENVIRON MICROB, V55, P116, DOI 10.1128/AEM.55.1.116-124.1989; ANDREWES AG, 1976, PHYTOCHEMISTRY, V15, P1009, DOI 10.1016/S0031-9422(00)84391-5; Baeza M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1493-5; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x; Cifuentes V, 1997, ANTON LEEUW INT J G, V72, P111, DOI 10.1023/A:1000200119447; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Contreras G, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-84; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fell JW, 1999, J IND MICROBIOL BIOT, V23, P677, DOI 10.1038/sj.jim.2900681; Fuentealba M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152403; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Goldstein A, 1975, Methods Enzymol, V42, P504; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; Hermosilla G, 2003, ANTON LEEUW INT J G, V84, P279, DOI 10.1023/A:1026090008405; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Kajiwara S, 1997, BIOCHEM J, V324, P421, DOI 10.1042/bj3240421; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Karunanithi S, 2012, GENETICS, V192, P869, DOI 10.1534/genetics.112.142661; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Klein CJL, 1999, J BIOTECHNOL, V68, P197, DOI 10.1016/S0168-1656(98)00205-3; Leiva K, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0428-2; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodato P, 2003, APPL ENVIRON MICROB, V69, P4676, DOI 10.1128/AEM.69.8.4676-4682.2003; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Marcoleta A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-190; Mercadante A. Z, 2004, CAROTENOIDS HDB; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller MW, 1976, INT J SYST BACTERIOL, V26, P6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Niklitschek M, 2012, MICROBIAL CAROTENOID, P219; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Ojima K, 2006, MOL GENET GENOMICS, V275, P148, DOI 10.1007/s00438-005-0072-x; Ostling J, 1996, MOL CELL BIOL, V16, P753; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Torres P, 1998, J AGR FOOD CHEM, V46, P354, DOI 10.1021/jf970570r; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; VALLIER LG, 1994, GENETICS, V137, P49; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; Verdoes JC, 1999, BIOTECHNOL BIOENG, V63, P750, DOI 10.1002/(SICI)1097-0290(19990620)63:6<750::AID-BIT13>3.0.CO;2-7; Wery J, 1996, YEAST, V12, P641; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wozniak A, 2011, FEMS YEAST RES, V11, P252, DOI 10.1111/j.1567-1364.2010.00711.x; Zimmermann FK, 1997, BIOCH GENETICS BIOTE	64	18	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162838	10.1371/journal.pone.0162838	http://dx.doi.org/10.1371/journal.pone.0162838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622474	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000063
J	Du, GL; Su, YX; Yao, H; Zhu, J; Ma, Q; Tuerdi, A; He, XD; Wang, L; Wang, ZQ; Xiao, S; Wang, SX; Su, LP				Du, Guo-li; Su, Yin-xia; Yao, Hua; Zhu, Jun; Ma, Qi; Tuerdi, Ablikm; He, Xiao-dong; Wang, Li; Wang, Zhi-qiang; Xiao, Shan; Wang, Shu-xia; Su, Li-ping			Metabolic Risk Factors of Type 2 Diabetes Mellitus and Correlated Glycemic Control/Complications: A Cross-Sectional Study between Rural and Urban Uygur Residents in Xinjiang Uygur Autonomous Region	PLOS ONE			English	Article							PREVALENCE; POPULATION; COMPLICATIONS; OBESITY; URBANIZATION; ASSOCIATION; GLUCOSE; ADULTS; TRENDS; WOMEN	Background Diabetes is a major global public health problem driven by a high prevalence of metabolic risk factors. Objective To describe the differences of metabolic risk factors of type 2 diabetes, as well as glycemic control and complicated diabetic complications between rural and urban Uygur residents in Xinjiang Uygur Autonomous Region of China. Methods This comparative cross-sectional study, conducted among 2879 urban and 918 rural participants in Xinjiang, China, assessed the metabolic risk factors of diabetes and related complications differences between urban and rural settlements. Results Compared to rural areas, urban participants had higher education level and more average income, little physical activity, less triglycerides and higher HDL-c (p < 0.05 respectively). Differences in metabolic risk factors by urban/rural residence included overweight or obesity, triglycerides (>= 1.71mmol/l), HDL-c (< 1.04 mmol/l), alcohol intake, and physical inactivity (p < 0.01 respectively). There was significant difference regarding the prevalence of HbA1c > 8% (48.1% versus 54.5%, p = 0.019) between rural and urban diabetic participants. No significant difference in the prevalence of type 2 diabetic complications between urban and rural participants (74.9% versus 72.2%; p = 0.263) was detected. Compared to rural participants, the most prevalent modifiable risk factors associated with diabetic complications in urban participants were obesity (BMI >= 28 Kg/m(2)), HDL-c (< 1.04 mmol/l), physical inactivity and irregular eating habits (p = 0.035, p = 0.001, p < 0.001, and p = 0.013, respectively). Conclusions Urban settlers were significantly more likely to have metabolic risk factors highlighting the need for public health efforts to improve health outcomes for these vulnerable populations. Diabetes related complications risk factors were prevalent amongst rural and urban diabetes settlers.	[Du, Guo-li; Zhu, Jun; Tuerdi, Ablikm; He, Xiao-dong; Xiao, Shan] Xinjiang Med Univ, Affiliated Hosp 1, Dept Endocrinol, Urumqi, Peoples R China; [Su, Yin-xia; Yao, Hua; Ma, Qi; Wang, Li] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Key Lab Xinjiang Metab Dis, Urumqi, Peoples R China; [Wang, Zhi-qiang] Xinjiang Med Univ, Dept Occupat & Environm Hlth, Urumqi, Peoples R China; [Wang, Shu-xia] Xinjiang Med Univ, Dept Hlth Check Ctr, Affiliated Hosp 1, Urumqi, Peoples R China; [Su, Li-ping] Xinjiang Med Univ, Dept Pathol, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Yao, H (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Key Lab Xinjiang Metab Dis, Urumqi, Peoples R China.	yaohua01@sina.com	Ma, Qi/HHM-3117-2022		National Basic Research Program of China (973 program) [2012CB722403]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	The survey was funded by the National Basic Research Program of China (973 program) (2012CB722403). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlNuaim AR, 1997, DIABETIC MED, V14, P595; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; [Anonymous], 1999, DEF DIAGN CLASS DI 1; Avogaro A, 2007, DIABETES CARE, V30, P1241, DOI 10.2337/dc06-2558; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Cai L, 2013, INT J CARDIOL, V165, P273, DOI 10.1016/j.ijcard.2011.08.039; Chinese Diabetes Society, 2014, CHIN J ENDOCRINOL ME, V30, P893, DOI [10.3760/cma.j.issn.1000-6699.2014.10.020, DOI 10.3760/CMA.J.ISSN.1000-6699.2014.10.020]; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Deepa M, 2014, Indian J Endocrinol Metab, V18, P379, DOI 10.4103/2230-8210.131191; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; Dong Mei-hua, 2011, CHIN J PREY CONTR CH, V19, P568; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Gao WG, 2009, DIABETIC MED, V26, P1220, DOI 10.1111/j.1464-5491.2009.02832.x; Gharbi M, 2002, REV EPIDEMIOL SANTE, V50, P349; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hwang CK, 2012, DIABETES RES CLIN PR, V96, P271, DOI 10.1016/j.diabres.2011.12.001; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Khan Ataur Rahman, 2014, Glob J Health Sci, V6, P245, DOI 10.5539/gjhs.v6n4p245; KIRKENDALL WM, 1967, CIRCULATION, V36, P980, DOI 10.1161/01.CIR.36.6.980; Lee HY, 2010, J KOREAN MED SCI, V25, P1777, DOI 10.3346/jkms.2010.25.12.1777; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Li LL, 2008, CLIN EXP PHARMACOL P, V35, P187, DOI 10.1111/j.1440-1681.2007.04796.x; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Lynch CP, 2011, J DIABETES COMPLICAT, V25, P387, DOI 10.1016/j.jdiacomp.2011.08.003; Motala AA, 2002, DIABETES-METAB RES, V18, pS14, DOI 10.1002/dmrr.284; Mwanri AW, 2014, DIABETES RES CLIN PR, V103, P71, DOI 10.1016/j.diabres.2013.11.021; Obirikorang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129494; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Sabir AA, 2013, ETHNIC DIS, V23, P374; Salvotelli L, 2015, J DIABETES COMPLICAT, V29, P1066, DOI 10.1016/j.jdiacomp.2015.06.014; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tin STW, 2014, DIABETES RES CLIN PR, V103, P114, DOI 10.1016/j.diabres.2013.09.017; Sluijs I, 2015, DIABETES, V64, P3028, DOI 10.2337/db14-0742; Sodjinou R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-84; Sumanatilleke MR, 2012, SRI LANKA J DIABETES, V2, P17; [王婷婷 Wang Tingting], 2014, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V30, P755; Weng X, 2007, PUBLIC HEALTH NUTR, V10, P131, DOI 10.1017/S1368980007226023; Xia ZF, 2013, IRAN J PUBLIC HEALTH, V42, P222; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270; Yao H, 2015, INT J ENV RES PUB HE, V12, P11797, DOI 10.3390/ijerph120911797; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zabetian A, 2014, DIABETES RES CLIN PR, V104, P206, DOI 10.1016/j.diabres.2014.01.005; Zaman Forhad Akhtar, 2014, J Nat Sci Biol Med, V5, P383, DOI 10.4103/0976-9668.136195; ZIMMET P, 1981, DIABETES, V30, P45, DOI 10.2337/diabetes.30.1.45	49	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162611	10.1371/journal.pone.0162611	http://dx.doi.org/10.1371/journal.pone.0162611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622506	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000044
J	Yang, QH; Liao, JY; Huang, J; Li, YP; Huang, SG; Zhou, HT; Xie, Y; Pan, J; Li, YH; Wang, JH; Wang, J				Yang, Qinghua; Liao, Jianyi; Huang, Jie; Li, Yi Ping; Huang, Shungen; Zhou, Huiting; Xie, Yi; Pan, Jian; Li, Yanhong; Wang, Jiang Huai; Wang, Jian			Cardiopulmonary Bypass Down-Regulates NOD Signaling and Inflammatory Response in Children with Congenital Heart Disease	PLOS ONE			English	Article							MURAMYL DIPEPTIDE; INFECTION; RIP2	In the present study, we aimed to examine the impact of cardiopulmonary bypass (CPB) on expression and function of NOD1 and NOD2 in children with congenital heart disease (CHD), in an attempt to clarify whether NOD1 and NOD2 signaling is involved in the modulation of host innate immunity against postoperative infection in pediatric CHD patients. Peripheral blood samples were collected from pediatric CHD patients at five different time points: before CPB, immediately after CPB, and 1, 3, and 7 days after CPB. Real-time PCR, Western blot, and ELISA were performed to measure the expression of NOD1 and NOD2, their downstream signaling pathways, and inflammatory cytokines at various time points. Proinflammatorycytokine IL-6 and TNF-alpha levels in response to stimulation with either the NOD1 agonist Tri-DAP or the NOD2 agonist MDP were significantly reduced after CPB compared with those before CPB, which is consistent with a suppressed inflammatory response postoperatively. The expression of phosphorylated RIP2 and activation of the downstream signaling pathways NF-kB p65 and MAPK p38 upon Tri-DAP or MDP stimulation in PBMCs were substantially inhibited after CPB. The mRNA level of NOD1 and protein levels of NOD1 and NOD2 were also markedly decreased after CPB. Our results demonstrated that NOD-mediated signaling pathways were substantially inhibited after CPB, which correlates with the suppressed inflammatory response and may account, at least in part, for the increased risk of postoperative infection in pediatric CHD patients.	[Yang, Qinghua; Liao, Jianyi; Huang, Shungen; Wang, Jian] Soochow Univ, Childrens Hosp, Dept Pediat Surg, Suzhou, Peoples R China; [Huang, Jie] Soochow Univ, Childrens Hosp, Dept Pediat Cardiol, Suzhou, Peoples R China; [Li, Yi Ping; Zhou, Huiting; Xie, Yi; Pan, Jian; Li, Yanhong] Soochow Univ, Childrens Hosp, Pediat Res Inst, Suzhou, Peoples R China; [Wang, Jiang Huai] Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland	Soochow University - China; Soochow University - China; Soochow University - China; University College Cork	Wang, J (corresponding author), Soochow Univ, Childrens Hosp, Dept Pediat Surg, Suzhou, Peoples R China.; Wang, JH (corresponding author), Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland.	jh.wang@ucc.ie; wj196312@gmail.com			National Natural Science Foundation of China [81272143, 81420108022]; National Natural Science Foundation of Jiangsu Province [BK2011310]; Jiangsu Innovation Team [LJ201141]; Jiang Su Province Program of innovative and Entrepreneurial Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Innovation Team; Jiang Su Province Program of innovative and Entrepreneurial Talents	This work was supported by the National Natural Science Foundation of China (Grants 81272143 and 81420108022), the National Natural Science Foundation of Jiangsu Province (Grant BK2011310), Jiangsu Innovation Team (Grant LJ201141), and Jiang Su Province Program of innovative and Entrepreneurial Talents (2011-2014).	Bist P, 2014, INFECT IMMUN, V82, P1112, DOI 10.1128/IAI.01459-13; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Li YP, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.10.008; Maharana J, 2015, MOL BIOSYST, V11, P2324, DOI 10.1039/c5mb00212e; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Moreno L, 2013, BRIT J PHARMACOL, V170, P475, DOI 10.1111/bph.12300; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Sirard JC, 2007, PLOS PATHOG, V3, P1829, DOI 10.1371/journal.ppat.0030152; Takeuchi D, 2015, CIRC J, V79, P1828, DOI 10.1253/circj.CJ-15-0042; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vijarnsorn Chodchanok, 2012, Journal of the Medical Association of Thailand, V95, P761	16	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162179	10.1371/journal.pone.0162179	http://dx.doi.org/10.1371/journal.pone.0162179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622570	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000017
J	Li, SX; Kyvik, KO; Duan, HP; Zhang, DF; Pang, ZC; Hjelmborg, J; Tan, QH; Kruse, T; Dalgard, C				Li, Shuxia; Kyvik, Kirsten Ohm; Duan, Haiping; Zhang, Dongfeng; Pang, Zengchang; Hjelmborg, Jacob; Tan, Qihua; Kruse, Torben; Dalgard, Christine			Longitudinal Investigation into Genetics in the Conservation of Metabolic Phenotypes in Danish and Chinese Twins	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; SYNDROME TRAITS; HERITABILITY; GLUCOSE; COMPONENTS; INSULIN; DISEASE	Longitudinal twin studies on long term conservation of individual metabolic phenotypes can help to explore the genetic and environmental basis in maintaining metabolic homeostasis and metabolic health. We performed a longitudinal twin study on 12 metabolic phenotypes from Danish twins followed up for 12 years and Chinese twins traced for 7 years. The study covered a relatively large sample of 502 pairs of Danish adult twins with a mean age at intake of 38 years and a total of 181 Chinese adult twin pairs with a mean baseline age of 39.5 years. Bivariate twin models were fitted to the longitudinal measurements taken at two time points (at baseline and follow-up) to estimate the genetic and environmental contributions to phenotype variation and correlation at and between the two time points. High genetic components in the regulation of intra-individual phenotype correlation or stability over time were estimated in both Danish (h(2)>0.75 except fasting blood glucose) and Chinese (h(2)>0.72 except blood pressure) twins; moderate to high genetic contribution to phenotype variation at the two time points were also estimated except for the low genetic regulation on glucose in Danish and on blood pressure in Chinese twins. Meanwhile the bivariate twin models estimated shared environmental contributions to the variance and covariance in fasting blood glucose in Danish twins, and in systolic and diastolic blood pressure, low and high density lipoprotein cholesterol in Chinese twins. Overall, our longitudinal twin study on long-termstability of metabolic phenotypes in Danish and Chinese twins identified a common pattern of high genetic control over phenotype conservation, and at the same time revealed population-specific patterns of genetic and common environmental regulation on the variance as well as covariance of glucose and blood pressure.	[Li, Shuxia; Tan, Qihua; Kruse, Torben] Univ Southern Denmark, Dept Clin Res, Human Genet Unit, Odense, Denmark; [Kyvik, Kirsten Ohm] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Kyvik, Kirsten Ohm] Odense Univ Hosp, Odense Patient Data Explorat Network OPEN, Odense, Denmark; [Duan, Haiping; Pang, Zengchang] Qingdao Ctr Dis Control & Prevent, Qingdao, Peoples R China; [Zhang, Dongfeng] Qingdao Univ, Dept Publ Hlth, Coll Med, Qingdao, Peoples R China; [Hjelmborg, Jacob; Tan, Qihua] Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark; [Dalgard, Christine] Univ Southern Denmark, Dept Publ Hlth, Environm Med, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Qingdao University; University of Southern Denmark; University of Southern Denmark	Li, SX (corresponding author), Univ Southern Denmark, Dept Clin Res, Human Genet Unit, Odense, Denmark.	sli@health.sdu.dk	Hjelmborg, Jacob/AAN-5966-2020; Tan, Qihua/AAG-2582-2019; Tan, Qihua/F-1349-2015; Kyvik, Kirsten Ohm/K-5680-2016	Hjelmborg, Jacob/0000-0001-9630-9149; Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Dalgard, Christine/0000-0001-8184-3429; Li, Shuxia/0000-0001-8095-3175; Kyvik, Kirsten Ohm/0000-0003-2981-0245	Region of South Denmark [127676]; Novo Nordisk Foundation - Medical and Natural Sciences Research; European Regional Development Fund - Interreg 4a Southern Denmark-Schleswig-KERN; US National Institute of Aging-National Institutes of Health; Danish Research Council for Health and Disease; Danish Diabetes Association; Danish Heart Foundation; Novo Nordisk Fonden [NNF13OC0007493] Funding Source: researchfish	Region of South Denmark; Novo Nordisk Foundation - Medical and Natural Sciences Research; European Regional Development Fund - Interreg 4a Southern Denmark-Schleswig-KERN; US National Institute of Aging-National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Health and Disease; Danish Diabetes Association; Danish Heart Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Region of South Denmark PhD Grant 2012 j.nr. 127676 European Foundation for the Study of Diabetes - EFSD/CDS/Lilly Programme 2013 (Dr. Qihua Tan); Novo Nordisk Foundation - Medical and Natural Sciences Research 2013 (Dr. Qihua Tan); European Regional Development Fund - Interreg 4a Southern Denmark-Schleswig-KERN; US National Institute of Aging-National Institutes of Health; Danish Research Council for Health and Disease; Danish Diabetes Association; and Danish Heart Foundation.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Duan HP, 2011, OBESITY FACTS, V4, P99, DOI 10.1159/000327735; Fenger M, 2007, ATHEROSCLEROSIS, V191, P40, DOI 10.1016/j.atherosclerosis.2006.04.024; Fran CE, 2007, TWIN RES HUM GENET, V10, P537, DOI 10.1375/twin.10.4.537; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Li SX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148396; Li SX, 2014, HYPERTENS RES, V37, P954, DOI 10.1038/hr.2014.95; Li SX, 2013, OBESITY, V21, P1908, DOI 10.1002/oby.20217; Luo BF, 2010, J MED GENET, V47, P415, DOI 10.1136/jmg.2009.068932; Neale MC, 1997, BEHAV GENET, V27, P113, DOI 10.1023/A:1025681223921; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; Plaxton WC., 2004, FUNCTIONAL METABOLIS; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Snieder H, 1999, GENET EPIDEMIOL, V16, P426, DOI 10.1002/(SICI)1098-2272(1999)16:4<426::AID-GEPI8>3.3.CO;2-2; Sung J, 2009, J CLIN ENDOCR METAB, V94, P4946, DOI 10.1210/jc.2009-1268; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Yousri NA, 2014, METABOLOMICS, V10, P1005, DOI 10.1007/s11306-014-0629-y; Zabaneh D, 2009, DIABETOLOGIA, V52, P2585, DOI 10.1007/s00125-009-1504-7; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X; Zhang SC, 2010, PEDIATR RES, V68, P316, DOI 10.1203/00006450-201011001-00618	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162805	10.1371/journal.pone.0162805	http://dx.doi.org/10.1371/journal.pone.0162805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618179	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100054
J	Zeng, Y; Ruan, WL; He, JX; Zhang, JR; Liang, WH; Chen, YQ; He, QH; He, JX				Zeng, Yuan; Ruan, Wenli; He, Jiaxi; Zhang, Jianrong; Liang, Wenhua; Chen, Yaoqi; He, Qihua; He, Jianxing			Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INDUCED KILLER-CELLS; DENDRITIC CELLS; CHEMOTHERAPY; INTERLEUKIN-2; SURVIVAL; RECURRENCE; RESECTION; EFFICACY; THERAPY; TRIAL	Background Adoptive immunotherapy (AI) has been applied in the treatment of non-small-cell lung cancer (NSCLC) patients, but the value of postoperative AI has been inconclusive largely as a result of the small number of patients included in each study. We performed a systematic review and meta-analysis to address this issue for patients with postoperative NSCLC. Methods Pubmed, Embase, Cochrane Library were searched for randomized controlled trials comparing adoptive immunotherapy with control therapies in postoperative NSCLC patients. The primary endpoint was overall survival. Hazard ratio (HR) was estimated and 95% confidence intervals (CI) were calculated using a fixed-effect model. Results Compared with control therapies, analyses of 4 randomized controlled trials (472 patients) showed a significant benefit of adoptive immunotherapy on survival (hazard ratio [ HR] 0.61, 95% CI 0.45-0.84, p = 0.002), and a 39% reduction in the relative risk of death (no evidence of a difference between trials; p = 0.16, I-2 = 42%). In subgroup analyses by treatment cycles and treatment regimen, significant OS benefit was found in combination therapy of AI with chemotherapy, regardless of whether or not the treatment cycles were more than 10 cycles. Conclusion Adoptive immunotherapy has the potential to improve overall survival in postoperative NSCLC. The findings suggest this is a valid treatment option for these patients. Further randomized clinical trials are urgently needed.	[Zeng, Yuan; He, Jiaxi; Zhang, Jianrong; Liang, Wenhua; Chen, Yaoqi; He, Qihua; He, Jianxing] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Dept Cardiothorac Surg, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China; [Zeng, Yuan; He, Jiaxi; Zhang, Jianrong; Liang, Wenhua; Chen, Yaoqi; He, Qihua; He, Jianxing] China State Key Lab Resp Dis, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China; [Ruan, Wenli] Guangzhou Zisheng Biotech Co Ltd, 11 Zhu Jiang East Rd, Guangzhou 510120, Guangdong, Peoples R China	Guangzhou Medical University	He, JX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Dept Cardiothorac Surg, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China.; He, JX (corresponding author), China State Key Lab Resp Dis, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China.	drhe_jianxing@163.com	Zhang, Jianrong/AAU-2359-2020	Zhang, Jianrong/0000-0003-4688-5222; He, Jianxing/0000-0003-1737-8192; Wenhua, Liang/0000-0002-1391-8238; He, Jiaxi/0000-0003-2726-6629	Guangzhou Zisheng Biotech Company Limited	Guangzhou Zisheng Biotech Company Limited	The authors received no specific funding for this work. Guangzhou Zisheng Biotech Company Limited provided support in the form of salaries for authors [WR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Although a main author Wenli Ruan is now working for Guangzhou Zisheng Biotech Company Limited, the company didn't provide financial support. Wenli Ruan contributed partly in methodology, validation, formal analysis and investigation, writing (original draft preparation). She is just interested in cancer immunotherapy and has the opportunity to participate in our study.	Berghmans T, 2005, LUNG CANCER, V49, P13, DOI 10.1016/j.lungcan.2005.01.002; Datta D, 2003, CHEST, V123, P2096, DOI 10.1378/chest.123.6.2096; Felip E, 2013, CURR OPIN ONCOL, V25, P115, DOI 10.1097/CCO.0b013e32835ca1b0; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Kimura H, 1997, CANCER, V80, P42, DOI 10.1002/(SICI)1097-0142(19970701)80:1<42::AID-CNCR6>3.0.CO;2-H; Kimura H, 2015, CANCER IMMUNOL IMMUN, V64, P51, DOI 10.1007/s00262-014-1613-0; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Li K, 2015, J CANCER RES CLIN, V141, P1249, DOI 10.1007/s00432-014-1867-0; Li RM, 2012, CANCER IMMUNOL IMMUN, V61, P2125, DOI 10.1007/s00262-012-1260-2; PAPA MZ, 1986, CANCER RES, V46, P4973; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ratto GB, 1996, CANCER, V78, P244, DOI 10.1002/(SICI)1097-0142(19960715)78:2<244::AID-CNCR9>3.0.CO;2-L; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Shi SB, 2014, J IMMUNOTHER, V37, P250, DOI 10.1097/CJI.0000000000000015; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062847; Wu CP, 2008, ANTICANCER RES, V28, P3997; Xie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042879; Zhao M, 2014, EXP THER MED, V7, P1403, DOI 10.3892/etm.2014.1574; Zhong RB, 2011, CANCER IMMUNOL IMMUN, V60, P1497, DOI 10.1007/s00262-011-1060-0	25	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162630	10.1371/journal.pone.0162630	http://dx.doi.org/10.1371/journal.pone.0162630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618180	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100034
J	Afifi, F; Anuar, NB; Shamshirband, S; Choo, KKR				Afifi, Firdaus; Anuar, Nor Badrul; Shamshirband, Shahaboddin; Choo, Kim-Kwang Raymond			DyHAP: Dynamic Hybrid ANFIS-PSO Approach for Predicting Mobile Malware	PLOS ONE			English	Article							CUSTOMER SATISFACTION; VARIABLE SELECTION; NEURAL-NETWORKS; CONTROLLER	To deal with the large number of malicious mobile applications (e.g. mobile malware), a number of malware detection systems have been proposed in the literature. In this paper, we propose a hybrid method to find the optimum parameters that can be used to facilitate mobile malware identification. We also present a multi agent system architecture comprising three system agents (i.e. sniffer, extraction and selection agent) to capture and manage the pcap file for data preparation phase. In our hybrid approach, we combine an adaptive neuro fuzzy inference system (ANFIS) and particle swarm optimization (PSO). Evaluations using data captured on a real-world Android device and the MalGenome dataset demonstrate the effectiveness of our approach, in comparison to two hybrid optimization methods which are differential evolution (ANFIS-DE) and ant colony optimization (ANFIS-ACO).	[Afifi, Firdaus; Anuar, Nor Badrul; Shamshirband, Shahaboddin] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA; [Choo, Kim-Kwang Raymond] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA, Australia; [Choo, Kim-Kwang Raymond] China Univ Geosci, Sch Comp Sci, Wuhan, Peoples R China	Universiti Malaya; University of Texas System; University of Texas at San Antonio (UTSA); University of South Australia; China University of Geosciences	Anuar, NB (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.; Choo, KKR (corresponding author), Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA.; Choo, KKR (corresponding author), Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA, Australia.; Choo, KKR (corresponding author), China Univ Geosci, Sch Comp Sci, Wuhan, Peoples R China.	badrul@um.edu.my; raymond.choo@fulbrightmail.org	S.Band, Shahab/AAD-3311-2021; S.Band, Shahab/ABI-7388-2020; Choo, Kim-Kwang Raymond/A-3634-2009; Anuar, Nor Badrul/B-3101-2010; Afifi, Firdaus/P-1969-2019; Afifi, Firdaus/GWD-0977-2022	S.Band, Shahab/0000-0002-8963-731X; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Anuar, Nor Badrul/0000-0003-4380-5303; Afifi, Firdaus/0000-0002-5906-8195; Shamshirband, Shahaboddin/0000-0002-6605-498X	Ministry of Science, Technology and Innovation [eScienceFund 01-01-03-SF0914]	Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by the Ministry of Science, Technology and Innovation, under Grant eScienceFund 01-01-03-SF0914.	Ab Razak MF, 2016, J NETW COMPUT APPL, V75, P58, DOI 10.1016/j.jnca.2016.08.022; Aldair AA, 2011, INT J SMART SENS INT, V4, P224, DOI 10.21307/ijssis-2017-437; Andersson FO, 2000, CHEMOMETR INTELL LAB, V51, P61, DOI 10.1016/S0169-7439(00)00057-5; [Anonymous], 2015, J INFORM PRIVACY SEC, DOI [10.1080/15536548.2015.1073510, DOI 10.1080/15536548.2015.1073510]; Anubis, 2013, AN AN UNKN BIN; Areed FG, 2010, AIN SHAMS ENG J, V1, P71, DOI 10.1016/j.asej.2010.09.008; Azfar A, 2016, ELECTRON COMMER RES, V16, P73, DOI 10.1007/s10660-015-9208-1; Bashir ZA, 2009, IEEE T POWER SYST, V24, P20, DOI 10.1109/TPWRS.2008.2008606; Basser H, 2015, APPL SOFT COMPUT, V30, P642, DOI 10.1016/j.asoc.2015.02.011; Burguera I., 2011, P 1 ACM WORKSHOP SEC, P15, DOI DOI 10.1145/2046614.2046619; Castellano G, 2000, NEUROCOMPUTING, V31, P1, DOI 10.1016/S0925-2312(99)00146-0; Catalao JPS, 2011, IEEE T POWER SYST, V26, P137, DOI 10.1109/TPWRS.2010.2049385; Chan KY, 2011, EXPERT SYST APPL, V38, P9799, DOI 10.1016/j.eswa.2011.02.020; Choo KKR, 2011, COMPUT SECUR, V30, P719, DOI 10.1016/j.cose.2011.08.004; CNET, 2014, ANDR NABS 53 US SMAR; D'Orazio C, 2016, COMPUT SECUR, V56, P94, DOI 10.1016/j.cose.2015.06.009; D'Orazio C, 2015, P ANN HICSS, P5175, DOI 10.1109/HICSS.2015.611; Dastranj M.R., 2011, AUST J BASIC APPL SC, V5, P1499; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dieterle F, 2003, ANAL CHIM ACTA, V490, P71, DOI 10.1016/S0003-2670(03)00338-6; Dimitrakapoulos Dionyssis G., 2011, SECUR COMMUN NETWORK, P1; Distler D, 2001, MALWARE ANAL INTRO; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; Do Q, 2015, COMPUT SECUR, V48, P74, DOI 10.1016/j.cose.2014.10.016; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Egele M, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2089125.2089126; F-Secure, 2014, Q2 2014 MOB THREAT R; Farnden J., 2015, P 21 AM C INF SYST A, P1; Feizollah A., 2014, MALAYSIAN J COMPUT S, V26; Garcia-Teodoro P, 2009, COMPUT SECUR, V28, P18, DOI 10.1016/j.cose.2008.08.003; Global Web Index, 2015, 80 INT US OWN SMARTP; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hosoz M, 2011, EXPERT SYST APPL, V38, P14148, DOI 10.1016/j.eswa.2011.04.225; Huang C.-Y., 2012, ADV INTELLIGENT SYST, V21, P111; Inayat Z, 2016, J NETW COMPUT APPL, V62, P53, DOI 10.1016/j.jnca.2015.12.006; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Javanmardi S, 2015, INT J GRID UTIL COMP, V6, P57, DOI 10.1504/IJGUC.2015.066397; Jiang HM, 2012, APPL SOFT COMPUT, V12, P726, DOI 10.1016/j.asoc.2011.10.020; Juang C, 2010, COMBINATION PARTICLE; Kennedy J, 1998, EVOLUTIONARY PROGRAM, VVII, P579, DOI [10.1007/BFb0040809, DOI 10.1007/BFB0040809]; Khajeh A, 2009, EXPERT SYST APPL, V36, P5728, DOI 10.1016/j.eswa.2008.06.051; Kurnaz S, 2010, EXPERT SYST APPL, V37, P1229, DOI 10.1016/j.eswa.2009.06.009; Kwong CK, 2009, EXPERT SYST APPL, V36, P11262, DOI 10.1016/j.eswa.2009.02.094; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Petkovic D, 2012, NEURAL COMPUT APPL, V21, P2065, DOI 10.1007/s00521-011-0629-z; Petkovic D, 2012, EXPERT SYST APPL, V39, P13295, DOI 10.1016/j.eswa.2012.05.072; Petkovic D, 2012, EXPERT SYST APPL, V39, P9477, DOI 10.1016/j.eswa.2012.02.111; Pooranian Z, 2015, J COMB OPTIM, V30, P413, DOI 10.1007/s10878-013-9644-6; Ravi S, 2011, MOD SIMUL ENG, V2011, DOI 10.1155/2011/101437; Samhouri M, 2009, AIP CONF PROC, V1159, P135, DOI 10.1063/1.3223918; SandDroid, 2013, SANDROID AUT ANDR PR; Sangkatsanee P, 2011, COMPUT COMMUN, V34, P2227, DOI 10.1016/j.comcom.2011.07.001; Scarfone K., 2012, NIST SPEC PUBL, V800-94, P111; Sharif M, 2008, LECT NOTES COMPUT SC, V5283, P481; Shojafar M, 2015, CLUSTER COMPUT, V18, P829, DOI 10.1007/s10586-014-0420-x; Shoorehdeli MA, 2009, APPL SOFT COMPUT, V9, P833, DOI 10.1016/j.asoc.2008.11.001; Singh R, 2012, APPL SOFT COMPUT, V12, P40, DOI 10.1016/j.asoc.2011.09.010; Sivakumar R., 2010, INT J COMPUT APPL, V2, P67, DOI DOI 10.5120/1538-141; Sofge DA, 2002, ARTIF INTELL; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Szor P., 2005, ART COMPUTER VIRUS R; Takagi T., 1983, P IFAC S FUZZ INF KN, P55, DOI [10.1016/S1474-6670(17)62005-6, DOI 10.1016/S1474-6670(17)62005-6]; Techcrunch, 2013, ANDR ACC 79 ALL MOB; Thangaraj R, 2011, APPL MATH COMPUT, V217, P5208, DOI 10.1016/j.amc.2010.12.053; tshark, 2013, TSHARK THE WIR NETW; Van Der Merwe H, 2012, ANAL ANDROID APPL, P1; Wahida B.R.S.D., 2011, INT J MODELING OPTIM, V1, P24, DOI DOI 10.7763/IJM0.2011.V1.5; Walls J, 2015, 2015 IEEE TRUSTCOM/BIGDATASE/ISPA, VOL 1, P1053, DOI 10.1109/Trustcom.2015.482; Yerima SY, 2014, IET INFORM SECUR, V8, P25, DOI 10.1049/iet-ifs.2013.0095; Yu W, 2004, IEEE T FUZZY SYST, V12, P411, DOI 10.1109/TFUZZ.2004.825067; Yuan XH, 2008, ENERG CONVERS MANAGE, V49, P2966, DOI 10.1016/j.enconman.2008.06.017; Zainab AN, 2009, MALAYAS J COMPUT SCI, V22, P1; Zhou YJ, 2012, P IEEE S SECUR PRIV, P95, DOI 10.1109/SP.2012.16	73	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162627	10.1371/journal.pone.0162627	http://dx.doi.org/10.1371/journal.pone.0162627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611312	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000383255900136
J	Anbazhagan, P; Uday, A; Moustafa, SSR; Al-Arifi, NSN				Anbazhagan, P.; Uday, Anjali; Moustafa, Sayed S. R.; Al-Arifi, Nassir S. N.			Pseudo-Spectral Damping Reduction Factors for the Himalayan Region Considering Recorded Ground-Motion Data	PLOS ONE			English	Article							RESPONSE SPECTRA; BUILDINGS; DURATION; SYSTEMS	Ground-motion prediction equations that are used to predict acceleration values are generally developed for a 5% viscous damping ratio. Special structures and structures that use damping devices may have damping ratios other than the conventionally used ratio of 5%. Hence, for such structures, the intensity measures predicted by conventional ground-motion prediction equations need to be converted to a particular level of damping using a damping reduction factor (DRF). DRF is the ratio of the spectral ordinate at 5% damping to the ordinate at a defined level of damping. In this study, the DRF has been defined using the spectral ordinate of pseudo-spectral acceleration and the effect of factors such as the duration of ground motion, magnitude, hypocenter distance, site classification, damping, and period are studied. In this study, an attempt has also been made to develop an empirical model for the DRF that is specifically applicable to the Himalayan region in terms of these predictor variables. A recorded earthquake with 410 horizontal motions was used, with data characterized by magnitudes ranging from 4 to 7.8 and hypocentral distances up to 520 km. The damping was varied from 0.5-30% and the period range considered was 0.02 to 10 s. The proposed model was compared and found to coincide well with models in the existing literature. The proposed model can be used to compute the DRF at any specific period, for any given value of predictor variables.	[Anbazhagan, P.; Uday, Anjali] Indian Inst Sci, Dept Civil Engn, Bangalore, Karnataka, India; [Anbazhagan, P.; Moustafa, Sayed S. R.; Al-Arifi, Nassir S. N.] King Saud Univ, Dept Geol & Geophys, Riyadh, Saudi Arabia; [Moustafa, Sayed S. R.] Natl Res Inst Astron & Geophys, Seismol Dept, Cairo, Egypt	Indian Institute of Science (IISC) - Bangalore; King Saud University; Egyptian Knowledge Bank (EKB); National Research Institute of Astronomy & Geophysics - NRIAG	Anbazhagan, P (corresponding author), Indian Inst Sci, Dept Civil Engn, Bangalore, Karnataka, India.; Anbazhagan, P (corresponding author), King Saud Univ, Dept Geol & Geophys, Riyadh, Saudi Arabia.	anbazhagan2005@gmail.com	Al-Arifi, Nassir N/B-3626-2014; Panjamani, Anbazhagan/D-3720-2014; Moustafa, Sayed S. R./Q-1832-2019; Moustafa, Sayed/J-1494-2019	Panjamani, Anbazhagan/0000-0001-9804-5423; 	Science and Engineering Research Board (SERB), Department of Science and Technology (DST), India [SERB/F/162/2015-2016]; Deanship of Scientific Research at the King Saud University [PRG-1436-06]	Science and Engineering Research Board (SERB), Department of Science and Technology (DST), India; Deanship of Scientific Research at the King Saud University	The first author thanks the Science and Engineering Research Board (SERB), Department of Science and Technology (DST), India, for funding the project titled, "Measurement of shear wave velocity at deep soil sites and site response studies," Ref: SERB/F/162/2015-2016. The authors extend their sincere appreciation to the Deanship of Scientific Research at the King Saud University for funding this Prolific Research Group (PRG-1436-06).	Ashour S. A., 1987, THESIS U MICHIGAN; Atkinson GM, 2004, SEISMOL RES LETT, V75, P541, DOI 10.1785/gssrl.75.4.541; Bommer JJ, 2005, EARTHQ ENG STRUCT D, V34, P145, DOI 10.1002/eqe.414; Cameron WI, 2007, B SEISMOL SOC AM, V97, P934, DOI 10.1785/0120060034; Cardone D, 2009, B EARTHQ ENG, V7, P273, DOI 10.1007/s10518-008-9097-y; Hatzigeorgiou GD, 2010, EARTHQ ENG STRUCT D, V39, P1239, DOI 10.1002/eqe.991; Idriss I.M., 1993, 93625 NIST GCR; Kempton JJ, 2006, EARTHQ SPECTRA, V22, P985, DOI 10.1193/1.2358175; Kumar A, 2012, SEISMOL RES LETT, V83, P59, DOI 10.1785/gssrl.83.1.59; Lin YY, 2005, EARTHQ ENG STRUCT D, V34, P1427, DOI 10.1002/eqe.499; Lin YY, 2004, J STRUCT ENG-ASCE, V130, P1667, DOI 10.1061/(ASCE)0733-9445(2004)130:11(1667); Lin YY, 2003, J STRUCT ENG-ASCE, V129, P206, DOI 10.1061/(ASCE)0733-9445(2003)129:2(206); Malhotra PK, 2006, B SEISMOL SOC AM, V96, P506, DOI 10.1785/0120050062; Mittal H., 2012, INT J GEOSCI, V3, P1151, DOI [10.4236/ijg.2012.326117, DOI 10.4236/IJG.2012.326117]; Naeim F, 2001, STRUCT DES TALL BUIL, V10, P361, DOI 10.1002/tal.180; Newmark N. M., 1982, EARTHQUAKE SPECTRA D; Priestley MJN, 2003, MALL MILN LECT I U S; Ramirez OM, 2002, EARTHQ SPECTRA, V18, P531, DOI 10.1193/1.1509762; Rezaeian S, 2014, EARTHQ SPECTRA, V30, P939, DOI 10.1193/100512EQS298M; Simon G., 2001, DURATION CHARACTERIS; Stafford PJ, 2008, J STRUCT ENG-ASCE, V134, P1364, DOI 10.1061/(ASCE)0733-9445(2008)134:8(1364); Tolis SV, 1999, J EARTHQ ENG, V3, P107, DOI 10.1142/S1363246999000065; WU JP, 1989, J STRUCT ENG-ASCE, V115, P1412, DOI 10.1061/(ASCE)0733-9445(1989)115:6(1412)	23	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161137	10.1371/journal.pone.0161137	http://dx.doi.org/10.1371/journal.pone.0161137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611854	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900012
J	Mallet, JD; Dorr, MM; Desgarnier, MCD; Bastien, N; Gendron, SP; Rochette, PJ				Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.			Faster DNA Repair of Ultraviolet-Induced Cyclobutane Pyrimidine Dimers and Lower Sensitivity to Apoptosis in Human Corneal Epithelial Cells than in Epidermal Keratinocytes	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; MOLECULAR-MECHANISMS; XPC PROTEIN; DAMAGED DNA; UV DAMAGE; PHOTOPRODUCTS; LIGHT; P53; EPIDEMIOLOGY	Absorption of UV rays by DNA generates the formation of mutagenic cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) pyrimidone photoproducts (6-4PP). These damages are the major cause of skin cancer because in turn, they can lead to signature UV mutations. The eye is exposed to UV light, but the cornea is orders of magnitude less prone to UV-induced cancer. In an attempt to shed light on this paradox, we compared cells of the corneal epithelium and the epidermis for UVB-induced DNA damage frequency, repair and cell death sensitivity. We found similar CPD levels but a 4-time faster UVB-induced CPD, but not 6-4PP, repair and lower UV-induced apoptosis sensitivity in corneal epithelial cells than epidermal. We then investigated levels of DDB2, a UV-induced DNA damage recognition protein mostly impacting CPD repair, XPC, essential for the repair of both CPD and 6-4PP and p53 a protein upstream of the genotoxic stress response. We found more DDB2, XPC and p53 in corneal epithelial cells than in epidermal cells. According to our results analyzing the protein stability of DDB2 and XPC, the higher level of DDB2 and XPC in corneal epithelial cells is most likely due to an increased stability of the protein. Taken together, our results show that corneal epithelial cells have a better efficiency to repair UV-induced mutagenic CPD. On the other hand, they are less prone to UV-induced apoptosis, which could be related to the fact that since the repair is more efficient in the HCEC, the need to eliminate highly damaged cells by apoptosis is reduced.	[Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.] Univ Laval, Hop St Sacrement, CHU Quebec, Axe Med Regeneratrice,Ctr Rech, Quebec City, PQ, Canada; [Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.] Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada; [Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.] Univ Laval, Dept Ophtalmol & ORL Chirurg Cerv Faciale, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Rochette, PJ (corresponding author), Univ Laval, Hop St Sacrement, CHU Quebec, Axe Med Regeneratrice,Ctr Rech, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, Dept Ophtalmol & ORL Chirurg Cerv Faciale, Quebec City, PQ, Canada.	Patrick.rochette@orlo.ulaval.ca	Rochette, Patrick/HHN-2300-2022	Rochette, Patrick/0000-0002-0678-8869	Natural Sciences and Engineering Research Council of Canada; Reseau de recherche en sante de la vision du FRQS;  [RGPIN-2016-05864]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Reseau de recherche en sante de la vision du FRQS; 	This work was supported by Grant number: RGPIN-2016-05864; Funding agency: Natural Sciences and Engineering Research Council of Canada; Website: http://www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to La Banque de cellules du LOEX for providing NHEK and to La Banque de tissus oculaires du CUO de Quebec, supported by the Reseau de recherche en sante de la vision du FRQS for providing eye specimens.	Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; ANANTHASWAMY HN, 1990, PHOTOCHEM PHOTOBIOL, V52, P1119, DOI 10.1111/j.1751-1097.1990.tb08452.x; [Anonymous], 1985, MUTAT RES, DOI 10.1016/j.mrrev.2008.09.001; Araujo SJ, 2000, GENE DEV, V14, P349; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Barckhausen C, 2014, ONCOGENE, V33, P1964, DOI 10.1038/onc.2013.141; Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; BERGSTRESSER PR, 1978, J INVEST DERMATOL, V70, P280, DOI 10.1111/1523-1747.ep12541516; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Brash DE, 2005, SEMIN CANCER BIOL, V15, P97, DOI 10.1016/j.semcancer.2004.08.006; Brash DE, 2001, J INVEST DERMATOL, V117, P1234, DOI 10.1046/j.0022-202x.2001.01554.x; BRASH DE, 1988, PHOTOCHEM PHOTOBIOL, V48, P59; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; Choy CKM, 2011, OPTOMETRY VISION SCI, V88, P507, DOI 10.1097/OPX.0b013e31820e9fe2; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cook BE, 1999, OPHTHALMOLOGY, V106, P746, DOI 10.1016/S0161-6420(99)90161-6; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Ferguson-Yates BE, 2008, CARCINOGENESIS, V29, P70, DOI 10.1093/carcin/bgm244; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Han WN, 2011, J BIOL CHEM, V286, P22825, DOI 10.1074/jbc.M111.222349; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hey T, 2002, BIOCHEMISTRY-US, V41, P6583, DOI 10.1021/bi012202t; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; Holmquist GP, 1997, MUTAT RES-REV MUTAT, V386, P69, DOI 10.1016/S1383-5742(96)00045-2; HUTCHINSON F, 1994, MUTAT RES-FUND MOL M, V309, P11, DOI 10.1016/0027-5107(94)90037-X; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Jin SK, 2001, J CELL SCI, V114, P4139; Kao AA, 2012, OPHTHALMOLOGY, V119, P1773, DOI 10.1016/j.ophtha.2012.02.049; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Knezevic D, 2007, P NATL ACAD SCI USA, V104, P11286, DOI 10.1073/pnas.0701318104; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kulms D, 2002, SKIN PHARMACOL APPL, V15, P342, DOI 10.1159/000064539; LEBKOWSKI JS, 1985, P NATL ACAD SCI USA, V82, P8606, DOI 10.1073/pnas.82.24.8606; LEE GA, 1994, OPHTHALMOLOGY, V101, P360; Lerman S., 1980, RADIANT ENERGY EYE, P73; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallet JD, 2013, PHOTOCH PHOTOBIO SCI, V12, P1310, DOI 10.1039/c3pp25408a; Mallet JD, 2011, PHOTOCHEM PHOTOBIOL, V87, P1363, DOI 10.1111/j.1751-1097.2011.00977.x; MCGREGOR WG, 1991, MOL CELL BIOL, V11, P1927, DOI 10.1128/MCB.11.4.1927; MILLER JH, 1983, ANNU REV GENET, V17, P215, DOI 10.1146/annurev.ge.17.120183.001243; Mitchell DL, 1985, MUTAT RES, V143, P109; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Newton R, 1996, LANCET, V347, P1450, DOI 10.1016/S0140-6736(96)91685-2; Nijhof JGW, 2007, CARCINOGENESIS, V28, P792, DOI 10.1093/carcin/bgl213; NORREN DV, 1974, VISION RES, V14, P1237, DOI 10.1016/0042-6989(74)90222-3; Norval M, 2007, PHOTOCH PHOTOBIO SCI, V6, P232, DOI 10.1039/b700018a; Oh KS, 2011, PHOTOCHEM PHOTOBIOL, V87, P729, DOI 10.1111/j.1751-1097.2011.00909.x; Oh KS, 2011, J INVEST DERMATOL, V131, P785, DOI 10.1038/jid.2010.352; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022; Ramkumar HL, 2011, SURV OPHTHALMOL, V56, P348, DOI 10.1016/j.survophthal.2011.03.001; Ramos T, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/601731; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007; Rochette PJ, 2006, PHOTOCHEM PHOTOBIOL, V82, P1370, DOI 10.1562/2004-12-01-RA-390; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; SAGE E, 1993, PHOTOCHEM PHOTOBIOL, V57, P163, DOI 10.1111/j.1751-1097.1993.tb02273.x; Sasaki H, 2011, EYE CONTACT LENS, V37, P191, DOI 10.1097/ICL.0b013e31821fbf29; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Shields CL, 2004, SURV OPHTHALMOL, V49, P3, DOI 10.1016/j.survophthal.2003.10.008; Shimmura S, 2006, OCUL SURF, V4, P74, DOI 10.1016/S1542-0124(12)70029-0; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun EC, 1997, CANCER EPIDEM BIOMAR, V6, P73; TAYLOR HR, 1989, PHOTOCHEM PHOTOBIOL, V50, P489, DOI 10.1111/j.1751-1097.1989.tb05553.x; Thilly W G, 1983, Basic Life Sci, V23, P337; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Xu GG, 2000, J INVEST DERMATOL, V114, P628, DOI 10.1046/j.1523-1747.2000.00943.x; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211; YOUNG RW, 1994, OPTOMETRY VISION SCI, V71, P125, DOI 10.1097/00006324-199402000-00013; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198	88	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162212	10.1371/journal.pone.0162212	http://dx.doi.org/10.1371/journal.pone.0162212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611318	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900058
J	Pakanen, VM; Orell, M; Vatka, E; Rytkonen, S; Broggi, J				Pakanen, Veli-Matti; Orell, Markku; Vatka, Emma; Rytkonen, Seppo; Broggi, Juli			Different Ultimate Factors Define Timing of Breeding in Two Related Species	PLOS ONE			English	Article							TIT PARUS-MONTANUS; CLIMATE-CHANGE; GREAT TITS; POPULATION FLUCTUATIONS; TROPHIC INTERACTIONS; FOOD AVAILABILITY; SOCIAL-DOMINANCE; NORTHERN FINLAND; CLUTCH-SIZE; MARSH TIT	Correct reproductive timing is crucial for fitness. Breeding phenology even in similar species can differ due to different selective pressures on the timing of reproduction. These selection pressures define species' responses to warming springs. The temporal match-mismatch hypothesis suggests that timing of breeding in animals is selected to match with food availability (synchrony). Alternatively, time-dependent breeding success (the date hypothesis) can result from other seasonally deteriorating ecological conditions such as intra-or interspecific competition or predation. We studied the effects of two ultimate factors on the timing of breeding, synchrony and other time-dependent factors (time-dependence), in sympatric populations of two related forest-dwelling passerine species, the great tit (Parus major) and the willow tit (Poecile montanus) by modelling recruitment with long-termcapture-recapture data. We hypothesized that these two factors have different relevance for fitness in these species. We found that local recruitment in both species showed quadratic relationships with both time-dependence and synchrony. However, the importance of these factors was markedly different between the studied species. Caterpillar food played a predominant role in predicting the timing of breeding of the great tit. In contrast, for the willow tit time-dependence modelled as timing in relation to conspecifics was more important for local recruitment than synchrony. High caterpillar biomass experienced during the pre- and post-fledging periods increased local recruitment of both species. These contrasting results confirm that these species experience different selective pressures upon the timing of breeding, and hence responses to climate change may differ. Detailed information about life-history strategies is required to understand the effects of climate change, even in closely related taxa. The temporal match-mismatch hypothesis should be extended to consider subsequent critical periods when food needs to be abundantly available.	[Pakanen, Veli-Matti; Orell, Markku; Vatka, Emma; Rytkonen, Seppo] Univ Oulu, Dept Ecol, POB 3000, FIN-90014 Oulu, Finland; [Broggi, Juli] UO CISC, Res Unit Biodivers, UMIB, PA, Ed Invest 5a C Gonzalo Gutierrez Quiros S-N, Mieres 33600, Spain; [Broggi, Juli] Lund Univ, Sect Evolutionary Ecol, Dept Biol, S-22362 Lund, Sweden	University of Oulu; Lund University	Pakanen, VM (corresponding author), Univ Oulu, Dept Ecol, POB 3000, FIN-90014 Oulu, Finland.	veli-matti.pakanen@oulu.fi	Broggi, Juli/AAB-1796-2020; Pakanen, Veli-Matti/L-8134-2015	Pakanen, Veli-Matti/0000-0003-4838-9927; Broggi, Juli/0000-0002-1706-4014	Academy of Finland, Research Council for Biosciences and Environment [128193, 258638, 278759]; Thule Institute of the University of Oulu; Foundations' Professor Pool	Academy of Finland, Research Council for Biosciences and Environment(Academy of Finland); Thule Institute of the University of Oulu; Foundations' Professor Pool	The Academy of Finland, Research Council for Biosciences and Environment (to MO, project numbers 128193 and 258638; to VMP, project number 278759) http://www.aka.fi/en/, Thule Institute of the University of Oulu (to MO) http://www.oulu.fi/thuleinstitute/, and Foundations' Professor Pool (to MO) http://www.professoripooli.fi/index_en.php?cat=1&lang=3.	Ahola MP, 2009, J ANIM ECOL, V78, P1298, DOI 10.1111/j.1365-2656.2009.01596.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dias PC, 1996, IBIS, V138, P644, DOI 10.1111/j.1474-919X.1996.tb04766.x; DRENT RH, 1980, ARDEA, V68, P225; Drent RH, 2006, ARDEA, V94, P305; DUNN E K, 1976, British Birds, V69, P45; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Eeva T, 2012, J ORNITHOL, V153, P653, DOI 10.1007/s10336-011-0783-1; Eeva T, 2000, CAN J ZOOL, V78, P67, DOI 10.1139/cjz-78-1-67; EKMAN J, 1989, WILSON BULL, V101, P263; Garcia-Navas V, 2011, OECOLOGIA, V165, P639, DOI 10.1007/s00442-010-1858-z; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; Goodenough AE, 2011, BIRD STUDY, V58, P221, DOI 10.1080/00063657.2010.548006; Goodenough AE, 2010, CLIMATIC CHANGE, V102, P687, DOI 10.1007/s10584-010-9932-4; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Harrap S, 1996, TITS NUTHACHES TREEC; Johansson J, 2014, J ANIM ECOL, V83, P440, DOI 10.1111/1365-2656.12151; KOIVULA K, 1993, BEHAV ECOL SOCIOBIOL, V33, P283, DOI 10.1007/BF02027126; Koivula K, 1996, IBIS, V138, P624, DOI 10.1111/j.1474-919X.1996.tb04763.x; Lambrechts MM, 2000, ECOGRAPHY, V23, P525, DOI 10.1034/j.1600-0587.2000.230502.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LENS L, 1993, BEHAV ECOL SOCIOBIOL, V33, P79; Lof ME, 2012, P ROY SOC B-BIOL SCI, V279, P3161, DOI 10.1098/rspb.2012.0431; MINOT EO, 1981, J ANIM ECOL, V50, P375, DOI 10.2307/4061; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; NILSSON JA, 1989, J ANIM ECOL, V58, P619, DOI 10.2307/4852; NILSSON JA, 1988, J ANIM ECOL, V57, P917, DOI 10.2307/5101; ORELL M, 1989, IBIS, V131, P112, DOI 10.1111/j.1474-919X.1989.tb02750.x; ORELL M, 1983, ANN ZOOL FENN, V20, P99; ORELL M, 1983, HOLARCTIC ECOL, V6, P413; ORELL M, 1983, ARDEA, V71, P183; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Post E, 2001, P ROY SOC B-BIOL SCI, V268, P15, DOI 10.1098/rspb.2000.1324; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2013, SCIENCE, V340, P488, DOI 10.1126/science.1232870; Rytkonen S, 1996, J AVIAN BIOL, V27, P21, DOI 10.2307/3676957; Rytkonen S, 2003, J AVIAN BIOL, V34, P288, DOI 10.1034/j.1600-048X.2003.03041.x; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; VANBALEN JH, 1973, ARDEA, V61, P1; Vatka E, 2016, GLOBAL CHANGE BIOL, V22, P1585, DOI 10.1111/gcb.13144; Vatka E, 2014, OECOLOGIA, V176, P595, DOI 10.1007/s00442-014-3022-7; Vatka E, 2011, GLOBAL CHANGE BIOL, V17, P3002, DOI 10.1111/j.1365-2486.2011.02430.x; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2012, J ORNITHOL, V153, pS75, DOI 10.1007/s10336-011-0770-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Wesolowski T, 1998, ARDEA, V86, P89; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; ZANDT HS, 1994, OECOLOGIA, V97, P399, DOI 10.1007/BF00317331	55	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162643	10.1371/journal.pone.0162643	http://dx.doi.org/10.1371/journal.pone.0162643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611971	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900143
J	Rucker, V; Keil, U; Fitzgerald, AP; Malzahn, U; Prugger, C; Ertl, G; Heuschmann, PU; Neuhauser, H				Ruecker, Viktoria; Keil, Ulrich; Fitzgerald, Anthony P.; Malzahn, Uwe; Prugger, Christof; Ertl, Georg; Heuschmann, Peter U.; Neuhauser, Hannelore			Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MONICA AUGSBURG; POPULATION; PREVALENCE; VALIDATION; MORTALITY; ABSOLUTE; TOOL	Estimation of absolute risk of cardiovascular disease (CVD), preferably with population-specific risk charts, has become a cornerstone of CVD primary prevention. Regular recalibration of risk charts may be necessary due to decreasing CVD rates and CVD risk factor levels. The SCORE risk charts for fatal CVD risk assessment were first calibrated for Germany with 1998 risk factor level data and 1999 mortality statistics. We present an update of these risk charts based on the SCORE methodology including estimates of relative risks from SCORE, risk factor levels from the German Health Interview and Examination Survey for Adults 2008-11 (DEGS1) and official mortality statistics from 2012. Competing risks methods were applied and estimates were independently validated. Updated risk charts were calculated based on cholesterol, smoking, systolic blood pressure risk factor levels, sex and 5-year age-groups. The absolute 10-year risk estimates of fatal CVD were lower according to the updated risk charts compared to the first calibration for Germany. In a nationwide sample of 3062 adults aged 40-65 years free of major CVD from DEGS1, the mean 10-year risk of fatal CVD estimated by the updated charts was lower by 29% and the estimated proportion of high risk people (10-year risk > = 5%) by 50% compared to the older risk charts. This recalibration shows a need for regular updates of risk charts according to changes in mortality and risk factor levels in order to sustain the identification of people with a high CVD risk.	[Ruecker, Viktoria; Malzahn, Uwe; Heuschmann, Peter U.] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Keil, Ulrich] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Fitzgerald, Anthony P.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Dept Stat, Cork, Ireland; [Malzahn, Uwe; Heuschmann, Peter U.] Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany; [Prugger, Christof] Charite, Inst Publ Hlth, Berlin, Germany; [Ertl, Georg] Univ Hosp Wurzburg, Dept Med 1, Wurzburg, Germany; [Ertl, Georg; Heuschmann, Peter U.] Univ Wurzburg, Comprehens Heart Failure Ctr Wurzburg, Wurzburg, Germany; [Neuhauser, Hannelore] Robert Koch Inst Berlin, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Neuhauser, Hannelore] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany	University of Wurzburg; University of Munster; University College Cork; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Wurzburg; Robert Koch Institute; German Centre for Cardiovascular Research	Neuhauser, H (corresponding author), Robert Koch Inst Berlin, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.; Neuhauser, H (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	neuhauserh@rki.de	Fitzgerald, Tony/AAB-5331-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Prugger, Christof/0000-0003-1845-0950; Neuhauser, Hannelore K./0000-0002-6605-6221; Fitzgerald, Tony/0000-0001-6437-5686	German Centre of Cardiovascular Research, DZHK [MDC2014Z3]; Federal Ministry of Education and Research (BMBF); BMBF (German Ministry of Education and Research); German Cardiac Society	German Centre of Cardiovascular Research, DZHK; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Cardiac Society	The work of VR has been supported by the German Centre of Cardiovascular Research, DZHK, grant MDC2014Z3 (http://dzhk.de/en/). The DZHK is funded by the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). We thank the German Cardiac Society for their general support and Dr. Beyersmann, Ulm, for statistical comments.	[Anonymous], 1999, GESUNDHEITSWESEN, V61, P121; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2016, EUR J PREV CARDIOL, V23, P1093, DOI 10.1177/2047487315588390; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; De Backer G, 2003, ATHEROSCLEROSIS, V171, P145, DOI 10.1016/j.atherosclerosis.2003.10.001; Diener A, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-13; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Germano G, 2012, EUR HEART J, V33, P137; Gohlke H, 2007, EUR J CARDIOV PREV R, V14, P141, DOI 10.1097/01.hjr.0000244581.30421.69; Hense H.-W., 2005, DTSCH ARZTEBL, V102, P1808; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jackson R, 2000, BMJ-BRIT MED J, V320, P659, DOI 10.1136/bmj.320.7236.659; Jdanov DA, 2014, EUR J EPIDEMIOL, V29, P621, DOI 10.1007/s10654-014-9947-7; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Marques-Vidal P, 2008, EUR J CARDIOV PREV R, V15, P402, DOI 10.1097/HJR.0b013e3282fb040f; Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; Neuhauser HK, 2015, J HUM HYPERTENS, V29, P247, DOI 10.1038/jhh.2014.82; Panagiotakos Demosthenes B, 2007, Hellenic J Cardiol, V48, P55; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Thamm M, 1999, Gesundheitswesen, V61 Spec No, pS90; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; Truthmann J, 2015, P 10 M GERM EP SOC; van Dis I, 2010, EUR J CARDIOV PREV R, V17, P244, DOI 10.1097/HJR.0b013e328337cca2	29	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162188	10.1371/journal.pone.0162188	http://dx.doi.org/10.1371/journal.pone.0162188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612145	Green Published, gold			2022-12-27	WOS:000383255900053
J	Lin, ZG; Page, P; Li, L; Qin, Y; Zhang, YY; Hu, FL; Neumann, P; Zheng, HQ; Dietemann, V				Lin, Zheguang; Page, Paul; Li, Li; Qin, Yao; Zhang, Yingying; Hu, Fuliang; Neumann, Peter; Zheng, Huoqing; Dietemann, Vincent			Go East for Better Honey Bee Health: Apis cerana Is Faster at Hygienic Behavior than A. mellifera	PLOS ONE			English	Article							VARROA-JACOBSONI OUD; AMERICAN FOULBROOD; COLONY LOSSES; BROOD; HYMENOPTERA; RESISTANCE; DISEASE; APIDAE; DESTRUCTOR; RESPONSES	The poor health status of the Western honey bee, Apis mellifera, compared to its Eastern counterpart, Apis cerana, is remarkable. This has been attributed to lower pathogen prevalence in A. cerana colonies and to their ability to survive infestations with the ectoparasitic mite, Varroa destructor. These properties have been linked to an enhanced removal of dead or unhealthy immature bees by adult workers in this species. Although such hygienic behavior is known to contribute to honey bee colony health, comparative data of A. mellifera and A. cerana in performing this task are scarce. Here, we compare for the first time the removal of freeze-killed brood in one population of each species and over two seasons in China. Our results show that A. cerana was significantly faster than A. mellifera at both opening cell caps and removing freeze-killed brood. The fast detection and removal of diseased brood is likely to limit the proliferation of pathogenic agents. Given our results can be generalized to the species level, a rapid hygienic response could contribute to the better health of A. cerana. Promoting the fast detection and removal of worker brood through adapted breeding programs could further improve the social immunity of A. mellifera colonies and contribute to a better health status of the Western honey bee worldwide.	[Lin, Zheguang; Li, Li; Qin, Yao; Zhang, Yingying; Hu, Fuliang; Zheng, Huoqing] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Page, Paul; Dietemann, Vincent] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Neumann, Peter] Chiang Mai Univ, Dept Biol, Bee Protect Lab, Fac Sci, Chiang Mai, Thailand; [Neumann, Peter; Dietemann, Vincent] Univ Pretoria, Dept Zool & Entomol, Social Insect Res Grp, Pretoria, South Africa	Zhejiang University; Swiss Federal Research Station Agroscope; University of Bern; Chiang Mai University; University of Pretoria	Zheng, HQ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China.	hqzheng@zju.edu.cn	Zheng, Huoqing/AAQ-3307-2021; Neumann, Peter/C-9964-2015	Neumann, Peter/0000-0001-5163-5215	Modern Agro-industry Technology Research System [CARS-45]; Science and Technology Department of Zhejiang Province, China [2012C12906-19]; Fundamental Research Funds for the Central Universities; Swiss National Science Foundation grant [31003A_147363]; Vinetum Foundation	Modern Agro-industry Technology Research System; Science and Technology Department of Zhejiang Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Vinetum Foundation	This work was supported by Modern Agro-industry Technology Research System (No. CARS-45) and Science and Technology Department of Zhejiang Province, China (No. 2012C12906-19) to F.H., by the Fundamental Research Funds for the Central Universities to H.Z., by a Swiss National Science Foundation grant (No. 31003A_147363) to V.D. and P.N. and by the Vinetum Foundation to P.N. All of the funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Palacio MA, 2010, APIDOLOGIE, V41, P602, DOI 10.1051/apido/2010022; ANDERSON DL, 1989, MITES PATHOGENS EURO; Athreya S.V.R., 2013, Current Biotica, V7, P101; BOECKING O, 1992, EXP APPL ACAROL, V16, P321, DOI 10.1007/BF01218574; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Briggs CJ, 1996, THEOR POPUL BIOL, V50, P149, DOI 10.1006/tpbi.1996.0027; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; Chantawannakul P, 2016, APIDOLOGIE, V47, P301, DOI 10.1007/s13592-015-0407-5; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YW, 2000, J APICULT RES, V39, P169, DOI 10.1080/00218839.2000.11101038; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Danka RG, 2013, APIDOLOGIE, V44, P447, DOI 10.1007/s13592-013-0195-8; de Guzman LI, 2015, J APICULT RES, V54, P216, DOI 10.1080/00218839.2015.1117294; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; GILLIAM M, 1983, APIDOLOGIE, V14, P29, DOI 10.1051/apido:19830103; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; Gramacho KP, 2003, BEHAV ECOL SOCIOBIOL, V54, P472, DOI 10.1007/s00265-003-0643-y; Harbo JR, 1999, J ECON ENTOMOL, V92, P261, DOI 10.1093/jee/92.2.261; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Jung JW, 2014, J ASIA-PAC ENTOMOL, V17, P639, DOI 10.1016/j.aspen.2014.01.012; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Liang Q, 2009, BEE PROTECTION; Masterman R, 2000, J INSECT BEHAV, V13, P87, DOI 10.1023/A:1007767626594; Meunier J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0102; MILNE CP, 1985, ANN ENTOMOL SOC AM, V78, P841, DOI 10.1093/aesa/78.6.841; Mondet F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25444; Mondet F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10454; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; Neumann P, 2012, TRENDS PARASITOL, V28, P353, DOI 10.1016/j.pt.2012.06.004; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Page P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27210; Pajuelo AG, 2008, J APICULT RES, V47, P84, DOI 10.1080/00218839.2008.11101429; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; PENG YSC, 1987, J INVERTEBR PATHOL, V49, P259, DOI [10.1016/0022-2011(87)90125-X, 10.1016/0022-2011(87)90057-7]; Rasolofoarivao H, 2015, GENET MOL RES, V14, P5879, DOI 10.4238/2015.June.1.5; RATH W, 1990, APIDOLOGIE, V21, P311, DOI 10.1051/apido:19900406; ROSENKRANZ P, 1993, J APICULT RES, V32, P89, DOI 10.1080/00218839.1993.11101292; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; ROTHENBUHLER WC, 1964, AM ZOOL, V4, P111; Soroker V, 2011, APIDOLOGIE, V42, P192, DOI 10.1051/apido/2010047; Spivak M, 1998, APIDOLOGIE, V29, P291, DOI 10.1051/apido:19980308; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Spivak M, 1998, BEE WORLD, V79, P169, DOI 10.1080/0005772X.1998.11099408; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Spivak M, 1998, J ECON ENTOMOL, V91, P64, DOI 10.1093/jee/91.1.64; Strange JP, 2009, J ECON ENTOMOL, V102, P485, DOI 10.1603/029.102.0204; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Topolska G, 2010, J APICULT RES, V49, P126, DOI 10.3896/IBRA.1.49.1.27; Toufailia HMA, 2015, J APICULT RES, V53, P555; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Woltedji D, 2012, J PROTEOME RES, V11, P4526, DOI 10.1021/pr300298w; Xonis C., 2015, Bulgarian Journal of Agricultural Science, V21, P674; Yanez O, 2015, J APICULT RES, V54, P179, DOI 10.1080/00218839.2015.1128145; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Zhao HX, 2015, GENET MOL RES, V14, P6482, DOI 10.4238/2015.June.12.1	59	23	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162647	10.1371/journal.pone.0162647	http://dx.doi.org/10.1371/journal.pone.0162647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606819	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600071
J	Ludzik, J; Witkowski, AM; Roterman-Konieczna, I; Bassoli, S; Farnetani, F; Pellacani, G				Ludzik, J.; Witkowski, A. M.; Roterman-Konieczna, I.; Bassoli, S.; Farnetani, F.; Pellacani, G.			Improving Diagnostic Accuracy of Dermoscopically Equivocal Pink Cutaneous Lesions with Reflectance Confocal Microscopy in Telemedicine Settings: Double Reader Concordance Evaluation of 316 Cases	PLOS ONE			English	Article							IN-VIVO; MELANOMA DETECTION; SKIN-LESIONS; MULTICENTER; TELEDERMATOLOGY; TELEDIAGNOSIS; PERFORMANCE; TOMOGRAPHY; TUMORS; FACE	Background Solitary pink lesions in differential diagnosis with hypopigmented/amelanotic melanoma present a diagnostic challenge in daily practice and are regularly referred for second expert opinion. Reflectance confocal microscopy (RCM) has been shown to improve diagnostic accuracy of dermoscopically equivocal pink lesions. No studies have been performed to evaluate the effect of adding a second expert reader and automatic removal of lesions with discordant management recommendations and its potential effect on diagnostic sensitivity and final management of these lesions in retrospective or telemedicine settings. Objective To improve diagnostic accuracy and reduce potential mismanagement of dermoscopically equivocal pink cutaneous lesions by implementing double reader concordance evaluation of RCM images. Methods 316 dermoscopically equivocal pink lesions with dermoscopy-RCM image sets were evaluated retrospectively. Accuracy of three readers was evaluated by single reader evaluation of dermoscopy only and dermoscopy-RCM image sets and finally by double reader evaluation of dermoscopy-RCM image sets. Lesions with discordant diagnosis between two readers were automatically recommended for excision. Results Dermoscopy only evaluation resulted in an overall sensitivity of 95.9% and specificity of 33.6%, with 1 of 12 amelanotic melanomas mismanaged. Dermoscopy-RCM image set single reader evaluation resulted in an overall sensitivity of 93.9% and overall specificity of 54.2%, with 1 of 12 melanomas mismanaged. Dermoscopy-RCM image set double reader concordance evaluation resulted in an overall sensitivity of 98.3% and specificity of 42.7%, with no amelanotic melanoma mismanagement. Conclusion Evaluation of dermoscopy-RCM image sets of equivocal pink lesions by a single reader in telemedicine settings is limited by the potential for misdiagnosis of dangerous malignant lesions. Double reader concordance evaluation with automatic referral of lesions for removal in the case of discordant diagnosis improves the diagnostic sensitivity in this subset of lesions and reduce potential misdiagnosis in settings where a second expert opinion may be employed.	[Ludzik, J.; Witkowski, A. M.; Bassoli, S.; Farnetani, F.; Pellacani, G.] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy; [Ludzik, J.; Roterman-Konieczna, I.] Jagiellonian Univ, Coll Med, Dept Biostat & Telemed, Krakow, Poland	Universita di Modena e Reggio Emilia; Jagiellonian University; Collegium Medicum Jagiellonian University	Witkowski, AM (corresponding author), Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy.	alexander.witkowski@unimore.it	pellacani, giovanni/E-8573-2011	pellacani, giovanni/0000-0002-7222-2951; farnetani, francesca/0000-0001-7088-9077	European grant DIAGNOPTICS [CIP-ICT-PSP.2013.3.5, 621066]	European grant DIAGNOPTICS	The study has been supported by the European grant DIAGNOPTICS, call CIP-ICT-PSP.2013.3.5 (grant no. 621066). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardigo M, 2015, BRIT J DERMATOL, V173, P6, DOI 10.1111/bjd.13820; Argenziano G, 2012, J AM ACAD DERMATOL, V67, P54, DOI 10.1016/j.jaad.2011.07.019; Arzberger E, 2016, ACTA DERM VENEREOL; Bashshur RL, 2015, TELEMED E-HEALTH, V21, P953, DOI 10.1089/tmj.2015.0146; Braga JCT, 2009, J AM ACAD DERMATOL, V61, P230, DOI 10.1016/j.jaad.2009.02.036; Coates SJ, 2015, J AM ACAD DERMATOL, V72, P577, DOI 10.1016/j.jaad.2014.08.014; Dimitrow E, 2009, J INVEST DERMATOL, V129, P1752, DOI 10.1038/jid.2008.439; Fabbrocini G, 2008, J EUR ACAD DERMATOL, V22, P229, DOI 10.1111/j.1468-3083.2007.02400.x; Farnetani F, 2015, JAMA DERMATOL, V151, P1075, DOI 10.1001/jamadermatol.2015.0810; Ferrara G, 2004, J TELEMED TELECARE, V10, P34, DOI 10.1258/135763304322764176; Gambichler T, 2015, J EUR ACAD DERMATOL, V29, P537, DOI 10.1111/jdv.12621; Giacomel J, 2013, DERMATOL CLIN, V31, P649, DOI 10.1016/j.det.2013.06.005; Guida S, 2015, BRIT J DERMATOL; Guitera P, 2016, BRIT J DERMATOL, V175, P1311, DOI 10.1111/bjd.14749; Guitera P, 2010, J INVEST DERMATOL, V130, P2080, DOI 10.1038/jid.2010.84; Jaimes N, 2012, DERMATOL SURG, V38, P1437, DOI 10.1111/j.1524-4725.2012.02438.x; Landow SM, 2014, J AM ACAD DERMATOL, V71, P570, DOI 10.1016/j.jaad.2014.02.021; Longo C, 2015, BRIT J DERMATOL, V173, P31, DOI 10.1111/bjd.13689; Maier T, 2013, J EUR ACAD DERMATOL, V27, pe42, DOI 10.1111/j.1468-3083.2012.04465.x; Menzies SW, 2013, JAMA DERMATOL, V149, P699, DOI 10.1001/jamadermatol.2013.2466; Monheit G, 2011, ARCH DERMATOL, V147, P188, DOI 10.1001/archdermatol.2010.302; Pellacani G, 2016, J EUR ACAD DERMATOL, V30, P413, DOI 10.1111/jdv.13408; Pellacani G, 2014, BRIT J DERMATOL, V171, P1044, DOI 10.1111/bjd.13148; Piccolo D, 2000, J TELEMED TELECARE, V6, P132, DOI 10.1258/1357633001935202; Pizzichetta MA, 2004, BRIT J DERMATOL, V150, P1117, DOI 10.1111/j.1365-2133.2004.05928.x; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Rao BK, 2013, J AM ACAD DERMATOL, V69, pE295, DOI 10.1016/j.jaad.2013.07.022; Stanganelli I, 2015, BRIT J DERMATOL, V172, P365, DOI 10.1111/bjd.13373; Tromme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109339; Witkowski AM, 2016, SKIN RES TECHNOL, V22, P230, DOI 10.1111/srt.12254; Zalaudek I, 2010, J AM ACAD DERMATOL, V63, P377, DOI 10.1016/j.jaad.2009.11.697	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162495	10.1371/journal.pone.0162495	http://dx.doi.org/10.1371/journal.pone.0162495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606812	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600051
J	Han, WJ; Coutinho, E; Ruan, HB; Li, HF; Schuller, B; Yu, XJ; Zhu, X				Han, Wenjing; Coutinho, Eduardo; Ruan, Huabin; Li, Haifeng; Schuller, Bjoern; Yu, Xiaojie; Zhu, Xuan			Semi-Supervised Active Learning for Sound Classification in Hybrid Learning Environments	PLOS ONE			English	Article								Coping with scarcity of labeled data is a common problem in sound classification tasks. Approaches for classifying sounds are commonly based on supervised learning algorithms, which require labeled data which is often scarce and leads to models that do not generalize well. In this paper, we make an efficient combination of confidence-based Active Learning and Self-Training with the aim of minimizing the need for human annotation for sound classification model training. The proposed method pre-processes the instances that are ready for labeling by calculating their classifier confidence scores, and then delivers the candidates with lower scores to human annotators, and those with high scores are automatically labeled by the machine. We demonstrate the feasibility and efficacy of this method in two practical scenarios: pool-based and stream-based processing. Extensive experimental results indicate that our approach requires significantly less labeled instances to reach the same performance in both scenarios compared to Passive Learning, Active Learning and Self-Training. A reduction of 52.2% in human labeled instances is achieved in both of the pool-based and stream-based scenarios on a sound classification task considering 16,930 sound instances.	[Han, Wenjing; Yu, Xiaojie; Zhu, Xuan] Samsung R&D Inst China Beijing SRC B, Language Comp Lab, Beijing, Peoples R China; [Coutinho, Eduardo] Univ Liverpool, Dept Mus, Liverpool, Merseyside, England; [Coutinho, Eduardo; Schuller, Bjoern] Imperial Coll London, Dept Comp, London, England; [Ruan, Huabin] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Li, Haifeng; Schuller, Bjoern] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Peoples R China; [Schuller, Bjoern] Univ Passau, Complex Syst Engn, Passau, Germany	University of Liverpool; Imperial College London; Tsinghua University; Harbin Institute of Technology; University of Passau	Ruan, HB (corresponding author), Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China.	ruanhuabin@mail.tsinghua.edu.cn	Coutinho, Eduardo/K-1391-2019; yu, xiaojie/GSI-9676-2022	Coutinho, Eduardo/0000-0001-5234-1497; Schuller, Bjorn/0000-0002-6478-8699	National Natural Science Foundation of China [61171186, 61271345]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012047]; European Research Council [338164]; European Union's Horizon research and innovation program [645378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); European Research Council(European Research Council (ERC)European Commission); European Union's Horizon research and innovation program	This work was supported by National Natural Science Foundation of China, No. 61171186, 61271345, www.nsfc.gov.cn, HL; Fundamental Research Funds for the Central Universities, HIT.NSRIF.2012047, www.moe.gov.cn, HL; European Research Council, No. 338164, http://erc.europa.eu/, BS; and European Union's Horizon 2020 research and innovation program, 645378, EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IEEE INT C AC SPEECH; Beygelzimer A, 2008, P INT C MACH LEARN, P49; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Bujrbidge R, 2007, LECT NOTES COMPUT SC, V4881, P209; Chapelle O., 2006, SEMISUPERVISED LEARN; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; COHN D, 1994, MACH LEARN, V15, P201, DOI 10.1007/BF00993277; Cui XD, 2012, IEEE T AUDIO SPEECH, V20, P1923, DOI 10.1109/TASL.2012.2191955; de Sa Virginia R., 1994, NEURIPS, P112; Duan SF, 2014, ARTIF INTELL REV, V42, P637, DOI 10.1007/s10462-012-9362-y; DUDA RO, 2001, PATTERN CLASSIFICATI; Eyben F., 2010, ACM MULTIMEDIA MM, P1459, DOI DOI 10.1145/1873951.1874246; Ferguson BG, 2006, DEF SEC S ORL FLOR U; Fleury A, 2008, IEEE ENG MED BIO, P4644, DOI 10.1109/IEMBS.2008.4650248; Foggia P, 2015, PATTERN RECOGN LETT, V65, P22, DOI 10.1016/j.patrec.2015.06.026; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Tran HD, 2011, INT CONF ACOUST SPEE, P2272; Phan H, 2015, EUR SIGNAL PR CONF, P2546, DOI 10.1109/EUSIPCO.2015.7362844; Jiaxing Ye, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P5944, DOI 10.1109/ICASSP.2014.6854744; Jin F, 2014, NEUROCOMPUTING, V123, P362, DOI 10.1016/j.neucom.2013.07.033; Lewis D. D., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P3; Li MK, 2006, IEEE T PATTERN ANAL, V28, P1251, DOI 10.1109/TPAMI.2006.156; Litvak D, 2008, IEEE ENG MED BIO, P4632, DOI 10.1109/IEMBS.2008.4650245; McCallum Andrew, 1998, ICML, DOI DOI 10.1023/A:1007692713085; Muslea I., 2002, INT C MACH LEARN, VVolume 2, P435; Phuong NC, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTING, MANAGEMENT AND TELECOMMUNICATIONS (COMMANTEL), P330, DOI 10.1109/ComManTel.2013.6482415; Nowak R., 2009, ADV NEURAL INFORM PR, P1366; Peng YT, 2009, IEEE INT CON MULTI, P1218, DOI 10.1109/ICME.2009.5202720; Piczak KJ, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1015, DOI 10.1145/2733373.2806390; Platt JC, 2000, ADV NEUR IN, P61; Riccardi G, 2005, IEEE T SPEECH AUDI P, V13, P504, DOI 10.1109/TSA.2005.848882; Roma G, 2012, P INT C MULT RETR, P1; Roy Nicholas, 2001, P 18 INT C MACH LEAR, P441; Schuller B, 2012, P INT AUD VIS EM CHA; Settles B., 2010, TECHNICAL REPORT, DOI DOI 10.1016/J.MATLET.2010.11.072; Seung H. S., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P287, DOI 10.1145/130385.130417; Tomanek K., 2009, P JOINT C 47 ANN M A, P1039; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Tur G, 2005, SPEECH COMMUN, V45, P171, DOI 10.1016/j.specom.2004.08.002; Valenzise G, 2007, 2007 IEEE CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P21, DOI 10.1109/AVSS.2007.4425280; Wang JC, 2014, IEEE T AUTOM SCI ENG, V11, P607, DOI 10.1109/TASE.2013.2285131; Wang M, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1899412.1899414; Yarowsky D, 1995, P ACL, P189, DOI [10.3115/981658.981684, DOI 10.3115/981658.981684]; Zhang Z, 2012, P INTERSPEECH; Zhang Z, 2012, P 37 IEEE INT C AC S, P25; Zhou ZH, 2004, LECT NOTES COMPUT SC, V3201, P525; Zhu X., 2003, P INT C MACH LEARN I, V3; Zhu X., 2006, COMPUT SCI, V2, P4	48	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162075	10.1371/journal.pone.0162075	http://dx.doi.org/10.1371/journal.pone.0162075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627768	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600017
J	Lee, PY; Lin, SI; Liao, YT; Lin, RM; Hsu, CC; Huang, KY; Chen, YT; Tsai, YJ				Lee, Pei-Yun; Lin, Sang-I; Liao, Yu-Ting; Lin, Ruey-Mo; Hsu, Che-Chia; Huang, Kuo-Yuan; Chen, Yi-Ting; Tsai, Yi-Ju			Postural Responses to a Suddenly Released Pulling Force in Older Adults with Chronic Low Back Pain: An Experimental Study	PLOS ONE			English	Article							OSWESTRY-DISABILITY-INDEX; CHINESE VERSION; PHYSICAL-ACTIVITY; ELDERLY PERSONS; BALANCE; STABILITY; TRUNK; PREVALENCE; STRATEGY; PERTURBATIONS	Chronic low back pain (CLBP), one of the most common musculoskeletal conditions in older adults, might affect balance and functional independence. The purpose of this study was to investigate the postural responses to a suddenly released pulling force in older adults with and without CLBP. Thirty community-dwelling older adults with CLBP and 26 voluntary controls without CLBP were enrolled. Participants were required to stand on a force platform while, with one hand, they pulled a string that was fastened at the other end to a 2-kg or to a 4-kg force in the opposite direction at a random order. The number of times the participants lost their balance and motions of center of pressure (COP) when the string was suddenly released were recorded. The results demonstrated that although the loss of balance rates for each pulling force condition did not differ between groups, older adults with CLBP had poorer postural responses: delayed reaction, larger displacement, higher velocity, longer path length, and greater COP sway area compared to the older controls. Furthermore, both groups showed larger postural responses in the 4-kg pulling force condition. Although aging is generally believed to be associated with declining balance and postural control, these findings highlight the effect of CLBP on reactive balance when responding to an externally generated force in an older population. This study also suggests that, for older adults with CLBP, in addition to treating them for pain and disability, reactive balance evaluation and training, such as reaction and movement strategy training should be included in their interventions. Clinicians and older patients with CLBP need to be made aware of the significance of impaired reactive balance and the increased risk of falls when encountering unexpected perturbations.	[Lee, Pei-Yun; Lin, Sang-I; Liao, Yu-Ting; Chen, Yi-Ting; Tsai, Yi-Ju] Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan, Taiwan; [Lin, Ruey-Mo] China Med Univ, Tainan Municipal An Nan Hosp, Dept Orthoped, Tainan, Taiwan; [Hsu, Che-Chia; Huang, Kuo-Yuan] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan	National Cheng Kung University; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Tsai, YJ (corresponding author), Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan, Taiwan.	yijutsai@mail.ncku.edu.tw	Chen, Yi/HIR-2608-2022; Tsai, Yi-Ju/C-3324-2009	Tsai, Yi-Ju/0000-0003-4082-2634	Ministry of Science and Technology of Taiwan [NSC 101-2314-B-006-008, NSC 102-2314-B-006-003-MY3]; Taiwan National Science Council; National Cheng Kung University Hospital	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This study was supported by research grants from the Ministry of Science and Technology of Taiwan (NSC 101-2314-B-006-008 and NSC 102-2314-B-006-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the research grants from the Taiwan National Science Council and National Cheng Kung University Hospital. We thank Pei-Ying Hsieh for her help collecting data.	Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; Carty CP, 2015, AGE AGEING, V44, P109, DOI 10.1093/ageing/afu054; Cohen J, 1977, F TESTS MEANS ANAL V, P273; Cooper NA, 2016, EUR SPINE J, V25, P1258, DOI 10.1007/s00586-015-4027-6; da Cunha-Filho Inacio Teixeira, 2010, Physiotherapy Theory and Practice, V26, P49, DOI 10.3109/09593980802602844; de Freitas PB, 2010, J ELECTROMYOGR KINES, V20, P693, DOI 10.1016/j.jelekin.2009.11.009; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Fairbank J C, 1980, Physiotherapy, V66, P271; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Hamaoui A, 2004, NEUROSCI LETT, V357, P135, DOI 10.1016/j.neulet.2003.12.047; Henry SM, 2006, CLIN BIOMECH, V21, P881, DOI 10.1016/j.clinbiomech.2006.04.016; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Kamaz M, 2007, DIAGN INTERV RADIOL, V13, P144; Kaya BK, 1998, J GERONTOL A-BIOL, V53, pM126, DOI 10.1093/gerona/53A.2.M126; Kim HJ, 2011, SPINE, V36, pE588, DOI 10.1097/BRS.0b013e3181f92d8e; Kim S, 2012, J BIOMECH, V45, P1379, DOI 10.1016/j.jbiomech.2012.03.001; Klass M, 2008, J APPL PHYSIOL, V104, P739, DOI 10.1152/japplphysiol.00550.2007; Kuo YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128318; Lee CE, 2007, SPINE, V32, P1329, DOI 10.1097/BRS.0b013e318059af3b; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; LEE JH, 1995, SPINE, V20, P1994, DOI 10.1097/00007632-199509150-00006; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; Lue YJ, 2008, SPINE, V33, P2354, DOI 10.1097/BRS.0b013e31818018d8; Macfarlane DJ, 2007, J SCI MED SPORT, V10, P45, DOI 10.1016/j.jsams.2006.05.003; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Mazaheri M, 2013, GAIT POSTURE, V37, P12, DOI 10.1016/j.gaitpost.2012.06.013; Mazzocchio R, 2001, BMC Musculoskelet Disord, V2, P4, DOI 10.1186/1471-2474-2-4; Melton BL, 2016, SPINE, DOI 10.1097/brs.0000000000001563; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Mok NW, 2013, EXP BRAIN RES, V231, P305, DOI 10.1007/s00221-013-3692-0; Mok NW, 2011, SPINE, V36, pE45, DOI 10.1097/BRS.0b013e3181dfce83; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Muraki S, 2011, ARTHRIT CARE RES, V63, P1425, DOI 10.1002/acr.20562; O'Sullivan PB, 2003, SPINE, V28, P1074, DOI 10.1097/00007632-200305150-00022; Parthan Anju, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P359, DOI 10.1586/14737167.6.3.359; Pei LB, 2010, J INT MED RES, V38, P1985, DOI 10.1177/147323001003800612; Pinto RZ, 2014, EUR J PAIN, V18, P1190, DOI 10.1002/j.1532-2149.2014.00468.x; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; Ringheim I, 2015, GAIT POSTURE, V42, P584, DOI 10.1016/j.gaitpost.2015.09.008; Rottermund J, 2015, MED PR, V66, P771, DOI 10.13075/mp.5893.00121; Scheele J, 2012, EUR J PHYS REHAB MED, V48, P379; Shahvarpour A, 2014, J ELECTROMYOGR KINES, V24, P394, DOI 10.1016/j.jelekin.2014.03.007; Shumway-Cook A., 2007, MOTOR CONTROL TRANSL; Simmonds MJ, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/214980; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Tucker K, 2009, J NEUROSCI, V29, P10820, DOI 10.1523/JNEUROSCI.5211-08.2009; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Vuillerme N, 2009, GAIT POSTURE, V30, P122, DOI 10.1016/j.gaitpost.2009.03.004; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Wertli MM, 2014, SPINE J, V14, P2658, DOI 10.1016/j.spinee.2014.02.033; Wertli MM, 2014, SPINE J, V14, P2639, DOI 10.1016/j.spinee.2014.03.003; Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005; Yarjanian JA, 2013, PM&R, V5, P39, DOI 10.1016/j.pmrj.2012.08.017; 1999, LANCET, V354, P581, DOI DOI 10.1016/S0140-6736(99)01312-4	62	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162187	10.1371/journal.pone.0162187	http://dx.doi.org/10.1371/journal.pone.0162187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622646	gold, Green Submitted, Green Published			2022-12-27	WOS:000383681000018
J	Liu, WF; Shu, HH; Zhao, GD; Peng, SL; Xiao, JF; Zhang, GR; Liu, KX; Huang, WQ				Liu, Wei-Feng; Shu, Hai-Hua; Zhao, Guo-Dong; Peng, Shu-Ling; Xiao, Jin-Fang; Zhang, Guan-Rong; Liu, Ke-Xuan; Huang, Wen-Qi			Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TOTAL HIP; GASTROINTESTINAL TOXICITY; POSTOPERATIVE PAIN; PLATELET-AGGREGATION; SELECTIVE INHIBITOR; MORPHINE ANALGESIA; DOUBLE-BLIND; ANESTHESIA; EFFICACY	Objective This multicenter, randomized, placebo-controlled study evaluated the efficacy and side effects of parecoxib during patient-controlled epidural analgesia (PCEA) after abdominal hysterectomy. Methods A total of 240 patients who were scheduled for elective abdominal hysterectomy under combined spinal-epidural anesthesia received PCEA plus postoperative intravenous parecoxib 40 mg or saline every 12 h for 48 h after an initial preoperative dose of parecoxib 40 mg or saline. An epidural loading dose of a mixture of 6 mL of 0.25% ropivacaine and 2 mg morphine was administered 30 min before the end of surgery, and PCEA was initiated using 1.25 mg/mL ropivacaine and 0.05 mg/mL morphine with a 2-mL/h background infusion and 2-mL bolus with a 15-min lockout. The primary end point of this study was the quantification of the PCEA-sparing effect of parecoxib. Results Demographic data were similar between the two groups. Patients in the parecoxib group received significantly fewer self-administrated boluses (0 (0, 3) vs. 7 (2, 15), P < 0.001) and less epidural morphine (5.01 +/- 0.44 vs. 5.95 +/- 1.29 mg, P < 0.001) but experienced greater pain relief compared with the control group (P < 0.001). Patient global satisfaction was higher in the parecoxib group than the control group (P < 0.001). Length of hospitalization (9.50 +/- 2.1, 95% CI 9.12 +/- 9.88 vs. 10.41 +/- 2.6, 95% CI 9.95 +/- 10.87, P = 0.003) and postoperative vomiting (17% vs. 29%, P < 0.05) were also reduced in the parecoxib group. There were no serious adverse effects in either group. Conclusion Our data suggest that adjunctive parecoxib during PCEA following abdominal hysterectomy is safe and efficacious in reducing pain, requirements of epidural analgesics, and side effects.	[Liu, Wei-Feng; Shu, Hai-Hua; Liu, Ke-Xuan; Huang, Wen-Qi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Zhao, Guo-Dong] GuangDong Gen Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Zhao, Guo-Dong; Zhang, Guan-Rong] GuangDong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Peng, Shu-Ling] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Xiao, Jin-Fang] NanFang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Guan-Rong] GuangDong Gen Hosp, Hlth Management Examinat Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liu, KX; Huang, WQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China.	liukexuan705@163.com; huangwenqi86@aliyun.com	huang, wen/GXW-0661-2022	Liu, Ke-Xuan/0000-0003-0221-366X	National Natural Science Foundation of China [30872446, 81171847]; Fundamental Research Funds for the Central Universities in China; China Education program for New Century Excellent Talents of Ministry of Education [NCET-10-0853]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; China Education program for New Century Excellent Talents of Ministry of Education	This work was partially funded by grants from the National Natural Science Foundation of China (30872446, 81171847, to Ke-Xuan Liu) and partially by "the Fundamental Research Funds for the Central Universities" in China and the China Education program for New Century Excellent Talents of Ministry of Education (NCET-10-0853 to Ke-Xuan Liu). The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon E, 2003, Minerva Anestesiol, V69, P443; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Ashburn MA, 2012, ANESTHESIOLOGY, V116, P248, DOI 10.1097/ALN.0b013e31823c1030; Bainbridge D, 2006, CAN J ANAESTH, V53, P46, DOI 10.1007/BF03021527; Block BM, 2003, JAMA-J AM MED ASSOC, V290, P2455, DOI 10.1001/jama.290.18.2455; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bugter MLT, 2003, CAN J ANAESTH, V50, P445, DOI 10.1007/BF03021054; Buvanendran A, 2003, JAMA-J AM MED ASSOC, V290, P2411, DOI 10.1001/jama.290.18.2411; COUSINS MJ, 1984, ANESTHESIOLOGY, V61, P276; Dirkmann D, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0015-y; Elia N, 2005, ANESTHESIOLOGY, V103, P1296, DOI 10.1097/00000542-200512000-00025; Ferguson SE, 2009, GYNECOL ONCOL, V114, P111, DOI 10.1016/j.ygyno.2009.03.014; Govind P, 2015, ACTA ANAESTH SCAND, V59, P98, DOI 10.1111/aas.12434; Graff J, 2007, J THROMB HAEMOST, V5, P2376, DOI 10.1111/j.1538-7836.2007.02782.x; Graff J, 2007, CLIN THER, V29, P438, DOI 10.1016/S0149-2918(07)80082-8; GRASS JA, 1993, ANESTHESIOLOGY, V78, P642, DOI 10.1097/00000542-199304000-00005; Han G, 2014, PHARMACOLOGY, V93, P193, DOI 10.1159/000362214; Horlocker TT, 2006, J AM ACAD ORTHOP SUR, V14, P126, DOI 10.5435/00124635-200603000-00003; Inoue S, 2009, MINERVA ANESTESIOL, V75, P498; Joshi GP, 2004, ANESTH ANALG, V98, P336, DOI 10.1213/01.ANE.0000093390.94921.4A; Joshi W, 2003, ANESTH ANALG, V97, P35, DOI 10.1213/01.ANE.0000069507.93582.6E; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KEHLET H, 1993, ANESTH ANALG, V77, P1048; Leese PT, 2003, J CLIN PHARMACOL, V43, P504, DOI 10.1177/0091270003252234; LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019; Malan TP, 2003, ANESTHESIOLOGY, V98, P950, DOI 10.1097/00000542-200304000-00023; Marret E, 2005, ANESTHESIOLOGY, V102, P1249, DOI 10.1097/00000542-200506000-00027; Marret E, 2003, ANESTHESIOLOGY, V98, P1497; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Neuss H, 2010, J SURG RES, V162, P88, DOI 10.1016/j.jss.2009.01.029; Ng A, 2004, BRIT J ANAESTH, V92, P846, DOI 10.1093/bja/aeh161; Niruthisard S, 2007, ANESTH ANALG, V105, P822, DOI 10.1213/01.ane.0000277489.87015.1d; Nong L, 2013, J SURG RES, V183, P821, DOI 10.1016/j.jss.2013.02.059; Nussmeier NA, 2006, ANESTHESIOLOGY, V104, P518, DOI 10.1097/00000542-200603000-00020; RIGG JRA, 1991, ANAESTH INTENS CARE, V19, P404, DOI 10.1177/0310057X9101900318; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Senard M, 2010, BRIT J ANAESTH, V105, P196, DOI 10.1093/bja/aeq129; Silverman DG, 2003, CAN J ANAESTH, V50, P1004, DOI 10.1007/BF03018363; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Tang J, 2002, ANESTHESIOLOGY, V96, P1305, DOI 10.1097/00000542-200206000-00007; Vadalouca A, 2009, PAIN PRACT, V9, P181, DOI 10.1111/j.1533-2500.2009.00271.x; Wang X, 2015, MED SCI MONITOR, V21, P52, DOI 10.12659/MSM.892224; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; White PF, 2007, CAN J ANAESTH, V54, P342, DOI 10.1007/BF03022655; Woelk JL, 2014, OBSTET GYNECOL, V123, P255, DOI 10.1097/AOG.0000000000000090; WU Xin-min, 2007, CHIN J ANESTHESIOL, V27, P8; Yeh CC, 2005, ANESTH ANALG, V100, P1384, DOI 10.1213/01.ANE.0000148687.51613.B5; Zhang XW, 2005, ANAESTHESIA, V60, P990, DOI 10.1111/j.1365-2044.2005.04299.x	48	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162589	10.1371/journal.pone.0162589	http://dx.doi.org/10.1371/journal.pone.0162589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622453	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000042
J	Mun, JK; Youn, J; Cho, JW; Oh, ES; Kim, JS; Park, S; Jang, W; Park, JS; Koh, SB; Lee, JH; Park, HK; Kim, HJ; Jeon, BS; Shin, HW; Choi, SA; Kim, SJ; Choi, SM; Park, JY; Kim, JY; Chung, SJ; Lee, CS; Ahn, TB; Kim, WC; Kim, HS; Cheon, SM; Kim, JW; Kim, HT; Lee, JY; Kim, JS; Kim, EJ; Kim, JM; Lee, KS; Kim, JS; Kim, MJ; Baik, JS; Park, KJ; Kim, HJ; Park, MY; Kang, JH; Song, SK; Kim, YD; Yun, JY; Lee, HW; Song, IU; Sohn, YH; Lee, PH; Park, JH; Oh, HG; Park, KW; Kwon, DY				Mun, Jun Kyu; Youn, Jinyoung; Cho, Jin Whan; Oh, Eung-Seok; Kim, Ji Sun; Park, Suyeon; Jang, Wooyoung; Park, Jin Se; Koh, Seong-Beom; Lee, Jae Hyeok; Park, Hee Kyung; Kim, Han-Joon; Jeon, Beom S.; Shin, Hae-Won; Choi, Sun-Ah; Kim, Sang Jin; Choi, Seong-Min; Park, Ji-Yun; Kim, Ji Young; Chung, Sun Ju; Lee, Chong Sik; Ahn, Tae-Beom; Kim, Won Chan; Kim, Hyun Sook; Cheon, Sang Myung; Kim, Jae Woo; Kim, Hee-Tae; Lee, Jee-Young; Kim, Ji Sun; Kim, Eun-Joo; Kim, Jong-Min; Lee, Kwang Soo; Kim, Joong-Seok; Kim, Min-Jeong; Baik, Jong Sam; Park, Ki-Jong; Kim, Hee Jin; Park, Mee Young; Kang, Ji Hoon; Song, Sook Kun; Kim, Yong Duk; Yun, Ji Young; Lee, Ho-Won; Song, In-Uk; Sohn, Young H.; Lee, Phil Hyu; Park, Jeong-Ho; Oh, Hyung Geun; Park, Kun Woo; Kwon, Do-Young			Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naive Parkinson's Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study	PLOS ONE			English	Article							KOREAN-VERSION; MOTOR SUBTYPES; PROGRESSION; VALIDATION; INVENTORY; BURDEN; SCALE; ONSET	Despite the clinical impact of non-motor symptoms (NMS) in Parkinson's disease (PD), the characteristic NMS in relation to the motor subtypes of PD is not well elucidated. In this study, we enrolled drug-naive PD patients and compared NMS between PD subtypes. We enrolled 136 drug-naive, early PD patients and 50 normal controls. All the enrolled PD patients were divided into tremor dominant (TD) and non-tremor dominant (NTD) subtypes. The Non-Motor Symptom Scale and scales for each NMS were completed. We compared NMS and the relationship of NMS with quality of life between normal controls and PD patients, and between the PD subtypes. Comparing with normal controls, PD patients complained of more NMS, especially mood/cognitive symptoms, gastrointestinal symptoms, unexplained pain, weight change, and change in taste or smell. Between the PD subtypes, the NTD subtype showed higher total NMS scale score and sub-score about weight change. Weight change was the characteristic NMS related to NTD subtype even after controlled other variables with logistic regression analysis. Even from the early stage, PD patients suffer from various NMS regardless of dopaminergic medication. Among the various NMS, weight change is the characteristic NMS associated with NTD subtype in PD patients.	[Mun, Jun Kyu; Youn, Jinyoung; Cho, Jin Whan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Mun, Jun Kyu; Youn, Jinyoung; Cho, Jin Whan] Samsung Med Ctr, Ctr Neurosci, Seoul, South Korea; [Oh, Eung-Seok] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Neurol, Daejeon, South Korea; [Kim, Ji Sun] Soonchunhyang Univ, Coll Med, Dept Neurol, Seoul Hosp, Seoul, South Korea; [Park, Suyeon] Soonchunhyang Univ, Coll Med, Seoul Hosp, Dept Biostat, Seoul, South Korea; [Jang, Wooyoung] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Neurol, Kangnung, South Korea; [Park, Jin Se] Inje Univ, Haeundae Paik Hosp, Dept Neurol, Coll Med, Busan, South Korea; [Koh, Seong-Beom] Korea Univ, Coll Med, Guro Hosp, Dept Neurol, Seoul, South Korea; [Lee, Jae Hyeok] Pusan Natl Univ, Yangsan Hosp, Dept Neurol, Yangsan, South Korea; [Park, Hee Kyung] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Neurol, Ilsan, South Korea; [Kim, Han-Joon; Jeon, Beom S.] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Shin, Hae-Won] Chung Ang Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Choi, Sun-Ah] Insurance Corp Ilsan Hosp, Natl Hlth, Dept Neurol, Ilsan, South Korea; [Kim, Sang Jin] Inje Univ, Busan Paik Hosp, Dept Neurol, Busan, South Korea; [Choi, Seong-Min] Chonnam Natl Univ, Sch Med, Dept Neurol, Gwangju, South Korea; [Park, Ji-Yun] Presbyterian Med Ctr, Dept Neurol, Jeonju, South Korea; [Kim, Ji Young] Inje Univ, Seoul Paik Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Chung, Sun Ju] Univ Ulsan, Coll Med, Dept Neurol, Seoul, South Korea; [Ahn, Tae-Beom] Kyung Hee Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Won Chan; Kim, Hyun Sook] CHA Univ, Coll Med, Dept Neurol, Bundang, South Korea; [Cheon, Sang Myung] Dong A Univ, Coll Med, Dept Neurol, Busan, South Korea; [Kim, Hee-Tae] Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Jee-Young] Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea; [Kim, Ji Sun] Chungbuk Natl Univ Hosp, Coll Med, Dept Neurol, Jeonju, South Korea; [Kim, Eun-Joo] Pusan Natl Univ, Sch Med, Dept Neurol, Busan, South Korea; [Kim, Eun-Joo] Med Res Inst, Busan, South Korea; [Kim, Jong-Min] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Bundang, South Korea; [Lee, Kwang Soo; Kim, Joong-Seok] Catholic Univ Korea, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Min-Jeong] Kosin Univ, Coll Med, Dept Neurol, Busan, South Korea; [Baik, Jong Sam] Inje Univ, Sanggye Paik Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Park, Ki-Jong] Gyeongsang Natl Univ, Sch Med, Dept Neurol, Jinju, South Korea; [Kim, Hee Jin] Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea; [Park, Mee Young] Yeungnam Univ, Coll Med, Dept Neurol, Daegu, South Korea; [Kang, Ji Hoon; Song, Sook Kun] Jeju Natl Univ Hosp, Dept Neurol, Jeju, South Korea; [Kim, Yong Duk] Konyang Univ Hosp, Dept Neurol, Daejeon, South Korea; [Yun, Ji Young] Ewha Womans Univ, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Lee, Ho-Won] Kyungpook Natl Univ, Sch Med, Dept Neurol, Daegu, South Korea; [Song, In-Uk] Catholic Univ Korea, Coll Med, Dept Neurol, Incheon, South Korea; [Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Jeong-Ho] Soonchunhyang Univ, Coll Med, Bucheon Hosp, Dept Neurol, Bucheon, South Korea; [Oh, Hyung Geun] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Neurol, Cheonan, South Korea; [Park, Kun Woo] Korea Univ, Coll Med, Anam Hosp, Dept Neurol, Seoul, South Korea; [Kwon, Do-Young] Korea Univ, Ansan Hosp, Dept Neurol, Ansan, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Chungnam National University; Chungnam National University Hospital; Soonchunhyang University; Soonchunhyang University; University of Ulsan; Inje University; Korea University; Korea University Medicine (KU Medicine); Pusan National University; Pusan National University Hospital; Inje University; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Inje University; Chonnam National University; Inje University; University of Ulsan; Kyung Hee University; Pochon Cha University; Dong A University; Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Pusan National University; Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Inje University; Gyeongsang National University; Konkuk University; Konkuk University Medical Center; Yeungnam University; Jeju National University; Konyang University; Konyang University Hospital; Ewha Womans University; Kyungpook National University; Catholic University of Korea; Yonsei University; Yonsei University Health System; Soonchunhyang University; Soonchunhyang University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Youn, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Youn, J (corresponding author), Samsung Med Ctr, Ctr Neurosci, Seoul, South Korea.	genian.youn@gmail.com	KIM, WON CHAN/AAJ-4506-2020; Youn, Jinyoung/ABD-4588-2020; Oh, Eungseok/AAL-8935-2020; Ahn, Tae-Beom/AAG-1309-2021	Oh, Eungseok/0000-0003-2068-3235; Ahn, Tae-Beom/0000-0002-7315-6298; Chung, Sun Ju/0000-0003-4118-8233; Kim, Han-Joon/0000-0001-8219-9663; Park, Hee Kyung/0000-0001-6339-0059; Lee, Jee-Young/0000-0002-9120-2075				Akbar U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124541; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bohnen NI, 2013, NEUROLOGY, V81, P1611, DOI 10.1212/WNL.0b013e3182a9f558; Brown RG, 2005, PARKINSONISM RELAT D, V11, P49, DOI 10.1016/j.parkreldis.2004.07.007; Brown RG, 2011, J NEUROL NEUROSUR PS, V82, P803, DOI 10.1136/jnnp.2010.213652; Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; Chen HL, 2003, ANN NEUROL, V53, P676, DOI 10.1002/ana.10577; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jo SA, 2007, INT J GERIATR PSYCH, V22, P218, DOI 10.1002/gps.1664; Kashihara K, 2006, J NEUROL, V253, P38, DOI 10.1007/s00415-006-7009-0; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kim TH, 2010, DEMENT GERIATR COGN, V29, P363, DOI 10.1159/000297523; Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197; Koh SB, 2012, J CLIN NEUROL, V8, P276, DOI 10.3988/jcn.2012.8.4.276; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; Mollenhauer B, 2013, NEUROLOGY, V81, P1226, DOI 10.1212/WNL.0b013e3182a6cbd5; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Reinoso G, 2015, EUR J NEUROL, V22, P457, DOI 10.1111/ene.12476; Sauerbier A, 2016, PARKINSONISM RELAT D, V22, pS41, DOI 10.1016/j.parkreldis.2015.09.027; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; van de Berg Wilma D J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS28, DOI 10.1016/S1353-8020(11)70011-6; Vikdahl M, 2014, CLIN NUTR, V33, P1132, DOI 10.1016/j.clnu.2013.12.012; Yuan YS, 2013, CNS NEUROSCI THER, V19, P889, DOI 10.1111/cns.12165; Zis P, 2015, EUR J NEUROL, V22, P1145, DOI 10.1111/ene.12733; Zis P, 2014, J PARKINSON DIS, V4, P541, DOI 10.3233/JPD-140372	33	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162254	10.1371/journal.pone.0162254	http://dx.doi.org/10.1371/journal.pone.0162254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622838	gold, Green Submitted, Green Published			2022-12-27	WOS:000383681000020
J	Peeters, ETHM; Neefjes, REM; van Zuidam, BG				Peeters, Edwin T. H. M.; Neefjes, Rozemarijn E. M.; van Zuidam, Bastiaan G.			Competition between Free-Floating Plants Is Strongly Driven by Previously Experienced Phosphorus Concentrations in the Water Column	PLOS ONE			English	Article							SUBMERGED MACROPHYTES; AQUATIC PLANTS; DIFFERENTIAL RESPONSES; AZOLLA; TEMPERATURE; GROWTH; DEFICIENCY; DITCHES; ALGAE	Nutrients can determine the outcome of the competition between different floating plant species. The response of floating plants to current phosphorus levels may be affected by previously experienced phosphorus concentrations because some species have the ability to store excess phosphorus for later use. This might have an impact on their competition. Here, we investigate the effect of previous and actual phosphorus concentrations on the growth rate of free-floating plant species (Azolla filiculoides, Lemna minor/gibba and Ricciocarpus natans) and the effect of phosphorus history on the competition between L. minor/gibba and A. filiculoides and between L. minor/gibba and R. natans. As expected, plant growth was lower when previously kept at low instead of high phosphorus concentrations. Growth of L. minor/gibba and A. filiculoides with a phosphorus rich history was comparable for low and high actual phosphorus concentrations, however, internal phosphorus concentrations were significantly lower with low actual phosphorus concentration. This indicates that both species perform luxury phosphorus uptake. Furthermore, internal P concentration in Azolla and Lemna increased within two weeks after a period of P deficit without a strong increase in growth. A. filiculoides in a mixture with L. minor/gibba grew faster than its monoculture. Morphological differences may explain why A. filiculoides outcompeted L. minor/gibba and these differences may be induced by phosphorus concentrations in the past. Growth of L. minor/gibba was only reduced by the presence of A. filiculoides with a high phosphorus history. Growth of L. minor/gibba and R. natans in mixtures was positively affected only when they had a high phosphorus history themselves and their competitor a low phosphorus history. These observations clearly indicate that phosphorus history of competing plants is important for understanding the outcome of the competition. Therefore, actual and previously experienced phosphorus concentrations should be taken into account in future studies dealing with competition between plants.	[Peeters, Edwin T. H. M.; Neefjes, Rozemarijn E. M.; van Zuidam, Bastiaan G.] Wageningen Univ, Aquat Ecol andWater Qual Management Grp, Wageningen, Netherlands; [Neefjes, Rozemarijn E. M.] RIWA Rhine Water Works, Nieuwegein, Netherlands; [van Zuidam, Bastiaan G.] Water Board Rijn & IJssel, Doetinchem, Netherlands	Wageningen University & Research	Peeters, ETHM (corresponding author), Wageningen Univ, Aquat Ecol andWater Qual Management Grp, Wageningen, Netherlands.	edwin.peeters@wur.nl		Peeters, Edwin T.H.M./0000-0003-2541-1829				[Anonymous], 1986, FAMILY LEMNACEAE A M; Cheng WG, 2010, HYDROBIOLOGIA, V656, P5, DOI 10.1007/s10750-010-0441-2; Costa ML, 2010, P 14 RAMIRAN INT C L; Dickinson MB, 1998, AM MIDL NAT, V140, P55, DOI 10.1674/0003-0031(1998)140[0055:CASFFA]2.0.CO;2; Forchhammer NC, 1999, FRESHWATER BIOL, V41, P183, DOI 10.1046/j.1365-2427.1999.00390.x; Garbey C, 2004, FRESHWATER BIOL, V49, P346, DOI 10.1111/j.1365-2427.2004.01188.x; Gibson CE, 2001, CHEMOSPHERE, V42, P215, DOI 10.1016/S0045-6535(00)00128-4; GOPAL B, 1993, BOT REV, V59, P155, DOI 10.1007/BF02856599; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hill MP, 1999, HYDROBIOLOGIA, V415, P203, DOI 10.1023/A:1003869230591; Hussner A, 2012, WEED RES, V52, P297, DOI 10.1111/j.1365-3180.2012.00926.x; Hutchinson G. E, 1975, TREATISE LIMNOLOGY; Janes RA, 1996, HYDROBIOLOGIA, V340, P23, DOI 10.1007/BF00012729; Klein J. C., 2008, THESIS; KUSHARI DP, 1991, SOIL SCI PLANT NUTR, V37, P271, DOI 10.1080/00380768.1991.10415037; KUSHARI DP, 1992, SOIL SCI PLANT NUTR, V38, P65, DOI 10.1080/00380768.1992.10416953; LUMPKIN TA, 1980, ECON BOT, V34, P111, DOI 10.1007/BF02858627; Lurling M, 2006, ANN LIMNOL-INT J LIM, V42, P65, DOI 10.1051/limn/2006010; MCILRAITH AL, 1989, CAN J BOT, V67, P2904, DOI 10.1139/b89-373; Milne J, 2007, FUND APPL LIMNOL, V169, P169, DOI 10.1127/1863-9135/2007/0169-0169; Netten JJC, 2011, FRESHWATER BIOL, V56, P1761, DOI 10.1111/j.1365-2427.2011.02611.x; Netten JJC, 2010, FUND APPL LIMNOL, V177, P125, DOI 10.1127/1863-9135/2010/0177-0125; Njambuya J, 2011, AQUAT BOT, V94, P158, DOI 10.1016/j.aquabot.2011.02.001; NNI, 1997, 13395 NNI NENENISO; NNI, 1986, 6663 NNI NEN; NNI, 1990, 6646 NNI NEN; NOVOZAMSKY I, 1984, NETH J AGR SCI, V32, P322; NOVOZAMSKY I, 1983, COMMUN SOIL SCI PLAN, V14, P239, DOI 10.1080/00103628309367359; Peeters ETHM, 2013, J APPL ECOL, V50, P585, DOI 10.1111/1365-2664.12066; Pot R, 2003, VELDGIDS WATER OEVER; Rejmankova E., 1975, AQUAT BOT, V1, P423, DOI [10.1016/0304-3770(75)90042-X, DOI 10.1016/0304-3770(75)90042-X]; Roijackers R, 2004, ARCH HYDROBIOL, V160, P401, DOI 10.1127/0003-9136/2004/0160-0401; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SUBUDHI BPR, 1981, SOIL SCI PLANT NUTR, V27, P237, DOI 10.1080/00380768.1981.10431275; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; TUNG HF, 1983, NEW PHYTOL, V93, P423, DOI 10.1111/j.1469-8137.1983.tb03442.x; van der Heide T, 2006, AQUAT BOT, V84, P171, DOI 10.1016/j.aquabot.2005.09.004; Verdonschot RCM, 2014, LIMNOLOGY, V15, P225, DOI 10.1007/s10201-013-0416-x; Wu ZH, 2007, AQUAT BOT, V86, P316, DOI 10.1016/j.aquabot.2006.11.008	39	11	11	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162780	10.1371/journal.pone.0162780	http://dx.doi.org/10.1371/journal.pone.0162780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622519	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000055
J	Sun, X; Li, YQ; Zheng, MZ; Zuo, WS; Zheng, WZ				Sun, Xu; Li, Yongqing; Zheng, Meizhu; Zuo, Wenshu; Zheng, Wenzhu			MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1	PLOS ONE			English	Article							CASPASE-9 ACTIVATION; SUPPRESSION; CHEMORESISTANCE; BIOGENESIS; EXPRESSION; RESISTANCE; MIGRATION; THERAPY; PROTEIN; ROS	Drug resistance remains a significant challenge in the treatment of triple-negative breast cancer (TNBC). Recent studies have demonstrated that this drug resistance is associated with a group of cells known as cancer stem cells (CSCs), which are believed to determine the sensitivity of tumor cells to cancer treatment. MicroRNAs (miRNAs) are small, non-coding RNAs that play significant roles in normal and cancer cells. MiR-223 reportedly acts as a tumor suppressor in a range of cancers. However, the role of miR-223 in TNBC, especially in triple-negative breast cancer stem cells (TNBCSCs), remains unknown. Here, we found that miR-223 expression was down-regulated in CD44(+)CD24(-/low) TNBCSCs compared with non-CSCs. Furthermore, we found that miR-223 overexpression resensitized TNBCSCs to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. The HAX-1 gene, which is located in the mitochondria and functions as an anti-apoptotic protein, was found to be directly regulated by miR-223 in MDA-MB-231 cells. We demonstrated that miR-223 overexpression promoted TRAIL-induced apoptosis through the mitochondria/ROS pathway. In conclusion, our results suggest that miR-223 increases the sensitivity of TNBCSCs to TRAIL-induced apoptosis by targeting HAX-1. Our findings have improved our understanding of the role of miR-223 in TNBC and may contribute to TNBC treatment.	[Sun, Xu] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Gastrointestinal Surg, Jinan 250117, Peoples R China; [Li, Yongqing; Zheng, Meizhu; Zuo, Wenshu] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Breast Canc Ctr, Jinan 250117, Peoples R China; [Zheng, Wenzhu] Jinan Lixia Dist Peoples Hosp, Emergency Med, Jinan 250000, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan	Zheng, MZ (corresponding author), Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Breast Canc Ctr, Jinan 250117, Peoples R China.	jnmeizhuzheng@126.com			Key research and development program of Shandong Province [2015GSF118132]	Key research and development program of Shandong Province	This study is supported by the Key research and development program of Shandong Province (grant no: 2015GSF118132) received by Meizhu Zheng. URL: http://www.sdstc.gov.cn/gggs/1000008680.htm.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Arnedos M, 2012, THER ADV MED ONCOL, V4, P195, DOI 10.1177/1758834012444711; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bimonte S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1065230; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; den Hollander P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00250; Duan WJ, 2010, J PHARMACOL SCI, V113, P48, DOI 10.1254/jphs.09315FP; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gucalp Ayca, 2011, Chemother Res Pract, V2011, P696208, DOI 10.1155/2011/696208; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; He HF, 2016, TUMOR BIOL, V37, P1599, DOI 10.1007/s13277-015-3844-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kurozumi A, 2016, CANCER SCI, V107, P84, DOI 10.1111/cas.12842; Laussmann MA, 2012, J BIOL CHEM, V287, P14402, DOI 10.1074/jbc.M111.304378; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Piggott L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2945; Pinto CA, 2013, CANCER LETT, V341, P56, DOI 10.1016/j.canlet.2013.06.003; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Shaw J, 2006, CIRC RES, V99, P336, DOI 10.1161/01.RES.0000239408.03169.94; Sheng CY, 2015, INT J CLIN EXP MED, V8, P20904; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Tang YL, 2015, INT J CLIN EXP PATHO, V8, P11224; Trebinska A, 2014, FEBS LETT, V588, P2921, DOI 10.1016/j.febslet.2014.05.042; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xie XH, 2015, TUMOR BIOL, V36, P7185, DOI 10.1007/s13277-015-3438-7; Yan JL, 2015, ONCOL REP, V34, P2776, DOI 10.3892/or.2015.4202; Ye ZQ, 2016, TUMOR BIOL, V37, P4509, DOI 10.1007/s13277-015-4267-4; Yousefi M, 2014, ARCH IRAN MED, V17, P366, DOI 0141705/AIM.0011; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zheng YB, 2016, ONCOL REP, V35, P683, DOI 10.3892/or.2015.4417; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	38	60	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162754	10.1371/journal.pone.0162754	http://dx.doi.org/10.1371/journal.pone.0162754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618431	gold, Green Submitted, Green Published			2022-12-27	WOS:000383653100046
J	Hoppmann, AS; Schlosser, P; Backofen, R; Lausch, E; Kottgen, A				Hoppmann, Anselm S.; Schlosser, Pascal; Backofen, Rolf; Lausch, Ekkehart; Koettgen, Anna			GenToS: Use of Orthologous Gene Information to Prioritize Signals from Human GWAS	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANDIDATE GENES; DISEASE GENES; MOUSE; LOCI; PRESSURE; RESOURCE	Genome-wide association studies (GWAS) evaluate associations between genetic variants and a trait or disease of interest free of prior biological hypotheses. GWAS require stringent correction for multiple testing, with genome-wide significance typically defined as association p-value <5*10(-8). This study presents a new tool that uses external information about genes to prioritize SNP associations (GenToS). For a given list of candidate genes, GenToS calculates an appropriate statistical significance threshold and then searches for trait-associated variants in summary statistics from human GWAS. It thereby allows for identifying trait-associated genetic variants that do not meet genome-wide significance. The program additionally tests for enrichment of significant candidate gene associations in the human GWAS data compared to the number expected by chance. As proof of principle, this report used external information from a comprehensive resource of genetically manipulated and systematically phenotyped mice. Based on selected murine phenotypes for which human GWAS data for corresponding traits were publicly available, several candidate gene input lists were derived. Using GenToS for the investigation of candidate genes underlying murine skeletal phenotypes in data from a large human discovery GWAS meta-analysis of bone mineral density resulted in the identification of significantly associated variants in 29 genes. Index variants in 28 of these loci were subsequently replicated in an independent GWAS replication step, highlighting that they are true positive associations. One signal, COL11A1, has not been discovered through GWAS so far and represents a novel human candidate gene for altered bone mineral density. The number of observed genes that contained significant SNP associations in human GWAS based on murine candidate gene input lists was much greater than the number expected by chance across several complex human traits (enrichment p-value as low as 10(-10)). GenToS can be used with any candidate gene list, any GWAS summary file, runs on a desktop computer and is freely available.	[Hoppmann, Anselm S.; Lausch, Ekkehart] Univ Freiburg, Fac Med, Med Ctr, Dept Pediat Genet, Freiburg, Germany; [Hoppmann, Anselm S.; Koettgen, Anna] Univ Freiburg, Fac Med, Med Ctr, Div Genet Epidemiol,Inst Med Biometry & Stat, Freiburg, Germany; [Schlosser, Pascal] Univ Freiburg, Fac Med, Med Ctr, Inst Med Biometry & Stat, Freiburg, Germany; [Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Kottgen, A (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Div Genet Epidemiol,Inst Med Biometry & Stat, Freiburg, Germany.	anna.koettgen@uniklinik-freiburg.de	Schlosser, Pascal/AAJ-6526-2020	Schlosser, Pascal/0000-0002-8460-0462	Deutsche Forschungsgemeinschaft [SFB 1140, KO 3598/3-1, SFB 992]; Bundesministerium fur Bildung und Forschung [031 A538A]; Bundesministerium fur Bildung und Forschung through FACE; EU [602300]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung through FACE(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) through grants SFB 1140, KO 3598/3-1 and SFB 992, by the Bundesministerium fur Bildung und Forschung (www.bmbf.de) through grants 031 A538A (German Network for Bioinformatics) and FACE, and by the EU Seventh Framework Programme (http://cordis.europa.eu/fp7/home_en.html) through grant 602300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; Ashbrook DG, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00171; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Butkiewicz M, 2016, BIOINFORMATICS, V32, P2361, DOI 10.1093/bioinformatics/btw130; Deo RC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0534-8; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pers TH, 2013, NUCLEIC ACIDS RES, V41, pW104, DOI 10.1093/nar/gkt387; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wuttke M, 2015, NEPHROL DIAL TRANSPL; Zhang L, 2014, HUM MOL GENET, V23, P1923, DOI 10.1093/hmg/ddt575	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162466	10.1371/journal.pone.0162466	http://dx.doi.org/10.1371/journal.pone.0162466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612175	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900105
J	Pan, YL; Wang, XM; Liu, L; Wang, H; Luo, MZ				Pan, Yonglong; Wang, Xiaoming; Liu, Lin; Wang, Hao; Luo, Meizhong			Whole Genome Mapping with Feature Sets from High-Throughput Sequencing Data	PLOS ONE			English	Article							PHYSICAL MAP; EVOLUTION; CLONES; SYSTEM; GENE; BAC; FRAGMENTS; SHOTGUN; SYMAP; FPC	A good physical map is essential to guide sequence assembly in de novo whole genome sequencing, especially when sequences are produced by high-throughput sequencing such as next-generation-sequencing (NGS) technology. We here present a novel method, Feature sets-based Genome Mapping (FGM). With FGM, physical map and draft whole genome sequences can be generated, anchored and integrated using the same data set of NGS sequences, independent of restriction digestion. Method model was created and parameters were inspected by simulations using the Arabidopsis genome sequence. In the simulations, when similar to 4.8X genome BAC library including 4,096 clones was used to sequence the whole genome, similar to 90% of clones were successfully connected to physical contigs, and 91.58% of genome sequences were mapped and connected to chromosomes. This method was experimentally verified using the existing physical map and genome sequence of rice. Of 4,064 clones covering 115 Mb sequence selected from similar to 3 tiles of 3 chromosomes of a rice draft physical map, 3,364 clones were reconstructed into physical contigs and 98 Mb sequences were integrated into the 3 chromosomes. The physical map-integrated draft genome sequences can provide permanent frameworks for eventually obtaining high-quality reference sequences by targeted sequencing, gap filling and combining other sequences.	[Luo, Meizhong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Luo, MZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	mzluo@mail.hzau.edu.cn		Wang, Xiaoming/0000-0002-6105-5377	National Programs for High Technology Research and Development [863 Project] [2012AA10A305]; National Basic Research Program [the "973" project] [2009CB118404]; Chinese 111 Project [B07041]	National Programs for High Technology Research and Development [863 Project]; National Basic Research Program [the "973" project](National Basic Research Program of China); Chinese 111 Project	This work was supported by the National Programs for High Technology Research and Development [863 Project: 2012AA10A305], the National Basic Research Program [the "973" project, 2009CB118404] and the Chinese 111 Project B07041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2005, THEOR APPL GENET, V111, P1596, DOI 10.1007/s00122-005-0091-3; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Butler D, 2002, NATURE, V420, P460, DOI 10.1038/420460a; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Christie AE, 2015, GEN COMP ENDOCR, V210, P63, DOI 10.1016/j.ygcen.2014.10.005; Cvikova K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0429-1; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eastman AW, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00769; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114; Keinath MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16413; Kim J, 2013, P NATL ACAD SCI USA, V110, P1785, DOI 10.1073/pnas.1220349110; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Lin HY, 2012, MOL PLANT, V5, P218, DOI 10.1093/mp/ssr085; Lounsberry ZT, 2015, MOL ECOL RESOUR, V15, P893, DOI 10.1111/1755-0998.12365; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Morioka MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151963; Oeveren Jv, 2011, GENOME RES, V21, P8, DOI [10.1101/gr.112094.110gr.185579.114, DOI 10.1101/GR.112094.110GR.185579.114]; Okura VK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00342; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Plomion C, 2016, MOL ECOL RESOUR, V16, P254, DOI 10.1111/1755-0998.12425; Poursarebani N, 2014, PLANT J, V79, P334, DOI 10.1111/tpj.12550; Sasaki T, 2005, PLANT CELL PHYSIOL, V46, P3, DOI 10.1093/pcp/pci503; Saski CA, 2015, METHODS MOL BIOL, V1227, P55, DOI 10.1007/978-1-4939-1652-8_3; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Sulston J, 1988, CABIOS, V4, P8; Tang HB, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0044-y; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vu GTH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009089; Wang C, 2013, GENETICS, V195, P723, DOI 10.1534/genetics.113.157115; Wu CC, 2004, GENOME RES, V14, P319, DOI 10.1101/gr.1405004; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	47	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161583	10.1371/journal.pone.0161583	http://dx.doi.org/10.1371/journal.pone.0161583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611682	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900022
J	Yeh, JJ; Wang, YC; Kao, CH				Yeh, Jun-Jun; Wang, Yu-Chiao; Kao, Chia-Hung			Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism	PLOS ONE			English	Article							POPULATION-BASED-COHORT; DEEP-VEIN THROMBOSIS; COPD OVERLAP; ENDOTHELIAL DYSFUNCTION; MANAGEMENT; METAANALYSIS; PREVALENCE; BIOMARKERS; INCREASES; EVENTS	Purpose We conducted a cohort study to clarify this relationship between asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) and pulmonary embolism (PE). Methods From the National Health Insurance Research Database of Taiwan, we identified patients who had a diagnosis of asthma and a diagnosis of COPD (defined as ACOS) and concurrent treatment between January 1999 and December 2009 (ACOS cohort: n = 14,150; non-ACOS cohort: n = 55,876). Cox proportional hazards regression analysis was performed to determine the adjusted hazard ratios (aHRs) for PE of the ACOS cohort compared with the non-ACOS cohort. Results Comparing the ACOS cohort with the non-ACOS cohort, the aHR of PE was 2.08 (95% confidence intervals [ CIs]: 1.56-2.76). The risk of PE was higher in ACOS cohort than non-ACOS cohort, regardless of age, sex, comorbidity, inhaled corticosteroids (ICSs) and oral steroids (OSs) used. For ages ranging from 20 to 65 years, the aHR of PE was 2.53 (95% CI: 1.44-4.44) in the ACOS cohort. ACOS patients using ICSs (aHR: 1.97, 95% CI: 1.29-3.01) or OSs (aHR: 1.97, 95% CI: 1.46-2.65), the risk of PE was higher than in the non-ACOS cohort. The risk of PE increased with the number of outpatient visits and hospitalizations necessitated, ranging from 2.32 (95% CI: 1.54-3.52) in patients having 3-9 visits to 4.20 (95% CI: 2.74-6.44) for those having > 9 visits. Conclusions ACOS is associated with increased risk of PE, particularly patients with a high frequency of AE-even in young adults or people without comorbidities.	[Yeh, Jun-Jun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW 105-TDU-B-212-133019]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; China Medical University Hospital	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; China Medical University Hospital	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW 105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Bagot CN, 2008, BRIT J HAEMATOL, V143, P180, DOI 10.1111/j.1365-2141.2008.07323.x; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Becattini C, 2016, CHEST, V149, P192, DOI 10.1378/chest.15-0808; Braman SS, 2015, ALLERGY ASTHMA PROC, V36, P11, DOI 10.2500/aap.2015.36.3802; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Cannegieter SC, 2015, BLOOD, V125, P229, DOI 10.1182/blood-2014-06-577783; Chen WJ, 2014, COPD, V11, P438, DOI 10.3109/15412555.2013.813927; Cheng SL, 2014, DRUG DES DEV THER, V8, P601, DOI 10.2147/DDDT.S63100; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; Chung WS, 2015, THROMB HAEMOSTASIS, V114, P812, DOI 10.1160/TH14-10-0868; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000755; Chung WS, 2014, EUR RESPIR J, V43, P801, DOI 10.1183/09031936.00043313; Condliffe R, 2014, THORAX, V69, P174, DOI 10.1136/thoraxjnl-2013-204667; D'Urzo A, 2015, EXPERT OPIN PHARMACO, V16, P1845, DOI 10.1517/14656566.2015.1067682; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Dentali F, 2016, THROMB HAEMOSTASIS, V115, P399, DOI 10.1160/TH15-02-0172; Fimognari Filippo Luca, 2008, Int J Chron Obstruct Pulmon Dis, V3, P89; Ghebre MA, 2015, J ALLERGY CLIN IMMUN, V135, P63, DOI 10.1016/j.jaci.2014.06.035; Huang WC, 2015, INT J CHRONIC OBSTR, V10, P2121, DOI 10.2147/COPD.S92062; Kahn SR, 2015, BLOOD, V126; King PT, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0068-z; Knoflach M, 2005, ARCH INTERN MED, V165, P2521, DOI 10.1001/archinte.165.21.2521; Kumbhare S, 2016, ANN AM THORAC SOC, V13, P803, DOI 10.1513/AnnalsATS.201508-554OC; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Majoor CJ, 2013, EUR RESPIR J, V42, P655, DOI 10.1183/09031936.00150312; Meyer G, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0122-z; Motte S, 2016, EUR RESPIR J, V47, P203, DOI 10.1183/13993003.00281-2015; O'Connell C, 2015, BLOOD, V125, P1877, DOI 10.1182/blood-2014-08-551879; Parulekar AD, 2016, CURR OPIN PULM MED, V22, P59, DOI 10.1097/MCP.0000000000000231; Phillips CL, 2012, THORAX, V67, P639, DOI 10.1136/thoraxjnl-2011-200874; Piovella F, 2016, CLIN RESPIR J, V10, P545, DOI 10.1111/crj.12264; Reddel HK, 2015, J ALLERGY CLIN IMMUN, V136, P546, DOI 10.1016/j.jaci.2015.06.043; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Sneeboer M, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA4567; Sneeboer MMS, 2016, J ALLERGY CLIN IMMUN, V137, P1727, DOI 10.1016/j.jaci.2015.10.038; Sneeboer MMS, 2016, THROMB RES, V140, P46, DOI 10.1016/j.thromres.2016.02.010; Stuijver DJE, 2013, CHEST, V143, P1337, DOI 10.1378/chest.12-1446; Torres-Macho J, 2013, AM J EMERG MED, V31, P1646, DOI 10.1016/j.ajem.2013.08.037; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Wanner A, 2010, AM J RESP CRIT CARE, V182, P1344, DOI 10.1164/rccm.201001-0038PP; Wedzicha JA, 2016, AM J RESP CRIT CARE, V193, P937, DOI 10.1164/rccm.201601-0015ED; Woods JA, 2014, INT J CHRONIC OBSTR, V9, P421, DOI 10.2147/COPD.S51012; Yoo HHB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010222.pub3	46	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162483	10.1371/journal.pone.0162483	http://dx.doi.org/10.1371/journal.pone.0162483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611495	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900112
J	Zeng, Y; Hu, XP; Suh, SJ				Zeng, Yuan; Hu, Xing Ping; Suh, Sang-Jin			Characterization of Antibacterial Activities of Eastern Subterranean Termite, Reticulitermes flavipes, against Human Pathogens	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; IMMUNE-RESPONSE; ANTIMICROBIAL PEPTIDES; FUNGAL PATHOGENS; INSECT IMMUNITY; PROTEIN; ANTIFUNGAL; INFECTION; BACTERIA; GENES	The emergence and dissemination of multidrug resistant bacterial pathogens necessitate research to find new antimicrobials against these organisms. We investigated antimicrobial production by eastern subterranean termites, Reticulitermes flavipes, against a panel of bacteria including three multidrug resistant (MDR) and four non-MDR human pathogens. We determined that the crude extract of naive termites had a broad-spectrum activity against the non-MDR bacteria but it was ineffective against the three MDR pathogens Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii. Heat or trypsin treatment resulted in a complete loss of activity suggesting that antibacterial activity was proteinaceous in nature. The antimicrobial activity changed dramatically when the termites were fed with either heat-killed P. aeruginosa or MRSA. Heat-killed P. aeruginosa induced activity against P. aeruginosa and MRSA while maintaining or slightly increasing activity against non-MDR bacteria. Heat-killed MRSA induced activity specifically against MRSA, altered the activity against two other Gram-positive bacteria, and inhibited activity against three Gram-negative bacteria. Neither the naive termites nor the termites challenged with heat-killed pathogens produced antibacterial activity against A. baumannii. Further investigation demonstrated that hemolymph, not the hindgut, was the primary source of antibiotic activity. This suggests that the termite produces these antibacterial activities and not the hindgut microbiota. Two-dimensional gel electrophoretic analyses of 493 hemolymph protein spots indicated that a total of 38 and 65 proteins were differentially expressed at least 2.5-fold upon being fed with P. aeruginosa and MRSA, respectively. Our results provide the first evidence of constitutive and inducible activities produced by R. flavipes against human bacterial pathogens.	[Zeng, Yuan; Hu, Xing Ping] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Suh, Sang-Jin] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Hu, XP (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.; Suh, SJ (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	huxingp@auburn.edu; suhsang@auburn.edu	Zeng, Yuan/R-3106-2018	Zeng, Yuan/0000-0003-2813-8960; Suh, Sang-Jin/0000-0002-4597-0137	National Institute of Food and Agriculture/United States Department of Agriculture Hatch program [ALA015-1-15005]; Auburn University Intramural Grant Program; Auburn University Detection and Food Safety Peaks of Excellence program [USDA 2005-3439415674A]; NSF EPSCoR [NSF-EPS11-58862]	National Institute of Food and Agriculture/United States Department of Agriculture Hatch program; Auburn University Intramural Grant Program; Auburn University Detection and Food Safety Peaks of Excellence program; NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the National Institute of Food and Agriculture/United States Department of Agriculture Hatch program (ALA015-1-15005), unrestricted industry funds, the Auburn University Intramural Grant Program, the Auburn University Detection and Food Safety Peaks of Excellence program (USDA 2005-3439415674A) and NSF EPSCoR (NSF-EPS11-58862).	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; Anju KM, 2015, WORLD J MICROB BIOT, V31, P621, DOI 10.1007/s11274-015-1816-3; Beck G, 1996, J BIOL CHEM, V271, P11035, DOI 10.1074/jbc.271.19.11035; Benz J, 2014, CURR OPIN MICROBIOL, V17, P1, DOI 10.1016/j.mib.2013.11.002; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bulmer MS, 2010, INSECT MOL BIOL, V19, P669, DOI 10.1111/j.1365-2583.2010.01023.x; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chouvenc T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1885; Chouvenc T, 2009, J INVERTEBR PATHOL, V101, P130, DOI 10.1016/j.jip.2009.04.005; Dossey AT, 2010, NAT PROD REP, V27, P1737, DOI 10.1039/c005319h; FAULHABER LM, 1992, IMMUNOLOGY, V75, P378; Finnerty CM, 1999, PROTEIN SCI, V8, P242; Gao Q., 2014, SOCIAL IMMUNITY EXPR, DOI [10.1128/AEM.03193-12, DOI 10.1128/AEM.03193-12]; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Hu XP, 2004, ENVIRON ENTOMOL, V33, P197, DOI 10.1603/0046-225X-33.2.197; Hussain A, 2012, AFR J MICROBIOL RES, V6, P995, DOI 10.5897/AJMR11.1078; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; LILLEENGEN K, 1948, ACTA PATHOLOGICA M S, V77, P1; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15106; Masson F, 2015, J INNATE IMMUN, V7, P290, DOI 10.1159/000368928; Matsuura K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000813; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Rosengaus RB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00607; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123391; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; Shrestha S, 2010, J INSECT PHYSIOL, V56, P324, DOI 10.1016/j.jinsphys.2009.11.008; Sitohy MZ, 2014, FUNCT FOODS HEALTH D, V4, P451; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Suetsugu Y, 2013, G3-GENES GENOM GENET, V3, P1481, DOI 10.1534/g3.113.006239; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; Taniai K, 2006, INSECT MOL BIOL, V15, P269, DOI 10.1111/j.1365-2583.2006.00639.x; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thompson GJ, 2003, INSECT MOL BIOL, V12, P1, DOI 10.1046/j.1365-2583.2003.00381.x; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Zeng Y, 2014, ADV RES, V2, P455	51	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162249	10.1371/journal.pone.0162249	http://dx.doi.org/10.1371/journal.pone.0162249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611223	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900070
J	Zhang, J; Zhang, SC; Li, LT; Xing, Y; Cao, MQ; Wu, JH; Jiang, B; Zhang, T				Zhang, Jian; Zhang, Shichuan; Li, Lintao; Xing, Yan; Cao, Maoqiu; Wu, Jinhua; Jiang, Bin; Zhang, Ting			Effects of Ionizing Radiation on Physical Properties of Peripherally Inserted Central Catheter	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; BLOOD-STREAM INFECTION; CANCER-PATIENTS; COMPLICATIONS; CHEMOTHERAPY; METAANALYSIS; RADIOTHERAPY; PLACEMENT; RISK	Peripherally inserted central catheter (PICC) has been widely used to treat cancer patients. It is unknown whether or not it can be applied safely during radiotherapy. The study aimed to investigate the direct effects of gamma radiation on physical properties of PICC. A total of 60 catheters were included in this study. Thirty PICCs were exposed to a radiation field, and another 30 PICCs received radiation in a 3-cm homogeneity water equivalent phantom and then were irradiated. Each group was divided into three subgroups: 10 PICCs were given conventional fractionation, 2 Gy per fraction, 5 fractions per week; 10 PICCs were continuously given hypofractionation, 10 Gy per fraction, for 6 weeks; and 10 PICCs were given mock radiation as controls. The physical properties of these catheters were analyzed after radiation. None of the PICCs leaked under 300-kPa airflow pressure lasting 15 seconds. Fracture force values and liquid velocity values of all PICCs were within the normal range. The liquid velocity values of the control groups were higher than the two groups that received radiation (P < 0.05), and there was no difference between the two irradiation groups (P > 0.05). There were no statistical differences among the conventional fractionation group, hypofractionation group, and control group when compared to the fracture force values in two parts (P > 0.05). The physical property of PICC is quite stable with a clinically relevant dose of gamma radiation. It is likely that PICC can be used safely in patients receiving radiotherapy, although further in vivo and clinical studies are required.	[Zhang, Jian; Zhang, Shichuan; Li, Lintao; Xing, Yan; Cao, Maoqiu; Wu, Jinhua; Zhang, Ting] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China; [Jiang, Bin] Sichuan Canc Hosp, Dept Thorac Surg, Chengdu, Sichuan, Peoples R China; [Zhang, Jian; Jiang, Bin] Sichuan Canc Hosp, Dept Nursing, Chengdu, Sichuan, Peoples R China; [Zhang, Ting] Sichuan Canc Hosp, Dept Gynecol Oncol, Chengdu, Sichuan, Peoples R China		Zhang, T (corresponding author), Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China.; Zhang, T (corresponding author), Sichuan Canc Hosp, Dept Gynecol Oncol, Chengdu, Sichuan, Peoples R China.	sccancerhospital@outlook.com						Alexandrou E, 2014, CRIT CARE MED, V42, P536, DOI 10.1097/CCM.0b013e3182a667f0; Bai XH, 2013, J CANCER RES THER, V9, P664, DOI 10.4103/0973-1482.126475; Breugom AJ, 2015, LANCET ONCOL, V16, P200, DOI 10.1016/S1470-2045(14)71199-4; Burns Tim, 2010, Radiol Manage, V32, P28; Chopra V, 2015, ANN INTERN MED, V163, pS1, DOI 10.7326/M15-0744; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Chopra V, 2012, JAMA-J AM MED ASSOC, V308, P1527, DOI 10.1001/jama.2012.12704; Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Cotogni P, 2013, JPEN-PARENTER ENTER, V37, P375, DOI 10.1177/0148607112460552; Gunderson LL, 2007, CLINICAL RADIATION O; Leung TK, 2011, CANCER NURS, V34, pE25, DOI 10.1097/NCC.0b013e3181f1ad6f; Linnemann B, 2014, SEMIN THROMB HEMOST, V40, P382, DOI 10.1055/s-0034-1371005; Matsuzaki A, 2006, SUPPORT CARE CANCER, V14, P153, DOI 10.1007/s00520-005-0848-x; Pikwer A, 2012, ANAESTHESIA, V67, P65, DOI 10.1111/j.1365-2044.2011.06911.x; Simone CB, 2015, TRANSL LUNG CANCER R, V4, P545, DOI 10.3978/j.issn.2218-6751.2015.10.05; Uygun I, 2011, ACTA CIR BRAS, V26, P404, DOI 10.1590/S0102-86502011000500014; Walker G., 2013, BR J NURS, V22, pS9, DOI DOI 10.12968/BJ0N.2013.22.SUP19.S9	18	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162837	10.1371/journal.pone.0162837	http://dx.doi.org/10.1371/journal.pone.0162837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611595	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900177
J	Chow, LH; Chen, YH; Wu, WC; Chang, EP; Huang, EYK				Chow, Lok-Hi; Chen, Yuan-Hao; Wu, Wan-Chuan; Chang, En-Pei; Huang, Eagle Yi-Kung			Sex Difference in Oxytocin-Induced Anti-Hyperalgesia at the Spinal Level in Rats with Intraplantar Carrageenan-Induced Inflammation	PLOS ONE			English	Article							ANGIOTENSIN-IV; MORPHINE ANTINOCICEPTION; ELECTRICAL-STIMULATION; CEREBROSPINAL-FLUID; INDUCED ANALGESIA; OPIOID RECEPTORS; CORD; PAIN; AMINOPEPTIDASE; MICE	Previously, we demonstrated intrathecal administration of oxytocin strongly induced anti-hyperalgesia in male rats. By using an oxytocin-receptor antagonist (atosiban), the descending oxytocinergic pathway was found to regulate inflammatory hyperalgesia in our previous study using male rats. The activity of this neural pathway is elevated during hyperalgesia, but whether this effect differs in a sex-dependent manner remains unknown. We conducted plantar tests on adult male and female virgin rats in which paw inflammation was induced using carrageenan. Exogenous (i.t.) application of oxytocin exerted no anti-hyperalgesic effect in female rats, except at an extremely high dose. Female rats exhibited similar extent of hyperalgesia to male rats did when the animals received the same dose of carrageenan. When atosiban was administered alone, the severity of hyperalgesia was not increased in female rats. Moreover, insulin-regulated aminopeptidase (IRAP) was expressed at higher levels in the spinal cords of female rats compared with those of male rats. Oxytocin-induced anti-hyperalgesia exhibits a sex-dependent difference in rats. This difference can partially result from the higher expression of IRAP in the spinal cords of female rats, because IRAP functions as an enzyme that degrades oxytocin. Our study confirms the existence of a sex difference in oxytocin-induced anti-hyperalgesia at the spinal level in rats.	[Wu, Wan-Chuan; Chang, En-Pei; Huang, Eagle Yi-Kung] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chow, Lok-Hi] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Chow, Lok-Hi] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chow, Lok-Hi] Natl Yang Ming Univ, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Chen, Yuan-Hao] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Huang, EYK (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	eyh58@mail.ndmctsgh.edu.tw	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council, Taiwan, ROC [NSC 96-2320-B-016-020-MY3, NSC 99-2320-B-016-002-MY3]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by the grants (NSC 96-2320-B-016-020-MY3 and NSC 99-2320-B-016-002-MY3) from National Science Council, Taiwan, ROC.	Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; ARLETTI R, 1993, NEUROPEPTIDES, V24, P125, DOI 10.1016/0143-4179(93)90075-L; Cheng BC, 2012, PEPTIDES, V36, P9, DOI 10.1016/j.peptides.2012.03.019; Chow LH, 2004, J BIOMED SCI, V11, P717, DOI 10.1159/000081817; Chow LH, 2004, CAN J ANAESTH, V51, P905, DOI 10.1007/BF03018888; Chow LH, 2013, PEPTIDES, V39, P21, DOI 10.1016/j.peptides.2012.10.012; Condes-Lara M, 2006, BRAIN RES, V1081, P126, DOI 10.1016/j.brainres.2006.01.050; Condes-Lara M, 2005, BRAIN RES, V1045, P124, DOI 10.1016/j.brainres.2005.03.020; Condes-Lara M, 2007, BRAIN RES, V1160, P20, DOI 10.1016/j.brainres.2007.05.031; Condes-Lara M, 2009, EUR J NEUROSCI, V30, P1056, DOI 10.1111/j.1460-9568.2009.06899.x; DADDONA MM, 1994, NEUROREPORT, V5, P1833, DOI 10.1097/00001756-199409080-00037; Eliava M, 2016, NEURON, V89, P1291, DOI 10.1016/j.neuron.2016.01.041; Gao L, 2004, REGUL PEPTIDES, V120, P53, DOI 10.1016/j.regpep.2004.02.011; Horio J, 1999, BIOCHEM BIOPH RES CO, V262, P269, DOI 10.1006/bbrc.1999.1184; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; LUNDEBERG T, 1994, NEUROSCI LETT, V170, P153, DOI 10.1016/0304-3940(94)90262-3; MADRAZO I, 1987, APPL NEUROPHYSIOL, V50, P427; Martinez-Lorenzan G, 2008, PAIN, V140, P265, DOI 10.1016/j.pain.2008.08.015; Miranda-Cardenas Y, 2006, PAIN, V122, P182, DOI 10.1016/j.pain.2006.01.029; Nomura M, 2002, PLACENTA, V23, P631, DOI 10.1053/plac.2002.0861; Petersson M, 1996, NEUROSCI LETT, V212, P87, DOI 10.1016/0304-3940(96)12773-7; Petersson M, 2001, PEPTIDES, V22, P1479, DOI 10.1016/S0196-9781(01)00469-7; Puder BA, 2001, J NEUROSCI RES, V64, P53, DOI 10.1002/jnr.1053; Reeta K, 2006, REGUL PEPTIDES, V135, P85, DOI 10.1016/j.regpep.2006.04.004; Robinson DA, 2002, J PHYSIOL-LONDON, V540, P593, DOI 10.1113/jphysiol.2001.013492; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAKAGI T, 1985, HORM METAB RES, V17, P308, DOI 10.1055/s-2007-1013526; Uhl-Bronner S, 2005, NEUROSCIENCE, V135, P147, DOI 10.1016/j.neuroscience.2005.05.025; XU XJ, 1994, NEUROREPORT, V5, P750, DOI 10.1097/00001756-199403000-00003; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x; YANG J, 1994, SPINE, V19, P867, DOI 10.1097/00007632-199404150-00001; Yang J, 2007, PEPTIDES, V28, P1113, DOI 10.1016/j.peptides.2007.03.003; YIRMIYA R, 1990, BRAIN RES, V537, P169, DOI 10.1016/0006-8993(90)90354-E; Yu SQ, 2003, BRAIN RES, V983, P13, DOI 10.1016/S0006-8993(03)03019-1	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162218	10.1371/journal.pone.0162218	http://dx.doi.org/10.1371/journal.pone.0162218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606886	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255600031
J	Marcus, HJ; Payne, CJ; Kailaya-Vasa, A; Griffiths, S; Clark, J; Yang, GZ; Darzi, A; Nandi, D				Marcus, Hani J.; Payne, Christopher J.; Kailaya-Vasa, Ahilan; Griffiths, Sara; Clark, James; Yang, Guang-Zhong; Darzi, Ara; Nandi, Dipankar			A "Smart" Force-Limiting Instrument for Microsurgery: Laboratory and In Vivo Validation	PLOS ONE			English	Article							HAND; DEVICE	Residents are required to learn a multitude of skills during their microsurgical training. One such skill is the judicious application of force when handling delicate tissue. An instrument has been developed that indicates to the surgeon when a force threshold has been exceeded by providing vibrotactile feedback. The objective of this study was to validate the use of this " smart" force-limiting instrument for microsurgery. A laboratory and an in vivo experiment were performed to evaluate the force-limiting instrument. In the laboratory experiment, twelve novice surgeons were randomly allocated to use either the force-limiting instrument or a standard instrument. Surgeons were then asked to performmicrosurgical dissection in a model. In the in vivo experiment, an intermediate surgeon performed microsurgical dissection in a stepwise fashion, alternating every 30 seconds between use of the force-limiting instrument and a standard instrument. The primary outcomes were the forces exerted and the OSATS scores. In the laboratory experiment, the maximal forces exerted by novices using the force-limiting instrument were significantly less than using a standard instrument, and were comparable to intermediate and expert surgeons (0.637N versus 4.576N; p = 0.007). In the in vivo experiment, the maximal forces exerted with the force-limiting instrumentwere also significantly less than with a standard instrument (0.441N versus 0.742N; p < 0.001). Notably, use of the force-limiting instrument did not significantly impede the surgical workflow as measured by the OSATS score (p > 0.1). In conclusion, the development and use of this force-limiting instrument in a clinical setting may improve patient safety.	[Marcus, Hani J.; Payne, Christopher J.; Griffiths, Sara; Clark, James; Yang, Guang-Zhong; Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, Hamlyn Ctr, London, England; [Marcus, Hani J.; Nandi, Dipankar] Imperial Coll Healthcare NHS Trust, Dept Neurosurg, London, England; [Kailaya-Vasa, Ahilan] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Neurosurg, Romford, Essex, England	Imperial College London; Imperial College London	Marcus, HJ (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, Hamlyn Ctr, London, England.; Marcus, HJ (corresponding author), Imperial Coll Healthcare NHS Trust, Dept Neurosurg, London, England.	hani.marcus10@imperial.ac.uk	Nandi, Dipankar/AAN-7186-2020	Kailaya-Vasan, Ahilan/0000-0002-6495-2903	Imperial College Wellcome Trust Clinical Fellowship; Wates Foundation Fellowship; MRC [G0701698] Funding Source: UKRI; Medical Research Council [G0701698] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	Imperial College Wellcome Trust Clinical Fellowship; Wates Foundation Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	H.J. Marcus is supported by an Imperial College Wellcome Trust Clinical Fellowship. C.J. Payne is supported by a Wates Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2014, ANN SURG, V259, P1041, DOI 10.1097/SLA.0000000000000595; Dawe SR, 2014, ANN SURG, V259, P236, DOI 10.1097/SLA.0000000000000245; Gan LS, 2015, WORLD NEUROSURG, V84, P537, DOI 10.1016/j.wneu.2015.04.001; Gonenc B, 2012, IEEE INT C INT ROBOT, P4125, DOI 10.1109/IROS.2012.6385715; Harada K, 2011, IEEE ENG MED BIO, P6700, DOI 10.1109/IEMBS.2011.6091652; Harada N, 2011, NEUROL MED-CHIR, V51, P567, DOI 10.2176/nmc.51.567; Maddahi Y, 2016, INT J MED ROBOT COMP, V12, P528, DOI 10.1002/rcs.1679; Marcus H, 2013, NEUROSURGERY, V72, pA124, DOI 10.1227/NEU.0b013e318270d010; Payne CJ, 2015, ANN BIOMED ENG, V43, P2185, DOI 10.1007/s10439-015-1258-y; Payne CJ, 2014, ANN BIOMED ENG, V42, P1594, DOI 10.1007/s10439-014-1042-4; Payne CJ, 2012, IEEE INT CONF ROBOT, P1583, DOI 10.1109/ICRA.2012.6225306; Salcudean SE, 1997, LECT NOTES COMPUT SC, V1205, P789, DOI 10.1007/BFb0029304; Stetten GD, 2011, HAND HELD FORCE MAGN; Sutherland GR, 2008, IEEE ENG MED BIOL, V27, P59, DOI 10.1109/EMB.2007.910272; Taylor R, 1999, LECT NOTES COMPUT SC, V1679, P1031	15	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162232	10.1371/journal.pone.0162232	http://dx.doi.org/10.1371/journal.pone.0162232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622693	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000019
J	Raja, WK; Mungenast, AE; Lin, YT; Ko, T; Abdurrob, F; Seo, J; Tsai, LH				Raja, Waseem K.; Mungenast, Alison E.; Lin, Yuan-Ta; Ko, Tak; Abdurrob, Fatema; Seo, Jinsoo; Tsai, Li-Huei			Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; NEURODEGENERATIVE DISORDERS; HYPOTHETICAL MODEL; CEREBRAL ORGANOIDS; DYNAMIC BIOMARKERS; MISSENSE MUTATION; AMYLOID PROTEIN; CULTURE-SYSTEM; DOWN-SYNDROME; MOUSE MODEL	The dismal success rate of clinical trials for Alzheimer's disease (AD) motivates us to develop model systems of AD pathology that have higher predictive validity. The advent of induced pluripotent stem cells (iPSCs) allows us to model pathology and study disease mechanisms directly in human neural cells from healthy individual as well as AD patients. However, two-dimensional culture systems do not recapitulate the complexity of neural tissue, and phenotypes such as extracellular protein aggregation are difficult to observe. We report brain organoids that use pluripotent stem cells derived from AD patients and recapitulate AD-like pathologies such as amyloid aggregation, hyperphosphorylated tau protein, and endosome abnormalities. These pathologies are observed in an age-dependent manner in organoids derived from multiple familial AD (fAD) patients harboring amyloid precursor protein (APP) duplication or presenilin1 (PSEN1) mutation, compared to controls. The incidence of AD pathology was consistent amongst several fAD lines, which carried different mutations. Although these are complex assemblies of neural tissue, they are also highly amenable to experimental manipulation. We find that treatment of patient-derived organoids with beta- and gamma-secretase inhibitors significantly reduces amyloid and tau pathology. Moreover, these results show the potential of this model system to greatly increase the translatability of pre-clinical drug discovery in AD.	[Raja, Waseem K.; Mungenast, Alison E.; Lin, Yuan-Ta; Abdurrob, Fatema; Seo, Jinsoo; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Ko, Tak] MIT, Induced Pluripotent Stem Cell Core Facil, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Seo, Jinsoo/AAD-4950-2019	Seo, Jinsoo/0000-0001-6432-6964; Mungenast, Alison/0000-0003-1020-0471	National Institutes of Health [RF1AG042978, RF1AG048029, R01NS051874]; JPB foundation; Picower Institute Innovation Fund; Robert A. and Renee E. Belfer Family Foundation; Belfer Neurodegeneration Consortium; NATIONAL INSTITUTE ON AGING [RF1AG048029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Picower Institute Innovation Fund; Robert A. and Renee E. Belfer Family Foundation; Belfer Neurodegeneration Consortium; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (https://www.nih.gov/), Grant numbers: RF1AG042978, RF1AG048029, and R01NS051874 to LHT; Jeffry M. Picower and Barbara Picower (JPB foundation) (http://www.jpbfoundation.org/), Picower Institute Innovation Fund to LHT; and the Robert A. and Renee E. Belfer Family Foundation and Belfer Neurodegeneration Consortium to LHT. The funder provided support in the form of salaries for authors WKR, AM, YL, FA, and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Association A., 2013, ALZHEIMERS DEMENT, V8, P131, DOI DOI 10.1016/J.JALZ.2012.02.001; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cataldo A, 2001, ANN NEUROL, V50, P661, DOI 10.1002/ana.1254.abs; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Cucullo L, 2002, BRAIN RES, V951, P243, DOI 10.1016/S0006-8993(02)03167-0; D'Avanzo C, 2015, BIOESSAYS, V37, P1139, DOI 10.1002/bies.201500063; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Fjell AM, 2012, MOL NEUROBIOL, V45, P153, DOI 10.1007/s12035-011-8228-7; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goate A, 2006, J ALZHEIMERS DIS, V9, P341; GOLDGABER D, 1987, J NEURAL TRANSM, P23; Graeber MB, 1997, NEUROGENETICS, V1, P73, DOI 10.1007/s100480050011; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hossini AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1262-5; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; IOVINO M, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV222; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Janke D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057227; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee VMY GoedertM, 2001, NEURODEGENERATIVE TA, DOI [10.1146/annurev.neuro.24.1.1121, DOI 10.1146/ANNUREV.NEURO.24.1.1121]; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Miller J, 2014, AGING-US, V6, P246, DOI 10.18632/aging.100653; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; ROBAKIS NK, 1987, LANCET, V1, P384; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; WISNIEWSKI HM, 1989, ACTA NEUROPATHOL, V78, P22, DOI 10.1007/BF00687398; Wren MC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0042-7; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	91	266	270	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161969	10.1371/journal.pone.0161969	http://dx.doi.org/10.1371/journal.pone.0161969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622770	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000010
J	Ropars, J; Lempereur, M; Vuillerot, C; Tiffreau, V; Peudenier, S; Cuisset, JM; Pereon, Y; Leboeuf, F; Delporte, L; Delpierre, Y; Gross, R; Brochard, S				Ropars, Juliette; Lempereur, Mathieu; Vuillerot, Carole; Tiffreau, Vincent; Peudenier, Sylviane; Cuisset, Jean-Marie; Pereon, Yann; Leboeuf, Fabien; Delporte, Ludovic; Delpierre, Yannick; Gross, Raphael; Brochard, Sylvain			Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SPASTIC CEREBRAL-PALSY; WALKING; SPEED; DEVIATION; PROFILES; INDEX	The aim of this prospective study was to investigate changes in muscle activity during gait in children with Duchennemuscular Dystrophy (DMD). Dynamic surface electromyography recordings (EMGs) of 16 children with DMD and pathological gait were compared with those of 15 control children. The activity of the rectus femoris (RF), vastus lateralis (VL), medial hamstrings (HS), tibialis anterior (TA) and gastrocnemius soleus (GAS) muscles was recorded and analysed quantitatively and qualitatively. The overall muscle activity in the children with DMD was significantly different from that of the control group. Percentage activation amplitudes of RF, HS and TA were greater throughout the gait cycle in the children with DMD and the timing of GAS activity differed from the control children. Significantly greater muscle coactivation was found in the children with DMD. There were no significant differences between sides. Since the motor command is normal in DMD, the hyper-activity and co-contractions likely compensate for gait instability and muscle weakness, however may have negative consequences on the muscles and may increase the energy cost of gait. Simple rehabilitative strategies such as targeted physical therapies may improve stability and thus the pattern of muscle activity.	[Ropars, Juliette; Peudenier, Sylviane] CHRU Brest, Serv Pediat, Brest, France; [Ropars, Juliette; Lempereur, Mathieu; Brochard, Sylvain] INSERM, U1101, Lab Traitement Informat Med, Brest, France; [Lempereur, Mathieu; Brochard, Sylvain] CHRU Brest, Serv Med Phys & Readaptat, Brest, France; [Vuillerot, Carole] Serv Cent Reeduc Pediat, Escale, Lyon, France; [Vuillerot, Carole] CNRS, UMR5558, Pierre Benite, France; [Tiffreau, Vincent] CHRU Lille, Serv Med Phys & Readaptat, Lille, France; [Cuisset, Jean-Marie; Gross, Raphael] CHRU Lille, Serv Neurol Pediat, Lille, France; [Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires Nantes Anger, Nantes, France; [Pereon, Yann] Atlantic Gene Therapy Inst, Nantes, France; [Leboeuf, Fabien] CHU Nantes, Pole Med Phys & Readaptat, Nantes, France; [Delporte, Ludovic] Hosp Civils Lyon, Plateforme Mouvement & Handicap, Bron, France; [Delpierre, Yannick] Ctr Arche, Serv Reeduc Neurol Pediat, Le Mans, France	CHU Brest; Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHU Lyon	Ropars, J (corresponding author), CHRU Brest, Serv Pediat, Brest, France.; Ropars, J (corresponding author), INSERM, U1101, Lab Traitement Informat Med, Brest, France.	juliette.ropars@chu-brest.fr	Brochard, Sylvain/AAI-7291-2021; Mathieu, Lempereur/G-5470-2012	Brochard, Sylvain/0000-0002-4950-1696; Mathieu, Lempereur/0000-0002-6717-7033; Delpierre, Yannick/0000-0002-4505-7014				Baker R, 2012, GAIT POSTURE, V35, P612, DOI 10.1016/j.gaitpost.2011.12.008; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Bervet K, 2013, J ELECTROMYOGR KINES, V23, P930, DOI 10.1016/j.jelekin.2013.02.006; Boccardi S, 1997, J PHYS REHABILITATIO, V33, P13; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chang WN, 2007, J ELECTROMYOGR KINES, V17, P437, DOI 10.1016/j.jelekin.2006.02.003; Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; Damiano DL, 2000, ARCH PHYS MED REHAB, V81, P895, DOI 10.1053/apmr.2000.5579; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DE LUCA CJ, 1988, ELECTROEN CLIN NEURO, V69, P568, DOI 10.1016/0013-4694(88)90169-1; Doglio L, 2011, EUR J PHYS REHAB MED, V47, P587; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Ganea R, 2012, J CHILD NEUROL, V27, P30, DOI 10.1177/0883073811413581; Gaudreault N, 2005, CRIT REV PHYS REHAB, V17, P231; Gaudreault N, 2010, GAIT POSTURE, V32, P342, DOI 10.1016/j.gaitpost.2010.06.003; Gianola S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065414; Gross R, 2013, CLIN BIOMECH, V28, P312, DOI 10.1016/j.clinbiomech.2013.01.002; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Khodadadeh S, 1990, Proc Inst Mech Eng H, V204, P241, DOI 10.1243/PIME_PROC_1990_204_262_02; KHODADADEH S, 1986, LANCET, V2, P544, DOI 10.1016/S0140-6736(86)90114-5; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Patte K., 2000, Annales de Readaptation et de Medecine Physique, V43, P57, DOI 10.1016/S0168-6054(00)88728-0; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Shiavi R, 1998, MED BIOL ENG COMPUT, V36, P171, DOI 10.1007/BF02510739; SUTHERLAND DH, 1981, DEV MED CHILD NEUROL, V23, P3; Thomas SS, 2010, J CHILD NEUROL, V25, P1103, DOI 10.1177/0883073810371002; Unnithan V B, 1996, Electromyogr Clin Neurophysiol, V36, P487; VIGNOS PJ, 1963, JAMA-J AM MED ASSOC, V184, P89, DOI 10.1001/jama.1963.03700150043007	35	21	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161938	10.1371/journal.pone.0161938	http://dx.doi.org/10.1371/journal.pone.0161938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622734	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000009
J	Poher, AL; Arsenijevic, D; Asrih, M; Dulloo, AG; Jornayvaz, FR; Rohner-Jeanrenaud, F; Veyrat-Durebex, C				Poher, Anne-Laure; Arsenijevic, Denis; Asrih, Mohamed; Dulloo, Abdul G.; Jornayvaz, Francois R.; Rohner-Jeanrenaud, Francoise; Veyrat-Durebex, Christelle			Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; BROWN ADIPOSE-TISSUE; ARCUATE NUCLEUS; FOOD-INTAKE; GENE-EXPRESSION; NEURONS; MICE; HYPOTHALAMUS; PHENOTYPE; ADULTHOOD	Physiological processes at adulthood, such as energy metabolism and insulin sensitivity may originate before or weeks after birth. These underlie the concept of fetal and/or neonatal programming of adult diseases, which is particularly relevant in the case of obesity and type 2 diabetes. The aim of this study was to determine the impact of a perinatal high fat diet on energy metabolism and on leptin as well as insulin sensitivity, early in life and at adulthood in two strains of rats presenting different susceptibilities to diet-induced obesity. The impact of a perinatal high fat diet on glucose tolerance and diet-induced obesity was also assessed. The development of glucose intolerance and of increased fat mass was confirmed in the obesity-prone Wistar rat, even after 28 days of age. By contrast, in obesity-resistant Lou/C rats, an improved early leptin signaling may be responsible for the lack of deleterious effect of the perinatal high fat diet on glucose tolerance and increased adiposity in response to high fat diet at adulthood. Altogether, this study shows that, even if during the perinatal period adaptation to the environment appears to be genetically determined, adaptive mechanisms to nutritional challenges occurring at adulthood can still be observed in rodents.	[Poher, Anne-Laure; Rohner-Jeanrenaud, Francoise; Veyrat-Durebex, Christelle] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Poher, Anne-Laure; Rohner-Jeanrenaud, Francoise] Univ Geneva, Dept Med Specialties, Lab Metab, Fac Med, Geneva, Switzerland; [Arsenijevic, Denis; Dulloo, Abdul G.] Univ Fribourg, Dept Med Physiol, Fribourg, Switzerland; [Asrih, Mohamed; Jornayvaz, Francois R.] Univ Lausanne Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Fribourg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Veyrat-Durebex, C (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.	christelle.veyrat-durebex@unige.ch	Jornayvaz, François/AAL-2134-2020; Arsenijevic, Denis/O-8315-2016	Arsenijevic, Denis/0000-0001-5741-9652; DULLOO, Abdul/0000-0003-3877-6149; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Poher, Anne-Laure/0000-0002-6657-4336; Jornayvaz, Francois/0000-0001-9425-3137	Societe Francophone du Diabete	Societe Francophone du Diabete	The work was supported by Societe Francophone du Diabete.	Aalinkeel R, 2001, AM J PHYSIOL-ENDOC M, V281, pE640, DOI 10.1152/ajpendo.2001.281.3.E640; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Martinez JA, 2012, P NUTR SOC, V71, P276, DOI 10.1017/S0029665112000055; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Baquero AF, 2014, J NEUROSCI, V34, P9982, DOI 10.1523/JNEUROSCI.0933-14.2014; Bazin H., 1990, THE LOUVAIN LOU RATS, P43; Beall MH, 2004, CLIN OBSTET GYNECOL, V47, P957, DOI 10.1097/01.grf.0000135668.61661.9c; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Coupe Berengere, 2013, Front Endocrinol (Lausanne), V4, P38, DOI 10.3389/fendo.2013.00038; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Delahaye F, 2010, AM J PHYSIOL-REG I, V299, pR101, DOI 10.1152/ajpregu.00604.2009; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; LINN TC, 1981, ARCH BIOCHEM BIOPHYS, V209, P613, DOI 10.1016/0003-9861(81)90320-9; Marcelino H, 2013, DIABETES, V62, P362, DOI 10.2337/db12-0255; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Parente LB, 2008, CLIN NUTR, V27, P623, DOI 10.1016/j.clnu.2008.05.005; Pedrazzi P, 1998, PEPTIDES, V19, P157, DOI 10.1016/S0196-9781(97)00258-1; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Poher AL, 2015, DIABETES, V64, P3700, DOI 10.2337/db15-0210; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Taleux N, 2008, INT J OBESITY, V32, P639, DOI 10.1038/sj.ijo.0803759; Ueno N, 1998, MECH AGEING DEV, V100, P67, DOI 10.1016/S0047-6374(97)00123-1; Veyrat-Durebex C, 1998, MECH AGEING DEV, V103, P223, DOI 10.1016/S0047-6374(98)00013-X; Veyrat-Durebex C, 1997, PHYSIOL BEHAV, V62, P1273, DOI 10.1016/S0031-9384(97)00304-1; Veyrat-Durebex C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073452; Veyrat-Durebex C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1146, DOI 10.1152/ajpendo.00575.2010; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162517	10.1371/journal.pone.0162517	http://dx.doi.org/10.1371/journal.pone.0162517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618559	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100027
J	He, Y; Yan, DY; Zheng, DP; Hu, ZM; Li, HW; Li, JL				He, Yue; Yan, Daoyu; Zheng, Dianpeng; Hu, Zhiming; Li, Hongwei; Li, Jinlong			Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; DNA-REPLICATION; PROTEIN CDC6; CHECKPOINT; SPINDLE; ARREST; MICROTUBULES; MITOSIS; EXIT; INHIBITION	Paclitaxel (PTX) is an antimitotic drug that possesses potent anticancer activity, but its therapeutic potential in the clinic has been hindered by drug resistance. Here, we reporta mechanism by which cancer cells can exit from the PTX-induced mitotic arrest, i.e. mitotic slippage, and avoid subsequent death resulting in drug resistance. In cells experiencing mitotic slippage, Cdc6 protein level was significantly upregulated, Cdk1 activity was inhibited, and Cohesin/Rad21 was cleaved as a result. Cdc6 depletion by RNAi or Norcantharidin inhibited PTX-induced Cdc6 up-regulation, maintained Cdk1 activity, and repressed Cohesin/Rad21 cleavage. In all, this resulted in reduced mitotic slippage and reversal of PTX resistance. Moreover, in synchronized cells, the role of Cdc6 in mitotic exit under PTX pressure was also confirmed. This study indicates that Cdc6 may promote mitotic slippage by inactivation of Cdk1. Targeting of Cdc6 may serve as a promising strategy for enhancing the anticancer activity of PTX.	[He, Yue; Yan, Daoyu; Zheng, Dianpeng; Hu, Zhiming; Li, Hongwei; Li, Jinlong] Southern Med Univ, Sch Biotechnol, Inst Biotherapy, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Li, HW; Li, JL (corresponding author), Southern Med Univ, Sch Biotechnol, Inst Biotherapy, Guangzhou, Guangdong, Peoples R China.	hongwei1@yahoo.com; lijinlong@smu.edu.cn			National Natural Science Foundation of China [81272482, 81373122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from National Natural Science Foundation of China Grants 81272482 (JL), and in part from National Natural Science Foundation of China Grants 81373122 (ZH), http://www.nsfc.gov.cn/.	Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Brito DA, 2008, J CELL BIOL, V182, P623, DOI 10.1083/jcb.200805072; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Calzada A, 2001, NATURE, V412, P355, DOI 10.1038/35085610; Chen SS, 2013, AM J CHINESE MED, V41, P665, DOI 10.1142/S0192415X13500468; Chen SS, 2013, INT J MOL MED, V32, P43, DOI 10.3892/ijmm.2013.1359; Chiang PC, 2010, BIOCHEM PHARMACOL, V79, P162, DOI 10.1016/j.bcp.2009.08.022; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; El Dika M, 2014, DEV BIOL, V396, P67, DOI 10.1016/j.ydbio.2014.09.023; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giovinazzi S, 2013, CELL CYCLE, V12, P2598, DOI 10.4161/cc.25591; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Flores ML, 2012, BREAST CANCER RES TR, V133, P917, DOI 10.1007/s10549-011-1864-9; Misiukiewicz K, 2014, ANTI-CANCER DRUG, V25, P561, DOI 10.1097/CAD.0000000000000086; Murphy N, 2005, J CLIN PATHOL, V58, P525, DOI 10.1136/jcp.2004.018895; Ojima I, 2014, BIOORGAN MED CHEM, V22, P5060, DOI 10.1016/j.bmc.2014.02.036; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Rohnalter V, 2015, ONCOTARGET, V6, P40005, DOI 10.18632/oncotarget.5552; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Wu Z, 2009, NEOPLASIA, V11, P66, DOI 10.1593/neo.81048; Xiao J, 2013, NEOPLASMA; Yim H, 2010, P NATL ACAD SCI USA, V107, P19742, DOI 10.1073/pnas.1013557107; Yu CC, 2012, INT J ONCOL, V41, P1050, DOI 10.3892/ijo.2012.1511; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang SJ, 2012, CELL SIGNAL, V24, P1803, DOI 10.1016/j.cellsig.2012.05.009; Zhu Y, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28672	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162633	10.1371/journal.pone.0162633	http://dx.doi.org/10.1371/journal.pone.0162633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611665	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900139
J	Kozak, RP; Urbanowicz, PA; Punyadeera, C; Reiding, KR; Jansen, BC; Royle, L; Spencer, DI; Fernandes, DL; Wuhrer, M				Kozak, Radoslaw P.; Urbanowicz, Paulina A.; Punyadeera, Chamindie; Reiding, Karli R.; Jansen, Bas C.; Royle, Louise; Spencer, Daniel I.; Fernandes, Daryl L.; Wuhrer, Manfred			Variation of Human Salivary O-Glycome	PLOS ONE			English	Article							LINKED OLIGOSACCHARIDES; STRUCTURAL-ANALYSIS; PROTEOMIC ANALYSIS; BLOOD-GROUP; GLYCOSYLATION; PROTEINS; GLYCANS; GLYCOPROTEINS; BIOMARKER; RELEASE	The study of saliva O-glycosylation is receiving increasing attention due to the potential of glycans for disease biomarkers, but also due to easy access and non-invasive collection of saliva as biological fluid. Saliva is rich in glycoproteins which are secreted from the bloodstream or produced by salivary glands. Mucins, which are highly O-glycosylated proteins, are particularlyabundant in human saliva. Their glycosylation is associated with blood group and secretor status, and represents a reservoir of potential disease biomarkers. This study aims to analyse and compare O-glycans released from whole human mouth saliva collected 3 times a day from a healthy individual over a 5 days period. O-linked glycans were released by hydrazinolysis, labelled with procainamide and analysed by ultra-high performance liquid chromatography with fluorescence detection (UHPLC-FLR) coupled to electrospray ionization mass spectrometry (ESI-MS/MS). The sample preparation method showed excellent reproducibility and can therefore be used for biomarker discovery. Our data demonstrates that the O-glycosylation in human saliva changes significantly during the day. These changes may be related to changes in the salivary concentrations of specific proteins.	[Kozak, Radoslaw P.; Urbanowicz, Paulina A.; Royle, Louise; Spencer, Daniel I.; Fernandes, Daryl L.] Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England; [Punyadeera, Chamindie] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, 60 Musk Ave, Kelvin Grove, Australia; [Reiding, Karli R.; Jansen, Bas C.; Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands	Culham Science Centre; UK Atomic Energy Authority; Queensland University of Technology (QUT); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kozak, RP (corresponding author), Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England.	rad.kozak@ludger.com	Wuhrer, Manfred/ABE-9168-2020; Punyadeera, Chamindie K/L-9038-2013	Wuhrer, Manfred/0000-0002-0814-4995; Punyadeera, Chamindie K/0000-0001-9039-8259; Jansen, Bas Cornelis/0000-0001-8617-0980	European Union [278535]	European Union(European Commission)	This work was supported by the European Union's Seventh Framework Program (FP7-Health-F5-2011) under grant agreement no 278535 (HighGlycan). Ludger Ltd is a commercial bioscience company specialising in development and validation of glycoprofiling technology. The following authors declare competing financial interest(s): RPK, PAU, LR, DIS, DLF are employed by Ludger Ltd. In addition, products from Ludger were used in this research. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; This work was supported by the European Union's Seventh Framework Program (FP7-Health-F5-2011) under grant agreement no 278535 (HighGlycan).	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Amado Francisco M. L., 2007, P347, DOI 10.1007/978-1-59745-432-2_16; Ambatipudi KS, 2009, J PROTEOME RES, V8, P5093, DOI 10.1021/pr900478h; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Amerongen AVN, 1995, GLYCOBIOLOGY, V5, P733, DOI 10.1093/glycob/5.8.733; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Borzym-Kluczyk M, 2011, CLIN CHEM LAB MED, V49, P885, DOI 10.1515/CCLM.2011.137; Cabras T, 2009, J PROTEOME RES, V8, P4126, DOI 10.1021/pr900212u; Chaudhury NMA, 2016, MOL CELL PROTEOMICS, V15, P1048, DOI 10.1074/mcp.M115.052993; Clerc F, 2016, GLYCOCONJUGATE J, V33, P309, DOI 10.1007/s10719-015-9626-2; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dowling P, 2008, J PROTEOMICS, V71, P168, DOI 10.1016/j.jprot.2008.04.004; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Epstein JB, 2000, CANCER-AM CANCER SOC, V89, P2258, DOI 10.1002/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z; Everest-Dass AV, 2013, J AM SOC MASS SPECTR, V24, P895, DOI 10.1007/s13361-013-0610-4; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Fleissig Y, 2010, ORAL DIS, V16, P831, DOI 10.1111/j.1601-0825.2010.01696.x; Foo JYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048452; Gornik O, 2012, BBA-GEN SUBJECTS, V1820, P1318, DOI 10.1016/j.bbagen.2011.12.004; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Hu S, 2010, METHODS MOL BIOL, V666, P31, DOI 10.1007/978-1-60761-820-1_3; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karlsson NG, 2009, GLYCOBIOLOGY, V19, P288, DOI 10.1093/glycob/cwn136; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kawashima H, 2012, BIOL PHARM BULL, V35, P1637, DOI 10.1248/bpb.b12-00412; Kozak RP, 2015, ANAL BIOCHEM, V486, P38, DOI 10.1016/j.ab.2015.06.006; Kozak RP, 2014, ANAL BIOCHEM, V453, P29, DOI 10.1016/j.ab.2014.02.030; Kozak RP, 2012, ANAL BIOCHEM, V423, P119, DOI 10.1016/j.ab.2012.01.002; Lamont R. J., 2010, ORAL MICROBIOLOGY GL; Merry AH, 2002, ANAL BIOCHEM, V304, P91, DOI 10.1006/abio.2002.5620; Mohamed R, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-19; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Ovchinnikov DA, 2014, BIOMARK INSIGHTS, V9, P53, DOI [10.4137/BMI.S16199, 10.4137/BMIMI.S16199]; PATEL T, 1993, BIOCHEMISTRY-US, V32, P679, DOI 10.1021/bi00053a037; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Punyadeera C, 2011, J IMMUNOL METHODS, V373, P19, DOI 10.1016/j.jim.2011.07.013; Royle Louise, 2006, V347, P125; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schulz BL, 2007, GLYCOBIOLOGY, V17, P698, DOI 10.1093/glycob/cwm036; Schulz BL, 2013, CRIT REV BIOTECHNOL, V33, P246, DOI 10.3109/07388551.2012.687361; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Sondej Melissa, 2009, Clin Proteomics, V5, P52, DOI 10.1007/s12014-008-9021-0; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Srivastava A, 2008, ARCH ORAL BIOL, V53, P1058, DOI 10.1016/j.archoralbio.2008.05.006; Ten Cate AR, 1998, ORAL HISTOLOGY DEV S, VFifth; Thomsson KA, 2005, GLYCOBIOLOGY, V15, P791, DOI 10.1093/glycob/cwi059; Zad M, 2015, CLIN ORAL INVEST, V19, P2147, DOI 10.1007/s00784-015-1495-3; Zauber H, 2012, PROTEOMICS, V12, P2221, DOI 10.1002/pmic.201100228; Zauner G, 2012, BIOL CHEM, V393, P687, DOI 10.1515/hsz-2012-0144; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; [张丽华 Zhang Lihua], 2010, [工业水处理, Industrial Water Treatment], V30, P5	55	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162824	10.1371/journal.pone.0162824	http://dx.doi.org/10.1371/journal.pone.0162824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610614	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900172
J	Liu, Y; Gibson, GR; Walton, GE				Liu, Yue; Gibson, Glenn R.; Walton, Gemma E.			An In Vitro Approach to Study Effects of Prebiotics and Probiotics on the Faecal Microbiota and Selected Immune Parameters Relevant to the Elderly	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; LACTOBACILLUS-ACIDOPHILUS NCFM; HUMAN INTESTINAL MICROBIOTA; MIXTURE B-GOS; GUT MICROBIOTA; HUMAN FECES; BIFIDOBACTERIUM-LACTIS; BACTERIAL-POPULATIONS; SITU HYBRIDIZATION; AGE	The aging process leads to alterations of gut microbiota and modifications to the immune response, such changes may be associated with increased disease risk. Prebiotics and probiotics can modulate microbiome changes induced by aging; however, their effects have not been directly compared. The aim of this study was to use anaerobic batch culture fermenters to assess the impact of various fermentable carbohydrates and microorganisms on the gut microbiota and selected immune markers. Elderly volunteers were used as donors for these experiments to enable relevance to an aging population. The impact of fermentation supernatants on immune markers relevant to the elderly were assessed in vitro. Levels of IL-1 beta, IL-6, IL-8, IL-10 and TNF-alpha in peripheral blood mononuclear cell culture supernatants were measured using flow cytometry. Trans-galactooligosaccharides (B-GOS) and inulin both stimulated bifidobacteria compared to other treatments (p < 0.05). Fermentation supernatants taken from faecal batch cultures supplemented with B-GOS, inulin, B. bifidum, L. acidophilus and Ba. coagulans inhibited LPS induced TNF-alpha (p < 0.05). IL-10 production, induced by LPS, was enhanced by fermentation supernatants from faecal batch cultures supplemented with B-GOS, inulin, B. bifidum, L. acidophilus, Ba. coagulans and Bac. thetaiotaomicron (p < 0.05). To conclude, prebiotics and probiotics could lead to potentially beneficial effects to host health by targeting specific bacterial groups, increasing saccharolytic fermentation and decreasing inflammation associated with aging. Compared to probiotics, prebiotics led to greater microbiota modulation at the genus level within the fermenters.	[Liu, Yue; Gibson, Glenn R.; Walton, Gemma E.] Univ Reading, Dept Food & Nutr Sci, POB 226, Reading, Berks, England	University of Reading	Walton, GE (corresponding author), Univ Reading, Dept Food & Nutr Sci, POB 226, Reading, Berks, England.	g.e.walton@reading.ac.uk						Agrawal A, 2008, J CLIN IMMUNOL, V28, P14, DOI 10.1007/s10875-007-9127-6; Arunachalam K, 2000, EUR J CLIN NUTR, V54, P263, DOI 10.1038/sj.ejcn.1600938; Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Bjorklund M, 2012, AGE, V34, P987, DOI 10.1007/s11357-011-9294-5; BROKLEHU.JC, 1972, P ROY SOC MED, V65, P66, DOI 10.1177/003591577206500126; Bruunsgaard H, 2001, EXP GERONTOL, V37, P127, DOI 10.1016/S0531-5565(01)00162-0; Butcher SK, 2001, J LEUKOCYTE BIOL, V70, P881; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; CASTELL D O, 1988, Practical Gastroenterology, V12, P37; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costabile A, 2010, BRIT J NUTR, V104, P1007, DOI 10.1017/S0007114510001571; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; FAO/WHO, 2001, HEALTH AND NUTRITION; FAO/WHO, GUID EV PROB FOOD 20; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Gavini Francoise, 2001, Microbial Ecology in Health and Disease, V13, P40, DOI 10.1080/089106001750071690; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; GOODWIN JS, 1995, NUTR REV, V53, pS41; Guigoz Y, 2002, NUTR RES, V22, P13, DOI 10.1016/S0271-5317(01)00354-2; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harmsen HJM, 2000, APPL ENVIRON MICROB, V66, P4523, DOI 10.1128/AEM.66.10.4523-4527.2000; Honda H., 2011, International Journal of Probiotics and Prebiotics, V6, P65; Honda H, 2011, ANAEROBE, V17, P36, DOI 10.1016/j.anaerobe.2010.12.006; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Imaoka A, 2008, WORLD J GASTROENTERO, V14, P2511, DOI 10.3748/wjg.14.2511; Jensen GS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-15; Kleessen B, 1997, AM J CLIN NUTR, V65, P1397, DOI 10.1093/ajcn/65.5.1397; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Langkamp-Henken B, 2004, J AM GERIATR SOC, V52, P3, DOI 10.1111/j.1532-5415.2004.52003.x; Langkamp-Henken B, 2006, J AM GERIATR SOC, V54, P1861, DOI 10.1111/j.1532-5415.2006.00982.x; Liu TF, 2012, INFLAMMATION, V35, P1676, DOI 10.1007/s10753-012-9484-z; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608, DOI 10.1128/AEM.62.12.4608-4613.1996; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Newton J P, 1993, Gerodontology, V10, P16, DOI 10.1111/j.1741-2358.1993.tb00074.x; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Ogue-Bon E, 2010, FEMS MICROBIOL ECOL, V73, P587, DOI 10.1111/j.1574-6941.2010.00915.x; Ouwehand AC, 2008, FEMS IMMUNOL MED MIC, V53, P18, DOI 10.1111/j.1574-695X.2008.00392.x; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Peterson CT, 2015, CLIN EXP IMMUNOL, V179, P363, DOI 10.1111/cei.12474; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Saemann MD, 2000, FASEB J, V14, P2380; Schiffrin EJ, 2010, MUTAT RES-FUND MOL M, V690, P50, DOI 10.1016/j.mrfmmm.2009.07.011; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Tonna I, 2005, POSTGRAD MED J, V81, P367, DOI 10.1136/pgmj.2004.028480; Tzortzis G, 2005, J NUTR, V135, P1726, DOI 10.1093/jn/135.7.1726; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Vendrig JC, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-147; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vulevic J, 2008, AM J CLIN NUTR, V88, P1438, DOI 10.3945/ajcn.2008.26242; Vulevic J, 2015, BRIT J NUTR, V114, P586, DOI 10.1017/S0007114515001889; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x; WHO, FACTS AG 2014; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Yagamata A, 1965, JAP J GASTROENTEROL, V62, P229	72	39	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162604	10.1371/journal.pone.0162604	http://dx.doi.org/10.1371/journal.pone.0162604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612304	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000383255900132
J	Pamphlett, R; Jew, SK				Pamphlett, Roger; Jew, Stephen Kum			Age-Related Uptake of Heavy Metals in Human Spinal Interneurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MULTIPLE-SCLEROSIS; INTERMEDIATE ZONE; NEURONS; CORD; ALS; MOTONEURONS; DYSFUNCTION; MECHANISMS	Toxic heavy metals have been implicated in the loss of spinal motoneurons in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). Motoneuron loss in the spinal anterior horn is severe in ALS/MND at the time of death, making this tissue unsuitable for examination. We therefore examined spinal cords of people without muscle weakness to look for any presence of heavy metals that could make these neurons susceptible to damage. Spinal cord samples from 50 individuals aged 1-95 y who had no clinical or histopathological evidence of spinal motoneuron loss were studied. Seven mu m formalin-fixed paraffin-embedded sections were stained for heavy metals with silver nitrate autometallography (AMG(HM)) which detects intracellular mercury, silver or bismuth. Neurons in the spinal cord were classified as interneurons or alpha-motoneurons based on their site and cell body diameter. Spinal interneurons containing heavy metals were present in 8 of 24 people (33%) aged 61-95 y, but not at younger ages. These AMG(HM) interneurons were most numerous in the lumbar spinal cord, with moderate numbers in the caudal cervical cord, few in the rostral cervical cord, and almost none in the thoracic cord. All people with AMG(HM) interneurons had occasional AMG(HM) staining in alpha-motoneurons as well. In one man AMG(HM) staining was present in addition in dorsomedial nucleus and sensory neurons. In conclusion, heavy metals are present in many spinal interneurons, and in a few alpha-motoneurons, in a large proportion of older people. Damage to inhibitory interneurons from toxic metals in later life could result in excitotoxic injury to motoneurons and may underlie motoneuron injury or loss in conditions such as ALS/MND, multiple sclerosis, sarcopenia and calf fasciculations.	[Pamphlett, Roger; Jew, Stephen Kum] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia	University of Sydney; University of Sydney	Pamphlett, R (corresponding author), Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au		Pamphlett, Roger/0000-0003-3326-7273	Aimee Stacey Memorial and Ignacy Burnett Bequests; Multiple Sclerosis Research Australia; University of Sydney; NSW Office for Health and Medical Research; Royal Prince Alfred Hospital Sydney; Trish MS Research Foundation; Levy Foundation; Collier Charitable Fund; Medical Advances Without Animals Trust; FIL Foundation	Aimee Stacey Memorial and Ignacy Burnett Bequests; Multiple Sclerosis Research Australia; University of Sydney(University of Sydney); NSW Office for Health and Medical Research; Royal Prince Alfred Hospital Sydney; Trish MS Research Foundation; Levy Foundation; Collier Charitable Fund; Medical Advances Without Animals Trust; FIL Foundation	This work was supported by the Aimee Stacey Memorial and Ignacy Burnett Bequests. The Multiple Sclerosis Research Australia Brain Bank at the Brain and Mind Centre in Sydney, Australia is supported by Multiple Sclerosis Research Australia, the University of Sydney, the NSW Office for Health and Medical Research, Royal Prince Alfred Hospital Sydney, the Trish MS Research Foundation, the Levy Foundation, the Collier Charitable Fund, the Medical Advances Without Animals Trust, and the FIL Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4; Aragones JM, 2016, AMYOTROPH LATERAL SC, V8421, P1; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Callaghan B, 2011, NEURODEGENER DIS, V8, P1, DOI 10.1159/000315405; Eisen AA, 1997, SPINAL CORD DIS BASI, P175; Fermont J, 2009, AMYOTROPH LATERAL SC, P1; FUNG SJ, 1987, BRAIN RES, V402, P230, DOI 10.1016/0006-8993(87)90029-1; Gautier G, 2010, AMYOTROPH LATERAL SC, V11, P379, DOI 10.3109/17482960903426543; Gilmore CP, 2009, BRAIN PATHOL, V19, P642, DOI 10.1111/j.1750-3639.2008.00228.x; HARVEY DG, 1979, ARCH NEUROL-CHICAGO, V36, P615, DOI 10.1001/archneur.1979.00500460049005; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; Ismail A, 2013, J NEUROL NEUROSUR PS, V84, P79, DOI 10.1136/jnnp-2012-303326; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Kale Shubha P, 2005, Int J Environ Res Public Health, V2, P14, DOI 10.3390/ijerph2005010014; Kasarskis E J, 1993, Prog Clin Biol Res, V380, P299; KAWAMURA Y, 1977, J NEUROPATH EXP NEUR, V36, P861, DOI 10.1097/00005072-197709000-00010; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lacorte E, 2016, NEUROSCI BIOBEHAV R, V66, P61, DOI 10.1016/j.neubiorev.2016.04.007; LEXELL J, 1991, J ANAT, V174, P239; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Morahan JM, 2007, AM J MED GENET B, V144B, P885, DOI 10.1002/ajmg.b.30543; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Ramirez-Jarquin UN, 2014, NEUROPHARMACOLOGY, V82, P101, DOI 10.1016/j.neuropharm.2013.10.003; OYANAGI K, 1989, ACTA NEUROPATHOL, V77, P343, DOI 10.1007/BF00687368; Pacyna EG, 2010, ATMOS ENVIRON, V44, P2487, DOI 10.1016/j.atmosenv.2009.06.009; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett Roger, 2013, Acta Neuropathol Commun, V1, P13, DOI 10.1186/2051-5960-1-13; Pearson KG., 2013, PRINCIPLES NEURAL SC, p790; Peters TL, 2016, NEUROTOXICOLOGY, V54, P119, DOI 10.1016/j.neuro.2016.03.022; Pugdahl K, 2007, J NEUROL NEUROSUR PS, V78, P746, DOI 10.1136/jnnp.2006.098533; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Selin N. E., 2008, GLOBAL BIOGEOCHEM CY, V22, P2; SHEFNER JM, 1992, MUSCLE NERVE, V15, P1265, DOI 10.1002/mus.880151108; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stoltenberg M, 2000, HISTOCHEM J, V32, P645, DOI 10.1023/A:1004115130843; TAKAHASHI H, 1992, ACTA NEUROPATHOL, V84, P465, DOI 10.1007/BF00304464; Terao S, 1996, ACTA NEUROPATHOL, V92, P109, DOI 10.1007/s004010050497; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Turner MR, 2015, J NEUROL NEUROSUR PS, V86, P667, DOI 10.1136/jnnp-2014-308946; Turner MR, 2012, AMYOTROPH LATERAL SC, V13, P245, DOI 10.3109/17482968.2011.636050; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162260	10.1371/journal.pone.0162260	http://dx.doi.org/10.1371/journal.pone.0162260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611334	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900071
J	Ren, J; Yuan, W; Wang, RH; Wang, QP; Li, Y; Xue, CF; Yan, YL; Ma, XW; Tan, L; Liu, Z				Ren, Juan; Yuan, Wei; Wang, Ruihua; Wang, Qiuping; Li, Yi; Xue, Chaofan; Yan, Yanli; Ma, Xiaowei; Tan, Li; Liu, Zi			Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer	PLOS ONE			English	Article							DOSE-VOLUME PARAMETERS; COMPUTED-TOMOGRAPHY; CARCINOMA; RADIATION; RECOMMENDATIONS; OPTIMIZATION; BLADDER; ORGANS; TERMS; RISK	Objective The purpose of this study was to comprehensively compare the 3-dimensional (3D) magnetic resonance imaging (MRI)-guided and conventional 2-dimensional (2D) point A-based intracavitary brachytherapy (BT) planning for cervical cancer with regard to target dose coverage and dosages to adjacent organs-at risk (OARs). Methods A total of 79 patients with cervical cancer were enrolled to receive 2D point A-based BT planning and then immediately to receive 3D planning between October 2011 and April 2013 at the First Hospital Affiliated to Xi'an Jiao Tong University (Xi'an, China). The dose-volume histogram (DVH) parameters for gross tumor volume (GTV), high-risk clinical target volume (HR-CTV), intermediate-risk clinical target volume (IR-CTV) and OARs were compared between the 2D and 3D planning. Results In small tumors, there was no significant difference in most of the DVHs between 2D and 3D planning (all p>0.05). While in big tumors, 3D BT planning significantly increased the DVHs for most of the GTV, HR-CTV and IR-CTV, and some OARs compared with 2D planning (all P<0.05). In 3D planning, DVHs for GTV, HR-CTV, IR-CTV and some OARs were significantly higher in big tumors than in small tumors (all p<0.05). In contrast, in 2D planning, DVHs for almost all of the HR-CTV and IR-CTV were significantly lower in big tumors (all p<0.05). In eccentric tumors, 3D planning significantly increased dose coverage but decreased dosages to OARs compared with 2D planning (p<0.05). In tumors invading adjacent tissues, the target dose coverage in 3D planning was generally significantly higher than in 2D planning (P<0.05); the dosages to the adjacent rectum and bladder were significantly higher but those to sigmoid colon were lower in 3D planning (all P<0.05). Conclusions 3D MRI image-guided BT planning exhibits advantages over 2D planning in a complex way, generally showing advantages for the treatment of cervical cancer except small tumors.	[Ren, Juan; Yuan, Wei; Wang, Ruihua; Li, Yi; Liu, Zi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Oncol, Dept Radiotherapy, Xian, Shaanxi, Peoples R China; [Wang, Qiuping] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Imaging, Xian, Shaanxi, Peoples R China; [Xue, Chaofan; Yan, Yanli; Ma, Xiaowei; Tan, Li] Xi An Jiao Tong Univ, Sch Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Ren, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Oncol, Dept Radiotherapy, Xian, Shaanxi, Peoples R China.	869491533@qq.com			National Natural Science Foundation of China [31201060/C0709, 30973175/H1621, 81172490/H1621]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study (including the study design and performance, data collection and analysis, preparation of the manuscript) was supported by the National Natural Science Foundation of China (Juan Ren: 31201060/C0709, 30973175/H1621, 81172490/H1621) (http://www.nsfc.gov.cn/).	Chargari C, 2009, INT J RADIAT ONCOL, V74, P133, DOI 10.1016/j.ijrobp.2008.06.1912; Charvolin JY, 2001, B CANCER, V88, P1207; De Brabandere M, 2008, RADIOTHER ONCOL, V88, P217, DOI 10.1016/j.radonc.2007.10.026; Dimopoulos JCA, 2009, RADIOTHER ONCOL, V93, P311, DOI 10.1016/j.radonc.2009.07.001; Dimopoulos JCA, 2009, INT J RADIAT ONCOL, V75, P56, DOI 10.1016/j.ijrobp.2008.10.033; Haie-Meder C, 2005, RADIOTHER ONCOL, V74, P235, DOI 10.1016/j.radonc.2004.12.015; Hashim N, 2014, ASIAN PAC J CANCER P, V15, P5259, DOI 10.7314/APJCP.2014.15.13.5259; ICRU, 1985, 38 ICRU; Ju SG, 2013, J RADIAT RES, V54, P349, DOI 10.1093/jrr/rrs091; Kirisits C, 2005, INT J RADIAT ONCOL, V62, P901, DOI 10.1016/j.ijrobp.2005.02.040; Koom WS, 2007, INT J RADIAT ONCOL, V68, P1446, DOI 10.1016/j.ijrobp.2007.02.009; Lindegaard JC, 2008, INT J RADIAT ONCOL, V71, P756, DOI 10.1016/j.ijrobp.2007.10.032; Ma DJ, 2011, RADIOTHER ONCOL, V98, P139, DOI 10.1016/j.radonc.2010.10.004; Madan R, 2014, ASIAN PAC J CANCER P, V15, P4717, DOI 10.7314/APJCP.2014.15.11.4717; Nakano T, 2005, CANCER-AM CANCER SOC, V103, P92, DOI 10.1002/cncr.20734; Onal C, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-95; Petsuksiri J, 2012, ASIAN PAC J CANCER P, V13, P1713, DOI 10.7314/APJCP.2012.13.5.1713; Potter R, 2006, RADIOTHER ONCOL, V78, P67, DOI 10.1016/j.radonc.2005.11.014; Potter R, 2007, RADIOTHER ONCOL, V83, P148, DOI 10.1016/j.radonc.2007.04.012; Sadozye AH, 2012, CURR ONCOL REP, V14, P519, DOI 10.1007/s11912-012-0275-3; Tanderup K, 2010, RADIOTHER ONCOL, V94, P173, DOI 10.1016/j.radonc.2010.01.001; Tharavichitkul E, 2011, J RADIAT RES, V52, P634, DOI 10.1269/jrr.10154; Viswanathan AN, 2007, INT J RADIAT ONCOL, V68, P491, DOI 10.1016/j.ijrobp.2006.12.021; Wang B, 2009, BRACHYTHERAPY, V8, P240, DOI 10.1016/j.brachy.2008.10.004; Zwahlen D, 2009, INT J RADIAT ONCOL, V74, P1157, DOI 10.1016/j.ijrobp.2008.09.010	25	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161932	10.1371/journal.pone.0161932	http://dx.doi.org/10.1371/journal.pone.0161932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611853	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900038
J	Tsai, LT; Liao, KM; Jang, Y; Hu, FC; Wu, WC				Tsai, Li-Ting; Liao, Kuo-Meng; Jang, Yuh; Hu, Fu-Chang; Wu, Wei-Chi			Detecting Visual Function Abnormality with a Contrast-Dependent Visual Test in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RETINOPATHY; SENSITIVITY; MELLITUS; ACUITY; PERIMETRY; DISEASE; PREVALENCE; DEMENTIA; RETINA; RISK	In addition to diabetic retinopathy, diabetes also causes early retinal neurodegeneration and other eye problems, which cause various types of visual deficits. This study used a computer-based visual test (Macular Multi-Function Assessment (MMFA)) to assess contrast-dependent macular visual function in patients with type 2 diabetes to collect more visual information than possible with only the visual acuity test. Because the MMFA is a newly developed test, this study first compared the agreement and discriminative ability of the MMFA and the Early Treatment Diabetic Retinopathy Study (ETDRS) contrast acuity charts. Then symbol discrimination performances of diabetic patients and controls were evaluated at 4 contrast levels using the MMFA. Seventy-seven patients and 45 controls participated. The agreement between MMFA and ETDRS scores was examined by fitting three-level linear mixed-effect models to estimate the intraclass correlation coefficients (ICCs). The estimated areas under the receiver operating characteristic (ROC) curve were used to compare the discriminative ability of diseased versus non-diseased participants between the two tests. The MMFA scores of patients and controls were compared with multiple linear regression analysis after adjusting the effects of age, sex, hypertension and cataract. Results showed that the scores of the MMFA and ETDRS tests displayed high levels of agreement and acceptable and similar discriminative ability. The MMFA performance was correlated with the severity of diabetic retinopathy. Most of the MMFA scores differed significantly between the diabetic patients and controls. In the low contrast condition, the MMFA scores were significantly lower for 006Eon-DR patients than for controls. The potential utility of the MMFA as an easy screening tool for contrast-dependent visual function and for detecting early functional visual change in patients with type 2 diabetes is discussed.	[Tsai, Li-Ting] Univ Alabama Birmingham, Dept Occupat Therapy, Grad Certificate Low Vis Rehabil, Birmingham, AL USA; [Tsai, Li-Ting; Jang, Yuh] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei, Taiwan; [Liao, Kuo-Meng] Taipei City Hosp, Zhong Xiao Branch, Dept Endocrine & Metab, Taipei, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wu, Wei-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Gueishan Township, Taoyuan County, Taiwan; [Wu, Wei-Chi] Chang Gung Univ, Sch Med, Gueishan Township, Taoyuan County, Taiwan	University of Alabama System; University of Alabama Birmingham; National Taiwan University; Taipei City Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University	Wu, WC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Gueishan Township, Taoyuan County, Taiwan.; Wu, WC (corresponding author), Chang Gung Univ, Sch Med, Gueishan Township, Taoyuan County, Taiwan.	weichi666@gmail.com		JANG, YUH/0000-0003-2332-8319	Minister of Science and Technology Research Grants [NSC 99-2314-B-002-138-MY3, MOST 104-2314-B-182A-100-MY2]; Chang Gung Memorial Hospital Research Grants [CMRPG3E0521, CMRPG3E0522]; Department of Endocrine and Metabolism, Zhong-Xiao Branch of Taipei City Hospital in Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	Minister of Science and Technology Research Grants; Chang Gung Memorial Hospital Research Grants; Department of Endocrine and Metabolism, Zhong-Xiao Branch of Taipei City Hospital in Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Minister of Science and Technology Research Grants (NSC 99-2314-B-002-138-MY3, MOST 104-2314-B-182A-100-MY2), and Chang Gung Memorial Hospital Research Grants (CMRPG3E0521 and CMRPG3E0522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Department of Endocrine and Metabolism, Zhong-Xiao Branch of Taipei City Hospital in Taiwan. The authors would like to thank the diabetes educators of the Department of Endocrine and Metabolism, Zhong-Xiao Branch, Taipei City Hospital, Yuh-Fon Liu, Yi-Hsiu Chen, and Rui-Xiang Fan, for helping with data collection and case referral. The first author also thanks Jen-Hung Chen, a computer engineer, for help with developing the MMFA, and Fan-Ya Su, a research assistant, for assisting with data collection.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786, DOI DOI 10.1016/S0161-6420(13)38012-9; ANSTIS SM, 1974, VISION RES, V14, P589, DOI 10.1016/0042-6989(74)90049-2; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Arend O, 1997, INVEST OPHTH VIS SCI, V38, P1819; Balcer LJ, 2012, J NEUROL SCI, V318, P119, DOI 10.1016/j.jns.2012.03.009; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bikbova G, 2012, CURR DIABETES REV, V8, P294, DOI 10.2174/157339912800840479; Billino J, 2008, VISION RES, V48, P1254, DOI 10.1016/j.visres.2008.02.014; Chan AHS, 2005, BEHAV INFORM TECHNOL, V24, P81, DOI 10.1080/0144929042000267073; Chen KL, 2009, J REHABIL MED, V41, P273, DOI 10.2340/16501977-0319; Chen SJ, 2008, ACTA DIABETOL, V45, P7, DOI 10.1007/s00592-007-0012-9; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cole ED, 2016, CLIN EXP OPHTHALMOL, V44, P289, DOI 10.1111/ceo.12711; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Davies N, 2003, VISION RES, V43, P2377, DOI 10.1016/S0042-6989(03)00405-X; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gualtieri M, 2011, INVEST OPHTH VIS SCI, V52, P1151, DOI 10.1167/iovs.09-3705; Hansen MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139148; Hart W. M., 1987, ADLERS PHYSL EYE CLI, P429; Ismail GM, 1998, OPHTHAL PHYSL OPT, V18, P3, DOI 10.1016/S0275-5408(97)00043-4; Kaiserman I, 2005, AM J OPHTHALMOL, V139, P498, DOI 10.1016/j.ajo.2004.10.022; LEVI DM, 1985, VISION RES, V25, P963, DOI 10.1016/0042-6989(85)90207-X; Majaj NJ, 2002, VISION RES, V42, P1165, DOI 10.1016/S0042-6989(02)00045-7; Miles WR, 1930, J GEN PSYCHOL, V3, P412, DOI 10.1080/00221309.1930.9918218; Nittala MG, 2012, RETINA-J RET VIT DIS, V32, P1302, DOI 10.1097/IAE.0b013e3182365a24; Pitsas C, 2015, INT J OPHTHALMOL-CHI, V8, P1013, DOI 10.3980/j.issn.2222-3959.2015.05.29; Rizzo MR, 2010, DIABETES CARE, V33, P2169, DOI 10.2337/dc10-0389; Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119; Schreiber AK, 2015, WORLD J DIABETES, V6, P432, DOI 10.4239/wjd.v6.i3.432; Scialfa CT, 2013, J GERONTOL B-PSYCHOL, V68, P522, DOI 10.1093/geronb/gbs086; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Spry PGD, 2005, J GLAUCOMA, V14, P11, DOI 10.1097/01.ijg.0000145813.46848.b8; Stavrou Efty P, 2003, Clin Exp Optom, V86, P152; Stavrou EP, 2005, ACTA OPHTHALMOL SCAN, V83, P574, DOI 10.1111/j.1600-0420.2005.00527.x; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Sukha AY, 2009, OPTOMETRY VISION SCI, V86, P1086, DOI 10.1097/OPX.0b013e3181b48635; To L, 2013, VISION RES, V90, P15, DOI 10.1016/j.visres.2013.04.011; Trauzettel-Klosinski S, 2003, GRAEF ARCH CLIN EXP, V241, P988, DOI 10.1007/s00417-003-0757-y; Tsai LT, 2013, J VIS, V13, P582; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; West BW., 2015, LINEAR MIXED MODELS, V2; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zhang JY, 2007, INVEST OPHTH VIS SCI, V48, P2383, DOI 10.1167/iovs.06-1195; Zhang XY, 2013, INT J BIOCHEM CELL B, V45, P1525, DOI 10.1016/j.biocel.2013.03.002; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; [No title captured]	47	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162383	10.1371/journal.pone.0162383	http://dx.doi.org/10.1371/journal.pone.0162383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611680	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900087
J	Yang, SH; Gao, YH; Zhang, SL; Zhang, Q; Sun, DX				Yang, Shaohua; Gao, Yahui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao			Identification of Genetic Associations and Functional Polymorphisms of SAA1 Gene Affecting Milk Production Traits in Dairy Cattle	PLOS ONE			English	Article							SERUM-AMYLOID-A; PROTEIN; PERCENTAGE; COWS; DNA	Our initial RNA sequencing (RNA-seq) revealed that the Serum amyloid A1 (SAA1) gene was differentially expressed in the mammary glands of lactating Holstein cows with extremely high versus low phenotypic values of milk protein and fat percentage. To further validate the genetic effect and potential molecular mechanisms of SAA1 gene involved in regulating milk production traits in dairy cattle, we herein performed a study through genotype-phenotype associations. Six identified SNPs were significantly associated with one or more milk production traits (0.00002< P < 0.0025), providing additional evidence for the potential role of SAA1 variants in milk production traits in dairy cows. Subsequently, both luciferase assay and electrophoretic mobility shift assay (EMSA) clearly demonstrated that the allele A of g.-963C> A increased the promoter activity by binding the PARP factor while allele C did not. Bioinformatics analysis indicated that the secondary structure of SAA protein changed by the substitution A/G in the locus c. +2510A>G. Our findings were the first to reveal the significant associations of the SAA1 gene with milk production traits, providing basis for further biological function validation, and two identified SNPs, g.-963C>A and c. +2510A>G, may be considered as genetic markers for breeding in dairy cattle.	[Yang, Shaohua; Gao, Yahui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Minist Agr,Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Sun, DX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Minist Agr,Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	sundx@cau.edu.cn			National Science and Technology Programs of China [2013AA102504, 2011BAD28B02, 2014ZX08009-053B]; Beijing Natural Science Foundation [6152013]; Beijing Dairy Industry Innovation Team [BAIC06-2016]; earmarked fund for Modern Agro-industry Technology Research System [CARS-37]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Science and Technology Programs of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Dairy Industry Innovation Team; earmarked fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work was financially supported by the National Science and Technology Programs of China (2013AA102504, 2011BAD28B02, 2014ZX08009-053B), Beijing Natural Science Foundation (6152013), the Beijing Dairy Industry Innovation Team (BAIC06-2016), the earmarked fund for Modern Agro-industry Technology Research System (CARS-37) and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The authors would also like to appreciate the Dairy Data Center of China for providing the official EBVs data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; BOVENHUIS H, 1992, J DAIRY SCI, V75, P2549, DOI 10.3168/jds.S0022-0302(92)78017-5; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; Eckersall PD, 2001, VET REC, V148, P35, DOI 10.1136/vr.148.2.35; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gronlund U, 2003, J DAIRY RES, V70, P379, DOI 10.1017/S0022029903006484; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Islas-Trejo A, 2010, 9 WORLD C GEN APPL L, V2, P343; Jacobsen S, 2005, VET IMMUNOL IMMUNOP, V104, P21, DOI 10.1016/j.vetimm.2004.09.031; Jia MW, 2004, BIOPOLYMERS, V73, P16, DOI 10.1002/bip.10496; Kho Y, 2008, BIOSCI BIOTECH BIOCH, V72, P70, DOI 10.1271/bbb.70374; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KluveBeckerman B, 1997, BIOCHEM J, V322, P663, DOI 10.1042/bj3220663; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kovacevic-Filipovic M, 2012, VET IMMUNOL IMMUNOP, V145, P120, DOI 10.1016/j.vetimm.2011.10.015; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Martin P, 2002, REPROD NUTR DEV, V42, P433, DOI 10.1051/rnd:2002036; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; O'Mahony MC, 2006, RES VET SCI, V80, P155, DOI 10.1016/j.rvsc.2005.05.005; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Said RS, 2016, BIOCHEM PHARMACOL, V103, P140, DOI 10.1016/j.bcp.2016.01.019; SIBYLLE G, 2000, FASEB J, V14, P1159; Stasio L. di, 2000, Zootecnica e Nutrizione Animale, V26, P69; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zi C, 2013, INT J MOL SCI, V14, P24126, DOI 10.3390/ijms141224126	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162195	10.1371/journal.pone.0162195	http://dx.doi.org/10.1371/journal.pone.0162195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610623	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900055
J	Seitz, J; Hueck, M; Dahmen, B; Schulte-Ruther, M; Legenbauer, T; Herpertz-Dahlmann, B; Konrad, K				Seitz, Jochen; Hueck, Manuel; Dahmen, Brigitte; Schulte-Ruether, Martin; Legenbauer, Tanja; Herpertz-Dahlmann, Beate; Konrad, Kerstin			Attention Network Dysfunction in Bulimia Nervosa - An fMRI Study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EATING-DISORDERS; DEFICIT/HYPERACTIVITY DISORDER; SYMPTOMS; ADHD; CHILDREN; SYSTEMS; SAMPLE	Objective Recent evidence has suggested an increased rate of comorbid ADHD and subclinical attentional impairments in bulimia nervosa (BN) patients. However, little is known regarding the underlying neural mechanisms of attentional functions in BN. Method Twenty BN patients and twenty age-and weight-matched healthy controls (HC) were investigated using a modified version of the Attention Network Task (ANT) in an fMRI study. This design enabled an investigation of the neural mechanisms associated with the three attention networks involved in alerting, reorienting and executive attention. Results The BN patients showed hyperactivation in parieto-occipital regions and reduced deactivation of default-mode-network (DMN) areas during alerting compared with HCs. Posterior cingulate activation during alerting correlated with the severity of eating-disorder symptoms within the patient group. Conversely, BN patients showed hypoactivation during reorienting and executive attention in anterior cingulate regions, the temporo-parietal junction (TPJ)and parahippocampus compared with HCs, which was negatively associated with global ADHD symptoms and impulsivity, respectively. Discussion Our findings demonstrate altered brain mechanisms in BN associated with all three attentional networks. Failure to deactivate the DMN and increased parieto-occipital activation required for alerting might be associated with a constant preoccupation with food or body image-related thoughts. Hypoactivation of executive control networks and TPJ might increase the likelihood of inattentive and impulsive behaviors and poor emotion regulation. Thus, dysfunction in the attentional network in BN goes beyond an altered executive attentional domain and needs to be considered in the diagnosis and treatment of BN.	[Seitz, Jochen; Hueck, Manuel; Dahmen, Brigitte; Schulte-Ruether, Martin; Herpertz-Dahlmann, Beate; Konrad, Kerstin] Rhein Westfal TH Aachen, Univ Hosp, Dept Child & Adolescent Psychiat Psychotherapy &, Aachen, Germany; [Seitz, Jochen] Maastricht Univ, Fac Psychol & Cognit Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Schulte-Ruether, Martin] JARA BRAIN, D-52074 Aachen, Germany; [Legenbauer, Tanja] Ruhr Univ Bochum, Univ Hosp Hamm, LWL Child & Adolescent Psychiat, Hamm, Germany; [Legenbauer, Tanja] Johannes Gutenberg Univ Mainz, Psychiat Outpatient Clin, Mainz, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; Ruhr University Bochum; Johannes Gutenberg University of Mainz	Seitz, J (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Child & Adolescent Psychiat Psychotherapy &, Aachen, Germany.; Seitz, J (corresponding author), Maastricht Univ, Fac Psychol & Cognit Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	jseitz@ukaachen.de	Konrad, Kerstin/H-7747-2013; , Martin/F-4784-2013; Dahmen, Brigitte/AAH-2565-2020; Seitz, Jochen/AAE-7363-2019	Konrad, Kerstin/0000-0001-9039-2615; , Martin/0000-0002-7198-9923; Seitz, Jochen/0000-0002-0110-7980				Backes V, 2011, EUR ARCH PSY CLIN N, V261, P155, DOI 10.1007/s00406-011-0264-9; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Bydlowski S, 2005, INT J EAT DISORDER, V37, P321, DOI 10.1002/eat.20132; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cortese S, 2007, INT J OBESITY, V31, P340, DOI 10.1038/sj.ijo.0803400; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; DeJong H, 2013, EUR PSYCHIAT, V28, P1, DOI 10.1016/j.eurpsy.2011.07.002; Dillo W., 2010, GMS German Medical Science, V8, pDoc9; Drimmer EJ, 2003, NUTRITION, V19, P76, DOI 10.1016/S0899-9007(02)01045-6; Duchesne Monica, 2004, Rev. Bras. Psiquiatr., V26, P107, DOI 10.1590/S1516-44462004000200008; Dukarm CP, 2005, J WOMENS HEALTH, V14, P345, DOI 10.1089/jwh.2005.14.345; Fagundo AB, 2013, EUR EAT DISORD REV, V21, P493, DOI 10.1002/erv.2259; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Galderisi S, 2011, PSYCHOL MED, V41, P839, DOI 10.1017/S0033291710001303; Garner M, 2012, PSYCHOPHARMACOLOGY, V223, P67, DOI 10.1007/s00213-012-2690-4; Herpertz-Dahlmann B, 2009, CHILD ADOL PSYCH CL, V18, P31, DOI 10.1016/j.chc.2008.07.005; Hoste RR, 2012, CURR PSYCHIAT REP, V14, P391, DOI 10.1007/s11920-012-0280-0; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Keshen A, 2013, EAT DISORD, V21, P360, DOI 10.1080/10640266.2013.797828; Konrad K, 2006, BIOL PSYCHIAT, V59, P643, DOI 10.1016/j.biopsych.2005.08.013; Krall SC, 2015, BRAIN STRUCT FUNCT, V220, P587, DOI 10.1007/s00429-014-0803-z; Legenbauer T, 2008, J CLIN PSYCHOL, V64, P687, DOI 10.1002/jclp.20483; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; Lyche P, 2011, ARCH CLIN NEUROPSYCH, V26, P38, DOI 10.1093/arclin/acq095; Marsh R, 2015, BIOL PSYCHIAT, V77, P616, DOI 10.1016/j.biopsych.2013.07.017; Marsh R, 2011, AM J PSYCHIAT, V168, P1210, DOI 10.1176/appi.ajp.2011.11010094; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; McAdams Carrie J, 2013, Front Psychiatry, V4, P103, DOI 10.3389/fpsyt.2013.00103; Mikami AY, 2010, INT J EAT DISORDER, V43, P248, DOI 10.1002/eat.20692; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Schneider MF, 2010, PSYCHIAT RES-NEUROIM, V183, P75, DOI 10.1016/j.pscychresns.2010.04.005; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Schulte-Ruther M, 2014, SOC COGN AFFECT NEUR, V9, P1118, DOI 10.1093/scan/nst088; Seitz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063891; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Stice E, 2009, J ABNORM PSYCHOL, V118, P587, DOI 10.1037/a0016481; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Van den Eynde F, 2011, ACTA PSYCHIAT SCAND, V124, P120, DOI 10.1111/j.1600-0447.2011.01701.x; Waxman SE, 2009, EUR EAT DISORD REV, V17, P408, DOI 10.1002/erv.952; Weider S, 2015, INT J EAT DISORDER, V48, P397, DOI 10.1002/eat.22283; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wentz E, 2005, EUR CHILD ADOLES PSY, V14, P431, DOI 10.1007/s00787-005-0494-3; Yates WR, 2009, INT J EAT DISORDER, V42, P375, DOI 10.1002/eat.20627; Yilmaz Z, 2011, PROG NEURO-PSYCHOPH, V35, P948, DOI 10.1016/j.pnpbp.2011.01.012	49	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161329	10.1371/journal.pone.0161329	http://dx.doi.org/10.1371/journal.pone.0161329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607439	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600005
J	Tsan, MF; Grabenbauer, M; Nguyen, Y				Tsan, Min-Fu; Grabenbauer, Michael; Nguyen, Yen			Lapse in Institutional Animal Care and Use Committee Continuing Reviews	PLOS ONE			English	Review								The United States federal animal welfare regulations and the Public Health Service Policy on Humane Care and Use of Laboratory Animals require that institutional animal care and use committees (IACUCs) conduct continuing reviews of all animal research activities. However, little is known about the lapse rate of IACUC continuing reviews, and how frequently investigators continue research activities during the lapse. It is also not clear what factors may contribute to an institution's lapse in IACUC continuing reviews. As part of the quality assurance program, the Department of Veterans Affairs (VA) has collected performance metric data for animal care and use programs since 2011. We analyzed IACUC continuing review performance data at 74-75 VA research facilities from 2011 through 2015. The IACUC continuing review lapse rates improved from 5.6% in 2011 to 2.7% in 2015. The rate of investigators continuing research activities during the lapse also decreased from 47.2% in 2012 to 7.4% in 2015. The type of IACUCs used and the size of animal research programs appeared to have no effect in facility's rates of lapse in IACUC continuing reviews. While approximately 80% of facilities reported no lapse in IACUC continuing reviews, approximately 14% of facilities had lapse rates of >10% each year. Some facilities appeared to be repeat offenders. Four facilities had IACUC lapse rates of >10% in at least 3 out of 5 years, suggesting a system problem in these facilities requiring remedial actions to improve their IACUC continuing review processes.	[Tsan, Min-Fu] McGuire Res Inst, Richmond, VA 23249 USA; [Grabenbauer, Michael; Nguyen, Yen] Dept Vet Affairs, Off Res Oversight, Washington, DC USA		Tsan, MF (corresponding author), McGuire Res Inst, Richmond, VA 23249 USA.	minfu.tsan@gmail.com						[Anonymous], [No title captured]; Cassel CK, 2014, NEW ENGL J MED, V371, P2145, DOI 10.1056/NEJMp1408345; Liu I, 2005, TEST-SPAIN, V14, P1, DOI 10.1007/BF02595397; Matthews DE, 1988, USING UNDERSTANDING, P178; Oki G S, 1996, Contemp Top Lab Anim Sci, V35, P53; *PUBL HLTH SERV, 2002, POL HUM CAR US LAB A; Tsan Min-Fu, 2015, Fed Pract, V32, P58; Tsan MF, 2015, CLIN TRIALS, V12, P224, DOI 10.1177/1740774514568688; Tsan Min-Fu, 2014, IRB, V36, P9; U.S. Department of Veterans Affairs, 2011, VHA HDB; United States Department of Veterans Affairs Office of Research Oversight, 2015, RES COMPL OFF AUD TO; Vanderford DA, 2015, LAB ANIMAL, V44, P395, DOI 10.1038/laban.856	12	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162141	10.1371/journal.pone.0162141	http://dx.doi.org/10.1371/journal.pone.0162141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606820	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600021
J	Yang, QZ; Wang, F; Rao, JP				Yang, Qingzhen; Wang, Feng; Rao, Jingping			Effect of Putrescine Treatment on Chilling Injury, Fatty Acid Composition and Antioxidant System in Kiwifruit	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; ETHYLENE BIOSYNTHESIS; BREAKDOWN INCIDENCE; HYDROGEN-PEROXIDE; HEAT-TREATMENT; ASCORBIC-ACID; FRUIT-QUALITY; POLYAMINES; TOLERANCE; GLUTATHIONE	We investigated the effects of different concentrations (0, 1, 2 and 4 mM) of putrescine on chilling injury, fruit quality, ethylene production rate, fatty acid composition and the antioxidant system of cold-stored kiwifruit (Actinidia chinensis Planch. var. chinensis 'Hongyang'). We achieved a significant decrease in ethylene production, maintained fruit quality and alleviated chilling injury during storage via treatment with 2 mM putrescine. Furthermore, putrescine treatment inhibited increases in superoxide anion production rate and H2O2 concentration, while maintaining higher membrane lipid unsaturation as well as increased activities of superoxide dismutase and catalase. In addition, putrescine treatment enhanced the activities of antioxidant enzymes related to the ascorbate-glutathione cycle while causing higher levels of ascorbic acid and reduced glutathione. Our results suggest that induced tolerance against chilling injury via putrescine treatment in cold-stored kiwifruit may be due to enhanced antioxidant activity, increased unsaturation of membrane lipids, and inhibited ethylene production.	[Yang, Qingzhen; Rao, Jingping] Northwest A&F Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China; [Yang, Qingzhen; Wang, Feng] Yuncheng Univ, Dept Life Sci, Yuncheng 044000, Shanxi Province, Peoples R China	Northwest A&F University - China; Yuncheng University	Rao, JP (corresponding author), Northwest A&F Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China.	raojingpingxn@163.com			National Science and Technology Pillar Program during the Twelfth Five-year Plan Period of China [2015BAD16B03]	National Science and Technology Pillar Program during the Twelfth Five-year Plan Period of China	This research was supported by the National Science and Technology Pillar Program (No. 2015BAD16B03) during the Twelfth Five-year Plan Period of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aghdam MS, 2013, SCI HORTIC-AMSTERDAM, V156, P73, DOI 10.1016/j.scienta.2013.03.028; ARPAIA ML, 1985, J AM SOC HORTIC SCI, V110, P200; Barman K, 2011, SCI HORTIC-AMSTERDAM, V130, P795, DOI 10.1016/j.scienta.2011.09.005; Ben-Amor M, 1999, PLANT CELL ENVIRON, V22, P1579, DOI 10.1046/j.1365-3040.1999.00509.x; Burdon J, 2014, POSTHARVEST BIOL TEC, V94, P41, DOI 10.1016/j.postharvbio.2014.03.005; Cao SF, 2011, FOOD CHEM, V127, P1777, DOI 10.1016/j.foodchem.2011.02.059; Cao SF, 2009, J AGR FOOD CHEM, V57, P8439, DOI 10.1021/jf902114y; CASTILLO FJ, 1988, ENVIRON EXP BOT, V28, P231, DOI 10.1016/0098-8472(88)90033-0; Cheng SC, 2015, POSTHARVEST BIOL TEC, V109, P130, DOI 10.1016/j.postharvbio.2015.05.012; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; EDWARDS EA, 1990, PLANTA, V180, P278, DOI 10.1007/BF00194008; Gerasopoulos D, 2005, POSTHARVEST BIOL TEC, V36, P303, DOI 10.1016/j.postharvbio.2005.01.005; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Khan AS, 2007, POSTHARVEST BIOL TEC, V46, P36, DOI 10.1016/j.postharvbio.2007.03.018; Khosroshahi Mohammad Reza Zokaee, 2008, International Journal of Postharvest Technology and Innovation, V1, P278, DOI 10.1504/IJPTI.2008.021462; Ma QS, 2014, POSTHARVEST BIOL TEC, V97, P102, DOI 10.1016/j.postharvbio.2014.05.018; MARRE E, 1958, BIOCHIM BIOPHYS ACTA, V30, P453, DOI 10.1016/0006-3002(58)90089-1; Martínez-Téllez M. A., 2008, Rev. Chapingo Ser.Hortic, V14, P243; Martinez-Tellez MA, 2002, BIOCHEM BIOPH RES CO, V295, P98, DOI 10.1016/S0006-291X(02)00631-9; Maul P, 2008, PLANT CELL ENVIRON, V31, P752, DOI 10.1111/j.1365-3040.2008.01793.x; Mirdehghan SH, 2007, POSTHARVEST BIOL TEC, V44, P26, DOI 10.1016/j.postharvbio.2006.11.010; Mirdehghan SH, 2007, POSTHARVEST BIOL TEC, V44, P19, DOI 10.1016/j.postharvbio.2006.11.001; Murshed R, 2014, PHYSIOL MOL BIOL PLA, V20, P15, DOI 10.1007/s12298-013-0209-z; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Qiao Yongjin, 2006, Food Science, China, V27, P246; Rui HJ, 2010, J SCI FOOD AGR, V90, P1557, DOI 10.1002/jsfa.3993; Saba MK, 2012, J AGR FOOD CHEM, V60, P8947, DOI 10.1021/jf302088e; Sfakiotakis E, 2005, POSTHARVEST BIOL TEC, V38, P169, DOI 10.1016/j.postharvbio.2005.06.010; Shen WY, 2000, PLANT PHYSIOL, V124, P431, DOI 10.1104/pp.124.1.431; Singh SP, 2013, INT J FOOD SCI TECH, V48, P363, DOI 10.1111/j.1365-2621.2012.03196.x; SMITH TA, 1985, ANNU REV PLANT PHYS, V36, P117, DOI 10.1146/annurev.pp.36.060185.001001; Song LL, 2009, FOOD CHEM, V114, P1216, DOI 10.1016/j.foodchem.2008.10.080; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55; Wang Q, 2012, SCI HORTIC-AMSTERDAM, V144, P195, DOI 10.1016/j.scienta.2012.07.018; Wongsheree T, 2009, POSTHARVEST BIOL TEC, V51, P91, DOI 10.1016/j.postharvbio.2008.05.015; Yang QZ, 2013, J SCI FOOD AGR, V93, P3691, DOI 10.1002/jsfa.6195; Yang QZ, 2012, HORTIC ENVIRON BIOTE, V53, P505, DOI 10.1007/s13580-012-0101-8; Zhang ZK, 2010, HORTSCIENCE, V45, P1713, DOI 10.21273/HORTSCI.45.11.1713	42	30	32	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162159	10.1371/journal.pone.0162159	http://dx.doi.org/10.1371/journal.pone.0162159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607076	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600023
J	Weng, YJ; Husebekk, A; Skogen, B; Kjaer, M; Lin, LT; Burnouf, T				Weng, Ying-Jan; Husebekk, Anne; Skogen, Bjorn; Kjaer, Mette; Lin, Liang-Tzung; Burnouf, Thierry			Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CAPRYLIC-ACID; HUMAN PLASMA; INTRACRANIAL HEMORRHAGE; VIRAL SAFETY; PRODUCTS; NANOFILTRATION; INACTIVATION; IGG; CHROMATOGRAPHY	Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a severe disease that is caused by maternal alloantibodies generated during pregnancy or at delivery as a result of incompatibility between maternal and fetal human platelet antigens (HPAs) inherited from the father. Antibody-mediated immune suppression using anti-HPA-1a immunoglobulins is thought to be able to prevent FNAIT caused by HPA-1a. A fractionation process to prepare anti-HPA-1a immunoglobulin (Ig) G (IgG) from human plasma was therefore developed. Anti-HPA-1a plasma was obtained from volunteer mothers who underwent alloimmunization against HPA-1a during a previous pregnancy. Plasma was cryoprecipitated and the supernatant treated with caprylic acid and solvent/detergent (S/D), purified by chromatography, nanofiltered, concentrated, and sterile-filtered. The anti-HPA-1a immunoglobulin fraction was characterized for purity and safety. PAK12 and quantitative monoclonal antibody immobilization of platelet antigen (MAIPA) assays were used to detect anti-HPA-1a IgG. Hepatitis C virus (HCV) removal during nanofiltration was assessed by spiking experiments, using cell culture-derived reporter HCV and luciferase analysis. The caprylic acid treatment precipitated non-Ig proteins yielding a 90% pure Ig supernatant. S-HyperCel chromatography of the S/D-treated supernatant followed by HyperCel STAR AX provided high IgG recovery (>80%) and purity (>99.5%), and efficient IgA and IgM removal. Concentrations of complement factors C3 and C4 were < 0.5 and < 0.4 mg/dL, respectively. The final IgG could be nanofiltered on Planova 20N under conditions removing more than 3 log HCV infectivity to baseline mock infection level, and concentrated to ca. 30 g/L. Proteolytic activity and thrombin generation were low in the final fraction. The Pak12 and MAIPA assays showed good recovery of anti-HPA-1a throughout the process. Clinical-grade HPA-1a IgG can be prepared using a process compliant with current quality requirements opening perspectives for the prevention of FNAIT.	[Weng, Ying-Jan; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Husebekk, Anne; Skogen, Bjorn] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Skogen, Bjorn; Kjaer, Mette] Univ Hosp North Norway, Dept Lab Med, Tromso, Norway; [Kjaer, Mette] Finnmark Hosp Trust, Hammerfest, Norway; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan	Taipei Medical University; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Taipei Medical University; Taipei Medical University	Burnouf, T (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243; Lin, Liang-Tzung/0000-0001-7374-7234	National Science Council of Taiwan [NSC 102-2320-B-038-041-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council of Taiwan (NSC 102-2320-B-038-041-MY3). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abdulla I, 2014, J IMMUNOL METHODS, V402, P15, DOI 10.1016/j.jim.2013.11.001; [Anonymous], 2015, HUMAN ANTI D IMMUNOG, P2657; Arnold D M, 2012, J Thromb Haemost, V10, P695, DOI 10.1111/j.1538-7836.2012.04664.x; Bertrand G, 2014, TRANSFUSION; Burnouf T, 2005, CURR NANOSCI, V1, P189, DOI 10.2174/157341305774642894; Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x; Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129; Burnouf T, 2007, TRANSFUS MED REV, V21, P101, DOI 10.1016/j.tmrv.2006.11.001; Busse JB, 2008, BLOOD REV, V22, P33, DOI 10.1016/j.blre.2007.09.002; Caballero S, 2014, BIOLOGICALS, V42, P79, DOI 10.1016/j.biologicals.2013.10.003; Caballero S, 2010, BIOLOGICALS, V38, P486, DOI 10.1016/j.biologicals.2010.02.008; Chilcott J, 2003, REV CLIN EFFECTIVENE; Chou ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117800; Daniel GW, 2012, TRANSFUSION, V52, P2113, DOI 10.1111/j.1537-2995.2012.03589.x; Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x; Dichtelmuller H, 2002, BIOLOGICALS, V30, P135, DOI 10.1006/biol.2002.0332; El-Ekiaby M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003501; Germishuizen WA, 2014, BIOLOGICALS, V42, P260, DOI 10.1016/j.biologicals.2014.04.002; Horowitz B, 2004, WHO TECH REP SER, V924, P1; Husebekk A, 2011, ISBT SCI SERIES, V6, P261; Kamphuis MM, 2010, BJOG-INT J OBSTET GY, V117, P1335, DOI 10.1111/j.1471-0528.2010.02657.x; Kanhai HHH, 2006, FETAL DIAGN THER, V21, P55, DOI 10.1159/000089048; KIEFEL V, 1987, BLOOD, V70, P1722; KIEFEL V, 1992, TRANSFUSION MED, V2, P181, DOI 10.1111/j.1365-3148.1992.tb00153.x; Killie MK, 2008, HAEMATOLOGICA, V93, P870, DOI 10.3324/haematol.12515; Killie MK, 2010, TRANSFUS APHER SCI, V43, P149, DOI 10.1016/j.transci.2010.07.001; Kjeldsen-Kragh J, 2007, BLOOD, V110, P833, DOI 10.1182/blood-2006-08-040121; Kjeldsen-Kragh J, 2012, CURR OPIN HEMATOL, V19, P469, DOI 10.1097/MOH.0b013e328358f86c; Koenderman AHL, 2012, BIOLOGICALS, V40, P473, DOI 10.1016/j.biologicals.2012.07.010; Korneyeva M, 2002, BIOLOGICALS, V30, P153, DOI 10.1006/biol.2002.0334; Kumpel BM, 2001, TRENDS IMMUNOL, V22, P26, DOI 10.1016/S1471-4906(00)01801-9; Lebing W, 2003, VOX SANG, V84, P193, DOI 10.1046/j.1423-0410.2003.00285.x; Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; MORAIS V, 2014, IMMUNOGLOBULIN PURIF, P137, DOI DOI 10.1007/978-1-52703-977-2_13; Ni HY, 2006, BLOOD, V107, P2976, DOI 10.1182/blood-2005-06-2562; Parkkinen J, 2006, VOX SANG, V90, P97, DOI 10.1111/j.1423-0410.2005.00731.x; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Roemisch JR, 2011, IDENTIFICATION ACTIV; ROJAS G, 1994, TOXICON, V32, P351, DOI 10.1016/0041-0101(94)90087-6; Spencer JA, 2001, AUST NZ J OBSTET GYN, V41, P45, DOI 10.1111/j.1479-828X.2001.tb01293.x; Thorpe SJ, 2003, VOX SANG, V85, P313, DOI 10.1111/j.0042-9007.2003.00367.x; Tiblad E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070984; Tiller H, 2012, TRANSFUSION, V52, P1446, DOI 10.1111/j.1537-2995.2011.03480.x; Turner ML, 2005, TRANSFUSION, V45, P1945, DOI 10.1111/j.1537-2995.2005.00645.x; van den Akker ESA, 2008, BEST PRACT RES CL OB, V22, P3, DOI 10.1016/j.bpobgyn.2007.08.001; Vargas M, 2015, VOX SANG, V108, P169, DOI 10.1111/vox.12209; WHO, 2015, ANN 1 19 WHO MOD LIS; Williamson LM, 1998, BLOOD, V92, P2280, DOI 10.1182/blood.V92.7.2280.2280_2280_2287; World Health Organization, 2010, WHO GUIDELINES PRODU; Wu YW, 2014, TRANSFUSION, V54, P169, DOI 10.1111/trf.12243; Yougbare I, 2015, J CLIN INVEST, V125, P1545, DOI 10.1172/JCI77820; Zdravic D, 2016, SEMIN FETAL NEONAT M, V21, P19, DOI 10.1016/j.siny.2015.12.004	53	5	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162973	10.1371/journal.pone.0162973	http://dx.doi.org/10.1371/journal.pone.0162973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627660	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600070
J	Daryabor, F; Ool, SH; Abu Samah, A; Akbari, A				Daryabor, Farshid; Ool, See Hai; Abu Samah, Azizan; Akbari, Abolghasem			Tides and Their Dynamics over the Sunda Shelf of the Southern South China Sea	PLOS ONE			English	Article							TIDAL DYNAMICS; PENINSULAR MALAYSIA; EAST-COAST; MODEL; CIRCULATION; TOPOGRAPHY; TEMPERATURE; SIMULATION; SURFACE	A three-dimensional Regional Ocean Modelling System is used to study the tidal characteristics and their dynamics in the Sunda Shelf of the southern South China Sea. In this model, the outer domain is set with a 25 km resolution and the inner one, with a 9 km resolution. Calculations are performed on the inner domain. The model is forced at the sea surface by climatological monthly mean wind stress, freshwater (evaporation minus precipitation), and heat fluxes. Momentum and tracers (such as temperature and salinity) are prescribed in addition to the tidal heights and currents extracted from the Oregon State University TOPEX/Poseidon Global Inverse Solution (TPXO7.2) at the open boundaries. The results are validated against observed tidal amplitudes and phases at 19 locations. Results show that the mean average power energy spectrum (in unit m(2)/s/cph) for diurnal tides at the southern end of the East Coast of Peninsular Malaysia is approximately 43% greater than that in the East Malaysia region located in northern Borneo. In contrast, for the region of northern Borneo the semidiurnal power energy spectrum is approximately 25% greater than that in the East Coast of Peninsular Malaysia. This implies that diurnal tides are dominant along the East Coast of Peninsular Malaysia while both diurnal and semidiurnal tides dominate almost equally in coastal East Malaysia. Furthermore, the diurnal tidal energy flux is found to be 60% greater than that of the semidiurnal tides in the southern South China Sea. Based on these model analyses, the significant tidal mixing frontal areas are located primarily off Sarawak coast as indicated by high chlorophyll-a concentrations in the area.	[Daryabor, Farshid; Ool, See Hai; Abu Samah, Azizan] Univ Malaya, Inst Postgrad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia; [Daryabor, Farshid; Abu Samah, Azizan] Univ Malaya, Inst Postgrad Studies, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia; [Akbari, Abolghasem] Univ Malaysia Pahang, Fac Civil Engn & Earth Resources, Kuantan 26300, Pahang, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaysia Pahang	Daryabor, F (corresponding author), Univ Malaya, Inst Postgrad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia.; Daryabor, F (corresponding author), Univ Malaya, Inst Postgrad Studies, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia.	fdaryabor@um.edu.my	Akbari, Abolghasem/L-5971-2019; Akbari, Abolghasem/N-1341-2014; Daryabor, Farshid/A-9345-2019; ABU SAMAH, AZIZAN HJ/B-8295-2010; Daryabor, Farshid/K-6084-2015	Akbari, Abolghasem/0000-0003-4394-1970; Akbari, Abolghasem/0000-0003-4394-1970; Daryabor, Farshid/0000-0001-8217-8504; Daryabor, Farshid/0000-0001-8217-8504	Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences [IOES-2014a]; University of Malaya	Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences; University of Malaya(Universiti Malaya)	This research study is funded by the Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES-2014a, Air-Ocean-Land Interaction). Grant Receiver: Azizan Abu Samah.; The authors are grateful to the Department of Survey and Mapping Malaysia for the supply of the tide gauge data. This research study is funded by the Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES-2014a, Air-Ocean-Land Interaction). It is also strongly encouraged by the Director of IOES and supported by the Vice-Chancellor of the University of Malaya. Above all, the authors greatly appreciate the invaluable and constructive comments and suggestions by the reviewers on this manuscript.	Akhir M.F., 2015, OPEN J MAR SCI, V5, P273, DOI [10.4236/ojms.2015.53022, DOI 10.4236/OJMS.2015.53022]; An H.S., 1977, J OCEANOGR SOC JPN, V33, P103, DOI [10.1007/BF02110016, DOI 10.1007/BF02110016]; Antonov J.I., 2006, NOAA ATLAS NESDIS, V62, P182; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bowden K.F., 1983, PHYSICAL OCEANOGRAPH, DOI DOI 10.4319/LO.1985.30.2.0449; Chao SY, 1996, DEEP-SEA RES PT I, V43, P445, DOI 10.1016/0967-0637(96)00025-8; CHAPMAN DC, 1985, J PHYS OCEANOGR, V15, P1060, DOI 10.1175/1520-0485(1985)015<1060:NTOCSO>2.0.CO;2; Chu PC, 1999, J PHYS OCEANOGR, V29, P2971, DOI 10.1175/1520-0485(1999)029<2971:DMFTSC>2.0.CO;2; da Silva A.M., 1994, ATLAS SURFACE MARINE, V6; Daryabor F., 2015, OCEAN SCI DISCUSS, V12, P275, DOI [10.5194/osd-12-275-2015, DOI 10.5194/OSD-12-275-2015]; Daryabor F, 2010, IEGU GEN ASSEM C ABS, V12, P778; Daryabor F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158415; Daryabor F, 2015, OCEAN DYNAM, V65, P93, DOI 10.1007/s10236-014-0787-5; Daryabor F, 2014, SAINS MALAYS, V43, P389; Davies AM, 1997, CONT SHELF RES, V17, P165, DOI 10.1016/S0278-4343(96)00025-8; Debreu L, 2008, COMPUT GEOSCI-UK, V34, P8, DOI 10.1016/j.cageo.2007.01.009; Ding Y, 2012, OCEAN DYNAM, V62, P515, DOI 10.1007/s10236-011-0518-0; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Egbert GD, 2001, J GEOPHYS RES-OCEANS, V106, P22475, DOI 10.1029/2000JC000699; Fang GH, 1999, CONT SHELF RES, V19, P845, DOI 10.1016/S0278-4343(99)00002-3; Flather R. A., 1976, Memoires de la Societe Royal des Sciences de Liege. Collection in-8, V10, P141; FOREMAN MGG, 1993, J GEOPHYS RES-OCEANS, V98, P2509, DOI 10.1029/92JC02470; Green JAM, 2013, DEEP-SEA RES PT I, V78, P42, DOI 10.1016/j.dsr.2013.04.006; Guo X., 1998, J OCEANOGR, V54, P651, DOI [10.1007/BF02823285, DOI 10.1007/BF02823285]; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Hu JY, 2003, J GEOPHYS RES, V108, P1978; Jan S, 2002, J OCEANOGR, V58, P837, DOI 10.1023/A:1022827330693; Janekovic I, 2012, CONT SHELF RES, V34, P30, DOI 10.1016/j.csr.2011.11.017; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Locarnini RA, 2005, NOAA ATLAS NESDIS, V61, P182; Lorbacher K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2003JC002157; Mao QW, 2006, CHINESE SCI BULL, V51, P26, DOI 10.1007/s11434-006-9026-x; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/s1463-5003(00)00013-5; Mohn C, 2013, OCEAN DYNAM, V63, P195, DOI 10.1007/s10236-013-0597-1; MOROZOV EG, 1995, DEEP-SEA RES PT I, V42, P135, DOI 10.1016/0967-0637(95)92886-C; Moum JN, 2002, J PHYS OCEANOGR, V32, P2113, DOI 10.1175/1520-0485(2002)032<2113:OOBMOT>2.0.CO;2; Nakamoto S, 2000, GEOPHYS RES LETT, V27, P747, DOI 10.1029/1999GL002371; Niwa Y, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001923; ORLANSKI I, 1976, J COMPUT PHYS, V21, P251, DOI 10.1016/0021-9991(76)90023-1; Pawlowicz R, 2002, COMPUT GEOSCI-UK, V28, P929, DOI 10.1016/S0098-3004(02)00013-4; Ray R.D., 2005, J OCEANOGRAPHY SOC O, V18, P74, DOI [10.5670/oceanog.2005.07, DOI 10.5670/OCEANOG.2005.07, DOI 10.5670/0CEAN0G.2005.07]; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE; Yanagi T., 2001, J OCEANOGR, V57, P461, DOI [10.1023/A:1021237721368, DOI 10.1023/A:1021237721368]; Yanagi T., 1998, J OCEANOGR, V54, P143, DOI DOI 10.1007/BF02751690; Yao ZG, 2012, OCEAN DYNAM, V62, P753, DOI 10.1007/s10236-011-0517-1; YE AL, 1983, GEOPHYS J ROY ASTR S, V72, P691, DOI 10.1111/j.1365-246X.1983.tb02827.x; Zu TT, 2008, DEEP-SEA RES PT I, V55, P137, DOI 10.1016/j.dsr.2007.10.007	51	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162170	10.1371/journal.pone.0162170	http://dx.doi.org/10.1371/journal.pone.0162170			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622552	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000016
J	Pedral-Sampaio, G; Alves, JS; Schriefer, A; Magalhaes, A; Meyer, R; Glesby, MJ; Carvalho, EM; Carvalho, LP				Pedral-Sampaio, Geraldo; Alves, Jesse S.; Schriefer, Albert; Magalhaes, Andrea; Meyer, Roberto; Glesby, Marshall J.; Carvalho, Edgar M.; Carvalho, Lucas P.			Detection of IgG Anti-Leishmania Antigen by Flow Cytometry as a Diagnostic Test for Cutaneous Leishmaniasis	PLOS ONE			English	Article							AMERICAN TEGUMENTARY LEISHMANIASIS; BRAZILIENSIS IMMUNOGLOBULIN-G; VIANNIA BRAZILIENSIS; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; MUCOCUTANEOUS LEISHMANIASIS; MUCOSAL LEISHMANIASIS; TRYPANOSOMA-CRUZI; PCR ASSAY; INFECTION	Diagnosis of cutaneous leishmaniasis (CL) relies on clinical presentation, parasite isolation, histopathologic evaluation and positive Montenegro skin test. However, the low amounts of parasites in the lesion of these individuals make parasite isolation and histopatologic diagnosis unreliable, often leading to false-negative results. Also, 15% of people living in endemic areas have sub-clinical infection characterized by positive Montenegro skin test, which may contribute to misdiagnosis. Although the main Leishmania killing mechanism is through cell-mediated immune response, antibodies against Leishmania antigens are found in infected individuals. Here our goal was to develop a new serological technique using polystyrene microspheres sensitized with soluble Leishmania antigens as a tool for the detection of IgG in serum from CL patients by flow cytometry. To validate the assay we carried out a comparative test (ELISA) commonly used as a diagnostic test for parasitic diseases. To determine cross-reactivity we used serum from patients with Chagas disease, caused by a trypanosome that has several proteins with high homology to those of the Leishmania genus. We observed that the flow cytometry technique was more sensitive than the ELISA, but, less specific. Our results show that the flow cytometry serologic test can be used to confirm CL cases in L. braziliensis transmission areas, however, presence of Chagas disease has to be ruled out in these individuals.	[Pedral-Sampaio, Geraldo; Meyer, Roberto] Univ Fed Bahia, Inst Ciencias Saude, Lab Imunol, Salvador, BA, Brazil; [Alves, Jesse S.; Schriefer, Albert; Magalhaes, Andrea; Carvalho, Edgar M.; Carvalho, Lucas P.] Univ Fed Bahia, Complexo Hosp Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Glesby, Marshall J.] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA; [Schriefer, Albert; Carvalho, Edgar M.; Carvalho, Lucas P.] INCT DT, Salvador, BA, Brazil; [Carvalho, Edgar M.; Carvalho, Lucas P.] FIOCRUZ BA, Lab Avancado Saude Publ, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Cornell University; Fundacao Oswaldo Cruz	Carvalho, LP (corresponding author), Univ Fed Bahia, Complexo Hosp Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.; Carvalho, LP (corresponding author), INCT DT, Salvador, BA, Brazil.; Carvalho, LP (corresponding author), FIOCRUZ BA, Lab Avancado Saude Publ, Salvador, BA, Brazil.	carvalholp76@gmail.com	Carvalho, Lucas/AAP-1844-2020; Schriefer, Albert/AAP-2765-2020	Schriefer, Albert/0000-0002-5496-6789	Japan Society for the Promotion of Science, Tokyo, Japan [24593126, 16K11836]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (C) 24593126 and 16K11836 from the Japan Society for the Promotion of Science, Tokyo, Japan (https://www.jsps.go.jp/j-grantsinaid/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pereira VRA, 2012, DIAGN MICR INFEC DIS, V74, P292, DOI 10.1016/j.diagmicrobio.2012.06.025; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; BADARO R, 1983, AM J TROP MED HYG, V32, P480, DOI 10.4269/ajtmh.1983.32.480; BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344; Carvalho LP, 2007, PARASITE IMMUNOL, V29, P251, DOI 10.1111/j.1365-3024.2007.00940.x; Cavalcanti MD, 2013, MOL CELL PROBE, V27, P122, DOI 10.1016/j.mcp.2013.01.003; Chiaramonte MG, 1999, ACTA TROP, V72, P295, DOI 10.1016/S0001-706X(99)00005-4; de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5; de Oliveira AP, 2013, J IMMUNOL METHODS, V387, P245, DOI 10.1016/j.jim.2012.11.002; GUTIERREZ Y, 1991, AM J TROP MED HYG, V45, P281, DOI 10.4269/ajtmh.1991.45.281; MALCHIODI EL, 1994, CLIN EXP IMMUNOL, V97, P417, DOI 10.1111/j.1365-2249.1994.tb06104.x; MARTINS-FILHO OA, 1995, CLIN DIAGN LAB IMMUN, V2, P569, DOI 10.1128/CDLI.2.5.569-573.1995; Morgado FN, 2008, BRIT J DERMATOL, V158, P50, DOI 10.1111/j.1365-2133.2007.08255.x; ONEIL CE, 1993, AM J TROP MED HYG, V49, P181, DOI 10.4269/ajtmh.1993.49.181; PAPPAS MG, 1983, AM J TROP MED HYG, V32, P1260, DOI 10.4269/ajtmh.1983.32.1260; Passos S, 2005, CLIN DIAGN LAB IMMUN, V12, P1164, DOI 10.1128/CDLI.12.10.1164-1167.2005; Pissinate JF, 2008, J IMMUNOL METHODS, V336, P193, DOI 10.1016/j.jim.2008.04.018; REED SG, 1987, J IMMUNOL, V138, P1596; Rocha RDR, 2006, TROP MED INT HEALTH, V11, P156, DOI 10.1111/j.1365-3156.2005.01552.x; Rocha Roberta Dias Rodrigues, 2002, Rev. Soc. Bras. Med. Trop., V35, P551, DOI 10.1590/S0037-86822002000600002; Rodriguez V, 1996, PARASITE IMMUNOL, V18, P341, DOI 10.1046/j.1365-3024.1996.d01-113.x; Romero GAS, 2005, ACTA TROP, V93, P49, DOI 10.1016/j.actatropica.2004.09.005; Schnorr D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001947; Silvestre R, 2009, AM J TROP MED HYG, V81, P202, DOI 10.4269/ajtmh.2009.81.202; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Souza AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066110; Szargiki R, 2009, BRAZ J INFECT DIS, V13, P47, DOI 10.1590/S1413-86702009000100011; Tsukayama P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001956; Vidigal CD, 2008, ACTA TROP, V107, P208, DOI 10.1016/j.actatropica.2008.04.026; Weigle KA, 2002, J CLIN MICROBIOL, V40, P601, DOI 10.1128/JCM.40.2.601-606.2002; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11	33	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162793	10.1371/journal.pone.0162793	http://dx.doi.org/10.1371/journal.pone.0162793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622535	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000056
J	Lopez, J; Fernandez, SN; Gonazlez, R; Solana, MJ; Urbano, J; Lopez-Herce, J				Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus			Different Respiratory Rates during Resuscitation in a Pediatric Animal Model of Asphyxial Cardiac Arrest	PLOS ONE			English	Article							PLUS CHEST COMPRESSIONS; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; COUNCIL GUIDELINES; TREATMENT RECOMMENDATIONS; INTERNATIONAL CONSENSUS; SPONTANEOUS CIRCULATION; CHILDREN; EPIDEMIOLOGY; VENTILATION	Aims Actual resuscitation guidelines recommend 10 respirations per minute (rpm) for advanced pediatric life support. This respiratory rate (RR) is much lower than what is physiological for children. The aim of this study is to compare changes in ventilation, oxygenation, haemodynamics and return of spontaneous circulation (ROSC) rates with three RR. Methods An experimental model of asphyxial cardiac arrest (CA) in 46 piglets (around 9.5 kg) was performed. Resuscitation with three different RR (10, 20 and 30 rpm) was carried out. Haemodynamics and gasometrical data were obtained at 3, 9, 18 and 24 minutes after beginning of resuscitation. Measurements were compared between the three groups. Results No statistical differences were found in ROSC rate between the three RR (37.5%, 46.6% and 60% in the 10, 20 and 30 rpm group respectively P = 0.51). 20 and 30 rpm groups had lower PaCO2 values than 10 rpm group at 3 minutes (58 and 55 mmHg vs 75 mmHg P = 0.08). 30 rpm group had higher PaO2 (61 mmHg) at 3 minutes than 20 and 10 rpm groups (53 and 45 mmHg P = 0.05). No significant differences were found in haemodynamics or tissue perfusion between hyperventilated (PaCO2 <30 mmHg), normoventilated (30-50 mmHg) and hypoventilated (>50 mmHg) animals. PaO2 was significantly higher in hyperventilated (PaO2 153 mmHg) than in normoventilated (79 mmHg) and hypoventilated (47 mmHg) piglets (P<0.001). Conclusions Our study confirms the hypothesis that higher RR achieves better oxygenation and ventilation without affecting haemodynamics. A higher RR is associated but not significantly with better ROSC rates.	[Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Gregorio Maranon Gen Univ Hosp, Pediat Intens Care Unit, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Univ Complutense Madrid, Sch Med, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Gregorio Maranon Hlth Res Inst, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Carlos III Hlth Inst, Mother Child Hlth & Dev Network RedSAMID, Bilbao, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid	Lopez, J; Lopez-Herce, J (corresponding author), Gregorio Maranon Gen Univ Hosp, Pediat Intens Care Unit, Madrid, Spain.; Lopez, J; Lopez-Herce, J (corresponding author), Univ Complutense Madrid, Sch Med, Madrid, Spain.; Lopez, J; Lopez-Herce, J (corresponding author), Gregorio Maranon Hlth Res Inst, Madrid, Spain.; Lopez, J; Lopez-Herce, J (corresponding author), Carlos III Hlth Inst, Mother Child Hlth & Dev Network RedSAMID, Bilbao, Spain.	dr_pyta@yahoo.es; pielvi@hotmail.com	Fernandez Lafever, Sarah Nicole/AAE-4978-2022; Cortes, Rafael Gonzalez/ABB-4855-2020; Lopez-Herce, Jesus/A-1602-2019; Lopez, Jorge/AAD-4109-2022	Fernandez Lafever, Sarah Nicole/0000-0003-4859-5966; Cortes, Rafael Gonzalez/0000-0002-3259-7898; Lopez-Herce, Jesus/0000-0001-6105-9178; Lopez, Jorge/0000-0002-9942-6399; Urbano, Javier/0000-0002-3511-2905; SOLANA, MARIA JOSE/0000-0001-6083-2528	Carlos III Health Institute [PI12/01307]; Mother-Child Health and Development Network (Red SAMID) - RETICS - PN I+D+I (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF) [RD12/0026]	Carlos III Health Institute(Instituto de Salud Carlos III); Mother-Child Health and Development Network (Red SAMID) - RETICS - PN I+D+I (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission)	This work was supported by Carlos III Health Institute (PI12/01307): JL SNF RG MJS JU JL-H, URL: http://www.isciii.es/; Mother-Child Health and Development Network (Red SAMID) - RETICS funded by the PN I+D+I 2008-2011 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), ref. RD12/0026: JL SNF RG MJS JU JL-H, URL: http://www.redsamid.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Aufderheide TP, 2006, CURR OPIN CRIT CARE, V12, P207, DOI 10.1097/01.ccx.0000224863.55711.56; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; Botran M, 2011, INTENS CARE MED, V37, P1873, DOI 10.1007/s00134-011-2338-6; del Castillo J, 2012, RESUSCITATION, V83, P1456, DOI 10.1016/j.resuscitation.2012.07.019; Gazmuri RJ, 2007, CIRCULATION, V116, P2501, DOI 10.1161/CIRCULATIONAHA.107.186228; Gonzalez R, 2014, PEDIATR CRIT CARE ME, V15, pE280, DOI 10.1097/PCC.0000000000000127; Herlitz J, 2005, RESUSCITATION, V64, P37, DOI 10.1016/j.resuscitation.2004.06.019; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Kjaergaard J, 2015, RESUSCITATION, V96, P310, DOI 10.1016/j.resuscitation.2015.06.021; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Lopez-Herce J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0607-9; Lopez-Herce J, 2013, INTENS CARE MED, V39, P309, DOI 10.1007/s00134-012-2709-7; Lopez-Herce J, 2011, RESUSCITATION, V82, P755, DOI 10.1016/j.resuscitation.2011.02.013; Lopez-Herce J, 2011, INTENS CARE MED, V37, P147, DOI 10.1007/s00134-010-2006-2; Lopez-Herce J, 2010, LANCET, V375, P1321, DOI 10.1016/S0140-6736(10)60316-9; Maconochie IK, 2015, RESUSCITATION, V95, pE147, DOI 10.1016/j.resuscitation.2015.07.044; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Iglesias JM, 2010, INTENS CARE MED, V36, P712, DOI 10.1007/s00134-010-1777-9; O'Leary F, 2015, ARCH DIS CHILD, V100, P733, DOI 10.1136/archdischild-2014-307401; O'Neill JF, 2007, RESUSCITATION, V73, P82, DOI 10.1016/j.resuscitation.2006.09.012; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Rajan S, 2015, RESUSCITATION, V88, P12, DOI 10.1016/j.resuscitation.2014.11.025; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; Roberts BW, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-9; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Sutton RM, 2015, RESUSCITATION, V93, P150, DOI 10.1016/j.resuscitation.2015.04.010; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; Yannopoulos D, 2010, CRIT CARE MED, V38, P254, DOI 10.1097/CCM.0b013e3181b42f6c; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162185	10.1371/journal.pone.0162185	http://dx.doi.org/10.1371/journal.pone.0162185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618183	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100014
J	Wu, DC; Guo, M; Philips, MA; Qu, LZ; Jiang, LY; Li, J; Chen, XJ; Chen, ZC; Chen, L; Chen, YH				Wu, Daichao; Guo, Ming; Philips, Michael A.; Qu, Lingzhi; Jiang, Longying; Li, Jun; Chen, Xiaojuan; Chen, Zhuchu; Chen, Lin; Chen, Yongheng			Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455	PLOS ONE			English	Article							FACTOR RECEPTOR 4; HUMAN BREAST; GROWTH; INHIBITOR; POTENT; MUTATIONS; XENOGRAFT; AZD4547; BINDING; FAMILY	Aberrant FGFR4 signaling has been documented abundantly in various human cancers. The majority of FGFR inhibitors display significantly reduced potency toward FGFR4 compared to FGFR1-3. However, LY2874455 has similar inhibition potency for FGFR1-4 with IC50 less than 6.4 nM. To date, there is no published crystal structure of LY2874455 in complex with any kinase. To better understand the pan-FGFR selectivity of LY2874455, we have determined the crystal structure of the FGFR4 kinase domain bound to LY2874455 at a resolution of 2.35 angstrom. LY2874455, a type I inhibitor for FGFR4, binds to the ATP-binding pocket of FGFR4 in a DFG-in active conformation with three hydrogen bonds and a number of van der Waals contacts. After alignment of the kinase domain sequence of 4 FGFRs, and superposition of the ATP-binding pocket of 4 FGFRs, our structural analyses reveal that the interactions of LY2874455 to FGFR4 are largely conserved in 4 FGFRs, explaining at least partly, the broad inhibitory activity of LY2874455 toward 4 FGFRs. Consequently, our studies reveal new insights into the pan-FGFR selectivity of LY2874455 and provide a structural basis for developing novel FGFR inhibitors that target FGFR1-4 broadly.	[Wu, Daichao; Guo, Ming; Qu, Lingzhi; Jiang, Longying; Li, Jun; Chen, Xiaojuan; Chen, Zhuchu; Chen, Lin; Chen, Yongheng] Cent S Univ, Struct Biol Lab, Key Lab Canc Prote, Chinese Minist Hlth,XiangYa Hosp, Changsha 410008, Hunan, Peoples R China; [Philips, Michael A.; Chen, Lin; Chen, Yongheng] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Chen, Yongheng] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	Central South University; University of Southern California	Chen, L; Chen, YH (corresponding author), Cent S Univ, Struct Biol Lab, Key Lab Canc Prote, Chinese Minist Hlth,XiangYa Hosp, Changsha 410008, Hunan, Peoples R China.; Chen, L; Chen, YH (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA 90089 USA.; Chen, YH (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	linchen@usc.edu; yonghenc@163.com			National Natural Science Foundation of China [81372904, 81570537, 81272971]; Science and Technology Department of Hunan Province [2015SK2037]; Hunan 555 project; "Shenghua Scholar" project of Central South University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province; Hunan 555 project; "Shenghua Scholar" project of Central South University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Natural Science Foundation of China (Y.C., project numbers 81372904 and 81570537, Z.C. project number 81272971). This project was supported by the Science and Technology Department of Hunan Province (2015SK2037), Hunan 555 project (Y.C.), and "Shenghua Scholar" project of Central South University (Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Chen YH, 2015, NUCLEIC ACIDS RES, V43, P1268, DOI 10.1093/nar/gku1373; Desai A, 2016, J THORAC ONCOL, V11, P9, DOI 10.1016/j.jtho.2015.08.003; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Duan YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106225; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gowardhan B, 2005, BRIT J CANCER, V92, P320, DOI 10.1038/sj.bjc.6602274; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Ho HK, 2014, DRUG DISCOV TODAY, V19, P51, DOI 10.1016/j.drudis.2013.07.021; Huang ZF, 2015, ACS CHEM BIOL, V10, P299, DOI 10.1021/cb500674s; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Lesca E, 2014, J MOL BIOL, V426, P3744, DOI 10.1016/j.jmb.2014.09.004; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lu CM, 2015, CELLS TISSUES ORGANS, V201, P26, DOI 10.1159/000441349; Motoda N, 2011, INT J ONCOL, V38, P133, DOI 10.3892/ijo_00000832; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; Penault Llorca F, INT J CANC; Repana Dimitra, 2015, Diseases, V3, P294, DOI 10.3390/diseases3040294; Roidl A, 2010, ONCOGENE, V29, P1543, DOI 10.1038/onc.2009.432; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Tan L, 2014, P NATL ACAD SCI USA, V111, pE4869, DOI 10.1073/pnas.1403438111; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Treiber DK, 2013, CHEM BIOL, V20, P745, DOI 10.1016/j.chembiol.2013.06.001; Tucker JA, 2014, STRUCTURE, V22, P1764, DOI 10.1016/j.str.2014.09.019; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wu DC, 2014, PROCESS BIOCHEM, V49, P402, DOI 10.1016/j.procbio.2014.01.005; Yamada SM, 2002, NEUROL RES, V24, P244, DOI 10.1179/016164102101199864; Zhao GS, 2011, MOL CANCER THER, V10, P2200, DOI 10.1158/1535-7163.MCT-11-0306	32	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162491	10.1371/journal.pone.0162491	http://dx.doi.org/10.1371/journal.pone.0162491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618313	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100025
J	Acharya, KP; Paudel, PK; Neupane, PR; Kohl, M				Acharya, Krishna Prasad; Paudel, Prakash Kumar; Neupane, Prem Raj; Koehl, Michael			Human-Wildlife Conflicts in Nepal: Patterns of Human Fatalities and Injuries Caused by Large Mammals	PLOS ONE			English	Article							HUMAN-ELEPHANT CONFLICT; RHINOCEROS RHINOCEROS-UNICORNIS; CHITWAN NATIONAL-PARK; PANTHERA-TIGRIS; PREY SELECTION; TIGER RESERVE; DRY SEASON; CONSERVATION; COEXISTENCE; LIVESTOCK	Injury and death from wildlife attacks often result in people feeling violent resentment and hostility against the wildlife involved and, therefore, may undermine public support for conservation. Although Nepal, with rich biodiversity, is doing well in its conservation efforts, human-wildlife conflicts have been a major challenge in recent years. The lack of detailed information on the spatial and temporal patterns of human-wildlife conflicts at the national level impedes the development of effective conflict mitigation plans. We examined patterns of human injury and death caused by large mammals using data from attack events and their spatiotemporal dimensions collected from a national survey of data available in Nepal over five years (2010-2014). Data were analyzed using logistic regression and chi-square or Fisher's exact tests. The results show that Asiatic elephants and common leopards are most commonly involved in attacks on people in terms of attack frequency and fatalities. Although one-horned rhinoceros and bears had a higher frequency of attacks than Bengal tigers, tigers caused more fatalities than each of these two species. Attacks by elephants peaked in winter and most frequently occurred outside protected areas in human settlements. Leopard attacks occurred almost entirely outside protected areas, and a significantly greater number of attacks occurred in human settlements. Attacks by one-horned rhinoceros and tigers were higher in the winter, mainly in forests inside protected areas; similarly, attacks by bears occurred mostly within protected areas. We found that human settlements are increasingly becoming conflict hotspots, with burgeoning incidents involving elephants and leopards. We conclude that species-specific conservation strategies are urgently needed, particularly for leopards and elephants. The implications of our findings for minimizing conflicts and conserving these imperiled species are discussed.	[Acharya, Krishna Prasad] Govt Nepal, Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal; [Paudel, Prakash Kumar] Nepal Acad Sci & Technol, POB 3323, Khumaltar, Lalitpur, Nepal; [Acharya, Krishna Prasad; Neupane, Prem Raj; Koehl, Michael] Univ Hamburg, World Forestry, Leuschnerstr 91, D-21031 Hamburg, Germany; [Neupane, Prem Raj] Friends Nat, Kathmandu, Nepal	Nepal Academy of Science & Technology (NAST); University of Hamburg	Acharya, KP (corresponding author), Govt Nepal, Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal.; Acharya, KP (corresponding author), Univ Hamburg, World Forestry, Leuschnerstr 91, D-21031 Hamburg, Germany.	kpacharya1@hotmail.com	Puadel, Prakash K/J-5094-2014	Puadel, Prakash K/0000-0001-5583-7615				Acharya K, 2016, AN ASSESSMENT OF ZER; Acharya KP, 2002, INT FOREST REV, V4, P149, DOI 10.1505/IFOR.4.2.149.17447; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Aryal A, 2016, ETHOL ECOL EVOL, V28, P117, DOI 10.1080/03949370.2014.1002115; Bagchi S, 2003, J ZOOL, V260, P285, DOI 10.1017/S0952836903003765; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Choudhury Anwaruddin, 2004, Human Dimensions of Wildlife, V9, P261, DOI 10.1080/10871200490505693; Constant NL, 2015, BIODIVERS CONSERV, V24, P2967, DOI 10.1007/s10531-015-0989-2; DHM, 2015, ANNUAL WEATHER SUMMA; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Distefano E., 2015, HUMAN WILDLIFE CONFL; Dowie M., 2011, CONSERVATION REFUGEE; Dunham KM, 2010, ORYX, V44, P185, DOI 10.1017/S003060530999086X; Dutta AK, 1991, THE GREAT INDIAN ONE; FAO, 1999, COUNTRY REPORT; GoN/ MoFSC, 2007, THE ELEPHANT CONSERV; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Heinen JT, 2015, CONSERV SCI, V3; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jnawali Sit, 1989, PARK PEOPLE CONFLICT; Jnawali SR, 2011, THE STATUS OF NEPALS; Kabir M, 2014, EUR J WILDLIFE RES, V60, P291, DOI 10.1007/s10344-013-0782-z; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; LAURIE A, 1982, J ZOOL, V196, P307; Madhusudan MD, 2003, ENVIRON MANAGE, V31, P466, DOI 10.1007/s00267-002-2790-8; Mikkola K., 2002, COMMUNITY FORESTRYS; MOFSC, 2015, STRATEGY AND ACTION; Murphy ST, 2013, ORYX, V47, P361, DOI 10.1017/S003060531200124X; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Pandey P, 2016, EUR J WILDLIFE RES, V62, P103, DOI 10.1007/s10344-015-0978-5; Pant G, 2016, ORYX, V50, P724, DOI 10.1017/S0030605315000381; Parker GE, 2006, ORYX, V40, P343, DOI 10.1017/S0030605306000822; Paudel PK, 2015, GEOFORUM, V64, P192, DOI 10.1016/j.geoforum.2015.06.021; Paudel PK, 2015, APPL GEOGR, V56, P127, DOI 10.1016/j.apgeog.2014.11.018; Paudel Prakash Kumar, 2012, P1; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Primack RB, 2013, CONSERVATION BIOL; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; Santiapillai C, 1990, THE ASIAN ELEPHANT A; Sillero-Zubiri C., 2007, KEY TOPICS CONSERVAT, P266; Stattersfield A., 1998, ENDEMIC BIRD AREAS O; Steinheim G, 2005, J ZOOL, V265, P377, DOI 10.1017/S0952836905006448; Stoen OG, 1996, MAMMALIA, V60, P363; Subedi N, 2013, ORYX, V47, P352, DOI 10.1017/S0030605313000562; Sukumar R, 1992, THE ASIAN ELEPHANT E; Sukumar R., 2003, THE LIVING ELEPHANTS, V85, P581, DOI [10.1644/1545-1542(2004)0852.0.CO;2, DOI 10.1644/1545-1542(2004)0852.0.CO;2]; Thapa K., 2015, ETHOL ECOL EVOL, P1; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2014, SCIENCE, V344, P475, DOI 10.1126/science.1252690; White PCL, 2010, WILDLIFE RES, V37, P623, DOI 10.1071/WR10191; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wilson S, 2015, ORYX, V49, P140, DOI 10.1017/S0030605313000513; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P388; Zhang L, 2003, BIOL CONSERV, V112, P453, DOI 10.1016/S0006-3207(02)00335-X	63	88	95	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161717	10.1371/journal.pone.0161717	http://dx.doi.org/10.1371/journal.pone.0161717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612174	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900027
J	Laqmani, A; Kurfurst, M; Butscheidt, S; Sehner, S; Schmidt-Holtz, J; Behzadi, C; Nagel, HD; Adam, G; Regier, M				Laqmani, Azien; Kurfuerst, Maximillian; Butscheidt, Sebastian; Sehner, Susanne; Schmidt-Holtz, Jakob; Behzadi, Cyrus; Nagel, Hans Dieter; Adam, Gerhard; Regier, Marc			CT Pulmonary Angiography at Reduced Radiation Exposure and Contrast Material Volume Using Iterative Model Reconstruction and iDose(4) Technique in Comparison to FBP	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; IMPROVED IMAGE QUALITY; CHEST CT; INDUCED NEPHROTOXICITY; DIAGNOSTIC-ACCURACY; CLINICAL-TRIAL; 80 KVP; EMBOLISM; REDUCTION	Purpose To assess image quality of CT pulmonary angiography (CTPA) at reduced radiation exposure (RD-CTPA) and contrast medium (CM) volume using two different iterative reconstruction (IR) algorithms (iDose(4) and iterative model reconstruction (IMR)) in comparison to filtered back projection (FBP). Materials and Methods 52 patients (body weight < 100 kg, mean BMI: 23.9) with suspected pulmonary embolism (PE) underwent RD-CTPA (tube voltage: 80 kV; mean CTDIvol: 1.9 mGy) using 40 ml CM. Data were reconstructed using FBP and two different IR algorithms (iDose(4) and IMR). Subjective and objective image quality and conspicuity of PE were assessed in central, segmental, and subsegmental arteries. Results Noise reduction of 55% was achieved with iDose(4) and of 85% with IMR compared to FBP. Contrast-to-noise ratio significantly increased with iDose(4) and IMR compared to FBP (p<0.05). Subjective image quality was rated significantly higher at IMR reconstructions in comparison to iDose(4) and FBP. Conspicuity of central and segmental PE significantly improved with the use of IMR. In subsegmental arteries, iDose(4) was superior to IMR. Conclusion CTPA at reduced radiation exposure and contrast medium volume is feasible with the use of IMR, which provides improved image quality and conspicuity of pulmonary embolism in central and segmental arteries.	[Laqmani, Azien; Kurfuerst, Maximillian; Butscheidt, Sebastian; Schmidt-Holtz, Jakob; Behzadi, Cyrus; Adam, Gerhard; Regier, Marc] Univ Med Ctr Hamburg Eppendorf, Dept Intervent & Diagnost Radiol & Nucl Med, Hamburg, Germany; [Sehner, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Laqmani, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Intervent & Diagnost Radiol & Nucl Med, Hamburg, Germany.	a.laqmani@uke.de	Regier, Marc/G-8781-2018; Regier, Marc/W-5427-2019					Apfaltrer P, 2014, EUR J RADIOL, V83, P322, DOI 10.1016/j.ejrad.2013.11.005; Buhk JH, 2013, ROFO-FORTSCHR RONTG, V185, P741, DOI 10.1055/s-0033-1335937; Costello JE, 2013, AM J ROENTGENOL, V201, P1283, DOI 10.2214/AJR.12.9720; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Haage P, 2000, AM J ROENTGENOL, V174, P1049, DOI 10.2214/ajr.174.4.1741049; Henes FOG, 2012, J THORAC IMAG, V27, P113, DOI 10.1097/RTI.0b013e31820b8696; Holmquist F, 2009, ACTA RADIOL, V50, P181, DOI 10.1080/02841850802657269; Jones SE, 2005, RADIOLOGY, V237, P329, DOI 10.1148/radiol.2371041520; Kalra MK, 2015, RADIOGRAPHICS, V35, P1706, DOI 10.1148/rg.2015150118; Kalra MK, 2013, AM J ROENTGENOL, V201, pW235, DOI 10.2214/AJR.12.9569; Katzberg RW, 2010, RADIOLOGY, V256, P21, DOI 10.1148/radiol.10092000; Khawaja RDA, 2014, J COMPUT ASSIST TOMO, V38, P613, DOI 10.1097/RCT.0000000000000087; Kim MJ, 2009, J COMPUT ASSIST TOMO, V33, P416, DOI 10.1097/RCT.0b013e318181fab5; Laqmani A, 2016, EUR RADIOL, V26, P216, DOI 10.1007/s00330-015-3810-4; Laqmani A, 2014, EUR J RADIOL, V83, P1962, DOI 10.1016/j.ejrad.2014.06.016; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Lell MM, 2015, INVEST RADIOL, V50, P161, DOI 10.1097/RLI.0000000000000119; Lu GM, 2014, EUR RADIOL, V24, P3260, DOI 10.1007/s00330-014-3365-9; Mayo-Smith WW, 2014, RADIOLOGY, V273, P657, DOI 10.1148/radiol.14132328; McCollough CH, 2008, HEALTH PHYS, V95, P508, DOI 10.1097/01.HP.0000326343.35884.03; Mehta D, 2011, EPOS, DOI [10.1594/ecr2011/C-1938, DOI 10.1594/ECR2011/C-1938, 10.1594/ecr2011/C-1938.2011]; Mehta D., 2013, MED PHYS INT, V1, P147; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; Padole A, 2014, AM J ROENTGENOL, V203, P772, DOI 10.2214/AJR.13.12312; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; Safriel Y, 2002, CLIN IMAG, V26, P101, DOI 10.1016/S0899-7071(01)00366-7; Singh T, 2011, J MED IMAG RADIAT ON, V55, P143, DOI 10.1111/j.1754-9485.2011.02243.x; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Szucs-Farkas Z, 2014, INVEST RADIOL, V49, P201, DOI 10.1097/RLI.0000000000000016; Szucs-Farkas Z, 2011, AM J ROENTGENOL, V197, pW852, DOI 10.2214/AJR.11.6750; Szucs-Farkas Z, 2009, INVEST RADIOL, V44, P793, DOI 10.1097/RLI.0b013e3181bfe230; Szucs-Farkas Z, 2008, INVEST RADIOL, V43, P871, DOI 10.1097/RLI.0b013e3181875e86; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744; You SY, 2007, J COMPUT ASSIST TOMO, V31, P677, DOI 10.1097/RCT.0b013e318038d8fb; Yuki H, 2015, ACTA RADIOL; Yuki H, 2014, J CARDIOVASC COMPUT, V8, P115, DOI 10.1016/j.jcct.2013.12.010; Zhang F, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150766	43	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162429	10.1371/journal.pone.0162429	http://dx.doi.org/10.1371/journal.pone.0162429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611448				2022-12-27	WOS:000383255900098
J	Pankhurst, MW; Clark, CA; Zarek, J; Laskin, CA; McLennan, IS				Pankhurst, Michael W.; Clark, Christine A.; Zarek, Judith; Laskin, Carl A.; McLennan, Ian S.			Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study	PLOS ONE			English	Article							ANTI-MULLERIAN-HORMONE; INHIBITING SUBSTANCE; ANTIMULLERIAN HORMONE; MLLERIAN HORMONE; VOLUME EXPANSION; HUMAN BLOOD; VITAMIN-D; SERUM; ESTRADIOL; PRECURSOR	Circulating Anti-Mullerian hormone (AMH) is derived from the gonads, and is a mixture of the prohormone(proAMH), which does not bind to AMH receptors, and receptor-competent AMH. The functions of a hormone are partially defined by the factors that control its levels. Ovarian reserve accounts for 55 similar to 75% of the woman-to-woman variation in AMH level, leaving over 25% of the biological variation to be explained. Pregnancy has been reported to decrease circulating AMH levels, but the observations are inconsistent, with the effect of pregnancy on the bioactivity of AMH being unknown. We have therefore undertaken a longitudinal study of circulating proAMH and total AMH during pregnancy. Serum samples were drawn at 6-8 gestational time-points (first trimester to post-partum) from 25 healthy women with prior uneventful pregnancies. The total AMH and proAMH levels were measured at each time-point using ELISA. The level of circulating total AMH progressively decreased during pregnancy, in all women (p<0.001). On average, the percentage decline between the first trimester and 36-39 weeks' gestation was 61.5%, with a standard deviation of 13.0% (range 30.4-81.2%). The percentage decline in total AMH levels associated with maternal age (R = -0.53, p = 0.024), but not with the women's first trimester AMH level. The postpartum total AMH levels showed no consistent relationship to the woman's first trimester values (range 31-273%). This raises the possibility that a fundamental determinant of circulating AMH levels is reset during pregnancy. The ratio of proAMH to total AMH levels exhibited little or no variation during pregnancy, indicating that the control of the cleavage/activation of AMH is distinct from the mechanisms that control the total level of AMH.	[Pankhurst, Michael W.; McLennan, Ian S.] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Clark, Christine A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Clark, Christine A.; Zarek, Judith; Laskin, Carl A.] LifeQuest Ctr Reprod Med, Toronto, ON, Canada; [Zarek, Judith] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON, Canada	University of Otago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McLennan, IS (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.	ian.mclennan@otago.ac.nz	Pankhurst, Michael/F-2585-2017	Pankhurst, Michael/0000-0002-0976-5742	Health Research Council New Zealand [14-441]	Health Research Council New Zealand(Health Research Council of New Zealand)	This study was funded by the Health Research Council New Zealand (www.hrc.govt.nz/, 14-441 to ISM, MWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2005, CLIN ENDOCRINOL, V63, P267, DOI 10.1111/j.1365-2265.2005.02336.x; Bentzen JG, 2013, J CLIN ENDOCR METAB, V98, P1602, DOI 10.1210/jc.2012-1829; DEKEL N, 1977, INT J FERTIL, V22, P24; Dennis NA, 2012, J CLIN ENDOCR METAB, V97, P2450, DOI 10.1210/jc.2012-1213; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P1720, DOI 10.1158/1055-9965.EPI-07-0311; Gerli S, 2015, ENDOCRINE, V50, P250, DOI 10.1007/s12020-014-0515-4; GOVAN ADT, 1968, J ENDOCRINOL, V40, P421, DOI 10.1677/joe.0.0400421; GOVAN ADT, 1970, J ENDOCRINOL, V48, P235, DOI 10.1677/joe.0.0480235; Griesinger G, 2012, J CLIN ENDOCR METAB, V97, P2160, DOI 10.1210/jc.2012-1070; Grynberg M, 2012, J CLIN ENDOCR METAB, V97, pE1649, DOI 10.1210/jc.2011-3133; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; Irani M, 2014, FERTIL STERIL, V102, P460, DOI 10.1016/j.fertnstert.2014.04.046; Jeppesen JV, 2013, MOL HUM REPROD, V19, P519, DOI 10.1093/molehr/gat024; Kissell KA, 2014, HUM REPROD, V29, P1764, DOI 10.1093/humrep/deu142; Koninger A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-60; Kumar A, 2010, J IMMUNOL METHODS, V362, P51, DOI 10.1016/j.jim.2010.08.011; La Marca A, 2005, HUM REPROD, V20, P1569, DOI 10.1093/humrep/deh819; La Marca A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/959487; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; Lockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402; Lockwood GM, 1998, HUM REPROD UPDATE, V4, P284, DOI 10.1093/humupd/4.3.284; Lutterodt M, 2009, REPROD BIOMED ONLINE, V18, P694, DOI 10.1016/S1472-6483(10)60016-8; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McLennan IS, 2015, J ENDOCRINOL, V226, pR45, DOI 10.1530/JOE-15-0206; McNeilly AS, 1997, J MAMMARY GLAND BIOL, V2, P291, DOI 10.1023/A:1026340606252; Namkung J, 2012, J CLIN ENDOCR METAB, V97, P3224, DOI 10.1210/jc.2012-1538; Nelson SM, 2010, FERTIL STERIL, V93, P1356, DOI 10.1016/j.fertnstert.2009.07.1676; Novembri R, 2015, PLACENTA, V36, P731, DOI 10.1016/j.placenta.2015.04.009; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Pankhurst MW, 2016, FERTIL STERIL, V106, P1238, DOI 10.1016/j.fertnstert.2016.06.010; Pankhurst MW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12783; Pankhurst MW, 2016, ENDOCRINOLOGY, V157, P1622, DOI 10.1210/en.2015-1834; Pankhurst MW, 2016, MOL CELL ENDOCRINOL, V419, P165, DOI 10.1016/j.mce.2015.10.013; Pankhurst MW, 2014, FERTIL STERIL, V101, P846, DOI 10.1016/j.fertnstert.2013.12.009; Pankhurst MW, 2013, AM J PHYSIOL-ENDOC M, V305, pE1241, DOI 10.1152/ajpendo.00395.2013; Pfennig F, 2015, GEN COMP ENDOCR, V223, P87, DOI 10.1016/j.ygcen.2015.09.025; PIVARNIK JM, 1994, OBSTET GYNECOL, V83, P265; Segev DL, 2000, J BIOL CHEM, V275, P28371, DOI 10.1074/jbc.M004554200; SHORT RV, 1993, ANN MED, V25, P175, DOI 10.3109/07853899309164164; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; STARUP J, 1974, ACTA OBSTET GYN SCAN, V53, P211, DOI 10.3109/00016347409162159; Vanky E, 2012, FERTIL STERIL, V97, P509, DOI 10.1016/j.fertnstert.2011.11.021; Wang J, 2009, FERTIL STERIL, V91, P1195, DOI 10.1016/j.fertnstert.2008.01.028; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; Whittaker PG, 1996, OBSTET GYNECOL, V88, P33, DOI 10.1016/0029-7844(96)00095-6	54	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162509	10.1371/journal.pone.0162509	http://dx.doi.org/10.1371/journal.pone.0162509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612037	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900118
J	Scharnweber, K; Strandberg, U; Karlsson, K; Eklov, P				Scharnweber, Kristin; Strandberg, Ursula; Karlsson, Konrad; Eklov, Peter			Decrease of Population Divergence in Eurasian Perch (Perca fluviatilis) in Browning Waters: Role of Fatty Acids and Foraging Efficiency	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; FRESH-WATER; HERBIVOROUS ZOOPLANKTON; ECOLOGICAL SPECIATION; FISH COMMUNITIES; LIPID-METABOLISM; LAKES; SESTON; LIMITATION; SELECTION	Due to altered biogeochemical processes related to climate change, highly colored dissolved organic carbon (DOC) from terrestrial sources will lead to a water "brownification" in many freshwater systems of the Northern Hemisphere. This will create deteriorated visual conditions that have been found to affect habitat-specific morphological variations in Eurasian perch (Perca fluviatilis) in a previous study. So far, potential drivers and ultimate causes of these findings have not been identified. We conducted a field study to investigate the connection between morphological divergence and polyunsaturated fatty acid (PUFA) composition of perch from six lakes across a gradient of DOC concentration. We expected a decrease in the prevalence of PUFAs, which are important for perch growth and divergence with increasing DOC concentrations, due to the restructuring effects of DOC on aquatic food webs. In general, rate of morphological divergence in perch decreased with increasing DOC concentrations. Proportions of specific PUFAs (22:6n-3, 18:3n-3, 20:5n-3, and 20:4n-6) identified to primarily contribute to overall differences between perch caught in clear and brown-water lakes tended to be connected to overall decline of morphological divergence. However, no overall significant relationship was found, indicating no severe limitation of essential fatty acids for perch inhabiting brown water lakes. We further broaden our approach by conducting a laboratory experiment on foraging efficiency of perch. Therefore, we induced pelagic and littoral phenotypes by differences in habitat-structure and feeding mode and recorded attack rate in a feeding experiment. Generally, fish were less efficient in foraging on littoral prey (Ephemeroptera) when visual conditions were degraded by brown water color. We concluded that browning water may have a strong effect on the forager's ability to find particular food resources, resulting in the reduced development of evolutionary traits, such as habitat-specific morphological divergence.	[Scharnweber, Kristin; Eklov, Peter] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Strandberg, Ursula] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Karlsson, Konrad] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden	Uppsala University; University of Eastern Finland; Stockholm University	Scharnweber, K (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden.	kristin.scharnweber@ebc.uu.se			Swedish Research Council Formas; Swedish Research Council VR; Academy of Finland [263350]; German Academic Exchange Service (DAAD); Olsson Borghs Stifelse	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); Academy of Finland(Academy of Finland); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Olsson Borghs Stifelse	Financial support came from the Swedish Research Council Formas, and the Swedish Research Council VR to PE, the Academy of Finland (grant number 263350) to US, and the German Academic Exchange Service (DAAD), and Olsson Borghs Stifelse to KS.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Ask J, 2009, LIMNOL OCEANOGR, V54, P2034, DOI 10.4319/lo.2009.54.6.2034; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; Bartels P, 2016, ECOSYSTEMS, V19, P955, DOI 10.1007/s10021-016-9978-x; Bartels P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043641; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell JG, 2003, AQUACULTURE, V218, P491, DOI 10.1016/S0044-8486(02)00370-8; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brothers S, 2014, LIMNOL OCEANOGR, V59, P1388, DOI 10.4319/lo.2014.59.4.1388; Craig N, 2015, LIMNOL OCEANOGR, V60, P2079, DOI 10.1002/lno.10153; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; EKLOV P, 1992, ANIM BEHAV, V44, P313, DOI 10.1016/0003-3472(92)90037-A; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Faithfull CL, 2011, LIMNOL OCEANOGR, V56, P1703, DOI 10.4319/lo.2011.56.5.1703; Finstad AG, 2014, ECOL LETT, V17, P36, DOI 10.1111/ele.12201; FREDRICKSON HL, 1986, FEMS MICROBIOL ECOL, V38, P381, DOI 10.1111/j.1574-6968.1986.tb01751.x; Frost PC, 2003, J N AM BENTHOL SOC, V22, P51, DOI 10.2307/1467977; Galloway AWE, 2014, FRESHWATER BIOL, V59, P1902, DOI 10.1111/fwb.12394; Gutseit K, 2007, FRESHWATER BIOL, V52, P28, DOI 10.1111/j.1365-2427.2006.01668.x; Happel A, 2015, J GREAT LAKES RES, V41, P172, DOI 10.1016/j.jglr.2015.03.025; Heintz RA, 2004, T AM FISH SOC, V133, P559, DOI 10.1577/T03-035.1; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hilt S, 2013, FRESHWATER BIOL, V58, P2027, DOI 10.1111/fwb.12188; Hiltunen M, 2015, LIMNOL OCEANOGR, V60, P303, DOI 10.1002/lno.10028; JONES RI, 1992, HYDROBIOLOGIA, V229, P73, DOI 10.1007/BF00006992; Jonsson M, 2013, CAN J FISH AQUAT SCI, V70, P1685, DOI 10.1139/cjfas-2013-0150; Karlsson J, 2015, ECOLOGY, V96, P2870, DOI 10.1890/15-0515.1; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Keller W, 2006, ENVIRON MONIT ASSESS, V115, P419, DOI 10.1007/s10661-006-7237-x; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lau DCP, 2013, LIMNOL OCEANOGR, V58, P1149, DOI 10.4319/lo.2013.58.4.1149; Lau DCP, 2012, FRESHWATER BIOL, V57, P24, DOI 10.1111/j.1365-2427.2011.02690.x; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; Lepisto L, 1998, HYDROBIOLOGIA, V370, P89, DOI 10.1023/A:1017014330045; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Mirman D., 2016, CROWTH CURVE ANAL VI; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Muller-Navarra DC, 2006, ARCH HYDROBIOL, V167, P501, DOI 10.1127/0003-9136/2006/0167-0501; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Murray DS, 2014, AQUACULTURE, V431, P85, DOI 10.1016/j.aquaculture.2014.03.039; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Olsson J, 2005, EVOL ECOL RES, V7, P1109; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parrish CC, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P4; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; PERSSON L, 1986, ECOLOGY, V67, P355, DOI 10.2307/1938578; Petrisic MG, 2013, GEOMICROBIOL J, V30, P291, DOI 10.1080/01490451.2012.688789; Puebla O, 2009, J FISH BIOL, V75, P960, DOI 10.1111/j.1095-8649.2009.02358.x; R Core Team, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ranaker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102002; Ranaker L, 2012, FRESHWATER BIOL, V57, P1761, DOI 10.1111/j.1365-2427.2012.02836.x; Ravet JL, 2010, ECOLOGY, V91, P180, DOI 10.1890/08-2037.1; Rengefors K, 2012, HARMFUL ALGAE, V18, P65, DOI 10.1016/j.hal.2012.04.005; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Scharnweber K, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1387; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Schindler DE, 2008, ALGAL BOWL OVERFERTI, DOI [10.1111/fwb.12188, DOI 10.1111/FWB.12188]; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Shoup DE, 2009, T AM FISH SOC, V138, P1018, DOI 10.1577/T09-015.1; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Solomon CT, 2015, ECOSYSTEMS, V18, P376, DOI 10.1007/s10021-015-9848-y; Stasko AD, 2012, ENVIRON REV, V20, P173, DOI [10.1139/A2012-010, 10.1139/a2012-010]; Strandberg U, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00382.1; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Volk C, 2012, AQUAT ECOL, V46, P85, DOI 10.1007/s10452-011-9383-7; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Vrede T, 2011, OIKOS, V120, P886, DOI 10.1111/j.1600-0706.2010.18939.x; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Xu XL, 2002, LIPIDS, V37, P297, DOI 10.1007/s11745-002-0894-2; YANG XW, 1994, CAN J FISH AQUAT SCI, V51, P1391, DOI 10.1139/f94-139; Zhang J, 2010, LIMNOL OCEANOGR, V55, P30, DOI 10.4319/lo.2010.55.1.0030	87	7	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162470	10.1371/journal.pone.0162470	http://dx.doi.org/10.1371/journal.pone.0162470			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610617	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900107
J	Treloar, C; McCredie, L; Lloyd, AR				Treloar, Carla; McCredie, Luke; Lloyd, Andrew R.			The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?	PLOS ONE			English	Article							HEPATITIS-C; EXCHANGE; MAINTENANCE; PREVALENCE; INJECTION; PROGRAMS; PEOPLE	Aim A formal Needle and Syringe Program (NSP) is not provided in Australian prisons. Injecting equipment circulates in prisons as part of an informal and illegal economy. This paper examined how this economy generates blood-borne virus (BBV) risk and risk mitigation opportunities for inmates. Method The HITS-p cohort recruited New South Wales inmates who had reported ever injecting drugs and who had a negative HCV serological test within 12 months prior to enrolment. For this study, qualitative interviews were conducted with 30 participants enrolled in HITS-p. Participants included 10 women and were incarcerated in 12 prisons. Results A needle/syringewas nominated as being typically priced in the 'inside' prison economy at $100-$150, with a range of $50-$350. Purchase or hire of equipment was paid for in cash (including transactions that occurred outside prison) and in exchange for drugs and other commodities. A range of other resources was required to enable successful needle/syringe economies, especially relationships with visitors and other prisoners, and violence to ensure payment of debts. Strategies to mitigate BBV risk included retaining one needle/syringe for personal use while hiring out others, keeping drug use (and ownership of equipment) "quiet", stealing used equipment from the prison health clinic, and manufacture of syringes from other items available in the prison. Conclusions The provision of prison NSP would disrupt the inside economies built around contraband needles/syringes, as well as minimise BBV risk. However, any model of prison NSP should	[Treloar, Carla] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [McCredie, Luke; Lloyd, Andrew R.] UNSW Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Treloar, C (corresponding author), UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia.	c.treloar@unsw.edu.au	Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Treloar, Carla/0000-0002-8230-0386	National Health and Medical Research Council [APP1016351]; NSW Health; NHMRC Fellowship [APP1043067]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NSW Health; NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council (APP1016351) and NSW Health. The funders had no direct role in the conduct of this research or the presentation of findings. ARL is supported by NHMRC Fellowship (APP1043067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Scott LK, 2014, INT J PUBLIC HEALTH, V59, P3, DOI 10.1007/s00038-013-0526-6; Boelen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100749; Bonnycastle KD, 2011, HOWARD J CRIM JUSTIC, V50, P17; Bonnycastle KD, 2011, PRISON J, V91, P325, DOI 10.1177/0032885511409893; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bretana N, 2015, EMERG INFECT DIS, V21; Butler T, 2015, REPORT 2004 2010 201; Cooke DJ, 2008, CRIM JUSTICE BEHAV, V35, P1065, DOI 10.1177/0093854808318867; Copes H, 2010, VICTIMS OFFENDERS, V6, P1, DOI 10.1080/15564886.2011.534005; Crewe B., 2006, HOWARD J CRIM JUST, V45, P347, DOI [DOI 10.1111/j.1468-2311.2006.00428.x, 10.1111/j.1468-2311.2006.00428.x, DOI 10.1111/J.1468-2311.2006.00428.X]; de Viggiani N, 2007, SOCIOL HEALTH ILL, V29, P115, DOI 10.1111/j.1467-9566.2007.00474.x; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Dolan K, 2010, EUROPEAN J EPIDEMIOL; Dolan KA, 1998, DRUG ALCOHOL REV, V17, P153, DOI 10.1080/09595239800186951; Fetherston J, 2013, J SUBST USE, V18, P65, DOI 10.3109/14659891.2012.760008; Hughes R, 2003, J OFFENDER REHABIL, V37, P47, DOI [10.1300/J076v37n03_03, DOI 10.1300/J076V37N03_03]; Hughes RA, 2000, EUR ADDICT RES, V6, P20, DOI 10.1159/000019005; Kalinich D, 1987, J CRIME JUSTICE, V10, P1; KALINICH DB, 1985, CRIM JUSTICE BEHAV, V12, P435, DOI 10.1177/0093854885012004003; Lankenau Stephen E, 2001, Prison J, V81, P142; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Levy MH, 2012, MED J AUSTRALIA, V197, P382, DOI 10.5694/mja12.10228; Lines R, 2005, INT J PRISON HEALTH, V1, P49, DOI 10.1080/17449200500157085; Luciani F, 2014, ADDICTION, V109, P1695, DOI 10.1111/add.12643; Mjaland K, 2014, PUNISHM SOC, V16, P336, DOI 10.1177/1462474514527149; Nathani J, 2010, DRUG ALCOHOL REV, V29, P413, DOI 10.1111/j.1465-3362.2009.00165.x; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Sarang A, 2010, SUBST USE MISUSE, V45, P813, DOI 10.3109/10826081003590938; Stafford J, 2016, FINDINGS ILLICIT DRU; Stover H, 2016, DRUG-EDUC PREV POLIC, V23, P103, DOI 10.3109/09687637.2016.1148117; Stover H., 2003, International Journal of Drug Policy, V14, P437, DOI 10.1016/j.drugpo.2003.08.001; Tompkins CNE, 2016, DRUG-EDUC PREV POLIC, V23, P144, DOI 10.3109/09687637.2015.1085490; Tompkins CNE, 2013, INT J PRISON HEALTH, V9, P68, DOI 10.1108/17449201311326943; Treloar C, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0045-2; UNODC, 2015, HDB START MAN NEEDL; WELLFORD C, 1967, J CRIM LAW CRIMINOL, V58, P197, DOI 10.2307/1140837; Wright NMJ, 2015, INT J PRISON HEALTH, V11, P17, DOI 10.1108/IJPH-09-2014-0032	39	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162399	10.1371/journal.pone.0162399	http://dx.doi.org/10.1371/journal.pone.0162399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611849	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900089
J	Wendling, RJ; Christensen, AM; Quast, AD; Atzet, SK; Mann, BK				Wendling, Rian J.; Christensen, Amanda M.; Quast, Arthur D.; Atzet, Sarah K.; Mann, Brenda K.			Effect of Carboxymethylation on the Rheological Properties of Hyaluronan	PLOS ONE			English	Article							SODIUM HYALURONATE; ACID; OSTEOARTHRITIS; SUBSTITUTION; HYDROGELS; EFFICACY; STARCH; SAFETY; WATER; KNEE	Chemical modifications made to hyaluronan to enable covalent crosslinking to forma hydrogel or to attach other molecules may alter the physical properties as well, which have physiological importance. Here we created carboxymethyl hyaluronan (CMHA) with varied degree of modification and investigated the effect on the viscosity of CMHA solutions. Viscosity decreased initially as modification increased, with a minimum viscosity for about 3040% modification. This was followed by an increase in viscosity around 45-50% modification. The pH of the solution had a variable effect on viscosity, depending on the degree of carboxymethyl modification and buffer. The presence of phosphates in the buffer led to decreased viscosity. We also compared large-scale production lots of CMHA to lab-scale and found that large-scale required extended reaction times to achieve the same degree of modification. Finally, thiolated CMHA was disulfide crosslinked to create hydrogels with increased viscosity and shear-thinning aspects compared to CMHA solutions.	[Wendling, Rian J.; Mann, Brenda K.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Christensen, Amanda M.; Atzet, Sarah K.; Mann, Brenda K.] SentrX Anim Care Inc, Salt Lake City, UT 84108 USA; [Quast, Arthur D.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Mann, BK (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Mann, BK (corresponding author), SentrX Anim Care Inc, Salt Lake City, UT 84108 USA.	bmann@eyegatepharma.com			University of Utah; SentrX Animal Care	University of Utah; SentrX Animal Care	RW was supported by an Undergraduate Research Opportunities Program award from the University of Utah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors received no specific funding for this work. SentrX Animal Care provided support in the form of salaries for authors AC, SKA, and BKM, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almond A, 2005, CARBOHYD RES, V340, P907, DOI 10.1016/j.carres.2005.01.014; Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195; Brandt FS, 2008, CLIN INTERV AGING, V3, P153; Brandt KD, 2001, CLIN ORTHOP RELAT R, P130; Calinescu C, 2007, INT J PHARMACEUT, V343, P18, DOI 10.1016/j.ijpharm.2007.04.017; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Choi JI, 2010, CARBOHYD POLYM, V79, P1080, DOI 10.1016/j.carbpol.2009.10.041; Choi KY, 2012, COLLOID SURFACE B, V99, P82, DOI 10.1016/j.colsurfb.2011.10.029; Fakhari A, 2013, ACTA BIOMATER, V9, P7081, DOI 10.1016/j.actbio.2013.03.005; Falcone SJ, 2006, J BIOMED MATER RES A, V76A, P721, DOI 10.1002/jbm.a.30623; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gatej L, 2005, BIOMACROMOLECULES, V6, P61, DOI 10.1021/bm040050m; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009; Juni P, 2007, ARTHRITIS RHEUM-US, V56, P3610, DOI 10.1002/art.23026; Kogan G., 2007, HYALURONIC ACID, V47, P393; Krause WE, 2001, BIOMACROMOLECULES, V2, P65, DOI 10.1021/bm0055798; Li H, 2004, BIOMACROMOLECULES, V5, P895, DOI 10.1021/bm034463j; Mann BK., 2012, INT J CELL BIOL; Pasqui D, 2012, POLYMERS-BASEL, V4, P1517, DOI 10.3390/polym4031517; Patil KP, 2011, J BIOSCI BIOENG, V111, P286, DOI 10.1016/j.jbiosc.2010.10.012; Petta D, 2016, FRONT BIOENG BIOT C, DOI [10.3389/conf.FBIOE.2016.01.01092, DOI 10.3389/CONF.FBIOE.2016.01.01092]; Prestwich GD, 2008, CURR PHARM BIOTECHNO, V9, P242, DOI 10.2174/138920108785161523; Reddy K.J., 2013, J BIOSCI BIOTECHNOL, V2, P173; Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019; Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j; Shi XW, 2006, J APPL POLYM SCI, V100, P4689, DOI 10.1002/app.23040; Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Stojanovic Z, 2005, STARCH-STARKE, V57, P79, DOI 10.1002/star.200400342; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Vanderhooft JL, 2007, BIOMACROMOLECULES, V8, P2883, DOI 10.1021/bm0703564; Wang J, 2005, J COLLOID INTERF SCI, V291, P75, DOI 10.1016/j.jcis.2005.04.095; Williams DL, 2013, INT J BIOMATER, V2013, DOI 10.1155/2013/460437; Williams DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099766; Yue W, 2012, CARBOHYD POLYM, V89, P709, DOI 10.1016/j.carbpol.2012.03.081	36	5	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162849	10.1371/journal.pone.0162849	http://dx.doi.org/10.1371/journal.pone.0162849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611817	Green Published, gold			2022-12-27	WOS:000383255900180
J	Johnson, AR; Caudill, CL; Tumbleston, JR; Bloomquist, CJ; Moga, KA; Ermoshkin, A; Shirvanyants, D; Mecham, SJ; Luft, JC; DeSimone, JM				Johnson, Ashley R.; Caudill, Cassie L.; Tumbleston, John R.; Bloomquist, Cameron J.; Moga, Katherine A.; Ermoshkin, Alexander; Shirvanyants, David; Mecham, Sue J.; Luft, J. Christopher; DeSimone, Joseph M.			Single-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface Production	PLOS ONE			English	Article							BIODEGRADABLE POLYMER MICRONEEDLES; DRUG; SKIN; DELIVERY; ENCAPSULATION; INSERTION; INSULIN; ARRAYS; FORCE; PAIN	Microneedles, arrays of micron-sized needles that painlessly puncture the skin, enable transdermal delivery of medications that are difficult to deliver using more traditional routes. Many important design parameters, such as microneedle size, shape, spacing, and composition, are known to influence efficacy, but are notoriously difficult to alter due to the complex nature of microfabrication techniques. Herein, we utilize a novel additive manufacturing ("3D printing") technique called Continuous Liquid Interface Production (CLIP) to rapidly prototype sharp microneedles with tuneable geometries (size, shape, aspect ratio, spacing). This technology allows for mold-independent, one-step manufacturing of microneedle arrays of virtually any design in less than 10 minutes per patch. Square pyramidal CLIP microneedles composed of trimethylolpropane triacrylate, polyacrylic acid and photopolymerizable derivatives of polyethylene glycol and polycaprolactone were fabricated to demonstrate the range of materials that can be utilized within this platform for encapsulating and controlling the release of therapeutics. These CLIP microneedles effectively pierced murine skin ex vivo and released the fluorescent drug surrogate rhodamine.	[Johnson, Ashley R.; DeSimone, Joseph M.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27514 USA; [Johnson, Ashley R.; DeSimone, Joseph M.] North Carolina State Univ, Chapel Hill, NC 27517 USA; [Caudill, Cassie L.; Bloomquist, Cameron J.; Luft, J. Christopher; DeSimone, Joseph M.] Univ N Carolina, Dept Mol Pharmaceut, Chapel Hill, NC 27510 USA; [Tumbleston, John R.; Ermoshkin, Alexander; Shirvanyants, David; DeSimone, Joseph M.] Carbon, Redwood City, CA 94063 USA; [Moga, Katherine A.; DeSimone, Joseph M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 28223 USA; [Mecham, Sue J.; DeSimone, Joseph M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Nanomed, Chapel Hill, NC 27514 USA; [DeSimone, Joseph M.] Univ N Carolina, Dept Chem & Biomol Engn, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	DeSimone, JM (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27514 USA.; DeSimone, JM (corresponding author), North Carolina State Univ, Chapel Hill, NC 27517 USA.; DeSimone, JM (corresponding author), Univ N Carolina, Dept Mol Pharmaceut, Chapel Hill, NC 27510 USA.; DeSimone, JM (corresponding author), Carbon, Redwood City, CA 94063 USA.; DeSimone, JM (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 28223 USA.; DeSimone, JM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Inst Nanomed, Chapel Hill, NC 27514 USA.; DeSimone, JM (corresponding author), Univ N Carolina, Dept Chem & Biomol Engn, Chapel Hill, NC 27599 USA.	desimone@email.unc.edu		Bloomquist, Cameron/0000-0003-0565-5586	Carbon, Inc.; Defense Threat Reduction Agency [HDTRA1-13-1-0045]; Carbon	Carbon, Inc.; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Carbon	Carbon, Inc. and the Defense Threat Reduction Agency (HDTRA1-13-1-0045) provided financial support of this research. JRT, AE, DS, and JMD are employees of Carbon, Inc. and aided in study design. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Defense Threat Reduction Agency (HDTRA1 -13-1-0045) and Carbon for supporting this research. Bob Pinschmidt, Rima Janusziewicz and Adam Quintanilla are acknowledged for their contributions to useful scientific discussions.	Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Chu LY, 2011, J CONTROL RELEASE, V149, P242, DOI 10.1016/j.jconrel.2010.10.033; Chu LY, 2010, J PHARM SCI-US, V99, P4228, DOI 10.1002/jps.22140; Davis SP, 2005, IEEE T BIO-MED ENG, V52, P909, DOI 10.1109/TBME.2005.845240; Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010; DeMario MD, 1998, J CLIN ONCOL, V16, P2557, DOI 10.1200/JCO.1998.16.7.2557; Demir YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077289; DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/NMAT3550, 10.1038/nmat3550]; DeMuth PC, 2010, ADV MATER, V22, P4851, DOI 10.1002/adma.201001525; Donnelly RF, 2010, J CONTROL RELEASE, V147, P333, DOI 10.1016/j.jconrel.2010.08.008; Donnelly RF, 2010, DRUG DELIV, V17, P187, DOI 10.3109/10717541003667798; Fernando GJP, 2010, PLOS ONE; Gibson I, 2010, ADDITIVE MANUFACTURI, P70; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Gittard SD, 2010, EXPERT OPIN DRUG DEL, V7, P513, DOI 10.1517/17425241003628171; Haq MI, 2009, BIOMED MICRODEVICES, V11, P35, DOI 10.1007/s10544-008-9208-1; Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+; JANSEN H, 1995, J MICROMECH MICROENG, V5, P115, DOI 10.1088/0960-1317/5/2/015; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kochhar JS, 2013, J PHARM SCI-US, V102, P4100, DOI 10.1002/jps.23724; Kochhar JS, 2012, INT J NANOMED, V7, P3143, DOI 10.2147/IJN.S32000; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048; Lee K, 2012, BIOMATERIALS, V33, P7309, DOI 10.1016/j.biomaterials.2012.06.065; Ling MH, 2013, ACTA BIOMATER, V9, P8952, DOI 10.1016/j.actbio.2013.06.029; Moga KA, 2013, ADV MATER, V25, P5060, DOI 10.1002/adma.201300526; Mukerjee E, 2004, SENSOR ACTUAT A-PHYS, V114, P267, DOI 10.1016/j.sna.2003.11.008; Olatunji O, 2013, J PHARM SCI-US, V102, P1209, DOI 10.1002/jps.23439; Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002; Park JH, 2010, J KOREAN PHYS SOC, V56, P1223, DOI 10.3938/jkps.56.1223; Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Qiu YQ, 2008, J CONTROL RELEASE, V129, P144, DOI 10.1016/j.jconrel.2008.04.019; Romgens AM, 2014, J MECH BEHAV BIOMED, V40, P397, DOI 10.1016/j.jmbbm.2014.09.015; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Vecchione R, 2014, ADV FUNCT MATER, V24, P3515, DOI 10.1002/adfm.201303679; Verbaan FJ, 2008, J CONTROL RELEASE, V128, P80, DOI 10.1016/j.jconrel.2008.02.009; Wilke N, 2005, MICROELECTRON J, V36, P650, DOI 10.1016/j.mejo.2005.04.044; Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5; Zhou C, 2013, RAPID PROTOTYPING J, V19, P153, DOI 10.1108/13552541311312148	41	106	117	9	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162518	10.1371/journal.pone.0162518	http://dx.doi.org/10.1371/journal.pone.0162518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607247	Green Published, gold			2022-12-27	WOS:000383255600054
J	Maki, S				Maki, Syou			Magnetothermal Convection of Water with the Presence or Absence of a Magnetic Force Acting on the Susceptibility Gradient	PLOS ONE			English	Article							SUPERCONDUCTING MAGNET; ARCHIMEDES LEVITATION; PARAMAGNETIC FLUID; CRYSTAL-GROWTH; FIELD; SEPARATION; CRYSTALLIZATION; LYSOZYME; QUALITY; AIR	Heat transfer of magnetothermal convection with the presence or absence of the magnetic force acting on the susceptibility gradient (f(sc)) was examined by three-dimensional numerical computations. Thermal convection of water enclosed in a shallow cylindrical vessel (diameter over vessel height = 6.0) with the Rayleigh-Benard model was adopted as the model, under the conditions of Prandtl number 6.0 and Ra number 7000, respectively. The momentum equations of convection were nondimensionalized, which involved the term of f(sc) and the term of magnetic force acting on the magnetic field gradient (f(b)). All the computations resulted in axisymmetric steady rolls. The values of the averaged Nu, the averaged velocity components U, V, and W, and the isothermal distributions and flow patterns were almost completely the same, regardless of the presence or absence of the term of f(sc). As a result, we found that the effect of f(sc) was extremely small, although much previous research emphasized the effect with paramagnetic solutions under an unsteady state. The magnitude of f(sc) depends not only on magnetic conditions (magnitudes of magnetic susceptibility and magnetic flux density), but also on the thermal properties of the solution (thermal conductivity, thermal diffusivity, and viscosity). Therefore the effect of f(b) becomes dominant on the magnetothermal convection. Active control over the density gradient with temperature will be required to advance heat transfer with the effect of f(sc).	[Maki, Syou] Osaka Ohtani Univ, Fac Pharm, Lab Mol Chem, 3-11-1 Nishikiori Kita, Tondabayashi City, Osaka 5848540, Japan		Maki, S (corresponding author), Osaka Ohtani Univ, Fac Pharm, Lab Mol Chem, 3-11-1 Nishikiori Kita, Tondabayashi City, Osaka 5848540, Japan.	makisyo@osaka-ohtani.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [15K04669]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The author, S. Maki, received the following specific funding for this work. JSPS (Japan Society for the Promotion of Science) KAKENHI (Grant-in-Aid for Scientific Research) (C) (Grant number 15K04669).	Akamatsu M, 2003, NUMER HEAT TR A-APPL, V43, P9, DOI [10.1080/10407780307301, 10.1080/10407780390122547]; [Anonymous], 1986, CRC HDB PHYS; Astier JP, 1998, ACTA CRYSTALLOGR D, V54, P703, DOI 10.1107/S0907444997020052; Ataka M, 2002, ACTA CRYSTALLOGR D, V58, P1708, DOI 10.1107/S0907444902014415; BEAUGNON E, 1991, NATURE, V349, P470, DOI 10.1038/349470a0; Berry M. V., 1997, European Journal of Physics, V18, P307, DOI 10.1088/0143-0807/18/4/012; BRAITHWAITE D, 1991, NATURE, V354, P134, DOI 10.1038/354134a0; Bund A, 2005, J PHYS CHEM B, V109, P19845, DOI 10.1021/jp053341d; Catherall AT, 2003, NATURE, V422, P579, DOI 10.1038/422579a; Chandrasekhar C., 1961, HYDRODYNAMIC HYDROMA, P68; Chie K, 2003, J PHYS CHEM B, V107, P14374, DOI 10.1021/jp030688c; Coey JMD, 2007, J SOLID STATE ELECTR, V11, P711, DOI 10.1007/s10008-006-0254-4; Duan WY, 2005, J PHYS CHEM B, V109, P13445, DOI 10.1021/jp050469m; Faraday M., 1847, LONDON EDINBURGH DUB, V31, P401, DOI DOI 10.1080/14786444708645886; Filar P, 2006, J HEAT TRANS-T ASME, V128, P183, DOI 10.1115/1.2142334; Fujiwara Y, 2006, MOL PHYS, V104, P1659, DOI 10.1080/00268970600643556; Hayashi S, 2010, IEEE T APPL SUPERCON, V20, P945, DOI 10.1109/TASC.2010.2040161; HELLUMS JD, 1964, AICHE J, V10, P110, DOI 10.1002/aic.690100131; Hirt C. W., 1975, TECH REP; Holman J. P., 1992, HEAT TRANSFER, P663; Huang J, 1998, PHYS REV E, V57, P5564, DOI 10.1103/PhysRevE.57.5564; Kaneda M, 2002, J HEAT TRANS-T ASME, V124, P17, DOI 10.1115/1.1418369; Kimura T, 2000, CHEM LETT, P1294, DOI 10.1246/cl.2000.1294; Krause A, 2007, ELECTROCHIM ACTA, V52, P6338, DOI 10.1016/j.electacta.2007.04.054; Landau LD, 1960, ELECTRODYNAMICS CONT, V8, P142; Leventis N, 2005, J AM CHEM SOC, V127, P4988, DOI 10.1021/ja043169b; Leventis N, 2007, J SOLID STATE ELECTR, V11, P727, DOI 10.1007/s10008-006-0193-0; Lin SX, 2000, BIOCHEM BIOPH RES CO, V275, P274, DOI 10.1006/bbrc.2000.3294; Lopez-Alcaraz P, 2007, EUR PHYS J E, V24, P145, DOI 10.1140/epje/i2007-10225-1; Maki S, 2004, J CRYST GROWTH, V261, P557, DOI 10.1016/j.jcrysgro.2003.09.033; Maki S, 2002, J HEAT TRANS-T ASME, V124, P667, DOI 10.1115/1.1482082; Maki S, 2014, J FOOD ENG, V120, P31, DOI 10.1016/j.jfoodeng.2013.07.006; Maki S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.033402; Motokawa M, 1998, PHYSICA B, V256, P618, DOI 10.1016/S0921-4526(98)00583-3; Mutschke G, 2010, ELECTROCHIM ACTA, V55, P9060, DOI 10.1016/j.electacta.2010.08.046; Nishikawa K., 1992, HEAT TRANSFER, P457; OBrien RN, 1997, J APPL ELECTROCHEM, V27, P573, DOI 10.1023/A:1018402813235; Ozoe H, 1998, NUMER HEAT TR B-FUND, V33, P355, DOI 10.1080/10407799808915038; Poodt PWG, 2006, CRYST GROWTH DES, V6, P2275, DOI 10.1021/cg0600546; Rabah KL, 2004, J ELECTROANAL CHEM, V571, P85, DOI 10.1016/j.jelechem.2004.04.014; Tagawa T, 2002, INT J HEAT MASS TRAN, V45, P267, DOI 10.1016/S0017-9310(01)00149-1; Takayama T, 2004, PHYSICA B, V346, P272, DOI 10.1016/j.physb.2004.01.064; Tanimoto Y, 2001, INT J APPL ELECTROM, V14, P311; Tanimoto Y, 2005, ENV SCI, V18, P53; Udagawa C, 2014, J PHYS CHEM B, V118, P4889, DOI 10.1021/jp5015675; Uetake H, 1999, J APPL PHYS, V85, P5735, DOI 10.1063/1.370268; Uhlemann M, 2005, J ELECTROCHEM SOC, V152, pC817, DOI 10.1149/1.2073167; WAKAYAMA NI, 1993, COMBUST FLAME, V93, P207, DOI 10.1016/0010-2180(93)90103-A; Wakayama NI, 1997, J CRYST GROWTH, V178, P653, DOI 10.1016/S0022-0248(97)00149-8; Waskaas M, 1999, J PHYS CHEM B, V103, P4876, DOI 10.1021/jp984730t; Weier T, 2007, ELECTROCHEM COMMUN, V9, P2479, DOI 10.1016/j.elecom.2007.07.026; Yang YJ, 2003, LANGMUIR, V19, P9446, DOI 10.1021/la0345688; Yin DC, 2004, J CRYST GROWTH, V270, P184, DOI 10.1016/j.jcrysgro.2004.05.106; Yokoi H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1861394	54	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0160090	10.1371/journal.pone.0160090	http://dx.doi.org/10.1371/journal.pone.0160090			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606823	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600001
J	Oliveira, ERA; Goncalves, AJS; Costa, SM; Azevedo, AS; Mantuano-Barradas, M; Nogueira, ACMA; Alves, AMB				Oliveira, Edson R. A.; Goncalves, Antonio J. S.; Costa, Simone M.; Azevedo, Adriana S.; Mantuano-Barradas, Marcio; Nogueira, Ana Cristina M. A.; Alves, Ada M. B.			Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; BALB/C MICE; VIRUS-INFECTION; NS1 GENE; CD4(+); PROTECTION; RESPONSES; DISEASE; TRAFFICKING; ANESTHETICS	Dengue disease has emerged as a major public health issue across tropical and subtropical countries. Infections caused by dengue virus (DENV) can evolve to life-threatening forms, resulting in about 20,000 deaths every year worldwide. Several animal models have been described concerning pre-clinical stages in vaccine development against dengue, each of them presenting limitations and advantages. Among these models, a traditional approach is the inoculation of a mouse-brain adapted DENV variant in immunocompetent animals by the intracerebral (i.c.) route. Despite the historical usage and relevance of this model for vaccine testing, little is known about the mechanisms by which the protection is developed upon vaccination. To cover this topic, a DNA vaccine based on the DENV non-structural protein 1 (pcTPANS1) was considered and investigations were focused on the induced T cell-mediated immunity against i.c.-DENV infection. Immunophenotyping assays by flow cytometry revealed that immunization with pcTPANS1 promotes a sustained T cell activation in spleen of i.c.-infected mice. Moreover, we found that the downregulation of CD45RB on T cells, as an indicator of cell activation, correlated with absence of morbidity upon virus challenge. Adoptive transfer procedures supported by CFSE-labeled cell tracking showed that NS1-specific T cells induced by vaccination, proliferate and migrate to peripheral organs of infected mice, such as the liver. Additionally, in late stages of infection (from the 7th day onwards), vaccinated mice also presented reduced levels of circulating IFN-gamma and IL-12p70 in comparison to non-vaccinated animals. In conclusion, this work presented new aspects about the T cell-mediated immunity concerning DNA vaccination with pcTPANS1 and the i.c. infection model. These insights can be explored in further studies of anti-dengue vaccine efficacy.	[Oliveira, Edson R. A.; Goncalves, Antonio J. S.; Costa, Simone M.; Azevedo, Adriana S.; Mantuano-Barradas, Marcio; Nogueira, Ana Cristina M. A.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil; [Nogueira, Ana Cristina M. A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Nogueira, ACMA; Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil.; Nogueira, ACMA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, Brazil.	ana.martins@ioc.fiocruz.br; ada@ioc.fiocruz.br	Nogueira, Ana Cristina M A/C-2200-2013	Oliveira, Edson RA/0000-0002-8606-7454; Souza Azevedo, Adriana/0000-0001-7401-5107	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [44371/2014-0]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/110.271/2014]; Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) [573547/2008-4]; Programa de Desenvolvimento Tecnologico e Inovacao em Saude da Fundacao Oswaldo Cruz (PDTIS-FIOCRUZ) [RVR11]	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Programa de Desenvolvimento Tecnologico e Inovacao em Saude da Fundacao Oswaldo Cruz (PDTIS-FIOCRUZ)	This work was supported by the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) (grant number: 44371/2014-0) - http://www.cnpq.br/, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (grant number: E26/110.271/2014) - http://www.faperj.br/, Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) (grant number: 573547/2008-4) - http://www.cpqrr.fiocruz.br/inctv/, Programa de Desenvolvimento Tecnologico e Inovacao em Saude da Fundacao Oswaldo Cruz (PDTIS-FIOCRUZ) (grant number: RVR11) - http://www.castelo.fiocruz.br/vpplr/pdtis.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Bentivoglio M, 2014, TRENDS NEUROSCI, V37, P325, DOI 10.1016/j.tins.2014.03.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buitrago S, 2008, J AM ASSOC LAB ANIM, V47, P11; Camirand G, 2014, J CLIN INVEST, V124, P4603, DOI 10.1172/JCI74087; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15; de Matos AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003520; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Goncalves AJS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004277; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Gurunathan S, 2000, CURR OPIN IMMUNOL, V12, P442, DOI 10.1016/S0952-7915(00)00118-7; Hawk TA, 2005, FORMULARY LAB ANIMAL; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Krummey SM, 2016, J IMMUNOL, V196, P2838, DOI 10.4049/jimmunol.1500639; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387; Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Remakus S, 2013, ADV EXP MED BIOL, V785, P77, DOI 10.1007/978-1-4614-6217-0_9; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486; Sung JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046292; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; World Health Organization, 2009, DENGUE GUIDELINES DI; Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709	51	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163240	10.1371/journal.pone.0163240	http://dx.doi.org/10.1371/journal.pone.0163240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631083	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900139
J	Dey, P; Panga, V; Raghunathan, S				Dey, Poulami; Panga, Venugopal; Raghunathan, Srivatsan			A Cytokine Signalling Network for the Regulation of Inducible Nitric Oxide Synthase Expression in Rheumatoid Arthritis	PLOS ONE			English	Article							NF-KAPPA-B; IFN-GAMMA; GENE-EXPRESSION; UP-REGULATION; TGF-BETA; MACROPHAGE ACTIVATION; JAK/STAT PATHWAY; SYNOVIAL-FLUID; NO SYNTHASE; PROTEIN	In rheumatoid arthritis (RA), nitric oxide (NO) is implicated in inflammation, angiogenesis and tissue destruction. The enzyme inducible nitric oxide synthase (iNOS) is responsible for the localised over-production of NO in the synovial joints affected by RA. The pro-and anti-inflammatory cytokines stimulate the synovial macrophages and the fibroblast-like synoviocytes to express iNOS. Therefore, the cytokine signalling network underlying the regulation of iNOS is essential to understand the pathophysiology of the disease. By using information from the literature, we have constructed, for the first time, the cytokine signalling network involved in the regulation of iNOS expression. Using the differential expression patterns obtained by re-analysing the microarray data on the RA synovium and the synovial macrophages available in the Gene Expression Omnibus (GEO) database, we aimed to establish the role played by the network genes towards iNOS regulation in the RA synovium. Our analysis reveals that the network genes belonging to interferon (IFN) and interleukin-10 (IL-10) pathways are always up-regulated in the RA synovium whereas the genes which are part of the anti-inflammatory transforming growth factor-beta (TGF-beta) signalling pathway are mostly down-regulated. We observed a consistent up-regulation of the transcription factor signal transducers and activators of transcription 1 (STAT1) in the RA synovium and the macrophages. Interestingly, we found a consistent up-regulation of the iNOS interacting protein ras-related C3 botulinum toxin substrate 2 (RAC2) in the RA synovium as well as the macrophages. Importantly, we have constructed a model to explain the impact of IFN and IL-10 pathways on Rac2-iNOS interaction leading to over-production of NO and thereby causing chronic inflammation in the RA synovium. The interplay between STAT1 and RAC2 in the regulation of NO could have implications for the identification of therapeutic targets for RA.	[Dey, Poulami; Panga, Venugopal; Raghunathan, Srivatsan] IBAB, Biotech Pk,Elect City Phase 1, Bengaluru 560100, Karnataka, India; [Dey, Poulami; Panga, Venugopal] Manipal Univ, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Raghunathan, S (corresponding author), IBAB, Biotech Pk,Elect City Phase 1, Bengaluru 560100, Karnataka, India.	srivatsan@ibab.ac.in		panga, venugopal/0000-0002-9262-3277	Indian Council of Medical Research (ICMR), India [3/1/3JRF-2013/HRD-106(20835)]; Council of Scientific and Industrial Research (CSIR), INDIA [09/1086(0001)/2012-EMR-1]; Department of Biotechnology, Government of India [BTPR12422/MED/31/287/2014]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), INDIA(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors received their salaries from the following funding agencies: Poulami Dey from Indian Council of Medical Research (ICMR), India, Grant No. 3/1/3JRF-2013/HRD-106(20835). Venugopal Panga from Council of Scientific and Industrial Research (CSIR), INDIA, Grant No. 09/1086(0001)/2012-EMR-1. Srivatsan Raghunathan from Department of Biotechnology, Government of India, Grant No. BTPR12422/MED/31/287/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Avramescu Carmen, 2005, Rom J Morphol Embryol, V46, P87; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; Borderie D, 2002, NITRIC OXIDE-BIOL CH, V6, P271, DOI 10.1006/niox.2001.0418; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Burke SJ, 2013, MOL ENDOCRINOL, V27, P1724, DOI 10.1210/me.2013-1159; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chan ED, 1999, J IMMUNOL, V162, P415; CHEN E, 1993, ARTHRITIS RHEUM, V36, P901, DOI 10.1002/art.1780360706; CHESROWN SE, 1994, BIOCHEM BIOPH RES CO, V200, P126, DOI 10.1006/bbrc.1994.1424; Coccia EM, 2000, INT IMMUNOL, V12, P977, DOI 10.1093/intimm/12.7.977; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Fearon U, 1999, ANN NY ACAD SCI, V878, P619, DOI 10.1111/j.1749-6632.1999.tb07743.x; Gao QY, 2016, INT J MOL MED, V37, P347, DOI 10.3892/ijmm.2015.2433; Grabowski PS, 1996, BRIT J RHEUMATOL, V35, P207; Grabowski PS, 1997, BRIT J RHEUMATOL, V36, P651; Guo Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146640; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Hiroi M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/369693; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Ivashkiv LB, 2003, ARTHRITIS RHEUM, V48, P2092, DOI 10.1002/art.11095; Jyoti A, 2014, ANTIOXID REDOX SIGN, V20, P417, DOI 10.1089/ars.2012.4970; Kaur J, 2014, IJRCI, V2, pOA2; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kuncewicz T, 2001, AM J PHYSIOL-RENAL, V281, pF326, DOI 10.1152/ajprenal.2001.281.2.F326; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee S, 2005, CANC RES, V65; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Luu K, 2014, IMMUNOL CELL BIOL, P1; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Nguyen H, 2003, J INTERF CYTOK RES, V23, P183, DOI 10.1089/107999003765027384; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Paramalingam SS, 2007, ANN ACAD MED SINGAP, V36, P96; Park KS, 2009, J MOL BIOL, V390, P595, DOI 10.1016/j.jmb.2009.05.036; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Ueki Y, 1996, J RHEUMATOL, V23, P230; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; Walker JG, 2005, J RHEUMATOL, V32, P1650; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Woetzel D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4526; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618	71	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161306	10.1371/journal.pone.0161306	http://dx.doi.org/10.1371/journal.pone.0161306			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626941	gold, Green Submitted, Green Published			2022-12-27	WOS:000383680600004
J	Ge, Y; Bruno, M; Haykal-Coates, N; Wallace, K; Andrews, D; Swank, A; Winnik, W; Ross, JA				Ge, Yue; Bruno, Maribel; Haykal-Coates, Najwa; Wallace, Kathleen; Andrews, Debora; Swank, Adam; Winnik, Witold; Ross, Jeffrey A.			Proteomic Assessment of Biochemical Pathways That Are Critical to Nickel-Induced Toxicity Responses in Human Epithelial Cells	PLOS ONE			English	Article							14-3-3 PROTEINS; EXPRESSION; HYPOXIA; HIF-1-ALPHA; BINDING; MARKERS; NI(II); A2	Understanding the mechanisms underlying toxicity initiated by nickel, a ubiquitous environmental contaminant and known human carcinogen is necessary for proper assessment of its risks to human and environment. Among a variety of toxic mechanisms, disruption of protein responses and protein response-based biochemical pathways represents a key mechanism through which nickel induces cytotoxicity and carcinogenesis. To identify protein responses and biochemical pathways that are critical to nickel-induced toxicity responses, we measured cytotoxicity and changes in expression and phosphorylation status of 14 critical biochemical pathway regulators in human BEAS-2B cells exposed to four concentrations of nickel using an integrated proteomic approach. A subset of the pathway regulators, including interleukin-6, and JNK, were found to be linearly correlated with cell viability, and may function as molecular determinants of cytotoxic responses of BEAS-2B cells to nickel exposures. In addition, 128 differentially expressed proteins were identified by two dimensional electrophoresis (2-DE) and mass spectrometry. Principal component analysis, hierarchical cluster analyses, and ingenuity signaling pathway analysis (IPA) identified putative nickel toxicity pathways. Some of the proteins and pathways identified have not previously been linked to nickel toxicity. Based on the consistent results obtained from both ELISA and 2-DE proteomic analysis, we propose a core signaling pathway regulating cytotoxic responses of human BEAS-2B cells to nickel exposures, which integrates a small set of proteins involved in glycolysis and gluconeogenesis pathways, apoptosis, protein degradation, and stress responses including inflammation and oxidative stress.	[Ge, Yue; Bruno, Maribel; Haykal-Coates, Najwa; Wallace, Kathleen; Andrews, Debora; Swank, Adam; Winnik, Witold; Ross, Jeffrey A.] US EPA, Natl Hlth & Environm Effects Res Lab, Durham, NC USA	United States Environmental Protection Agency	Ge, Y (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Durham, NC USA.	Ge.Yue@epa.gov	Ross, Jeffrey/E-4782-2010	Ross, Jeffrey/0000-0002-7002-4548	US Environmental Protection Agency; Pathfinder Innovation Project (PIP) from Office of Research and Development (ORD), US Environmental Protection Agency	US Environmental Protection Agency(United States Environmental Protection Agency); Pathfinder Innovation Project (PIP) from Office of Research and Development (ORD), US Environmental Protection Agency	The research was funded by Pathfinder Innovation Project from US Environmental Protection Agency.; This research was supported by the Pathfinder Innovation Project (PIP) from Office of Research and Development (ORD), US Environmental Protection Agency. The authors also would like to thank Drs. Sheau-Fung Thai, Aimen Farraj, and Charlene McQueen for their very helpful comments on this manuscript, and Alan Tennant for his assistance on the apoptosis imaging. The information in this document has been funded wholly by the US Environmental Protection Agency. It has been subjected to review by the National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views of the Agency nor doesmention of trade names or commercial products constitute endorsement or recommendation for use.	Ambler DR, 2012, SYST BIOL REPROD MED, V58, P324, DOI 10.3109/19396368.2012.713439; Andrew AS, 2001, AM J PHYSIOL-LUNG C, V281, pL607, DOI 10.1152/ajplung.2001.281.3.L607; BERNAL SD, 1985, CRC CR REV ONCOL-HEM, V3, P191, DOI 10.1016/S1040-8428(85)80026-3; Branescu C, 2013, CHIRURGIA-BUCHAREST, V108, P206; Brant KA, 2009, TOXICOL SCI, V107, P227, DOI 10.1093/toxsci/kfn208; Carpenter RL, 2013, CURR CANCER DRUG TAR, V13, P252; Chen L, 2009, ENVIRON HEALTH PERSP, V117, P1124, DOI 10.1289/ehp.0800157; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Ding J, 2009, CANCER EPIDEM BIOMAR, V18, P1720, DOI 10.1158/1055-9965.EPI-09-0115; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741; GUENICHE A, 1994, ARCH DERMATOL RES, V286, P466, DOI 10.1007/BF00371573; Harris GK, 2001, MUTAT RES, V533, P2183; HARTWIG A, 1994, TOXICOL LETT, V72, P353, DOI 10.1016/0378-4274(94)90048-5; Jung H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.558; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kim HL, 2012, ONCOL REP, V28, P1959, DOI 10.3892/or.2012.2057; Kim SU, 2014, STEM CELLS, V32, P998, DOI 10.1002/stem.1593; Kirkaldy AA, 2003, CLIN EXP IMMUNOL, V134, P447, DOI 10.1111/j.1365-2249.2003.02306.x; Krueger I, 1999, CARCINOGENESIS, V20, P1177, DOI 10.1093/carcin/20.7.1177; Leikauf GD, 2002, CHEST, V121, p70S, DOI 10.1378/chest.121.3_suppl.70S; LEONARD A, 1981, MUTAT RES, V87, P1, DOI 10.1016/0165-1110(81)90002-6; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Park JH, 2006, RESPIROLOGY, V11, P269, DOI 10.1111/j.1440-1843.2006.00849.x; Reinstein E, 2004, ISR MED ASSOC J, V6, P420; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Tessier DM, 2006, TOXICOL LETT, V167, P114, DOI 10.1016/j.toxlet.2006.08.015; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wawryk-Gawda E, 2014, PROTOPLASMA, V251, P525, DOI 10.1007/s00709-013-0548-1; Wesselkamper SC, 2006, AM J RESP CELL MOL, V34, P73, DOI 10.1165/rcmb.2005-0248OC; Wezynfeld NE, 2014, CHEM RES TOXICOL, V27, P1996, DOI 10.1021/tx500337w; Wong VC, 2013, TOXICOL APPL PHARM, V269, P233, DOI 10.1016/j.taap.2013.03.023; Xu XH, 2015, ONCOL REP, V33, P2121, DOI 10.3892/or.2015.3837	40	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162522	10.1371/journal.pone.0162522	http://dx.doi.org/10.1371/journal.pone.0162522			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626938	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600040
J	Nurek, M; Kostopoulou, O				Nurek, Martine; Kostopoulou, Olga			What You Find Depends on How You Measure It: Reactivity of Response Scales Measuring Predecisional Information Distortion in Medical Diagnosis	PLOS ONE			English	Article							COGNITIVE FORCING STRATEGIES; DECISION-MAKING; PREFERENCE; CONSISTENCY; HYPOTHESIS; REVERSALS; JUDGMENTS; COHERENCE; VALIDITY; SEARCH	"Predecisional information distortion" occurs when decision makers evaluate new information in a way that is biased towards their leading option. The phenomenon is well established, as is the method typically used to measure it, termed "stepwise evolution of preference" (SEP). An inadequacy of this method has recently come to the fore: it measures distortion as the total advantage afforded a leading option over its competitor, and therefore it cannot differentiate between distortion to strengthen a leading option ("proleader" distortion) and distortion to weaken a trailing option ("antitrailer" distortion). To address this, recent research introduced new response scales to SEP. We explore whether and how these new response scales might influence the very proleader and antitrailer processes that they were designed to capture ("reactivity"). We used the SEP method with concurrent verbal reporting: fifty family physicians verbalized their thoughts as they evaluated patient symptoms and signs ("cues") in relation to two competing diagnostic hypotheses. Twenty-five physicians evaluated each cue using the response scale traditional to SEP (a single response scale, returning a single measure of distortion); the other twenty-five did so using the response scales introduced in recent studies (two separate response scales, returning two separate measures of distortion: proleader and antitrailer). We measured proleader and antitrailer processes in verbalizations, and compared verbalizations in the single-scale and separate-scales groups. Response scales did not appear to affect proleader processes: the two groups of physicians were equally likely to bolster their leading diagnosis verbally. Response scales did, however, appear to affect antitrailer processes: the two groups denigrated their trailing diagnosis verbally to differing degrees. Our findings suggest that the response scales used to measure information distortion might influence its constituent processes, limiting their generalizability across and beyond experimental studies.	[Nurek, Martine] Kings Coll London, Fac Life Sci & Med, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Kostopoulou, Olga] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England	University of London; King's College London; Imperial College London	Kostopoulou, O (corresponding author), Imperial Coll London, Fac Med, Dept Surg & Canc, London, England.	o.kostopoulou@imperial.ac.uk		Nurek, Martine/0000-0002-4252-4692	King's Interdisciplinary Social Science Doctoral Training Centre (Economic & Social Research Council) award [ES/J500057/1]; Economic and Social Research Council [1105197] Funding Source: researchfish	King's Interdisciplinary Social Science Doctoral Training Centre (Economic & Social Research Council) award; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by a King's Interdisciplinary Social Science Doctoral Training Centre (Economic & Social Research Council) award to MN (grant number ES/J500057/1; http://www.kcl.ac.uk/study/pg/school/dtc/welcome.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlund L, 2003, ORGAN BEHAV HUM DEC, V91, P108, DOI 10.1016/S0749-5978(02)00529-0; Blanchard SJ, 2014, PSYCHOL SCI, V25, P812, DOI 10.1177/0956797613512663; Boyle PJ, 2012, J BEHAV DECIS MAKING, V25, P217, DOI 10.1002/bdm.725; Brownstein AL, 2003, PSYCHOL BULL, V129, P545, DOI 10.1037/0033-2909.129.4.545; Carlson KA, 2006, J CONSUM RES, V32, P513, DOI 10.1086/500481; Carlson KA, 2004, ORGAN BEHAV HUM DEC, V94, P48, DOI 10.1016/j.obhdp.2004.02.001; Carlson KA, 2001, J EXP PSYCHOL-APPL, V7, P91, DOI 10.1037//1076-898X.7.2.91; Chaxel AS, 2015, J EXP SOC PSYCHOL, V60, P1, DOI 10.1016/j.jesp.2015.04.007; Croskerry P, 2003, ANN EMERG MED, V41, P110, DOI 10.1067/mem.2003.22; DeKay ML, 2015, CURR DIR PSYCHOL SCI, V24, P405, DOI 10.1177/0963721415587876; DeKay ML, 2014, ORGAN BEHAV HUM DEC, V125, P134, DOI 10.1016/j.obhdp.2014.07.003; Dekay ML, 2011, J BEHAV DECIS MAKING, V24, P394, DOI 10.1002/bdm.699; Dekay ML, 2009, ORGAN BEHAV HUM DEC, V109, P79, DOI 10.1016/j.obhdp.2008.12.001; Engel C, 2013, J BEHAV DECIS MAKING, V26, P272, DOI 10.1002/bdm.1761; Ericsson K. A., 2011, HDB PROCESS TRACING, P89; Ericsson K.A., 1993, PROTOCOL ANAL VERBAL; Fox MC, 2011, PSYCHOL BULL, V137, P316, DOI 10.1037/a0021663; Glockner A, 2010, J BEHAV DECIS MAKING, V23, P439, DOI 10.1002/bdm.668; Graber M, 2003, ACAD MED, V78, P781, DOI 10.1097/00001888-200308000-00004; Graber ML, 2012, BMJ QUAL SAF, V21, P535, DOI 10.1136/bmjqs-2011-000149; HARTE JM, 1994, ACTA PSYCHOL, V87, P95, DOI 10.1016/0001-6918(94)90046-9; Holyoak KJ, 1999, J EXP PSYCHOL GEN, V128, P3, DOI 10.1037/0096-3445.128.1.3; Hsee CK, 1996, ORGAN BEHAV HUM DEC, V67, P247, DOI 10.1006/obhd.1996.0077; Huber O, 1997, ACTA PSYCHOL, V95, P15, DOI 10.1016/S0001-6918(96)00028-5; Kostopoulou O, 2017, MED DECIS MAKING, V37, P9, DOI 10.1177/0272989X16644563; Kostopoulou O, 2012, MED DECIS MAKING, V32, P831, DOI 10.1177/0272989X12447241; Kostopoulou O, 2009, JUDGM DECIS MAK, V4, P408; Larrick R.P., 2004, BLACKWELL HDB JUDGME, P316, DOI [DOI 10.1002/9780470752937.CH16, 10.1002/9780470752937.ch16]; LICHTENSTEIN S, 1971, J EXP PSYCHOL, V89, P46, DOI 10.1037/h0031207; Meloy MG, 2006, J MARKETING RES, V43, P267, DOI 10.1509/jmkr.43.2.267; Meloy MG, 2004, ORGAN BEHAV HUM DEC, V93, P114, DOI 10.1016/j.obhdp.2003.12.002; Miller SA, 2013, JUDGM DECIS MAK, V8, P662; MONTGOMERY H, 1994, ACTA PSYCHOL, V87, P155, DOI 10.1016/0001-6918(94)90049-3; Montgomery H., 1989, PROCESS STRUCTURE HU, P135; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Norman GR, 1997, ADV HEALTH SCI EDUC, V2, P173, DOI 10.1023/A:1009784330364; Nurek M, 2014, JUDGM DECIS MAK, V9, P572; Polman E, 2012, ORGAN BEHAV HUM DEC, V119, P78, DOI 10.1016/j.obhdp.2012.05.004; Polman E, 2010, J EXP SOC PSYCHOL, V46, P432, DOI 10.1016/j.jesp.2009.11.003; Russo JE, 2011, J ECONOMETRICS, V162, P132, DOI 10.1016/j.jeconom.2010.07.004; Russo JE, 2008, J EXP PSYCHOL GEN, V137, P456, DOI 10.1037/a0012786; Russo JE, 2006, PSYCHOL SCI, V17, P899, DOI 10.1111/j.1467-9280.2006.01800.x; Russo JE, 2015, FRONT COGN PSYCHOL, P91; Russo JE, 2010, J CONSUM PSYCHOL, V20, P338, DOI 10.1016/j.jcps.2010.06.005; Russo JE, 1998, J MARKETING RES, V35, P438, DOI 10.2307/3152163; Russo JE, 1996, ORGAN BEHAV HUM DEC, V66, P102, DOI 10.1006/obhd.1996.0041; RUSSO JE, 1989, MEM COGNITION, V17, P759, DOI 10.3758/BF03202637; Russo JE, 2000, MANAGE SCI, V46, P13, DOI 10.1287/mnsc.46.1.13.15127; Schmidt HG, 1993, EDUC PSYCHOL REV, V5, P205, DOI 10.1007/BF01323044; Schulte-Mecklenbeck M., 2010, HDB PROCESS TRACING; Sherbino J, 2014, CAN J EMERG MED, V16, P34, DOI 10.2310/8000.2013.130860; Simon D, 2001, J EXP PSYCHOL LEARN, V27, P1250, DOI 10.1037//0278-7393.27.5.1250; Simon D, 2004, J PERS SOC PSYCHOL, V86, P814, DOI 10.1037/0022-3514.86.6.814; Svenson O., 1989, PROCESS STRUCTURE HU, P65; Willingham D.T., 2008, ARTS ED POLICY REV, V109, P21, DOI [DOI 10.3200/AEPR.109.4.21-32, 10.3200/AEPR.109.4.21-32]	56	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162562	10.1371/journal.pone.0162562	http://dx.doi.org/10.1371/journal.pone.0162562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627673	gold, Green Published			2022-12-27	WOS:000383680600043
J	Shim, E; Kim, D; Woo, H; Cho, Y				Shim, Eunyoung; Kim, Dohyeong; Woo, Hyekyung; Cho, Youngtae			Designing a Sustainable Noise Mapping System Based on Citizen Scientists Smartphone Sensor Data	PLOS ONE			English	Article							INTERPOLATION; HEALTH	In this study, we attempted to assess the feasibility of collecting population health data via mobile devices. Specifically, we constructed noise maps based on sound information monitored by individuals' smartphones. We designed a sustainable way of creating noise maps that can overcome the shortcomings of existing station-based noise-monitoring systems. Three hundred and nine Seoul residents aged 20-49 years who used Android-based smartphones were recruited, and the subjects installed a special application that we developed for this study. This application collected information on sound and geographical location every 10 min for 7 days. Using GIS, we were able to construct various types of noise maps of Seoul (e.g., daytime/nighttime and weekdays/weekends) using the information on sound and geographical location obtained via the users' smartphones. Despite the public health importance of noise management, a number of countries and cities lack a sustainable system to monitor noise. This pilot study showed the possibility of using the smartphones of citizen scientists as an economical and sustainable way of monitoring noise, particularly in an urban context in developing countries.	[Shim, Eunyoung; Woo, Hyekyung; Cho, Youngtae] Seoul Natl Univ, Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Shim, Eunyoung; Woo, Hyekyung; Cho, Youngtae] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Kim, Dohyeong] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX USA; [Shim, Eunyoung] Samsung Fire & Marine Insurance, Dept New Business, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Dallas	Cho, Y (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea.; Cho, Y (corresponding author), Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea.	youngtae@snu.ac.kr	Woo, hyekyung/AFJ-9969-2022		Seoul National University [900-20130074]; Seoul National University Brain Fusion Research Grant	Seoul National University; Seoul National University Brain Fusion Research Grant	This work was funded by Seoul National University #900-20130074 (Youngtae Cho).; This study was supported by the Seoul National University Brain Fusion Research Grant.	Babak O, 2009, STOCH ENV RES RISK A, V23, P543, DOI 10.1007/s00477-008-0226-6; Boulos MNK, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-67; Brush A, 2013, P SIGCHI C HUM FACT; Chatzimilioudis G, 2012, IEEE INTERNET COMPUT, V16, P36, DOI 10.1109/MIC.2012.70; Council NR, 2012, URB MET FOR MON M US; D'Hondt E, 2013, PERVASIVE MOB COMPUT, V9, P681, DOI 10.1016/j.pmcj.2012.09.002; Faggiani A, 2012, MOD OPT MOB AD HOC W; Guo B., 2014, PERV COMP COMM WORKS; Hurtley C., 2009, NIGHT NOISE GUIDELIN; Kanjo E, 2010, MOBILE NETW APPL, V15, P562, DOI 10.1007/s11036-009-0217-y; Kardous CA, 2014, J ACOUST SOC AM, V135, pEL186, DOI 10.1121/1.4865269; Kim S., 2011, P SIGCHI C HUM FACT; Lian KY, 2013, SENSORS-BASEL, V13, P17379, DOI 10.3390/s131217379; Lu GY, 2008, COMPUT GEOSCI-UK, V34, P1044, DOI 10.1016/j.cageo.2007.07.010; Ma HR, 2013, J KOREAN SOC SAFETY, V28, P24; Maisonneuve Nicolas, 2009, P 10 ANN INT C DIG G; Oke AO., 2013, ACTA GEOGRAPHICA DEB, V7, P48; Organization WH, BURD DIS ENV NOISE20; Ramos Y., 2015, J EXPOSURE SCI ENV E; Rana R., 2010, P 9 ACM IEEE INT C I; Rana R, 2015, PERVASIVE MOB COMPUT, V17, P1, DOI 10.1016/j.pmcj.2014.02.001; Spitzhirn M., 2016, ADV ERGONOMIC DESIGN, P281; Stevens M., 2010, WORKSH UBIQ CROWD; Yanosk JD, 2008, ATMOS ENVIRON, V42, P4047, DOI 10.1016/j.atmosenv.2008.01.044	24	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161835	10.1371/journal.pone.0161835	http://dx.doi.org/10.1371/journal.pone.0161835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626273	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600010
J	Crespo-Lopez, ME; Costa-Malaquias, A; Oliveira, EHC; Miranda, MS; Arrifano, GPF; Souza-Monteiro, JR; Sagica, FES; Fontes, EA; Maia, CSF; Macchi, BM; do Nascimento, JLM				Crespo-Lopez, Maria Elena; Costa-Malaquias, Allan; Oliveira, Edivaldo H. C.; Miranda, Moyses S.; Arrifano, Gabriela P. F.; Souza-Monteiro, Jose R.; Sagica, Fernanda Espirito-Santo; Fontes-Junior, Eneas A.; Maia, Cristiane S. F.; Macchi, Barbarella M.; do Nascimento, Jose Luiz M.			Is Low Non-Lethal Concentration of Methylmercury Really Safe? A Report on Genotoxicity with Delayed Cell Proliferation	PLOS ONE			English	Article							TAPAJOS RIVER-BASIN; LOW-LEVEL; DNA-DAMAGE; INDUCED NEUROTOXICITY; MOLECULAR-MECHANISMS; MERCURY POLLUTION; OXIDATIVE STRESS; BRAZILIAN AMAZON; EXPOSURE; APOPTOSIS	Human exposure to relatively low levels of methylmercury is worrying, especially in terms of its genotoxicity. It is currently unknown as to whether exposure to low levels of mercury (below established limits) is safe. Genotoxicity was already shown in lymphocytes, but studies with cells of the CNS (as the main target organ) are scarce. Moreover, disturbances in the cell cycle and cellular proliferation have previously been observed in neuronal cells, but no data are presently available for glial cells. Interestingly, cells of glial origin accumulate higher concentrations of methylmercury than those of neuronal origin. Thus, the aim of this work was to analyze the possible genotoxicity and alterations in the cell cycle and cell proliferation of a glioma cell line (C6) exposed to a low, non-lethal and non-apoptotic methylmercury concentration. Biochemical (mitochondrial activity) and morphological (integrity of the membrane) assessments confirmed the absence of cell death after exposure to 3 mu M methylmercury for 24 hours. Even without promoting cell death, this treatment significantly increased genotoxicity markers (DNA fragmentation, micronuclei, nucleoplasmic bridges and nuclear buds). Changes in the cell cycle profile (increased mitotic index and cell populations in the S and G2/M phases) were observed, suggesting arrest of the cycle. This delay in the cycle was followed, 24 hours after methylmercury withdrawal, by a decrease number of viable cells, reduced cellular confluence and increased doubling time of the culture. Our work demonstrates that exposure to a low sublethal concentration of MeHg considered relatively safe according to current limits promotes genotoxicity and disturbances in the proliferation of cells of glial origin with sustained consequences after methylmercury withdrawal. This fact becomes especially important, since this cellular type accumulates more methylmercury than neurons and displays a vital role protecting the CNS, especially in chronic intoxication with this heavy metal.	[Crespo-Lopez, Maria Elena; Costa-Malaquias, Allan; Arrifano, Gabriela P. F.; Souza-Monteiro, Jose R.] Fed Univ Para, Inst Ciencias Biol, Lab Farmacol Mol, BR-66075110 Belem, Para, Brazil; [Oliveira, Edivaldo H. C.; Sagica, Fernanda Espirito-Santo] Inst Evandro Chagas, Dept Meio Ambiente, Lab Cultura Tecidos & Citogenet, BR-67030000 Ananindeua, Para, Brazil; [Miranda, Moyses S.] Fed Univ Para, Inst Ciencias Biol, Lab Fertilizacao In Vitro, BR-66075110 Belem, Para, Brazil; [Fontes-Junior, Eneas A.; Maia, Cristiane S. F.] Fed Univ Para, Inst Ciencias Saude, Lab Farmacol Inflamacao & Comportamento, BR-66075110 Belem, Para, Brazil; [Macchi, Barbarella M.; do Nascimento, Jose Luiz M.] Fed Univ Para, Inst Ciencias Saude, Lab Neuroquim Mol & Celular, BR-66075110 Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Crespo-Lopez, ME (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Farmacol Mol, BR-66075110 Belem, Para, Brazil.	maria.elena.crespo.lopez@gmail.com	de Oliveira, Edivaldo H. C./C-3368-2013; DE PAULA FONSECA ARRIFANO, GABRIELA/E-3451-2014; Miranda, Moysés dos Santos/X-1691-2019; Macchi, Barbarella/ACM-9455-2022; Crespo-Lopez, Maria Elena/X-7912-2018; Maia, Cristiane/E-7217-2016; Fontes-Júnior, Enéas Andrade/ABF-8064-2020; Fontes-Júnior, Enéas Andrade/R-6372-2018	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; DE PAULA FONSECA ARRIFANO, GABRIELA/0000-0003-2817-3539; Miranda, Moysés dos Santos/0000-0001-7771-8174; Crespo-Lopez, Maria Elena/0000-0002-1335-6853; Maia, Cristiane/0000-0003-4493-7375; Fontes-Júnior, Enéas Andrade/0000-0002-6186-9581; Sagica, Fernanda/0000-0002-0578-2692; Macchi, Barbarella/0000-0002-8667-1942; do Nascimento, jose/0000-0003-3647-9124	Conselho Nacional de Ciencia e Tecnologia em Pesquisa (CNPq, Brazil) [467143/2014-5, 447568/ 2014-0]; Instituto Evandro Chagas (IEC, Brazil); CNPq; Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)	Conselho Nacional de Ciencia e Tecnologia em Pesquisa (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Instituto Evandro Chagas (IEC, Brazil); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, Brazil)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Ciencia e Tecnologia em Pesquisa (CNPq, Brazil; grants 467143/2014-5 and 447568/ 2014-0) and Instituto Evandro Chagas (IEC, Brazil). J.L.M. do Nascimento, E.H.C. Oliveira and M.E. Crespo-Lopez thank CNPq for their CNPq fellowships. Also, A. Costa-Malaquias, J. R. Souza-Monteiro and G.P.F. Arrifano thank Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, Brazil) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) for their PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger N, 2005, NEUROTOXICOLOGY, V26, P149, DOI 10.1016/j.neuro.2004.12.005; Belletti S, 2002, J NEUROSCI RES, V70, P703, DOI 10.1002/jnr.10419; Nevado JJB, 2010, ENVIRON INT, V36, P593, DOI 10.1016/j.envint.2010.03.011; Nevado JJB, 2009, MICROCHEM J, V93, P12, DOI 10.1016/j.microc.2009.03.008; Bose R, 2012, TOXICOL SCI, V130, P383, DOI 10.1093/toxsci/kfs257; BURBACHER TM, 1990, NEUROTOXICOL TERATOL, V12, P191, DOI 10.1016/0892-0362(90)90091-P; Burke K, 2006, NEUROTOXICOLOGY, V27, P970, DOI 10.1016/j.neuro.2006.09.001; Carta P, 2003, NEUROTOXICOLOGY, V24, P617, DOI 10.1016/S0161-813X(03)00080-9; Ceccatelli S, 2013, J INTERN MED, V273, P490, DOI 10.1111/joim.12045; Ceccatelli S, 2010, CHEM-BIOL INTERACT, V188, P301, DOI 10.1016/j.cbi.2010.04.007; Costa-Malaquias A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110815; Crespo-Lopez ME, 2007, ENVIRON INT, V33, P141, DOI 10.1016/j.envint.2006.08.005; Crespo-Lopez ME, 2011, ENVIRON INT, V37, P136, DOI 10.1016/j.envint.2010.08.009; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; Crespo-Lopez ME, 2005, REV NEUROLOGIA, V40, P441, DOI 10.33588/rn.4007.2004499; Dare E, 2001, FREE RADICAL BIO MED, V30, P1347, DOI 10.1016/S0891-5849(01)00526-3; Das S, 2011, CHEM-BIOL INTERACT, V193, P129, DOI 10.1016/j.cbi.2011.06.002; Falnoga I, 2000, ENVIRON RES, V84, P211, DOI 10.1006/enrs.2000.4116; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Harada M, 2001, ENVIRON INT, V27, P285, DOI 10.1016/S0160-4120(01)00059-9; Hong Ji-Young, 2014, J Cancer Prev, V19, P273, DOI 10.15430/JCP.2014.19.4.273; Huyck RW, 2015, NEUROTOXICOL TERATOL, V47, P102, DOI 10.1016/j.ntt.2014.11.010; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Magos L, 1987, TOXICITY METHYL MERC, P24; Mendoza MAC, 2002, TOXICOL APPL PHARM, V178, P117, DOI 10.1006/taap.2001.9267; Miura K, 1999, TOXICOL APPL PHARM, V160, P279, DOI 10.1006/taap.1999.8781; Morris MC, 2016, JAMA-J AM MED ASSOC, V315, P489, DOI 10.1001/jama.2015.19451; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; Pieper I, 2014, METALLOMICS, V6, P662, DOI 10.1039/c3mt00337j; Pinheiro MCN, 2007, ENVIRON INT, V33, P56, DOI 10.1016/j.envint.2006.06.024; PONCE RA, 1994, TOXICOL APPL PHARM, V127, P83, DOI 10.1006/taap.1994.1142; Martin-Doimeadios RC, 2014, ENVIRON SCI POLLUT R, V21, P7466, DOI 10.1007/s11356-014-2680-7; Safeliu C, 2001, NEUROTOXICOLOGY, V22, P317, DOI 10.1016/S0161-813X(01)00015-8; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sokolowski K, 2013, DEV NEUROBIOL, V73, P936, DOI 10.1002/dneu.22119; Strober W., 2001, CURRENT PROTOCOLS IM; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Takahashi A, 2004, INT J RADIAT ONCOL, V60, P591, DOI 10.1016/j.ijrobp.2004.05.062; Thomas P, 2003, MUTAGENESIS, V18, P187, DOI 10.1093/mutage/18.2.187; USEPA, 1997, MERC STUD REP C HLTH, VV; WHO, 1990, INT PROGR CHEM SAF, P101; Xu MY, 2010, BRAIN RES, V1359, P272, DOI 10.1016/j.brainres.2010.08.069; Zhang P, 2009, FREE RADICAL RES, V43, P224, DOI 10.1080/10715760802677348	44	32	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162822	10.1371/journal.pone.0162822	http://dx.doi.org/10.1371/journal.pone.0162822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622704	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000060
J	Liu, CZ; Sun, ZY; Jou, JW; Cui, Q; Zhao, G; Qiu, J; Tu, S				Liu, Chengzhen; Sun, Zhiyi; Jou, Jerwen; Cui, Qian; Zhao, Guang; Qiu, Jiang; Tu, Shen			Unconscious Processing of Facial Emotional Valence Relation: Behavioral Evidence of Integration between Subliminally Perceived Stimuli	PLOS ONE			English	Article							CONSCIOUS PERCEPTION; INTERHEMISPHERIC SUMMATION; INHIBITORY MECHANISMS; AFFECTIVE BLINDSIGHT; AWARENESS; ATTENTION; EXPRESSIONS; BRAIN; FEAR; RECOGNITION	Although a few studies have investigated the integration between some types of unconscious stimuli, no research has yet explored the integration between unconscious emotional stimuli. This study was designed to provide behavioral evidence for the integration between unconsciously perceived emotional faces (same or different valence relation) using a modified priming paradigm. In two experiments, participants were asked to decide whether two faces in the target, which followed two subliminally presented faces of same or different emotional expressions, were of the same or different emotional valence. The interstimulus interval (ISI) between the prime and the target was manipulated (0, 53, 163 ms). In Experiment 1, prime visibility was assessed post-experiment. In Experiment 2, it was assessed on each trial. Interestingly, in both experiments, unconsciously processed valence relation of the two faces in the prime generated a negative priming effect in the response to the supraliminally presented target, independent of the length of ISI. Further analyses suggested that the negative priming was probably caused by a motor response incongruent relation between the subliminally perceived prime and the supraliminally perceived target. The visual feature incongruent relation across the prime and target was not found to play a role in the negative priming. Because the negative priming was found at short ISI, an attention mechanism as well as a motor inhibition mechanism were proposed in the generation of the negative priming effect. Overall, this study indicated that the subliminal valence relation was processed, and that integration between different unconsciously perceived stimuli could occur.	[Liu, Chengzhen; Tu, Shen] China West Normal Univ, Inst Educ, Dept Psychol, Nanchong 637002, Peoples R China; [Sun, Zhiyi; Qiu, Jiang] Southwest Univ, Fac Psychol, Chongqing 400715, Peoples R China; [Jou, Jerwen] Univ Texas Rio Grande Valley, Dept Psychol Sci, Edinburg, TX 78539 USA; [Cui, Qian] Univ Elect Sci & Technol China, Sch Polit Sci & Publ Adm, Chengdu 610054, Peoples R China; [Zhao, Guang] Liaoning Normal Univ, Sch Psychol, Dalian 116029, Peoples R China	China West Normal University; Southwest University - China; University of Texas System; University of Texas Rio Grande Valley; University of Electronic Science & Technology of China; Liaoning Normal University	Tu, S (corresponding author), China West Normal Univ, Inst Educ, Dept Psychol, Nanchong 637002, Peoples R China.	shentu614@yeah.net		Tu, Shen/0000-0001-9111-2398	National Natural Science Foundation of China [31500871, 31400870, 31400901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31500871, 31400870, 31400901). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atas A, 2013, CONSCIOUS COGN, V22, P1422, DOI 10.1016/j.concog.2013.09.011; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Balconi M, 2013, CONSCIOUS COGN, V22, P771, DOI 10.1016/j.concog.2013.04.013; Bertini C, 2013, CORTEX, V49, P985, DOI 10.1016/j.cortex.2012.02.006; Boy F, 2010, P NATL ACAD SCI USA, V107, P11134, DOI 10.1073/pnas.1001925107; Carlson JM, 2010, BRAIN COGNITION, V73, P20, DOI 10.1016/j.bandc.2010.01.007; Cecere R, 2014, J COGNITIVE NEUROSCI, V26, P2564, DOI 10.1162/jocn_a_00671; Celeghin A, 2015, CONSCIOUS COGN, V36, P414, DOI 10.1016/j.concog.2015.05.007; Celeghin A, 2015, EXP BRAIN RES, V233, P1617, DOI 10.1007/s00221-015-4236-6; Damian MF, 2001, J EXP PSYCHOL HUMAN, V27, P154, DOI 10.1037/0096-1523.27.1.154; de Gelder B, 2002, P NATL ACAD SCI USA, V99, P4121, DOI 10.1073/pnas.062018499; de Gelder B, 2001, NEUROREPORT, V12, P385, DOI 10.1097/00001756-200102120-00040; de Gelder B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00054; Doi H, 2015, CEREB CORTEX, V25, P817, DOI 10.1093/cercor/bht282; Faivre N, 2014, PSYCHOL SCI, V25, P2006, DOI 10.1177/0956797614547916; Faivre N, 2011, J VISION, V11, DOI 10.1167/11.3.2; Gibbons H, 2009, CONSCIOUS COGN, V18, P383, DOI 10.1016/j.concog.2009.02.007; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kentridge RW, 2004, NEUROPSYCHOLOGIA, V42, P831, DOI 10.1016/j.neuropsychologia.2003.11.001; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; LADAVAS E, 1993, COGNITION EMOTION, V7, P95, DOI 10.1080/02699939308409179; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Lin ZC, 2014, J VISION, V14, DOI 10.1167/14.1.27; Lin ZC, 2014, PSYCHOL SCI, V25, P296, DOI 10.1177/0956797613504964; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Montoro PR, 2014, CONSCIOUS COGN, V25, P1, DOI 10.1016/j.concog.2014.01.004; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Norman LJ, 2013, PSYCHOL SCI, V24, P836, DOI 10.1177/0956797612461449; Pinto Y, 2015, J VISION, V15, DOI 10.1167/15.8.13; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Sumner Petroc, 2008, Adv Cogn Psychol, V3, P317, DOI 10.2478/v10053-008-0033-0; Szczepanowski R, 2013, CONSCIOUS COGN, V22, P212, DOI 10.1016/j.concog.2012.12.003; Tamietto M, 2008, NEUROPSYCHOLOGIA, V46, P820, DOI 10.1016/j.neuropsychologia.2007.11.002; Tamietto M, 2015, CORTEX, V62, P56, DOI 10.1016/j.cortex.2014.10.009; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; Tu S., 2014, ADV PSYCHOL, V4, P373; Tu S., 2014, RELATIONSHIP CONSCIO; Tu S., 2013, WORLD J NEUROSCI, V3, P298, DOI DOI 10.4236/WJNS.2013.34041; Tu S, 2013, CONSCIOUS COGN, V22, P479, DOI 10.1016/j.concog.2013.02.007; van Gaal S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0212; Van Opstal F, 2011, CONSCIOUS COGN, V20, P1860, DOI 10.1016/j.concog.2011.09.004; Van Opstal F, 2010, CONSCIOUS COGN, V19, P999, DOI 10.1016/j.concog.2010.05.002; Wang YH, 2014, CONSCIOUS COGN, V29, P235, DOI 10.1016/j.concog.2014.08.020; Webb TW, 2016, J COGNITIVE NEUROSCI, V28, P842, DOI 10.1162/jocn_a_00931; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Yun XY, 2011, NEUROSCI LETT, V498, P10, DOI 10.1016/j.neulet.2011.04.040	51	7	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162689	10.1371/journal.pone.0162689	http://dx.doi.org/10.1371/journal.pone.0162689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622600	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000047
J	Vafai, SB; Mevers, E; Higgins, KW; Fomina, Y; Zhang, JM; Mandinova, A; Newman, D; Shaw, SY; Clardy, J; Mootha, VK				Vafai, Scott B.; Mevers, Emily; Higgins, Kathleen W.; Fomina, Yevgenia; Zhang, Jianming; Mandinova, Anna; Newman, David; Shaw, Stanley Y.; Clardy, Jon; Mootha, Vamsi K.			Natural Product Screening Reveals Naphthoquinone Complex I Bypass Factors	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; APOPTOSIS; DISEASE; PINK1; CELLS; DEFICIENCY; IDEBENONE; OXIDATION; NDUFA9	Deficiency of mitochondrial complex I is encountered in both rare and common diseases, but we have limited therapeutic options to treat this lesion to the oxidative phosphorylation system (OXPHOS). Idebenone and menadione are redox-active molecules capable of rescuing OXPHOS activity by engaging complex I-independent pathways of entry, often referred to as "complex I bypass." In the present study, we created a cellular model of complex I deficiency by using CRISPR genome editing to knock out Ndufa9 in mousemyoblasts, and utilized this cell line to develop a high-throughput screening platform for novel complex I bypass factors. We screened a library of similar to 40,000 natural product extracts and performed bioassay-guided fractionation on a subset of the top scoring hits. We isolated four plant-derived 1,4-naphthoquinone complex I bypass factors with structural similarity to menadione: chimaphilin and 3-chloro-chimaphilin from Chimaphila umbellata and dehydro-alpha-lapachone and dehydroiso-alpha-lapachone from Stereospermum euphoroides. We also tested a small number of structurally related naphthoquinones from commercial sources and identified two additional compounds with complex I bypass activity: 2-methoxy-1,4-naphthoquinone and 2-methoxy-3-methyl-1,4,-naphthoquinone. The six novel complex I bypass factors reported here expand this class of molecules and will be useful as tool compounds for investigating complex I disease biology.	[Vafai, Scott B.; Higgins, Kathleen W.; Fomina, Yevgenia; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Vafai, Scott B.; Higgins, Kathleen W.; Fomina, Yevgenia; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Vafai, Scott B.; Higgins, Kathleen W.; Fomina, Yevgenia; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mevers, Emily; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Zhang, Jianming; Mandinova, Anna] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Newman, David] NCI, Nat Prod Branch, Frederick, MD 21701 USA; [Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Vafai, SB; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Vafai, SB; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Vafai, SB; Mootha, VK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Mootha, VK (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	svafai@broadinstitute.org; vamsi@hms.harvard.edu		Zhang, Jianming/0000-0001-6326-3906; Higgins, Kathleen/0000-0002-3551-9502	NIH [R01GM099683]; KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources); KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [KL2 TR001100]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources); KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health)	This work was supported by a T-R01 grant R01GM099683 from NIH to VKM. VKM is an investigator of the Howard Hughes Medical Institute. SBV was supported by a KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award KL2 TR001100). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	[Anonymous], 2015, EMA4800392015 EUR ME; ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615; ARNASON T, 1981, CAN J BOT, V59, P2189, DOI 10.1139/b81-287; CONOVER TE, 1963, BIOCHIM BIOPHYS ACTA, V67, P268; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; Erb M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036153; Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267; Garkavtsev I, 2011, P NATL ACAD SCI USA, V108, P11596, DOI 10.1073/pnas.1104225108; Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012; Gueyen N, 2015, REDOX BIOL, V4, P289, DOI 10.1016/j.redox.2015.01.009; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Ishigooka M., 1995, International Urology and Nephrology, V27, P61; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; La Morgia C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00141; Ma WD, 2014, FOOD CHEM TOXICOL, V70, P1, DOI 10.1016/j.fct.2014.04.014; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Ong JYH, 2015, LIFE SCI, V135, P158, DOI 10.1016/j.lfs.2015.03.019; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Raja S., 2014, International Journal of Phytomedicine, V6, P464; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162686	10.1371/journal.pone.0162686	http://dx.doi.org/10.1371/journal.pone.0162686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622560	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000046
J	Song, IA; Seo, KS; Oh, AY; Baik, JS; Kim, JH; Hwang, JW; Jeon, YT				Song, In-Ae; Seo, Kwang-Suk; Oh, Ah-Young; Baik, Ji-Seok; Kim, Jin Hee; Hwang, Jung-Won; Jeon, Young-Tae			Dexmedetomidine Injection during Strabismus Surgery Reduces Emergence Agitation without Increasing the Oculocardiac Reflex in Children: A Randomized Controlled Trial	PLOS ONE			English	Article							SEVOFLURANE ANESTHESIA; GENERAL-ANESTHESIA; PEDIATRIC-PATIENTS; DESFLURANE; DELIRIUM; ADENOTONSILLECTOMY; HALOTHANE; SEDATION; REMIFENTANIL; METAANALYSIS	Objective Dexmedetomidine is known to reduce the incidence of emergence agitation, which is a common complication after inhalational anesthesia like sevoflurane or desflurane in children. However, the dose of dexmedetomidine used for this purpose is reported variously and the most effective dose is not known. In this study, we tried to find the most effective dose of dexmedetomidine to reduce the incidence of emergence agitation in children undergoing strabismus surgery without the complications like oculocardiac reflex (OCR) or postoperative vomiting. Methods We randomized 103 pediatric patients aged 2-6 years and undergoing elective strabismus surgery into four groups. Anesthesia was induced with sevoflurane and maintained with desflurane. At the start of induction, dexmedetomidine, delivered at 0.25, 0.5, or 1 mu g/kg, or saline was infused intravenously in the D0.25, D0.5, D1 groups, respectively. The primary outcome measure was the incidence of emergence agitation and the secondary outcome measure was the incidence of intraoperative OCR, postoperative vomiting, and desaturation events. Results The incidence of emergence agitation was 60, 48, 44, and 21% (P = 0.005) and the incidence of intraoperative OCR was 36, 36, 36, and 37% (P = 0.988) in the control, D0.25, D0.5, and D1 groups, respectively. And, postoperative vomiting rate and desaturation events were low in the all groups. Conclusion Dexmedetomidine decreased the incidence of emergence agitation without increasing intraoperative oculocardiac reflex. Dexmedetomidine delivered at 1 mu g/kg was more effective at reducing emergence agitation than lower doses in children undergoing strabismus surgery under desflurane anesthesia.	[Song, In-Ae; Oh, Ah-Young; Kim, Jin Hee; Hwang, Jung-Won; Jeon, Young-Tae] Seoul Natl Univ, Dept Anesthesiol & Pain Med, Bundang Hosp, Seongnam, South Korea; [Seo, Kwang-Suk] Seoul Natl Univ, Dept Dent Anesthesiol, Sch Dent, Seoul, South Korea; [Oh, Ah-Young; Kim, Jin Hee; Hwang, Jung-Won; Jeon, Young-Tae] Seoul Natl Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea; [Baik, Ji-Seok] Pusan Natl Univ Hosp, Dept Anesthesiol & Pain Med, Busan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Pusan National University Hospital	Oh, AY (corresponding author), Seoul Natl Univ, Dept Anesthesiol & Pain Med, Bundang Hosp, Seongnam, South Korea.; Oh, AY (corresponding author), Seoul Natl Univ, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea.	ohahyoung@hanmail.net		Seo, Kwang-Suk/0000-0001-5906-0639				Aono J, 1997, ANESTHESIOLOGY, V87, P1298, DOI 10.1097/00000542-199712000-00006; Aouad MT, 2005, CURR OPIN ANESTHESIO, V18, P614, DOI 10.1097/01.aco.0000188420.84763.35; Bhana N, 2000, DRUGS, V59, P263, DOI 10.2165/00003495-200059020-00012; BLOOR BC, 1992, ANESTHESIOLOGY, V77, P1134, DOI 10.1097/00000542-199212000-00014; Chen JY, 2013, CAN J ANESTH, V60, P385, DOI 10.1007/s12630-013-9886-x; Choi SR, 2009, J ANESTH, V23, P489, DOI 10.1007/s00540-009-0801-0; Dahmani S, 2010, BRIT J ANAESTH, V104, P216, DOI 10.1093/bja/aep376; Dong YX, 2010, ANAESTH INTENS CARE, V38, P718, DOI 10.1177/0310057X1003800416; Gan TJ, 2006, ANESTH ANALG, V102, P1884, DOI 10.1213/01.ANE.0000219597.16143.4D; Guler G, 2005, PEDIATR ANESTH, V15, P762, DOI 10.1111/j.1460-9592.2004.01541.x; Ibacache ME, 2004, ANESTH ANALG, V98, P60, DOI 10.1213/01.ANE.0000094947.20838.8E; Isik B, 2006, PEDIATR ANESTH, V16, P748, DOI 10.1111/j.1460-9592.2006.01845.x; Kagawa K, 2005, ANESTH ANALG, V101, P1689, DOI 10.1213/01.ANE.0000184185.69471.F6; KAMIBAYASHI T, 1995, ANESTHESIOLOGY, V83, P1082, DOI 10.1097/00000542-199511000-00022; KEEGAN NJ, 1995, ANAESTHESIA, V50, P200, DOI 10.1111/j.1365-2044.1995.tb04555.x; Khan ZP, 1999, ANAESTHESIA, V54, P146, DOI 10.1046/j.1365-2044.1999.00659.x; Kim J, 2014, YONSEI MED J, V55, P508, DOI 10.3349/ymj.2014.55.2.508; Lam F, 2012, PEDIATR CARDIOL, V33, P1069, DOI 10.1007/s00246-012-0227-6; Manworren Renee C B, 2003, Pediatr Nurs, V29, P140; Mason KP, 2008, PEDIATR ANESTH, V18, P393, DOI 10.1111/j.1460-9592.2008.02451.x; Merkel S I, 1997, Pediatr Nurs, V23, P293; Mizrak A, 2011, MED PRIN PRACT, V20, P427, DOI 10.1159/000324554; Na HS, 2013, ACTA ANAESTH SCAND, V57, P100, DOI 10.1111/aas.12006; Oh AY, 2005, ACTA ANAESTH SCAND, V49, P297, DOI 10.1111/j.1399-6576.2005.00687.x; Olutoye OA, 2010, ANESTH ANALG, V111, P490, DOI 10.1213/ANE.0b013e3181e33429; Rhiu S, 2011, EYE, V25, P154, DOI 10.1038/eye.2010.168; Schmidt AP, 2007, PEDIATR ANESTH, V17, P667, DOI 10.1111/j.1460-9592.2006.02185.x; Shukry M, 2005, PEDIATR ANESTH, V15, P1098, DOI 10.1111/j.1460-9592.2005.01660.x; Sikich N, 2004, ANESTHESIOLOGY, V100, P1138, DOI 10.1097/00000542-200405000-00015; Souter MJ, 2007, J NEUROSURG ANESTH, V19, P38, DOI 10.1097/01.ana.0000211027.26550.24; Sun L, 2014, ACTA ANAESTH SCAND, V58, P642, DOI 10.1111/aas.12292; Tirel O, 2006, BRIT J ANAESTH, V96, P480, DOI 10.1093/bja/ael034; Vlajkovic GP, 2007, ANESTH ANALG, V104, P84, DOI 10.1213/01.ane.0000250914.91881.a8; Voepel-Lewis T, 2003, ANESTH ANALG, V96, P1625, DOI 10.1213/01.ANE.0000062522.21048.61; WATCHA MF, 1992, CAN J ANAESTH, V39, P649, DOI 10.1007/BF03008224; Welborn LG, 1996, ANESTH ANALG, V83, P917, DOI 10.1097/00000539-199611000-00005; Ye Weidi, 2014, Zhonghua Yi Xue Za Zhi, V94, P1479; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099718	38	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162785	10.1371/journal.pone.0162785	http://dx.doi.org/10.1371/journal.pone.0162785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617832	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100052
J	Al-Gaadi, KA; Hassaballa, AA; Tola, E; Kayad, AG; Madugundu, R; Alblewi, B; Assiri, F				Al-Gaadi, Khalid A.; Hassaballa, Abdalhaleem A.; Tola, ElKamil; Kayad, Ahmed G.; Madugundu, Rangaswamy; Alblewi, Bander; Assiri, Fahad			Prediction of Potato Crop Yield Using Precision Agriculture Techniques	PLOS ONE			English	Article							SATELLITE	Crop growth and yield monitoring over agricultural fields is an essential procedure for food security and agricultural economic return prediction. The advances in remote sensing have enhanced the process of monitoring the development of agricultural crops and estimating their yields. Therefore, remote sensing and GIS techniques were employed, in this study, to predict potato tuber crop yield on three 30 ha center pivot irrigated fields in an agricultural scheme located in the Eastern Region of Saudi Arabia. Landsat-8 and Sentinel-2 satellite images were acquired during the potato growth stages and two vegetation indices (the normalized difference vegetation index (NDVI) and the soil adjusted vegetation index (SAVI)) were generated from the images. Vegetation index maps were developed and classified into zones based on vegetation health statements, where the stratified random sampling points were accordingly initiated. Potato yield samples were collected 2-3 days prior to the harvest time and were correlated to the adjacent NDVI and SAVI, where yield prediction algorithms were developed and used to generate prediction yield maps. Results of the study revealed that the difference between predicted yield values and actual ones (prediction error) ranged between 7.9 and 13.5% for Landsat-8 images and between 3.8 and 10.2% for Sentinel-2 images. The relationship between actual and predicted yield values produced R-2 values ranging between 0.39 and 0.65 for Landsat-8 images and between 0.47 and 0.65 for Sentinel-2 images. Results of this study revealed a considerable variation in field productivity across the three fields, where high-yield areas produced an average yield of above 40 t ha(-1); while, the low-yield areas produced, on the average, less than 21 t ha(-1). Identifying such great variation in field productivity will assist farmers and decision makers in managing their practices.	[Al-Gaadi, Khalid A.; Hassaballa, Abdalhaleem A.; Tola, ElKamil; Madugundu, Rangaswamy] King Saud Univ, PARC, Riyadh, Saudi Arabia; [Al-Gaadi, Khalid A.; Kayad, Ahmed G.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Alblewi, Bander; Assiri, Fahad] Saudi Agr Dev Co INMA, Wadi Eddawasir, Saudi Arabia	King Saud University; King Saud University	Hassaballa, AA (corresponding author), King Saud Univ, PARC, Riyadh, Saudi Arabia.	ahassaballa@ksu.edu.sa	Kayad, Ahmed/E-7601-2017; Hassaballa, Abdalhaleem/AAB-7566-2022; Hassaballa, Abdalhaleem/AAV-4851-2021; Tola, ElKamil/AAX-8777-2021; Tola, ElKamil/E-8523-2017; Madugundu, Rangaswamy/N-9214-2013	Kayad, Ahmed/0000-0003-3396-938X; Hassaballa, Abdalhaleem/0000-0001-5881-7273; Tola, ElKamil/0000-0003-0927-9688; Madugundu, Rangaswamy/0000-0002-5326-4785	King Saud University; Vice Deanship of Research Chairs; Saudi Agricultural Development Company (INMA)	King Saud University(King Saud University); Vice Deanship of Research Chairs; Saudi Agricultural Development Company (INMA)	This study was financially supported by King Saud University, Vice Deanship of Research Chairs. I declare that the Saudi Agricultural Development Company (INMA) has provided the support in the form of making the field (the study area) available for data collection. However, INMA did not have any additional role in the data collection and analysis, decision to publish, the preparation of this manuscript, or any financial commitment.	Baez-Gonzalez AD, 2005, AGRON J, V97, P418, DOI 10.2134/agronj2005.0418; Baez-Gonzalez AD, 2002, CROP SCI, V42, P1943, DOI 10.2135/cropsci2002.1943; Bala SK, 2009, INT J REMOTE SENS, V30, P2491, DOI 10.1080/01431160802552744; Dadhwal V. K., 2000, Indian Journal of Agricultural Economics, V55, P55; Doraiswamy PC, 2003, PHOTOGRAMM ENG REM S, V69, P665, DOI 10.14358/PERS.69.6.665; Elhag M, 2016, INT J REMOTE SENS, V14, P1495; Funk C, 2009, REMOTE SENS ENVIRON, V113, P115, DOI 10.1016/j.rse.2008.08.015; Gat N, 2000, ESTIMATING SUGAR BEE; GopalaPillai S, 1999, T ASAE, V42, P1911, DOI 10.13031/2013.13356; GROTEN SME, 1993, INT J REMOTE SENS, V14, P1495, DOI 10.1080/01431169308953983; Hassaballa A. A., 2011, 2011 Proceedings of the International Conference on Space Science and Communication (IconSpace 2011), P20, DOI 10.1109/IConSpace.2011.6015844; Hassaballa A. Abdalla, 2013, CASP J APPL SCI RES, V2, P182; Hassaballa AA, 2014, ARAB J GEOSCI, V7, P2831, DOI 10.1007/s12517-013-0990-6; Haverkort AJ, 1995, CURRENT ISSUES PRODU, V3, P396; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Jayanthi H, 2003, THESIS; Lamb DW, 1999, WEED RES, V39, P481, DOI 10.1046/j.1365-3180.1999.00167.x; Lillesand T.M., 1994, REMOTE SENSING IMAGE, Vthird, P750; Liu WT, 2002, INT J REMOTE SENS, V23, P1161, DOI 10.1080/01431160110076126; Lobell DB, 2005, AGRON J, V97, P241; Los SO, 1998, THESIS; Magri Antoni, 2005, Precision Agriculture, V6, P87, DOI 10.1007/s11119-004-0687-7; Miura T, 2000, IEEE T GEOSCI REMOTE, V38, P1399, DOI 10.1109/36.843034; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Palaniswami MS, 2008, HORTICULTURE SCI SER, V09, P167; PRINCE SD, 1990, EAST SCH AG, P169; Rasmussen MS, 1997, INT J REMOTE SENS, V18, P1059, DOI 10.1080/014311697218575; Reynolds CA, 2000, INT J REMOTE SENS, V21, P3487, DOI 10.1080/014311600750037516; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sawasawa Haig L S, 2003, THESIS; Senay GB, 1998, T ASAE, V41, P489, DOI 10.13031/2013.17170; SHARMA T, 1993, INT J REMOTE SENS, V14, P2509, DOI 10.1080/01431169308904289; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Taylor J. C., 1997, Precision agriculture '97. Volume II. Technology, IT and management. Papers presented at the First European Conference on Precision Agriculture, Warwick University, UK, 7-10 September 1997., P713; Yang ChengHai, 2000, Precision Agriculture, V2, P7, DOI 10.1023/A:1009928431735; Yang P., 2004, P 20 ISPRS C P COMMI, P150	36	75	75	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162219	10.1371/journal.pone.0162219	http://dx.doi.org/10.1371/journal.pone.0162219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611577	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900060
J	Baumgartner, S; Mensink, RP; Plat, J				Baumgartner, Sabine; Mensink, Ronald P.; Plat, Jogchum			Effects of a Plant Sterol or Stanol Enriched Mixed Meal on Postprandial Lipid Metabolism in Healthy Subjects	PLOS ONE			English	Article							NONFASTING TRIGLYCERIDES; HEART-DISEASE; FATTY-ACIDS; CHOLESTEROL; LIPEMIA; PLASMA; RISK; LIPOPROTEINS; CONSUMPTION; MARGARINE	Background Evidence is increasing that plant sterols and stanols not only lower fasting serum low-density lipoprotein concentrations, but also those of triglycerides (TG). Insight into effects of these components on postprandial TG metabolism, an emerging risk factor for cardiovascular disease, is missing. Objective Our objective was to examine the 8-hour postprandial response after consuming plant sterol or stanol enriched margarine as part of a mixed meal. Methods This postprandial study was part of a randomized crossover study in which 42 subjects consumed plant sterol enriched (3 g/d plant sterols), plant stanol enriched (3 g/d plant stanols), and control margarines for 4 weeks. After each period, subjects consumed a shake enriched with 3g plant sterols (sterol period), 3g plant stanols (stanol period) or no addition (control period). Subjects received a second shake with no addition after 4 hours. Results TG and apoB48 incremental areas under the curves (iAUC) of the total (0-8h) and 1st meal response (0-4h) were comparable between the meals and in all age categories (I: 18-35y, II: 36-52y, III: 53-69y). In subjects aged 53-69y, TG iAUC after the 2nd meal (4-8h) was higher in the stanol period as compared with the sterol (63.1 +/- 53.0 mmol/L/min; P < 0.01) and the control period (43.2 +/- 52.4 mmol/L/min; P < 0.05). ApoB48 iAUC after the 2nd meal was higher after the stanol than after the sterol period (67.1 +/- 77.0 mg/L/min; P < 0.05) and tended to be higher than after the control period (43.1 +/- 64.5 mg/L/min; P = 0.08) in subjects aged 53-69y. These increased postprandial responses may be due to reduced lipoprotein lipase activity, since postprandial apoCIII/II ratios were increased after stanol consumption compared with the control meal. Conclusion Postprandial TG and apoB48 responses are age-dependently increased after plant stanol consumption, which might be related to a changed clearance of triglyceride-rich lipoproteins.	[Baumgartner, Sabine; Mensink, Ronald P.; Plat, Jogchum] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Baumgartner, S (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands.	sabine.baumgartner@maastrichtuniversity.nl			Netherlands Organization for Scientific Research (TOP) [91208006]	Netherlands Organization for Scientific Research (TOP)(Netherlands Organization for Scientific Research (NWO))	The project was funded by the Netherlands Organization for Scientific Research, http://www.nwo.nl (TOP grant No. 91208006). Prof J. Plat received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Baumgartner S, 2013, ATHEROSCLEROSIS, V227, P414, DOI 10.1016/j.atherosclerosis.2013.01.012; Beaumier-Gallon G, 1998, ATHEROSCLEROSIS, V141, pS81, DOI 10.1016/S0021-9150(98)00223-8; Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100; Cohn JS, 2006, CLIN LAB MED, V26, P773, DOI 10.1016/j.cll.2006.07.003; COHN JS, 1993, J LIPID RES, V34, P2033; De Smet E, 2012, MOL NUTR FOOD RES, V56, P1058, DOI 10.1002/mnfr.201100722; Demonty I, 2013, EUR J NUTR, V52, P153, DOI 10.1007/s00394-011-0297-x; Demonty I, 2006, AM J CLIN NUTR, V84, P1534, DOI 10.1093/ajcn/84.6.1534; Fielding B, 2011, P NUTR SOC, V70, P342, DOI 10.1017/S002966511100084X; Fransen HP, 2007, J NUTR, V137, P1301, DOI 10.1093/jn/137.5.1301; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Gylling H, 2012, EUR J NUTR, V51, P615, DOI 10.1007/s00394-011-0249-5; Gylling H, 2014, ATHEROSCLEROSIS, V232, P346, DOI 10.1016/j.atherosclerosis.2013.11.043; Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8; Hovenkamp E, 2008, PROG LIPID RES, V47, P37, DOI 10.1016/j.plipres.2007.10.001; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P237, DOI 10.1016/j.atherosclerosis.2011.09.047; Jackson KG, 2010, ATHEROSCLEROSIS, V208, P246, DOI 10.1016/j.atherosclerosis.2009.06.030; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Masson CJ, 2011, J NUTR, V141, P816, DOI 10.3945/jn.110.136432; Moens SJB, 2014, CURR OPIN LIPIDOL, V25, P418, DOI 10.1097/MOL.0000000000000130; Naissides M, 2004, ATHEROSCLEROSIS, V177, P401, DOI 10.1016/j.atherosclerosis.2004.07.025; Naumann E, 2008, J AM COLL NUTR, V27, P117, DOI 10.1080/07315724.2008.10719683; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Plat J, 2012, ATHEROSCLEROSIS, V225, P521, DOI 10.1016/j.atherosclerosis.2012.09.018; Relas H, 2001, BRIT J NUTR, V85, P141, DOI 10.1079/BJN2000231; Relas H, 2000, METABOLISM, V49, P473, DOI 10.1016/S0026-0495(00)80011-6; Rideout TC, 2010, MOL NUTR FOOD RES, V54, pS7, DOI 10.1002/mnfr.201000027; Sanders TAB, 2011, AM J CLIN NUTR, V94, P1433, DOI 10.3945/ajcn.111.017459; Sarwar N, 2009, CURR OPIN LIPIDOL, V20, P275, DOI 10.1097/MOL.0b013e32832dd4dc; Schonewille M, 2014, J LIPID RES, V55, P2554, DOI 10.1194/jlr.M052407; Silva KKDR, 2005, EUR J NUTR, V44, P377, DOI 10.1007/s00394-004-0538-3; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WILSON DE, 1983, METABOLISM, V32, P514, DOI 10.1016/0026-0495(83)90016-1; Xiao CT, 2012, BBA-MOL CELL BIOL L, V1821, P736, DOI 10.1016/j.bbalip.2011.09.019; Zheng CY, 2014, CURR OPIN LIPIDOL, V25, P35, DOI 10.1097/MOL.0000000000000040	37	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160396	10.1371/journal.pone.0160396	http://dx.doi.org/10.1371/journal.pone.0160396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611192	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900005
J	DiStefano, PV; Smrcka, AV; Glading, AJ				DiStefano, Peter V.; Smrcka, Alan V.; Glading, Angela J.			Phospholipase C epsilon Modulates Rap1 Activity and the Endothelial Barrier	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; CELL-CELL JUNCTIONS; VASCULAR-PERMEABILITY; CARDIAC-HYPERTROPHY; SIGNALING NETWORKS; FOCAL ADHESIONS; STRESS FIBERS; RHO KINASE; RAS; BETA	The phosphoinositide-specific phospholipase C, PLC epsilon, is a unique signaling protein with known roles in regulating cardiac myocyte growth, astrocyte inflammatory signaling, and tumor formation. PLC epsilon is also expressed in endothelial cells, however its role in endothelial regulation is not fully established. We show that endothelial cells of multiple origins, including human pulmonary artery (HPAEC), human umbilical vein (HUVEC), and immortalized brain microvascular (hCMEC/D3) endothelial cells, express PLC epsilon. Knockdown of PLC epsilon in arterial endothelial monolayers decreased the effectiveness of the endothelial barrier. Concomitantly, RhoA activity and stress fiber formation were increased. PLC epsilon-deficient arterial endothelial cells also exhibited decreased Rap1-GTP levels, which could be restored by activation of the Rap1 GEF, Epac, to rescue the increase in monolayer leak. Reintroduction of PLC epsilon rescued monolayer leak with both the CDC25 GEF domain and the lipase domain of PLC epsilon required to fully activate Rap1 and to rescue endothelial barrier function. Finally, we demonstrate that the barrier promoting effects PLC epsilon are dependent on Rap1 signaling through the Rap1 effector, KRIT1, which we have previously shown is vital for maintaining endothelial barrier stability. Thus we have described a novel role for PLC epsilon PIP2 hydrolytic and Rap GEF activities in arterial endothelial cells, where PLC epsilon-dependent activation of Rap1/KRIT1 signaling promotes endothelial barrier stability.	[DiStefano, Peter V.; Smrcka, Alan V.; Glading, Angela J.] Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA	University of Rochester	Glading, AJ (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	angela_glading@urmc.rochester.edu	Glading, Angela/AAI-3455-2020	Glading, Angela/0000-0002-1830-6601	National Institutes of Health [HL117885-01]; American Heart Association predoctoral fellowship [14PRE2038009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant HL117885-01 to A.J. Glading and American Heart Association predoctoral fellowship 14PRE2038009 to P.V. DiStefano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beziau DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123769; Bijli KM, 2016, AM J PHYSIOL-LUNG C, V311, pL517, DOI 10.1152/ajplung.00069.2016; Bogatcheva NV, 2003, AM J PHYSIOL-LUNG C, V285, pL415, DOI 10.1152/ajplung.00364.2001; Bokhari SM, 2006, J INVEST DERMATOL, V126, P460, DOI 10.1038/sj.jid.5700071; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145689; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Corr M, 2012, ARTERIOSCL THROM VAS, V32, P2702, DOI 10.1161/ATVBAHA.112.300115; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; DiStefano PV, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582304; Dusaban SS, 2015, J BIOL CHEM, V290, P26776, DOI 10.1074/jbc.M115.676098; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Hoeppner LH, 2012, BLOOD, V120, P2167, DOI 10.1182/blood-2012-03-417824; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Lo Vasco VR, 2011, J CLIN PATHOL, V64, P911, DOI 10.1136/jclinpath-2011-200096; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Meliton A, 2015, AM J RESP CELL MOL, V53, P834, DOI 10.1165/rcmb.2014-0376OC; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Pappa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1036-1; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Post A, 2015, MOL CELL BIOL, V35, P2495, DOI 10.1128/MCB.01453-14; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sahoo T, 2001, GENOMICS, V71, P123, DOI 10.1006/geno.2000.6426; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Sumagin R, 2008, AM J PHYSIOL-HEART C, V295, pH969, DOI 10.1152/ajpheart.00400.2008; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162338	10.1371/journal.pone.0162338	http://dx.doi.org/10.1371/journal.pone.0162338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612188	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900079
J	Enoru, JO; Yang, B; Krishnamachari, S; Villanueva, E; DeMaio, W; Watanyar, A; Chinnasamy, R; Arterburn, JB; Perez, RG				Enoru, Julius O.; Yang, Barbara; Krishnamachari, Sesha; Villanueva, Ernesto; DeMaio, William; Watanyar, Adiba; Chinnasamy, Ramesh; Arterburn, Jeffrey B.; Perez, Ruth G.			Preclinical Metabolism, Pharmacokineticsand In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; TYROSINE-HYDROXYLASE PHOSPHORYLATION; RELAPSING MULTIPLE-SCLEROSIS; SYNUCLEIN TRANSGENIC MICE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DOPAMINERGIC CELLS; ALZHEIMERS-DISEASE; RECEPTOR MODULATOR; DRUG FTY720	Parkinson's disease (PD) is a neurodegenerative aging disorder in which postmortemPD brain exhibits neuroinflammation, as well as synucleinopathy-associated protein phosphatase 2A (PP2A) enzymatic activity loss. Based on our translational research, we began evaluating the PD-repurposing-potential of an anti-inflammatory, neuroprotective, and PP2A stimulatory oral drug that is FDA-approved for multiple sclerosis, FTY720 (fingolimod, Gilenya 1). We also designed two new FTY720 analogues, FTY720-C2 and FTY720Mitoxy, with modifications that affect drug potency and mitochondrial localization, respectively. Herein, we describe the metabolic stability and metabolic profiling of FTY720-C2 and FTY720-Mitoxy in liver microsomes and hepatocytes. Using mouse, rat, dog, monkey, and human liver microsomes the intrinsic clearance of FTY720-C2 was 22.5, 79.5, 6.0, 20.2 and 18.3 similar to L/min/mg; and for FTY720-Mitoxy was 1.8, 7.8, 1.4, 135.0 and 17.5 mu L/min/mg, respectively. In hepatocytes, both FTY720-C2 and FTY720-Mitoxy were metabolized from the octyl side chain, generating a series of carboxylic acids similar to the parent FTY720, but without phosphorylated metabolites. To assess absorption and distribution, we gave equivalent single intravenous (IV) or oral doses of FTY720-C2 or FTY720-Mitoxy to C57BL/ 6 mice, with two mice per time point evaluated. After IV delivery, both FTY720-C2 and FTY720-Mitoxy were rapidly detected in plasma and brain; and reached peak concentrations at the first sampling time points. After oral dosing, FTY720-C2 was present in plasma and brain, although FTY720-Mitoxy was not orally bioavailable. Brain-to-plasma ratio of both compounds increased time-dependently, suggesting a preferential partitioning to the brain. PP2A activity in mouse adrenal gland increased similar to 2-fold after FTY720-C2 or FTY720Mitoxy, as compared to untreated controls. In summary, FTY720-C2 and FTY720-Mitoxy both (i) crossed the blood-brain-barrier; (ii) produced metabolites similar to FTY720, except without phosphorylated species that cause S1P(1)-mediated-immunosuppression; and (iii) stimulated in vivo PP2A activity, all of which encourage additional preclinical assessment.	[Enoru, Julius O.; DeMaio, William; Watanyar, Adiba] Ric Biosci LLC, In Vitro & Mol Metab Lab, Concord, OH USA; [Yang, Barbara; Krishnamachari, Sesha; Villanueva, Ernesto; Perez, Ruth G.] Texas Tech Univ Hlth Sci Ctr El Paso, Paul L Foster Sch Med, Ctr Emphasis Neurosci, Dept Biomed Sci,Grad Sch Biomed Sci, El Paso, TX 79905 USA; [Chinnasamy, Ramesh; Arterburn, Jeffrey B.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Perez, RG (corresponding author), Texas Tech Univ Hlth Sci Ctr El Paso, Paul L Foster Sch Med, Ctr Emphasis Neurosci, Dept Biomed Sci,Grad Sch Biomed Sci, El Paso, TX 79905 USA.	ruth.g.perez@ttuhsc.edu	Perez, Ruth G./AAK-9844-2020		Lizanell and Colbert Coldwell Foundation; Texas Tech University Health Sciences Center El Paso Startup Funds; Ricerca Biosciences, LLC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; Texas Tech University Health Sciences Center El Paso Startup Funds; Ricerca Biosciences, LLC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for the project was provided by the Lizanell and Colbert Coldwell Foundation and by Texas Tech University Health Sciences Center El Paso Startup Funds to RGP. These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Much of the work was contracted with Ricerca Biosciences, LLC, who provided support in the form of salaries to these authors (JOE, WDM, and AW). The commercial entity did not play any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors of the manuscript assisted with experimental design, data generation, data analysis, and figure and manuscript preparation, and manuscript editing, as described in the Author Contributions section.	Albert R, 2005, J MED CHEM, V48, P5373, DOI 10.1021/jm050242f; Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Alexander Garrett E, 2004, Dialogues Clin Neurosci, V6, P259; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Banks WA, 2010, FORUM NUTR, V63, P102, DOI 10.1159/000264398; Benskey M. J., 2016, J NEUROCHEM; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BLASCHKO H, 1967, BIOCHEM J, V104, P545, DOI 10.1042/bj1040545; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Di Pardo A, 2014, HUM MOL GENET, V23, P2251, DOI 10.1093/hmg/ddt615; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Farrell KF, 2014, J NEUROCHEM, V128, P536, DOI 10.1111/jnc.12481; Fathi AR, 2002, ANAL BIOCHEM, V310, P208, DOI 10.1016/S0003-2697(02)00377-9; Gao F, 2012, PHARMACOL BIOCHEM BE, V103, P187, DOI 10.1016/j.pbb.2012.08.025; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Jin Y, 2011, DRUG METAB DISPOS, V39, P191, DOI 10.1124/dmd.110.035378; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kovarik JM, 2004, THER DRUG MONIT, V26, P585, DOI 10.1097/00007691-200412000-00001; Kovarik JM, 2005, J CLIN PHARMACOL, V45, P446, DOI 10.1177/0091270004274288; Kovarik JM, 2004, BRIT J CLIN PHARMACO, V57, P586, DOI 10.1111/j.1365-2125.2003.02065.x; Kovarik JM, 2007, BIOPHARM DRUG DISPOS, V28, P97, DOI 10.1002/bdd.535; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Liu F, 2005, EUROPEAN J NEUROSCIE, V22; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Matloubian M, 2004, NATURE, V427; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Motulsky HJ, 2007, PRISM VERSION 5 0 ST; Noda H, 2013, J NEUROIMMUNOL, V256, P13, DOI 10.1016/j.jneuroim.2012.12.005; Oaks JJ, 2013, BLOOD, V122, P1923, DOI 10.1182/blood-2013-03-492181; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porras J. L., 2014, POTENTIAL CONTRIBUTI, P51; Sharma S, 2011, J PHARMACOL PHARMACO, V2, P49, DOI 10.4103/0976-500X.77118; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snelder N, 2014, DRUG METAB DISPOS, V42, P1367, DOI 10.1124/dmd.113.056770; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vargas-Medrano J, 2014, ACS MED CHEM LETT, V5, P782, DOI 10.1021/ml500128g; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Wu J, 2012, NEUROSCIENCE, V207, P288, DOI 10.1016/j.neuroscience.2012.01.028; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zollinger M, 2011, DRUG METAB DISPOS, V39, P199, DOI 10.1124/dmd.110.035907	65	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162162	10.1371/journal.pone.0162162	http://dx.doi.org/10.1371/journal.pone.0162162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611691	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900049
J	Jeong, JH; Woo, YJ; Chua, S; Jo, YH				Jeong, Jae Hoon; Woo, Young Jae; Chua, Streamson, Jr.; Jo, Young-Hwan			Single-Cell Gene Expression Analysis of Cholinergic Neurons in the Arcuate Nucleus of the Hypothalamus	PLOS ONE			English	Article							ANOREXIGENIC PROOPIOMELANOCORTIN NEURONS; NEUROPEPTIDE-Y NEURONS; MUSCARINIC ACETYLCHOLINE-RECEPTORS; REGULATES GLUCOSE-HOMEOSTASIS; NERVOUS-SYSTEM CONTROL; POMC NEURONS; FOOD-INTAKE; ENERGY-BALANCE; AGRP NEURONS; INSULIN SENSITIVITY	The cholinoceptive system in the hypothalamus, in particular in the arcuate nucleus (ARC), plays a role in regulating food intake. Neurons in the ARC contain multiple neuropeptides, amines, and neurotransmitters. To study molecular and neurochemical heterogeneity of ARC neurons, we combine single-cell qRT-PCR and single-cell whole transcriptome amplification methods to analyze expression patterns of our hand-picked 60 genes in individual neurons in the ARC. Immunohistochemical and single-cell qRT-PCR analyses show choline acetyltransferase (ChAT)-expressing neurons in the ARC. Gene expression patterns are remarkably distinct in each individual cholinergic neuron. Two-thirds of cholinergic neurons express tyrosine hydroxylase (Th) mRNA. A large subset of these Th-positive cholinergic neurons is GABAergic as they express the GABA synthesizing enzyme glutamate decarboxylase and vesicular GABA transporter transcripts. Some cholinergic neurons also express the vesicular glutamate transporter transcript gene. POMC and POMC-processing enzyme transcripts are found in a subpopulation of cholinergic neurons. Despite this heterogeneity, gene expression patterns in individual cholinergic cells appear to be highly regulated in a cell-specific manner. In fact, membrane receptor transcripts are clustered with their respective intracellular signaling and downstream targets. This novel population of cholinergic neurons may be part of the neural circuitries that detect homeostatic need for food and control the drive to eat.	[Jeong, Jae Hoon; Chua, Streamson, Jr.; Jo, Young-Hwan] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA; [Woo, Young Jae] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Jo, Young-Hwan] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA.; Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	young-hwan.jo@einstein.yu.edu		Jo, Young-Hwan/0000-0001-6939-8000; Woo, Young/0000-0002-9233-5099	NIDDK [RO1DK092246]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092246, P30DK026687, P30DK057521] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK (RO1DK092246) to Y.-H.J.	Acuna-Goycolea C, 2009, J NEUROSCI, V29, P1503, DOI 10.1523/JNEUROSCI.5147-08.2009; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Brown DA, 2010, J MOL NEUROSCI, V41, P340, DOI 10.1007/s12031-010-9377-2; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Coll AP, 2004, J CLIN ENDOCR METAB, V89, P2557, DOI 10.1210/jc.2004-0428; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fu LY, 2010, J NEUROSCI, V30, P10205, DOI 10.1523/JNEUROSCI.2098-10.2010; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Guo L, 2004, P NATL ACAD SCI USA, V101, P11797, DOI 10.1073/pnas.0403165101; Huang H, 2011, J NEUROPHYSIOL, V106, P1191, DOI 10.1152/jn.00740.2010; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jeong JH, 2015, MOL METAB, V4, P483, DOI 10.1016/j.molmet.2015.03.006; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Lee DK, 2015, NATURE COMM IN PRESS; Lee DK, 2015, PLOS ONE IN PRESS; Lee DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7618; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Qi Y, 2015, J NEUROSCI, V35, P13171, DOI 10.1523/JNEUROSCI.0855-15.2015; Qiu J, 2014, CELL METAB, V19, P682, DOI 10.1016/j.cmet.2014.03.004; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Roepke TA, 2011, J NEUROSCI, V31, P11825, DOI 10.1523/JNEUROSCI.1395-11.2011; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Sohn JW, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00085; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Team RC, 2015, R LANG ENV STAT COMP; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Woolf NJ, 1999, TRENDS NEUROSCI, V22, P540, DOI 10.1016/S0166-2236(99)01474-5; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Zhang XB, 2015, J NEUROSCI, V35, P14966, DOI 10.1523/JNEUROSCI.0293-15.2015	50	29	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162839	10.1371/journal.pone.0162839	http://dx.doi.org/10.1371/journal.pone.0162839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611685	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900178
J	Ouyang, Y; Xie, JY; Yang, M; Zhang, XY; Ren, H; Wang, WM; Chen, N				Ouyang, Yan; Xie, Jingyuan; Yang, Meng; Zhang, Xiaoyan; Ren, Hong; Wang, Weiming; Chen, Nan			Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY-RELATED GLOMERULOPATHY; KIDNEY-DISEASE; METABOLIC SYNDROME; NATURAL-HISTORY; SERUM C3; COMPLEMENT; ASSOCIATION; PROGRESSION; MORTALITY	Studies on the relationship between body mass index (BMI) and renal progression in IgA Nephropathy (IgAN) were limited, especially for underweight patients with IgAN. To elucidate the clinical features and effect of underweight on renal function deterioration in this disease, we recruited IgAN patients with diagnostic age >= 18 years old and a baseline estimated glomerular filtration rate (eGFR) >= 15 ml/min/1.73m(2) from our center between 1985 and 2014. Patients secondary to systemic diseases or follow-up less than 6 months were excluded. All patients' clinical data at renal biopsy and during follow-up were recorded. Renal outcome was defined as end-stage kidney disease (ESRD). Baseline body mass index (BMI) was calculated by weight (kg) over squared height (m(2)). According to WHO Asian guideline, BMI was categorized as follows: <18.5kg/m(2) (underweight), 18.5-22.99kg/m(2) (normal weight), 23-27.49kg/m(2) (overweight) and obese (>= 27.5 kg/m(2)). Of 930 primary IgAN patients enrolled in this study, mean age at renal biopsy was 37.6 years and 49.2% were men. Totally, 114 (12.3%) ESRD occurred after a mean follow-up of 47.1 months. More ESRD happened in underweight patients (17.3%) compared to patients with normal weight (13.2%), overweight (11.0%) or obesity (9.5%). By multivariate Cox regression analysis, underweight was independently associated with a higher risk of ESRD after adjustment for demographic characteristics and clinical variables (HR: 3.5, 95% CI: 1.3-9.5, P = 0.01) comparing to normal weight. Underweight patients had lower hemoglobin, serum uric acid, triglycerides, cholesterol and lymphocyte counts than patients with normal weight. Furthermore, BMI was positively correlated with serum C3 (r = 0.25, p <0.001). Our research finds that underweight is an independent risk factor for kidney disease progression in IgAN, which might be associated with malnutrition status and decreased C3 levels.	[Ouyang, Yan; Xie, Jingyuan; Yang, Meng; Zhang, Xiaoyan; Ren, Hong; Wang, Weiming; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Inst Nephrol,Ruijin Hosp, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Chen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Inst Nephrol,Ruijin Hosp, Shanghai 200025, Peoples R China.	cnrj100@126.com	Xie, Jingyuan/AAX-2708-2021; xie, jing/GRY-1689-2022		National Basic Research Program of China 973 [2012CB517604, 2012CB517701]; Health industry research projects [201002010]; National Key Technology RD Program [2011BAI10B06, 12-5]; National Natural Science Foundation of China [81570598, 81370015]; Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant [20152207]; Shanghai Science and Technology Committee [14430721000]	National Basic Research Program of China 973(National Basic Research Program of China); Health industry research projects; National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	NC is supported by grants from the National Basic Research Program of China 973 (No. 2012CB517604, No. 2012CB517701, http://www.nsfc.gov.cn/), Health industry research projects (No. 201002010, http://www.moh.gov.cn), and National Key Technology R&D Program (12-5) (No. 2011BAI10B06, http://www.nsfc.gov.cn/). JX is supported by the National Natural Science Foundation of China (No. 81570598, 81370015, http://www.nsfc.gov.cn/), Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant (20152207, http://www.shmec.gov.cn), Shanghai Science and Technology Committee (No. 14430721000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Berthoux F, 2013, NEPHROL DIAL TRANSPL, V28, P160, DOI 10.1093/ndt/gft286; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; CHOY LN, 1992, J BIOL CHEM, V267, P12736; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; Dittmann K, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-87; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Gabrielsson BG, 2003, OBES RES, V11, P699, DOI 10.1038/oby.2003.100; Gao BX, 2016, EUR J INTERN MED, V29, P46, DOI 10.1016/j.ejim.2015.11.020; GERMINARIO R, 1993, METABOLISM, V42, P574, DOI 10.1016/0026-0495(93)90215-A; Hartley G H, 2001, EDTNA ERCA J, V27, P101; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; Hernandez-Mijares A, 2012, EUR J CLIN INVEST, V42, P503, DOI 10.1111/j.1365-2362.2011.02606.x; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Ikizler TA, 2008, CURR OPIN NEPHROL HY, V17, P162, DOI 10.1097/MNH.0b013e3282f5dbce; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; Khedr A, 2011, J RENAL NUTR, V21, P455, DOI 10.1053/j.jrn.2010.12.001; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040495; Kiryluk K, 2013, ANNU REV MED, V64, P339, DOI 10.1146/annurev-med-041811-142014; Komatsu H, 2004, INTERNAL MED, V43, P1023, DOI 10.2169/internalmedicine.43.1023; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Krikken JA, 2007, KIDNEY INT, V71, P260, DOI 10.1038/sj.ki.5002011; Kwan BCH, 2007, CLIN J AM SOC NEPHRO, V2, P992, DOI 10.2215/CJN.04221206; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; McCarthy M, 2004, LANCET, V364, P2169, DOI 10.1016/S0140-6736(04)17613-7; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; Muscari A, 1998, ACTA CARDIOL, V53, P345; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; Nakayama K, 2008, J CLIN LAB ANAL, V22, P114, DOI 10.1002/jcla.20227; Obermayr RP, 2009, NEPHROL DIAL TRANSPL, V24, P2421, DOI 10.1093/ndt/gfp075; Ogden CL, 2003, ENDOCRIN METAB CLIN, V32, P741, DOI 10.1016/S0889-8529(03)00074-4; Onat A, 2005, CLIN SCI, V108, P129, DOI 10.1042/CS20040198; Othman M, 2009, NEPHRON CLIN PRACT, V113, pC16, DOI 10.1159/000228071; Ricardo AC, 2015, AM J KIDNEY DIS, V65, P412, DOI 10.1053/j.ajkd.2014.09.016; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; SCHENA FP, 1990, AM J MED, V89, P209; Shimamoto M, 2015, J CLIN LAB ANAL, V29, P353, DOI 10.1002/jcla.21778; Sowers JR, 2007, KIDNEY INT, V71, P719, DOI 10.1038/sj.ki.5002006; Tomino Y, 2000, J CLIN LAB ANAL, V14, P220, DOI 10.1002/1098-2825(2000)14:5<220::AID-JCLA4>3.3.CO;2-U; Tsuboi N, 2013, CLIN EXP NEPHROL, V17, P379, DOI 10.1007/s10157-012-0719-y; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Wang LP, 2010, J CLIN PATHOL, V63, P697, DOI 10.1136/jcp.2009.074278; Wang WM, 2013, CONTRIB NEPHROL, V181, P75, DOI 10.1159/000348460; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Xie J, 2016, J AM SOC NEPHROL; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Zhou FD, 2009, NEPHROL DIAL TRANSPL, V24, P870, DOI 10.1093/ndt/gfn554; Zhou XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061208; ZIMMER B, 1982, EUR J IMMUNOL, V12, P426, DOI 10.1002/eji.1830120513	64	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162044	10.1371/journal.pone.0162044	http://dx.doi.org/10.1371/journal.pone.0162044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611091	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900043
J	Stearns, NA; Zhou, SX; Petri, M; Binder, SR; Pisetsky, DS				Stearns, Nancy A.; Zhou, Shuxia; Petri, Michelle; Binder, Steven R.; Pisetsky, David S.			The Use of Poly-L-Lysine as a Capture Agent to Enhance the Detection of Antinuclear Antibodies by ELISA	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LINKED-IMMUNOSORBENT-ASSAY; ACID-BINDING POLYMERS; ENZYME-IMMUNOASSAY; IMMUNOFLUORESCENCE ASSAY; ANTIINFLAMMATORY AGENTS; AUTOANTIBODY DETECTION; DEFINED SPECIFICITIES; MULTIPLEX IMMUNOASSAY; RECOMBINANT ANTIGENS	Antibodies to nuclear antigens (antinuclear antibodies or ANAs) are the serological hallmark of systemic lupus erythematosus (SLE). These antibodies bind diverse nuclear antigens that include DNA, histones and non-histone proteins as well as complexes of proteins with DNA and RNA. Because of the frequency of ANA expression in SLE, testing is an important component of clinical evaluation as well as determination of eligibility for clinical trials or utilization of certain therapies. Immunofluorescence assays have been commonly used for this purpose although this approach can be limited by issues of throughput, variability and difficulty in determining positivity. ELISA and multiplex assays are also useful approaches although these assays may give an incomplete picture of antibodies present. To develop a sensitive and quantitative ANA assay, we have explored an ELISA platformin which plates are pre-coated with a positively charged nucleic acid binding polymer (NABP) to increase adherence of antigens containing DNA or RNA. As a source of antigens, we have used supernatants of Jurkat cells undergoing apoptosis in vitro. As results presented show, a poly-L-lysine (PLL) pre-coat significantly enhances detection of antibodies to DNA as well as antigens such as histones, SSA, SSB and RNP. Comparison of the ELISA assay with the PLL pre-coat with a multiplex assay using the BioPlex (R) 2200 system indicated good agreement in results for a panel of lupus sera. Together, these studies indicate that a pre-coat with a positively charged polymer can increase the sensitivity of an ANA ELISA using as antigens molecules released from dead and dying cells. This assay platform may facilitate ANA testing by providing an ensemble of antigens more similar in composition and structure with antigens present in vivo, with a NABP promoting adherence via charge-charge interactions.	[Stearns, Nancy A.; Pisetsky, David S.] Duke Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol, Durham, NC 27710 USA; [Pisetsky, David S.] VA Med Ctr, Med Res Serv, Durham, NC 27705 USA; [Zhou, Shuxia; Binder, Steven R.] Bio Rad Labs Clin Diagnost Grp, 400 Alfred Nobel Dr, Hercules, CA USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Div Rheumatol, 1830 East Monument St,Suite 7500, Baltimore, MD USA	Duke University; Johns Hopkins University	Pisetsky, DS (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol, Durham, NC 27710 USA.; Pisetsky, DS (corresponding author), VA Med Ctr, Med Res Serv, Durham, NC 27705 USA.	david.pisetsky@duke.edu		Binder, Steven/0000-0003-4091-2090	VA Merit Review; Alliance for Lupus Research; National Institutes of Health [AR43727]; Bio-Rad	VA Merit Review(US Department of Veterans Affairs); Alliance for Lupus Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bio-Rad	This study received funding from VA Merit Review, Alliance for Lupus Research, and National Institutes of Health AR43727. Co-authors Shuxia Zhou and Steven R. Binder received salary from Bio-Rad, a commercial company, during this study. The contributions of Bio-Rad relate to the performance of the comparative study, establishment of cut-off values and review of the manuscript. Bio-Rad did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Al Sawah S, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000066; Gonzalez DA, 2011, IMMUNOL LETT, V140, P30, DOI 10.1016/j.imlet.2011.06.001; Bardin N, 2009, AUTOIMMUNITY, V42, P63, DOI 10.1080/08916930802354906; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; BenoreParsons M, 1997, BIOTECHNIQUES, V23, P128, DOI 10.2144/97231st04; Bernardini S, 2004, CLIN CHEM LAB MED, V42, P1155, DOI 10.1515/CCLM.2004.235; Binder SR, 2006, LUPUS, V15, P412, DOI 10.1191/0961203306lu2326oa; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; Choy JS, 2012, TRENDS BIOCHEM SCI, V37, P425, DOI 10.1016/j.tibs.2012.06.006; Copple SS, 2012, AM J CLIN PATHOL, V137, P825, DOI 10.1309/AJCPICNFG7UCES1S; Copple SS, 2011, AM J CLIN PATHOL, V135, P678, DOI 10.1309/AJCP6R8EELGODAYW; Dieker J, 2016, ARTHRITIS RHEUMATOL, V68, P462, DOI 10.1002/art.39417; Dieker JW, 2005, J IMMUNOL METHODS, V296, P83, DOI 10.1016/j.jim.2004.10.010; Fangtham M, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0360-0; Faria AC, 2005, J RHEUMATOL, V32, P1267; Fritzler MJ, 2003, J RHEUMATOL, V30, P2374; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Gniewek RA, 1997, CLIN DIAGN LAB IMMUN, V4, P185, DOI 10.1128/CDLI.4.2.185-188.1997; Hayashi N, 2001, CLIN CHEM, V47, P1649; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Holl EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069413; Ippolito A, 2011, LUPUS, V20, P250, DOI 10.1177/0961203310385738; Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; KAVAI M, 1982, J IMMUNOL METHODS, V48, P169, DOI 10.1016/0022-1759(82)90191-0; Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; KLOTZ JL, 1979, J IMMUNOL METHODS, V29, P155, DOI 10.1016/0022-1759(79)90065-6; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Moder KG, 2007, J RHEUMATOL, V34, P978; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Munoz LE, 2009, ARTHRITIS RHEUM-US, V60, P1733, DOI 10.1002/art.24535; N'Soukpoe-Kossi CN, 2007, DNA CELL BIOL, V26, P28, DOI 10.1089/dna.2006.9999; Nakajima A, 2008, J BIOL CHEM, V283, P24128, DOI 10.1074/jbc.M802996200; Op De Beeck K, 2012, AUTOIMMUN REV, V12, P137, DOI 10.1016/j.autrev.2012.02.013; Pisetsky DS, 2012, EXPERT REV CLIN IMMU, V8, P1, DOI [10.1586/eci.11.82, 10.1586/ECI.11.82]; Pisetsky DS, 2010, AUTOIMMUN REV, V10, P35, DOI 10.1016/j.autrev.2010.07.007; RUBIN RL, 1983, J IMMUNOL METHODS, V63, P359, DOI 10.1016/S0022-1759(83)80009-X; Satoh M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00181; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; SEKINE H, 1969, BIOCHIM BIOPHYS ACTA, V174, P202, DOI 10.1016/0005-2787(69)90243-3; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Shovman O, 2005, ANN NY ACAD SCI, V1050, P380, DOI 10.1196/annals.1313.120; Sjowall C, 2008, J RHEUMATOL, V35, P1994; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; Stearns NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040862; STOKES RP, 1982, J CLIN PATHOL, V35, P566, DOI 10.1136/jcp.35.5.566; Suer W, 2004, J AUTOIMMUN, V22, P325, DOI 10.1016/j.jaut.2004.02.002; SUTJITA M, 1989, J CLIN LAB ANAL, V3, P34, DOI 10.1002/jcla.1860030108; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; Tan EM, 1999, ARTHRITIS RHEUM, V42, P455, DOI 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tan EM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4482; Tench CM, 2000, LUPUS, V9, P374, DOI 10.1191/096120300678828451; Ullal AJ, 2011, J AUTOIMMUN, V36, P173, DOI 10.1016/j.jaut.2011.02.001; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2010, MOL IMMUNOL, V48, P248, DOI 10.1016/j.molimm.2010.08.003; van Vollenhoven RF, 2012, ANN RHEUM DIS, V71, P1343, DOI 10.1136/annrheumdis-2011-200937; Wahren M, 1998, J AUTOIMMUN, V11, P29, DOI 10.1006/jaut.1997.0173; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Wirestam L, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0856-2; Zhang Y, 2015, J CONTROL RELEASE, V213, pE136, DOI 10.1016/j.jconrel.2015.05.230	68	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161818	10.1371/journal.pone.0161818	http://dx.doi.org/10.1371/journal.pone.0161818			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611194	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900031
J	Kunkanjanawan, T; Carter, RL; Prucha, MS; Yang, JJ; Parnpai, R; Chan, AWS				Kunkanjanawan, Tanut; Carter, Richard L.; Prucha, Melinda S.; Yang, Jinjing; Parnpai, Rangsun; Chan, Anthony W. S.			miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells	PLOS ONE			English	Article							MUTANT HUNTINGTIN; ALZHEIMERS-DISEASE; NONCODING RNAS; CAG REPEATS; EXPRESSION; MODEL; DYSREGULATION; APOPTOSIS; MOUSE; GENE	Huntington's disease (HD) is an inherited neurodegenerative disorder caused by the expansion of polyglutamine (polyQ) tract that leads to motor, cognitive and psychiatric impairment. Currently there is no cure for HD. A transgenic HD nonhuman primate (HD-NHP) model was developed with progressive development of clinical and pathological features similar to human HD, which suggested the potential preclinical application of the HD-NHP model. Elevated expression of miR-196a was observed in both HD-NHP and human HD brains. Cytotoxicity and apoptosis were ameliorated by the overexpression of miR-196a in HD-NHP neural progenitor cells (HD-NPCs) and differentiated neural cells (HD-NCs). The expression of apoptosis related gene was also down regulated. Mitochondrial morphology and activity were improved as indicated by mitotracker staining and the upregulation of CBP and PGC-1a in HD-NPCs overexpressing miR-196a. Here we demonstrated the amelioration of HD cellular phenotypes in HD-NPCs and HD-NCs overexpressing miR-196a. Our results also suggested the regulatory role of miR-196a in HD pathogenesis that may hold the key for understanding molecular regulation in HD and developing novel therapeutics.	[Kunkanjanawan, Tanut; Carter, Richard L.; Prucha, Melinda S.; Yang, Jinjing; Chan, Anthony W. S.] Yerkes Natl Primate Res Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Kunkanjanawan, Tanut; Carter, Richard L.; Prucha, Melinda S.; Yang, Jinjing; Chan, Anthony W. S.] Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA; [Kunkanjanawan, Tanut; Parnpai, Rangsun] Suranaree Univ Technol, Sch Biotechnol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima 30000, Thailand	Emory University; Suranaree University of Technology	Chan, AWS (corresponding author), Yerkes Natl Primate Res Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.; Chan, AWS (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	awchan@emory.edu			ORIP/NIH [OD010930]; NINDS/NIH [NS084163]; Royal Golden Jubilee PhD program of Thailand Research Fund; Office of Research and Infrastructure Program (ORIP)/OD [P51OD11132]; NINDS [NS084163]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084163] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, R24OD010930] Funding Source: NIH RePORTER	ORIP/NIH; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Royal Golden Jubilee PhD program of Thailand Research Fund(Thailand Research Fund (TRF)); Office of Research and Infrastructure Program (ORIP)/OD; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by ORIP/NIH: OD010930 and NINDS/NIH: NS084163. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All experimental procedures described in this study were approved by Emory Environmental Health and Biosafety committee. Study using human tissue complied with NIH guidelines. Human brain tissues were provided by Emory Alzheimer's disease Research Center and the Emory Neuroscience NINDS Core Facilities (ENNCF). Transgenic HD monkey brain tissues and NPCs were provided by the Transgenic Huntington's disease monkey resource (THDMR) sponsored by the ORIP/NIH (OD010930). We thank Dr. Oskar Laur of the Emory Custom Cloning Core Facility and Ms. Leslee Sinclair for her assistance in proofing and editing. Tanut Kunkanjanawan and Rangsan Pranpai are supported by the Royal Golden Jubilee PhD program of Thailand Research Fund. YNPRC is supported by the Office of Research and Infrastructure Program (ORIP)/OD P51OD11132. This study is supported in part by grant awarded by the NINDS (NS084163) and the ORIP/NIH (OD010930; Transgenic Huntington's Disease Monkey Resource) to AWSC.	Acuna AI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3917; Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Bagashev A, 2014, APOPTOSIS, V19, P1202, DOI 10.1007/s10495-014-1003-2; Batchelor RH, 2004, ANAL BIOCHEM, V329, P35, DOI 10.1016/j.ab.2004.02.007; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Berrios GE, 2001, PSYCHIAT RES, V102, P217, DOI 10.1016/S0165-1781(01)00257-8; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Carter RL, 2014, STEM CELL REP, V3, P585, DOI 10.1016/j.stemcr.2014.07.011; Chan AWS, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-36; Chan Anthony W. S., 2012, Frontiers in Genetics, V3, P82, DOI 10.3389/fgene.2012.00082; Chan AWS, 2010, CELL REPROGRAM, V12, P509, DOI 10.1089/cell.2010.0019; Chan AWS, 2015, PLOS ONE IN PRESS; Chan AWS, 2014, TRANSGENIC ANIMAL TE; Chang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046492; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen S, 2012, NEUROCHEM RES, V37, P2805, DOI 10.1007/s11064-012-0874-2; Chen Y, 2014, DRUG DISCOVERY TODAY; Cheng PH, 2013, AM J HUM GENET, V93, P306, DOI 10.1016/j.ajhg.2013.05.025; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Choi YS, 2009, NEUROBIOL DIS, V36, P259, DOI 10.1016/j.nbd.2009.07.014; Eckmann J, 2014, MOL NEUROBIOL, P1; Fu MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137637; Galkina EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095556; Gambazzi L, 2010, J PHARMACOL EXP THER, V335, P13, DOI 10.1124/jpet.110.167551; Giampa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064037; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Her L-S, 2014, BRAIN PATHOLOGY; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; HUET O, 1992, CYTOMETRY, V13, P532, DOI 10.1002/cyto.990130513; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Jin YNN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057932; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kocerha J, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-46; Kocerha J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-88; Kocerha J, 2009, NEUROMOL MED, V11, P162, DOI 10.1007/s12017-009-8066-1; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Li Y, 2014, MOL BIOSYST, V10, P1757, DOI 10.1039/c4mb00066h; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Martin E, 2011, HUM MOL GENET, V20, P2422, DOI 10.1093/hmg/ddr148; Mastrokolias A, 2015, EUR J HUM GENET; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Moran S, 2015, THERIOGENOLOGY; Muller S, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-17; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Putkhao K, 2013, STEM CELLS DEV, V22, P1198, DOI 10.1089/scd.2012.0469; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Severino P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-533; Snider BJ, 2003, NEUROSCIENCE, V120, P617, DOI 10.1016/S0306-4522(03)00382-8; Soldati C, 2013, J NEUROCHEM, V124, P418, DOI 10.1111/jnc.12090; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Toulmond S, 2004, BRIT J PHARMACOL, V141, P689, DOI 10.1038/sj.bjp.0705662; Tsai M-M, 2014, CANC LETT; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Vis JC, 2005, ACTA NEUROPATHOL, V109, P321, DOI 10.1007/s00401-004-0957-5; Wade BE, 2014, J NEUROSCI, V34, P8411, DOI 10.1523/JNEUROSCI.0775-14.2014; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yoon G, 2006, NEUROLOGY, V67, P1265, DOI 10.1212/01.wnl.0000238390.86304.4e; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zhu DW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-301; Zizak VS, 2005, COGN BEHAV NEUROL, V18, P198, DOI 10.1097/01.wnn.0000192134.53616.39	73	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162788	10.1371/journal.pone.0162788	http://dx.doi.org/10.1371/journal.pone.0162788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631085	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900079
J	Ayala, AJ; Dimitrov, KM; Becker, CR; Goraichuk, IV; Arns, CW; Bolotin, VI; Ferreira, HL; Gerilovych, AP; Goujgoulova, GV; Martini, MC; Muzyka, DV; Orsi, MA; Scagion, GP; Silva, RK; Solodiankin, OS; Stegniy, BT; Miller, PJ; Afonso, CL				Ayala, Andrea J.; Dimitrov, Kiril M.; Becker, Cassidy R.; Goraichuk, Iryna V.; Arns, Clarice W.; Bolotin, Vitaly I.; Ferreira, Helena L.; Gerilovych, Anton P.; Goujgoulova, Gabriela V.; Martini, Matheus C.; Muzyka, Denys V.; Orsi, Maria A.; Scagion, Guilherme P.; Silva, Renata K.; Solodiankin, Olexii S.; Stegniy, Boris T.; Miller, Patti J.; Afonso, Claudio L.			Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; AVIAN INFLUENZA-VIRUSES; MOLECULAR EPIDEMIOLOGY; DOMESTIC-ANIMALS; RECENT OUTBREAKS; POULTRY; STRAIN; TRANSMISSION; GENOTYPES; CHICKENS	Our study demonstrates the repeated isolation of vaccine-derived Newcastle disease viruses from different species of wild birds across four continents from 1997 through 2014. The data indicate that at least 17 species from ten avian orders occupying different habitats excrete vaccine-derived Newcastle disease viruses. The most frequently reported isolates were detected among individuals in the order Columbiformes (n = 23), followed in frequency by the order Anseriformes (n = 13). Samples were isolated from both free-ranging (n = 47) and wild birds kept in captivity (n = 7). The number of recovered vaccine-derived viruses corresponded with the most widely utilized vaccines, LaSota (n = 28) and Hitchner B1 (n = 19). Other detected vaccine-derived viruses resembled the PHY-LMV2 and V4 vaccines, with five and two cases, respectively. These results and the ubiquitous and synanthropic nature of wild pigeons highlight their potential role as indicator species for the presence of Newcastle disease virus of low virulence in the environment. The reverse spillover of live agents from domestic animals to wildlife as a result of the expansion of livestock industries employing massive amounts of live virus vaccines represent an underappreciated and poorly studied effect of human activity on wildlife.	[Ayala, Andrea J.] Univ Georgia, Coll Vet Med, Athens, GA USA; [Ayala, Andrea J.; Dimitrov, Kiril M.; Goraichuk, Iryna V.; Miller, Patti J.; Afonso, Claudio L.] ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA; [Dimitrov, Kiril M.; Goujgoulova, Gabriela V.] Natl Diagnost Res Vet Med Inst, Sofia, Bulgaria; [Becker, Cassidy R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Goraichuk, Iryna V.; Bolotin, Vitaly I.; Gerilovych, Anton P.; Muzyka, Denys V.; Solodiankin, Olexii S.; Stegniy, Boris T.] Natl Sci Ctr, Inst Expt & Clin Vet Med, Kharkiv, Ukraine; [Arns, Clarice W.; Scagion, Guilherme P.] Univ Estadual Campinas, UNICAMP, Inst Biol, Lab Anim Virol, Campinas, SP, Brazil; [Ferreira, Helena L.] Univ Sao Paulo, Coll Anim Sci & Food Engn, Dept Vet Med, Sao Paulo, Brazil; [Ferreira, Helena L.] Univ Sao Paulo, Grad Program Expt Epidemiol Zoonosis, Sao Paulo, Brazil; [Ferreira, Helena L.; Silva, Renata K.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Postgrad Program Expt Epidemiol Zoonoses, Sao Paulo, Brazil; [Orsi, Maria A.] Natl Agr Lab Sao Paulo, Campinas, SP, Brazil	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); National Veterinary Medical Institute - Bulgaria; University System of Georgia; University of Georgia; National Academy of Agrarian Sciences of Ukraine; National Scientific Center "Institute of Experimental & Clinical Veterinary Medicine"; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Afonso, CL (corresponding author), ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA.	Claudio.Afonso@ars.usda.gov	Gerilovych, Anton/N-5608-2019; Денис, Muzyka Denys Музыка/AAP-5876-2020; Dimitrov, Kiril M./I-4280-2019; Stegniy, Borys/AAD-2967-2020; Lage Ferreira, Helena/A-2046-2010; Goraichuk, Iryna/AAC-5395-2019; Martini, Matheus C/E-9416-2015; Miller, Patti/T-3933-2019; Bolotin, Vitaliy/AAA-4161-2021; Arns, Clarice/F-2762-2015	Dimitrov, Kiril M./0000-0002-5525-4492; Stegniy, Borys/0000-0003-1787-5789; Lage Ferreira, Helena/0000-0002-3261-3712; Goraichuk, Iryna/0000-0002-5841-5765; Martini, Matheus C/0000-0003-0135-4364; Bolotin, Vitaliy/0000-0001-9875-6639; Orsi, Maria Angela/0000-0002-6114-197X; Muzyka, Denys/0000-0003-1598-6338; Gerilovych, Anton/0000-0002-3280-4172; Solodiankin, Oleksii/0000-0002-8698-0390; Arns, Clarice/0000-0002-7308-460X	DTRA BAA project [FRCALL 12-6-3412-0005]; FAPESP [2013/02059-2, 2015/11510-5]; American Ornithologists' Union; Oconee Audubon Society; Odum School of Ecology; USDA, ARS [CRIS 6040-32000-064]	DTRA BAA project; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); American Ornithologists' Union; Oconee Audubon Society; Odum School of Ecology; USDA, ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by USDA, ARS, CRIS 6040-32000-064, DTRA BAA project FRCALL 12-6-3412-0005, FAPESP 2013/02059-2, FAPESP 2015/11510-5, the American Ornithologists' Union, the Oconee Audubon Society, and the Odum School of Ecology.	Aldous EW, 2004, AVIAN PATHOL, V33, P258, DOI 10.1080/0307945042000195768; Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; Alexander DJ, 2006, AVIAN PATHOL, V35, P99, DOI 10.1080/03079450600597444; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2015, EPIDEMIOLOGY PREVENT; Ayala AJ, 2013, THESIS; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Brown C, 1999, VET PATHOL, V36, P125, DOI 10.1354/vp.36-2-125; Cardenas-Garcia S, 2015, BIOLOGICALS, V43, P136, DOI 10.1016/j.biologicals.2014.11.003; Caron A, 2014, PREV VET MED, V117, P590, DOI 10.1016/j.prevetmed.2014.09.014; Cherkasova EA, 2005, J VIROL, V79, P1062, DOI 10.1128/JVI.79.2.1062-1070.2005; Chong YL, 2013, INFECT GENET EVOL, V17, P260, DOI 10.1016/j.meegid.2013.04.025; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Clifford DL, 2009, BIOL CONSERV, V142, P2559, DOI 10.1016/j.biocon.2009.06.001; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; Coppo MJC, 2013, AVIAN PATHOL, V42, P195, DOI 10.1080/03079457.2013.800634; Czegledi A, 2002, EPIDEMIOL INFECT, V129, P679, DOI 10.1017/S0950268802007732; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Deem SL, 2012, ANIM CONSERV, V15, P73, DOI 10.1111/j.1469-1795.2011.00489.x; DeSante DF, 2015, 127 I BIRD POP; Devlin JM, 2016, CURR OPIN VIROL, V19, P23, DOI 10.1016/j.coviro.2016.06.007; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dimitrov KM, 2016, J CLIN MICROBIOL, V54, P1228, DOI 10.1128/JCM.03044-15; Etikan I., 2016, AMERICAL J THEORETIC, V5, P1, DOI [DOI 10.11648/J.ATAS.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; Garcia SC, 2013, APPL ENVIRON MICROB, V79, P4985, DOI 10.1128/AEM.00993-13; Gilchrist P, 2005, WORLD POULTRY SCI J, V61, P198, DOI 10.1079/WPS200451; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; GOLDHAFT TM, 1980, AVIAN DIS, V24, P297, DOI 10.2307/1589696; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Herczeg J, 2001, AVIAN PATHOL, V30, P163, DOI 10.1080/03079450120044000; HITCHNER SB, 1975, AVIAN DIS, V19, P215, DOI 10.2307/1588975; Hull J, 2006, CONDOR, V108, P435, DOI 10.1650/0010-5422(2006)108[435:VOWNVA]2.0.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaleta E. F., 1988, Newcastle disease., P197; Kasambe R., 2014, MISTNET, V15, P10; Kim BY, 2012, INFECT GENET EVOL, V12, P478, DOI 10.1016/j.meegid.2011.12.004; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kuiken T, 1998, CAN VET J, V39, P299; LaRussa P, 1997, J INFECT DIS, V176, P1072, DOI 10.1086/516514; Lebarbenchon C, 2013, INFLUENZA OTHER RESP, V7, P1237, DOI 10.1111/irv.12070; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; LEFEBVRE L, 1985, AUK, V102, P886; Magnus M., 2008, ESSENTIALS INFECT DI; Manning L., 2004, British Food Journal, V106, P819, DOI 10.1108/00070700410561414; Marangon S, 2007, REV SCI TECH OIE, V26, P265, DOI 10.20506/rst.26.1.1742; da Silva TAM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0837-y; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; MCCANDLISH IAP, 1992, VET REC, V130, P27, DOI 10.1136/vr.130.2.27; Menendez KR, 2014, AVIAN PATHOL, V43, P108, DOI 10.1080/03079457.2014.886004; Miller M, 2013, COMP IMMUNOL MICROB, V36, P263, DOI 10.1016/j.cimid.2012.07.005; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00235; Miller PJ, 2015, INFECT GENET EVOL, V29, P216, DOI 10.1016/j.meegid.2014.10.032; Miller PJ, 2013, DEV COMP IMMUNOL, V41, P505, DOI 10.1016/j.dci.2013.06.007; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Miller PJ, 2013, DIS OFPOULTRY, V13th, P89, DOI DOI 10.1002/9781119421481.CH3; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; Morton DB, 2007, REV SCI TECH OIE, V26, P157, DOI 10.20506/rst.26.1.1735; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Nusser SM, 2008, J WILDLIFE MANAGE, V72, P52, DOI 10.2193/2007-317; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; OIE, 2014, NEW DIS MAN DIAGN 2, V1; Ollinger M., 2000, FoodReview, V23, P2; Palmer MV, 2007, CURR TOP MICROBIOL, V315, P195; Palya V, 2012, AVIAN DIS, V56, P282, DOI 10.1637/9935-091511-Reg.1; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pedersen JC, 2004, J CLIN MICROBIOL, V42, P2329, DOI 10.1128/JCM.42.5.2329-2334.2004; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Prosperi M, 2013, MOL EPIDEMIOLOGY COM; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Pyle P, 1997, IDENTIFICATION GUIDE; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Ranstam J, 2009, OSTEOARTHR CARTILAGE, V17, P1416, DOI 10.1016/j.joca.2009.04.007; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Saif YM, 2002, AVIAN DIS, V46, P505, DOI 10.1637/0005-2086(2002)046[0505:IMITSF]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samour J, 2014, J AVIAN MED SURG, V28, P1, DOI 10.1647/2011-041; SAS Institute Inc, 1999, MULTTEST P CAR, P2311; Seewagen CL, 2008, J FIELD ORNITHOL, V79, P80, DOI 10.1111/j.1557-9263.2007.00132.x; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Siembieda J. L., 2011, Animal Health Research Reviews, V12, P95, DOI 10.1017/S1466252311000041; SMYTH GK, 1989, J ROY STAT SOC B MET, V51, P47; Snoeck CJ, 2013, APPL ENVIRON MICROB, V79, P639, DOI 10.1128/AEM.02437-12; Sol D, 2000, ECOGRAPHY, V23, P307, DOI 10.1034/j.1600-0587.2000.d01-1639.x; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Sol D, 1998, CONDOR, V100, P298, DOI 10.2307/1370270; Sol D, 2008, BIOL J LINN SOC, V93, P657, DOI 10.1111/j.1095-8312.2008.00957.x; Soos C, 2008, AUK, V125, P445, DOI 10.1525/auk.2008.06235; Swayne DE, 2014, ECOHEALTH, V11, P94, DOI 10.1007/s10393-013-0861-3; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomazelli LM, 2010, VET MICROBIOL, V146, P155, DOI 10.1016/j.vetmic.2010.05.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; United States Department of Agriculture, 2009, DEC FIND NO SIGN IMP; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x; VANECK JHH, 1991, AVIAN PATHOL, V20, P497, DOI 10.1080/03079459108418787; Vargha A, 1998, J EDUC BEHAV STAT, V23, P170, DOI 10.3102/10769986023002170; WESTBURY HA, 1984, AUST VET J, V61, P5, DOI 10.1111/j.1751-0813.1984.tb07120.x; Woodford MH, 2009, TROP ANIM HEALTH PRO, V41, P1023, DOI 10.1007/s11250-008-9269-4; Yuan XY, 2013, VIRUS GENES, V46, P377, DOI 10.1007/s11262-012-0863-1; Zanetti F, 2005, AVIAN DIS, V49, P546, DOI 10.1637/7381-051605R.1; Zhu W, 2010, VIRUS GENES, V40, P231, DOI 10.1007/s11262-009-0436-0	113	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162484	10.1371/journal.pone.0162484	http://dx.doi.org/10.1371/journal.pone.0162484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626272	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600037
J	Braselmann, E; Chaney, JL; Champion, MM; Clark, PL				Braselmann, Esther; Chaney, Julie L.; Champion, Matthew M.; Clark, Patricia L.			DegP Chaperone Suppresses Toxic Inner Membrane Translocation Intermediates	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; BACTERIAL OUTER-MEMBRANE; AUTOTRANSPORTER VIRULENCE PROTEINS; ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI; CELL-ENVELOPE; EXTRACYTOPLASMIC STRESS; PROTEOLYTIC ACTIVITY; PASSENGER PROTEINS; FOLDING MECHANISM	The periplasm of Gram-negative bacteria includes a variety of molecular chaperones that shepherd the folding and targeting of secreted proteins. A central player of this quality control network is DegP, a protease also suggested to have a chaperone function. We seren-dipitously discovered that production of the Bordetella pertussis autotransporter virulence protein pertactin is lethal in Escherichia coli Delta degP strains. We investigated specific contributions of DegP to secretion of pertactin as a model system to test the functions of DegP in vivo. The DegP chaperone activity was sufficient to restore growth during pertactin production. This chaperone dependency could be relieved by changing the pertactin signal sequence: an E. coli signal sequence leading to co-translational inner membrane (IM) translocation was sufficient to suppress lethality in the absence of DegP, whereas an E. coli post-translational signal sequence was sufficient to recapitulate the lethal phenotype. These results identify a novel connection between the DegP chaperone and the mechanism used to translocate a protein across the IM. Lethality coincided with loss of periplasmic proteins, soluble sigma(E), and proteins regulated by this essential stress response. These results suggest post-translational IM translocation can lead to the formation of toxic periplasmic folding intermediates, which DegP can suppress.	[Braselmann, Esther; Chaney, Julie L.; Champion, Matthew M.; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Braselmann, Esther] Univ Colorado Boulder, Dept Chem & Biochem, Boulder, CO 80309 USA; [Braselmann, Esther] Univ Colorado Boulder, BioFrontiers Inst, Boulder, CO 80309 USA; [Chaney, Julie L.] Siemens Healthineers, 3400 Middlebury St, Elkhart, IN 46516 USA	University of Notre Dame; University of Notre Dame; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Siemens AG	Braselmann, E (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Braselmann, E (corresponding author), Univ Colorado Boulder, Dept Chem & Biochem, Boulder, CO 80309 USA.; Braselmann, E (corresponding author), Univ Colorado Boulder, BioFrontiers Inst, Boulder, CO 80309 USA.	esther.braselmann@colorado.edu		Clark, Patricia/0000-0001-5462-8248; Champion, Matthew M./0000-0001-5927-5277	National Institutes of Health (US) [R01 GM097573]; Notre Dame CBBI Graduate Fellowship (National Institutes of Health grant) [T32 GM075762]; Henry Luce Foundation	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame CBBI Graduate Fellowship (National Institutes of Health grant); Henry Luce Foundation	This project was supported by the National Institutes of Health (US) grant R01 GM097573 to PLC. EB was supported by a Notre Dame CBBI Graduate Fellowship (National Institutes of Health grant T32 GM075762). JLC was supported by a Clare Boothe Luce Graduate Fellowship from the Henry Luce Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Barnard TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/j.jmb.2011.10.049; Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Baud C, 2011, MOL MICROBIOL, V80, P1625, DOI 10.1111/j.1365-2958.2011.07672.x; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Braselmann E, 2012, J PHYS CHEM LETT, V3, P1063, DOI 10.1021/jz201654k; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; CastilloKeller M, 2003, J BACTERIOL, V185, P148, DOI 10.1128/JB.185.1.148-154.2003; Celik N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043245; Champion MM, 2014, J PROTEOME RES, V13, P5151, DOI 10.1021/pr500484w; Champion MM, 2003, MOL MICROBIOL, V47, P383, DOI 10.1046/j.1365-2958.2003.03294.x; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Chevalier N, 2004, J MOL MICROB BIOTECH, V8, P7, DOI 10.1159/000082076; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Desvaux M, 2007, MICROBIOL-SGM, V153, P59, DOI 10.1099/mic.0.29091-0; Desvaux M, 2006, FEMS MICROBIOL LETT, V264, P22, DOI 10.1111/j.1574-6968.2006.00425.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Drobnak I, 2015, J BIOL CHEM, V290, P10104, DOI 10.1074/jbc.M114.629170; Dutta PR, 2003, J BIOL CHEM, V278, P39912, DOI 10.1074/jbc.M303595200; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ge X, 2014, FEBS J, V281, P1226, DOI 10.1111/febs.12701; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Huber D, 2008, STRUCTURE, V16, P989, DOI 10.1016/j.str.2008.06.004; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Jong WSP, 2008, BIOCHEM BIOPH RES CO, V368, P522, DOI 10.1016/j.bbrc.2008.01.122; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jong WSP, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-85; Jong WSP, 2010, J BIOL CHEM, V285, P39682, DOI 10.1074/jbc.M110.167650; Jose J, 1996, GENE, V178, P107, DOI 10.1016/0378-1119(96)00343-5; Jose J, 2012, J BIOTECHNOL, V161, P92, DOI 10.1016/j.jbiotec.2012.04.001; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Leyton DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5239; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Mansell TJ, 2010, PROTEIN SCI, V19, P1079, DOI 10.1002/pro.388; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Mutalik VK, 2009, J BACTERIOL, V191, P7279, DOI 10.1128/JB.01047-09; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Norell D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6396; Penas AD, 1997, J BACTERIOL, V179, P6862; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Purdy GE, 2002, INFECT IMMUN, V70, P6355, DOI 10.1128/IAI.70.11.6355-6364.2002; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Sauri A, 2012, J MOL BIOL, V416, P335, DOI 10.1016/j.jmb.2011.12.047; Sauri A, 2011, J MOL BIOL, V412, P553, DOI 10.1016/j.jmb.2011.07.035; Sawa J, 2010, CURR OPIN STRUC BIOL, V20, P253, DOI 10.1016/j.sbi.2010.01.014; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Sklar JG, 2007, DEFINING ROLES PERIP, P2473; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Teh MY, 2012, MICROBIOL-SGM, V158, P2835, DOI 10.1099/mic.0.062471-0; Tozakidis IEP, 2015, NEW BIOTECHNOL, V32, P644, DOI 10.1016/j.nbt.2014.12.008; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; Weski J, 2012, J BACTERIOL, V194, P3225, DOI 10.1128/JB.00221-12; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	93	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162922	10.1371/journal.pone.0162922	http://dx.doi.org/10.1371/journal.pone.0162922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626276	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600064
J	Lojo, N; Rasic, Z; Sever, AZ; Kolenc, D; Vukusic, D; Drmic, D; Zoricic, I; Sever, M; Seiwerth, S; Sikiric, P				Lojo, Nermin; Rasic, Zarko; Sever, Anita Zenko; Kolenc, Danijela; Vukusic, Darko; Drmic, Domagoj; Zoricic, Ivan; Sever, Marko; Seiwerth, Sven; Sikiric, Predrag			Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats	PLOS ONE			English	Article							NITRIC-OXIDE; NO-SYSTEM; BPC-157; THERAPY; MICE; RANITIDINE; ENCEPHALOPATHY; COUNTERACTION; ATTENUATION; INHIBITION	Stable gastric pentadecapeptide BPC 157 was previously used to ameliorate wound healing following major surgery and counteract diclofenac toxicity. To resolve the increasing early risks following major massive small bowel resectioning surgery, diclofenac combined with nitric oxide (NO) system blockade was used, suggesting therapy with BPC 157 and the nitric oxide synthase (NOS substrate) L-arginine, is efficacious. Immediately after anastomosis creation, short-bowel rats were untreated or administered intraperitoneal diclofenac (12 mg/kg), BPC 157 (10 mu g/kg or 10 ng/kg), L-NG-nitroarginine methyl ester (L-NAME, 5 mg/kg), L-arginine (100 mg/kg) alone or combined, and assessed 24 h later. Short-bowel rats exhibited poor anastomosis healing, failed intestine adaptation, and gastrointestinal, liver, and brain lesions, which worsened with diclofenac. This was gradually ameliorated by immediate therapy with BPC 157 and L-arginine. Contrastingly, NOS-blocker L-NAME induced further aggravation and lesions gradually worsened. Specifically, rats with surgery alone exhibited mild stomach/duodenum lesions, considerable liver lesions, and severe cerebral/hippocampal lesions while those also administered diclofenac showed widespread severe lesions in the gastrointestinal tract, liver, cerebellar nuclear/Purkinje cells, and cerebrum/hippocampus. Rats subjected to surgery, diclofenac, and L-NAME exhibited the mentioned lesions, worsening anastomosis, and macro/microscopical necrosis. Thus, rats subjected to surgery alone showed evidence of deterioration. Furtheremore, rats subjected to surgery and administered diclofenac showed worse symptoms, than the rats subjected to surgery alone did. Rats subjected to surgery combined with diclofenac and L-NAME showed the worst deterioration. Rats subjected to surgery exhibited habitual adaptation of the remaining small intestine, which was markedly reversed in rats subjected to surgery and diclofenac, and those with surgery, diclofenac, and L-NAME. BPC 157 completely ameliorated symptoms in massive intestinal resection-, massive intestinal resection plus diclofenac-, and massive intestinal resection plus diclofenac plus L-NAME-treated short bowel rats that presented with cyclooxygenase (COX)-NO-system inhibition. L-arginine ameliorated only L-NAME-induced aggravation of symptoms in rats subjected to massive intestinal resection and administered diclofenac plus L-NAME.	[Lojo, Nermin; Rasic, Zarko; Vukusic, Darko; Drmic, Domagoj; Zoricic, Ivan; Sever, Marko; Sikiric, Predrag] Univ Zagreb, Sch Med, Dept Pharmacol, POB 916,Salata 11, Zagreb 10000, Croatia; [Sever, Anita Zenko; Kolenc, Danijela; Seiwerth, Sven] Univ Zagreb, Sch Med, Dept Pathol, Salata 9, Zagreb 10000, Croatia	University of Zagreb; University of Zagreb	Sikiric, P (corresponding author), Univ Zagreb, Sch Med, Dept Pharmacol, POB 916,Salata 11, Zagreb 10000, Croatia.	sikiric@mef.hr			Ministry of Science, Education and Sports, Republic of Croatia [108-1083570-3635, 108-1080321-0389]	Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	Ministry of Science, Education and Sports, Republic of Croatia [grants' numbers 108-1083570-3635, 108-1080321-0389]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Ministry of Science, Education, and Sports of the Republic of Croatia (grant numbers: 108-1083570-3635 and 108-1080321-0389).	Balenovic D, 2009, REGUL PEPTIDES, V156, P83, DOI 10.1016/j.regpep.2009.05.008; Baric M, 2016, LIFE SCI, V148, P63, DOI 10.1016/j.lfs.2016.02.029; Barisic I, 2013, REGUL PEPTIDES, V181, P50, DOI 10.1016/j.regpep.2012.12.007; Bilic I, 2001, LIFE SCI, V68, P1905, DOI 10.1016/S0024-3205(00)01025-0; Bilic M, 2005, BURNS, V31, P310, DOI 10.1016/j.burns.2004.10.013; Cesarec V, 2013, EUR J PHARMACOL, V701, P203, DOI 10.1016/j.ejphar.2012.11.055; Chang C.H., 2011, J APPL PHYSIOL, V110, P774; Chang CH, 2014, MOLECULES, V19, P19066, DOI 10.3390/molecules191119066; Grgic T, 2016, EUR J PHARMACOL, V780, P1, DOI 10.1016/j.ejphar.2016.02.038; Hrelec M, 2009, J PHYSIOL PHARMACOL, V60, P161; Huang TL, 2015, DRUG DES DEV THER, V9, P2485, DOI 10.2147/DDDT.S82030; Ilic S, 2010, J PHYSIOL PHARMACOL, V61, P241; Ilic S, 2009, J PHYSIOL PHARMACOL, V60, P107; Ilic S, 2011, EUR J PHARMACOL, V667, P322, DOI 10.1016/j.ejphar.2011.05.038; Ilic S, 2011, LIFE SCI, V88, P535, DOI 10.1016/j.lfs.2011.01.015; Klein M, 2012, EUR SURG RES, V48, P73, DOI 10.1159/000336208; Klicek R, 2013, J PHYSIOL PHARMACOL, V64, P597; Klicek R, 2008, J PHARMACOL SCI, V108, P7, DOI 10.1254/jphs.FP0072161; Mikus D, 2001, BURNS, V27, P817, DOI 10.1016/S0305-4179(01)00055-9; Murase T, 2003, AM J PHYSIOL-REG I, V284, pR354, DOI 10.1152/ajpregu.00065.2002; Prkacin I, 2001, J PHYSIOL-PARIS, V95, P315, DOI 10.1016/S0928-4257(01)00044-4; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; Seiwerth S, 2014, CURR PHARM DESIGN, V20, P1121, DOI 10.2174/13816128113199990421; Sever M, 2009, DIGEST DIS SCI, V54, P2070, DOI 10.1007/s10620-008-0598-y; Sikiric P, 2003, BURNS, V29, P323, DOI 10.1016/S0305-4179(03)00004-4; Sikiric P, 2012, CURR MED CHEM, V19, P126, DOI 10.2174/092986712803414015; Sikiric P, 2001, J PHYSIOL-PARIS, V95, P261, DOI 10.1016/S0928-4257(01)00036-5; SIKIRIC P, 1993, LIFE SCI, V53, pPL291, DOI 10.1016/0024-3205(93)90589-U; Sikiric P, 1997, J PHYSIOL-PARIS, V91, P113, DOI 10.1016/S0928-4257(97)89474-0; Sikiric P, 1997, EUR J PHARMACOL, V332, P23, DOI 10.1016/S0014-2999(97)01033-9; Sikiric P, 2014, CURR PHARM DESIGN, V20, P1126, DOI 10.2174/13816128113190990411; Sikiric P, 2013, CURR PHARM DESIGN, V19, P76; Sikiric P, 2011, CURR PHARM DESIGN, V17, P1612, DOI 10.2174/138161211796196954; Sikiric P, 2010, CURR PHARM DESIGN, V16, P1224, DOI 10.2174/138161210790945977; Stupnisek M, 2012, THROMB RES, V129, P652, DOI 10.1016/j.thromres.2011.07.035; Tkalcevic VI, 2007, EUR J PHARMACOL, V570, P212, DOI 10.1016/j.ejphar.2007.05.072; Trettin A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/212576; Tudor M, 2010, REGUL PEPTIDES, V160, P26, DOI 10.1016/j.regpep.2009.11.012; Vuksic T, 2007, SURG TODAY, V37, P768, DOI 10.1007/s00595-006-3498-9	39	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162590	10.1371/journal.pone.0162590	http://dx.doi.org/10.1371/journal.pone.0162590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627764	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600044
J	Greene, M; Lai, YJ; Pajcini, K; Bailis, W; Pear, WS; Lancaster, E				Greene, Maxwell; Lai, Yongjie; Pajcini, Kostandin; Bailis, Will; Pear, Warren S.; Lancaster, Eric			Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand	PLOS ONE			English	Article							PARANEOPLASTIC CEREBELLAR DEGENERATION; INTRACELLULAR DOMAIN; TRANSACTIVATION; DIFFERENTIATION; ACTIVATION; MYOGENESIS; PATHWAY; MYOD; TR	Delta/Notch-like EGF-related receptor (DNER) has been reported to act as a Notch ligand, despite lacking a Delta/Serrate/Lag (DSL) binding domain common to all other known ligands. The established Notch ligand Delta-like 1 (DLL1), but not DNER, activated Notch1 in a luciferase assay, prevented the differentiation of myoblasts through Notch signaling, and bound Notch-fc in a cell-based assay. DNER is not a Notch ligand and its true function remains unknown.	[Greene, Maxwell; Lai, Yongjie; Lancaster, Eric] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pajcini, Kostandin; Bailis, Will; Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Pajcini, Kostandin] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Bailis, Will] Yale Sch Med, Dept Immunobiol, New Haven, CT USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University	Lancaster, E (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.	eric.lancaster@uphs.upenn.edu			National Institutes of Health; National Institute of Neurologic Diseases and Stroke [R25 NS065745, K08 NS075142]; Dana Foundation Neuroimmunology award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS075142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dana Foundation Neuroimmunology award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MG is supported by National Institutes of Health, National Institute of Neurologic Diseases and Stroke, grant R25 NS065745, http://www.ninds.nih.gov/. EL is supported by National Institutes of Health, National Institute of Neurologic Diseases and Stroke, grant K08 NS075142, http://www.ninds.nih. gov/, and a Dana Foundation Neuroimmunology award, http://www.dana.org/.	Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; de Graaff E, 2012, ANN NEUROL, V71, P815, DOI 10.1002/ana.23550; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; Greene M, 2014, JAMA NEUROL, V71, P1003, DOI 10.1001/jamaneurol.2014.999; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Shawber C, 1996, DEVELOPMENT, V122, P3765; Tohgo A, 2006, MOL CELL NEUROSCI, V31, P326, DOI 10.1016/j.mcn.2005.10.003	16	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161157	10.1371/journal.pone.0161157	http://dx.doi.org/10.1371/journal.pone.0161157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622512	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000004
J	Jamal, S; Arora, S; Scaria, V				Jamal, Salma; Arora, Sonam; Scaria, Vinod			Computational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic Modifiers	PLOS ONE			English	Article							METHYLATION; PATTERNS; GENOME; NOISE; G9A	Background The dynamic and differential regulation and expression of genes is majorly governed by the complex interactions of a subset of biomolecules in the cell operating at multiple levels starting from genome organisation to protein post-translational regulation. The regulatory layer contributed by the epigenetic layer has been one of the favourite areas of interest recently. This layer of regulation as we know today largely comprises of DNA modifications, histone modifications and noncoding RNA regulation and the interplay between each of these major components. Epigenetic regulation has been recently shown to be central to development of a number of disease processes. The availability of datasets of high-throughput screens for molecules for biological properties offer a new opportunity to develop computational methodologies which would enable in-silico screening of large molecular libraries. Methods In the present study, we have used data from high throughput screens for the inhibitors of epigenetic modifiers. Computational predictive models were constructed based on the molecular descriptors. Machine learning algorithms for supervised training, Naive Bayes and Random Forest, were used to generate predictive models for the small molecule inhibitors of histone methyl-transferases and demethylases. Random forest, with the accuracy of 80%, was identified as the most accurate classifier. Further we complemented the study with substructure search approach filtering out the probable pharmacophores from the active molecules leading to drug molecules. Results We show that effective use of appropriate computational algorithms could be used to learn molecular and structural correlates of biological activities of small molecules. The computational models developed could be potentially used to screen and identify potential new biological activities of molecules from large molecular libraries and prioritise them for in-depth biological assays. To the best of our knowledge, this is the first and most comprehensive computational analysis towards understanding activities of small molecules inhibitors of epigenetic modifiers.	[Jamal, Salma] CSIR Open Source Drug Discovery Unit CSIR OSDD, Delhi, India; [Arora, Sonam] Delhi Technol Univ, Delhi, India; [Scaria, Vinod] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; Delhi Technological University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Scaria, V (corresponding author), CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.in	Scaria, Vinod/AAS-3151-2021; Arora, Sonam/AAY-4466-2021	Scaria, Vinod/0000-0001-7644-7181	CSIR-OSDD; Council of Scientific and Industrial Research (CSIR), India [BSC0122]; National Knowledge Network (NKN); CDAC-Garuda	CSIR-OSDD; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); National Knowledge Network (NKN); CDAC-Garuda	SJ acknowledges a Project Fellowship from CSIR-OSDD. This work was funded by the Council of Scientific and Industrial Research (CSIR), India through Grant BSC0122 (CARDIOMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Chetana Sachidanandan and Dr. Shantanu Sengupta for reviewing the manuscript. The authors are also thankful for discussions with members of the Open Source Drug Discovery (OSDD) Programme. SJ acknowledges a Project Fellowship from CSIR-OSDD. The authors acknowledge the support from National Knowledge Network (NKN) and CDAC-Garuda for computing. The authors acknowledge technical help and support from the CDAC-Garuda team, especially Ms. Janaki Chintalapati, Ms. Mangala N and Dr. Subrata Chattopadhyay.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bouckaert RR, 2010, J MACH LEARN RES, V11, P2533; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Budapest H, CHEMAXON JCSEARCH VE; Budapest H, 2008, CHEMAXON LIB MCS VER; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chen B, 2012, J CHEM INF MODEL, V52, P792, DOI 10.1021/ci200615h; Cigliano RA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-57; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ekins Sean, 2013, Methods Mol Biol, V993, P245, DOI 10.1007/978-1-62703-342-8_16; Falk H, 2011, J BIOMOL SCREEN, V16, P1196, DOI 10.1177/1087057111421631; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839; Huang SY, 2010, INT J MOL SCI, V11, P3016, DOI 10.3390/ijms11083016; Jamal S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-55; Jamal S, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-16; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kumar N, 2006, DRUG DISCOV TODAY, V11, P806, DOI 10.1016/j.drudis.2006.07.010; Leong HS, 2013, CANCER RES, V73, P1591, DOI 10.1158/0008-5472.CAN-12-3019; Liu KJ, 2005, J CHEM INF MODEL, V45, P515, DOI 10.1021/ci049847v; Lv SL, 2012, OMICS, V16, P552, DOI 10.1089/omi.2012.0005; Miller-Jensen K, 2011, TRENDS BIOTECHNOL, V29, P517, DOI 10.1016/j.tibtech.2011.05.004; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Mund C, 2010, BIOESSAYS, V32, P949, DOI 10.1002/bies.201000061; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ozboyaci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014765; Periwal Vinita, 2012, BMC Pharmacology, V12, P1, DOI 10.1186/1471-2210-12-1; Periwal Vinita, 2011, BMC Res Notes, V4, P504, DOI 10.1186/1756-0500-4-504; Piekarz RL, 2009, CLIN CANCER RES, V15, P3918, DOI 10.1158/1078-0432.CCR-08-2788; Quinn Amy M, 2011, Curr Chem Genomics, V5, P95, DOI 10.2174/1875397301005010095; Rabinowitz JR, 2008, ENVIRON HEALTH PERSP, V116, P573, DOI 10.1289/ehp.11077; Sati S, 2012, NUCLEIC ACIDS RES, V40, P10018, DOI 10.1093/nar/gks776; Sean E, 2006, WILEY SERIES DRUG DI; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Shu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027346; Svetnik V, 2005, J CHEM INF MODEL, V45, P786, DOI 10.1021/ci0500379; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Unoki M, 2011, RECENT PAT ANTI-CANC, V6, P116, DOI 10.2174/157489211793980024; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wang XQD, 2011, CURR GENOMICS, V12, P307, DOI 10.2174/138920211796429772; Xu J, 2002, MOLECULES, V7, P566, DOI 10.3390/70800566	49	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0083032	10.1371/journal.pone.0083032	http://dx.doi.org/10.1371/journal.pone.0083032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622288	Green Submitted, gold, Green Published			2022-12-27	WOS:000383681000001
J	Morita, T; Shima, Y; Wing, JB; Sakaguchi, S; Ogata, A; Kumanogoh, A				Morita, Takayoshi; Shima, Yoshihito; Wing, James Badger; Sakaguchi, Shimon; Ogata, Atsushi; Kumanogoh, Atsushi			The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; SYNOVIAL-FLUID; PERIPHERAL-BLOOD; DISEASE-ACTIVITY; EXPRESSION; ALPHA; RECEPTORS; PHENOTYPE; JOINTS; CTLA-4	Background Regulatory T cells (Tregs) have important functions in peripheral immune tolerance. Dysfunction of Tregs is considered to be a pivotal cause of autoimmune diseases, including rheumatoid arthritis (RA). However, previous reports describing the proportion of Tregs among CD4(+) T cells in RA patients were controversial because a range of markers are used to identify Tregs with little consensus. To clarify the status of Tregs in RA, we investigated the proportion of Tregs with focusing on the definitions of them. Methods We identified the studies reporting the proportion of Tregs in RA patients using PubMed and Google Scholar. We performed a systematic review of them and a meta-analysis to evaluate the proportion of Tregs (FOXP3-positive and/or CD25-positive) among CD4(+) T cells in peripheral blood (PB) and synovial fluid (SF) of RA patients and control subjects. Results A total 31 studies were selected. The proportion of Tregs defined by all definitions among CD4(+) T cells in PB was not significantly different between RA patients and control subjects (-0.65, [-1.30, 0.01]). Then we performed sub-analyses based on individual definitions. The proportion of Tregs defined by either CD25 or FOXP3 alone did not differ between RA patients and control subjects. The proportion of Tregs defined by both FOXP3 and CD25 was lower in RA patients than that in control subjects (-2.42 [-3.49, -1.34]). The proportion of Tregs defined by both FOXP3 and CD25 was higher in SF than that in PB among RA patients (3.27 [0.40, 6.14]). Conclusion The status of Tregs varied according to the definition system. The proportion of Tregs defined by stricter and functionally validated methods decreased in PB and increased in SF among RA patients. If the proportion of Tregs differs in RA, accurate and functionally relevant definitions of Tregs are necessary to elucidate their status in RA.	[Morita, Takayoshi; Shima, Yoshihito; Ogata, Atsushi; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan; [Morita, Takayoshi; Wing, James Badger; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Osaka, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto, Japan; [Ogata, Atsushi] NTT West Osaka Hosp, Div Allergy Rheumatol & Connect Tissue Dis, Osaka, Japan	Osaka University; Osaka University; Kyoto University	Ogata, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan.; Ogata, A (corresponding author), NTT West Osaka Hosp, Div Allergy Rheumatol & Connect Tissue Dis, Osaka, Japan.	ogata@imed3.med.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Morita, Takayoshi/AAW-2706-2021; Wing, James Badger/H-6256-2019; Morita, Takayoshi/AAZ-4112-2021	Wing, James Badger/0000-0002-3462-1003; Morita, Takayoshi/0000-0002-7111-9506; Ogata, Atsushi/0000-0003-3944-3442	Japan Society for the Promotion of Science [25460495]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Scientific Research (C) from Japan Society for the Promotion of Science, No. 25460495. A. Ogata had gotten this grant.	Abaza N, 2013, EGYPT RHEUMATOL, V35, P185, DOI 10.1016/j.ejr.2013.03.005; Al-Shukaili A, 2009, OPEN AUTOIMMUNITY J, V1, P5; Al-Zifzaf DS, 2015, EGYPT RHEUMATOL, V37, P7, DOI 10.1016/j.ejr.2014.06.004; Barbieri A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/729654; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Chen JW, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/535361; Chen MH, 2011, CLIN RHEUMATOL, V30, P1181, DOI 10.1007/s10067-011-1721-6; Chen Ruilin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P886; Cribbs AP, 2014, ARTHRITIS RHEUMATOL, V66, P2344, DOI 10.1002/art.38715; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Daien CI, 2015, RHEUMATOLOGY, V54, P601, DOI 10.1093/rheumatology/keu363; David B, 2015, J IMMUNOL, V195, P5616, DOI [10.4049/jimmunol.1500391, DOI 10.4049/JIMMUNOL.1500391]; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Furuzawa-Carballeda J, 2011, EUR J CLIN INVEST, V41, P1037, DOI 10.1111/j.1365-2362.2011.02491.x; Gaafar T, 2015, J CLIN CELL IMMUNOL, V6, P381, DOI DOI 10.4172/2155-9899.1000381; Gao S, 2014, INFLAMM RES, V63, P441, DOI 10.1007/s00011-014-0716-6; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guggino G, 2015, RHEUMATOL INT, V35, P171, DOI 10.1007/s00296-014-3030-2; Han GM, 2008, CELL IMMUNOL, V253, P92, DOI 10.1016/j.cellimm.2008.05.007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Zhi-xiang, 2009, Zhonghua Yi Xue Za Zhi, V89, P2476; Ito Y, 2014, SCIENCE, V346, P363, DOI 10.1126/science.1259077; Ji L, 2013, INT J RHEUM DIS; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kao Jun-Kai, 2007, Journal of Microbiology Immunology and Infection, V40, P419; Kim JR, 2012, J KOREAN MED SCI, V27, P1009, DOI 10.3346/jkms.2012.27.9.1009; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Lastovicka J., 2013, RES IMMUNOL, V2013; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Li G, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0157-0; Loza MJ, 2011, CELL IMMUNOL, V271, P110, DOI 10.1016/j.cellimm.2011.06.010; MANICOURT DH, 1993, ARTHRITIS RHEUM, V36, P490, DOI 10.1002/art.1780360409; Matsuki F, 2013, BIOCHEM BIOPH RES CO, V438, P778, DOI 10.1016/j.bbrc.2013.05.120; Sempere-Ortells JM, 2009, AUTOIMMUNITY, V42, P636, DOI 10.3109/08916930903061491; Minami Rumi, 2006, Nihon Rinsho Meneki Gakkai Kaishi, V29, P37; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moradi B, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4545; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; OCEBM Levels of Evidence Working Group, OXFORD 2011 LEVELS E; Paradowska-Gorycka A, 2015, J RHEUMATOL, V42, P170, DOI 10.3899/jrheum.131381; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Tang TT, 2011, J LIPID RES, V52, P1023, DOI 10.1194/jlr.M010876; Ursaciuc Cornel, 2010, Roum Arch Microbiol Immunol, V69, P79; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093; Wells G.A., NEWCASTLE OTTAWA SCA; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Xavier V, 2007, BLOOD, V108, P253; Xiao H, 2011, J CLIN IMMUNOL, V31, P1112, DOI 10.1007/s10875-011-9559-x; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yoon BY, 2007, IMMUNE NETW, V7, P124; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zhu J, 2015, ACUPUNCT MED, V33, P305, DOI 10.1136/acupmed-2014-010732	63	55	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162306	10.1371/journal.pone.0162306	http://dx.doi.org/10.1371/journal.pone.0162306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622457	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000022
J	Bisetegn, TA; Mihretie, G; Muche, T				Bisetegn, Telake Azale; Mihretie, Getnet; Muche, Tefera			Prevalence and Predictors of Depression among Pregnant Women in Debretabor Town, Northwest Ethiopia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; RIO-DE-JANEIRO; RISK-FACTORS; ANTENATAL DEPRESSION; ADDIS-ABABA; OUTCOMES; HEALTH; BRAZIL; PERSISTENCE; ANXIETY	Background Depression during pregnancy is a major health problem because it is prevalent and chronic, and its impact on birth outcome and child health is serious. Several psychosocial and obstetric factors have been identified as predictors. Evidence on the prevalence and predictors of antenatal depression is very limited in Ethiopia. This study aims to determine prevalence and associated factors with antenatal depression. Methods Community based cross-sectional study was conducted among 527 pregnant women recruited in a cluster sampling method. Data were collected by face-to-face interviews on socio-demographic, obstetric, and psychosocial characteristics. Depression symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS). The List of Threatening Experiences questionnaire (LTE-Q) and the Oslo Social Support Scale (OSS3) were used to assess stressful events and social support, respectively. Data were entered into Epi-info and analyzed using SPSS-20. Descriptive and logistic regression analyses were carried out. Results The prevalence of antenatal depression was found to be 11.8%. Having debt (OR = 2.79, 95% CI = 1.33, 5.85), unplanned pregnancy (OR = 2.39, 95% CI = (1.20, 4.76), history of stillbirth (OR = 3.97, 95% CI = (1.67,9.41), history of abortion (OR = 2.57, 95% CI = 1.005, 6.61), being in the third trimester of pregnancy (OR = 1.70, 95% CI = 1.07,2.72), presence of a complication in the current pregnancy (OR = 3.29, 95% CI = 1.66,6.53), and previous history of depression (OR = 3.48, 95% CI = 1.71,7.06) were factors significantly associated with antenatal depression. Conclusion The prevalence of antenatal depression was high, especially in the third trimester. Poverty, unmet reproductive health needs, and obstetric complications are the main determinants of antenatal depression. For early detection and appropriate intervention, screening for depression during the routine antenatal care should be promoted.	[Bisetegn, Telake Azale] Univ Gondar, Coll Med & Hlth Sci, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia; [Mihretie, Getnet] Univ Gondar, Coll Med & Hlth Sci, Dept Psychiat, Gondar, Ethiopia; [Muche, Tefera] Amanuel Mental Specialized Hosp, Addis Ababa, Ethiopia	University of Gondar; University of Gondar	Bisetegn, TA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia.	telakea@yahoo.com			University of Gondar; Amanuel mental specialized hospital	University of Gondar; Amanuel mental specialized hospital	Our special appreciation goes to University of Gondar and Amanuel mental specialized hospital for providing support for this research project. We would like to express our thanks to the women who participated in the study for generously giving their time and energy to complete interviews.	Adewuya AO, 2007, DEPRESS ANXIETY, V24, P15, DOI 10.1002/da.20221; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; [Anonymous], 2006, PLOS MED, V3, pe252; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bennett HA, 2004, CLIN DRUG INVEST, V24, P157, DOI 10.2165/00044011-200424030-00004; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Boen H, 2012, BMC GERIATR, V12; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; DDHO, 2012, DEB DISTR HLTH OFF A; Dibaba Y, 2014, PLOS ONE; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Faisal-Cury A., 2016, PSYCHOL HEALTH MED, P1; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fernandes M., 2014, CHILD CARE HLTH DEV; Fisher J, 2013, J AFFECT DISORDERS, V146, P213, DOI 10.1016/j.jad.2012.09.007; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gausia K, 2009, ARCH WOMEN MENT HLTH, V12, P351, DOI 10.1007/s00737-009-0080-7; Gentile S, 2015, NEUROSCIENCE; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Jenkins R, 2010, INT J ENV RES PUB HE, V7, P2543, DOI 10.3390/ijerph7062543; Lovisi GM, 2005, PSYCHOL MED, V35, P1485, DOI 10.1017/S0033291705005362; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Medhin G, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-32; Motrico E, 2013, J AFFECT DISORDERS, V150, P931, DOI 10.1016/j.jad.2013.05.017; Pereira PK, 2014, CAD SAUDE PUBLICA, V30, P1654, DOI 10.1590/0102-311X00080213; Pereira PK, 2009, CAD SAUDE PUBLICA, V25, P2725, DOI 10.1590/S0102-311X2009001200019; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; STEIN M, 1991, ARCH GEN PSYCHIAT, V48, P171; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; van Heyningen T, 2016, J AFFECT DISORDERS, V203, P121, DOI 10.1016/j.jad.2016.05.052	35	44	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161108	10.1371/journal.pone.0161108	http://dx.doi.org/10.1371/journal.pone.0161108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618181	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100004
J	Ghandchi, FP; Caetano-Anolles, G; Clough, SJ; Ort, DR				Ghandchi, Frederick P.; Caetano-Anolles, Gustavo; Clough, Steven J.; Ort, Donald R.			Investigating the Control of Chlorophyll Degradation by Genomic Correlation Mining	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEAF SENESCENCE; GENE-EXPRESSION; ARABIDOPSIS; BREAKDOWN; PROTEIN; PHEOPHORBIDE; CATABOLITES; OXYGENASE; ENZYMES	Chlorophyll degradation is an intricate process that is critical in a variety of plant tissues at different times during the plant life cycle. Many of the photoactive chlorophyll degradation intermediates are exceptionally cytotoxic necessitating that the pathway be carefully coordinated and regulated. The primary regulatory step in the chlorophyll degradation pathway involves the enzyme pheophorbide a oxygenase (PAO), which oxidizes the chlorophyll intermediate pheophorbide a, that is eventually converted to non-fluorescent chlorophyll catabolites. There is evidence that PAO is differentially regulated across different environmental and developmental conditions with both transcriptional and post-transcriptional components, but the involved regulatory elements are uncertain or unknown. We hypothesized that transcription factors modulate PAO expression across different environmental conditions, such as cold and drought, as well as during developmental transitions to leaf senescence and maturation of green seeds. To test these hypotheses, several sets of Arabidopsis genomic and bioinformatic experiments were investigated and re-analyzed using computational approaches. PAO expression was compared across varied environmental conditions in the three separate datasets using regression modeling and correlation mining to identify gene elements co-expressed with PAO. Their functions were investigated as candidate upstream transcription factors or other regulatory elements that may regulate PAO expression. PAO transcript expression was found to be significantly up-regulated in warm conditions, during leaf senescence, and in drought conditions, and in all three conditions significantly positively correlated with expression of transcription factor Arabidopsis thaliana activating factor 1 (ATAF1), suggesting that ATAF1 is triggered in the plant response to these processes or abiotic stresses and in result up-regulates PAO expression. The proposed regulatory network includes the freezing, senescence, and drought stresses modulating factor ATAF1 and various other transcription factors and pathways, which in turn act to regulate chlorophyll degradation by up-regulating PAO expression.	[Ghandchi, Frederick P.; Caetano-Anolles, Gustavo; Ort, Donald R.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ghandchi, Frederick P.; Caetano-Anolles, Gustavo; Clough, Steven J.; Ort, Donald R.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Clough, Steven J.] Univ Illinois, USDA ARS, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA; [Ort, Donald R.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Ort, Donald R.] Univ Illinois, USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Ort, DR (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Ort, DR (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.; Ort, DR (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.; Ort, DR (corresponding author), Univ Illinois, USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL 61801 USA.	d-ort@illinois.edu		Ort, Donald/0000-0002-5435-4387	Illinois Department of Crop Sciences and Institute for Genomic Biology	Illinois Department of Crop Sciences and Institute for Genomic Biology	We thank University of Illinois Department of Crop Sciences and Institute for Genomic Biology for their support.	Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cheng YD, 2012, FOOD CHEM, V135, P415, DOI 10.1016/j.foodchem.2012.05.017; Christ B, 2012, PLANT PHYSIOL, V158, P628, DOI 10.1104/pp.111.188870; Chung DW, 2006, PLANT PHYSIOL, V142, P88, DOI 10.1104/pp.106.084483; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang L, 2015, EXPRESSION VITIS AMU; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hortensteiner S, 2013, PLANT MOL BIOL, V82, P505, DOI 10.1007/s11103-012-9940-z; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Hortensteiner S, 1999, CELL MOL LIFE SCI, V56, P330, DOI 10.1007/s000180050434; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen MK, 2013, FEBS OPEN BIO, V3, P321, DOI 10.1016/j.fob.2013.07.006; Lai B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1433-4; Lee J, 2009, J FOOD SCI, V74, pC481, DOI 10.1111/j.1750-3841.2009.01242.x; Maracchi G, 2005, CLIMATIC CHANGE, V70, P117, DOI 10.1007/s10584-005-5939-7; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Park S, 2015, PLANT J, V82, P193, DOI 10.1111/tpj.12796; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Qiu K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005399; Rosa RK, 2015, GLOBAL CHANGE BIOL, V21, P4520, DOI 10.1111/gcb.13040; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; WARD K, 1992, J AM OIL CHEM SOC, V69, P1039, DOI 10.1007/BF02541074; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xu C, 2016, GLOB CHANG BIOL; Zhang XL, 2011, J PLANT PHYSIOL, V168, P2081, DOI 10.1016/j.jplph.2011.06.011	27	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162327	10.1371/journal.pone.0162327	http://dx.doi.org/10.1371/journal.pone.0162327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618630	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100018
J	Boortz, KA; Syring, KE; Pound, LD; Wang, YD; Oeser, JK; O'Brien, RM				Boortz, Kayla A.; Syring, Kristen E.; Pound, Lynley D.; Wang, Yingda; Oeser, James K.; O'Brien, Richard M.			Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression	PLOS ONE			English	Article							SUBUNIT-RELATED PROTEIN; GLYCOGEN-STORAGE-DISEASE; PHOSPHOHISTIDINE-ENZYME INTERMEDIATE; STIMULATED INSULIN-SECRETION; G-6-PASE CATALYTIC SUBUNIT; FASTING GLUCOSE-LEVELS; BODY-MASS INDEX; PHENOME-WIDE; MISSING HERITABILITY; GENE-EXPRESSION	Elevated fasting blood glucose (FBG) has been associated with increased risk for development of type 2 diabetes. Single nucleotide polymorphisms (SNPs) in G6PC2 are the most important common determinants of variations in FBG in humans. Studies using G6pc2 knockout mice suggest that G6pc2 regulates the glucose sensitivity of insulin secretion. G6PC2 and the related G6PC1 and G6PC3 genes encode glucose-6-phosphatase catalytic subunits. This study describes a functional analysis of 22 non-synonymous G6PC2 SNPs, that alter amino acids that are conserved in human G6PC1, mouse G6pc1 and mouse G6pc2, with the goal of identifying variants that potentially affect G6PC2 activity/expression. Published data suggest strong conservation of catalytically important amino acids between all four proteins and the related G6PC3 isoform. Because human G6PC2 has very low glucose-6-phosphatase activity we used an indirect approach, examining the effect of these SNPs on mouse G6pc1 activity. Using a novel in situ functional assay for glucose-6-phosphatase activity we demonstrate that the amino acid changes associated with the human G6PC2 rs144254880 (Arg79Gln), rs149663725 (Gly114Arg) and rs2232326 (Ser324Pro) SNPs reduce mouse G6pc1 enzyme activity without affecting protein expression. The Arg79Gln variant alters an amino acid mutation of which, in G6PC1, has previously been shown to cause glycogen storage disease type 1a. We also demonstrate that the rs368 382511 (Gly8Glu), rs138726309 (His177Tyr), rs2232323 (Tyr207Ser) rs374055555 (Arg293Trp), rs2232326 (Ser324Pro), rs137857125 (Pro313Leu) and rs2232327 (Pro340-Leu) SNPs confer decreased G6PC2 protein expression. In summary, these studies identify multiple G6PC2 variants that have the potential to be associated with altered FBG in humans.	[Boortz, Kayla A.; Syring, Kristen E.; Pound, Lynley D.; Wang, Yingda; Oeser, James K.; O'Brien, Richard M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	O'Brien, RM (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	richard.obrien@vanderbilt.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK092589]; NIH [DK092589]; Vanderbilt Molecular Endocrinology Training Program [5T32 DK07563]; NIH, Vanderbilt Diabetes Research Training Center [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK092589, T32DK007563] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Molecular Endocrinology Training Program; NIH, Vanderbilt Diabetes Research Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research in the laboratory of RO'B was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant DK092589 to RO'B and by NIH grant P60 DK20593, which supports the Vanderbilt Diabetes Research Training Center. KES and LDP were supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to John Hutton (1948-2012) for the numerous insights he contributed to this project. The following graduate students contributed to these studies: Courtney Copeland, Peter Kropp, Bethany Carboneau, Elijah Trefts and Brandon Bout. We thank Dr. Chris Newgard for providing the 832/13 cell line. Research in the laboratory of R.O'B. was supported by NIH grant DK092589 to R.O'B. and by NIH grant P60 DK20593, which supports the Vanderbilt Diabetes Research Training Center. K. E. S. and L. D. P. were supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. R.O'B. is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis.	Abdul-Ghani MA, 2009, DIABETES CARE, V32, pS194, DOI 10.2337/dc09-S309; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Banka S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-84; Bell GI, 1996, ANNU REV PHYSIOL, V58, P171, DOI 10.1146/annurev.physiol.58.1.171; Bischof LJ, 2001, DIABETES, V50, P502, DOI 10.2337/diabetes.50.3.502; Boortz KA, 2016, ENDOCRINOLOGY, V157, P3002, DOI 10.1210/en.2016-1245; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2010, DIABETES, V59, P2662, DOI 10.2337/db10-0389; Boustead JN, 2004, J MOL ENDOCRINOL, V32, P33, DOI 10.1677/jme.0.0320033; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Ghosh A, 2004, J BIOL CHEM, V279, P12479, DOI 10.1074/jbc.M313271200; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Hornbuckle LA, 2001, AM J PHYSIOL-ENDOC M, V281, pE713, DOI 10.1152/ajpendo.2001.281.4.E713; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; Lawes CMM, 2004, DIABETES CARE, V27, P2836; LEI KJ, 1995, J BIOL CHEM, V270, P11882, DOI 10.1074/jbc.270.20.11882; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin SR, 2015, MOL GENET METAB, V114, P41, DOI 10.1016/j.ymgme.2014.11.012; Llewellyn CH, 2013, INT J OBESITY, V37, P1506, DOI 10.1038/ijo.2013.30; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Mahajan A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004876; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marmugi A, 2016, DIABETES, V65, P1009, DOI 10.2337/db15-1334; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Newgard CB, 1997, DIABETOLOGIA, V40, pS42, DOI 10.1007/s001250051398; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Pound LD, 2013, DIABETES, V62, P1547, DOI 10.2337/db12-1067; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Shameli Afshin, 2007, Rev Diabet Stud, V4, P25, DOI 10.1900/RDS.2007.4.25; SPETH M, 1986, FEBS LETT, V202, P32, DOI 10.1016/0014-5793(86)80643-3; Streeper RS, 1998, P NATL ACAD SCI USA, V95, P9208, DOI 10.1073/pnas.95.16.9208; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Trinh K, 1997, J BIOL CHEM, V272, P24837, DOI 10.1074/jbc.272.40.24837; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wall ML, 2015, DIABETES, V64, P2129, DOI 10.2337/db14-0745; Wang D, 2006, ENDOCRINOLOGY, V147, P350, DOI 10.1210/en.2005-1014; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390	73	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162439	10.1371/journal.pone.0162439	http://dx.doi.org/10.1371/journal.pone.0162439			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611587	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900099
J	Chen, DF; Zheng, JX; Gerasimcik, N; Lagerstedt, K; Sjogren, H; Abrahamsson, J; Fogelstrand, L; Martensson, IL				Chen, Dongfeng; Zheng, Junxiong; Gerasimcik, Natalija; Lagerstedt, Kristina; Sjogren, Helene; Abrahamsson, Jonas; Fogelstrand, Linda; Martensson, Inga-Lill			The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							SURROGATE LIGHT-CHAIN; TRANSCRIPTION FACTORS; DNA METHYLATION; CHILDHOOD; DIFFERENTIATION; SIGNATURES; CLASSIFICATION; ACTIVATION; CHECKPOINT; SELECTION	Precursor-B cell receptor (pre-BCR) signaling represents a crucial checkpoint at the pre-B cell stage. Aberrant pre-BCR signaling is considered as a key factor for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) development. BCP-ALL are believed to be arrested at the pre-BCR checkpoint independent of pre-BCR expression. However, the cellular stage at which BCP-ALL are arrested and whether this relates to expression of the pre-BCR components (IGHM, IGLL1 and VPREB1) is still unclear. Here, we show differential protein expression and copy number variation (CNV) patterns of the pre-BCR components in pediatric BCP-ALL. Moreover, analyzing six BCP-ALL data sets (n = 733), we demonstrate that TCF3-PBX1 ALL express high levels of IGHM, IGLL1 and VPREB1, and are arrested at the pre-B stage. By contrast, ETV6-RUNX1 ALL express low levels of IGHM or VPREB1, and are arrested at the pro-B stage. Irrespective of subtype, ALL with high levels of IGHM, IGLL1 and VPREB1 are arrested at the pre-B stage and correlate with good prognosis in high-risk pediatric BCP-ALL (n = 207). Our findings suggest that BCP-ALL are arrested at different cellular stages, which relates to the expression pattern of the pre-BCR components that could serve as prognostic markers for high-risk pediatric BCP-ALL patients.	[Chen, Dongfeng; Zheng, Junxiong; Gerasimcik, Natalija; Lagerstedt, Kristina; Martensson, Inga-Lill] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Sjogren, Helene; Fogelstrand, Linda] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Abrahamsson, Jonas] Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Fogelstrand, Linda] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Queen Silvia Children's Hospital; University of Gothenburg	Martensson, IL (corresponding author), Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	lill.martensson@rheuma.gu.se	Gerasimcik, Natalija/M-4350-2019; Abrahamsson, Jonas/I-5786-2012	Gerasimcik, Natalija/0000-0001-9680-035X; Abrahamsson, Jonas/0000-0002-9240-3522; Martensson, Inga-Lill/0000-0003-3415-0560	Barncancerfonden [TJ2014-0083]; Cancerfonden [CAN2014/886]; Assar Gabrielsson Fond [FB 15-57]; Lions Cancerfond; ALF; IngaBritt och Arne Lundbergs Forskning Stiftelse; Stiftelsen Wilhelm och Martina Lundgrens Vetenskap; Adlerbertska forskningsstiftelsen	Barncancerfonden; Cancerfonden(Swedish Cancer Society); Assar Gabrielsson Fond; Lions Cancerfond; ALF; IngaBritt och Arne Lundbergs Forskning Stiftelse; Stiftelsen Wilhelm och Martina Lundgrens Vetenskap; Adlerbertska forskningsstiftelsen	This work has been supported by grants from: Barncancerfonden (TJ2014-0083, DC, http://www.barncancerfonden.se), Cancerfonden (CAN2014/886, ILM, https://www.cancerfonden.se/), Assar Gabrielsson Fond (FB 15-57, DC, http://www.agfond.se/), Lions Cancerfond (2012:20, DC, http://www.lionscancerfond.se/), ALF (GBG, ILM, http://www.fou.nu/is/alfgbg), IngaBritt och Arne Lundbergs Forskning Stiftelse (ILM, http://www.lundbergsstiftelsen.se/en/home/), Stiftelsen Wilhelm och Martina Lundgrens Vetenskap (DC, http://www.wmlundgren.se/), Adlerbertska forskningsstiftelsen (DC, http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Andersson A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-6; Buchner M, 2015, IMMUNOL REV, V263, P192, DOI 10.1111/imr.12235; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Chiaretti S, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.073; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Conley ME, 2010, J IMMUNOL, V184, P1127, DOI 10.4049/jimmunol.0990113; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Eswaran J, 2015, LEUKEMIA, V29, P1623, DOI 10.1038/leu.2015.113; Figueroa ME, 2013, J CLIN INVEST, V123, P3099, DOI 10.1172/JCI66203; Geng HM, 2015, CANCER CELL, V27, P409, DOI 10.1016/j.ccell.2015.02.003; Gisler R, 2002, J IMMUNOL, V168, P5130, DOI 10.4049/jimmunol.168.10.5130; Harrison CJ, 2013, HEMATOL-AM SOC HEMAT, P118, DOI 10.1182/asheducation-2013.1.118; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kohrer S, 2016, LEUKEMIA, V30, P1246, DOI 10.1038/leu.2016.9; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lemmers B, 2000, LEUKEMIA, V14, P2103, DOI 10.1038/sj.leu.2401932; Li ZG, 2009, BLOOD, V114, P4486, DOI 10.1182/blood-2009-04-218123; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Mundt C, 2006, INT IMMUNOL, V18, P163, DOI 10.1093/intimm/dxh359; Nordlund J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r105; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Somasundaram R, 2015, BLOOD, V126, P144, DOI 10.1182/blood-2014-12-575688; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tsuzuki S, 2004, P NATL ACAD SCI USA, V101, P8443, DOI 10.1073/pnas.0402063101; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	36	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162638	10.1371/journal.pone.0162638	http://dx.doi.org/10.1371/journal.pone.0162638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611867	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900142
J	Cho, U; Kim, HM; Park, HS; Kwon, OJ; Lee, A; Jeong, SW				Cho, Uiju; Kim, Hae-Mi; Park, Hong Sik; Kwon, Oh-Joo; Lee, Ahwon; Jeong, Seong-Whan			Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers	PLOS ONE			English	Article							GOLGI-SNARE; COMPLEX; APOPTOSIS; TRANSPORT; TARGETS	Objective The protein GS28 (28-kDa Golgi SNARE protein) has been described as a SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptors) protein family member that plays a critical role in mammalian ER-Golgi or intra-Golgi vesicle transport. Little is known about the possible roles of GS28 in pathological conditions. The purpose of this study was to evaluate GS28 expression in cervical cancer tissues and explore its correlation with clinicopathological features and prognosis. Methods We investigated GS28 expression in 177 cervical cancer tissues by using immunohistochemistry and evaluated the correlation of GS28 expression with clinicopathological features, the expression of p53 and Bcl-2, and prognosis of cervical cancer patients. Immunoblotting was performed using six freshly frozen cervical cancer tissues to confirm the subcellular localization of GS28. Results Immunoreactivity of GS28 was observed in both nuclear and cytoplasmic compartments of cervical cancer cells. High nuclear expression of GS28 was associated with advanced tumor stages (P = 0.036) and negative expression of p53 (P = 0.036). In multivariate analyses, patients with high nuclear expression of GS28 showed significantly worse overall survival (OS) (hazard ratio = 3.785, P = 0.003) and progression-free survival (PFS) (hazard ratio = 3.019, P = 0.008), compared to those with low or no nuclear expression. It was also a reliable, independent prognostic marker in subgroups of patients with early stage T1 and negative lymph node metastasis in OS (P = 0.008 and 0.019, respectively). The nuclear expression of GS28 was confirmed by immunoblotting. Conclusion High nuclear expression of GS28 is associated with poor prognosis in early-stage cervical cancer patients. GS28 might be a novel prognostic marker and a potential therapeutic target in cervical cancer treatment.	[Cho, Uiju; Park, Hong Sik] Catholic Univ Korea, St Vincents Hosp, Dept Hosp Pathol, Coll Med, Suwon, South Korea; [Kim, Hae-Mi; Kwon, Oh-Joo; Jeong, Seong-Whan] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul, South Korea; [Lee, Ahwon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Jeong, SW (corresponding author), Catholic Univ Korea, Dept Biochem, Coll Med, Seoul, South Korea.; Lee, A (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hosp Pathol, Seoul, South Korea.	klee@catholic.ac.kr; swjeong@catholic.ac.kr		Cho, Uiju/0000-0002-6229-8418	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2011752]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	The research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011752) (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Iida M, 2014, MOL CLIN ONCOL, V2, P647, DOI 10.3892/mco.2014.324; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Lee HO, 2011, KOREAN J PHYSIOL PHA, V15, P149, DOI 10.4196/kjpp.2011.15.3.149; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lu M, 2008, MOL CELL ENDOCRINOL, V287, P72, DOI 10.1016/j.mce.2008.01.028; Maekawa M, 2009, GENES CELLS, V14, P1003, DOI 10.1111/j.1365-2443.2009.01325.x; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; McAdam AJ, 2015, ROBBINS COTRAN PATHO, V9; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Meng JH, 2015, BBA-REV CANCER, V1856, P1, DOI 10.1016/j.bbcan.2015.04.002; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; Qiu JT, 2012, GYNECOL ONCOL, V127, P472, DOI 10.1016/j.ygyno.2012.08.008; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Rosenbaum EE, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585166; Ruan Q, 2004, EXP CELL RES, V294, P51, DOI 10.1016/j.yexcr.2003.10.022; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; Sun NK, 2012, BIOCHEM J, V444, P303, DOI 10.1042/BJ20112223; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876; Ulloa F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119707; Volchuk A, 2004, MOL BIOL CELL, V15, P1506, DOI 10.1091/mbc.E03-08-0625; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005; Zhou RY, 2015, EUR J OBSTET GYN R B, V195, P210, DOI 10.1016/j.ejogrb.2015.10.006	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162623	10.1371/journal.pone.0162623	http://dx.doi.org/10.1371/journal.pone.0162623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611086	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900134
J	Cristea, IA; Kok, RN; Cuijpers, P				Cristea, Ioana A.; Kok, Robin N.; Cuijpers, Pim			The Effectiveness of Cognitive Bias Modification Interventions for Substance Addictions: A Meta-Analysis	PLOS ONE			English	Article							ATTENTIONAL BIAS	Background and Aims Cognitive bias modification (CBM) interventions, presumably targeting automatic processes, are considered particularly promising for addictions. We conducted a meta-analysis examining randomized controlled trials (RCTs) of CBM for substance addiction outcomes. Methods Studies were identified through systematic searches in bibliographical databases. We included RCTs of CBM interventions, alone or in combination with other treatments, for any type of addiction. We examined trial risk of bias, publication bias and possible moderators. Effects sizes were computed for post-test and follow-up, using a random-effects model. We grouped outcome measures and reported results for addiction (all related measures), craving and cognitive bias. Results We identified 25 trials, 18 for alcohol problems, and 7 for smoking. At post-test, there was no significant effect of CBM for addiction, g = 0.08 (95% CI -0.02 to 0.18) or craving, g = 0.05 (95% CI -0.06 to 0.16), but there was a significant, moderate effect on cognitive bias, g = 0.60 (95% CI 0.39 to 0.79). Results were similar for alcohol and smoking outcomes taken separately. Follow-up addiction outcomes were reported in 7 trials, resulting in a small but significant effect of CBM, g = 0.18 (95% CI 0.03 to 0.32). Results for addiction and craving did not differ by substance type, sample type, delivery setting, bias targeted or number of sessions. Risk of bias was high or uncertain in most trials, for most criteria considered. Meta-regression analyses revealed significant inverse relationships between risk of bias and effect sizes for addiction outcomes and craving. The relationship between cognitive bias and respectively addiction ESs was not significant. There was consistent evidence of publication bias in the form of funnel plot asymmetry. Conclusions Our results cast serious doubts on the clinical utility of CBM interventions for addiction problems, but sounder methodological trials are necessary before this issue can be settled. We found no indication that positive effects on biases translate into effects on addiction outcomes.	[Cristea, Ioana A.] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania; [Cristea, Ioana A.] Univ Padua, Dept Gen Psychol, Padua, Italy; [Kok, Robin N.] Univ Southern Denmark, Dept Psychol, Fac Hlth Sci, Odense, Denmark; [Kok, Robin N.] Odense Univ Hosp, Dept Clin Innovat, Ctr Innovat Med Technol, Odense, Denmark; [Kok, Robin N.; Cuijpers, Pim] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Psychol, Amsterdam, Netherlands; [Kok, Robin N.; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Kok, Robin N.; Cuijpers, Pim] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Babes Bolyai University from Cluj; University of Padua; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Cristea, IA (corresponding author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania.; Cristea, IA (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	ioana.cristea@ubbcluj.ro	Cristea, Ioana Alina/E-7490-2011; Cuijpers, Pim/G-1703-2013	Cristea, Ioana Alina/0000-0002-9854-7076; Kok, Robin/0000-0001-9845-282X				Beard C, 2011, EXPERT REV NEUROTHER, V11, P299, DOI [10.1586/ern.10.194, 10.1586/ERN.10.194]; Borenstein M., 2009, INTRO METAANALYSIS; CAREY B, 2012, NY TIMES; Christiansen P, 2015, ADDICT BEHAV, V44, P43, DOI 10.1016/j.addbeh.2014.10.005; Clarke PJF, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cox WM, 2014, CNS SPECTRUMS, V19, P215, DOI 10.1017/S1092852914000091; Cristea IA, BR J PSYCHI IN PRESS; Cristea IA, 2015, J CHILD PSYCHOL PSYC, V56, P723, DOI 10.1111/jcpp.12383; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Leeman Robert F, 2014, Curr Addict Rep, V1, P41; MacLeod C, 2012, ANNU REV CLIN PSYCHO, V8, P189, DOI 10.1146/annurev-clinpsy-032511-143052; Macleod C, 2012, AM J PSYCHIAT, V169, P118, DOI 10.1176/appi.ajp.2011.11111682; MacLeod C, 2012, CURR OPIN PSYCHIATR, V25, P114, DOI 10.1097/YCO.0b013e32834fda4a; Marhe R, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00185; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Orsini N., 2006, HETEROGI STATA MODUL; Wiers RW, 2015, ADDICT BEHAV, V40, P21, DOI 10.1016/j.addbeh.2014.08.010; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547	26	121	121	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162226	10.1371/journal.pone.0162226	http://dx.doi.org/10.1371/journal.pone.0162226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611692	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900062
J	Demond, H; Trapphoff, T; Dankert, D; Heiligentag, M; Grummer, R; Horsthemke, B; Eichenlaub-Ritter, U				Demond, Hannah; Trapphoff, Tom; Dankert, Deborah; Heiligentag, Martyna; Gruemmer, Ruth; Horsthemke, Bernhard; Eichenlaub-Ritter, Ursula			Preovulatory Aging In Vivo and In Vitro Affects Maturation Rates, Abundance of Selected Proteins, Histone Methylation Pattern and Spindle Integrity in Murine Oocytes	PLOS ONE			English	Article							SUBCORTICAL MATERNAL COMPLEX; EARLY EMBRYONIC-DEVELOPMENT; PREANTRAL FOLLICLE CULTURE; MOUSE OOCYTES; CHROMOSOME MISALIGNMENT; REPRODUCTIVE TOXICOLOGY; MESSENGER-RNA; HETEROCHROMATIN; MSY2; EXPRESSION	Delayed ovulation and delayed fertilization can lead to reduced developmental competence of the oocyte. In contrast to the consequences of postovulatory aging of the oocyte, hardly anything is known about the molecular processes occurring during oocyte maturation if ovulation is delayed (preovulatory aging). We investigated several aspects of oocyte maturation in two models of preovulatory aging: an in vitro follicle culture and an in vivo mouse model in which ovulation was postponed using the GnRH antagonist cetrorelix. Both models showed significantly reduced oocyte maturation rates after aging. Furthermore, in vitro preovulatory aging deregulated the protein abundance of the maternal effect genes Smarca4 and Nlrp5, decreased the levels of histone H3K9 trimethylation and caused major deterioration of chromosome alignment and spindle conformation. Protein abundance of YBX2, an important regulator of mRNA stability, storage and recruitment in the oocyte, was not affected by in vitro aging. In contrast, in vivo preovulatory aging led to reduction in Ybx2 transcript and YBX2 protein abundance. Taken together, preovulatory aging seems to affect various processes in the oocyte, which could explain the low maturation rates and the previously described failures in fertilization and embryonic development.	[Demond, Hannah; Horsthemke, Bernhard] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany; [Trapphoff, Tom; Heiligentag, Martyna; Eichenlaub-Ritter, Ursula] Univ Bielefeld, Inst Gene Technol Microbiol, Bielefeld, Germany; [Dankert, Deborah; Gruemmer, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Inst Anat, Essen, Germany	University of Duisburg Essen; University of Bielefeld; University of Duisburg Essen	Horsthemke, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany.	bernhard.horsthemke@uni-due.de		Demond, Hannah/0000-0003-4706-4792	German Research Foundation (DFG) [EI 199/7-1, GR 1138/12-1, HO 949/21-1, FOR 1041]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study has been supported by the German Research Foundation (DFG, www.dfg.de, EI 199/7-1 vertical bar GR 1138/12-1 vertical bar HO 949/21-1 and FOR 1041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens I, 2004, HUM REPROD, V19, P398, DOI 10.1093/humrep/deh074; Al-Inany H, 2007, REPROD BIOMED ONLINE, V14, P640, DOI 10.1016/S1472-6483(10)61059-0; Al-Inany HG, 2011, HUM REPROD UPDATE, V17, P435, DOI 10.1093/humupd/dmr004; Bittner AK, 2011, FERTIL STERIL, V95, P2390, DOI 10.1016/j.fertnstert.2011.03.022; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Carey TS, 2015, MOL CELL BIOL, V35, P4158, DOI 10.1128/MCB.00546-15; Clarke HJ, 2012, POSTTRANSCRIPTIONAL; Cortvrindt RG, 2002, HUM REPROD UPDATE, V8, P243, DOI 10.1093/humupd/8.3.243; Dankert D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108907; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Dejardin J, 2015, TRENDS GENET, V31, P661, DOI 10.1016/j.tig.2015.09.003; Demant M, 2012, HUM REPROD, V27, P1096, DOI 10.1093/humrep/der453; Eymery A, 2016, DEVELOPMENT; Fernandes R, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093583; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Han LS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Kang MK, 2011, BMB REP, V44, P147, DOI 10.5483/BMBRep.2011.44.3.147; Kim B, 2014, DEV BIOL, V386, P331, DOI 10.1016/j.ydbio.2013.12.025; Kim J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005970; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lu YQ, 2016, MOL HUM REPROD, V22, P252, DOI 10.1093/molehr/gaw001; Manosalva I, 2010, THERIOGENOLOGY, V74, P1539, DOI 10.1016/j.theriogenology.2010.06.024; Medvedev S, 2008, DEV BIOL, V321, P205, DOI 10.1016/j.ydbio.2008.06.016; Medvedev S, 2011, BIOL REPROD, V85, P575, DOI 10.1095/biolreprod.111.091710; Nath S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00060; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Roberts R, 2002, HUM REPROD, V17, P2950, DOI 10.1093/humrep/17.11.2950; Sanchez F, 2012, J ASSIST REPROD GEN, V29, P141, DOI 10.1007/s10815-011-9690-x; SMITS LJ, 1995, MED HYPOTHESES, V45, P441, DOI 10.1016/0306-9877(95)90218-X; Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056; Sun FY, 2004, MUTAGENESIS, V19, P13, DOI 10.1093/mutage/geg040; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Trapphoff T, 2016, HUM REPROD, V31, P133, DOI 10.1093/humrep/dev279; Trapphoff T, 2013, FERTIL STERIL, V100, P1758, DOI 10.1016/j.fertnstert.2013.08.021; Trapphoff T, 2010, HUM REPROD, V25, P3025, DOI 10.1093/humrep/deq278; van de Werken C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6868; van den Berg IM, 2011, HUM REPROD, V26, P1181, DOI 10.1093/humrep/der030; Vogt E, 2009, REPROD BIOMED ONLINE, V19, P352, DOI 10.1016/S1472-6483(10)60169-1; Yang F, 2012, INT J DEV BIOL, V56, P889, DOI 10.1387/ijdb.120246rd; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yu JY, 2002, BIOL REPROD, V67, P1093, DOI 10.1095/biolreprod67.4.1093; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260; Yu XJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5887; Zhu K, 2015, MOL HUM REPROD, V21, P320, DOI 10.1093/molehr/gau116	50	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162722	10.1371/journal.pone.0162722	http://dx.doi.org/10.1371/journal.pone.0162722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611906	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900155
J	Kampmann, C; Abu-Tair, T; Gokce, S; Lampe, C; Reinke, J; Mengel, E; Hennermann, JB; Wiethoff, CM				Kampmann, Christoph; Abu-Tair, Tariq; Goekce, Seyfullah; Lampe, Christina; Reinke, Joerg; Mengel, Eugen; Hennermann, Julia B.; Wiethoff, Christiane M.			Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; AORTIC-VALVE-REPLACEMENT; WALL STRESS; DIAGNOSIS; CHILDREN; GROWTH; CONTRACTILITY; DYSFUNCTION; VALIDATION; FAILURE	Background Mucopolysaccharidosis (MPS) IVA is a rare lysosomal storage disorder with multiple skeletal and non-skeletal abnormalities requiring multiple surgical interventions. It is well known that patients with MPS IVA suffer from tachycardia, but cardiac and hemodynamic alterations have not been reported to date. We investigated the cardiovascular and hemodynamic alterations in patients with MPS IVA and developed a possible patho-mechanism for cardiovascular deterioration during anesthesia. Material and Methods In this observational study, serial cardiac examinations were performed in 54 patients with MPS IVA who were followed at the Children's Hospital of the Mainz Medical University (Mainz, Germany) between 1991 and 2014 (follow-up 1-24 years; median 5.8 years). Results were compared with data from a large central European cohort of more than 2000 healthy infants and children. Results None of the patients had arterial hypertension, but 4% had evidence of increased pulmonary artery pressure. Patients developed aortic root extension up to 6.9 standard deviations above normal. Left-sided valve leaflet thickening occurred in 26 patients (five with valve disease). Patients had lower left ventricular dimensions (z: -1.02 +/- 0.1), lower stroke volumes (z: -2.3 +/- 0.17), lower left ventricular mass (z: -1.5 +/- 0.21), but higher wall thickness (z: +0.8 +/- 0.16), and higher work index (z: + 2.5 +/- 0.2) compared to healthy control subjects. Cardiac output was preserved by an increase in heart rate of 21%. Sixty % of patients showed impaired diastolic filling; heart rate (99.0 +/- 1.8 vs. 92.0 +/- 2.1 bpm), age (18.0 +/- 1.8 vs. 14.2 +/- 1 years), and cardiothoracic ratio (61.6 +/- 3.6% vs. 55 +/- 4.2%) of these patients were higher compared to those with normal filling. Conclusions The results of this study suggest an age-progressive disproportion of the intra-thoracic organs of patients with MPS IVA, which is accompanied by aortic root extension and thickened left ventricles, with reduced stroke volumes, impaired diastolic filling patterns, and increased heart rates.	[Kampmann, Christoph; Abu-Tair, Tariq; Wiethoff, Christiane M.] Mainz Med Univ, Ctr Dis Childhood & Adolescence, Div Pediat Cardiol & Congenital Heart Dis, Mainz, Germany; [Goekce, Seyfullah; Lampe, Christina; Reinke, Joerg; Mengel, Eugen; Hennermann, Julia B.] Mainz Med Univ, Ctr Dis Childhood & Adolescence, Div Metab Dis Villa Metab, Mainz, Germany		Kampmann, C (corresponding author), Mainz Med Univ, Ctr Dis Childhood & Adolescence, Div Pediat Cardiol & Congenital Heart Dis, Mainz, Germany.	kampmann@mail.uni-mainz.de			Miller Medical Communications (Brindle, Lancashire, UK); BioMarin Europe Ltd. (London, UK)	Miller Medical Communications (Brindle, Lancashire, UK); BioMarin Europe Ltd. (London, UK)	Support for third-party writing assistance for this manuscript, provided by Miller Medical Communications (Brindle, Lancashire, UK), was provided by BioMarin Europe Ltd. (London, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for third-party writing assistance for this manuscript, provided by Miller Medical Communications (Brindle, Lancashire, UK), was provided by BioMarin Europe Ltd. (London, UK).	Barry MO, 2006, J HEART VALVE DIS, V15, P839; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; COLAN SD, 1984, J AM COLL CARDIOL, V4, P715, DOI 10.1016/S0735-1097(84)80397-6; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Douglas P S, 1986, Cardiovasc Clin, V17, P103; DOUGLAS PS, 1987, J AM COLL CARDIOL, V9, P945, DOI 10.1016/S0735-1097(87)80253-X; Foster RE, 1998, AM HEART J, V136, P269, DOI 10.1053/hj.1998.v136.89405; GAASCH WH, 1975, AM J CARDIOL, V36, P193, DOI 10.1016/0002-9149(75)90525-1; Hendriksz CJ, 2013, MOL GENET METAB, V110, P54, DOI 10.1016/j.ymgme.2013.04.002; IRELAND MA, 1981, BRIT HEART J, V46, P113; JOHN RM, 1990, ARCH DIS CHILD, V65, P746, DOI 10.1136/adc.65.7.746; Kampmann C, 2000, HEART, V83, P667, DOI 10.1136/heart.83.6.667; Miwa K, 2008, CLIN CARDIOL, V31, P328, DOI 10.1002/clc.20227; Montano AM, 2008, AM J MED GENET A, V146A, P1286, DOI 10.1002/ajmg.a.32281; Muenzer J, 2004, J PEDIATR-US, V144, pS27, DOI 10.1016/j.jpeds.2004.01.052; Nicolini F, 2008, HEART SURG FORUM, V11, pE96, DOI 10.1532/HSF98.20071197; Pagel PS, 2009, J CARDIOTHOR VASC AN, V23, P855, DOI 10.1053/j.jvca.2008.12.009; REICHEK N, 1982, CIRCULATION, V65, P99, DOI 10.1161/01.CIR.65.1.99; Roelandt J, 1980, Eur Heart J, V1, P375; Schmailzl KJG, 1994, KARDIALE ULTRASCHALL; STROBECK JE, 1981, HERZ, V6, P275; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	28	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162612	10.1371/journal.pone.0162612	http://dx.doi.org/10.1371/journal.pone.0162612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610627	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900133
J	Vasconcellos, AD; Viranyi, Z; Range, F; Ades, C; Scheidegger, JK; Mostl, E; Kotrschal, K				Vasconcellos, Angelica da Silva; Viranyi, Zsofia; Range, Friederike; Ades, Cesar; Scheidegger, Joerdis Kristin; Moestl, Erich; Kotrschal, Kurt			Training Reduces Stress in Human-Socialised Wolves to the Same Degree as in Dogs	PLOS ONE			English	Article							HUMAN-ANIMAL RELATIONSHIP; POSITIVE REINFORCEMENT; ENVIRONMENTAL ENRICHMENT; PLASMA-CORTISOL; ZOO ANIMALS; CHRONIC CORTICOSTERONE; BEHAVIORAL-RESPONSES; SALIVARY CORTISOL; RHESUS MACAQUES; WELFARE	The welfare of animals in captivity is of considerable societal concern. A major source of stress, especially for wild animals, is the lack of control over their environment, which includes not being able to avoid contact with human beings. Paradoxically, some studies have shown that interactions with human beings may improve the welfare of wild animals in captivity. Here, we investigated the behavioural (behaviours indicative of cooperation or stress) and physiological (variations in salivary cortisol concentrations) effects of the increasingly used practice of training wild animals as a way to facilitate handling and/or as behavioural enrichment. We evaluated the effects of indoor training sessions with familiar caretakers on nine human-socialised individuals of a wild species, the wolf (Canis lupus), in comparison to nine individuals of its domesticated form, the dog (Canis lupus familiaris). All animals were raised and kept in intraspecific packs under identical conditions-in accordance with the social structure of the species-in order to control for socialisation with human beings and familiarity with training. We also collected saliva samples of trainers to measure GC and testosterone concentrations, to control for the effects of trainers' stress levels on the responses of the animals. During the training sessions, separated from pack members, the animals stayed voluntarily close to the trainers and mostly adequately performed requested behaviours, indicating concentration to the task. Similarly to dogs, the salivary cortisol level of wolves-used as an index of stress-dropped during these sessions, pointing to a similar stress-reducing effect of the training interaction in both subspecies. The responses to the requested behaviours and the reduction in salivary cortisol level of wolves and dogs varied across trainers, which indicates that the relaxing effect of training has a social component. This points to another factor affecting the welfare of animals during the sessions, beside the rewarding effect of getting food and control over the situation by successfully completing a task. As all responses performed by the animals corresponded to cues already familiar to them, the reported effects were likely due to the above cited factors rather than to a learning process. Our results support previous findings suggesting that training is a potentially powerful tool for improving welfare in some wild social canids by creating structured and positive interactions between these animals and their human caretakers.	[Vasconcellos, Angelica da Silva] Pontificia Univ Catolica Minas Gerais, Program Postgrad Vertebrate Biol, Belo Horizonte, MG, Brazil; [Vasconcellos, Angelica da Silva; Ades, Cesar] Univ Sao Paulo, Inst Psychol, Sao Paulo, SP, Brazil; [Vasconcellos, Angelica da Silva; Viranyi, Zsofia; Range, Friederike; Scheidegger, Joerdis Kristin; Kotrschal, Kurt] Wolf Sci Ctr, Enrstbrunn, Austria; [Viranyi, Zsofia; Range, Friederike] Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Moestl, Erich] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Dept Biomed Sci, Vienna, Austria; [Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria	Pontificia Universidade Catolica de Minas Gerais; Universidade de Sao Paulo; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Vasconcellos, AD (corresponding author), Pontificia Univ Catolica Minas Gerais, Program Postgrad Vertebrate Biol, Belo Horizonte, MG, Brazil.; Vasconcellos, AD (corresponding author), Univ Sao Paulo, Inst Psychol, Sao Paulo, SP, Brazil.; Vasconcellos, AD (corresponding author), Wolf Sci Ctr, Enrstbrunn, Austria.	angelicavasconcellos@gmail.com	Vasconcellos, Angélica S/J-2024-2014	Vasconcellos, Angélica S/0000-0003-2326-0713; Range, Friederike/0000-0003-3127-5536	Sao Paulo Research Foundation [2009/14258-4]; Coordination for the Improvement of Higher Education Personnel [BEX 5274/09-5]; Austrian Science Fund [P21244-B17, I 1271-B24]; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [311870]; Vienna Science and Technology Fund [CS11-026]; Austrian Ministry of Science; University of Vienna; Veterinary University Vienna	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Austrian Science Fund(Austrian Science Fund (FWF)); European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); Vienna Science and Technology Fund; Austrian Ministry of Science; University of Vienna; Veterinary University Vienna	ASV was supported by Sao Paulo Research Foundation (Project no. 2009/14258-4, http://www.fapesp.br/en) and Coordination for the Improvement of Higher Education Personnel (project grant BEX 5274/09-5, http://www.capes.gov.br). FR was financially supported by the Austrian Science Fund (project P21244-B17, https://www.fwf.ac.at/en/) and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013, https://erc.europa.eu/)/ERC Grant Agreement n. 311870, ZV by the Austrian Science Fund (project I 1271-B24, https://www.fwf.ac.at/en/) and the Vienna Science and Technology Fund (project CS11-026, www.wwtf.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Agatha Sacramento Rodrigues and Vinicius Frayze David for statistical advice. The Wolf Science Center was established by Kurt Kotrschal, Friederike Range and Zsofia Viranyi in 2008 based on a private society; we are grateful for support by the Austrian Ministry of Science, by the University of Vienna, the Veterinary University Vienna and a number of private sponsors. We are particularly grateful to our team of trainers, Bea Belenyi, Marianne Heberlein, Christina Mayer, Marleen Hentrup, Rita Takacs, for the daily routine care, handling and training of the animals. We also thank two anonymous reviewers for their thorough work and their constructive comments on the manuscript. Dr. Ades passed away before the submission of the final version of this manuscript. Dr. Vasconcellos accepts responsibility for the integrity and validity of the data collected and analysed.	Alliger AA, 2011, J APPL ANIM WELF SCI, V14, P271, DOI 10.1080/10888705.2011.600153; Anderson Ursula S., 2002, Journal of Applied Animal Welfare Science, V5, P125, DOI 10.1207/S15327604JAWS0502_03; Baker K, 2004, ANIM WELFARE, V13, P239; Baker KC, 2009, J APPL ANIM WELF SCI, V12, P236, DOI 10.1080/10888700902956011; Bardgett ME, 1996, PHYSIOL BEHAV, V59, P1111, DOI 10.1016/0031-9384(95)02172-8; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; BAYNE KAL, 1993, CONTEMP TOP LAB ANIM, V32, P6; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; Bloomsmith M. A., 1999, American Journal of Primatology, V49, P35; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Boitani L., 2003, NATURE ENV SERIES; Brauer J, 2013, APPL ANIM BEHAV SCI, V148, P138, DOI 10.1016/j.applanim.2013.07.009; Broom D M, 1991, Behav Processes, V25, P117, DOI 10.1016/0376-6357(91)90014-Q; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Burman OHP, 2008, BIOL LETTERS, V4, P330, DOI 10.1098/rsbl.2008.0113; Cafazzo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098594; Carlstead Kathy, 1996, P317; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; CARPENTER E, 1980, ANIMALS ETHICS REPOR; Carrasco L, 2009, ANIM WELFARE, V18, P9; Chamove A.S., 1989, P183; Cibulski L, 2014, BEHAV PROCESS, V103, P129, DOI 10.1016/j.beproc.2013.11.013; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Coleman K, 2010, APPL ANIM BEHAV SCI, V124, P142, DOI 10.1016/j.applanim.2010.02.008; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coppola CL, 2006, PHYSIOL BEHAV, V87, P537, DOI 10.1016/j.physbeh.2005.12.001; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; De Rouck M, 2005, ANIM WELFARE, V14, P229; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; FRANK H, 1983, BEHAV PROCESS, V8, P363, DOI 10.1016/0376-6357(83)90024-4; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Ginsburg B.E., 1987, Perspectives in Vertebrate Science, V4, P401; Greiveldinger L, 2007, PHYSIOL BEHAV, V92, P675, DOI 10.1016/j.physbeh.2007.05.012; Griffin JA, 2012, ANIMALS AFFECT US EX; Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007; HANSON JD, 1976, BEHAV BIOL, V16, P333, DOI 10.1016/S0091-6773(76)91460-7; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Haubenhofer DK, 2007, SOC ANIM, V15, P127, DOI 10.1163/156853007X187090; Haubenhofer Dorit Karla, 2006, Journal of Applied Animal Welfare Science, V9, P165, DOI 10.1207/s15327604jaws0902_5; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; Hemetsberger J, 2010, INTERACT STUD, V11, P380, DOI 10.1075/is.11.3.03hem; HEMSWORTH PH, 1993, ANIM WELFARE, V2, P33; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Herzog H., 2010, SOME WE LOVE SOME WE; Hogan LA, 2011, APPL ANIM BEHAV SCI, V134, P217, DOI 10.1016/j.applanim.2011.07.010; Horn L, 2013, ANIM COGN, V16, P435, DOI 10.1007/s10071-012-0584-9; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; Hosey G., 2014, INT J COMP PSYCHOL, V27, P117, DOI [10.5811/westjem.2011.5.6700, 10.46867/ijcp.2014.27.01.01, DOI 10.46867/IJCP.2014.27.01.01]; Hosey G, 2013, J APPL ANIM WELF SCI, V16, P338, DOI 10.1080/10888705.2013.827916; Hosey GR, 2000, ANIM WELFARE, V9, P343; HUBRECHT RC, 1993, APPL ANIM BEHAV SCI, V37, P345, DOI 10.1016/0168-1591(93)90123-7; Inglis IR., 1983, EXPLORATION ANIMALS, P72; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Kalbe C, 2010, GENES BRAIN BEHAV, V9, P75, DOI 10.1111/j.1601-183X.2009.00536.x; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Klinghammer E, 1987, MAN WOLF ADV ISSUES, P31; Kotrschal K., 2012, WOLF HUND MENSCH GES; Lambeth SP, 2006, AM J PRIMATOL, V68, P245, DOI 10.1002/ajp.20148; Ligout S, 2010, J VET BEHAV, V5, P49, DOI DOI 10.1016/J.JVEB.2009.09.027; LINE SW, 1990, LAB ANIM, V24, P213, DOI 10.1258/002367790780866245; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; Maloney MA, 2007, AM J PRIMATOL, V69, P53; Manciocco A, 2009, APPL ANIM BEHAV SCI, V120, P100, DOI 10.1016/j.applanim.2009.05.007; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; MASON JW, 1968, PSYCHOSOM MED, V30, P576, DOI 10.1097/00006842-196809000-00020; McBride SD, 2001, ANIM WELFARE, V10, P173; McCormick Wanda, 2003, P9; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGowan RTS, 2014, ANIM COGN, V17, P577, DOI 10.1007/s10071-013-0688-x; McKinley Jean, 2003, Journal of Applied Animal Welfare Science, V6, P209, DOI 10.1207/S15327604JAWS0603_06; Mech L. D., 2007, WOLVES BEHAV ECOLOGY; Melfi V, 2013, APPL ANIM BEHAV SCI, V147, P299, DOI 10.1016/j.applanim.2013.04.011; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Miklosi A., 2007, DOG BEHAV EVOLUTION; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Minier DE, 2011, APPL ANIM BEHAV SCI, V132, P178, DOI 10.1016/j.applanim.2011.04.009; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Normando S, 2009, APPL ANIM BEHAV SCI, V116, P211, DOI 10.1016/j.applanim.2008.10.005; Norusis MJ, 2010, IBM SPSS STAT 19 ADV, P35; O'Brien JK, 2008, ANIM WELFARE, V17, P125; Owen Y, 2011, J APPL ANIM WELF SCI, V14, P124, DOI 10.1080/10888705.2011.551625; Packard Jane M., 2003, P35; Patzl M, 1990, ENTWICKLUNG BIOTIN S; Pomerantz O, 2009, AM J PRIMATOL, V71, P687, DOI 10.1002/ajp.20703; POOLE TB, 1987, ZOO BIOL, V6, P315, DOI 10.1002/zoo.1430060406; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Range F, 2007, ANIM BEHAV, V73, P1033, DOI 10.1016/j.anbehav.2006.07.015; Range F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0220; Range Friederike, 2014, Front Psychol, V5, P1582, DOI 10.3389/fpsyg.2014.01582; Range F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00868; Range F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086559; Reimers M, 2007, HORM BEHAV, V51, P428, DOI 10.1016/j.yhbeh.2006.12.011; Rennie LJ, 2003, ANIM WELFARE, V12, P591; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Rochais C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00108; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; SALZEN E. A., 1962, SYMPOSIA ZOOL SOC LONDON, V8, P199; Sambrook TD, 1997, ANIM WELFARE, V6, P207; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; Savastano Gina, 2003, Journal of Applied Animal Welfare Science, V6, P247, DOI 10.1207/S15327604JAWS0603_09; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Schapiro SJ, 1996, APPL ANIM BEHAV SCI, V48, P159, DOI 10.1016/0168-1591(96)01038-6; Scott JP., 1965, GENETICS SOCIAL BEHA; Shiverdecker MD, 2013, PHYSIOL BEHAV, V109, P75, DOI 10.1016/j.physbeh.2012.12.002; Shyne A, 2010, J APPL ANIM WELF SCI, V13, P56, DOI 10.1080/10888700903372069; Tallet C, 2008, DEV PSYCHOBIOL, V50, P147, DOI 10.1002/dev.20254; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Veissier I, 2007, PHYSIOL BEHAV, V92, P429, DOI 10.1016/j.physbeh.2006.11.008; VINCENT IC, 1992, RES VET SCI, V53, P342, DOI 10.1016/0034-5288(92)90137-Q; VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601; Waiblinger S, 2003, APPL ANIM BEHAV SCI, V84, P23, DOI 10.1016/S0168-1591(03)00148-5; Ward SJ, 2013, APPL ANIM BEHAV SCI, V147, P179, DOI 10.1016/j.applanim.2013.05.008; Westlund K, 2014, APPL ANIM BEHAV SCI, V152, P1, DOI 10.1016/j.applanim.2013.12.009; Wielkiewicz R. M., 1980, COPING HLTH, P1; Young LJ, 2005, J COMP NEUROL, V493, P51, DOI 10.1002/cne.20771; Young RJ, 2004, ANIM WELFARE, V13, P225	123	16	16	3	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162389	10.1371/journal.pone.0162389	http://dx.doi.org/10.1371/journal.pone.0162389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611784	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900088
J	Westerholt, R; Steiger, E; Resch, B; Zipf, A				Westerholt, Rene; Steiger, Enrico; Resch, Bernd; Zipf, Alexander			Abundant Topological Outliers in Social Media Data and Their Effect on Spatial Analysis	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; EXPANSION METHOD; TWITTER; AUTOCORRELATION; ASSOCIATION; INDICATORS; SCIENCE; IMPACT; MATRIX	Twitter and related social media feeds have become valuable data sources to many fields of research. Numerous researchers have thereby used social media posts for spatial analysis, since many of them contain explicit geographic locations. However, despite its widespread use within applied research, a thorough understanding of the underlying spatial characteristics of these data is still lacking. In this paper, we investigate how topological outliers influence the outcomes of spatial analyses of social media data. These outliers appear when different users contribute heterogeneous information about different phenomena simultaneously from similar locations. As a consequence, various messages representing different spatial phenomena are captured closely to each other, and are at risk to be falsely related in a spatial analysis. Our results reveal indications for corresponding spurious effects when analyzing Twitter data. Further, we show how the outliers distort the range of outcomes of spatial analysis methods. This has significant influence on the power of spatial inferential techniques, and, more generally, on the validity and interpretability of spatial analysis results. We further investigate how the issues caused by topological outliers are composed in detail. We unveil that multiple disturbing effects are acting simultaneously and that these are related to the geographic scales of the involved overlapping patterns. Our results show that at some scale configurations, the disturbances added through overlap are more severe than at others. Further, their behavior turns into a volatile and almost chaotic fluctuation when the scales of the involved patterns become too different. Overall, our results highlight the critical importance of thoroughly considering the specific characteristics of social media data when analyzing them spatially.	[Westerholt, Rene; Steiger, Enrico; Zipf, Alexander] Heidelberg Univ, Inst Geog, GISci, Heidelberg, Germany; [Resch, Bernd] Salzburg Univ, Dept Geoinformat, Z GIS, Salzburg, Austria; [Resch, Bernd] Harvard Univ, IQSS, Ctr Geog Anal, Cambridge, MA 02138 USA	Ruprecht Karls University Heidelberg; Salzburg University; Harvard University	Westerholt, R (corresponding author), Heidelberg Univ, Inst Geog, GISci, Heidelberg, Germany.	westerholt@uni-heidelberg.de	Zipf, Alexander/AAC-2318-2020; Westerholt, René/P-5634-2019; Resch, Bernd/ABE-4625-2021	Zipf, Alexander/0000-0003-4916-9838; Westerholt, René/0000-0001-8228-3814; Resch, Bernd/0000-0002-2233-6926	scholarship of the Landesgraduiertenforderung Baden-Worttemberg; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	scholarship of the Landesgraduiertenforderung Baden-Worttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This research was partially funded by a scholarship of the Landesgraduiertenforderung Baden-Worttemberg. We further acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing.	Aldstadt J, 2006, GEOGR ANAL, V38, P327, DOI 10.1111/j.1538-4632.2006.00689.x; [Anonymous], 2012, P 6 INT AAAI C WEBL; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Anselin L., 1998, SPATIAL DEPENDENCE L, P237; Atkinson PM, 2001, PROG PHYS GEOG, V25, P111, DOI 10.1191/030913301676370948; Bachmaier M, 2008, PRECIS AGRIC, V9, P173, DOI 10.1007/s11119-008-9056-2; Bavaud F, 2014, LECT NOTES COMPUT SC, V8728, P81, DOI 10.1007/978-3-319-11593-1_6; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Casetti E, 1997, INT REGIONAL SCI REV, V20, P9, DOI 10.1177/016001769702000102; CASETTI E, 1972, GEOGR ANAL, V4, P81, DOI 10.1111/j.1538-4632.1972.tb00458.x; Cliff A, 1973, SPATIAL AUTOCORRELAT; Cresci S, 2015, DECIS SUPPORT SYST, V80, P56, DOI 10.1016/j.dss.2015.09.003; Cressie N., 2011, STAT SPATIO TEMPORAL; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; de Albuquerque JP, 2015, INT J GEOGR INF SCI, V29, P667, DOI 10.1080/13658816.2014.996567; DEJONG P, 1984, GEOGR ANAL, V16, P17; Dixon PM, 2013, ENCY ENV, V5, DOI [10.1002/9780470057339. var046.pub2, DOI 10.1002/9780470057339.VAR046.PUB2]; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fischer MM, 2010, HDB APPL SPATIAL ANA, P3; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gaetan C., 2010, SPATIAL STAT MODELIN, V81; Gayo-Avello D, 2012, IEEE INTERNET COMPUT, V16, P91, DOI 10.1109/MIC.2012.137; Getis A, 2004, GEOGR ANAL, V36, P90, DOI 10.1353/geo.2004.0002; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Getis A, 2009, GEOGR ANAL, V41, P404, DOI 10.1111/j.1538-4632.2009.00768.x; Gilani Z, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P37, DOI 10.1145/2872518.2889360; Griffith DA, 2006, J GEOGR SYST, V8, P335, DOI 10.1007/s10109-006-0034-9; Griffith DA, 2008, ENVIRON PLANN A, V40, P2751, DOI 10.1068/a38218; Haustein S, 2016, J ASSOC INF SCI TECH, V67, P232, DOI 10.1002/asi.23456; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Iosa M, 2012, BEHAV BRAIN RES, V226, P124, DOI 10.1016/j.bbr.2011.09.007; Lee R, 2013, PERS UBIQUIT COMPUT, V17, P605, DOI 10.1007/s00779-012-0510-9; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lenormand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105407; Longley PA, 2015, ENVIRON PLANN A, V47, P465, DOI 10.1068/a130122p; Mislove A., 2011, P INT AAAI C WEB SOC, V5; MukherjeeS Sarkar A, 2016, ARTIF INTELL, V8, P123; Newsome TH, 1998, TRANSPORTATION, V25, P357, DOI 10.1023/A:1005082827030; Oliver M. A., 2010, HDB APPL SPATIAL ANA, P319, DOI DOI 10.1007/978-3-642-03647-7_17; Ord JK, 2012, ANN REGIONAL SCI, V48, P529, DOI 10.1007/s00168-011-0492-y; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ord JK, 2001, J REGIONAL SCI, V41, P411, DOI 10.1111/0022-4146.00224; Paez A., 2004, GEOJOURNAL, V61, P53, DOI [10.1007/s10708-005-0877-5, DOI 10.1007/S10708-005-0877-5]; Rae A, 2015, REG STUD REG SCI, V2, P1, DOI 10.1080/21681376.2014.990678; Rai RK, 2007, TRANSPORT RES REC, P70, DOI 10.3141/2021-09; Rogerson PA, 2015, GEOGR ANAL, V47, P20, DOI 10.1111/gean.12055; Rogerson PA, 2012, GEOGR ANAL, V44, P121, DOI 10.1111/j.1538-4632.2012.00840.x; Sengstock C., 2012, P 20 INT C ADV GEOGR, P149, DOI 10.1145/2424321.2424342; Shimatani K, 2002, BIOMETRICAL J, V44, P325, DOI 10.1002/1521-4036(200204)44:3<325::AID-BIMJ325>3.0.CO;2-B; Shortridge A, 2007, COMPUT ENVIRON URBAN, V31, P362, DOI 10.1016/j.compenvurbsys.2006.07.001; Steiger E, 2015, T GIS, V19, P809, DOI 10.1111/tgis.12132; Steiger E, 2015, COMPUT ENVIRON URBAN, V54, P255, DOI 10.1016/j.compenvurbsys.2015.09.007; Sui DZ, 2004, ANN ASSOC AM GEOGR, V94, P269, DOI 10.1111/j.1467-8306.2004.09402003.x; Tiefelsdorf M, 1997, GEOGR ANAL, V29, P248; Tiefelsdorf M, 1999, ENVIRON PLANN A, V31, P165, DOI 10.1068/a310165; Xu M, 2014, ANN REGIONAL SCI, V52, P697, DOI 10.1007/s00168-014-0605-5	60	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162360	10.1371/journal.pone.0162360	http://dx.doi.org/10.1371/journal.pone.0162360			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611199	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900083
J	Barranco, I; Tvarijonaviciute, A; Perez-Patino, C; Vicente-Carrillo, A; Parrilla, I; Ceron, JJ; Martinez, EA; Rodriguez-Martinez, H; Roca, J				Barranco, Isabel; Tvarijonaviciute, Asta; Perez-Patino, Cristina; Vicente-Carrillo, Alejandro; Parrilla, Inmaculada; Ceron, Jose J.; Martinez, Emilio A.; Rodriguez-Martinez, Heriberto; Roca, Jordi			Glutathione Peroxidase 5 Is Expressed by the Entire Pig Male Genital Tract and Once in the Seminal Plasma Contributes to Sperm Survival and In Vivo Fertility	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; BOAR SPERM; OXIDATIVE STRESS; MOUSE EPIDIDYMIS; SPERMATOZOA; GPX5; INTEGRITY; QUALITY; SEMEN	Glutathione peroxidase-5 (GPX5) is an H2O2-scavenging enzyme identified in boar seminal plasma (SP). This study attempted to clarify its origin and role on sperm survival and fertility after artificial insemination (AI). GPX5 was expressed (Western blot and immunocytochemistry using a rabbit primary polyclonal antibody) in testes, epididymis and accessory sex glands (6 boars). SP-GPX5 concentration differed among boars (11 boars, P < 0.001), among ejaculates within boar (44 ejaculates, P < 0.001) and among portions within ejaculate (15 ejaculates). The first 10 mL of the spermrich fraction (SRF, sperm-peak portion) had a significantly lower concentration (8.87 +/- 0.78 ng/mL) than the rest of the SRF and the post-SRF (11.66 +/- 0.79 and 12.37 +/- 0.79 ng/mL, respectively, P < 0.005). Spermmotility of liquid-stored semen AI-doses (n = 44, at 15-17 degrees C during 72h) declined faster in AI-doses with low concentrations of SP-GPX5 compared to those with high-levels. Boars (n = 11) with high SP-GPX5 showed higher farrowing rates and litter sizes than those with low SP-GPX5 (a total of 5,275 inseminated sows). In sum, GPX5 is widely expressed in the boar genital tract and its variable presence in SP shows a positive relationship with sperm quality and fertility outcomes of liquid-stored semen AI-doses.	[Barranco, Isabel; Tvarijonaviciute, Asta; Perez-Patino, Cristina; Parrilla, Inmaculada; Ceron, Jose J.; Martinez, Emilio A.; Roca, Jordi] Univ Murcia, Fac Vet Sci, Dept Med & Anim Surg, Murcia, Spain; [Vicente-Carrillo, Alejandro; Rodriguez-Martinez, Heriberto] Linkoping Univ, Dept Clin & Expt Med IKE, Linkoping, Sweden	University of Murcia; Linkoping University	Roca, J (corresponding author), Univ Murcia, Fac Vet Sci, Dept Med & Anim Surg, Murcia, Spain.	roca@um.es	Barranco, Isabel/AAA-5368-2020; Martinez, Emilio A/I-1901-2015; Parrilla, Inmaculada/I-1045-2015; Rodriguez, Heriberto/G-2675-2012; Rodriguez-Martinez, Heriberto/AAG-4076-2020; Tvarijonaviciute, Asta/U-4303-2017; Ceron, Jose J/H-9043-2015	Barranco, Isabel/0000-0001-9873-814X; Martinez, Emilio A/0000-0003-1260-9721; Rodriguez, Heriberto/0000-0002-5194-2124; Rodriguez-Martinez, Heriberto/0000-0002-5194-2124; Tvarijonaviciute, Asta/0000-0002-5323-5001; Ceron, Jose J/0000-0002-8654-1793; Parrilla, Inmaculada/0000-0002-5121-758X; Vicente Carrillo, Alejandro/0000-0002-0256-1958	Ministerio de Economia y Competitividad Madrid (Spain) [AGL2012-39903, AGL2015-68738-R]; Seneca Foundation Murcia (Spain) [19892/GERM/15]; Swedish Research Council (VR) [521-2011-6353]; Swedish Research Council Formas [221-2011-512]; Research Council in Southeast Sweden (FORSS), Sweden [378091/312971]; Ministerio de Educacion, Cultura y Deporte, Spain; Fundacion Seneca, Murcia, Spain	Ministerio de Economia y Competitividad Madrid (Spain); Seneca Foundation Murcia (Spain)(Fundacion Seneca); Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Research Council in Southeast Sweden (FORSS), Sweden; Ministerio de Educacion, Cultura y Deporte, Spain; Fundacion Seneca, Murcia, Spain(Fundacion Seneca)	This work is supported by: Ministerio de Economia y Competitividad (AGL2012-39903, AGL2015-68738-R) Madrid (Spain); Seneca Foundation (19892/GERM/15) Murcia (Spain); The Swedish Research Council (VR, 521-2011-6353); The Swedish Research Council Formas (221-2011-512); The Research Council in Southeast Sweden (FORSS, 378091/312971), Sweden; Ministerio de Educacion, Cultura y Deporte, Spain (IB); and Fundacion Seneca, Murcia, Spain (CP-P).	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Barranco I, 2015, ANDROLOGY-US, V3, P315, DOI 10.1111/andr.309; Barranco I, 2015, SCI REP-UK, V5, DOI 10.1038/srep18538; Boe-Hansen GB, 2008, THERIOGENOLOGY, V69, P728, DOI 10.1016/j.theriogenology.2007.12.004; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Broekhuijse MLWJ, 2012, J ANIM SCI, V90, P4327, DOI 10.2527/jas.2012-5040; Chabory E, 2010, J ANIM SCI, V88, P1321, DOI 10.2527/jas.2009-2583; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Drevet JR, 2006, MOL CELL ENDOCRINOL, V250, P70, DOI 10.1016/j.mce.2005.12.027; Fraga CG, 2014, BBA-GEN SUBJECTS, V1840, P931, DOI 10.1016/j.bbagen.2013.06.030; Gharagozloo P, 2016, HUM REPROD, V31, P252, DOI 10.1093/humrep/dev302; Grignard E, 2005, THERIOGENOLOGY, V64, P1016, DOI 10.1016/j.theriogenology.2005.01.008; Guthrie HD, 2006, J ANIM SCI, V84, P2089, DOI 10.2527/jas.2005-766; Jelezarsky L, 2008, THERIOGENOLOGY, V69, P139, DOI 10.1016/j.theriogenology.2007.08.016; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; Moreno SG, 2003, BIOL CHEM, V384, P635, DOI 10.1515/BC.2003.070; Noblanc A, 2011, J ANDROL, V32, P641, DOI 10.2164/jandrol.110.012823; Novak S, 2010, J ANDROL, V31, P188, DOI 10.2164/jandrol.109.007583; Okamura N, 1997, BBA-GEN SUBJECTS, V1336, P99, DOI 10.1016/S0304-4165(97)00016-0; Popwell JM, 2004, ANIM REPROD SCI, V81, P97, DOI 10.1016/j.anireprosci.2003.08.007; Radomil L, 2011, REPROD DOMEST ANIM, V46, P39, DOI 10.1111/j.1439-0531.2011.01865.x; Rejraji H, 2002, MOL REPROD DEV, V63, P96, DOI 10.1002/mrd.10136; Roca J, 2016, THERIOGENOLOGY, V86, P187, DOI 10.1016/j.theriogenology.2015.11.026; Roca J, 2016, ANIM REPROD SCI, V169, P24, DOI 10.1016/j.anireprosci.2016.02.028; Rodriguez-Martinez H, 2008, THERIOGENOLOGY, V70, P1242, DOI 10.1016/j.theriogenology.2008.06.007; Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x; Tvrda E, 2011, ACTA VET HUNG, V59, P465, DOI 10.1556/AVet.2011.034; Vernet P, 1997, MOL REPROD DEV, V47, P87, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;87::AID-MRD12&gt;3.0.CO;2-X; Vicente-Carrillo A, 2016, MOL REPROD DEV, V83, P724, DOI 10.1002/mrd.22675; Vilagran I, 2015, ANDROLOGY-US, V3, P345, DOI 10.1111/andr.12009; Vilagran I, 2016, ANIM REPROD SCI, V165, P22, DOI 10.1016/j.anireprosci.2015.12.001; Williams K, 1998, MOL HUM REPROD, V4, P841, DOI 10.1093/molehr/4.9.841; Zhang T, 2008, REPROD FERT DEVELOP, V20, P615, DOI 10.1071/RD08008	34	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162958	10.1371/journal.pone.0162958	http://dx.doi.org/10.1371/journal.pone.0162958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627110	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600068
J	Rengier, F; Worz, S; Melzig, C; Ley, S; Fink, C; Benjamin, N; Partovi, S; von Tengg-Kobligk, H; Rohr, K; Kauczor, HU; Grunig, E				Rengier, Fabian; Woerz, Stefan; Melzig, Claudius; Ley, Sebastian; Fink, Christian; Benjamin, Nicola; Partovi, Sasan; von Tengg-Kobligk, Hendrik; Rohr, Karl; Kauczor, Hans-Ulrich; Gruenig, Ekkehard			Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; QUANTIFICATION; ECHOCARDIOGRAPHY; HEMODYNAMICS; SEGMENTATION; DIAGNOSIS; UTILITY	Purpose To demonstrate feasibility of automated 3D volumetry of central pulmonary arteries based on magnetic resonance angiography (MRA), to assess pulmonary artery volumes in patients with pulmonary hypertension compared to healthy controls, and to investigate the potential of the technique for predicting pulmonary hypertension. Methods MRA of pulmonary arteries was acquired at 1.5T in 20 patients with pulmonary arterial hypertension and 21 healthy normotensive controls. 3D model-based image analysis software was used for automated segmentation of main, right and left pulmonary arteries (MPA, RPA and LPA). Volumes indexed to vessel length and mean, minimum and maximum diameters along the entire vessel course were assessed and corrected for body surface area (BSA). For comparison, diameters were also manually measured on axial reconstructions and double oblique multiplanar reformations. Analyses were performed by two cardiovascular radiologists, and by one radiologist again after 6 months. Results Mean volumes of MPA, RPA and LPA for patients/controls were 5508 +/- 1236/3438 +/- 749, 3522 +/- 934/1664 +/- 468 and 3093 +/- 692/1812 +/- 474 mu l/(cm length x m(2) BSA) (all p<0.001). Mean, minimum and maximum diameters along the entire vessel course were also significantly increased in patients compared to controls (all p<0.001). Intra-and interobserver agreement were excellent for both volume and diameter measurements using 3D segmentation (intraclass correlation coefficients 0.971-0.999, p<0.001). Area under the curve for predicting pulmonary hypertension using volume was 0.998 (95% confidence interval 0.990-1.0, p<0.001), compared to 0.967 using manually measured MPA diameter (95% confidence interval 0.910-1.0, p<0.001). Conclusions Automated MRA-based 3D volumetry of central pulmonary arteries is feasible and demonstrated significantly increased volumes and diameters in patients with pulmonary arterial hypertension compared to healthy controls. Pulmonary artery volume may serve as a superior predictor for pulmonary hypertension compared to manual measurements on axial images but verification in a larger study population is warranted.	[Rengier, Fabian; Melzig, Claudius; von Tengg-Kobligk, Hendrik; Kauczor, Hans-Ulrich] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Rengier, Fabian; Melzig, Claudius; Benjamin, Nicola; Kauczor, Hans-Ulrich; Gruenig, Ekkehard] Heidelberg Univ, TLRC, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Rengier, Fabian; Melzig, Claudius; Benjamin, Nicola; Kauczor, Hans-Ulrich; Gruenig, Ekkehard] Heidelberg Univ, German Ctr Lung Res DZL, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Rengier, Fabian; von Tengg-Kobligk, Hendrik; Kauczor, Hans-Ulrich] German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Woerz, Stefan; Rohr, Karl] Heidelberg Univ, BIOQUANT, IPMB, Dept Bioinformat & Funct Genom,Biomed Comp Vis Gr, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Woerz, Stefan; Rohr, Karl] German Canc Res Ctr, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Ley, Sebastian] Radiol Isar Klinikum, Sonnenstr 22-24, D-80331 Munich, Germany; [Ley, Sebastian] Ludwig Maximilians Univ Hosp Munich, Clin Radiol, Marchioninistr 15, D-81377 Munich, Germany; [Fink, Christian] Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Fink, Christian] AKH Celle, Dept Radiol, Siemenspl 4, D-29223 Celle, Germany; [Partovi, Sasan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Radiol, 11100 Euclid Ave, Cleveland, OH USA; [von Tengg-Kobligk, Hendrik] Inselspital Bern, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Freiburgstr 10, CH-3010 Bern, Switzerland; [Gruenig, Ekkehard] Univ Heidelberg Hosp, Thoraxklin, Ctr Pulm Hypertens, Rontgenstr 1, D-69126 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Ruprecht Karls University Heidelberg; Case Western Reserve University; Case Western Reserve University Hospital; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg	Rengier, F (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Rengier, F (corresponding author), Heidelberg Univ, TLRC, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Rengier, F (corresponding author), Heidelberg Univ, German Ctr Lung Res DZL, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Rengier, F (corresponding author), German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	fabian.rengier@web.de	Kauczor, HU/AAX-6033-2021; von Tengg-Kobligk, Hendrik/N-6792-2019; Ley, Sebastian/I-3426-2013; Benjamin, Nicola/AAJ-4360-2021; Kauczor, Hans-Ulrich/AAU-5955-2021	von Tengg-Kobligk, Hendrik/0000-0003-3207-3223; Ley, Sebastian/0000-0001-9269-2670; Rengier, Fabian/0000-0001-9424-4652	German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF) [82DZL00401, 82DZL00402, 82DZL00404]; German Research Foundation (Deutsche Forschungsgemeinschaft); University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg)	German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg)	This study was supported by the German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF; 82DZL00401, 82DZL00402, 82DZL00404). We also acknowledge financial support by the German Research Foundation (Deutsche Forschungsgemeinschaft) and the University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF; 82DZL00401, 82DZL00402, 82DZL00404). We also acknowledge financial support by the German Research Foundation (Deutsche Forschungsgemeinschaft) and the University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg) within the funding programme Open Access Publishing.	Biesdorf A, 2012, MED IMAGE ANAL, V16, P1187, DOI 10.1016/j.media.2012.05.010; Corson N, 2014, ACAD RADIOL, V21, P523, DOI 10.1016/j.acra.2013.12.015; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Du Bois D, 1989, Nutrition, V5, P303; Froelich JJ, 2008, EUR J RADIOL, V67, P466, DOI 10.1016/j.ejrad.2007.08.022; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gerges M, 2015, CAN J CARDIOL, V31, P521, DOI 10.1016/j.cjca.2015.01.019; KURIYAMA K, 1984, INVEST RADIOL, V19, P16, DOI 10.1097/00004424-198401000-00005; Linguraru MG, 2014, PULM CIRC, V4, P319, DOI 10.1086/675997; Perez-Enguix D, 2007, TRANSPL P, V39, P2405, DOI 10.1016/j.transproceed.2007.07.055; Rajaram S, 2012, J RHEUMATOL, V39, P1265, DOI 10.3899/jrheum.110987; Shen YC, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000256; Sztrymf B, 2010, EUR RESPIR J, V35, P1286, DOI 10.1183/09031936.00070209; Tan RT, 1998, CHEST, V113, P1250, DOI 10.1378/chest.113.5.1250; Truong QA, 2012, CIRC-CARDIOVASC IMAG, V5, P147, DOI 10.1161/CIRCIMAGING.111.968610; Vachiery JL, 2012, EUR RESPIR REV, V21, P313, DOI 10.1183/09059180.00005412; Wang B, 2013, EUR REV MED PHARMACO, V17, P923; Worz S, 2007, IEEE T IMAGE PROCESS, V16, P1994, DOI 10.1109/TIP.2007.901204; Worz S, 2010, IEEE T BIO-MED ENG, V57, P2359, DOI 10.1109/TBME.2010.2053539	19	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162516	10.1371/journal.pone.0162516	http://dx.doi.org/10.1371/journal.pone.0162516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626802	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600039
J	Slattery, ML; Herrick, JS; Pellatt, AJ; Wolff, RK; Mullany, LE				Slattery, Martha L.; Herrick, Jennifer S.; Pellatt, Andrew J.; Wolff, Roger K.; Mullany, Lila E.			Telomere Length, TERT, and miRNA Expression	PLOS ONE			English	Article							B-DEPENDENT TRANSCRIPTION; COLON-CANCER; CELL LYMPHOMA; RISK; DEREGULATION; MECHANISMS; MICRORNAS	It has been proposed that miRNAs are involved in the control of telomeres. We test that hypothesis by examining the association between miRNAs and telomere length (TL). Additionally, we evaluate if genetic variation in telomerase reverse transcriptase (TERT) is associated with miRNA expression levels. We use data from a population-based study of colorectal cancer (CRC), where we have previously shown associations between TL and TERT and CRC, to test associations between TL and miRNA expression and TERT and miRNA expression. To gain insight into functions of miRNAs associated with TERT we tested linear associations between miRNAs and their targeted gene mRNAs. An Agilent platformthat contained information on over 2000 miRNAs was used. TL was measured using a multiplexed quantitative PCR (qPCR). RNAseq was used to assess gene expression. Our sample consisted of 1152 individuals with SNP data and miRNA expression data; 363 individuals with both TL and miRNA; and 148 individuals with miRNA and mRNA data. Thirty-three miRNAs were directly associated with TL after adjusting for age and sex (false discovery rate (FDR) of 0.05). TERT rs2736118 was associated with differences in miRNA expression between carcinoma and normal colonic mucosa for 75 miRNAs (FDR < 0.05). Genes regulated by these miRNAs, as indicated by mRNA/miRNA associations, were associated with major signaling pathways beyond their TL-related functions, including PTEN, and PI3K/AKT signaling. Our data support a direct association between miRNAs and TL; differences in miRNA expression levels by TERT genotype were observed. Based on miRNA and targeted mRNA associations our data suggest that TERT is involved in non-TL-related functions by acting through altered miRNA expression.	[Slattery, Martha L.; Herrick, Jennifer S.; Pellatt, Andrew J.; Wolff, Roger K.; Mullany, Lila E.] Univ Utah, Dept Med, 383 Colorow, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Slattery, ML (corresponding author), Univ Utah, Dept Med, 383 Colorow, Salt Lake City, UT 84108 USA.	Marty.Slattery@hsc.utah.edu		Herrick, Jennifer/0000-0001-9257-8843; Pellatt, Andrew/0000-0002-0127-9790	National Cancer Institute at the National Institutes of Health [CA163683, CA48998, CA61757]; NATIONAL CANCER INSTITUTE [R01CA163683] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI grants CA163683, CA48998 and CA61757 from the National Cancer Institute at the National Institutes of Health. NCI was not involved in any of the work described in this manuscript.	[Anonymous], 2014, QIAGENS INGENUITY PA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boardman LA, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.3; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Cao JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128829; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Cottliar ASH, 2009, EUR J HAEMATOL, V83, P433, DOI 10.1111/j.1600-0609.2009.01313.x; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Ding DQ, 2013, FASEB J, V27, P4375, DOI 10.1096/fj.13-230904; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; Hosnijeh FS, 2014, INT J CANCER, V135, P2910, DOI 10.1002/ijc.28934; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jebaraj BMC, 2013, BLOOD, V121, P1184, DOI 10.1182/blood-2012-08-452649; Ladetto M, 2004, BLOOD, V103, P4644, DOI 10.1182/blood-2003-12-4412; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lassmann T, 2015, INT J MOL SCI, V16, P1192, DOI 10.3390/ijms16011192; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Nabetani A, 2011, J BIOCHEM, V149, P5, DOI 10.1093/jb/mvq119; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Pellatt AJ, 2013, MOL CARCINOGEN, V52, P507, DOI 10.1002/mc.21885; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Pellatt AJ, 2012, INT J MOL EPIDEMIOL, V3, P184; Pellatt DF, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.11; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Robaina MC, 2015, EXP MOL PATHOL, V98, P200, DOI 10.1016/j.yexmp.2015.03.006; Sestito Rosanna, 2014, RNA DIS; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Slattery ML, 2016, CARCINOGENESIS, V37, P245, DOI 10.1093/carcin/bgv249; Slattery ML, 2015, GENE CHROMOSOME CANC, V54, P527, DOI 10.1002/gcc.22265; Slattery ML, 2015, INT J CANCER, V137, P428, DOI 10.1002/ijc.29384; Slattery ML, 1997, CANCER RES, V57, P75; Uziel O, 2015, GENOMICS, V105, P5, DOI 10.1016/j.ygeno.2014.10.013	37	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162077	10.1371/journal.pone.0162077	http://dx.doi.org/10.1371/journal.pone.0162077			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627813	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600018
J	Hsiao, SH; Chiou, KR				Hsiao, Shih-Hung; Chiou, Kuan-Rau			Diastolic Heart Failure Predicted by Left Atrial Expansion Index in Patients with Severe Diastolic Dysfunction	PLOS ONE			English	Article							VENTRICULAR FILLING PRESSURE; PRESERVED EJECTION FRACTION; TISSUE DOPPLER; MYOCARDIAL-INFARCTION; FIBRILLATION; MORTALITY; VOLUME; ECHOCARDIOGRAPHY; CATHETERIZATION; COMMUNITY	Background Left atrial (LA) echocardiographic parameters are increasingly used to predict clinically relevant cardiovascular events. The study aims to evaluate the LA expansion index (LAEI) for predicting diastolic heart failure (HF) in patients with severe left ventricular (LV) diastolic dysfunction. Methods This prospective study enrolled 162 patients (65% male) with preserved LV systolic function and severe diastolic dysfunction (132 grade 2 patients, 30 grade 3 patients). All patients had sinus rhythm at enrollment. The LAEI was calculated as (Vol(max) - Vol(min)) x 100% / Vol(min), where Vol(max) was defined as maximal LA volume and Vol(min) was defined as minimal volume. The endpoint was hospitalization for HF withp reserved LV ejection fraction (HFpEF). Results The median follow-up duration was 2.9 years. Fifty-four patients had cardiovascular events, including 41 diastolic and 8 systolic HF hospitalizations. In these 54 patients, 13 in-hospital deaths and 5 sudden out-of-hospital deaths occurred. Multivariate analyses revealed that HFpEF was associated with LAEI. and atrial fibrillation during follow-up. For predicting HFpEF, the LAEI had a hazard ratio of 1.197per 10% decrease. In patients who had HFpEF events, the LAEI significantly (P< 0.0001) decreased from 69 +/- 18% to 39 +/- 11% during hospitalization. Although the LAEI improved during follow-up (53 +/- 13%), it did not return to baseline. Conclusions The LAEI predicts HFpEF in patients with severe diastolic dysfunction; it worsens during HFpEF events and partially recovers during followup.	[Hsiao, Shih-Hung; Chiou, Kuan-Rau] I Shou Univ, E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Hsiao, Shih-Hung; Chiou, Kuan-Rau] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chiou, Kuan-Rau] Kaohsiung Vet Gen Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital	Chiou, KR (corresponding author), I Shou Univ, E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.; Chiou, KR (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chiou, KR (corresponding author), Kaohsiung Vet Gen Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan.	krchiou@hotmail.com			Ministry of Science and Technology [102-2628-B-650-002-MY3]; Kaohsiung Veterans General Hospital [VGHKS102-010]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Veterans General Hospital	This work was funded by Ministry of Science and Technology (102-2628-B-650-002-MY3) and Kaohsiung Veterans General Hospital (VGHKS102-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlJaroudi W, 2012, CIRCULATION, V125, P782, DOI 10.1161/CIRCULATIONAHA.111.066423; [Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hsiao SH, 2013, CIRC J, V77, P2712, DOI 10.1253/circj.CJ-13-0463; Hsiao SH, 2013, EUR J HEART FAIL, V15, P1245, DOI 10.1093/eurjhf/hft087; Hsiao SH, 2012, AM J CARDIOL, V109, P748, DOI 10.1016/j.amjcard.2011.10.040; Hsiao SH, 2011, CIRC J, V75, P1942, DOI 10.1253/circj.CJ-11-0033; Hsiao SH, 2011, AM J CARDIOL, V107, P1117, DOI 10.1016/j.amjcard.2010.12.008; Hsiao SH, 2010, AM J CARDIOL, V105, P709, DOI 10.1016/j.amjcard.2009.10.052; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T; Liu JY, 2003, AM J CARDIOL, V91, P550, DOI 10.1016/S0002-9149(02)03304-0; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Ommen SR, 2000, CIRCULATION, V102, P1788; Ommen SR, 2000, MAYO CLIN PROC, V75, P24, DOI 10.4065/75.1.24; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Park HJ, 2011, CLIN CARDIOL, V34, P124, DOI 10.1002/clc.20850; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rivas-Gotz C, 2003, AM J CARDIOL, V91, P780, DOI 10.1016/S0002-9149(02)03433-1; Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Wang WH, 2012, ANN THORAC SURG, V93, P796, DOI 10.1016/j.athoracsur.2011.11.007; Whalley GA, 2002, J AM COLL CARDIOL, V39, P1787, DOI 10.1016/S0735-1097(02)01868-5; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475	32	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162599	10.1371/journal.pone.0162599	http://dx.doi.org/10.1371/journal.pone.0162599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622475	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000043
J	Miller, JRB; Jhala, YV; Schmitz, OJ				Miller, Jennifer R. B.; Jhala, Yadvendradev V.; Schmitz, Oswald J.			Human Perceptions Mirror Realities of Carnivore Attack Risk for Livestock: Implications for Mitigating Human-Carnivore Conflict	PLOS ONE			English	Article							TIGER RESERVE; SNOW LEOPARDS; CENTRAL INDIA; CONSERVATION; DEPREDATION; PREDATION; PATTERNS; WILDLIFE; WOLVES; FEAR	Human-carnivore conflict is challenging to quantify because it is shaped by both the realities and people's perceptions of carnivore threats. Whether perceptions align with realities can have implications for conflict mitigation: misalignments can lead to heightened and indiscriminant persecution of carnivores whereas alignments can offer deeper insights into human-carnivore interactions. We applied a landscape-scale spatial analysis of livestock killed by tigers and leopards in India to model and map observed attack risk, and surveyed owners of livestock killed by tigers and leopards for their rankings of threats across habitats to map perceived attack risk. Observed tiger risk to livestock was greatest near dense forests and at moderate distances from human activity while leopard risk was greatest near open vegetation. People accurately perceived spatial differences between tiger and leopard hunting patterns, expected greater threat in areas with high values of observed risk for both carnivores. Owners' perception of threats largely did not depend on environmental conditions surrounding their village (spatial location, dominant land-use or observed carnivore risk). Surveys revealed that owners who previously lost livestock to carnivores used more livestock protection methods than those who had no prior losses, and that owners who had recently lost livestock for the first time expressed greater interest in changing their protection methods than those who experienced prior losses. Our findings suggest that in systems where realities and perceptions of carnivore risk align, conservation programs and policies can optimize conservation outcomes by (1) improving the effectiveness of livestock protection methods and (2) working with owners who have recently lost livestock and are most willing to invest effort in adapting protection strategies to mitigate human-carnivore conflict.	[Miller, Jennifer R. B.; Schmitz, Oswald J.] Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Miller, Jennifer R. B.; Jhala, Yadvendradev V.] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Miller, Jennifer R. B.] Panthera, New York, NY 10018 USA; [Miller, Jennifer R. B.] Univ Cape Town, Human Wildlife Inst, Dept Biol Sci, Private Bag X3, ZA-7701 Cape Town, South Africa; [Miller, Jennifer R. B.] Cornell Univ, Dept Nat Resources, 111 Fernow Hall, Ithaca, NY 14853 USA	Yale University; Wildlife Institute of India; University of Cape Town; Cornell University	Miller, JRB (corresponding author), Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA.; Miller, JRB (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.; Miller, JRB (corresponding author), Panthera, New York, NY 10018 USA.; Miller, JRB (corresponding author), Univ Cape Town, Human Wildlife Inst, Dept Biol Sci, Private Bag X3, ZA-7701 Cape Town, South Africa.; Miller, JRB (corresponding author), Cornell Univ, Dept Nat Resources, 111 Fernow Hall, Ithaca, NY 14853 USA.	jmiller@panthera.org	Jhala, Yadvendradev/AAL-9711-2020		American Institute for Indian Studies Junior Research Fellowship; American Philosophical Society Lewis and Clark Fund for Exploration and Field Research; Association of Zoos & Aquariums Conservation Endowment Fund; John Ball Zoo Society Wildlife Conservation Fund; Yale Tropical Resources Institute Fellowship; National Science Foundation Graduate Research Fellowship Program	American Institute for Indian Studies Junior Research Fellowship; American Philosophical Society Lewis and Clark Fund for Exploration and Field Research; Association of Zoos & Aquariums Conservation Endowment Fund; John Ball Zoo Society Wildlife Conservation Fund; Yale Tropical Resources Institute Fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	JRBM was funded by the American Institute for Indian Studies Junior Research Fellowship, American Philosophical Society Lewis and Clark Fund for Exploration and Field Research, Association of Zoos & Aquariums Conservation Endowment Fund; John Ball Zoo Society Wildlife Conservation Fund; Yale Tropical Resources Institute Fellowship; and National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bruskotter JT, 2014, CONSERV LETT, V7, P158, DOI 10.1111/conl.12072; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Dhanwatey HS, 2013, ORYX, V47, P221, DOI 10.1017/S0030605311001803; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Jhala Y. V, 2014, SPATIAL POPULATION E; Karanth KK, 2013, ENVIRON MANAGE, V52, P1320, DOI 10.1007/s00267-013-0162-1; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Karanth KU, 2000, J ZOOL, V250, P255; KELLERT SR, 1985, BIOL CONSERV, V31, P167, DOI 10.1016/0006-3207(85)90047-3; Kolowski J, BIOL CONSERV, V128, P529; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Linnell JDC, 2012, TECH ECOL CONSERVAT, P314; Miller JRB, 2016, REG ENVIRON CHANGE, V16, P17, DOI 10.1007/s10113-015-0871-5; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; Miller JRB, 2014, J ANIM ECOL, V83, P214, DOI 10.1111/1365-2656.12111; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Negi Chandra Singh, 2005, International Journal of Biodiversity Science & Management, V1, P85; Negi H, 2012, TIGER CONSERVATION P; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Session G., 1987, ENV REV, V11, P105, DOI DOI 10.2307/3984023; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Suryawanshi KR, 2014, CONSERV BIOL, V28, P1657, DOI 10.1111/cobi.12320; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2017, BIOL REV, V92, P248, DOI 10.1111/brv.12227; Woodroffe R., 2005, CONSERV BIOL	34	30	30	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162685	10.1371/journal.pone.0162685	http://dx.doi.org/10.1371/journal.pone.0162685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617831	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100042
J	van der Lee, DI; Pont, MJ; Falkenburg, JHF; Griffioen, M				van der Lee, Dyantha I.; Pont, Margot J.; Falkenburg, J. H. Frederik; Griffioen, Marieke			The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; IDENTIFICATION; BINDING; TRANSPLANTATION; IMMUNOGENICITY; ASSOCIATION; NEOEPITOPES; REVEALS; PROTEIN; MHC	Allogeneic stem cell transplantation can be a curative treatment for hematological malignancies. After HLA-matched allogeneic stem cell transplantation, beneficial anti-tumor immunity as well as detrimental side-effects can develop due to donor-derived T-cells recognizing polymorphic peptides that are presented by HLA on patient cells. Polymorphic peptides on patient cells that are recognized by specific T-cells are called minor histocompatibility antigens (MiHA), while the respective peptides in donor cells are allelic variants. MiHA can be identified by reverse strategies in which large sets of peptides are screened for T-cell recognition. In these strategies, selection of peptides by prediction algorithms may be relevant to increase the efficiency of MiHA discovery. We investigated the value of online prediction algorithms for MiHA discovery and determined the in silico characteristics of 68 autosomal HLA class I-restricted MiHA that have been identified as natural ligands by forward strategies in which T-cells from in vivo immune responses after allogeneic stem cell transplantation are used to identify the antigen. Our analysis showed that HLA class I binding was accurately predicted for 87% of MiHA of which a relatively large proportion of peptides had strong binding affinity (56%). Weak binding affinity was also predicted for a considerable number of antigens (31%) and the remaining 13% of MiHA were not predicted as HLA class I binding peptides. Besides prediction for HLA class I binding, none of the other online algorithms significantly contributed to MiHA characterization. Furthermore, we demonstrated that the majority of MiHA do not differ from their allelic variants in in silico characteristics, suggesting that allelic variants can potentially be processed and presented on the cell surface. In conclusion, our analyses revealed the in silico characteristics of 68 HLA class I-restricted MiHA and explored the value of online algorithms to predict T-cell ligands that are created by genetic variants.	[van der Lee, Dyantha I.; Pont, Margot J.; Falkenburg, J. H. Frederik; Griffioen, Marieke] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Pont, Margot J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Fred Hutchinson Cancer Center	van der Lee, DI (corresponding author), Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands.	d.i.van_der_lee@lumc.nl	van der Lee, Dyantha/Y-2568-2018; Griffioen, Marieke/ABA-1561-2021	van der Lee, Dyantha/0000-0002-0369-3856; Griffioen, Marieke/0000-0002-3001-4441				Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104; Broen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021266; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Dolstra H, 2002, EUR J IMMUNOL, V32, P2748, DOI 10.1002/1521-4141(2002010)32:10<2748::AID-IMMU2748>3.0.CO;2-T; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Falkenburg JHF, 2011, BIOL BLOOD MARROW TR, V17, pS33, DOI 10.1016/j.bbmt.2010.11.009; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Griffioen M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00100; Hombrink P, 2015, CLIN CANCER RES, V21, P2177, DOI 10.1158/1078-0432.CCR-14-2188; Hombrink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022523; Horowitz M M, 1990, Clin Transpl, P41; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Pont MJ, 2016, CLIN CANC RES; Rapin Nicolas, 2010, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1817s88; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Spierings E, 2014, TISSUE ANTIGENS, V84, P347, DOI 10.1111/tan.12445; Stern M, 2014, LEUKEMIA, V28, P2235, DOI 10.1038/leu.2014.145; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Warren EH, 2012, BLOOD, V120, P2796, DOI 10.1182/blood-2012-04-347286; Wolfel C, 2008, CANCER IMMUNOL IMMUN, V57, P849, DOI 10.1007/s00262-007-0421-1; Zilberberg J, 2015, BIOL BLOOD MARROW TR, V21, P1000, DOI 10.1016/j.bbmt.2014.11.001	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162808	10.1371/journal.pone.0162808	http://dx.doi.org/10.1371/journal.pone.0162808			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618304	Green Submitted, gold, Green Published			2022-12-27	WOS:000383653100055
J	Buesa, I; Aira, Z; Azkue, JJ				Buesa, Itsaso; Aira, Zigor; Jatsu Azkue, Jon			Regulation of Nociceptive Plasticity Threshold and DARPP-32 Phosphorylation in Spinal Dorsal Horn Neurons by Convergent Dopamine and Glutamate Inputs	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NR2B-CONTAINING NMDA RECEPTORS; SUBSTANTIA-GELATINOSA NEURONS; EVOKED FIELD POTENTIALS; LATE-PHASE LTP; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; NR2B SUBUNIT; TYROSINE PHOSPHORYLATION; MEDIATED PHOSPHORYLATION	Dopamine can influence NMDA receptor function and regulate glutamate-triggered long-term changes in synaptic strength in several regions of the CNS. In spinal cord, regulation of the threshold of synaptic plasticity may determine the proneness to undergo sensitization and hyperresponsiveness to noxious input. In the current study, we increased endogenous dopamine levels in the dorsal horn by using re-uptake inhibitor GBR 12935. During the so-induced hyperdopaminergic transmission, conditioning low-frequency (1 Hz) stimulation (LFS) to the sciatic nerve induced long-termpotentiation (LTP) of C-fiber-evoked potentials in dorsal horn neurons. The magnitude of LTP was attenuated by blockade of either dopamine D1-like receptors (D1LRs) by with SCH 23390 or NMDA receptor subunit NR2B with antagonist Ro25-6981. Conditioning LFS during GBR 12935 administration increased phosphorylation of dopamine-and cAMP-regulated phosphoprotein of Mr 32kDa (DARPP-32) at threonine 34 residue in synaptosomal (P3) fraction of dorsal horn homogenates, as assessed by Western blot analysis, which was partially prevented by NR2B blockade prior to conditioning stimulation. Conditioning LFS also was followed by higher co-localization of phosphorylated form of NR2B at tyrosine 1472 and pDARPP-32(Thr34)-with postsynaptic marker PSD-95 in transverse L5 dorsal horn sections. Such increase could be significantly attenuated by D1LR blockade with SCH 23390. The current results support that coincidental endogenous recruitment of D1LRs and NR2B in dorsal horn synapses plays a role in regulating afferent-induced nociceptive plasticity. Parallel increases in DARPP-32 phosphorylationupon LTP induction suggests a role for this phosphoprotein as intracellular detector of convergent D1L- and NMDA receptor activation.	[Buesa, Itsaso; Aira, Zigor; Jatsu Azkue, Jon] Univ Basque Country UPV EHU, Sch Med & Dent, Dept Neurosci, Leioa 48940, Bizkaia, Spain	University of Basque Country	Azkue, JJ (corresponding author), Univ Basque Country UPV EHU, Sch Med & Dent, Dept Neurosci, Leioa 48940, Bizkaia, Spain.	jonjatsu.azkue@ehu.eus	Aira, Zigor/ABG-4661-2020; Buesa, Itsaso/ABF-6852-2020; Azkue, Jon Jatsu/H-2023-2015	BUESA SOBERA, ITXASO/0000-0002-2448-8819; Azkue, Jon Jatsu/0000-0002-8609-5500	Basque Government (Eusko Jaurlaritza) [IT782-13]; Ministerio de Economia y Compettividad(Spanish Government) [SAF2013-44533-P]	Basque Government (Eusko Jaurlaritza); Ministerio de Economia y Compettividad(Spanish Government)	This work was supported by the Basque Government (Eusko Jaurlaritza), Grant IT782-13 to JJA, URL: http://www.euskadi.eus and by the Ministerio de Economia y Compettividad(Spanish Government), Grant SAF2013-44533-P to JJA, URL: www.mineco.gob.es.	Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Aira Z, 2016, J NEUROSCI, V36, P5661, DOI 10.1523/JNEUROSCI.2469-15.2016; Aira Z, 2016, NEUROSCI LETT, V618, P152, DOI 10.1016/j.neulet.2016.03.006; Aira Z, 2014, PAIN, V155, P2526, DOI 10.1016/j.pain.2014.09.012; Aira Z, 2013, PAIN, V154, P1865, DOI 10.1016/j.pain.2013.06.009; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Azkue JJ, 2003, PAIN, V106, P373, DOI 10.1016/j.pain.2003.08.007; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; BECK H, 1995, J NEUROSCI METH, V58, P193, DOI 10.1016/0165-0270(94)00176-H; Bennett GJ, 2000, J PAIN SYMPTOM MANAG, V19, pS2; Buesa I, 2006, NEUROPHARMACOLOGY, V50, P585, DOI 10.1016/j.neuropharm.2005.11.005; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Cao J, 2011, NEUROPHARMACOLOGY, V60, P921, DOI 10.1016/j.neuropharm.2011.01.034; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen Y, 2014, BRAIN RES, V1570, P43, DOI 10.1016/j.brainres.2014.05.001; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gao X, 2001, BRAIN RES BULL, V54, P391, DOI 10.1016/S0361-9230(00)00460-3; Gu XP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-76; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hebb Donald O., 1949, ORG BEHAV; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HOKFELT T, 1979, ACTA PHYSIOL SCAND, V107, P393, DOI 10.1111/j.1748-1716.1979.tb06491.x; Hotte M, 2007, SYNAPSE, V61, P24, DOI 10.1002/syn.20339; Kim HY, 2015, PAIN, V156, P618, DOI 10.1097/01.j.pain.0000460354.09622.ec; Kim JYV, 2015, J NEUROSCI, V35, P6307, DOI 10.1523/JNEUROSCI.3481-14.2015; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Larsson M, 2011, NEUROSCIENTIST, V17, P256, DOI 10.1177/1073858409349913; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026065; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li ZC, 2011, J NEUROSCI, V31, P17527, DOI 10.1523/JNEUROSCI.3806-11.2011; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 2015, CURR PHARM DESIGN, V21, P895; Liu Y, 2014, ANESTH ANALG, V118, P1345, DOI 10.1213/ANE.0000000000000202; Luo XQ, 2014, BRAIN RES, V1542, P167, DOI 10.1016/j.brainres.2013.10.008; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 1997, J NEUROSCI, V17, P8147; Ogawa M, 2007, NEUROSCI RES, V57, P467, DOI 10.1016/j.neures.2006.11.011; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; Roggenhofer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062520; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rygh LJ, 1999, PAIN, V82, P305, DOI 10.1016/S0304-3959(99)00056-1; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; SEEBURG PH, 1995, RECENT PROG HORM RES, V50, P19; Sheynikhovich D, 2013, J NEUROSCI, V33, P13914, DOI 10.1523/JNEUROSCI.0466-13.2013; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; Stramiello M, 2008, NEUROPHARMACOLOGY, V55, P871, DOI 10.1016/j.neuropharm.2008.06.053; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; WALAAS SI, 1984, J NEUROSCI, V4, P84; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xia TJ, 2014, ANESTH ANALG, V119, P1208, DOI 10.1213/ANE.0000000000000394; Yang HW, 2005, J NEUROPHYSIOL, V94, P961, DOI 10.1152/jn.01324.2004; Yang LH, 2016, NEUROSCI LETT, V626, P135, DOI 10.1016/j.neulet.2015.12.044; Yang X, 2009, PAIN, V144, P162, DOI 10.1016/j.pain.2009.04.005; Youn DH, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/654257; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhang MJ, 2014, NEUROBIOL DIS, V68, P104, DOI 10.1016/j.nbd.2014.04.010; Zhou LJ, 2008, EXP NEUROL, V212, P507, DOI 10.1016/j.expneurol.2008.04.034	79	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162416	10.1371/journal.pone.0162416	http://dx.doi.org/10.1371/journal.pone.0162416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610622	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900094
J	Jalkanen, J; Maksimow, M; Hollmen, M; Jalkanen, S; Hakovirta, H				Jalkanen, Juho; Maksimow, Mikael; Hollmen, Maija; Jalkanen, Sirpa; Hakovirta, Harri			Compared to Intermittant Claudication Critical Limb Ischemia Is Associated with Elevated Levels of Cytokines	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; ATHEROSCLEROSIS; INFLAMMATION; MORTALITY; RISK; CHEMOKINES; PATHWAYS; MARKERS; CANCER	Critical limb ischemia (CLI) is the advanced stage of peripheral artery disease (PAD) and associated with an extremely poor clinical outcome. In order to understand the possible role of circulating cytokines and poor outcome associated with CLI we compared the circulating cytokine profile of patients with CLI against patients with intermittent claudication (IC). The levels of 48 circulating cytokines were examined in 226 consecutive patients with peripheral artery disease (PAD) admitted for elective, non-urgent, invasive treatment of IC or CLI. The PAD patient cohort was evenly distributed between subjects with IC (46.5%) and CLI (53.5%). As accustomed in PAD, CLI was associated with higher age, chronic kidney disease and diabetes when compared to IC (P < 0.01 for all). In multivariable linear regression modeling taking into account the baseline differences between IC and CLI groups CLI was independently associated with elevated levels of a large number of cytokines: IL-1 beta, IL-1ra, IL-2R alpha, IL-4, IL-6, IL-10, IFN-gamma, GM-CSF, G-CSF (P < 0.01 for all), and IL-2, IL-7, IL-12, IL-13, IL-17, bFGF, VEGF, SCGF-beta (P < 0.05 for all). The current findings indicate that CLI is associated with a circulating cytokine profile, which resembles serious medical conditions such as severe pancreatitis, sepsis, or even cancer. Compared to IC, CLI is a systemic inflammatory condition, which may explain the extremely poor outcome associated with it.	[Jalkanen, Juho; Hakovirta, Harri] Turku Univ Hosp, Dept Vasc Surg, Turku, Finland; [Jalkanen, Juho; Hakovirta, Harri] Turku Univ, Turku, Finland; [Maksimow, Mikael; Hollmen, Maija; Jalkanen, Sirpa] Turku Univ, Dept Microbiol & Immunol, Medicity Res Lab, Turku, Finland	University of Turku; University of Turku; University of Turku	Jalkanen, J (corresponding author), Turku Univ Hosp, Dept Vasc Surg, Turku, Finland.; Jalkanen, J (corresponding author), Turku Univ, Turku, Finland.	juho.jalkanen@utu.fi	Hollmén, Maija/B-5831-2017; Hakovirta, Harri/ABD-2437-2020	Hollmén, Maija/0000-0002-3250-7653; Hakovirta, Harri/0000-0002-1518-045X; Jalkanen, Juho/0000-0002-1693-8293	Academy of Finland; Sigrid Juselius Foundation; Orion Research Foundation; Clinical Research Fund (EVO) of Turku University Hospital	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion Research Foundation; Clinical Research Fund (EVO) of Turku University Hospital	The study was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Orion Research Foundation, and the Clinical Research Fund (EVO) of Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Bown MJ, 2001, EUR J VASC ENDOVASC, V22, P485, DOI 10.1053/ejvs.2001.1522; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Gray BH, 2010, ANN VASC SURG, V24, P349, DOI 10.1016/j.avsg.2009.07.034; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jalkanen J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-015-1651-x; Jalkanen J, 2015, CIRC RES, V116, P1206, DOI 10.1161/CIRCRESAHA.116.305715; JELNES R, 1986, BRIT MED J, V293, P1137, DOI 10.1136/bmj.293.6555.1137; Karinen Heikki, 2010, Duodecim, V126, P443; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Li JJ, 2005, MED HYPOTHESES, V64, P694, DOI 10.1016/j.mehy.2004.11.043; Li LH, 2017, CYTOKINE, V89, P173, DOI 10.1016/j.cyto.2015.12.017; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Morganti M, 2002, BIOMED PHARMACOTHER, V56, P317, DOI 10.1016/S0753-3322(02)00242-1; Nieminen A, 2014, CRIT CARE, V18, DOI 10.1186/cc13885; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Olumuyiwa-Akeredolu OOO, 2016, CURR PHARM DESIGN, V22, P918, DOI 10.2174/1381612822666151209153535; Reinecke H, 2015, EUR HEART J, V36, P932, DOI 10.1093/eurheartj/ehv006; Rolin J, 2014, J LEUKOCYTE BIOL, V95, P575, DOI 10.1189/jlb.1113571; Rollins KE, 2013, BRIT J SURG, V100, P1002, DOI 10.1002/bjs.9127; Rooke TW, 2011, J VASC SURG, V54, pE32, DOI 10.1016/j.jvs.2011.09.001; Ross J S, 2001, Am J Clin Pathol, V116 Suppl, pS97; Sampson UKA, 2014, GLOB HEART, V9, P145, DOI 10.1016/j.gheart.2013.12.008; Stehr A, 2010, EUR J VASC ENDOVASC, V39, P330, DOI 10.1016/j.ejvs.2009.09.025; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Teraa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055592; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009; Zernecke A, 2014, ARTERIOSCL THROM VAS, V34, P742, DOI 10.1161/ATVBAHA.113.301655	37	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162353	10.1371/journal.pone.0162353	http://dx.doi.org/10.1371/journal.pone.0162353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611073	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900082
J	Raimbault, B; Cointet, JP; Joly, PB				Raimbault, Benjamin; Cointet, Jean-Philippe; Joly, Pierre-Benoit			Mapping the Emergence of Synthetic Biology	PLOS ONE			English	Article							CHEMICAL-SYNTHESIS; GENOME; SCIENCE; PATHWAY; TALES	In this paper, we apply an original scientometric analyses to a corpus comprising synthetic biology (SynBio) publications in Thomson Reuters Web of Science to characterize the emergence of this new scientific field. Three results were drawn from this empirical investigation. First, despite the exponential growth of publications, the study of population level statistics (newcomers proportion, collaboration network structure) shows that SynBio has entered a stabilization process since 2010. Second, the mapping of textual and citational networks shows that SynBio is characterized by high heterogeneity and four different approaches: the central approach, where biobrick engineering is the most widespread; genome engineering; protocell creation; and metabolic engineering. We suggest that synthetic biology acts as an umbrella term allowing for the mobilization of resources, and also serves to relate scientific content and promises of applications. Third, we observed a strong intertwinement between epistemic and socio-economic dynamics. Measuring scientific production and impact and using structural analysis data, we identified a core set of mostly American scientists. Biographical analysis shows that these central and influential scientists act as "boundary spanners," meaning that their importance to the field lies not only in their academic contributions, but also in their capacity to interact with other social spaces that are outside the academic sphere.	[Raimbault, Benjamin; Cointet, Jean-Philippe; Joly, Pierre-Benoit] UPEM, INRA LISIS, Champs Sur Marne, France	INRAE; Universite Gustave-Eiffel	Raimbault, B (corresponding author), UPEM, INRA LISIS, Champs Sur Marne, France.	Benjamin.Raimbault@versailles.inra.fr	cointet, jean-philippe/AAX-3720-2021	cointet, jean-philippe/0000-0002-3172-3960				Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bettencourt LMA, 2011, P NATL ACAD SCI USA, V108, P19540, DOI 10.1073/pnas.1102712108; Bourret P, 2014, GENET SOC, P175; Campos L, 2009, SYNTHETIC BIOLOGY: THE TECHNOSCIENCE AND ITS SOCIETAL CONSEQUENCES, P5, DOI 10.1007/978-90-481-2678-1_2; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Church GMRegis, 2014, REGENESIS HOW SYNTHE; CRANE D, 1969, AM SOCIOL REV, V34, P335, DOI 10.2307/2092499; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Frickel S, 2005, AM SOCIOL REV, V70, P204, DOI 10.1177/000312240507000202; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GIERYN TF, 1983, AM SOCIOL REV, V48, P781, DOI 10.2307/2095325; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Heinemann M, 2006, BIOINFORMATICS, V22, P2790, DOI 10.1093/bioinformatics/btl469; Hilgartner S, 2015, CAPTURING THE IMAGIN, P15445, DOI [10.1073/pnas.2237126100, DOI 10.1073/PNAS.2237126100]; Hu XJ, 2015, PEERJ, V3, DOI 10.7717/peerj.728; Kuhn Thomas, 1962, STRUCTURE SCI REVOLU, V3rd; Kuhn TS, 1969, THE STRUCTURE OF SCI; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Luisi PL, 2006, NATURWISSENSCHAFTEN, V93, P1, DOI 10.1007/s00114-005-0056-z; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mogoutov A, 2007, RES POLICY, V36, P893, DOI 10.1016/j.respol.2007.02.005; Molyneux-Hodgson S, 2009, BIOSOCIETIES, V4, P129, DOI 10.1017/S1745855209990019; MULLINS NC, 1972, MINERVA, V10, P51, DOI 10.1007/BF01881390; O'Malley MA, 2008, BIOESSAYS, V30, P57, DOI 10.1002/bies.20664; Oldham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034368; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; Rip Arie., 2013, STI STUDIES, V9, P39, DOI DOI 10.14279/DEPOSITONCE-4480; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rule A, 2015, P NATL ACAD SCI USA, V112, P10837, DOI 10.1073/pnas.1512221112; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sauermann H, 2013, ORGAN SCI, V24, P889, DOI 10.1287/orsc.1120.0769; Senellart P, 2008, AUTOMATIC DISCOVERY, P25; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Stephanopoulos G, 2012, ACS SYNTH BIOL, V1, P514, DOI 10.1021/sb300094q; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Vincent BB, 2013, STUD HIST PHI PART C, V44, P122, DOI 10.1016/j.shpsc.2013.03.007; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039; Weeds J, 2005, COMPUT LINGUIST, V31, P439, DOI 10.1162/089120105775299122; Zucker LG, 2006, MOVEMENT OF STAR SCI	49	28	28	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161522	10.1371/journal.pone.0161522	http://dx.doi.org/10.1371/journal.pone.0161522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611324	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900019
J	Ronchetti, SA; Machiavelli, LI; Quinteros, FA; Duvilanski, BH; Cabilla, JP				Ronchetti, Sonia A.; Machiavelli, Leticia I.; Quinteros, Fernanda A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.			Nitric Oxide Plays a Key Role in Ovariectomy-Induced Apoptosis in Anterior Pituitary: Interplay between Nitric Oxide Pathway and Estrogen	PLOS ONE			English	Article							SENSITIVE-GUANYLYL CYCLASE; PROGRAMMED CELL-DEATH; PROLACTIN-RELEASE; INTERFERON-GAMMA; GENE-EXPRESSION; RAT; SYNTHASE; GLAND; HORMONE; INDUCTION	Changes in the estrogenic status produce deep changes in pituitary physiology, mainly because estrogens (E2) are one of the main regulators of pituitary cell population. Also, E2 negatively regulate pituitary neuronal nitric oxide synthase (nNOS) activity and expression and may thereby modulate the production of nitric oxide (NO), an important regulator of cell death and survival. Little is known about how ovary ablation affects anterior pituitary cell remodelling and molecular mechanisms that regulate this process have not yet been elucidated. In this work we used freshly dispersed anterior pituitaries as well as cell cultures from ovariectomized female rats in order to study whether E2 deficiency induces apoptosis in the anterior pituitary cells, the role of NO in this process and effects of E2 on the NO pathway. Our results showed that cell activity gradually decreases after ovariectomy (OVX) as a consequence of cell death, which is completely prevented by a pan-caspase inhibitor. Furthermore, there is an increase of fragmented nuclei and DNA cleavage thereby presenting the first direct evidence of the existence of apoptosis in the anterior pituitary gland after OVX. NO production and soluble guanylyl cyclase (sGC) expression in anterior pituitary cells increased concomitantly to the apoptosis. Inhibition of both, NO synthase (NOS) and sGC activities prevented the drop of cell viability after OVX, showing for the first time that increased NO levels and sGC activity observed post-OVX play a key role in the induction of apoptosis. Conversely, E2 and prolactin treatments decreased nNOS expression and activity in pituitary cells from OVX rats in a time-and E2 receptor-dependent manner, thus suggesting interplay between NO and E2 pathways in anterior pituitary.	[Ronchetti, Sonia A.; Machiavelli, Leticia I.; Quinteros, Fernanda A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Dept Quim Biol, Buenos Aires, DF, Argentina; [Ronchetti, Sonia A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.] Univ Buenos Aires, Fac Med, Inst Invest Biomed INBIOMED UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Dept Quim Biol, Buenos Aires, DF, Argentina.; Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed INBIOMED UBA CONICET, Buenos Aires, DF, Argentina.	jcabilla@ffyb.uba.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2012 1038, PIP 5536]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010 1668, PICT 2013 1324]; Universidad de Buenos Aires [B100473]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012 1038 to JPC and PIP 5536 to BHD), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010 1668 to BHD and PICT 2013 1324 to JPC), and Universidad de Buenos Aires (B100473 to BHD).	Aoki MD, 2001, HISTOCHEM CELL BIOL, V116, P215; Berman JR, 1998, UROLOGY, V51, P650, DOI 10.1016/S0090-4295(97)00683-3; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Bohlen HG, 2015, COMPR PHYSIOL, V5, P803, DOI 10.1002/cphy.c140052; BRYANT CE, 1995, J ENDOCRINOL, V146, P149, DOI 10.1677/joe.0.1460149; Cabilla JP, 2006, ENDOCRINOLOGY, V147, P4311, DOI 10.1210/en.2006-0367; Cabilla JP, 2009, AM J PHYSIOL-ENDOC M, V296, pE731, DOI 10.1152/ajpendo.90795.2008; Candolfi M, 2006, FRONT HORM RES, V35, P9, DOI 10.1159/000094260; Candolfi M, 2004, NEUROENDOCRINOLOGY, V80, P83, DOI 10.1159/000081313; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; Ceccatelli S, 1997, BRAIN RES BULL, V44, P533, DOI 10.1016/S0361-9230(97)00239-6; CECCATELLI S, 1993, P NATL ACAD SCI USA, V90, P11292, DOI 10.1073/pnas.90.23.11292; Corbacho AM, 2003, FEBS LETT, V544, P171, DOI 10.1016/S0014-5793(03)00499-X; Dawn B, 2002, ANN NY ACAD SCI, V962, P18, DOI 10.1111/j.1749-6632.2002.tb04053.x; de Tassigny XD, 2009, J NEUROCHEM, V109, P214, DOI 10.1111/j.1471-4159.2009.05949.x; Dogusan Z, 2001, J NEUROIMMUNOL, V120, P58, DOI 10.1016/S0165-5728(01)00420-9; DREWETT N, 1993, NEUROENDOCRINOLOGY, V57, P89; DUVILANSKI BH, 1995, P NATL ACAD SCI USA, V92, P170, DOI 10.1073/pnas.92.1.170; Feil Robert, 2008, V184, P529; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Garrel G, 1998, ENDOCRINOLOGY, V139, P2163, DOI 10.1210/en.139.4.2163; Gonzalez-Hernandez T, 2000, J HISTOCHEM CYTOCHEM, V48, P1639, DOI 10.1177/002215540004801207; Grams AE, 2010, NEUROENDOCRINOLOGY, V92, P128, DOI 10.1159/000314196; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Leong SK, 2002, ANN NY ACAD SCI, V962, P161, DOI 10.1111/j.1749-6632.2002.tb04066.x; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; MacRitchie AN, 1997, CIRC RES, V81, P355, DOI 10.1161/01.RES.81.3.355; Poliandri AHB, 2004, FREE RADICAL BIO MED, V37, P1463, DOI 10.1016/j.freeradbiomed.2004.07.017; Qian X, 1999, ENDOCRINE, V11, P123, DOI 10.1385/ENDO:11:2:123; Quinteros FA, 2007, TOXICOL APPL PHARM, V218, P79, DOI 10.1016/j.taap.2006.10.017; Raso GM, 1999, J NEUROCHEM, V73, P2272, DOI 10.1046/j.1471-4159.1999.0732272.x; RHODE PR, 1991, MOL CELL ENDOCRINOL, V82, P1, DOI 10.1016/0303-7207(91)90003-B; Sahni D, 2006, PITUITARY, P19; Seifert R, 2015, PHARMACOL THERAPEUT, V148, P154, DOI 10.1016/j.pharmthera.2014.12.002; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Sharina IG, 2011, NITRIC OXIDE-BIOL CH, V25, P265, DOI 10.1016/j.niox.2011.08.001; Shimojo T, 1999, EXP CELL RES, V247, P38, DOI 10.1006/excr.1998.4310; Spady TJ, 1999, ENDOCRINE, V11, P217, DOI 10.1385/ENDO:11:3:217; Taimor G, 2000, CARDIOVASC RES, V45, P588, DOI 10.1016/S0008-6363(99)00272-2; Tamura K, 2000, LIFE SCI, V66, pPL259, DOI 10.1016/S0024-3205(00)00488-4; Valenti L, 2003, CELL IMMUNOL, V221, P50, DOI 10.1016/S0008-8749(03)00064-9; Vankelecom H, 1997, MOL CELL ENDOCRINOL, V129, P157, DOI 10.1016/S0303-7207(97)04054-9; Vankelecom H, 1997, J HISTOCHEM CYTOCHEM, V45, P847, DOI 10.1177/002215549704500609; VANNESSELROOIJ JHJ, 1992, CARCINOGENESIS, V13, P277, DOI 10.1093/carcin/13.2.277; Velardez MO, 2004, ENDOCRINOLOGY, V145, P2064, DOI 10.1210/en.2003-1263; Velardez MO, 2003, HORM RES, V60, P111, DOI 10.1159/000072521; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Xia Y, 2004, ENDOCRINOLOGY, V145, P4550, DOI 10.1210/en.2004-0327; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	55	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162455	10.1371/journal.pone.0162455	http://dx.doi.org/10.1371/journal.pone.0162455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611913	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900103
J	Schneeberger, VE; Allaj, V; Gardner, EE; Poirier, JT; Rudin, CM				Schneeberger, Valentina E.; Allaj, Viola; Gardner, Eric E.; Poirier, J. T.; Rudin, Charles M.			Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis	PLOS ONE			English	Article							CANCER-CELL-LINES; PANCREATIC-CANCER; DRUG DEVELOPMENT; READ ALIGNMENT; MOUSE MODELS; METASTASIS; SAMPLES; PROGRESSION; ONCOLOGY; PLATFORM	Patient-derived xenograft (PDX) mouse models are increasingly used for preclinical therapeutic testing of human cancer. A limitation in molecular and genetic characterization of PDX tumors is the presence of integral murine stroma. This is particularly problematic for genomic sequencing of PDX models. Rapid and dependable approaches for quantitating stromal content and purifying the malignant human component of these tumors are needed. We used a recently developed technique exploiting species-specific polymerase chain reaction (PCR) amplicon length (ssPAL) differences to define the fractional composition of murine and human DNA, which was proportional to the fractional composition of cells in a series of lung cancer PDX lines. We compared four methods of human cancer cell isolation: fluorescence-activated cell sorting (FACS), an immunomagnetic mouse cell depletion (MCD) approach, and two distinct EpCAM-based immunomagnetic positive selection methods. We further analyzed DNA extracted from the resulting enriched human cancer cells by targeted sequencing using a clinically validated multi-gene panel. Stromal content varied widely among tumors of similar histology, but appeared stable over multiple serial tumor passages of an individual model. FACS and MCD were superior to either positive selection approach, especially in cases of high stromal content, and consistently allowed high quality human-specific genomic profiling. ssPAL is a dependable approach to quantitation of murine stromal content, and MCD is a simple, efficient, and high yield approach to human cancer cell isolation for genomic analysis of PDX tumors.	[Schneeberger, Valentina E.; Allaj, Viola; Poirier, J. T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA; [Schneeberger, Valentina E.; Allaj, Viola; Poirier, J. T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Gardner, Eric E.] Johns Hopkins Univ, Pharmacol Grad Training Program, Baltimore, MD USA; [Poirier, J. T.; Rudin, Charles M.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Cornell University	Poirier, JT; Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.; Poirier, JT; Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Poirier, JT; Rudin, CM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY USA.	poirierj@mskcc.org; rudinc@mskcc.org	Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Poirier, John/0000-0001-9795-5644; Gardner, Eric/0000-0002-1552-2675	National Cancer Institute [P30 CA008748]; LUNGevity Foundation Career Development Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); LUNGevity Foundation Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute P30 CA008748 - JTP CMR - and LUNGevity Foundation Career Development Award-JTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGKURLAND CL, 1986, CANCER RES, V46, P5730; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Das Thakur M, 2014, J PATHOL, V232, P103, DOI 10.1002/path.4285; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gray DR, 2004, CANCER RES, V64, P1712, DOI 10.1158/0008-5472.CAN-03-2700; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Huang PG, 2011, COMPARATIVE MED, V61, P227; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Khaled WT, 2014, SEMIN CELL DEV BIOL, V27, P54, DOI 10.1016/j.semcdb.2014.04.003; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; LEFRANCOIS D, 1989, INT J CANCER, V44, P871, DOI 10.1002/ijc.2910440521; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2010, BIOTECHNIQUES, V48, P211, DOI 10.2144/000113363; Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Mita MM, 2013, EXPERT OPIN INV DRUG, V22, P317, DOI 10.1517/13543784.2013.759557; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raimondi C, 2013, EXPERT REV MOL DIAGN, V13, P499, DOI [10.1586/ERM.13.33, 10.1586/erm.13.33]; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Rossello FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074432; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Tso KY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1172; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18	40	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160587	10.1371/journal.pone.0160587	http://dx.doi.org/10.1371/journal.pone.0160587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611664	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900009
J	Wang, JX; Zhu, SL; Wang, J; Lin, Y; Pei, YW; Sun, DP; Zhang, Y; Wang, XJ; Xu, WB; Ding, SJ				Wang, Jian-xing; Zhu, Shuang-li; Wang, Jing; Lin, Yi; Pei, Yao-wen; Sun, Da-peng; Zhang, Yong; Wang, Xian-jun; Xu, Wen-bo; Ding, Shu-jun			Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China	PLOS ONE			English	Article							MOUTH-DISEASE; 71 INFECTION; FOOT; HAND; SEROEPIDEMIOLOGY; CHILDREN; OUTBREAK; VACCINE; EPIDEMIC; EFFICACY	Background Hand, foot, and mouth disease has become very common in mainland of China in recent years, and enterovirus A71 and coxsackievirus A16 are its major etiologic factors. Here we investigated the seroprevalence of enterovirus A71 and coxsackievirus A16 based on a large group of healthy individuals in Shandong province, China. Methods A total of 1378 healthy individuals were tested for serum neutralizing antibodies against enterovirus A71 and coxsackievirus A16 using a micro neutralization test. Results The overall seroprevalence of enterovirus A71 neutralizing antibodies was 74.75%. It increased significantly from 48.84% in children aged 0-1 years old to 88.64% in those aged 20-29 years (p < 0.01) and decreased to 85.71% in adults > 40 years old with a significant gender-specific difference (p < 0.01). The overall coxsackievirus A16 antibody prevalence was 71.77%. It increased significantly from 39.53% in children aged 0-1 years to 80.68% in those aged 10-19 years (p < 0.01) and decreased to 75.63% in adults > 40 years without a gender-specific difference. Nearly 50% of the children < 1 year were susceptible to enterovirus A71 infection versus 40% to coxsackievirus A16 infection. Sample collection time and place also played a role in the enterovirus A71 and coxsackievirus A16 positive rates. The overall rates in January were significantly lower than those in April and August (p < 0.01); enterovirus A71 positive rates in Jinan city (capital city of Shandong province) were lower than those in Jining city and Zibo city (p < 0.05); and oxsackievirus A16 positive rates in Jining city were significantly higher than those in Jinan city and Zibo city (p < 0.01). Conclusion There were significant differences among age groups, locations, and time points in the seroprevalence rates of enterovirus A71 and coxsackievirus A16 neutralizing antibodies in healthy people in Shandong province.	[Wang, Jian-xing; Wang, Jing; Lin, Yi; Pei, Yao-wen; Sun, Da-peng; Wang, Xian-jun; Ding, Shu-jun] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Inst Viral Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China; [Zhu, Shuang-li; Zhang, Yong; Xu, Wen-bo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, WHO WPRO Reg Polio Reference Lab, Beijing 102206, Peoples R China; [Zhu, Shuang-li; Zhang, Yong; Xu, Wen-bo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, Key Lab Med Virol & Viral Dis, Beijing 102206, Peoples R China; [Wang, Jing] Shandong Univ, Sch Publ Hlth, Jinan 250012, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong University	Ding, SJ (corresponding author), Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Inst Viral Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China.	dsj_jn@126.com		Zhang, Yong/0000-0002-2692-5437	Science and Technology Development Plan of Shandong Province [2009GG10002055]; Shandong Natural Science Foundation [ZR2013HM052]; Shandong Medical Science and Technology Development Program [2013WS0157]	Science and Technology Development Plan of Shandong Province; Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Medical Science and Technology Development Program	This study was supported by Science and Technology Development Plan of Shandong Province to Xianjun Wang (http://www.sdstc.gov.cn) (Grant No. 2009GG10002055); Shandong Natural Science Foundation to Xianjun Wang (http://www.sdnsf.gov.cn) (Grant No. ZR2013HM052); and Shandong Medical Science and Technology Development Program to Xianjun Wang (http://www.sdwsjs.gov.cn) (Grant No. 2013WS0157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; Akhmadishina LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097404; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Castro Ceyla M.O., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P65, DOI 10.1590/S0036-46652005000200002; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Feng XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11700; Gomes MDC, 2002, MEM I OSWALDO CRUZ, V97, P47, DOI 10.1590/S0074-02762002000100006; Gu HY, 2014, PEDIATR INFECT DIS J, V33, P1302, DOI 10.1097/INF.0000000000000467; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Horwood PF, 2016, EMERG INFECT DIS, V22, P92, DOI 10.3201/eid2201.151323; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang Y, 2015, J MED VIROL, V87, P1471, DOI 10.1002/jmv.24200; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Juhela S, 1998, J MED VIROL, V54, P226, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;226::AID-JMV14&gt;3.0.CO;2-F; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li JX, 2016, EXPERT REV VACCINES, V15, P129, DOI 10.1586/14760584.2016.1096782; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080515; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Lim CT, 2015, EPIDEMIOL INFECT, P1; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu LD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0448-7; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Pallansch M, 2013, FIELDS VIROLOGY, V1, P490; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; Wong KT, 2000, NEW ENGL J MED, V342, P356; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yan JJ, 2001, J MED VIROL, V65, P331, DOI 10.1002/jmv.2038; Yang F, 2011, CLIN INFECT DIS, V53, P400, DOI 10.1093/cid/cir346; Yang Q, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0571-x; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	52	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162373	10.1371/journal.pone.0162373	http://dx.doi.org/10.1371/journal.pone.0162373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611441	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900085
J	Laverty, JT; Underwood, SM; Matz, RL; Posey, LA; Carmel, JH; Caballero, MD; Fata-Hartley, CL; Ebert-May, D; Jardeleza, SE; Cooper, MM				Laverty, James T.; Underwood, Sonia M.; Matz, Rebecca L.; Posey, Lynmarie A.; Carmel, Justin H.; Caballero, Marcos D.; Fata-Hartley, Cori L.; Ebert-May, Diane; Jardeleza, Sarah E.; Cooper, Melanie M.			Characterizing College Science Assessments: The Three-Dimensional Learning Assessment Protocol	PLOS ONE			English	Article							BLOOMS TAXONOMY; EXPLANATION; ARGUMENT; BIOLOGY; DISTINCTION; INVENTORY; OSBORNE; FACULTY	Many calls to improve science education in college and university settings have focused on improving instructor pedagogy. Meanwhile, science education at the K-12 level is undergoing significant changes as a result of the emphasis on scientific and engineering practices, crosscutting concepts, and disciplinary core ideas. This framework of "three-dimensional learning" is based on the literature about how people learn science and how we can help students put their knowledge to use. Recently, similar changes are underway in higher education by incorporating three-dimensional learning into college science courses. As these transformations move forward, it will become important to assess three-dimensional learning both to align assessments with the learning environment, and to assess the extent of the transformations. In this paper we introduce the Three-Dimensional Learning Assessment Protocol (3D-LAP), which is designed to characterize and support the development of assessment tasks in biology, chemistry, and physics that align with transformation efforts. We describe the development process used by our interdisciplinary team, discuss the validity and reliability of the protocol, and provide evidence that the protocol can distinguish between assessments that have the potential to elicit evidence of three-dimensional learning and those that do not.	[Laverty, James T.; Matz, Rebecca L.; Caballero, Marcos D.; Jardeleza, Sarah E.; Cooper, Melanie M.] Michigan State Univ, CREATE STEM Inst, E Lansing, MI 48824 USA; [Underwood, Sonia M.; Posey, Lynmarie A.; Carmel, Justin H.; Cooper, Melanie M.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Caballero, Marcos D.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Fata-Hartley, Cori L.] Michigan State Univ, Coll Nat Sci, E Lansing, MI 48824 USA; [Ebert-May, Diane] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Laverty, James T.] Kansas State Univ, Dept Phys, Cardwell Hall, Manhattan, KS 66506 USA; [Underwood, Sonia M.] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Underwood, Sonia M.] Florida Int Univ, STEM Transformat Inst, Miami, FL 33199 USA; [Jardeleza, Sarah E.] Salisbury Univ, Univ Anal Reporting & Assessment, Salisbury, MD USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Kansas State University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University System of Maryland; Salisbury University	Laverty, JT (corresponding author), Michigan State Univ, CREATE STEM Inst, E Lansing, MI 48824 USA.; Laverty, JT (corresponding author), Kansas State Univ, Dept Phys, Cardwell Hall, Manhattan, KS 66506 USA.	laverty@ksu.edu	Underwood, Sonia/AAW-5740-2021; Caballero, Marcos/H-1292-2013; Underwood, Sonia/AAF-2718-2021; Carmel, Justin/X-2957-2019; Matz, Rebecca L./AAF-2969-2021	Underwood, Sonia/0000-0002-4919-2758; Caballero, Marcos/0000-0003-0717-4583; Carmel, Justin/0000-0001-9281-3751; Matz, Rebecca L./0000-0002-8220-7720; Cooper, Melanie/0000-0002-7050-8649; Posey, Lynmarie/0000-0001-7713-0637	Association of American Universities [2012PG-EDU005]; MMC; Association of American Universities' Undergraduate STEM Education Initiative; Office of the Provost of Michigan State University; Helmsley Charitable Trust	Association of American Universities; MMC; Association of American Universities' Undergraduate STEM Education Initiative; Office of the Provost of Michigan State University; Helmsley Charitable Trust	The Leona M. and Harry B. Helmsley Charitable Trust (http://helmsleytrust.org/) awarded the Association of American Universities (http://www.aau.edu/): Grant #2012PG-EDU005. Michigan State University received a sub-award of that grant (MMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the Association of American Universities' Undergraduate STEM Education Initiative (which is funded by the Helmsley Charitable Trust) and by the Office of the Provost of Michigan State University. We thank the faculty who provided assessment tasks for our review, engaged in discussions of core ideas, and have taken steps to incorporate three-dimensional learning into their courses.	AERA, 2014, STAND ED PSYCH TEST; Aikenhead GS, 2005, SCI EDUC, V89, P242, DOI 10.1002/sce.20046; American Association for the Advancement of Science, 2007, ATL SCI LIT, V2; American Association for the Advancement of Science (AAAS), 2001, AM ASS ADV SCI ATL S; Anderson L. W., 2000, TAXONOMY LEARNING TE; [Anonymous], 2001, KNOWING WHAT STUDENT; [Anonymous], 2000, PEOPLE LEARN BRAIN M; [Anonymous], 1996, NAT SCI ED STAND; [Anonymous], 2015, REACHING STUDENTS WH; [Anonymous], 2007, TAKING SCI SCH LEARN; [Anonymous], 2007, COMMITTEE PROSPERING; [Anonymous], 2013, NGSS LEAD STATES NEX; [Anonymous], 2014, DEV ASSESSMENTS NEXT; Berland LK, 2012, SCI EDUC, V96, P808, DOI 10.1002/sce.21000; Bloom B. S., 1956, HDB 1 COGNITIVE DOMA; Bretz S. L., 2014, ACS SYM SER, V1166, P155, DOI 10.1021/bk-2014-1166.ch009; Brewer C. A., 2011, VSION CHANGE UNDERGR; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; College Board, 2014, AP CHEM; College Board, 2011, AP BIOL CURR FRAM; College Board, 2015, AP PHYS; College Board, 2015, AP PHYS 2 ALG BAS CU; Cooper MM, 2015, SCIENCE, V350, P281, DOI 10.1126/science.aab0933; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; Duggan S, 2002, INT J SCI EDUC, V24, P661, DOI 10.1080/09500690110110133; Freeman S., 2014, P NATL ACAD SCI; Gardner David P., 1983, NATION RISK IMPERATI; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Hall K. L, 2013, EXAMINING EFFECTS ST; Hammer D, RESOURCES FRAMING TR; Henderson C, 2011, J RES SCI TEACH, V48, P952, DOI 10.1002/tea.20439; HESTENES D, 1987, AM J PHYS, V55, P440, DOI 10.1119/1.15129; Hestenes D., 1992, PHYS TEACH, V30, P141, DOI [DOI 10.1119/1.2343497, https://doi.org/10.1119/1.2343497]; Knight JK, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.15-04-0093; Laverty JT, 2014, PHYS EDUC RES CONF, P147, DOI 10.1119/perc.2014.pr.033; Lawrenz F, 2009, J RES SCI TEACH, V46, P961, DOI 10.1002/tea.20292; Lemons PP, 2013, CBE-LIFE SCI EDUC, V12, P47, DOI 10.1187/cbe.12-03-0024; Linn RL, 1988, ED MEASUREMENT; McDonald J., 2015, J COLL SCI TEACH, V45, P13, DOI [10.2505/4/jcst15_045_01_13, DOI 10.2505/4/JCST15_045_01_13]; Mislevy Robert J., 2004, BRIEF INTRO EVIDENCE; Momsen J, 2013, CBE-LIFE SCI EDUC, V12, P239, DOI 10.1187/cbe.12-08-0130; Mulford DR, 2002, J CHEM EDUC, V79, P739, DOI 10.1021/ed079p739; National Research Council, 2012, FRAM K 12 SCI ED; National Research Council, 2012, DISCIPLINE BASED ED; Osborne J, 2012, SCI EDUC, V96, P814, DOI 10.1002/sce.21034; Osborne JF, 2011, SCI EDUC, V95, P627, DOI 10.1002/sce.20438; President's Council of Advisors on Science and Technology, 2012, REP PRES; Rising Above the Gathering Storm Committee, 2010, RISING GATHERING STO; Schmidt WH, 2002, SPLINTERED VISION; Schwarz CV, 2009, J RES SCI TEACH, V46, P632, DOI 10.1002/tea.20311; Smith D., 2015, VISION CHANGE UNDERG; Smith MK, 2008, CBE-LIFE SCI EDUC, V7, P422, DOI 10.1187/cbe.08-08-0045; Stanger-Hall KF, 2012, CBE-LIFE SCI EDUC, V11, P294, DOI 10.1187/cbe.11-11-0100; Torrance H, 2012, OXFORD REV EDUC, V38, P323, DOI 10.1080/03054985.2012.689693; Towns MH, 2014, J CHEM EDUC, V91, P1426, DOI 10.1021/ed500076x; TREAGUST DF, 1988, INT J SCI EDUC, V10, P159, DOI 10.1080/0950069880100204; Wenger E., 1999, COMMUNITIES PRACTICE; Wiggins G, 2005, SOC STUD GRADE, V6, P31; Windschitl M, 2008, SCI EDUC, V92, P941, DOI 10.1002/sce.20259; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306; Zheng AY, 2008, SCIENCE, V319, P414, DOI 10.1126/science.1147852	61	124	124	15	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162333	10.1371/journal.pone.0162333	http://dx.doi.org/10.1371/journal.pone.0162333			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606671	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600039
J	Trainor, AM; McDonald, RI; Fargione, J				Trainor, Anne M.; McDonald, Robert I.; Fargione, Joseph			Energy Sprawl Is the Largest Driver of Land Use Change in United States	PLOS ONE			English	Article							NUCLEAR-ENERGY; BIODIVERSITY CONSERVATION; PHOTOVOLTAIC GENERATION; ECOSYSTEM SERVICES; BRADSHAW 2015; SHALE-GAS; IMPACTS; POLICY; EFFICIENCY; ENVIRONMENT	Energy production in the United States for domestic use and export is predicted to rise 27% by 2040. We quantify projected energy sprawl (new land required for energy production) in the United States through 2040. Over 200,000 km(2) of additional land area will be directly impacted by energy development. When spacing requirements are included, over 800,000 km(2) of additional land area will be affected by energy development, an area greater than the size of Texas. This pace of development in the United States is more than double the historic rate of urban and residential development, which has been the greatest driver of conversion in the United States since 1970, and is higher than projections for future land use change from residential development or agriculture. New technology now places 1.3 million km(2) that had not previously experienced oil and gas development at risk of development for unconventional oil and gas. Renewable energy production can be sustained indefinitely on the same land base, while extractive energy must continually drill and mine new areas to sustain production. We calculated the number of years required for fossil energy production to expand to cover the same area as renewables, if both were to produce the same amount of energy each year. The land required for coal production would grow to equal or exceed that of wind, solar and geothermal energy within 2-31 years. In contrast, it would take hundreds of years for oil production to have the same energy sprawl as biofuels. Meeting energy demands while conserving nature will require increased energy conservation, in addition to distributed renewable energy and appropriate siting and mitigation.	[Trainor, Anne M.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [McDonald, Robert I.] Nature Conservancy, Global Cities Program, 1815 N Lynn St, Arlington, VA USA; [Fargione, Joseph] Nature Conservancy, Minneapolis, MN USA; [Trainor, Anne M.] Nature Conservancy, Africa Program, Cincinnati, OH USA	Yale University; Nature Conservancy; Nature Conservancy	Trainor, AM (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.; Fargione, J (corresponding author), Nature Conservancy, Minneapolis, MN USA.; Trainor, AM (corresponding author), Nature Conservancy, Africa Program, Cincinnati, OH USA.	Anne.trainor@tnc.org; Jfargione@tnc.org		McDonald, Robert/0000-0002-7273-6549	Nature Conservancy's NatureNet Science Fellows program	Nature Conservancy's NatureNet Science Fellows program	This work was supported by the Nature Conservancy's NatureNet Science Fellows program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams LS, 2015, ECOL INDIC, V52, P153, DOI 10.1016/j.ecolind.2014.11.031; ALL Consulting, 2003, COAL BED METH PRIM N; Allred BW, 2015, SCIENCE, V348, P401, DOI 10.1126/science.aaa4785; Amos J, 2009, MEASURING DIRECT LAN; [Anonymous], 2009, LAND USE REQUIREMENT; Aroonruengsawat A, 2012, ENERG J, V33, P31, DOI 10.5547/ISSN0195-6574-EJ-Vol33-No1-2; Arora S, 2010, BIOFUELS-UK, V1, P911, DOI 10.4155/BFS.10.60; Bernhardt ES, 2012, ENVIRON SCI TECHNOL, V46, P8115, DOI 10.1021/es301144q; Bevan G, 2012, RENEWABLE ENERGY CLI, P8; Biewick Laura H, 2008, AREAS HIST OIL GAS E; Brook BW, 2015, CONSERV BIOL, V29, P702, DOI 10.1111/cobi.12433; Bureau of Land Mangament, 2008, APPR PIN RES MAN PLA; Colborn T, 2011, HUM ECOL RISK ASSESS, V17, P1039, DOI 10.1080/10807039.2011.605662; Colorado Oil and Gas Conservation Commission, 2015, SER DRILL DEV PROD A, P1; Denholm P, 2008, ENERG POLICY, V36, P3531, DOI 10.1016/j.enpol.2008.05.035; Department of Energy, 2008, 20 PERC WIND EN 2030; Diesendorf M, 2016, CONSERV BIOL, V30, P666, DOI 10.1111/cobi.12692; Edenhofer O., 2015, CLIMATE CHANGE 2014; [EIA (U.S. Energy Information Administration) U.S. Energy Information Administration Office of Integrated and International Energy Analysis U.S. Department of Energy], 2013, ANN EN OUTL 2013 PRO; Fargione J, 2010, P NATL ACAD SCI USA, V107, P18745, DOI 10.1073/pnas.1014045107; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Fargione JE, 2010, ANNU REV ECOL EVOL S, V41, P351, DOI 10.1146/annurev-ecolsys-102209-144720; Federal Energy Regulatory Commission, 2014, COMPL LIST ISS LIC; Fthenakis V, 2009, RENEW SUST ENERG REV, V13, P1465, DOI 10.1016/j.rser.2008.09.017; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gillingham K, 2006, ANNU REV ENV RESOUR, V31, P161, DOI 10.1146/annurev.energy.31.020105.100157; Gottschalk K, 2012, EXPLORING ENV EFFECT; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hebblewhite Mark, 2011, P71; Hellweg S, 2003, INT J LIFE CYCLE ASS, V8, P8, DOI 10.1065/lca2002.09.097; Hendrickson O, 2016, CONSERV BIOL, V30, P661, DOI 10.1111/cobi.12693; Henle K, 2016, CONSERV BIOL, V30, P663, DOI 10.1111/cobi.12691; Holditch SA, 2013, J UNCONV OIL GAS RES, V1-2, P2, DOI 10.1016/j.juogr.2013.05.001; Horizon Systems Corporation, NHDPLUS VERS 2; Hughes JD, 2013, NATURE, V494, P307, DOI 10.1038/494307a; Inman M, 2014, NATURE, V516, P28, DOI 10.1038/516028a; Jacobson MZ, 2011, ENERG POLICY, V39, P1154, DOI 10.1016/j.enpol.2010.11.040; Jenner S, 2013, ENERG POLICY, V53, P442, DOI 10.1016/j.enpol.2012.11.010; Jiang M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034014; Johnson N., 2010, PENNSYLVANIA ENERGY; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Jordaan SM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024004; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kyba CCM, 2014, ENERG ENVIRON SCI, V7, P1806, DOI 10.1039/c4ee00566j; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Lee R, 2012, REBOUND EFFECT MORE; Ludlow SM, 2015, CONDOR, V117, P64, DOI 10.1650/CONDOR-14-79.1; Lutz BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073203; Maloney KO, 2012, ENVIRON PRAC, V14, P278, DOI 10.1017/S146604661200035X; Maugeri L., 2013, SHALE OIL BOOM US PH; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Meyfroidt P, 2013, CURR OPIN ENV SUST, V5, P438, DOI 10.1016/j.cosust.2013.04.003; Miskimins JL, 2009, SPE PROD OPER, V24, P353, DOI 10.2118/114170-PA; Moosavian SM, 2013, RENEW SUST ENERG REV, V25, P44, DOI 10.1016/j.rser.2013.03.030; Nicot JP, 2012, ENVIRON SCI TECHNOL, V46, P3580, DOI 10.1021/es204602t; Nicot Jean-Philippe, 2012, OIL GAS WATER USE TE; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Ong S, 2013, LAND USE REQUIREMENT, P1, DOI DOI 10.2172/1086349; Ong S., 2012, LAND USE WIND SOLAR; Rybach L., 2010, Geothermics, V39, P365, DOI 10.1016/j.geothermics.2010.08.002; Sathaye J, 2011, RENEWABLE ENERGY SOURCES AND CLIMATE CHANGE MITIGATION: SPECIAL REPORT OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P707; Shortall R, 2015, RENEW SUST ENERG REV, V44, P391, DOI 10.1016/j.rser.2014.12.020; Sleeter BM, 2013, GLOBAL ENVIRON CHANG, V23, P733, DOI 10.1016/j.gloenvcha.2013.03.006; Texas Office of the Secretary of State, 2004, RULE 3 37 STAT SPAC; Thoyre A, 2015, J POLIT ECOL, V22, P146, DOI 10.2458/v22i1.21082; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; U.S. Energy Information Administration, 2014, US EL FLOW; United States Environmental Protection Agency, 2014, LIGHT DUT AUT TECHN; United States Government Accountability Office Report, 2012, INF SHAL RES DEV ENV; Wang M, 2011, ENERG POLICY, V39, P5726, DOI 10.1016/j.enpol.2010.03.052; Weisser D, 2007, ENERGY, V32, P1543, DOI 10.1016/j.energy.2007.01.008; Westcott P., 2014, USDA AGR PROJECTIONS	73	120	122	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162269	10.1371/journal.pone.0162269	http://dx.doi.org/10.1371/journal.pone.0162269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607423	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600034
J	Weirich, F; Gremer, L; Mirecka, EA; Schiefer, S; Hoyer, W; Heise, H				Weirich, Franziska; Gremer, Lothar; Mirecka, Ewa A.; Schiefer, Stephanie; Hoyer, Wolfgang; Heise, Henrike			Structural Characterization of Fibrils from Recombinant Human Islet Amyloid Polypeptide by Solid-State NMR: The Central FGAILS Segment Is Part of the beta-Sheet Core	PLOS ONE			English	Article							RESOLUTION 3-DIMENSIONAL STRUCTURE; DYNAMIC NUCLEAR-POLARIZATION; CHEMICAL-SHIFTS; ROTATING SOLIDS; HUMAN AMYLIN; FULL-LENGTH; CORRELATION SPECTROSCOPY; RESONANCE ASSIGNMENTS; MOLECULAR-STRUCTURE; SECONDARY STRUCTURE	Amyloid deposits formed from islet amyloid polypeptide (IAPP) are a hallmark of type 2 diabetes mellitus and are known to be cytotoxic to pancreatic beta-cells. The molecular structure of the fibrillar form of IAPP is subject of intense research, and to date, different models exist. We present results of solid-state NMR experiments on fibrils of recombinantly expressed and uniformly C-13, N-15-labeled human IAPP in the non-amidated, free acid form. Complete sequential resonance assignments and resulting constraints on secondary structure are shown. A single set of chemical shifts is found for most residues, which is indicative of a high degree of homogeneity. The core region comprises three to four beta-sheets. We find that the central 23-FGAILS-28 segment, which is of critical importance for amyloid formation, is part of the core region and forms a beta-strand in our sample preparation. The eight N-terminal amino acid residues of IAPP, forming a ring-like structure due to a disulfide bridge between residues C2 and C7, appear to be well defined but with an increased degree of flexibility. This study supports the elucidation of the structural basis of IAPP amyloid formation and highlights the extent of amyloid fibril polymorphism.	[Weirich, Franziska; Gremer, Lothar; Hoyer, Wolfgang; Heise, Henrike] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Weirich, Franziska; Gremer, Lothar; Mirecka, Ewa A.; Schiefer, Stephanie; Hoyer, Wolfgang; Heise, Henrike] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Heise, H (corresponding author), Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Heise, H (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	h.heise@fz-juelich.de	Gremer, Lothar/H-9128-2013; Heise, Henrike/A-7703-2010; Hoyer, Wolfgang/H-6193-2013	Gremer, Lothar/0000-0001-7065-5027; Heise, Henrike/0000-0002-9081-3894; Hoyer, Wolfgang/0000-0003-4301-5416; Weirich, Franziska/0000-0001-8279-3566	Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; DFG [HE 3243/4-1]	Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; DFG(German Research Foundation (DFG))	This work was supported by the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf and the DFG (HE 3243/4-1).r The authors acknowledge access to the Julich-Dusseldorf Biomolecular NMR Center that is jointly run by Forschungszentrum Julich and Heinrich-Heine-University Dusseldorf. This work was supported by the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf and the DFG (HE 3243/4-1).	Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Alexandrescu AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056467; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; BILLETER M, 1982, J MOL BIOL, V155, P321, DOI 10.1016/0022-2836(82)90008-0; BLOEMBERGEN N, 1949, PHYSICA, V15, P386, DOI 10.1016/0031-8914(49)90114-7; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Cope SM, 2013, BIOPHYS J, V105, P1661, DOI 10.1016/j.bpj.2013.08.026; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gardiennet C, 2008, J BIOMOL NMR, V40, P239, DOI 10.1007/s10858-008-9229-3; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Hansen DF, 2010, J AM CHEM SOC, V132, P7589, DOI 10.1021/ja102090z; HARTMANN SR, 1962, PHYS REV, V128, P2042, DOI 10.1103/PhysRev.128.2042; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2001, J MAGN RESON, V150, P198, DOI 10.1006/jmre.2001.2343; Hohwy M, 2002, J CHEM PHYS, V117, P4973, DOI 10.1063/1.1488136; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kosicka I, 2014, PROTEIN EXPRES PURIF, V99, P119, DOI 10.1016/j.pep.2014.04.002; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Lewandowski JR, 2013, ACCOUNTS CHEM RES, V46, P2018, DOI 10.1021/ar300334g; Lopez del Amo JM, 2012, ANGEW CHEM INT EDIT, V51, P6136, DOI 10.1002/anie.201200965; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; Martin OA, 2010, J BIOMOL NMR, V46, P217, DOI 10.1007/s10858-010-9396-x; Mirecka EA, 2014, J BIOTECHNOL, V191, P221, DOI 10.1016/j.jbiotec.2014.06.006; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Ni QZ, 2013, ACCOUNTS CHEM RES, V46, P1933, DOI 10.1021/ar300348n; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002; Sauvee C, 2013, ANGEW CHEM INT EDIT, V52, P10858, DOI 10.1002/anie.201304657; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Seidel K, 2004, PHYS CHEM CHEM PHYS, V6, P5090, DOI 10.1039/b411689e; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Stevens TJ, 2011, J BIOMOL NMR, V51, P437, DOI 10.1007/s10858-011-9569-2; Sumner MO, 2004, J MOL BIOL, V335, P1279, DOI DOI 10.1016/J.JMB.2003.11.048; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991	67	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161243	10.1371/journal.pone.0161243	http://dx.doi.org/10.1371/journal.pone.0161243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607147	Green Published, gold			2022-12-27	WOS:000383255600003
J	Baumann, FM; Yuzefpolskiy, Y; Sarkar, S; Kalia, V				Baumann, Florian M.; Yuzefpolskiy, Yevgeniy; Sarkar, Surojit; Kalia, Vandana			Dicer Regulates the Balance of Short-Lived Effector and Long-Lived Memory CD8 T Cell Lineages	PLOS ONE			English	Article							SELECTIVE EXPRESSION; IMMUNE-SYSTEM; DIFFERENTIATION; MIRNA; RESPONSES; FATES; INFECTIONS; ACTIVATION; MICRORNAS; PRECURSOR	MicroRNAs constitute a major post-transcriptional mechanism for controlling protein expression, and are emerging as key regulators during T cell development and function. Recent reports of augmented CD8 T cell activation and effector differentiation, and aberrant migratory properties upon ablation of Dicer/miRNAs in naive cells have established a regulatory role of miRNAs during priming. Whether miRNAs continue to exert similar functions or are dispensable during later stages of CD8 T cell expansion and memory differentiation remains unclear. Here, we report a critical role of Dicer/miRNAs in regulating the balance of long-lived memory and short-lived terminal effector fates during the post-priming stages when CD8 T cells undergo clonal expansion to generate a large cytotoxic T lymphocyte (CTL) pool and subsequently differentiate into a quiescent memory state. Conditional ablation of Dicer/miRNAs in early effector CD8 T cells following optimal activation and expression of granzyme B, using unique dicer(fl/fl) gzmb-cre mice, led to a strikingly diminished peak effector size relative to wild-type antigen-specific cells in the same infectious milieu. Diminished expansion of Dicer-ablated CD8 T cells was associated with lack of sustained antigen-driven proliferation and reduced accumulation of short-lived effector cells. Additionally, Dicer-ablated CD8 T cells exhibited more pronounced contraction after pathogen clearance and comprised a significantly smaller proportion of the memory pool, despite significantly higher proportions of CD127(Hi) memory precursors at the effector peak. Combined with previous reports of dynamic changes in miRNA expression as CD8 T cells differentiate from naive to effector and memory states, these findings support distinct stage-specific roles of miRNA-dependent gene regulation during CD8 T cell differentiation.	[Sarkar, Surojit; Kalia, Vandana] Univ Washington, Sch Med, Dept Pediat, Div Hematol & Oncol, Seattle, WA 98195 USA; [Sarkar, Surojit; Kalia, Vandana] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA; [Sarkar, Surojit] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Baumann, Florian M.; Yuzefpolskiy, Yevgeniy] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kalia, V (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Hematol & Oncol, Seattle, WA 98195 USA.; Kalia, V (corresponding author), Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA.	sarkarkalia@gmail.com			National Institutes of Health [AI113803, AI103748]; USDA AES project [4531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI103748, R03AI113803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA AES project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded, in part, by research grants from the National Institutes of Health to V.K. (AI113803) and S.S. (AI103748), and USDA AES project #4531 (Mechanisms of Immune Responses to Pathogens and Vaccines V.K. and S.S.).; The authors would like to thank Dr. Joshy Jacob (Emory University, Atlanta) for kindly providing the granzyme B-cre mice. This work was funded, in part, by research grants from the National Institutes of Health to VK (AI113803) and SS (AI103748), and USDA AES project #4531 (Mechanisms of Immune Responses to Pathogens and Vaccines V.K. and S.S.).	Andrade F, 2010, IMMUNOL REV, V235, P128, DOI 10.1111/j.0105-2896.2010.00909.x; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Dai WP, 2015, LIVER INT, V35, P1234, DOI 10.1111/liv.12660; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Feng Y, 2012, RNA, V18, P2083, DOI 10.1261/rna.033688.112; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Khan AA, 2013, BLOOD, V121, P4473, DOI 10.1182/blood-2012-06-435412; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00178; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Liu Juan, 2013, Cancer Biology Medicine, V10, P131, DOI 10.7497/j.issn.2095-3941.2013.03.002; Maris CH, 2003, J IMMUNOL, V171, P2393, DOI 10.4049/jimmunol.171.5.2393; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Pepin G, 2012, NUCLEIC ACIDS RES, V40, P11603, DOI 10.1093/nar/gks903; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Stadnisky MD, 2011, BLOOD, V117, P5133, DOI 10.1182/blood-2010-12-324632; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; Tsai CY, 2013, J VIROL, V87, P2348, DOI 10.1128/JVI.01742-12; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162674	10.1371/journal.pone.0162674	http://dx.doi.org/10.1371/journal.pone.0162674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627450	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600051
J	Hu, JH; Ye, F; Cui, M; Lee, P; Wei, CG; Hao, YY; Wang, XQ; Wang, YB; Lu, ZH; Galsky, M; McBride, R; Wang, L; Wang, DW; Cordon-Cardo, C; Wang, CX; Zhang, DY				Hu, Jinghai; Ye, Fei; Cui, Miao; Lee, Peng; Wei, Chengguo; Hao, Yuanyuan; Wang, Xiaoqing; Wang, Yanbo; Lu, Zhihua; Galsky, Matthew; McBride, Russell; Wang, Li; Wang, Dongwen; Cordon-Cardo, Carlos; Wang, Chunxi; Zhang, David Y.			Protein Profiling of Bladder Urothelial Cell Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RADICAL CYSTECTOMY; SIGNALING NETWORK; FACTOR RECEPTOR; CANCER; EXPRESSION; MUTATIONS; PROGNOSIS; CISPLATIN; SURVIVAL	This study aimed to detect protein changes that can assist to understand the underlying biology of bladder cancer. The data showed forty five proteins were found to be differentially expressed comparing tumors vs non-tumor tissues, of which EGFR and cdc2p34 were correlated with muscle invasion and histological grade. Ten proteins (beta-catenin, HSP70, autotaxin, Notch4, PSTPIP1, DPYD, ODC, cyclinB1, calretinin and EPO) were able to classify muscle invasive BCa (MIBC) into 2 distinct groups, with group 2 associated with poorer survival. Finally, 3 proteins (P2X7, cdc25B and TFIIH p89) were independent factors for favorable overall survival.	[Hu, Jinghai; Hao, Yuanyuan; Wang, Xiaoqing; Wang, Yanbo; Lu, Zhihua; Wang, Chunxi] Jilin Univ, Hosp 1, Dept Urol, Changchun 130021, Jilin, Peoples R China; [Ye, Fei; Cui, Miao; McBride, Russell; Cordon-Cardo, Carlos; Zhang, David Y.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY 10010 USA; [Wei, Chengguo] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Galsky, Matthew] Mt Sinai Sch Med, Dept Med, Div Hematol & Oncol, New York, NY USA; [Wang, Li] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Wang, Li] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA; [Wang, Dongwen] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan 030002, Shanxi, Peoples R China	Jilin University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Shanxi Medical University	Wang, CX (corresponding author), Jilin Univ, Hosp 1, Dept Urol, Changchun 130021, Jilin, Peoples R China.; Zhang, DY (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.	chunxi_wang@126.com; david.zhang@mssm.edu	cui, miao/HCH-7244-2022		Science and Technology Department of Jilin Province, China [20140414003GH]	Science and Technology Department of Jilin Province, China	This work was supported by Science and Technology Department of Jilin Province, China (grant 20140414003GH) (http://www.jlkjxm.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Broggini M, 2000, ANTICANCER RES, V20, P4835; Canesin G, 2010, TUMOR BIOL, V31, P277, DOI 10.1007/s13277-010-0033-9; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Colquhoun AJ, 2002, POSTGRAD MED J, V78, P584, DOI 10.1136/pmj.78.924.584; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Gala JL, 2000, CLIN CANCER RES, V6, P4049; Gore JL, 2010, JNCI-J NATL CANCER I, V102, P802, DOI 10.1093/jnci/djq121; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hakabayashi H, 2006, J CLIN PATHOL, V59, P725, DOI 10.1136/jcp.2005.029546; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Kaczmarek Piotr, 2006, Polish Journal of Pathology, V57, P41; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Lee BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035812; Lugli A, 2003, HUM PATHOL, V34, P994, DOI 10.1053/S0046-8177(03)00339-3; MacArthur BD, 2010, BIOINFORMATICS, V26, P143, DOI 10.1093/bioinformatics/btp628; MELLON K, 1995, J UROLOGY, V153, P919, DOI 10.1016/S0022-5347(01)67604-3; MESSING EM, 1987, J UROLOGY, V138, P1329, DOI 10.1016/S0022-5347(17)43593-2; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Sonpavde G, 2010, LANCET ONCOL, V11, P861, DOI 10.1016/S1470-2045(10)70086-3; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Vashistha V, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-966; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wang DG, 2011, AM J PATHOL, V179, P1657, DOI 10.1016/j.ajpath.2011.06.010; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Ye F, 2009, NUTR CANCER, V61, P530, DOI 10.1080/01635580902803719; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhang DY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-20; Zhang Z, 2014, TUMOR BIOL, V35, P2503, DOI 10.1007/s13277-013-1331-9	40	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161922	10.1371/journal.pone.0161922	http://dx.doi.org/10.1371/journal.pone.0161922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626805	Green Submitted, gold, Green Published			2022-12-27	WOS:000383680600012
J	Martinez-Torres, AO; Mosquera, MM; De Ory, F; Gonzalez-Praetorius, A; Echevarria, JE				Martinez-Torres, Alex O.; Mosquera, Maria M.; De Ory, Fernando; Gonzalez-Praetorius, Alejandro; Echevarria, Juan E.			Genetic Characterization of Rubella Virus Strains Detected in Spain, 1998-2014	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; OUTBREAK	The National Plan for the Elimination of Rubella was implemented in Spain in 2008 using the logistics of the National Plan for the Elimination of Measles that have been employed since year 2000. Molecular characterization of rubella virus (RUBV) is important for disease surveillance and for monitoring elimination of the disease throughout the world. We describe the first complete series of data regarding the circulation of RUBV genotypes in Spain. The 739-nucleotide fragment designated by the WHO for RUBV genotyping was sequenced in 88 selected cases collected from 1998 to 2014. Five genotypes were identified: 1E, 2B, 1J, 1I, and 1a. Genotype 1E was predominant between 1998 and 2003 but was replaced by genotype 2B, which was detected in sporadic cases in 2004, 2006, 2008, 2012, 2013 and 2014. There was an outbreak of genotype 2B in Algeciras (Andalusia) in 2008. Genotype 1J caused an outbreak in Madrid in 2004/2005 and sporadic cases in 2005 and 2007. Genotype 1I was found to have infected an immune-suppressed patient with neurological symptoms in 2008. Finally, vaccine strain RA 27/3 was detected in three sporadic cases, two of them immune-suppressed and without a recent history of vaccination. This suggests that during these years there were a series of imported sporadic cases and outbreaks, confirming the findings of epidemiological data analysis. The importation sources were generally consistent with our geographic and cultural ties, mainly with Europe (genotypes 1E, 2B, 1I) and Latin America (1J).	[Martinez-Torres, Alex O.; Mosquera, Maria M.; De Ory, Fernando; Echevarria, Juan E.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Martinez-Torres, Alex O.] Univ Panama, Lab Microbiol Expt & Aplicada, Vicerrectoria Invest & Postgrad, Ciudad De Panama, Panama; [Gonzalez-Praetorius, Alejandro] Hosp Univ Guadalajara, Secc Microbiol, Guadalajara, Spain; [Mosquera, Maria M.; De Ory, Fernando; Echevarria, Juan E.] CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad de Panama; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Martinez-Torres, AO (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.; Martinez-Torres, AO (corresponding author), Univ Panama, Lab Microbiol Expt & Aplicada, Vicerrectoria Invest & Postgrad, Ciudad De Panama, Panama.	amartinet13@hotmail.com	Echevarria, Juan E./F-7913-2016	Echevarria, Juan E./0000-0001-7522-850X; Gonzalez Praetorius, Alejandro/0000-0002-7886-0321; Martinez-Torres, Alex Omar/0000-0002-5001-6217; Mosquera Gutierrez, Maria del Mar/0000-0001-5863-7424	fellowship for Ph.D. Study by Republic of Panama; Acuerdo de Encomienda de Gestion entre la Direccion General de Salud Publica del Ministerio de Sanidad y Consumo y el Instituto de Salud Carlos III; Strategic Action on Health of the Instituto de Salud Carlos III [FIS PI12/02006]	fellowship for Ph.D. Study by Republic of Panama; Acuerdo de Encomienda de Gestion entre la Direccion General de Salud Publica del Ministerio de Sanidad y Consumo y el Instituto de Salud Carlos III(Instituto de Salud Carlos III); Strategic Action on Health of the Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work has received financial support from the fellowship for Ph.D. Study by Republic of Panama and Acuerdo de Encomienda de Gestion entre la Direccion General de Salud Publica del Ministerio de Sanidad y Consumo y el Instituto de Salud Carlos III. No expediente: DGVI-1429/05-3, and Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (IP12/02006). Also, has been developed under the Project FIS PI12/02006 funded by the Strategic Action on Health of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Amela Heras C., 2000, Boletin Epidemiologico Semanal, V8, P169; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P216; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2005, B EP COM MADR, V11, P33; Calendario vacunal 1999, 1999, B EP COM MADR, V4, P50; CHANTLER J, 2001, FIELDS VIROLOGY, P963; Frey TK, 1998, J INFECT DIS, V178, P642, DOI 10.1086/515370; Hinman A R, 1998, Rev Panam Salud Publica, V4, P156; Martinez-Torres AO, 2009, J CLIN MICROBIOL, V47, P158, DOI 10.1128/JCM.00469-08; Masa J, 2009, INFORME ANUAL PLAN E, P1; Masa-Calles J, 2015, VIGILANCIA SARAMPION, P1; Mosquera MD, 2002, J CLIN MICROBIOL, V40, P111, DOI 10.1128/JCM.40.1.111-116.2002; Mosquera Mdel M., 2010, DESARROLLO DIAGNOSTI, P192; Mosquera MDM, 2006, ENFERM INFEC MICR CL, V24, P251, DOI 10.1016/S0213-005X(06)73771-5; Nuevo Calendario Vacunal, 1996, B EP COM MADR, V19, P25; Pena-Rey I, 2009, B EPIDEMIOL SEM, V17, P85; Rota P. A., 2005, Morbidity and Mortality Weekly Report, V54, P1100; Sanz JC, 2004, ENFERM INFEC MICR CL, V22, P197, DOI 10.1157/13058030; Torner N, 2005, EUROSURVEILLANCE, V11; Vauloup-Fellous C, 2010, J CLIN MICROBIOL, V48, P2530, DOI 10.1128/JCM.00181-10; World Health Organization, 2003, STRAT PLAN MEASL CON; Zheng DP, 2003, EMERG INFECT DIS, V9, P1523; Zheng DP, 2003, J INFECT DIS, V187, P1587, DOI 10.1086/374972	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162403	10.1371/journal.pone.0162403	http://dx.doi.org/10.1371/journal.pone.0162403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622271	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000031
J	Pitts, S; Pelser, E; Meeks, J; Smith, D				Pitts, Svetlana; Pelser, Elizabeth; Meeks, Julian; Smith, Dean			Odorant Responses and Courtship Behaviors Influenced by at4 Neurons in Drosophila	PLOS ONE			English	Article							PHEROMONE-SENSITIVE NEURONS; OR65A OLFACTORY NEURONS; CUTICULAR HYDROCARBONS; GUSTATORY NEURONS; MELANOGASTER; ATTRACTION; ACTIVATION; AGGRESSION; SUBUNIT; ACETATE	In insects, pheromones function as triggers to elicit complex behavior programs, such as courtship and mating behavior. In most species, the neurons tuned to pheromones are localized in a specific subset of olfactory sensilla located on the antenna called trichoid sensilla. In Drosophila there are two classes of trichoid sensilla, at1 sensilla that contain the dendrites of a single neuron that is specifically tuned to the male-specific pheromone 11-cis vaccenyl acetate (cVA), and at4 sensilla that contain three neurons with relatively poorly defined chemical specificity and function. Using a combination of odorant receptor mutant analysis, single sensillum electrophysiology and optogenetics, we have examined the chemical tuning and behavioral consequences of the three at4 olfactory neuron classes. Our results indicate that one class, Or65abc neurons, are unresponsive to cVA pheromone, and function to inhibit courtship behaviors in response to an unknown ligand, while the other two neuron classes, Or88a and Or47b neurons, are sensitive to a diverse array of fly and non-fly odors, and activation of these neurons has little direct impact on courtship behaviors.	[Pitts, Svetlana; Pelser, Elizabeth; Meeks, Julian; Smith, Dean] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Smith, Dean] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Smith, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Smith, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu		Scheuermann, Elizabeth/0000-0002-7498-7130; Smith, Dean/0000-0002-4271-0436	National Institute on Deafness and Other Communication Disorders [R01DC011751]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015230, R01DC011751] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institute on Deafness and Other Communication Disorders, R01DC011751 to Dr. Dean Smith.	BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dweck HKM, 2015, P NATL ACAD SCI USA, V112, pE2829, DOI 10.1073/pnas.1504527112; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Elmore T, 2003, J NEUROSCIENCE IN PR; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hendrickson RC, 2008, J NEUROSCI, V28, P12523, DOI 10.1523/JNEUROSCI.2715-08.2008; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/nmeth.2765, 10.1038/NMETH.2765]; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lebreton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07119; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu T, 2012, J NEUROSCI, V32, P11879, DOI 10.1523/JNEUROSCI.1376-12.2012; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Meeks JP, 2010, NAT NEUROSCI, V13, P723, DOI 10.1038/nn.2546; Munch D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21841; Ronderos DS, 2014, J NEUROSCI, V34, P3959, DOI 10.1523/JNEUROSCI.4582-13.2014; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; van der Goes van Naters W, 2007, CURR BIOL, V17, P606, DOI DOI 10.1016/J.CUB.2007.02.043; Vogt RG, 2005, PHYSL BIOCH PHARM MO, P753; Wang L. F., 2011, FOREIGN LANGUAGE WOR, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022325; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	35	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162761	10.1371/journal.pone.0162761	http://dx.doi.org/10.1371/journal.pone.0162761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617442	Green Submitted, Green Published, gold			2022-12-27	WOS:000383653100050
J	Wang, C; Liu, QF; Chen, FF; Xu, WJ; Zhang, CQ; Xiao, W				Wang, Chao; Liu, Qingfa; Chen, Fangfang; Xu, Wenjuan; Zhang, Caiqing; Xiao, Wei			IL-25 Promotes Th2 Immunity Responses in Asthmatic Mice via Nuocytes Activation	PLOS ONE			English	Article							TYPE-2 IMMUNITY; AIRWAY HYPERREACTIVITY; THERAPEUTIC TARGETS; LYMPHOID-CELLS; INNATE; INTERLEUKIN-25; DISEASE; LUNG; INFLAMMATION; CYTOKINES	Background Interleukin-25 (IL-25) is a potent activator of type-2 immune responses, and is responsible for airway inflammation in asthma. Previous reports have shown that IL-25 expressed hyper-reactivity in an experimental mouse-model of asthma. In addition, the production of IL-13/IL-5 promoted by nuocytes induced airway inflammation. Thus, it has been questioned whether blocking IL-25 against its receptor IL-17BR could inhibit the expression of IL-13 and IL-5 via nuocytes, and further protect against inflammation in ovalbumin (OVA) induced mouse-model of asthma. Methods In this study, in order to investigate the correlation among IL-25, IL-5, IL-13 and nuocyte activities, we used OVA-sensitization and -challenging to induce the mouse model of asthma. The murine asthmatic model was validated by histology. The expressions of IL-5, IL-13 and IL-25 were detected by ELISA, quantitative real-time PCR, and western blotting of the lung tissue. Nuocyte activation was identified by the levels of ICOS (clone C398.4A) and T1/ST2 (cloneDJ8) (acting as nuocytes surface markers) in the bronchoalveolar lavage fluid (BALF). This, in turn, was done by means of flow cytometry. The expressions of IL-25, IL-5 and IL-13 in our murine model were detected in the BALF. Results The mice sensitized and challenged with OVA showed a high expression of IL-25 in both the mRNA and protein levels in lungs. The expressions of ICOS and T1/ST2 in BALF were increased. A significant correlation between IL-25 mRNA, protein, and other Th2-cell producing cytokines (such as IL-5 and IL-13) moreover were identified. Furthermore, when the asthmatic mice were treated with anti-IL-25, both the inflammatory cells' infiltration and the inflammatory cytokines' secretion were significantly decreased. The present findings indicate that IL-25 might be involved in a series of asthmatic immune responses, playing an important role in the increase of nuocytes, and that its activation is necessary in maintaining Th2 central memory and sustaining asthmatic inflammation. Conclusion This study showed that IL-25 promoted the accumulation of ICOS and T1/ST2 on nuocytes, further induced the pro-inflammatory Th2 cells, and promoted Th2 cytokine responses in OVA-induced airway inflammation.	[Wang, Chao; Chen, Fangfang; Xu, Wenjuan; Zhang, Caiqing] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China; [Liu, Qingfa] Shandong Univ, Sch Med Sci, Jinan, Shandong, Peoples R China; [Xiao, Wei] Shandong Univ, Qilu Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Zhang, CQ (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China.; Xiao, W (corresponding author), Shandong Univ, Qilu Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China.	freezcq66@163.com; xiaoxingxingxh@163.com			Department of Science and Technology Foundation [2012 GSF 11830]; Natural and Science Foundation of Shandong Province, China [ZR2013HM046]	Department of Science and Technology Foundation; Natural and Science Foundation of Shandong Province, China	This work was supported by the Department of Science and Technology Foundation (2012 GSF 11830), and the Natural and Science Foundation of Shandong Province, China (ZR2013HM046).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Balazs Antus, 2012, Orvosi Hetilap, V153, P1847, DOI 10.1556/OH.2012.29494; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Barlow JL, 2011, J LEUKOCYTE BIOL, V90, P867, DOI 10.1189/jlb.0311160; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Camelo A, 2012, J GASTROENTEROL, V47, P1198, DOI 10.1007/s00535-012-0591-2; Cully M, 2014, NAT REV DRUG DISCOV, V13, P810, DOI 10.1038/nrd4473; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Groves AM, 2012, AM J RESP CELL MOL, V47, P776, DOI 10.1165/rcmb.2011-0433OC; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Ji XY, 2014, INT J CLIN EXP PATHO, V7, P7554; Kaiko GE, 2011, CURR OPIN ALLERGY CL, V11, P39, DOI 10.1097/ACI.0b013e328342322f; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kim JY, 2013, EXP DERMATOL, V22, P219, DOI 10.1111/exd.12092; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Petersen BC, 2012, FUTURE MED CHEM, V4, P833, DOI [10.4155/fmc.12.39, 10.4155/FMC.12.39]; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Shifren A, 2012, J ALLERGY, V2012, P1, DOI DOI 10.1155/2012/316049; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Silverman J, 2012, LAB ANIMAL, V41, P230, DOI 10.1038/laban0812-230; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Yang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059441; Yao XJ, 2015, RESPIROLOGY, V20, P730, DOI 10.1111/resp.12546	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162393	10.1371/journal.pone.0162393	http://dx.doi.org/10.1371/journal.pone.0162393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617447	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100020
J	Alexandrino, AV; Goto, LS; Novo-Mansur, MTM				Alexandrino, Andre Vessoni; Goto, Leandro Seiji; Marques Novo-Mansur, Maria Teresa			treA Codifies for a Trehalase with Involvement in Xanthomonas citri subsp citri Pathogenicity	PLOS ONE			English	Article							ESCHERICHIA-COLI; METABOLISM; DNA	Citrus canker, caused by the bacterium Xanthomonas citri subsp. citri (Xcc), is a severe disease of citrus. Xcc presents broad spectrum of citrus hosts including economically important species whereas X. fuscans subsp. aurantifolii-type C (XauC) causes a milder disease and only infects Citrus aurantifolia. Trehalase catalyzes hydrolysis of the disaccharide trehalose, a sugar that has been reported to be related to Xcc pathogenicity. We expressed the recombinant gene product and assessed Xcc trehalase structural and kinetics data. The recombinant protein presented 42.7% of secondary structures in alpha-helix and 13% in beta-sheets, no quaternary structure in solution, and Michaelis-Menten constant (K-M) of 0.077 mM and V-max 55.308 mu Mol glucose.min(-1).mg protein(-1) for trehalose. A Xcc mutant strain (Xcc Delta treA) was produced by gene deletion from Xcc genome. Enzymatic activity of trehalase was determined in Xcc, XauC and Xcc Delta treA cellular lysates, showing the highest values for XauC in in vitro infective condition and no activity for Xcc Delta treA. Finally, leaves of Citrus aurantifolia infected with Xcc Delta treA showed much more drenching and necrosis than those infected by wild type Xcc. We concluded that trehalase contributes to alleviate bacterial virulence and that inability for trehalose hydrolysis may promote higher Xcc infectivity.	[Alexandrino, Andre Vessoni; Goto, Leandro Seiji; Marques Novo-Mansur, Maria Teresa] Univ Fed Sao Carlos, Dept Genet & Evolucao, LBBMA, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos	Alexandrino, AV (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, LBBMA, Sao Carlos, SP, Brazil.	avalex@uol.com.br	Mansur, Maria Teresa Marques Novo/G-4779-2012; Alexandrino, André Vessoni/M-9295-2016	Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Alexandrino, André Vessoni/0000-0002-0111-3491	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/50910-2]; Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil); Fundecitrus (Araraquara-SP, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES-PNPD [23038.006942/2011-31]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [131047/2013-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil); Fundecitrus (Araraquara-SP, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES-PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Project 07/50910-2), Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil) and Fundecitrus (Araraquara-SP, Brazil). LSG is recipient of a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES-PNPD Institucional 23038.006942/2011-31. AVA received a scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Process 131047/2013-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Project 07/50910-2) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD Institucional 23038.006942/2011-31) for financial support and to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Process 131047/2013-2) for providing a scholarship to A.V.A. We also thank the support from Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil) and Fundecitrus (Araraquara-SP, Brazil), especially to Dr. Franklin Behlau and Tamiris Garcia da Silva.	Ausubel F, 2002, SHORT PROTOCOLS MOL, V2; Bramucci MG, 1996, APPL ENVIRON MICROB, V62, P3948, DOI 10.1128/AEM.62.11.3948-3953.1996; Brodmann D, 2002, MOL PLANT MICROBE IN, V15, P693, DOI 10.1094/MPMI.2002.15.7.693; Civerolo E, 1984, J RIO GRANDE VALLEY; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Djonovic S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003217; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Facincani AP, 2014, FUNCT INTEGR GENOMIC, V14, P205, DOI 10.1007/s10142-013-0340-5; FERREIRA H, 1995, APPL MICROBIOL BIOT, V43, P651, DOI 10.1007/BF00164769; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Goto LS, BIOCH BIOPHYSICA ACT; Goto M., 1992, Plant diseases of international importance. Volume III. Diseases of fruit crops., P170; Gottwald T. R., 2002, PLANT HLTH PROG, P10, DOI [10.1094/PHP2002-081201-RV, DOI 10.1094/PHP2002-081201-RV]; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Moreira LM, 2005, OMICS, V9, P43, DOI 10.1089/omi.2005.9.43; PADMANABHAN D, 1974, Indian Phytopathology, V27, P215; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piazza A, 2015, J EXP BOT, V66, P2795, DOI 10.1093/jxb/erv095; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; TOURINHODOSSANTOS CF, 1994, BRAZ J MED BIOL RES, V27, P627; Trinder P., 1969, ANN CLIN BIOCH; Uhland K, 2000, J BIOL CHEM, V275, P23439, DOI 10.1074/jbc.M002793200	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162886	10.1371/journal.pone.0162886	http://dx.doi.org/10.1371/journal.pone.0162886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611974	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900182
J	Cossellu, G; Motta, V; Dioni, L; Angelici, L; Vigna, L; Farronato, G; Pesatori, AC; Bollati, V				Cossellu, Gianguido; Motta, Valeria; Dioni, Laura; Angelici, Laura; Vigna, Luisella; Farronato, Giampietro; Pesatori, Angela Cecilia; Bollati, Valentina			Titanium and Zirconium Levels Are Associated with Changes in MicroRNAs Expression: Results from a Human Cross-Sectional Study on Obese Population	PLOS ONE			English	Article							METAL; OSTEOBLAST; MIRNA; STABILITY; TOXICITY; CELLS; IONS	Objectives In this study on 90 individuals we aimed at evaluating the microRNAs (miRNAs) expression profile associated with personal levels of Titanium (Ti) and Zirconium (Zr) traced in hair samples. Ti and Zr materials are broadly used for dental implants but the biological reactions triggered by a long term presence of these materials in the oral cavity still need to be assessed. MiRNAs are mechanisms that need to be investigated as they play a fundamental role in the control of gene expression following external stimuli and contribute to a wide range of pathophysiological processes. Methods Using the TaqMan 1 Low-Density Array, we assessed the expression levels of 377 human miRNAs in peripheral blood of 90 subjects. Hair samples were analyzed for Ti and Zr content using Inductively Coupled Plasma-Mass Spectrometry. We performed multivariable regression analysis to investigate the effects of Ti and Zr exposure on miRNA expression levels. We used the Ingenuity Pathway Analysis (IPA) software to explore the functional role of the investigated miRNAs and the related target genes. Results Seven miRNAs (miR-99b, miR-142-5p, miR-152, miR-193a-5p, miR-323-3p, miR-335, miR-494) resulted specifically associated with Zr levels. The functional target analysis showed that miRNAs are involved in mechanisms such as inflammation, skeletal and connective tissue disorders. Conclusions Our data suggest that Zr is more bioactive than Ti and show that miRNAs are relevant molecular mechanisms sensitive to Zr exposure.	[Cossellu, Gianguido; Farronato, Giampietro] Univ Milan, Dept Biomed Surg & Dent Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Via Commenda 10, I-20122 Milan, Italy; [Motta, Valeria; Dioni, Laura; Angelici, Laura; Pesatori, Angela Cecilia; Bollati, Valentina] Univ Milan, EPIGET Epidemiol Epigenet & Toxicol Lab, Dept Clin Sci & Community Hlth, Milan, Italy; [Vigna, Luisella; Pesatori, Angela Cecilia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Workers Hlth Protect & Promot Unit, Milan, Italy; [Pesatori, Angela Cecilia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Cossellu, G (corresponding author), Univ Milan, Dept Biomed Surg & Dent Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Via Commenda 10, I-20122 Milan, Italy.	gianguido.cossellu@unimi.it	Angelici, Laura/AAC-2633-2019; pesatori, angela/K-5742-2016	Vigna, Luisella/0000-0001-5014-721X; Cossellu, Gianguido/0000-0001-6442-5591; pesatori, angela/0000-0002-0261-3252; Bollati, Valentina/0000-0002-0370-9598; Angelici, Laura/0000-0003-3731-1606	EU Programme "Ideas" [ERC-2011-StG 282413]	EU Programme "Ideas"	This project received support from the EU Programme "Ideas" (ERC-2011-StG 282413 to Dr. V. Bollati).	Ahmad I, 1998, INT J PERIODONT REST, V18, P455; An J, 2014, TOXICOL LETT, V229, P158, DOI 10.1016/j.toxlet.2014.06.002; Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Bass D A, 2001, Altern Med Rev, V6, P472; Bennett WD, 2004, J APPL PHYSIOL, V97, P821, DOI 10.1152/japplphysiol.01403.2003; Bollati V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1137; Bollati V, 2010, ENVIRON HEALTH PERSP, V118, P763, DOI 10.1289/ehp.0901300; CHOWDHURY BA, 1987, PROG FOOD NUTR SCI, V11, P55; Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3; Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30; Flatebo RS, 2006, J PERIODONTOL, V77, P1201, DOI 10.1902/jop.2006.050406; ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B; Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Jenkins DW, 1979, EPA600479049; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005; Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003; Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675; Linkevicius T, 2008, INT J ORAL MAX IMPL, V23, P449; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Motta V, 2013, TOXICOL SCI, V132, P307, DOI 10.1093/toxsci/kft013; Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025; Olmedo DG, 2008, J MATER SCI-MATER M, V19, P3049, DOI 10.1007/s10856-008-3438-x; Palmieri A, 2008, J MATER SCI-MATER M, V19, P2471, DOI 10.1007/s10856-008-3386-5; Palmieri A, 2008, CLIN IMPLANT DENT R, V10, P200, DOI 10.1111/j.1708-8208.2007.00078.x; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Puchyr RF, 1998, BIOL TRACE ELEM RES, V62, P167, DOI 10.1007/BF02783969; Raffaelli L, 2008, J BIOMED MATER RES A, V86A, P959, DOI 10.1002/jbm.a.31693; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Ryu HW, 2015, TOX RESEARCH, V31, P1, DOI 10.5487/TR.2015.31.1.001; Soto-Alvaredo J, 2014, METALLOMICS, V6, P1702, DOI 10.1039/c4mt00133h; Spalinger MR, 2015, INFLAMM BOWEL DIS, V21, P645, DOI 10.1097/MIB.0000000000000297; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0; Yang HC, 2003, DRUG CHEM TOXICOL, V26, P75, DOI 10.1081/DCT-120020403	39	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161916	10.1371/journal.pone.0161916	http://dx.doi.org/10.1371/journal.pone.0161916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611787	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900037
J	Gu, FY; Xiao, Q; Chu, LW; Yu, K; Matthews, CE; Hsing, AW; Caporaso, NE				Gu, Fangyi; Xiao, Qian; Chu, Lisa W.; Yu, Kai; Matthews, Charles E.; Hsing, Ann W.; Caporaso, Neil E.			Sleep Duration and Cancer in the NIH-AARP Diet and Health Study Cohort	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; RETIRED-PERSONS DIET; BREAST-CANCER; AMERICAN-ASSOCIATION; POSTMENOPAUSAL WOMEN; NATIONAL-INSTITUTES; OHSAKI COHORT; RISK; METAANALYSIS; DEPRESSION	Background Very few studies have examined sleep duration in relation to cancer incidence with the exception of breast cancer. Methods We assessed the associations between sleep duration and incidences of total and 18 site-specific cancers in the NIH-AARP Health and Diet Study cohort, with 173,327 men and 123,858 women aged 51-72 years at baseline. Self-reportedsleep duration categories were assessed via questionnaire. We used multivariable Cox proportional hazards regression to estimate hazard ratios (HR) and 95% confidence intervals (CI), using 7-8 hours/night as the reference. Results We observed a significantly increased risk of stomach cancer among male short sleepers (multivariable HR5-6 vs. 7-8 hours = 1.29; 95% CI: 1.05, 1.59; P-trend = 0.03). We also observed suggestive associations in either short or long sleepers, which did not reach overall significance (P-trend > 0.05), including increased risks in male short sleepers for cancers of head and neck (HR<5vs. 7-8 hours = 1.39; 95% CI: 1.00-1.95), bladder (HR5-6vs. 7-8 hours = 1.10; 95% CI: 1.00-1.20), thyroid (HR<5 vs. 7-8 hours = 2.30; 95% CI: 1.06, 5.02), Non-Hodgkin Lymphoma (NHL) (HR5-6vs. 7-8 hours = 1.17; 95% CI: 1.02-1.33), and myeloma (HR<5vs. 7-8 hours = 2.06; 95% CI: 1.20-3.51). In women, the suggestive associations include a decreased total cancer risk (HR<5vs. 7-8 hours = 0.9; 95% CI: 0.83-0.99) and breast cancer risk (HR<5vs. 7-8 hours = 0.84; 95% CI: 0.71-0.98) among short sleepers. A decreased ovarian cancer risk (HR >= 9 vs. 7-8 hours = 0.50; 95% CI: 0.26-0.97) and an increased NHL risk (HR >= 9 vs. 7-8 hours = 1.45; 95% CI: 1.00-2.11) were observed among long sleepers. Conclusion In an older population, we observed an increased stomach cancer risk in male short sleepers and suggestive associations with short or long sleep duration for many cancer risks in both genders.	[Gu, Fangyi; Xiao, Qian; Yu, Kai; Matthews, Charles E.; Caporaso, Neil E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chu, Lisa W.; Hsing, Ann W.] Canc Prevent Inst Calif, Fremont, CA USA; [Chu, Lisa W.; Hsing, Ann W.] Stanford Canc Inst, Palo Alto, CA USA; [Hsing, Ann W.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University	Gu, FY (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	Guf@mail.nih.gov	matthews, Charles e/E-8073-2015	matthews, Charles e/0000-0001-8037-3103	Intramural Research Program of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors are supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. The sponsor had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Anisimov VN, 2003, CRIT REV ONCOL HEMAT, V46, P221, DOI 10.1016/S1040-8428(03)00021-0; BLIWISE DL, 1993, J CLIN PSYCHOL, V49, P471, DOI 10.1002/1097-4679(199307)49:4<471::AID-JCLP2270490403>3.0.CO;2-7; Bliwise DL, 2007, SLEEP, V30, P1614, DOI 10.1093/sleep/30.12.1614; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Foley DJ, 2007, AM J GERIAT PSYCHIAT, V15, P344, DOI 10.1097/01.JGP.0000249385.50101.67; Fujiwara Y, 2012, J GASTROENTEROL, V47, P760, DOI 10.1007/s00535-012-0601-4; Girschik J, 2013, AM J EPIDEMIOL, V177, P316, DOI 10.1093/aje/kws422; Haus EL, 2013, SLEEP MED REV, V17, P273, DOI 10.1016/j.smrv.2012.08.003; Horne J, 2011, BIOL PSYCHOL, V87, P1, DOI 10.1016/j.biopsycho.2010.10.004; Jiao L, 2013, BRIT J CANCER, V108, P213, DOI 10.1038/bjc.2012.561; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Kakizaki M, 2008, BRIT J CANCER, V99, P176, DOI 10.1038/sj.bjc.6604425; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Luo JH, 2013, AM J EPIDEMIOL, V177, P42, DOI 10.1093/aje/kws193; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Malik SW, 2005, PRIMARY CARE, V32, P475, DOI 10.1016/j.pop.2005.02.011; McElroy JA, 2006, J SLEEP RES, V15, P241, DOI 10.1111/j.1365-2869.2006.00523.x; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Monk TH, 2013, J SLEEP RES, V22, P201, DOI 10.1111/jsr.12003; Patel SR, 2009, OBES REV, V10, P61, DOI 10.1111/j.1467-789X.2009.00664.x; Pinheiro SP, 2006, CANCER RES, V66, P5521, DOI 10.1158/0008-5472.CAN-05-4652; Qian X, 2014, BR J CANC; Qin YY, 2014, INT J CANCER, V134, P1166, DOI 10.1002/ijc.28452; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Sturgeon SR, 2012, CANCER CAUSE CONTROL, V23, P547, DOI 10.1007/s10552-012-9912-2; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Vogtmann E, 2013, SLEEP, V36, P1437, DOI 10.5665/sleep.3032; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu AH, 2013, INT J CANCER, V132, P891, DOI 10.1002/ijc.27653; Xie FJ, 2013, WORLD J GASTROENTERO, V19, P6098, DOI 10.3748/wjg.v19.i36.6098; Zhang XH, 2013, SLEEP, V36, P681, DOI 10.5665/sleep.2626; Zizi F, 2010, CURR DIABETES REP, V10, P43, DOI 10.1007/s11892-009-0082-x	38	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161561	10.1371/journal.pone.0161561	http://dx.doi.org/10.1371/journal.pone.0161561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611440	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900020
J	Liu, S; Li, Q; Zhang, Y; Li, QS; Ye, BD; Wu, DJ; Wu, L; Lu, HT; Ji, CH				Liu, Shan; Li, Qing; Zhang, Ying; Li, Qiushuang; Ye, Baodong; Wu, Dijiong; Wu, Li; Lu, Hanti; Ji, Conghua			Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis	PLOS ONE			English	Article							SUSCEPTIBILITY; HLA-DRB1; ALLELES; DISEASE; HLA-DRB1-ASTERISK-1501; POPULATION; SEVERITY; TRIALS	This study aimed to review and quantitatively analyze (1) the association of aplastic anemia (AA) with human leukocyte antigen (HLA)-DRB1* 15 and HLA-DRB1* 15:01 polymorphisms and (2) the association of HLA-DRB1* 15 and HLA-DRB1* 15:01 polymorphisms with response to immunosuppressive therapy (IST) in AA. Published studies have reported conflicting and heterogeneous results regarding the association of HLA-DRB1* 15 and HLA-DRB1* 15:01 polymorphisms with response to IST in AA. The PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Chinese BioMedical Literature, Wang-fang and Chinese Social Sciences Citation Index databases were searched. All relevant publications were searched through December 2015. Odds ratio (OR), risk ratio (RR), and 95% confidence intervals (CI) for the comparison between case-control or cohort studies were evaluated. Finally, 24 articles were identified. For HLA-DRB1* 15 and HLA-DRB1* 15:01, the OR (95% CI) was 2.24(1.33-3.77), P < 0.01 and 2.50(1.73-3.62), P < 0.01, respectively; and the overall pooled RR was 1.72 (1.30-2.29), P < 0.01 and 1.59 (1.29-1.96), P < 0.01, respectively. Statistical evidence showed no publication bias (P > 0.05). Sensitivity analyses revealed that the results were statistically robust. The meta-analysis suggested that HLA-DRB1* 15 and HLA-DRB1* 15:01 polymorphisms might be associated with increased AA risk in Asians. IST might be more effective in HLA-DRB1* 15(+) and HLA-DRB1* 15:01(+) Asian patients with AA than in HLA-DRB1* 15- and HLA-DRB1* 15:01-Asian patients with AA. Future studies with adequate methodological quality on gene-gene and gene-environment interactions and gene treatment may yield valid results.	[Liu, Shan; Zhang, Ying; Li, Qiushuang; Wu, Li; Lu, Hanti; Ji, Conghua] Zhejiang Prov Hosp Tradit Chinese Med, Ctr Clin Evaluat & Anal, Hangzhou, Zhejiang, Peoples R China; [Li, Qing; Ye, Baodong; Wu, Dijiong] Zhejiang Prov Hosp Tradit Chinese Med, Dept Hematol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Ji, CH (corresponding author), Zhejiang Prov Hosp Tradit Chinese Med, Ctr Clin Evaluat & Anal, Hangzhou, Zhejiang, Peoples R China.	Jchi2005@126.com	liu, shan/GOK-1928-2022; Wu, Dijiong/AGV-5476-2022	liu, shan/0000-0001-9139-3257; Wu, Dijiong/0000-0003-2338-9365	State Administration of Traditional Chinese Medicine of the People's Republic of China [JDZX2012172]; Administration of Traditional Chinese Medicine of Zhejiang Province [2016ZA084]	State Administration of Traditional Chinese Medicine of the People's Republic of China; Administration of Traditional Chinese Medicine of Zhejiang Province	This work was supported by grants from the State Administration of Traditional Chinese Medicine of the People's Republic of China (No. JDZX2012172), the Administration of Traditional Chinese Medicine of Zhejiang Province (No. 2016ZA084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; Chen Y, 2007, ZHONGHUA NEI KE ZA Z, P46; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhaliwal JS, 2011, HUM IMMUNOL, V72, P889, DOI 10.1016/j.humimm.2011.06.013; Fernandez-Torres J, 2012, HUM IMMUNOL, V73, P840, DOI 10.1016/j.humimm.2012.04.012; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Yong-Lan, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1212; Huo Ming-rui, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P296, DOI 10.3760/cma.j.issn.1003-9406.2011.03.013; Kapustin SI, 2001, ANN HEMATOL, V80, P66, DOI 10.1007/s002770000234; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Liang Xiao-Lan, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1208; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mu Xiao-Yan, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P897; Nakao S, 1996, BRIT J HAEMATOL, V92, P155, DOI 10.1046/j.1365-2141.1996.293825.x; NAKAO S, 1994, BLOOD, V84, P4257, DOI 10.1182/blood.V84.12.4257.bloodjournal84124257; Narita A, 2015, HAEMATOLOGICA, V100, P1546, DOI 10.3324/haematol.2015.132530; Niu ZL, 2015, INT J RHEUM DIS, V18, P17, DOI 10.1111/1756-185X.12528; Oguz FS, 2002, HAEMATOLOGICA, V87, P772; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Peinemann F, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005039; [乔文婧 Qiao Wenjing], 2010, [山东大学学报. 医学版, Journal of Shandong University. Health Science], V48, P73; Rehman S, 2009, IMMUNOL INVEST, V38, P812, DOI 10.3109/08820130903271415; Schrezenmeier H, 2015, EXPERT REV HEMATOL, V8, P89, DOI 10.1586/17474086.2015.978759; Shin SH, 2014, KOREAN J INTERN MED, V29, P713, DOI 10.3904/kjim.2014.29.6.713; Song EY, 2008, HUM IMMUNOL, V69, P354, DOI 10.1016/j.humimm.2008.04.009; Song EY, 2010, HUM IMMUNOL, V71, P88, DOI 10.1016/j.humimm.2009.10.002; Sugimori C, 2007, EXP HEMATOL, V35, P13, DOI 10.1016/j.exphem.2006.09.002; [孙伟正 Sun Weizheng], 2004, [中医杂志, Journal of Traditional Chinese Medicine], V45, P450; [汤爱萍 Tang Aiping], 2002, [江西医学院学报, Acta Academiae Medicinae Jiangxi], V42, P43; Wang Fan, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P188; Wang M, 2014, HUM IMMUNOL, V75, P867, DOI 10.1016/j.humimm.2014.06.011; Wells G., 1999, NEWCASTLE OTTAWA SCA; [杨碧云 Yang Biyun], 2004, [江西医学院学报, Acta Academiae Medicinae Jiangxi], V44, P18; Yang M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-307; Yari F, 2008, INT J IMMUNOGENET, V35, P453, DOI 10.1111/j.1744-313X.2008.00810.x; Ye BD, 2014, CHIN J INTEGR MED, V20, P903, DOI 10.1007/s11655-014-2026-9; Zhu CT, 2015, INT J CLIN EXP MED, V8, P10256; 杨恩芹, 2004, [中华血液学杂志, Chinese Journal of Hematology], V25, P116; 杨碧云, 2002, [中华血液学杂志, Chinese Journal of Hematology], V23, P276	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162382	10.1371/journal.pone.0162382	http://dx.doi.org/10.1371/journal.pone.0162382			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611583	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900086
J	Song, NJ; Kim, S; Jang, BH; Chang, SH; Yun, UJ; Park, KM; Waki, H; Li, DY; Tontonoz, P; Park, KW				Song, No-Joon; Kim, Suji; Jang, Byung-Hyun; Chang, Seo-Hyuk; Yun, Ui Jeong; Park, Ki-Moon; Waki, Hironori; Li, Dean Y.; Tontonoz, Peter; Park, Kye Won			Small Molecule-Induced Complement Factor D (Adipsin) Promotes Lipid Accumulation and Adipocyte Differentiation	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; ADIPOSE-TISSUE; TRIGLYCERIDE SYNTHESIS; OBESITY; EXPRESSION; BIOLOGY; BINDING; PHOSPHORYLATION	Adipocytes are differentiated by various transcriptional cascades integrated on the master regulator, Ppar gamma. To discover new genes involved in adipocyte differentiation, preadipocytes were treated with three newly identified pro-adipogenic small molecules and GW7845 (a Ppar gamma agonist) for 24 hours and transcriptional profiling was analyzed. Four genes, Peroxisome proliferator-activated receptor gamma (Ppar gamma), human complement factor D homolog (Cfd), Chemokine (C-C motif) ligand 9 (Ccl9), and GIPC PDZ Domain Containing Family Member 2 (Gipc2) were induced by at least two different small molecules but not by GW7845. Cfd and Ccl9 expressions were specific to adipocytes and they were altered in obese mice. Small hairpinRNA (shRNA) mediated knockdown of Cfd in preadipocytes inhibited lipid accumulation and expression of adipocyte markers during adipocyte differentiation. Overexpression of Cfd promoted adipocyte differentiation, increased C3a production, and led to induction of C3a receptor (C3aR) target gene expression. Similarly, treatments with C3a or C3aR agonist (C4494) also promoted adipogenesis. C3aR knockdown suppressed adipogenesis and impaired the pro-adipogenic effects of Cfd, further suggesting the necessity for C3aR signaling in Cfd-mediated pro-adipogenic axis. Together, these data show the action of Cfd in adipogenesis and underscore the application of small molecules to identify genes in adipocytes.	[Song, No-Joon; Kim, Suji; Jang, Byung-Hyun; Chang, Seo-Hyuk; Yun, Ui Jeong; Park, Ki-Moon; Park, Kye Won] Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon 16419, South Korea; [Waki, Hironori] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan; [Li, Dean Y.] Univ Utah, Dept Med, Program Mol Med, 15 North 2030 East, Salt Lake City, UT 84112 USA; [Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Sungkyunkwan University (SKKU); University of Tokyo; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Park, KW (corresponding author), Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon 16419, South Korea.	kwpark@skku.edu	Waki, Hironori/AAE-3942-2020	Waki, Hironori/0000-0002-5302-9793; Park, Kye Won/0000-0003-2771-249X	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2016M3A9B6903451]; Ministry of Education, Science and Technology, Republic of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants (NRF-2016M3A9B6903451) funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF, www.nrf.re.kr), the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2014, BMB REP, V47, P587, DOI 10.5483/BMBRep.2014.47.10.176; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim CS, 2003, FEBS LETT, V548, P125, DOI 10.1016/S0014-5793(03)00728-2; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; LOWELL BB, 1990, ENDOCRINOLOGY, V126, P1514, DOI 10.1210/endo-126-3-1514; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Park KW, 2010, J LIPID RES, V51, P2775, DOI 10.1194/jlr.M008490; Park KW, 2009, MOL CELL BIOL, V29, P3905, DOI 10.1128/MCB.00002-09; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; SISSONS JGP, 1976, NEW ENGL J MED, V294, P461, DOI 10.1056/NEJM197602262940902; Song NJ, 2013, J LIPID RES, V54, P1385, DOI 10.1194/jlr.M035576; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200; YASRUEL Z, 1991, LIPIDS, V26, P495, DOI 10.1007/BF02536592; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	38	56	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162228	10.1371/journal.pone.0162228	http://dx.doi.org/10.1371/journal.pone.0162228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611793	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900063
J	Stires, H; Saboya, M; Globerman, SP; Cohick, WS				Stires, Hillary; Saboya, Mariana; Globerman, Samantha P.; Cohick, Wendie S.			Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; OVARIAN HORMONES; BODY-WEIGHT; FOOD-INTAKE; 17-BETA-ESTRADIOL; SENSITIVITY; TAMOXIFEN; EXPOSURE; ROUTE	A role for estrogens in breast cancer is widely accepted, however, recent evidence highlights that timing and exposure levels are important in determining whether they elicit harmful versus beneficial effects. The rat chemical carcinogen model has been widely used to study the effects of estrogens but conclusions on the levels that lead to tumor development and an absolute requirement for progesterone (P4) are lacking. A newer method of hormone administration mixes hormones with nut butter for peroral consumption allowing for a less stressful method of long-termadministration with lower spikes in serum estradiol (E2) levels. The present study was designed to determine if estrogens alone at a physiological dose can drive carcinogen-induced tumors in ovariectomized (OVX) rats or if P4 is also required using this method of hormone administration. Short-termstudies were conducted to determine the dose of estrogen (E) that would lead to increased uterine weight following OVX. Subsequently, rats were OVX on postnatal day (PND) 40 then treated daily with E (600 mu g/kg/day), P4 (15 mg/kg/day), or the combination. On PND 50, all rats were injected with nitrosomethylurea to induce mammary tumors. Uterine weights, body weights, and serum E2 levels were measured to demonstrate the efficacy of the method for increasing E2 levels during long-termtreatment. After 26 weeks, tumor incidence was similar in Sham, E, and E + P4 animals indicating that E was sufficient to induce tumorigenesis when hormone levels were normalized by this method. This study demonstrates peroral administration can be used in long-termstudies to elucidate relationships between different types and levels of steroid hormones.	[Stires, Hillary; Saboya, Mariana; Globerman, Samantha P.; Cohick, Wendie S.] Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Cohick, WS (corresponding author), Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08901 USA.	cohick@aesop.rutgers.edu		Saboya, Mariana/0000-0001-5793-0020; Stires, Hillary/0000-0002-0177-2024				Arques O, 2012, STANDARDIZED RELATIV; Aupperlee MD, 2007, ENDOCRINOLOGY, V148, P2290, DOI 10.1210/en.2006-1721; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BARTOSHUK LM, 1988, CHEM SENSES, V13, P517, DOI 10.1093/chemse/13.4.517; Bigsby RA, 2002, CANCER LETT, V179, P113, DOI 10.1016/S0304-3835(02)00032-0; Blank EW, 2008, P NATL ACAD SCI USA, V105, P3527, DOI 10.1073/pnas.0710535105; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Chan M, 2014, J NEUROENDOCRINOL, V26, P386, DOI 10.1111/jne.12159; Clarke RB, 1997, CANCER RES, V57, P4987; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Gleason CE, 2005, ANN NY ACAD SCI, V1052, P93, DOI 10.1196/annals.1347.007; GOTTARDIS MM, 1987, CANCER RES, V47, P4020; GRUBBS CJ, 1985, J NATL CANCER I, V74, P927; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Hilakivi-Clarke L, 2013, J MAMMARY GLAND BIOL, V18, P25, DOI 10.1007/s10911-013-9274-8; Isaksson IM, 2011, SCAND J CLIN LAB INV, V71, P583, DOI 10.3109/00365513.2011.596944; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; JORDAN VC, 1976, EUR J CANCER, V12, P419, DOI 10.1016/0014-2964(76)90030-X; Kerdelhue B, 2002, BREAST CANCER RES TR, V73, P13, DOI 10.1023/A:1015239128480; Kopper Nathan W, 2009, Drug Des Devel Ther, V2, P193; Kupfer D, 1987, Reprod Toxicol, V1, P147; Liu J, 2015, NEUROSCIENCE, V290, P103, DOI 10.1016/j.neuroscience.2015.01.042; LONGCOPE C, 1985, J STEROID BIOCHEM, V23, P1065, DOI 10.1016/0022-4731(85)90068-8; Lubet RA, 1998, CARCINOGENESIS, V19, P1345, DOI 10.1093/carcin/19.8.1345; Mirkin S, 2015, MATURITAS, V81, P28, DOI 10.1016/j.maturitas.2015.02.266; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Newbold RR, 2001, REPROD TOXICOL, V15, P245, DOI 10.1016/S0890-6238(01)00130-7; OCONNELL MB, 1995, J CLIN PHARMACOL, V35, pS18, DOI 10.1002/j.1552-4604.1995.tb04143.x; OHI Y, 1992, VIRCHOWS ARCH B, V62, P365, DOI 10.1007/BF02899705; Polanco TA, 2010, ALCOHOL CLIN EXP RES, V34, P1879, DOI 10.1111/j.1530-0277.2010.01276.x; Rajkumar L, 2001, P NATL ACAD SCI USA, V98, P11755, DOI 10.1073/pnas.201393798; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHWARTZ SM, 1981, AM J PHYSIOL, V240, pE499, DOI 10.1152/ajpendo.1981.240.5.E499; Stevenson JC, 2009, CLIMACTERIC, V12, P86, DOI 10.1080/13697130903007389; Strom JO, 2008, SCAND J CLIN LAB INV, V68, P814, DOI 10.1080/00365510802409703; Swanson SM, 2003, ANTICANCER RES, V23, P3207; Theodorsson A, 2005, SCAND J CLIN LAB INV, V65, P699, DOI 10.1080/00365510500375206; VERDEAL K, 1982, EUR J CANCER CLIN ON, V18, P1171, DOI 10.1016/0277-5379(82)90099-2; WADE GN, 1975, J COMP PHYSIOL PSYCH, V88, P183, DOI 10.1037/h0076186; WADE GN, 1972, PHYSIOL BEHAV, V8, P523, DOI 10.1016/0031-9384(72)90340-X; Witte MM, 2010, GEN COMP ENDOCR, V166, P520, DOI 10.1016/j.ygcen.2010.01.006	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162662	10.1371/journal.pone.0162662	http://dx.doi.org/10.1371/journal.pone.0162662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611094	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900147
J	Witzel, TC; Rodger, AJ; Burns, FM; Rhodes, T; Weatherburn, P				Witzel, T. Charles; Rodger, Alison J.; Burns, Fiona M.; Rhodes, Tim; Weatherburn, Peter			HIV Self-Testing among Men Who Have Sex with Men (MSM) in the UK: A Qualitative Study of Barriers and Facilitators, Intervention Preferences and Perceived Impacts	PLOS ONE			English	Article							ACCEPTABILITY	Introduction Innovative strategies, such as HIV self-testing (HIVST), could increase HIV testing rates and diagnosis. Evidence to inform the design of an HIVST intervention in the UK is scarce with very little European data on this topic. This study aims to understand values and preferences for HIVST interventions targeting MSM in the UK. We explore the acceptability of HIVST among MSM in the context of known barriers and facilitators to testing for HIV; assess preferences for, and the concerns about, HIVST. Methods Six focus group discussions (FGD) were conducted with 47 MSM in London, Manchester and Plymouth. HIVST as a concept was discussed and participants were asked to construct their ideal HIVST intervention. OraQuick (TM) and BioSure (TM) kits were then demonstrated and participants commented on procedure, design and instructions. FGDs were recorded and transcribed verbatim, then analysed thematically. Results Convenience and confidentiality of HIVST was seen to facilitate testing. Issues with domestic privacy problematised confidentiality. HIVST kits and instructions were thought to be unnecessarily complicated, and did not cater to the required range of abilities. The window period was the most important element of an HIVST, with strong preference for 4th generation testing. Kits which used a blood sample were more popular than those using saliva due to higher perceived accuracy although phobia of needles and/or blood meant some would only access HIVST if a saliva sample option was available. A range of access options was important to maintain convenience and privacy. HIVST kits were assumed to increase frequency of testing, with concerns related to the dislocation of HIVST from sexual health care pathways and services. Discussion Utility of HIVST arises from relatively high levels of confidentiality and convenience. Until 4th generation assays are available HIVST will be seen as supplementary in a UK context.	[Witzel, T. Charles; Weatherburn, Peter] London Sch Hyg & Trop Med, Sigma Res, Dept Social & Environm Hlth Res, Publ Hlth & Policy, London, England; [Rodger, Alison J.; Burns, Fiona M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Rhodes, Tim] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Publ Hlth & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Witzel, TC (corresponding author), London Sch Hyg & Trop Med, Sigma Res, Dept Social & Environm Hlth Res, Publ Hlth & Policy, London, England.	Charles.witzel@lshtm.ac.uk	Rhodes, Tim/DNJ-9679-2022; Weatherburn, Peter/AAC-2701-2019	Weatherburn, Peter/0000-0002-4950-6163; Witzel, T Charles/0000-0003-4262-261X; Rhodes, Tim/0000-0003-2400-9838	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-1212-20006]; National Institute for Health Research; PANTHEON [RP-PG-1212-20006]; National Institute for Health Research [RP-PG-1212-20006] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); PANTHEON; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (grant reference number RP-PG-1212-20006). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. This research is being conducted as part of a National Institute for Health Research funded programme grant called PANTHEON; a collaborative project between University College London, the London School of Hygiene and Tropical Medicine, the Medical Research Council and others. The grant number for PANTHEON (under which this project falls) is RP-PG-1212-20006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; Banda J, 2015, BODY SOC, V21, P24, DOI 10.1177/1357034X14528391; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Dodds C, 2007, BMJ-BRIT MED J, V334, P1329, DOI 10.1136/bmj.39245.570093.BE; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Flowers P, 2017, HIV MED, V18, P245, DOI 10.1111/hiv.12420; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; Glasgow RE, 2013, JAIDS-J ACQ IMM DEF, V63, pS26, DOI 10.1097/QAI.0b013e3182920286; Ibitoye M, 2014, AIDS BEHAV, V18, P933, DOI 10.1007/s10461-013-0668-9; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; KATZ D, 2012, ACCEPTABILITY EASE U; Knussen C, 2014, AIDS CARE, V26, P297, DOI 10.1080/09540121.2013.824543; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lorenc T, 2011, HEALTH EDUC RES, V26, P834, DOI 10.1093/her/cyr064; Love My Town, 2015, ALL UK TOWNS CIT POP; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; McDaid LM, 2016, HIV MED, V17, P683, DOI 10.1111/hiv.12373; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; National AIDS Trust, 2015, HIV PREV ENGL HIGH P; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Skingsley A, 2015, HIV UK 2015 SITUATIO; Westrop SJ, 2013, CONTR HIV EP ANT AV; Witzel TC, BMJ OPEN IN PRESS; Yin Z, 2014, HIV UK 2014 REPORT D	24	59	64	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162713	10.1371/journal.pone.0162713	http://dx.doi.org/10.1371/journal.pone.0162713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611777	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000383255900153
J	Baghbaderani, BA; Tian, XH; Cadet, JS; Shah, K; Walde, A; Tran, H; Kovarcik, DP; Clarke, D; Fellner, T				Baghbaderani, Behnam Ahmadian; Tian, Xinghui; Cadet, Jean Scotty; Shah, Kevan; Walde, Amy; Tran, Huan; Kovarcik, Don Paul; Clarke, Diana; Fellner, Thomas			A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; DIMERIZATION; DERIVATION; PATHWAYS; BLOOD	Human pluripotent stem cells (hPSCs) present an unprecedented opportunity to advance human health by offering an alternative and renewable cell resource for cellular therapeutics and regenerative medicine. The present demand for high quality hPSCs for use in both research and clinical studies underscores the need to develop technologies that will simplify the cultivation process and control variability. Here we describe the development of a robust, defined and xeno-free hPSC medium that supports reliable propagation of hPSCs and generation of human induced pluripotent stem cells (hiPSCs) from multiple somatic cell types; long-term serial subculturing of hPSCs with every-other-day (EOD) medium replacement; and banking fully characterized hPSCs. The hPSCs cultured in this medium for over 40 passages are genetically stable, retain high expression levels of the pluripotency markers TRA-1-60, TRA-1-81, Oct-3/4 and SSEA-4, and readily differentiate into ectoderm, mesoderm and endoderm. Importantly, the medium plays an integral role in establishing a cGMP-compliant process for the manufacturing of hiPSCs that can be used for generation of clinically relevant cell types for cell replacement therapy applications.	[Baghbaderani, Behnam Ahmadian; Tian, Xinghui; Cadet, Jean Scotty; Shah, Kevan; Walde, Amy; Tran, Huan; Kovarcik, Don Paul; Clarke, Diana; Fellner, Thomas] Lonza Walkersville Inc, Walkersville, MD 21793 USA		Baghbaderani, BA (corresponding author), Lonza Walkersville Inc, Walkersville, MD 21793 USA.	behnam.ahmadianbaghbaderani@lonza.com		Shah, Kevan/0000-0002-6284-2030; Ahmadian Baghbaderani, Behnam/0000-0001-6033-625X				Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Baghbaderani B. A., 2015, BIOPROCESS INT, V13, P10; Baghbaderani BA, 2015, STEM CELL REP, V5, P647, DOI 10.1016/j.stemcr.2015.08.015; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Levenstein ME, 2008, STEM CELLS, V26, P3099, DOI 10.1634/stemcells.2007-1056; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Lotz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056289; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088012; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Rodin S, 2014, NAT PROTOC, V9, P2354, DOI 10.1038/nprot.2014.159; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier Ludovic, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01d04s4; Ward CM, 2004, EXP CELL RES, V293, P229, DOI 10.1016/j.yexcr.2003.10.017; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161229	10.1371/journal.pone.0161229	http://dx.doi.org/10.1371/journal.pone.0161229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606941	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600002
J	Benitez-Porres, J; Alvero-Cruz, JR; de Albornoz, MC; Correas-Gomez, L; Barrera-Exposito, J; Dorado-Guzman, M; Moore, JB; Carnero, EA				Benitez-Porres, Javier; Ramon Alvero-Cruz, Jose; Carrillo de Albornoz, Margarita; Correas-Gomez, Lorena; Barrera-Exposito, Jesus; Dorado-Guzman, Manuel; Moore, Justin B.; Carnero, Elvis A.			The Influence of 2-Year Changes in Physical Activity, Maturation, and Nutrition on Adiposity in Adolescent Youth	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; BIOLOGICAL MATURATION; SELF-PERCEPTIONS; SKELETAL AGE; MATURITY; VALIDATION; CHILDREN; DECLINE; GROWTH; GIRLS	The aim of this longitudinal study was to explore temporal patterns of physical activity (PA) and adiposity in Spanish adolescents. Eighty healthy adolescents were followed over a 2-year period (42 girls and 38 boys). A PA score was estimated using the Physical Activity Questionnaire for Adolescents (PAQ-A). Adiposity was assessed by anthropometric measurements; body mass index (BMI) and fat mass percent (FMP) were calculated using standard equations. Sexual maturity was estimated by percentage of predicted adult stature. Dietary intake was assessed by a self-administered food-frequency questionnaire. Three assessments were performed: September 2011 (S1), 2012 (S2), and 2013 (S3). A repeated-measures ANOVA was conducted to examine temporal changes in PA and FMP and sex change in maturation categories (two factor mixed-design, 2x2x3). A stepwise linear regression was conducted in order to estimate the predictors of FMP change. Significant changes for FMP were found between S1, S2, and S3 (23.41 +/- 8.24 vs. 21.89 +/- 7.82 vs. 22.05 +/- 8.06, p < 0.05; respectively); a significant interaction of FMP with sex was observed (F = 4.387, p < 0.05 for S2-S3), but not for maturation. PA at S2 was significantly higher than S3 (2.58 +/- 0.72 vs. 2.29 +/- 0.73, p < 0.001). An interaction between PA change and sex was statically significant (F = 4.889, p < 0.05 for S2-S3). A reduction in PA was observed after the S2 period without changes in adiposity. In contrast, a significant reduction in FMP was seen between S1 and S2, while PA did not significantly change. There were no significant differences for nutritional variables between S1 and S3, and nutrition was not a determinant of the changes in PA or FMP. Our results suggest that body composition changes observed during adolescence are not driven by changes in PA. Moreover, the interaction analysis suggests that PA behavior is affected by sex, but is not modified by maturation.	[Benitez-Porres, Javier; Correas-Gomez, Lorena; Barrera-Exposito, Jesus; Dorado-Guzman, Manuel; Carnero, Elvis A.] Univ Malaga, Biodynam & Body Composit Lab, Malaga, Spain; [Ramon Alvero-Cruz, Jose; Carrillo de Albornoz, Margarita] Univ Malaga, Exercise Physiol Lab, Malaga, Spain; [Moore, Justin B.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC USA; [Carnero, Elvis A.] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL USA	Universidad de Malaga; Universidad de Malaga; Wake Forest University; Adventist Health Services; AdventHealth	Benitez-Porres, J (corresponding author), Univ Malaga, Biodynam & Body Composit Lab, Malaga, Spain.	benitez@uma.es	Correas-Gómez, Lorena/F-8722-2015; Moore, Justin B/B-9357-2012; Benítez-Porres, Javier/R-5211-2019	Correas-Gómez, Lorena/0000-0002-1838-8993; Moore, Justin B/0000-0003-4059-0538; Benítez-Porres, Javier/0000-0001-7546-7965	Spanish Ministry of Education, Culture and Sport [AP2010-0583]; Spanish Ministry of Economy and Competitiveness [DEP2011-30565]	Spanish Ministry of Education, Culture and Sport(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by: JBP, AP2010-0583, Spanish Ministry of Education, Culture and Sport: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2012-14470; and EAC, DEP2011-30565, Spanish Ministry of Economy and Competitiveness: http://www.boe.es/diario_boe/txt.php?id=BOE-A-2012-1299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2007, CAN J PUBLIC HEALTH, V98, P97, DOI 10.1007/BF03404317; Bacil Eliane Denise Araújo, 2015, Rev. paul. pediatr., V33, P114, DOI 10.1016/j.rpped.2014.11.003; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Benefice E, 2001, AM J HUM BIOL, V13, P808, DOI 10.1002/ajhb.1126; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; COLE TJ, 1994, STAT MED, V13, P2477, DOI 10.1002/sim.4780132311; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Cumming SP, 2014, SCAND J MED SCI SPOR, V24, pe20, DOI 10.1111/sms.12103; Cumming SP, 2008, J ADOLESCENT HEALTH, V42, P480, DOI 10.1016/j.jadohealth.2007.10.005; Davison KK, 2007, SOC SCI MED, V64, P2391, DOI 10.1016/j.socscimed.2007.02.033; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Dumith SC, 2012, PUBLIC HEALTH NUTR, V15, P2237, DOI 10.1017/S1368980012000948; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Fawkner S, 2014, J SPORT SCI, V32, P392, DOI 10.1080/02640414.2013.825733; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Ham SA, 2007, MED SCI SPORT EXER, V39, P52, DOI 10.1249/01.mss.0000235886.17229.42; KHAMIS HJ, 1994, PEDIATRICS, V94, P504; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Knowles AM, 2009, J ADOLESCENCE, V32, P555, DOI 10.1016/j.adolescence.2008.06.001; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Malina RM, 2005, CLIN J SPORT MED, V15, P125, DOI 10.1097/01.jsm.0000164287.42066.63; Malina RM, 2007, CLIN J SPORT MED, V17, P362, DOI 10.1097/JSM.0b013e31815400f4; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Martinez-Gomez D, 2011, MED CLIN-BARCELONA, V136, P13, DOI 10.1016/j.medcli.2010.05.013; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Moore JB, 2014, AM J PREV MED, V46, P289, DOI 10.1016/j.amepre.2013.11.001; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sherar LB, 2007, MED SCI SPORT EXER, V39, P830, DOI 10.1249/mss.0b013e3180335c3c; Sherar LB, 2010, PEDIATR EXERC SCI, V22, P332, DOI 10.1123/pes.22.3.332; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Smart JEH, 2012, J PHYS ACT HEALTH, V9, P86, DOI 10.1123/jpah.9.1.86; Spruijt-Metz D, 2011, J RES ADOLESCENCE, V21, P129, DOI 10.1111/j.1532-7795.2010.00719.x; Staiano AE, 2013, AM J HUM BIOL, V25, P473, DOI 10.1002/ajhb.22380; Telama R, 2000, MED SCI SPORT EXER, V32, P1617; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Twisk JWR, 2002, INT J SPORTS MED, V23, pS44	43	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162395	10.1371/journal.pone.0162395	http://dx.doi.org/10.1371/journal.pone.0162395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27607063	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255600043
J	Wang, XZ; Tian, YS; Wang, HQ; Zhang, YB				Wang, Xingzheng; Tian, Yushi; Wang, Haoqian; Zhang, Yongbing			Stereo Matching by Filtering-Based Disparity Propagation	PLOS ONE			English	Article								Stereo matching is essential and fundamental in computer vision tasks. In this paper, a novel stereo matching algorithm based on disparity propagation using edge-aware filtering is proposed. By extracting disparity subsets for reliable points and customizing the cost volume, the initial disparity map is refined through filtering-based disparity propagation. Then, an edge-aware filter with low computational complexity is adopted to formulate the cost column, which makes the proposed method independent on the local window size. Experimental results demonstrate the effectiveness of the proposed scheme. Bad pixels in our output disparity map are considerably decreased. The proposed method greatly outperforms the adaptive support-weight approach and other conditional window-based local stereo matching algorithms.	[Wang, Xingzheng; Tian, Yushi; Wang, Haoqian; Zhang, Yongbing] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen, Peoples R China; [Wang, Xingzheng; Tian, Yushi; Wang, Haoqian; Zhang, Yongbing] Shenzhen Inst Future Media Technol, Shenzhen, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Wang, HQ (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen, Peoples R China.; Wang, HQ (corresponding author), Shenzhen Inst Future Media Technol, Shenzhen, Peoples R China.	wanghaoqian@tsinghua.edu.cn			National Natural Science Foundation of China [61471213, 61571259, 61531014]; Shenzhen Fundamental Research fund [JCYJ20140509172959961, JCYJ20160331185006518]; Natural Science Foundation of Guangdong Province [2015A030310173]; National High-tech RAMP;D Program of China (863 Program) [2015AA015901]; NSFC fund [61471213, 61571259, 61531014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research fund; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National High-tech RAMP;D Program of China (863 Program); NSFC fund(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Natural Science Foundation of China (61471213, 61571259, 61531014), Shenzhen Fundamental Research fund (JCYJ20140509172959961, JCYJ20160331185006518), Natural Science Foundation of Guangdong Province (2015A030310173) and National High-tech R&D Program of China (863 Program, 2015AA015901).r This work is partially supported by the NSFC fund (61471213, 61571259, 61531014), Shenzhen Fundamental Research fund (JCYJ20140509172959961, JCYJ20160331185006518), Natural Science Foundation of Guangdong Province(2015A030310173) and National High-tech R&D Program of China (863 Program, 2015AA015901)	Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; De-Maeztu L, 2011, PATTERN RECOGN LETT, V32, P1643, DOI 10.1016/j.patrec.2011.06.027; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; Huang Y, 2015, NEUROCOMPUTING, V149, P914, DOI 10.1016/j.neucom.2014.07.043; Klaus A, 2006, INT C PATT RECOG, P15; Kolmogorov V, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P508, DOI 10.1109/ICCV.2001.937668; Larsen ES, 2007, IEEE I CONF COMP VIS, P1440; Li LQ, 2015, AEU-INT J ELECTRON C, V69, P281, DOI 10.1016/j.aeue.2014.09.013; Li YS, 2016, MULTIMED TOOLS APPL, V75, P2487, DOI 10.1007/s11042-015-2637-y; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Luo X, 2015, KNOWL-BASED SYST, V90, P23, DOI 10.1016/j.knosys.2015.10.003; Montserrat T, 2009, IEEE IMAGE PROC, P2353, DOI 10.1109/ICIP.2009.5413610; Pan ZQ, 2015, IEEE T BROADCAST, V61, P166, DOI 10.1109/TBC.2015.2419824; Porikli F., 2008, P IEEE C COMP VIS PA, P1; Qian Y, 2009, IET COMPUT VIS, V3, P213, DOI 10.1049/iet-cvi.2009.0034; Ren YJ, 2015, J INTERNET TECHNOL, V16, P317, DOI 10.6138/JIT.2015.16.2.20140918; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Su Z, 2013, IEEE T MULTIMEDIA, V15, P535, DOI 10.1109/TMM.2012.2237025; Sun J, 2003, IEEE T PATTERN ANAL, V25, P787, DOI 10.1109/TPAMI.2003.1206509; Xia ZH, 2014, SECUR COMMUN NETW, V7, P1283, DOI 10.1002/sec.864; Yang QX, 2012, PROC CVPR IEEE, P1402, DOI 10.1109/CVPR.2012.6247827; Yang QX, 2009, PROC CVPR IEEE, P557, DOI 10.1109/CVPRW.2009.5206542; Yoon KJ, 2006, IEEE T PATTERN ANAL, V28, P650, DOI 10.1109/TPAMI.2006.70; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177	27	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162939	10.1371/journal.pone.0162939	http://dx.doi.org/10.1371/journal.pone.0162939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626800	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600066
J	Demmer, DL; Beilin, LJ; Hands, B; Burrows, S; Pennell, CE; Lye, SJ; Mountain, JA; Mori, TA				Demmer, Denise L.; Beilin, Lawrence J.; Hands, Beth; Burrows, Sally; Pennell, Craig E.; Lye, Stephen J.; Mountain, Jennifer A.; Mori, Trevor A.			Dual Energy X-Ray Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the 'Gold Standard' Tarnished?	PLOS ONE			English	Article							BODY-FAT; CARDIOVASCULAR-DISEASE; ABDOMINAL ADIPOSITY; WAIST CIRCUMFERENCE; OBESITY; PERCENTAGE; WOMEN; MEN; EPIDEMIOLOGY; ASSOCIATION	Background and Aims Assessment of adiposity using dual energy x-ray absorptiometry (DXA) has been considered more advantageous in comparison to anthropometry for predicting cardio-metabolic risk in the older population, by virtue of its ability to distinguish total and regional fat. Nonetheless, there is increasing uncertainty regarding the relative superiority of DXA and little comparative data exist in young adults. This study aimed to identify which measure of adiposity determined by either DXA or anthropometry is optimal within a range of cardio-metabolic risk factors in young adults. Methods and Results 1138 adults aged 20 years were assessed by DXA and standard anthropometry from the Western Australian Pregnancy Cohort (Raine) Study. Cross-sectional linear regression analyses were performed. Waist to height ratio was superior to any DXA measure with HDL-C. BMI was the superior model in relation to blood pressure than any DXA measure. Midriff fat mass (DXA) and waist circumference were comparable in relation to glucose. For all the other cardio-metabolic variables, anthropometric and DXA measures were comparable. DXA midriff fat mass compared with BMI or waist hip ratio was the superior measure for triglycerides, insulin and HOMA-IR. Conclusion Although midriff fat mass (measured by DXA) was the superior measure with insulin sensitivity and triglycerides, the anthropometric measures were better or equal with various DXA measures for majority of the cardio-metabolic risk factors. Our findings suggest, clinical anthropometry is generally as useful as DXA in the evaluation of the individual cardio-metabolic risk factors in young adults.	[Demmer, Denise L.; Beilin, Lawrence J.; Burrows, Sally; Mori, Trevor A.] Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, Perth, WA, Australia; [Hands, Beth] Univ Notre Dame Australia, Inst Hlth Res, Perth, WA, Australia; [Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Lye, Stephen J.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Mountain, Jennifer A.] Univ Western Australia, Sch Populat Hlth, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; University of Notre Dame Australia; University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia	Demmer, DL (corresponding author), Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, Perth, WA, Australia.	denise.demmer@uwa.edu.au	Mori, Trevor/H-5485-2014; Hands, Beth/W-1379-2019; Pennell, Craig/ABD-6902-2020; Lye, Stephen J/E-7269-2013	Mori, Trevor/0000-0002-5264-9229; Pennell, Craig/0000-0002-0937-6165; Lye, Stephen J/0000-0002-3305-4406; Demmer, Denise/0000-0003-0751-7304	Canadian Institutes for Health Research [MOP 82893]; Australian National Health and Medical Research Council; Lions Eye Institute in Western Australia; Australian Foundation for the Prevention of Blindness; Alcon Research Institute	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Lions Eye Institute in Western Australia; Australian Foundation for the Prevention of Blindness; Alcon Research Institute(Novartis)	DXA scanning was funded by Canadian Institutes for Health Research (Grant MOP 82893). The Raine Study 20 year follow up assessment was funded by project grants from the Australian National Health and Medical Research Council, the Lions Eye Institute in Western Australia, Australian Foundation for the Prevention of Blindness and the Alcon Research Institute. Core management of the Raine study is provided by the Raine Medical Research Foundation; The University of Western Australia (UWA); the Telethon Kids Institute; the UWA Faculty of Medicine, Dentistry and Health Sciences; the Women and Infants Research Foundation and Curtin University.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Celi M, 2013, AGING CLIN EXP RES, V25, pS47, DOI 10.1007/s40520-013-0074-1; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cui Zhaohui, 2013, Int J Body Compos Res, V11, P85; de Mutsert R, 2014, AM J EPIDEMIOL, V179, P1353, DOI 10.1093/aje/kwu052; Duren Dana L, 2008, J Diabetes Sci Technol, V2, P1139; Elisha B, 2013, EUR J NUTR, V52, P145, DOI 10.1007/s00394-011-0296-y; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Freedman DS, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0493-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garvey WT, 2014, ENDOCR PRACT, V20, P977, DOI 10.4158/EP14280.PS; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Huang RC, 2011, DIABETES CARE, V34, P1019, DOI 10.2337/dc10-1809; Ito H, 2003, INT J OBESITY, V27, P232, DOI 10.1038/sj.ijo.802226; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Krachler B, 2013, J OBESITY, V2013, P14; Laster Andrew J, 2014, N C Med J, V75, P132; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McTigue KM, 2006, OBESITY, V14, P1485, DOI 10.1038/oby.2006.171; Muller HP, 2011, NMR BIOMED, V24, P17, DOI 10.1002/nbm.1549; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Pasco JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029580; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Shiga T., 2009, World Congress on Medical Physics and Biomedical Engineering. World Congress 2009. Diagnostic and Therapeutic Instrumentation, Clinical Engineering, P338, DOI 10.1007/978-3-642-03885-3_94; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Washington State Health Care Authority, 2014, SCREEN MON TESTS OST; World Health Organization,, 2015, OB OV; Zhang J, 2012, J BONE MINER RES, V27, P858, DOI 10.1002/jbmr.1534	36	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162164	10.1371/journal.pone.0162164	http://dx.doi.org/10.1371/journal.pone.0162164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622523	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000014
J	Duan, A; Bedggood, PA; Bui, BV; Metha, AB				Duan, Angelina; Bedggood, Phillip A.; Bui, Bang V.; Metha, Andrew B.			Evidence of Flicker-Induced Functional Hyperaemia in the Smallest Vessels of the Human Retinal Blood Supply	PLOS ONE			English	Article							OXYGEN-TENSION; INDUCED VASODILATATION; CAPILLARY PERICYTES; CARDIAC CYCLE; IN-VIVO; FLOW; DIAMETER; BRAIN; HETEROGENEITY; PRESSURE	Regional changes in blood flow are initiated within neural tissue to help fuel local differences in neural activity. Classically, this response was thought to arise only in larger arterioles and venules. However, recently, it has been proposed that a) the smallest vessels of the circulation make a comparable contribution, and b) the response should be localised intermittently along such vessels, due to the known distribution of contractile mural cells. To assess these hypotheses in human neural tissue in vivo, we imaged the retinal microvasculature (diameters 3-28 mu m) non-invasively, using adaptive optics, before and after delivery of focal (360 mu m) patches of flickering visible light. Our results demonstrated a definite average response in 35% of all vessel segments analysed. In these responding vessels, the magnitude of proportional dilation (mean +/- SEM for pre-capillary arterioles 13 +/- 5%, capillaries 31 +/- 8%, and post-capillary venules 10 +/- 3%) is generally far greater than the magnitudes we and others have measured in the larger retinal vessels, supporting proposition a) above. The dilations observed in venules were unexpected based on previous animal work, and may be attributed either to differences in stimulus or species. Response heterogeneity across the network was high; responses were also heterogeneous along individual vessels (45% of vessel segments showed demonstrable locality in their response). These observations support proposition b) above. We also observed a definite average constriction across 7% of vessel segments (mean +/- SEM constriction for capillaries -16 +/- 3.2%, and post-capillary venules -18 +/- 12%), which paints a picture of dynamic redistribution of flow throughout the smallest vessel networks in the retina in response to local, stimulus-driven metabolic demand.	[Duan, Angelina; Bedggood, Phillip A.; Bui, Bang V.; Metha, Andrew B.] Univ Melbourne, Dept Optometryand Vis Sci, Parkville, Vic, Australia	University of Melbourne	Metha, AB (corresponding author), Univ Melbourne, Dept Optometryand Vis Sci, Parkville, Vic, Australia.	ametha@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Duan, Angelina/Y-5284-2019; Metha, Andrew/H-2401-2015	Bui, Bang/0000-0001-7298-1352; Duan, Angelina/0000-0002-6221-5782; Metha, Andrew/0000-0003-2997-4362; Bedggood, Phillip/0000-0001-5144-3694	Australian Research Council (ARC) Discovery Early Career Researcher Award [DE120101931]; ARC Future Fellowship Award [FT130100388]; ARC Discovery Project Grant [DP0984649]; Australian Postgraduate Award from the Australian Government; A.E. Rowden White Foundation benevolent bequest; Melbourne Neuroscience Institute (MNI) Interdisciplinary Seed Fund award from the University of Melbourne	Australian Research Council (ARC) Discovery Early Career Researcher Award(Australian Research Council); ARC Future Fellowship Award(Australian Research Council); ARC Discovery Project Grant(Australian Research Council); Australian Postgraduate Award from the Australian Government(Australian Research CouncilAustralian Government); A.E. Rowden White Foundation benevolent bequest; Melbourne Neuroscience Institute (MNI) Interdisciplinary Seed Fund award from the University of Melbourne	This research was supported by: an Australian Research Council (ARC) Discovery Early Career Researcher Award (DE120101931); an ARC Future Fellowship Award (FT130100388); an ARC Discovery Project Grant (DP0984649), an Australian Postgraduate Award from the Australian Government; an A.E. Rowden White Foundation benevolent bequest, and a Melbourne Neuroscience Institute (MNI) Interdisciplinary Seed Fund award from the University of Melbourne.	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bedggood P, 2014, OPT LETT, V39, P610, DOI 10.1364/OL.39.000610; Bedggood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079251; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; BRAUN RD, 1992, MICROVASC RES, V44, P73, DOI 10.1016/0026-2862(92)90103-V; CANHAM PB, 1968, CIRC RES, V22, P405, DOI 10.1161/01.RES.22.3.405; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chan G, 2012, INVEST OPHTH VIS SCI, V53, P5502, DOI 10.1167/iovs.12-10265; CHEN HC, 1994, EYE, V8, P97, DOI 10.1038/eye.1994.19; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fischer MJM, 2010, MICROVASC RES, V80, P258, DOI 10.1016/j.mvr.2010.04.004; Formaz F, 1997, CURR EYE RES, V16, P1252, DOI 10.1076/ceyr.16.12.1252.5021; Garhofer G, 2004, J GLAUCOMA, V13, P340, DOI 10.1097/00061198-200408000-00013; Garhofer G, 2004, VISION RES, V44, P833, DOI 10.1016/j.visres.2003.11.013; Garhofer G, 2003, INVEST OPHTH VIS SCI, V44, P5309, DOI 10.1167/iovs.03-0587; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hao H, 2012, INVEST OPHTH VIS SCI, V53, P5799, DOI 10.1167/iovs.11-9326; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Humer MF, 1996, J APPL PHYSIOL, V81, P895, DOI 10.1152/jappl.1996.81.2.895; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; Mishra A, 2014, NAT PROTOC, V9, P323, DOI 10.1038/nprot.2014.019; Nagel E, 2004, INVEST OPHTH VIS SCI, V45, P1486, DOI 10.1167/iovs.03-0667; Newman EA, 2013, J CEREBR BLOOD F MET, V33, P1685, DOI 10.1038/jcbfm.2013.145; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Palkovits S, 2014, J CEREBR BLOOD F MET, V34, P1914, DOI 10.1038/jcbfm.2014.161; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Polak K, 2002, INVEST OPHTH VIS SCI, V43, P2721; Pournaras CJ, 2013, OPHTHALMOLOGICA, V229, P61, DOI 10.1159/000338186; RIVA CE, 1986, INVEST OPHTH VIS SCI, V27, P1706; Roy C S, 1890, J Physiol, V11, P85; Schallek J, 2013, INVEST OPHTH VIS SCI, V54, P8237, DOI 10.1167/iovs.13-12581; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; Seifertl B U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P678, DOI 10.1515/bmte.2002.47.s1b.678; SIMS DE, 1986, TISSUE CELL, V18, P153, DOI 10.1016/0040-8166(86)90026-1; SKALAK R, 1969, SCIENCE, V164, P717, DOI 10.1126/science.164.3880.717; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Terai N, 2012, ACTA OPHTHALMOL, V90, pE524, DOI 10.1111/j.1755-3768.2012.02486.x	44	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162621	10.1371/journal.pone.0162621	http://dx.doi.org/10.1371/journal.pone.0162621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617960	gold, Green Published			2022-12-27	WOS:000383653100033
J	Ritz, L; Coulbault, L; Lannuzel, C; Boudehent, C; Segobin, S; Eustache, F; Vabret, F; Pitel, AL; Beaunieux, H				Ritz, Ludivine; Coulbault, Laurent; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene			Clinical and Biological Risk Factors for Neuropsychological Impairment in Alcohol Use Disorder	PLOS ONE			English	Article							BRAIN-DAMAGE; WERNICKES ENCEPHALOPATHY; COGNITIVE PERFORMANCE; PHOSPHATE-ESTERS; LIVER FIBROSIS; SCREENING TOOL; THIAMINE; DEFICITS; MEMORY; BLOOD	The effects of alcoholism on cognitive and motor functioning are heterogeneous. While the role of some factors (patterns of alcohol consumption, eating habits or associated liver disease) has been hypothesized, the origins of this heterogeneity remain difficult to establish. The goals of the present study were thus to identify the clinical and biological risk factors for alcohol-related neuropsychological impairments and to determine the threshold beyond which these risk factors can be considered significant. Thirty alcoholic patients and 15 healthy controls had a blood test and underwent a neuropsychological examination. Alcohol severity measures, and liver, thiamine and malnutrition variables, were included in logistic regression models to determine the risk factors for cognitive and motor impairments (executive functions, visuospatial abilities, verbal episodic memory, ataxia), as well as those related to the severity of patients' overall neuropsychological profile (moderate or severe impairments). Liver fibrosis was found to be a risk factor for executive impairments and also for ataxia, when it was associated with long-termalcohol misuse and symptoms of withdrawal. Altered thiamine metabolism was solely predictive of verbal episodic memory impairments. This combination of biological abnormalities was associated with a profile of moderate neuropsychological impairments. Malnutrition was associated with a profile of more severe impairments. Malnutrition, altered liver function and thiamine metabolism explain, at least partially, the heterogeneity of alcohol-related neuropsychological impairments. Our findings could allow clinicians to identify patients at particular risk of severe neuropsychological impairments before the onset of irreversible and debilitating neurological complications.	[Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] INSERM, U1077, Caen, France; [Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] Univ Caen Normandie, UMR S1077, Caen, France; [Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] Ecole Prat Hautes Etud, UMR S1077, Caen, France; [Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] Ctr Hosp Univ, U1077, Caen, France; [Boudehent, Celine; Vabret, Francois] Ctr Hosp Univ, Serv Addictol, Caen, France; [Coulbault, Laurent] Ctr Hosp Univ, Lab Biochim, Caen, France; [Coulbault, Laurent] Univ Caen Normandie, Lab EA4650, Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; Universite de Caen Normandie	Beaunieux, H (corresponding author), INSERM, U1077, Caen, France.; Beaunieux, H (corresponding author), Univ Caen Normandie, UMR S1077, Caen, France.; Beaunieux, H (corresponding author), Ecole Prat Hautes Etud, UMR S1077, Caen, France.; Beaunieux, H (corresponding author), Ctr Hosp Univ, U1077, Caen, France.	helene.beaunieux@unicaen.fr	Eustache, Francis/J-9465-2015; Ritz, Ludivine/AAL-4269-2020	Eustache, Francis/0000-0003-4460-8686; BEAUNIEUX, HELENE/0000-0003-1354-6558; PITEL, Anne Lise/0000-0001-8573-9506; Segobin, Shailendra/0000-0003-1977-8210	French National Institute for Health and Medical Research (INSERM); French National Agency for Research (ANR); Postdoc Return (Retour Post-Doctorants, PDOC) program; Lower Normandy Regional Council; Mission Interministerielle de Lutte contre les Drogues Et les Conduites Addictives (MILDECA)	French National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Agency for Research (ANR)(French National Research Agency (ANR)); Postdoc Return (Retour Post-Doctorants, PDOC) program; Lower Normandy Regional Council; Mission Interministerielle de Lutte contre les Drogues Et les Conduites Addictives (MILDECA)	This work was supported by the French National Institute for Health and Medical Research (INSERM), the French National Agency for Research (ANR), the Postdoc Return (Retour Post-Doctorants, PDOC) program, Lower Normandy Regional Council, and the Mission Interministerielle de Lutte contre les Drogues Et les Conduites Addictives (MILDECA).	ARRIA AM, 1991, ALCOHOL CLIN EXP RES, V15, P932, DOI 10.1111/j.1530-0277.1991.tb05192.x; Beatty WW, 2000, ALCOHOL CLIN EXP RES, V24, P149, DOI 10.1097/00000374-200002000-00003; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Caine D, 1997, J NEUROL NEUROSUR PS, V62, P51, DOI 10.1136/jnnp.62.1.51; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Ceccanti M, 2005, ALCOHOL ALCOHOLISM, V40, P283, DOI 10.1093/alcalc/agh162; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V105, P1; CUSHMAN P, 1985, ALCOHOL CLIN EXP RES, V9, P103, DOI 10.1111/j.1530-0277.1985.tb05527.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; der Collectif Linden MV, 2004, EVALUATION TROUBLES; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox AM, 2000, ALCOHOL ALCOHOLISM, V35, P52, DOI 10.1093/alcalc/35.1.52; Fregly AR, 1971, DTIC DOCUMENT; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Grefex G. O., 2008, FONCTIONS EXECUTIVES; Harper C, 2006, EUR J NEUROL, V13, P1078, DOI 10.1111/j.1468-1331.2006.01530.x; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HERVE C, 1995, CLIN CHIM ACTA, V234, P91, DOI 10.1016/0009-8981(94)05980-7; Ihara H, 2000, J NEUROL NEUROSUR PS, V68, P731, DOI 10.1136/jnnp.68.6.731; Junghanns K, 2004, ALCOHOL ALCOHOLISM, V39, P113, DOI 10.1093/alcalc/agh028; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Losa R, 2005, J PHARMACEUT BIOMED, V37, P1025, DOI 10.1016/j.jpba.2004.08.038; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Mancinelli R, 2009, ALCOHOL ALCOHOLISM, V44, P177, DOI 10.1093/alcalc/agn117; MOLINA JA, 1994, ACTA NEUROL SCAND, V89, P384; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; O'Mahony JF, 2005, ADDICT BEHAV, V30, P369, DOI 10.1016/j.addbeh.2004.05.008; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pfefferbaum A, 2004, AM J PSYCHIAT, V161, P1190, DOI 10.1176/appi.ajp.161.7.1190; Pitel AL, 2011, NEUROPSYCHOPHARMACOL, V36, P580, DOI 10.1038/npp.2010.189; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Ritz L, 2015, ALCOHOL CLIN EXP RES, V39, P2249, DOI 10.1111/acer.12888; RYBACK RS, 1971, Q J STUD ALCOHOL, V32, P995; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan EV, 2000, ALCOHOL CLIN EXP RES, V24, P611, DOI 10.1097/00000374-200005000-00005; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; TALLAKSEN CME, 1992, ALCOHOL CLIN EXP RES, V16, P320, DOI 10.1111/j.1530-0277.1992.tb01384.x; Thomson A D, 2000, Alcohol Alcohol Suppl, V35, P2; Tsai GC, 1998, ANNU REV MED, V49, P173; Wechsler D, 2001, MEM 3 ECHELLE CLIN M; Wetterling T, 1998, ALCOHOL ALCOHOLISM, V33, P424; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62	50	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0159616	10.1371/journal.pone.0159616	http://dx.doi.org/10.1371/journal.pone.0159616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617840	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100002
J	Chi, A; Wen, SJ; Monga, M; Almubarak, M; He, XQ; Rojanasakul, Y; Tse, W; Remick, SC				Chi, Alexander; Wen, Sijin; Monga, Manish; Almubarak, Mohammed; He, Xiaoqing; Rojanasakul, Yon; Tse, William; Remick, Scot C.			Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TUMOR-CONTROL; RADIATION; CONCURRENT; EXPERIENCE; TOXICITY; TRIAL	Background Image-guided (IG) intensity-modulated radiotherapy (IMRT) enables maximal tumor margin reduction for the sparing of organs at risk (OARs) when used to treat locally advanced non-small cell lung cancer (NSCLC) with definitive chemo-radiation. It also allows for the incorporation of stereotactic ablative radiotherapy (SABR) into the treatment regimen. Here, we describe our initial experience in combining definitive upfront SABR to the primary lesion with chemo-radiation delivered with conventionally fractionated IG-IMRT to the remaining regional disease; along with clinical outcome following chemo-radiation with conventionally fractionated IG-IMRT alone in the treatment of locally advanced NSCLC. Methods The clinical outcome of 29 patients with locally advanced NSCLC who underwent conventionally fractionated IG-IMRT, or definitive upfront SABR followed by IG-IMRT combined with chemotherapy (induction, concurrent, or both) was retrospectively reviewed. Results After a median follow up of 23.7 months, the median overall survival (OS) and progression-free survival (PFS) were 19.8 and 11.3 months, respectively. The 2 year local, regional, and distant control was 60%, 62%, and 38%, respectively. No local failure was observed in 3 patients following SABR + IG-IMRT while 6/26 patients failed locally following IG-IMRT alone. SABR + IG-IMRT was well tolerated. No >= grade 3 radiation-related toxicity was observed. Conclusion Definitive upfront SABR followed by IG-IMRT in selected patients with locally advanced NSCLC warrants further investigation in future clinical trials, while chemo-radiation with IG-IMRT alone was well tolerated.	[Chi, Alexander] West Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Wen, Sijin] West Virginia Univ, Sch Publ Hlth, Dept Biostat, Morgantown, WV 26506 USA; [Monga, Manish] Bristol Meyers Squibb, Oncol, Princeton, NJ USA; [Almubarak, Mohammed; Remick, Scot C.] West Virginia Univ, Mary Babb Randolph Canc Ctr, Div Hematol & Oncol, Morgantown, WV 26506 USA; [He, Xiaoqing; Rojanasakul, Yon] West Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; [Tse, William] Univ Louisville, James Graham Brown Canc Ctr, Dept Hematol, Louisville, KY 40292 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; University of Louisville	Chi, A (corresponding author), West Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	achiaz2010@gmail.com		Wen, Sijin/0000-0002-6955-2917	NIGMS NIH HHS [U54 GM104942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Ball D, 2013, J THORAC ONCOL, V8, P315, DOI 10.1097/JTO.0b013e31827dc74d; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Bral S, 2010, INT J RADIAT ONCOL, V77, P1352, DOI 10.1016/j.ijrobp.2009.06.075; Cannon DM, 2013, J CLIN ONCOL, V31, P4343, DOI 10.1200/JCO.2013.51.5353; Chi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00151; Chi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00156; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Donato V, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00286; Fowler JF, 2004, INT J RADIAT ONCOL, V60, P1241, DOI 10.1016/j.ijrobp.2004.07.691; Guckenberger M, 2012, STRAHLENTHER ONKOL, V188, P894, DOI 10.1007/s00066-012-0161-9; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Jiang ZQ, 2012, INT J RADIAT ONCOL, V83, P332, DOI 10.1016/j.ijrobp.2011.06.1963; Kong FM, 2005, INT J RADIAT ONCOL, V63, P324, DOI 10.1016/j.ijrobp.2005.02.010; Liao ZXX, 2010, INT J RADIAT ONCOL, V76, P775, DOI 10.1016/j.ijrobp.2009.02.032; Meng DQ, 2013, LUNG CANCER, V81, P1, DOI 10.1016/j.lungcan.2013.03.019; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Soliman M, 2013, RADIOTHER ONCOL, V106, P299, DOI 10.1016/j.radonc.2012.12.008; Sura S, 2008, RADIOTHER ONCOL, V87, P17, DOI 10.1016/j.radonc.2008.02.005; Toulany M, 2007, MOL CANCER RES, V5, P863, DOI 10.1158/1541-7786.MCR-06-0297; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162453	10.1371/journal.pone.0162453	http://dx.doi.org/10.1371/journal.pone.0162453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611833	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900102
J	Duprey-Diaz, MV; Blagburn, JM; Blanco, RE				Duprey-Diaz, Mildred V.; Blagburn, Jonathan M.; Blanco, Rosa E.			Exogenous Modulation of Retinoic Acid Signaling Affects Adult RGC Survival in the Frog Visual System after Optic Nerve Injury	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; MIDBRAIN DOPAMINERGIC-NEURONS; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR-2; GANGLION-CELL DEATH; RANA-PIPIENS; UP-REGULATION; SPINAL-CORD; X-RECEPTOR; INTRACEREBRAL HEMORRHAGE	After lesions to the mammalian optic nerve, the great majority of retinal ganglion cells (RGCs) die before their axons have even had a chance to regenerate. Frog RGCs, on the other hand, suffer only an approximately 50% cell loss, and we have previously investigated the mechanisms by which the application of growth factors can increase their survival rate. Retinoic acid (RA) is a vitamin A-derived lipophilic molecule that plays major roles during development of the nervous system. The RA signaling pathway is also present in parts of the adult nervous system, and components of it are upregulated after injury in peripheral nerves but not in the CNS. Here we investigate whether RA signaling affects long-term RGC survival at 6 weeks after axotomy. Intraocular injection of all-trans retinoic acid (ATRA), the retinoic acid receptor (RAR) type-alpha agonist AM80, the RAR beta agonist CD2314, or the RAR. agonist CD1530, returned axotomized RGC numbers to almost normal levels. On the other hand, inhibition of RA synthesis with disulfiram, or of RAR receptors with the pan-RAR antagonist Ro-41-5253, or the RAR beta antagonist LE135E, greatly reduced the survival of the axotomized neurons. Axotomy elicited a strong activation of the MAPK, STAT3 and AKT pathways; this activation was prevented by disulfiram or by RAR antagonists. Finally, addition of exogenous ATRA stimulated the activation of the first two of these pathways. Future experiments will investigate whether these strong survival-promoting effects of RA are mediated via the upregulation of neurotrophins.	[Duprey-Diaz, Mildred V.; Blanco, Rosa E.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Duprey-Diaz, Mildred V.; Blagburn, Jonathan M.; Blanco, Rosa E.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Blanco, RE (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.; Blanco, RE (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	rosa.blanco@upr.edu		Blagburn, Jonathan/0000-0002-7681-2764	NIGMS grant [GM116692, GM061838]; NINDS grant [NS081726]; NSF [DBI 0115825]; DoD [52680-RT-ISP]; NIMHD [G12 MD007600]; NIH [GM116692, NS081726, NIGMS GM061838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, SC3GM116692, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS081726] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIGMS grant; NINDS grant; NSF(National Science Foundation (NSF)); DoD(United States Department of Defense); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIGMS grant GM116692 to REB and NINDS grant NS081726 to JMB. MVD was supported in part by NIGMS grant GM061838 and a teaching assistantship from the University of Puerto Rico Medical Sciences Campus. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; REB is supported by NIH grant GM116692, JMB by NIH grant NS081726. MVD was supported by NIH grant NIGMS GM061838 and a teaching assistantship from the University of Puerto Rico Medical Sciences Campus. The Institute confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (Research Centers for Minority Institutions). We also want to thank Dr. Maria Sosa and Dr. Jorge Miranda for valuable comments on the manuscript.	Agudo M, 2010, NEUROBIOL DIS, V37, P147, DOI 10.1016/j.nbd.2009.09.018; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Arrieta O, 2005, EUR J CLIN INVEST, V35, P201, DOI 10.1111/j.1365-2362.2005.01467.x; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BEAZLEY LD, 1986, VISION RES, V26, P543, DOI 10.1016/0042-6989(86)90003-9; Blanco RE, 2000, J COMP NEUROL, V423, P646; Blanco RE, 2008, J NEUROSCI RES, V86, P3382, DOI 10.1002/jnr.21793; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen L, 2014, NEUROPHARMACOLOGY, V78, P3, DOI 10.1016/j.neuropharm.2012.12.004; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chung JJ, 2000, MOL BRAIN RES, V83, P52, DOI 10.1016/S0169-328X(00)00196-0; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Denisenko-Nehrbass NI, 2001, MOL BRAIN RES, V87, P246, DOI 10.1016/S0169-328X(01)00002-X; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Driscoll WJ, 1999, MOL PHARMACOL, V55, P1067, DOI 10.1124/mol.55.6.1067; Duprey-Diaz MV, 2016, J CHEM NEUROANAT, V77, P80, DOI 10.1016/j.jchemneu.2016.05.008; Duprey-Diaz MV, 2012, J CHEM NEUROANAT, V46, P35, DOI 10.1016/j.jchemneu.2012.08.003; Duprey-Diaz MV, 2002, J COMP NEUROL, V454, P456, DOI 10.1002/cne.10451; Esteves M, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00020; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Ferrari N, 1998, MOL CELL BIOL, V18, P6482, DOI 10.1128/MCB.18.11.6482; Goncalves MB, 2015, J NEUROSCI, V35, P15731, DOI 10.1523/JNEUROSCI.1339-15.2015; Goodman T, 2012, HIPPOCAMPUS, V22, P2171, DOI 10.1002/hipo.22037; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; Hernandez-Pedro N, 2008, TRANSL RES, V152, P31, DOI 10.1016/j.trsl.2008.05.007; Hou NL, 2015, MOL NEUROBIOL, V51, P633, DOI 10.1007/s12035-014-8741-6; HUMPHREY MF, 1987, J COMP NEUROL, V266, P209, DOI 10.1002/cne.902660207; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Janesick A, 2014, DEVELOPMENT, V141, P2260, DOI 10.1242/dev.103705; Jarvis CI, 2010, EUR J NEUROSCI, V32, P1246, DOI 10.1111/j.1460-9568.2010.07426.x; Jiang W, 2012, J NEUROCHEM, V121, P932, DOI 10.1111/j.1471-4159.2012.07697.x; Jokic N, 2007, J NEUROCHEM, V103, P1821, DOI 10.1111/j.1471-4159.2007.04893.x; Kagechika H, 2002, CURR MED CHEM, V9, P591, DOI 10.2174/0929867024606975; Kampmann E, 2007, NEUROSCI LETT, V426, P18, DOI 10.1016/j.neulet.2007.07.039; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Katsuki H, 2009, J NEUROCHEM, V110, P707, DOI 10.1111/j.1471-4159.2009.06171.x; Kawahara K, 2014, J ALZHEIMERS DIS, V42, P587, DOI 10.3233/JAD-132720; Kharasch ED, 1999, DRUG METAB DISPOS, V27, P717; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kolarcik Christi L, 2012, Am J Neurodegener Dis, V1, P130; Kurauchi Y, 2011, J NEUROCHEM, V116, P323, DOI 10.1111/j.1471-4159.2010.06916.x; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Levin LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P488, DOI 10.1001/archopht.1996.01100130484027; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matsushita H, 2014, J NEUROSCI RES, V92, P1024, DOI 10.1002/jnr.23379; Matsushita H, 2011, J CEREBR BLOOD F MET, V31, P222, DOI 10.1038/jcbfm.2010.80; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; McCaffery P, 1999, MECH DEVELOP, V85, P201; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Mills KJ, 1996, CELL GROWTH DIFFER, V7, P327; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Ningaraj NS, 2001, J BIOMED SCI, V8, P104; Nishikiori N, 2008, CLIN OPHTHALMOL, V2, P233; Oztokatli H, 2012, FASEB J, V26, P617, DOI 10.1096/fj.11-192450; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Qi XR, 2015, CEREB CORTEX, V25, P75, DOI 10.1093/cercor/bht203; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ransom J, 2014, J NEUROCHEM, V129, P366, DOI 10.1111/jnc.12620; Rios-Munoz W, 2005, J NEUROCHEM, V93, P1422, DOI 10.1111/j.1471-4159.2005.03129.x; Ruhl R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005213; Sakamoto K, 2010, EUR J PHARMACOL, V635, P56, DOI 10.1016/j.ejphar.2010.03.001; SCALIA F, 1985, BRAIN RES, V344, P267, DOI 10.1016/0006-8993(85)90804-2; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Shinozaki Y, 2007, NEUROSCIENCE, V147, P153, DOI 10.1016/j.neuroscience.2007.04.032; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Soto I, 2003, J NEUROSCI RES, V73, P507, DOI 10.1002/jnr.10673; Soto I, 2006, BRAIN RES, V1103, P65, DOI 10.1016/j.brainres.2006.05.062; Stoney P.N., 2015, BRAIN STRUCT FUNCT; Takenaga M, 2009, BIOL PHARM BULL, V32, P225, DOI 10.1248/bpb.32.225; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Thompson Haskell Gloria, 2002, J Comp Neurol, V452, P228; Umemiya H, 1997, BIOCHEM BIOPH RES CO, V233, P121, DOI 10.1006/bbrc.1997.6414; Vega-Melendez GS, 2014, J NEUROSCI RES, V92, P13, DOI 10.1002/jnr.23303; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; VONHOLST A, 1995, MOL CELL NEUROSCI, V6, P185; Wang X, 1998, NEUROSCI LETT, V240, P9, DOI 10.1016/S0304-3940(97)00927-0; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x	92	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162626	10.1371/journal.pone.0162626	http://dx.doi.org/10.1371/journal.pone.0162626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611191	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900135
J	Magnussen, B; Gradel, KO; Jensen, TG; Kolmos, HJ; Pedersen, C; Vinholt, PJ; Lassen, AT				Magnussen, Bjarne; Gradel, Kim Oren; Jensen, Thoger Gorm; Kolmos, Hans Jorn; Pedersen, Court; Vinholt, Pernille Just; Lassen, Annmarie Touborg			Association between Hypoalbuminaemia and Mortality in Patients with Community-Acquired Bacteraemia Is Primarily Related to Acute Disorders	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM-ALBUMIN; ORGAN FAILURE; SEVERE SEPSIS; INFLAMMATION; DISEASE; INTERLEUKIN-6; MALNUTRITION; MORBIDITY; ILLNESS	We sought to investigate whether hypoalbuminaemia was mainly caused by acute or chronic factors in patients with community-acquired bacteraemia. In this population-based study, we considered 1844 adult cases of community-acquired bacteraemia that occurred in Funen, Denmark between 2000 and 2008. We used a stepwise prognostic predisposition-insult-response-organ dysfunction (PIRO) logistic regression model by initially including age and comorbidity, then added bacterial species, and finally sepsis severity. The models were furthermoreanalysed using receiver operating characteristic (ROC) curves. Outcomes comprised mortality incidence on days 0-30 and 31-365 after the bacteraemia episode. Each step was performed with and without baseline albumin level measured on the date of bacteraemia. In 422 patients, their latest albumin measurement taken 8-30 days before the date of bacteraemia was also used in the analysis together with the baseline albumin level. For each decrease of 1g/L in plasma albumin level, the odds ratios (95% confidence intervals) of mortality in the period of 0-30 days after bacteraemia were 0.86 (0.84-0.88) in both predisposition (P) and predisposition-insult (PI) models and 0.87 (0.85-0.89) in the full PIRO-model. The AUC values were 0.78 and 0.66 for mortality in the period of 0-30 days in the model comprising only predisposition factors with and without albumin levels added as a factor, respectively. The AUC values in the full PIRO-model were 0.81 and 0.73 with and without consideration of albumin levels, respectively. A higher proportion of patients died within 30 days if there was a decrease in the albumin level between days 8 and 30 before bacteraemia and the actual bacteraemia date. A single plasma albumin measurement on the bacteraemia date was a better prognostic predictor of short-termmortality than the sepsis severity score.	[Magnussen, Bjarne; Gradel, Kim Oren] Odense Univ Hosp, Ctr Clin Epidemiol, South, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark; [Magnussen, Bjarne; Gradel, Kim Oren] Univ Southern Denmark, Inst Clin Res, Res Unit Clin Epidemiol, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark; [Jensen, Thoger Gorm; Kolmos, Hans Jorn] Odense Univ Hosp, Dept Clin Microbiol, JB Winsloews Vej 21,2nd Floor, DK-5000 Odense C, Denmark; [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, Sdr Blvd 29,Entrance 20, DK-5000 Odense C, Denmark; [Vinholt, Pernille Just] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Sdr Blvd 29,Entrance 40, DK-5000 Odense, Denmark; [Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, Klovervaenget 25,Entrance 63-65, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Magnussen, B (corresponding author), Odense Univ Hosp, Ctr Clin Epidemiol, South, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark.; Magnussen, B (corresponding author), Univ Southern Denmark, Inst Clin Res, Res Unit Clin Epidemiol, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark.	bjarne.magnussen@rsyd.dk	Gradel, Kim/AAC-6171-2019; Lassen, Annmarie/AAA-5816-2019	Gradel, Kim/0000-0002-5611-2031; Just Vinholt, Pernille/0000-0002-2035-0169; Magnussen, Bjarne/0000-0001-5553-020X; Jensen, Thoger Gorm/0000-0002-3889-0016; Lassen, Annmarie/0000-0003-4942-6152				Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Beathard GA, 1975, SERUM PROTEIN ABNORM; Bishara J, 1997, EUR J CLIN MICROBIOL, V16, P563, DOI 10.1007/BF02447917; Blunt MC, 1998, ANAESTHESIA, V53, P755, DOI 10.1046/j.1365-2044.1998.00488.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; FLECK A, 1989, P NUTR SOC, V48, P347, DOI 10.1079/PNS19890050; Franch-Arcas G, 2001, CLIN NUTR, V20, P265, DOI 10.1054/clnu.2001.0438; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Gradel KO, 2011, CLIN MICROBIOL INFEC, V17, P627, DOI 10.1111/j.1469-0691.2010.03284.x; Gradel KO, 2013, APMIS, V121, P835, DOI 10.1111/apm.12040; Hansson LO, 1997, SCAND J CLIN LAB INV, V57, P111, DOI 10.1080/00365519709056378; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hills M., 1993, STAT MODELS EPIDEMIO, P271; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; Johnson AM, 1999, CLIN CHEM LAB MED, V37, P91, DOI 10.1515/CCLM.1999.017; Kaysen GA, 1998, J AM SOC NEPHROL, V9, P2368; Klein S, 1990, Gastroenterology, V99, P1845; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEIBOVICI L, 1993, AGE AGEING, V22, P431, DOI 10.1093/ageing/22.6.431; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Macdonald SPJ, 2014, ACAD EMERG MED, V21, P1257, DOI 10.1111/acem.12515; McCluskey A, 1996, ANAESTHESIA, V51, P724, DOI 10.1111/j.1365-2044.1996.tb07883.x; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, P251; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Rigaud D, 2000, AM J CLIN NUTR, V72, P355; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Sitges-Serra A, 1998, Curr Opin Clin Nutr Metab Care, V1, P9, DOI 10.1097/00075197-199801000-00003; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; WHITELAW DA, 1992, J AM GERIATR SOC, V40, P996, DOI 10.1111/j.1532-5415.1992.tb04475.x; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X	45	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160466	10.1371/journal.pone.0160466	http://dx.doi.org/10.1371/journal.pone.0160466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611431	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900007
J	Ortega-Campos, E; Garcia-Garcia, J; Gil-Fenoy, MJ; Zaldivar-Basurto, F				Ortega-Campos, Elena; Garcia-Garcia, Juan; Jose Gil-Fenoy, Maria; Zaldivar-Basurto, Flor			Identifying Risk and Protective Factors in Recidivist Juvenile Offenders: A Decision Tree Approach	PLOS ONE			English	Article							SERVICE/CASE MANAGEMENT INVENTORY; PREDICTIVE-VALIDITY; GENDER-DIFFERENCES; YOUNG OFFENDERS; YOUTH LEVEL; ADOLESCENCE; BEHAVIORS; PROGRAMS; SAMPLE; CLASSIFICATION	Research on juvenile justice aims to identify profiles of risk and protective factors in juvenile offenders. This paper presents a study of profiles of risk factors that influence young offenders toward committing sanctionable antisocial behavior (S-ASB). Decision tree analysis is used as a multivariate approach to the phenomenon of repeated sanctionable antisocial behavior in juvenile offenders in Spain. The study sample was made up of the set of juveniles who were charged in a court case in the Juvenile Court of Almeria (Spain). The period of study of recidivism was two years from the baseline. The object of study is presented, through the implementation of a decision tree. Two profiles of risk and protective factors are found. Risk factors associated with higher rates of recidivism are antisocial peers, age at baseline S-ASB, problems in school and criminality in family members.	[Ortega-Campos, Elena; Garcia-Garcia, Juan; Jose Gil-Fenoy, Maria; Zaldivar-Basurto, Flor] Univ Almeria, Dept Psychol, Standing Seminar Juvenile Justice, Carretera Sacramento S-N, La Canada De San Urbano 04120, Almeria, Spain	Universidad de Almeria	Garcia-Garcia, J (corresponding author), Univ Almeria, Dept Psychol, Standing Seminar Juvenile Justice, Carretera Sacramento S-N, La Canada De San Urbano 04120, Almeria, Spain.	jgarciag@ual.es	Garcia-Garcia, Juan/L-7116-2014; Ortega-Campos, Elena/I-4627-2017	Garcia-Garcia, Juan/0000-0002-0123-8497; Ortega-Campos, Elena/0000-0003-1994-7109	Ministry of Economy and Competitiveness (Spain) [DER2014-58084-R]	Ministry of Economy and Competitiveness (Spain)	This work was supported by the Ministry of Economy and Competitiveness (Spain) [DER2014-58084-R]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2015, J ABNORM CHILD PSYCH, V43, P999, DOI 10.1007/s10802-014-9961-y; Anderson VR, 2016, PSYCHOL CRIME LAW, V22, P666, DOI 10.1080/1068316X.2016.1174861; Andrews DA, 2010, PSYCHOLOGY OF CRIMINAL CONDUCT, 5TH EDITION, P1; Andrews D.A., 1994, PSYCHOL CRIMINAL CON; ANDREWS DA, 1990, CRIM JUSTICE BEHAV, V17, P19, DOI 10.1177/0093854890017001004; Andrews DA, 2006, CRIME DELINQUENCY, V52, P7, DOI 10.1177/0011128705281756; Arregui J.L., 2012, THESIS; Assink M, 2016, INT J OFFENDER THER, V60, P847, DOI 10.1177/0306624X14558204; Barnes AR, 2016, J OFFENDER REHABIL, V55, P21, DOI 10.1080/10509674.2015.1107004; Biggs D., 1991, J APPL STAT, V18, P49, DOI [DOI 10.1080/02664769100000005, 10.1080/02664769100000005]; Blanch M, 2013, PRESTACIONES BENEFIC; Bravo A, 2009, PSICOTHEMA, V21, P615; Capdevila M, 2013, ACTUALIZACION TASA R; Chambers J, 2001, J ADOLESCENCE, V24, P209, DOI 10.1006/jado.2001.0377; Council of Europe, 2011, GUID CHILD FRIENDL H; Cuervo K, 2015, INT J OFFENDER THER, V59, P1149, DOI 10.1177/0306624X14557917; Duda R.O., 2006, PATTERN CLASSIFICATI; Eeren HV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131255; Escobar M, 2007, CTR INVESTIGACIONES; Farrington DP, 2012, OXFORD HDB CRIME PRE, P46; Fazel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130390; Fergusson DM, 2007, J ADOLESCENCE, V30, P33, DOI 10.1016/j.adolescence.2005.05.007; Foley RM, 2001, J EMOT BEHAV DISORD, V9, P248, DOI 10.1177/106342660100900405; Garcia J., 2012, EDUPSYKHE, V11, P287; Garcia-Garcia J, 2010, PSYCHOL EMOT MOTIV A, P333; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Geller A, 2009, SOC SCI QUART, V90, P1186, DOI 10.1111/j.1540-6237.2009.00653.x; Grieger L, 2014, CRIM JUSTICE BEHAV, V41, P613, DOI 10.1177/0093854813511432; Gutierrez J., 2008, ADV PRINCIPLES IMPRO, P132, DOI [DOI 10.4018/978-1-60566-172-8.CH008, 10.4018/978-1-60566-172-8.ch008]; Harder AT, 2015, INT J OFFENDER THER, V59, P1047, DOI 10.1177/0306624X14531036; Hart J. L., 2007, YOUTH VIOLENCE JUV J, V5, P367, DOI DOI 10.1177/1541204006297367; Hartman JL, 2009, INT J OFFENDER THER, V53, P249, DOI 10.1177/0306624X08326910; Kass GV, 1980, J R STAT SOC C-APPL, P119; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Lai V, 2016, YOUTH VIOLENCE JUV J, V14, P313, DOI 10.1177/1541204015615193; Lipsey M.W., 2000, EFFECTIVE INTERVENTI; Luque, 2005, REINCIDENCIA DELITO; Makarios M, 2017, CRIME DELINQUENCY, V63, P683, DOI 10.1177/0011128715572094; Mannheim H, 1965, COMP CRIMINOLGY; Miller HA, 2015, SEX ABUSE-J RES TR, V27, P34, DOI 10.1177/1079063214564389; Moffitt T.E., 2006, DEV PSYCHOPATHOL, V3, P570, DOI DOI 10.1002/9780470939406.CH15; Monahan J, 2005, PSYCHIAT SERV, V56, P810, DOI 10.1176/appi.ps.56.7.810; Murray J, 2008, CRIME JUSTICE, V37, P133, DOI 10.1086/520070; Observatorio de la Infancia, 2015, B DIST MIN SAN SERV, V16; Office of Juvenile Justice and Delinquency Prevention, 2014, CEL 40 YEARS WORK TO; Ortega E., 2012, EDUPSYKHE, V11, P171; Ortega-Campos E., 2014, REV MEXICANA PSICOLO, V31, P111; Parent G, 2012, CRIM JUSTICE BEHAV, V39, P1647, DOI 10.1177/0093854812451680; Ramirez AM, 2015, JUVENILE FAM COURT J, V66, P31, DOI 10.1111/jfcj.12025; Rennie C, 2010, J FORENSIC PSYCHI PS, V21, P407, DOI 10.1080/14789940903452311; Ribeaud D, 2010, EUR J CRIMINOL, V7, P460, DOI 10.1177/1477370810378116; Richardson R, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19010; San Juan C, 2010, PERFIL PSICOSOCIAL A; Shepherd SM, 2016, J CRIM PSYCHOL, V6, P51, DOI 10.1108/JCP-02-2016-0006; Steadman HJ, 2000, LAW HUMAN BEHAV, V24, P83, DOI 10.1023/A:1005478820425; Stein DM, 2015, J CHILD ADOLES SUBST, V24, P80, DOI 10.1080/1067828X.2013.764371; Stemmler, 2011, ANTISOCIAL BEHAV CRI, P71; Thomas Stuart, 2003, Crim Behav Ment Health, V13, P153, DOI 10.1002/cbm.538; Tolan PH, 1994, MONOGRAPH PREPARED C; UNICEF, 2011, STAT WORLDS CHILDR 2; Van der Put C, 2011, THESIS; Viljoen JL, 2009, CRIM JUSTICE BEHAV, V36, P981, DOI 10.1177/0093854809340991; Warren J. I., 2009, INT J FORENSIC MENT, V8, P245, DOI DOI 10.1080/14999011003635670; Weaver RD, 2015, RES SOCIAL WORK PRAC, V25, P201, DOI 10.1177/1049731514521302; Weerman FM, 2010, EUR J CRIMINOL, V7, P339, DOI 10.1177/1477370810373729; Welsh BC, 2014, J EXP CRIMINOL, V10, P207, DOI 10.1007/s11292-013-9182-3; Willoughby T, 2007, APPL DEV SCI, V11, P89, DOI 10.1080/10888690701384954	67	15	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160423	10.1371/journal.pone.0160423	http://dx.doi.org/10.1371/journal.pone.0160423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611313	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900006
J	da Silva, EC; Roriz, AKC; Eickemberg, M; Mello, AL; Cortes, EBQ; Feitosa, CA; Medeiros, JMB; Ramos, LB				da Silva, Emanuelle Cruz; Carneiro Roriz, Anna Karla; Eickemberg, Michaela; Mello, Adriana Lima; Quadros Cortes, Elvira Barbosa; Feitosa, Caroline Alves; Barreto Medeiros, Jairza Maria; Ramos, Lilian Barbosa			Factors Associated with Anemia in the Institutionalized Elderly	PLOS ONE			English	Article							PREVALENCE; HEALTH	As a common problem in long-term care facilities (LTCFs), anemia affects 25-63% of the elderly. The aim of the present study was to describe the prevalence and characteristics of anemia and its associated factors in the institutionalized elderly. The cross-sectional study was carried out with three hundred thirteen individuals aged >= 60 years, of both genders, living in long-term care facilities for the elderly in Salvador, Bahia, Brazil. Poisson regression (PR) with robust variance estimates was used to assess the factors related to anemia. The prevalence of anemia was 38%. Mild anemia was predominant in both genders (male: 26.8%; female: 21.1%), as normocytic and normochromic anemia, with no anisocytosis (69.75%). Anemia was associated with thinness (PR: 1.68; 95% CI: 1.04-2.72) and with moderate (PR: 1.98; 95% CI: 1.07-3.63) and total (PR: 2.61; 95% CI: 1.34-5.07) dependence in the final model. Severe dependence exhibited borderline significance (PR: 1.94; 95% CI: 1.00-3.77). The prevalence of anemia was high in the institutionalized elderly in both genders, with characteristics suggesting chronic diseases as the causal factor, and the frequency of occurrence was higher in thinness elderly with moderate to total dependence.	[da Silva, Emanuelle Cruz; Barreto Medeiros, Jairza Maria; Ramos, Lilian Barbosa] Univ Fed Bahia UFBA, Univ Fed Bahia, Food Nutr & Hlth Grad Program, Salvador, BA, Brazil; [da Silva, Emanuelle Cruz; Carneiro Roriz, Anna Karla; Eickemberg, Michaela; Mello, Adriana Lima; Ramos, Lilian Barbosa] Univ Fed Bahia, Aging Related Res & Intervent Ctr, Salvador, BA, Brazil; [Carneiro Roriz, Anna Karla; Mello, Adriana Lima; Barreto Medeiros, Jairza Maria; Ramos, Lilian Barbosa] Univ Fed Bahia, Sch Nutr, Dept Nutr Sci, Salvador, BA, Brazil; [Eickemberg, Michaela; Feitosa, Caroline Alves] Univ Fed Bahia, Collect Hlth Inst, Collect Hlth Grad Program, Salvador, BA, Brazil; [Eickemberg, Michaela; Feitosa, Caroline Alves] Bahian Sch Med & Publ Hlth, Salvador, BA, Brazil; [Quadros Cortes, Elvira Barbosa] Univ Fed Bahia, Fac Med, Dept Med, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia	da Silva, EC (corresponding author), Univ Fed Bahia UFBA, Univ Fed Bahia, Food Nutr & Hlth Grad Program, Salvador, BA, Brazil.; da Silva, EC (corresponding author), Univ Fed Bahia, Aging Related Res & Intervent Ctr, Salvador, BA, Brazil.	emanuelle_cruz@hotmail.com	BARRETOMEDEIROS, JAIRZA MARIA/AAF-6159-2021; Wachholz, Patrick/G-5142-2010	Wachholz, Patrick/0000-0002-4474-009X; C. RORIZ, ANNA KARLA/0000-0002-1768-5646	Bahia State Research Foundation - FAPESB [PET 0007/2013]	Bahia State Research Foundation - FAPESB	The present study was funded by Bahia State Research Foundation - FAPESB (grant PET 0007/2013 to LBR; URL: http://www.fapesb.ba.gov.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Family Physicians American Dietetic Association, 2002, PHYS GUID NUTR CHRON; Andres E, 2013, GERIATR GERONTOL INT, V13, P519, DOI 10.1111/ggi.12017; Andres E, 2008, EUR J INTERN MED, V19, P488, DOI 10.1016/j.ejim.2008.01.016; [Anonymous], 2002, DIABETES CARE S1, V26, pS5; Nakashima ATA, 2012, NUTRITION, V28, P640, DOI 10.1016/j.nut.2011.09.016; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Azeredo Z, 2003, REV FACUL MED LISBOA, V8, P199; Balducci L, 2006, CRIT REV ONCOL HEMAT, V58, P156, DOI 10.1016/j.critrevonc.2005.09.003; Bosco RD, 2013, CAD SAUDE PUBLICA, V29, P1322, DOI 10.1590/S0102-311X2013000700007; Cereda E, 2011, J AM MED DIR ASSOC, V12, P174, DOI 10.1016/j.jamda.2010.11.013; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Corona LP, 2014, REV SAUDE PUBL, V48, P723, DOI 10.1590/S0034-8910.2014048005039; Du Bois D, 1989, NUTRITION, V5, P863; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Jelliffe D B, 1966, Monogr Ser World Health Organ, V53, P3; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Macedo VF, 2011, REV BRAS GERIATR GER, V5, P214; MAHONEY F I, 1965, Md State Med J, V14, P61; Morley JE, 2012, J AM MED DIR ASSOC, V13, P191, DOI 10.1016/j.jamda.2011.12.057; Onem Y, 2010, ARCH GERONTOL GERIAT, V50, P56, DOI 10.1016/j.archger.2009.01.010; Sgnaolin Vanessa, 2013, Rev. Bras. Hematol. Hemoter., V35, P115, DOI 10.5581/1516-8484.20130032; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Tettamanti M, 2010, HAEMATOL-HEMATOL J, V95, P1849, DOI 10.3324/haematol.2010.023101; Tseng CK, 2012, ARCH GERONTOL GERIAT, V55, P77, DOI 10.1016/j.archger.2011.06.019; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 1995, WHO TECHN REP SER	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162240	10.1371/journal.pone.0162240	http://dx.doi.org/10.1371/journal.pone.0162240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607057	Green Published, gold			2022-12-27	WOS:000383255600032
J	Li, MY; Liu, XY; Liu, ZX; Sun, Y; Liu, MX; Wang, XL; Zhang, HF; Zheng, XB; Zhang, ZG				Li, Mengying; Liu, Xinyu; Liu, Zhixi; Sun, Yi; Liu, Muxing; Wang, Xiaoli; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang			Glycoside Hydrolase MoGls2 Controls Asexual/Sexual Development, Cell Wall Integrity and Infectious Growth in the Rice Blast Fungus	PLOS ONE			English	Article							RETICULUM GLUCOSIDASE-II; ENDOPLASMIC-RETICULUM; MAGNAPORTHE-GRISEA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CANDIDA-ALBICANS; N-GLYCOSYLATION; USTILAGO-MAYDIS; QUALITY-CONTROL; PATHOGENICITY	N-linked glycosylation is a way of glycosylation for newly synthesized protein, which plays a key role in the maturation and transport of proteins. Glycoside hydrolases (GHs) are essential in this process, and are involved in processing of N-linked glycoproteins or degradation of carbohydrate structures. Here, we identified and characterized MoGls2 in Magnaporthe oryzae, which is a yeast glucosidase II homolog Gls2 and is required for trimming the final glucose in N-linked glycans and normal cell wall synthesis. Target deletion of MoGLS2 in M. oryzae resulted in a reduced mycelial growth, an increased conidial production, delayed conidial germination and loss the ability of sexual reproduction. Pathogenicity assays revealed that the Delta Mogls2 mutant showed significantly decreased in virulence and infectious growth. Further studies showed that the mutant was less sensitive to salt and osmotic stress, and increased sensitivity to cell wall stresses. Additionally, the Delta Mogls2 mutant showed a defect in cell wall integrity. Our results indicate that MoGls2 is a key protein for the growth and development of M. oryzae, involving in the regulation of asexual/sexual development, stress response, cell wall integrity and infectious growth.	[Li, Mengying; Liu, Xinyu; Sun, Yi; Liu, Muxing; Wang, Xiaoli; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China; [Li, Mengying; Liu, Xinyu; Sun, Yi; Liu, Muxing; Wang, Xiaoli; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China; [Liu, Zhixi] Agr Bur Ningxiang Cty, Changsha 410600, Hunan, Peoples R China	Nanjing Agricultural University	Zhang, HF (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China.; Zhang, HF (corresponding author), Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China.	hfzhang@njau.edu.cn			Natural Science Foundation of China [31471736]; Fundamental Research Funds for the Central Universities [KYZ201304]; Agriculture Innovation Foundation of Jiangsu Province of China [CX(15)1054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Agriculture Innovation Foundation of Jiangsu Province of China	This study was supported by the Natural Science Foundation of China (Grant No: 31471736 to H. Zhang), the Fundamental Research Funds for the Central Universities (Grant No: KYZ201304 to H. Zhang), and the Agriculture Innovation Foundation of Jiangsu Province of China (Grant No: CX(15)1054 to Z. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chen XL, 2014, PLANT CELL, V26, P1360, DOI 10.1105/tpc.114.123588; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2015, CURR PROTEIN PEPT SC, V16, P31, DOI 10.2174/1389203716666150213160438; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez-Alvarez A, 2013, PLANT CELL, V25, P4676, DOI 10.1105/tpc.113.115691; Frade-Perez MD, 2010, ANTON LEEUW INT J G, V98, P291, DOI 10.1007/s10482-010-9437-1; Geysens S, 2005, APPL ENVIRON MICROB, V71, P2910, DOI 10.1128/AEM.71.6.2910-2924.2005; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Qi ZQ, 2012, MOL PLANT PATHOL, V13, P677, DOI 10.1111/j.1364-3703.2011.00779.x; Satoh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20575; Schirawski J, 2005, PLANT CELL, V17, P3532, DOI 10.1105/tpc.105.036285; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Strasser R, 2016, GLYCOBIOLOGY, V26, P926, DOI 10.1093/glycob/cww023; STROUS GJ, 1987, J BIOL CHEM, V262, P3620; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Wang JM, 2013, MOL PLANT PATHOL, V14, P470, DOI 10.1111/mpp.12020; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Zhang HF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002450; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x	34	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162243	10.1371/journal.pone.0162243	http://dx.doi.org/10.1371/journal.pone.0162243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607237	gold, Green Published			2022-12-27	WOS:000383255600033
J	Lancefield, TF; Patel, SK; Freeman, M; Velkoska, E; Wai, B; Srivastava, PM; Horrigan, M; Farouque, O; Burrell, LM				Lancefield, Terase F.; Patel, Sheila K.; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M.; Horrigan, Mark; Farouque, Omar; Burrell, Louise M.			The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation	PLOS ONE			English	Article							ENDOGENOUS SECRETORY RECEPTOR; TYPE-2 DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; ENDOTHELIAL-CELLS; SOLUBLE RECEPTOR; HEART-FAILURE; GENE POLYMORPHISMS; CIRCULATING LEVELS; ENDPRODUCTS LEVELS; CLEAVED RECEPTOR	Objective Upregulation of the receptor for advanced glycation end products (RAGE) has been proposed as a pathophysiological mechanism underlying the development of atrial fibrillation (AF). We sought to investigate if soluble RAGE levels are associated with AF in Caucasian patients. Methods Patients (n = 587) were prospectively recruited and serum levels of soluble RAGE (sRAGE) and endogenous secretory RAGE (esRAGE) measured. The patients included 527 with sinus rhythm, 32 with persistent AF (duration > 7 days, n = 32) and 28 with paroxysmal AF (duration <7 days, n = 28). Results Patients with AF were older and had a greater prevalence of heart failure than patients in sinus rhythm. Circulating RAGE levels were higher in patients with persistent AF [median sRAGE 1190 (724-2041) pg/ml and median esRAGE 452 (288-932) pg/ml] compared with paroxysmal AF [sRAGE 799 (583-1033) pg/ml and esRAGE 279 (201-433) pg/ml, p <= 0.01] or sinus rhythm [sRAGE 782 (576-1039) pg/ml and esRAGE 289 (192-412) pg/ml, p < 0.001]. In multi-variable logistic regression analysis, independent predictors of persistent AF were age, heart failure, sRAGE [odds ratio 1.1 per 100 pg/ml, 95% confidence interval (CI) 1.0-1.1, p = 0.001] and esRAGE [odds ratio 1.3 per 100 pg/ml, 95% CI 1.1-1.4, p < 0.001]. Heart failure and age were the only independent predictors of paroxysmal AF. In AF patients, sRAGE [odds ratio 1.1 per 100 pg/ml, 95% CI 1.1-1.2, p = 0.007] and esRAGE [odds ratio 1.3 per 100 pg/ml, 95% CI 1.0-1.5, p = 0.017] independently predicted persistent compared with paroxysmal AF. Conclusions Soluble RAGE is elevated in Caucasian patients with AF, and both sRAGE and esRAGE predict the presence of persistent AF.	[Lancefield, Terase F.; Patel, Sheila K.; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M.; Farouque, Omar; Burrell, Louise M.] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Lancefield, Terase F.; Wai, Bryan; Srivastava, Piyush M.; Horrigan, Mark; Farouque, Omar; Burrell, Louise M.] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia; [Freeman, Melanie] Box Hill Hosp, Dept Cardiol, Box Hill, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Box Hill Hospital	Lancefield, TF (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia.; Lancefield, TF (corresponding author), Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia.	terase.lancefield@austin.org.au			National Heart Foundation Clinical Research Scholarship; Pfizer Cardiovascular Lipid grant	National Heart Foundation Clinical Research Scholarship; Pfizer Cardiovascular Lipid grant	This work was supported by the National Heart Foundation Clinical Research Scholarship (http://heartfoundation.org.au) to TL and the Pfizer Cardiovascular Lipid grant (https://www.pfizergrants.com.au/grants/CardiovascularLipid.aspx) to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Begieneman MPV, 2015, AM J PATHOL, V185, P2096, DOI 10.1016/j.ajpath.2015.04.018; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; BRETT J, 1993, AM J PATHOL, V143, P1699; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chen MC, 2008, AM J CARDIOL, V102, P861, DOI 10.1016/j.amjcard.2008.05.038; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Gao JX, 2010, J HUM GENET, V55, P668, DOI 10.1038/jhg.2010.85; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hudson BI, 2011, ATHEROSCLEROSIS, V216, P192, DOI 10.1016/j.atherosclerosis.2011.01.024; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Kalousova M, 2007, NEPHROL DIAL TRANSPL, V22, P2020, DOI 10.1093/ndt/gfm050; Katakami N, 2005, DIABETES CARE, V28, P2716, DOI 10.2337/diacare.28.11.2716; Kato T, 2008, J CARDIOVASC ELECTR, V19, P415, DOI 10.1111/j.1540-8167.2007.01037.x; Kato T, 2006, J CARDIOVASC ELECTR, V17, P890, DOI 10.1111/j.1540-8167.2006.00528.x; Koyama Y, 2008, J CARD FAIL, V14, P133, DOI 10.1016/j.cardfail.2007.10.019; Liu B, 2014, INT HEART J, V55, P499, DOI 10.1536/ihj.14-107; Lu L, 2010, CHINESE MED J-PEKING, V123, P594, DOI 10.3760/cma.j.issn.0366-6999.2010.05.017; Lu L, 2009, ATHEROSCLEROSIS, V206, P540, DOI 10.1016/j.atherosclerosis.2008.12.045; Nakamura K, 2005, MICROVASC RES, V70, P137, DOI 10.1016/j.mvr.2005.10.002; Nakamura K, 2008, MICROVASC RES, V76, P52, DOI 10.1016/j.mvr.2007.09.004; Peng WH, 2009, ARCH MED RES, V40, P393, DOI 10.1016/j.arcmed.2009.06.008; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Qu YC, 2009, SCAND CARDIOVASC J, V43, P292, DOI 10.1080/14017430802651803; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Raposeiras-Roubin S, 2012, INT J CARDIOL, V157, P397, DOI 10.1016/j.ijcard.2011.05.072; Raposeiras-Roubin S, 2010, EUR J HEART FAIL, V12, P1092, DOI 10.1093/eurjhf/hfq117; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Selvin E, 2013, DIABETES, V62, P2116, DOI 10.2337/db12-1528; Tikellis C, 2008, AM J PHYSIOL-ENDOC M, V295, pE323, DOI 10.1152/ajpendo.00024.2008; Walker D, 2015, EXPERT OPIN INV DRUG, V24, P393, DOI 10.1517/13543784.2015.1001490; Wang LJ, 2011, EUR J HEART FAIL, V13, P440, DOI 10.1093/eurjhf/hfq231; Yan XX, 2013, INT J CARDIOL, V166, P242, DOI 10.1016/j.ijcard.2012.08.055; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhao DD, 2012, INT J CARDIOL, V158, P471, DOI 10.1016/j.ijcard.2012.05.042	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161715	10.1371/journal.pone.0161715	http://dx.doi.org/10.1371/journal.pone.0161715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627677	Green Published, gold			2022-12-27	WOS:000383680600007
J	Maricelli, JW; Lu, QL; Lin, DC; Rodgers, BD				Maricelli, Joseph W.; Lu, Qi L.; Lin, David C.; Rodgers, Buel D.			Trendelenburg-Like Gait, Instability and Altered Step Patterns in a Mouse Model for Limb Girdle Muscular Dystrophy 2i	PLOS ONE			English	Article							FUKUTIN-RELATED PROTEIN; 6-MINUTE WALK TEST; GENE-THERAPY; FUNCTIONAL GLYCOSYLATION; ALPHA-DYSTROGLYCAN; MDX MICE; MUSCLE; FORCE; MUTATIONS; HUMANS	Limb-girdlemuscular dystrophy type 2i (LGMD2i) affects thousands of lives with shortened life expectancy mainly due to cardiac and respiratory problems and difficulty with ambulation significantly compromising quality of life. Limited studies have noted impaired gait in patients and animal models of different muscular dystrophies, but not in animal models of LGMD2i. Our goal, therefore, was to quantify gait metrics in the fukutin-related protein P448L mutant (P448L) mouse, a recently developed model for LGMD2i. The Noldus Cat-Walk XT motion capture system was used to identify multiple gait impairments. An average galloping body speed of 35 cm/s for both P448L and C57BL/6 wild-type mice was maintained to ensure differences in gait were due only to strain physiology. Compared to wildtype mice, P448L mice reach maximum contact 10% faster and have 40% more paw surface area during stance. Additionally, force intensity at the time of maximum paw contact is roughly 2-fold higher in P448L mice. Paw swing time is reduced in P448L mice without changes in stride length as a faster swing speed compensates. Gait instability in P448L mice is indicated by 50% higher instances of 3 and 4 paw stance support and conversely, 2-fold fewer instances of single paw stance support and no instance of zero paw support. This leads to lower variation of normal step patterns used and a higher use of uncommon step patterns. Similar anomalies have also been noted in muscular dystrophy patients due to weakness in the hip abductor muscles, producing a Trendelenburg gait characterized by "waddling" and more pronounced shifts to the stance leg. Thus, gait of P448L mice replicates anomalies commonly seen in LGMD2i patients, which is not only potentially valuable for assessing drug efficacy in restoring movement biomechanics, but also for better understanding them.	[Maricelli, Joseph W.; Rodgers, Buel D.] Washington State Univ, Sch Mol Biol, Washington Ctr Muscle Biol, Pullman, WA 99164 USA; [Lu, Qi L.] Carolinas Med Ctr, Dept Neurol, Charlotte, NC 28203 USA; [Lin, David C.] Washington State Univ, Washington Ctr Muscle Biol, Dept Integrat Physiol & Neurosci, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	Washington State University; Carolinas Medical Center; Washington State University	Rodgers, BD (corresponding author), Washington State Univ, Sch Mol Biol, Washington Ctr Muscle Biol, Pullman, WA 99164 USA.	dan.rodgers@wsu.edu	lu, qi/HHS-2115-2022; Rodgers, Dan/AAA-5343-2020	Lin, David/0000-0003-4492-0944; Rodgers, Buel/0000-0003-0751-1105	LGMD2iFund; Carolinas Muscular Dystrophy Research Endowment	LGMD2iFund; Carolinas Muscular Dystrophy Research Endowment	LGMD2iFund http://www.lgmd2ifund.org and Carolinas Muscular Dystrophy Research Endowment http://www.givecarolinas.org/.	Adachi W, 2011, IEEE ENG MED BIO, P4022, DOI 10.1109/IEMBS.2011.6090999; Alexander RM, 2004, J ANAT, V204, P321, DOI 10.1111/j.0021-8782.2004.00289.x; ALEXANDER RM, 1982, LOCOMOTION ANIMALS, P81, DOI DOI 10.1007/978-94-011-6009-4_5; Avaria MDA, 1999, REV MED CHILE, V127, P65; Awano H, 2015, NEUROMUSCULAR DISORD, V25, P474, DOI 10.1016/j.nmd.2015.03.004; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Blaeser A, 2013, HUM GENET, V132, P923, DOI 10.1007/s00439-013-1302-7; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Fischer D, 2005, J NEUROL, V252, P538, DOI 10.1007/s00415-005-0684-4; Flynn J M, 2001, J Am Acad Orthop Surg, V9, P89; Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274; Goddard MA, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.31; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hammaren E, 2015, NEUROMUSCULAR DISORD, V25, P141, DOI 10.1016/j.nmd.2014.11.004; HENSINGER RN, 1986, PEDIATR CLIN N AM, V33, P1355; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Izco FM, 2005, NEUROLOGIA, V20, P341; Krag TO, 2015, J NEUROPATH EXP NEUR, V74, P1137, DOI [10.1093/jnen/74.12.1137, 10.1097/NEN.0000000000000260]; Margeta M, 2009, MUSCLE NERVE, V40, P883, DOI 10.1002/mus.21432; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2012, NEUROSCI LETT, V527, P90, DOI 10.1016/j.neulet.2012.04.078; Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732; Mendes CS, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0154-0; Mercuri E, 2005, PEDIATR ANN, V34, P560, DOI 10.3928/0090-4481-20050701-13; Mercuri E, 2003, ANN NEUROL, V53, P537, DOI 10.1002/ana.10559; Moller KA, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Pai VS, 1996, J ARTHROPLASTY, V11, P174, DOI 10.1016/S0883-5403(05)80013-0; Pane Marika, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.a93d9904d57dcb08936f2ea89bca6fe6; Papa R, PEDIAT NEUROLOGY; Papa R, 2016, PEDIATR NEUROL, V55, P58, DOI 10.1016/j.pediatrneurol.2015.11.004; Pegoraro E., 1993, GENEREVIEWS R; Petri H, 2015, INT J CARDIOL, V182, P403, DOI 10.1016/j.ijcard.2014.12.090; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; READ L, 1986, J BONE JOINT SURG BR, V68, P481, DOI 10.1302/0301-620X.68B3.3733820; Rijken NHM, 2015, GAIT POSTURE, V42, P295, DOI 10.1016/j.gaitpost.2015.06.005; Ropars J, 2015, COMPUT METHOD BIOMEC, V18, P2042, DOI 10.1080/10255842.2015.1069615; Rosales XQ, 2012, PEDIATR NEUROL, V46, P13, DOI 10.1016/j.pediatrneurol.2011.08.014; Shklyar I, 2015, PEDIATR NEUROL, V52, P202, DOI 10.1016/j.pediatrneurol.2014.09.014; Simoes GF, 2014, BRAIN BEHAV, V4, P738, DOI 10.1002/brb3.250; Smith BJH, 2015, J APPL PHYSIOL, V119, P704, DOI 10.1152/japplphysiol.01014.2014; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tsujiuchi N, 2014, IEEE ENG MED BIO, P2521, DOI 10.1109/EMBC.2014.6944135; Vasudevan PN, 1997, J BONE JOINT SURG BR, V79B, P462, DOI 10.1302/0301-620X.79B3.7495; de Albuquerque MAV, 2015, ARQ NEURO-PSIQUIAT, V73, P993, DOI 10.1590/0004-282X20150168; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Webb AA, 2011, JOVE-J VIS EXP, DOI 10.3791/2138; Xu L, 2013, MOL THER, V21, P1832, DOI 10.1038/mt.2013.156; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161984	10.1371/journal.pone.0161984	http://dx.doi.org/10.1371/journal.pone.0161984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627455	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600015
J	Arai, K; Eguchi, T; Rahman, MM; Sakamoto, R; Masuda, N; Nakatsura, T; Calderwood, SK; Kozaki, K; Itoh, M				Arai, Kazuya; Eguchi, Takanori; Rahman, M. Mamunur; Sakamoto, Ruriko; Masuda, Norio; Nakatsura, Tetsuya; Calderwood, Stuart K.; Kozaki, Ken-ichi; Itoh, Manabu			A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-COLON-CARCINOMA; I RECEPTOR KINASE; OVARIAN-CANCER; TRANSFORMING GROWTH-FACTOR-BETA-1; SPHEROID FORMATION; CELL-CULTURE; STEM-CELLS; E-CADHERIN; EXPRESSION	Epithelial-mesenchymal transition (EMT) is a crucial pathological event in cancer, particularly in tumor cell budding and metastasis. Therefore, control of EMT can represent a novel therapeutic strategy in cancer. Here, we introduce an innovative three-dimensional (3D) high-throughput screening (HTS) system that leads to an identification of EMT inhibitors. For the establishment of the novel 3D-HTS system, we chose NanoCulture Plates (NCP) that provided a gel-free micro-patterned scaffold for cells and were independent of other spheroid formation systems using soft-agar. In the NCP-based 3D cell culture system, A549 lung cancer cells migrated, gathered, and then formed multiple spheroids within 7 days. Live cell imaging experiments showed that an established EMT-inducer TGF-beta promoted peripheral cells around the core of spheroids to acquire mesenchymal spindle shapes, loss of intercellular adhesion, and migration from the spheroids. Along with such morphological change, EMT-related gene expression signatures were altered, particularly alteration of mRNA levels of ECAD/CDH1, NCAD/CDH2, VIM and ZEB1/TCF8. These EMT-related phenotypic changes were blocked by SB431542, a TGF-beta receptor I (TGF beta R1) inhibitor. Inside of the spheroids were highly hypoxic; in contrast, spheroid-derived peripheral migrating cells were normoxic, revealed by visualization and quantification using Hypoxia Probe. Thus, TGF-beta-triggeredEMT caused spheroid hypoplasia and loss of hypoxia. Spheroid EMT inhibitory (SEMTIN) activity of SB431542 was calculated from fluorescence intensities of the Hypoxia Probe, and then was utilized in a drug screening of EMT-inhibitory small molecule compounds. In a pilot screening, 9 of 1,330 compounds were above the thresholds of the SEMTIN activity and cell viability. Finally, two compounds SB-525334 and SU9516 showed SEMTIN activities in a dose dependent manner. SB-525334 was a known TGF beta R1 inhibitor. SU9516 was a cyclin-dependent kinase 2 (CDK2) inhibitor, which we showed also had an EMT-inhibitory activity. The half maximal inhibitory concentration (IC50) of SB-525334 and SU9516 were 0.31 mu M and 1.21 mu M, respectively, while IC50 of SB431542 was 2.38 mu M. Taken together, it was shown that this 3D NCP-based HTS system was useful for screening of EMT-regulatory drugs.	[Arai, Kazuya; Sakamoto, Ruriko; Masuda, Norio; Itoh, Manabu] SCIVAX Life Sci Inc, Kawasaki, Kanagawa, Japan; [Arai, Kazuya; Rahman, M. Mamunur] SCIVAX USA Inc, Woburn, MA 01801 USA; [Eguchi, Takanori; Calderwood, Stuart K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; [Eguchi, Takanori; Kozaki, Ken-ichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan; [Eguchi, Takanori] Okayama Univ, Sch Dent, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan; [Nakatsura, Tetsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Okayama University; Okayama University; National Cancer Center - Japan	Arai, K (corresponding author), SCIVAX Life Sci Inc, Kawasaki, Kanagawa, Japan.; Arai, K (corresponding author), SCIVAX USA Inc, Woburn, MA 01801 USA.; Eguchi, T (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA.; Eguchi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan.; Eguchi, T (corresponding author), Okayama Univ, Sch Dent, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan.	kazuya_arai@organogenix.com; eguchi@okayama-u.ac.jp		Eguchi, Takanori/0000-0002-3297-6126	SCIVAX Life Sciences Inc.; Joint Center for Radiation Therapy (JCRT) grant at Harvard Medical School; JSPS KAKENHI [JP16K11722]	SCIVAX Life Sciences Inc.; Joint Center for Radiation Therapy (JCRT) grant at Harvard Medical School; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	SCIVAX Life Sciences Inc. provided support in the form of salaries for authors KA, MMR, RS, NM and MI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a Joint Center for Radiation Therapy (JCRT) grant at Harvard Medical School 2015 (to TE and SKC) and JSPS KAKENHI JP16K11722 (to TE). The specific roles of these authors are articulated in the "author contributions" section.	Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Brown KA, 2004, BREAST CANCER RES, V6, pR130, DOI 10.1186/bcr762; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Calone I., 2012, Experimental Oncology, V34, P9; Choi KS, 1999, J BIOL CHEM, V274, P31775, DOI 10.1074/jbc.274.45.31775; Chua KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033183; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Elsayed M, 2014, NANOMEDICINE-UK, V9, P349, DOI 10.2217/nnm.13.200; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Gao N, 2006, MOL PHARMACOL, V70, P645, DOI 10.1124/mol.106.024505; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Liu J, 2014, INT J CLIN EXP PATHO, V7, P6943; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Opyrchal M, 2014, INT J ONCOL, V45, P1193, DOI 10.3892/ijo.2014.2523; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Park MC, 2016, CANCER RES, V76, P1044, DOI 10.1158/0008-5472.CAN-14-2611; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Storch Katja, 2012, Chemother Res Pract, V2012, P319287, DOI 10.1155/2012/319287; SUTHERLAND RM, 1986, CANCER RES, V46, P5320; Takai M, 2014, J OVARIAN RES, V7, DOI [10.1186/1757-2215-7-38, 10.1186/1757-2215-7-76]; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05646; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Yu B, 2002, BIOCHEM PHARMACOL, V64, P1091, DOI 10.1016/S0006-2952(02)01264-9; Zang R., 2012, INT J BIOTECHNOL WEL, V1, P31, DOI DOI 10.6000/1927-3037.2012.01.01.02; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948	47	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162394	10.1371/journal.pone.0162394	http://dx.doi.org/10.1371/journal.pone.0162394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622654	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000029
J	Hernandez, CC; Klassen, TL; Jackson, LG; Gurba, K; Hu, NN; Noebels, JL; Macdonald, RL				Hernandez, Ciria C.; Klassen, Tara L.; Jackson, Laurel G.; Gurba, Katharine; Hu, Ningning; Noebels, Jeffrey L.; Macdonald, Robert L.			Deleterious Rare Variants Reveal Risk for Loss of GABA(A) Receptor Function in Patients with Genetic Epilepsy and in the General Population	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; AGONIST BINDING-SITE; MISSENSE MUTATIONS; STRUCTURAL DETERMINANTS; ENDOPLASMIC-RETICULUM; GATING MECHANISM; FEBRILE SEIZURES; BETA-2 SUBUNITS; A RECEPTORS; MOUSE MODEL	Genetic epilepsies (GEs) account for approximately 50% of all seizure disorders, and familial forms includemutations in single GABA(A) receptor subunit genes (GABRs). In 144 sporadic GE cases (GECs), exome sequencing of 237 ion channel genes identified 520 GABR variants. Among these variants, 33 rare variants in 11 GABR genes were present in 24 GECs. To assess functional risk of variants in GECs, we selected 8 variants found in GABRA, 3 in GABRB, and 3 in GABRG and compared them to 18 variants found in the general population for GABRA1 (n = 9), GABRB3 (n = 7), and GABRG2 (n = 2). To identify deleterious variants and gain insight into structure-function relationships, we studied the gating properties, surface expression and structural perturbations of the 32 variants. Significant reduction of GABAA receptor function was strongly associated with variants scored as deleterious and mapped within the N-terminal and transmembrane domains. In addition, 12 out of 17 variants mapped along the beta+/alpha- GABA binding interface, were associated with reduction in channel gating and were predicted to cause structural rearrangements of the receptor by in silico simulations. Missense or nonsensemutations of GABRA1, GABRB3 and GABRG2 primarily impair subunit biogenesis. In contrast, GABR variants affected receptor function by impairing gating, suggesting that different mechanisms are operating in GABR epilepsy susceptibility variants and disease-causingmutations. The functional impact of single GABR variants found in individuals with sporadic GEs warrants the use of molecular diagnosis and will ultimately improve the treatment of genetic epilepsies by using a personalized approach.	[Hernandez, Ciria C.; Hu, Ningning; Macdonald, Robert L.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Klassen, Tara L.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6S 1Z3, Canada; [Jackson, Laurel G.; Gurba, Katharine] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Vanderbilt University; University of British Columbia; Vanderbilt University; Baylor College of Medicine	Hernandez, CC; Macdonald, RL (corresponding author), Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA.	ciria.hernandez@vanderbilt.edu; robert.macdonald@vanderbilt.edu			National Institutes of Health [R01 NS33300]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102924, UC2HL103010, RC2HL102923, UC2HL102923, RC2HL102925, UC2HL102926, UC2HL102925, RC2HL102926, UC2HL102924, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health via grant No. R01 NS33300 (to R. L. M.).; The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bianchi MT, 2002, J PHYSIOL-LONDON, V544, P3, DOI 10.1113/jphysiol.2002.020255; Bianchi MT, 2002, J NEUROSCI, V22, P5321; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Dibbens LM, 2009, NEUROSCI LETT, V453, P162, DOI 10.1016/j.neulet.2009.02.038; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hernandez CC, 2011, J PHYSIOL-LONDON, V589, P5857, DOI 10.1113/jphysiol.2011.218883; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hirose S, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.0013-9580.2005.461011.x; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Huang X, 2014, NEUROBIOL DIS, V68, P167, DOI 10.1016/j.nbd.2014.04.015; James VM, 2013, NEUROBIOL DIS, V52, P137, DOI 10.1016/j.nbd.2012.12.001; Janve VS, 2016, ANN NEUROL, V79, P806, DOI 10.1002/ana.24631; Kang JQ, 2004, J NEUROSCI, V24, P8672, DOI 10.1523/JNEUROSCI.2717-04.2004; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lo WY, 2014, NEUROCHEM RES, V39, P1088, DOI 10.1007/s11064-013-1187-9; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Macdonald R.L., 2012, JASPERS BASIC MECH E, V4th, DOI 10.1093/med/9780199746545.003.0057; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; Marini C, 2004, EPILEPSIA, V45, P467, DOI 10.1111/j.0013-9580.2004.46803.x; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Shen XM, 2012, NEUROLOGY, V79, P449, DOI 10.1212/WNL.0b013e31825b5bda; Shen XM, 2012, J CLIN INVEST, V122, P2613, DOI 10.1172/JCI63415; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Srivastava S, 2014, AM J MED GENET A, V164, P2914, DOI 10.1002/ajmg.a.36714; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Venkatachalan SP, 2012, J BIOL CHEM, V287, P6714, DOI 10.1074/jbc.M111.316836; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	54	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162883	10.1371/journal.pone.0162883	http://dx.doi.org/10.1371/journal.pone.0162883			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622563	gold, Green Submitted, Green Published			2022-12-27	WOS:000383681000066
J	Bondo, KJ; Pearl, DL; Janecko, N; Boerlin, P; Reid-Smith, RJ; Parmley, J; Jardine, CM				Bondo, Kristin J.; Pearl, David L.; Janecko, Nicol; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.			Impact of Season, Demographic and Environmental Factors on Salmonella Occurrence in Raccoons (Procyon lotor) from Swine Farms and Conservation Areas in Southern Ontario	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; FLORIDA RACCOONS; FECAL SAMPLES; PREVALENCE; FOOD; INFECTIONS; SURVIVAL; MANURE	Salmonella has been detected in the feces of many wildlife species, including raccoons (Procyon lotor), but little is known about the epidemiology of Salmonella in wildlife living in different habitat types. Our objective was to investigate demographic, temporal, and climatic factors associated with the carriage of Salmonella in raccoons and their environment on swine farms and conservation areas. Using a repeated cross-sectional study design, we collected fecal samples from raccoons and environmental samples (soil, manure pits, dumpsters) on 5 swine farms and 5 conservation areas in Ontario, Canada once every five weeks from May to November, 2011-2013. Salmonellawas detected in 26% (279/1093; 95% CI 22.9-28.2) of raccoon fecal samples, 6% (88/1609; 95% CI 4.5-6.8) of soil samples, 30% (21/69; 95% CI 20.0-42.7) of manure pit samples, and 23% (7/31; 95% CI 9.6-41.0) of dumpster samples. Of samples testing positive for Salmonella, antimicrobial resistance was detected in 5% (14/279; 95% CI 2.8-8.3) of raccoon fecal, 8% (7/89; 95% CI 3.2-15.5) of soil, 10% (2/21; 95% CI 1.2-30.4) of manure pit, and 0/7 dumpster samples. Usingmulti-level multivariable logistic regression analyses, we found location type (swine farmor conservation area) was not a significant explanatory variable for Salmonella occurrence in raccoon feces or soil (p > 0.05). However, detection of Salmonella in raccoon feces was associated with rainfall, season, and sex with various interaction effects among these variables. We detected a variety of Salmonella serovars that infect humans and livestock in the feces of raccoons indicating that raccoons living near humans, regardless of location type, may play a role in the epidemiology of salmonellosis in livestock and humans in southwestern Ontario.	[Bondo, Kristin J.; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Pearl, David L.; Janecko, Nicol; Reid-Smith, Richard J.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Janecko, Nicol; Reid-Smith, Richard J.; Parmley, Jane] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Janecko, Nicol] Univ Vet & Pharmaceut Sci Brno, Dept Biol & Wildlife Dis, Brno, Czech Republic; [Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; University of Guelph; Public Health Agency of Canada; University of Veterinary Sciences Brno; University of Guelph	Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.; Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada.	cjardi01@uoguelph.ca			National Science and Engineering Research Council (NSERC); United States Department of Agriculture (USDA); Ontario Graduate Scholarship (OGS	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Ontario Graduate Scholarship (OGS(Ontario Graduate Scholarship)	Funding was provided by the National Science and Engineering Research Council (NSERC; CMJ). KJB received support through the United States Department of Agriculture (USDA) and an Ontario Graduate Scholarship (OGS). In-kind support was provided by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez-Aldapa CA, 2011, SALMONELLA - A DANGEROUS FOODBORNE PATHOGEN, P21; Allen SE, 2013, J WILDLIFE DIS, V49, P432, DOI 10.7589/2012-05-142; Andres S, 2013, ZOONOSES PUBLIC HLTH, V60, P355, DOI 10.1111/j.1863-2378.2012.01542.x; Arrus KM, 2006, LIVEST SCI, V102, P226, DOI 10.1016/j.livsci.2006.03.021; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barza M, 2002, CLIN INFECT DIS, V34, pS126, DOI 10.1086/340250; Behravesh CB, 2010, PEDIATRICS, V126, P477, DOI 10.1542/peds.2009-3273; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; BIGLER WJ, 1974, ARCH ENVIRON HEALTH, V28, P261, DOI 10.1080/00039896.1974.10666483; Bolton FJ, 1999, EPIDEMIOL INFECT, V122, P7, DOI 10.1017/S0950268898001915; Bondo KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P303, DOI 10.1111/zph.12232; Bondo KJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0563-x; Broadfoot JD, 2001, ECOL APPL, V11, P295, DOI 10.1890/1051-0761(2001)011[0295:RASPMF]2.0.CO;2; Chamberlain MJ, 2003, J WILDLIFE MANAGE, V67, P334, DOI 10.2307/3802775; Chen HM, 2013, PEDIATR NEONATOL, V54, P147, DOI 10.1016/j.pedneo.2013.01.010; Cole D, 2005, EMERG INFECT DIS, V11, P935; Colwell RR, 2009, MICROBIOL MONOGR, V10, P121, DOI 10.1007/7171_2009_1; Cowled BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046310; Davies RH, 1996, J VET MED B, V43, P119, DOI 10.1111/j.1439-0450.1996.tb00295.x; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Essex Regional Conservation Authority (ERCA), 2020, ESS REG CONS AUTH 20, P1; Finley R, 2007, CAN VET J, V48, P69; Forshell LP, 2006, REV SCI TECH OIE, V25, P541, DOI 10.20506/rst.25.2.1683; FRITZELL EK, 1978, CAN J ZOOL, V56, P260, DOI 10.1139/z78-035; Funk J, 2004, J SWINE HEALTH PROD, V12, P246; Garcia R, 2010, APPL ENVIRON MICROB, V76, P5025, DOI 10.1128/AEM.00628-10; Gehrt SD, 1997, J MAMMAL, V78, P921, DOI 10.2307/1382952; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Government of Canada, 2015, CAN INT PROGR ANT RE; Government of Canada, 2013, OV FOODNET CAN FORM; Government of Canada, 2011, CAN INT PROGR ANT RE; Government of Canada, 2014, FOODNET CAN 2010 ANN; Government of Canada, 2012, NAT ENT SURV PROGR N; Greig J, 2015, ZOONOSES PUBLIC HLTH, V62, P269, DOI 10.1111/zph.12147; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; HART RP, 1985, APPL ENVIRON MICROB, V49, P1276, DOI 10.1128/AEM.49.5.1276-1281.1985; Hilbert F, 2012, FOOD RES INT, V45, P603, DOI 10.1016/j.foodres.2011.08.015; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Jardine C, 2011, J WILDLIFE DIS, V47, P344, DOI 10.7589/0090-3558-47.2.344; Kalwasinska A, 2013, ENVIRON SCI-PROC IMP, V15, P1078, DOI 10.1039/c3em30728j; Kinde H, 1997, AVIAN DIS, V41, P392, DOI 10.2307/1592195; KOURANY M, 1970, AM J TROP MED HYG, V19, P632, DOI 10.4269/ajtmh.1970.19.632; KOURANY M, 1976, AM J TROP MED HYG, V25, P449, DOI 10.4269/ajtmh.1976.25.449; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Leonard EK, 2011, ZOONOSES PUBLIC HLTH, V58, P140, DOI 10.1111/j.1863-2378.2009.01320.x; Levantesi C, 2012, FOOD RES INT, V45, P587, DOI 10.1016/j.foodres.2011.06.037; Luque I, 2009, VET MICROBIOL, V134, P396, DOI 10.1016/j.vetmic.2008.08.015; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P4030, DOI 10.1128/AEM.70.7.4030-4034.2004; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P2089, DOI 10.1128/AEM.70.4.2089-2097.2004; McLaughlin MR, 2012, WATER RES, V46, P4949, DOI 10.1016/j.watres.2012.06.023; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller S, 2015, J WILDLIFE DIS, V51, P60, DOI 10.7589/2014-02-046; MORSE EV, 1976, AM J PUBLIC HEALTH, V66, P82, DOI 10.2105/AJPH.66.1.82; MORSE EV, 1983, J ENVIRON SCI HEAL A, V18, P541, DOI 10.1080/10934528309375122; Navarro-Gonzalez N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051614; Newell D. G., 2003, Microbial food safety in animal agriculture: current topics, P211, DOI 10.1002/9780470752616.ch22; Pedersen K, 2006, J WILDLIFE DIS, V42, P46, DOI 10.7589/0090-3558-42.1.46; Pesapane R, 2013, ECOHEALTH, V10, P115, DOI 10.1007/s10393-013-0838-2; Potter AS, 2011, J WILDLIFE DIS, V47, P880, DOI 10.7589/0090-3558-47.4.880; Ram JL, 2007, WATER RES, V41, P3605, DOI 10.1016/j.watres.2007.04.013; REILLY WJ, 1981, VET REC, V108, P553, DOI 10.1136/vr.108.26.553; RIVEST P, 1981, CAN J ZOOL, V59, P1755, DOI 10.1139/z81-241; Rodriguez A, 2006, J FOOD PROTECT, V69, P2576, DOI 10.4315/0362-028X-69.11.2576; Rosatte R, 2010, J MAMMAL, V91, P122, DOI 10.1644/08-MAMM-A-201R2.1; Saeed A.M., 1999, SALMONELLA ENTERICA, V1st; Schiellerup P, 2001, Ugeskr Laeger, V163, P5677; Smith K, 2000, CAMPYLOBACTER, P483; SONENSHINE DE, 1972, J WILDLIFE MANAGE, V36, P838, DOI 10.2307/3799438; Su LH, 2005, J ANTIMICROB CHEMOTH, V55, P846, DOI 10.1093/jac/dki116; Teale CJ, 2002, J APPL MICROBIOL, V92, p85S, DOI 10.1046/j.1365-2672.92.5s1.20.x; Thomas JL, 2013, J APPL MICROBIOL, V114, P907, DOI 10.1111/jam.12079; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; THOMASON BM, 1975, APPL MICROBIOL, V30, P764, DOI 10.1128/AEM.30.5.764-767.1975; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Very KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P223, DOI 10.1111/zph.12222; Veterinary Drugs Directorate, 2009, CAT ANT DRUGS BAS IM; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; WHITE FH, 1975, ARCH ENVIRON HEALTH, V30, P602, DOI 10.1080/00039896.1975.10666788; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; You YW, 2006, APPL ENVIRON MICROB, V72, P5777, DOI 10.1128/AEM.00791-06; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635; Ziemer CJ, 2010, J ANIM SCI, V88, pE84, DOI 10.2527/jas.2009-2331	83	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161497	10.1371/journal.pone.0161497	http://dx.doi.org/10.1371/journal.pone.0161497			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611198	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900018
J	Ding, H; Cao, L; Ren, YZ; Choo, KKR; Shi, BY				Ding, Hong; Cao, Lin; Ren, Yizhi; Choo, Kim-Kwang Raymond; Shi, Benyun			Reputation-Based Investment Helps to Optimize Group Behaviors in Spatial Lattice Networks	PLOS ONE			English	Article							REPLICATOR DYNAMICS; COOPERATION; EVOLUTION; SELECTION; GAMES	Encouraging cooperation among selfish individuals is crucial in many real-world systems, where individuals' collective behaviors can be analyzed using evolutionary public goods game. Along this line, extensive studies have shown that reputation is an effective mechanism to investigate the evolution of cooperation. In most existing studies, participating individuals in a public goods game are assumed to contribute unconditionally into the public pool, or they can choose partners based on a common reputation standard (e.g., preferences or characters). However, to assign one reputation standard for all individuals is impractical in many real-world deployment. In this paper, we introduce a reputation tolerance mechanism that allows an individual to select its potential partners and decide whether or not to contribute an investment to the public pool based on its tolerance to other individuals' reputation. Specifically, an individual takes part in a public goods game only if the number of participants with higher reputation exceeds the value of its tolerance. Moreover, in this paper, an individual's reputation can increase or decrease in a bounded interval based on its historical behaviors. We explore the principle that how the reputation tolerance and conditional investment mechanisms can affect the evolution of cooperation in spatial lattice networks. Our simulation results demonstrate that a larger tolerance value can achieve an environment that promote the cooperation of participants.	[Ding, Hong; Cao, Lin; Ren, Yizhi; Shi, Benyun] Hangzhou Dianzi Univ, Sch Comp Sci & Technol, Hangzhou 310018, Zhejiang, Peoples R China; [Ding, Hong; Ren, Yizhi; Shi, Benyun] Hangzhou Dianzi Univ, Minist Educ, Key Lab Complex Syst Modeling & Simulat, Hangzhou 310018, Zhejiang, Peoples R China; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA; [Choo, Kim-Kwang Raymond] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5059, Australia	Hangzhou Dianzi University; Hangzhou Dianzi University; University of Texas System; University of Texas at San Antonio (UTSA); University of South Australia	Ren, YZ; Shi, BY (corresponding author), Hangzhou Dianzi Univ, Sch Comp Sci & Technol, Hangzhou 310018, Zhejiang, Peoples R China.; Ren, YZ; Shi, BY (corresponding author), Hangzhou Dianzi Univ, Minist Educ, Key Lab Complex Syst Modeling & Simulat, Hangzhou 310018, Zhejiang, Peoples R China.	renyz@hdu.edu.cn; benyunshi@outlook.com	Choo, Kim-Kwang Raymond/A-3634-2009	Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Shi, Benyun/0000-0003-2734-3794	National Natural Science Foundation of China [61100194, 61272173, 81402760]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61100194 and 61272173): YRZ http://www.nsfc.gov.cn/ and National Natural Foundation of China (No.: 81402760): BYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036260; Cong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035776; Cuesta JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07843; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026117; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Hartig B, 2015, J BEHAV EXP ECON, V55, P48, DOI 10.1016/j.socec.2015.01.001; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Kamvar S.D., 2003, P 12 INT C WORLD WID, P640, DOI DOI 10.1145/775152.775242; Leigh SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062084; Li Z, 2012, IEEE T MOBILE COMPUT, V11, P1287, DOI 10.1109/TMC.2011.151; Morsky B, 2016, J THEOR BIOL, V404, P383, DOI 10.1016/j.jtbi.2016.06.020; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Pruitt JN, 2014, NATURE, V514, P359, DOI 10.1038/nature13811; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Shutters ST, 2015, JASSS-J ARTIF SOC S, V18, P1; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Tian LL, 2013, CHAOS SOLITON FRACT, V54, P65, DOI 10.1016/j.chaos.2013.05.017; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Uchida S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036111; Uchida S, 2010, J THEOR BIOL, V263, P13, DOI 10.1016/j.jtbi.2009.11.013; Wang XF, 2013, CHAOS SOLITON FRACT, V56, P181, DOI 10.1016/j.chaos.2013.07.019; Wang YF, 2015, IEEE T NETW SERV MAN, V12, P75, DOI 10.1109/TNSM.2015.2397883; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wu B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003381; Wu B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046106; Wu D, 2014, IEEE T VEH TECHNOL, V63, P4659, DOI 10.1109/TVT.2014.2315785; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Zhou RF, 2007, IEEE T PARALL DISTR, V18, P460, DOI [10.1109/TPDS.2007.1021, 10.1109/TPDS.2007.1015]; Zhuang WH, 2012, IEEE WIREL COMMUN, V19, P10, DOI 10.1109/MWC.2012.6189408	48	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162781	10.1371/journal.pone.0162781	http://dx.doi.org/10.1371/journal.pone.0162781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611686	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000383255900165
J	Guo, YY; Deng, YJ; Li, XQ; Ning, Y; Lin, XP; Guo, SM; Chen, MX; Han, M				Guo, YanYan; Deng, YuanJun; Li, XiaoQing; Ning, Yong; Lin, XuePing; Guo, ShuiMing; Chen, MeiXue; Han, Min			Glutaminolysis Was Induced by TGF-beta 1 through PP2Ac Regulated Raf-MEK-ERK Signaling in Endothelial Cells	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; GLUTAMINASE EXPRESSION; TUMOR-CELLS; METABOLISM; CANCER; PROLIFERATION; DEPHOSPHORYLATION; INHIBITION; ACTIVATION; KINASE	Vascular endothelial cells can survive under hypoxic and inflammatory conditions by alterations of the cellular energy metabolism. In addition to high rates of glycolysis, glutaminolysis is another importantway of providing the required energy to support cellular sprouting in such situations. However, the exact mechanism in which endothelial cells upregulate glutaminolysis remains unclear. Here we demonstrated that protein phosphatase 2A (PP2A)-mediated Raf-MEK-ERK signaling was involved in glutaminolysis in endothelial cells. Using models of human umbilical vein endothelial cells (HUVECs) treated with transforming growth factor-beta 1 (TGF-beta 1), we observed a dramatic induction in cellular glutamate levels accompanied by Raf-MEK-ERK activation. By addition of U0126, the specific inhibitor of MEK1/2, the expression of kidney-type glutaminase (KGA, a critical glutaminase in glutaminolysis) was significantly decreased. Moreover, inhibition of PP2A by okadaic acid (OA), a specific inhibitor of PP2A phosphatase activity or by depletion of its catalytic subunit (PP2Ac), led to a significant inactivation of Raf-MEK-ERK signaling and reduced glutaminolysis in endothelial cells. Taken together, these results indicated that PP2A-dependent Raf-MEK-ERK activation was involved in glutaminolysis and inhibition of PP2A signals was sufficient to block Raf-MEK-ERK pathway and reduced glutamine metabolism in endothelial cells.	[Guo, YanYan; Deng, YuanJun; Li, XiaoQing; Ning, Yong; Lin, XuePing; Guo, ShuiMing; Chen, MeiXue; Han, Min] Huazhong Univ Sicence & Technol, Tongji Hosp, Dept Nephrol, Div Internal Med,Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Han, M (corresponding author), Huazhong Univ Sicence & Technol, Tongji Hosp, Dept Nephrol, Div Internal Med,Tongji Med Coll, Wuhan, Hubei, Peoples R China.	minhan@tjh.tjmu.edu.cn			National Natural Science Foundation of China [81270770, 81370798, 81470948]; Natural Science Foundation of Hubei Province [2014CFB255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by grants of the National Natural Science Foundation of China (No. 81270770, 81370798, 81470948) and the Natural Science Foundation of Hubei Province (No. 2014CFB255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Aledo JC, 2004, BIOESSAYS, V26, P778, DOI 10.1002/bies.20063; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeLaBarre B, 2014, CHEM BIOL, V21, P1143, DOI 10.1016/j.chembiol.2014.08.007; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; Fukuda G, 2005, DIABETES-METAB RES, V21, P367, DOI 10.1002/dmrr.527; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Khan Zia Ali, 2003, Exp Diabesity Res, V4, P287, DOI 10.1155/EDR.2003.287; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Martin-Rufian M, 2014, J MOL MED, V92, P277, DOI 10.1007/s00109-013-1105-2; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Unterluggauer H, 2008, BIOGERONTOLOGY, V9, P247, DOI 10.1007/s10522-008-9134-x; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Welbourne T, 2001, NEWS PHYSIOL SCI, V16, P157, DOI 10.1152/physiologyonline.2001.16.4.157; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162658	10.1371/journal.pone.0162658	http://dx.doi.org/10.1371/journal.pone.0162658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612201	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900145
J	Pogue, SL; Taura, T; Bi, MY; Yun, Y; Sho, A; Mikesell, G; Behrens, C; Sokolovsky, M; Hallak, H; Rosenstock, M; Sanchez, E; Chen, HM; Berenson, J; Doyle, A; Nock, S; Wilson, DS				Pogue, Sarah L.; Taura, Tetsuya; Bi, Mingying; Yun, Yong; Sho, Angela; Mikesell, Glen; Behrens, Collette; Sokolovsky, Maya; Hallak, Hussein; Rosenstock, Moti; Sanchez, Eric; Chen, Haiming; Berenson, James; Doyle, Anthony; Nock, Steffen; Wilson, David S.			Targeting Attenuated Interferon-alpha to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODIES; CANCER-IMMUNOTHERAPY; RANDOMIZED-TRIALS; BONE-MARROW; IFN-ALPHA; MAINTENANCE; DELIVERY; THERAPY; PROTEIN	Interferon-alpha (IFN alpha) has been prescribed to effectively treat multiple myeloma (MM) and other malignancies for decades. Its use has waned in recent years, however, due to significant toxicity and a narrow therapeutic index (TI). We sought to improve IFN alpha's TI by, first, attaching it to an anti-CD38 antibody, thereby directly targeting it to MM cells, and, second, by introducing an attenuating mutation into the IFN alpha portion of the fusion protein rendering it relatively inactive on normal, CD38 negative cells. This anti-CD38-IFN alpha(attenuated) immunocytokine, or CD38-Attenukine (TM), exhibits 10,000-fold increased specificity for CD38 positive cells in vitro compared to native IFN alpha and, significantly, is similar to 6,000-fold less toxic to normal bone marrow cells in vitro than native IFN alpha. Moreover, the attenuating mutation significantly decreases IFN alpha biomarker activity in cynomolgus macaques indicating that this approach may yield a better safety profile in humans than native IFN alpha or a non-attenuated IFN alpha immunocytokine. In human xenograft MM tumor models, anti-CD38-IFN alpha(attenuated) exerts potent anti-tumor activity in mice, inducing complete tumor regression in most cases. Furthermore, anti-CD38-IFN alpha(attenuated) is more efficacious than standard MM treatments (lenalidomide, bortezomib, dexamethasone) and exhibits strong synergy with lenalidomide and with bortezomib in xenograft models. Our findings suggest that tumor-targeted attenuated cytokines such as IFN alpha can promote robust tumor killing while minimizing systemic toxicity.	[Pogue, Sarah L.; Taura, Tetsuya; Bi, Mingying; Yun, Yong; Sho, Angela; Mikesell, Glen; Nock, Steffen; Wilson, David S.] Teva Pharmaceut, Global Branded Biol Div, Redwood City, CA USA; [Behrens, Collette; Doyle, Anthony] Teva Pharmaceut, Global Branded Biol Div, Sydney, NSW, Australia; [Sokolovsky, Maya; Hallak, Hussein; Rosenstock, Moti] Teva Pharmaceut, Global Branded Biol Div, Netanya, Israel; [Sanchez, Eric; Chen, Haiming; Berenson, James] Inst Myeloma & Bone Canc Res, West Hollywood, CA USA	Teva Pharmaceutical Industries	Pogue, SL (corresponding author), Teva Pharmaceut, Global Branded Biol Div, Redwood City, CA USA.	Sarah.Pogue@tevapharm.com			Teva Pharmaceuticals; Teva	Teva Pharmaceuticals(Teva Pharmaceutical Industries); Teva(Teva Pharmaceutical Industries)	All studies presented in this manuscript were funded solely by Teva Pharmaceuticals and was not by any outside sources. Teva Pharmaceuticals provided support in the form of salaries for authors SP, TT, MB, YY, AS, GM, CB, MS, HH, MR, AD, SN, and DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Authors JB, HC, and ES are part of a non-profit organization, Institute of Myeloma and Bone Cancer Research, which performed studies in this manuscript. Teva Pharmaceuticals funded these studies.; We thank Darlene Jenkins, Ph.D., a writer funded by Teva, for providing drafts and edits of this manuscript. We gratefully acknowledge Maxwell Stevens and Teresa Domagala for provision of reagents and Simon Tout for thorough review of this manuscript.	Al-Zahrani H, 2003, LEUKEMIA LYMPHOMA, V44, P471, DOI 10.1080/1042819021000055066; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Campbell RA, 2006, INT J ONCOL, V28, P1409; Campbell Richard A, 2008, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1409s40; Chillemi A, 2014, FRONT BIOSCI-LANDMRK, V19, P152, DOI 10.2741/4201; Committee NRCU, 2011, GUIDE FOR THE CARE A; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dryden MW, 2005, VET THER, V6, P15; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; El-Amm J, 2015, AM J CLIN ONCOL-CANC, V38, P315, DOI 10.1097/COC.0b013e3182a4676b; Frey K, 2011, INTEGR BIOL-UK, V3, P468, DOI 10.1039/c0ib00099j; Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x; Fritz E, 2000, ANN ONCOL, V11, P1427, DOI 10.1023/A:1026548226770; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; Huang TH, 2007, J IMMUNOL, V179, P6881, DOI 10.4049/jimmunol.179.10.6881; Jeon S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-240; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kirkwood J, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.33078; Lin P, 2004, AM J CLIN PATHOL, V121, P482, DOI 10.1039/74R4TB90BUWH27JX; List T, 2013, CLIN PHARMACOL-ADV A, V5, P29, DOI 10.2147/CPAA.S49231; LUDWIG H, 1995, ANN ONCOL, V6, P467, DOI 10.1093/oxfordjournals.annonc.a059217; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; MELLSTEDT H, 1979, LANCET, V1, P245; OBrien S, 1996, LEUKEMIA LYMPHOMA, V23, P247, DOI 10.3109/10428199609054827; Olfert ED, 1993, GUIDE CARE USE EXPT; Osborn BL, 2002, J PHARMACOL EXP THER, V303, P540, DOI 10.1124/jpet.102.037002; OZZELLO L, 1993, BREAST CANCER RES TR, V25, P265, DOI 10.1007/BF00689841; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Rossi EA, 2011, BLOOD, V118, P1877, DOI 10.1182/blood-2011-03-343145; Rossi EA, 2009, BLOOD, V114, P3864, DOI 10.1182/blood-2009-06-228890; Rozewski DM, 2012, AAPS J, V14, P872, DOI 10.1208/s12248-012-9401-2; Santonocito AM, 2004, LEUKEMIA RES, V28, P469, DOI 10.1016/j.leukres.2003.09.015; Schaar CG, 2005, ANN ONCOL, V16, P634, DOI 10.1093/annonc/mdi125; SCHLESINGER JJ, 1983, VIROLOGY, V125, P8, DOI 10.1016/0042-6822(83)90059-4; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sondergeld P, 2015, CLIN ADV HEMATOL ONC, V13, P599; Stewart WEI, 1981, INTERFERON SYSTEM, P135; Thakur ML, 1997, J IMMUNOTHER, V20, P194, DOI 10.1097/00002371-199705000-00004; Trown PW, 1986, CANCER S, V57, P1648; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Yoo EM, 2015, J INTERF CYTOK RES, V35, P281, DOI 10.1089/jir.2014.0125	47	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162472	10.1371/journal.pone.0162472	http://dx.doi.org/10.1371/journal.pone.0162472			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611189	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900109
J	Uhde, AK; Herder, V; Khan, MA; Ciurkiewicz, M; Schaudien, D; Teich, R; Floess, S; Baumgartner, W; Huehn, J; Beineke, A				Uhde, Ann-Kathrin; Herder, Vanessa; Khan, Muhammad Akram; Ciurkiewicz, Malgorzata; Schaudien, Dirk; Teich, Rene; Floess, Stefan; Baumgaertner, Wolfgang; Huehn, Jochen; Beineke, Andreas			Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THEILERS MURINE ENCEPHALOMYELITIS; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; VIRUS-INFECTION; CROHNS-DISEASE; CYTOKINE PRODUCTION; MATRIX METALLOPROTEINASES	Theiler's murine encephalomyelitis virus (TMEV)-infection is a widely used animal model for studying demyelinating disorders, including multiple sclerosis (MS). The immunosuppressive cytokine Interleukin (IL)-10 counteracts hyperactive immune responses and critically controls immune homeostasis in infectious and autoimmune disorders. In order to investigate the effect of signaling via Interleukin-10 receptor (IL-10R) in infectious neurological diseases, TMEV-infected SJL mice were treated with IL-10R blocking antibody (Ab) in the acute and chronic phase of the disease. The findings demonstrate that (i) Ab-mediated IL-10 neutralization leads to progressive colitis with a reduction in Foxp3(+) regulatory T cells and increased numbers of CD8(+)CD44(+) memory T cells as well as activated CD4(+)CD69(+) and CD8(+)CD69(+) T cells in uninfected mice. (ii) Concurrent acute TMEV-infection worsened enteric disease-mediated by IL-10R neutralization. Virus-triggered effects were associated with an enhanced activation of CD4(+) T helper cells and CD8(+) cytotoxic T lymphocytes and augmented cytokine expression. By contrast, (iii) IL-10R neutralization during chronic TMEV-infection was not associated with enhanced peripheral immunopathology but an increased CD3(+) T cell influx in the spinal cord. IL-10R neutralization causes a breakdown in peripheral immune tolerance in genetically predisposed mice, which leads to immune-mediated colitis, resembling inflammatory bowel disease. Hyperactive immune state following IL-10R blockade is enhanced by central nervous system-restricted viral infection in a disease phase-dependent manner.	[Uhde, Ann-Kathrin; Herder, Vanessa; Khan, Muhammad Akram; Ciurkiewicz, Malgorzata; Baumgaertner, Wolfgang; Beineke, Andreas] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Herder, Vanessa; Khan, Muhammad Akram; Ciurkiewicz, Malgorzata; Baumgaertner, Wolfgang; Beineke, Andreas] Ctr Syst Neurosci, Hannover, Germany; [Khan, Muhammad Akram] PMAS Arid Agr Univ, Dept Pathobiol, Fac Vet & Anim Sci, Rawalpindi, Pakistan; [Schaudien, Dirk] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Teich, Rene; Floess, Stefan; Huehn, Jochen] Helmholtz Ctr Infect Res, Expt Immunol, Braunschweig, Germany	University of Veterinary Medicine Hannover, Foundation; Arid Agriculture University; Fraunhofer Gesellschaft; Helmholtz Association; Helmholtz-Center for Infection Research	Beineke, A (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.; Beineke, A (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	andreas.beineke@tiho-hannover.de	Herder, Vanessa/AAG-6647-2020	Khan, Muhammad Akram/0000-0003-2137-9614; Ciurkiewicz, Malgorzata/0000-0001-6277-7366; Herder, Vanessa/0000-0003-4814-1382	Deutsche Forschungsgemeinschaft (DFG) [BE 4200/1-2, HU 1300/5-2]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of Ministry of Science and Culture of Lower Saxony	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of Ministry of Science and Culture of Lower Saxony	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 4200/1-2; HU 1300/5-2) and in part by a grant from the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Bettina Buck, Petra Grunig, Kerstin Schone, Caroline Schutz, Danuta Waschke, Kirsten Lohr and Beate Pietzsch for the excellent technical support. The BeAn-strain of TMEV was a generous gift of Prof. Dr. H. L. Lipton (Department of Microbiology-Immunology, University of Illinois, Chicago, IL, USA). This study was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 4200/1-2; HU 1300/5-2) and in part by a grant from the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony.	Alkhawajah MM, 2013, MULT SCLER J, V19, P259, DOI 10.1177/1352458512461393; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Ban H, 2008, MOL MED REP, V1, P647, DOI 10.3892/mmr_00000006; Begue B, 2011, AM J GASTROENTEROL, V106, P1544, DOI 10.1038/ajg.2011.112; Belz GT, 2009, IMMUNOL CELL BIOL, V87, P364, DOI 10.1038/icb.2009.22; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bosca-Watts Marta Maia, 2015, World J Gastrointest Pathophysiol, V6, P1, DOI 10.4291/wjgp.v6.i1.1; Bowen JL, 2009, J IMMUNOL, V183, P6971, DOI 10.4049/jimmunol.0902193; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Calderon-Gomez E, 2016, GASTROENTEROLOGY; Charles PC, 1999, J NEUROIMMUNOL, V100, P64, DOI 10.1016/S0165-5728(99)00189-7; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Creery WD, 1996, EUR J IMMUNOL, V26, P1273, DOI 10.1002/eji.1830260614; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; DELPRETE G, 1993, J IMMUNOL, V150, P353; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; Ebert EC, 2009, CLIN EXP IMMUNOL, V155, P65, DOI 10.1111/j.1365-2249.2008.03802.x; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Embry Ashton F., 2004, Journal of Nutritional & Environmental Medicine (Abingdon), V14, P307, DOI 10.1080/13590840500088289; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Frede N, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-10; Funderburg NT, 2013, IMMUNOLOGY, V140, P87, DOI 10.1111/imm.12114; Garcia-Vega E, 2004, BEHAV RES THER, V42, P367, DOI 10.1016/S0005-7967(03)00146-3; Gerhauser I, 2007, J NEUROPATH EXP NEUR, V66, P809, DOI 10.1097/nen.0b013e3181461f31; Gerhauser I, 2007, J NEUROIMMUNOL, V188, P86, DOI 10.1016/j.jneuroim.2007.05.019; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Groters S, 2005, ACTA NEUROPATHOL, V110, P369, DOI 10.1007/s00401-005-1055-z; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hang L, 2013, J IMMUNOL, V191, P1927, DOI 10.4049/jimmunol.1201457; Hansenne I, 2009, NEUROIMMUNOMODULAT, V16, P35, DOI 10.1159/000179665; Hansmann F, 2012, ACTA NEUROPATHOL, V124, P127, DOI 10.1007/s00401-012-0942-3; Heinrich F, 2015, VET IMMUNOL IMMUNOP, V168, P140, DOI 10.1016/j.vetimm.2015.10.015; Herder V, 2014, BRAIN PATHOL; Herder V, 2012, J NEUROIMMUNOL, V249, P27, DOI 10.1016/j.jneuroim.2012.04.010; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Ito S, 1999, BLOOD, V93, P1456, DOI 10.1182/blood.V93.5.1456; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; James JA, 1998, J IMMUNOL, V160, P502; Jin YH, 2007, J VIROL, V81, P11690, DOI 10.1128/JVI.01034-07; Jin YH, 2013, J VIROL, V87, P11538, DOI 10.1128/JVI.01967-13; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kayama H, 2012, INT IMMUNOL, V24, P673, DOI 10.1093/intimm/dxs094; Kreutzer M, 2012, BRAIN PATHOL, V22, P454, DOI 10.1111/j.1750-3639.2011.00541.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kummerfeld M, 2012, INTERVIROLOGY, V55, P401, DOI 10.1159/000336563; Kummerfeld M, 2009, J VIROL METHODS, V160, P185, DOI 10.1016/j.jviromet.2009.04.030; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann Hans, 2009, Rinsho Shinkeigaku, V49, P715; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Li BF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7131; Li J, 2004, AM J GASTROENTEROL, V99, P1129, DOI 10.1111/j.1572-0241.2004.04155.x; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lin MT, 1998, VIROLOGY, V245, P270, DOI 10.1006/viro.1998.9170; Lindsey JW, 1996, IMMUNOGENETICS, V44, P292, DOI 10.1007/s002510050126; Lipton H L, 1976, UCLA Forum Med Sci, P263; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Lord JD, 2015, WORLD J GASTROENTERO, V21, P11236, DOI 10.3748/wjg.v21.i40.11236; Lord JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136485; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Lutz C, 2015, CLIN EXP IMMUNOL, V181, P343, DOI 10.1111/cei.12635; MALEFYT RD, 1991, J EXP MED, V174, P915; Mardini HE, 2004, DIGEST DIS SCI, V49, P492, DOI 10.1023/B:DDAS.0000020509.23162.cc; Marlow GJ, 2013, WORLD J GASTROENTERO, V19, P3931, DOI 10.3748/wjg.v19.i25.3931; Massacesi L, 2002, CLIN NEUROL NEUROSUR, V104, P177, DOI 10.1016/S0303-8467(02)00035-5; Matullo CM, 2010, J VIROL, V84, P312, DOI 10.1128/JVI.00727-09; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Meinl E, 2008, J NEUROL SCI, V274, P42, DOI 10.1016/j.jns.2008.06.032; Monteyne P, 1997, IMMUNOL REV, V159, P163, DOI 10.1111/j.1600-065X.1997.tb01014.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moore TC, 2012, J VIROL, V86, P10841, DOI 10.1128/JVI.01402-12; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray PD, 1998, J NEUROSCI, V18, P7306; Navarrete-Talloni MJ, 2010, BRAIN PATHOL, V20, P890, DOI 10.1111/j.1750-3639.2010.00383.x; Niino M, 2014, J NEUROIMMUNOL, V270, P86, DOI 10.1016/j.jneuroim.2014.03.011; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Nouri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106335; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Owens GP, 2009, ANN NEUROL, V65, P639, DOI 10.1002/ana.21641; Pachner AR, 2011, J NEUROIMMUNOL, V232, P35, DOI 10.1016/j.jneuroim.2010.09.026; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Peltoniemi J, 2002, J NEUROIMMUNOL, V132, P83, DOI 10.1016/S0165-5728(02)00312-0; Podojil JR, 2013, J AUTOIMMUN, V44, P71, DOI 10.1016/j.jaut.2013.04.001; Pringproa K, 2008, INT J DEV NEUROSCI, V26, P283, DOI 10.1016/j.ijdevneu.2008.01.008; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Richards MH, 2011, J AUTOIMMUN, V36, P142, DOI 10.1016/j.jaut.2010.12.005; Richter K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003735; Rocha CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085923; RODRIGUEZ M, 1994, J IMMUNOL, V153, P3811; Rodriguez M, 1996, J IMMUNOL, V157, P5699; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; ROSE NR, 1973, CLIN EXP IMMUNOL, V15, P281; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SADOVNICK AD, 1989, NEW ENGL J MED, V321, P762; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Shim JO, 2014, J HUM GENET, V59, P337, DOI 10.1038/jhg.2014.32; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; SMITH QR, 1993, ADV EXP MED BIOL, V331, P83; SOUZA CMD, 1974, J IMMUNOL, V112, P1369; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Stasi C, 2008, DIGEST DIS, V26, P156, DOI 10.1159/000116774; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Trandem K, 2011, J VIROL, V85, P6822, DOI 10.1128/JVI.00510-11; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; Tsunoda I, 2008, FUTURE VIROL, V3, P579, DOI 10.2217/17460794.3.6.579; Uhlig HH, 2014, GASTROENTEROLOGY, V147, P990, DOI 10.1053/j.gastro.2014.07.023; Ulrich R, 2008, NEUROPATH APPL NEURO, V34, P603, DOI 10.1111/j.1365-2990.2008.00956.x; Ulrich R, 2005, DEV NEUROSCI-BASEL, V27, P408, DOI 10.1159/000088455; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; Ulrich R, 2010, J CELL MOL MED, V14, P434, DOI 10.1111/j.1582-4934.2008.00646.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Yacyshyn B, 1996, DIGEST DIS SCI, V41, P2493, DOI 10.1007/BF02100148; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	129	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161883	10.1371/journal.pone.0161883	http://dx.doi.org/10.1371/journal.pone.0161883			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611574	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000383255900034
J	Dunker, KJ; Sepulveda, AJ; Massengill, RL; Olsen, JB; Russ, OL; Wenburg, JK; Antonovich, A				Dunker, Kristine J.; Sepulveda, Adam J.; Massengill, Robert L.; Olsen, Jeffrey B.; Russ, Ora L.; Wenburg, John K.; Antonovich, Anton			Potential of Environmental DNA to Evaluate Northern Pike (Esox lucius) Eradication Efforts: An Experimental Test and Case Study	PLOS ONE			English	Article							SOUTH-CENTRAL ALASKA; FISH; STREAM; EDNA; SALMONIDS; CONSUMPTION; SEDIMENTS; WATER; RIVER; TIME	Determining the success of invasive species eradication efforts is challenging because populations at very low abundance are difficult to detect. Environmental DNA (eDNA) sampling has recently emerged as a powerful tool for detecting rare aquatic animals; however, detectable fragments of DNA can persist over time despite absence of the targeted taxa and can therefore complicate eDNA sampling after an eradication event. This complication is a large concern for fish eradication efforts in lakes since killed fish can sink to the bottom and slowly decay. DNA released from these carcasses may remain detectable for long periods. Here, we evaluated the efficacy of eDNA sampling to detect invasive Northern pike (Esox lucius) following piscicide eradication efforts in southcentral Alaskan lakes. We used field observations and experiments to test the sensitivity of our Northern pike eDNA assay and to evaluate the persistence of detectable DNA emitted from Northern pike carcasses. We then used eDNA sampling and traditional sampling (i.e., gillnets) to test for presence of Northern pike in four lakes subjected to a piscicide-treatment designed to eradicate this species. We found that our assay could detect an abundant, free-roaming population of Northern pike and could also detect low-densities of Northern pike held in cages. For these caged Northern pike, probability of detection decreased with distance from the cage. We then stocked three lakes with Northern pike carcasses and collected eDNA samples 7, 35 and 70 days post-stocking. We detected DNA at 7 and 35 days, but not at 70 days. Finally, we collected eDNA samples similar to 230 days after four lakes were subjected to piscicide-treatments and detected Northern pike DNA in 3 of 179 samples, with a single detection at each of three lakes, though we did not catch any Northern pike in gillnets. Taken together, we found that eDNA can help to inform eradication efforts if used in conjunction with multiple lines of inquiry and sampling is delayed long enough to allow full degradation of DNA in the water.	[Dunker, Kristine J.; Antonovich, Anton] Alaska Dept Fish & Game, Sport Fish Div, 333 Raspberry Rd, Anchorage, AK 99518 USA; [Sepulveda, Adam J.] US Geol Survey, Northen Rocky Mt Sci Ctr, Bozeman, MT USA; [Massengill, Robert L.] Alaska Dept Fish & Game, Sport Fish Div, Soldotna, AK USA; [Olsen, Jeffrey B.; Russ, Ora L.; Wenburg, John K.] US Fish & Wildlife Serv, Conservat Genet Lab, Anchorage, AK USA	Alaska Department of Fish & Game; United States Department of the Interior; United States Geological Survey; Alaska Department of Fish & Game; United States Department of the Interior; US Fish & Wildlife Service	Sepulveda, AJ (corresponding author), US Geol Survey, Northen Rocky Mt Sci Ctr, Bozeman, MT USA.	asepulveda@usgs.gov	Wenburg, John/Y-4373-2019	Wenburg, John/0000-0001-9831-1672	Alaska Sustainable Salmon Fund; National Habitat Partnership; US Fish and Wildlife Service	Alaska Sustainable Salmon Fund; National Habitat Partnership; US Fish and Wildlife Service(US Fish & Wildlife Service)	Support was provided by Alaska Sustainable Salmon Fund (to KJM, RLM); National Habitat Partnership (Kenai Peninsula Chapter) to (to KJM, RLM); and US Fish and Wildlife Service (to JBO, OLR, JKW).	[Anonymous], 2006, SAS MIXED MODELS; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bradbury A., 1986, ROTENONE TROUT STOCK; Campbell K, 2004, ORYX, V38, P328, DOI 10.1017/S0030605304000572; Carim KJ, 2015, PROTOCOL COLLECTING; Casselman JM, 1996, CAN J FISH AQUAT SCI, V53, P161, DOI 10.1139/cjfas-53-S1-161; Clout M.N., 2002, TURNING TIDE ERADICA, P1; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; DAWSON V K, 1991, North American Journal of Fisheries Management, V11, P226, DOI 10.1577/1548-8675(1991)011<0226:RPIFPE>2.3.CO;2; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dunker KJ, 2013, ALEXANDER CREEK NO P; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Finlayson B, 2005, FISHERIES, V30, P10, DOI 10.1577/1548-8446(2005)30[10:NITRON]2.0.CO;2; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; INCE BW, 1976, J FISH BIOL, V8, P79, DOI 10.1111/j.1095-8649.1976.tb03909.x; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Johnson BM, 2008, N AM J FISH MANAGE, V28, P1941, DOI 10.1577/M07-199.1; Knapp RA, 1998, RESTOR ECOL, V6, P207, DOI 10.1111/j.1526-100X.1998.06212.x; Laramie MB, US GEOLOGICAL SURVEY, P15; Ling N, 2003, ROTENONE REV ITS TOX; Mack R. N, 2002, TURNING TIDE ERADICA, P164; Massengill RL, 2008, ALASKA DEP FISH GAME, V14-12; Massengill RL, 2011, FISHERY DATA SERIES, P11; Matisoo-Smith E, 2008, QUATERN INT, V184, P139, DOI 10.1016/j.quaint.2007.09.013; Morrison SA, 2007, FRONT ECOL ENVIRON, V5, P271, DOI 10.1890/1540-9295(2007)5[271:FTDAEE]2.0.CO;2; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Muhlfeld CC, 2008, N AM J FISH MANAGE, V28, P636, DOI 10.1577/M07-004.1; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Olsen JB, 2016, CONSERV GENET RESOUR, V8, P89, DOI 10.1007/s12686-016-0526-y; Olsen JB, 2015, CONSERV GENET RESOUR, V7, P615, DOI 10.1007/s12686-015-0459-x; Oslund S, 2011, RECREATIONAL FISHERI; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rayner TS, 2006, NEW ZEAL J MAR FRESH, V40, P477, DOI 10.1080/00288330.2006.9517437; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rout TM, 2009, J APPL ECOL, V46, P782, DOI 10.1111/j.1365-2664.2009.01678.x; Sepulveda AJ, 2015, ECOL FRESHW FISH, V24, P519, DOI 10.1111/eff.12164; Sepulveda AJ, 2013, ECOL FRESHW FISH, V22, P268, DOI 10.1111/eff.12024; Simberloff D, 2009, BIOL INVASIONS, V11, P149, DOI 10.1007/s10530-008-9317-z; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thresher RE, 2008, FISHERIES, V33, P114, DOI 10.1577/1548-8446-33.3.114; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2015, CONSERV GENET, P1	49	50	53	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162277	10.1371/journal.pone.0162277	http://dx.doi.org/10.1371/journal.pone.0162277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626271	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600028
J	Grosse-Kreul, J; Busch, M; Winter, C; Pikos, S; Stephan, H; Dunker, N				Grosse-Kreul, Jan; Busch, Maike; Winter, Claudia; Pikos, Stefanie; Stephan, Harald; Duenker, Nicole			Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines	PLOS ONE			English	Article							GASTRIC-MUCOSAL EPITHELIUM; SIGNALING PATHWAY; MAMMARY-CARCINOMA; IN-VITRO; APOPTOSIS; DISEASE; CANCER; MIGRATION; DIFFERENTIATION; PROGRESSION	Trefoil factor family (TFF) peptides have been shown to effect cell proliferation, apoptosis, migration and invasion of normal cells and various cancer cell lines. In the literature TFF peptides are controversially discussed as tumor suppressors and potential tumor progression factors. In the study presented, we investigated the effect of TFF3 overexpression on growth, viability, migration and tumorigenicity of the human retinoblastoma cell lines Y-79, WERI-Rb1, RBL-13 and RBL-15. As revealed by WST-1 and TUNEL assays as well as DAPI and BrdU cell counts, recombinant human TFF3 significantly lowers retinoblastoma cell viability and increases apoptosis levels. Transient TFF3 overexpression likewise significantly increases RB cell apoptosis. Stable, lentiviral TFF3 overexpression lowers retinoblastoma cell viability, proliferation and growth and significantly increases cell death in retinoblastoma cells. Blockage experiments using a broad-spectrum caspase inhibitor and capase-3 immunocytochemistry revealed the involvement of caspases in general and of caspase-3 in particular in TFF3 induced apoptosis in retinoblastoma cell lines. Soft agarose and in ovo chicken chorioallantoic membrane (CAM) assays revealed that TFF3 overexpression influences anchorage independent growth and significantly decreases the size of tumors forming from retinoblastoma cells. Our study demonstrates that forced TFF3 expression exerts a significant pro-apoptotic, anti-proliferative, and tumor suppressive effect in retinoblastoma cells, setting a starting point for new additive chemotherapeutic approaches in the treatment of retinoblastoma.	[Grosse-Kreul, Jan; Busch, Maike; Winter, Claudia; Pikos, Stefanie; Duenker, Nicole] Univ Duisburg, Inst Anat 2, Fac Med, Dept Neuroanat, Essen, Germany; [Stephan, Harald] Univ Duisburg, Childrens Hosp, Div Haematol & Oncol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Busch, M; Dunker, N (corresponding author), Univ Duisburg, Inst Anat 2, Fac Med, Dept Neuroanat, Essen, Germany.	maike.busch@uk-essen.de; nicole.duenker@uk-essen.de	Stephan, Harald/AAT-6802-2021; Busch, Maike Anna/AGI-3929-2022	Busch, Maike Anna/0000-0001-9651-031X; Dunker, Nicole/0000-0003-1273-0644	Else Kroner Fresenius Stiftung foundation	Else Kroner Fresenius Stiftung foundation	This work was supported by the Else Kroner Fresenius Stiftung foundation (http://www.ekfs.de/de/die-stiftung/) to JG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abols A, 2015, NEOPLASMA, V62, P914, DOI 10.4149/neo_2015_111; Belovari T, 2015, BOSNIAN J BASIC MED, V15, P33, DOI 10.17305/bjbms.2015.251; Bernstein HG, 2015, AMINO ACIDS, V47, P1053, DOI 10.1007/s00726-015-1938-9; Bossenmeyer-Pourie C, 2002, J CELL BIOL, V157, P761, DOI 10.1083/jcb200108056; Busch M, 2014, HISTOCHEM CELL BIOL, V34, P1001; Busch Maike, 2015, BioMolecular Concepts, V6, P343, DOI 10.1515/bmc-2015-0020; Chen YH, 2000, BIOCHEM BIOPH RES CO, V274, P576, DOI 10.1006/bbrc.2000.3176; Dieckow J, 2016, INVEST OPHTH VIS SCI, V57, P56, DOI 10.1167/iovs.15-18129; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Goke MN, 2001, EXP CELL RES, V264, P337, DOI 10.1006/excr.2000.5116; GRIEGEL S, 1990, INT J CANCER, V46, P125, DOI 10.1002/ijc.2910460123; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Haubold M, 2010, INT J BIOL SCI, V6, P700; Hinz M, 2004, PEPTIDES, V25, P827, DOI 10.1016/j.peptides.2004.01.020; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; HOFFMANN W, 1993, TRENDS BIOCHEM SCI, V18, P239, DOI 10.1016/0968-0004(93)90170-R; Hoffmann W, 2013, HDB BIOL ACTIVE PEPT, P1338; Kannan N, 2010, NEOPLASIA, V12, P1041, DOI 10.1593/neo.10916; Khoury Thaer, 2005, Int J Gastrointest Cancer, V35, P171, DOI 10.1385/IJGC:35:3:171; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lin JF, 2015, MOL CELL BIOCHEM, V404, P263, DOI 10.1007/s11010-015-2386-2; Lubka M, 2009, J APPL GENET, V50, P167, DOI 10.1007/BF03195669; MCFALL RC, 1977, CANCER RES, V37, P1003; Montoya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138366; Palmer TD, 2011, JOVE-J VIS EXP, DOI 10.3791/2815; Pandey V, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0429-3; Paulsen FP, 2008, J BIOL CHEM, V283, P13418, DOI 10.1074/jbc.M800177200; Paunel-Gorgulu AN, 2011, HISTOCHEM CELL BIOL, V135, P461, DOI 10.1007/s00418-011-0810-6; Perera O, 2015, CANCER LETT, V361, P104, DOI 10.1016/j.canlet.2015.02.051; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Philippeit C, 2014, CELL PHYSIOL BIOCHEM, V34, P1001, DOI 10.1159/000366316; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Rickman DS, 2010, NEOPLASIA, V12, P1031, DOI 10.1593/neo.10866; Rosler S, 2010, ARTHRITIS RHEUM-US, V62, P815, DOI 10.1002/art.27295; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schulze U, 2014, INVEST OPHTH VIS SCI, V55, P3037, DOI 10.1167/iovs.13-13423; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Storesund T, 2009, EUR J ORAL SCI, V117, P511, DOI 10.1111/j.1600-0722.2009.00652.x; Sun ZR, 2014, INT J ONCOL, V45, P1123, DOI 10.3892/ijo.2014.2527; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; TOMITA M, 1995, BIOCHEM J, V311, P293, DOI 10.1042/bj3110293; Uchino H, 1999, Hum Cell, V12, P181; Uchino H, 2000, GASTROENTEROLOGY, V118, P60, DOI 10.1016/S0016-5085(00)70414-8; Weise A, 2013, HISTOCHEM CELL BIOL, V139, P323, DOI 10.1007/s00418-012-1028-y; Wright NA, 1997, FEBS LETT, V408, P121, DOI 10.1016/S0014-5793(97)00424-9; Yamachika T, 2002, CLIN CANCER RES, V8, P1092; Yio XY, 2005, CLIN EXP METASTAS, V22, P157, DOI 10.1007/s10585-005-6615-z; Zijlstra A, 2002, CANCER RES, V62, P7083	52	9	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0163025	10.1371/journal.pone.0163025	http://dx.doi.org/10.1371/journal.pone.0163025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626280	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600073
J	Maitre, J; Paillard, T				Maitre, Julien; Paillard, Thierry			Postural Effects of Vestibular Manipulation Depend on the Physical Activity Status	PLOS ONE			English	Article							PAROXYSMAL POSITIONAL VERTIGO; VESTIBULOOCULAR REFLEX; SELF-MOTION; GALVANIC STIMULATION; CUPULAR DEPOSITS; VISUAL CUES; BODY; HABITUATION; SYSTEM; RESPONSES	The purpose of this study was to compare the effects of galvanic vestibular stimulation (GVS) on postural control for participants of different physical activity status (i.e. active and non-active). Two groups of participants were recruited: one group of participants who regularly practised sports activities (active group, n = 17), and one group of participants who did not practise physical and/or sports activities (non-active group, n = 17). They were compared in a reference condition (i.e bipedal stance with eyes open) and four vestibular manipulation condition (i.e. GVS at 0.5 mA and 3 mA, in accordance with two designs) lasting 20 seconds. The centre of foot pressure displacement velocities were compared between the two groups. The main results indicate that the regular practice of sports activities counteracts postural control disruption caused by GVS. The active group demonstrated better postural control than the non-active group when subjected to higher vestibular manipulation. The active group may have developed their ability to reduce the influence of inaccurate vestibular signals. The active participants could identify the relevant sensory input, thought a better central integration, which enables them to switch faster between sensory inputs.	[Maitre, Julien; Paillard, Thierry] Univ Pau & Pays Adour, EA 4445, Dept STAPS, Lab Mouvement Equilibre Performance & Sante, Tarbes, France	Universite de Pau et des Pays de l'Adour	Maitre, J (corresponding author), Univ Pau & Pays Adour, EA 4445, Dept STAPS, Lab Mouvement Equilibre Performance & Sante, Tarbes, France.	maitre.julien@univ-pau.fr	Maitre, Julien/L-7972-2019	Maitre, Julien/0000-0001-9630-0240	Association Nationale de la Recherche et de la Technologie; Conseil General des Hautes Pyrenees	Association Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Conseil General des Hautes Pyrenees(Region Occitanie)	The investigation was supported by grants from the Association Nationale de la Recherche et de la Technologie and the Conseil General des Hautes Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini D, 2009, SPORT SCI HLTH, V5, P129, DOI DOI 10.1007/S1S1332-009-00888-4; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Balter SGT, 2004, ACTA OTO-LARYNGOL, V124, P1015, DOI 10.1080/00016480410015730; Balter SGT, 2004, NEUROSCI LETT, V366, P71, DOI 10.1016/j.neulet.2004.05.015; Banfield GK, 2000, J LARYNGOL OTOL, V114, P501; Bonan IV, 2016, CLIN NEUROPHYSIOL, V127, P842, DOI 10.1016/j.clinph.2015.03.026; Bonan IV, 2013, CLIN NEUROPHYSIOL, V124, P713, DOI 10.1016/j.clinph.2012.09.019; Bringoux L, 2000, J VESTIBUL RES-EQUIL, V10, P251; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; BRONSTEIN AM, 1986, EXP BRAIN RES, V63, P655, DOI 10.1007/BF00237488; Cauquil AS, 1997, GAIT POSTURE, V6, P210, DOI 10.1016/S0966-6362(97)00011-8; Cauquil AS, 1998, NEUROSCI LETT, V245, P37, DOI 10.1016/S0304-3940(98)00161-X; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Clement G, 2001, EUR J APPL PHYSIOL, V85, P539, DOI 10.1007/s004210100494; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; Clement G, 2007, J VESTIBUL RES-EQUIL, V17, P227; Clement G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111107; Clendaniel RA, 2010, J NEUROL PHYS THER, V34, P111, DOI 10.1097/NPT.0b013e3181deca01; CREMIEUX J, 1994, PERCEPT MOTOR SKILL, V78, P67, DOI 10.2466/pms.1994.78.1.67; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Denise P., 2005, SCI MOT, V55, P101, DOI [10.3917/sm.055.0101, DOI 10.3917/SM.055.0101]; Deshpande N, 2007, EXP BRAIN RES, V176, P43, DOI 10.1007/s00221-006-0593-5; Deveze A, 2014, NEUROPHYSIOL CLIN, V44, P49, DOI 10.1016/j.neucli.2013.10.138; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Eikema DJA, 2014, NEUROSCI LETT, V561, P112, DOI 10.1016/j.neulet.2013.12.048; Ferre ER, 2013, NEUROSCI LETT, V550, P35, DOI 10.1016/j.neulet.2013.06.046; Ferre ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086379; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Forbes PA, 2015, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00094; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; Gibb R, 2011, AVIAT SPACE ENVIR MD, V82, P717, DOI 10.3357/ASEM.3048.2011; Grunfeld EA, 2000, J VESTIBUL RES-EQUIL, V10, P193; Hartmann M, 2014, EXP BRAIN RES, V232, P1249, DOI 10.1007/s00221-014-3841-0; Heroux ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124532; Hopper Diana M, 2014, J Dance Med Sci, V18, P67, DOI 10.12678/1089-313X.18.2.67; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Isableu B, 1998, HUM MOVEMENT SCI, V17, P367, DOI 10.1016/S0167-9457(98)00005-0; Kerrigan MA, 2013, PM&R, V5, P778, DOI 10.1016/j.pmrj.2013.05.010; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; Kim KS, 2013, J INT ADV OTOL, V9, P175; Kusunoki T, 2005, J LARYNGOL OTOL, V119, P87, DOI 10.1258/0022215053420040; LACOUR M, 1974, ACTA OTO-LARYNGOL, V78, P399, DOI 10.3109/00016487409126372; Lee MY, 2004, LARYNGOSCOPE, V114, P897, DOI 10.1097/00005537-200405000-00021; Lopez C, 2015, MULTISENS RES, V28, P525, DOI 10.1163/22134808-00002490; Maitre J, 2015, SCAND J MED SCI SPOR, V25, pE82, DOI 10.1111/sms.12256; Maitre J, 2013, EUR J APPL PHYSIOL, V113, P1821, DOI 10.1007/s00421-013-2608-9; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; MERGNER T, 1995, MULTISENSORY CONTROL OF POSTURE, P157; MORIARTY B, 1992, LARYNGOSCOPE, V102, P56; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Negahban H, 2013, GAIT POSTURE, V38, P226, DOI 10.1016/j.gaitpost.2012.11.016; Otsuka K, 2003, ACTA OTO-LARYNGOL, V123, P515, DOI 10.1080/0036554021000028094; Paillard T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891390; Paillard T, 2011, EUR J APPL PHYSIOL, V111, P1619, DOI 10.1007/s00421-010-1782-2; PARNES LS, 1992, LARYNGOSCOPE, V102, P988; Schmidt L, 2013, NEUROPSYCHOLOGIA, V51, P893, DOI 10.1016/j.neuropsychologia.2013.02.013; Sharoni Z, 2001, ANN OTO RHINOL LARYN, V110, P127, DOI 10.1177/000348940111000207; SHELHAMER M, 1994, EXP BRAIN RES, V100, P328; Son GML, 2008, J APPL PHYSIOL, V105, P1210, DOI 10.1152/japplphysiol.01398.2006; St George RJ, 2011, J PHYSIOL-LONDON, V589, P807, DOI 10.1113/jphysiol.2010.197665; Tanguy S, 2008, EUR J APPL PHYSIOL, V104, P1031, DOI 10.1007/s00421-008-0859-7; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; TERAMOTO K, 1994, EUR ARCH OTO-RHINO-L, V251, P218, DOI 10.1007/BF00628427; TILIKET C, 1994, EXP BRAIN RES, V100, P316; Vrabec JT, 1998, ARCH OTOLARYNGOL, V124, P223, DOI 10.1001/archotol.124.2.223; Wardman DL, 2002, ADV EXP MED BIOL, V508, P119; Welling DB, 1997, LARYNGOSCOPE, V107, P90, DOI 10.1097/00005537-199701000-00018; Yang Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/567690; Yelnik AP, 2006, GAIT POSTURE, V24, P262, DOI 10.1016/j.gaitpost.2005.09.007	74	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162966	10.1371/journal.pone.0162966	http://dx.doi.org/10.1371/journal.pone.0162966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627441	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600069
J	Oelze, VM; Douglas, PH; Stephens, CR; Surbeck, M; Behringer, V; Richards, MP; Fruth, B; Hohmann, G				Oelze, Vicky M.; Douglas, Pamela Heidi; Stephens, Colleen R.; Surbeck, Martin; Behringer, Verena; Richards, Michael P.; Fruth, Barbara; Hohmann, Gottfried			The Steady State Great Ape? Long Term Isotopic Records Reveal the Effects of Season, Social Rank and Reproductive Status on Bonobo Feeding Behavior	PLOS ONE			English	Article							TAI-NATIONAL-PARK; PAN-PANISCUS; DIETARY VARIABILITY; WILD CHIMPANZEES; STABLE-ISOTOPES; LOMAKO FOREST; HAIR; CONSUMPTION; DELTA-N-15; RATIOS	Dietary ecology of extant great apes is known to respond to environmental conditions such as climate and food availability, but also to vary depending on social status and life history characteristics. Bonobos (Pan paniscus) live under comparatively steady ecological conditions in the evergreen rainforests of the Congo Basin. Bonobos are an ideal species for investigating influences of sociodemographic and physiological factors, such as female reproductive status, on diet. We investigate the long term dietary pattern in wild but fully habituated bonobos by stable isotope analysis in hair and integrating a variety of long-term sociodemographic information obtained through observations. We analyzed carbon and nitrogen stable isotopes in 432 hair sections obtained from 101 non-invasively collected hair samples. These samples represented the dietary behavior of 23 adult bonobos from 2008 through 2010. By including isotope and crude protein data from plants we could establish an isotope baseline and interpret the results of several general linear mixed models using the predictors climate, sex, social rank, reproductive state of females, adult age and age of infants. We found that low canopy foliage is a useful isotopic tracer for tropical rainforest settings, and consumption of terrestrial herbs best explains the temporal isotope patterns we found in carbon isotope values of bonobo hair. Only the diet of male bonobos was affected by social rank, with lower nitrogen isotope values in low-ranking young males. Female isotope values mainly differed between different stages of reproduction (cycling, pregnancy, lactation). These isotopic differences appear to be related to changes in dietary preference during pregnancy (high protein diet) and lactation (high energy diet), which allow to compensate for different nutritional needs during maternal investment.	[Oelze, Vicky M.; Douglas, Pamela Heidi; Stephens, Colleen R.; Surbeck, Martin; Behringer, Verena; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Saxony, Germany; [Oelze, Vicky M.] IDiv German Ctr Integrat Biodivers Res, Leipzig, Saxony, Germany; [Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Saxony, Germany; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC, Canada; [Fruth, Barbara] Ludwig Maximilians Univ Munchen, Div Neurobiol, Bavaria, Germany; [Fruth, Barbara] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Flanders, Belgium	Max Planck Society; Max Planck Society; University of British Columbia; University of Munich	Oelze, VM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Saxony, Germany.; Oelze, VM (corresponding author), IDiv German Ctr Integrat Biodivers Res, Leipzig, Saxony, Germany.	viktoria_oelze@eva.mpg.de	Richards, Michael/O-3717-2016; Behringer, Verena/AAE-9054-2022	Richards, Michael/0000-0001-5274-8887; Behringer, Verena/0000-0001-6338-7298	Wenner-Gren-Foundation (Grant "Isotope Ecology of the Salonga Bonobo - Tracing Dietary Variation and Seasonality by Stable isotope Analyses of Hair") [8573]	Wenner-Gren-Foundation (Grant "Isotope Ecology of the Salonga Bonobo - Tracing Dietary Variation and Seasonality by Stable isotope Analyses of Hair")	This project was generously funded by the Wenner-Gren-Foundation (Grant 8573 "Isotope Ecology of the Salonga Bonobo - Tracing Dietary Variation and Seasonality by Stable isotope Analyses of Hair", October 2011).	Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Blumenthal SA, 2012, P NATL ACAD SCI USA, V109, P21277, DOI 10.1073/pnas.1215782109; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P269, DOI 10.1017/CBO9780511542343.011; Brockman DK, 2005, SEASONALITY IN PRIMA; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Cernusak LA, 2009, FUNCT PLANT BIOL, V36, P199, DOI 10.1071/FP08216; Chapman Colin A., 1994, P41; CLEVELAND WS, 1984, AM STAT, V38, P261, DOI 10.2307/2683400; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Crowley BE, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22510; Deschner T, 2012, RAPID COMMUN MASS SP, V26, P69, DOI 10.1002/rcm.5312; Douglas PH, 2014, PRIMATES, V55, P533, DOI 10.1007/s10329-014-0436-0; Drews B, 2011, ZOO BIOL, V30, P241, DOI 10.1002/zoo.20304; Fahy GE, 2013, P NATL ACAD SCI USA, V110, P5829, DOI 10.1073/pnas.1221991110; Fruth B, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P231, DOI 10.1017/CBO9780511606397.023; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gehring C, 2004, BASIC APPL ECOL, V5, P567, DOI 10.1016/j.baae.2004.09.005; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; HOHMANN G, 1993, FOLIA PRIMATOL, V60, P225, DOI 10.1159/000156695; Hohmann G., 2006, FEEDING ECOLOGY APES; Hohmann G., 2003, PAN AFR NEWS, V10, P25, DOI DOI 10.5134/143430; Hohmann G, 2008, FOLIA PRIMATOL, V79, P103, DOI 10.1159/000110679; Hohmann Gottfried, 2006, P123; Hohmann G, 2010, AM J PHYS ANTHROPOL, V141, P476, DOI 10.1002/ajpa.21168; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Kalhan SC, 2000, AM J CLIN NUTR, V71, p1249S, DOI 10.1093/ajcn/71.5.1249s; Kohn MJ, 1999, SCIENCE, V283, P335, DOI 10.1126/science.283.5400.335; Kristal MB, 2012, ECOL FOOD NUTR, V51, P177, DOI 10.1080/03670244.2012.661325; LEE PC, 1987, J ZOOL, V213, P409, DOI 10.1111/j.1469-7998.1987.tb03717.x; Loudon JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100758; MALENKY RK, 1991, AM J PRIMATOL, V23, P153, DOI 10.1002/ajp.1350230303; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McClure PA, 1987, REPRODUCTIVE ENERGET, P241; McGrew WC, 1996, FOOD STATUS QUEST IN, P39; MEDINA E, 1980, OECOLOGIA, V45, P377, DOI 10.1007/BF00540209; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mundry R, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22499; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Oelze VM, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22497; Oelze VM, 2014, J HUM EVOL, V66, P95, DOI 10.1016/j.jhevol.2013.10.003; Oelze VM, 2011, P NATL ACAD SCI USA, V108, P9792, DOI 10.1073/pnas.1018502108; Oelze VM, 2016, J HUM EVOL UNPUB; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reitsema LJ, 2012, AM J PRIMATOL, V74, P926, DOI 10.1002/ajp.22045; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Surbeck M, 2013, BEHAV ECOL SOCIOBIOL, V67, P1767, DOI 10.1007/s00265-013-1584-8; Surbeck M, 2009, AM J PRIMATOL, V71, P171, DOI 10.1002/ajp.20634; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Tobin DJ, 2005, ISS TOXICOL, P3; TUTIN CEG, 1993, J TROP ECOL, V9, P241, DOI 10.1017/S0266467400007239; Ungar PS, 2011, SCIENCE, V334, P190, DOI 10.1126/science.1207701; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Williams LJ, 2011, AM J PHYS ANTHROPOL, V145, P125, DOI 10.1002/ajpa.21479; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	69	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162091	10.1371/journal.pone.0162091	http://dx.doi.org/10.1371/journal.pone.0162091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626279	Green Published, Green Accepted, gold			2022-12-27	WOS:000383680600019
J	Phipps, ML; Lillo, AM; Shou, YL; Schmidt, EN; Paavola, CD; Naranjo, L; Bemdich, S; Swanson, BI; Bradbury, ARM; Martinez, JS				Phipps, M. Lisa; Lillo, Antoinetta M.; Shou, Yulin; Schmidt, Emily N.; Paavola, Chad D.; Naranjo, Leslie; Bemdich, Sara; Swanson, Basil I.; Bradbury, Andrew R. M.; Martinez, Jennifer S.			Beyond Helper Phage: Using "Helper Cells" to Select Peptide Affinity Ligands	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; GENERAL STRATEGY; CAPSULAR ANTIGEN; LIBRARIES; ANTIBODY; PROTEINS; VECTORS; DOMAINS; SITES	Peptides are important affinity ligands for microscopy, biosensing, and targeted delivery. However, because they can have low affinity for their targets, their selection from large naive libraries can be challenging. When selecting peptidic ligands from display libraries, it is important to: 1) ensure efficient display; 2) maximize the ability to select high affinity ligands; and 3) minimize the effect of the display context on binding. The "helper cell" packaging system has been described as a tool to produce filamentous phage particles based on phagemid constructs with varying display levels, while remaining free of helper phage contamination. Here we report on the first use of this system for peptide display, including the systematic characterization and optimization of helper cells, their inefficient use in antibody display and their use in creating and selecting from a set of phage display peptide libraries. Our libraries were analyzed with unprecedented precision by standard or deep sequencing, and shown to be superior in quality than commercial gold standards. Using our helper cell libraries, we have obtained ligands recognizing Yersinia pestis surface antigen F1V and L-glutamine-binding periplasmic protein QBP. In the latter case, unlike any of the peptide library selections described so far, we used a combination of phage and yeast display to select intriguing peptide ligands. Based on the success of our selections we believe that peptide libraries obtained with helper cells are not only suitable, but preferable to traditional phage display libraries for selection of peptidic ligands.	[Phipps, M. Lisa; Martinez, Jennifer S.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA; [Lillo, Antoinetta M.; Shou, Yulin; Schmidt, Emily N.; Naranjo, Leslie; Bemdich, Sara; Swanson, Basil I.; Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Paavola, Chad D.] NASA, Space Biosci Div, Ames Res Ctr, Moffett Field, CA 94035 USA; [Martinez, Jennifer S.] Los Alamos Natl Lab, Inst Mat Sci, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Los Alamos National Laboratory	Martinez, JS (corresponding author), Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA.; Martinez, JS (corresponding author), Los Alamos Natl Lab, Inst Mat Sci, Los Alamos, NM 87545 USA.	jenm@lanl.gov		Bradbury, Andrew/0000-0002-5567-8172	National Nuclear Security Administration of the U.S. Department of Energy [DE-AC52-06NA25396]	National Nuclear Security Administration of the U.S. Department of Energy(National Nuclear Security Administration)	Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the U.S. Department of Energy under contract DE-AC52-06NA25396.; This work was performed at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the U.S. Department of Energy under contract DE-AC52-06NA25396.	Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chasteen L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl772; Cherepanov P A, 1991, Mol Gen Mikrobiol Virusol, P19; Crochet AP, 2010, BIOSENS BIOELECTRON, V26, P55, DOI 10.1016/j.bios.2010.05.012; D'Angelo S, 2014, MABS-AUSTIN, V6, P160, DOI 10.4161/mabs.27105; Ferrara F, 2013, J IMMUNOL METHODS, V395, P83, DOI 10.1016/j.jim.2013.06.010; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Goncharov A Iu, 1992, Mol Gen Mikrobiol Virusol, P10; Gonzalez-Techera A, 2007, ANAL CHEM, V79, P7799, DOI 10.1021/ac071323h; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Lillo AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027756; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; McCafferty J, 2015, CURR OPIN CHEM BIOL, V26, P16, DOI 10.1016/j.cbpa.2015.01.003; Qi H, 2012, J MOL BIOL, V417, P129, DOI 10.1016/j.jmb.2012.01.038; ROBERTS D, 1993, GENE, V128, P67, DOI 10.1016/0378-1119(93)90154-U; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Siegel RW, 2004, GENOME RES, V14, P1119, DOI 10.1101/gr.1821804; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; STENGELE I, 1990, J MOL BIOL, V212, P143, DOI 10.1016/0022-2836(90)90311-9; Zwick MB, 1998, CURR OPIN BIOTECH, V9, P427, DOI 10.1016/S0958-1669(98)80017-7	25	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0160940	10.1371/journal.pone.0160940	http://dx.doi.org/10.1371/journal.pone.0160940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626637	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600002
J	Zhu, SY; Henninger, K; McGrath, BC; Cavener, DR				Zhu, Siying; Henninger, Keely; McGrath, Barbara C.; Cavener, Douglas R.			PERK Regulates Working Memory and Protein Synthesis-Dependent Memory Flexibility	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; TRANSGENIC MICE; KINASE PERK; SPONTANEOUS-ALTERNATION; TRANSLATIONAL CONTROL; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; SHORT-TERM; EXPRESSION	PERK (EIF2AK3) is an ER-resident eIF2 alpha kinase required for memory flexibility and metabotropic glutamate receptor-dependent long-term depression, processes known to be dependent on new protein synthesis. Here we investigated PERK's role in working memory, a cognitive ability that is independent of new protein synthesis, but instead is dependent on cellular Ca2+ dynamics. We found that working memory is impaired in forebrain-specific Perk knockout and pharmacologically PERK-inhibited mice. Moreover, inhibition of PERK in wild-type mice mimics the fear extinction impairment observed in forebrain-specific Perk knockout mice. Our findings reveal a novel role of PERK in cognitive functions and suggest that PERK regulates both Ca2+ -dependent working memory and protein synthesis-dependent memory flexibility.	[Zhu, Siying; Henninger, Keely; McGrath, Barbara C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu			National Institutes of Health [DK088140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK088140 (to DRC), http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Brown AP, 2000, CONTEMP TOP LAB ANIM, V39, P17; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; El-Hassar L, 2011, J PHYSIOL-LONDON, V589, P3211, DOI 10.1113/jphysiol.2011.209783; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; GULDIN WO, 1981, BRAIN BEHAV EVOLUT, V19, P93, DOI 10.1159/000121636; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Hagenston AM, 2008, CEREB CORTEX, V18, P407, DOI 10.1093/cercor/bhm075; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hayashi K, 2007, NEUROREPORT, V18, P719, DOI 10.1097/WNR.0b013e3280d9e880; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Jacobsen CF, 1935, ARCH NEURO PSYCHIATR, V33, P558, DOI 10.1001/archneurpsyc.1935.02250150108009; Khan ZU, 2011, BEHAV BRAIN RES, V219, P329, DOI 10.1016/j.bbr.2010.12.039; Kolb B, 1990, THE CEREBRAL CORTEX, pxii; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mikami A, 2007, EUR J PHARMACOL, V575, P82, DOI 10.1016/j.ejphar.2007.07.010; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; PENETAR DM, 1983, PHARMACOL BIOCHEM BE, V19, P963, DOI 10.1016/0091-3057(83)90399-4; Runyan JD, 2005, LEARN MEMORY, V12, P103, DOI 10.1101/lm.89405; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Trinh MA, 2014, LEARN MEMORY, V21, P298, DOI 10.1101/lm.032219.113; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wolf A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147733; Yamanaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084036; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	52	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162766	10.1371/journal.pone.0162766	http://dx.doi.org/10.1371/journal.pone.0162766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627766	Green Submitted, gold, Green Published			2022-12-27	WOS:000383680600053
J	Gesesew, HA; Woldemichael, K; Massa, D; Mwanri, L				Gesesew, Hailay Abrha; Woldemichael, Kifle; Massa, Desalegn; Mwanri, Lillian			Farmers Knowledge, Attitudes, Practices and Health Problems Associated with Pesticide Use in Rural Irrigation Villages, Southwest Ethiopia	PLOS ONE			English	Article							SYMPTOMS; EXPOSURE; WORKERS; MANAGEMENT; TANZANIA	Background In Ethiopia, pesticides are widely used for a variety of purposes. The occurrence of contamination and poisoning for farmers is highly reporteddue to unsafe handling practices and their usage. We assessed knowledge, attitudes and experiences of previous pesticide exposure, and related health problems among farmers who use irrigation in Jimma Zone, Southwest Ethiopia. Methods A community based cross-sectional study was conducted among farmers living in the zone. Respondents were 796 irrigation farmers from 20 kebeles (lowest administration unit) in Jimma Zone. Data were collected using a pretested and structured questionnaire via face-to-face interviews. Both descriptive and inferential statistics analysis were performed. A binary logistic regression was used to identify factors associated with attitudes of farmers towards the safe use of pesticides at P value of <= 0.05 in the final model. Results Among the participants, 54.4% (95% CI, 50.7-58%) knew at least one pesticide control method and 53.7% had positive attitudes towards safe use of pesticide. The mean score of attitudes was found to be 3.9(+/- 0.4). Knowledge including each of the following: the names of the pesticides (AOR, 0.41; 95% CI, 0.25-0.67), methods of pest control and the use of gloves during pesticide exposure (AOR, 1.52; 95% CI, 1.07-2.16) was found to be independent predictor of the farmers' attitudes about safe use of pesticides. Past exposure of pesticide was reportedby 89.6% of farmers. Participants reported ingestion (88.9%) and inhalation (90.4%) as possible mechanisms of pesticide exposure. Nearly 42% of farmers had never used any personal protective equipment (PPE) to protect themselves against pesticide exposure. Farmers reported several health complications, which were perceived as complications of pesticide exposure, including: headache, nausea and vomiting, skin rash and irritation and abdominal pain. Conclusions The study exposed the existence of high probability of pesticide exposure, the low safe use of pesticide and the low use of PPE. However, but farmers had positive attitudes towards safe use of pesticides. These findings appeal for the development of effective public health strategies to improve farmers' awareness and safe use of PPE. In addition, there is a need to informfarmers about integrated pest management to prevent severe health complications, which may occur as a result of unsafe and inappropriate use of pesticides.	[Gesesew, Hailay Abrha; Woldemichael, Kifle; Massa, Desalegn] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Gesesew, Hailay Abrha; Mwanri, Lillian] Flinders Univ S Australia, Fac Med Nursing & Hlth Sci, Discipline Publ Hlth, Adelaide, SA, Australia	Jimma University; Flinders University South Australia	Gesesew, HA (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.; Gesesew, HA (corresponding author), Flinders Univ S Australia, Fac Med Nursing & Hlth Sci, Discipline Publ Hlth, Adelaide, SA, Australia.	hailushepi@gmail.com	Gesesew, Hailay/AAF-6486-2020; Mwanri, Lillian/AGG-3711-2022	Gesesew, Hailay/0000-0002-3531-4400; Mwanri, Lillian/0000-0002-5792-7785	Global Disaster Preparedness Center (GDPC); Response 2 Resilience (R2R)	Global Disaster Preparedness Center (GDPC); Response 2 Resilience (R2R)	We thank Global Disaster Preparedness Center (GDPC) and Response 2 Resilience (R2R) [http://preparecenter.org/activities/research-resilienceand-preparedness-%E2%80%93-small-grants-program] for funding this study. KW received the grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi OC, 2007, SCI RES ESSAYS, V2, P204; [Anonymous], 2015, PESTICIDES OUR HLTH; Bruce F, 2008, PESTICIDE APPL SAFET; Clarke EEK, 1997, OCCUP MED-OXFORD, V47, P301, DOI 10.1093/occmed/47.5.301; CSA, 2007, POP HOUS CENS REP ET; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Daten Fakten, 2012, PESTICIDES HLTH HAZA; enHealth, 2010, ENV HLTH PRACT MAN R; EPA, 2004, EX EXP SCEN, P6; FAO, 2006, INT COD COND DISTR U; Faria N M, 2000, Cad Saude Publica, V16, P115, DOI 10.1590/S0102-311X2000000100012; Henry D., 2013, Journal of Agriculture and Rural Development in the Tropics and Subtropics, V114, P59; Ibitayo OO, 2006, RISK ANAL, V26, P989, DOI 10.1111/j.1539-6924.2006.00794.x; Issa Y, 2010, ENV HLTH, V9; Karunamoorthi K, 2012, ARCH ENVIRON OCCUP H, V67, P109, DOI 10.1080/19338244.2011.598891; Konradsen F, 2003, TOXICOLOGY, V192, P249, DOI 10.1016/S0300-483X(03)00339-1; Lekei EE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-389; Mekonnen Y, 2002, OCCUP MED-OXFORD, V52, P311, DOI 10.1093/occmed/52.6.311; Nalwanga E, 2011, J ENV PUBLIC HLTH, V200, P1; Negatu B, 2016, ANN OCCUP HYG, V60, P551, DOI 10.1093/annhyg/mew004; Ngowi A, 2002, HLTH IMPACTS PESTICI; Ngowi A, 2007, CROP PROT, V26, P1617, DOI 10.1016/j.cropro.2007.01.008; Parron T, 1996, HUM EXP TOXICOL, V15, P957, DOI 10.1177/096032719601501203; Rathinam X, 2005, Med J Malaysia, V60, P118; Rathinam X, 2005, MED J MALAYSIA, V60, P125; Recena MCP, 2006, ENVIRON RES, V102, P230, DOI 10.1016/j.envres.2006.01.007; Sa'ed H, 2008, KNOWLEDGE PRACTICES; Salameh PR, 2004, ENVIRON RES, V94, P1, DOI 10.1016/S0013-9351(03)00092-6; Sekiyama Makiko, 2007, Environmental Sciences, V14, P23; SIVAYOGANATHAN C, 1995, SOC SCI MED, V40, P431, DOI 10.1016/0277-9536(94)00143-H; Wheeler WB, 2002, J AGR FOOD CHEM, V50, P4151, DOI 10.1021/jf0256438; Wondgwichit D, 2012, J MED MED SCI, V3, P034; Yassin MM, 2002, OCCUP ENVIRON MED, V59, P387, DOI 10.1136/oem.59.6.387	33	41	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162527	10.1371/journal.pone.0162527	http://dx.doi.org/10.1371/journal.pone.0162527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622668	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000037
J	Tkatchenko, AV; Luo, XY; Tkatchenko, TV; Vaz, C; Tanavde, VM; Maurer-Stroh, S; Zauscher, S; Gonzalez, P; Young, TL				Tkatchenko, Andrei V.; Luo, Xiaoyan; Tkatchenko, Tatiana V.; Vaz, Candida; Tanavde, Vivek M.; Maurer-Stroh, Sebastian; Zauscher, Stefan; Gonzalez, Pedro; Young, Terri L.			Large-Scale microRNA Expression Profiling Identifies Putative Retinal miRNA-mRNA Signaling Pathways Underlying Form-Deprivation Myopia in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TREE SHREW SCLERA; EPITHELIAL-MESENCHYMAL TRANSITION; EYE GROWTH-REGULATION; GENE-EXPRESSION; MICROARRAY ANALYSIS; NONCODING RNAS; MOUSE RETINA; LINEAGE DIFFERENTIATION; PROTEIN EXPRESSION	Development of myopia is associated with large-scale changes in ocular tissue gene expression. Although differential expression of coding genes underlying development of myopia has been a subject of intense investigation, the role of non-coding genes such as microRNAs in the development of myopia is largely unknown. In this study, we explored myopia-associated miRNA expression profiles in the retina and sclera of C57Bl/6J mice with experimentally induced myopia using microarray technology. We found a total of 53 differentially expressed miRNAs in the retina and no differences in miRNA expression in the sclera of C57BL/6J mice after 10 days of visual form deprivation, which induced -6.93 +/- 2.44 D (p < 0.000001, n = 12) of myopia. We also identified their putative mRNA targets among mRNAs found to be differentially expressed in myopic retina and potential signaling pathways involved in the development of form-deprivation myopia using miRNA-mRNA interaction network analysis. Analysis of myopia-associated signaling pathways revealed that myopic response to visual form deprivation in the retina is regulated by a small number of highly integrated signaling pathways. Our findings highlighted that changes in microRNA expression are involved in the regulation of refractive eye development and predicted how they may be involved in the development of myopia by regulating retinal gene expression.	[Tkatchenko, Andrei V.; Tkatchenko, Tatiana V.] Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA; [Tkatchenko, Andrei V.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA; [Luo, Xiaoyan; Gonzalez, Pedro] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Luo, Xiaoyan] Duke Univ, Sch Med, Ctr Human Genet, Durham, NC USA; [Vaz, Candida; Tanavde, Vivek M.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Tanavde, Vivek M.] ASTAR, Inst Med Biol, Singapore, Singapore; [Zauscher, Stefan] Duke Univ, Dept Mech Engn & Mat Sci, Pratt Sch Engn, Durham, NC 27706 USA; [Young, Terri L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA	Columbia University; Columbia University; Duke University; Duke University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Duke University; University of Wisconsin System; University of Wisconsin Madison	Tkatchenko, AV (corresponding author), Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.; Tkatchenko, AV (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA.; Young, TL (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	avt2130@cumc.columbia.edu; tyoung6@wisc.edu	Maurer-Stroh, Sebastian/Q-9476-2019; Tanavde, Vivek/B-4758-2011; Vaz, Candida/HHZ-7196-2022	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Tanavde, Vivek/0000-0001-7404-5568; Zauscher, Stefan/0000-0002-2290-7178	National Institutes of Health/National Eye Institute grant [R01EY023839]; National Institutes of Health/National Eye Institute [R01EY023287, R01EY016228, R01EY014685, P30EY019007]; Duke Eye Center Exploring Grant; Research to Prevent Blindness (New York, NY); Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison; Acquavella Family Foundation; University of Wisconsin Centennial Scholar Fund; NATIONAL EYE INSTITUTE [R01EY023839, P30EY019007, R01EY016228, R01EY023287, R01EY014685] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute grant; National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Duke Eye Center Exploring Grant; Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison; Acquavella Family Foundation; University of Wisconsin Centennial Scholar Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by National Institutes of Health/National Eye Institute grant R01EY023839, (www.nih.gov) (to AVT), National Institutes of Health/National Eye Institute grants R01EY023287 and R01EY016228, (www.nih.gov) (to PG), National Institutes of Health/National Eye Institute grant R01EY014685, (www.nih.gov) (to TLY), National Institutes of Health/National Eye Institute grant P30EY019007 (Core Support for Vision Research) (to AVT), Duke Eye Center Exploring Grant and unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University and the Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison. These research was funded with support from the Acquavella Family Foundation, Joseph C. Connors, and the University of Wisconsin Centennial Scholar Fund.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexander LJ, 1994, PRIMARY CARE POSTERI; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1; Ashby R, 2010, MOL VIS, V16, P639; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P3726, DOI 10.1167/iovs.09-4615; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Banerjee P, 2015, STEM CELLS; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Brand C, 2007, MOL VIS, V13, P920; Calissano M, 2010, MOL CELL NEUROSCI, V45, P317, DOI 10.1016/j.mcn.2010.06.015; Chase HB, 1942, GENETICS, V27, P0339; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chen JC, 2006, VISION RES, V46, P4096, DOI 10.1016/j.visres.2006.07.033; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040849; Chen KC, 2012, INVEST OPHTH VIS SCI, V53, P2732, DOI 10.1167/iovs.11-9272; Chivukula RR, 2009, CELL, V137, P606, DOI 10.1016/j.cell.2009.04.059; Conte I, 2013, CELL MOL LIFE SCI, V70, P4141, DOI 10.1007/s00018-013-1335-z; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; de Sousa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056908; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Bernardini E, 2014, J BIOL CHEM, V289, P3383, DOI 10.1074/jbc.M113.495531; Diaz-Martin J, 2014, J PATHOL, V232, P319, DOI 10.1002/path.4289; Engelsvold DH, 2013, EXP EYE RES, V115, P189, DOI 10.1016/j.exer.2013.07.003; Feldkaemper MP, 2009, INVEST OPHTH VIS SCI, V50, P13, DOI 10.1167/iovs.08-1702; Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Fischer AJ, 1997, CAN J OPHTHALMOL, V32, P373; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354; Gao H, 2011, MOL VIS, V17, P903; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Gonzalez P, 2014, J OCUL PHARMACOL TH, V30, P128, DOI 10.1089/jop.2013.0191; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hwang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046521; Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P611, DOI 10.1167/iovs.10-6115; Jin ZB, 2009, MOL VIS, V15, P523; KALTER H, 1968, TERATOLOGY, V1, P193, DOI 10.1002/tera.1420010208; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Koch FLP, 1939, ARCH PATHOL, V28, P171; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kushwaha R, 2014, STEM CELLS DEV, V23, P1149, DOI 10.1089/scd.2013.0262; La Torre A, 2013, P NATL ACAD SCI USA, V110, pE2362, DOI 10.1073/pnas.1301837110; Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Li DD, 2015, GENE, V572, P198, DOI 10.1016/j.gene.2015.07.010; Li ZY, 2015, HUM REPROD, V30, P507, DOI 10.1093/humrep/dev001; Liang CL, 2011, INVEST OPHTH VIS SCI, V52, P3500, DOI 10.1167/iovs.10-5859; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Maiorano NA, 2012, INT J MOL SCI, V13, P558, DOI 10.3390/ijms13010558; Mathis U, 2007, GRAEF ARCH CLIN EXP, V245, P267, DOI 10.1007/s00417-006-0282-x; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McGarvey KM, 2015, MAMM GENOME, V26, P379, DOI 10.1007/s00335-015-9585-8; McGlinn AM, 2007, INVEST OPHTH VIS SCI, V48, P3430, DOI 10.1167/iovs.06-1538; Mei Y, 2013, J CELL BIOCHEM, V114, P1374, DOI 10.1002/jcb.24479; Metlapally R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078984; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Morgan Ian G, 2003, Clin Exp Optom, V86, P276; NGUYENLEGROS J, 1994, INVEST OPHTH VIS SCI, V35, P2906; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oyster CW., 1999, HUMAN EYE STRUCTURE; Pandi SPS, 2013, INVEST OPHTH VIS SCI, V54, P8140, DOI 10.1167/iovs.13-12631; Papadopoulos EI, 2015, GENE, V554, P174, DOI 10.1016/j.gene.2014.10.043; Pararajasegaram R, 1999, AM J OPHTHALMOL, V128, P359; Paschou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046189; Pattanayak Debasis, 2005, Indian Journal of Experimental Biology, V43, P7; Qi J, 2013, HUM GENET, V132, P1395, DOI 10.1007/s00439-013-1346-8; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Rada JAS, 2009, MOL VIS, V15, P778; Ryan D, 2006, MOL VIS, V12, P1175; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schippert R, 2008, MOL VIS, V14, P1589; SELTNER RLP, 1995, VISION RES, V35, P1265, DOI 10.1016/0042-6989(94)00244-G; Shelton L, 2008, MOL VIS, V14, P1465; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Singh SK, 2015, STEM CELL RES, V15, P305, DOI 10.1016/j.scr.2015.05.003; Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035; STONE RA, 1988, P NATL ACAD SCI USA, V85, P257, DOI 10.1073/pnas.85.1.257; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Tkatchenko AV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005432; Tkatchenko AV, 2006, P NATL ACAD SCI USA, V103, P4681, DOI 10.1073/pnas.0600589103; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P1297, DOI 10.1167/iovs.09-4153; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P21, DOI 10.1167/iovs.08-2767; Trumbach D, 2015, CELL TISSUE RES, V359, P161, DOI 10.1007/s00441-014-1911-z; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Vessey KA, 2005, INVEST OPHTH VIS SCI, V46, P3922, DOI 10.1167/iovs.04-1026; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang HC, 2014, CANCER INFORM, V13, P25, DOI 10.4137/CIN.S14074; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091199; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu SB, 2009, PROG RETIN EYE RES, V28, P87, DOI 10.1016/j.preteyeres.2008.11.003; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046	122	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162541	10.1371/journal.pone.0162541	http://dx.doi.org/10.1371/journal.pone.0162541			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622715	gold, Green Submitted, Green Published			2022-12-27	WOS:000383681000038
J	Johansson, E; Larisch, LM; Marcus, C; Hagstromer, M				Johansson, Elin; Larisch, Lisa-Marie; Marcus, Claude; Hagstromer, Maria			Calibration and Validation of a Wrist- and Hip-Worn Actigraph Accelerometer in 4-Year-Old Children	PLOS ONE			English	Article							RATING-SCALE CARS; PHYSICAL-ACTIVITY; SAMPLE-SIZE; CUT-POINTS; COMPARABILITY; VALIDITY; MONITORS; YOUTH	Introduction To determine time spent at different physical activity intensities, accelerometers need calibration. The aim of this study was to develop and cross-validate intensity thresholds for the Actigraph GT3X+ accelerometer for wrist and hip placement in four-year-old children. Methods In total 30 children (49 months, SD 3.7) were recruited from five preschools in Stockholm. Equipped with an accelerometer on the wrist and another on the hip, children performed three indoor activities and one free-play session while being video recorded. Subsequently, physical activity intensity levels were coded every 5th second according to the Children's Activity Rating Scale. Receiver Operating Characteristic (ROC) curves was used to develop wrist and hip intensity thresholds, the upper threshold for sedentary, and lower threshold for moderate-to-vigorous physical activity (MVPA), for the vertical axis (VA) and for the vector magnitude (VM). A leave-one-out method was used to cross-validate the thresholds. Results Intensity thresholds for wrist placement were <= 178 (VA) and <= 328 (VM) for sedentary and >= 871 (VA) and >= 1393 (VM) counts/5 seconds for MVPA. The corresponding thresholds for hip placement were <= 43 (VA) and <= 105 (VM) for sedentary and >= 290 (VA) and >= 512 (VM) for MVPA. The quadratic weighted Kappa was 0.92 (95% CI 0.91-0.93) (VA) and 0.95 (95% CI 0.94-0.96) (VM) for the wrist-worn accelerometer and 0.76 (98% CI 0.74-0.77) and 0.86 (95% CI 0.85-0.87) for the hip-worn. Conclusion Using wrist placement and the VM when measuring physical activity with accelerometry in 4-year-old children is recommended.	[Johansson, Elin; Hagstromer, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Larisch, Lisa-Marie; Marcus, Claude] Karolinska Inst, Dept Clin Sci Technol & Intervent, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Johansson, E (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	elin.johansson@ki.se	Marcus, Claude/ABE-1177-2020	Marcus, Claude/0000-0003-0890-2650	Swedish Council for Working Life and Social Research; Swedish Research Council; Karolinska Institutet	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This study was funded by The Swedish Council for Working Life and Social Research; The Swedish Research Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Chandler JL, 2015, PEDIAT OBES; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Costa S, 2014, J SCI MED SPORT, V17, P617, DOI 10.1016/j.jsams.2013.11.005; Crouter SE, 2015, MED SCI SPORT EXER, V47, P944, DOI 10.1249/MSS.0000000000000502; DURANT RH, 1993, MED SCI SPORT EXER, V25, P1415; Ekblom O, 2012, J PHYS ACT HEALTH, V9, P389, DOI 10.1123/jpah.9.3.389; Fairclough SJ, 2015, MED SCI SPORTS EXERC; Feito Y, 2011, MED SCI SPORT EXER, V43, P861, DOI 10.1249/MSS.0b013e3181fefd40; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Johansson E, 2015, PEDIATR OBES, V10, P1, DOI 10.1111/j.2047-6310.2013.00213.x; Johansson E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0161-0; Keadle SK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1210; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; PUHL J, 1990, RES Q EXERCISE SPORT, V61, P26, DOI 10.1080/02701367.1990.10607475; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Rosenberger ME, 2013, MED SCI SPORT EXER, V45, P964, DOI 10.1249/MSS.0b013e31827f0d9c; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sirard JR, 2005, J PHYS ACT HEALTH, V2, P345, DOI DOI 10.1123/JPAH.2.3.345; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; Trost SG, 2012, OBESITY, V20, P2317, DOI 10.1038/oby.2011.364; Cauwenberghe E, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-67; Van Cauwenberghe E, 2011, INT J PEDIATR OBES, V6, pE582, DOI 10.3109/17477166.2010.526223	28	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162436	10.1371/journal.pone.0162436	http://dx.doi.org/10.1371/journal.pone.0162436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617962	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100023
J	Arcipowski, KM; Bulic, M; Gurbuxani, S; Licht, JD				Arcipowski, Kelly M.; Bulic, Marinka; Gurbuxani, Sandeep; Licht, Jonathan D.			Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CHROMATIN REMODELING GENES; BILE-ACID HOMEOSTASIS; MYELODYSPLASTIC SYNDROMES; SOMATIC MUTATIONS; LYSINE-4 METHYLTRANSFERASES; COLORECTAL-CANCER; CELL CARCINOMA; CRUCIAL ROLES; STEM-CELLS	Two of the most common myeloid malignancies, myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), are associated with exceedingly low survival rates despite recent therapeutic advances. While their etiology is not completely understood, evidence suggests that certain chromosomal abnormalities contribute to MDS and AML progression. Among the most frequent chromosomal abnormalities in these disorders are alterations of chromosome 7: either complete loss of one copy of chromosome 7 (-7) or partial deletion of 7q (del(7q)), both of which increase the risk of progression from MDS to AML and are associated with chemoresistance. Notably, 7q36.1, a critical minimally deleted region in 7q, includes the gene encoding the histone methyltransferase mixed-lineage leukemia 3 (MLL3), which is also mutated in a small percentage of AML patients. However, the mechanisms by which MLL3 loss contributes to malignancy are unknown. Using an engineered mouse model expressing a catalytically inactive form of Mll3, we found a significant shift in hematopoiesis toward the granulocyte/macrophage lineage, correlating with myeloid infiltration and enlargement of secondary lymphoid organs. Therefore, we propose that MLL3 loss in patients may contribute to the progression of MDS and AML by promoting myelopoiesis.	[Arcipowski, Kelly M.; Bulic, Marinka; Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Gurbuxani, Sandeep] Univ Chicago, Med Ctr, Dept Clin Hematol Hematopathol, Chicago, IL 60637 USA; [Licht, Jonathan D.] Univ Florida, Hlth Canc Ctr, Gainesville, FL 32611 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago Medical Center; State University System of Florida; University of Florida	Licht, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.; Licht, JD (corresponding author), Univ Florida, Hlth Canc Ctr, Gainesville, FL 32611 USA.	jdlicht@ufl.edu	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NIH/NCI [R01CA180475]; Leukemia and Lymphoma Society SCOR Award; NIH Oncogenesis and Developmental Biology Training Grant [T32CA080621-11]; Northwestern University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [R01CA180475] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society SCOR Award; NIH Oncogenesis and Developmental Biology Training Grant; Northwestern University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI Grant R01CA180475 and a Leukemia and Lymphoma Society SCOR Award (to J.D.L.) and NIH T32CA080621-11 Oncogenesis and Developmental Biology Training Grant (to K.M.A.). This work was also supported in part by the Northwestern University Mouse Histology and Phenotyping Laboratory and a Cancer Center Support Grant (NCI CA060553).	Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Braun T, 2013, BEST PRACT RES CL HA, V26, P327, DOI 10.1016/j.beha.2013.09.003; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Kim DH, 2015, HEPATOLOGY, V61, P1012, DOI 10.1002/hep.27578; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li WD, 2013, BLOOD, V121, P1478, DOI 10.1182/blood-2012-12-470559; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lu QJ, 2013, J AUTOIMMUN, V41, P1, DOI 10.1016/j.jaut.2013.01.010; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Puente X.S., 2015, NATURE; Rankin EB, 2015, MOL GENET METAB, V116, P24, DOI 10.1016/j.ymgme.2015.07.004; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shetty V, 2000, BLOOD, V96, P1388, DOI 10.1182/blood.V96.4.1388.h8001388_1388_1392; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Visconte V, 2014, BLOOD RES, V49, P216, DOI 10.5045/br.2014.49.4.216; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang L, 2015, LEUKEMIA RES, V39, P6, DOI 10.1016/j.leukres.2014.10.006	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162515	10.1371/journal.pone.0162515	http://dx.doi.org/10.1371/journal.pone.0162515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610619	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255900120
J	Chae, KJ; Jin, GY; Jung, HN; Kwon, KS; Choi, H; Lee, YC; Chung, MJ; Park, HS				Chae, Kum Ju; Jin, Gong Yong; Jung, Hyun Nyeong; Kwon, Keun Sang; Choi, Hyemi; Lee, Yong Chul; Chung, Myoung Ja; Park, Ho Sung			Differentiating Smoking-Related Interstitial Fibrosis (SRIF) from Usual Interstitial Pneumonia (UIP) with Emphysema Using CT Features Based on Pathologically Proven Cases	PLOS ONE			English	Article							COMBINED PULMONARY-FIBROSIS; PROGRESSION; SURVIVAL; SOCIETY; DISEASE; LUNG	Objective To differentiate smoking-related interstitial fibrosis (SRIF) from usual interstitial pneumonia (UIP) with emphysema on CT in combined pulmonary fibrosis and emphysema (CPFE) patients. Materials and Methods This study was approved by the institutional review board and informed consent was waived. We included 65 patients who underwent lung biopsy under the suspicion of UIP pattern on HRCT, and after radiologic-pathologic correlation, they were divided into three groups: UIP without emphysema (n = 30), UIP with emphysema (n = 26), and SRIF (n = 9). The quantitative extent of emphysema in the entire lung was visually assessed and fibrotic patterns were qualitatively analyzed based on six characteristics (asymmetry, juxta-subpleural sparing, emphysema beside the honeycombing area, absence of ground grass attenuation/reticulation in honeycombing area, inhomogeneous honeycombing, and absence of honeycombing in the upper lobes). Kaplan-Meier analysis was used for survival analysis, and logistic regression with a receiver operating characteristic curve was used to predict the possibility of SRIF. Results In qualitative analysis of fibrotic patterns, SRIF tended to exhibit more than three of six fibrotic features, whereas UIP with emphysema demonstrated about two of these characteristics (p = 0.035). In addition, SRIF had a higher extent of emphysema than UIP with emphysema when they have same amount of fibrosis (p = 0.014). In patients with SRIF, 5-year survival rate was 85.7%, while it was 40.7% in UIP with emphysema patients (p = 0.035). Conclusion Fibrotic CT patterns and survival rate differed between SRIF and UIP with emphysema among CPFE patients, which explains the variable prognosis of CPFE.	[Chae, Kum Ju; Jin, Gong Yong; Jung, Hyun Nyeong] Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Radiol,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea; [Kwon, Keun Sang] Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Prevent Med,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea; [Choi, Hyemi] Chonbuk Natl Univ, Dept Stat, Jeonju, Jeonbuk, South Korea; [Choi, Hyemi] Chonbuk Natl Univ, Inst Appl Stat, Jeonju, Jeonbuk, South Korea; [Lee, Yong Chul] Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Internal Med,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea; [Chung, Myoung Ja; Park, Ho Sung] Chonbuk Natl Univ, Res Inst Clin Med, Dept Pathol, Sch Med, Jeonju, Jeonbuk, South Korea; [Chae, Kum Ju] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Seoul National University (SNU); Seoul National University Hospital	Jin, GY (corresponding author), Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Radiol,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea.	gyjin@chonbuk.ac.kr						Akagi T, 2009, RESP MED, V103, P1209, DOI 10.1016/j.rmed.2009.02.001; American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; Chae KJ, 2015, EUR RADIOL, V25, P2326, DOI 10.1007/s00330-015-3617-3; CHAN KL, 1987, J AM COLL CARDIOL, V9, P549, DOI 10.1016/S0735-1097(87)80047-5; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Cottin V, 2009, CHEST, V136, P1, DOI 10.1378/chest.09-0538; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Inomata M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-104; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Katzenstein ALA, 2012, MODERN PATHOL, V25, pS68, DOI 10.1038/modpathol.2011.154; Katzenstein ALA, 2010, HUM PATHOL, V41, P316, DOI 10.1016/j.humpath.2009.09.003; Kawabata Y, 2008, HISTOPATHOLOGY, V53, P707, DOI 10.1111/j.1365-2559.2008.03183.x; Kitaguchi Y, 2013, RESP MED, V107, P1986, DOI 10.1016/j.rmed.2013.06.015; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Kurashima K, 2010, RESPIROLOGY, V15, P843, DOI 10.1111/j.1440-1843.2010.01778.x; Matsuoka S, 2015, J COMPUT ASSIST TOMO, V39, P153, DOI 10.1097/RCT.0000000000000184; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Silva CIS, 2008, RADIOLOGY, V247, P251, DOI 10.1148/radiol.2471070369; Silva CIS, 2008, RADIOLOGY, V246, P288, DOI 10.1148/radiol.2453061881; Sugino K, 2014, RESPIROLOGY, V19, P239, DOI 10.1111/resp.12207; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Washko GR, 2010, ACAD RADIOL, V17, P48, DOI 10.1016/j.acra.2009.07.016	27	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162231	10.1371/journal.pone.0162231	http://dx.doi.org/10.1371/journal.pone.0162231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611866	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900064
J	Jones, DL; Cook, R; Potter, JE; Miron-Shatz, T; Chakhtoura, N; Spence, A; Byrne, MM				Jones, Deborah Lynne; Cook, Ryan; Potter, JoNell Efantis; Miron-Shatz, Talya; Chakhtoura, Nahida; Spence, Andrew; Byrne, Margaret M.			Fertility Desires among Women Living with HIV	PLOS ONE			English	Article							CONJOINT-ANALYSIS; INFECTED WOMEN; REPRODUCTIVE-AGE; INTENTIONS; CARE; PREFERENCES; PREGNANCY; CONVERSATIONS; WILLINGNESS; PROVIDERS	Objective Rates of pregnancy among women living with HIV (WLHIV) have increased with the availability of effective HIV treatment. Planning for pregnancy and childbirth is an increasingly important element of HIV care. Though rates of unintended pregnancies are high among women in general, among couples affected by HIV, significant planning and reproductive decisions must be considered to prevent negative health consequences for WLHIV and their neonates. To gain insight into this reproductive decision-making process among WLHIV, this study explored women's knowledge, attitudes and practices regarding fertility planning, reproductive desires, and safer conception practices. It was hypothesized that pregnancy desires would be influenced by partners, families, the potential risk of HIV transmission to infants, and physicians' recommendations. Methods WLHIV of childbearing age were recruited from urban South Florida, and completed an assessment of demographics (N = 49), fertility desires and a conjoint survey of factors associated with reproductive decision-making. Results Using conjoint analysis, we found that different decision paths exist for different types of women: Younger women and those with less education desired children if their partners wanted children; reproductive desires among those with less education, and with less HIV pregnancy-related knowledge, displayed a trend toward additional emphasis on their family's desires. Conversely, older women and those with more education appeared to place more importance on physician endorsement in their plans for childbearing. Conclusions Results of this study highlight the importance of ongoing preconception counselling for all women of reproductive age during routine HIV care. Counselling should be tailored to patient characteristics, and physicians should consider inclusion of families and/or partners in the process.	[Jones, Deborah Lynne; Cook, Ryan; Spence, Andrew] Univ Miami, Miller Sch Med, Psychiat & Behav Sci, Miami, FL 33136 USA; [Potter, JoNell Efantis; Chakhtoura, Nahida] Univ Miami, Miller Sch Med, Obstet & Gynecol, Miami, FL 33136 USA; [Miron-Shatz, Talya] Ono Acad Coll, Kiryat Ono, Israel; [Miron-Shatz, Talya] Ctr Med Publ Interest, New York, NY USA; [Byrne, Margaret M.] Univ Miami, Miller Sch Med, Epidemiol & Publ Hlth, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Jones, DL (corresponding author), Univ Miami, Miller Sch Med, Psychiat & Behav Sci, Miami, FL 33136 USA.	djones@med.miami.edu		Cook, Ryan/0000-0001-8754-995X; Jones, Deborah/0000-0002-4106-8891	University of Miami Miller School of Medicine's Scientific Advisory Committee [UM SAC 2013-33]; Miami Center for AIDS Research [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER	University of Miami Miller School of Medicine's Scientific Advisory Committee; Miami Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant from the University of Miami Miller School of Medicine's Scientific Advisory Committee (UM SAC 2013-33), with support from the Miami Center for AIDS Research (P30AI073961) and the women participating, without whom this research would not be possible.	Centers for Disease Control and Prevention, PRECONCEPTION HEALTH; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Coll AS, 2016, AIDS CARE, V28, P513, DOI 10.1080/09540121.2015.1112349; Cuca YP, 2015, QUAL HEALTH RES; Cunningham CE, 2014, SCH MENT HEALTH, V6, P1, DOI 10.1007/s12310-013-9110-8; De la Cruz NG, 2011, AIDS BEHAV, V15, P1233, DOI 10.1007/s10461-010-9788-7; Finger JL, 2012, AIDS PATIENT CARE ST, V26, P173, DOI 10.1089/apc.2011.0225; Finocchario-Kessler S, 2010, AIDS BEHAV, V14, P1106, DOI 10.1007/s10461-009-9637-8; Finocchario-Kessler S, 2010, AIDS PATIENT CARE ST, V24, P317, DOI 10.1089/apc.2009.0293; Francois-Xavier Bagnoud (FXB), 2012, HIV PREC CAR TOOLK; Garbers S, 2013, J WOMENS HEALTH, V22, P930, DOI 10.1089/jwh.2013.4247; GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Hauser JR, MARKETING RES MODELI, P141; Hoyt MJ, 2012, INFECT DIS OBSTET GY; JACCARD J, 1986, J CONSUM RES, V12, P463, DOI 10.1086/208530; Jean J, 2015, HLTH CARE WOMEN INT, DOI 10.1080/07399332.2015.1107068; Jones DL, 2010, OPEN ACCESS J CONTR, V1, P23; Kateeb ET, 2014, J PUBLIC HEALTH DENT, V74, P234, DOI 10.1111/jphd.12052; Kuhfeld W. F., 2010, MARKETING RES METHOD; Lee SJ, 2013, AIDS CARE, V25, P1592, DOI 10.1080/09540121.2013.793272; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; LOUVIERE JJ, 1988, J TRANSP ECON POLICY, V22, P93; Magnus M, 2013, AIDS PATIENT CARE ST, V27, P297, DOI 10.1089/apc.2012.0423; Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001; Miller WB, 2002, J APPL BIOBEHAV RES, V7, P1, DOI 10.1111/j.1751-9861.2002.tb00073.x; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Orme B, 2010, GETTING STARTED CONJ, P77; Orme BK, SAWTOOTH SOFTWARE C, P209; Rahangdale L, 2014, JAIDS-J ACQ IMM DEF, V65, P306, DOI 10.1097/QAI.0000000000000014; Rodriguez Violeta J, 2017, J Int Assoc Provid AIDS Care, V16, P133, DOI 10.1177/2325957415612127; Rollnick S, 2008, COPD, V5, P203, DOI [10.1080/15412550802093108, DOI 10.1080/15412550802093108]; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sivell S, 2012, PATIENT EDUC COUNS, V88, P209, DOI 10.1016/j.pec.2012.03.012; Smith ML, 2014, BREAST CANCER RES TR, V145, P83, DOI 10.1007/s10549-014-2909-7; Squires KE, 2011, AIDS PATIENT CARE ST, V25, P279, DOI 10.1089/apc.2010.0228; Steiner RJ, 2013, AIDS, V27, pS113, DOI 10.1097/QAD.0000000000000059; Steiner RJ, 2013, AM J PUBLIC HEALTH, V103, P1357, DOI 10.2105/AJPH.2013.301265; Sutton MY, 2014, JAIDS-J ACQ IMM DEF, V65, P350, DOI 10.1097/QAI.0000000000000054; Trimble C, 2013, HEALTH AFFAIR, V32, P436, DOI 10.1377/hlthaff.2012.1214	41	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160190	10.1371/journal.pone.0160190	http://dx.doi.org/10.1371/journal.pone.0160190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27610626	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900003
J	Kryukov, K; Imanishi, T				Kryukov, Kirill; Imanishi, Tadashi			Human Contamination in Public Genome Assemblies	PLOS ONE			English	Article							DNA	Contamination in genome assembly can lead to wrong or confusing results when using such genome as reference in sequence comparison. Although bacterial contamination is well known, the problem of human-originated contamination received little attention. In this study we surveyed 45,735 available genome assemblies for evidence of human contamination. We used lineage specificity to distinguish between contamination and conservation. We found that 154 genome assemblies contain fragments that with high confidence originate as contamination from human DNA. Majority of contaminating human sequences were present in the reference human genome assembly for over a decade. We recommend that existing contaminated genomes should be revised to remove contaminated sequence, and that new assemblies should be thoroughly checked for presence of human DNA before submitting them to public databases.	[Kryukov, Kirill; Imanishi, Tadashi] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan	Tokai University	Imanishi, T (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan.	imanishi@tokai.ac.jp	Imanishi, Tadashi/R-3076-2019	Imanishi, Tadashi/0000-0002-1182-9127	Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan [13800633]; Japan Initiative for Global Research Network on Infectious Diseases (JGRID) Grant from the Ministry of Education, Culture, Sport, Science and Technology of Japan [15666369]; Japan Agency for Medical Research and Development (AMED); Tokai University School of Medicine	Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Initiative for Global Research Network on Infectious Diseases (JGRID) Grant from the Ministry of Education, Culture, Sport, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokai University School of Medicine	This research was partially supported by the Health Labour Sciences Research Grant [13800633] from the Ministry of Health, Labour and Welfare of Japan, and by the Japan Initiative for Global Research Network on Infectious Diseases (JGRID) Grant [15666369] from the Ministry of Education, Culture, Sport, Science and Technology of Japan, and Japan Agency for Medical Research and Development (AMED). Funding for open access charge was provided by Tokai University School of Medicine.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2001, GENOME RES, V11, P1541, DOI 10.1101/gr.183201; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, pD599, DOI 10.1093/nar/gku1062	17	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162424	10.1371/journal.pone.0162424	http://dx.doi.org/10.1371/journal.pone.0162424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611326	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900097
J	Dias, PEM; Miranda, GE; Beaini, TL; Melani, RFH				Miamoto Dias, Paulo Eduardo; Miranda, Geraldo Elias; Beaini, Thiago Leite; Haltenhoff Melani, Rodolfo Francisco			Practical Application of Anatomy of the Oral Cavity in Forensic Facial Reconstruction	PLOS ONE			English	Article							LABIAL MORPHOLOGY; MOUTH-WIDTH; UPPER LIP; FACE; APPROXIMATION; TISSUES; GROWTH	The oral cavity's importance in defining the facial region makes it a primary feature for forensic facial reconstruction (FFR). The aim of this study is to construct a pattern of reference for dimensions and proportions of the lips and establish parameters that may help estimate the vermilion borders' height dimensions and the mouth's width. By means of cone beam computed tomography, divided into two samples: sample 1 (n = 322; 137 male, 185 female) verified the linear distances delimited by anatomical landmarks in soft tissue. The sample 2 (n = 108; 40 male, 68 female), verified the proportions among the height of the vermilion borders, width of the mouth, and linear distances between craniometric landmarks in hard tissues, both from a Brazilian database. The measurements were completed using OsiriX, and the results were analyzed by means of descriptive statistics at a level of significance of 5%. The height of the vermilion borders corresponded to approximately 26% of the width of the mouth. The width of the mouth increased over the course of time in men and remained stable in women. In men, a mean intercanine distance of 75% of the total mouth's width was found; for women, it was 80%. The parameters of the relations between soft and hard tissues in the oral cavity region presented that the distance between landmarks ID-SM (Infradentale-Supramentale) corresponded to 55% of the height of the vermilion borders of the mouth for both sexes, while the distance between landmarks PM-SD (Philtrum medium-Supradentale) corresponded to 85% in men and 88% in women. Mean values of 97% of the width of the mouth in women and 93% in men were attributed to the distance between the mentonian foramina. It was not possible to estimate the height of the labial vermilion borders by the bone measurements, FIs-Fli (Foramen incisivus superius-inferius) and NS-GN (Nasospinale-Gnathion). Profound knowledge of the anatomy and morphology of the oral cavity may contribute to increasing the precision of FFRs and help with human identification.	[Miamoto Dias, Paulo Eduardo; Miranda, Geraldo Elias; Beaini, Thiago Leite; Haltenhoff Melani, Rodolfo Francisco] Univ Sao Paulo, Sch Dent, Dept Social Dent, Lab Forens Anthropol & Odontol OFLAB, Sao Paulo, Brazil	Universidade de Sao Paulo	Miranda, GE (corresponding author), Univ Sao Paulo, Sch Dent, Dept Social Dent, Lab Forens Anthropol & Odontol OFLAB, Sao Paulo, Brazil.	geraldoelias@usp.br	Beaini, Thiago/AAK-9658-2020; Melani, Rodolfo Francisco Haltenhoff/B-7205-2013; MIRANDA, GERALDO/D-1704-2015	Beaini, Thiago/0000-0003-0034-624X; Melani, Rodolfo Francisco Haltenhoff/0000-0001-7148-3503; Yuquilema Miranda, Elias/0000-0002-1760-747X; MIRANDA, GERALDO/0000-0003-1240-3256				Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; Almeida NH, 2013, FORENSIC SCI INT, V231, P401, DOI [10.1016/j.forsciint.2013.05.024, DOI 10.1016/J.FORSCIINT.2013.05.024]; Anic-Milosevic S, 2010, J CRANIO MAXILL SURG, V38, P90, DOI 10.1016/j.jcms.2009.03.013; Cattoni Débora Martins, 2009, Pró-Fono R. Atual. Cient., V21, P25, DOI 10.1590/S0104-56872009000100005; Daboul A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048281; De Menezes M, 2011, INT J ORAL MAX SURG, V40, P856, DOI 10.1016/j.ijom.2011.03.004; Dias P.E.M., 2013, J RES DENT, V1, P351; FARKAS LG, 1984, AM J ORTHOD DENTOFAC, V86, P52, DOI 10.1016/0002-9416(84)90276-8; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P318, DOI 10.1597/1545-1569(1992)029<0318:GPOTNR>2.3.CO;2; Ferrario VF, 2000, J ANAT, V196, P415, DOI 10.1046/j.1469-7580.2000.19630415.x; Ferrario VF, 2009, J ORAL MAXIL SURG, V67, P1832, DOI 10.1016/j.joms.2009.04.080; Gerasimov M., 1971, THE FACE FINDER; Iblher N, 2008, J PLAST RECONSTR AES, V61, P1170, DOI 10.1016/j.bjps.2008.06.001; Moyers R. E., 1988, HDB ORTHODONTICS, V4; Oliveira R N, 2000, J Forensic Odontostomatol, V18, P32; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; RHINE JS, 1980, J FORENSIC SCI, V25, P847; Rogers CR, 2009, J ANAT, V214, P36, DOI 10.1111/j.1469-7580.2008.01004.x; SFORZA C, 2010, FORENSIC SCI INT, V182, pE1, DOI DOI 10.1016/J.F0RSCIINT.2010.04.050; Stephan CN, 2003, J FORENSIC SCI, V48, P725; Stephan CN, 2003, AM J PHYS ANTHROPOL, V121, P48, DOI 10.1002/ajpa.10166; Stephan CN, 2002, FORENSIC SCI INT, V130, P29, DOI 10.1016/S0379-0738(02)00279-7; Stephan CN, 2008, J FORENSIC ODONTOSTO, V26, P2; Tedeschi-Oliveira S.V., 2009, FORENSIC SCI INT, V193, pe1, DOI DOI 10.1016/J.F0RSCIINT.2009.09.002; Thompson LA, 2004, DISCOURSE PROCESS, V38, P145, DOI 10.1207/s15326950dp3801_6; Wilkinson C, 2010, J ANAT, V216, P235, DOI 10.1111/j.1469-7580.2009.01182.x; Wilkinson CM, 2003, J FORENSIC SCI, V48, P728; Wilkinson CM, 2003, J FORENSIC SCI, V48, P12; Wong WW, 2010, J PLAST RECONSTR AES, V63, P2032, DOI 10.1016/j.bjps.2009.12.015	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162732	10.1371/journal.pone.0162732	http://dx.doi.org/10.1371/journal.pone.0162732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612284	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900158
J	Stutika, C; Mietzsch, M; Gogol-Doring, A; Weger, S; Sohn, M; Chen, W; Heilbronn, R				Stutika, Catrin; Mietzsch, Mario; Gogol-Doering, Andreas; Weger, Stefan; Sohn, Madlen; Chen, Wei; Heilbronn, Regine			Comprehensive Small RNA-Seq of Adeno-Associated Virus (AAV)-Infected Human Cells Detects Patterns of Novel, Non-Coding AAV RNAs in the Absence of Cellular miRNA Regulation	PLOS ONE			English	Article							DNA-REPLICATION; GENE-EXPRESSION; ADENOVIRUS REPLICATION; MICRORNAS; TYPE-2; TRANSCRIPTION; REVEALS; GENOMES; ORIGIN; INTEGRATION	Most DNA viruses express small regulatory RNAs, which interfere with viral or cellular gene expression. For adeno-associated virus (AAV), a small ssDNA virus with a complex biphasic life cycle miRNAs or other small regulatory RNAs have not yet been described. This is the first comprehensive Illumina-based RNA-Seq analysis of small RNAs expressed by AAV alone or upon co-infection with helper adenovirus or HSV. Several hotspots of AAV-specific small RNAs were detected mostly close to or within the AAV-ITR and apparently transcribed from the newly identified anti-p5 promoter. An additional small RNA hotspot was located downstream of the p40 promoter, from where transcription of non-coding RNAs associated with the inhibition of adenovirus replication were recently described. Parallel detection of known Ad and HSV miRNAs indirectly validated the newly identified small AAV RNA species. The predominant small RNAs were analyzed on Northern blots and by human argonaute protein-mediated co-immunoprecipitation. None of the small AAV RNAs showed characteristics of bona fide miRNAs, but characteristics of alternative RNA processing indicative of differentially regulated AAV promoter-associated small RNAs. Furthermore, the AAV-induced regulation of cellular miRNA levels was analyzed at different time points post infection. In contrast to other virus groups AAV infection had virtually no effect on the expression of cellular miRNA, which underscores the long-established concept that wild-type AAV infection is apathogenic.	[Stutika, Catrin; Mietzsch, Mario; Weger, Stefan; Heilbronn, Regine] Charite, Inst Virol, Campus Benjamin Franklin, Berlin, Germany; [Gogol-Doering, Andreas] Tech Hsch Mittelhessen, Giessen, Germany; [Sohn, Madlen; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Funct Genom & Syst Biol, Berlin, Germany; [Mietzsch, Mario] Univ Florida, Dept Biochem & Mol Biol, Struct Biol Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; State University System of Florida; University of Florida	Heilbronn, R (corresponding author), Charite, Inst Virol, Campus Benjamin Franklin, Berlin, Germany.	regine.heilbronn@charite.de	Heilbronn, Regine/E-1349-2013; Mietzsch, Mario/AAU-4233-2021	Heilbronn, Regine/0000-0001-6412-3278; Mietzsch, Mario/0000-0001-8957-3363; Weger, Stefan/0000-0002-0906-5252	Sonnenfeld-Stiftung, Berlin; Charite Universitatsmedizin Berlin	Sonnenfeld-Stiftung, Berlin; Charite Universitatsmedizin Berlin	RH received funding by the Sonnenfeld-Stiftung, Berlin; http://www.sonnenfeld-stiftung.de/. CS received a Ph.D. scholarship from Charite Universitatsmedizin Berlin.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14; BLACKLOW NR, 1967, P NATL ACAD SCI USA, V58, P1410, DOI 10.1073/pnas.58.4.1410; Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000; Brister JR, 1999, J VIROL, V73, P9325, DOI 10.1128/JVI.73.11.9325-9336.1999; BULLER RML, 1981, J VIROL, V40, P241, DOI 10.1128/JVI.40.1.241-247.1981; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Damm K, 2015, METHODS MOL BIOL, V1296, P41, DOI 10.1007/978-1-4939-2547-6_5; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024; GEORGFRIES B, 1984, VIROLOGY, V134, P64, DOI 10.1016/0042-6822(84)90272-1; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Harris CJ, 2015, NUCLEIC ACIDS RES, V43, P7590, DOI 10.1093/nar/gkv604; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; He SM, 2008, CRIT REV MICROBIOL, V34, P175, DOI [10.1080/10408410802482008, 10.1080/10408410802482008 ]; HEILBRONN R, 1990, J VIROL, V64, P3012, DOI 10.1128/JVI.64.6.3012-3018.1990; Huser D, 2014, J VIROL, V88, P11253, DOI 10.1128/JVI.01356-14; Jing XJ, 2001, VIROLOGY, V291, P140, DOI 10.1006/viro.2001.1192; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Keam Simon P., 2015, Life-Basel, V5, P1638, DOI 10.3390/life5041638; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; MCPHERSON RA, 1985, VIROLOGY, V147, P217, DOI 10.1016/0042-6822(85)90243-0; Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038; Mietzsch M, 2014, J VIROL, V88, P2991, DOI 10.1128/JVI.03371-13; Munson DJ, 2012, ARCH VIROL, V157, P1677, DOI 10.1007/s00705-012-1345-4; Pereira DJ, 1997, J VIROL, V71, P1079, DOI 10.1128/JVI.71.2.1079-1088.1997; Qiu JM, 2002, J VIROL, V76, P12435, DOI 10.1128/JVI.76.24.12435-12447.2002; Rother S, 2011, BIOCHIMIE, V93, P1905, DOI 10.1016/j.biochi.2011.07.032; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Stilwell JL, 2004, MOL THER, V9, P337, DOI 10.1016/j.ymthe.2003.11.007; Stutika C, 2016, J VIROL, V90, P1278, DOI 10.1128/JVI.02750-15; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; THOMSON BJ, 1994, VIROLOGY, V204, P304, DOI 10.1006/viro.1994.1535; Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06; Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11; Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang LN, 2015, J GEN VIROL, V96, P2780, DOI 10.1099/jgv.0.000229; Wang XS, 1997, J VIROL, V71, P3077, DOI 10.1128/JVI.71.4.3077-3082.1997; Wang XS, 1996, J VIROL, V70, P1668, DOI 10.1128/JVI.70.3.1668-1677.1996; Weger S, 2016, J VIROL, V90, P3981, DOI 10.1128/JVI.03120-15; WEINDLER FW, 1991, J VIROL, V65, P2476, DOI 10.1128/JVI.65.5.2476-2483.1991; Winter K, 2012, J VIROL, V86, P5099, DOI 10.1128/JVI.06991-11; Yan BX, 2012, CELL MOL LIFE SCI, V69, P2833, DOI 10.1007/s00018-012-0953-1; Yang JS, 1999, J VIROL, V73, P9468, DOI 10.1128/JVI.73.11.9468-9477.1999; Zhao HX, 2015, VIROLOGY, V478, P99, DOI 10.1016/j.virol.2015.01.033	65	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161454	10.1371/journal.pone.0161454	http://dx.doi.org/10.1371/journal.pone.0161454			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611072	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000383255900017
J	Val-Laillet, D; Meurice, P; Clouard, C				Val-Laillet, David; Meurice, Paul; Clouard, Caroline			Familiarity to a Feed Additive Modulates Its Effects on Brain Responses in Reward and Memory Regions in the Pig Model	PLOS ONE			English	Article							APPETITE SUPPRESSING PROPERTIES; BODY-WEIGHT CONTROL; SWEET ORANGE AROMA; OLFACTORY STIMULATION; CHEMICAL-COMPOUNDS; FOOD PREFERENCES; ESSENTIAL OIL; DOMESTIC PIG; FLAVOR; TASTE	Brain responses to feed flavors with or without a feed additive (FA) were investigated in piglets familiarized or not with this FA. Sixteen piglets were allocated to 2 dietary treatments from weaning until d 37: the naive group (NAI) received a standard control feed and the familiarized group (FAM) received the same feed added with a FA mainly made of orange extracts. Animals were subjected to a feed transition at d 16 post-weaning, and to 2-choice feeding tests at d 16 and d 23. Production traits of the piglets were assessed up to d 28 post-weaning. From d 26 onwards, animals underwent 2 brain imaging sessions (positron emission tomography of (18)FDG) under anesthesia to investigate the brain activity triggered by the exposure to the flavors of the feed with (FA) or without (C) the FA. Images were analyzed with SPM8 and a region of interest (ROI)-based small volume correction (p < 0.05, k >= 25 voxels per cluster). The brain ROI were selected upon their role in sensory evaluation, cognition and reward, and included the prefrontal cortex, insular cortex, fusiformgyrus, limbic system and corpus striatum. The FAM animals showed a moderate preference for the novel post-transition FA feed compared to the C feed on d 16, i.e., day of the feed transition (67% of total feed intake). The presence or absence of the FA in the diet from weaning had no impact on body weight, average daily gain, and feed efficiency of the animals over the whole experimental period (p >= 0.10). Familiar feed flavors activated the prefrontal cortex. The amygdala, insular cortex, and prepyriformarea were only activated in familiarized animals exposed to the FA feed flavor. The perception of FA feed flavor in the familiarized animals activated the dorsal striatum differently than the perception of the C feed flavor in naive animals. Our data demonstrated that the perception of FA in familiarized individuals induced different brain responses in regions involved in reward anticipation and/or perception processes than the familiar control feed flavor in naive animals. Chronic exposure to the FA might be necessary for positive hedonic effects, but familiarity only cannot explain them.	[Val-Laillet, David; Meurice, Paul; Clouard, Caroline] INRA, ADNC UR1341, St Gilles, France	INRAE	Val-Laillet, D (corresponding author), INRA, ADNC UR1341, St Gilles, France.	david.val-laillet@rennes.inra.fr	Clouard, Caroline/K-1255-2014; Val-Laillet, David/B-4328-2008; VAL-LAILLET, David/AAH-6454-2021	Clouard, Caroline/0000-0002-5562-6057; Val-Laillet, David/0000-0002-6256-7737; 	Phode Sciences (Terssac, France); BPI France	Phode Sciences (Terssac, France); BPI France	The study was funded by Phode Sciences (Terssac, France-http://www.phode.com/en/) and BPI France (http://www.bpifrance.fr/)-formerly OSEO. Phode Science participated to the discussion of the experimental protocol and results but had no role in decision to publish or preparation of the manuscript. BPI France had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by Phode Sciences (Terssac, France-http://www.phode.com/en/) and BPI France (http://www.bpifrance.fr/-formerly OSEO). Phode Science participated to the discussion of the experimental protocol and results but had no role in decision to publish or preparation of the manuscript. BPI France had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sensory functional ingredients were provided by Phode Laboratories (Terssac, France). The authors would like to thank our partners from Phode Sciences, who participated to the discussion of the experimental protocols and results: Virginie Noirot, Pierre Etienne, Maxime Champagnac, and Daniel Eclache, as well as Bertrand Medina (Laboratoires Phode) for proofreading. The authors acknowledge Charles-Henri Malbert who initially developed the brain imaging protocol in pigs and part of the data processing method. The authors also gratefully acknowledge the efforts and cooperation of the technical staff, and especially Alain Chauvin, Francis Legouevec, Regis Janvier and Vincent Piedvache for participating in this study and taking care of the animals.	Astell KJ, 2013, PLANT FOOD HUM NUTR, V68, P213, DOI 10.1007/s11130-013-0361-1; Brooks SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060393; Burger KS, 2014, NEUROIMAGE, V99, P122, DOI 10.1016/j.neuroimage.2014.05.066; CAMPBELL RG, 1976, ANIM PROD, V23, P417, DOI 10.1017/S0003356100031536; Cautela D, 2008, J AGR FOOD CHEM, V56, P5407, DOI 10.1021/jf8006823; Chambers ES, 2009, J PHYSIOL-LONDON, V587, P1779, DOI 10.1113/jphysiol.2008.164285; Chang KM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/946537; Clouard C, 2014, J ANIM SCI, V92, P2133, DOI 10.2527/jas.2013-6809; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Clouard C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00861; Clouard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037968; Clouard C, 2012, APPL ANIM BEHAV SCI, V138, P36, DOI 10.1016/j.applanim.2012.01.016; Conrad MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107650; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Danilova V, 2002, METH NE FRO NEUROSCI, P247; Faturi CB, 2010, PROG NEURO-PSYCHOPH, V34, P605, DOI 10.1016/j.pnpbp.2010.02.020; Frank GKW, 2008, NEUROIMAGE, V39, P1559, DOI 10.1016/j.neuroimage.2007.10.061; Gattuso G, 2007, MOLECULES, V12, P1641, DOI 10.3390/12081641; Gaultier A, 2011, EUR J NEUROSCI, V34, P1500, DOI 10.1111/j.1460-9568.2011.07848.x; Goes TC, 2012, J ALTERN COMPLEM MED, V18, P798, DOI 10.1089/acm.2011.0551; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Henkin RI, 2001, J COMPUT ASSIST TOMO, V25, P493, DOI 10.1097/00004728-200107000-00001; Jacela JY, 2010, J SWINE HEALTH PROD, V18, P27, DOI 10.4148/2378-5977.7069; Jafarzadeh Mehdi, 2013, Adv Biomed Res, V2, P10, DOI 10.4103/2277-9175.107968; KENNEDY JM, 1972, ANIM BEHAV, V20, P706, DOI 10.1016/S0003-3472(72)80142-8; KING RH, 1979, AUST J EXP AGR, V19, P695, DOI 10.1071/EA9790695; Komiya M, 2006, BEHAV BRAIN RES, V172, P240, DOI 10.1016/j.bbr.2006.05.006; Komori T, 1995, EUR NEUROPSYCHOPHARM, V5, P477, DOI 10.1016/0924-977X(95)00020-P; KOMORI T, 1995, NEUROIMMUNOMODULAT, V2, P174, DOI 10.1159/000096889; Langendijk P, 2007, LIVEST SCI, V108, P284, DOI 10.1016/j.livsci.2007.01.083; Lehrner J, 2000, PHYSIOL BEHAV, V71, P83, DOI 10.1016/S0031-9384(00)00308-5; Lyly M, 2009, EUR J NUTR, V48, P251, DOI 10.1007/s00394-009-0009-y; Morrone LA, 2007, PHARMACOL RES, V55, P255, DOI 10.1016/j.phrs.2006.11.010; Nishijo H, 1992, Asia Pac J Clin Nutr, V1, P3; Rolls ET, 2006, PHILOS T R SOC B, V361, P1123, DOI 10.1098/rstb.2006.1852; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Saiyudthong S, 2011, PHYTOTHER RES, V25, P858, DOI 10.1002/ptr.3325; Schdne F, 2006, J ANIM PHYSIOL AN N, V90, P500; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; Simitzis PE, 2008, PHYSIOL BEHAV, V93, P529, DOI 10.1016/j.physbeh.2007.10.013; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Stice E, 2013, AM J CLIN NUTR, V98, P1377, DOI 10.3945/ajcn.113.069443; Stohs SJ, 2013, PLANT FOOD HUM NUTR, V68, P329, DOI 10.1007/s11130-013-0376-7; Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048; Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Yi LT, 2008, LIFE SCI, V82, P741, DOI 10.1016/j.lfs.2008.01.007	48	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162660	10.1371/journal.pone.0162660	http://dx.doi.org/10.1371/journal.pone.0162660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610625	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900146
J	van Dixhoorn, IDE; Reimert, I; Middelkoop, J; Bolhuis, JE; Wisselink, HJ; Koerkamp, PWGG; Kemp, B; Stockhofe-Zurwieden, N				van Dixhoorn, Ingrid D. E.; Reimert, Inonge; Middelkoop, Jenny; Bolhuis, J. Elizabeth; Wisselink, Henk J.; Koerkamp, Peter W. G. Groot; Kemp, Bas; Stockhofe-Zurwieden, Norbert			Enriched Housing Reduces Disease Susceptibility to Co-Infection with Porcine Reproductive and Respiratory Virus (PRRSV) and Actinobacillus pleuropneumoniae (A. pleuropneumoniae) in Young Pigs	PLOS ONE			English	Article							INDIVIDUAL COPING CHARACTERISTICS; ENVIRONMENTAL ENRICHMENT; GROWING PIGS; LEUKOCYTE SUBPOPULATIONS; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; STRESS HORMONES; LACTATING SOWS; FINISHING PIGS; GROWTH-RATE	Until today, anti-microbial drugs have been the therapy of choice to combat bacterial diseases. Resistance against antibiotics is of growing concern in man and animals. Stress, caused by demanding environmental conditions, can reduce immune protection in the host, influencing the onset and outcome of infectious diseases. Therefore psychoneuro-immunological intervention may prove to be a successful approach to diminish the impact of diseases and antibiotics use. This study was designed to investigate the effect of social and environmental enrichment on the impact of disease, referred to as "disease susceptibility", in pigs using a co-infection model of PRRSV and A. pleuropneumoniae. Twenty-eight pigs were raised in four pens under barren conditions and twenty-eight other pigs were raised in four pens under enriched conditions. In the enriched pens a combination of established social and environmental enrichment factors were introduced. Two pens of the barren (BH) and two pens of the enriched housed (EH) pigs were infected with PRRSV followed by A. pleuropneumoniae, the other two pens in each housing treatment served as control groups. We tested if differences in disease susceptibility in terms of pathological and clinical outcome were related to the different housing regimes and if this was reflected in differences in behavioural and immunological states of the animals. Enriched housed pigs showed a faster clearance of viral PRRSV RNA in blood serum (p = 0.014) and histologically 2.8 fold less interstitial pneumonia signs in the lungs (p = 0.014). More barren housed than enriched housed pigs developed lesions in the lungs (OR = 19.2, p = 0.048) and the lesions in the barren housed pigs showed a higher total pathologic tissue damage score (p<0.001) than those in enriched housed pigs. EH pigs showed less stress-related behaviour and differed immunologically and clinically from BH pigs. We conclude that enriched housing management reduces disease susceptibility to co-infection of PRRSV and A. pleuropneumoniae in pigs. Enrichment positively influences behavioural state, immunological response and clinical outcome in pigs.	[van Dixhoorn, Ingrid D. E.] Univ Wageningen & Res Ctr, Livestock Res, Wageningen, Netherlands; [Reimert, Inonge; Middelkoop, Jenny; Bolhuis, J. Elizabeth; Kemp, Bas] Univ Wageningen & Res Ctr, Adaptat Physiol Grp, Wageningen, Netherlands; [Wisselink, Henk J.; Stockhofe-Zurwieden, Norbert] Univ Wageningen & Res Ctr, Cent Vet Inst, Lelystad, Netherlands; [Koerkamp, Peter W. G. Groot] Univ Wageningen & Res Ctr, Farm Technol Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van Dixhoorn, IDE (corresponding author), Univ Wageningen & Res Ctr, Livestock Res, Wageningen, Netherlands.	ingrid.vandixhoorn@wur.nl	Koerkamp, Peter WG Groot/D-2807-2013; Wisselink, Henk/AAL-6283-2020	Koerkamp, Peter WG Groot/0000-0002-3935-4071; Wisselink, Henk/0000-0002-3747-8054; van Dixhoorn, Ingrid/0000-0003-3642-2523	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was funded by the Dutch Ministry of Economic Affairs.	Amory JR, 2006, VET REC, V158, P260, DOI 10.1136/vr.158.8.260; Averos X, 2010, APPL ANIM BEHAV SCI, V127, P73, DOI 10.1016/j.applanim.2010.09.010; Beattie VE, 2005, ANIM SCI, V80, P307, DOI 10.1079/ASC40040307; Beattie VE, 2000, ANIM SCI, V70, P443, DOI 10.1017/S1357729800051791; BEATTIE VE, 1995, ANIM WELFARE, V4, P207; Becker PM, 2012, VET MICROBIOL, V154, P316, DOI 10.1016/j.vetmic.2011.07.011; Biondi M, 1997, PSYCHOTHER PSYCHOSOM, V66, P3, DOI 10.1159/000289101; Bolhuis JE, 2007, LIVEST SCI, V109, P108, DOI 10.1016/j.livsci.2007.01.100; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Bolhuis JE, 2006, APPL ANIM BEHAV SCI, V101, P68, DOI 10.1016/j.applanim.2006.01.001; Bolhuis JE, 2005, APPL ANIM BEHAV SCI, V93, P213, DOI 10.1016/j.applanim.2005.01.006; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Bracke MBM, 2013, J AGR ENVIRON ETHIC, V26, P847, DOI 10.1007/s10806-012-9410-2; Camerlink I, 2014, J ANIM SCI, V92, P2612, DOI 10.2527/jas.2013-7220; Camerlink I, 2012, APPL ANIM BEHAV SCI, V142, P11, DOI 10.1016/j.applanim.2012.09.004; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; Chaloupkova H, 2007, APPL ANIM BEHAV SCI, V103, P25, DOI 10.1016/j.applanim.2006.04.020; Cho JG, 2006, THERIOGENOLOGY, V66, P655, DOI 10.1016/j.theriogenology.2006.04.024; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; DANTZER R, 1989, LIFE SCI, V44, P1995, DOI 10.1016/0024-3205(89)90345-7; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; Di Martino G, 2013, RES VET SCI, V95, P1271, DOI 10.1016/j.rvsc.2013.08.012; Doeschl-Wilson AB, 2009, J ANIM SCI, V87, P1638, DOI 10.2527/jas.2008-1447; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Elenkov IJ, 1999, BEST PRACT RES CL EN, V13, P583, DOI 10.1053/beem.1999.0045; EWALD C, 1994, BERL MUNCH TIERARZTL, V107, P256; Frossard JP, 2012, VET MICROBIOL, V158, P308, DOI 10.1016/j.vetmic.2012.03.004; GALINA L, 1994, VET REC, V134, P60, DOI 10.1136/vr.134.3.60; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gomez-Laguna J, 2009, VIRAL IMMUNOL, V22, P261, DOI 10.1089/vim.2009.0003; HENSEL A, 1993, J AEROSOL MED, V6, P73, DOI 10.1089/jam.1993.6.73; Jirawattanapong P, 2010, RES VET SCI, V88, P11, DOI 10.1016/j.rvsc.2009.06.007; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KAMP EM, 1987, VET MICROBIOL, V13, P249, DOI 10.1016/0378-1135(87)90087-3; KHANSARI DN, 1990, IMMUNOL TODAY, V11, P170, DOI 10.1016/0167-5699(90)90069-L; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kutzer T, 2009, APPL ANIM BEHAV SCI, V121, P16, DOI 10.1016/j.applanim.2009.08.004; Lamontagne L, 2003, VIRAL IMMUNOL, V16, P395, DOI 10.1089/088282403322396181; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Melotti L, 2011, APPL ANIM BEHAV SCI, V133, P144, DOI 10.1016/j.applanim.2011.05.018; Meulenberg JJM, 2000, VET RES, V31, P11, DOI 10.1051/vetres:2000054; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Nielsen EK, 2000, ACTA AGR SCAND A-AN, V50, P30, DOI 10.1080/090647000423906; Nielsen J, 2003, VET IMMUNOL IMMUNOP, V93, P135, DOI 10.1016/S0165-2427(03)00068-0; Oostindjer M, 2010, J ANIM SCI, V88, P3554, DOI 10.2527/jas.2010-2940; Oostindjer M, 2011, APPL ANIM BEHAV SCI, V134, P31, DOI 10.1016/j.applanim.2011.06.011; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Poltorak A, 1999, PNEUMOLOGIE, V53; Proudfoot K, 2015, VET J, V206, P15, DOI 10.1016/j.tvjl.2015.05.024; Pruett Stephen B., 2003, Pathophysiology, V9, P133, DOI 10.1016/S0928-4680(03)00003-8; Reimert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108700; ROEPSTORFF A, 1990, VET PARASITOL, V36, P245, DOI 10.1016/0304-4017(90)90036-B; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Schroder-Petersen DL, 2001, VET J, V162, P196, DOI 10.1053/tvjl.2001.0605; Shi KC, 2008, VET MICROBIOL, V129, P367, DOI 10.1016/j.vetmic.2007.11.020; Skjerve E, 1998, INT J FOOD MICROBIOL, V45, P195, DOI 10.1016/S0168-1605(98)00162-7; Sneddon IA, 2000, ANIM WELFARE, V9, P373; Stege H, 2001, PREV VET MED, V50, P153, DOI 10.1016/S0167-5877(01)00194-5; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Tonepohl B, 2012, APPL ANIM BEHAV SCI, V140, P137, DOI 10.1016/j.applanim.2012.05.002; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; Van Gucht S, 2004, VET IMMUNOL IMMUNOP, V102, P165, DOI 10.1016/j.vetimm.2004.09.006; Velthuis AGJ, 2002, EPIDEMIOL INFECT, V129, P203, DOI 10.1017/S0950268802007252; Weesendorp E, 2014, VET MICROBIOL, V174, P127, DOI 10.1016/j.vetmic.2014.09.010; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296	70	39	39	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161832	10.1371/journal.pone.0161832	http://dx.doi.org/10.1371/journal.pone.0161832			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606818	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600011
J	Guala, GF				Guala, Gerald F.			The Importance of Species Name Synonyms in Literature Searches	PLOS ONE			English	Article								The synonyms of biological species names are shown to be an importantcomponent in comprehensive searches of electronic scientific literature databases but they are not well leveraged within the major literature databases examined. For accepted or valid species names in the Integrated Taxonomic Information System (ITIS) which have synonyms in the system, and which are found in citations within PLoS, PMC, PubMed or Scopus, both the percentage of species for which citations will not be found if synonyms are not used, and the percentage increase in number of citations found by including synonyms are very often substantial. However, there is no correlation between the number of synonyms per species and the magnitude of the effect. Further, the number of citations found does not generally increase proportionally to the number of synonyms available. Users looking for literature on specific species across all of the resources investigated here are often missing large numbers of citations if they are not manually augmenting their searches with synonyms. Of course, missing citations can have serious consequences by effectively hiding critical information. Literature searches should include synonym relationships and a new web service in ITIS, with examples of how to apply it to this issue, was developed as a result of this study, and is here announced, to aide in this.	[Guala, Gerald F.] US Geol Survey, Core Sci Syst Mission Area, Core Sci Analyt Synth & Lib Program, 959 Natl Ctr, Reston, VA 22092 USA	United States Department of the Interior; United States Geological Survey	Guala, GF (corresponding author), US Geol Survey, Core Sci Syst Mission Area, Core Sci Analyt Synth & Lib Program, 959 Natl Ctr, Reston, VA 22092 USA.	ggaula@usgs.gov		Guala, Gerald/0000-0002-4972-3782	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	Support was provided by U.S. Geological Survey base funding.	Roskov Y, 2014, SPECIES 2000 ITIS C; Ruggiero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119248	2	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162648	10.1371/journal.pone.0162648	http://dx.doi.org/10.1371/journal.pone.0162648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627118	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600050
J	Heinonen, J; Numminen, J; Hlushchuk, Y; Antell, H; Taatila, V; Suomala, J				Heinonen, Jarmo; Numminen, Jussi; Hlushchuk, Yevhen; Antell, Henrik; Taatila, Vesa; Suomala, Jyrki			Default Mode and Executive Networks Areas: Association with the Serial Order in Divergent Thinking	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; CREATIVE COGNITION; WORKING-MEMORY; FMRI; CORTEX; INSIGHT; GENERATION; PRECUNEUS; DYNAMICS	Scientific findings have suggested a two-fold structure of the cognitive process. By using the heuristic thinking mode, people automatically process information that tends to be invariant across days, whereas by using the explicit thinking mode people explicitly process information that tends to be variant compared to typical previously learned information patterns. Previous studies on creativity found an association between creativity and the brain regions in the prefrontal cortex, the anterior cingulate cortex, the default mode network and the executive network. However, which neural networks contribute to the explicit mode of thinking during idea generation remains an open question. We employed an fMRI paradigm to examine which brain regions were activated when participants (n = 16) mentally generated alternative uses for everyday objects. Most previous creativity studies required participants to verbalize responses during idea generation, whereas in this study participants produced mental alternatives without verbalizing. This study found activation in the left anterior insula when contrasting idea generation and object identification. This finding suggests that the insula (part of the brain's salience network) plays a role in facilitating both the central executive and default mode networks to activate idea generation. We also investigated closely the effect of the serial order of idea being generated on brain responses: The amplitude of fMRI responses correlated positively with the serial order of idea being generated in the anterior cingulate cortex, which is part of the central executive network. Positive correlation with the serial order was also observed in the regions typically assigned to the default mode network: the precuneus/ cuneus, inferior parietal lobule and posterior cingulate cortex. These networks support the explicit mode of thinking and help the individual to convert conventional mental models to new ones. The serial order correlated negatively with the BOLD responses in the posterior presupplementarymotor area, left premotor cortex, right cerebellum and left inferior frontal gyrus. This finding might imply that idea generation without a verbal processing demand reflecting lack of need for new object identification in idea generation events. The results of the study are consistent with recent creativity studies, which emphasize that the creativity process involves working memory capacity to spontaneously shift between different kinds of thinking modes according to the context.	[Heinonen, Jarmo; Hlushchuk, Yevhen; Antell, Henrik; Suomala, Jyrki] Laurea Univ Appl Sci, NeuroLab, Espoo, Finland; [Heinonen, Jarmo; Hlushchuk, Yevhen; Suomala, Jyrki] Aalto Univ, AALTO, Aalto NeuroImaging, Espoo, Finland; [Numminen, Jussi] Univ Helsinki, Toolo Hosp, Helsinki Med Imaging Ctr, Helsinki, Finland; [Antell, Henrik] Biomedicum Helsinki, Neurosurg Res Grp, Helsinki, Finland; [Taatila, Vesa] Turku Univ Appl Sci, Turku, Finland; [Suomala, Jyrki] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Hlushchuk, Yevhen; Antell, Henrik] Helsinki Univ Hosp, HUS Med Imaging Ctr, Radiol, Helsinki, Finland; [Hlushchuk, Yevhen; Antell, Henrik] Univ Helsinki, Helsinki, Finland	Laurea University of Applied Sciences; Aalto University; Hyvinkaan Sairaala; University of Helsinki; University of Helsinki; University of Turku; University of California System; University of California Santa Barbara; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Suomala, J (corresponding author), Laurea Univ Appl Sci, NeuroLab, Espoo, Finland.; Suomala, J (corresponding author), Aalto Univ, AALTO, Aalto NeuroImaging, Espoo, Finland.; Suomala, J (corresponding author), Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA.	jyrki.suomala@laurea.fi	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Hlushchuk, Yevhen/0000-0001-6869-6305	CAL4INO (Creative Activities in Learning for Innovation) project - European Union Lifelong Learning Programme; NeuroService Project - Finnish Funding Agency for Innovation (TEKES) [2191/31/2013]	CAL4INO (Creative Activities in Learning for Innovation) project - European Union Lifelong Learning Programme; NeuroService Project - Finnish Funding Agency for Innovation (TEKES)	This work was supported by the CAL4INO (Creative Activities in Learning for Innovation) project funded by the European Union Lifelong Learning Programme) (VT) and the NeuroService Project funded by the Finnish Funding Agency for Innovation (TEKES; www.TEKES.fi) grant 2191/31/2013(JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden R, 2010, BEHAV BRAIN RES, V214, P143, DOI 10.1016/j.bbr.2010.05.015; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Beaty RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep10964; Beaty RE, 2014, NEUROPSYCHOLOGIA, V64, P92, DOI 10.1016/j.neuropsychologia.2014.09.019; Beaty RE, 2012, PSYCHOL AESTHET CREA, V6, P309, DOI 10.1037/a0029171; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Benedek M, 2014, NEUROIMAGE, V88, P125, DOI 10.1016/j.neuroimage.2013.11.021; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Chrysikou EG, 2011, HUM BRAIN MAPP, V32, P665, DOI 10.1002/hbm.21056; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Derrfuss J, 2012, NEUROIMAGE, V59, P3829, DOI 10.1016/j.neuroimage.2011.11.051; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Eklund A, 2015, ARXIV 151101863 MATH; Eliasmith C., 2013, HOW TO BUILD A BRAIN; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fink A, 2012, HUM BRAIN MAPP, V33, P2603, DOI 10.1002/hbm.21387; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gabora L, 2010, CREATIVITY RES J, V22, P1, DOI 10.1080/10400410903579494; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Geary D C, 2005, ORIGIN OF MIND EVOLU; Gilhooly KJ, 2007, BRIT J PSYCHOL, V98, P611, DOI 10.1111/j.2044-8295.2007.tb00467.x; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guilford J. P., 1967, THE NATURE OF HUMAN; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Hinds O, 2013, J NEUROPHYSIOL, V109, P1250, DOI 10.1152/jn.00533.2011; Howard-Jones PA, 2005, COGNITIVE BRAIN RES, V25, P240, DOI 10.1016/j.cogbrainres.2005.05.013; Jung RE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00330; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Keskinen, 2006, P 28 ANN C COGN SCI, P2204; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Luo JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076444, 10.1371/journal.pone.0049231]; Mazaika P., 2009, NEUROIMAGE, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ramachandran V, 2003, J CONSCIOUSNESS STUD, V10, P49; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Schlegel A, 2013, P NATL ACAD SCI USA, V110, P16277, DOI 10.1073/pnas.1311149110; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Silvia PJ, 2012, INTELLIGENCE, V40, P343, DOI 10.1016/j.intell.2012.02.005; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; THAGARD P, 2010, STUD COMPUT INTELL, V314, P447; Thagard P, 2011, COGNITIVE SCI, V35, P1, DOI 10.1111/j.1551-6709.2010.01142.x; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088	73	40	40	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162234	10.1371/journal.pone.0162234	http://dx.doi.org/10.1371/journal.pone.0162234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627760	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600026
J	Li, M; Huang, YB; Du, X; Li, SS; Ji, JC; Patel, A; Gao, RL; Wu, YF				Li, Min; Huang, Yubei; Du, Xin; Li, Shenshen; Ji, Jiachao; Patel, Anushka; Gao, Runlin; Wu, Yangfeng			Impact of Prior Use of Four Preventive Medications on Outcomes in Patients Hospitalized for Acute Coronary Syndrome-Results from CPACS-2 Study	PLOS ONE			English	Article							PRIOR ASPIRIN USE; GLOBAL REGISTRY; EVENTS GRACE; UNSTABLE ANGINA; STATIN THERAPY; ASSOCIATION; RISK	Background It is widely reported that long-term use of four preventive medications (antiplatelet agents, angiotensin converting enzyme inhibitor /angiotensin receptor blocker, statin and beta-blockers) reduce the risk of subsequent acute coronary syndromes (ACS). It is unclear whether these four medications benefit patients who develop ACS despite its use. Methods and Results Logistic regression and propensity-score was applied among 14790 ACS patients to assess the association between prior use of four preventive medications and in-hospital outcomes including severity of disease at presentation (type of ACS, systolic blood pressure <90 mmHg, and heart rate> = 100 beats/min), complicating arrhythmia and major adverse cardiovascular events (MACEs, including all deaths, non-fatal myocardial infarction or re-infarction, and non-fatal stroke). Prior use of each of the four medications was significantly associated with less severity of disease (ORs ranged from 0.40 to 0.82, all P<0.05), less arrhythmia (ORs ranged from 0.45 to 0.64, all P<0.05), and reduced risk of MACEs (ORs ranged from 0.59 to 0.73, all P<0.05) during hospitalization. Multiple variable-adjusted ORs of MACEs were 0.77, 0.67, 0.48 and 0.59 respectively in patients with 1, 2, 3 and 4 medications in comparison with patients with none, and other clinical outcomes showed the same trend (P for trend < 0.05). Conclusions Among ACS patients in our study, those with prior use of four preventive medications presented with less disease severity, developed less arrhythmia and had a lower risk of in-hospital MACEs. The value of taking these medications may beyond just preventing occurrence of the disease.	[Li, Min; Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China; [Huang, Yubei] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Du, Xin; Li, Shenshen; Ji, Jiachao; Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Du, Xin] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Patel, Anushka] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Gao, Runlin] Chinese Acad Med Sci, Cardiovasc Inst, Dept Cardiol, Beijing, Peoples R China; [Gao, Runlin] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Gao, Runlin] Peking Union Med Coll, Beijing, Peoples R China	Peking University; Tianjin Medical University; Peking University; Capital Medical University; George Institute for Global Health; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.	ywu@georgeinstitute.org.cn	Huang, Yubei/AAE-8296-2020	Patel, Anushka/0000-0003-3825-4092	Sanofi, China	Sanofi, China(Sanofi-Aventis)	The source of funding used to support the CPACS-2 study is from Sanofi, China, through an unrestricted research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 1999, AM J CARDIOL, V83, P1147, DOI 10.1016/S0002-9149(99)00049-1; Amad H, 2012, CAN J CARDIOL, V28, P48, DOI 10.1016/j.cjca.2011.09.003; Borzak S, 1998, AM J CARDIOL, V81, P678, DOI 10.1016/S0002-9149(97)01006-0; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; HERLITZ J, 1995, CARDIOLOGY, V86, P56, DOI 10.1159/000176831; Lancaster GI, 2001, INT J CARDIOL, V80, P201, DOI 10.1016/S0167-5273(01)00495-8; Portnay EL, 2005, J AM COLL CARDIOL, V46, P967, DOI 10.1016/j.jacc.2005.06.049; Rich JD, 2010, J AM COLL CARDIOL, V56, P1376, DOI 10.1016/j.jacc.2010.06.028; Rong Ye, 2010, Crit Pathw Cardiol, V9, P134, DOI 10.1097/HPC.0b013e3181f01eac; Santopinto J, 2001, AM HEART J, V141, P566, DOI 10.1067/mhj.2001.113994; Singh SM, 2012, AM J CARDIOL, V109, P332, DOI 10.1016/j.amjcard.2011.09.018; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Spencer FA, 2002, AM J CARDIOL, V90, P1056, DOI 10.1016/S0002-9149(02)02769-8; Vedre A, 2009, AM J CARDIOL, V104, P1613, DOI 10.1016/j.amjcard.2009.07.045	15	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0163068	10.1371/journal.pone.0163068	http://dx.doi.org/10.1371/journal.pone.0163068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626640	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600074
J	Salem, L; Saleh, N; Desamericq, G; Youssov, K; Dolbeau, G; Cleret, L; Bourhis, ML; Azulay, JP; Krystkowiak, P; Verny, C; Morin, F; Moutereau, S; Bachoud-Levi, AC; Maison, P				Salem, Linda; Saleh, Nadine; Desamericq, Gaelle; Youssov, Katia; Dolbeau, Guillaume; Cleret, Laurent; Bourhis, Marie-Laure; Azulay, Jean-Philippe; Krystkowiak, Pierre; Verny, Christophe; Morin, Francoise; Moutereau, Stephane; Bachoud-Levi, Anne-Catherine; Maison, Patrick		French Huntington Study Grp	Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease	PLOS ONE			English	Article							DIABETES-MELLITUS; ALZHEIMER-DISEASE; RESISTANCE; HORMONE; BRAIN; NEUROPROTECTION; MECHANISMS; GLUCOSE; MEMORY	Background Huntington's disease (HD) is one of several neurodegenerative disorders that have been associated with metabolic alterations. Changes in Insulin Growth Factor 1 (IGF-1) and/or insulin input to the brain may underlie or contribute to the progress of neurodegenerative processes. Here, we investigated the association over time between changes in plasma levels of IGF-1 and insulin and the cognitive decline in HD patients. Methods We conducted a multicentric cohort study in 156 patients with genetically documented HD aged from 22 to 80 years. Among them, 146 patients were assessed at least twice with a follow- up of 3.5 +/- 1.8 years. We assessed their cognitive decline using the Unified Huntington's Disease Rating Scale, and their IGF-1 and insulin plasmatic levels, at baseline and once a year during the follow-up. Associations were evaluated using a mixed-effect linear model. Results In the cross-sectional analysis at baseline, higher levels of IGF-1 and insulin were associated with lower cognitive scores and thus with a higher degree of cognitive impairment. In the longitudinal analysis, the decrease of all cognitive scores, except the Stroop interference, was associated with the IGF-1 level over time but not of insulin. Conclusions IGF-1 levels, unlike insulin, predict the decline of cognitive function in HD.	[Salem, Linda; Saleh, Nadine; Desamericq, Gaelle; Youssov, Katia; Dolbeau, Guillaume; Cleret, Laurent; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Univ Paris Est, Fac Med, Creteil, France; [Salem, Linda; Saleh, Nadine; Desamericq, Gaelle; Youssov, Katia; Dolbeau, Guillaume; Cleret, Laurent; Bachoud-Levi, Anne-Catherine; Maison, Patrick] INSERM, U955, Equipe 01, Neuropsychol Intervent, Creteil, France; [Salem, Linda; Saleh, Nadine; Desamericq, Gaelle; Youssov, Katia; Cleret, Laurent; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Ecole Normale Super, Dept Etud Cognit, Paris, France; [Salem, Linda; Saleh, Nadine; Desamericq, Gaelle; Youssov, Katia; Cleret, Laurent; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Hop H Mondor A Chenevier, AP HP, Ctr Reference Malad Huntington Neurol Cognit, Creteil, France; [Dolbeau, Guillaume; Bourhis, Marie-Laure] Hop H Mondor A Chenevier, AP HP, Unite Rech Clin, Creteil, France; [Azulay, Jean-Philippe] Hop La Timone, Serv Neurol & Pathol Mouvement, Marseille, France; [Krystkowiak, Pierre] CHU Amiens, Dept Neurol, Amiens, France; [Verny, Christophe] CHU Angers, Ctr Reference Malad Neurogenet, Serv Neurol, Angers, France; [Morin, Francoise] Hop Avicenne, AP HP, GHU NORD, Etab Francais Sang, Bobigny, France; [Moutereau, Stephane] Hop H Mondor A Chenevier, AP HP, Dept Biochim Pharmacotoxicol, Creteil, France; [Salem, Linda] Servier, Suresne, France; [Saleh, Nadine] Lebanese Univ, Fac Publ Hlth, Fanar, Lebanon; [Desamericq, Gaelle] Amgen Inc, Boulogne, France; [Dolbeau, Guillaume] Hop Bretonneau, CHRU, Tours, France; [Dolbeau, Guillaume] INSERM, CIC 1415, Tours, France; [Maison, Patrick] ANSM, St Denis, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Lebanese University; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bachoud-Levi, AC (corresponding author), Univ Paris Est, Fac Med, Creteil, France.; Bachoud-Levi, AC (corresponding author), INSERM, U955, Equipe 01, Neuropsychol Intervent, Creteil, France.; Bachoud-Levi, AC (corresponding author), Ecole Normale Super, Dept Etud Cognit, Paris, France.; Bachoud-Levi, AC (corresponding author), Hop H Mondor A Chenevier, AP HP, Ctr Reference Malad Huntington Neurol Cognit, Creteil, France.	bachoud@gmail.com	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; tranchant, christine/0000-0002-2895-1292	Gis [A02216JS /A04159JS]; Assistance Publique - Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); INSERM; Ministry of Health	Gis; Assistance Publique - Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministry of Health	A-C Bachoud-Levi is the PI of the biomarker program financed first by Gis A02216JS /A04159JS and then Assistance Publique - Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); she had full access to all of the data for this study and takes responsibility for the integrity of the data and the accuracy of data analysis. She is supported by an interface contract from INSERM and is the head of the French National Centre for Huntington's disease, granted by the Ministry of Health.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Arwert LI, 2005, GROWTH HORM IGF RES, V15, P47, DOI 10.1016/j.ghir.2004.11.004; Aziz NA, 2010, EUR J NEUROL, V17, P280, DOI 10.1111/j.1468-1331.2009.02798.x; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carro E, 2003, MOL NEUROBIOL, V27, P153, DOI 10.1385/MN:27:2:153; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Craft S, 2006, ALZ DIS ASSOC DIS, V20, P298, DOI 10.1097/01.wad.0000213866.86934.7e; FARRER LA, 1985, CLIN GENET, V27, P62; Fernandez AM, 1999, EUR J NEUROSCI, V11, P2019, DOI 10.1046/j.1460-9568.1999.00623.x; Golden C.J., 1978, STROOP COLOR WORD TE; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kern W, 2001, NEUROENDOCRINOLOGY, V74, P270, DOI 10.1159/000054694; Lopes C, 2014, MOL NEUROBIOL, V49, P1126, DOI 10.1007/s12035-013-8585-5; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f; Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005; Okereke OI, 2010, NEUROEPIDEMIOLOGY, V34, P200, DOI 10.1159/000289351; Plastino M, 2010, J NEUROL SCI, V288, P112, DOI 10.1016/j.jns.2009.09.022; PODOLSKY S, 1972, LANCET, V1, P1356; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Saleh N, 2010, NEUROLOGY, V75, P57, DOI 10.1212/WNL.0b013e3181e62076; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; Torres-Aleman I, 2007, EXPERT OPIN THER TAR, V11, P1535, DOI 10.1517/14728222.11.12.1535; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Watson GS, 2009, J ALZHEIMERS DIS, V18, P595, DOI 10.3233/JAD-2009-1165; Watson GS, 2006, NEUROBIOL AGING, V27, P38, DOI 10.1016/j.neurobiolaging.2004.11.011; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; 1996, MOVEMENT DISORD, V11, P136, DOI DOI 10.1002/MDS.870110204	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162890	10.1371/journal.pone.0162890	http://dx.doi.org/10.1371/journal.pone.0162890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627435	Green Submitted, gold, Green Published			2022-12-27	WOS:000383680600060
J	Guzman-Perez, V; Bumke-Vogt, C; Schreiner, M; Mewis, I; Borchert, A; Pfeiffer, AFH				Guzman-Perez, Valentina; Bumke-Vogt, Christiane; Schreiner, Monika; Mewis, Inga; Borchert, Andrea; Pfeiffer, Andreas F. H.			Benzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human Cells	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION PATHWAYS; TYPE-2 DIABETIC-PATIENTS; BLIND CLINICAL-TRIAL; HIGH-FAT DIET; OXIDATIVE STRESS; BROCCOLI SPROUTS; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; IN-VITRO	Nasturtium (Tropaeolum majus L.) contains high concentrations of benzylglcosinolate. We found that a hydrolysis product of benzyl glucosinolate-the benzyl isothiocyanate (BITC)modulates the intracellular localization of the transcription factor Forkhead box O 1 (FOXO1). FoxO transcription factors can antagonize insulin effects and trigger a variety of cellular processes involved in tumor suppression, longevity, development and metabolism. The current study evaluated the ability of BITC-extracted as intact glucosinolate from nasturtium and hydrolyzed with myrosinase-to modulate i) the insulin-signaling pathway, ii) the intracellular localization of FOXO1 and, iii) the expression of proteins involved in gluconeogenesis, antioxidant response and detoxification. Stably transfected human osteosarcoma cells (U-2 OS) with constitutive expression of FOXO1 protein labeled with GFP (green fluorescent protein) were used to evaluate the effect of BITC on FOXO1. Human hepatoma HepG2 cell cultures were selected to evaluate the effect on gluconeogenic, antioxidant and detoxification genes and protein expression. BITC reduced the phosphorylation of protein kinase B (AKT/PKB) and FOXO1; promoted FOXO1 translocation from cytoplasm into the nucleus antagonizing the insulin effect; was able to down-regulate the gene and protein expression of gluconeogenic enzymes; and induced the gene expression of antioxidant and detoxification enzymes. Knockdown analyses with specific siRNAs showed that the expression of gluconeogenic genes was dependent on nuclear factor (erythroid derived)-like2 (NRF2) and independent of FOXO1, AKT and NAD-dependent deacetylase sirtuin-1 (SIRT1). The current study provides evidence that BITC might have a role in type 2 diabetes T2D by reducing hepatic glucose production and increasing antioxidant resistance.	[Guzman-Perez, Valentina; Bumke-Vogt, Christiane; Borchert, Andrea; Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany; [Guzman-Perez, Valentina] Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia; [Bumke-Vogt, Christiane; Pfeiffer, Andreas F. H.] Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Bumke-Vogt, Christiane; Schreiner, Monika; Mewis, Inga] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Qual, Erfurt, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Pontificia Universidad Javeriana; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Guzman-Perez, V (corresponding author), German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany.; Guzman-Perez, V (corresponding author), Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia.	vguzman@javeriana.edu.co	Guzmán-Pérez, Valentina/AAB-5471-2020; Pfeiffer, Andreas F.H./AAJ-2311-2020	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Guzman-Perez, Valentina/0000-0002-6668-3161; Schreiner, Monika/0000-0002-5629-4429	"Investitionsbank Berlin" (IBB) [10140311]; "German Academic Exchange Service" (DAAD); Pontificia Universidad Javeriana Bogota DC (Colombia) [A/09/72490]	"Investitionsbank Berlin" (IBB); "German Academic Exchange Service" (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Pontificia Universidad Javeriana Bogota DC (Colombia)	CB-V was in part funded by "Investitionsbank Berlin" (IBB): http://www.ibb.de/Foerderangebote.aspx Project Titel: "Entwicklung einer biotechnologischen Methode zur Identifikation gesundheitlich vorteilhafter Pflanzeninhaltsstoffe zur Pravention von Diabetes Typ 2", Ref-No: 10140311. VG was funded by the "German Academic Exchange Service" (DAAD) and Pontificia Universidad Javeriana Bogota DC (Colombia): https://www.daad.de/de/index.html, Ref-No: A/09/72490, http://www.javeriana.edu.co/home. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2008, EUR J CLIN NUTR, V62, P324, DOI 10.1038/sj.ejcn.1602750; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bahadoran Z, 2011, EUR J CLIN NUTR, V65, P972, DOI 10.1038/ejcn.2011.59; Bahadoran Z, 2013, J MED FOOD, V16, P375, DOI 10.1089/jmf.2012.2559; Bahadoran Z, 2012, INT J FOOD SCI NUTR, V63, P767, DOI 10.3109/09637486.2012.665043; Bahadoran Z, 2012, DIABETES RES CLIN PR, V96, P348, DOI 10.1016/j.diabres.2012.01.009; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Bumke-Vogt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104321; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanschen FS, 2014, ANGEW CHEM INT EDIT, DOI [10.1002/anie, 10.1002/ijc.24555, DOI 10.1002/ANIE.2009/07/09]; Jiao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041168; Ju YH, 2014, INT J ONCOL, V44, P1284, DOI 10.3892/ijo.2014.2269; Kim DH, 2013, J DIABETES, V5, P233, DOI 10.1111/1753-0407.12027; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Krajka-Kuzniak V, 2015, J PHYSIOL BIOCHEM, V71, P227, DOI 10.1007/s13105-015-0401-4; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lacroix IME, 2014, MOL NUTR FOOD RES, V58, P61, DOI 10.1002/mnfr.201300223; Lippmann D, 2014, FOOD FUNCT, V5, P1073, DOI 10.1039/c3fo60676g; Liu BN, 2013, CELL BIOCHEM BIOPHYS, V66, P81, DOI 10.1007/s12013-012-9456-9; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Schreiner M, 2009, INNOV FOOD SCI EMERG, V10, P93, DOI 10.1016/j.ifset.2008.10.001; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; Smith GR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011092; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Steinbrecher A, 2009, INT J CANCER, V125, P2179, DOI 10.1002/ijc.24555; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Waterman C, 2014, PHYTOCHEMISTRY, V103, P114, DOI 10.1016/j.phytochem.2014.03.028; Xiao D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032597, 10.1371/journal.pone.0046874]; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yun H, 2014, FEBS J, V281, P4421, DOI 10.1111/febs.12949; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; Zhu Y, 2013, ASIAN PAC J CANCER P, V14, P2607, DOI 10.7314/APJCP.2013.14.4.2607	67	27	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162397	10.1371/journal.pone.0162397	http://dx.doi.org/10.1371/journal.pone.0162397			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622707	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000030
J	Horwitz, V; Davidson, B; Stern, D; Trope, CG; Re'em, TT; Reich, R				Horwitz, Vered; Davidson, Ben; Stern, Dganit; Trope, Claes G.; Re'em, Tali Tavor; Reich, Reuven			Ezrin Is Associated with Disease Progression in Ovarian Carcinoma	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; EXPRESSION; P130CAS; PHOSPHORYLATION; PROTEINS; SRC; PHENOTYPE; INVASION; HEALTH; TUMOR	Objective Ezrin and p130Cas are structural proteins with an important role in signaling pathways and have been shown to promote cancer dissemination. We previously reportedon overexpression of both ezrin and p130Cas in breast carcinoma effusions compared to primary carcinomas. Since ovarian and breast carcinomas share the ability to disseminate by forming malignant effusions, we sought to study the role of these molecules in ovarian carcinoma (OC). Methods OC cell lines were cultured in two different 3-dimensional conditions, on alginate scaffolds and as spheroids, which served as models for solid tumor and malignant effusions, respectively. shRNA was used to reduce protein expression in the cells. The malignant potential was evaluated by chemo-invasion assay, branching capacity on Matrigel and rate of proliferation. Subsequently, clinical specimens of high-grade serous carcinoma effusions, ovarian tumors and solid metastases were analyzed for ezrin and p130Cas expression. Results Higher ezrin expression was found in cells composing the spheroids compared to their counterparts cultured on alginate scaffold and in clinical samples of malignant effusions compared to solid tumors. In addition, reduced Ezrin expression impaired the invasion ability and the branching capacity of OC cells to a greater extent than reduced p130Cas expression. However, ezrin and p130Cas expression in effusions was unrelated to clinical outcome. Conclusions The 3-dimensional cell cultures were found to mimic the different tumor sites and be applicable as a model. The in vitro results concur with the clinical specimen analysis, suggesting that in OC, the role of ezrin in disease progression is more pronounced than that of p130Cas.	[Horwitz, Vered; Stern, Dganit; Reich, Reuven] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, Jerusalem, Israel; [Horwitz, Vered] Israel Inst Biol Res, Dept Pharmacol, Ness Ziona, Israel; [Davidson, Ben] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Davidson, Ben; Trope, Claes G.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Davidson, Ben] Norwegian Radium Hosp, Gynecol Oncol Oslo Univ Hosp, Oslo, Norway; [Re'em, Tali Tavor] Azrieli Coll Engn, Dept Pharmaceut Engn, Jerusalem, Israel; [Reich, Reuven] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Jerusalem, Israel; [Reich, Reuven] Hebrew Univ Jerusalem, Adolf & Klara Brettler Ctr Res Mol Pharmacol & Th, Jerusalem, Israel	Hebrew University of Jerusalem; University of Oslo; University of Oslo; University of Oslo; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Reich, R (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, Jerusalem, Israel.; Davidson, B (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway.; Davidson, B (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.; Davidson, B (corresponding author), Norwegian Radium Hosp, Gynecol Oncol Oslo Univ Hosp, Oslo, Norway.; Reich, R (corresponding author), Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Jerusalem, Israel.; Reich, R (corresponding author), Hebrew Univ Jerusalem, Adolf & Klara Brettler Ctr Res Mol Pharmacol & Th, Jerusalem, Israel.	bend@medisin.uio.no; reich@cc.huji.ac.il			Inger and John Fredriksen Foundation for Ovarian Cancer Research	Inger and John Fredriksen Foundation for Ovarian Cancer Research	This work was supported by Inger and John Fredriksen Foundation for Ovarian Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada M, 2014, BBA-MOL CELL BIOL L, V1841, P727, DOI 10.1016/j.bbalip.2013.07.002; Banerjee A K, 1994, Eur J Surg Oncol, V20, P33; Barrett A, 2013, CELL SIGNAL, V25, P766, DOI 10.1016/j.cellsig.2012.12.019; Bruce A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140506; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Chen ZC, 2001, CANCER-AM CANCER SOC, V92, P3068, DOI 10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5; Cho A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00245; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Davidson B., 2011, SEROUS EFFUSIONSETIO, V47-68, P167; DIETERICH M, 1994, ACTA CYTOL, V38, P945; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gschwantler-Kaulich D, 2013, CELL ONCOL, V36, P485, DOI 10.1007/s13402-013-0153-5; Guiro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118724; Heiska L, 2011, ONCOGENE, V30, P4953, DOI 10.1038/onc.2011.207; Hempel N, 2013, MOL CANCER RES, V11, P303, DOI 10.1158/1541-7786.MCR-12-0478; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Jin TF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-191; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Kong JN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-520; Konstantinovsky S, 2012, CLIN EXP METASTAS, V29, P527, DOI 10.1007/s10585-012-9468-2; Konstantinovsky S, 2010, J ONCOL, V2010, DOI 10.1155/2010/969084; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Miao Y, 2012, FOLIA HISTOCHEM CYTO, V50, P392, DOI [10.5603/FHC.2012.0053, 10.5603/11957]; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Nick AM, 2011, JNCI-J NATL CANCER I, V103, P1596, DOI 10.1093/jnci/djr372; Nikonova AS, 2014, IUBMB LIFE, V66, P387, DOI 10.1002/iub.1282; Ohtani K, 1999, CANCER LETT, V147, P31, DOI 10.1016/S0304-3835(99)00272-4; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Piao JJ, 2015, EXP MOL PATHOL, V98, P1, DOI 10.1016/j.yexmp.2014.11.003; Ren L, 2014, ADV EXP MED BIOL, V804, P181, DOI 10.1007/978-3-319-04843-7_10; Sandercock AM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0415-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tatullo M, 2016, INT J IMMUNOPATH PH, V29, P3, DOI 10.1177/0394632015617951; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THIGPEN JT, 1994, J CLIN ONCOL, V12, P1748, DOI 10.1200/JCO.1994.12.9.1748; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002	40	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162502	10.1371/journal.pone.0162502	http://dx.doi.org/10.1371/journal.pone.0162502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622508	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000034
J	Raikova, R; Krutki, P; Celichowski, J				Raikova, Rositsa; Krutki, Piotr; Celichowski, Jan			A General Mathematical Algorithm for Predicting the Course of Unfused Tetanic Contractions of Motor Units in Rat Muscle	PLOS ONE			English	Article							MEDIAL GASTROCNEMIUS-MUSCLE; FORCE OUTPUT; SUMMATION; CAT; DECOMPOSITION; STIMULATION; ACTIVATION; PATTERNS; BEHAVIOR	An unfused tetanus of a motor unit (MU) evoked by a train of pulses at variable interpulse intervals is the sum of non-equal twitch-like responses to these stimuli. A tool for a precise prediction of these successive contractions for MUs of different physiological types with different contractile properties is crucial for modeling the whole muscle behavior during various types of activity. The aim of this paper is to develop such a general mathematical algorithm for the MUs of the medial gastrocnemius muscle of rats. For this purpose, tetanic curves recorded for 30 MUs (10 slow, 10 fast fatigue-resistant and 10 fast fatigable) were mathematically decomposed into twitch-like contractions. Each contraction was modeled by the previously proposed 6-parameter analytical function, and the analysis of these six parameters allowed us to develop a prediction algorithm based on the following input data: parameters of the initial twitch, the maximum force of a MU and the series of pulses. Linear relationship was found between the normalized amplitudes of the successive contractions and the remainder between the actual force levels at which the contraction started and the maximum tetanic force. The normalization was made according to the amplitude of the first decomposed twitch. However, the respective approximation lines had different specific angles with respect to the ordinate. These angles had different and non-overlapping ranges for slow and fast MUs. A sensitivity analysis concerning this slope was performed and the dependence between the angles and the maximal fused tetanic force normalized to the amplitude of the first contraction was approximated by a power function. The normalized MU contraction and half-relaxation times were approximated by linear functions depending on the normalized actual force levels at which each contraction starts. The normalization was made according to the contraction time of the first contraction. The actual force levels were calculated initially from the recorded tetanic curves and subsequently from the modeled curves obtained from the summation of all models of the preceding contractions (the so called "full prediction"). The preciseness of the prediction was verified by two coefficients estimating the error between the modeled and the experimentally recorded curves. The proposed approach was tested for 30 MUs from the database and for three additional MUs, not included in the initial set. It was concluded that this general algorithm can be successfully used for modeling of a unfused tetanus course of a single MU of fast and slow type.	[Raikova, Rositsa] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Sofia, Bulgaria; [Krutki, Piotr; Celichowski, Jan] Univ Sch Phys Educ, Dept Neurobiol, Poznan, Poland	Bulgarian Academy of Sciences	Raikova, R (corresponding author), Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Sofia, Bulgaria.	rosi.raikova@biomed.bas.bg	Raikova, Rositsa/S-5718-2017; Krutki, Piotr/W-4011-2018; Celichowski, Jan/R-1162-2018	Krutki, Piotr/0000-0003-4193-5171; Celichowski, Jan/0000-0002-0394-3309	Bulgarian Academy of Sciences; Polish Academy of Sciences	Bulgarian Academy of Sciences; Polish Academy of Sciences	This study was partly supported by a bilateral agreement between the Bulgarian Academy of Sciences and the Polish Academy of Sciences.	Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; Boe SG, 2005, MUSCLE NERVE, V31, P365, DOI 10.1002/mus.20266; BURKE RE, 1976, BRAIN RES, V109, P515, DOI 10.1016/0006-8993(76)90031-7; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Celichowski J, 2014, J NEUROPHYSIOL, V112, P3116, DOI 10.1152/jn.00895.2013; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; HENNIG R, 1987, ACTA PHYSIOL SCAND, V130, P133, DOI 10.1111/j.1748-1716.1987.tb08119.x; Jones KE, 2005, J NEUROPHYSIOL, V94, P2255, DOI 10.1152/jn.00430.2005; KANDA K, 1992, J PHYSIOL-LONDON, V448, P677, DOI 10.1113/jphysiol.1992.sp019064; Krutki P, 2008, J PHYSIOL PHARMACOL, V59, P85; Krutki P, 2006, ARCH ITAL BIOL, V144, P11; MacIntosh BR, 2007, J BIOMECH, V40, P1066, DOI 10.1016/j.jbiomech.2006.04.009; MASUDA T, 1991, J ELECTROMYOGR KINES, V1, P116, DOI 10.1016/1050-6411(91)90005-P; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; PARRY DJ, 1990, CAN J PHYSIOL PHARM, V68, P51, DOI 10.1139/y90-007; Raikova R, 2010, J BIOMECH, V43, P1546, DOI 10.1016/j.jbiomech.2010.01.034; Raikova R, 2007, J ELECTROMYOGR KINES, V17, P121, DOI 10.1016/j.jelekin.2006.01.005; Raikova R, 2016, COMPUT METHOD BIOMEC, V19, P763, DOI 10.1080/10255842.2015.1062090; Raikova R, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/625427; Ralkova R, 2008, J ELECTROMYOGR KINES, V18, P741, DOI 10.1016/j.jelekin.2007.02.010; STEIN RB, 1979, BRAIN RES, V175, P372, DOI 10.1016/0006-8993(79)91019-9; STEIN RB, 1981, J GEN PHYSIOL, V78, P277, DOI 10.1085/jgp.78.3.277; Tansey KE, 1996, J NEUROPHYSIOL, V75, P38, DOI 10.1152/jn.1996.75.1.38; Westergaard RH, 2011, J NEUROPHYSIOL, V85, P1777	25	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162385	10.1371/journal.pone.0162385	http://dx.doi.org/10.1371/journal.pone.0162385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622581	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000028
J	Sanchez-Munoz, G; de Andres, AL; Jimenez-Garcia, R; Carrasco-Garrido, P; Hernandez-Barrera, V; Pedraza-Serrano, F; Puente-Maestu, L; de Miguel-Diez, J				Sanchez-Munoz, Gema; Lopez de Andres, Ana; Jimenez-Garcia, Rodrigo; Carrasco-Garrido, Pilar; Hernandez-Barrera, Valentin; Pedraza-Serrano, Fernando; Puente-Maestu, Luis; de Miguel-Diez, Javier			Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013)	PLOS ONE			English	Article							ORPHAN; DIAGNOSIS; DISEASE	Objective To analyze changes in the incidence, diagnostic procedures, comorbidity, length of hospital stay (LOHS), costs and in-hospital mortality (IHM) for patients with bronchiectasis who were hospitalized in Spain over a 10-year period. Methods We included all admissions for patients diagnosed with bronchiectasis as primary or secondary diagnosis during 2004-2013. Results 282,207 patients were admitted to the study. After controlling for possible confounders, we observed a significant increase in the incidence of hospitalizations over the study period when bronchiectasis was a secondary diagnosis. When bronchiectasis was the primary diagnosis we observed a significant decline in the incidence. In all cases, this pathology was more frequent in males, and the average age and comorbidity increased significantly during the study period (p< 0.001). When bronchiectasis was the primary diagnosis, the most frequent secondary diagnosis was Pseudomonas aeruginosa infection. When bronchiectasis was the secondary diagnosis, the most frequent primary diagnosis was COPD. IHM was low, tending to decrease from 2004 to 2013 (p< 0.05). The average LOHS decreased significantly during the study period in both cases (p< 0.001). The mean cost per patient decreased in patients with bronchiectasis as primary diagnosis, but it increased for cases of bronchiectasis as secondary diagnosis (p< 0.001). Conclusions Our results reveal an increase in the incidence of hospital admissions for patients with bronchiectasis as a secondary diagnosis from 2004 to 2013, as opposed to cases of bronchiectasis as the primary diagnosis. Although the average age and comorbidity significantly increased over time, both IHM and average LOHS significantly decreased.	[Sanchez-Munoz, Gema; Pedraza-Serrano, Fernando; Puente-Maestu, Luis; de Miguel-Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Fac Med,Resp Dept, Madrid, Spain; [Lopez de Andres, Ana; Jimenez-Garcia, Rodrigo; Carrasco-Garrido, Pilar; Hernandez-Barrera, Valentin] Univ Rey Juan Carlos, Dept Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; Universidad Rey Juan Carlos	de Miguel-Diez, J (corresponding author), Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Fac Med,Resp Dept, Madrid, Spain.	javier.miguel@salud.madrid.org	Lopez-de-Andres, Ana/D-4498-2019; Lopez-de-Andres, Ana/AAD-8703-2019; Jimenez-Garcia, Rodrigo/D-4953-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; de Miguel-Diez, Javier/0000-0003-4543-573X; Hernandez-Barrera, Valentin/0000-0001-5790-1959; Puente-Maestu, Luis/0000-0001-8501-0117				Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; [Anonymous], 2004, HOSP EP STAT 2002 20, P203; [Anonymous], POPULATION ESTIMATES; BARKER AF, 1988, AM REV RESPIR DIS, V137, P969, DOI 10.1164/ajrccm/137.4.969; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donat Y, 2008, ARCH BRONCONEUMOL, V44, P60; Garcia MAM, 2005, ARCH BRONCONEUMOL, V41, P407; Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309; Goeminne PC, 2016, EUR RESPIR J, V47, P10, DOI 10.1183/13993003.01567-2015; Goeminne PC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-21; Instituto Nacional de la Salud, 2001, CONJ MIN BAS DAT HOS; Instituto Nacional de la Salud. CMBD Insalud, 2000, CMBD INS AN GRDS; Joish VN, 2013, APPL HEALTH ECON HEA, V11, P299, DOI 10.1007/s40258-013-0027-z; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lara B, 2011, ARCH BRONCONEUMOL, V47, P389, DOI 10.1016/j.arbres.2011.04.002; De Souza-Galvao ML, 2010, ARCH BRONCONEUMOL, V46, P8, DOI 10.1016/S0300-2896(10)70003-X; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Ministerio de Empleo y Seguridad Social, EXPL EST CONJ MIN BA; National Cancer Institute, 2013, JOINP REGR PROGR VER; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071109; Roberts HJ, 2010, RESP MED, V104, P981, DOI 10.1016/j.rmed.2010.02.022; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Seitz AE, 2012, CHEST, V142, P432, DOI 10.1378/chest.11-2209; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Tsang KW, 2004, INT J TUBERC LUNG D, V8, P691; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed	32	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162282	10.1371/journal.pone.0162282	http://dx.doi.org/10.1371/journal.pone.0162282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622273	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000021
J	Azzouz, DF; Martin, GV; Arnoux, F; Balandraud, N; Martin, T; Dubucquoi, S; Hachulla, E; Farge-Bancel, D; Tiev, K; Cabane, J; Bardin, N; Chiche, L; Martin, M; Caillet, EC; Kanaan, SB; Harle, JR; Granel, B; Diot, E; Roudier, J; Auger, I; Lambert, NC				Azzouz, Doua F.; Martin, Gabriel V.; Arnoux, Fanny; Balandraud, Nathalie; Martin, Thierry; Dubucquoi, Sylvain; Hachulla, Eric; Farge-Bancel, Dominique; Tiev, Kiet; Cabane, Jean; Bardin, Nathalie; Chiche, Laurent; Martin, Marielle; Caillet, Eleonore C.; Kanaan, Sami B.; Harle, Jean Robert; Granel, Brigitte; Diot, Elisabeth; Roudier, Jean; Auger, Isabelle; Lambert, Nathalie C.			Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus	PLOS ONE			English	Article							ALLOGRAFT INFLAMMATORY FACTOR-1; SYSTEMIC-SCLEROSIS; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; REVISED CRITERIA; ANGIOGENESIS; ERYTHEMATOSUS	In a pilot ProtoArray analysis, we identified 6 proteins out of 9483 recognized by autoantibodies (AAb) from patients with systemic sclerosis (SSc). We further investigated the 6 candidates by ELISA on hundreds of controls and patients, including patients with Systemic Lupus Erythematosus (SLE), known for high sera reactivity and overlapping AAb with SSc. Only 2 of the 6 candidates, Ephrin type-B receptor 2 (EphB2) and Three prime Histone mRNA EXonuclease 1 (THEX1), remained significantly recognized by sera samples from SSc compared to controls (healthy or with rheumatic diseases) with, respectively, 34% versus 14% (P = 2.10(-4)) and 60% versus 28% (P = 3.10(-8)). Above all, EphB2 and THEX1 revealed to be mainly recognized by SLE sera samples with respectively 56%, (P = 2.10(-10)) and 82% (P = 5.10(-13)). As anti-EphB2 and anti-THEX1 AAb were found in both diseases, an epitope mapping was realized on each protein to refine SSc and SLE diagnosis. A 15-mer peptide from EphB2 allowed to identify 35% of SLE sera samples (N = 48) versus only 5% of any other sera samples (N = 157), including SSc sera samples. AAb titers were significantly higher in SLE sera (P< 0.0001) and correlated with disease activity (p< 0.02). We could not find an epitope on EphB2 protein for SSc neither on THEX1 for SSc or SLE. We showed that patients with SSc or SLE have AAb against EphB2, a protein involved in angiogenesis, and THEX1, a 3'-5' exoribonuclease involved in histone mRNA degradation. We have further identified a peptide from EphB2 as a specific and sensitive tool for SLE diagnosis.	[Azzouz, Doua F.; Martin, Gabriel V.; Arnoux, Fanny; Balandraud, Nathalie; Martin, Marielle; Caillet, Eleonore C.; Kanaan, Sami B.; Roudier, Jean; Auger, Isabelle; Lambert, Nathalie C.] INSERM, UMRs 1097, Parc Sci Luminy, Marseille, France; [Azzouz, Doua F.; Martin, Gabriel V.; Arnoux, Fanny; Martin, Marielle; Caillet, Eleonore C.; Kanaan, Sami B.; Granel, Brigitte; Lambert, Nathalie C.] Aix Marseille Univ, Marseille, France; [Balandraud, Nathalie; Roudier, Jean; Auger, Isabelle] Hop St Marguerite, AP HM, IML, Rhumatol, Marseille, France; [Martin, Thierry] Hop Univ Strasbourg, Serv Immunol Clin, Strasbourg, France; [Martin, Thierry] CNRS, UPR 3572, Strasbourg, France; [Dubucquoi, Sylvain] Ctr Hosp Reg & Univ Lille, Inst Immunol, Lille, France; [Dubucquoi, Sylvain] Univ Lille, EA 2686, Lille, France; [Hachulla, Eric] Hop Claude Huriez, Ctr Natl Reference Sclerodermie Syst, Serv Med Interne, Lille, France; [Farge-Bancel, Dominique] Hop St Louis, Serv Med Interne & Pathol Vasc, Paris, France; [Farge-Bancel, Dominique] Hop St Louis, INSERM, U697, Paris, France; [Tiev, Kiet; Cabane, Jean] Hop St Louis, Serv Med Interne, Paris, France; [Bardin, Nathalie; Granel, Brigitte] Fac Pharm Marseille, UMR S Endothelium Pathol Vasc & Cibles Therapeut, Marseille, France; [Chiche, Laurent; Harle, Jean Robert; Granel, Brigitte] Ctr Competence PACA Ouest Prise Charge Malad Auto, Pole Med Interne, AP HM, Marseille, France; [Chiche, Laurent] Aix Marseille Univ, CIML, INSERM, CNRS UMR7280, Marseille, France; [Diot, Elisabeth] CHU Bretonneau, Serv Med Interne, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Tours	Lambert, NC (corresponding author), INSERM, UMRs 1097, Parc Sci Luminy, Marseille, France.; Lambert, NC (corresponding author), Aix Marseille Univ, Marseille, France.	nathalie.lambert@inserm.fr	Balandraud, Nathalie/ABD-6012-2020; Bardin, Nathalie/AAL-3663-2020; Lambert, Nathalie C/P-6816-2016; roudier, jean/A-8654-2011; Dubucquoi, Sylvain/I-5756-2018; HACHULLA, ERIC/R-8488-2018; AUGER, ISABELLE/P-6294-2016	Balandraud, Nathalie/0000-0002-3839-0185; Bardin, Nathalie/0000-0003-3680-082X; Lambert, Nathalie C/0000-0001-5817-8686; roudier, jean/0000-0001-5435-8567; Dubucquoi, Sylvain/0000-0002-8962-3719; HACHULLA, ERIC/0000-0001-7432-847X; AUGER, ISABELLE/0000-0002-1414-8095; Martin, Thierry/0000-0002-2776-2641	Groupe Francophone de Recherche sur la Sclerodermie (GFRS); Association des sclerodermiques de France; Arthritis Fondation Courtin; Societe Francaise de Rhumatologie; INSERM; Association des Sclerodermiques de France (ASF)	Groupe Francophone de Recherche sur la Sclerodermie (GFRS); Association des sclerodermiques de France; Arthritis Fondation Courtin; Societe Francaise de Rhumatologie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association des Sclerodermiques de France (ASF)	This study was supported by the Groupe Francophone de Recherche sur la Sclerodermie (GFRS), the Association des sclerodermiques de France but also Arthritis Fondation Courtin and the Societe Francaise de Rhumatologie and the INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Groupe Francophone de Recherche sur la Sclerodermie (GFRS); Association des Sclerodermiques de France (ASF), Arthritis Fondation Courtin, Societe Francaise de Rhumatologie and the INSERM. We are thankful to all participating subjects, to the Filiere des Maladies Autoimmunes et Autoinflammatoires Rares (FAI2R) for clinical data sharing with the help of Sarahe Dehimat and finally to Elisabeth Eynier for all the administrative management.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Alkassab F, 2007, RHEUMATOLOGY, V46, P1248, DOI 10.1093/rheumatology/kem057; Allanore Y, 2007, CLASSIFICATION EVALU; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Avouac J, 2011, RHEUMATOLOGY, V50, P1494, DOI 10.1093/rheumatology/keq448; Charpin C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3165; Cieslik Pawel, 2008, Pol Arch Med Wewn, V118, P57; Congi L, 2010, CLIN EXP RHEUMATOL, V28, P304; Del Galdo F, 2006, ARTHRITIS RHEUM-US, V54, P2616, DOI 10.1002/art.22010; Elhai M, 2016, ANN RHEUM DIS, V75, P163, DOI 10.1136/annrheumdis-2014-206386; Hachulla E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/s12016-010-8198-y; Ho KT, 2003, ARTHRITIS RES THER, V5, P80, DOI 10.1186/ar628; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mehra S, 2013, AUTOIMMUN REV, V12, P340, DOI 10.1016/j.autrev.2012.05.011; Nihtyanova SI, 2010, NAT REV RHEUMATOL, V6, P112, DOI 10.1038/nrrheum.2009.238; Otieno FG, 2007, TISSUE ANTIGENS, V69, P583, DOI 10.1111/j.1399-0039.2007.00830.x; PETERSON LS, 1995, MAYO CLIN PROC, V70, P1068, DOI 10.4065/70.11.1068; Reveille JD, 2006, AUTOIMMUN REV, V5, P389, DOI 10.1016/j.autrev.2005.10.012; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Sobanski V, 2014, ARTHRITIS RHEUMATOL, V66, P407, DOI 10.1002/art.38219; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Sun KH, 2001, RHEUMATOLOGY, V40, P750, DOI 10.1093/rheumatology/40.7.750; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Thomas MF, 2014, TRENDS GENET, V30, P298, DOI 10.1016/j.tig.2014.05.003; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Walker UA, 2007, ANN RHEUMATIC DIS; Yang XC, 2006, J BIOL CHEM, V281, P30447, DOI 10.1074/jbc.M602947200; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0160283	10.1371/journal.pone.0160283	http://dx.doi.org/10.1371/journal.pone.0160283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617966	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100003
J	Kurikawa, T; Kaneko, K				Kurikawa, Tomoki; Kaneko, Kunihiko			Dynamic Organization of Hierarchical Memories	PLOS ONE			English	Article							SPONTANEOUS CORTICAL ACTIVITY; NEURAL-NETWORKS; FINE INFORMATION; VISUAL-CORTEX; SENSORY INPUT; PATTERNS; NEURONS; STATES; MODEL	In the brain, external objects are categorized in a hierarchical way. Although it is widely accepted that objects are represented as static attractors in neural state space, this view does not take account interaction between intrinsic neural dynamics and external input, which is essential to understand how neural system responds to inputs. Indeed, structured spontaneous neural activity without external inputs is known to exist, and its relationship with evoked activities is discussed. Then, how categorical representation is embedded into the spontaneous and evoked activities has to be uncovered. To address this question, we studied bifurcation process with increasing input after hierarchically clustered associative memories are learned. We found a "dynamic categorization"; neural activity without input wanders globally over the state space including all memories. Then with the increase of input strength, diffuse representation of higher category exhibits transitions to focused ones specific to each object. The hierarchy of memories is embedded in the transition probability from one memory to another during the spontaneous dynamics. With increased input strength, neural activity wanders over a narrower state space including a smaller set of memories, showing more specific category or memory corresponding to the applied input. Moreover, such coarse-to-fine transitions are also observed temporally during transient process under constant input, which agrees with experimental findings in the temporal cortex. These results suggest the hierarchy emerging through interaction with an external input underlies hierarchy during transient process, as well as in the spontaneous activity.	[Kurikawa, Tomoki] RIKEN Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama 3510198, Japan; [Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Meguro Ku, Tokyo 1538902, Japan; [Kurikawa, Tomoki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	RIKEN; University of Tokyo; Japan Society for the Promotion of Science	Kurikawa, T (corresponding author), RIKEN Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama 3510198, Japan.; Kurikawa, T (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan.	tomoki.kurikawa@riken.jp			Ministry of Education, Culture, Sports, Science and Techonology and Japan society for the promotion of science [4103, 255431]; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science and Techonology and Japan society for the promotion of science; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Neural creativity for communication (No. 4103)" and KAKENHI No. 255431 from The Ministry of Education, Culture, Sports, Science and Techonology and Japan society for the promotion of science, URL: https://www.jsps.go.jp/english/e-grants/, the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Japan Agency for Medical Research and Development (AMED).	Abbott LF, 2009, INTERACTIONS INTRINS, P1; AMARI SI, 1977, BIOL CYBERN, V26, P175, DOI 10.1007/BF00365229; Amit Daniel J., 1992, MODELING BRAIN FUNCT; BACCI S, 1990, J PHYS A-MATH GEN, V23, P1801, DOI 10.1088/0305-4470/23/10/020; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Cartling B, 1996, BIOL CYBERN, V74, P63, DOI 10.1007/BF00199138; CORTES C, 1987, J PHYS A-MATH GEN, V20, P4449, DOI 10.1088/0305-4470/20/13/044; Dayan P, 2001, COMPUTATIONAL NEUROS; Deco G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002395; Engel A., 1990, PHYS REV A, V42; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; GUTFREUND H, 1988, PHYS REV A, V37, P570, DOI 10.1103/PhysRevA.37.570; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kurikawa T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002943; Kurikawa T, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/48002; Luczak A, 2013, J NEUROSCI, V33, P1684, DOI 10.1523/JNEUROSCI.2928-12.2013; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marre O, 2009, J NEUROSCI, V29, P14596, DOI 10.1523/JNEUROSCI.0753-09.2009; Matsumoto N, 2005, J COMPUT NEUROSCI, V18, P85, DOI 10.1007/s10827-005-5476-4; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Siri B, 2008, NEURAL COMPUT, V20, P2937, DOI 10.1162/neco.2008.05-07-530; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Toya K, 2000, J PHYS A-MATH GEN, V33, P2725, DOI 10.1088/0305-4470/33/14/308; VIRASORO MA, 1988, EUROPHYS LETT, V7, P293, DOI 10.1209/0295-5075/7/4/002; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162640	10.1371/journal.pone.0162640	http://dx.doi.org/10.1371/journal.pone.0162640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618549	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100037
J	Chen, L; Zhang, J; Xu, J; Wan, L; Teng, KX; Xiang, J; Zhang, R; Huang, ZB; Liu, YM; Li, WH; Liu, X				Chen, Lan; Zhang, Ju; Xu, Jie; Wan, Lu; Teng, Kaixuan; Xiang, Jin; Zhang, Rui; Huang, Zebo; Liu, Yongmei; Li, Wenhua; Liu, Xin			rBm alpha TX14 Increases the Life Span and Promotes the Locomotion of Caenorhabditis Elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; SCORPION TOXINS; RESPONSE GENES; BREAST-CANCER; TUMOR-GROWTH; C. ELEGANS; VENOM; IDENTIFICATION; NEMATODE; CHANNEL	The scorpion has been extensively used in various pharmacological profiles or as food supplies. The exploration of scorpion venom has been reported due to the presence of recombinant peptides. rBm alpha TX14 is an alpha-neurotoxin extracted from the venom gland of the East Asian scorpion Buthus martensii Karsch and can affect ion channel conductance. Here, we investigated the functions of rBm alpha TX14 using the Caenorhabditis elegans model. Using western blot analysis, rBm alpha TX14 was shown to be expressed both in the cytoplasm and inclusion bodies in the E.coli Rosetta (DE3) strain. Circular dichroism spectroscopy analysis demonstrated that purified rBm alpha TX14 retained its biological structures. Next, feeding nematodes with E.coli Rosetta (DE3) expressing rBm alpha TX14 caused extension of the life span and promoted the locomotion of the nematodes. In addition, we identified several genes that play various roles in the life span and locomotion of C. elegans through microarray analysis and quantitative real-time PCR. Furthermore, if the amino acid site H-15 of rBm alpha TX14 was mutated, rBm alpha TX14 no longer promoted the C. elegans life span. In conclusion, the results not only demonstrated the functions and mechanism of rBm alpha TX14 in C. elegans, but also provided the new sight in the utility of recombinant peptides from scorpion venom.	[Chen, Lan; Zhang, Ju; Xu, Jie; Wan, Lu; Teng, Kaixuan; Xiang, Jin; Zhang, Rui; Huang, Zebo; Liu, Yongmei; Liu, Xin] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430071, Peoples R China; [Chen, Lan; Zhang, Ju; Xu, Jie; Wan, Lu; Teng, Kaixuan; Xiang, Jin; Zhang, Rui; Huang, Zebo; Liu, Yongmei; Liu, Xin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China; [Li, Wenhua] Wuhan Univ, Sch Life Sci, Wuhan 430071, Peoples R China; [Huang, Zebo] Guangdong Pharmaceut Univ, Guangdong Prov Key Lab Biotechnol Drug Candidates, Sch Biosci & Biopharmaceut, Guangzhou 510006, Guangdong, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Guangdong Pharmaceutical University	Liu, X (corresponding author), Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430071, Peoples R China.; Liu, X (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China.	lx@whu.edu.cn	Huang, Zebo/AAF-2382-2019	Huang, Zebo/0000-0003-2431-3741	National Program on Key Basic Research Project (973 Program) [2010CB529804]; National Natural Science Foundation of China [31400155, 81472550, 81274048]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Program on Key Basic Research Project (973 Program, No. 2010CB529804), which is received by XL. The work was also supported by the National Natural Science Foundation of China. XL received the fundings which number is 31400155 or 81472550;ZBH received the funding which number is 81274048.The URLs of the funder's website is (http://www.nsfc.gov.cn). All the fundings have role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Program on Key Basic Research Project (973 Program, No. 2010CB529804) and the National Natural Science Foundation of China (Grant No. 31400155, 81472550 and 81274048). The DNA sequence of rBm alpha TX14 was kindly provided by Prof. Zhijian Cao (College of Life Sciences, Wuhan University).	Bea RD, 2015, PEPTIDES, V68, P228, DOI 10.1016/j.peptides.2014.10.008; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cao LY, 2012, PEPTIDES, V36, P213, DOI 10.1016/j.peptides.2012.04.010; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Cecchim AL, 2006, TOXICOL APPL PHARM, V217, P196, DOI 10.1016/j.taap.2006.09.003; Chen G, 2015, MOL NUTR FOOD RES, V59, P293, DOI 10.1002/mnfr.201400483; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dai H, 2012, PROTEIN EXPRES PURIF, V82, P325, DOI 10.1016/j.pep.2012.02.001; Du Q, 2015, TOXINS, V7, P219, DOI 10.3390/toxins7020219; Eom HJ, 2013, TOXICOL APPL PHARM, V270, P106, DOI 10.1016/j.taap.2013.03.028; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Franzen J, 2012, ECOTOXICOLOGY, V21, P557, DOI 10.1007/s10646-011-0816-9; Gaglia MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003133; Gao SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7323; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hill AJ, 2014, CURR BIOL, V24, P2399, DOI 10.1016/j.cub.2014.08.040; Honda Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023527; Kramer LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014291; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Li WH, 2014, MOL NUTR FOOD RES, V58, P863, DOI 10.1002/mnfr.201300404; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Qin C, 2014, MOL PHARMACEUT, V11, P3233, DOI 10.1021/mp400691z; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Razani B, 2001, J CLIN INVEST, V108, P1553, DOI 10.1172/JCI14611; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Sharma V, 2016, BIOINFORM BIOL INSIG, V10, P1, DOI 10.4137/BBI.S37130; Shen EZ, 2014, NATURE, V508, P128, DOI 10.1038/nature13012; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Stone CE, 2009, DEV BIOL, V329, P201, DOI 10.1016/j.ydbio.2009.02.030; Tatar M, 2005, CELL METAB, V2, P281, DOI 10.1016/j.cmet.2005.10.006; Ueno S, 2012, BIOCHEM BIOPH RES CO, V420, P552, DOI 10.1016/j.bbrc.2012.03.032; Velazquez-Marrero C, 2014, J BIOL CHEM, V289, P29261, DOI 10.1074/jbc.M114.604306; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; Wang K, 2006, BIOTECHNOL LETT, V28, P1767, DOI 10.1007/s10529-006-9155-y; Wang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109977; Wen Q, 2012, NEURON, V76, P750, DOI 10.1016/j.neuron.2012.08.039; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Zhang HR, 2012, BIOCHEM J, V441, P417, DOI 10.1042/BJ20110621; Zhu SY, 2000, TOXICON, V38, P1653, DOI 10.1016/S0041-0101(00)00081-7; Zugasti O, 2005, GENOME RES, V15, P1402, DOI 10.1101/gr.3935405	54	2	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161847	10.1371/journal.pone.0161847	http://dx.doi.org/10.1371/journal.pone.0161847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611314	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900032
J	Morishita, F; Yadav, RP; Eang, MT; Saint, S; Nishikiori, N				Morishita, Fukushi; Yadav, Rajendra-Prasad; Eang, Mao Tan; Saint, Saly; Nishikiori, Nobuyuki			Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; PULMONARY TUBERCULOSIS; DIAGNOSIS; IMPACT; COSTS; LEVEL; TB	Background Despite free TB services available in public health facilities, TB patients often face severe financial burden due to TB. WHO set a new global target that no TB-affected families experience catastrophic costs due to TB. To monitor the progress and strategize the optimal approach to achieve the target, there is a great need to assess baseline cost data, explore potential proxy indicators for catastrophic costs, and understand what intervention mitigates financial burden. In Cambodia, nationwide active case finding (ACF) targeting household and neighbourhood contacts was implemented alongside routine passive case finding (PCF). We analyzed household cost data from ACF and PCF to determine the financial benefit of ACF, update the baseline cost data, and explore whether any dissaving patterns can be a proxy for catastrophic costs in Cambodia. Methods In this cross-sectional comparative study, structured interviews were carried out with 108 ACF patients and 100 PCF patients. Direct and indirect costs, costs before and during treatment, costs as percentage of annual household income and dissaving patterns were compared between the two groups. Results The median total costs were lower by 17% in ACF than in PCF ($240.7 [IQR 65.5-594.6] vs $290.5 [IQR 113.6-813.4], p = 0.104). The median costs before treatment were significantly lower in ACF than in PCF ($5.1 [IQR 1.5-25.8] vs $22.4 [IQR 4.4-70.8], p < 0.001). Indirect costs constituted the largest portion of total costs (72.3% in ACF and 61.5% in PCF). Total costs were equivalent to 11.3% and 18.6% of annual household income in ACF and PCF, respectively. ACF patients were less likely to dissave to afford TB-related expenses. Costs as percentage of annual household income were significantly associated with an occurrence of selling property (p = 0.02 for ACF, p = 0.005 for PCF). Conclusions TB-affected households face severe financial hardship in Cambodia. ACF has the great potential to mitigate the costs incurred particularly before treatment. Social protection schemes that can replace lost income are critically needed to compensate for the most devastating costs in TB. An occurrence of selling household property can be a useful proxy for catastrophic cost in Cambodia.	[Morishita, Fukushi; Nishikiori, Nobuyuki] WHO, Reg Off Western Pacific, Manila, Philippines; [Yadav, Rajendra-Prasad] WHO, Representat Off Philippines, Manila, Philippines; [Eang, Mao Tan; Saint, Saly] Minist Hlth, Natl Ctr TB & Leprosy Control, Phnom Penh, Cambodia	WHO Western Pacific Regional Office; World Health Organization; WHO Western Pacific Regional Office; World Health Organization	Morishita, F (corresponding author), WHO, Reg Off Western Pacific, Manila, Philippines.	morishita.fukushi@gmail.com		Yadav, Rajendra Prasad/0000-0002-0398-1313; Nishikiori, Nobuyuki/0000-0003-0962-8868	Government of Japan through Ministry of Health, Labour and Welfare; Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Stop TB Partnership's TB REACH Initiative; Government of Canada; Bill and Melinda Gates Foundation	Government of Japan through Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Stop TB Partnership's TB REACH Initiative; Government of Canada(CGIAR); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was conducted by World Health Organization with the financial support from the Government of Japan through Ministry of Health, Labour and Welfare and from the Government of the Republic of Korea through Korean Centers for Disease Control & Prevention. The main intervention (active case finding) was a part of project activities funded by the Stop TB Partnership's TB REACH Initiative. TB REACH is primarily supported by the Government of Canada, with additional funding from the Bill and Melinda Gates Foundation. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the WHO.	Alavi Seyed Mohammad, 2014, Tanaffos, V13, P14; Annear PL., 2015, HLTH SYSTEMS TRANSIT; [Anonymous], 2015, WHOHTMTB201519; [Anonymous], 2009, IMPL HLTH EQ FUNDS G; [Anonymous], 2011, REP 2 NAT TUB PREV S; [Anonymous], 2013, WHOHTMTB201311; [Anonymous], 2014, TUB REP 2013 KINGD C; [Anonymous], 2014, WHOHTMTB20148; [Anonymous], 2005, WHOHTMTB2005325; [Anonymous], 2012, CAMB SOC SEC FORM EC; Bigdeli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146147; Chen S, 2015, INT CON DISTR COMP S, P1, DOI 10.1109/ICDCS.2015.9; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Jacobs B, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0383-z; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; KNCV Tuberculosis Foundation WHO the Japan Anti-Tuberculosis Association, 2009, TOOL EST PAT COSTS T; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kuznetsov VN, 2014, INT J CIRCUMPOL HEAL, P73; Laokri S, 2013, B WORLD HEALTH ORGAN, V91, P277, DOI 10.2471/BLT.12.110015; Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Madan J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1138-z; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; Morishita F, 2015, WEST PAC SURVEILL RE, V6, DOI [10.2471/WPSAR.2014.5.4.005, 10.5365/wpsar.2014.5.4.005]; National Center for Tuberculosis and Leprosy Control, 2011, NAT HLTH STRAT PLAN; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Pichenda K, 2012, INT J TUBERC LUNG D, V16, P828, DOI 10.5588/ijtld.11.0688; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Richter LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086225; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Ukwaja K, 2012, INT J TUBERC LUNG D, V16; Wang CS, 2008, INFECTION, V36, P335, DOI 10.1007/s15010-008-7199-8; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, 67 WORLD HLTH ASS 20; World Health Organization, 2015, WHOHTMTB201522; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162796	10.1371/journal.pone.0162796	http://dx.doi.org/10.1371/journal.pone.0162796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611908	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900168
J	Sakai, S; Tanimoto, K; Imbe, A; Inaba, Y; Shishikura, K; Tanimoto, Y; Ushiroyama, T; Terasaki, J; Hanafusa, T				Sakai, Satoshi; Tanimoto, Keiji; Imbe, Ayumi; Inaba, Yuiko; Shishikura, Kanako; Tanimoto, Yoshimi; Ushiroyama, Takahisa; Terasaki, Jungo; Hanafusa, Toshiaki			Decreased beta-Cell Function Is Associated with Reduced Skeletal Muscle Mass in Japanese Subjects without Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; OLDER PERSONS; SECRETION; AGE; MELLITUS; HEALTH; INDIVIDUALS; SENSITIVITY; POPULATION; METABOLISM	Background Decreased insulin secretion has a great impact on the incidence of type 2 diabetes in Japanese subjects. It is not clear whether beta-cell function is related to muscle mass in subjects without diabetes. We investigated the relationship between beta-cell function and skeletal muscle mass in Japanese subjects without diabetes. Methods The study included 1098 subjects (538 men and 560 women) aged 40 to 79 years, without diabetes (fasting glucose lower than 126 mg/dL and glycosylated hemoglobin lower than 6.5%), who consulted Osaka Medical College Health Science Clinic for a medical examination. Appendicular muscle mass was measured by bioelectrical impedance analysis. Appendicular muscle mass index was calculated as appendicular muscle mass divided by height squared (kg/m(2)). The homeostatic model assessment of beta-cell function was used to assess beta-cell function. The homeostatic model assessment of insulin resistance was used as a measure of insulin resistance. The association between appendicular muscle mass index and clinical parameters of beta-cell function and insulin resistance was examined. Results Log-transformed homeostatic model assessment of beta-cell function and Log-transformed homeostatic model assessment of insulin resistance showed a normal distribution. In both men and women, there was a significant positive correlation between appendicular muscle mass index and clinical parameters of beta-cell function and insulin resistance. Tertile analysis, following stratification according to appendicular muscle mass index, found that low appendicular muscle mass index was significantly associated with the Log homeostatic model assessment of beta-cell function and Log-transformed homeostatic model assessment of insulin resistance. Conclusion This study shows that decreased beta cell function is associated with reduced skeletal muscle mass in Japanese subjects without diabetes.	[Sakai, Satoshi; Tanimoto, Keiji; Imbe, Ayumi; Inaba, Yuiko; Shishikura, Kanako; Tanimoto, Yoshimi; Terasaki, Jungo; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan; [Ushiroyama, Takahisa] Osaka Med Coll, Hlth Sci Clin, Takatsuki, Osaka 5691121, Japan	Osaka Medical College; Osaka Medical College	Tanimoto, K (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan.	in1120@osaka-med.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [26860424]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 26860424.	Anbalagan VP, 2013, DIABETES TECHNOL THE, V15, P768, DOI 10.1089/dia.2013.0068; Bolanowski M, 2001, Med Sci Monit, V7, P1029; Chiu KC, 2000, CLIN ENDOCRINOL, V53, P569, DOI 10.1046/j.1365-2265.2000.01132.x; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Fujita S, 2007, DIABETES, V56, P1615, DOI 10.2337/db06-1566; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; Iozzo P, 1999, J CLIN ENDOCR METAB, V84, P863, DOI 10.1210/jc.84.3.863; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Katsuta H, 2015, ENDOCR J, V62, P485, DOI 10.1507/endocrj.EJ14-0611; Lee SW, 2015, DIABETES METAB J, V39, P37, DOI 10.4093/dmj.2015.39.1.37; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Li CL, 2003, DIABETES RES CLIN PR, V59, P225, DOI 10.1016/S0168-8227(02)00249-8; Metter EJ, 1999, J GERONTOL A-BIOL, V54, pB207, DOI 10.1093/gerona/54.5.B207; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Nagasaka S, 2007, DIABETES CARE, V30, pe43; Nagasaka Shoichiro, 2007, Diabetes Care, V30, pe43, DOI 10.2337/dc07-0016; Oya J, 2014, INTERNAL MED, V53, P941, DOI 10.2169/internalmedicine.53.1580; POLONSKY K, 1983, J CLIN INVEST, V72, P1114, DOI 10.1172/JCI111036; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Shishikura K, 2014, ENDOCR J, V61, P281, DOI 10.1507/endocrj.EJ13-0375; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Tanaka KI, 2015, CALCIF TISSUE INT; Tanimoto Y, 2013, GERIATR GERONTOL INT, V13, P958, DOI 10.1111/ggi.12037; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162603	10.1371/journal.pone.0162603	http://dx.doi.org/10.1371/journal.pone.0162603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612202	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900131
J	Bellon, MR; Ntandou-Bouzitou, GD; Caracciolo, F				Bellon, Mauricio R.; Ntandou-Bouzitou, Gervais D.; Caracciolo, Francesco			On-Farm Diversity and Market Participation Are Positively Associated with Dietary Diversity of Rural Mothers in Southern Benin, West Africa	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HEALTH; POLICY; SCALE; BIODIVERSITY; ADEQUACY; ANDES	Objective The objective of this study is to test the extent to which, under different opportunities for market participation, the diversity of plant species rural households grow or collect (on-farm diversity), and the variety of foods mothers purchase (market diversity) are associated with their dietary diversity. Methods Rural households from three districts in southern Benin were interviewed during dry (n = 472) and wet (n = 482) seasons between 2011 and 2012. Villages within districts and their households were selected randomly according to market accessibility, with a mother selected from each household. Information on on-farm diversity was collected using a semi-structured questionnaire. Market diversity was obtained through a 7-day food frequency questionnaire that elicited if foods were purchased. Dietary diversity was derived from a quantitative 24-hour food recall. A system of three simultaneous equations via a Generalized Methods of Moments was estimated to address potential endogeneity between dietary diversity and on-farm diversity and market diversity. Results Results show rich on-farm diversity with more than 65 different edible plant species grown or collected by households. More than 70% of foods consumed by mothers were purchased in 55 market places. More than 50% of mothers met minimum dietary diversity with at least 5 food groups consumed. Diagnostic tests indicated the existence of endogeneity. Econometric results showed that on-farm and market diversities were positively associated with mothers' dietary diversity (p < 0.05) once market opportunities, seasonality and other socioeconomic factors were controlled for. Conclusion Results provide evidence of a positive relationship between on-farm diversity and dietary diversity among participant mothers. They demonstrate the important contribution of market diversity to their dietary diversity. Links among these three facets of diversity suggest that production for self-consumption and food purchases complement rather than replace each other in their contribution to dietary diversity and thus dietary quality.	[Bellon, Mauricio R.] Biovers Int, Maccarese, Italy; [Ntandou-Bouzitou, Gervais D.] Biovers Int, Cotonou, Benin; [Caracciolo, Francesco] Univ Naples Federico II, Portici, Italy	Alliance; Bioversity International; Alliance; Bioversity International; University of Naples Federico II	Bellon, MR (corresponding author), Biovers Int, Maccarese, Italy.	m.bellon@cgiar.org	Bellon, Mauricio/L-9546-2019; Caracciolo, Francesco/D-6147-2013	Caracciolo, Francesco/0000-0001-9430-7529; Bellon, Mauricio/0000-0003-0642-3402	Bill and Melinda Gates Foundation [OPP53227]; Ministry of Agriculture; Centre communal pour la promotion de l'agriculture (CeCPA) of Bohicon; Centre communal pour la promotion de l'agriculture (CeCPA) of Allada; Centre communal pour la promotion de l'agriculture (CeCPA) of Toffo; University of Abomey Calavi	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Centre communal pour la promotion de l'agriculture (CeCPA) of Bohicon; Centre communal pour la promotion de l'agriculture (CeCPA) of Allada; Centre communal pour la promotion de l'agriculture (CeCPA) of Toffo; University of Abomey Calavi	This work was supported by Bill and Melinda Gates Foundation grant OPP53227, http://www.gatesfoundation.org/, MRB. CGIAR Research Program on Agriculture for Nutrition and Health led by IFPRI, http://www.a4nh.cgiar.org/, no specific grant number, funded part of the time of MRB and GNB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Laurian Unnevehr, Janet Lauderdale, Jon Hellin and four anonymous reviewers for comments on an earlier version and Arwen Bailey for editorial assistance. We are grateful to study participants and local communities for their full support and to the University of Abomey Calavi and the extension services of the Ministry of Agriculture, the Centre communal pour la promotion de l'agriculture (CeCPA) of Bohicon, Allada and Toffo for their guidance and support.	Adelman I., 2003, REV ECON HOUSEHOLD, V1, P33, DOI [10.1023/A:1021847430758, DOI 10.1023/A:1021847430758]; Anderson C. L., 2010, Seed trade in rural markets: implications for crop diversity and agricultural development, P31; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Barrett CB, 2008, FOOD POLICY, V33, P299, DOI 10.1016/j.foodpol.2007.10.005; Bellon MR, 2015, WORLD DEV, V70, P162, DOI 10.1016/j.worlddev.2015.01.014; BELLON MR, 1993, ECON DEV CULT CHANGE, V41, P763, DOI 10.1086/452047; Berti PR, 2015, P NATL ACAD SCI USA, V112, pE5656, DOI 10.1073/pnas.1517006112; BRUNDY JM, 1971, REV ECON STAT, V53, P207, DOI 10.2307/1937965; Cameron A. C., 2013, REGRESSION ANAL COUN, V53, DOI [10.1017/CBO9781139013567, DOI 10.1017/CBO9781139013567]; Cameron C., 2005, MICROECONOMETRICS US, P1056; Carletto G, 2015, J DEV STUD, V51, P945, DOI 10.1080/00220388.2015.1018908; Chamberlin J, 2013, WORLD DEV, V41, P245, DOI 10.1016/j.worlddev.2012.06.004; Daniels M, 2014, M REACH CONSENSUS GL; DEJANVRY A, 1995, WORLD DEV, V23, P1349, DOI 10.1016/0305-750X(95)00056-I; Delisle H, 2012, BRIT J NUTR, V107, P1534, DOI 10.1017/S0007114511004661; Dercon S, 2005, 194 FCND IFPRI, V2005; Devaux A, 2009, FOOD POLICY, V34, P31, DOI 10.1016/j.foodpol.2008.10.007; Dillon A, 2015, J DEV STUD, V51, P976, DOI 10.1080/00220388.2015.1018902; Erenstein O, 2006, AGR ECOSYST ENVIRON, V117, P205, DOI 10.1016/j.agee.2006.03.033; Fan S., 2013, SUBSISTENCE PROFIT T; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Food and Agriculture Organization of the United Nations, 2011, PROF NUTR PAYS REP B; Gibson RS., 2008, INT FOOD POLICY RES; Gomez MI, 2013, FOOD POLICY, V42, P129, DOI 10.1016/j.foodpol.2013.06.009; Hayashi Fumio, 2000, ECONOMETRICS; Hazell P, 2010, WORLD DEV, V38, P1349, DOI 10.1016/j.worlddev.2009.06.012; Heckman JJ, 2005, ECONOMETRICA, V73, P669, DOI 10.1111/j.1468-0262.2005.00594.x; Hirvonen K, 2014, 69 EDRI IFPRI; Honfo F. G., 2010, African Journal of Food Science, V4, P184; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; INSD, 2022, CINQ REC GEN POP HAB; Institut National de la Statistique et de l'Analyse Economique, 2004, CAH VILL QUART VILL; Institut National de la Statistique et de l'Analyse Economique (INSAE), 2014, ENQ GRAPP IND MULT M; Institut National de la Statistique (INS) au Niger and Macro International Inc, 2007, ENQ DEM SANT 2006; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Keding GB, 2012, FOOD SECUR, V4, P129, DOI 10.1007/s12571-011-0163-y; Keleman A, 2013, HUM ECOL, V41, P683, DOI 10.1007/s10745-013-9566-z; Key N, 2000, AM J AGR ECON, V82, P245, DOI 10.1111/0002-9092.00022; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Lemay-Boucher P, 2014, J INT DEV, V26, P46, DOI 10.1002/jid.2839; Luckett BG, 2015, PUBLIC HEALTH NUTR, V18, P2479, DOI 10.1017/S136898001500169X; M'Kaibi FK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1755-9; Magnani R, 1997, SAMPLING GUIDE; Malapit HJL, 2015, J DEV STUD, V51, P1097, DOI 10.1080/00220388.2015.1018904; McDermott J, 2015, FOOD SECUR, V7, P593, DOI 10.1007/s12571-015-0462-9; Muhanji G, 2011, INT J AGR SUSTAIN, V9, P194, DOI 10.3763/ijas.2010.0561; Muller C, 2009, FOOD POLICY, V34, P166, DOI 10.1016/j.foodpol.2008.10.010; Nichols A, 2007, STATA J, V7, P507, DOI 10.1177/1536867X0700700403; Oyarzun PJ, 2013, ECOL FOOD NUTR, V52, P515, DOI 10.1080/03670244.2013.769099; Pingali P, 2015, FOOD SECUR, V7, P583, DOI 10.1007/s12571-015-0461-x; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Remans R, 2015, P NATL ACAD SCI USA, V112, pE6082, DOI 10.1073/pnas.1518531112; Remans R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021235; Republique du Benin, 2014, AN GLOB VULN SEC AL; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Setimela P, 2005, EUPHYTICA, V145, P123, DOI 10.1007/s10681-005-0625-4; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, pE5657, DOI 10.1073/pnas.1517209112; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Singh L. S., 1986, AGR HOUSEHOLD MODELS; Slack A., 1996, FOOD INSECURITY NUTR; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Torheim LE, 2013, DIET QUALITY, P105, DOI [10.1007/978-1-4614-7339-8_9, DOI 10.1007/978-1-4614-7339-8_9]; Windmeijer FAG, 1997, J APPL ECONOMET, V12, P281	68	72	72	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162535	10.1371/journal.pone.0162535	http://dx.doi.org/10.1371/journal.pone.0162535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606782	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600060
J	van der Heijden, MJE; Araghi, SO; Jeekel, J; Reiss, IKM; Hunink, MGM; van Dijk, M				van der Heijden, Marianne J. E.; Araghi, Sadaf Oliai; Jeekel, Johannes; Reiss, Irwin K. M.; Hunink, M. G. Myriam; van Dijk, Monique			Do Hospitalized Premature Infants Benefit from Music Interventions? A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Review							INTENSIVE-CARE-UNIT; PRETERM INFANTS; ACOUSTIC STIMULATION; THERAPY; WEIGHT; LIVE; NEWBORN; STRESS; NICU	Objective Neonatal intensive care units (NICU) around the world increasingly use music interventions. The most recent systematic review of randomized controlled trials (RCT) dates from 2009. Since then, 15 new RCTs have been published. We provide an updated systematic review on the possible benefits of music interventions on premature infants' well-being. Methods We searched 13 electronic databases and 12 journals from their first available date until August 2016. Included were all RCTs published in English with at least 10 participants per group, including infants born prematurely and admitted to the NICU. Interventions were either recorded music interventions or live music therapy interventions. All control conditions were accepted as long as the effects of the music intervention could be analysed separately. A meta-analysis was not possible due to incompleteness and heterogeneity of the data. Results After removal of duplicates the searches retrieved 4893 citations, 20 of which fulfilled the inclusion/exclusion criteria. The 20 included studies encompassed 1128 participants receiving recorded or live music interventions in the NICU between 24 and 40 weeks gestational age. Twenty-six different outcomes were reported which we classified into three categories: physiological parameters; growth and feeding; behavioural state, relaxation outcomes and pain. Live music interventions were shown to improve sleep in three out of the four studies and heart rate in two out of the four studies. Recorded music improved heart rate in two out of six studies. Better feeding and sucking outcomes were reported in one study using live music and in two studies using recorded music. Conclusions Although music interventions show promising results in some studies, the variation in quality of the studies, age groups, outcome measures and timing of the interventions across the studies makes it difficult to draw strong conclusions on the effects of music in premature infants.	[van der Heijden, Marianne J. E.] Dept Paediat, Erasmus MC, Rotterdam, Netherlands; [Araghi, Sadaf Oliai; Jeekel, Johannes] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Reiss, Irwin K. M.] Erasmus MC, Dept Neonatol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [van Dijk, Monique] Intens Care Erasmus MC, Div Neonatol, Dept Paediat, Rotterdam, Netherlands; [van Dijk, Monique] Intens Care Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	van der Heijden, MJE (corresponding author), Dept Paediat, Erasmus MC, Rotterdam, Netherlands.	m.j.e.vanderheijden@erasmusmc.nl		van Dijk, Monique/0000-0002-9856-0318	Internal Grant Erasmus MC for Integrative Medicine; Stichting Coolsingel; Stichting Mathilde Elise; Erasmus Stichting; Gilles Hondius Foundation; Stichting Aelwijn Florisz; Stichting Aerarium Sanctius; Stichting van Ommeren/De Voogt; Verhagen Stichting; Stichting Swart-van Essen	Internal Grant Erasmus MC for Integrative Medicine; Stichting Coolsingel; Stichting Mathilde Elise; Erasmus Stichting; Gilles Hondius Foundation; Stichting Aelwijn Florisz; Stichting Aerarium Sanctius; Stichting van Ommeren/De Voogt; Verhagen Stichting; Stichting Swart-van Essen	The following parties contributed funding to this study: Internal Grant Erasmus MC for Integrative Medicine, Stichting Coolsingel, Stichting Mathilde Elise, Erasmus Stichting, Gilles Hondius Foundation, Stichting Aelwijn Florisz, Stichting Aerarium Sanctius, Stichting van Ommeren/De Voogt, Verhagen Stichting, Stichting Swart-van Essen. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alipour Z, 2013, COMPLEMENT THER CLIN, V19, P128, DOI 10.1016/j.ctcp.2013.02.007; Allen KA, 2013, ADV NEONAT CARE, V13, P349, DOI 10.1097/ANC.0b013e3182a0278b; ALS H, 1986, PEDIATRICS, V78, P1123; Als H, 1984, MANUAL NATURALISTIC; Amini E, 2013, J Neonatal Perinatal Med, V6, P295, DOI 10.3233/NPM-1371313; [Anonymous], 1974, Pediatrics, V54, P476; Arnon S, 2006, BIRTH-ISS PERINAT C, V33, P131, DOI 10.1111/j.0730-7659.2006.00090.x; Aydin D, 2012, HEALTHMED, V6, P3162; Bayat M, 2014, BMJ, V99, pA82; Bo LK, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e49; Butt M L, 2000, Can J Nurs Res, V31, P17; CAINE J, 1991, J MUSIC THER, V28, P180, DOI 10.1093/jmt/28.4.180; Calabro J, 2005, AUSTR J MUSIC THERAP, V14, P3; Chorna OD, 2014, PEDIATRICS, V133, P462, DOI 10.1542/peds.2013-2547; Dorn F, 2014, CHRONOBIOL INT, V31, P1062, DOI 10.3109/07420528.2014.948183; Farhat A., 2010, J NEONATAL PERINAT M, V3, P103; Garunkstiene R, 2014, NORD J MUSIC THER, V23, P71, DOI 10.1080/08098131.2013.809783; Graven S N, 2000, J Perinatol, V20, pS88; Hanson-Abromeit D, 2005, MUSIC THER PERSPECT, V23, P76, DOI 10.1093/mtp/23.1.76; Hartling L, 2009, ARCH DIS CHILD-FETAL, V94, pF349, DOI 10.1136/adc.2008.148411; Haslbeck FB, 2012, NORD J MUSIC THER, V21, P203, DOI 10.1080/08098131.2011.648653; Higgins JPT GSe, 2009, COCHRANE HDB SYSTEMA, P2013; Hiniker RKM, 1994, DEV SUPPORTIVE CARE; Hodges AL, 2010, SO ONLINE J NURSING, V10, p8p; Jabraeili Mahnaz, 2016, J Caring Sci, V5, P85, DOI 10.15171/jcs.2016.009; Joyce B A, 2001, J Pediatr Health Care, V15, P105, DOI 10.1016/S0891-5245(01)45632-X; Keith DR, 2009, J MUSIC THER, V46, P191, DOI 10.1093/jmt/46.3.191; Kemper KJ, 2008, J ALTERN COMPLEM MED, V14, P1185, DOI 10.1089/acm.2008.0283; Lai HL, 2006, INT J NURS STUD, V43, P139, DOI 10.1016/j.ijnurstu.2005.04.008; Loewy J, 2013, PEDIATRICS, V131, P902, DOI 10.1542/peds.2012-1367; Lubetzky R, 2010, PEDIATRICS, V125, pE24, DOI 10.1542/peds.2009-0990; Marchette L, 1989, Pediatr Nurs, V15, P207; MARCHETTE L, 1991, NURS RES, V40, P241; Cardoso MVLML, 2014, REV LAT-AM ENFERM, V22, P810, DOI 10.1590/0104-1169.0029.2484; Neal DO, 2008, NEONATAL NETW, V27, P319, DOI 10.1891/0730-0832.27.5.319; Olischar M, 2011, ACTA PAEDIATR, V100, P670, DOI 10.1111/j.1651-2227.2011.02171.x; Polkki T, 2012, EFFECTIVENESS MUSIC; Schlez A, 2011, ISR MED ASSOC J, V13, P354; Schoemark H, 1999, PHYSL BEHAV ASSESSME; Shoemark H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00487; Standley J, 2012, NEONATAL NETW, V31, P311, DOI 10.1891/0730-0832.31.5.311; Standley Jayne M, 2003, J Pediatr Nurs, V18, P169; Standley Jayne M, 2010, Pediatr Nurs, V36, P138; Standley Jayne M, 2002, J Pediatr Nurs, V17, P107, DOI 10.1053/jpdn.2002.124128; Tramo MJ., 2011, MUSIC MED, V3, P72, DOI DOI 10.1177/1943862111400613; Wachman EM, 2011, ARCH DIS CHILD-FETAL, V96, pF305, DOI 10.1136/adc.2009.182014; Walworth D., 2012, J NEONATAL NURSING, V18, P210, DOI DOI 10.1016/J.JNN.2012.01.001; Whipple J, 2008, J MUSIC THER, V45, P227, DOI 10.1093/jmt/45.3.227; Wirth L, 2016, J PERINATOL, V36, P486, DOI 10.1038/jp.2016.1	49	43	43	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161848	10.1371/journal.pone.0161848	http://dx.doi.org/10.1371/journal.pone.0161848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606900	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600012
J	Durham, J; Warner, M; Phengsavanh, A; Sychareun, V; Vongxay, V; Rickart, K				Durham, Jo; Warner, Melissa; Phengsavanh, Alongkone; Sychareun, Vanphanom; Vongxay, Viengnakhone; Rickart, Keith			Stakeholder Analysis of Community Distribution of Misoprostol in Lao PDR: A Qualitative Study	PLOS ONE			English	Article							PREVENT POSTPARTUM HEMORRHAGE; HEALTH-SERVICES; OBSTETRIC CARE; COUNTRIES; FRAMEWORK; PAKISTAN; BIRTH; WOMEN	Background Globally, significant progress has been made in reducing maternal mortality, yet in many low-resource contexts it remains unacceptably high. Many of these deaths are due to postpartum haemorrhage and are preventable with access to essential obstetric care. Where there are barriers to access, maternal deaths could be prevented if community-level misoprostol was available. The purpose of this study was to explore perceptions of stakeholders regarding misoprostol use in the Lao People's Democratic Republic, a setting with high maternal mortality. Methods Semi-structured interviews were conducted with 35 stakeholders in the capital, Vientiane and in one northern province identified as a site for a possible intervention. The sample included international and national stakeholders involved in policy-making and providing maternal and reproductive health services. Findings Most stakeholders supported a pilot program for community distribution of misoprostol but levels of awareness of the drug's use in preventing postpartum haemorrhage and level of influence over policy direction varied considerably. Some international organizations, all identified as powerful in influencing policy, were ambivalent about the use of community distribution of misoprostol. Concerns related to the capacity of village health workers or lay people to safely administer misoprostol, whether its distribution would undermine efforts to improve access to safe delivery services and active management of the third stage of labour, the ease with which prescription drugs can be bought over the counter, and technical, logistical, and financial constraints. Conclusion Access to appropriate oxytocic drugs is a matter of health equity. In settings without access to essential obstetrical care, misoprostol represents a viable solution for the prevention of postpartum haemorrhage. Understanding stakeholders' perspectives and their legitimate concerns on misoprostol can inform interventions in order to assuage these concerns and enable disadvantaged women to access misoprostol and its potentially life-saving benefits.	[Durham, Jo; Warner, Melissa] Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld 4006, Australia; [Phengsavanh, Alongkone; Sychareun, Vanphanom; Vongxay, Viengnakhone] Univ Hlth Sci, Viangchan, Laos; [Rickart, Keith] Queensland Govt, Dept Hlth, Hlth Serv & Clin Innovat Div, Communicable Dis Unit,Chief Hlth Officer Branch, Brisbane, Qld 4006, Australia	University of Queensland; Queensland Health	Durham, J (corresponding author), Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld 4006, Australia.	m.durham@uq.edu.au	Durham, Jo/A-1977-2014	Durham, Jo/0000-0003-0544-9424				AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Akkhavong Kongsap Paphassarang C, 2014, HLTH SYSTEM REV; Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; Brugha R, 2000, HEALTH POLICY PLANN, V15, P239, DOI 10.1093/heapol/15.3.239; Bryman A., 2012, SOCIAL RES METHOD, V4th ed., P809; Buse K., 2012, MAKING HLTH POLICY; Carey G, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0207-6; Commission on information and accountability for Women's and Children's Health, 2000, KEEPING PROMISES MEA; Creswell J., 2009, RES DESIGN QUALITATI, V3; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Douangvichit Daovieng, 2012, Journal of the Medical Association of Thailand, V95, P1126; Ejembi C, 2010, PREVENTION OF POSTPA; Gynuity, 2006, POSTPARTUM HEMORRHAG; Hoa DT, 2012, BMC PUBLIC HEALTH, V12, P641, DOI [10.1186/1471-2458-12-641, DOI 10.1186/1471-2458-12-641]; Hyder A, 2010, PUBLIC HEALTH, V124, P159, DOI 10.1016/j.puhe.2009.12.006; Jacobs B, 2012, REPROD HEALTH MATTER, V20, P112, DOI 10.1016/S0968-8080(12)40649-8; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Lalonde A, 2012, INT J GYNECOL OBSTET, V117, P108, DOI 10.1016/j.ijgo.2012.03.001; Manithip C, 2013, MIDWIFERY, V29, P195, DOI 10.1016/j.midw.2011.12.010; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; Mertens DM, 2010, TRANSFORMATIVE RESEA; Mir AM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-120; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; MoH LSB/MPI MoES, 2012, LAO SOCIAL INDICATOR; National Institute of Statistics Directorate General for Health Macro, 2011, CAMBODIA DEMOGRAPHIC; Oladapo OT, 2012, INT J GYNECOL OBSTET, V119, P105, DOI 10.1016/j.ijgo.2012.08.004; Patton M.Q., 2008, ESSENTIALS UTILIZATI, V4th; Potts M, 2010, LANCET, V375, P459, DOI 10.1016/S0140-6736(10)60192-4; Prata N, 2013, HEALTH POLICY PLANN, V28, P339, DOI 10.1093/heapol/czs068; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Sanghvi H, 2010, INT J GYNECOL OBSTET, V108, P276, DOI 10.1016/j.ijgo.2009.12.003; Schmeer K., 1999, GUIDELINES FOR CONDU; Sihavong A, 2006, SEX TRANSM INFECT, V82, P182, DOI 10.1136/sti.2005.016352; Smith JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-44; Starrs A, 2012, INT J GYNECOL OBSTET, V116, P1, DOI 10.1016/j.ijgo.2011.10.005; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; UNDP, 2012, COUNTRY ANALYSIS REP; Varvasovszky Z, 2000, HEALTH POLICY PLANN, V15, P338, DOI 10.1093/heapol/15.3.338; World Health Organization, 2012, WHO RECOMMENDATIONS; World Health Organization, 2014, MAT MORT; World Health Organization, 2014, THE COUNTRY COOPERAT	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162154	10.1371/journal.pone.0162154	http://dx.doi.org/10.1371/journal.pone.0162154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631089	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900029
J	Kaisaki, PJ; Cutts, A; Popitsch, N; Camps, C; Pentony, MM; Wilson, G; Page, S; Kaur, K; Vavoulis, D; Henderson, S; Gupta, A; Middleton, MR; Karydis, I; Talbot, DC; Schuh, A; Taylor, JC				Kaisaki, Pamela J.; Cutts, Anthony; Popitsch, Niko; Camps, Carme; Pentony, Melissa M.; Wilson, Gareth; Page, Suzanne; Kaur, Kulvinder; Vavoulis, Dimitris; Henderson, Shirley; Gupta, Avinash; Middleton, Mark R.; Karydis, Ioannis; Talbot, Denis C.; Schuh, Anna; Taylor, Jenny C.			Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis	PLOS ONE			English	Article							BIOPSY; HETEROGENEITY; TRIAL	Use of circulating tumour DNA (ctDNA) as a liquid biopsy has been proposed for potential identification and monitoring of solid tumours. We investigate a next-generation sequencing approach for mutation detection in ctDNA in two related studies using a targeted panel. The first study was retrospective, using blood samples taken from melanoma patients at diverse timepoints before or after treatment, aiming to evaluate correlation between mutations identified in biopsy and ctDNA, and to acquire a first impression of influencing factors. We found good concordance between ctDNA and tumour mutations of melanoma patients when blood samples were collected within one year of biopsy or before treatment. In contrast, when ctDNA was sequenced after targeted treatment in melanoma, mutations were no longer found in 9 out of 10 patients, suggesting the method might be useful for detecting treatment response. Building on these findings, we focused the second study on ctDNA obtained before biopsy in lung patients, i.e. when a tentative diagnosis of lung cancer had been made, but no treatment had started. The main objective of this prospective study was to evaluate use of ctDNA in diagnosis, investigating the concordance of biopsy and ctDNA-derived mutation detection. Here we also found positive correlation between diagnostic lung biopsy results and pre-biopsy ctDNA sequencing, providing support for using ctDNA as a cost-effective, non-invasive solution when the tumour is inaccessible or when biopsy poses significant risk to the patient.	[Kaisaki, Pamela J.; Popitsch, Niko; Camps, Carme; Pentony, Melissa M.; Wilson, Gareth; Kaur, Kulvinder; Vavoulis, Dimitris; Taylor, Jenny C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kaisaki, Pamela J.; Popitsch, Niko; Camps, Carme; Pentony, Melissa M.; Wilson, Gareth; Kaur, Kulvinder; Vavoulis, Dimitris; Gupta, Avinash; Middleton, Mark R.; Karydis, Ioannis; Taylor, Jenny C.] NIHR Oxford BRC, Oxford, England; [Cutts, Anthony; Page, Suzanne; Vavoulis, Dimitris; Henderson, Shirley; Schuh, Anna] John Radcliffe Hosp, Oxford Univ Hosp, Natl Hlth Serv Translat Mol Diagnost Ctr, Biomed Res Ctr, Oxford, England; [Gupta, Avinash; Middleton, Mark R.; Karydis, Ioannis; Talbot, Denis C.] Univ Oxford, Churchill Hosp, Dept Oncol, Oxford, England; [Wilson, Gareth] Francis Crick Inst, London, England; [Kaur, Kulvinder] Millenium Hlth, San Diego, CA USA; [Karydis, Ioannis] Univ Southampton, Canc Sci Acad Unit, Southampton, Hants, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Francis Crick Institute; University of Southampton	Kaisaki, PJ (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Kaisaki, PJ (corresponding author), NIHR Oxford BRC, Oxford, England.	pamela.kaisaki@well.ox.ac.uk	Herrero, Carlos Camps/L-3073-2017; wei, wei/HHR-8613-2022; Vavoulis, Dimitris/AAF-1690-2020	Herrero, Carlos Camps/0000-0002-0648-5403; Karydis, Ioannis/0000-0002-8308-3141; Anna, schuh/0000-0002-3938-8490; Karydis, Ioannis/0000-0003-0284-3549; Taylor, Jenny/0000-0003-3602-5704	Innovate UK [10809-62174]; National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust [090532/Z/09/Z]; Cancer Research UK [8466] Funding Source: researchfish	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	This study was supported by grants from: Technology Strategy Board (now called Innovate UK) (TP No: 10809-62174) (JCT and AS), https://www.gov.uk/government/organisations/innovate-uk; National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford (JCT and AS), http://oxfordbrc.nihr.ac.uk/; The Wellcome Trust (090532/Z/09/Z) (JCT), http://www.wellcome.ac.uk/; Oxford Experimental Cancer Medicine Centre (MRM), http://www.ecmcnetwork.org.uk/. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Brinza D, 2015, 106 ANN M AM ASS CAN; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang GA, 2016, MOL ONCOL, V10, P157, DOI 10.1016/j.molonc.2015.09.005; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Juratli MA, 2014, HEAD NECK-J SCI SPEC, V36, P1207, DOI 10.1002/hed.23439; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lebofsky R, 2015, MOL ONCOL, V9, P783, DOI 10.1016/j.molonc.2014.12.003; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Page K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077963; Patterson SE, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0061-7; Robertson EG, 2011, CLIN RADIOL, V66, P1007, DOI 10.1016/j.crad.2011.05.012; White HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045073; Xu S, 2016, CANCER LETT, V370, P324, DOI 10.1016/j.canlet.2015.11.005	23	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162809	10.1371/journal.pone.0162809	http://dx.doi.org/10.1371/journal.pone.0162809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626278	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600055
J	Lkhagvasuren, G; Shin, H; Lee, SE; Tumen, D; Kim, JH; Kim, KY; Kim, K; Park, AJ; Lee, HW; Kim, MJ; Choi, J; Choi, JH; Min, NY; Lee, KH				Lkhagvasuren, Gavaachimed; Shin, Heejin; Lee, Si Eun; Tumen, Dashtseveg; Kim, Jae-Hyun; Kim, Kyung-Yong; Kim, Kijeong; Park, Ae Ja; Lee, Ho Woon; Kim, Mi Jin; Choi, Jaesung; Choi, Jee-Hye; Min, Na Young; Lee, Kwang-Ho			Molecular Genealogy of a Mongol Queen's Family and Her Possible Kinship with Genghis Khan	PLOS ONE			English	Article							Y-CHROMOSOME; MITOCHONDRIAL-DNA; STR HAPLOTYPES; MODERN HUMANS; TAVAN-TOLGOI; EAST; SEQUENCE; RESOLUTION; PHYLOGENY; INDIA	Members of the Mongol imperial family (designated the Golden family) are buried in a secret necropolis; therefore, none of their burial grounds have been found. In 2004, we first discovered 5 graves belonging to the Golden family in Tavan Tolgoi, Eastern Mongolia. To define the genealogy of the 5 bodies and the kinship among them, SNP and/or STR profiles of mitochondria, autosomes, and Y chromosomes were analyzed. Four of the 5 bodies were determined to carry the mitochondrial DNA haplogroup D4, while the fifth carried haplogroup CZ, indicating that this individual had no kinship with the others. Meanwhile, Y-SNP and Y-STR profiles indicate that the males examined belonged to the R1b-M343 haplogroup. Thus, their East Asian D4 or CZ matrilineal and West Eurasian R1b-M343 patrilineal origins reveal genealogical admixture between Caucasoid and Mongoloid ethnic groups, despite a Mongoloid physical appearance. In addition, Y chromosomal and autosomal STR profiles revealed that the four D4-carrying bodies bore the relationship of either mother and three sons or four full siblings with almost the same probability. Moreover, the geographical distribution of R1b-M343-carrying modern-day individuals demonstrates that descendants of Tavan Tolgoi bodies today live mainly in Western Eurasia, with a high frequency in the territories of the past Mongol khanates. Here, we propose that Genghis Khan and his family carried Y-haplogroup R1b-M343, which is prevalent in West Eurasia, rather than the Y-haplogroup C3c-M48, which is prevalent in Asia and which is widely accepted to be present in the family members of Genghis Khan. Additionally, Tavan Tolgoi bodies may have been the product of marriages between the lineage of Genghis Khan's Borjigin clan and the lineage of either the Ongud or Hongirad clans, indicating that these individuals were members of Genghis Khan's immediate family or his close relatives.	[Lkhagvasuren, Gavaachimed; Lee, Kwang-Ho] Chung Ang Univ, Grad Sch, Dept Sci Cultural Heritage, Seoul, South Korea; [Shin, Heejin; Lee, Si Eun; Lee, Ho Woon; Kim, Mi Jin; Choi, Jaesung; Choi, Jee-Hye; Min, Na Young; Lee, Kwang-Ho] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Tumen, Dashtseveg] Natl Univ Mongolia, Sch Social Sci, Dept Anthropol & Archaeol, Ulaanbaatar, Mongolia; [Kim, Jae-Hyun] Dong A Univ, Coll Humanities, Dept Archaeol & Art Hist, Busan, South Korea; [Kim, Kyung-Yong] Chung Ang Univ, Coll Med, Inst Med Sci, Seoul, South Korea; [Park, Ae Ja] Chung Ang Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Chung Ang University; Chung Ang University; National University of Mongolia; Dong A University; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Lee, KH (corresponding author), Chung Ang Univ, Grad Sch, Dept Sci Cultural Heritage, Seoul, South Korea.; Lee, KH (corresponding author), Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea.	leemanse@cau.ac.kr	Kim, Mi Jin/GXH-9639-2022	Lee, Si Eun/0000-0003-2452-8988	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2012R1A2A2A03047236]; Chung-Ang University	National Research Foundation of Korea (NRF) grant - Korea government (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Chung-Ang University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A2A2A03047236) (www.nrf.re.kr/). This research was also supported by the Chung-Ang University Graduate Research Scholarship in 2015.; The authors would like to thank the late Dr. Navaan D. who first discovered the Tavan Tolgoi burial site and excavated valuable artifacts from several graves. We would also like to thank Dr. Ki-Won Park at the Korea National Forensic Service for kinship analysis. Furthermore, we sincerely thank Mrs. Undral B. for providing valuable information about the artifacts excavated. This research was supported by the Chung-Ang University Graduate Research Scholarship in 2015.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Atwood CP., 2004, ENCY MONGOLIA MONGOL, P423; Barnes I, 1998, HIST ATLAS ASIA WORL, P60; Barta JL, 2013, FORENSIC SCI INT, V231, P340, DOI 10.1016/j.forsciint.2013.06.004; Batsaikhan Z., 2006, THE XIONGNU, P26; Batsaikhan Z, 2008, MON J ANTHROPOL ARCH, V4, P37; Blair S., 2005, COMPENDIUM CHRONICLE; Brothwell D., 1981, DIGGING BONES EXCAVA; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Edson S M, 2004, Forensic Sci Rev, V16, P63; Ellis N, 2002, GENOME RES, V12, P339; Enkhtsetseg D., 2008, SECRET HIST MONGOLS; Fenner JN, 2014, J ARCHAEOL SCI, V46, P231, DOI 10.1016/j.jas.2014.03.017; Ge Jianye, 2012, Investig Genet, V3, P1, DOI 10.1186/2041-2223-3-1; Ge JY, 2011, J FORENSIC SCI, V56, P1448, DOI 10.1111/j.1556-4029.2011.01867.x; Grousset R., 1970, EMPIRE STEPPES HIST; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; International Society of Genetic Genealogy, 2015, Y DNA HAPL TREE VERS; Izgi O, 2002, THE TURKS, VI, P89; Jackson P., 2005, MONGOLS W, P87; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Keyser-Tracqui C, 2003, AM J HUM GENET, V73, P247, DOI 10.1086/377005; Kim AJ, 2010, BMB REP, V43, P133, DOI 10.5483/BMBRep.2010.43.2.133; Kim K, 2008, AM J PHYS ANTHROPOL, V136, P114, DOI 10.1002/ajpa.20782; Kim K, 2010, AM J PHYS ANTHROPOL, V142, P429, DOI 10.1002/ajpa.21242; Kim SH, 2010, INT J LEGAL MED, V124, P653, DOI 10.1007/s00414-010-0501-1; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lacau H, 2012, EUR J HUM GENET, V20, P1063, DOI 10.1038/ejhg.2012.59; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-483; Maji S, 2008, INT J HUM GENET, V8, P85, DOI 10.1080/09723757.2008.11886022; Mousavi A., 1997, HAZARAS AFGHANISTAN; Mrsic G, 2012, MOL BIOL REP, V39, P7727, DOI 10.1007/s11033-012-1610-3; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; NAKAHASHI T, 1986, J ANTHROPOL SOC NIP, V94, P289; Navaan D, 2006, SILK ROAD, V4, P55; Navaan D, 2006, MON J ANTHR ARCHAEOL, V2, P10; Ochir A, 2005, HIST MONGOLIA; Pearson K, 1899, PHIL T R SOC LOND A, V192, P169, DOI [DOI 10.1098/RSTA.1899.0004, 10.1098/rsta.1899.0004]; Phillips JRS, 1998, MEDIEVAL EXPANSION E, P115; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Rachewiltz ID, 2006, SECRET HIST MONGOLS; Ratchnevsky P., 1991, G KHAN HIS LIFE LEGA, P145; Roewer L, 2008, INT J LEGAL MED, V122, P219, DOI 10.1007/s00414-007-0222-2; Roewer L, 2007, FORENSIC SCI INT, V173, P204, DOI 10.1016/j.forsciint.2006.11.013; Roux JP., 1993, HIST MONGOL EMPIRE; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders JJ., 1971, HIST MONGOL CONQUEST, P41; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sukh baatar G, 1980, ANCIENT ANCESTORS MO; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tumen D., 2005, E MONGOLIA REPORT RE; Tumen D., 2008, MONGOLIAN J ANTHR AR, V4, P162; Tumen D., 2006, MONGOLIAN J ANTHR AR, V54, P90; Tumen D., 2006, SILK ROAD, V4, P51; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang Y, 2015, ELECTROPHORESIS, V36, P2546, DOI 10.1002/elps.201500089; Waterson J., 2007, KNIGHTS ISLAM WARS M, P192; Weatherford, 2005, GENGHIS KHAN MAKING; Weatherford Jack, 2010, SECRET HIST MONGOL Q; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Youn M, 2007, RADIOCARBON, V49, P685, DOI 10.1017/S0033822200042570; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	74	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161622	10.1371/journal.pone.0161622	http://dx.doi.org/10.1371/journal.pone.0161622			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627454	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600006
J	Vallejo-Medina, P; Marchal-Bertrand, L; Gomez-Lugo, M; Espada, JP; Sierra, JC; Soler, F; Morales, A				Vallejo-Medina, Pablo; Marchal-Bertrand, Laurent; Gomez-Lugo, Mayra; Pedro Espada, Jose; Carlos Sierra, Juan; Soler, Franklin; Morales, Alexandra			Adaptation and Validation of the Brief Sexual Opinion Survey (SOS) in a Colombian Sample and Factorial Equivalence with the Spanish Version	PLOS ONE			English	Article							ASSERTIVENESS SCALE SAS; FUNCTIONING QUESTIONNAIRE; FIT INDEXES; WOMEN; RELIABILITY; EROTOPHILIA; PREDICTORS; INVARIANCE; ATTITUDES; VALIDITY	Attitudes toward sexuality are a key variable for sexual health. It is really important for psychology and education to have adapted and validated questionnaires to evaluate these attitudes. Therefore, the objective of this research was to adapt, validate and calculate the equivalence of the Colombia Sexual Opinion Survey as compared to the same survey from Spain. To this end, a total of eight experts were consulted and 1,167 subjects from Colombia and Spain answered the Sexual Opinion Survey, the Sexual Assertiveness Scale, the Massachusetts General Hospital-Sexual Functioning Questionnaire, and the Sexuality Scale. The evaluation was conducted by online and the results show adequate qualitative and quantitative properties of the items, with adequate reliability and external validity and compliance with the strong invariance between the two countries. Consequently, the Colombia Sexual Opinion Survey is a valid and reliable scale and its scores can be compared with the ones from the Spain survey, with minimum bias.	[Vallejo-Medina, Pablo; Marchal-Bertrand, Laurent; Gomez-Lugo, Mayra] Fdn Univ Konrad Lorenz, SexLabKL, Bogota, Colombia; [Pedro Espada, Jose; Morales, Alexandra] Univ Miguel Hernandez, Sch Psychol, Elche, Spain; [Carlos Sierra, Juan] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Soler, Franklin] Univ Rosario, Sch Psychol, Bogota, Colombia	Universidad Miguel Hernandez de Elche; University of Granada; Universidad del Rosario	Vallejo-Medina, P (corresponding author), Fdn Univ Konrad Lorenz, SexLabKL, Bogota, Colombia.	pablo.vallejom@konradlorenz.edu.co	Morales, Alexandra/F-6119-2014; Vallejo-Medina, Pablo/P-8862-2018; Sierra, Juan Carlos/G-3044-2010; ESPADA, JOSE P/L-7482-2014; Soler, Franklin/K-1669-2016	Morales, Alexandra/0000-0002-9518-3166; Vallejo-Medina, Pablo/0000-0002-8527-1584; Sierra, Juan Carlos/0000-0002-5593-9803; Soler, Franklin/0000-0003-1408-7875; ESPADA, JOSE P./0000-0001-5248-6258	Fundacion Universitaria Konrad Lorenz [2014-003, 95109141]	Fundacion Universitaria Konrad Lorenz	This work was funded by Fundacion Universitaria Konrad Lorenz, Grant: 2014-003 no95109141, http://www.konradlorenz.edu.co/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN LR, 1980, EDUC PSYCHOL MEAS, V40, P955, DOI 10.1177/001316448004000419; AIKEN LR, 1985, EDUC PSYCHOL MEAS, V45, P131, DOI 10.1177/0013164485451012; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Educational Research Association [AERA] American Psychological Association [APA] & National Council on Measurement in Education [NCME], 2014, STANDARDS FOR EDUCAT; [Anonymous], 2013, UNAIDS REP GLOB AIDS; BARAK A, 1992, J APPL SOC PSYCHOL, V22, P17, DOI 10.1111/j.1559-1816.1992.tb01519.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrne B., 2009, STRUCTURAL EQUATION, V2nd ed.; BYRNE D, 1977, PERS SOC PSYCHOL B, V3, P3, DOI 10.1177/014616727600300102; Sierra JC, 2012, ATEN PRIM, V44, P516, DOI 10.1016/j.aprim.2012.02.004; Sierra JC, 2012, PSICOTHEMA, V24, P316; Sierra JC, 2011, AN PSICOL-SPAIN, V27, P17; Carpintero E, 1994, CUADERNOS MED PSICOS, V31, P52; Carretero-Dios H, 2007, INT J CLIN HLTH PSYC, V7, P863; Carvalho J, 2010, J SEX MED, V7, P928, DOI 10.1111/j.1743-6109.2009.01568.x; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Olvera FJD, 2013, REV INT ANDROL, V11, P9, DOI 10.1016/j.androl.2012.09.003; Olvera FJD, 2012, REV INT ANDROL, V10, P125; Dimitrov DM, 2010, MEAS EVAL COUNS DEV, V43, P121, DOI 10.1177/0748175610373459; Elosua P, 2014, REV LAT AM PSICOL, V46, P117, DOI 10.1016/S0120-0534(14)70015-9; Fisher TD, 2012, J SEX RES, V49, P69, DOI 10.1080/00224499.2011.565429; FISHER WA, 1988, J SEX RES, V25, P123, DOI 10.1080/00224498809551448; GILBERT FS, 1984, J SEX RES, V20, P293, DOI 10.1080/00224498409551227; Gillen MM, 2006, J YOUTH ADOLESCENCE, V35, P243, DOI 10.1007/s10964-005-9005-6; Hall CL, 2014, J SEX RES, V51, P184, DOI 10.1080/00224499.2012.716872; Harkabus LC, 2013, HEALTH PROMOT PRACT, V14, P751, DOI 10.1177/1524839912465420; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HURLBERT DF, 1993, J SEX MARITAL THER, V19, P154, DOI 10.1080/00926239308404899; INJUVE, 2012, INF JUV ESP 2012; Joyal CC, 2015, J SEX MED, V12, P328, DOI 10.1111/jsm.12734; Kelley EL, 2015, PSYCHOL VIOLENCE, V5, P144, DOI 10.1037/a0038854; Labbate LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P221, DOI 10.1159/000056257; Lameiras M, 1998, ANAL MODIFICACION CO, V23, P27; Lameiras-Fernandez M, 1997, CUAD MED PSICO PSIQU, V42-43, P46; Lawyer SR, 2013, PSYCHOL REC, V63, P803, DOI 10.11133/j.tpr.2013.63.4.007; Lemer JL, 2013, INT J SEX HEALTH, V25, P104, DOI 10.1080/19317611.2012.722593; Lemieux SR, 2008, PSYCHOL WOMEN QUART, V32, P126, DOI 10.1111/j.1471-6402.2008.00418.x; Marchal-Bertrand L, 2016, REV LAT AM PSICOL, V48, P88, DOI 10.1016/j.rlp.2016.01.001; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merino C., 2009, AN PSICOL-SPAIN, V25, P169, DOI DOI 10.6018/71631; Montero I, 2007, INT J CLIN HLTH PSYC, V7, P847; Morokoff PJ, 1997, J PERS SOC PSYCHOL, V73, P790, DOI 10.1037/0022-3514.73.4.790; Moyano N, 2013, INT J CLIN HLTH PSYC, V13, P189, DOI 10.1016/S1697-2600(13)70023-1; Muniz J, 2013, PSICOTHEMA, V25, P151, DOI 10.7334/psicothema2013.24; Nobre PJ, 2006, J SEX RES, V43, P68, DOI 10.1080/00224490609552300; Nunnally J. C., 1995, TEORIA PSICOMETRICA, V3rd; Osterlind SJ, 1989, WHAT IS CONSTRUCTING, P1; Ponseti J, 2010, ARCH SEX BEHAV, V39, P1073, DOI 10.1007/s10508-009-9587-2; Rico-Fernandez R, 2004, METODOL CIENCIAS COM, P273; RISE J, 1993, HEALTH EDUC RES, V8, P485, DOI 10.1093/her/8.4.485; Sanders SA, 2006, AM J HEALTH BEHAV, V30, P460, DOI 10.5993/AJHB.30.5.2; Santos-Iglesias P, 2013, ARCH SEX BEHAV, V42, P1043, DOI 10.1007/s10508-012-9998-3; Santos-Iglesias P, 2010, INT J CLIN HLTH PSYC, V10, P553; Semph ME, 1979, THESIS; SNELL WE, 1989, J SEX RES, V26, P256, DOI 10.1080/00224498909551510; Soler F, 2016, INTERN J PSYCH PSYCH, V16, pxx; TANNER WM, 1988, J SEX RES, V25, P537, DOI 10.1080/00224498809551481; Vallejo-Medina P, GUIDELINES TRA UNPUB; Vallejo-Medina P, 2014, REV INT ANDROL, V12, P47, DOI 10.1016/j.androl.2013.04.004; WIEDERMAN MW, 1993, J RES PERS, V27, P88, DOI 10.1006/jrpe.1993.1006	61	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162531	10.1371/journal.pone.0162531	http://dx.doi.org/10.1371/journal.pone.0162531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627114	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600041
J	Warnke, P; Devide, A; Weise, M; Frickmann, H; Schwarz, NG; Schaffler, H; Ottl, P; Podbielski, A				Warnke, Philipp; Devide, Annette; Weise, Mirjam; Frickmann, Hagen; Schwarz, Norbert Georg; Schaeffler, Holger; Ottl, Peter; Podbielski, Andreas			Utilizing Moist or Dry Swabs for the Sampling of Nasal MRSA Carriers? An In Vivo and In Vitro Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INADEQUATE ANTIMICROBIAL TREATMENT; PORT-A-CUL; TRANSPORT-SYSTEMS; NEISSERIA-GONORRHOEAE; HOSPITAL ADMISSION; ANAEROBIC-BACTERIA; RAPID DETECTION; RECOVERY; RISK	This study investigates the quantitative bacterial recovery of Methicillin-resistant-Staphylococcus aureus (MRSA) in nasal screenings by utilizing dry or moistened swabs within an in vivo and an in vitro experimental setting. 135 nasal MRSA carriers were each swabbed in one nostril with a dry and in the other one with a moistened rayon swab. Quantitative bacterial recovery was measured by standard viable count techniques. Furthermore, an anatomically correct artificial nose model was inoculated with a numerically defined suspension of MRSA and swabbed with dry and moistened rayon, polyurethane-foam and nylon-flocked swabs to test these different settings and swab-materials under identical laboratory conditions. In vivo, quantities of MRSA per nostril in carriers varied between <10(1) and >10(7) colony forming units, with a median of 2.15x10(4) CFU. However, no statistically significant differences could be detected for the recovery of MRSA quantities when swabbing nasal carriers with moist or dry rayon swabs. In vitro testing confirmed the in vivo data for swabs with rayon, polyurethane and nylon-flocked tips, since pre-moistening of swabs did not significantly affect the quantities of retrieved bacteria. Therefore, pre-moistening of swabs prior to nasal MRSA sampling provides no advantage in terms of recovering greater bacterial quantities and therefore can be omitted. In addition, this situation can be mimicked in an in vitro model, thereby providing a useful basis for future in vitro testings of new swab types or target organisms for screening approaches.	[Warnke, Philipp; Devide, Annette; Weise, Mirjam; Frickmann, Hagen; Podbielski, Andreas] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Frickmann, Hagen] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Schwarz, Norbert Georg] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Hamburg, Germany; [Schaeffler, Holger] Univ Med Rostock, Div Gastroenterol & Endocrinol, Dept Internal Med, Rostock, Germany; [Ottl, Peter] Univ Med Rostock, Dept Prosthodont & Mat Sci, Rostock, Germany	University of Rostock; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; University of Rostock	Warnke, P (corresponding author), Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de	Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837				Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Barber S, 1998, PATHOLOGY, V30, P179, DOI 10.1080/00313029800169196; Barenfanger J, 2000, J CLIN MICROBIOL, V38, P2824, DOI 10.1128/JCM.38.8.2824-2828.2000; Bartolitius L, 2014, EUR J MICROBIOL IMMU, V4, P159, DOI 10.1556/EUJMI-D-14-00020; BJURSTROM L, 1992, AM J VET RES, V53, P665; BROOK I, 1987, J CLIN MICROBIOL, V25, P2020, DOI 10.1128/JCM.25.10.2020-2022.1987; Citron DM, 2000, J CLIN MICROBIOL, V38, P892, DOI 10.1128/JCM.38.2.892-894.2000; Claro T, 2014, INFECT CONT HOSP EP, V35, P869, DOI 10.1086/676858; Codrington L, 2013, AM J INFECT CONTROL, V41, P469, DOI 10.1016/j.ajic.2012.09.011; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Davis MF, 2012, APPL ENVIRON MICROB, V78, P2474, DOI 10.1128/AEM.06886-11; Dolan A, 2011, J HOSP INFECT, V79, P227, DOI 10.1016/j.jhin.2011.05.011; DONATELLI J, 1992, J CLIN MICROBIOL, V30, P138, DOI 10.1128/JCM.30.1.138-142.1992; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farhat SE, 2001, J CLIN MICROBIOL, V39, P2958, DOI 10.1128/JCM.39.8.2958-2960.2001; Frickmann H, 2012, EUR J MICROBIOL IMMU, V2, P128, DOI 10.1556/EuJMI.2.2012.2.5; Frickmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063222; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Hagiya H, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-10; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hindiyeh M, 2001, J CLIN MICROBIOL, V39, P377, DOI 10.1128/JCM.39.1.377-380.2001; Hsu LY, 2005, J CLIN MICROBIOL, V43, P2923, DOI 10.1128/JCM.43.6.2923-2925.2005; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Landers TF, 2010, J CLIN MICROBIOL, V48, P2235, DOI 10.1128/JCM.01958-09; Lemmen SW, 2001, INT J HYG ENVIR HEAL, V203, P245, DOI 10.1078/S1438-4639(04)70035-8; Melter O., 2006, EURO SURVEILL, V11; Mermel LA, 2010, INFECT CONT HOSP EP, V31, P592, DOI 10.1086/652778; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Obee P, 2007, J HOSP INFECT, V65, P35, DOI 10.1016/j.jhin.2006.09.010; Olsen CC, 1999, J CLIN MICROBIOL, V37, P3583, DOI 10.1128/JCM.37.11.3583-3585.1999; Osterblad M, 2003, J CLIN MICROBIOL, V41, P1894, DOI 10.1128/JCM.41.5.1894-1900.2003; Pang B. C. M., 2007, Legal Medicine, V9, P181, DOI 10.1016/j.legalmed.2006.12.003; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Roelofsen E, 1999, J CLIN MICROBIOL, V37, P3041, DOI 10.1128/JCM.37.9.3041-3043.1999; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; Shiferaw T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-39; Stenehjem E, 2013, AM J INFECT CONTROL, V41, P405, DOI 10.1016/j.ajic.2012.07.017; Sweet D, 1997, J FORENSIC SCI, V42, P320; Thomasma SM, 2013, J FORENSIC SCI, V58, P465, DOI 10.1111/1556-4029.12036; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102215; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	58	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0163073	10.1371/journal.pone.0163073	http://dx.doi.org/10.1371/journal.pone.0163073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626801	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600075
J	Fagundez, G; Perez-Freixo, H; Eyene, J; Momo, JC; Biye, L; Esono, T; Ayecab, MOM; Benito, A; Aparicio, P; Herrador, Z				Fagundez, Gabriela; Perez-Freixo, Hugo; Eyene, Juan; Carlos Momo, Juan; Biye, Lucia; Esono, Teodoro; Mba Ayecab, Marcial Ondo; Benito, Agustin; Aparicio, Pilar; Herrador, Zaida			Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea	PLOS ONE			English	Article							TREATMENT DEFAULT; TB; DETERMINANTS; NONADHERENCE; HIV; DISTRICTS; COUNTRIES; DISEASE	Equatorial Guinea has one of the highest burden of tuberculosis (TB) in Africa. Incomplete adherence to TB treatment has been identified as one of the most serious remaining problem in tuberculosis control. The following study is aimed at determining the adherence to anti-tuberculosis treatment in Equatorial Guinea and its determinants, as well as at assessing the knowledge of the people about the disease. In this cross-sectional study, participants were recruited by non-probabilistic consecutive sampling amongst patients who attended the reference units for TB in Bata and Malabo between March and July 2015. Socio-demographic and clinical data were collected. Adherence to treatment and knowledge about TB were assessed by Morisky-Green-Levine and Batalla tests and a questionnaire on adherence related factors specifically prepared for this research. Descriptive statistics were computed to summarize the data and bivariate analyses by adherence profile were performed with chi(2) test for categorical data. A total of 98 patients with TB were interviewed. 63.27% of interviewees had good knowledge about TB (Batalla test) while 78.57% of respondents were adherent according to the Morisky-Green-Levine test. A low educational level, lack of family support and lack of medical advice about the disease were significantly associated to lower adherence level. Patients with re-infection (due to relapse or treatment failure) and those who have suffered from drug shortageswere also less adherents. The National Programme for TB Control should consider improving the early diagnosis and follow-up of TB cases, as well as the implementation of all components of DOTS (Directly observed Treatment, short-course) strategy all over the country.	[Fagundez, Gabriela] Hosp Univ 12 Octubre, Dept Prevent Med, Madrid, Spain; [Perez-Freixo, Hugo] Hosp Clin Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain; [Eyene, Juan; Carlos Momo, Juan; Biye, Lucia; Esono, Teodoro; Mba Ayecab, Marcial Ondo] Minist Hlth & Social Welf, Natl TB & Leprosy Control Program PNLP Spanish, Malabo, Equat Guinea; [Benito, Agustin; Aparicio, Pilar; Herrador, Zaida] Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Benito, Agustin; Aparicio, Pilar; Herrador, Zaida] Spanish Trop Dis Res Network RICET Spanish, Madrid, Spain	Hospital Universitario 12 de Octubre; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT)	Herrador, Z (corresponding author), Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain.; Herrador, Z (corresponding author), Spanish Trop Dis Res Network RICET Spanish, Madrid, Spain.	zherrador@isciii.es		Perez Freixo, Hugo/0000-0002-0816-577X; Benito, Agustin/0000-0001-8229-5540; Herrador, Zaida/0000-0002-6508-3818				Alobu I, 2014, ASIAN PAC J TROP MED, V7, P977, DOI 10.1016/S1995-7645(14)60172-3; Barnestein-Fonseca P, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-6; Herrero MB, 2015, CAD SAUDE PUBLICA, V31, P1983, DOI 10.1590/0102-311X00024314; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; CIA, 2015, WORLD FACTB EQ GUIN; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Espinosa Garcia J, 2012, Semergen, V38, P292, DOI 10.1016/j.semerg.2012.01.001; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Harper M, 2003, T ROY SOC TROP MED H, V97, P506, DOI 10.1016/S0035-9203(03)80007-X; Hasker E, 2010, INT J TUBERC LUNG D, V14, P1132; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Marquez Contreras E, 2006, ATEN PRIM, V38, P325, DOI DOI 10.1157/13093369; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; PNUD en Guinea Ecuatorial, 2011, ENC DEM SAL GUIN EC; Republica de Guinea Ecuatorial Sistema de las Naciones Unidas, 2009, 2 INF NAC OBJ DES MI; RIEDER HL, 2002, INTERVENTIONS TUBERC; Ross EA, 2002, INT J ARTIF ORGANS, V25, P1061, DOI 10.1177/039139880202501104; Salmanton-Garcia J, 2016, AIDS CARE, V28, P543, DOI 10.1080/09540121.2015.1124976; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Tudo G, 2004, INT J TUBERC LUNG D, V8, P1458; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Weltgesundheitsorganisation, 2003, ADH LONG THERM THER; WHO, 2015, EQ GUIN WHO STAT PRO; World Bank, 2014, WORLD DEV IND 2014; World Health Organisation, 2006, TUB AIR TRAV GUID PR; World Health Organization, TUB TRAD FOR POL DIP; World Health Organization, 2015, GLOB TUB REP 2015; Yone EWP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000289; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	37	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161995	10.1371/journal.pone.0161995	http://dx.doi.org/10.1371/journal.pone.0161995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622461	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000012
J	Wu, WS; Lai, FJ				Wu, Wei-Sheng; Lai, Fu-Jou			Detecting Cooperativity between Transcription Factors Based on Functional Coherence and Similarity of Their Target Gene Sets	PLOS ONE			English	Article							STATISTICAL-METHODS; FACTOR PAIRS; CELL-CYCLE; IDENTIFICATION; EXPRESSION; DATABASE; INFORMATION; PREDICTION; NETWORK; BINDING	In eukaryotic cells, transcriptional regulation of gene expression is usually achieved by cooperative transcription factors (TFs). Therefore, knowing cooperative TFs is the first step toward uncovering the molecular mechanisms of gene expression regulation. Many algorithms based on different rationales have been proposed to predict cooperative TF pairs in yeast. Although various types of rationales have been used in the existing algorithms, functional coherence is not yet used. This prompts us to develop a new algorithm based on functional coherence and similarity of the target gene sets to identify cooperative TF pairs in yeast. The proposed algorithm predicted 40 cooperative TF pairs. Among them, three (Pdc2-Thi2, Hot1-Msn1 and Leu3-Met28) are novel predictions, which have not been predicted by any existing algorithms. Strikingly, two (Pdc2-Thi2 and Hot1-Msn1) of the three novel predictions have been experimentally validated, demonstrating the power of the proposed algorithm. Moreover, we show that the predictions of the proposed algorithm are more biologically meaningful than the predictions of 17 existing algorithms under four evaluation indices. In summary, our study suggests that new algorithms based on novel rationales are worthy of developing for detecting previously unidentifiable cooperative TF pairs.	[Wu, Wei-Sheng; Lai, Fu-Jou] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan	National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019		National Cheng University; Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2]	National Cheng University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Cheng University and Ministry of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-137; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; Chang YH, 2006, BIOINFORMATICS, V22, P2276, DOI 10.1093/bioinformatics/btl380; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen MJM, 2012, BIOINFORMATICS, V28, P701, DOI 10.1093/bioinformatics/bts002; Chuang CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-400; Datta D, 2008, BIOINFORMATICS, V24, P545, DOI 10.1093/bioinformatics/btm523; Elati M, 2007, BIOINFORMATICS, V23, P2407, DOI 10.1093/bioinformatics/btm352; Gyenesei A, 2007, BIOINFORMATICS, V23, P1927, DOI 10.1093/bioinformatics/btm276; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; He D, 2006, GCC 2006: FIFTH INTERNATIONAL CONFERENCE ON GRID AND COOPERATIVE COMPUTING WORKSHOPS, PROCEEDINGS, P357; Hu ZH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-49; Karczewski KJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004122; LAI FJ, 2014, BMC SYST BIOL S4, V8, DOI DOI 10.1186/1752-0509-8-; Lai FJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S2; Lai FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S9; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mojzita D, 2006, MOL GENET GENOMICS, V276, P147, DOI 10.1007/s00438-006-0130-z; Nagamine N, 2005, NUCLEIC ACIDS RES, V33, P4828, DOI 10.1093/nar/gki793; Nemer G, 2001, ANN MED, V33, P604, DOI 10.3109/07853890109002106; Rep M, 1999, MOL CELL BIOL, V19, P5474; Spivak AT, 2016, G3-GENES GENOM GENET, V6, P653, DOI 10.1534/g3.115.024331; Tanguay RM., 1998, BIOCH CELL BIOL, V66, P584; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tsai HK, 2005, P NATL ACAD SCI USA, V102, P13532, DOI 10.1073/pnas.0505874102; Wang JB, 2007, J BIOMED INFORM, V40, P707, DOI 10.1016/j.jbi.2007.02.003; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P5943, DOI 10.1093/nar/gkp625; Wu WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159213; Wu WS, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw092; Wu WS, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S10; Wu WS, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S5-S9; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129; Yang TH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-102; Yang Y, 2010, CELL RES, V20, P1276, DOI 10.1038/cr.2010.146; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P917, DOI 10.1093/nar/gkj487; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162931	10.1371/journal.pone.0162931	http://dx.doi.org/10.1371/journal.pone.0162931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27623007	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000070
J	Cai, GJ; Zhang, BF; Ma, CY; Shi, GW; Weng, WJ; Xue, SL				Cai, Gaojun; Zhang, Bifeng; Ma, Chunyan; Shi, Ganwei; Weng, Weijin; Xue, Sheliang			Associations of Rs3744841 and Rs3744843 Polymorphisms in Endothelial Lipase Gene with Risk of Coronary Artery Disease and Lipid Levels in a Chinese Population	PLOS ONE			English	Article							VARIANTS; LOCI		[Cai, Gaojun; Ma, Chunyan; Shi, Ganwei; Weng, Weijin; Xue, Sheliang] Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Zhang, Bifeng] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada	Jiangsu University; McMaster University	Cai, GJ (corresponding author), Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China.	cgj982@126.com						Abd El-Aziz TA, 2014, J CLIN LIPIDOL, V8, P381, DOI 10.1016/j.jacl.2014.06.001; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Cai GJ, 2014, GENET MOL RES, V13, P1059, DOI 10.4238/2014.February.20.7; Cai GJ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0154-7; Cai GJ, 2012, MOL BIOL REP, V39, P9879, DOI 10.1007/s11033-012-1854-y; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miksztowicz V, 2014, ARTERIOSCLER THROMB, V32, P3033; Sun L, 2014, J ATHEROSCLER THROMB, V21, P313, DOI 10.5551/jat.20131; Szpakowicz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129820; Toosi S, 2015, J CARDIOVASC THORAC, V7, P118, DOI 10.15171/jcvtr.2015.25; Wang XB, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0079-1; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Xie L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007621; Yamakawa-Kobayashi K, 2003, HUM GENET, V113, P311, DOI 10.1007/s00439-003-0985-6; Ye HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135683	19	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162727	10.1371/journal.pone.0162727	http://dx.doi.org/10.1371/journal.pone.0162727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612170	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900157
J	Catalan, V; Gomez-Ambrosi, J; Rodriguez, A; Ramirez, B; Izaguirre, M; Hernandez-Lizoain, JL; Baixauli, J; Marti, P; Valenti, V; Moncada, R; Silva, C; Salvador, J; Fruhbeck, G				Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Izaguirre, Maitane; Luis Hernandez-Lizoain, Jose; Baixauli, Jorge; Marti, Pablo; Valenti, Victor; Moncada, Rafael; Silva, Camilo; Salvador, Javier; Fruhbeck, Gema			Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; VISCERAL ADIPOSE-TISSUE; COLORECTAL-CANCER; GASTRIC BYPASS; BREAST-CANCER; LIPOCALIN 2; TUMOR PROGRESSION; PLASMA YKL-40; RECEPTOR 4; BODY-FAT	Background Excess adipose tissue represents a major risk factor for the development of colon cancer with inflammation and extracellular matrix (ECM) remodeling being proposed as plausible mechanisms. The aim of this study was to investigate whether obesity can influence circulating levels of inflammation-related extracellular matrix proteins in patients with colon cancer (CC), promoting a microenvironment favorable for tumor growth. Methods Serum samples obtained from 79 subjects [26 lean (LN) and 53 obese (OB)] were used in the study. Enrolled subjects were further subclassified according to the established diagnostic protocol for CC (44 without CC and 35 with CC). Anthropometric measurements as well as circulating metabolites and hormones were determined. Circulating concentrations of the ECM proteins osteopontin (OPN), chitinase-3-like protein 1 (YKL-40), tenascin C (TNC) and lipocalin-2 (LCN-2) were determined by ELISA. Results Significant differences in circulating OPN, YKL-40 and TNC concentrations between the experimental groups were observed, being significantly increased due to obesity (P<0.01) and colon cancer (P<0.05). LCN-2 levels were affected by obesity (P<0.05), but no differences were detected regarding the presence or not of CC. A positive association (P<0.05) with different inflammatory markers was also detected. Conclusions To our knowledge, we herein show for the first time that obese patients with CC exhibit increased circulating levels of OPN, YKL-40 and TNC providing further evidence for the influence of obesity on CC development via ECM proteins, representing promising diagnostic biomarkers or target molecules for therapeutics.	[Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Izaguirre, Maitane; Fruhbeck, Gema] Univ Navarra Clin, Metab Res Lab, Pamplona, Spain; [Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Izaguirre, Maitane; Valenti, Victor; Moncada, Rafael; Silva, Camilo; Salvador, Javier; Fruhbeck, Gema] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Pamplona, Spain; [Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Valenti, Victor; Moncada, Rafael; Silva, Camilo; Fruhbeck, Gema] Inst Invest Sanitaria Navarra IdiSNA, Obes & Adipobiol Grp, Pamplona, Spain; [Luis Hernandez-Lizoain, Jose; Baixauli, Jorge; Marti, Pablo; Valenti, Victor] Clin Univ Navarra, Dept Surg, Pamplona, Spain; [Moncada, Rafael] Clin Univ Navarra, Dept Anesthesia, Pamplona, Spain; [Silva, Camilo; Salvador, Javier; Fruhbeck, Gema] Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra; University of Navarra; University of Navarra	Fruhbeck, G (corresponding author), Univ Navarra Clin, Metab Res Lab, Pamplona, Spain.; Fruhbeck, G (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Pamplona, Spain.; Fruhbeck, G (corresponding author), Inst Invest Sanitaria Navarra IdiSNA, Obes & Adipobiol Grp, Pamplona, Spain.; Fruhbeck, G (corresponding author), Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain.	gfruhbeck@unav.es	Catalan, Victoria/H-3566-2017; Martí Ciriquián, Pablo/C-4320-2015; Ramírez, Beatriz/I-1922-2017; Gómez-Ambrosi, Javier/D-2984-2017; Fons, Jorge Baixauli/F-1654-2011; Rodriguez, Amaia/D-3044-2019	Catalan, Victoria/0000-0002-7513-7509; Martí Ciriquián, Pablo/0000-0002-6877-784X; Ramírez, Beatriz/0000-0003-3381-7220; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Rodriguez, Amaia/0000-0002-2180-461X; valenti, victor/0000-0002-7074-2849; Silva Frojan, Camilo/0000-0002-3466-1291	Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII) [PI12/00515, PI13/00460, PI14/00950]; Department of Health of the Gobierno de Navarra of Spain [48/2011, 58/2011]; Fundacion Caja Navarra [20-2014]; ISCIII, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBEROBN, Spain	Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII); Department of Health of the Gobierno de Navarra of Spain; Fundacion Caja Navarra; ISCIII, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBEROBN, Spain	This work was supported by Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII) (PI12/00515, PI13/00460 and PI14/00950), by the Department of Health (48/2011 and 58/2011) of the Gobierno de Navarra of Spain, by Fundacion Caja Navarra (20-2014) and by the ISCIII, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBEROBN, Spain.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Allin KH, 2012, BRIT J CANCER, V106, P199, DOI 10.1038/bjc.2011.501; Berezin AE, 2013, ATHEROSCLEROSIS, V229, P475, DOI 10.1016/j.atherosclerosis.2013.06.003; Brellier F, 2012, J CELL MOL MED, V16, P32, DOI 10.1111/j.1582-4934.2011.01360.x; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Catalan V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00275; Catalan V, 2012, HISTOL HISTOPATHOL, V27, P1515, DOI 10.14670/HH-27.1515; Catalan V, 2012, J CLIN ENDOCR METAB, V97, pE1880, DOI 10.1210/jc.2012-1670; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fruhbeck G, 2015, NAT REV ENDOCRINOL, V11, P465, DOI 10.1038/nrendo.2015.84; Fruhbeck G, 2012, NAT REV ENDOCRINOL, V8, P570, DOI 10.1038/nrendo.2012.165; Fung KYC, 2013, CANCER BIOMARK, V13, P75, DOI 10.3233/CBM-130335; Ge T, 2015, MED ONCOL, V32, P367; Gomez-Ambrosi J, 2006, OBES SURG, V16, P262, DOI 10.1381/096089206776116525; Gomez-Ambrosi J, 2002, CLIN BIOCHEM, V35, P315, DOI 10.1016/S0009-9120(02)00320-X; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Haydon AMM, 2006, GUT, V55, P62, DOI 10.1136/gut.2005.068189; Hempen M, 2009, OBES SURG, V19, P1557, DOI 10.1007/s11695-009-9917-4; Johansen JS, 2015, CANC EPIDEMIOL BIOMA; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Kant P, 2011, NAT REV GASTRO HEPAT, V8, P224, DOI 10.1038/nrgastro.2011.23; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Matsumoto T, 2001, CLIN EXP RHEUMATOL, V19, P655; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nielsen AR, 2011, CYTOKINE, V55, P152, DOI 10.1016/j.cyto.2011.03.014; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Parekh N, 2012, ANNU REV NUTR, V32, P311, DOI 10.1146/annurev-nutr-071811-150713; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Perez-Hernandez AI, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00065; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pichler M, 2013, BRIT J CANCER, V109, P1123, DOI 10.1038/bjc.2013.443; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sung MK, 2011, ANN NY ACAD SCI, V1229, P61, DOI 10.1111/j.1749-6632.2011.06094.x; Tastekin D, 2014, TUMOR BIOL, V35, P6619, DOI 10.1007/s13277-014-1875-3; Wang LK, 2011, J GASTROINTEST SURG, V15, P652, DOI 10.1007/s11605-011-1445-6; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294	56	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162189	10.1371/journal.pone.0162189	http://dx.doi.org/10.1371/journal.pone.0162189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612200	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900054
J	Chu, CS; Chou, PH; Lin, CH; Cheng, C; Tsai, CJ; Lan, TH; Huang, MW; Nestadt, G				Chu, Che-Sheng; Chou, Po-Han; Lin, Ching-Heng; Cheng, Chin; Tsai, Chia-Jui; Lan, Tsuo-Hung; Huang, Min-Wei; Nestadt, Gerald			Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study	PLOS ONE			English	Article							CEREBROVASCULAR EVENTS; ANTIDEPRESSANT USE; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; HEMORRHAGIC STROKE; METABOLIC SYNDROME; UNITED-STATES; FOLLOW-UP; METAANALYSIS; ASSOCIATION	Background Previous research has suggested a link between antidepressants use and the development of cerebrovascular events, but there has never been any study investigating the risk of stroke in obsessive-compulsive disorder (OCD) patients treated with a selective serotonin reuptake inhibitor (SSRI). Methods A retrospective observational cohort study was conducted using data from the National Health Insurance Database of Taiwan between the year of 2001 and 2009. A total of 527 OCD patients with 412 subjects in the SSRI use group and 115 in the non SSRI use group were included. Multivariable Cox proportional-hazards models were used to explore the associations between SSRI use and the occurrence of stroke, controlling for age, gender, concomitant medications, and comorbid medical illnesses. Results A total of nineteen OCD patients were diagnosed with new onset of stroke during the follow-up period including six cases in the SSRI group and thirteen in the non SSRI use group. SSRI use was demonstrated to be associated with a decreased risk of stroke (hazard ratio [HR] = 0.30; 95% confidence interval [CI] = 0.10-0.86, P = 0.02). The increase in age-related risk of strokes was 2.55 per decade (HR = 2.55; 95% CI = 1.74-3.75, P<0.001). Alternatively, sex, concomitant use of aspirin and non-steroidal anti-inflammatorydrugs, and comorbidities with angina pectoris, diabetes mellitus, hypertension, and hyperlipidemia were not found to be associated with an increased risk for stroke in OCD patients. Conclusions Our study showed that SSRI use was associated with decreased risk of stroke in OCD patients. Further investigation into the possible biological mechanisms underlying the relationship between stroke and SSRI use in OCD patients is warranted.	[Chu, Che-Sheng] Taichung Vet Gen Hosp, Puli Branch, Dept Psychiat, Nantou, Taiwan; [Chou, Po-Han; Tsai, Chia-Jui; Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Chou, Po-Han; Lan, Tsuo-Hung] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chou, Po-Han; Lan, Tsuo-Hung] Natl Chiao Tung Univ, Dept Photon, Hsinchu, Taiwan; [Chou, Po-Han] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Chin] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Lan, Tsuo-Hung] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lan, Tsuo-Hung] NHRI, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Huang, Min-Wei] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Nestadt, Gerald] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; Johns Hopkins University	Lan, TH (corresponding author), Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan.; Lan, TH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei, Taiwan.; Lan, TH (corresponding author), Natl Chiao Tung Univ, Dept Photon, Hsinchu, Taiwan.; Lan, TH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Lan, TH (corresponding author), NHRI, Ctr Neuropsychiat Res, Miaoli, Taiwan.	tosafish@gmail.com		Chou, Po-Han/0000-0002-4148-457X; Lan, Tsuo-Hung/0000-0002-2796-1026	Taichung Veterans General Hospital, Taiwan [TCVGH-NHRI10405, TCVGH-1047324D, TCVGH-1047312C, TCVGH-104G211, TCVGH-VHCY1058603, TCVGH-1054002B]; National Science Council, Taiwan [MOST 103-2314-B-075A-006]	Taichung Veterans General Hospital, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-NHRI10405, TCVGH-1047324D, TCVGH-1047312C, TCVGH-104G211, TCVGH-VHCY1058603, TCVGH-1054002B) and the National Science Council, Taiwan (MOST 103-2314-B-075A-006).	Albert U, 2013, GEN HOSP PSYCHIAT, V35, P154, DOI 10.1016/j.genhosppsych.2012.10.004; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Bak S, 2002, STROKE, V33, P1465, DOI 10.1161/01.STR.0000018589.56991.BA; Barbui C, 2005, INT CLIN PSYCHOPHARM, V20, P169, DOI 10.1097/00004850-200505000-00008; Bismuth-Evenzal Y, 2012, J AFFECT DISORDERS, V136, P99, DOI 10.1016/j.jad.2011.08.013; Bloch MH, 2010, MOL PSYCHIATR, V15, P850, DOI 10.1038/mp.2009.50; Bollini P, 1999, BRIT J PSYCHIAT, V174, P297, DOI 10.1192/bjp.174.4.297; Chen SJ, 2012, BRIT J PSYCHIAT, V200, P374, DOI 10.1192/bjp.bp.111.092098; Chen Y, 2008, ANN PHARMACOTHER, V42, P177, DOI 10.1345/aph.1K369; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien C, 2007, PSYCHIAT SERV, V58, P554, DOI 10.1176/appi.ps.58.4.554; Chou PH, 2016, SCHIZOPHR RES, V174, P137, DOI 10.1016/j.schres.2016.03.027; Chou PH, 2015, J PSYCHIATR RES, V68, P186, DOI 10.1016/j.jpsychires.2015.06.017; Chou PH, 2014, PSYCHOSOMATICS, V55, P155, DOI 10.1016/j.psym.2013.06.003; Chou PH, 2013, EUR CHILD ADOLES PSY, V22, P301, DOI 10.1007/s00787-012-0369-3; Chou PH, 2012, PSYCHOSOMATICS, V53, P463, DOI 10.1016/j.psym.2012.03.007; de Abajo FJ, 2000, BRIT J CLIN PHARMACO, V50, P43, DOI 10.1046/j.1365-2125.2000.00216.x; Douglas I, 2011, BRIT J CLIN PHARMACO, V71, P116, DOI 10.1111/j.1365-2125.2010.03797.x; Drummond LM, 2012, GEN HOSP PSYCHIAT, V34, P618, DOI 10.1016/j.genhosppsych.2012.02.001; Eaton WW, 2013, AM J EPIDEMIOL, V178, P1366, DOI 10.1093/aje/kwt219; Endres M, 2011, EUR HEART J, V32, P545, DOI 10.1093/eurheartj/ehq472; Farooqui AA, 2012, CELL MOL LIFE SCI, V69, P741, DOI 10.1007/s00018-011-0840-1; Fontenelle IS, 2010, PSYCHIAT RES, V179, P198, DOI 10.1016/j.psychres.2009.04.005; Galan AM, 2009, THROMB HAEMOSTASIS, V102, P511, DOI 10.1160/TH08-12-0810; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Hergovich N, 2000, CLIN PHARMACOL THER, V68, P435, DOI 10.1067/mcp.2000.110456; Hung CC, 2013, AM J GERIAT PSYCHIAT, V21, P811, DOI 10.1016/j.jagp.2013.01.018; Jackson CA, 2013, STROKE, V44, P1555, DOI 10.1161/STROKEAHA.113.001147; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kharofa J, 2007, STROKE, V38, P3049, DOI 10.1161/STROKEAHA.107.491472; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Kuo CC, 2011, COMPR PSYCHIAT, V52, P662, DOI 10.1016/j.comppsych.2011.01.002; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Markarian Y, 2010, CLIN PSYCHOL REV, V30, P78, DOI 10.1016/j.cpr.2009.09.005; Merikangas KR, 1997, ARCH NEUROL-CHICAGO, V54, P362, DOI 10.1001/archneur.1997.00550160012009; Mortensen JK, 2014, STROKE, V45, P2121, DOI 10.1161/STROKEAHA.114.005302; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Salminen M, 2011, ACTA DIABETOL, V48, P157, DOI 10.1007/s00592-010-0251-z; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Schlienger RG, 2004, DRUG SAFETY, V27, P1157, DOI 10.2165/00002018-200427140-00006; Skop BP, 1996, PSYCHOSOMATICS, V37, P12, DOI 10.1016/S0033-3182(96)71592-X; Smoller JW, 2011, AM J PSYCHIAT, V168, P457, DOI 10.1176/appi.ajp.2011.11020336; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Stein DJ, 2012, CURR PSYCHIAT REP, V14, P211, DOI 10.1007/s11920-012-0268-9; Swenson JR, 2006, CAN J PSYCHIAT, V51, P923, DOI 10.1177/070674370605101408; Tsukamoto Y, 2012, J STROKE CEREBROVASC, V21, P547, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.005; VANZWIETEN PA, 1987, J CARDIOVASC PHARM, V10, pS19, DOI 10.1097/00005344-198706103-00006; Veale D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2183; WAGNER A, 1990, J AFFECT DISORDERS, V20, P101, DOI 10.1016/0165-0327(90)90123-P; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064	51	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162239	10.1371/journal.pone.0162239	http://dx.doi.org/10.1371/journal.pone.0162239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27612144	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900066
J	Liu, LJ; Yao, FJ; Lu, GH; Xu, CG; Xu, Z; Tang, K; Cheng, YJ; Gao, XR; Wu, SH				Liu, Li-Juan; Yao, Feng-Juan; Lu, Gui-Hua; Xu, Cheng-Gui; Xu, Zhe; Tang, Kai; Cheng, Yun-Jiu; Gao, Xiu-Ren; Wu, Su-Hua			The Role of the Rho/ROCK Pathway in Ang II and TGF-beta 1-Induced Atrial Remodeling	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; INDUCED CARDIAC-HYPERTROPHY; RHO-KINASE; TGF-BETA; MYOCARDIAL-INFARCTION; FACTOR EXPRESSION; RAT MODEL; FIBROSIS; FIBRILLATION; FIBROBLASTS	Objectives To study the role of the Rho/ROCK pathway in Ang II and TGF-beta 1-induced atrial remodeling. Methods and Results A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-beta 1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-beta 1 (1.32 +/- 0.38), Collagen-I(1.33 +/- 0.91), CTGF(5.83 +/- 3.71), RhoA(1.23 +/- 0.57) and ROCK-1 (1.02 +/- 0.27) in the left atriumwere significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89 +/- 0.05 and 1.27 +/- 0.03, respectively) and CTGF (0.87 +/- 0.04 and 0.91 +/- 0.02, respectively) expression. The expression mRNA of ROCK-1(1.74 +/- 0.13) and CTGF (2.28 +/- 0.11) can upregulated by TGF-beta 1, and down-regulated by Simvastatin (1.22 +/- 0.03 vs 2.27 +/- 0.11), Y27632 (1.01 +/- 0.04 vs 1.64 +/- 0.03), Los (1.04 +/- 0.11 vs 1.26 +/- 0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-beta 1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA. Conclusions The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-beta 1/RhoA/ROCK-1 or the TGF-beta 1/Smad2/3 signaling pathway.	[Liu, Li-Juan; Lu, Gui-Hua; Xu, Cheng-Gui; Xu, Zhe; Tang, Kai; Cheng, Yun-Jiu; Gao, Xiu-Ren; Wu, Su-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yao, Feng-Juan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ultrasonog, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Gao, XR; Wu, SH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	xiurengao@163.com; wusuhua@hotmail.com		Liu, Li-juan/0000-0001-8068-8498; Xu, Chenggui/0000-0001-5993-5263	National Natural Science Foundation of China [81370285, 81370284]; Guangdong Province Science and Technology Program [2012B031800091]; Guangzhou City Science and Technology Program [201508020057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Program; Guangzhou City Science and Technology Program	This work was supported by National Natural Science Foundation of China (No. 81370285), Guangdong Province Science and Technology Program (No. 2012B031800091), Guangzhou City Science and Technology Program (No. 201508020057) to Dr. Wu; National Natural Science Foundation of China (No. 81370284) to Dr. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Ames A, 2006, CIRCULATION, V113, pE666, DOI 10.1161/CIRCULATIONAHA.105.613083; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bourgier C, 2005, GUT, V54, P336, DOI 10.1136/gut.2004.051169; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cui B, 2011, AUTON NEUROSCI-BASIC, V161, P87, DOI 10.1016/j.autneu.2011.01.004; Cui YK, 2015, EXP THER MED, V9, P631, DOI 10.3892/etm.2014.2143; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gao XR, 2009, EUR J PHARMACOL, V606, P115, DOI 10.1016/j.ejphar.2008.12.049; Gervaz P, 2009, CURR MOL MED, V9, P273, DOI 10.2174/156652409787847164; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369; Heusinger-Ribeiro J, 2001, J AM SOC NEPHROL, V12, P1853, DOI 10.1681/ASN.V1291853; Huang ZH, 2006, AM J PHYSIOL-LUNG C, V290, pL1291, DOI 10.1152/ajplung.00443.2005; Iqbal MB, 2005, BMJ-BRIT MED J, V330, P238, DOI 10.1136/bmj.330.7485.238; Ko WC, 2011, CIRC J, V75, P1592, DOI 10.1253/circj.CJ-10-0892; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Lee SJ, 2013, BIOCHEM J, V456, P109, DOI 10.1042/BJ20130744; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mun JH, 2014, WOUND REPAIR REGEN, V22, P125, DOI 10.1111/wrr.12136; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Ohnishi H, 1998, J MOL CELL CARDIOL, V30, P2411, DOI 10.1006/jmcc.1998.0799; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Wang YX, 2005, EUR J PHARMACOL, V512, P215, DOI 10.1016/j.ejphar.2005.02.024; Washida N, 2011, NEPHROL DIAL TRANSPL, V26, P2770, DOI 10.1093/ndt/gfr012; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang J, 2013, INT J BIOCHEM CELL B, V45, P657, DOI 10.1016/j.biocel.2012.12.016; Yeh YH, 2015, J MOL CELL CARDIOL, V82, P84, DOI 10.1016/j.yjmcc.2015.03.004; Zhai YS, 2008, EUR J PHARMACOL, V587, P196, DOI 10.1016/j.ejphar.2008.03.006; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zhou H, 2011, ACTA PHARMACOL SIN, V32, P999, DOI 10.1038/aps.2011.54	39	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161625	10.1371/journal.pone.0161625	http://dx.doi.org/10.1371/journal.pone.0161625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611832	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900024
J	Thompson, SM; Callstrom, MR; Jondal, DE; Butters, KA; Knudsen, BE; Anderson, JL; Lien, KR; Sutor, SL; Lee, JS; Thorgeirsson, SS; Grande, JP; Roberts, LR; Woodrum, DA				Thompson, Scott M.; Callstrom, Matthew R.; Jondal, Danielle E.; Butters, Kim A.; Knudsen, Bruce E.; Anderson, Jill L.; Lien, Karen R.; Sutor, Shari L.; Lee, Ju-Seog; Thorgeirsson, Snorri S.; Grande, Joseph P.; Roberts, Lewis R.; Woodrum, David A.			Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; IN-VITRO; DISEASE RECURRENCE; RAPID PROGRESSION; TUMOR PROGRESSION; POOR-PROGNOSIS; RISK-FACTORS; CELL-LINES; PHOSPHORYLATION; GROWTH	Thermal ablative therapies are important treatment options in the multidisciplinary care of patients with hepatocellular carcinoma (HCC), but lesions larger than 2-3 cm are plagued with high local recurrence rates and overall survival of these patients remains poor. Currently no adjuvant therapies exist to prevent local HCC recurrence in patients undergoing thermal ablation. The molecular mechanisms mediating HCC resistance to thermal ablation induced heat stress and local recurrence remain unclear. Here we demonstrate that the HCC cells with a poor prognostic hepatic stem cell subtype (Subtype HS) are more resistant to heat stress than HCC cells with a better prognostic hepatocyte subtype (Subtype HC). Moreover, sublethal heat stress rapidly induces phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dependent-protein kinase B (AKT) survival signaling in HCC cells in vitro and at the tumor ablation margin in vivo. Conversely, inhibition of PI3K/mTOR complex 2 (mTORC2)-dependent AKT phosphorylation or direct inhibition of AKT function both enhance HCC cell killing and decrease HCC cell survival to sublethal heat stress in both poor and better prognostic HCC subtypes while mTOR complex 1 (mTORC1)-inhibition has no impact. Finally, we showed that AKT isoforms 1, 2 and 3 are differentially upregulated in primaryhuman HCCs and that overexpression of AKT correlates with worse tumor biology and pathologic features (AKT3) and prognosis (AKT1). Together these findings define a novel molecular mechanism whereby heat stress induces PI3K/mTORC2-dependent AKT survival signaling in HCC cells and provide a mechanistic rationale for adjuvant AKT inhibition in combination with thermal ablation as a strategy to enhance HCC cell killing and prevent local recurrence, particularly at the ablation margin.	[Thompson, Scott M.; Callstrom, Matthew R.; Jondal, Danielle E.; Butters, Kim A.; Anderson, Jill L.; Woodrum, David A.] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55902 USA; [Knudsen, Bruce E.; Lien, Karen R.; Grande, Joseph P.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Sutor, Shari L.] Mayo Clin, Coll Med, Genom Res Ctr, Rochester, MN USA; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Thorgeirsson, Snorri S.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic	Thompson, SM; Woodrum, DA (corresponding author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55902 USA.	thompson.scott@mayo.edu; woodrum.david@mayo.edu	Grande, Joseph P./AAG-2128-2020; Lee, Ju-Seog/X-1786-2018	Grande, Joseph P./0000-0001-5674-1682; Lee, Ju-Seog/0000-0002-5666-9753; Roberts, Lewis/0000-0001-7885-8574	National Institutes of Health (NIH) [NIH C06 RR018898]; Society of Interventional Radiology (SIR) Foundation Allied Scientist Training Grant; Mayo Clinic Center for Clinical and Translational Science (CCaTS) through National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024150]; NIH from the National Cancer Institute (NCI) [R01 CA177686]; Mayo Clinic Center for Clinical and Translational Science (CCaTS) MD/PhD in Clinical and Translational Science [TL1 RR024152, TL1 TR000137]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Interventional Radiology (SIR) Foundation Allied Scientist Training Grant; Mayo Clinic Center for Clinical and Translational Science (CCaTS) through National Center for Research Resources (NCRR), a component of the NIH; NIH from the National Cancer Institute (NCI); Mayo Clinic Center for Clinical and Translational Science (CCaTS) MD/PhD in Clinical and Translational Science	Infrastructure support provided by National Institutes of Health (NIH; https://www.nih.gov/) construction grant NIH C06 RR018898. Research support provided in part by the Society of Interventional Radiology (SIR) Foundation (http://www.sirfoundation.org/) Allied Scientist Training Grant (SMT), Mayo Clinic Center for Clinical and Translational Science (CCaTS; http://www.mayo.edu/ctsa) through grant number UL1 RR024150 from the National Center for Research Resources (NCRR), a component of the NIH (LRR, DAW) and NIH grant number R01 CA177686 from the National Cancer Institute (NCI) (DAW). The funding sources did not play any role in the study design, data collection or analysis, decision to publish or preparation of the manuscript. Dr. Thompson's MD, PhD training was supported by Mayo Clinic Center for Clinical and Translational Science (CCaTS) MD/PhD in Clinical and Translational Science TL1 RR024152 and TL1 TR000137. The contents herein are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Ahmed M, 2011, SURG ONCOL CLIN N AM, V20, P237, DOI 10.1016/j.soc.2010.11.011; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Angonese C, 2006, GUT, V55, P435; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dhanasekaran R, 2016, J HEPATOL, V64, P736, DOI 10.1016/j.jhep.2015.09.008; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FIELD S B, 1983, Radiotherapy and Oncology, V1, P179, DOI 10.1016/S0167-8140(83)80020-6; Gedaly R, 2012, ANTICANCER RES, V32, P2531; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hara S, 2008, BIOCHEM BIOPH RES CO, V370, P123, DOI 10.1016/j.bbrc.2008.03.042; Harrison LE, 2003, J AM COLL SURGEONS, V197, P759, DOI 10.1016/S1072-7515(03)00750-6; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Huynh H, 2007, MOL CANCER THER, V6, P138, DOI 10.1158/1535-7163.MCT-06-0436; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kang TW, 2015, RADIOLOGY; Kao WY, 2011, EUR J GASTROEN HEPAT, V23, P528, DOI 10.1097/MEG.0b013e328346d529; Kei SK, 2008, AM J ROENTGENOL, V190, P1544, DOI 10.2214/AJR.07.2798; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kuger S, 2013, TRANSL ONCOL, V6, P169, DOI 10.1593/tlo.12364; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Liu CH, 2010, EUR RADIOL, V20, P877, DOI 10.1007/s00330-009-1610-4; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mertyna P, 2008, INT J HYPERTHER, V24, P550, DOI 10.1080/02656730802035662; Mertyna P, 2007, J VASC INTERV RADIOL, V18, P647, DOI 10.1016/j.jvir.2007.02.033; Minko T, 1999, J CONTROL RELEASE, V59, P133, DOI 10.1016/S0168-3659(98)00186-2; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Ng KK, 2008, J GASTROINTEST SURG, V12, P183, DOI 10.1007/s11605-007-0276-y; Park HG, 2005, CELL MOL LIFE SCI, V62, P10, DOI 10.1007/s00018-004-4208-7; Portolani N, 2003, HEPATO-GASTROENTEROL, V50, P2179; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ruzzenente A, 2004, WORLD J GASTROENTERO, V10, P1137; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; SCHAMHART DHJ, 1984, CANCER RES, V44, P4507; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Seki T, 2001, EUR J GASTROEN HEPAT, V13, P291, DOI 10.1097/00042737-200103000-00014; Semba S, 2002, CLIN CANCER RES, V8, P1957; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Shiozawa K, 2009, HEPATO-GASTROENTEROL, V56, P1689; Thompson SM, 2014, CARDIOVASC INTER RAD, V37, P1343, DOI 10.1007/s00270-013-0828-3; Thompson SM, 2014, LASER SURG MED, V46, P290, DOI 10.1002/lsm.22231; Thompson SM, 2013, INVEST RADIOL, V48, P413, DOI 10.1097/RLI.0b013e31827a4a3f; Thompson SM, 2013, CARDIOVASC INTER RAD, V36, P198, DOI 10.1007/s00270-012-0466-1; Thompson SM, 2012, J VASC INTERV RADIOL, V23, P385, DOI 10.1016/j.jvir.2011.11.018; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang BW, 2011, EUR J RADIOL, V79, P196, DOI 10.1016/j.ejrad.2010.02.010; Yang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059879; Yang JD, 2012, MAYO CLIN PROC, V87, P9, DOI 10.1016/j.mayocp.2011.07.001; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Yin XY, 2009, CANCER-AM CANCER SOC, V115, P1914, DOI 10.1002/cncr.24196; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]	75	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162634	10.1371/journal.pone.0162634	http://dx.doi.org/10.1371/journal.pone.0162634			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611696	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900140
J	Vann, NC; Pham, FD; Hayes, JA; Kottick, A; Del Negro, CA				Vann, Nikolas C.; Pham, Francis D.; Hayes, John A.; Kottick, Andrew; Del Negro, Christopher A.			Transient Suppression of Dbx1 PreBotzinger Interneurons Disrupts Breathing in Adult Mice	PLOS ONE			English	Article							RESPIRATORY RHYTHM-GENERATOR; PRE-BOTZINGER COMPLEX; SPINAL-CORD; IN-VIVO; NEURONS; MOTOR; SOMATOSTATIN; ACTIVATION; DIVERSITY; PATTERN	Interneurons derived from Dbx1-expressing precursors located in the brainstem preBotzinger complex (preBotC) putatively form the core oscillator for inspiratory breathing movements. We tested this Dbx1 core hypothesis by expressing archaerhodopsin in Dbx1-derived interneurons and then transiently hyperpolarizing these neurons while measuring respiratory rhythm in vitro or breathing in vagus-intact adult mice. Transient illumination of the preBotC interrupted inspiratory rhythm in both slice preparations and sedated mice. In awake mice, light application reduced breathing frequency and prolonged the inspiratory duration. Support for the Dbx1 core hypothesis previously came from embryonic and perinatal mouse experiments, but these data suggest that Dbx1-derived preBotC interneurons are rhythmogenic in adult mice too. The neural origins of breathing behavior can be attributed to a localized and genetically well-defined interneuron population.	[Vann, Nikolas C.; Pham, Francis D.; Hayes, John A.; Kottick, Andrew; Del Negro, Christopher A.] Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23185 USA	William & Mary	Del Negro, CA (corresponding author), Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23185 USA.	cadeln@wm.edu	Del Negro, Christopher A./AAB-4565-2020	Del Negro, Christopher A./0000-0002-7848-8224; Pham, Francis/0000-0003-1082-8533	National Institutes of Health [R01 HL104127]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health grant R01 HL104127 (PI: CDN) supported this work.	Abbott SBG, 2013, J NEUROSCI, V33, P3164, DOI 10.1523/JNEUROSCI.1046-12.2013; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Cui Y, 2016, NEURON, V91, P602, DOI 10.1016/j.neuron.2016.07.003; Deschenes M, 2016, NEURON, V90, P374, DOI 10.1016/j.neuron.2016.03.007; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Flecknell P, 2015, LAB ANIMAL ANAESTHES; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Funk GD, 2013, RESP PHYSIOL NEUROBI, V186, P236, DOI 10.1016/j.resp.2013.01.011; Gabitto MI, 2016, CELL, V165, P220, DOI 10.1016/j.cell.2016.01.026; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Guyenet PG, 2016, J PHYSIOL-LONDON, V594, P1529, DOI 10.1113/JP271480; Guyenet PG, 2013, AM J PHYSIOL-REG I, V305, pR187, DOI 10.1152/ajpregu.00054.2013; Guyenet PG, 2002, J NEUROSCI, V22, P3806; Hilaire G, 2004, RESP PHYSIOL NEUROBI, V143, P187, DOI 10.1016/j.resp.2004.04.016; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; Holloway BB, 2013, J NEUROSCI, V33, P18792, DOI 10.1523/JNEUROSCI.2916-13.2013; KLEINMAN LI, 1964, J APPL PHYSIOL, V19, P360, DOI 10.1152/jappl.1964.19.2.360; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Llona I, 2005, BIOL RES, V38, P347, DOI 10.4067/S0716-97602005000400006; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marchenko V, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0011-16.2016; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Picardo MCD, 2013, J PHYSIOL-LONDON, V591, P2687, DOI 10.1113/jphysiol.2012.250118; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Ptak K, 2009, J NEUROSCI, V29, P3720, DOI 10.1523/JNEUROSCI.5271-08.2009; Revill AL, 2015, ELIFE, V4, DOI 10.7554/eLife.12301; Ruangkittisakul A., 2014, PHYSL REP, V2, P2; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz H, 2002, ACTA PHYSIOL SCAND, V174, P367, DOI 10.1046/j.1365-201x.2002.00955.x; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; Song H, J NEUROSCI  IN PRESS; Song NN, 2015, RESP PHYSIOL NEUROBI, V219, P25, DOI 10.1016/j.resp.2015.07.015; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Stornetta RL, 2002, J COMP NEUROL, V444, P207, DOI 10.1002/cne.10142; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; Wang XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03427; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	52	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162418	10.1371/journal.pone.0162418	http://dx.doi.org/10.1371/journal.pone.0162418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611210	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900096
J	Gao, L; Cui, WN; Zhang, PY; Jang, A; Zhu, WQ; Zhang, JY				Gao, Ling; Cui, Weina; Zhang, Pengyuan; Jang, Albert; Zhu, Wuqiang; Zhang, Jianyi			P-31 NMR 2D Mapping of Creatine Kinase Forward Flux Rate in Hearts with Postinfarction Left Ventricular Remodeling in Response to Cell Therapy	PLOS ONE			English	Article							INDUCED PLURIPOTENT STEM; FUNCTIONAL CONSEQUENCES; PORCINE MODEL; IN-VIVO; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; WALL STRESS; DIFFERENTIATION; HYPERTROPHY; CONTRIBUTES	Utilizing a fast P-31 magnetic resonance spectroscopy (MRS) 2-dimensional chemical shift imaging (2D-CSI) method, this study examined the heterogeneity of creatine kinase (CK) forward flux rate of hearts with postinfarction left ventricular (LV) remodeling. Immunosuppressed Yorkshire pigs were assigned to 4 groups: 1) A sham-operated normal group (SHAM, n = 6); 2) A 60 minutes distal left anterior descending coronary artery ligation and reperfusion (MI, n = 6); 3) Open patch group; ligation injury plus open fibrin patch over the site of injury (Patch, n = 6); and 4) Cell group, hiPSCs-cardiomyocytes,-endothelial cells, and-smooth muscle cells (2 million, each) were injected into the injured myocardium pass through a fibrin patch (Cell+Patch, n = 5). At 4 weeks, the creatine phosphate (PCr)/ATP ratio, CK forward flux rate (Flux (PCr -> ATP)), and k constant of CK forward flux rate (k(PCr -> ATP)) were severely decreased at border zone myocardium (BZ) adjacent to MI. Cell treatment results in significantly increase of PCr/ATP ratio and improve the value of k(PCr -> ATP) and Flux (PCr -> ATP) in BZ myocardium. Moreover, the BZ myocardial CK total activity and protein expression of CK mitochondria isozyme and CK myocardial isozyme were significantly reduced, but recovered in response to cell treatment. Thus, cell therapy results in improvement of BZ bioenergetic abnormality in hearts with postinfarction LV remodeling, which is accompanied by significantly improvements in BZ CK activity and CK isozyme expression. The fast 2D P-31 MR CSI mapping can reliably measure the heterogeneity of bioenergetics in hearts with post infarction LV remodeling.	[Gao, Ling; Zhu, Wuqiang; Zhang, Jianyi] Univ Alabama Birmingham, Sch Med, Dept Biomed Engn, Birmingham, AL 35233 USA; [Gao, Ling; Zhu, Wuqiang; Zhang, Jianyi] Univ Alabama Birmingham, Sch Engn, Birmingham, AL 35233 USA; [Cui, Weina; Zhang, Pengyuan; Jang, Albert] Univ Minnesota Twin Cities, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biomed Engn, Birmingham, AL 35233 USA.; Zhang, JY (corresponding author), Univ Alabama Birmingham, Sch Engn, Birmingham, AL 35233 USA.	jayzhang@uab.edu			National Institutes of Health [RO1 HL67828, RO1 HL95077, RO1 HL114120, UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, U01HL134764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1 HL67828; National Institutes of Health RO1 HL95077; National Institutes of Health RO1 HL114120; and National Institutes of Health UO1 HL100407.	Bao XP, 2015, STEM CELL RES, V15, P122, DOI 10.1016/j.scr.2015.05.004; Bolli R, 2015, J AM COLL CARDIOL, V66, P2000, DOI 10.1016/j.jacc.2015.09.002; Bottomley PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007328; Feygin J, 2008, AM J PHYSIOL-HEART C, V294, pH2313, DOI 10.1152/ajpheart.01288.2007; Gao L, 2014, J MOL CELL CARDIOL, V77, P102, DOI 10.1016/j.yjmcc.2014.10.004; Gao L, 2014, AM J PHYSIOL-HEART C, V306, pH1569, DOI 10.1152/ajpheart.00772.2013; Gupta A, 2012, J CLIN INVEST, V122, P291, DOI 10.1172/JCI57426; Guzun R, 2011, AMINO ACIDS, V40, P1333, DOI 10.1007/s00726-011-0854-x; Ilic D, 2015, BRIT MED BULL, V116, P19, DOI 10.1093/bmb/ldv045; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Karantalis V, 2015, J AM COLL CARDIOL, V66, P1990, DOI 10.1016/j.jacc.2015.08.879; Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Marchand M, 2014, STEM CELL TRANSL MED, V3, P91, DOI 10.5966/sctm.2013-0124; Matsa E, 2014, CIRC RES, V114, P21, DOI 10.1161/CIRCRESAHA.113.302895; MORIARTY TF, 1980, CIRC RES, V46, P321, DOI 10.1161/01.RES.46.3.321; ROBITAILLE PML, 1993, MAGNET RESON MED, V30, P4; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Weiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102; Xiong Q, 2015, AM J PHYSIOL-HEART C, V309, pH450, DOI 10.1152/ajpheart.00072.2015; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Xiong QA, 2011, CIRC RES, V108, P653, DOI 10.1161/CIRCRESAHA.110.231456; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Xiong Q, 2009, AM J PHYSIOL-HEART C, V297, pH1010, DOI 10.1152/ajpheart.01195.2008; Yang LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147155; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Ye Y, 2001, CIRCULATION, V103, P1570; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang S, 2014, BIOMATERIALS, V35, P3786, DOI 10.1016/j.biomaterials.2014.01.037	33	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162149	10.1371/journal.pone.0162149	http://dx.doi.org/10.1371/journal.pone.0162149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606901	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600022
J	Kushlev, K; Proulx, JDE				Kushlev, Kostadin; Proulx, Jason D. E.			The Social Costs of Ubiquitous Information: Consuming Information on Mobile Phones Is Associated with Lower Trust	PLOS ONE			English	Article								In an age already saturated with information, the ongoing revolution in mobile computing has expanded the realm of immediate information access far beyond our homes and offices. In addition to changing where people can access information, mobile computing has changed what information people access-from finding specific directions to a restaurant to exploring nearby businesses when on the go. Does this ability to instantly gratify our information needs anytime and anywhere have any bearing on how much we trust those around us-from neighbors to strangers? Using data from a large nationally representative survey (World Values Survey: Wave 6), we found that the more people relied on their mobile phones for information, the less they trusted strangers, neighbors and people from other religions and nationalities. In contrast, obtaining information through any other method-including TV, radio, newspapers, and even the Internet more broadly-predicted higher trust in those groups. Mobile information had no bearing on how much people trusted close others, such as their family. Although causality cannot be inferred, these findings provide an intriguing first glimpse into the possible unforeseen costs of convenient information access for the social lubricant of society-our sense of trust in one another.	[Kushlev, Kostadin] Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA; [Proulx, Jason D. E.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of Virginia; University of British Columbia	Kushlev, K (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	kushlevk@gmail.com	Kushlev, Kostadin/H-8780-2018	Kushlev, Kostadin/0000-0003-1025-3258				Blair Ann M., 2010, TOO MUCH KNOW MANAGI; Castells M., 1999, INFORM AGE, VIII; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Erikson EH, 1959, IDENTITY LIFE CYCLE; Ferrero G., 1894, REV PHILOSOPHIQUE FR, V37, P169; Fiske S. T., 2014, SOCIAL BEINGS CORE M; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Helliwell J., 2011, INT J WELL BEING, V1, P42, DOI DOI 10.5502/IJW.V1I1.9; Kawachi I., 2007, SOCIAL CAPITAL HLTH; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Mann T, 1990, GUIDE LIB RES METHOD; Marvin C, 1998, OLD TECHNOLOGIES WER; PUTNAM RD, 1995, J DEMOCRACY, V0006; Robinson JM, 2007, 2 DECADES AM NEWS 2; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Sandstrom GM, 2014, PERS SOC PSYCHOL B, V40, P910, DOI 10.1177/0146167214529799; Sandstrom GM, 2014, SOC PSYCHOL PERS SCI, V5, P437, DOI 10.1177/1948550613502990; Sheppard BH, 1998, ACAD MANAGE REV, V23, P422, DOI 10.2307/259287; Smith A, 2015, US SMARTPHONE USE 20; Sztompka P., 1999, TRUST SOCIOLOGICAL T; Vacha-Haase T, 2004, J COUNS PSYCHOL, V51, P473, DOI 10.1037/0022-0167.51.4.473	23	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162130	10.1371/journal.pone.0162130	http://dx.doi.org/10.1371/journal.pone.0162130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606707	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600020
J	Scherer, L; Pfister, S				Scherer, Laura; Pfister, Stephan			Hydropower's Biogenic Carbon Footprint	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; MODEL SELECTION; RESOLUTION; WATER; RESERVOIRS	Global warming is accelerating and the world urgently needs a shift to clean and renewable energy. Hydropower is currently the largest renewable source of electricity, but its contribution to climate change mitigation is not yet fully understood. Hydroelectric reservoirs are a source of biogenic greenhouse gases and in individual cases can reach the same emission rates as thermal power plants. Little is known about the severity of their emissions at the global scale. Here we show that the carbon footprint of hydropower is far higher than previously assumed, with a global average of 173 kg CO2 and 2.95 kg CH4 emitted perMWh of electricity produced. This results in a combined average carbon footprint of 273 kg CO2e/MWh when using the global warming potential over a time horizon of 100 years (GWP100). Nonetheless, this is still below that of fossil energy sources without the use of carbon capture and sequestration technologies. We identified the dams most promising for capturing methane for use as alternative energy source. The spread among the similar to 1500 hydropower plants analysed in this study is large and highlights the importance of case-by-case examinations.	[Scherer, Laura; Pfister, Stephan] ETH, Inst Environm Engn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Scherer, L (corresponding author), ETH, Inst Environm Engn, Zurich, Switzerland.	scherer@ifu.baug.ethz.ch	Pfister, Stephan/B-1317-2011; Pfister, Stephan/AAE-8615-2019	Pfister, Stephan/0000-0001-8984-2041; Pfister, Stephan/0000-0001-8984-2041; Scherer, Laura/0000-0002-0194-9942				Baban SMJ, 2003, WATER RESOUR MANAG, V17, P1, DOI 10.1023/A:1023066705226; Bambace LAW, 2007, ENERGY, V32, P1038, DOI 10.1016/j.energy.2006.09.008; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Barton K., 2016, MUMIN MULTI MODEL IN; CARMA, 2015, CO2 EMISSIONS ENERGY; Chen H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012410; Cherubini F, 2011, GCB BIOENERGY, V3, P413, DOI 10.1111/j.1757-1707.2011.01102.x; DelSontro T, 2011, ENVIRON SCI TECHNOL, V45, P9866, DOI 10.1021/es2005545; dos Santos MA, 2006, ENERG POLICY, V34, P481, DOI 10.1016/j.enpol.2004.06.015; FAO, 2016, AQUASTAT DAMS; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hertwich EG, 2013, ENVIRON SCI TECHNOL, V47, P9604, DOI 10.1021/es401820p; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kumar A., 2011, IPCC SPECIAL REPORT; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Mendonca R, 2012, NAT GEOSCI, V5, P838, DOI 10.1038/ngeo1653; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nachtergaele F., 2012, HARMONIZED WORLD SOI; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Paish O, 2002, RENEW SUST ENERG REV, V6, P537, DOI 10.1016/S1364-0321(02)00006-0; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Scherer L, 2016, RENEW ENERG, V99, P711, DOI 10.1016/j.renene.2016.07.021; Scherer L, 2015, INT J LIFE CYCLE ASS, V20, P785, DOI 10.1007/s11367-015-0880-0; Scherer L, 2015, ENVIRON SCI TECHNOL, V49, P4971, DOI 10.1021/acs.est.5b00429; Schlomer S., 2014, CLIMATE CHANGE 2014; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Takeuchi K., 1997, IAHS PUBL, V240; Teodoru C.R., 2012, GLOB BIOGEOCHEM CYCL, V26; Turconi R, 2013, RENEW SUST ENERG REV, V28, P555, DOI 10.1016/j.rser.2013.08.013; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Yuksel I, 2010, RENEW SUST ENERG REV, V14, P462, DOI 10.1016/j.rser.2009.07.025	35	47	47	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161947	10.1371/journal.pone.0161947	http://dx.doi.org/10.1371/journal.pone.0161947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626943	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600013
J	Shih, HM; Hsu, TY; Chen, CY; Lin, CL; Kao, CH; Chen, CH; Yang, TY; Chen, WK				Shih, Hong-Mo; Hsu, Tai-Yi; Chen, Chih-Yu; Lin, Cheng-Li; Kao, Chia-Hung; Chen, Chao-Hsien; Yang, Tse-Yen; Chen, Wei-Kung			Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CALCIUM HOMEOSTASIS; DISEASE; EPIDEMIOLOGY; ASSOCIATION; GASTRITIS; WOMEN; MASS	Purpose Previous studies have reported conflicting results on the association between Helicobacter pylori infection and osteoporosis. A few studies have discussed the influence of H. pylori eradication therapy on bone mineral density. Methods We assessed the prevalence of osteoporosis among the H. pylori-infected population in Taiwan and the influence of early and late H. pylori eradication therapy on bone mineral density. Results Using data from Taiwan's National Health Insurance Research Database, we identified 5,447 patients who received H. pylori eradication therapy from 2000 to 2010 and 21,788 controls, frequency-matched according to age, sex, and year of receiving H. pylori eradication therapy. Those who received H. pylori eradication therapy were divided into two groups based on the time interval between the diagnosis of a peptic ulcer and commencement of eradication therapy. The risk of developing osteoporosis was higher in the early H. pylori treatment cohort (hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.23-1.89) and late H. pylori treatment cohort (HR = 1.69, 95% CI = 1.39-2.05), compared with the risk in the control cohort. When followed for less than 5 years, both the early and late cohorts had a higher risk of developing osteoporosis (HR = 1.69, 95% CI = 1.32-2.16 and HR = 1.72, 95% CI = 1.38-2.14). However, when the follow-up period was over 5 years, only the late eradication group exhibited a higher incidence of osteoporosis (HR = 1.62, 95% CI = 1.06-2.47). Conclusion The development of osteoporosis is complex and multi-factorial. Via this population-based cohort study and adjustment of possible confounding variables, we found H. pylori infection may be associated with an increased risk of developing osteoporosis in Taiwan. Early eradication could reduce the influence of H. pylori infection on osteoporosis when the follow-up period is greater than 5 years. Further prospective studies are necessary to discover the connection of H. pylori and osteoporosis.	[Shih, Hong-Mo; Hsu, Tai-Yi; Chen, Chih-Yu; Chen, Wei-Kung] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Shih, Hong-Mo; Hsu, Tai-Yi; Chen, Chih-Yu; Lin, Cheng-Li; Chen, Wei-Kung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Chen, Chao-Hsien; Yang, Tse-Yen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Yang, Tse-Yen] China Med Univ, China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, TY (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.; Yang, TY (corresponding author), China Med Univ, China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan.	hardawayoung@hotmail.com; yang_t_y@yahoo.com.tw	, ChihYu/J-3855-2013; yang, zhe yan/C-4259-2015	, ChihYu/0000-0001-9986-8413; yang, zhe yan/0000-0002-3165-132X; Shih, Hong-Mo/0000-0001-7732-3594	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	The Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039 -006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. Miss Cheng-Li Lin received her salary from The Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan for providing the service of statistical analysis, which is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan.	Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Asaoka D, 2015, THER CLIN RISK MANAG, V11, P381, DOI 10.2147/TCRM.S80647; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Ayesh MH, 2013, BRAZ J INFECT DIS, V17, P629, DOI 10.1016/j.bjid.2013.01.009; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; BISBALLE S, 1991, GUT, V32, P1303, DOI 10.1136/gut.32.11.1303; Calvet X, 2013, HELICOBACTER, V18, P5, DOI 10.1111/hel.12071; Chang YP, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/175729; Crabtree JE, 1995, LAB INVEST, V73, P742; DeGerome JH, 1996, JAMA-J AM MED ASSOC, V276, P1034, DOI 10.1001/jama.1996.03540130032015; Del Valle Elisa, 2007, Hemodial Int, V11, P315, DOI 10.1111/j.1542-4758.2007.00186.x; Dolev E, 1997, Harefuah, V132, P511; Figura N, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201743; Fotouk-kiai M, 2015, CASP J INTERN MED, V6, P62; Fujita T, 2001, J BONE MINER METAB, V19, P131, DOI 10.1007/s007740170031; Gillen D, 1998, GASTROENTEROLOGY, V114, P50, DOI 10.1016/S0016-5085(98)70632-8; Hsu CW, 2016, INTENS CARE MED, V42, P38, DOI 10.1007/s00134-015-4044-2; Kakehasi Adriana M., 2007, Arq. Gastroenterol., V44, P266, DOI 10.1590/S0004-28032007000300016; Kalantarhormozi MR, 2016, J BONE MINER METAB, V34, P422, DOI 10.1007/s00774-015-0688-9; Keller J, 2013, OSTEOPOROSIS INT, V24, P2737, DOI 10.1007/s00198-013-2335-4; Kim HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101852; Kouda K, 2011, BONE, V49, P275, DOI 10.1016/j.bone.2011.04.010; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Lin SY, 2015, INT J CLIN PRACT, V69, P604, DOI 10.1111/ijcp.12602; Majumdar D, 2011, MEDICINE, V39, P154; Mangione RA, 2008, AM J HEALTH-SYST PH, V65, P1601, DOI 10.2146/ajhp080097; Maugeri D, 1998, ARCH GERONTOL GERIAT, V27, P159, DOI 10.1016/S0167-4943(98)00110-1; MOSS SF, 1994, GUT, V35, P1567, DOI 10.1136/gut.35.11.1567; Nabwera HM, 1999, J PHYSIOL PHARMACOL, V50, P711; Ngamruengphong S, 2011, AM J GASTROENTEROL, V106, P1209, DOI 10.1038/ajg.2011.113; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pavlovic Drasko, 2007, Lijec Vjesn, V129, P426; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; Sawicki A, 2003, OSTEOPOROSIS INT, V14, P983, DOI 10.1007/s00198-003-1459-3; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Suzuki T, 2001, J BONE MINER METAB, V19, P133, DOI 10.1007/s007740170032; Tiwari Shridhar, 2005, Indian J Gastroenterol, V24, P193; TOVEY FI, 1991, BRIT J SURG, V78, P1335, DOI 10.1002/bjs.1800781122; Tucker KL, 2005, J BONE MINER RES, V20, P152, DOI [10.1359/jbmr.2005.20.1.152, 10.1359/JBMR.041018]; Wang CC, 2015, MEDICINE, V94, pe1585; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060	43	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162645	10.1371/journal.pone.0162645	http://dx.doi.org/10.1371/journal.pone.0162645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626940	gold, Green Submitted, Green Published			2022-12-27	WOS:000383680600049
J	Eriksson, O; Wall, A; Olsson, U; Marteinsdottir, I; Holstad, M; Agren, H; Hartvig, P; Langstrom, B; Naessen, T				Eriksson, Olle; Wall, Anders; Olsson, Ulf; Marteinsdottir, Ina; Holstad, Maria; Agren, Hans; Hartvig, Per; Langstrom, Bengt; Naessen, Tord			Women with Premenstrual Dysphoria Lack the Seemingly Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A Possible Cause of Disabling Mood Symptoms	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; REUPTAKE INHIBITORS; GONADAL-STEROIDS; RECEPTOR-BINDING; MENSTRUAL-CYCLE; CORTEX; BRAIN; ASYMMETRY; MODULATION; PET	Study Objective To investigate potential quantitative and qualitative differences in brain serotonergic activity between women with Premenstrual Dysphoria (PMD) and asymptomatic controls. Background Serotonin-augmenting drugs alleviate premenstrual mood symptoms in the majority of women with PMD while serotonin-depleting diets worsen PMD symptoms, both indicating intrinsic differences in brain serotonergic activity in women with PMD compared to asymptomatic women. Methods Positron-emission tomography with the immediate precursor of serotonin, 5-hydroxytryptophan (5-HTP), radiolabelled by 11C in the beta-3 position, was performed in the follicular and luteal phases for 12 women with PMD and 8 control women. Brain radioactivity-a proxy for serotonin precursor uptake and synthesis-was measured in 9 regions of interest (ROIs): the right and left sides of the medial prefrontal cortex, dorsolateral prefrontal cortex, putamen and caudate nucleus, and the single "whole brain". Results There were no significant quantitative differences in brain 5-HTP-derived activity between the groups in either of the menstrual phases for any of the 9 ROIs. However, multivariate analysis revealed a significant quantitative and qualitative difference between the groups. Asymptomatic control women showed a premenstrual right sided relative increase in dorsolateral prefrontal cortex 5-HTP derived activity, whereas PMD women displayed the opposite (p = 0.0001). Menstrual phase changes in this asymmetry (premenstrual-follicular) correlated with changes in self ratings of 'irritability' for the entire group (rs = -0.595, p = 0.006). The PMD group showed a strong inverse correlation between phase changes (pre-menstrual-follicular) in plasma levels of estradiol and phase changes in the laterality (dx/sin) of radiotracer activity in the dorsolateral prefrontal ROI (r(s) = -0.635; 0.027). The control group showed no such correlation. Conclusion Absence of increased premenstrual right-sided relative 5-HTP-derived activity of the dorsolateral prefrontal cortices was found to strongly correlate to premenstrual irritability. A causal relationship here seems plausible, and the findings give further support to an underlying frontal brain disturbance in hormonally influenced serotonergic activity in women with PMD. Because of the small number of subjects in the study, these results should be considered preliminary, requiring verification in larger studies.	[Eriksson, Olle; Naessen, Tord] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Obstet & Gynaecol, Uppsala, Sweden; [Wall, Anders] Univ Uppsala Hosp, Dept Surg Sci, Unit Nucl Med & PET, Uppsala, Sweden; [Olsson, Ulf] Swedish Univ Agr Sci, Unit Appl Stat & Math, Uppsala, Sweden; [Marteinsdottir, Ina] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Holstad, Maria] Univ Uppsala Hosp, Dept Neurosci, Psychiat Unit, Uppsala, Sweden; [Agren, Hans] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hartvig, Per] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Langstrom, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Swedish University of Agricultural Sciences; Linkoping University; Uppsala University; Uppsala University Hospital; University of Gothenburg; University of Copenhagen; Uppsala University	Eriksson, O (corresponding author), Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Obstet & Gynaecol, Uppsala, Sweden.	olle.eriksson@kbh.uu.se			PET Foundation of the County of Uppsala; Amersham PET Fund; Swedish Medical Society; Soderstrom Konigska Foundation; Swedish Society for Medical Research; Family Planning Foundation of Uppsala University Hospital; Medical Faculty of the University of Uppsala	PET Foundation of the County of Uppsala; Amersham PET Fund; Swedish Medical Society; Soderstrom Konigska Foundation; Swedish Society for Medical Research; Family Planning Foundation of Uppsala University Hospital; Medical Faculty of the University of Uppsala	This study was financed by research grants from the PET Foundation of the County of Uppsala, the Amersham PET Fund, the Swedish Medical Society, the Soderstrom Konigska Foundation, the Swedish Society for Medical Research, and the Family Planning Foundation of Uppsala University Hospital. These were all the funding sources except for a total of about 12 months of salary to perform Clinical research at the Medical Faculty of the University of Uppsala provided to Olle Eriksson, in scattered monthly fractions, by the Medical Faculty of the University of Uppsala after yearly formal applications in competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2013, LATERALITY, V18, P437, DOI 10.1080/1357650X.2012.703206; Accortt EE, 2006, J ABNORM PSYCHOL, V115, P179, DOI 10.1037/0021-843X.115.1.179; Accortt EE, 2011, J AFFECT DISORDERS, V128, P178, DOI 10.1016/j.jad.2010.07.017; Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; AGREN H, 1994, PHARMACOPSYCHIATRY, V27, P2, DOI 10.1055/s-2007-1014265; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSSON JLR, 1995, J NUCL MED, V36, P670; Andrade R, 2011, NEUROPHARMACOLOGY, V61, P382, DOI 10.1016/j.neuropharm.2011.01.015; [Anonymous], 2006, SAS MIXED MODELS; Aznar S, 2013, MOL NEUROBIOL, V48, P841, DOI 10.1007/s12035-013-8472-0; Baller EB, 2013, AM J PSYCHIAT, V170, P305, DOI 10.1176/appi.ajp.2012.12030385; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Berman KF, 1997, P NATL ACAD SCI USA, V94, P8836, DOI 10.1073/pnas.94.16.8836; Berry MD, 1996, NEUROCHEM RES, V21, P1075, DOI 10.1007/BF02532418; Bismark AW, 2010, BIOL PSYCHOL, V83, P153, DOI 10.1016/j.biopsycho.2009.12.002; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brody A L, 2001, Semin Clin Neuropsychiatry, V6, P102, DOI 10.1053/scnp.2001.21837; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Celada P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00025; Davidson RJ, 2000, BIOL PSYCHIAT, V47, P85, DOI 10.1016/S0006-3223(99)00222-X; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dimmock PW, 2000, LANCET, V356, P1131, DOI 10.1016/S0140-6736(00)02754-9; Donaldson ZR, 2013, CURR OPIN NEUROBIOL, V23, P399, DOI 10.1016/j.conb.2013.01.011; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Eriksson E, 1999, INT CLIN PSYCHOPHARM, V14, pS27; ERIKSSON E, 1990, ACTA PSYCHIAT SCAND, V81, P87, DOI 10.1111/j.1600-0447.1990.tb06455.x; Eriksson O, 2006, PSYCHIAT RES-NEUROIM, V146, P107, DOI 10.1016/j.pscychresns.2005.02.012; Eriksson O, 2006, PSYCHONEUROENDOCRINO, V31, P415, DOI 10.1016/j.psyneuen.2005.10.004; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 1997, SCID 2; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hagberg GE, 2002, J CEREBR BLOOD F MET, V22, P1352, DOI 10.1097/01.WCB.0000040946.89393.9d; HAMMARBACK S, 1989, J PSYCHOSOM OBST GYN, V10, P25, DOI 10.3109/01674828909016676; Harlow SD, 2012, J CLIN ENDOCR METAB, V97, P1159, DOI 10.1210/jc.2011-3362; HARTVIG P, 1992, J NEURAL TRANSM-GEN, V88, P1, DOI 10.1007/BF01245032; Hecht David, 2013, Exp Neurobiol, V22, P173, DOI 10.5607/en.2013.22.3.173; Johansson J, 1994, SOUND RECORDING JAZZ; Johnson RA., 2007, APPL MULTIVARIATE ST; Jovanovic H, 2006, PSYCHIAT RES-NEUROIM, V148, P185, DOI 10.1016/j.pscychresns.2006.05.002; Kavoussi R, 1997, PSYCHIAT CLIN N AM, V20, P395, DOI 10.1016/S0193-953X(05)70319-1; Kim D R, 2004, Arch Womens Ment Health, V7, P37, DOI 10.1007/s00737-003-0027-3; Kranz GS, 2014, PSYCHONEUROENDOCRINO, V45, P1, DOI 10.1016/j.psyneuen.2014.03.004; Kugaya A, 2003, AM J PSYCHIAT, V160, P1522, DOI 10.1176/appi.ajp.160.8.1522; Landen M, 2001, PSYCHOPHARMACOLOGY, V155, P292, DOI 10.1007/s002130100718; LEARY PM, 1979, S AFR MED J, V55, P666; Leiser SC, 2015, ACS CHEM NEUROSCI, V6, P970, DOI 10.1021/cn500340j; Lindner KJ, 1997, NUCL MED BIOL, V24, P733, DOI 10.1016/S0969-8051(97)00114-5; LLOYD KG, 1972, J NEUROCHEM, V19, P1549, DOI 10.1111/j.1471-4159.1972.tb05099.x; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Marjoribanks J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001396.pub3; Mathersul D, 2008, EMOTION, V8, P560, DOI 10.1037/a0012811; Mengod G, 2015, ACS CHEM NEUROSCI, V6, P1089, DOI 10.1021/acschemneuro.5b00023; MENKES DB, 1994, J AFFECT DISORDERS, V32, P37, DOI 10.1016/0165-0327(94)90059-0; Moses EL, 2000, BIOL PSYCHIAT, V48, P854, DOI 10.1016/S0006-3223(00)00967-7; Moses-Kolko EL, 2003, FERTIL STERIL, V80, P554, DOI 10.1016/S0015-0282(03)00973-7; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; New AS, 2009, BIOL PSYCHIAT, V66, P1107, DOI 10.1016/j.biopsych.2009.07.015; NYBERG P, 1982, J NEURAL TRANSM, V54, P85, DOI 10.1007/BF01249281; Olivier B, 2015, EUR J PHARMACOL, V753, P2, DOI 10.1016/j.ejphar.2014.10.031; Olsson U., 2011, STAT LIFE SCI; Olsson U, 2011, STAT LIFE SCI, V2; Perach-Barzilay N, 2013, SOC NEUROSCI-UK, V8, P178, DOI 10.1080/17470919.2012.720602; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; SUGERMAN A A, 1970, Research Communications in Chemical Pathology and Pharmacology, V1, P526; SUMNER BEH, 1995, J STEROID BIOCHEM, V54, P15, DOI 10.1016/0960-0760(95)00075-B; Visser AKD, 2011, EUR J NUCL MED MOL I, V38, P576, DOI 10.1007/s00259-010-1663-2; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yang YL, 2005, BIOL PSYCHIAT, V57, P1103, DOI 10.1016/j.biopsych.2005.01.021; Yonkers KA, 2008, LANCET, V371, P1200, DOI 10.1016/S0140-6736(08)60527-9	74	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0159538	10.1371/journal.pone.0159538	http://dx.doi.org/10.1371/journal.pone.0159538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27617751	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100001
J	Kim, JE; Go, J; Koh, EK; Song, SH; Sung, JE; Lee, HA; Lee, YH; Hong, JT; Hwang, DY				Kim, Ji Eun; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Lee, Hyun Ah; Lee, Young Hee; Hong, Jin Tae; Hwang, Dae Youn			Gallotannin-Enriched Extract Isolated from Galla Rhois May Be a Functional Candidate with Laxative Effects for Treatment of Loperamide-Induced Constipation of SD Rats	PLOS ONE			English	Article							TANNINS; POMEGRANATE; INHIBITION; GROWTH; LEAVES; CELLS	Several natural products containing tannins are used as traditional medicines for treatment of constipation; however, their pharmacological mechanism is not well understood. The laxative effects of gallotannin-enriched extract isolated from Galla Rhois (GEGR) were investigated using a constipation model induced by loperamide (Lop) injection. After analysis for antioxidant activity of GEGR, alterations in the excretion parameters, histological structure, mucin secretion, and related protein levels were measured in the transverse colon of Sprague Dawley (SD) rats with Lop-induced constipation following treatment with 250, 500 and 1,000 mg/ml of GEGR. The number and weight of feces increased significantly by 48-79% and 128-159%, respectively, in the Lop+GEGR treated group relative to the Lop+vehicle treated group, while food intake and water consumption were maintained at a constant level. The thickness of mucosa, muscle and flat luminal surface, as well as the number of goblet cells and crypt of lieberkuhnwere enhanced in the Lop+GEGR treated group. Moreover, mucin secretion increased significantly in a dose dependent manner in the Lop+GEGR treated group. Furthermore, the downstream signaling pathway of the muscarinic acetylcholine receptors (mAChR) M2 and M3 was recovered by GEGR treatment, although the expression level varied. The levels of Ga expression and inositol triphosphate (IP3) concentration were also recovered in the Lop+GEGR treated group relative to the Lop+vehicle treated group. The results of the present study provide strong evidence that tannins distributed in various medicinal plants are important candidates for improving chronic constipation induced by Lop treatment in animal models.	[Kim, Ji Eun; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Lee, Hyun Ah; Hwang, Dae Youn] Pusan Natl Univ, Dept Biomat Sci, Coll Nat Resources & Life Sci, Life & Ind Convergence Res Inst, Miryang, South Korea; [Lee, Young Hee] Pusan Natl Univ, Dept Organ Mat Sci & Engn, Busan, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju, South Korea	Pusan National University; Pusan National University; Chungbuk National University	Hwang, DY (corresponding author), Pusan Natl Univ, Dept Biomat Sci, Coll Nat Resources & Life Sci, Life & Ind Convergence Res Inst, Miryang, South Korea.	dyhwang@pusan.ac.kr	Lee, Young Hee/A-5424-2013		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2058360]; Korea Institute of Planning Evaluation for Technology of Food, Agriculture, Forestry and Fisheries [114034-03-1-HD030]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Institute of Planning Evaluation for Technology of Food, Agriculture, Forestry and Fisheries	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2058360).; We thank Jin Hyang Hwang and the animal technicians for directing the Animal Facility and Care at the Laboratory Animal Resources Center. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2058360) and the Korea Institute of Planning Evaluation for Technology of Food, Agriculture, Forestry and Fisheries (grant no. 114034-03-1-HD030).	Abbas S, 2012, PHYTOTHER RES, V26, P704, DOI 10.1002/ptr.3634; AHN T, 1994, BIOCHEM BIOPH RES CO, V203, P326, DOI 10.1006/bbrc.1994.2185; Ahn YJ, 1998, J APPL MICROBIOL, V84, P439, DOI 10.1046/j.1365-2672.1998.00363.x; [Anonymous], 1969, FOOD COSMET TOXICOL, V7, P364; Ata N, 1996, ONCOL RES, V8, P503; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Burleigh DE, 1998, EUR J PHARMACOL, V152, P39; CELIK AF, 1995, ALIMENT PHARM THER, V9, P63; Cha ChunNam, 2013, Journal of Veterinary Clinics, V30, P353; Chae HS, 2010, AM J CHINESE MED, V38, P973, DOI 10.1142/S0192415X10008391; Clinton C, 2009, NAT MED J, V1, P13; De Lillo AR, 2000, AM J GASTROENTEROL, V95, P901, DOI 10.1016/S0002-9270(00)00718-8; Go Jun, 2015, Lab Anim Res, V31, P101, DOI 10.5625/lar.2015.31.3.101; Guarize L, 2012, NAT PROD RES, V26, P331, DOI 10.1080/14786411003754264; Hs S Oz, 2005, J NUTR BIOCH, V16, P297; Karlsson NG, 1997, J BIOL CHEM, V272, P27025, DOI 10.1074/jbc.272.43.27025; 차준남, 2013, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V28, P95, DOI 10.13103/JFHS.2013.28.2.095; Khalif IL, 2005, DIGEST LIVER DIS, V37, P838, DOI 10.1016/j.dld.2005.06.008; Khan N, 2007, CANCER RES, V67, P3475, DOI 10.1158/0008-5472.CAN-06-3941; Kim JE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-333; Kim SH, 2005, INT IMMUNOPHARMACOL, V5, P1820, DOI 10.1016/j.intimp.2005.06.007; Kumari M, 2012, RES J RECENT SCI, V1, P70; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Lee JJ, 2012, AVIAN PATHOL, V41, P403, DOI 10.1080/03079457.2012.702888; Lee S. M., 1997, J APPL ENTOMOL, V36, P83; Lee TY, 2006, J PHARM PHARMACOL, V58, P659, DOI 10.1211/jpp.58.5.0011; Lee YH, 2015, TEXT RES J, V85, P1045, DOI 10.1177/0040517514559580; Lee YH, 2009, MATERIALS, V2, P10, DOI 10.3390/ma2010010; Meite S, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-7; Najeeb-ur-Rehman, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-16; Oh H, 2003, PHYTOTHER RES, V17, P417, DOI 10.1002/ptr.1148; Philippe D, 2003, J CLIN INVEST, V111, P1329, DOI 10.1172/JCI200316750; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V126, P203, DOI 10.1016/S1095-6433(00)00194-X; Voderholzer WA, 1997, AM J GASTROENTEROL, V92, P95; Walia R, 2009, CURR OPIN PEDIATR, V21, P661, DOI 10.1097/MOP.0b013e32832ff241; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Zoppi G, 1998, ACTA PAEDIATR, V87, P836, DOI 10.1080/080352598750013590	39	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161144	10.1371/journal.pone.0161144	http://dx.doi.org/10.1371/journal.pone.0161144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618438	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100006
J	Li, YL; Ning, ZY; Cui, D; Mao, W; Bi, JD; Zhao, XY				Li, Yulin; Ning, Zhiying; Cui, Duo; Mao, Wei; Bi, Jingdong; Zhao, Xueyong			Litter Decomposition in a Semiarid Dune Grassland: Neutral Effect of Water Supply and Inhibitory Effect of Nitrogen Addition	PLOS ONE			English	Article							LEAF-LITTER; FOLIAR LITTER; ROOT; RAINFALL; QUALITY; DESERT; PRECIPITATION; RESPONSES; DYNAMICS; RELEASE	Background The decomposition of plant material in arid ecosystems is considered to be substantially controlled by water and N availability. The responses of litter decomposition to external N and water, however, remain controversial, and the interactive effects of supplementary N and water also have been largely unexamined. Methodology/Principal Findings A 3.5-year field experiment with supplementary nitrogen and water was conducted to assess the effects of N and water addition on mass loss and nitrogen release in leaves and fine roots of three dominant plant species (i.e., Artemisia halondendron, Setaria viridis, and Phragmites australis) with contrasting substrate chemistry (e.g. N concentration, lignin content in this study) in a desertified dune grassland of Inner Mongolia, China. The treatments included N addition, water addition, combination of N and water, and an untreated control. The decomposition rate in both leaves and roots was related to the initial litter N and lignin concentrations of the three species. However, litter quality did not explain the slower mass loss in roots than in leaves in the present study, and thus warrant further research. Nitrogen addition, either alone or in combination with water, significantly inhibited dry mass loss and N release in the leaves and roots of the three species, whereas water input had little effect on the decomposition of leaf litter and fine roots, suggesting that there was no interactive effect of supplementary N and water on litter decomposition in this system. Furthermore, our results clearly indicate that the inhibitory effects of external N on dry mass loss and nitrogen release are relatively strong in high-lignin litter compared with low-lignin litter. Conclusion/Significance These findings suggest that increasing precipitation hardly facilitates ecosystem carbon turnover but atmospheric N deposition can enhance carbon sequestration and nitrogen retention in desertified dune grasslands of northern China. Additionally, litter quality of plant species should be considered when modelling the carbon cycle and nutrient dynamics of this system.	[Li, Yulin; Ning, Zhiying; Cui, Duo; Mao, Wei; Bi, Jingdong; Zhao, Xueyong] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, 320 Donggang West Rd, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Li, YL (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, 320 Donggang West Rd, Lanzhou 730000, Peoples R China.	liyl@lzb.ac.cn			China national key research and development plan [2016YFC0500907]; National natural Science Foundation of China [31270501, 41471083]; "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences [XDA05050406]	China national key research and development plan; National natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported by China national key research and development plan (2016YFC0500907), the National natural Science Foundation of China (31270501 and 41471083), and "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (XDA05050406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Araujo PI, 2012, OECOLOGIA, V168, P221, DOI 10.1007/s00442-011-2063-4; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2009, ECOLOGY, V90, P2642, DOI 10.1890/08-1804.1; Austin AT, 2000, J ECOL, V88, P129, DOI 10.1046/j.1365-2745.2000.00437.x; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; Dence C.W., 1992, METHODS LIGNIN CHEM, P33, DOI [DOI 10.1007/978-3-642-74065-7_3, 10.1007/978-3-642-74065-7_3]; Fujii S, 2010, SOIL BIOL BIOCHEM, V42, P2224, DOI 10.1016/j.soilbio.2010.08.022; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Giese M, 2009, APPL SOIL ECOL, V41, P8, DOI 10.1016/j.apsoil.2008.08.002; Hamadi Z, 2000, J ARID ENVIRON, V46, P281, DOI 10.1006/jare.2000.0672; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Kemp PR, 2003, J ARID ENVIRON, V53, P21, DOI 10.1006/jare.2002.1025; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Lee H, 2014, SOIL BIOL BIOCHEM, V72, P123, DOI 10.1016/j.soilbio.2014.01.027; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; Liu P, 2010, OECOLOGIA, V162, P771, DOI 10.1007/s00442-009-1506-7; Liu X. M., 1996, WIND SANDY ENV VEGET; Lue C., 2007, J GEOPHYS RES, V112, DOI [DOI 10.1029/2006JD007990, 10. 1029/2006JD007990]; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P2743, DOI 10.1016/j.soilbio.2006.04.028; Ostertag R, 1999, OECOLOGIA, V121, P564, DOI 10.1007/s004420050963; Papa S, 2008, APPL SOIL ECOL, V40, P401, DOI 10.1016/j.apsoil.2008.06.013; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pucheta E, 2006, AUSTRAL ECOL, V31, P808, DOI 10.1111/j.1442-9993.2006.01635.x; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; STEINBERGER Y, 1990, OECOLOGIA, V82, P322, DOI 10.1007/BF00317478; Sullivan NH, 1999, BIOTROPICA, V31, P382, DOI 10.1111/j.1744-7429.1999.tb00380.x; Swift MJ, 1979, DECOMPOSITION IN TER; Throop Heather L., 2009, V70, P171, DOI 10.1007/978-3-540-68421-3_8; Treonis AM, 2000, FUNCT ECOL, V14, P460, DOI 10.1046/j.1365-2435.2000.00442.x; Vanderbilt KL, 2008, J ARID ENVIRON, V72, P696, DOI 10.1016/j.jaridenv.2007.10.010; Vivanco L, 2011, GLOBAL CHANGE BIOL, V17, P1963, DOI 10.1111/j.1365-2486.2010.02344.x; Wang XY, 2013, FRESEN ENVIRON BULL, V22, P12; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7; Zhao HL, 2006, CATENA, V65, P71, DOI 10.1016/j.catena.2005.10.001; Zhou RL, 2008, GEODERMA, V145, P370, DOI 10.1016/j.geoderma.2008.04.003	48	19	22	15	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162663	10.1371/journal.pone.0162663	http://dx.doi.org/10.1371/journal.pone.0162663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617439	Green Submitted, gold, Green Published			2022-12-27	WOS:000383653100040
J	Wang, CY; Li, CX; Wei, H; Xie, YZ; Han, WJ				Wang, Chaoying; Li, Changxiao; Wei, Hong; Xie, Yingzan; Han, Wenjiao			Effects of Long-Term Periodic Submergence on Photosynthesis and Growth of Taxodium distichum and Taxodium ascendens Saplings in the Hydro-Fluctuation Zone of the Three Gorges Reservoir of China	PLOS ONE			English	Article							TAMARACK LARIX-LARICINA; SPRUCE PICEA-MARIANA; PLANT-RESPONSES; MORPHOLOGICAL RESPONSES; FLOODING TOLERANCE; ANOXIA TOLERANCE; SEEDLINGS; WATER; SURVIVAL; FOREST	Responses of bald cypress (Taxodium distichum) and pond cypress (Taxodium ascendens) saplings in photosynthesis and growth to long-termperiodic submergence in situ in the hydro-fluctuation zone of the Three Gorges Dam Reservoir (TGDR) were studied. Water treatments of periodic deep submergence (DS) and moderate submergence (MS) in situ were imposed on 2-year-old bald cypress and pond cypress saplings. The effects of periodic submergence on photosynthesis and growth were investigated after 3 years (i.e. 3 cycles) compared to a control (i.e. shallow submergence, abbreviated as SS). Results showed that pond cypress had no significant change in net photosynthetic rate (P-n) in response to periodic moderate and deep submergence in contrast to a significant decrease in Pn of bald cypress under both submergence treatments, when compared to that of SS. Ratios of Chlorophyll a/b and Chlorophylls/Carotenoid of pond cypress were significantly increased in periodic moderate submergence and deep submergence, while bald cypress showed no significant change. Diameter at breast height (DBH) and tree height of both species were significantly reduced along with submergence depth. Relative diameter and height growth rates of the two species were also reduced under deeper submergence. Moreover, bald cypress displayed higher relative diameter growth rate than pond cypress under deep submergence mainly attributed to higher productivity of the larger crown area of bald cypress. When subjected to deep subergence, both species showed significant reduction in primary branch number, while in moderate submergence, bald cypress but not pond cypress showed significant reduction in primary branch number. These results indicate that both bald cypress and pond cypress are suitbale candidates for reforestation in the TGDR region thanks to their submergence tolerance characteristics, but bald cypress can grow better than pond cypress under deep submergence overall.	[Wang, Chaoying; Li, Changxiao; Wei, Hong; Xie, Yingzan; Han, Wenjiao] Southwest Univ, Key Lab Ecoenvironm Gorges Reservoir Reg 3, Minist Educ,Sch Life Sci, Chongqing Key Lab Plant Ecol & Resources Gorges R, Chongqing 400715, Peoples R China	Southwest University - China	Li, CX (corresponding author), Southwest Univ, Key Lab Ecoenvironm Gorges Reservoir Reg 3, Minist Educ,Sch Life Sci, Chongqing Key Lab Plant Ecol & Resources Gorges R, Chongqing 400715, Peoples R China.	lichangx@swu.edu.cn	Changxiao, Li/ABF-6885-2020	WEI, Hong/0000-0001-9073-0928; Li, Changxiao/0000-0002-5090-6201	Chongqing Municipality Key Forestry Research Project [Yulinkeyan 2015-6, Yulinkeyan 2016-8]; International Sci-Tech Cooperation Project of Ministry of Science and Technology [2015DFA90900]; Forestry Extension Project of China Central Finance [Yulinketui 2014-10]	Chongqing Municipality Key Forestry Research Project; International Sci-Tech Cooperation Project of Ministry of Science and Technology; Forestry Extension Project of China Central Finance	This study was supported by Chongqing Municipality Key Forestry Research Project (Nos. Yulinkeyan 2015-6, 2016-8), International Sci-Tech Cooperation Project of Ministry of Science and Technology (No. 2015DFA90900) and Forestry Extension Project of China Central Finance (No. Yulinketui 2014-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PH, 1999, PHOTOSYNTHETICA, V37, P543, DOI 10.1023/A:1007163206642; Angelov MN, 1996, TREE PHYSIOL, V16, P477; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Berry J. A., 1982, Photosynthesis. Volume II. Development, carbon metabolism, and productivity, P263; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Conner WH., 1997, WETL ECOL MANAG, V5, P99, DOI [10.1023/A:1008251127131, DOI 10.1023/A:1008251127131]; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; CRAWFORD RMM, 1992, ADV ECOL RES, V23, P93, DOI 10.1016/S0065-2504(08)60147-6; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Das KK, 2009, ENVIRON EXP BOT, V66, P425, DOI 10.1016/j.envexpbot.2009.02.015; Dixon MD, 2015, ECOHYDROLOGY, V8, P812, DOI 10.1002/eco.1613; Effler RS, 2006, FOREST ECOL MANAG, V226, P330, DOI 10.1016/j.foreco.2006.02.011; Elcan JM, 2002, PHOTOSYNTHETICA, V40, P177, DOI 10.1023/A:1021381204684; Fan Da-Yong, 2015, Chinese Journal of Plant Ecology, V39, P416, DOI 10.17521/cjpe.2015.0041; FISHER HM, 1990, FOREST SCI, V36, P18; Striker GG, 2012, ECOL RES, V27, P983, DOI 10.1007/s11284-012-0978-9; Gardiner ES, 2001, TREE PHYSIOL, V21, P1103, DOI 10.1093/treephys/21.15.1103; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI [10.1071/PP98095_ER, 10.1071/PP98095]; Gimeno V, 2012, ENVIRON EXP BOT, V78, P47, DOI 10.1016/j.envexpbot.2011.12.014; Gravatt DA, 1998, TREE PHYSIOL, V18, P411; Greenway H, 2003, FUNCT PLANT BIOL, V30, P999, DOI 10.1071/PP98096; Griffiths H, 2002, ANN BOT-LONDON, V89, P801, DOI 10.1093/aob/mcf159; Islam MA, 2004, TREES-STRUCT FUNCT, V18, P35, DOI 10.1007/s00468-003-0276-9; Islam MA, 2003, TREE PHYSIOL, V23, P545, DOI 10.1093/treephys/23.8.545; Ismail MR, 1996, SCI HORTIC-AMSTERDAM, V65, P229, DOI 10.1016/0304-4238(96)00897-7; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jackson MB, 2009, ANN BOT-LONDON, V103, P137, DOI 10.1093/aob/mcn242; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; KEELAND BD, 1995, CAN J FOREST RES, V25, P1084, DOI 10.1139/x95-120; Kozlowski TT, 2002, WETLANDS, V22, P550, DOI 10.1672/0277-5212(2002)022[0550:PEIOFO]2.0.CO;2; Kozlowski TT, 1997, TREE PHYSL MONOGR, V1, P1, DOI [DOI 10.1093/TREEPHYS/17.7.490, 10.1093/treephys/17.7.490]; Lavinsky AO, 2007, NEW FOREST, V34, P41, DOI 10.1007/s11056-006-9036-1; Lei ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091394; Li ChangXiao, 2010, Scientia Silvae Sinicae, V46, P144; Li CX, 2010, PLANT SOIL, V329, P481, DOI 10.1007/s11104-009-0174-z; Li ChangXiao, 2005, Scientia Silvae Sinicae, V41, P28; [李昌晓 Li Changxiao], 2005, [生态学报, Acta Ecologica Sinica], V25, P1953; Li CX, 2007, FRONT FOREST CHINA, V2, P310, DOI [10.1007/s11461-007-0050-z, DOI 10.1007/S11461-007-0050-Z]; Li X, 2011, ACTA ECOLOGICA SINIC, V31, P31, DOI DOI 10.1002/SIM.4341; Liu YF, 2006, J CHONGQING THREE GO, V22, P4; Liu ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107636; Lu ZJ, 2010, PLANT ECOL, V209, P153, DOI 10.1007/s11258-010-9732-y; Lundberg CJ, 2011, ECOL ENG, V37, P549, DOI 10.1016/j.ecoleng.2010.11.012; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Lv Q, 2010, THESIS; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Masaka K, 2012, J FOREST RES-JPN, V17, P421, DOI 10.1007/s10310-011-0306-1; MEGONIGAL JP, 1992, ECOLOGY, V73, P1182, DOI 10.2307/1940668; Mielke MS, 2010, TREE PHYSIOL, V30, P45, DOI 10.1093/treephys/tpp095; Mielke MS, 2010, ENVIRON EXP BOT, V68, P113, DOI 10.1016/j.envexpbot.2009.11.007; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Ortuno MF, 2007, BIOL PLANTARUM, V51, P292, DOI 10.1007/s10535-007-0058-0; Palta MM, 2012, WETLANDS, V32, P59, DOI 10.1007/s13157-011-0245-9; Parad GA, 2013, TREES-STRUCT FUNCT, V27, P1387, DOI 10.1007/s00468-013-0886-9; Pena-Fronteras JT, 2009, ANN BOT-LONDON, V103, P295, DOI 10.1093/aob/mcn085; PEZESHKI S R, 1987, Wetlands, V7, P1; Pezeshki S.R., 1996, WETL ECOL MANAG, V4, P245; Pezeshki SR, 2007, ECOL ENG, V29, P56, DOI 10.1016/j.ecoleng.2006.07.014; Pezeshki SR, 2006, J AM WATER RESOUR AS, V42, P191, DOI 10.1111/j.1752-1688.2006.tb03833.x; Pezeshki SR, 1998, PHOTOSYNTHETICA, V35, P381, DOI 10.1023/A:1006912318352; PEZESHKI SR, 1994, PHOTOSYNTHETICA, V30, P59; Pezeshki SR, 1999, J PLANT NUTR, V22, P1481, DOI 10.1080/01904169909365729; [秦洪文 Qin Hongwen], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P284; Ronzhina DA, 2004, RUSS J PLANT PHYSL+, V51, P21, DOI 10.1023/B:RUPP.0000011299.93961.8f; Scholes JD, 1997, OECOLOGIA, V109, P41, DOI 10.1007/s004420050056; Stiller V, 2009, ENVIRON EXP BOT, V67, P164, DOI 10.1016/j.envexpbot.2009.03.012; Striker GG, 2008, J AGRON CROP SCI, V194, P249, DOI 10.1111/j.1439-037X.2008.00317.x; Tan Shu-Duan, 2009, Wuhan Zhiwuxue Yanjiu, V27, P391; Tan SD, 2010, ACTA PHYSIOL PLANT, V32, P133, DOI 10.1007/s11738-009-0388-y; Tang JL, 2015, ENVIRON SCI POLLUT R, V22, P16709, DOI 10.1007/s11356-015-4805-z; van Eck WHJM, 2006, HYDROBIOLOGIA, V565, P59, DOI 10.1007/s10750-005-1905-7; van Eck WHJM, 2005, AQUAT BOT, V81, P253, DOI 10.1016/j.aquabot.2004.10.006; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vann CD, 2002, ENVIRON POLLUT, V116, pS31, DOI 10.1016/S0269-7491(01)00244-5; Wang AF, 2013, ANN FOREST SCI, V70, P781, DOI 10.1007/s13595-013-0325-5; Xu ZZ, 2010, PLANT SIGNAL BEHAV, V5, P649, DOI 10.4161/psb.5.6.11398; Yordanov I, 2000, PHOTOSYNTHETICA, V38, P171, DOI 10.1023/A:1007201411474; Zhang ZhiYong, 2010, Acta Prataculturae Sinica, V19, P146; Zhu Ni-ni, 2015, Forest Research, V28, P109	79	16	22	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162867	10.1371/journal.pone.0162867	http://dx.doi.org/10.1371/journal.pone.0162867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618547	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100057
J	Cheung, YC; Juan, YH; Lin, YC; Lo, YF; Tsai, HP; Ueng, SH; Chen, SC				Cheung, Yun-Chung; Juan, Yu-Hsiang; Lin, Yu-Ching; Lo, Yung-Feng; Tsai, Hsiu-Pei; Ueng, Shir-Hwa; Chen, Shin-Cheh			Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women	PLOS ONE			English	Article							DIGITAL BREAST TOMOSYNTHESIS; DIAGNOSTIC PERFORMANCE; BIOPSY; DESCRIPTORS; MULTICENTER; MALIGNANCY; CARCINOMA; TRIAL; RISK; MRI	Background Mammography screening is a cost-efficient modality with high sensitivity for detecting impalpable cancer with microcalcifications, and results in reduced mortality rates. However, the probability of finding microcalcifications without associated cancerous masses varies. We retrospectively evaluated the diagnosis and cancer probability of the non-mass screened microcalcifications by dual-energy contrast-enhanced spectral mammography (DE-CESM). Patients and Methods With ethical approval from our hospital, we enrolled the cases of DE-CESM for analysis under the following inclusion criteria: (1) referrals due to screened BI-RADS 4 microcalcifications; (2) having DE-CESM prior to stereotactic biopsy; (3) no associated mass found by sonography and physical examination; and (4) pathology-based diagnosis using stereotactic vacuum-assisted breast biopsy. We analyzed the added value of post-contrast enhancement on DE-CESM. Results A total of 94 biopsed lesions were available for analysis in our 87 women, yielding 27 cancers [19 ductal carcinoma in situ (DCIS), and 8 invasive ductal carcinoma (IDC)], 32 premalignant and 35 benign lesions. Of these 94 lesions, 33 showed associated enhancement in DE-CESM while the other 61 did not. All 8 IDC (100%) and 16 of 19 DCIS (84.21%) showed enhancement, but the other 3 DCIS (15.79%) did not. Overall sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 88.89%, 86.56%, 72.72%, 95.08% and 87.24%, respectively. The performances of DE-CESM on both amorphous and pleomorphic microcalcifications were satisfactory (AUC 0.8 and 0.92, respectively). The pleomorphous microcalcifications with enhancement showed higher positive predictive value (90.00% vs 46.15%, p = 0.013) and higher cancer probability than the amorphous microcalcifications (46.3% VS 15.1%). The Odds Ratio was 4.85 (95% CI: 1.84-12.82). Conclusion DE-CESM might provide added value in assessing the non-mass screened breast microcalcification, with enhancement favorable to the diagnosis of cancers or lack of enhancement virtually diagnostic for non-malignant lesions or noninvasive subgroup cancers.	[Cheung, Yun-Chung; Juan, Yu-Hsiang; Lin, Yu-Ching] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Lo, Yung-Feng; Tsai, Hsiu-Pei; Chen, Shin-Cheh] Chang Gung Mem Hosp Linkou, Dept Surg, Taoyuan, Taiwan; [Ueng, Shir-Hwa] Chang Gung Mem Hosp Linkou, Dept Pathol, Taoyuan, Taiwan; [Cheung, Yun-Chung; Juan, Yu-Hsiang; Lin, Yu-Ching; Lo, Yung-Feng; Tsai, Hsiu-Pei; Ueng, Shir-Hwa; Chen, Shin-Cheh] Chang Gung Univ, Coll Med, 5 Fuxing St, Taoyuan, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Cheung, YC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan.; Cheung, YC (corresponding author), Chang Gung Univ, Coll Med, 5 Fuxing St, Taoyuan, Taoyuan County, Taiwan.	alex2143@cgmh.org.tw						Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Bent CK, 2010, AM J ROENTGENOL, V194, P1378, DOI 10.2214/AJR.09.3423; Berg WA, 2003, AM J ROENTGENOL, V180, P1225, DOI 10.2214/ajr.180.5.1801225; Burnside ES, 2007, RADIOLOGY, V242, P388, DOI 10.1148/radiol.2422052130; Cheung YC, 2002, J CLIN ULTRASOUND, V30, P323, DOI 10.1002/jcu.10074; Cheung YC, 2016, EUR RADIOL, V26, P1082, DOI 10.1007/s00330-015-3904-z; Cheung YC, 2014, EUR RADIOL, V24, P2394, DOI 10.1007/s00330-014-3271-1; Dromain C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3210; Dromain C, 2011, EUR RADIOL, V21, P565, DOI 10.1007/s00330-010-1944-y; HOLLAND R, 1982, CANCER, V49, P2527, DOI 10.1002/1097-0142(19820615)49:12<2527::AID-CNCR2820491220>3.0.CO;2-E; Jochelson MS, 2013, RADIOLOGY, V266, P743, DOI 10.1148/radiol.12121084; Jorgensen KJ, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-12; Kettritz U, 2004, CANCER-AM CANCER SOC, V100, P245, DOI 10.1002/cncr.11887; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Lobbes MBI, 2014, EUR RADIOL, V24, P1668, DOI 10.1007/s00330-014-3154-5; Michell MJ, 2012, CLIN RADIOL, V67, P976, DOI 10.1016/j.crad.2012.03.009; Morris EA, 2003, AM J ROENTGENOL, V181, P619, DOI 10.2214/ajr.181.3.1810619; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Soo MS, 2003, AM J ROENTGENOL, V180, P941, DOI 10.2214/ajr.180.4.1800941; Spangler ML, 2011, AM J ROENTGENOL, V196, P320, DOI 10.2214/AJR.10.4656; Wallis MG, 2012, RADIOLOGY, V262, P788, DOI 10.1148/radiol.11103514	22	31	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162740	10.1371/journal.pone.0162740	http://dx.doi.org/10.1371/journal.pone.0162740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611215	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900161
J	Danevcic, T; Vezjak, MB; Zorec, M; Stopar, D				Danevcic, Tjasa; Vezjak, Maja Boric; Zorec, Masa; Stopar, David			Prodigiosin - A Multifaceted Escherichia coli Antimicrobial Agent	PLOS ONE			English	Article							SERRATIA-MARCESCENS; BACTERIAL PRODIGININES; ADAPTIVE RESPONSES; BIOSYNTHESIS; ANTICANCER; EXPRESSION; PIGMENT; COLORANTS; CELLS; ATP	Despite a considerable interest in prodigiosin, the mechanism of its antibacterial activity is still poorly understood. In this work, Escherichia coli cells were treated with prodigiosin to determine its antimicrobial effect on bacterial physiology. The effect of prodigiosin was concentration dependent. In prodigiosin treated cells above MIC value no significant DNA damage or cytoplasmic membrane disintegration was observed. The outer membrane, however, becomes leaky. Cells had severely decreased respiration activity. In prodigiosin treated cells protein and RNA synthesis were inhibited, cells were elongated but could not divide. Pre-treatment with prodigiosin improved E. coli survival rate in media containing ampicillin, kanamycin and erythromycin but not phleomycin. The results suggest that prodigiosin acts as a bacteriostatic agent in E. coli cells. If prodigiosin was diluted, cells resumed growth. The results indicate that prodigiosin has distinct mode of antibacterial action in different bacteria.	[Danevcic, Tjasa; Vezjak, Maja Boric; Stopar, David] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Microbiol Lab, Ljubljana, Slovenia; [Zorec, Masa] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Lab Microbiol & Microbial Biotechnol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Stopar, D (corresponding author), Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Microbiol Lab, Ljubljana, Slovenia.	david.stopar@bf.uni-lj.si			Slovenian Research Agency (ARRS grant) [1000-09-310208]; Slovenian Research Agency [P4-0116]	Slovenian Research Agency (ARRS grant); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The financial support from the Slovenian Research Agency (ARRS grant no. 1000-09-310208). This work was also supported by the Slovenian Research Agency grant P4-0116. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2004, J BACTERIOL, V186, P6133, DOI 10.1128/jb.186.18.6133-6141.2004; Ahn HJ, 2006, APPL ENVIRON MICROB, V72, P7383, DOI 10.1128/AEM.01246-06; Alihosseini F, 2008, BIOTECHNOL PROGR, V24, P742, DOI 10.1021/bp070481r; Alihosseini F, 2010, BIOTECHNOL PROGR, V26, P352, DOI 10.1002/btpr.346; Arivizhivendhan KV, 2015, RSC ADV, V5, P68621, DOI 10.1039/c5ra09172a; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; Boric M, 2011, MICROB ECOL, V62, P528, DOI 10.1007/s00248-011-9857-0; BURGER SR, 1985, APPL ENVIRON MICROB, V50, P487, DOI 10.1128/AEM.50.2.487-490.1985; Danevcic T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00027; Danevcic T, 2011, MICROB ECOL, V62, P198, DOI 10.1007/s00248-011-9870-3; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; GERBER N N, 1975, Critical Reviews in Microbiology, V3, P469, DOI 10.3109/10408417509108758; Haddix PL, 2008, J BACTERIOL, V190, P7453, DOI 10.1128/JB.00909-08; HOOD DW, 1992, GENE, V115, P5, DOI 10.1016/0378-1119(92)90533-U; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Ivancic T, 2009, MICROBIOL-SGM, V155, P3461, DOI 10.1099/mic.0.029637-0; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kawasaki T, 2009, J ANTIBIOT, V62, P271, DOI 10.1038/ja.2009.27; Konno H, 1998, J BIOCHEM-TOKYO, V124, P547, DOI 10.1093/oxfordjournals.jbchem.a022147; Lapenda JC, 2015, WORLD J MICROB BIOT, V31, P399, DOI 10.1007/s11274-014-1793-y; Lee JS, 2011, APPL ENVIRON MICROB, V77, P4967, DOI 10.1128/AEM.01986-10; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; Mensa B, 2011, ANTIMICROB AGENTS CH, V55, P5043, DOI 10.1128/AAC.05009-11; Meschke H, 2012, ENVIRON MICROBIOL, V14, P940, DOI 10.1111/j.1462-2920.2011.02665.x; Neissel OM, 1996, ESCHERICHIA COLI SAL, V2, P1683; Okamoto Hiroshi, 1998, Annals of the Phytopathological Society of Japan, V64, P294, DOI 10.3186/jjphytopath.64.294; Pandey R, 2009, CURR PHARM DESIGN, V15, P732, DOI 10.2174/138161209787582192; Perez-Tomas R, 2003, BIOCHEM PHARMACOL, V66, P1447, DOI 10.1016/S0006-2952(03)00496-9; Perez-Tomas R, 2010, CURR MED CHEM, V17, P2222, DOI 10.2174/092986710791331103; PURKAYASTHA M, 1960, NATURE, V187, P349, DOI 10.1038/187349a0; Radman M, 1974, MOL ENV ASPECTS MUTA, P128; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; RYAZANTSEVA IN, 1995, THERMOCHIM ACTA, V251, P63, DOI 10.1016/0040-6031(94)02148-H; Seganish JL, 2005, CHEM COMMUN, P5781, DOI 10.1039/b511847f; Shireen T, 2013, ANTIMICROB AGENTS CH, V57, P5134, DOI 10.1128/AAC.00780-13; Soto-Cerrato V, 2007, BIOCHEM PHARMACOL, V74, P1340, DOI 10.1016/j.bcp.2007.07.016; Stankovic N, 2014, APPL MICROBIOL BIOT, V98, P3841, DOI 10.1007/s00253-014-5590-1; Stankovic N, 2012, APPL MICROBIOL BIOT, V96, P1217, DOI 10.1007/s00253-012-4237-3; Staric N, 2010, MICROB ECOL, V60, P592, DOI 10.1007/s00248-010-9671-0; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Szomolay B, 2005, ENVIRON MICROBIOL, V7, P1186, DOI 10.1111/j.1462-2920.2005.00797.x; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531	45	45	48	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162412	10.1371/journal.pone.0162412	http://dx.doi.org/10.1371/journal.pone.0162412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612193	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900092
J	de Sa, PM; Castro, HA; Lopes, AJ; de Melo, PL				de Sa, Paula Morisco; Castro, Hermano Albuquerque; Lopes, Agnaldo Jose; de Melo, Pedro Lopes			Early Diagnosis of Respiratory Abnormalities in Asbestos-Exposed Workers by the Forced Oscillation Technique	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; AIRWAY-OBSTRUCTION; IMPEDANCE MEASUREMENTS; INCREASING DEGREES; WESTERN-AUSTRALIA; INPUT IMPEDANCE; CYSTIC-FIBROSIS; MECHANICS; ACCURACY; SMOKING	Background The current reference test for the detection of respiratory abnormalities in asbestos-exposed workers is spirometry. However, spirometry has several shortcomings that greatly affect the efficacy of current asbestos control programs. The forced oscillation technique (FOT) represents the current state-of-the-art technique in the assessment of lung function. This method provides a detailed analysis of respiratory resistance and reactance at different oscillatory frequencies during tidal breathing. Here, we evaluate the FOT as an alternative method to standard spirometry for the early detection and quantification of respiratory abnormalities in asbestos-exposed workers. Methodology/Principalfindings Seventy-two subjects were analyzed. The control group was composed of 33 subjects with a normal spirometric exam who had no history of smoking or pulmonary disease. Thirty-nine subjects exposed to asbestos were also studied, including 32 volunteers in radiological category 0/0 and 7 volunteers with radiological categories of 0/1 or 1/1. FOT data were interpreted using classical parameters as well as integer (InOr) and fractional-order (FrOr) modeling. The diagnostic accuracy was evaluated by investigating the area under the receiver operating characteristic curve (AUC). Exposed workers presented increased obstruction (resistance p<0.001) and a reduced compliance (p<0.001), with a predominance of obstructive changes. The FOT parameter changes were correlated with the standard pulmonary function analysis methods (R = -0.52, p<0.001). Early respiratory abnormalities were identified with a high diagnostic accuracy (AUC = 0.987) using parameters obtained from the FrOr modeling. This accuracy was significantly better than those obtained with classical (p<0.001) and InOr (p<0.001) model parameters. Conclusions The FOT improved our knowledge about the biomechanical abnormalities in workers exposed to asbestos. Additionally, a high diagnostic accuracy in the diagnosis of early respiratory abnormalities in asbestos-exposed workers was obtained. This makes the FOT particularly useful as a screening tool in the context of asbestos control and elimination. Moreover, it can facilitate epidemiological research and the longitudinal follow-up of asbestos exposure and asbestos-related diseases.	[de Sa, Paula Morisco; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil; [de Sa, Paula Morisco; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil; [de Sa, Paula Morisco; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, BioVasc Res Lab, Rio De Janeiro, Brazil; [Castro, Hermano Albuquerque] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose] Univ Estado Rio De Janeiro, Pulm Funct Testing Lab, Fac Med Sci, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Juiz de Fora; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, BioVasc Res Lab, Rio De Janeiro, Brazil.	plopes@uerj.br	Melo, Pedro/E-8440-2011; Lopes, Agnaldo José/AAB-5944-2019	Melo, Pedro/0000-0002-2081-6619; Lopes, Agnaldo José/0000-0001-8598-4878	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	The present study was funded by the Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq) and the Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A A B, 2010, J OCCUPATIONAL MED T, V5; Alfonso HS, 2005, MED J AUSTRALIA, V183, P184, DOI 10.5694/j.1326-5377.2005.tb06990.x; Alfonso HS, 2005, J OCCUP ENVIRON MED, V47, P573, DOI 10.1097/01.jom.0000165750.54747.27; Alfonso HS, 2004, THORAX, V59, P1052, DOI 10.1136/thx.2004.022806; Ameille J, 2010, AM J RESP CRIT CARE, V182, P526, DOI 10.1164/rccm.200812-1815OC; Bates JHT, 2011, COMPR PHYSIOL, V1, P1233, DOI 10.1002/cphy.c100058; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Becklake MR, 2007, INT J TUBERC LUNG D, V11, P356; Boros PW, 2004, RESPIRATION, V71, P374, DOI 10.1159/000079642; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Cavalcanti JV, 2006, RESP MED, V100, P2207, DOI 10.1016/j.rmed.2006.03.009; Croxton Thomas L., 2002, American Journal of Respiratory and Critical Care Medicine, V165, P838; de Melo PL, 2000, MED BIOL ENG COMPUT, V38, P102, DOI 10.1007/BF02344697; de Sa PM, 2013, CLINICS, V68, P644, DOI 10.6061/clinics/2013(05)11; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Mango AMGT, 2006, RESP MED, V100, P399, DOI 10.1016/j.rmed.2005.07.005; Faria ACD, 2010, CLINICS, V65, P1295, DOI 10.1590/S1807-59322010001200012; Dias RM, 2007, J BRAS PNEUMOL, V33, pxiii; Diong B, 2007, IEEE ENG MED BIOL, V26, P48, DOI 10.1109/MEMB.2007.289121; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Faria ACD, 2009, RESPIRATION; Faria ACD, 2016, COMPUT METH PROG BIO, V128, P12, DOI 10.1016/j.cmpb.2016.02.010; Faria ACD, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-22; Faria ACD, 2009, RESPIRATION, V78, P93, DOI 10.1159/000213756; Felten MK, 2014, INT ARCH OCC ENV HEA, V87, P195, DOI 10.1007/s00420-013-0853-1; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408, DOI 10.1152/jappl.1989.67.6.2408; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hotez PJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001859; International Labour Organization, 2002, GUID US ILO INT CLAS; International Social Security Association, 2010, DAT SOC SEC SOC PROT; Ionescu  C., 2006, ANN DUNAREA JOS U GA, P57; Ionescu C, 2013, HUMAN RESP SYSTEM AN; Ionescu C, 2011, COMPUT METH PROG BIO, V101, P315, DOI 10.1016/j.cmpb.2010.11.010; Ionescu C, 2010, COMPUT METH PROG BIO, V97, P78, DOI 10.1016/j.cmpb.2009.06.006; Ionescu CM, 2014, BIOMED SIGNAL PROCES, V11, P74, DOI 10.1016/j.bspc.2014.02.008; Ionescu CM, 2009, IEEE T BIO-MED ENG, V56, P978, DOI 10.1109/TBME.2008.2004966; JODOIN G, 1971, AM REV RESPIR DIS, V104, P525; Kaminsky DA, 2001, CURR OPIN ALLERGY CL, V1, P205; Langkulsen U, 2006, EUR J PUBLIC HEALTH, V16, P676, DOI 10.1093/eurpub/ckl061; LaPrad AS, 2008, RESP PHYSIOL NEUROBI, V163, P64, DOI 10.1016/j.resp.2008.04.015; Lima AN, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0007-7; Lopes Agnaldo José, 2008, J. bras. pneumol., V34, P264, DOI 10.1590/S1806-37132008000500004; Lopes AJ, 2006, JORNAL BRASILEIRO PN; Lorino AM, 1997, EUR RESPIR J, V10, P150, DOI 10.1183/09031936.97.10010150; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1696, DOI 10.1152/jappl.1996.80.5.1696; MacLeod D, 2001, MED BIOL ENG COMPUT, V39, P505, DOI 10.1007/BF02345140; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P1, DOI 10.1615/CritRevBiomedEng.v32.10; Magin RL, 2010, COMPUT MATH APPL, V59, P1586, DOI 10.1016/j.camwa.2009.08.039; Marín Martínez B., 2005, Anales Sis San Navarra, V28, P37; Marsili D, 2013, ANN I SUPER SANITA, V49, P249, DOI 10.4415/ANN_13_03_03; Meraz EG, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-21; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miranda IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061657; Mizell Kelly N, 2009, J Occup Med Toxicol, V4, P14, DOI 10.1186/1745-6673-4-14; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; NAGELS J, 1980, J APPL PHYSIOL, V49, P408, DOI 10.1152/jappl.1980.49.3.408; NAKADATE T, 1995, OCCUP ENVIRON MED, V52, P368, DOI 10.1136/oem.52.6.368; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Nilsson AM, 2014, SCAND J RHEUMATOL, V43, P324, DOI 10.3109/03009742.2013.856466; Ohar J, 2004, CHEST, V125, P744, DOI 10.1378/chest.125.2.744; OOSTVEEN E, 1991, J APPL PHYSIOL, V71, P1813, DOI 10.1152/jappl.1991.71.5.1813; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Park EK, 2014, SAF HEALTH WORK, V5, P234, DOI 10.1016/j.shaw.2014.07.007; Pereira CAC, 1992, J PNEUMOL, V18, P10; PESLIN R, 1986, B EUR PHYSIOPATH RES, V22, P621; Peters U, 2016, APPL PHYSIOL NUTR ME, V41, P538, DOI 10.1139/apnm-2015-0473; PHAM QT, 1995, EUR RESPIR J, V8, P1307, DOI 10.1183/09031936.95.08081307; Pira E, 2009, OCCUP ENVIRON MED, V66, P805, DOI 10.1136/oem.2008.044693; Polkey MI, 2004, EUR RESPIR J, V24, P718, DOI 10.1183/09031936.04.00073104; Qi GS, 2013, J ASTHMA, V50, P45, DOI 10.3109/02770903.2012.743154; Reisch S, 1999, BIOL CYBERN, V81, P25, DOI 10.1007/s004220050542; Reisch S, 1998, Technol Health Care, V6, P245; Sa PM, 2010, IEEE ENG MED BIO, P398, DOI 10.1109/IEMBS.2010.5627284; Sa PM, 2014, 24 C BRAS ENG BIOM U, P73; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Sociedade Brasileira de Pneumologia e Tisiologia SBPT, 2009, J PNEUMOL SUPPL 3, V38; Sridhar D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001487; STAPLES CA, 1989, AM REV RESPIR DIS, V139, P1502, DOI 10.1164/ajrccm/139.6.1502; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Van Noord J A, 1991, Eur Respir J, V4, P247; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Veiga J, 2009, CLINICS, V64, P649, DOI 10.1590/S1807-59322009000700008; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; Wang XR, 2010, J OCCUP HEALTH, V52, P272, DOI 10.1539/joh.L10062; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2014, COMPR CERV CANC CONT, P1; World Healthy Organization, 2012, OUTL DEV NAT PROGR E; Yang Shieh-Ching, 2009, Chang Gung Med J, V32, P438; 1983, AM REV RESP DIS, V127, P725	90	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161981	10.1371/journal.pone.0161981	http://dx.doi.org/10.1371/journal.pone.0161981			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612198	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900041
J	Lavoie, BR; Okoniewski, M; Fear, EC				Lavoie, Benjamin R.; Okoniewski, Michal; Fear, Elise C.			Estimating the Effective Permittivity for Reconstructing Accurate Microwave-Radar Images	PLOS ONE			English	Article							BREAST-CANCER DETECTION; POLYNOMIAL CHAOS; SENSITIVITY; SYSTEM	We present preliminary results from a method for estimating the optimal effective permittivity for reconstructing microwave-radar images. Using knowledge of how microwave-radar images are formed, we identify characteristics that are typical of good images, and define a fitness function to measure the relative image quality. We build a polynomial interpolant of the fitness function in order to identify the most likely permittivity values of the tissue. To make the estimation process more efficient, the polynomial interpolant is constructed using a locally and dimensionally adaptive sampling method that is a novel combination of stochastic collocation and polynomial chaos. Examples, using a series of simulated, experimental and patient data collected using the Tissue Sensing Adaptive Radar system, which is under development at the University of Calgary, are presented. These examples show how, using our method, accurate images can be reconstructed starting with only a broad estimate of the permittivity range.	[Lavoie, Benjamin R.; Okoniewski, Michal; Fear, Elise C.] Univ Calgary, Schulich Sch Engn, Dept Elect & Comp Engn, Calgary, AB T2N 1N4, Canada	University of Calgary	Lavoie, BR (corresponding author), Univ Calgary, Schulich Sch Engn, Dept Elect & Comp Engn, Calgary, AB T2N 1N4, Canada.	brlavoie@ucalgary.ca		Lavoie, Benjamin/0000-0002-5476-0561; Fear, Elise/0000-0002-9984-8188	Alberta Innovates Health Solutions; Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering; Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing	Alberta Innovates Health Solutions; Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering; Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing	ECF is supported by the Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing (http://www.albertatechfutures.ca/Research/BasicResearch/StrategicChairProgram.aspx), and by Alberta Innovates Health Solutions. MO is supported by the Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. Okoniewski is supported by the Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering, and E. Fear is supported by the Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing. The authors would like to thank Charlotte Curtis, Jeremie Bourqui and Doug Kurrant for their contributions.	Agarwal N, 2009, J COMPUT PHYS, V228, P7662, DOI 10.1016/j.jcp.2009.07.014; Bourqui J, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/851234; Bourqui J, 2014, PROC EUR CONF ANTENN, P77, DOI 10.1109/EuCAP.2014.6901696; Bourqui J, 2010, IEEE T ANTENN PROPAG, V58, P2318, DOI 10.1109/TAP.2010.2048844; Byrne D, 2015, IEEE T ANTENN PROPAG, V63, P1725, DOI 10.1109/TAP.2015.2398125; Crestaux T, 2009, RELIAB ENG SYST SAFE, V94, P1161, DOI 10.1016/j.ress.2008.10.008; Curtis C, 2014, PROC EUR CONF ANTENN, P72, DOI 10.1109/EuCAP.2014.6901695; Curtis C, 2013, PROC EUR CONF ANTENN, P628; Curtis C, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/235380; Curtis CF, 2015, USNC-URSI RADIO SCI, P306; Curtis CF, 2013, USNC-URSI RADIO SCI, P179, DOI 10.1109/USNC-URSI.2013.6715485; Deprez J.-F, 2012, Progress In Electromagnetics Research B, V42, P381; Elahi MA, 2015, USNC-URSI RADIO SCI, P307; Eldred M., 2009, AIAA J, P376; Fear EC, 2013, IEEE T MICROW THEORY, V61, P2119, DOI 10.1109/TMTT.2013.2255884; Fear EC, 2002, IEEE T BIO-MED ENG, V49, P812, DOI 10.1109/TBME.2002.800759; Garrett J, 2015, IEEE T ANTENN PROPAG, V63, P1693, DOI 10.1109/TAP.2015.2393854; Gerstner T, 1998, NUMER ALGORITHMS, V18, P209, DOI 10.1023/A:1019129717644; Guo L, 2015, IEEE T ANTENN PROPAG, V63, P3531, DOI 10.1109/TAP.2015.2434394; Kurrant D, 2015, IEEE T ANTENN PROPAG, V63, P4910, DOI 10.1109/TAP.2015.2476415; Kurrant D, 2013, IEEE T MICROW THEORY, V61, P2137, DOI 10.1109/TMTT.2013.2250993; Lazebnik M, 2007, PHYS MED BIOL, V52, P6093, DOI 10.1088/0031-9155/52/20/002; Ma X, 2009, J COMPUT PHYS, V228, P3084, DOI 10.1016/j.jcp.2009.01.006; Maklad B., 2012, Progress In Electromagnetics Research B, V39, P115, DOI 10.2528/PIERB11122208; Mobashsher AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152351; Nikolova NK, 2011, IEEE MICROW MAG, V12, P78, DOI 10.1109/MMM.2011.942702; Perko Z, 2014, J COMPUT PHYS, V260, P54, DOI 10.1016/j.jcp.2013.12.025; Porter E, 2013, IEEE ANTENN WIREL PR, V12, P229, DOI 10.1109/LAWP.2013.2247374; Santamaria Lancia Adran A., 2015, 29th European Photovoltaic Solar Energy Conference and Exhibition (EU PVSEC 2014); Sarafianou M, 2013, PROC EUR CONF ANTENN, P839; Sill JM, 2005, IEEE T MICROW THEORY, V53, P3312, DOI 10.1109/TMTT.2005.857330; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Sudret B, 2008, RELIAB ENG SYST SAFE, V93, P964, DOI 10.1016/j.ress.2007.04.002; Wiggett WS, 2012, S AFR J SURG, V50, P75, DOI 10.7196/SAJS.1103; Xiu DB, 2002, SIAM J SCI COMPUT, V24, P619, DOI 10.1137/S1064827501387826	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160849	10.1371/journal.pone.0160849	http://dx.doi.org/10.1371/journal.pone.0160849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611785	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900011
J	Sonter, LJ; Watson, KB; Wood, SA; Ricketts, TH				Sonter, Laura J.; Watson, Keri B.; Wood, Spencer A.; Ricketts, Taylor H.			Spatial and Temporal Dynamics and Value of Nature-Based Recreation, Estimated via Social Media	PLOS ONE			English	Article							ECOSYSTEM SERVICES; UNITED-STATES; LAND-USE; TOURISM; DEMAND	Conserved lands provide multiple ecosystem services, including opportunities for nature-based recreation. Managing this service requires understanding the landscape attributes underpinning its provision, and how changes in land management affect its contribution to human wellbeing over time. However, evidence from both spatially explicit and temporally dynamic analyses is scarce, often due to data limitations. In this study, we investigated nature-based recreation within conserved lands in Vermont, USA. We used geotagged photographs uploaded to the photo-sharingwebsite Flickr to quantify visits by in-state and out-of-state visitors, and we multiplied visits by mean trip expenditures to show that conserved lands contributed US $1.8 billion (US $0.18-20.2 at 95% confidence) to Vermont's tourism industry between 2007 and 2014. We found eight landscape attributes explained the pattern of visits to conserved lands; visits were higher in larger conserved lands, with less forest cover, greater trail density and more opportunities for snow sports. Some of these attributes differed from those found in other locations, but all aligned with our understanding of recreation in Vermont. We also found that using temporally static models to inform conservation decisions may have perverse outcomes for nature-based recreation. For example, static models suggest conserved land with less forest cover receive more visits, but temporally dynamic models suggest clearing forests decreases, rather than increases, visits to these sites. Our results illustrate the importance of understanding both the spatial and temporal dynamics of ecosystem services for conservation decision-making.	[Sonter, Laura J.; Watson, Keri B.; Ricketts, Taylor H.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Sonter, Laura J.; Watson, Keri B.; Ricketts, Taylor H.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA; [Wood, Spencer A.] Stanford Univ, Woods Inst Environm, Nat Capital Project, Stanford, CA 94305 USA; [Wood, Spencer A.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Vermont; University of Vermont; Stanford University; University of Washington; University of Washington Seattle	Sonter, LJ (corresponding author), Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA.; Sonter, LJ (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	lsonter@uvm.edu	Wood, Spencer/A-3603-2009; Sonter, Laura/I-6756-2013	Sonter, Laura/0000-0002-6590-3986; Watson, Keri/0000-0002-4471-5652	USDA McIntire-Stennis award [2014-32100-06050]	USDA McIntire-Stennis award	LJS and KBW were supported by a USDA McIntire-Stennis award #2014-32100-06050 to the Univesrity of Vermont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz WL, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P188; [Anonymous], 2021, LANG ENV STAT COMP; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002074; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Casalegno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068437; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chmura Economics and Analytics, 2011, BENCHM STUD EC IMP V; Crossman ND, 2013, CURR OPIN ENV SUST, V5, P509, DOI 10.1016/j.cosust.2013.06.003; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; FLETCHER JE, 1989, ANN TOURISM RES, V16, P514, DOI 10.1016/0160-7383(89)90006-6; Frechtling D. C., 1999, Journal of Travel Research, V37, P324, DOI 10.1177/004728759903700402; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Hill GW, 2006, FORESTRY, V79, P185, DOI 10.1093/forestry/cpl005; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Keeler BL, 2015, FRONT ECOL ENVIRON, V13, P76, DOI 10.1890/140124; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Maciejewski K, 2015, ECOL APPL, V25, P11, DOI 10.1890/13-2240.1; Neuvonen M, 2010, J NAT CONSERV, V18, P224, DOI 10.1016/j.jnc.2009.10.003; North East State Foresters Association, 2013, EC IMP VERM FOR BAS; Outdoor Industry Foundation, 2006, ACT OUTD RECR EC OUT; Palmer JF, 2008, J ENVIRON MANAGE, V89, P167, DOI 10.1016/j.jenvman.2007.01.064; Portland Research Group, 2007, VERM VIS PROF RES EC; School of Business Administration and Vermont Tourism Data Center, 2001, NAT SURV VERM VIS OU; Scott D, 2008, MITIG ADAPT STRAT GL, V13, P577, DOI 10.1007/s11027-007-9136-z; Sen A, 2014, ENVIRON RESOUR ECON, V57, P233, DOI 10.1007/s10640-013-9666-7; Termansen M, 2013, ECOL ECON, V92, P48, DOI 10.1016/j.ecolecon.2013.05.001; Tyrvainen L, 2014, FOREST POLICY ECON, V47, P4, DOI 10.1016/j.forpol.2013.05.007; USDA Forest Service, 2015, VIS US REP GREEN MOU; Vermont Departmentof Forests, 2013, VERM STAT COMPR OUTD; Vermont Legislative Joint Fiscal Office, 2015, FY2014 AG DEP BUDG; Vermont Tourism Research Centre, 2013, VERM TOUR RECR SURV; Watson JEM, 2016, CONSERV BIOL, V30, P243, DOI 10.1111/cobi.12645; Weyland F, 2014, ECOL INDIC, V39, P34, DOI 10.1016/j.ecolind.2013.11.023; Willemen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129785; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	38	100	106	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162372	10.1371/journal.pone.0162372	http://dx.doi.org/10.1371/journal.pone.0162372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611325	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900084
J	Watanabe, M; Hashimoto, K; Abe, Y; Kodama, EN; Nabika, R; Oishi, S; Ohara, S; Sato, M; Kawasaki, Y; Fujii, N; Hosoya, M				Watanabe, Masahiro; Hashimoto, Koichi; Abe, Yusaku; Kodama, Eiichi N.; Nabika, Ryota; Oishi, Shinya; Ohara, Shinichiro; Sato, Masatoki; Kawasaki, Yukihiko; Fujii, Nobutaka; Hosoya, Mitsuaki			A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo	PLOS ONE			English	Article							MEASLES-VIRUS; PARAMYXOVIRUS FUSION; INTRAVENTRICULAR INTERFERON; EDMONSTON STRAIN; F-PROTEIN; ENFUVIRTIDE; RIBAVIRIN; RECEPTOR; REGIONS; BRAIN	Subacute sclerosing panencephalitis (SSPE) is a persistent, progressive, and fatal degenerative disease resulting from persistent measles virus (MV) infection of the central nervous system. Most drugs used to treat SSPE have been reported to have limited effects. Therefore, novel therapeutic strategies are urgently required. The SSPE virus, a variant MV strain, differs virologically from wild-type MV strain. One characteristic of the SSPE virus is its defective production of cell-free virus, which leaves cell-to-cell infection as the major mechanism of viral dissemination. The fusion protein plays an essential role in this cell-to-cell spread. It contains two critical heptad repeat regions that forma six-helix bundle in the trimer similar to most viral fusion proteins. In the case of human immunodeficiency virus type-1 (HIV-1), a synthetic peptide derived from the heptad repeat region of the fusion protein enfuvirtide inhibits viral replication and is clinically approved as an anti-HIV-1 agent. The heptad repeat regions of HIV-1 are structurally and functionally similar to those of the MV fusion protein. We therefore designed novel peptides derived from the fusion protein heptad repeat region of the MV and examined their effects on the measles and SSPE virus replication in vitro and in vivo. Some of these synthetic novel peptides demonstrated high antiviral activity against both the measles (Edmonston strain) and SSPE (Yamagata-1 strain) viruses at nanomolar concentrations with no cytotoxicity in vitro. In particular, intracranial administration of one of the synthetic peptides increased the survival rate from 0% to 67% in an SSPE virus-infected nude mouse model.	[Watanabe, Masahiro; Hashimoto, Koichi; Abe, Yusaku; Ohara, Shinichiro; Sato, Masatoki; Kawasaki, Yukihiko; Hosoya, Mitsuaki] Fukushima Med Univ, Dept Pediat, Fukushima, Japan; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Sendai, Miyagi, Japan; [Nabika, Ryota; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	Fukushima Medical University; Tohoku University; Kyoto University	Watanabe, M (corresponding author), Fukushima Med Univ, Dept Pediat, Fukushima, Japan.	nabe5658@fmu.ac.jp	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; xing zhi, shi zhi/0000-0003-3289-5681	Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare, Japan	Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The work was supported by Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus Infection and from the Ministry of Health, Labour and Welfare, Japan, URL: http://prion.umin.jp/index.html, recipient: MH.; This work was supported by Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus Infection and the Ministry of Health, Labor and Welfare, Japan.	Akiyama M, 2009, J MED MICROBIOL, V58, P638, DOI 10.1099/jmm.0.005439-0; AYATA M, 1991, VIROLOGY, V180, P166, DOI 10.1016/0042-6822(91)90020-C; Ayata M, 2010, J VIROL, V84, P11189, DOI 10.1128/JVI.01075-10; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; CATTANEO R, 1986, VIROLOGY, V154, P97, DOI 10.1016/0042-6822(86)90433-2; CHAMBERS P, 1990, J GEN VIROL, V71, P3075, DOI 10.1099/0022-1317-71-12-3075; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; FUKUYAMA Y, 1987, BRAIN DEV-JPN, V9, P270, DOI 10.1016/S0387-7604(87)80044-X; Gardner AE, 2007, BIOCHEMISTRY-US, V46, P5094, DOI 10.1021/bi6025648; Garg RK, 2008, J NEUROL, V255, P1861, DOI 10.1007/s00415-008-0032-6; GRIFFIN DE, 2007, FIELDS VIROLOGY; HOMMA M, 1982, MICROBIOL IMMUNOL, V26, P1195, DOI 10.1111/j.1348-0421.1982.tb00270.x; HONDA Y, 1994, ANTIMICROB AGENTS CH, V38, P653, DOI 10.1128/AAC.38.4.653; Hosoya M, 2001, ANTIMICROB AGENTS CH, V45, P943, DOI 10.1128/AAC.45.3.943-945.2001; Hosoya M, 2004, ANTIMICROB AGENTS CH, V48, P4631, DOI 10.1128/AAC.48.12.4631-4635.2004; Joly V, 2010, EXPERT OPIN PHARMACO, V11, P2701, DOI 10.1517/14656566.2010.522178; JONES CE, 1982, LANCET, V1, P1034; KOMASE K, 1990, Virus Genes, V4, P163, DOI 10.1007/BF00678407; KUROKI S, 1989, BRAIN DEV-JPN, V11, P65, DOI 10.1016/S0387-7604(89)80012-9; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Makhortova NR, 2007, VIROLOGY, V362, P235, DOI 10.1016/j.virol.2007.02.033; Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; OHUCHI R, 1984, MICROBIOL IMMUNOL, V28, P757, DOI 10.1111/j.1348-0421.1984.tb00731.x; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Ozoemena LC, 2004, J MED VIROL, V73, P79, DOI 10.1002/jmv.20050; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; PAULABARBOSA MM, 1981, ANN NEUROL, V9, P400, DOI 10.1002/ana.410090414; Russell CJ, 2004, J VIROL, V78, P13727, DOI 10.1128/JVI.78.24.13727-13742.2004; Salditt A, 2010, J GEN VIROL, V91, P1464, DOI 10.1099/vir.0.018523-0; SCHEID A, 1977, VIROLOGY, V80, P54, DOI 10.1016/0042-6822(77)90380-4; STEINER I, 1989, J CHILD NEUROL, V4, P20, DOI 10.1177/088307388900400103; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Wild TF, 1997, J GEN VIROL, V78, P107, DOI 10.1099/0022-1317-78-1-107; Zhu JQ, 2002, BIOCHEM BIOPH RES CO, V299, P897, DOI 10.1016/S0006-291X(02)02761-4	43	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162823	10.1371/journal.pone.0162823	http://dx.doi.org/10.1371/journal.pone.0162823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612283	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900171
J	Hendler, R; Kidia, K; Machando, D; Crooks, M; Mangezi, W; Abas, M; Katz, C; Thornicroft, G; Semrau, M; Jack, H				Hendler, Reuben; Kidia, Khameer; Machando, Debra; Crooks, Megan; Mangezi, Walter; Abas, Melanie; Katz, Craig; Thornicroft, Graham; Semrau, Maya; Jack, Helen			"We Are Not Really Marketing Mental Health": Mental Health Advocacy in Zimbabwe	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SOUTH-AFRICA; LOW-INCOME; INVOLVEMENT; DISORDERS; SERVICES; DEPRESSION; STRATEGIES; PRIORITY; LESSONS	Introduction Few people with mental disorders in low and middle-income countries (LMICs) receive treatment, in part because mental disorders are highly stigmatized and do not enjoy priority and resources commensurate with their burden on society. Advocacy has been proposed as a means of building political will and community support for mental health and reducing stigma, but few studies have explored the practice and promise of advocacy in LMICs. Methods We conducted 30 semi-structured interviews with leaders in health and mental health in Zimbabwe to explore key stakeholder perceptions on the challenges and opportunities of the country's mental health system. We coded the transcripts using the constant comparative method, informed by principles of grounded theory. Few interview questions directly concerned advocacy, yet in our analysis, advocacy emerged as a prominent, cross-cutting theme across participants and interview questions. Results Two thirds of the respondents discussed advocacy, often in depth, returning to the concept throughout the interview and emphasizing their belief in advocacy's importance. Participants described six distinct components of advocacy: the advocates, to whom they advocate ("targets"), what they advocate for ("asks"), how advocates reach their targets ("access"), how they make their asks ("arguments"), and the results of their advocacy ("outcomes"). Discussion Despite their perception that mental health is widely misunderstood and under-appreciated in Zimbabwe, respondents expressed optimism that strategically speaking out can reduce stigma and increase access to care. Key issues included navigating hierarchies, empowering service users to advocate, and integrating mental health with other health initiatives. Understanding stakeholder perceptions sets the stage for targeted development of mental health advocacy in Zimbabwe and other LMICs.	[Hendler, Reuben; Kidia, Khameer; Katz, Craig] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA; [Hendler, Reuben; Kidia, Khameer; Machando, Debra; Jack, Helen] Kushinga, Harare, Zimbabwe; [Kidia, Khameer; Mangezi, Walter] Univ Zimbabwe, Dept Psychiat, Harare, Zimbabwe; [Machando, Debra] Womens Univ Africa, Dept Psychol, Harare, Zimbabwe; [Crooks, Megan; Abas, Melanie; Thornicroft, Graham; Semrau, Maya; Jack, Helen] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Jack, Helen] Harvard Med Sch, Boston, MA USA	Icahn School of Medicine at Mount Sinai; University of Zimbabwe; University of London; King's College London; Harvard University; Harvard Medical School	Jack, H (corresponding author), Kushinga, Harare, Zimbabwe.; Jack, H (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.; Jack, H (corresponding author), Harvard Med Sch, Boston, MA USA.	helen_jack@hms.harvard.edu	Thornicroft, Graham/B-4027-2010; Jack, Helen/AAB-3650-2020	Thornicroft, Graham/0000-0003-0662-0879; abas, melanie/0000-0003-1716-5584; Mangezi, Walter/0000-0002-8889-0487; Semrau, Maya/0000-0003-0366-1093; Jack, Helen/0000-0003-2815-4725	Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; European Union [305968]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust; Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre; Dementia Unit; King's College London; King's College Hospital NHS Foundation Trust; UK Government; Kushinga Project (Harare, Zimbabwe); National Institute for Health Research [NF-SI-0611-10053] Funding Source: researchfish	Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; European Union(European Commission); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust; Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Dementia Unit; King's College London; King's College Hospital NHS Foundation Trust; UK Government; Kushinga Project (Harare, Zimbabwe); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported in part by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship to KK (http://www.alphaomegaalpha.org/student_research.html). GT and MS are supported by the European Union Seventh Framework Programme (FP7/2007-2013) Emerald project. The development of the tools used to collect the data for this publication was funded in part by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 305968 (http://cordis.europa.eu/fp7/) (http://www.emerald-project.eu/). GT is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. GT acknowledges financial support from the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Unit awarded to South London and Maudsley NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust (http://www.nihr.ac.uk/about/collaborations-for-leadership-in-applied-health-research-and-care.htm). This paper is an output of the PRogramme for Improving Mental health carE (PRIME). The material has been funded by UK aid from the UK Government, however the views expressed do not necessarily reflect the UK Government's official policies. The Kushinga Project (Harare, Zimbabwe) provided support to HJ and KK. DM and WM volunteered their time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. GT is supported by the European Union Seventh Framework Programme (FP7/2007-2013) Emerald project. This paper is an output of the PRogramme for Improving Mental health carE (PRIME). The material has been funded by UK aid from the UK Government, however the views expressed do not necessarily reflect the UK Government's official policies. The research supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College London Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Unit awarded to South London and Maudsley NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Abas MA, 1997, PSYCHOL MED, V27, P59, DOI 10.1017/S0033291796004163; Abas MA, 2014, INT REV PSYCHIATR, V26, P453, DOI 10.3109/09540261.2014.924487; Abdulmalik J, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-5; [Anonymous], 1978, LANCET, V2, P1040; Beresford P, 2005, EPIDEMIOL PSICHIAT S, V14, P4, DOI 10.1017/S1121189X0000186X; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Bird P, 2011, HEALTH POLICY PLANN, V26, P357, DOI 10.1093/heapol/czq078; Bower P, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0896-6; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Burns JK, 2010, SAMJ S AFR MED J, V100, P654, DOI 10.7196/SAMJ.4427; Chatterjee S, 2014, LANCET, V383, P1385, DOI 10.1016/S0140-6736(13)62629-X; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Farrer L, 2015, MILBANK Q, V93, P392, DOI 10.1111/1468-0009.12112; Funk M, 2006, HEALTH PROMOT INT, V21, P70, DOI 10.1093/heapro/dai031; Glaser B.G., 1968, DISCOV GROUNDED THEO; HANN K, 2015, GLOBAL HLTH ACTION, V8; Harrison T., 2009, ADV PSYCHIAT TREATME, V15, P57; Heywood M, 2009, J HUM RIGHTS PRACT, V1, P14, DOI 10.1093/jhuman/hun006; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Kleintjes S, 2013, AFR J PSYCHIATRY, V16, P187, DOI [http://dx.doi.org/10.4314/ajpsy.v16i3.25, 10.4314/ajpsy.v16i3.25]; McCracken G., 1988, LONG INTERVIEW, V13; Mental Health Innovation Network, 2015, GLOB MENT HLTH POL I; Morselli PL, 2000, BIPOLAR DISORD, V2, P294, DOI 10.1034/j.1399-5618.2000.20310.x; Newbigging K, 2011, MENTAL HLTH TODAY BR, P24; Ntulo C, 2015, SELF ADVOCACY TOOL K; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patton M. Q., 2005, QUALITATIVE RES; Piette A, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0291-8; REICH MR, 1995, HEALTH POLICY, V32, P47, DOI 10.1016/0168-8510(95)00728-B; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Semrau M, 2015, BMC MED, P13; Semrau M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1323-8; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Swanson RC, 2012, HEALTH POLICY PLANN, V27, P54, DOI 10.1093/heapol/czs090; Thornicroft G, 2007, LANCET, V370, P807, DOI 10.1016/S0140-6736(07)61392-0; Tomes N, 2006, HEALTH AFFAIR, V25, P720, DOI 10.1377/hlthaff.25.3.720; Tomlinson M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001178; Trivedi P, 2014, INT REV PSYCHIATR, V26, P544, DOI 10.3109/09540261.2014.955087; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organization, 2007, EXP OP BARR FAC FACT; World Health Organization, 2003, MENT HLTH POL SERV G	47	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161860	10.1371/journal.pone.0161860	http://dx.doi.org/10.1371/journal.pone.0161860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27607240	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255600014
J	Soffan, A; Antony, B; Abdelazim, M; Shukla, P; Witjaksono, W; Aldosari, SA; Aldawood, AS				Soffan, Alan; Antony, Binu; Abdelazim, Mahmoud; Shukla, Paraj; Witjaksono, Witjaksono; Aldosari, Saleh A.; Aldawood, Abdulrahman S.			Silencing the Olfactory Co-Receptor RferOrco Reduces the Response to Pheromones in the Red Palm Weevil, Rhynchophorus ferrugineus	PLOS ONE			English	Article							RNA INTERFERENCE; ODORANT RECEPTORS; CHEMOSENSORY RECEPTOR; DATE PALM; IDENTIFICATION; COLEOPTERA; ORCO; GENE; CURCULIONIDAE; KNOCKDOWN	The red palm weevil (RPW, Rhynchophorus ferrugineus), one of the most widespread of all invasive insect pest species, is a major cause of severe damage to economically important palm trees. RPW exhibits behaviors very similar to those of its sympatric species, the Asian palm weevil (R. vulneratus), which is restricted geographically to the southern part of Southeast Asia. Although efficient and sustainable control of these pests remains challenging, olfactory-system disruption has been proposed as a promising approach for controlling palm weevils. Here, we report the cloning and sequencing of an olfactory co-receptor (Orco) from R. ferrugineus (RferOrco) and R. vulneratus (RvulOrco) and examine the effects of RferOrco silencing (RNAi) on odorant detection. RferOrco and RvulOrco encoding 482 amino acids showing 99.58% identity. The injection of double-stranded RNA (dsRNA) from RferOrco into R. ferrugineus pupae significantly reduced RferOrco gene expression and led to the failure of odor-stimulus detection, as confirmed through olfactometer and electroantennography (EAG) assays. These results suggest that olfactory-system disruption leading to reduced pheromone detection holds great potential for RPW pest-control strategies.	[Soffan, Alan; Antony, Binu; Abdelazim, Mahmoud; Shukla, Paraj; Aldosari, Saleh A.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Chair Date Palm Res, Riyadh 11451, Saudi Arabia; [Aldawood, Abdulrahman S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia; [Witjaksono, Witjaksono] Gadjah Mada Univ, Dept Plant Protect, Coll Agr, Yogyakarta 55281, Indonesia	King Saud University; King Saud University; Gadjah Mada University	Antony, B (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Chair Date Palm Res, Riyadh 11451, Saudi Arabia.	bantony@ksu.edu.sa	Witjaksono, Witjaksono/GOV-4618-2022; Antony, Binu/M-8562-2015; Soffan, Alan/AAG-2533-2020; Aldawood, Abdulrahman Saad/M-3657-2019	Antony, Binu/0000-0002-6292-620X; Soffan, Alan/0000-0003-3680-6295; Aldawood, Abdulrahman Saad/0000-0003-0721-6632	National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia [KACST-NSTIP 12-AGR2854-02];  [12-AGR2854-02];  [12-AGR2554-02]	National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia; ; 	BA and SAA are thankful for funds (grant no. KACST-NSTIP 12-AGR2854-02) provided by the National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia. AS is thankful to the researcher stipend obtained from 12-AGR2854-02 and 12-AGR2554-02 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research (awarded to BA, KACST-NSTIP 12-AGR2854-02) was provided by the National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia. We thank the King Saud University-Deanship of Scientific Research, Research Chair program, Saudi Arabia. AS thankful to the researcher stipend obtained from 12-AGR2854-02 and 12-AGR2554-02 projects.	Abdel-Azim M. M., 2012, Journal of Agricultural Science and Technology A, V2, P520; Abraham V. A., 1998, Sultan Qaboos University Journal for Scientific Research - Agricultural Sciences, V3, P77; Antony B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2362-6; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Chakravarthy AK, 2014, J ENVIRON BIOL, V35, P479; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dong XL, 2013, J INSECT PHYSIOL, V59, P26, DOI 10.1016/j.jinsphys.2012.11.004; Duxbury MS, 2004, J SURG RES, V117, P339, DOI 10.1016/j.jss.2003.09.010; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P227; Faleiro J. R., 2006, International Journal of Tropical Insect Science, V26, P135, DOI 10.1079/IJT2006113; Faleiro JR, 2014, FLA ENTOMOL, V97, P1529, DOI 10.1653/024.097.0427; Faleiro JR., 2006, FUND AGROALIMED, V06, P35; Fjose A, 2001, Biotechnol Annu Rev, V7, P31, DOI 10.1016/S1387-2656(01)07032-6; Franco TA, 2016, INSECT BIOCHEM MOLEC, V69, P82, DOI 10.1016/j.ibmb.2015.02.012; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Gries R, 2009, CAN ENTOMOL, V141, P145, DOI 10.4039/n09-010; Gunawardena NE, 1998, J CHEM ECOL, V24, P425, DOI 10.1023/A:1022304601123; Gunawardena Neelakanthi E., 1995, Journal of the National Science Council of Sri Lanka, V23, P71; Ha TS, 2008, CELL, V133, P761, DOI 10.1016/j.cell.2008.05.007; Hallett RH, 2004, J NAT HIST, V38, P2863, DOI 10.1080/00222930310001657874; HALLETT RH, 1993, NATURWISSENSCHAFTEN, V80, P328, DOI 10.1007/BF01141908; Hansen IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113692; Howlett N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-211; Hull JJ, 2012, ARCH INSECT BIOCHEM, V81, P179, DOI 10.1002/arch.21042; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; JAFFE K, 1993, J CHEM ECOL, V19, P1703, DOI 10.1007/BF00982302; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065931; Li KM, 2012, J CHEM ECOL, V38, P287, DOI 10.1007/s10886-012-0085-y; Lin W, 2015, INT J BIOL SCI, V11, P772, DOI 10.7150/ijbs.11898; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meier LR, 2014, THESIS; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Perez AL, 1996, J CHEM ECOL, V22, P357, DOI 10.1007/BF02055104; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Qiao Q, 2010, AGR SCI CHINA, V9, P1001, DOI 10.1016/S1671-2927(09)60183-8; Reichle C, 2013, ANIM BEHAV, V85, P225, DOI 10.1016/j.anbehav.2012.10.029; Roda A., 2011, Bulletin OEPP, V41, P116, DOI 10.1111/j.1365-2338.2011.02446.x; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Said I, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-14; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; SAS Institute, 2008, SAS STAT 9 2 US GUID; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Stelinski L, 2013, JOVE-J VIS EXP, DOI 10.3791/50229; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vosshall Leslie B., 2003, P567, DOI 10.1016/B978-012107151-6/50021-9; Wattanapongsiri A, 1965, THESIS; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159; Zhao YY, 2011, INSECT MOL BIOL, V20, P97, DOI 10.1111/j.1365-2583.2010.01049.x; Zhou YL, 2014, J INSECT PHYSIOL, V60, P31, DOI 10.1016/j.jinsphys.2013.10.006; Zhu F, 2013, INSECT BIOCHEM MOLEC, V43, P916, DOI 10.1016/j.ibmb.2013.07.008	71	19	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162203	10.1371/journal.pone.0162203	http://dx.doi.org/10.1371/journal.pone.0162203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606688	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255600029
J	Varela, R; Santos, F; Gomez-Gesteira, M; Alvarez, I; Costoya, X; Dias, JM				Varela, R.; Santos, F.; Gomez-Gesteira, M.; Alvarez, I.; Costoya, X.; Dias, J. M.			Influence of Coastal Upwelling on SST Trends along the South Coast of Java	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; DATA ASSIMILATION ANALYSIS; TROPICAL INDIAN-OCEAN; INTERANNUAL VARIABILITY; WORLD OCEAN; SUMATRA	The south coast of Java has warmed at a much lower rate than adjacent ocean locations over the last three decades (1982-2015). This behavior can be observed during the upwelling season (July-October) and it is especially patent in August and September when upwelling attains the highest values. Although different warming rates (ocean-coast) had been previously observed in other areas around the world, this behavior was always linked to situations where upwelling increased or remained unchanged. South Java warming is observed at ocean locations and cooling near shore but under a scenario of decreasing upwelling (similar to 30% in some cases). The origin of coastal cooling is due to changes in the vertical structure of the water column. A vein of subsurface water, which has cooled at a rate higher than 0.3 degrees C per decade, is observed to enter from the northwestern part of the study area following the South Java Current. This water only manifests at surface near coast, where it is pumped up by coastal upwelling.	[Varela, R.; Santos, F.; Gomez-Gesteira, M.; Alvarez, I.; Costoya, X.] Univ Vigo, Fac Ciencias, Environm Phys Lab, Ephyslab, Orense 32004, Spain; [Santos, F.; Alvarez, I.; Dias, J. M.] Univ Aveiro, Dept Fis, CESAM, P-3810193 Aveiro, Portugal	Universidade de Vigo; Universidade de Aveiro	Varela, R (corresponding author), Univ Vigo, Fac Ciencias, Environm Phys Lab, Ephyslab, Orense 32004, Spain.	ruvarela@uvigo.es	Gesteira, Moncho Gomez/R-9431-2019; Varela, Ruben/AAB-7411-2022; Dias, João Miguel/F-3292-2010	Gesteira, Moncho Gomez/0000-0002-0661-9731; Dias, João Miguel/0000-0002-7613-6241; Costoya, Xurxo/0000-0001-8050-760X; Santos, Fran/0000-0002-4576-3744; Varela, Ruben/0000-0001-9676-2349	Xunta de Galicia - European Regional Development Fund (FEDER) [GRC-2013-001]; Portuguese Science Foundation (FCT) [SFRH/BPD/97320/2013, C/MAR/LA0017/2013]	Xunta de Galicia - European Regional Development Fund (FEDER); Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology)	This research was also partially supported by Xunta de Galicia under projects GRC-2013-001 "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva)" co-funded by European Regional Development Fund (FEDER). The Portuguese Science Foundation (FCT) partially supported this research through a Post-doctoral grant (SFRH/BPD/97320/2013) of the second author and through the project Pest (C/MAR/LA0017/2013). CFSR data was obtained from Environmental Modeling Center/National Centers for Environmental Prediction/National Weather Service/NOAA/U.S. NCEP Climate Forecast System Reanalysis (CFSR) Monthly Products. Research Data Archive at the National Center for Atmospheric Research, Computational and Information Systems Laboratory (http://rda.ucar.edu/datasets/ds093.2/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was also partially supported by Xunta de Galicia under projects GRC-2013-001 "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva)" co-funded by European Regional Development Fund (FEDER). The Portuguese Science Foundation (FCT) partially supported this research through a Post-doctoral grant (SFRH/BPD/97320/2013) of the second author and through the project Pest (C/MAR/LA0017/2013). CFSR data was obtained from Environmental Modeling Center/National Centers for Environmental Prediction/National Weather Service/NOAA/U.S. NCEP Climate Forecast System Reanalysis (CFSR) Monthly Products. Research Data Archive at the National Center for Atmospheric Research, Computational and Information Systems Laboratory. http://rda.ucar.edu/datasets/ds093.2/.	Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Carton JA, 2000, J PHYS OCEANOGR, V30, P294, DOI 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2; Carton JA, 2000, J PHYS OCEANOGR, V30, P311, DOI [10.1175/1520-0485(2000)030<0311:ASODAA>2.0.CO;2, 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2]; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; Du Y, 2008, J CLIMATE, V21, P2451, DOI 10.1175/2007JCLI1753.1; Gomez-Gesteira M, 2008, ANN NY ACAD SCI, V1146, P320, DOI 10.1196/annals.1446.004; Gordon A L, 2005, OCEANOGRAPHY, V18, P13; Harrison DE, 2007, J PHYS OCEANOGR, V37, P174, DOI 10.1175/JPO3005.1; Iskandar I, 2010, OCEAN DYNAM, V60, P731, DOI 10.1007/s10236-010-0290-6; Kuswardani RTD, 2014, CHINESE SCI BULL, V59, P4516, DOI 10.1007/s11434-014-0549-2; Lemos RT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003051; Lengaigne M., 2013, BIOGEOSCIENCES, V10, P5841, DOI DOI 10.5194/BGD-10-5841-2013; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Ma JF, 2015, J GEOPHYS RES-OCEANS, V120, P7015, DOI 10.1002/2015JC010862; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; NYKJAER L, 1994, J GEOPHYS RES-OCEANS, V99, P14197, DOI 10.1029/94JC00814; Pardo PC, 2011, CLIM RES, V48, P231, DOI 10.3354/cr00989; Patti B, 2010, ESTUAR COAST SHELF S, V88, P45, DOI 10.1016/j.ecss.2010.03.004; Purba M, 2007, TORANI JURNAL ILMU K, V2, P140; Qu T., 2005, OCEANOGRAPHY, V18, P50, DOI [DOI 10.5670/OCEANOG.2005.05, 10.5670/oceanog.2005.05]; Rao SA, 2002, DEEP-SEA RES PT II, V49, P1549, DOI 10.1016/S0967-0645(01)00158-8; Reynolds R. W., 2009, WHATS NEW VERSION 2; Reynolds RW, 2010, J CLIMATE, V23, P3545, DOI 10.1175/2010JCLI3294.1; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Santos F, 2012, CONT SHELF RES, V47, P1, DOI 10.1016/j.csr.2012.07.023; Santos F, 2011, CONT SHELF RES, V31, P2012, DOI 10.1016/j.csr.2011.10.005; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; Santos F, INFLUENCE U IN PRESS; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; Siswanto, 2008, INT J REMOTE SENS EA, V5, P46; Sprintall J, 2010, DYNAM ATMOS OCEANS, V50, P140, DOI 10.1016/j.dynatmoce.2010.02.006; Susanto R.D., 2005, OCEANOGRAPHY, V18, P124, DOI [10.5670/oceanog.2005.13, DOI 10.5670/OCEANOG.2005.13]; Susanto RD, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001009; Susanto RD, 2001, GEOPHYS RES LETT, V28, P1599, DOI 10.1029/2000GL011844; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Varela R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10016; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Xue L, 2016, J MARINE SYST, V153, P10, DOI 10.1016/j.jmarsys.2015.08.003	41	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162122	10.1371/journal.pone.0162122	http://dx.doi.org/10.1371/journal.pone.0162122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606676	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600019
J	Chao, YJ; Chan, JF; Hsu, YHH				Chao, Yu-Jen; Chan, Jui-Fen; Hsu, Yuan-Hao Howard			Chemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin Fluctuation	PLOS ONE			English	Article							CELL-CYCLE; PHOSPHOLIPASE A(2); CANCER; BIOGENESIS; METABOLISM; MECHANISMS; EXPRESSION; ASYMMETRY; APOPTOSIS; DYNAMICS	Chemotherapy drugs have been prescribed for the systemic treatment of cancer. We selected three chemotherapy drugs, including methotrexate, mitomycine C and vincristine to inhibit the proliferation of HT1080 human fibrosarcoma cells in S, G2 and M phases of the cell cycle respectively. These chemotherapy drugs showed significant toxicity and growth inhibition to the cancer cells measured by MTT assay. After treated with a 50% inhibitory dosage for 48 hours, these cancer cells showed significant accumulation of cardiolipin (CL), which was a reverse trend of the nutritional deficiency induced arrest at G1 phase. The quantity of each CL species was further semi-quantitated by HPLC-ion trap mass spectrometer. Methotraxate treatment caused unique increases of acyl chain length on CL, which were the opposite of the serum starvation, mitomycine C and vincristine treatments. Although mitomycine C and vincristine have different mechanisms to induce cell cycle arrest, these two drugs displayed similar effects on decreasing chain length of CL. Continuation of CL synthesis during cell cycle arrest indicated the chemotherapy drugs resulting in the discoordination of the mitochondrial life cycle from the cell cycle and thus caused the accumulation of CL. These finding reveals that the pre-remodeling nascent CL accumulates during the methotraxate induced arrest; however, the post-remodeling mature CL accumulates during the mitomycine C and vincristine induced arrest after the synthesis phase.	[Chao, Yu-Jen; Chan, Jui-Fen; Hsu, Yuan-Hao Howard] Tunghai Univ, Dept Chem, Taichung, Taiwan; [Hsu, Yuan-Hao Howard] Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan	Tunghai University; Tunghai University	Hsu, YHH (corresponding author), Tunghai Univ, Dept Chem, Taichung, Taiwan.; Hsu, YHH (corresponding author), Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan.	howardhsu@thu.edu.tw	hsu, yuan-hao/B-5744-2009		Ministry of Science and Technology, R.O.C. [MOST 103-2113-M-029-002-MY2]; National Health Research Institutes, Taiwan [NHRI-EX104-10236SC]	Ministry of Science and Technology, R.O.C.; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Ministry of Science and Technology, R.O.C. (MOST 103-2113-M-029-002-MY2) and the National Health Research Institutes, Taiwan (NHRI-EX104-10236SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ONCOLOGIST, DOI [DOI 10.1002/STEM.140005, DOI 10.1634/THEONCOLOGIST.1-4-223]; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113680; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042; Genestier L, 2000, IMMUNOPHARMACOLOGY, V47, P247, DOI 10.1016/S0162-3109(00)00189-2; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kagan VE, 2015, ANTIOXID REDOX SIGN, V22, P1667, DOI 10.1089/ars.2014.6219; Kagan VE, 2014, CHEM PHYS LIPIDS, V179, P64, DOI 10.1016/j.chemphyslip.2013.11.010; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pamplona R, 1998, J LIPID RES, V39, P1989; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; PETRU E, 1995, GYNECOL ONCOL, V58, P48, DOI 10.1006/gyno.1995.1182; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; RICHARDSON VB, 1994, CYTOGENET CELL GENET, V66, P126, DOI 10.1159/000133682; SAKAI T, 1989, CANCER RES, V49, P1193; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Ting HC, 2015, J NUTR BIOCHEM, V26, P769, DOI 10.1016/j.jnutbio.2015.02.005; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Verweij J, 1999, Cancer Chemother Biol Response Modif, V18, P46; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Xiong W, 2012, ACTA BIOCH BIOPH SIN, V44, P347, DOI 10.1093/abbs/gms006; Ye C, 2014, J BIOENERG BIOMEMBR; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	51	4	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162457	10.1371/journal.pone.0162457	http://dx.doi.org/10.1371/journal.pone.0162457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627658	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600034
J	Fracanzani, AL; Pisano, G; Consonni, D; Tiraboschi, S; Baragetti, A; Bertelli, C; Norata, GD; Dongiovanni, P; Valenti, L; Grigore, L; Tonella, T; Catapano, A; Fargion, S				Fracanzani, Anna Ludovica; Pisano, Giuseppina; Consonni, Dario; Tiraboschi, Silvia; Baragetti, Andrea; Bertelli, Cristina; Norata, Giuseppe Danilo; Dongiovanni, Paola; Valenti, Luca; Grigore, Liliana; Tonella, Tatiana; Catapano, Alberico; Fargion, Silvia			Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; TERM-FOLLOW-UP; ARTERIAL STIFFNESS; METABOLIC SYNDROME; HEPATIC STEATOSIS; BODY-SIZE; FIBROSIS; RISK; SYSTEM; NAFLD	Background and Aims Epicardial adipose tissue (EAT) has been proposed as a cardiometabolic and hepatic fibrosis risk factor in patients with non alcoholic fatty liver disease (NAFLD). Aim of this study was to evaluate the role of EAT in NAFLD by analyzing 1) the association between EAT, the other metabolic parameters and the severity of steatosis 2) the relationship between cardiovascular (cIMT, cplaques, E/A), liver (presence of NASH and significant fibrosis) damage and metabolic risk factors including EAT 3) the relationship between EAT and genetic factors strongly influencing liver steatosis. Methods In a cross-sectional study, we considered 512 consecutive patients with NAFLD (confirmed by biopsy in 100). EAT, severity of steatosis, carotid intima-media thickness (cIMT) and plaques were evaluated by ultrasonography and results analysed by multiple linear and logistic regression models. Variables independently associated with EAT (mm) were female gender (p = 0.003), age (p = 0.001), BMI (p = 0.01), diastolic blood pressure (p = 0.009), steatosis grade 2 (p = 0.01) and 3 (p = 0.04), fatty liver index (p = 0.001) and statin use (p = 0.03). Variables independently associated with carotid IMT were age (p = 0.0001), hypertension (p = 0.009), diabetes (p = 0.04), smoking habits (p = 0.04) and fatty liver index (p = 0.02), with carotid plaques age (p = 0.0001), BMI (p = 0.03), EAT (p = 0.02),) and hypertension (p = 0.02), and with E/A age (p = 0.0001), diabetes (p = 0.005), hypertension (p = 0.04) and fatty liver index (p = 0.004). In the 100 patients with available liver histology non alcoholic steatohepatitis (NASH) was independently associated with EAT (p = 0.04) and diabetes (p = 0.054) while significant fibrosis with EAT (p = 0.02), diabetes (p = 0.01) and waist circumference (p = 0.05). No association between EAT and PNPLA3 and TM6SF2 polymorphisms was found. Conclusion In patients with NAFLD, EAT is associated with the severity of liver and vascular damage besides with the known metabolic risk factors.	[Fracanzani, Anna Ludovica; Pisano, Giuseppina; Tiraboschi, Silvia; Bertelli, Cristina; Dongiovanni, Paola; Valenti, Luca; Fargion, Silvia] Univ Milan, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Dept Pathophysiol & Transplantat, Milan, Italy; [Consonni, Dario] Univ Milan, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Epidemiol Unit, Milan, Italy; [Baragetti, Andrea; Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Baragetti, Andrea; Norata, Giuseppe Danilo] Ctr Studi Aterosclerosi Milan, Milan, Italy; [Grigore, Liliana] Bassini Hosp, Ctr Studi Aterosclerosi, Milan, Italy; [Tonella, Tatiana] Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Cardiovasc Med Unit, Milan, Italy; [Catapano, Alberico] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Catapano, Alberico] Multimed IRCCS, Milan, Italy	University of Milan; University of Milan; University of Milan; University of Milan; IRCCS Multimedica	Fracanzani, AL (corresponding author), Univ Milan, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Dept Pathophysiol & Transplantat, Milan, Italy.	anna.fracanzani@unimi.it	Consonni, Dario/AAM-2947-2020; Dongiovanni, Paola/AAC-9965-2019; Catapano, alberico/AAC-2827-2019; Fracanzani, Anna Ludovica/J-8986-2018; Norata, Giuseppe Danilo/AAC-2863-2019; Valenti, Luca/B-3695-2009	Consonni, Dario/0000-0002-8935-3843; Dongiovanni, Paola/0000-0003-4343-7213; Catapano, alberico/0000-0002-7593-2094; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Valenti, Luca/0000-0001-8909-0345; Norata, Giuseppe Danilo/0000-0002-6081-1257				Alp H, 2013, CAN J CARDIOL, V29, P1118, DOI 10.1016/j.cjca.2012.07.846; Altin C, 2016, ANGIOLOGY, V67, P961, DOI 10.1177/0003319716643669; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Baker AR, 2009, J CLIN ENDOCR METAB, V94, P261, DOI 10.1210/jc.2007-2579; Baragetti A, 2016, NUTR METAB CARDIOVAS, V26, P141, DOI 10.1016/j.numecd.2015.10.013; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Colak Y, 2012, EUR J GASTROEN HEPAT, V24, P613, DOI 10.1097/MEG.0b013e3283513f19; Corrao S, 2015, J HEPATOL, V62, P1212, DOI 10.1016/j.jhep.2015.01.010; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Drapkina J, 2014, Endosc Ultrasound, V3, pS2; Echouffo-Tcheugui J-B, 2013, Diabetes Metab, V39, P389, DOI 10.1016/j.diabet.2013.07.002; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; FOLSOM AR, 1994, STROKE, V25, P66, DOI 10.1161/01.STR.25.1.66; Garber AJ, 2006, DIABETES CARE, V29, P1955, DOI 10.2337/dc06-9913; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2016, CURR OPIN PHARMACOL, V27, P13, DOI 10.1016/j.coph.2016.01.004; Iacobellis G, 2014, OBESITY, V22, P332, DOI 10.1002/oby.20624; Iacobellis G, 2011, INT J BIOCHEM CELL B, V43, P1651, DOI 10.1016/j.biocel.2011.09.006; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Kaya H, 2013, J CARDIOL, V62, P343, DOI 10.1016/j.jjcc.2013.05.009; Khawaja T, 2011, AM J CARDIOL, V108, P397, DOI 10.1016/j.amjcard.2011.03.058; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LICATA G, 1995, J HYPERTENS, V13, P611, DOI 10.1097/00004872-199506000-00006; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Luna-Luna M, 2015, ARCH MED RES, V46, P392, DOI 10.1016/j.arcmed.2015.05.007; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Malavazos AE, 2010, AM J CARDIOL, V105, P1831, DOI 10.1016/j.amjcard.2010.01.368; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mukherjee D, 2002, AM HEART J, V144, P753, DOI 10.1067/mhj.2002.124865; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nakazato R, 2012, ATHEROSCLEROSIS, V221, P422, DOI 10.1016/j.atherosclerosis.2011.12.018; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Perseghin G, 2008, HEPATOLOGY, V47, P51, DOI 10.1002/hep.21983; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Petta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074089; Psychari SN, 2016, ANGIOLOGY, V67, P41, DOI 10.1177/0003319715576672; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Sinha Santosh Kumar, 2016, J Clin Med Res, V8, P410, DOI 10.14740/jocmr2468w; Sookoian S, 2008, J HEPATOL, V49, P600, DOI 10.1016/j.jhep.2008.06.012; Stein JH, 2004, CLIN CARDIOL, V27, P388, DOI 10.1002/clc.4960270704; Sunbul M, 2014, ATHEROSCLEROSIS, V237, P490, DOI 10.1016/j.atherosclerosis.2014.10.004; Targher G, 2006, DIABETES CARE, V29, P1178, DOI 10.2337/dc06-0233; Targher G, 2010, CLIN J AM SOC NEPHRO, V5, P2166, DOI 10.2215/CJN.05050610; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Topuz M, 2014, Clin Ter, V165, pe46, DOI 10.7417/CT.2014.1671; Ulucan S, 2015, J HEPATOL, V62, P1214, DOI 10.1016/j.jhep.2015.01.008; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Xia MF, 2016, ALIMENT PHARM THER, V43, P631, DOI 10.1111/apt.13521	63	31	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162473	10.1371/journal.pone.0162473	http://dx.doi.org/10.1371/journal.pone.0162473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627804	Green Published, gold			2022-12-27	WOS:000383680600036
J	Hong, SN; Jang, HJ; Ye, BD; Jeon, SR; Im, JP; Cha, JM; Kim, SE; Park, SJ; Kim, ER; Chang, DK				Hong, Sung Noh; Jang, Hyun Joo; Ye, Byong Duk; Jeon, Seong Ran; Im, Jong Pil; Cha, Jae Myung; Kim, Seong-Eun; Park, Soo Jung; Kim, Eun Ran; Chang, Dong Kyung			Diagnosis of Bleeding Meckel's Diverticulum in Adults	PLOS ONE			English	Article							DOUBLE-BALLOON ENTEROSCOPY; HETEROTOPIC GASTRIC-MUCOSA; CAPSULE ENDOSCOPY; SMALL-BOWEL; PULL ENTEROSCOPY; SCINTIGRAPHY; CHILDREN; EXPERIENCE	Background and Aims Various modalities have been used to diagnose Meckel's diverticulum (MD) in practice, but with their diagnostic accuracy deemed to be unsatisfactory for clinical practice. Moreover, the usefulness of these modalities has not been evaluated for the diagnosis of bleeding MD in adults, due to the relative rarity of this condition. Therefore, the aim of ourmulticenter study was to determine the most accurate modality for the preoperative diagnosis of bleeding MD in adults. Methods We conducted a retrospective analysis of the diagnostic accuracy for small bowel bleeding associated with MD of different modalities in patients >= 18 years old who underwent assessment for MD, with confirmation at the time of explorative surgery. Diagnostic accuracy of the different modalities was evaluated against the diagnosis obtained using technetium-99m pertechnetate scintigraphy (also known as Meckel's scan), considered to be the gold standard for the diagnosis of bleeding MD in pediatrics. Results Thirty-five adults were identified with bleeding in MD over the study period, between 2005 and 2012. Among these patients, only 24 (68.6%) were diagnosed with MD preoperatively. The mean (95% confidence interval) diagnostic accuracy of selected modalities was as follows: Meckel's scan, 21.4% (5.7%-51.2%); capsule endoscopy, 35.7% (14.0%-64.4%); balloon-assisted enteroscopy (BAE), 85.0% (61.1%-96.0%); angiography, 0.0% (0.0%-80.2%); computed tomography, 31.8% (14.7%-54.9%); and small-bowel follow-through, 62.5% (25.9%-90.0%). The diagnostic accuracy was significantly higher for BAE than for Meckel's scan (P = 0.001). Conclusions Among available diagnostic modalities, BAE provides the highest accuracy for the diagnosis of bleeding MD in adults and, therefore, should be considered as the preferred modality for preoperative diagnosis.	[Hong, Sung Noh; Kim, Eun Ran; Chang, Dong Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Jang, Hyun Joo] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Hwaseong, South Korea; [Ye, Byong Duk] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Jeon, Seong Ran] Soonchunhyang Univ, Coll Med, Inst Digest Res, Seoul, South Korea; [Im, Jong Pil] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Im, Jong Pil] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Cha, Jae Myung] Kyung Hee Univ, Gang Dong Kyung Hee Univ Hosp, Coll Med, Seoul, South Korea; [Kim, Seong-Eun] EwhaWomans Univ, Coll Med, Seoul, South Korea; [Park, Soo Jung] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University; University of Ulsan; Soonchunhyang University; Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Yonsei University; Yonsei University Health System	Jang, HJ (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Hwaseong, South Korea.	jhj1229@hallym.or.kr	Kim, Eun Ran/AAD-8003-2022; Ye, Byong Duk/AAF-4955-2020	Ye, Byong Duk/0000-0001-6647-6325; Kim, Eun Ran/0000-0002-0495-2565	National Research Foundation of Korea (NRF) grant - Korean government [NRF-2014R1A2A1A11052136]	National Research Foundation of Korea (NRF) grant - Korean government	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (NRF-2014R1A2A1A11052136).; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (NRF-2014R1A2A1A11052136). The authors would like to thank Small Intestinal Research Group of the Korean Association for the Study of Intestinal Diseases (KASID) for participation and assistance.	Clark JM, 2008, AM SURGEON, V74, P327; DATZ FL, 1991, SEMIN NUCL MED, V21, P140, DOI 10.1016/S0001-2998(05)80051-0; Elsayes KM, 2007, AM J ROENTGENOL, V189, P81, DOI 10.2214/AJR.06.1257; Emamian SA, 2001, CLIN NUCL MED, V26, P529, DOI 10.1097/00003072-200106000-00010; Ford PV, 1999, J NUCL MED, V40, P1226; He Q, 2013, SURGERY, V153, P549, DOI 10.1016/j.surg.2012.09.012; Levine MS, 2008, RADIOLOGY, V249, P445, DOI 10.1148/radiol.2491071336; Levy AD, 2004, RADIOGRAPHICS, V24, P565, DOI 10.1148/rg.242035187; Lin S, 2002, SOUTHERN MED J, V95, P1338; MACKEY WC, 1983, SURG GYNECOL OBSTET, V156, P56; Manner H, 2006, AM J GASTROENTEROL, V101, P1152, DOI 10.1111/j.1572-0241.2006.00558.x; May A, 2005, GASTROINTEST ENDOSC, V62, P62, DOI 10.1016/S0016-5107(05)01586-5; Min YW, 2014, ENDOSCOPY, V46, P59, DOI 10.1055/s-0033-1358803; Mylonaki M, 2002, ENDOSCOPY, V34, P1018, DOI 10.1055/s-2002-35850; Nakamura M, 2006, ENDOSCOPY, V38, P59, DOI 10.1055/s-2005-870446; Rerksuppaphol S, 2004, PEDIATR SURG INT, V20, P323, DOI 10.1007/s00383-004-1189-4; Rossi P, 1996, AM J ROENTGENOL, V166, P567, DOI 10.2214/ajr.166.3.8623629; Sagar J, 2006, J ROY SOC MED, V99, P501, DOI 10.1258/jrsm.99.10.501; SCHWARTZ MJ, 1984, AM J GASTROENTEROL, V79, P611; SFAKIANAKIS GN, 1981, J NUCL MED, V22, P732; Uchiyama S, 2010, SURG LAPARO ENDO PER, V20, P278, DOI 10.1097/SLE.0b013e3181f2f4a8; Wang C S, 1992, J Formos Med Assoc, V91, P63; WILLIAMS RS, 1981, BRIT J SURG, V68, P477, DOI 10.1002/bjs.1800680712	23	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162615	10.1371/journal.pone.0162615	http://dx.doi.org/10.1371/journal.pone.0162615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626641	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600047
J	Huang, YJ; Li, Y; Wang, FF; Lv, WG; Xie, X; Cheng, XD				Huang, YongJie; Li, Yang; Wang, Fen F.; Lv, WeiGuo; Xie, Xing; Cheng, Xiaodong			Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; UP-REGULATION; LUNG-CANCER; SMALL RNAS; GENES; CELLS; IDENTIFICATION; MECHANISMS; FAMILY	Cervical cancer is the most common cause of cancer-related deaths in women from developing countries. Identification of novel prognostic predictors or therapeutic targets may improve patient prognosis. In the current study, we demonstrated by real-timePCR that miR-224 expression was significantly upregulated (1.82-fold, P = 0.0025) in cervical cancer tissues (n = 126) compared with in normal cervical tissues (n = 64). Higher expression of miR-224 was significantly associated with poorer prognostic factors, including advanced FIGO stage, nodal metastasis, larger tumor size, vascular involvement and deep stromal invasion (all P < 0.05). Enforced expression of miR-224 promoted cell proliferation, migration and invasion in SiHa and CaSki cancer cell lines. Bioinformatic analysis indicated that RASSF8 (RAS-association domain family 8) was a potential target of miR-224. Western blot analysis and luciferase reporter assay showed that overexpressed miR-224 inhibited RASSF8 protein expression and decreased the activity of a luciferase reporter containing the 3' untranslated region (UTR) of RASSF8, respectively. Further, RASSF8 knockdown by specific RNAi showed similar effects in cervical cancer cells transfected with miR-224 mimic. Our findings suggest that miR-224 directly targets RASSF8 and thereby acts as a tumor promoter in cervical cancer progression.	[Huang, YongJie] Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Li, Yang; Wang, Fen F.; Lv, WeiGuo; Xie, Xing; Cheng, Xiaodong] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cheng, XD (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China.	chengxd@zju.edu.cn	Huang, yongjie/ABD-4114-2021		National Natural Science Foundation of China [81301687, 81302248]; Zhejiang Provincial Natural Science Foundation of China [LQ13H160003]; Ministry of Education of the People's Republic of China [20120101110019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (Grant No. 81301687, http://www.nsfc.gov.cn) to Y. Li, Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ13H160003, http://www.zjnsf.gov.cn), Ministry of Education of the People's Republic of China (Grant No. 20120101110019) to X. Xie, National Natural Science Foundation of China (Grant No 81302248) to Dr Fen f Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amankwatia EB, 2015, BRIT J CANCER, V112, P1480, DOI 10.1038/bjc.2015.125; An FM, 2015, J CLIN MED, V4, P1713, DOI 10.3390/jcm4091713; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Cui R, 2015, ONCOTARGET, V6, P21802, DOI 10.18632/oncotarget.5224; Cui R, 2015, P NATL ACAD SCI USA, V112, pE4288, DOI 10.1073/pnas.1502068112; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Falvella FS, 2006, ONCOGENE, V25, P3934, DOI 10.1038/sj.onc.1209422; Falvella FS, 2007, LUNG CANCER, V56, P1, DOI 10.1016/j.lungcan.2006.11.008; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garland SM, 2008, VACCINE, V26, pM89, DOI 10.1016/j.vaccine.2008.06.020; Hartmann C, 2004, M S-MED SCI, V20, P894, DOI 10.1051/medsci/20042010894; Huang L, 2012, BIOCHEM BIOPH RES CO, V425, P127, DOI 10.1016/j.bbrc.2012.07.025; KANAVOS P, 2006, EUROPEAN SOC MEDICAL, V8, P15, DOI DOI 10.1093/ANNONC/MDL983; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Lea JS, 2012, OBSTET GYN CLIN N AM, V39, P233, DOI 10.1016/j.ogc.2012.02.008; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma DL, 2012, ONCOL LETT, V4, P483, DOI 10.3892/ol.2012.742; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mavridis K, 2013, CLIN CHEM, V59, P261, DOI 10.1373/clinchem.2012.191502; Mencia N, 2011, BIOCHEM PHARMACOL, V82, P1572, DOI 10.1016/j.bcp.2011.08.009; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Shen SN, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-69; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wang Y, 2012, FASEB J, V26, P3032, DOI 10.1096/fj.11-201855	36	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162378	10.1371/journal.pone.0162378	http://dx.doi.org/10.1371/journal.pone.0162378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626930	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600031
J	Tang, DL; del Nido, PJ; Yang, C; Zuo, H; Huang, XY; Rathod, RH; Gooty, V; Tang, A; Wu, ZY; Billiar, KL; Geva, T				Tang, Dalin; del Nido, Pedro J.; Yang, Chun; Zuo, Heng; Huang, Xueying; Rathod, Rahul H.; Gooty, Vasu; Tang, Alexander; Wu, Zheyang; Billiar, Kristen L.; Geva, Tal			Patient-Specific MRI-Based Right Ventricle Models Using Different Zero-Load Diastole and Systole Geometries for Better Cardiac Stress and Strain Calculations and Pulmonary Valve Replacement Surgical Outcome Predictions	PLOS ONE			English	Article							REPAIRED TETRALOGY; MECHANICAL-PROPERTIES; MAGNETIC-RESONANCE; CROSS-VALIDATION; FALLOT; HEART; MYOCARDIUM; SURGERY; CLASSIFICATION; CONTRACTION	Background Accurate calculation of ventricular stress and strain is critical for cardiovascular investigations. Sarcomere shortening in active contraction leads to change of ventricular zero-stress configurations during the cardiac cycle. A new model using different zero-load diastole and systole geometries was introduced to provide more accurate cardiac stress/strain calculations with potential to predict post pulmonary valve replacement (PVR) surgical outcome. Methods Cardiac magnetic resonance (CMR) data were obtained from 16 patients with repaired tetralogy of Fallot prior to and 6 months after pulmonary valve replacement (8 male, 8 female, mean age 34.5 years). Patients were divided into Group 1 (n = 8) with better post PVR outcome and Group 2 (n = 8) with worse post PVR outcome based on their change in RV ejection fraction (EF). CMR-based patient-specific computational RV/LV models using one zero-load geometry (1G model) and two zero-load geometries (diastole and systole, 2G model) were constructed and RV wall thickness, volume, circumferential and longitudinal curvatures, mechanical stress and strain were obtained for analysis. Pairwise T-test and Linear Mixed Effect (LME) model were used to determine if the differences from the 1G and 2G models were statistically significant, with the dependence of the pair-wise observations and the patient-slice clustering effects being taken into consideration. For group comparisons, continuous variables (RV volumes, WT, C-and L-curvatures, and stress and strain values) were summarized as mean +/- SD and compared between the outcome groups by using an unpaired Student t-test. Logistic regression analysis was used to identify potential morphological and mechanical predictors for post PVR surgical outcome. Results Based on results from the 16 patients, mean begin-ejection stress and strain from the 2G model were 28% and 40% higher than that from the 1G model, respectively. Using the 2G model results, RV EF changes correlated negatively with stress (r = -0.609, P = 0.012) and with pre-PVR RV end-diastole volume (r = -0.60, P = 0.015), but did not correlate with WT, C-curvature, L-curvature, or strain. At begin-ejection, mean RV stress of Group 2 was 57.4% higher than that of Group 1 (130.1 +/- 60.7 vs. 82.7 +/- 38.8 kPa, P = 0.0042). Stress was the only parameter that showed significant differences between the two groups. The combination of circumferential curvature, RV volume and the difference between begin-ejection stress and end-ejection stress was the best predictor for post PVR outcome with an area under the ROC curve of 0.855. The begin-ejection stress was the best single predictor among the 8 individual parameters with an area under the ROC curve of 0.782. Conclusion The new 2G model may be able to provide more accurate ventricular stress and strain calculations for potential clinical applications. Combining morphological and mechanical parameters may provide better predictions for post PVR outcome.	[Tang, Dalin] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Tang, Dalin; Yang, Chun; Zuo, Heng; Huang, Xueying; Wu, Zheyang] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA; [del Nido, Pedro J.] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiac Surg, Dept Surg, Boston, MA USA; [Yang, Chun] China Informat Tech Designing & Consulting Inst C, Beijing, Peoples R China; [Huang, Xueying] Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China; [Rathod, Rahul H.; Gooty, Vasu; Tang, Alexander; Geva, Tal] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Dept Pediat, Boston, MA USA; [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Billiar, Kristen L.] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA	Southeast University - China; Worcester Polytechnic Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Xiamen University; Harvard University; Boston Children's Hospital; Harvard Medical School; Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Worcester	Tang, DL (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.; Tang, DL (corresponding author), Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA.	dtang@wpi.edu	Gooty, Vasu/AAL-4132-2020	Gooty, Vasu/0000-0002-1826-3568; Wu, Zheyang/0000-0003-0641-0791	National Heart, Lung and Blood Institute [1R01-HL 089269, R01-HL63095, 5P50HL074734]; National Sciences Foundation of China [11171030, 1571691, 11672001]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: National Heart, Lung and Blood Institute, 1R01-HL 089269, PIs: del Nido, Tang, Geva; National Heart, Lung and Blood Institute, R01-HL63095, del Nido; National Heart, Lung and Blood Institute, 5P50HL074734, Geva, del Nido; National Sciences Foundation of China 11171030 Yang; National Sciences Foundation of China, 1571691, Tang; and National Sciences Foundation of China, 11672001, Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner L, 2015, BIOMECH MODEL MECHAN; Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Chiu SN, 2012, CIRC-CARDIOVASC QUAL, V5, P120, DOI 10.1161/CIRCOUTCOMES.111.963603; Choi YJ, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00140; Costa KD, 1999, AM J PHYSIOL-HEART C, V276, pH595, DOI 10.1152/ajpheart.1999.276.2.H595; Das A, 2015, MED IMAGE ANAL, V19, P121, DOI 10.1016/j.media.2014.09.001; Fomovsky GM, 2011, J CARDIOVASC TRANSL, V4, P82, DOI 10.1007/s12265-010-9241-3; Gan Y, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S1-S9; Geva T, 2014, CIRC-CARDIOVASC IMAG, V7, P190, DOI 10.1161/CIRCIMAGING.113.000553; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Geva T, 2010, CIRCULATION, V122, pS201, DOI 10.1161/CIRCULATIONAHA.110.951178; Goetz WA, 2005, AM J PHYSIOL-HEART C, V289, pH196, DOI 10.1152/ajpheart.00867.2004; GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P82, DOI 10.1115/1.2895474; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Holmes Jeffery W, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1545; HUMPHREY JD, 1990, AM J PHYSIOL, V259, pH101, DOI 10.1152/ajpheart.1990.259.1.H101; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Kerckhoffs RCP, 2007, ANN BIOMED ENG, V35, P1, DOI 10.1007/s10439-006-9212-7; Kerckhoffs RCP, 2009, IEEE ENG MED BIO, P4281, DOI 10.1109/IEMBS.2009.5332708; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Krishnamurthy A, 2013, J COMPUT PHYS, V244, P4, DOI 10.1016/j.jcp.2012.09.015; MCCULLOCH A, 1992, CRIT REV BIOMED ENG, V20, P427; McKenzie ED, 2014, J THORAC CARDIOV SUR, V148, P1450, DOI 10.1016/j.jtcvs.2014.02.060; NOVAK VP, 1994, J BIOMECH, V27, P403, DOI 10.1016/0021-9290(94)90016-7; Ooi A, 2006, EUR J CARDIO-THORAC, V30, P917, DOI 10.1016/j.ejcts.2006.08.022; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; Pfeiffer ER, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026221; Saber NR, 2001, ANN BIOMED ENG, V29, P275, DOI 10.1114/1.1359452; SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122; SanchezQuintana D, 1996, HEART, V76, P280, DOI 10.1136/hrt.76.3.280; Tang DL, 2016, J THORAC CARDIOV SUR, V151, P687, DOI 10.1016/j.jtcvs.2015.09.106; Tang DL, 2014, J THORAC CARDIOV SUR, V147, P537, DOI 10.1016/j.jtcvs.2013.08.054; Tang DL, 2011, COMPUT STRUCT, V89, P1059, DOI 10.1016/j.compstruc.2010.12.012; Tang DL, 2010, PROG PEDIATR CARDIOL, V30, P51, DOI 10.1016/j.ppedcard.2010.09.007; Tang DL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913339; Valdez-Jasso D, 2012, J PHYSIOL-LONDON, V590, P4571, DOI 10.1113/jphysiol.2012.233015; Nguyen VT, 2015, CARDIOVASC ENG TECHN, V6, P412, DOI 10.1007/s13239-015-0244-8; WAIEN SA, 1992, J AM COLL CARDIOL, V20, P295, DOI 10.1016/0735-1097(92)90093-3	39	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162986	10.1371/journal.pone.0162986	http://dx.doi.org/10.1371/journal.pone.0162986			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627806	gold, Green Submitted, Green Published			2022-12-27	WOS:000383680600072
J	Ayubi, E; Doosti-Irani, A; Moghaddam, AS; Sani, M; Nazarzadeh, M; Mostafavi, E				Ayubi, Erfan; Doosti-Irani, Amin; Moghaddam, Ali Sanjari; Sani, Mohadeseh; Nazarzadeh, Milad; Mostafavi, Ehsan			The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis	PLOS ONE			English	Article							QUANTIFERON-TB GOLD; IN-TUBE; INFECTED INDIVIDUALS; LOW-PREVALENCE; RISK-FACTORS; KAPPA; BIAS; ASSOCIATION; AGREEMENT; SPOT.TB	Background Accurate diagnosis of latent tuberculosis infection (LTBI) is becoming increasingly concerning due to the increasing the HIV epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection. LTBI is diagnosed by tuberculin skin test (TST) and inter-feron- gamma release assays (IGRAs). Objectives The aim of the present study was to conduct a meta-analysis of published papers on the agreement (kappa) between TST and QuantiFERON-TB Gold In-Tube (QFT-GIT) tests for diagnosis of LTBI in HIV patient. Methods Electronic databases including PubMed/ Medline, Elsevier/ Scopus and Embase/ Ovidwere reviewed up Jan. 2016. We performed a random effect model meta-analysis for estimation of pooled Kappa between the two methods of diagnosis. Meta regression was used for assessing potential heterogeneity and Egger's test was used for assessing small study effect and publication bias. Results The initial search strategy produced 6744 records. Of them, 23 cross-sectional studies met the inclusion criteria and 20 studies entered in meta-analysis. The pooled kappa was andprevalence-adjusted and bias-adjusted kappa (PABAK) were 0.37 (95% CI: 0.28, 0.46) and 0.59 (0.49, 0.69). The discordance of TST-/QFT-GIT+ was more than TST+/QFT-GIT-. Kappa estimate between two tests was linearly associated with age and prevalence index and inversely associated with bias index. Conclusion Fair agreement between TST and QFT-GIT makes it difficult to know whether TST is as useful as the QFT-GIT in HIV-infected patients. The higher discordance of TST-/QFT-GIT+ in compared to TST+/QFT-GIT-can induce the higher sensitivity of QFT-GIT for diagnosis LTBI in HIV patients. Disagreement between two tests can be influenced by error in measurements and prevalence of HIV.	[Ayubi, Erfan] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Ayubi, Erfan; Doosti-Irani, Amin; Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Ayubi, Erfan; Doosti-Irani, Amin] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Moghaddam, Ali Sanjari] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran; [Sani, Mohadeseh] Zabol Univ Med Sci, Sch Med, Zabol, Iran; [Nazarzadeh, Milad] Sabzevar Univ Med Sci, Iranian Res Ctr Hlth Aging, Collaborat Ctr Metaanal Res ccMETA, Sabzevar, Iran; [Mostafavi, Ehsan] Res Ctr Emerging & Reemerging Infect Dis Akanlu, Hamadan, Iran	Shahid Beheshti University Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Mostafavi, E (corresponding author), Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran.; Mostafavi, E (corresponding author), Res Ctr Emerging & Reemerging Infect Dis Akanlu, Hamadan, Iran.	mmostafavi@pasteur.ac.ir	Mostafavi, Ehsan/A-7627-2011; Doosti-Irani, Amin/Q-1260-2016; Ayubi, Erfan/AAD-3213-2019; Nazarzadeh, Milad/J-8970-2014	Mostafavi, Ehsan/0000-0002-1997-517X; Doosti-Irani, Amin/0000-0003-0623-7503; Nazarzadeh, Milad/0000-0002-0576-8874				Aichelburg MC, 2014, INT J TUBERC LUNG D, V18, P709, DOI 10.5588/ijtld.13.0813; Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; Banerjee M, 1997, RES NURS HEALTH, V20, P465, DOI 10.1002/(SICI)1098-240X(199710)20:5<465::AID-NUR10>3.0.CO;2-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Cattamanchi A, 1999, J ACQ IMMUN DEF SYND, V56, P230; Cheallaigh CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053330; Chkhartishvili N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-513; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Converse PJ, 1997, J INFECT DIS, V176, P144, DOI 10.1086/514016; Davarpanah MA, 2009, IRAN RED CRESCENT ME, V11, P71; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fleiss J.L., 2013, STAT METHODS RATES P; Garcia-Elorriaga G, 2013, ASIAN PAC J TROP MED, V6, P135, DOI 10.1016/S1995-7645(13)60009-7; Gray J, 2012, CLIN INFECT DIS, V54, pE20, DOI 10.1093/cid/cir792; Hoehler FK, 2000, J CLIN EPIDEMIOL, V53, P499, DOI 10.1016/S0895-4356(99)00174-2; Jones S, 2007, INT J TUBERC LUNG D, V11, P1190; Kabeer BSA, 2011, DIAGN MICR INFEC DIS, V71, P236, DOI 10.1016/j.diagmicrobio.2011.07.012; Kimura M, 1999, J INFECT DIS, V179, P1297, DOI 10.1086/314707; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YM, 2013, INFECTION, V41, P1089, DOI 10.1007/s15010-013-0478-z; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Oni T, 2012, CLIN VACCINE IMMUNOL, V19, P1243, DOI 10.1128/CVI.00166-12; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pullar ND, 2014, INT J TUBERC LUNG D, V18, P180, DOI 10.5588/ijtld.13.0276; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Richeldi L, 2009, CHEST, V136, P198, DOI 10.1378/chest.08-2575; Santin M, 2011, DIAGN MICR INFEC DIS, V69, P59, DOI 10.1016/j.diagmicrobio.2010.09.005; Sauzullo I, 2010, INT J TUBERC LUNG D, V14, P834; Seshadri C, 2008, East Afr Med J, V85, P442; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Talati NJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-264; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650; WHO, TUB COUNTR PROF; World Health Organization, 2012, GLOB STRAT DENG PREV; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R	47	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161983	10.1371/journal.pone.0161983	http://dx.doi.org/10.1371/journal.pone.0161983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622293	gold, Green Published, Green Submitted			2022-12-27	WOS:000383681000011
J	Krafft, BA; Krag, LA; Engas, A; Nordrum, S; Bruheim, I; Herrmann, B				Krafft, Bjorn A.; Krag, Ludvig A.; Engas, Arill; Nordrum, Sigve; Bruheim, Inge; Herrmann, Bent			Quantifying the Escape Mortality of Trawl Caught Antarctic Krill (Euphausia superba)	PLOS ONE			English	Article							BEAM-TRAWL; SURVIVAL; DISCARDS; CODEND; MODEL; SEA; FISHERIES; SELECTION; ECOSYSTEM; CAPTURE	Antarctic krill (Euphausia superba) is an abundant fishery resource, the harvest levels of which are expected to increase. However, many of the length classes of krill can escape through commonly used commercial trawl mesh sizes. A vital component of the overall management of a fishery is to estimate the total fishing mortalityand quantify the mortality rate of individuals that escape from fishing gear. The methods for determining fishing mortality in krill are still poorly developed. We used a covered codend sampling technique followed by onboard observations made in holding tanks to monitor mortality rates of escaped krill. Haul duration, hydrological conditions, maximum fishing depth and catch composition all had no significant effect on mortality of krill escaping 16 mm mesh size nets, nor was any further mortality associated with the holding tank conditions. A non-parametric Kaplan-Meier analysis was used to model the relationship between mortality rates of escapees and time. There was a weak tendency, though not significant, for smaller individuals to suffer higher mortality than larger individuals. The mortality of krill escaping the trawl nets in our study was 4.4 +/- 4.4%, suggesting that krill are fairly tolerant of the capture-and-escape process in trawls.	[Krafft, Bjorn A.; Engas, Arill] Inst Marine Res, Bergen, Norway; [Krag, Ludvig A.] Tech Univ Denmark, DTU Aqua, Hirtshals, Denmark; [Nordrum, Sigve] Aker BioMarineAS, Oslo, Norway; [Bruheim, Inge] RimfrostAS, Fosnavag, Norway; [Herrmann, Bent] Fishing Gear Technol, SINTEF Fisheries & Aquaculture, Hirtshals, Denmark	Institute of Marine Research - Norway; Technical University of Denmark; SINTEF	Krafft, BA (corresponding author), Inst Marine Res, Bergen, Norway.	bjorn.krafft@imr.no		Herrmann, Bent/0000-0003-1325-6198; Krag, Ludvig Ahm/0000-0002-1531-1499	Research Council of Norway [243619, 222798]; Rimfrost AS; Aker BioMarine AS	Research Council of Norway(Research Council of Norway); Rimfrost AS; Aker BioMarine AS	The Research Council of Norway, grant number 243619 and 222798, funded travel costs and expedition equipment; grant number 243619 funded in addition salary and publication costs. The contribution by author BH, from SINTEF Fisheries and Aquaculture, was funded by the grant number 243619. Rimfrost AS sponsored shiptime and crew. Rimfrost AS and Aker BioMarine AS provided support in the form of salaries for authors IB and SN. Rimfrost AS provided valuable practical input regarding the framework needed for execution of the field experiments. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Atkinson A, 2001, MAR ECOL PROG SER, V216, P279, DOI 10.3354/meps216279; Broadhurst MK, 2007, FISHERIES MANAG ECOL, V14, P353, DOI 10.1111/j.1365-2400.2007.00563.x; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 2002, MAR FRESHWATER RES, V53, P1189, DOI 10.1071/MF02082; Budzinski E., 1985, 268 FAO, P46; Cabral HN, 2002, HYDROBIOLOGIA, V475, P449, DOI 10.1023/A:1020359913694; Chernick M., 2007, WILEY SERIES PROBABI; Chopin F, 1996, FISH RES, V25, P377, DOI 10.1016/0165-7836(95)00417-3; Efron B, 1982, SIAM MONOG, V38; Everson I., 2000, KRILL BIOL ECOLOGY F, P63; FAO, 2005, 457 FAO, P235; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Grant SM, 2013, ANTARCT SCI, V25, P603, DOI 10.1017/S0954102013000308; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; HILL BJ, 1990, AUST J MAR FRESH RES, V41, P53; Ingolfsson OA, 2007, ICES J MAR SCI, V64, P1836, DOI 10.1093/icesjms/fsm150; JEAN Y, 1963, J FISH RES BOARD CAN, V20, P497, DOI 10.1139/f63-038; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Krafft BA, 2015, POLAR BIOL, V38, P1687, DOI 10.1007/s00300-015-1735-7; Krafft BA, 2015, FISH RES, V170, P102, DOI 10.1016/j.fishres.2015.05.019; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Madsen N, 2012, AQUAT LIVING RESOUR, V25, P231, DOI 10.1051/alr/2012021; Marr J, 1962, 32 NAT I OC, P17; MCLOUGHLIN RJ, 1991, FISH RES, V11, P1, DOI 10.1016/0165-7836(91)90030-J; Metin C, 2004, FISH RES, V70, P49, DOI 10.1016/j.fishres.2004.06.013; Naidu K. S., 1988, J SHELLFISH RES, V7, P61; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Sangster GI, 1996, FISH RES, V25, P323, DOI 10.1016/0165-7836(95)00430-0; Siegel V, 2007, WGEMM0728 CCAMLR; Soldal AV, 1997, ICES J MAR SCI, V54, P117; Stoot LJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou011; Suuronen P, 1996, ICES J MAR SCI, V53, P691, DOI 10.1006/jmsc.1996.0088; Suuronen P, 1996, FISH RES, V25, P305, DOI 10.1016/0165-7836(95)00446-7; Suuronen P., 2005, FAO FISH TECHN PAP, V478, P72; VANBEEK FA, 1990, NETH J SEA RES, V26, P151, DOI 10.1016/0077-7579(90)90064-N; Vinogradov NN, 1960, CM1960F ICES, V172; WASSENBERG TJ, 1993, FISH RES, V17, P343, DOI 10.1016/0165-7836(93)90134-S; Wileman D.A., 1996, 1126 ICES COOP	41	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162311	10.1371/journal.pone.0162311	http://dx.doi.org/10.1371/journal.pone.0162311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622510	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000383681000024
J	Conen, D; Arendacka, B; Rover, C; Bergau, L; Munoz, P; Wijers, S; Sticherling, C; Zabel, M; Friede, T				Conen, David; Arendacka, Barbora; Roever, Christian; Bergau, Leonard; Munoz, Pascal; Wijers, Sofieke; Sticherling, Christian; Zabel, Markus; Friede, Tim			Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUDDEN CARDIAC DEATH; REDUCED EJECTION FRACTION; ADVANCED HEART-FAILURE; PRIMARY PREVENTION; SECONDARY PREVENTION; CLINICAL-PRACTICE; SEX-DIFFERENCES; THERAPY; OUTCOMES; CARDIOMYOPATHY	Background Some but not all prior studies have shown that women receiving a primary prophylactic implantable cardioverter defibrillator (ICD) have a lower risk of death and appropriate shocks than men. Purpose To evaluate the effect of gender on the risk of appropriate shock, all-cause mortality and inappropriate shock in contemporary studies of patients receiving a primary prophylactic ICD. Data Source PubMed, LIVIVO, Cochrane CENTRAL between 2010 and 2016. Study Selection Studies providing at least 1 gender-specific risk estimate for the outcomes of interest. Data Extraction Abstracts were screened independently for potentially eligible studies for inclusion. Thereby each abstract was reviewed by at least two authors. Data Synthesis Out of 680 abstracts retained by our search strategy, 20 studies including 46'657 patients had gender-specific information on at least one of the relevant endpoints. Mean age across the individual studies varied between 58 and 69 years. The proportion of women enrolled ranged from 10% to 30%. Across 6 available studies, women had a significantly lower risk of first appropriate shock compared with men (pooled multivariable adjusted hazard ratio 0.62 (95% CI [0.44; 0.88]). Across 14 studies reporting'multivariable adjusted gender-specific hazard ratio estimates for all-cause mortality, women had a lower risk of death than men (pooled hazard ratio 0.75 (95% CI [0.66; 0.86]). There was no statistically significant difference for the incidence of first inappropriate shocks (3 studies, pooled hazard ratio 0.99 (95% CI [0.56; 1.73]). Limitations Individual patient data were not available for most studies. Conclusion In this large contemporary meta-analysis, women had a significantly lower risk of appropriate shocks and death than men, but a similar risk of inappropriate shocks. These data may help to select patients who benefit from primary prophylactic ICD implantation.	[Conen, David] Univ Basel Hosp, Dept Med, Div Internal Med, Basel, Switzerland; [Arendacka, Barbora; Roever, Christian; Friede, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Bergau, Leonard; Munoz, Pascal] Univ Med Ctr Gottingen, Dept Cardiol, Gottingen, Germany; [Bergau, Leonard; Munoz, Pascal; Zabel, Markus] Univ Med Ctr Gottingen, Pulmonol & Clin Electrophysiol Div, Gottingen, Germany; [Wijers, Sofieke] Univ Med Ctr Utrecht, Dept Physiol & Cardiol, Utrecht, Netherlands; [Sticherling, Christian] Univ Basel Hosp, Dept Med, Div Cardiol, Basel, Switzerland; [Friede, Tim] German Ctr Cardiovasc Res DZHK, Partner Site Gotingen, Gottingen, Germany	University of Basel; University of Gottingen; University of Gottingen; University of Gottingen; Utrecht University; Utrecht University Medical Center; University of Basel; German Centre for Cardiovascular Research	Conen, D (corresponding author), Univ Basel Hosp, Dept Med, Div Internal Med, Basel, Switzerland.	david.conen@usb.ch	Röver, Christian/H-4892-2019; Sticherling, Christian/AAY-4435-2021; Friede, Tim/ABF-1132-2021	Röver, Christian/0000-0002-6911-698X; Sticherling, Christian/0000-0001-8428-7050; Friede, Tim/0000-0001-5347-7441; Bergau, Leonard/0000-0001-7025-9315; Kessel, Barbora/0000-0003-3589-4457	European Community [602299]; Swiss National Science Foundation [PP00P3_159322]	European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The research leading to the results has received funding from the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement. 602299, EU-CERTICD. David Conen was supported by grants of the Swiss National Science Foundation (PP00P3_159322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib SM, 2005, ANN INTERN MED, V142, P593, DOI 10.7326/0003-4819-142-8-200504190-00007; Amit G, 2014, EUROPACE, V16, P1175, DOI 10.1093/europace/euu015; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bilchick KC, 2012, J AM COLL CARDIOL, V60, P1647, DOI 10.1016/j.jacc.2012.07.028; Campbell NG, 2014, INT J CARDIOL, V175, P328, DOI 10.1016/j.ijcard.2014.05.023; Demirel F, 2014, INT J CARDIOL, V177, P392, DOI 10.1016/j.ijcard.2014.08.132; Gatzoulis KA, 2013, INT J CARDIOL, V167, P1360, DOI 10.1016/j.ijcard.2012.04.005; Ghanbari H, 2009, ARCH INTERN MED, V169, P1500, DOI 10.1001/archinternmed.2009.255; Gigli L, 2014, J CARDIOVASC MED, V15, P653, DOI 10.2459/JCM.0000000000000112; Hage FG, 2013, INT J CARDIOL, V165, P113, DOI 10.1016/j.ijcard.2011.07.087; Hjalmarson A, 1999, LANCET, V353, P2001; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Koller MT, 2008, CIRCULATION, V117, P1918, DOI 10.1161/CIRCULATIONAHA.107.742155; Kraaier K, 2014, EUROPACE, V16, P40, DOI 10.1093/europace/eut223; Levine YC, 2014, HEART RHYTHM, V11, P1109, DOI 10.1016/j.hrthm.2014.04.024; Loh JC, 2013, CIRC-HEART FAIL, V6, P411, DOI 10.1161/CIRCHEARTFAILURE.112.000178; MacFadden DR, 2012, ANN INTERN MED, V156, P195, DOI 10.7326/0003-4819-156-3-201202070-00007; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; Masoudi FA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002005; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Providencia R, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002756; Rodriguez-Manero M, 2016, REV ESP CARDIOL, V69, P272, DOI 10.1016/j.rec.2015.05.016; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Santangeli P, 2010, HEART RHYTHM, V7, P876, DOI 10.1016/j.hrthm.2010.03.042; Schmidt M, 2015, HEART RHYTHM, V12, P2018, DOI 10.1016/j.hrthm.2015.04.040; Seegers J, 2015, EUROPACE EUROPEAN PA, DOI [10.1093/europace/euv361, DOI 10.1093/EUROPACE/EUV361]; Smith T, 2011, CLIN CARDIOL, V34, P761, DOI 10.1002/clc.20970; Stabile G, 2013, J CARDIOVASC MED, V14, P110, DOI 10.2459/JCM.0b013e3283511f5b; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van der Heijden AC, 2013, HEART, V99, P1244, DOI 10.1136/heartjnl-2013-304013; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Weeke P, 2013, EUROPACE, V15, P1150, DOI 10.1093/europace/eut017; Wijers SC, 2013, NETH HEART J, V21, P274, DOI 10.1007/s12471-013-0407-x; Yung D, 2013, CIRCULATION, V127, P2383, DOI 10.1161/CIRCULATIONAHA.113.001442	36	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162756	10.1371/journal.pone.0162756	http://dx.doi.org/10.1371/journal.pone.0162756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618617	Green Published, gold			2022-12-27	WOS:000383653100048
J	Leotta, GA; Brusa, V; Galli, L; Adriani, C; Linares, L; Etcheverria, A; Sanz, M; Sucari, A; Garcia, PP; Signorini, M				Leotta, Gerardo A.; Brusa, Victoria; Galli, Lucia; Adriani, Cristian; Linares, Luciano; Etcheverria, Analia; Sanz, Marcelo; Sucari, Adriana; Peral Garcia, Pilar; Signorini, Marcelo			Comprehensive Evaluation and Implementation of Improvement Actions in Butcher Shops	PLOS ONE			English	Article							ESCHERICHIA-COLI O157; RETAIL GROUND-BEEF; LISTERIA-MONOCYTOGENES; BIOFILM FORMATION; FOOD; SALMONELLA; PREVALENCE; STATE; CUTS; CARCASSES	Foodborne pathogens can cause acute and chronic diseases and produce a wide range of symptoms. Since the consumption of ground beef is a risk factor for infections with some bacterial pathogens, we performed a comprehensive evaluation of butcher shops, implemented improvement actions for both butcher shops and consumers, and verified the impact of those actions implemented. A comprehensive evaluation was made and risk was quantified on a 1-100 scale as high-risk (1-40), moderate-risk (41-70) or low-risk (71-100). A total of 172 raw ground beef and 672 environmental samples were collected from 86 butcher shops during the evaluation (2010-2011) and verification (2013) stages of the study. Ground beef samples were analyzed for mesophilic aerobic organisms, Escherichia coli and coagulase-positive Staphylococcus aureus enumeration. Salmonella spp., E. coli O157:H7, non-O157 Shiga toxin-producing E. coli (STEC), and Listeria monocytogenes were detected and isolated from all samples. Risk quantification resulted in 43 (50.0%) high-risk, 34 (39.5%) moderate-risk, and nine (10.5%) low-risk butcher shops. Training sessions for 498 handlers and 4,506 consumers were held. Re-evaluation by risk quantification and microbiological analyses resulted in 19 (22.1%) high-risk, 42 (48.8%) moderate-risk and 25 (29.1%) low-risk butcher shops. The count of indicator microorganisms decreased with respect to the 2010-2011 period. After the implementation of improvement actions, the presence of L. monocytogenes, E. coli O157: H7 and stx genes in ground beef decreased. Salmonella spp. was isolated from 10 (11.6%) ground beef samples, without detecting statistically significant differences between both study periods (evaluation and verification). The percentage of pathogens in environmental samples was reduced in the verification period (Salmonella spp., 1.5%; L. monocytogenes, 10.7%; E. coli O157: H7, 0.6%; non-O157 STEC, 6.8%). Risk quantification was useful to identify those relevant facts in butcher shops. The reduction of contamination in ground beef and the environment was possible after training handlers based on the problems identified in their own butcher shops. Our results confirm the feasibility of implementing a comprehensive risk management program in butcher shops, and the importance of information campaigns targeting consumers. Further collaborative efforts would be necessary to improve foodstuffs safety at retail level and at home.	[Leotta, Gerardo A.; Brusa, Victoria; Galli, Lucia; Peral Garcia, Pilar] UNLP, Fac Ciencias Vet, CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulout, La Plata, Buenos Aires, Argentina; [Brusa, Victoria; Linares, Luciano] UNLP, Fac Ciencias Vet, Lab Microbiol Alimentos, La Plata, Buenos Aires, Argentina; [Adriani, Cristian] Municipalidad Berisso, Dept Seguridad Alimentaria, Berisso, Buenos Aires, Argentina; [Etcheverria, Analia; Sanz, Marcelo] UNCPBA, Fac Ciencias Vet, CICPBA, CONICET,Ctr Invest Vet Tandil CIVETAN, Buenos Aires, DF, Argentina; [Sucari, Adriana] Ctr Estudios Infectol Dr Daniel Stamboulian, Div Alimentos, Buenos Aires, DF, Argentina; [Signorini, Marcelo] INTA, CONICET EEA Rafaela, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Leotta, GA (corresponding author), UNLP, Fac Ciencias Vet, CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulout, La Plata, Buenos Aires, Argentina.	gerardo.leotta@gmail.com	Etcheverría, Analía/ABC-5883-2021; Signorini, Marcelo/B-7097-2009	Signorini, Marcelo/0000-0001-6537-8782; Peral-Garcia, Pilar/0000-0003-3015-4628	Argentine Beef Promotion Institute (IPCVA); PIP grant from CONICET (Argentina) [0266]; Science and Technology Agency (Argentina) [PICTO-2010-0082]	Argentine Beef Promotion Institute (IPCVA); PIP grant from CONICET (Argentina); Science and Technology Agency (Argentina)	The present study was supported by Argentine Beef Promotion Institute (IPCVA), PIP grant #0266 from CONICET (Argentina), PICTO-2010-0082 from Science and Technology Agency (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3138; Andrews W.H., 2011, BACTERIOLOGICAL ANAL; [Anonymous], 2016, B INT EP, V298; Antman J, 2014, INFORME ESPECIAL; Arnedo-Pena A, 2016, ENFERM INFEC MICR CL, V34, P544, DOI 10.1016/j.eimc.2015.11.016; Barlow RS, 2006, INT J FOOD MICROBIOL, V111, P1, DOI 10.1016/j.ijfoodmicro.2006.04.039; Beauchamp CS, 2012, J FOOD SCI, V77, pM343, DOI 10.1111/j.1750-3841.2012.02695.x; Berger S, 2016, SALMONELLOSIS GLOBAL; Bogard AK, 2013, J FOOD PROTECT, V76, P2132, DOI 10.4315/0362-028X.JFP-13-126; Bosilevac JM, 2007, J FOOD PROTECT, V70, P440, DOI 10.4315/0362-028X-70.2.440; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brusa V, 2016, FOODBORNE PATHOG DIS, V13, P163, DOI 10.1089/fpd.2015.2034; Brusa V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00171; Camargo AC, 2014, J FOOD PROTECT, V77, P1148, DOI 10.4315/0362-028X.JFP-13-434; de Paula CMD, 2014, VIGIL SANIT DEBATE, V2, P23, DOI 10.3395/vd.v2i4.442; Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426; Etcheverria AI, 2010, MEAT SCI, V86, P418, DOI 10.1016/j.meatsci.2010.05.027; EU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses, 2013, EU REF LAB E COL; Giaouris E, 2012, SALMONELLA DANGEROUS; Gounadaki AS, 2008, FOOD MICROBIOL, V25, P313, DOI 10.1016/j.fm.2007.10.001; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; International Organization for Standardization, 1664922001 ISO; International Organization for Standardization, 1129012004 ISO; International Organization for Standardization, 688811999 ISO; Jourdan N, 2008, EUROSURVEILLANCE, V13, P39; Ju WT, 2012, FOOD MICROBIOL, V32, P371, DOI 10.1016/j.fm.2012.07.017; KARCH H, 1993, J CLIN MICROBIOL, V31, P1200, DOI 10.1128/JCM.31.5.1200-1205.1993; Leotta G.A., 2005, Rev. argent. microbiol., V37, P1; Leotta GA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-46; Llorente P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/795104; Mangen MJJ, 2015, INT J FOOD MICROBIOL, V196, P84, DOI 10.1016/j.ijfoodmicro.2014.11.022; Manios SG, 2014, METHODS MOL BIOL, V1157, P251, DOI 10.1007/978-1-4939-0703-8_21; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; Maturin L, 2001, BACTERIOLOGICAL ANAL; Mora A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-13; Organizacion Panamericana de la Salud (OPS)-Instituto Panamericano de Proteccion de Alimentos y Zoonosis (INPPAZ), 2001, HACCP HERR ES IN AL; Papadopoulou OS, 2012, MEAT SCI, V90, P865, DOI 10.1016/j.meatsci.2011.11.008; Perez-Rodriguez F, 2010, MEAT SCI, V86, P479, DOI 10.1016/j.meatsci.2010.05.038; Phang HS, 2011, J FOOD PROTECT, V74, P1708, DOI 10.4315/0362-028X.JFP-10-417; Rhoades JR, 2009, FOOD MICROBIOL, V26, P357, DOI 10.1016/j.fm.2008.10.012; Rivas M, 2010, PATHOGENIC ESCHERICH, P142; Rodolpho D, 2007, BRAZ J MICROBIOL, V38, P599, DOI 10.1590/S1517-83822007000400004; Samadpour M, 2006, J FOOD PROTECT, V69, P441, DOI 10.4315/0362-028X-69.2.441; Sirsat SA, 2014, JOVE-J VIS EXP, DOI 10.3791/51402; Srednik ME, 2013, INVET, V15, P23; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Taylor EV, 2012, J FOOD PROTECT, V75, P341, DOI 10.4315/0362-028X.JFP-11-333; Todd ECD, 2008, J FOOD PROTECT, V71, P2339, DOI 10.4315/0362-028X-71.11.2339; Torso LM, 2015, J FOOD PROTECT, V78, P1272, DOI 10.4315/0362-028X.JFP-14-545; United States Department of Agriculture, 2011, MLG505 USDA; Vipham JL, 2012, J FOOD PROTECT, V75, P2110, DOI 10.4315/0362-028X.JFP-12-077; Wagner VR, 2013, BRAZ J MICROBIOL, V44, P723, DOI 10.1590/S1517-83822013005000064; Wang JJ, 2015, FOODBORNE PATHOG DIS, V12, P151, DOI 10.1089/fpd.2014.1837; Wasilenko JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00081; *WHO GLOB SALM SUR, 2006, PROGR REP 2000 2005; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Yang BW, 2010, INT J FOOD MICROBIOL, V141, P63, DOI 10.1016/j.ijfoodmicro.2010.04.015	57	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162635	10.1371/journal.pone.0162635	http://dx.doi.org/10.1371/journal.pone.0162635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618439	Green Published, gold			2022-12-27	WOS:000383653100036
J	Akiyama, T; Oishi, K; Wullaert, A				Akiyama, Takuya; Oishi, Kenji; Wullaert, Andy			Bifidobacteria Prevent Tunicamycin-Induced Endoplasmic Reticulum Stress and Subsequent Barrier Disruption in Human Intestinal Epithelial Caco-2 Monolayers	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CELL-DEATH; HOMOLOGOUS PROTEIN; COLITIS; PROBIOTICS; NECROSIS; TISSUE	Endoplasmic reticulum (ER) stress is caused by accumulation of unfolded and misfolded proteins in the ER, thereby compromising its vital cellular functions in protein production and secretion. Genome wide association studies in humans as well as experimental animal models linked ER stress in intestinal epithelial cells (IECs) with intestinal disorders including inflammatory bowel diseases. However, the mechanisms linking the outcomes of ER stress in IECs to intestinal disease have not been clarified. In this study, we investigated the impact of ER stress on intestinal epithelial barrier function using human colon carcinoma-derived Caco-2 monolayers. Tunicamycin-induced ER stress decreased the trans-epithelial electrical resistance of Caco-2 monolayers, concomitant with loss of cellular plasma membrane integrity. Epithelial barrier disruption in Caco-2 cells after ER stress was not caused by caspase- or RIPK1-dependent cell death but was accompanied by lysosomal rupture and up-regulation of the ER stress markers Grp78, sXBP1 and Chop. Interestingly, several bifidobacteria species inhibited tunicamycin-induced ER stress and thereby diminished barrier disruption in Caco-2 monolayers. Together, these results showed that ER stress compromises the epithelial barrier function of Caco-2 monolayers and demonstrate beneficial impacts of bifidobacteria on ER stress in IECs. Our results identify epithelial barrier loss as a potential link between ER stress and intestinal disease development, and suggest that bifidobacteria could exert beneficial effects on this phenomenon.	[Akiyama, Takuya; Oishi, Kenji; Wullaert, Andy] Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium; [Oishi, Kenji] Yakult Cent Inst, Tokyo, Japan; [Wullaert, Andy] VIB, Inflammat Res Ctr, Ghent, Belgium; [Wullaert, Andy] Univ Ghent, Dept Internal Med, Ghent, Belgium	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited; Flanders Institute for Biotechnology (VIB); Ghent University	Akiyama, T; Wullaert, A (corresponding author), Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium.; Wullaert, A (corresponding author), VIB, Inflammat Res Ctr, Ghent, Belgium.; Wullaert, A (corresponding author), Univ Ghent, Dept Internal Med, Ghent, Belgium.	takuya.akiyama@yher.be; andy.wullaert@ugent.be	Wullaert, Andy/R-1924-2019; Wullaert, Andy/D-2975-2018	Wullaert, Andy/0000-0001-5012-654X; Wullaert, Andy/0000-0001-5012-654X	Research Foundation-Flanders (FWO); FWO [G.0C49.13N]	Research Foundation-Flanders (FWO)(FWO); FWO(FWO)	AW holds a postdoctoral fellowship from the Research Foundation-Flanders (FWO, http://www.fwo.be/en/) and is supported by the FWO Odysseus return grant number G.0C49.13N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AW holds a postdoctoral fellowship from the Research Foundation-Flanders (FWO) and is supported by the FWO Odysseus return grant number G.0C49.13N.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Didari T, 2015, WORLD J GASTROENTERO, V21, P3072, DOI 10.3748/wjg.v21.i10.3072; Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530; Halpern MD, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2014.1000707; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hosomi S, 2015, CURR OPIN GASTROEN, V31, P81, DOI 10.1097/MOG.0000000000000144; Huang WC, 2009, J PHARMACOL EXP THER, V329, P524, DOI 10.1124/jpet.108.148122; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Laukens D, 2014, LAB INVEST, V94, P1419, DOI 10.1038/labinvest.2014.117; Lu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078491; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Saveljeva S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.548; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Treton X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101669; Treton X, 2011, GASTROENTEROLOGY, V141, P1024, DOI 10.1053/j.gastro.2011.05.033; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Waldschmitt N, 2014, MUCOSAL IMMUNOL, V7, P1452, DOI 10.1038/mi.2014.34	30	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162448	10.1371/journal.pone.0162448	http://dx.doi.org/10.1371/journal.pone.0162448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611782	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900101
J	Chen, DZ; Song, J; Zhao, Y; Zheng, X; Yu, AX				Chen, Dezhi; Song, Jian; Zhao, Yong; Zheng, Xun; Yu, Aixi			Systematic Review and Meta-Analysis of Surgical Zipper Technique versus Intracutaneous Sutures for the Closing of Surgical Incision	PLOS ONE			English	Review							WOUND CLOSURE; SKIN-CLOSURE; SURGERY	Background It is controversial whether surgical zipper technique (SZT), a non-invasive method of surgical wound closure, achieves a better outcome of incision healing than intracutaneous sutures (IS) in the surgery. This meta-analysis was performed to systematically analyze whether surgical zipper is superior to suture material for the incision closure. Methods Databases and reference lists were searched for randomized controlled trials (RCTs) comparing SZT with IS for the incision closure. Results Four RCTs with 678 patients were identified and analyzed. Compared with IS, SZT achieved similar incidence of postoperative complications, less time for incision closure, less cost of both surgeons' time and operating room time, no need for removing sutures and more comfort for the patients. Besides, SZT achieved perfect aesthetic results in various types of incisions with the exception of those with substantial curvatures, those with secretions, in obese patients or those under high tension. Conclusion The non-invasive zipper technique may be a more attractive option of incision closure in a wide spectrum of surgical areas.	[Chen, Dezhi; Song, Jian; Zhao, Yong; Zheng, Xun; Yu, Aixi] Wuhan Univ, Zhongnan Hosp, Dept Orthoped, Wuhan 430071, Hubei, Peoples R China	Wuhan University	Yu, AX (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthoped, Wuhan 430071, Hubei, Peoples R China.	yuaixi@whu.edu.cn			Wuhan Huanghe Elite Program	Wuhan Huanghe Elite Program	This work was supported by Wuhan Huanghe Elite Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Wuhan Huanghe Elite Program. We declare no conflict of interest in this study.	ALEXANDER JW, 1967, ANN SURG, V165, P192, DOI 10.1097/00000658-196702000-00005; Bitkover CY, 2000, ANN THORAC SURG, V69, P1110, DOI 10.1016/S0003-4975(99)01432-0; Boltri M, 1997, Minerva Chir, V52, P1405; Braxton JH, 2000, ANN THORAC SURG, V70, P2004, DOI 10.1016/S0003-4975(00)01814-2; Brega-Massone P, 2003, J SURG ONCOL, V84, P249, DOI 10.1002/jso.10326; Carcoforo P, 1996, G Chir, V17, P55; Chibbaro S, 2009, J CLIN NEUROSCI, V16, P535, DOI 10.1016/j.jocn.2008.08.004; Chow A, 2010, J AM COLL SURGEONS, V211, P114, DOI 10.1016/j.jamcollsurg.2010.03.013; CHU CC, 1984, AM J SURG, V147, P197, DOI 10.1016/0002-9610(84)90088-6; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Hasse FM, 1999, ZBL CHIR, V124, P210; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; JOHNSON P, 1985, ANN THORAC SURG, V40, P69, DOI 10.1016/S0003-4975(10)61173-3; Luck RP, 2008, PEDIATR EMERG CARE, V24, P137, DOI 10.1097/PEC.0b013e3181666f87; Onuminya J E, 2002, West Afr J Med, V21, P15; Onuminya JE, 2006, J NATL MED ASSOC, V98, P83; Patel RM, 2012, ORTHOPEDICS, V35, pE641, DOI 10.3928/01477447-20120426-16; Risnes I, 2002, SCAND CARDIOVASC J, V36, P378, DOI 10.1080/140174302762659120; Risnes I, 2002, EUR J CARDIO-THORAC, V22, P271, DOI 10.1016/S1010-7940(02)00265-8; Roolker W, 2002, ARCH ORTHOP TRAUM SU, V122, P2, DOI 10.1007/s004020100308; Xu LL, 2014, SPINE, V39, pE481, DOI 10.1097/BRS.0000000000000223	22	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162471	10.1371/journal.pone.0162471	http://dx.doi.org/10.1371/journal.pone.0162471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611083	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900108
J	Hoshina, S; Sekizuka, T; Kataoka, M; Hasegawa, H; Hamada, H; Kuroda, M; Katano, H				Hoshina, Shiho; Sekizuka, Tsuyoshi; Kataoka, Michiyo; Hasegawa, Hideki; Hamada, Hiromichi; Kuroda, Makoto; Katano, Harutaka			Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PRIMARY EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; RETICULOCYTE MATURATION; TRANSFERRIN RECEPTOR; VIRUS; IDENTIFICATION; DNA; IMPORT; PLASMA	Exosomes are small vesicles released from cells, into which microRNAs (miRNA) are specifically sorted and accumulated. Two gamma-herpesviruses, Kaposi sarcoma-associated herpesvirus(KSHV) and Epstein-Barr virus (EBV), encode miRNAs in their genomes and express virus-encoded miRNAs in cells and exosomes. However, there is little information about the detailed distribution of virus-encoded miRNAs in cells and exosomes. In this study, we thus identified virus-and host-encoded miRNAs in exosomes released from KSHV- or EBV-infected lymphoma cell lines and compared them with intracellular miRNAs using a next-generation sequencer. Sequencing analysis demonstrated that 48% of the annotated miRNAs in the exosomes from KSHV- infected cells originated from KSHV. Human mir-10b-5p and mir-143-3p were much more highly concentrated in exosomes than in cells. Exosomes contained more nonexact mature miRNAs that did not exactly match those in miR Base than cells. Among the KSHV-encoded miRNAs, miRK12-3-5p was the most abundant exact mature miRNA in both cells and exosomes that exactly matched those in miR ]Base. Recently identified EXO motifs, nucleotide motifs that control the loading of miRNAs into exosomes were frequently found within the sequences of KSHV- encoded miRNAs, and the presence of the EXO motif CCCT or CCCG was associated with the localization of miRNA in exosomes in KSHV- infected cells. These observations suggest that specific virus-encoded miRNAs are sorted by EXO motifs and accumulate in exosomes in virus-infected cells.	[Hoshina, Shiho; Kataoka, Michiyo; Hasegawa, Hideki; Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Hoshina, Shiho; Hamada, Hiromichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, 477-96 Owada Shinden, Chiba 2760046, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Tokyo Women's Medical University	Katano, H (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	katano@nih.go.jp	Hasegawa, Hideki/C-7978-2014	Katano, Harutaka/0000-0002-5332-4434; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Research Program on HIV/AIDS [15fk00410017h0101, 15fk041000h0103, 15fk0108011h0003, 16fk0410209j0102, 16fk0410108j0101, 16fk0410107j0001]; Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development [15fk0108011h0503, 16fk0108119j0001]; Japan Society for the Promotion of Science [15K08509]	Research Program on HIV/AIDS; Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by Research Program on HIV/AIDS (grant numbers 15fk00410017h0101, 15fk041000h0103, 15fk0108011h0003, 16fk0410209j0102, 16fk0410108j0101, and 16fk0410107j0001) and Research Program on Emerging and Re-emerging Infectious Diseases (grant numbers 15fk0108011h0503 and 16fk0108119j0001) from the Agency for Medical Research and Development, and Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (grant number 15K08509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Amoroso R, 2011, J VIROL, V85, P996, DOI 10.1128/JVI.01528-10; Baran-Marszak F, 2002, LAB INVEST, V82, P1463, DOI 10.1097/01.LAB.0000035025.51772.2B; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Feederle R, 2011, J VIROL, V85, P9801, DOI 10.1128/JVI.05100-11; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Katano H, 1999, J MED VIROL, V58, P394, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;394::AID-JMV12&gt;3.0.CO;2-H; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Osawa M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0086-5; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Rocca A, 2015, J CLIN VIROL, V70, P1, DOI 10.1016/j.jcv.2015.06.104; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; UHARA H, 1990, JPN J CANCER RES, V81, P272, DOI 10.1111/j.1349-7006.1990.tb02561.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035	34	33	35	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162574	10.1371/journal.pone.0162574	http://dx.doi.org/10.1371/journal.pone.0162574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611973	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900129
J	Ke, P; Shao, BZ; Xu, ZQ; Wei, W; Han, BZ; Chen, XW; Su, DF; Liu, C				Ke, Ping; Shao, Bo-Zong; Xu, Zhe-Qi; Wei, Wei; Han, Bin-Ze; Chen, Xiong-Wen; Su, Ding-Feng; Liu, Chong			Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages	PLOS ONE			English	Article							CB2 RECEPTOR; NITRIC-OXIDE; MOUSE MODEL; MICE; EXPRESSION; AUTOPHAGY; PATHWAY; CELLS; DISEASE; SUPPRESSION	Activation of cannabinoid receptor 2 (CB2R) ameliorates inflammation, but the underlying mechanism remains unclear. In the present study, we examined whether activation of CB2R could suppress the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome. In peritoneal macrophages isolated from C57BL/6 mice, LPS/DSS challenge for 24 h increased the expression of the components of NLRP3 inflammasome NLRP3, Casp-1 p20/Casp-1 p45 ratio, proIL-1 beta and IL-1 beta and also enhanced autophagy (LC3-II/LC3-I ratio, Beclin-1 and SQSTM1). Pretreatment of peritoneal macrophages with HU 308, a selective CB2R agonist, attenuated LPS/DSS-induced NLRP3 inflammasome activation, but further enhanced autophagy. In comparison with wild-type (WT) control, peritoneal macrophages from CB2R knockout (KO) mice had more robust NLRP3 inflammasome activation and attenuated autophagy upon LPS/DSS challenge. Knockdown autophagy-related gene 5 (Atg5) with a siRNA in peritoneal macrophages attenuated the inhibitory effects of HU 308 on LPS/DSS-induced NLRP3 inflammasome activation in vitro. In vivo, HU308 treatment attenuated DSS-induced colitis mice associated with reduced colon inflammation and inhibited NLRP3 inflammasome activation in wild-type mice. In CB2R KO mice, DSS-induced inflammation and NLRP3 inflammasome activation were more pronounced than those in WT control. Finally, we demonstrated that AMPK-mTOR-P70S6K signaling pathway was involved in this CB2R-mediated process. We conclude that activation of CB2R ameliorates DSS-induced colitis through enhancing autophagy that may inhibit NLRP3 inflammasome activation in macrophages.	[Ke, Ping; Shao, Bo-Zong; Xu, Zhe-Qi; Han, Bin-Ze; Su, Ding-Feng; Liu, Chong] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Wei, Wei] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiong-Wen] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA	Naval Medical University; Zhejiang Academy of Agricultural Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Su, DF; Liu, C (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.	dfsu2008@gmail.com; wanlc2004@aliyun.com	Chen, Xiongwen/D-5988-2012; Xu, Zhe-Qi/GXV-8629-2022	Chen, Xiongwen/0000-0002-3829-5815; 	Shanghai Natural Science Foundation of China [13ZR1448400]; State Key Program of National Natural Science of China [81230083]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243] Funding Source: NIH RePORTER	Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Shanghai Natural Science Foundation of China (13ZR1448400) received by CL and the State Key Program of National Natural Science of China (Grant No. 81230083) received by DFS. CL and D-FS contributed to the designing of the experiments and the analysis of data. CL made decision of submission and D-FS gave his valuable suggestion in organizing this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Berger ND, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-77; Budai MM, 2013, MOL IMMUNOL, V56, P471, DOI 10.1016/j.molimm.2013.05.005; Carbone F, 2014, CURR MED CHEM, V21, P4046, DOI 10.2174/0929867321666140915141332; Casarejos MJ, 2013, J ALZHEIMERS DIS, V35, P525, DOI 10.3233/JAD-130050; Cheluvappa R, 2014, INFLAMM BOWEL DIS, V20, P847, DOI 10.1097/MIB.0000000000000034; Cho DH, 2014, FREE RADICAL BIO MED, V76, P96, DOI 10.1016/j.freeradbiomed.2014.07.043; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Dando I, 2013, CELL DEATH DIS, P4; Gao Y, 2014, FREE RADICAL BIO MED, V72, P104, DOI 10.1016/j.freeradbiomed.2014.04.001; Gherbi K, 2014, BRIT J PHARMACOL, V171, P5431, DOI 10.1111/bph.12858; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gu JX, 2013, INT J CLIN EXP PATHO, V6, P2396; Guo WJ, 2014, AUTOPHAGY, V10, P972, DOI 10.4161/auto.28374; Harvey BS, 2013, CYTOKINE, V63, P209, DOI 10.1016/j.cyto.2013.04.032; Islam MS, 2014, BRIT J PHARMACOL, V171, P375, DOI 10.1111/bph.12452; Kong WM, 2014, CELL IMMUNOL, V287, P1, DOI 10.1016/j.cellimm.2013.11.002; Liu C, 2013, FREE RADICAL BIO MED, V65, P658, DOI 10.1016/j.freeradbiomed.2013.07.045; Liu C, 2009, CRIT CARE MED, V37, P634, DOI 10.1097/CCM.0b013e31819598f5; Liu H, 2015, GEN COMP ENDOCR, V210, P124, DOI 10.1016/j.ygcen.2014.09.006; Liu X, 2015, BRAIN BEHAV IMMUN, V46, P121, DOI 10.1016/j.bbi.2015.01.011; Liu Y, 2015, INNATE IMMUN-LONDON, V21, P587, DOI 10.1177/1753425914566205; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Maiuri MC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/584715; Menon D, 2014, FREE RADICAL BIO MED, V73, P318, DOI 10.1016/j.freeradbiomed.2014.05.020; Mitrovic M, 2010, BRIT J PHARMACOL, V160, P1430, DOI 10.1111/j.1476-5381.2010.00794.x; Pannuru P, 2014, CELL SIGNAL, V26, P2193, DOI 10.1016/j.cellsig.2014.06.014; Sanchez AJ, 2012, CLIN IMMUNOL, V142, P57, DOI 10.1016/j.clim.2011.02.010; Santoni G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0239-2; Schepetkin IA, 2015, J PHARMACOL EXP THER, V353, P505, DOI 10.1124/jpet.114.220251; Shao BZ, 2014, CNS NEUROSCI THER, V20, P1021, DOI 10.1111/cns.12349; Singh UP, 2012, TOXICOL APPL PHARM, V258, P256, DOI 10.1016/j.taap.2011.11.005; Tun X, 2014, FREE RADICAL BIO MED, V74, P108, DOI 10.1016/j.freeradbiomed.2014.06.020; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Zhang B, 2015, J CARD FAIL, V21, P426, DOI 10.1016/j.cardfail.2015.01.002; Zhong Y, 2013, FRONT IMMUNOL, P4; Zoppi S, 2014, BRIT J PHARMACOL, V171, P2814, DOI 10.1111/bph.12607	41	60	66	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0155076	10.1371/journal.pone.0155076	http://dx.doi.org/10.1371/journal.pone.0155076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611972	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900001
J	Lee, J; Ahn, E; Park, WK; Park, S				Lee, Joomin; Ahn, Eunsook; Park, Wyun Kon; Park, Seyeon			Phosphoproteome Profiling of SH-SY5y Neuroblastoma Cells Treated with Anesthetics: Sevoflurane and Isoflurane Affect the Phosphorylation of Proteins Involved in Cytoskeletal Regulation	PLOS ONE			English	Article							RHO-GTPASES; MECHANISMS; GABA(A); REORGANIZATION; DYNAMICS; INCREASE; POTENCY; KINASE; GROWTH; PAK1	Inhalation anesthetics are used to decrease the spinal cord transmission of painful stimuli. However, the molecular or biochemical processes within cells that regulate anesthetic-induced responses at the cellular level are largely unknown. Here, we report the phospho-proteome profile of SH-SY5y human neuroblastoma cells treated with sevoflurane, a clinically used anesthetic. Phosphoproteins were isolated from cell lysates and analyzed using two-dimensional gel electrophoresis. The phosphorylation of putative anesthetic-responsive marker proteins was validated using western blot analysis in cells treated with both sevoflurane and isoflurane. A total of 25 phosphoproteins were identified as differentially phosphorylated proteins. These included key regulators that signal cytoskeletal remodeling steps in pathways related to vesicle trafficking, axonal growth, and cell migration. These proteins included the Rho GTPase, Ras-GAP SH3 binding protein, Rho GTPase activating protein, actin-related protein, and actin. Sevoflurane and isoflurane also resulted in the dissolution of F-actin fibers in SH-SY5y cells. Our results show that anesthetics affect the phosphorylation of proteins involved in cytoskeletal remodeling pathways.	[Lee, Joomin] Chosun Univ, Dept Food & Nutr, Gwangju 61452, South Korea; [Ahn, Eunsook; Park, Seyeon] Dongduk Womens Univ, Dept Appl Chem, Seoul 02748, South Korea; [Park, Wyun Kon] Yonsei Univ, Dept Anesthesia & Pain, Coll Med, Seoul 03722, South Korea	Chosun University; Dongduk Women's University; Yonsei University; Yonsei University Health System	Park, S (corresponding author), Dongduk Womens Univ, Dept Appl Chem, Seoul 02748, South Korea.	sypark21@dongduk.ac.kr			National Research foundation of Korea (NRF) - Korean Government (Program for Basic Science) [NRF-2014R1A1A2053384]	National Research foundation of Korea (NRF) - Korean Government (Program for Basic Science)	This research was supported by a National Research foundation of Korea (NRF) grant funded by the Korean Government (Program for Basic Science: NRF-2014R1A1A2053384).	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cheng G, 2000, ANESTHESIOLOGY, V93, P1075, DOI 10.1097/00000542-200010000-00032; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Ginisty H, 1999, J CELL SCI, V112, P761; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hentschke H, 2005, EUR J NEUROSCI, V21, P93, DOI 10.1111/j.1460-9568.2004.03843.x; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lorenzetto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064350; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Martino A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00062; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papakonstanti EA, 1998, J CELL BIOCHEM, V70, P60, DOI 10.1002/(SICI)1097-4644(19980701)70:1<60::AID-JCB7>3.0.CO;2-1; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Park S, 2011, J CELL BIOCHEM, V112, P633, DOI 10.1002/jcb.22960; RAMPIL IJ, 1993, ANESTHESIOLOGY, V78, P707, DOI 10.1097/00000542-199304000-00014; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Schwarz K, 2012, OPEN J HEMATOL, V6, P1; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Torri G, 2010, MINERVA ANESTESIOL, V76, P215; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V361, P281, DOI 10.1016/j.bbrc.2007.06.156; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang SA, 2011, J BIOL CHEM, V286, P43816, DOI 10.1074/jbc.M111.310979; Ye XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052887; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	46	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162214	10.1371/journal.pone.0162214	http://dx.doi.org/10.1371/journal.pone.0162214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611435	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900059
J	Pereira, SM; Teixeira, CM; Carvalho, AS; Hernandez-Marrero, P				Pereira, Sandra Martins; Teixeira, Carla Margarida; Carvalho, Ana Sofia; Hernandez-Marrero, Pablo		InPalln	Compared to Palliative Care, Working in Intensive Care More than Doubles the Chances of Burnout: Results from a Nationwide Comparative Study	PLOS ONE			English	Article							MEDICAL ERRORS; OF-LIFE; MASLACH BURNOUT; SELF-CARE; PHYSICIANS; END; PROFESSIONALS; UNITS; ICU; MULTICENTER	Introduction Professionals working in intensive and palliative care units, hence caring for patients at the end-of-life, are at risk of developing burnout. Workplace conditions are determinant factors to develop this syndrome among professionals providing end-of-life care. Objectives To identify and compare burnout levels between professionals working in intensive and palliative care units; and to assess which workplace experiences are associated with burnout. Methods A nationwide, multicentre quantitative comparative survey study was conducted in Portugal using the following instruments: Maslach Burnout Inventory-Human Services Survey, Questionnaire of workplace experiences and ethical decisions, and Questionnaire of socio-demographic and professional characteristics. A total of 355 professionals from 10 intensive care and 9 palliative care units participated in the survey. A series of univariate and multivariate logistic regression analyses were performed; odds ratio sidelong with 95% confidence intervals were calculated. Results 27% of the professionals exhibited burnout. This was more frequent in intensive care units (OR = 2.525, 95% CI: 1.025-6.221, p =.006). Univariate regression analyses showed that higher burnout levels were significantly associated with conflicts, decisions to withhold/withdraw treatment, and implementing palliative sedation. When controlling for socio-demographic and educational characteristics, and setting (intensive care units versus palliative care units), higher burnout levels were significantly and positively associated with experiencing conflicts in the workplace. Having post-graduate education in intensive/palliative care was significantly but inversely associated to higher burnout levels. Conclusions Compared to palliative care, working in intensive care units more than doubled the likelihood of exhibiting burnout. Experiencing conflicts (e.g., with patients and/or families, intra and/or inter-teams) was the most significant determinant of burnout and having post-graduate education in intensive/palliative care protected professionals from developing this syndrome. This highlights the need for promoting empowering workplace conditions, such as team empowerment and conflict management. Moreover, findings suggest the need for implementing quality improvement strategies and organizational redesign strategies aimed at integrating the philosophy, principles and practices of palliative care in intensive care units.	[Pereira, Sandra Martins; Teixeira, Carla Margarida; Carvalho, Ana Sofia; Hernandez-Marrero, Pablo] Univ Catolica Portuguesa, Inst Bioet, Porto, Portugal; [Teixeira, Carla Margarida] Ctr Hosp Porto, Hosp Santo Antonio, Porto, Portugal; [Teixeira, Carla Margarida] Univ Porto, Inst Ciencias Biomed Dr Abel Salazar, Porto, Portugal	Universidade Catolica Portuguesa; Universidade do Porto	Hernandez-Marrero, P (corresponding author), Univ Catolica Portuguesa, Inst Bioet, Porto, Portugal.	pmarrero@porto.ucp.pt	Hernández-Marrero, Pablo/N-3873-2015; Pereira, Sandra Martins/N-3890-2015; Carvalho, Ana Sofia/ABK-1396-2022	Hernández-Marrero, Pablo/0000-0002-8893-3491; Pereira, Sandra Martins/0000-0003-4113-8957; Carvalho, Ana Sofia/0000-0003-1132-8880; Teixeira, Carla Margarida/0000-0002-9581-0756	Fundacao Grunenthal and Fundacao Merck, Sharp and Dohme	Fundacao Grunenthal and Fundacao Merck, Sharp and Dohme	This study was partially supported by Fundacao Grunenthal and Fundacao Merck, Sharp and Dohme (2007/2011), which provided financial support during the period of data collection.	Ahola K, 2005, J AFFECT DISORDERS, V88, P55, DOI 10.1016/j.jad.2005.06.004; Ali NA, 2011, AM J RESP CRIT CARE, V184, P803, DOI 10.1164/rccm.201103-0555OC; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Back AL, 2016, J PAIN SYMPTOM MANAG, V52, P284, DOI 10.1016/j.jpainsymman.2016.02.002; Bakker AB, 2005, J ADV NURS, V51, P276, DOI 10.1111/j.1365-2648.2005.03494.x; Bianchi R, 2014, INT J STRESS MANAGE, V21, P307, DOI 10.1037/a0037906; Block SD, 2001, JAMA-J AM MED ASSOC, V285, P2898, DOI 10.1001/jama.285.22.2898; Brenninkmeijer V, 2003, OCCUP ENVIRON MED, V60, P16; Chen KY, 2013, INT J MED SCI, V10, P1471, DOI 10.7150/ijms.6743; Chlan LL, 2013, CRIT CARE ALERT, V21, P65; Dewa CS, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-254; Dreano-Hartz S, 2016, PALLIAT SUPPORT CARE, V14, P402, DOI 10.1017/S1478951515000991; Dunwoodie DA, 2007, INTERN MED J, V37, P693, DOI 10.1111/j.1445-5994.2007.01384.x; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Embriaco N, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-34; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Fassier T, 2010, CURR OPIN CRIT CARE, V16, P654, DOI 10.1097/MCC.0b013e32834044f0; Garrouste-Orgeas M, 2015, INTENS CARE MED, V41, P273, DOI 10.1007/s00134-014-3601-4; Garrouste-Orgeas M, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-2; Hall LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159015; Hartog CS, 2015, INTENS CARE MED, V41, P331, DOI 10.1007/s00134-014-3517-z; Hayashino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035585; Hernandez-Marrero P, 2006, THESIS; Hernandez-Marrero P, 2016, AM J HOSP PALLIAT ME, V33, P723, DOI 10.1177/1049909115583486; Hill RC, 2016, PALLIATIVE MED, V30, P825, DOI 10.1177/0269216316637237; Hinson TD, 2011, J NURS ADMIN, V41, P103, DOI 10.1097/NNA.0b013e31820c7242; Howell MD, 2012, SEMIN RESP CRIT CARE, V33, P401, DOI 10.1055/s-0032-1322410; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Jones CB, 2008, J NURS ADMIN, V38, P11, DOI 10.1097/01.NNA.0000295636.03216.6f; Kamel G, 2015, AM J HOSP PALLIAT ME, V32, P758, DOI 10.1177/1049909114536979; Kearney MK, 2009, JAMA-J AM MED ASSOC, V301, P1155, DOI 10.1001/jama.2009.352; Koh MYH, 2015, PALLIATIVE MED, V29, P633, DOI 10.1177/0269216315575850; Lederer W, 2008, ANAESTH INTENS CARE, V36, P208, DOI 10.1177/0310057X0803600211; Leiter M.P., 1997, TRUTH BURNOUT ORG CA; Lepnurm R, 2009, CAN J PSYCHIAT, V54, P170, DOI 10.1177/070674370905400305; Li XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115799; Linzer M, 2014, J GEN INTERN MED, V29, P18, DOI 10.1007/s11606-013-2597-8; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 1997, EVALUATING STRESS BO, P191; Maslach C., 1981, MASLACH BURNOUT INVE; Maslach C., 2009, OXFORD HDB ORG WELL, P86, DOI [10.1093/oxfordhb/9780199211913.001.0001, DOI 10.1093/OXFORDHB/9780199211913.003.0005, 10.1093/oxfordhb/9780199211913.003.0005]; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; Meth ND, 2009, INTENS CARE MED, V35, P2068, DOI 10.1007/s00134-009-1639-5; Morgan L, 2011, DIMENS CRIT CARE NUR, V30, P133, DOI 10.1097/DCC.0b013e31820d2114; Moss M, 2016, CHEST, V150, P17, DOI 10.1016/j.chest.2016.02.649; Moss M, 2016, AM J RESP CRIT CARE, V194, P106, DOI 10.1164/rccm.201604-0708ST; Moss M, 2016, AM J CRIT CARE, V25, P368, DOI 10.4037/ajcc2016133; Muller M, 2010, Z PALLIATMEDIZIN, V11, P227, DOI 10.1055/s-0030-1248520; O'Mahony S, 2016, PALLIATIVE MED, V30, P189, DOI 10.1177/0269216315596459; Olthuis G, 2005, THEOR MED BIOETH, V26, P307, DOI 10.1007/s11017-005-4487-5; Pereira SM, 2012, INT J PALLIAT NURS, V18, P373, DOI 10.12968/ijpn.2012.18.8.373; Pereira SM, 2016, J PALLIAT MED, V19, P1130, DOI 10.1089/jpm.2016.0255; Pereira SM, 2011, NURS ETHICS, V18, P317, DOI 10.1177/0969733011398092; Pereira SM, 2011, THESIS; Perez GK, 2015, J PALLIAT MED, V18, P332, DOI 10.1089/jpm.2014.0221; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Prins JT, 2009, PSYCHOL HEALTH MED, V14, P654, DOI 10.1080/13548500903311554; Quenot JP, 2012, INTENS CARE MED, V38, P55, DOI 10.1007/s00134-011-2413-z; Reader TW, 2008, INTENS CARE MED, V34, P4, DOI 10.1007/s00134-007-0908-4; Reilly Jo Marie, 2004, J Palliat Med, V7, P55, DOI 10.1089/109662104322737250; Roelofs J, 2005, STRESS HEALTH, V21, P17, DOI 10.1002/smi.1032; Romani M, 2014, LIBYAN J MED, V9, DOI 10.3402/ljm.v9.23556; Sanso N, 2015, J PAIN SYMPTOM MANAG, V50, P200, DOI 10.1016/j.jpainsymman.2015.02.013; Savel RH, 2013, AM J CRIT CARE, V22, P277, DOI 10.4037/ajcc2013857; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Soderfeldt M, 1996, SCAND J PSYCHOL, V37, P437, DOI 10.1111/j.1467-9450.1996.tb00675.x; Squires Allison, 2014, Burn Res, V1, P59; St Ledger U, 2013, J ADV NURS, V69, P1869, DOI 10.1111/jan.12053; Swetz KM, 2009, J PALLIAT MED, V12, P773, DOI 10.1089/jpm.2009.0050; Teixeira C, 2014, J MED ETHICS, V40, P97, DOI 10.1136/medethics-2012-100619; Teixeira C, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-38; Trankle SA, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-41; van Mol MMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136955; Verdon M, 2008, INTENS CARE MED, V34, P152, DOI 10.1007/s00134-007-0907-5; Vieira S., 2007, THESIS; Waldman JD, 2004, HEALTH CARE MANAGE R, V29, P2, DOI 10.1097/00004010-200401000-00002; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Wurm W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149913	82	40	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162340	10.1371/journal.pone.0162340	http://dx.doi.org/10.1371/journal.pone.0162340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27612293	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900080
J	Vargas, J; Junco, M; Gomez, C; Lajud, N				Vargas, Javier; Junco, Mariana; Gomez, Carlos; Lajud, Naima			Early Life Stress Increases Metabolic Risk, HPA Axis Reactivity, and Depressive-Like Behavior When Combined with Postweaning Social Isolation in Rats	PLOS ONE			English	Article							MATERNAL SEPARATION; NEUROPEPTIDE-Y; GLUCOSE-HOMEOSTASIS; CUMULATIVE STRESS; NEUROENDOCRINE; CHILDHOOD; FEMALE; ADOLESCENT; EXPRESSION; ANXIETY	Early-life stress is associated with depression and metabolic abnormalities that increase the risk of cardiovascular disease and diabetes. Such associations could be due to increased glucocorticoid levels. Periodic maternal separation in the neonate and rearing in social isolation are potent stressors that increase hypothalamus-pituitary-adrenal axis activity. Moreover, social isolation promotes feed intake and body weight gain in rats subjected to periodic maternal separation; however, its effects on metabolic risks have not been described. In the present study, we evaluated whether periodic maternal separation, social isolation rearing, and a combination of these two stressors (periodic maternal separation + social isolation rearing) impair glucose homeostasis and its relation to the hypothalamus-pituitary-adrenalaxis and depressive-like behavior. Periodic maternal separation increased basal corticosterone levels, induced a passive coping strategy in the forced swimming test, and was associated with a mild (24%) increase in fasting glucose, insulin resistance, and dyslipidemia. Rearing in social isolation increased stress reactivity in comparison to both controls and in combination with periodic maternal separation, without affecting the coping strategy associated with the forced swimming test. However, social isolation also increased body weight gain, fasting glucose (120%), and insulin levels in rats subjected to periodic maternal separation. Correlation analyses showed that stress-induced effects on coping strategy on the forced swimming test (but not on metabolic risk markers) are associated with basal corticosterone levels. These findings suggest that maternal separation and post-weaning social isolation affect stress and metabolic vulnerability differentially and that early-life stress-related effects on metabolism are not directly dependent on glucocorticoid levels. In conclusion, our study supports the cumulative stress hypothesis, which suggests that metabolic risk markers arise when vulnerable individuals are exposed to social challenges later in life.	[Vargas, Javier; Junco, Mariana; Gomez, Carlos; Lajud, Naima] Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico	Instituto Mexicano del Seguro Social	Lajud, N (corresponding author), Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico.	naimalajud@yahoo.com.mx	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	Fondo de Investigacion en Salud - IMSS [FIS/IMSS/PROT/G11/976, FIS/IMSS/PROT/G13/1223]	Fondo de Investigacion en Salud - IMSS	The present work was supported by grant FIS/IMSS/PROT/G11/976 and FIS/IMSS/PROT/G13/1223 to NL from Fondo de Investigacion en Salud - IMSS. Funding source had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; Alastalo H, 2009, ANN MED, V41, P66, DOI 10.1080/07853890802301983; Asghar S., 2012, INT J CLIN MED, V3, P7, DOI [10.4236/ijcm.2012.37104, DOI 10.4236/IJCM.2012.37104]; Berge LI, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/164760; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; Bick J, 2015, DEV PSYCHOBIOL, V57, P131, DOI 10.1002/dev.21265; Biggio F, 2014, EUR NEUROPSYCHOPHARM, V24, P1152, DOI 10.1016/j.euroneuro.2014.03.009; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Brietzke E, 2012, REV BRAS PSIQUIATR, V34, P480, DOI 10.1016/j.rbp.2012.04.009; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; Cotella EM, 2013, STRESS, V16, P477, DOI 10.3109/10253890.2013.775241; D'mello AP, 2006, PSYCHONEUROENDOCRINO, V31, P395, DOI 10.1016/j.psyneuen.2005.10.003; Dallman MF, 2007, CURR ALZHEIMER RES, V4, P199, DOI 10.2174/156720507780362236; Dandekar MP, 2009, NEUROPSYCHOPHARMACOL, V34, P1288, DOI 10.1038/npp.2008.201; Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54; Daskalakis NP, 2014, PSYCHONEUROENDOCRINO, V39, P39, DOI 10.1016/j.psyneuen.2013.09.021; Daskalakis NP, 2012, PHYSIOL BEHAV, V106, P707, DOI 10.1016/j.physbeh.2012.01.015; Daskalakis NP, 2011, HORM BEHAV, V60, P165, DOI 10.1016/j.yhbeh.2011.04.003; Dimatelis JJ, 2016, METAB BRAIN DIS, V31, P109, DOI 10.1007/s11011-015-9723-8; Doom JR, 2014, J AM ACAD CHILD PSY, V53, P1206, DOI 10.1016/j.jaac.2014.08.006; Ebner K, 2005, HORM BEHAV, V47, P14, DOI 10.1016/j.yhbeh.2004.08.002; Ellenbroek BA, 2000, NEUROPSYCHOPHARMACOL, V23, P99, DOI 10.1016/S0893-133X(00)00088-9; Filipovic D, 2012, J NEURAL TRANSM, V119, P1275, DOI 10.1007/s00702-012-0776-0; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Gabory A, 2011, AM J CLIN NUTR, V94, p1943S, DOI 10.3945/ajcn.110.000927; Gilman SE, 2002, INT J EPIDEMIOL, V31, P359, DOI 10.1093/ije/31.2.359; Haley S, 2013, EARLY HUM DEV, V89, P387, DOI 10.1016/j.earlhumdev.2012.12.005; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hensleigh E, 2015, BEHAV BRAIN RES, V295, P3, DOI 10.1016/j.bbr.2014.12.008; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; Hulshof HJ, 2011, BEHAV BRAIN RES, V216, P552, DOI 10.1016/j.bbr.2010.08.038; Jahng JW, 2012, INT J DEV NEUROSCI, V30, P47, DOI 10.1016/j.ijdevneu.2011.10.001; Jahng JW, 2011, HORM BEHAV, V59, P213, DOI 10.1016/j.yhbeh.2010.11.010; Jimenez-Vasquez PA, 2001, DEV BRAIN RES, V131, P149, DOI 10.1016/S0165-3806(01)00264-4; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Konno J, 2008, NEUROSCI RES, V60, P259, DOI 10.1016/j.neures.2007.11.005; Krolow R, 2013, METABOLISM, V62, P1268, DOI 10.1016/j.metabol.2013.04.009; Krugel U, 2014, ARCH TOXICOL, V88, P853, DOI 10.1007/s00204-014-1203-0; Ladd CO, 2000, PROG BRAIN RES, V122, P81; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Lee JH, 2014, ENDOCRINOL METAB, V29, P169, DOI 10.3803/EnM.2014.29.2.169; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Mallei A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu067; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Martinac M, 2014, ACTA CLIN CROAT, V53, P55; McIntyre RS, 2012, INT J PSYCHIAT MED, V43, P165, DOI 10.2190/PM.43.2.e; McIntyre RS, 2009, CURR DIABETES REP, V9, P51, DOI 10.1007/s11892-009-0010-0; Miki T, 2013, BIOCHEM BIOPH RES CO, V442, P68, DOI 10.1016/j.bbrc.2013.11.005; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Morris MJ, 2015, NEUROSCI BIOBEHAV R, V58, P36, DOI 10.1016/j.neubiorev.2014.12.002; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008; Neumann ID, 1998, J PHYSIOL-LONDON, V508, P289, DOI 10.1111/j.1469-7793.1998.289br.x; Paternain L, 2013, STRESS, V16, P220, DOI 10.3109/10253890.2012.707708; Paternain L, 2012, NEUROENDOCRINOLOGY, V96, P249, DOI 10.1159/000341684; Paternain L, 2012, DIS MODEL MECH, V5, P691, DOI 10.1242/dmm.009043; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; Rana S, 2015, NEUROSCI LETT, V584, P146, DOI 10.1016/j.neulet.2014.10.011; Reis FMCV, 2012, STRESS, V15, P318, DOI 10.3109/10253890.2011.623740; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Ryu V, 2008, INT J OBESITY, V32, P1355, DOI 10.1038/ijo.2008.108; Ryu V, 2009, BRAIN RES, V1295, P127, DOI 10.1016/j.brainres.2009.08.006; Scherrer JF, 2011, TWIN RES HUM GENET, V14, P169, DOI 10.1375/twin.14.2.169; Shimizu H, 2008, ENDOCRINOLOGY, V149, P4544, DOI 10.1210/en.2008-0229; Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075; Solas M, 2010, NEUROPSYCHOPHARMACOL, V35, P1664, DOI 10.1038/npp.2010.13; Sominsky L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00434; Thamer S, 2014, J CHEM BIO PHY SCI, V4, P3232; Thorsell A, 2006, PHARMACOL BIOCHEM BE, V83, P28, DOI 10.1016/j.pbb.2005.12.005; Turecki G, 2016, BIOL PSYCHIAT, V79, P87, DOI 10.1016/j.biopsych.2014.11.022; van Zyl PJ, 2016, METAB BRAIN DIS, V31, P121, DOI 10.1007/s11011-015-9757-y; Weiss IC, 2001, PHARMACOL BIOCHEM BE, V70, P397, DOI 10.1016/S0091-3057(01)00626-8; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Yamada C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140094; Zimmerberg Betty, 2011, Front Psychiatry, V2, P39, DOI 10.3389/fpsyt.2011.00039; Zlatkovic J, 2012, NEUROSCIENCE, V223, P238, DOI 10.1016/j.neuroscience.2012.08.005; Zlatkovic J, 2014, MOL CELL BIOCHEM, V393, P43, DOI 10.1007/s11010-014-2045-z	84	63	64	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162665	10.1371/journal.pone.0162665	http://dx.doi.org/10.1371/journal.pone.0162665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611197	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900148
J	Verheul, RC; van Deutekom, JCT; Datson, NA				Verheul, Ruurd C.; van Deutekom, Judith C. T.; Datson, Nicole A.			Digital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy	PLOS ONE			English	Article							GENE; RELIABILITY; TRANSCRIPT; EXPRESSION; EFFICACY; MUTATION; DELETION; MODEL	Antisense oligonucleotides (AONs) in clinical development for Duchenne muscular dystrophy (DMD) aim to induce skipping of a specific exon of the dystrophin transcript during pre-mRNA splicing. This results in restoration of the open reading frame and consequently synthesis of a dystrophin protein with a shorter yet functional central rod domain. To monitor the molecular therapeutic effect of exon skip-inducing AONs in clinical studies, accurate quantification of pre- and post-treatment exon skip levels is required. With the recent introduction of 3rd generation digital droplet PCR (ddPCR), a state-of-the-arttechnology became available which allows absolute quantification of transcript copy numbers with and without specific exon skip with high precision, sensitivity and reproducibility. Using Taqman assays with probes targeting specific exon-exon junctions, we here demonstrate that ddPCR reproducibly quantified cDNA fragments with and without exon 51 of the DMD gene over a 4-log dynamic range. In a comparison of conventional nested PCR, qPCR and ddPCR using cDNA constructs with and without exon 51 mixed in different molar ratios using, ddPCR quantification came closest to the expected outcome over the full range of ratios (0-100%), while qPCR and in particular nested PCR overestimated the relative percentage of the construct lacking exon 51. Highest accuracy was similarly obtained with ddPCR in DMD patient-derived muscle cells treated with an AON inducing exon 51 skipping. We therefore recommend implementation of ddPCR for quantification of exon skip efficiencies of AONs in (pre)clinical development for DMD.	[Verheul, Ruurd C.; van Deutekom, Judith C. T.; Datson, Nicole A.] BioMarin NederlandBV, Leiden, Netherlands		Datson, NA (corresponding author), BioMarin NederlandBV, Leiden, Netherlands.	nicole.datson@bmrn.com	Datson, Nicole A./O-8797-2014	Datson, Nicole/0000-0003-2887-0238	BioMarin Nederland BV, Leiden, The Netherlands	BioMarin Nederland BV, Leiden, The Netherlands(Netherlands Government)	Funding was provided by BioMarin Nederland BV, Leiden, The Netherlands. The funder provided support in the form of salaries, equipment and facilities for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Anthony K, 2014, NEUROLOGY, V83, P2062, DOI 10.1212/WNL.0000000000001025; Anthony K, 2012, HUM GENE THER METHOD, V23, P336, DOI 10.1089/hgtb.2012.117; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Havenga MJE, 2002, J VIROL, V76, P4612, DOI 10.1128/JVI.76.9.4612-4620.2002; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; McDonald CM, 2013, MUSCLE NERVE, V48, P357, DOI 10.1002/mus.23905; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mirabella M, 1998, NEUROLOGY, V51, P592, DOI 10.1212/WNL.51.2.592; Mitrpant C, 2009, J GENE MED, V11, P46, DOI 10.1002/jgm.1265; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; Spitali P, 2013, FASEB J, V27, P4909, DOI 10.1096/fj.13-232025; Spitali P, 2010, LAB INVEST, V90, P1396, DOI [10.1038/labinvest.2010.98, 10.1038/labinvest.labinvest201098]; Tanganyika-de Winter CL, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.38; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P747, DOI 10.1136/jnnp-2013-306350; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P92, DOI 10.1136/jnnp-2012-304729; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; Verhaart IEC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.1; Verhaart IEC, 2013, NUCLEIC ACID THER, V23, P228, DOI 10.1089/nat.2012.0398; Vila MC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0070-6; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Vulin A, 2012, MOL THER, V20, P2120, DOI 10.1038/mt.2012.181; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; Wilton SD, 2015, TRENDS MOL MED, V21, P417, DOI 10.1016/j.molmed.2015.04.006; Wilton SD, 2014, NEUROMUSCULAR DISORD, V24, P463, DOI 10.1016/j.nmd.2014.03.007; Yokota T, 2011, METHODS MOL BIOL, V709, P299, DOI 10.1007/978-1-61737-982-6_20; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	41	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162467	10.1371/journal.pone.0162467	http://dx.doi.org/10.1371/journal.pone.0162467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612288	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900106
J	Yang, WQ; Liu, B; Huang, B; Huang, RW; Wang, LJ; Zhang, YH; Zhang, X; Wu, K				Yang, Wanqun; Liu, Bin; Huang, Biao; Huang, Ruiwang; Wang, Lijuan; Zhang, Yuhu; Zhang, Xiong; Wu, Kai			Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration	PLOS ONE			English	Article							DEMENTIA; NETWORK; SCALE	Background Despite improvement in motor symptoms, the effect of dopaminergic medications on cognition in patients with Parkinson's disease (PD) is less clear. The purpose of this study was to reveal levodopa-induced acute changes in the functional connectivity of the striatum in patients with PD compared with matched untreated patients and healthy volunteers. Methods Twenty-two patients with PD underwent functional magnetic resonance imaging both ON and OFF dopamine-replacement therapy on two consecutive days. Twenty-eight normal aging volunteers also did them without taking in levodopa. Three caudate seeds and two putamen seeds were selected to calculate functional connectivity intensity. Results Motor symptoms measured by UPDRS were significantly worse in PD OFF than PD ON. Decreased functional connectivity in PD OFF compared to controls was detected in the following seed regions: dorsal caudate, ventral putamen and dorsal putamen. Increases in connectivity in PD ON compared to controls were found in the primary and supplementary motor areas and the associative prefrontal and parietal regions, while decreases in anterior cingulate, ventromedial prefrontal cortex, and parahippocampal gyrus. For the ventral striatal seeds, decreased connectivity in PD ON compared to PD OFF was found in the ventromedial prefrontal and orbitofrontal regions, dorsolateral prefrontal regions. For the dorsal striatal seeds, increased connectivity in PD ON compared to PD OFF was observed in the primaryand secondary motor areas. Conclusion Our results suggest that levodopa significantly changes the motor and cognitive networks of the cortico-striatal pathways. This knowledge will lead clinicians to survey a broader range of symptoms in determining optimal therapy.	[Yang, Wanqun; Liu, Bin; Huang, Biao] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Huang, Ruiwang] South China Normal Univ, Ctr Study Appl Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Wang, Lijuan; Zhang, Yuhu; Zhang, Xiong] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Wu, Kai] South China Univ Technol, Dept Biomed Engn, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Kai] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Guangdong Academy of Medical Sciences & Guangdong General Hospital; South China Normal University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; South China University of Technology; Tohoku University	Huang, B (corresponding author), Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Guangdong, Peoples R China.; Wu, K (corresponding author), South China Univ Technol, Dept Biomed Engn, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Wu, K (corresponding author), Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.	cjr.huangbiao@vip.163.com; kaiwu@scut.edu.cn			National Foundation of Natural Science of China [81471654, 31400845]; Natural Science Foundation of Guangdong Province, China [2015A030313536]; Medical Science and Technology Research Foundation of Guangdong province [A2016136]	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Medical Science and Technology Research Foundation of Guangdong province	This work was supported National Foundation of Natural Science of China (81471654 and 31400845),Natural Science Foundation of Guangdong Province, China (2015A030313536) and Medical Science and Technology Research Foundation of Guangdong province (A2016136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck EN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144986; Bonnet AM, 2000, REV NEUROL, V156, P534; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Krajcovicova L, 2012, J NEURAL TRANSM, V119, P443, DOI 10.1007/s00702-011-0723-5; Kwak Y, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00143; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Manza P, 2016, HUM BRAIN MAPP, V37, P648, DOI 10.1002/hbm.23056; Martinu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111600; Mattis PJ, 2011, NEUROLOGY, V77, P858, DOI 10.1212/WNL.0b013e31822c6224; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Shoji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110547; Wu T, 2011, NEUROIMAGE, V55, P204, DOI 10.1016/j.neuroimage.2010.11.074; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Yang H, 2013, NEUROSCI LETT, V549, P24, DOI 10.1016/j.neulet.2013.05.080	22	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161935	10.1371/journal.pone.0161935	http://dx.doi.org/10.1371/journal.pone.0161935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611959	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900039
J	Zhang, ZY; Zhang, J; Yang, CJ; Lian, HY; Yu, H; Huang, XM; Cai, P				Zhang, Zi-Yan; Zhang, Jing; Yang, Chuan-Jun; Lian, Hui-Yong; Yu, Hui; Huang, Xiao-Mei; Cai, Peng			Coupling Mechanism of Electromagnetic Field and Thermal Stress on Drosophila melanogaster	PLOS ONE			English	Article							ALTERNATING MAGNETIC-FIELD; HEAT-SHOCK; OXIDATIVE STRESS; HIGH-TEMPERATURE; GENE-EXPRESSION; LIFE-SPAN; CAENORHABDITIS-ELEGANS; HSP70 EXPRESSION; DNA-DAMAGE; EXPOSURE	Temperature is an important factor in research on the biological effects of extremely low-frequency electromagnetic field (ELF-EMF), but interactions between ELF-EMF and temperature remain unknown. The effects of ELF-EMF (50 Hz, 3 mT) on the lifespan, locomotion, heat shock response (HSR), and oxidative stress (OS) of Canton-Special (CS) and mutant w1118 flies were investigated at 25 degrees C and 35 degrees C (thermal stress). Results showed that thermal stress accelerated the death rates of CS and w1118 flies, shortened their lifespan, and influenced their locomotion rhythm and activity. The upregulated expression levels of heat shock protein (HSP) 22, HSP26, and HSP70 indicated that HSR was enhanced. Thermal stress-induced OS response increased malondialdehyde content, enhanced superoxide dismutase activity, and decreased reactive oxygen species level. The effects of thermal stress on the death rates, lifespan, locomotion, and HSP gene expression of flies, especially w1118 line, were also enhanced by ELF-EMF. In conclusion, thermal stress weakened the physiological function and promoted the HSR and OS of flies. ELF-EMF aggravated damages and enhanced thermal stress-induced HSP and OS response. Therefore, thermal stress and ELF-EMF elicited a synergistic effect.	[Zhang, Zi-Yan; Yang, Chuan-Jun; Lian, Hui-Yong; Yu, Hui; Cai, Peng] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Zhang, Zi-Yan; Zhang, Jing; Huang, Xiao-Mei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Jing] Xiamen Univ, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University	Cai, P (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	pcai@iue.ac.cn	CAS, KLUEH/T-5743-2019	?, ??/0000-0003-0168-9201	Scientific Equipment Development Project of Chinese Academy of Sciences (CAS) [YZ201104]; Xiamen Science and Technology Plans Project [3502Z20126012]; National Natural Science Foundation of China [31270888]	Scientific Equipment Development Project of Chinese Academy of Sciences (CAS); Xiamen Science and Technology Plans Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by YZ201104, http://www.cas.cn/, Scientific Equipment Development Project of Chinese Academy of Sciences (CAS), Peng Cai; 3502Z20126012, http://www.xminfo.net.cn/, Xiamen Science and Technology Plans Project, Peng Cai; and 31270888, National Natural Science Foundation of China, Hui-Yong Lian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Akhras MA, 2008, ELECTROMAGN BIOL MED, V27, P155, DOI 10.1080/15368370802072125; Alfieri RR, 2006, RADIAT RES, V165, P95, DOI 10.1667/RR3487.1; Heredia-Rojas JA, 2010, IN VITRO CELL DEV-AN, V46, P758, DOI 10.1007/s11626-010-9342-y; Baker MK, 2014, J PHYS CHEM B, V118, P13590, DOI 10.1021/jp507027t; Bernardini C, 2007, BIOELECTROMAGNETICS, V28, P231, DOI 10.1002/bem.20299; Buldak RJ, 2012, BIOELECTROMAGNETICS, V33, P641, DOI 10.1002/bem.21732; Chatelain EH, 2011, J EXP ZOOL PART B, V316B, P188, DOI 10.1002/jez.b.21389; Chen CH, 2010, BREAST CANCER RES TR, V123, P569, DOI 10.1007/s10549-010-0782-6; Council EaS, 2015, UNECE ITU SMART SUST; FROHLICH H, 1982, BIOELECTROMAGNETICS, V3, P45, DOI 10.1002/bem.2250030109; Grover N, 2007, JNMA J Nepal Med Assoc, V46, P62; Guxens M, 2014, OCCUPATIONAL ENV S1, V71, pA50, DOI [10.1136/, 10. 1136/oemed- 2014- 102362.156 PMID: 25018385., DOI 10.1136/0EMED-2014-102362.156]; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Hofling F, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2901170; Jammes Y, 2009, J INTERN MED, V266, P196, DOI 10.1111/j.1365-2796.2009.02079.x; Junkersdorf B, 2000, BIOELECTROMAGNETICS, V21, P100, DOI 10.1002/(SICI)1521-186X(200002)21:2<100::AID-BEM4>3.0.CO;2-U; Kim BM, 2014, COMP BIOCHEM PHYS C, V166, P65, DOI 10.1016/j.cbpc.2014.07.005; Krebs RA, 1997, J EXP BIOL, V200, P2007; Lawrence A F, 1982, Neurol Res, V4, P115; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Li SS, 2013, MUTAT RES-GEN TOX EN, V758, P95, DOI 10.1016/j.mrgentox.2013.10.004; Liao PC, 2008, BIOCHEM BIOPH RES CO, V376, P637, DOI 10.1016/j.bbrc.2008.08.161; Liu Yun, 2002, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V20, P263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malagoli D, 2004, COMP BIOCHEM PHYS C, V137, P75, DOI 10.1016/j.cca.2003.11.007; Morono Y, 2015, ENV MICROBIOL REP, V7, P243, DOI 10.1111/1758-2229.12238; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; MUTERO A, 1994, MOL GEN GENET, V243, P699, DOI 10.1007/BF00279580; Naito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051902; Panagopoulos DJ, 2013, CELL BIOCHEM BIOPHYS, V67, P703, DOI 10.1007/s12013-013-9560-5; Pandey A, 2014, AGE, V36, P1139, DOI 10.1007/s11357-014-9628-1; Podda MV, 2014, EUR J NEUROSCI, V39, P893, DOI 10.1111/ejn.12465; Qin SY, 2016, NAT MATER, V15, P217, DOI [10.1038/NMAT4484, 10.1038/nmat4484]; Reale M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104973; Roosli M, 2007, NEUROEPIDEMIOLOGY, V28, P197, DOI 10.1159/000108111; Rolandi C, 2014, J EXP BIOL, V217, P4414, DOI 10.1242/jeb.109298; Sharma S, 2012, CHRONOBIOL INT, V29, P157, DOI 10.3109/07420528.2011.644875; Shi ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08471; Sorensen JG, 2013, J EXP BIOL, V216, P809, DOI 10.1242/jeb.076356; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Tipping DR, 1999, BIOELECTROMAGNETICS, V20, P129, DOI 10.1002/(SICI)1521-186X(1999)20:2<129::AID-BEM8>3.0.CO;2-Q; Tower J, 2014, J GERONTOL A-BIOL, V69, P253, DOI 10.1093/gerona/glt078; Villarini M, 2013, INT J RADIAT BIOL, V89, P562, DOI 10.3109/09553002.2013.782449; WALTER MF, 1990, DEV GENET, V11, P270, DOI 10.1002/dvg.1020110405; Ward BK, 2015, ANN NY ACAD SCI, V1343, P69, DOI 10.1111/nyas.12702; Wen J, 2009, BIOELECTROMAGNETICS, V30, P163, DOI 10.1002/bem.20461; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Williams KD, 2003, MOL ECOL, V12, P1165, DOI 10.1046/j.1365-294X.2003.01771.x; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; [张晶 Zhang Jing], 2014, [军事医学, Military Medical Sciences], V38, P321; Zhang SZ, 2015, J INSECT PHYSIOL, V73, P47, DOI 10.1016/j.jinsphys.2015.01.004; Zhao G, 2014, EUR J GYNAECOL ONCOL, V35, P264	54	8	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162675	10.1371/journal.pone.0162675	http://dx.doi.org/10.1371/journal.pone.0162675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611438	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900150
J	Cho, JH; Ryu, HM; Oh, EJ; Yook, JM; Ahn, JS; Jung, HY; Choi, JY; Park, SH; Kim, YL; Kwak, IS; Kim, CD				Cho, Jang-Hee; Ryu, Hye-Myung; Oh, Eun-Joo; Yook, Ju-Min; Ahn, Ji-Sun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kwak, Ihm Soo; Kim, Chan-Duck			Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-beta 1-Induced Epithelial Mesenchymal Transition	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TGF-BETA; INTERSTITIAL FIBROSIS; ALPHA-1-ANTITRYPSIN DEFICIENCY; OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; FIBROBLASTS; MECHANISMS; MICE; TNF	Alpha1-antitrypsin (AAT) exerts its anti-inflammatory effect through regulating the activity of serine proteinases. This study evaluated the inhibitory effects of AAT against the transforming growth factor (TGF)-beta 1 induced epithelial-to-mesenchymal transition (EMT) in unilateral ureter obstruction (UUO) mice and Madin-Darby canine kidney (MDCK) cells. C57BL/6 mice with induced UUO were injected intraperitoneally with AAT (80 mg/Kg) or vehicle for 7 days. MDCK cells were treated with TGF-beta 1 (2 ng/mL) for 48 hours to induce EMT, and co-treated with AAT (10 mg/mL) to inhibit the EMT. Masson's trichrome and Sirius red staining was used to estimate the extent of renal fibrosis in UUO mice. The expression of alpha-smooth muscle actin (alpha-SMA), vimentin, fibronectin, collagen I, and E-cadherin in MDCK cells and kidney tissue were evaluated. Masson's and Sirius red staining revealed that the area of renal fibrosis was significantly smaller in AAT treated UUO group compared with that of UUO and vehicle treated UUO groups. AAT treatment attenuated upregulation of Smad2/3 phosphorylation in UUO mouse model. Co-treatment of MDCK cells with TGF-beta 1 and AAT significantly attenuated the changes in the expression of alpha-SMA, vimentin, fibronectin, collagen I, and E-cadherin. AAT also decreased the phosphorylated Smad3 expression and the phosphorylated Smad3/Smad3 ratio in MDCK cells. AAT treatment inhibited EMT induced by TGF-beta 1 in MDCK cells and attenuated renal fibrosis in the UUO mouse model. The results of this work suggest that AAT could inhibit the process of EMT through the suppression of TGF-beta/Smad3 signaling.	[Cho, Jang-Hee; Ryu, Hye-Myung; Oh, Eun-Joo; Yook, Ju-Min; Ahn, Ji-Sun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kim, Chan-Duck] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kwak, Ihm Soo] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea	Kyungpook National University; Pusan National University; Pusan National University Hospital	Kim, CD (corresponding author), Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea.; Kwak, IS (corresponding author), Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.	iskwak@pusan.ac.kr; drcdkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Park, Sun/GSD-9620-2022	Cho, Jang-hee/0000-0002-7031-5214; Jung, Hee-Yeon/0000-0003-0232-7202	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001]; Korean Society of Nephrology; Baxter Healthcare for Aralast(R)	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Korean Society of Nephrology; Baxter Healthcare for Aralast(R)	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea (HI15C0001); by a grant from the Korean Society of Nephrology in 2015. Supported by Baxter Healthcare for Aralast (R). The commercial funder of the present study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Baxter Healthcare for Aralast (R).	Ai J, 2015, J AM SOC NEPHROL, V26, P1827, DOI 10.1681/ASN.2014040363; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; BLANK CA, 1994, ANN ALLERGY, V72, P105; BUCURENCI N, 1992, FEBS LETT, V300, P21, DOI 10.1016/0014-5793(92)80156-B; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Guo GJ, 2001, AM J PHYSIOL-RENAL, V280, pF777, DOI 10.1152/ajprenal.2001.280.5.F777; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; JOHNSON D, 1979, J BIOL CHEM, V254, P4022; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Libert C, 1996, J IMMUNOL, V157, P5126; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Misseri Rosalia, 2005, Curr Urol Rep, V6, P140, DOI 10.1007/s11934-005-0083-5; Park SH, 2007, J AM SOC NEPHROL, V18, P1497, DOI 10.1681/ASN.2005080866; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Ralston DR, 1997, J CLIN INVEST, V100, P1416, DOI 10.1172/JCI119662; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Stockley RA, 2002, AM J RESP CRIT CARE, V165, P1494, DOI 10.1164/rccm.2109013; Stockley RA, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.25; TRAVIS J, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P313; VanMolle W, 1997, J IMMUNOL, V159, P3555; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yaghmaei M, 2009, DIABETES RES CLIN PR, V84, P201, DOI 10.1016/j.diabres.2009.03.003; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	35	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162186	10.1371/journal.pone.0162186	http://dx.doi.org/10.1371/journal.pone.0162186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607429	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600025
J	Zhuang, L; Su, JB; Zhang, XL; Huang, HY; Zhao, LH; Xu, F; Chen, T; Wang, XQ; Wu, G; Wang, XH				Zhuang, Lei; Su, Jian-bin; Zhang, Xiu-lin; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Chen, Tong; Wang, Xue-qin; Wu, Gang; Wang, Xiao-hua			Serum Amylase Levels in Relation to Islet beta Cell Function in Patients with Early Type 2 Diabetes	PLOS ONE			English	Article							EXOCRINE PANCREATIC INSUFFICIENCY; GLUCOSE-TOLERANCE; METABOLIC SYNDROME; INSULIN-RESISTANCE; LIPASE; SECRETION; MECHANISM; RAT; SENSITIVITY; MELLITUS	Objective The insulin-pancreatic acinar axis may play a major role in pancreatic function. Amylase is an exocrine enzyme that is produced by pancreatic acinar cells, and low serum amylase levels may be associated with endocrine diseases, such as metabolic syndrome and diabetes. We hypothesized that low serum amylase levels may be associated with impaired islet beta cell function in type 2 diabetes. Therefore, we investigated the relationship between the serum amylase levels and islet beta cell function in patients with early type 2 diabetes. Methods The cross-sectional study recruited 2327 patients with a mean of 1.71 +/- 1.62 years since their diagnosis of type 2 diabetes, and all participants were treated with lifestyle intervention alone. Serum amylase levels, the 75-g oral glucose tolerance test (OGTT) and metabolic risk factors were examined in all participants. The insulin sensitivity index (Matsuda index, ISIMatsuda) and insulin secretion index (ratio of total area-under-the-insulin-curve to glucose-curve, AUC(ins/glu)) were derived from the OGTT. Integrated islet beta cell function was assessed by the Insulin Secretion-Sensitivity Index-2 (ISSI-2) (ISIMatsuda multiplied by AUC(ins/glu)). Results Serum amylase levels in the normal range were significantly correlated with ISIMatsuda, AUC(ins/glu) and ISSI-2 (r = 0.203, 0.246 and 0.413, respectively, p<0.001). The association of the serum amylase levels with ISSI-2 (adjusted r = 0.363, p<0.001) was closer than the association with ISIMatsuda (adjusted r = 0.191, p<0.001) and AUC(ins/glu) (adjusted r = 0.174, p<0.001) after adjusting for the anthropometric indices, time since the diagnosis of diabetes,lipid profiles, uric acid levels, estimated glomerular filtration rate, HbA1c levels, smoking and drinking using the partial correlation test. After adjusting for these metabolic risk factors in the multivariate regression analysis with the amylase levels as the dependent variable, ISSI-2 was the major independent contributor to the serum amylase levels (beta = 0.416, t = 21.72, p<0.001). Meanwhile, in a comparison of the groups with the highest and lowest quartiles of serum amylase levels, the mean difference in logISSI-2 was 0.902 (95% CI 0.823 to 0.982), and after adjusting for metabolic risk factors, the mean difference in logISSI-2 was 0.610 (0.537 to 0.683). Conclusions Serum amylase levels in the normal range are positively associated with integrated islet beta cell function in patients with early type 2 diabetes, as assessed by ISSI-2.	[Zhuang, Lei] Second Peoples Hosp Nantong City, Dept Endocrinol, 43 Xinglong St, Gangzha Dist 226002, Nantong, Peoples R China; [Su, Jian-bin; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Wang, Xue-qin; Wu, Gang; Wang, Xiao-hua] Nantong Univ, Affiliated Hosp 2, Dept Endocrinol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China; [Zhang, Xiu-lin; Chen, Tong] Nantong Univ, Affiliated Hosp 2, Dept Clin Lab, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China	Nantong University; Nantong University	Su, JB (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Endocrinol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.	sujbzjx@163.com	Su, Jian-bin/R-9181-2017	Su, Jian-bin/0000-0002-2138-0263	Scientific Research Program of Nantong [HS2012028]; Scientific Research Program of Health and Planning Commission of Jiangsu [H201553]	Scientific Research Program of Nantong; Scientific Research Program of Health and Planning Commission of Jiangsu	The study was funded by the Scientific Research Program of Nantong (HS2012028) and the Scientific Research Program of Health and Planning Commission of Jiangsu (H201553).	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aughsteen AA, 2002, SAUDI MED J, V23, P838; Barreto SG, 2010, AM J PHYSIOL-GASTR L, V299, pG10, DOI 10.1152/ajpgi.00077.2010; Eleftheriou Phaedra, 2014, Hell J Nucl Med, V17 Suppl 1, P35; Gupta V, 2005, POSTGRAD MED J, V81, P491, DOI 10.1136/pgmj.2003.009761; Jiang Chaw-Fung, 2002, Zhonghua Yi Xue Za Zhi (Taipei), V65, P49; Lee JG, 2011, CLIN CHIM ACTA, V412, P1848, DOI 10.1016/j.cca.2011.06.023; LEE KY, 1995, PANCREAS, V11, P190, DOI 10.1097/00006676-199508000-00013; LEE KY, 1994, AM J PHYSIOL, V267, pG207, DOI 10.1152/ajpgi.1994.267.2.G207; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Makela A, 1997, EUR J SURG, V163, P915; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muneyuki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-80; Nakajima Kei, 2011, BMC Res Notes, V4, P419, DOI 10.1186/1756-0500-4-419; Nakajima K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-34; Nathan DM, 2007, DIABETOLOGIA, V50, P2239, DOI 10.1007/s00125-007-0803-0; Patel R, 2004, MOL CELL BIOCHEM, V261, P83, DOI 10.1023/B:MCBI.0000028741.85353.c6; Patel R, 2006, ANN NY ACAD SCI, V1084, P71, DOI 10.1196/annals.1372.038; Patel R, 2006, ANN NY ACAD SCI, V1084, P58, DOI 10.1196/annals.1372.027; Quiros JA, 2008, PEDIATR CRIT CARE ME, V9, P418, DOI 10.1097/PCC.0b013e318172e99b; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Rizvi AA, 2003, DIABETES CARE, V26, P3193, DOI 10.2337/diacare.26.11.3193; SENO T, 1995, AM J GASTROENTEROL, V90, P2002; Swislocki A, 2005, HORM METAB RES, V37, P326, DOI 10.1055/s-2005-861478; Wang YM, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0077-5; Yadav D, 2002, AM J GASTROENTEROL, V97, P1309, DOI 10.1016/S0002-9270(02)04122-9; Yao JM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-185; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhao Y, 2014, SCAND J CLIN LAB INV, V74, P235, DOI 10.3109/00365513.2013.878469; Zini E, 2010, RES VET SCI, V89, P20, DOI 10.1016/j.rvsc.2010.01.006	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162204	10.1371/journal.pone.0162204	http://dx.doi.org/10.1371/journal.pone.0162204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606813	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600030
J	de Freitas-Blanco, VS; Franz-Montan, M; Groppo, FC; de Carvalho, JE; Figueira, GM; Serpe, L; Sousa, IMO; Damasio, VAG; Yamane, LT; de Paula, E; Rodrigues, RAF				de Freitas-Blanco, Veronica Santana; Franz-Montan, Michelle; Groppo, Francisco Carlos; de Carvalho, Joao Ernesto; Figueira, Glyn Mara; Serpe, Luciano; Oliveira Sousa, Ilza Maria; Guilherme Damasio, Viviane Aparecida; Yamane, Lais Thiemi; de Paula, Eneida; Ferreira Rodrigues, Rodney Alexandre			Development and Evaluation of a Novel Mucoadhesive Film Containing Acmella oleracea Extract for Oral Mucosa Topical Anesthesia	PLOS ONE			English	Article							IN-VITRO ASSAYS; SPILANTHES-ACMELLA; DENTAL ANXIETY; HELIOPSIS-LONGIPES; ANALGESIC ACTIVITY; SYSTEMIC TOXICITY; DELIVERY-SYSTEMS; SKIN PENETRATION; VIVO; PERMEATION	Purpose To develop an anesthetic mucoadhesive film containing Acmella oleracea (jambu) extract for topical use on oral mucosa. Methods Ethanolic extracts from aerial parts of jambu were prepared by maceration. Pigment removal was obtained by adsorption with activated carbon. Three mucoadhesive films were developed using a film casting method: 10 or 20% of crude jambu extract (10% JB and 20% JB), and 10% of crude jambu extract treated with activated carbon (10% JBC). The mucoadhesive films were characterized regarding their uniformity, thickness, pH, and spilanthol content, and their stability was evaluated during 120 days. Gas chromatography was used to quantify the amount of spilanthol. In vitro tests determined the permeation of spilanthol across pig esophageal epithelium mucosa in Franz diffusion cells. Topical anesthetic efficacy was assessed in vivo using a tail flick test in mice. Results The three mucoadhesive films showed physical stability and visual appearances suitable for use on oral mucosa. The permeation study revealed that the spilanthol from 10% JBC presented higher flux and permeability coefficient values, compared to 10% or 20% JB (p < 0.001). Moreover, 10% JBC showed better topical anesthetic efficacy than the other films (p < 0.01). Conclusion Mucoadhesive film containing crude extract of jambu treated with activated carbon is a potential alternative for oral, topical use, encouraging future clinical studies.	[de Freitas-Blanco, Veronica Santana; Franz-Montan, Michelle; Groppo, Francisco Carlos; de Carvalho, Joao Ernesto; Serpe, Luciano; Ferreira Rodrigues, Rodney Alexandre] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, Brazil; [de Freitas-Blanco, Veronica Santana; de Carvalho, Joao Ernesto; Figueira, Glyn Mara; Oliveira Sousa, Ilza Maria; Yamane, Lais Thiemi; Ferreira Rodrigues, Rodney Alexandre] Univ Estadual Campinas, Chem Biol & Agr Res Ctr CPQBA, Paulinia, Brazil; [de Carvalho, Joao Ernesto] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil; [Guilherme Damasio, Viviane Aparecida; de Paula, Eneida] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Rodrigues, RAF (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, Brazil.; Rodrigues, RAF (corresponding author), Univ Estadual Campinas, Chem Biol & Agr Res Ctr CPQBA, Paulinia, Brazil.	rodney@cpqba.unicamp.br	groppo, francisco carlos/HIK-2053-2022; Franz-Montan, Michelle/E-2865-2010; Figueira, Glyn/C-9605-2017; de Olivei Sousa, Ilza Maria/AAK-7866-2020; Franz-Montan, Michelle/V-3301-2019; de Paula, Eneida/C-3031-2013; Franz-Montan, Michelle/AAN-1071-2021	groppo, francisco carlos/0000-0002-8513-773X; Figueira, Glyn/0000-0002-0159-9735; Franz-Montan, Michelle/0000-0003-0760-1389; de Paula, Eneida/0000-0003-4504-5723; Franz-Montan, Michelle/0000-0003-0760-1389; Rodrigues, Rodney A. F./0000-0001-5631-0970	Brazilian National Council for Scientific and Technological Development (CNPq) [133666/2012-3]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq, #133666/2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Melh M, 2007, ORAL SURG ORAL MED O, V103, pE16, DOI 10.1016/j.tripleo.2006.11.033; Aksungur P, 2004, J CONTROL RELEASE, V98, P269, DOI 10.1016/j.jconrel.2004.05.002; Al-Melh Manal Abu, 2008, J Clin Dent, V19, P43; [Anonymous], 2003, GUIDE VALIDATION ANA; [Anonymous], 2007, FDA PUBLIC HEALTH AD; [Anonymous], 2008, PLANTAS MED BRASIL N; [Anonymous], 2010, PRODUCT MONOGRAPH EM; Anvisa, 2010, BRAZILIAN PHARMACOPO, P56; Armfield JM, 2013, COMMUNITY DENT ORAL, V41, P279, DOI 10.1111/cdoe.12005; Arrau S, 2011, J ETHNOPHARMACOL, V133, P164, DOI 10.1016/j.jep.2010.09.016; Bae SS, 2010, PHYTOCHEM ANALYSIS, V21, P438, DOI 10.1002/pca.1215; Bansal RC, 2005, ACTIVATED CARBON ADS, P1, DOI DOI 10.1201/9781420028812; Barman S., 2009, PHARM ONLINE, V1, P1027; Baruah R. N., 1993, Journal of Essential Oil Research, V5, P693; Bolognesi C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3995; Boonen J, 2010, J PHARMACEUT BIOMED, V53, P243, DOI 10.1016/j.jpba.2010.02.010; Briggs M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001177.pub3; Chakraborty A., 2004, Indian Journal of Pharmacology, V36, P148; Chakraborty A, 2010, INDIAN J PHARMACOL, V42, P277, DOI 10.4103/0253-7613.70106; Cilia-Lopez VG, 2010, PHARM BIOL, V48, P195, DOI 10.3109/13880200903078495; CORNWELL PA, 1994, J PHARM PHARMACOL, V46, P261, DOI 10.1111/j.2042-7158.1994.tb03791.x; de Araujo DR, 2010, PHARM RES-DORDR, V27, P1677, DOI 10.1007/s11095-010-0151-5; Del Consuelo ID, 2005, J PHARM SCI-US, V94, P2777, DOI 10.1002/jps.20409; del Consuelo ID, 2005, PHARM RES-DORDR, V22, P1525, DOI 10.1007/s11095-005-6020-y; Di Stasi LC, 2002, PLANTAS MEDICINAIS A, P472; Dias AMA, 2012, J SUPERCRIT FLUID, V61, P62, DOI 10.1016/j.supflu.2011.09.020; Diaz-del-Consuelo I, 2005, ARCH ORAL BIOL, V50, P981, DOI 10.1016/j.archoralbio.2005.04.008; Donaldson D, 1995, Anesth Prog, V42, P7; Eitner S, 2006, J ORAL REHABIL, V33, P588, DOI 10.1111/j.1365-2842.2005.01589.x; Fang C, 2008, EUR J PHARM BIOPHARM, V68, P735, DOI 10.1016/j.ejpb.2007.02.007; Fosquiera E, 2012, EFFECTIVENESS ACMELL; Franz TJ, 2009, SKIN PHARMACOL PHYS, V22, P276, DOI 10.1159/000235828; Franz-Montan M, 2015, J LIPOSOME RES, V25, P11, DOI 10.3109/08982104.2014.911315; Franz-Montan M, 2013, J LIPOSOME RES, V23, P54, DOI 10.3109/08982104.2012.742536; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; Gordon D, 2013, J ANXIETY DISORD, V27, P365, DOI 10.1016/j.janxdis.2013.04.002; GRANT GJ, 1993, J PHARMACOL TOXICOL, V29, P223, DOI 10.1016/1056-8719(93)90029-E; Hmud R, 2009, DENT ANXIETY CAUSES; HOLST A, 1985, SWED DENT J, V9, P185; Hutchins H S Jr, 1997, Anesth Prog, V44, P87; Jirovetz L, 2005, J ESSENT OIL RES, V17, P429, DOI 10.1080/10412905.2005.9698952; Kolesnikov Y, 2008, EUR J PHARMACOL, V579, P126, DOI 10.1016/j.ejphar.2007.10.014; Kulkarni U, 2010, J PHARM SCI-US, V99, P1265, DOI 10.1002/jps.21907; Kulkarni UD, 2011, AAPS PHARMSCITECH, V12, P579, DOI 10.1208/s12249-011-9624-z; Lehman PA, 2011, SKIN PHARMACOL PHYS, V24, P224, DOI 10.1159/000324884; Lemos T. L. G., 1991, Journal of Essential Oil Research, V3, P369; Ley Jakob P., 2006, V43, P21; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Malamed SF, 2013, MANUAL ANESTESIA LOC, V3; Marra DE, 2006, ARCH DERMATOL, V142, P1024, DOI 10.1001/archderm.142.8.1024; McGrath C, 2004, COMMUNITY DENT ORAL, V32, P67, DOI 10.1111/j.1600-0528.2004.00119.x; McMillan AS, 2000, BRIT J ORAL MAX SURG, V38, P58, DOI 10.1054/bjom.1999.0143; Meechan J G, 2005, Anesth Prog, V52, P91, DOI 10.2344/0003-3006(2005)52[91:FITDOI]2.0.CO;2; Meechan JG, 1996, BRIT DENT J, V181, P333, DOI 10.1038/sj.bdj.4809252; Miyazawa T, 2006, Agent for enhancing flavor of food/beverage products such as fish paste, milk beverages and snacks, contains plant extract or plant essential oil containing spilanthol, or spilanthol patent, Patent No. [JP2006296356-A 02, 2006296356]; Miyazawa T, 2006, Agent for enhancing flavor of food/beverage products such as fish paste, milk beverages and snacks, contains plant extract or plant essential oil containing spilanthol, or spilanthol patent, P17, Patent No. [JP2006296356-A 02, JP4530906-B2, JP2006296356-A, 4530906]; Miyazawa T, 2006, Agent for enhancing flavor of food/beverage products such as fish paste, milk beverages and snacks, contains plant extract or plant essential oil containing spilanthol, or spilanthol patent, P17, Patent No. [JP4530906-B2, 4530906]; Mohammed D, 2014, PHARM RES-DORDR, V31, P394, DOI 10.1007/s11095-013-1169-2; Morales JO, 2011, EUR J PHARM BIOPHARM, V77, P187, DOI 10.1016/j.ejpb.2010.11.023; Morris GA, 2010, BIOTECHNOL GENET ENG, V27, P257, DOI 10.1080/02648725.2010.10648153; Naik AD, 2012, J CHROMATOGR A, V1260, P61, DOI 10.1016/j.chroma.2012.08.043; Nokhodchi A, 2007, INT J PHARMACEUT, V335, P97, DOI 10.1016/j.ijpharm.2006.10.041; OECD, 2004, 428 ORG EC COOP DEV, DOI DOI 10.1787/9789264071087-EN; Nomura ECO, 2013, J ETHNOPHARMACOL, V150, P583, DOI 10.1016/j.jep.2013.09.007; Ogle Orrett E, 2012, Dent Clin North Am, V56, P133, DOI 10.1016/j.cden.2011.08.003; Ozsoy HD, 2010, J FOOD ENG, V101, P106, DOI 10.1016/j.jfoodeng.2010.06.018; Parirokh M, 2012, J ENDODONT, V38, P1553, DOI 10.1016/j.joen.2012.08.011; Prachayasittikul S, 2009, MOLECULES, V14, P850, DOI 10.3390/molecules14020850; Prachayasittikul V, 2013, EXCLI J, V12, P291; Ramsewak RS, 1999, PHYTOCHEMISTRY, V51, P729, DOI 10.1016/S0031-9422(99)00101-6; Rios MY, 2007, J ETHNOPHARMACOL, V110, P364, DOI 10.1016/j.jep.2006.09.041; Rodrigues R, 2014, INVENTORSPROCESSO PU; Rodrigues RAF, 2006, QUIM NOVA, V29, P368, DOI 10.1590/S0100-40422006000200030; Rodriguez-Reinoso F, 2001, ENCY MAT SCI TECHNOL, P22; Scheepers JC, 2011, AFR J BIOTECHNOL, V10, P16976, DOI 10.5897/AJB11.1999; Schuller AA, 2003, COMMUNITY DENT ORAL, V31, P116, DOI 10.1034/j.1600-0528.2003.00026.x; Sharma V, 2011, PHYTOMEDICINE, V18, P1161, DOI 10.1016/j.phymed.2011.06.001; Shin SC, 2004, INT J PHARMACEUT, V287, P73, DOI 10.1016/j.ijpharm.2004.08.012; States FaEMotU, 2000, SAFETY ASSESSMENT JA; Svensson P, 1992, Anesth Prog, V39, P79; Tran AN, 2014, J DRUGS DERMATOL, V13, P1118; van Wijk AJ, 2009, J DENT, V37, P700, DOI 10.1016/j.jdent.2009.05.023; Woolfson AD, 1998, INT J PHARM, V169, P83, DOI 10.1016/S0378-5173(98)00109-4; Wu LC, 2008, J AGR FOOD CHEM, V56, P2341, DOI 10.1021/jf073057e; Yadav R., 2011, INT J PHARM PHARM SC, V3, P245; Yang Z, 2013, INT J PHARMACEUT, V447, P231, DOI 10.1016/j.ijpharm.2013.02.048; Yu HY, 2002, J PHARM PHARMACOL, V54, P1221, DOI 10.1211/002235702320402062; Zhao W, 2011, INTRO NATURAL PRODUC, P5	88	21	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162850	10.1371/journal.pone.0162850	http://dx.doi.org/10.1371/journal.pone.0162850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626796	gold, Green Submitted, Green Published			2022-12-27	WOS:000383680600057
J	Bjorseth, A; Wichstrom, L				Bjorseth, Ase; Wichstrom, Lars			Effectiveness of Parent-Child Interaction Therapy (PCIT) in the Treatment of Young Children's Behavior Problems. A Randomized Controlled Study	PLOS ONE			English	Article							ONSET CONDUCT PROBLEMS; CONTROLLED-TRIAL; DISRUPTIVE BEHAVIOR; FATHER INVOLVEMENT; FOLLOW-UP; DSM-IV; PSYCHOSOCIAL TREATMENTS; HYPERKINETIC DISORDER; OPPOSITIONAL DEFIANT; NORWEGIAN CHILDREN	Objective The aim of the present investigation was to compare the effectiveness of Parent-Child Interaction Therapy (PCIT) with treatment as usual (TAU) in young children who were referred to regular child and adolescent mental health clinics for behavior problems. Method Eighty-one Norwegian families with two-to seven-year-old children (52 boys) who had scored >= 120 on the Eyberg Child Behavior Inventory (ECBI) were randomly assigned to receive either PCIT or TAU. The families were assessed 6 and 18 months after beginning treatment. Parenting skills were measured using the Dyadic Parent-Child Interaction Coding System (DPICS), and child behavior problems were measured using the ECBI and the Child Behavior Checklist (CBCL). Results Linear growth curve analyses revealed that the behavior problems of children receiving PCIT improved more compared with children receiving TAU according to mother reports (ECBI d = .64, CBCL d = .61, both p < .05) but not according to father report. Parents also improved with regard to Do and Don't skills (d = 2.58, d = 1.46, respectively, both p <= .001). At the 6-month assessment, which often occurred before treatment was finished, children who had received PCIT had lower father-rated ECBI and mother-rated CBCL-scores (p = .06) compared with those who had received TAU. At the 18-month follow-up, the children who had received PCIT showed fewer behavior problems compared with TAU according to mother (d = .37) and father (d = .56) reports on the ECBI and mother reports on the CBCL regarding externalizing problems (d = .39). Parents receiving PCIT developed more favorable Do Skills (6-month d = 1.81; 18-month d = 1.91) and Don't Skills (6-month d = 1.46; 18-month d = 1.42) according to observer ratings on the DPICS compared with those receiving TAU. Conclusion Children receiving PCIT in regular clinical practice exhibited a greater reduction in behavior problems compared with children receiving TAU, and their parents' parenting skills improved to a greater degree compared with those receiving TAU.	[Bjorseth, Ase] Nord Trondelag Hosp Trust, Levanger Hosp, Nord Trondelag, Norway; [Bjorseth, Ase; Wichstrom, Lars] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bjorseth, A (corresponding author), Nord Trondelag Hosp Trust, Levanger Hosp, Nord Trondelag, Norway.; Bjorseth, A (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway.	asegress@svt.ntnu.no			Liaison Committee [2005/4808]	Liaison Committee	This research was funded by grant 2005/4808 from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse ME, 2015, J CHILD FAMILY STUDI; Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; [Anonymous], 1999, INTEGRITY CHECKLISTS; Bagner D. M., 2015, J ABNORM CHILD PSYCH; Bagner DM, 2007, J CLIN CHILD ADOLESC, V36, P418, DOI 10.1080/15374410701448448; Bagner DM, 2013, BEHAV MODIF, V37, P356, DOI 10.1177/0145445512465307; Bagner DM, 2003, J CLIN CHILD ADOLESC, V32, P599, DOI 10.1207/S15374424JCCP3204_13; Beauchaine TP, 2005, J CONSULT CLIN PSYCH, V73, P371, DOI 10.1037/0022-006X.73.3.371; Brasil HHA, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-83; Budd KS, 2011, COGN BEHAV PRACT, V18, P502, DOI 10.1016/j.cbpra.2010.12.002; Carpenter AL, 2014, CLIN CHILD FAM PSYCH, V17, P340, DOI 10.1007/s10567-014-0172-4; Chaffin M, 2011, J CONSULT CLIN PSYCH, V79, P84, DOI 10.1037/a0021227; Comer JS, 2013, J AM ACAD CHILD PSY, V52, P26, DOI 10.1016/j.jaac.2012.10.001; Connolly JJ, 2015, THER INNOV REGUL SCI, V49, P632, DOI 10.1177/2168479015599811; COPLIN JW, 1991, CHILD FAM BEHAV THER, V13, P29; de Graaf I, 2008, FAM RELAT, V57, P553, DOI 10.1111/j.1741-3729.2008.00522.x; DeGarmo DS, 2004, PREV SCI, V5, P73, DOI 10.1023/B:PREV.0000023078.30191.e0; Drugli MB, 2010, JOURNAL OF CHILD PSY, V51, P559, DOI [10.1111/j.1469-7610.2009.02178.x, DOI 10.1111/J.1469-7610.2009.02178.X]; Egger HL, 2006, J AM ACAD CHILD PSY, V45, P538, DOI 10.1097/01.chi.0000205705.71194.b8; EISENSTADT TH, 1993, J CLIN CHILD PSYCHOL, V22, P42, DOI 10.1207/s15374424jccp2201_4; Ellis P.D., 2009, EFFECT SIZE EQUATION; Eyberg S. M., 1999, EYBERG CHILD BEHAV I; Eyberg S. M., 1999, PARENT CHILD INTERAC; Eyberg S. M., 2005, MANUAL DYADIC PARENT; Eyberg SM, 2008, J CLIN CHILD ADOLESC, V37, P215, DOI 10.1080/15374410701820117; Eyberg SM, 2001, CHILD FAM BEHAV THER, V23, P1, DOI 10.1300/J019v23n04_01; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foros P. B., 2012, ANGSTEN OPPDRAGELSE; Gerards SMPL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122240; Griffin C, 2010, INT J CLIN HLTH PSYC, V10, P279; Hagen KA, 2011, J CLIN CHILD ADOLESC, V40, P165, DOI 10.1080/15374416.2011.546050; Hansen SF, 2008, ECOTOXICOLOGY, V17, P438, DOI 10.1007/s10646-008-0210-4; Hedenbro M, 2002, SAMSPILLETS KRAFT MA; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; helsetilsyn S, 2000, ICD 10 PSYKISKE LIDE; Hembree-Kigin T, 1995, PARENT CHILD INTERAC; Hood KK, 2003, J CLIN CHILD ADOLESC, V32, P419, DOI 10.1207/S15374424JCCP3203_10; Jozefiak T, 2012, NORD J PSYCHIAT, V66, P311, DOI 10.3109/08039488.2011.638934; Kohlhoff J, 2014, CHILD FAM BEHAV THER, V36, P121, DOI 10.1080/07317107.2014.910733; Krol NPCM, 2006, J CLIN CHILD ADOLESC, V35, P127, DOI 10.1207/s15374424jccp3501_11; Lahey BB, 2006, J CHILD PSYCHOL PSYC, V47, P472, DOI 10.1111/j.1469-7610.2005.01590.x; Larsson B, 2009, EUR CHILD ADOLES PSY, V18, P42, DOI 10.1007/s00787-008-0702-z; Lenze SN, 2011, DEPRESS ANXIETY, V28, P153, DOI 10.1002/da.20770; Leung C, 2015, RES SOCIAL WORK PRAC, V25, P117, DOI 10.1177/1049731513519827; Lindhiem O, 2014, CLIN CHILD FAM PSYCH, V17, P41, DOI 10.1007/s10567-013-0136-0; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; Lundahl B, 2006, CLIN PSYCHOL REV, V26, P86, DOI 10.1016/j.cpr.2005.07.004; Lundahl BW, 2008, RES SOCIAL WORK PRAC, V18, P97, DOI 10.1177/1049731507309828; Lyons AM, 2010, J CHILD FAM STUD, V19, P516, DOI 10.1007/s10826-009-9323-5; McCabe K, 2012, BEHAV THER, V43, P606, DOI 10.1016/j.beth.2011.11.001; McCabe K, 2009, J CLIN CHILD ADOLESC, V38, P753, DOI 10.1080/15374410903103544; McNeil CB, 2010, ISSUES CLIN CHILD PS, P1, DOI 10.1007/978-0-387-88639-8; Menting ATA, 2013, CLIN PSYCHOL REV, V33, P901, DOI 10.1016/j.cpr.2013.07.006; Michelson D, 2013, CLIN CHILD FAM PSYCH, V16, P18, DOI 10.1007/s10567-013-0128-0; Muthen B., 2010, MPLUS USERS GUIDE; Nixon RDV, 2003, J CONSULT CLIN PSYCH, V71, P251, DOI 10.1037/0022-006X.71.2.251; Novik TS, 2000, EUR CHILD ADOLES PSY, V9, P54, DOI 10.1007/s007870050116; Nowak C, 2008, CLIN CHILD FAM PSYCH, V11, P114, DOI 10.1007/s10567-008-0033-0; Ogden T, 2008, J CONSULT CLIN PSYCH, V76, P607, DOI 10.1037/0022-006X.76.4.607; Patterson G. R., 1992, SOCIAL INTERACTIONAL, V4; Pearl E, 2012, PSYCHOL TRAUMA-US, V4, P204, DOI 10.1037/a0022948; Puliafico AC, 2012, CHILD ADOL PSYCH CL, V21, P607, DOI 10.1016/j.chc.2012.05.005; Reedtz C, 2008, SCAND J PSYCHOL, V49, P31, DOI 10.1111/j.1467-9450.2007.00621.x; Sanders MR, 2014, CLIN PSYCHOL REV, V34, P337, DOI 10.1016/j.cpr.2014.04.003; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Sigmarsdottir M, 2013, SCAND J PSYCHOL, V54, P468, DOI 10.1111/sjop.12078; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Tripp G, 1999, J AM ACAD CHILD PSY, V38, P156, DOI 10.1097/00004583-199902000-00014; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Webster-Stratton C, 2004, J CLIN CHILD ADOLESC, V33, P105, DOI 10.1207/S15374424JCCP3301_11; Webster-Stratton C, 1998, HDB PARENT TRAINING; WEBSTERSTRATTON C, 1984, J CONSULT CLIN PSYCH, V52, P666, DOI 10.1037/0022-006X.52.4.666; Weisz JR, 2013, JAMA PSYCHIAT, V70, P750, DOI 10.1001/jamapsychiatry.2013.1176; Weisz JR, 2005, ANNU REV PSYCHOL, V56, P337, DOI 10.1146/annurev.psych.55.090902.141449; Werba BE, 2006, BEHAV MODIF, V30, P618, DOI 10.1177/0145445504272977; Wichstrom L, 2014, PEDIATRICS, V133, P1054, DOI 10.1542/peds.2013-3184; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x	79	26	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0159845	10.1371/journal.pone.0159845	http://dx.doi.org/10.1371/journal.pone.0159845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622458	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000002
J	Iqbal, Z; Wilson, NE; Keller, MA; Michalik, DE; Church, JA; Nielsen-Saines, K; Deville, J; Souza, R; Brecht, ML; Thomas, MA				Iqbal, Zohaib; Wilson, Neil E.; Keller, Margaret A.; Michalik, David E.; Church, Joseph A.; Nielsen-Saines, Karin; Deville, Jaime; Souza, Raissa; Brecht, Mary-Lynn; Thomas, M. Albert			Pilot Assessment of Brain Metabolism in Perinatally HIV-Infected Youths Using Accelerated 5D Echo Planar J-Resolved Spectroscopic Imaging	PLOS ONE			English	Article							H-1 MR SPECTROSCOPY; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN-IMMUNODEFICIENCY-VIRUS; GROUP SPARSE RECONSTRUCTION; PROTON SPECTROSCOPY; N-ACETYLASPARTATE; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; GLUTAMATE; CHILDREN	Purpose To measure cerebral metabolite levels in perinatally HIV-infected youths and healthy controls using the accelerated five dimensional (5D) echo planar J-resolved spectroscopic imaging (EP-JRESI) sequence, which is capable of obtaining two dimensional (2D) J-resolved spectra from three spatial dimensions (3D). Materials and Methods After acquisition and reconstruction of the 5D EP-JRESI data, T-1-weighted MRIs were used to classify brain regions of interest for HIV patients and healthy controls: right frontal white (FW), medial frontal gray (FG), right basal ganglia (BG), right occipital white (OW), and medial occipital gray (OG). From these locations, respective J-resolved and TE-averaged spectra were extracted and fit using two different quantitation methods. The J-resolved spectra were fit using prior knowledge fitting (ProFit) while the TE-averaged spectra were fit using the advanced method for accurate robust and efficient spectral fitting (AMARES). Results Quantitation of the 5D EP-JRESI data using the ProFit algorithm yielded significant metabolic differences in two spatial locations of the perinatally HIV-infected youths compared to controls: elevated NAA/(Cr+Ch) in the FW and elevated Asp/(Cr+Ch) in the BG. Using the TE-averaged data quantified by AMARES, an increase of Glu/(Cr+Ch) was shown in the FW region. A strong negative correlation (r < -0.6) was shown between tCh/(Cr+Ch) quantified using ProFit in the FW and CD4 counts. Also, strong positive correlations (r > 0.6) were shown between Asp/(Cr+Ch) and CD4 counts in the FG and BG. Conclusion The complimentary results using ProFit fitting of J-resolved spectra and AMARES fitting of TE-averaged spectra, which are a subset of the 5D EP-JRESI acquisition, demonstrate an abnormal energy metabolism in the brains of perinatally HIV-infected youths. This may be a result of the HIV pathology and long-term combinational anti-retroviral therapy (cART). Further studies of larger perinatally HIV-infected cohorts are necessary to confirm these findings.	[Iqbal, Zohaib; Wilson, Neil E.; Souza, Raissa; Thomas, M. Albert] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA; [Keller, Margaret A.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pediat, Torrance, CA 90502 USA; [Keller, Margaret A.; Nielsen-Saines, Karin; Deville, Jaime] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Michalik, David E.] Miller Childrens Hosp Long Beach, Dept Pediat, Long Beach, CA 90806 USA; [Church, Joseph A.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Brecht, Mary-Lynn] Univ Calif Los Angeles, David Geffen Sch Med, Dept Behav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thomas, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA.	athomas@mednet.ucla.edu	Thomas, M. Albert/A-6176-2012; Thomas, M. Albert/J-7210-2019	Thomas, M. Albert/0000-0001-9037-2585; Thomas, M. Albert/0000-0001-9037-2585; Iqbal, Zohaib/0000-0002-5024-7509	National Institute of Health [R21-NS080649-02]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institute of Health R21-NS080649-02 awarded to Dr. Michael Albert Thomas (https://projectreporter.nih.gov/project_info_description.cfm?aid=8551779&icde=28687176).	Adalsteinsson E, 1999, MAGNET RESON MED, V41, P8, DOI 10.1002/(SICI)1522-2594(199901)41:1<8::AID-MRM3>3.0.CO;2-D; Banakar S, 2008, J MAGN RESON IMAGING, V27, P710, DOI 10.1002/jmri.21251; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; BROWN TR, 1982, P NATL ACAD SCI-BIOL, V79, P3523, DOI 10.1073/pnas.79.11.3523; Burns B, 2014, NMR BIOMED, V27, P191, DOI 10.1002/nbm.3052; Burns BL, 2014, ALGORITHMS, V7, P276, DOI 10.3390/a7030276; CHONG WK, 1993, RADIOLOGY, V188, P119, DOI 10.1148/radiology.188.1.8099750; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Ernst T, 2010, J MAGN RESON IMAGING, V32, P1045, DOI 10.1002/jmri.22366; Eslami R, 2010, IEEE T MED IMAGING, V29, P1297, DOI 10.1109/TMI.2010.2046673; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Fuchs A, 2014, MAGN RESON MED, V71, P458, DOI 10.1002/mrm.24703; Furuyama JK, 2012, MAGN RESON MED, V67, P1499, DOI 10.1002/mrm.24265; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Iqbal Z, 2016, P ISMRM SUNT CIT SIN; Iqbal Z, 2016, NMR BIOMED, V29, P329, DOI 10.1002/nbm.3469; Keller MA, 2006, NEUROLOGY, V66, P874, DOI 10.1212/01.wnl.0000203339.69771.d8; Keller MA, 2004, NEUROLOGY, V62, P1810, DOI 10.1212/01.WNL.0000125492.57419.25; KLOSE U, 1990, MAGNET RESON MED, V14, P26, DOI 10.1002/mrm.1910140104; Kreis R, 1996, J MAGN RESON SER B, V113, P103, DOI 10.1006/jmrb.1996.0163; Kreis R, 2016, MAGN RESON MED, V75, P15, DOI 10.1002/mrm.25568; Laubenberger J, 1996, RADIOLOGY, V199, P805, DOI 10.1148/radiology.199.3.8638009; Lu DF, 1996, RADIOLOGY, V199, P423, DOI 10.1148/radiology.199.2.8668788; MACURA S, 1983, J MAGN RESON, V53, P529, DOI 10.1016/0022-2364(83)90227-5; MANSFIELD P, 1984, MAGNET RESON MED, V1, P370, DOI 10.1002/mrm.1910010308; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mohamed MA, 2010, MAGN RESON IMAGING, V28, P1251, DOI 10.1016/j.mri.2010.06.007; Moller HE, 1999, J MAGN RESON IMAGING, V9, P10, DOI 10.1002/(SICI)1522-2586(199901)9:1<10::AID-JMRI2>3.0.CO;2-W; Nagarajan R, 2012, J NEUROIMMUNE PHARM, V7, P981, DOI 10.1007/s11481-012-9407-7; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Patel K, 2009, AIDS, V23, P1893, DOI 10.1097/QAD.0b013e32832dc041; PAVLAKIS SG, 1995, PEDIATR NEUROL, V12, P277, DOI 10.1016/0887-8994(95)00048-K; Pavlakis SG, 1998, AM J NEURORADIOL, V19, P383; POSSE S, 1995, MAGN RESON MED, V33, P34, DOI 10.1002/mrm.1910330106; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; RYNER LN, 1995, MAGN RESON IMAGING, V13, P853, DOI 10.1016/0730-725X(95)00031-B; Sailasuta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049272; Sailasuta N, 2009, NMR BIOMED, V22, P326, DOI 10.1002/nbm.1329; Salvan AM, 1998, PEDIATR RES, V44, P755, DOI 10.1203/00006450-199811000-00019; Schulte RF, 2006, NMR BIOMED, V19, P264, DOI 10.1002/nbm.1027; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Tardieu M, 2000, NEUROLOGY, V54, P1089, DOI 10.1212/WNL.54.5.1089; Thomas MA, 1996, JMRI-J MAGN RESON IM, V6, P453, DOI 10.1002/jmri.1880060307; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Tisell A, 2013, MAGN RESON MED, V70, P905, DOI 10.1002/mrm.24554; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wilson NE, 2016, MAGN RESON MED, V75, P42, DOI 10.1002/mrm.25605; Wilson NE, 2015, MAGN RESON MED, V74, P1199, DOI 10.1002/mrm.25988; Winston A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118608	56	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162810	10.1371/journal.pone.0162810	http://dx.doi.org/10.1371/journal.pone.0162810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622551	gold, Green Published			2022-12-27	WOS:000383681000057
J	Aung, T; Wei, CY; McFarland, W; Aung, YK; Khin, HSS				Aung, Tin; Wei, Chongyi; McFarland, Willi; Aung, Ye Kyaw; Khin, Hnin Su Su			Ownership and Use of Insecticide-Treated Nets among People Living in Malaria Endemic Areas of Eastern Myanmar	PLOS ONE			English	Article								Background Myanmar has the highest burden of malaria in the Greater Mekong. However, there is limited information on ownership and use of insecticide-treated nets (ITNs) in areas of Myanmar most severely affected by malaria. We describe ownership and use of ITNs among people in the malaria-endemic eastern parts of Myanmar and factors associated with ITN use. Methods A cross-sectional household survey using a multi-stage cluster design was conducted in malaria-endemic townships in eastern Myanmar during the high malaria season of August to September, 2014. An effective ITN was defined as 1) a long-lasting insecticide-treated net obtained within the past three years, or 2) any net treated with insecticide within the past year. Results In 4,679 households, the average number of ITNs per household was higher in rural compared to urban areas (0.6 vs. 0.4, p < 0.001) as well as the proportion of households owning at least one ITN (27.3% vs. 15.5%, p < 0.001). The proportion of households in which all members slept under an ITN was also higher in rural compared to urban areas (15.3% vs 6.9%, p < 0.001). In multivariate analysis, rural households (adjusted odds ratio [aOR] 1.78, 95% CI: 1.43-2.21, p<0.001), households in which respondents knew malaria is transmitted by mosquitoes (aOR 1.35, 95% CI: 1.10-1.65, p = 0.004), and in which respondents knew malaria can be prevented by ITN use (aOR 1.86, 95% CI: 1.28-2.70, p<0.001) were more likely to have all members sleep under an ITN. Compared to the lowest socio- economic quintile, households in the richest quintile were less likely to have all members sleep under an ITN (aOR 0.47; 95% CI: 0.33-0.66, p<0.001). Households in which the main income earner was a skilled worker or a businessman were less likely to have all members sleep under an ITN (aOR, 0.70, 95% CI: 0.52-0.96, p<0.025) compared to those headed by farmers or fishermen. Households in which all children slept under an ITN were more likely to be in rural areas (aOR 1.58, 95% CI: 1.19-2.09, p = 0.002) and have a household head who knew malaria can be prevented by ITN use (aOR 2.13, 95% CI: 1.30-3.50, p = 0.003). Children were less likely to have slept under an ITN in houses headed by skilled workers or businessmen (aOR 0.50, 95% CI: 0.33-0.75, p = 0.001) or unskilled workers (aOR 0.66, 95% CI: 0.49-0.89, p = 0.006) compared to households with farmers or fishermen. Higher socio-economic level was associated with lower ITN use by children (aOR 0.56, 95% CI: 0.36-0.88, p = 0.012, highest vs. lowest quintile). Conclusions The study found ownership of ITNs was low in Myanmar in comparison to the goal of one for every two household members. Use of ITNs was low even when present. Findings are of concern given the study areas were part of enhanced efforts to reduce artemisinin-resistant malaria. Nonetheless, groups vulnerable to malaria such as individuals in rural settings, lower socio-economic households, and workers in high mosquito exposure jobs, had higher rates of ITN ownership. Malaria knowledge was linked to effective ITN use suggesting that distribution campaigns should be complemented by behavior change communications.	[Aung, Tin; Aung, Ye Kyaw; Khin, Hnin Su Su] Populat Serv Int Myanmar, Yangon, Myanmar; [Wei, Chongyi; McFarland, Willi] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	McFarland, W (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Willi.McFarland@ucsf.edu	Aung, Ye Kyaw/AAC-7192-2022	Aung, Ye Kyaw/0000-0001-7488-6412	Department for International Development [202759-101, 40049299]; Bill and Melinda Gates Foundation [OPP1024757]	Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Department for International Development (Project Component no: 202759-101, Purchase Order no: 40049299) and the Bill and Melinda Gates Foundation (Grant no OPP1024757). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Global Malaria Programme, 2014, STAT REP ART RES; Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0727-y; MOH, 2014, UN MYANM NAT STRAT P; MOH, 2014, UN MYANM ANN REP NAT; MOH, 2012, UN MYANM NAT POL VEC; Nyunt MH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-211; Nyunt MH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1047-y; WHO, 2013, WORLD MALARIA REPORT 2013, P1	8	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162292	10.1371/journal.pone.0162292	http://dx.doi.org/10.1371/journal.pone.0162292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618440	gold, Green Submitted, Green Published			2022-12-27	WOS:000383653100016
J	Chen, HC; Chen, PY; Wu, MJ; Tai, MH; Yen, JH				Chen, Hung-Chen; Chen, Pei-Yi; Wu, Ming-Jiuan; Tai, Mi-Hsueh; Yen, Jui-Hung			Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells	PLOS ONE			English	Article							LDL RECEPTOR; TARGET GENES; CHOLESTEROL HOMEOSTASIS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; DEGRADATION; DISEASE; BINDING; MODEL; MICE	Tanshinone IIA, one of the most pharmacologically bioactive phytochemicals isolated from Salvia miltiorrhiza Bunge, possesses several biological activities such as anti-inflammation, anti-cancer, neuroprotection and hypolipidemic activities. In this study, we aim to investigate the hypocholesterolemic effect of tanshinone IIA in hepatic cells. We demonstrated that tanshinone IIA significantly increased the amount of low-density lipoprotein receptor (LDLR) and LDL uptake activity in HepG2 cells at the post-transcriptional regulation. We further demonstrated that tanshinone IIA inhibited the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA and mature protein, which may lead to an increase the cell-surface LDLR in hepatic cells. We further identified a regulatory DNA element involved in the tanshinone IIA-mediated PCSK9 down-regulation, which is located between the -411 and -336 positions of the PCSK9 promoter. Moreover, we found that tanshinone IIA markedly increased the nuclear forkhead box O3a (FoxO3a) level, enhanced FoxO3a/PCSK9 promoter complexes formation and decreased the PCSK9 promoter binding capacity of hepatocyte nuclear factor 1 alpha (HNF-1 alpha), resulting in suppression of PCSK9 gene expression. Finally, we found that the statin-induced PCSK9 overexpression was attenuated and the LDLR activity was elevated in a synergic manner by combination of tanshinone IIA treatment in HepG2 cells. Overall, our results reveal that the tanshinone IIA modulates LDLR level and activity via down-regulation of PCSK9 expression in hepatic cells. Our current findings provide a molecular basis of tanshinone IIA to develop PCSK9 inhibitors for cholesterol management.	[Chen, Hung-Chen; Tai, Mi-Hsueh; Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Chia Nan University of Pharmacy & Science	Yen, JH (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	imyenjh@mail.tcu.edu.tw			Ministry of Science and Technology, Taiwan [NSC-102-2313-B-320-001-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant NSC-102-2313-B-320-001-MY3 (to Dr. J-H Yen) from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaggia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124587; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cariou B, 2011, ATHEROSCLEROSIS, V216, P258, DOI 10.1016/j.atherosclerosis.2011.04.018; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chen PY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071282, 10.1371/journal.pone.0083227]; Chen WY, 2012, EUR J PHARMACOL, V674, P359, DOI 10.1016/j.ejphar.2011.10.040; Chen Z., 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/267976; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Ellison RC, 2005, AM J CARDIOL, V95, P1180, DOI 10.1016/j.amjcard.2005.01.046; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Giunzioni L, 2015, VASC HEALTH RISK MAN, V11, P493, DOI 10.2147/VHRM.S74692; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grundy SM, 1998, CIRCULATION, V97, P1436; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Harwood HJ, 1997, BIOCHEM J, V323, P649, DOI 10.1042/bj3230649; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu ZP, 2014, J LIPID RES, V55, P201, DOI 10.1194/jlr.M040394; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez D, 2008, DRUG NEWS PERSPECT, V21, P323, DOI 10.1358/dnp.2008.21.6.1246795; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Miller PE, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0578-1; Nho Richard Seonghun, 2014, World J Biol Chem, V5, P346, DOI 10.4331/wjbc.v5.i3.346; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rallidis LS, 2012, INT J CARDIOL, V159, P169, DOI 10.1016/j.ijcard.2011.07.048; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Smith BA, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0550-5; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Tai MH, 2014, MOL NUTR FOOD RES, V58, P2133, DOI 10.1002/mnfr.201400366; Tang FT, 2007, VASC PHARMACOL, V46, P427, DOI 10.1016/j.vph.2007.01.001; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Xu SW, 2012, TRANSL RES, V160, P114, DOI 10.1016/j.trsl.2012.01.008; Yen JH, 2011, MOL NUTR FOOD RES, V55, P733, DOI 10.1002/mnfr.201000226; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	56	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162414	10.1371/journal.pone.0162414	http://dx.doi.org/10.1371/journal.pone.0162414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617748	Green Submitted, gold, Green Published			2022-12-27	WOS:000383653100021
J	Zanin, M; Albernaz, ALM				Zanin, Marina; Mangabeira Albernaz, Ana Luisa			Impacts of Climate Change on Native Landcover: Seeking Future Climatic Refuges	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; AMAZON BASIN; BIODIVERSITY; FOREST; VULNERABILITY; CONSERVATION; DYNAMICS; HABITAT; DEFORESTATION; DISTRIBUTIONS	Climate change is a driver for diverse impacts on global biodiversity. We investigated its impacts on native landcover distribution in South America, seeking to predict its effect as a new force driving habitat loss and population isolation. Moreover, we mapped potential future climatic refuges, which are likely to be key areas for biodiversity conservation under climate change scenarios. Climatically similar native landcovers were aggregated using a decision tree, generating a reclassified landcover map, from which 25% of the map's coverage was randomly selected to fuel distribution models. We selected the best geographical distribution models among twelve techniques, validating the predicted distribution for current climate with the landcover map and used the best technique to predict the future distribution. All landcover categories showed changes in area and displacement of the latitudinal/longitudinal centroid. Closed vegetation was the only landcover type predicted to expand its distributional range. The range contractions predicted for other categories were intense, even suggesting extirpation of the sparse vegetation category. The landcover refuges under future climate change represent a small proportion of the South American area and they are disproportionately represented and unevenly distributed, predominantly occupying five of 26 South American countries. The predicted changes, regardless of their direction and intensity, can put biodiversity at risk because they are expected to occur in the near future in terms of the temporal scales of ecological and evolutionary processes. Recognition of the threat of climate change allows more efficient conservation actions.	[Zanin, Marina; Mangabeira Albernaz, Ana Luisa] Emilio Goeldi Museum Para, Earth Sci & Ecol Ctr, Av Perimetral,1901 Terra Firme, BR-66077830 Belem, PA, Brazil; [Zanin, Marina] Univ Fed Espirito Santo, Nat & Human Ctr Sci, Dept Biol, Vitoria, Espirito Santo, Brazil	Museu Paraense Emilio Goeldi; Universidade Federal do Espirito Santo	Zanin, M (corresponding author), Emilio Goeldi Museum Para, Earth Sci & Ecol Ctr, Av Perimetral,1901 Terra Firme, BR-66077830 Belem, PA, Brazil.; Zanin, M (corresponding author), Univ Fed Espirito Santo, Nat & Human Ctr Sci, Dept Biol, Vitoria, Espirito Santo, Brazil.	marinazaning@gmail.com	Zanin, Marina/AAN-6327-2020; Zanin, Marina/D-7139-2015; Albernaz, Ana Luisa KM/K-5226-2012	Zanin, Marina/0000-0001-7112-7381; Zanin, Marina/0000-0001-7112-7381; Albernaz, Ana Luisa KM/0000-0001-9299-4361	CAPES fellowship through the INCT Biodiversity [574008/2008-0]; Land Use in the Amazon Project	CAPES fellowship through the INCT Biodiversity(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Land Use in the Amazon Project	MZ was supported by CAPES fellowship number 574008/2008-0 through the INCT Biodiversity and Land Use in the Amazon Project.	Aber J. D., 2001, TERRESTRIAL ECOSYSTE; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Banks WE, 2011, J ANTHROPOL ARCHAEOL, V30, P359, DOI 10.1016/j.jaa.2011.05.003; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 2017, CLASSIFICATION REGRE; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Cardozo FD, 2011, REMOTE SENS-BASEL, V3, P2110, DOI 10.3390/rs3102110; Carmel Y, 2001, ECOL APPL, V11, P268, DOI 10.1890/1051-0761(2001)011[0268:SPMOMV]2.0.CO;2; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cuyckens GAE, 2015, J ARID ENVIRON, V115, P14, DOI 10.1016/j.jaridenv.2014.12.009; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P519, DOI 10.1111/j.1529-8817.2003.00779.x; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Descombes P, 2015, GLOBAL CHANGE BIOL, V21, P2479, DOI 10.1111/gcb.12868; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Eigenbrod F, 2015, GLOBAL CHANGE BIOL, V21, P275, DOI 10.1111/gcb.12669; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Ermert V, 2012, ENVIRON HEALTH PERSP, V120, P77, DOI 10.1289/ehp.1103681; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Fei SL, 2016, LANDSCAPE ECOL, V31, P31, DOI 10.1007/s10980-015-0272-7; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fordham DA, 2013, ECOGRAPHY, V36, P956, DOI 10.1111/j.1600-0587.2013.00147.x; Forrest JL, 2012, BIOL CONSERV, V150, P129, DOI 10.1016/j.biocon.2012.03.001; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Fyllas NM, 2009, GLOBAL ECOL BIOGEOGR, V18, P64, DOI 10.1111/j.1466-8238.2008.00419.x; Gimona A, 2015, LANDSCAPE ECOL, V30, P771, DOI 10.1007/s10980-015-0158-8; Harper EB, 2011, ECOL APPL, V21, P1225, DOI 10.1890/10-0506.1; Hastie T., 1986, STAT SCI, V1, P297; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Huberty C.J., 1994, APPL DISCRIMINANT AN; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2004, MAP VEG BRAS, P1; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Lapola DM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003357; Legendre P., 2012, NUMERICAL ECOLOGY; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Luzzi R, 2001, J MATH SOCIOL, V25, P179, DOI 10.1080/0022250X.2001.9990250; Machado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072283; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marino J, 2011, DIVERS DISTRIB, V17, P311, DOI 10.1111/j.1472-4642.2011.00744.x; McCullagh P., 1989, GEN LINEAR MODELS, DOI [10. 1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6, 10.1007/978-1-4899-3242-6]; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; OLIVEIRA G, 2012, BIODIVERS CONSERV, V21, P2913, DOI DOI 10.1007/S10531-012-0346-7; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; RICHARDS P. W., 1952, The tropical rain forest. An ecological study.; Riitters K, 2016, LANDSCAPE ECOL, V31, P137, DOI 10.1007/s10980-015-0270-9; Rosa IMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077231; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Silverio DV, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0427; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Zanin M, 2015, J NAT CONSERV, V23, P90, DOI 10.1016/j.jnc.2014.06.003; Zomer RJ, 2014, CLIMATIC CHANGE, V125, P445, DOI 10.1007/s10584-014-1176-2	82	4	4	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162500	10.1371/journal.pone.0162500	http://dx.doi.org/10.1371/journal.pone.0162500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618445	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100026
J	Ambang, T; Tan, JS; Ong, S; Wong, KT; Goh, KJ				Ambang, Tomica; Tan, Joo-San; Ong, Sheila; Wong, Kum-Thong; Goh, Khean-Jin			Clinicopathological Features of Telbivudine-Associated Myopathy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; DISEASE; ANALOGS	Telbivudine, a thymidine nucleoside analog, is a common therapeutic option for chronic hepatitis B infection. While raised serum creatine kinase is common, myopathy associated with telbivudine is rare. Reports on its myopathological features are few and immunohistochemical analyses of inflammatory cell infiltrates have not been previously described. We describe the clinical, myopathological and immunohistochemical features of four patients who developed myopathy after telbivudine therapy for chronic hepatitis B infection. All four patients presented with progressive proximal muscle weakness, elevation of serum creatine kinase and myopathic changes on electromyography. Muscle biopsies showed myofiber degeneration/necrosis, regeneration, and fibers with cytoplasmic bodies and cytochrome c oxidase deficiency. There was minimal inflammation associated with strong sarcolemmal overexpression of class I major histocompatibility complex (MHC class I). Upon withdrawal of telbivudine, muscle weakness improved in all patients and eventually completely resolved in three. In our series, telbivudine-associated myopathy is characterized by necrotizingmyopathy which improved on drug withdrawal. Although the occasional loss of cytochrome c oxidase is consistent with mitochondrial toxicity, the overexpression of MHC class I in all patients could suggest an underlying immune-mediated mechanism which may warrant further investigation.	[Ambang, Tomica; Tan, Joo-San; Goh, Khean-Jin] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia; [Ambang, Tomica; Tan, Joo-San; Wong, Kum-Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Ong, Sheila] Queen Elizabeth Hosp, Dept Med, Kota Kinabalu, Sabah, Malaysia	Universiti Malaya; Universiti Malaya	Goh, KJ (corresponding author), Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia.	gohkj@ummc.edu.my	Wong, Kum Thong/B-2788-2010; Goh, Khean Jin/D-1990-2010	Goh, Khean Jin/0000-0001-5416-9627	UM/MoHE High Impact Research Grant [H-20001-E00031]; Ministry of Higher Education, Malaysia	UM/MoHE High Impact Research Grant; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by the UM/MoHE/08 High Impact Research Grant H-20001-E00031, Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharin Janudin, 2014, Electron Physician, V6, P863, DOI 10.14661/2014.863-867; Bryant ML, 2001, ANTIMICROB AGENTS CH, V45, P229, DOI 10.1128/AAC.45.1.229-235.2001; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Departmentof Health U.S. and Human Services National Institute of Health National Cancer Institute, 2009, COMM TERM CRIT ADV E; Dong Y, 2012, HEPATOL INT, V6, P120; ENGEL AG, 2004, MYOLOGY, P681; Finsterer J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-323; Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011; Fung J, 2014, J GASTROEN HEPATOL, V29, P428, DOI 10.1111/jgh.12499; Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388; Jin JL, 2013, WORLD J GASTROENTERO, V19, P5575, DOI 10.3748/wjg.v19.i33.5575; Jung M, 2011, HEPATOL INT, V5, P117; Kim EH, 2013, CLIN MOL HEPATOL, V19, P82, DOI 10.3350/cmh.2013.19.1.82; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee SW, 2013, INTERN MED J, V43, P1048, DOI 10.1111/imj.12237; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; Preusse C, 2012, AM J PATHOL, V181, P2161, DOI 10.1016/j.ajpath.2012.08.033; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959; Wang M, 2012, INT J CLIN PHARM-NET, V34, P422, DOI 10.1007/s11096-012-9633-3; Xu HL, 2014, J CLIN PATHOL, V67, P999, DOI 10.1136/jclinpath-2013-202069; Zou XJ, 2011, J VIRAL HEPATITIS, V18, P892, DOI 10.1111/j.1365-2893.2010.01412.x	24	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162760	10.1371/journal.pone.0162760	http://dx.doi.org/10.1371/journal.pone.0162760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611456	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900163
J	Davison, M; Treangen, TJ; Koren, S; Pop, M; Bhaya, D				Davison, Michelle; Treangen, Todd J.; Koren, Sergey; Pop, Mihai; Bhaya, Devaki			Diversity in a Polymicrobial Community Revealed by Analysis of Viromes, Endolysins and CRISPR Spacers	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; THERMOPHILIC CYANOBACTERIA; PHYLOGENETIC ANALYSIS; COMPARATIVE GENOMICS; HUMAN MICROBIOME; VIRAL DIVERSITY; RESISTANCE; EXPRESSION; BIOFILMS; PHOTOSYNTHESIS	The polymicrobial biofilm communities in Mushroom and Octopus Spring in Yellowstone National Park (YNP) are well characterized, yet little is known about the phage populations. Dominant species, Synechococcus sp. JA-2-3B'a(2-13), Synechococcus sp. JA-3-3Ab, Chloroflexus sp. Y-400-fl, and Roseiflexus sp. RS-1, contain multiple CRISPR-Cas arrays, suggesting complex interactions with phage predators. To analyze phage populations from Octopus Spring biofilms, we sequenced a viral enriched fraction. To assemble and analyze phage metagenomic data, we developed a custom module, VIRITAS, implemented within the MetAMOS framework. This module bins contigs into groups based on tetranucleotide frequencies and CRISPR spacer-protospacer matching and ORF calling. Using this pipeline we were able to assemble phage sequences into contigs and bin them into three clusters that corroborated with their potential host range. The virome contained 52,348 predicted ORFs; some were clearly phage-like; 9319 ORFs had a recognizable Pfam domain while the rest were hypothetical. Of the recognized domains with CRISPR spacer matches, was the phage endolysin used by lytic phage to disrupt cells. Analysis of the endolysins present in the thermophilic cyanophage contigs revealed a subset of characterized endolysins as well as a Glyco_hydro_108 (PF05838) domain not previously associated with sequenced cyanophages. A search for CRISPR spacer matches to all identified phage endolysins demonstrated that a majority of endolysin domains were targets. This strategy provides a general way to link host and phage as endolysins are known to be widely distributed in bacteriophage. Endolysins can also provide information about host cell wall composition and have the additional potential to be used as targets for novel therapeutics.	[Davison, Michelle; Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Treangen, Todd J.; Koren, Sergey; Pop, Mihai] Ctr Bioinformat & Computat Biol, Biomol Sci Bldg, College Pk, MD 20742 USA; [Davison, Michelle; Bhaya, Devaki] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pop, Mihai] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Treangen, Todd J.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD 21702 USA; [Koren, Sergey] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA	Carnegie Institution for Science; Stanford University; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Davison, M; Bhaya, D (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.; Davison, M; Bhaya, D (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mdavison@carnegiescience.edu; dbhaya@carnegiescience.edu	Koren, Sergey/AAE-8314-2019; Pop, Mihai/A-7987-2013; Davison, Michelle/AAE-2573-2021	Pop, Mihai/0000-0001-9617-5304; Davison, Michelle/0000-0002-0748-949X; Koren, Sergey/0000-0002-1472-8962	National Institutes of Health [R01HG004885]; National Science Foundation [IIS-0812111]; National Science Foundation Division of Molecular and Cellular Biosciences [1024755, 1331151]; Carnegie Institution for Science; Stanford Department of Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Division of Molecular and Cellular Biosciences(National Science Foundation (NSF)); Carnegie Institution for Science; Stanford Department of Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Mihai Pop would like to acknowledge funding from National Institutes of Health grant # R01HG004885 and National Science Foundation grant # IIS-0812111. Devaki Bhaya would like to acknowledge funding from National Science Foundation Division of Molecular and Cellular Biosciences # 1024755 and National Science Foundation Division of Molecular and Cellular Biosciences # 1331151 and the Carnegie Institution for Science. Michelle Davison would like to acknowledge funding from the Stanford Department of Biology, as a portion of this work was done during her PhD.	Adriaenssens EM, 2014, APPL ENVIRON MICROB, V80, P4470, DOI 10.1128/AEM.00878-14; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson JB, 2013, APPL ENVIRON MICROB, V79, P6755, DOI 10.1128/AEM.01946-13; Frank DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007811; Gervasi T, 2014, APPL MICROBIOL BIOT, V98, P2495, DOI 10.1007/s00253-013-5128-y; Gomez-Garcia MR, 2011, ISME J, V5, P141, DOI 10.1038/ismej.2010.96; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Hua ZS, 2015, ISME J, V9, P1280, DOI 10.1038/ismej.2014.212; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Jensen SI, 2011, ISME J, V5, P317, DOI 10.1038/ismej.2010.131; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Kimura S, 2013, APPL ENVIRON MICROBI; Klatt CG, 2007, ENVIRON MICROBIOL, V9, P2067, DOI 10.1111/j.1462-2920.2007.01323.x; Klatt CG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00106; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lopes A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1027; Mao JZ, 2013, FEMS MICROBIOL LETT, V342, P30, DOI 10.1111/1574-6968.12104; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Mayer MJ, 2012, APPL ENVIRON MICROB, V78, P3685, DOI 10.1128/AEM.07884-11; Mazumdar V, 2013, METABOLIC PROXIMITY, V8, DOI [10.1371/journal.pone.0077617, DOI 10.1371/JOURNAL.PONE.0077617]; Mizuno CM, 2013, APPL ENVIRON MICROB, V79, P688, DOI 10.1128/AEM.02742-12; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Milferstedt K, 2013, DISTURBANCE FREQUENC, V8, DOI [10.1371/journal.pone.0080692, DOI 10.1371/JOURNAL.PONE.0080692]; Miyake K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-56; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Ogilvie LA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3420; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Ohsumi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116647; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Peterson BW, 2015, FEMS MICROBIOL REV, V39, P234, DOI 10.1093/femsre/fuu008; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pope PB, 2011, ISME J, V5, P341, DOI 10.1038/ismej.2010.116; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Rubio L, 2016, CRIT REV BIOTECHNOL, V36, P542, DOI 10.3109/07388551.2014.993587; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Rosen MJ, 2015, SCIENCE, V348, P1019, DOI 10.1126/science.aaa4456; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Sakowski EG, 2014, P NATL ACAD SCI USA, V111, P15786, DOI 10.1073/pnas.1401322111; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Semenyuk EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087757; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Simpson JT, 2015, ANNU REV GENOM HUM G, V16, P153, DOI 10.1146/annurev-genom-090314-050032; Skennerton CT, 2013, NUCLEIC ACIDS RES, P183; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; Sullivan MB, 2015, J VIROL, V89, P2459, DOI 10.1128/JVI.03289-14; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Teeling H, 2012, CURRENT OPPORTUNITIE; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Ultsch A, 2005, ESOM MAPS TOOLS FOR; Ursell T, 2013, MOTILITY ENHANCEMENT, V9, DOI [10.1371/journal.pcbi.1003205, DOI 10.1371/JOURNAL.PCBI.1003205]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Wilmes P, 2008, ISME J, V2, P853, DOI 10.1038/ismej.2008.38; Wu S, 2014, CARBOHYD METABOL, V9, DOI [10.1371/journal.pone.0099204, DOI 10.1371/JOURNAL.PONE.0099204]; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z; Zago CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123206; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	96	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160574	10.1371/journal.pone.0160574	http://dx.doi.org/10.1371/journal.pone.0160574			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611571	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900008
J	Molbak, K; Hansen, ND; Valentiner-Branth, P				Molbak, Kare; Hansen, Niels Dalum; Valentiner-Branth, Palle			Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; ADOLESCENT GIRLS; IMMUNIZATION; SYMPTOMS; RISK	Background Since 2013 the number of suspected adverse reactions to the quadrivalent human papillomavirus (HPV) vaccine reported to the Danish Medicines Agency (DMA) has increased. Due to the resulting public concerns about vaccine safety, the coverage of HPV vaccinations in the childhood vaccination programme has declined. The aim of the present study was to determine health care-seeking prior to the first HPV vaccination among females who suspected adverse reactions to HPV vaccine. Methods In this registry-based case-control study, we included as cases vaccinated females with reports to the DMA of suspected severe adverse reactions. We selected controls without reports of adverse reactions from the Danish vaccination registry and matched by year of vaccination, age of vaccination, and municipality, and obtained from the Danish National Patient Registry and The National Health Insurance Service Register the history of health care usage two years prior to the first vaccine. We analysed the data by logistic regression while adjusting for the matching variables. Results The study included 316 cases who received first HPV vaccine between 2006 and 2014. Age range of cases was 11 to 52 years, with a peak at 12 years, corresponding to the recommended age at vaccination, and another peak at 19 to 28 years, corresponding to a catch-up programme targeting young women. Compared with 163,910 controls, cases had increased care-seeking in the two years before receiving the first HPV vaccine. A multivariable model showed higher use of telephone/email consultations (OR 1.9; 95% CI 1.2-3.2), physiotherapy (OR 2.1; 95% CI 1.6-2.8) and psychologist/psychiatrist (OR 1.9; 95% CI 1.3-2.7). Cases were more likely to have a diagnosis in the ICD-10 chapters of diseases of the digestive system (OR 1.6; 95% CI 1.0-2.4), of the musculoskeletal system (OR 1.6; 95% CI 1.1-2.2), symptoms or signs not classified elsewhere (OR 1.8; 95% CI 1.3-2.5) as well as injuries (OR 1.5; 95% CI 1.2-1.9). Conclusion Before receiving the first HPV vaccination, females who suspected adverse reactions has symptoms and a health care-seeking pattern that is different from the matched population. Pre-vaccination morbidity should be taken into account in the evaluation of vaccine safety signals.	[Molbak, Kare; Valentiner-Branth, Palle] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark; [Hansen, Niels Dalum] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Hansen, Niels Dalum] IBM Denmark, Holte, Denmark	Statens Serum Institut; University of Copenhagen	Molbak, K (corresponding author), Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark.	krm@ssi.dk		Molbak, Kare/0000-0002-3100-4990	Innovation Fund Denmark; IBM Denmark	Innovation Fund Denmark; IBM Denmark(International Business Machines (IBM))	The study was in part supported by a grant from Innovation Fund Denmark and IBM Denmark (PhD grant to Niels Dalum Hansen). Niels Dalum Hansen is partly employed by IBM Denmark. IBM Denmark provided support in the form of a part of the salary for author Niels Dalum Hansen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2016, DECLINE UPTAKE HPV V; Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; Brinth L, 2015, INT J VACCINES VACCI, V1, DOI [DOI 10.15406/ijvv.2015.01.00003, 10.15406/ijvv.2015.01.00003]; Brinth L, 2015, DAN MED J, V62; Callreus T, 2009, VACCINE, V27, P2954, DOI 10.1016/j.vaccine.2009.02.106; Cameron RL, 2016, INTERN MED J; Donegan K, 2013, VACCINE, V31, P4961, DOI 10.1016/j.vaccine.2013.08.024; Fonteneau L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2575-7; Global Advisory Committee on Vaccine Safety, 2015, WEEKLY EPID REC, V91, P21; Hanley SJB, 2015, LANCET, V386, P248, DOI 10.1016/S0140-6736(15)61280-6; Kinoshita T, 2014, INTERNAL MED, V53, P2185, DOI 10.2169/internalmedicine.53.3133; Klein NP, 2012, ARCH PEDIAT ADOL MED, V166, P1140, DOI 10.1001/archpediatrics.2012.1451; KRAUSE TG, 2012, EURO SURVEILL, V17; Peveler R, 1997, J PSYCHOSOM RES, V42, P245, DOI 10.1016/S0022-3999(96)00292-9; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; Scheller NM, 2015, JAMA-J AM MED ASSOC, V313, P54, DOI 10.1001/jama.2014.16946; The Danish Health Authority the Danish Medicines Authority and Statens Serum Institut, ANN REP DAN CHILDH V	17	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162520	10.1371/journal.pone.0162520	http://dx.doi.org/10.1371/journal.pone.0162520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611088	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900121
J	Narmadha, G; Yenugu, S				Narmadha, Ganapathy; Yenugu, Suresh			In Silico and Biochemical Characterization of Lysozyme-Like Proteins in the Rat	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; OXIDATIVE STRESS; SPERM-BINDING; HE-2 FAMILY; EPIDIDYMIS; SPERMATOZOA; CAPACITATION; RECOGNITION; FERTILITY; RECEPTOR	Background Spermatogenesis and sperm maturation in the male reproductive tract is dictated by a variety of proteins secreted in the testis and epididymis. Though the proteome of these tissues is known, the functional role of many of these proteins remains uncharacterized. In this study, we characterize the rat Lysozyme-like (Lyzl) genes and proteins. Methods In silico tools were used to predict the primary, secondary and tertiary structures. Reverse transcription PCR, immunofluorescence and immunoblotting were used to determine the expression pattern. Lysozyme like enzyme activity was assessed by standard assays. Results Six rat Lyzl genes namely Lyzl1, Lyzl3, Lyzl4, Lyzl5, Lyzl6 and Lyzl7 were found to be highly conserved among the vertebrates with higher homology to mouse counterparts than with human counterparts. All the LYZL proteins contained the characteristic 4 disulfide bridges similar to c-type lysozyme. Only LYZL 1 and 6, conserved the active site amino acids of the lysozyme. Molecular modeling studies indicated that LYZL proteins exhibit strikingly similar three-dimensional structures among themselves. The secondary structure analysis of the recombinant LYZL proteins indicated the presence of alpha-helix, beta-sheet and random coil with a-helix being the majority. Docking studies indicated the peptidoglycan binding nature of LYZL proteins. All the rat Lyzl mRNA transcripts (Lyzl1, Lyzl3, Lyzl4, Lyzl5, Lyzl6 and Lyzl7) are predominantly expressed in testes though some of them are expressed in tissues other than reproductive tract. Their expression was androgen independent. The rat LYZL proteins are localized in the germinal epithelium and on the spermatozoa. Recombinant LYZL1 and 6 possessed muramidase, isopeptidase and antibacterial activities. The mechanism of antibacterial action of LYZL1 and LYZL6 involved bacterial membrane damage and leakage of cellular contents. Only LYZL1 and 6 possess peptidoglycan binding ability, whereas LYZL3, LYZL4 and LYZL5 possess hyaluronan binding ability suggesting a possible functional divergence of these proteins. LYZL3, LYZL4 and LYZL7 possessed free radical scavenging property, suggesting that they may act as antioxidants. Conclusion The divergent properties of LYZL proteins indicate that they may have a role in sperm function, innate immunity and other physiological process as well.	[Narmadha, Ganapathy; Yenugu, Suresh] Univ Hyderabad, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Yenugu, S (corresponding author), Univ Hyderabad, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India.	ysnaidu@yahoo.com	Yenugu, Suresh/Y-7661-2019	Yenugu, Suresh/0000-0002-5431-2267				Aitken RJ, 2008, ADV EXP MED BIOL, V636, P154, DOI 10.1007/978-0-387-09597-4_9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashrafzadeh A, 2013, INT J MED SCI, V10, P1649, DOI 10.7150/ijms.6395; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Ghosh I, 2007, J REPROD FERTIL S, V63, P539; Guo CY, 2009, J BIOTECHNOL, V139, P33, DOI 10.1016/j.jbiotec.2008.10.003; Guyonnet B, 2012, ISOLATION PROTEOMIC, P1; Hall SH, 2007, ASIAN J ANDROL, V9, P453, DOI 10.1111/j.1745-7262.2007.00298.x; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Handwaskar RUC, 2007, HYALURONIDASE AND CO, V32, P755; HARRIS ME, 1981, EXPERIENTIA, V37, P426, DOI 10.1007/BF01959901; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; Jean-Louis D, 2016, ANIM REPROD SCI, V169, P76, DOI 10.1016/j.anireprosci.2016.02.034; Jiborn T, 2004, J ANDROL, V25, P564; Jin YZ, 1997, MOL REPROD DEV, V47, P490, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;490::AID-MRD16&gt;3.0.CO;2-#; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kirchhoff C, 1998, REV REPROD, V3, P86; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li J, 2011, MOL CELLULAR PROTEOM, V3, P1; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Memarpoor-Yazdi M, 2012, J FUNCT FOODS, V4, P278, DOI 10.1016/j.jff.2011.12.004; Mendeluk GR, 1997, ARCH ANDROLOGY, V38, P7, DOI 10.3109/01485019708988526; Mihajlovic M, 2012, BBA-BIOMEMBRANES, V1818, P1274, DOI 10.1016/j.bbamem.2012.01.016; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Novo DJ, 2000, ANTIMICROB AGENTS CH, V44, P827, DOI 10.1128/AAC.44.4.827-834.2000; OHNO N, 1989, J BIOL CHEM, V264, P4434; Rajesh A, 2015, J REPROD IMMUNOL, V110, P117, DOI 10.1016/j.jri.2015.02.009; Rajesh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032633; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rodriguez CM, 2001, REPRODUCTION, V122, P41, DOI 10.1530/reprod/122.1.41; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; Sreerama N, 2004, METHOD ENZYMOL, V2, P1; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Syntin P, 1999, BIOL REPROD, V60, P1542, DOI 10.1095/biolreprod60.6.1542; Takeshita K, 2003, CELL MOL LIFE SCI, V60, P1944, DOI 10.1007/s00018-003-3082-z; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang Z-q, 2013, NOVEL LIPOPOLYSACCHA; Wei J, 2013, ASIAN J ANDROL, V14, P834; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394; Wiwanitkit Viroj, 2010, J Hum Reprod Sci, V3, P146, DOI 10.4103/0974-1208.74158; Yenugu S, 2003, BIOCHEM J, V372, P473, DOI 10.1042/BJ20020225; Yenugu S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-23; Yenugu Suresh, 2004, Reprod Biol Endocrinol, V2, P61, DOI 10.1186/1477-7827-2-61; Yenugu S, 2010, J PEPT SCI, V16, P337, DOI 10.1002/psc.1246; You SJ, 2010, FOOD RES INT, V43, P848, DOI 10.1016/j.foodres.2009.12.004; Yudin AI, 2003, BIOL REPROD, V69, P1118, DOI 10.1095/biolreprod.103.016105; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	60	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161909	10.1371/journal.pone.0161909	http://dx.doi.org/10.1371/journal.pone.0161909			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611690	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900036
J	Naseri, NN; Bonica, J; Xu, H; Park, LC; Arjomand, J; Chen, ZM; Gibson, GE				Naseri, Nima N.; Bonica, Joseph; Xu, Hui; Park, Larry C.; Arjomand, Jamshid; Chen, Zhengming; Gibson, Gary E.			Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patients	PLOS ONE			English	Article							KETOGLUTARATE DEHYDROGENASE COMPLEX; PYRUVATE-DEHYDROGENASE; ALPHA-KETOGLUTARATE; PATHOLOGICAL LENGTH; TRANSGENIC MOUSE; ALZHEIMER BRAIN; MITOCHONDRIAL; PROTEIN; MODELS; DAMAGE	Metabolic dysfunction is well-documented in Huntington's disease (HD). However, the link between the mutant huntingtin (mHTT) gene and the pathology is unknown. The tricarboxylic acid (TCA) cycle is the main metabolic pathway for the production of NADH for conversion to ATP via the electron transport chain (ETC). The objective of this study was to test for differences in enzyme activities, mRNAs and protein levels related to the TCA cycle between lymphoblasts from healthy subjects and from patients with HD. The experiments utilize the advantages of lymphoblasts to reveal new insights about HD. The large quantity of homogeneous cell populations permits multiple dynamic measures to be made on exactly comparable tissues. The activities of nine enzymes related to the TCA cycle and the expression of twenty-nine mRNAs encoding for these enzymes and enzyme complexes were measured. Cells were studied under baseline conditions and during metabolic stress. The results support our recent findings that the activities of the pyruvate dehydrogenase complex (PDHC) and succinate dehydrogenase (SDH) are elevated in HD. The data also show a large unexpected depression in MDH activities. Furthermore, message levels for isocitrate dehydrogenase 1 (IDH1) were markedly increased in in HD lymphoblasts and were responsive to treatments. The use of lymphoblasts allowed us to clarify that the reported decrease in aconitase activity in HD autopsy brains is likely due to secondary hypoxic effects. These results demonstrate the mRNA and enzymes of the TCA cycle are critical therapeutic targets that have been understudied in HD.	[Naseri, Nima N.; Bonica, Joseph; Xu, Hui; Gibson, Gary E.] Weill Cornell Med Coll, Brain & Mind Res Inst, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Healthcare Policy & Res, Div Biostat & Epidemiol, 425 East 61st St, New York, NY 10065 USA; [Park, Larry C.; Arjomand, Jamshid] CHDI Management CHDI Fdn Inc, 6080 Ctr Dr Suite 100, Los Angeles, CA 90045 USA	Cornell University; Cornell University	Gibson, GE (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	ggibson@med.cornell.edu			CHDI; NIH [PP-AG14930]; Burke Medical Research Institute; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	CHDI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Medical Research Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by CHDI, NIH PP-AG14930 and the Burke Medical Research Institute. CHDI Foundation is also the employer of two authors (LCP and JA). Beyond their intellectual contributions to the design of the study and preparation of the manuscript, CHDI foundation staff did not play a role in primary figures, data collection and analysis or the decision to publish this manuscript. The rest of funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen OA, 2001, ANN NEUROL, V50, P112, DOI 10.1002/ana.1085; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; Beal MF, NEUROCHEMICAL HISTOL; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Bubber P, 2004, NEUROCHEM INT, V45, P1021, DOI 10.1016/j.neuint.2004.05.007; BUTTERWORTH J, 1985, J NEUROL SCI, V67, P161, DOI 10.1016/0022-510X(85)90112-1; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Cooper AJL, 1997, P NATL ACAD SCI USA, V94, P12604, DOI 10.1073/pnas.94.23.12604; Cooper AJL, 1998, AGE, V21, P25, DOI 10.1007/s11357-998-0004-x; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Fu WJJ, 2006, COMPUT BIOL CHEM, V30, P21, DOI 10.1016/j.compbiolchem.2005.10.005; Gibson GE, 2000, NEUROCHEM INT, V36, P97, DOI 10.1016/S0197-0186(99)00114-X; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Holness MJ, REGULATION PYRUVATE; Jenkins BG, EVIDENCE IMPAIRMENT; Kim J, MITOCHONDRIAL LOSS D, P1460; Klivenyi P, 2004, J NEUROCHEM, V88, P1352, DOI 10.1046/j.1471-4159.2003.02263.x; Kuhl De Fau-Markham CH, 1985, LOCAL CEREBRAL GLUCO, P199; Kuhl De Fau-Metter EJ, 1984, ANN NEUROL, P119; Kuhl De Fau-Phelps ME, 1982, ANN NEUROL, P425; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Naseri NN, 2015, J NEUROPATH EXP NEUR, V74, P527, DOI 10.1097/NEN.0000000000000197; Orth M, 2011, J NEUROL NEUROSUR PS, V82, P1409, DOI 10.1136/jnnp.2010.209668; PRINCE J, 1994, J NEURAL TRANSM-PARK, V8, P171, DOI 10.1007/BF02260938; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023; 1996, MOVEMENT DISORD, V11, P136, DOI DOI 10.1002/MDS.870110204	42	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160384	10.1371/journal.pone.0160384	http://dx.doi.org/10.1371/journal.pone.0160384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611087	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255900004
J	Samimi-Rad, K; Rahimnia, R; Sadeghi, M; Malekpour, SA; Marzban, M; Keshvari, M; Kiani, SJ; Alavian, SM				Samimi-Rad, Katayoun; Rahimnia, Ramin; Sadeghi, Mahdi; Malekpour, Seyed Amir; Marzban, Mona; Keshvari, Maryam; Kiani, Seyed Jalal; Alavian, Seyed-Moayed			Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran	PLOS ONE			English	Article							DRUG-USERS; MOLECULAR EPIDEMIOLOGY; GENETIC HISTORY; RISK-FACTORS; INFECTION; PREVALENCE; PHYLOGENIES; JMODELTEST; PRISONERS; INJECTION	The high rate of hepatitis C virus (HCV) infection among transfusion related risk groups such as patients with inherited bleeding disorders highlighting the investigation on prevalent subtypes and their epidemic history among this group. In this study, 166 new HCV NS5B sequences isolated from patients with inherited bleeding disorders together with 29 sequences related to hemophiliacs obtained from a previous study on diversity of HCV in Iran were analyzed. The most prevalent subtype was 1a (65%), followed by 3a (18.7%), 1b (14.5%), 4(1.2%) and 2k (0.6%). Subtypes 1a and 3a showed exponential expansion during the 20th century. Whereas expansion of 3a started around 20 years earlier than 1a among the study patients, the epidemic growth of 1a revealed a delay of about 10 years compared with that found for this subtype in developed countries. Our results supported the view that the spread of 3a reached the plateau 10 years prior to the screening of blood donors for HCV. Rather, 1a reached the plateau when screening program was implemented. The differences observed in the epidemic behavior of HCV-1a and 3a may be associated with different transmission routes of two subtypes. Indeed, expansion of 1a was more commonly linked to blood transfusion, while 3a was more strongly associated to drug use and specially IDU after 1960. Our findings also showed HCV transmission through blood products has effectively been controlled from late 1990s. In conclusion, the implementation of strategies such as standard surveillance programs and subsiding antiviral treatments seems to be essential to both prevent new HCV infections and to decline the current and future HCV disease among Iranian patients with inherited bleeding disorders.	[Samimi-Rad, Katayoun; Marzban, Mona; Kiani, Seyed Jalal] Tehran Univ Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran; [Rahimnia, Ramin] Tehran Univ Med Sci, Sch Adv Technol Med, Dept Nano Med, Tehran, Iran; [Sadeghi, Mahdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Malekpour, Seyed Amir] Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Keshvari, Maryam] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran; [Alavian, Seyed-Moayed] Baqiatallah Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Tehran; Baqiyatallah University of Medical Sciences (BMSU)	Samimi-Rad, K (corresponding author), Tehran Univ Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran.	Ksamimirad@sina.tums.ac.ir	Kiani, Seyed Jalal/L-7731-2018; Keshvari, Maryam/C-6678-2017	Kiani, Seyed Jalal/0000-0002-5499-8924; 				Abolghasemi H, 2009, IRAN J PUBLIC HEALTH, V38, P82; Ahmadi J, 2007, AM J DRUG ALCOHOL AB, V33, P483, DOI 10.1080/00952990701301293; Alizadeh AHM, 2005, WORLD J GASTROENTERO, V11, P4085, DOI 10.3748/wjg.v11.i26.4085; Amiri Z. Mohtasham, 2007, Eastern Mediterranean Health Journal, V13, P250; Azizi MH, 2015, ARCH IRAN MED, V18, P393, DOI 015186/AIM.0016; Culasso ACA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044757; DALVAND S, 1984, DRUG ALCOHOL DEPEN, V14, P87, DOI 10.1016/0376-8716(84)90023-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Farhadi Langeroodi M, 1998, PRINCIPLES BLOOD TRA, P27; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagan H, 2005, AIDS, V19, pS199, DOI 10.1097/01.aids.0000192090.61753.d4; Keshvari M, 2010, IRAN RED CRESCENT ME, V12, P608; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Malekinejad M, 2015, INT J INFECT DIS, V40, P116, DOI 10.1016/j.ijid.2015.09.022; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Oliveira AB, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-38; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Quaglio G, 2003, CLIN INFECT DIS, V37, P33, DOI 10.1086/375566; Reid G, 2002, REVISITING HIDDEN EP, P100; Rezvan H, 2007, TRANSFUSION MED, V17, P425, DOI 10.1111/j.1365-3148.2007.00794.x; Samimi-Rad K, 2007, HAEMOPHILIA, V13, P156, DOI 10.1111/j.1365-2516.2006.01415.x; Samimi-Rad K, 2004, J MED VIROL, V74, P246, DOI 10.1002/jmv.20170; Samimi-Rad K., 2012, Eastern Mediterranean Health Journal, V18, P227; Samimi-Rad K, 2013, HEPAT MON, V13, DOI [10.5812/hepatmon.7699, 10.5812/hepatmon.76]; Samimi-Rad K, 2012, ARCH VIROL, V157, P1959, DOI 10.1007/s00705-012-1369-9; Somi Mohammad H, 2008, Saudi J Kidney Dis Transpl, V19, P461; Wada K, 1999, ADDICTION, V94, P1063, DOI 10.1046/j.1360-0443.1999.947106311.x; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162492	10.1371/journal.pone.0162492	http://dx.doi.org/10.1371/journal.pone.0162492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611688	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900114
J	Sarkisjan, D; Julsing, JR; Smid, K; de Klerk, D; van Kuilenburg, ABP; Meinsma, R; Lee, YB; Kim, DJ; Peters, GJ				Sarkisjan, Dzjemma; Julsing, Joris R.; Smid, Kees; de Klerk, Daniel; van Kuilenburg, Andre B. P.; Meinsma, Rutger; Lee, Young B.; Kim, Deog J.; Peters, Godefridus J.			The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2	PLOS ONE			English	Article							HUMAN CANCER-CELLS; ANTITUMOR-ACTIVITY; NUCLEOSIDE ANALOGS; LUNG-CANCER; GEMCITABINE; EXPRESSION; METHYLATION; CHEMOTHERAPY; AZACITIDINE; SENSITIVITY	Fluorocyclopentenylcytosine (RX-3117) is an orally available cytidine analog, currently in Phase I clinical trial. RX-3117 has promising antitumor activity in various human tumor xenografts including gemcitabine resistant tumors. RX-3117 is activated by uridine-cytidine kinase (UCK). Since UCK exists in two forms, UCK1 and UCK2, we investigated which form is responsible for RX-3117 phosphorylation. For that purpose we transfected A549 and SW1573 cell lines with UCK-siRNAs. Transfection of UCK1-siRNA efficiently downregulated UCK1-mRNA, but not UCK2-mRNA expression, and did not affect sensitivity to RX-3117. However, transfection of UCK2-siRNA completely downregulated UCK2-mRNA and protein and protected both A549 and SW1573 against RX-3117. UCK enzyme activity in two panels of tumor cell lines and xenograft cells correlated only with UCK2-mRNA expression (r = 0.803 and 0.915, respectively), but not with UCK1-mRNA. Moreover, accumulation of RX-3117 nucleotides correlated with UCK2 expression. In conclusion, RX-3117 is activated by UCK2 which may be used to select patients potentially sensitive to RX-3117.	[Sarkisjan, Dzjemma; Julsing, Joris R.; Smid, Kees; de Klerk, Daniel; Peters, Godefridus J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Meinsma, Rutger] Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Amsterdam, Netherlands; [Lee, Young B.; Kim, Deog J.] Rexahn Pharmaceut Inc, Rockville, MD USA	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Peters, GJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	gj.peters@vumc.nl	; Peters, Godefridus J/C-7562-2013	van Kuilenburg, Andre/0000-0002-7989-4910; Peters, Godefridus J/0000-0002-5447-2877	Rexahn Pharmaceuticals, Inc.	Rexahn Pharmaceuticals, Inc.	GJP received a grant from Rexahn Pharmaceuticals, Inc. This study was supported by Rexahn Pharmaceuticals, Inc. Employees (the 19 coauthors) participated in the design of the studies and the execution, discussed data and commented on the manuscript, and approved final submission.; This study was supported by Rexahn Pharmaceuticals, Inc. Employees (the coauthors) participated in the design of the studies and the execution, discussed data and commented on the manuscript, and approved final submission.	Backus HHJ, 2001, ANN ONCOL, V12, P779, DOI 10.1023/A:1011112227044; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Choi WJ, 2012, J MED CHEM, V55, P4521, DOI 10.1021/jm3004009; Davidsson J, 2007, HUM MOL GENET, V16, P2215, DOI 10.1093/hmg/ddm173; Galvani E, 2013, NEOPLASIA, V15, P61, DOI 10.1593/neo.121434; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; KEEPERS YP, 1991, EUR J CANCER, V27, P897, DOI 10.1016/0277-5379(91)90142-Z; Le Chevalier T, 2005, LUNG CANCER, V47, P69, DOI 10.1016/j.lungcan.2004.10.014; Murata D, 2004, DRUG METAB DISPOS, V32, P1178, DOI 10.1124/dmd.104.000737; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters GJ, 2014, NUCLEOS NUCLEOT NUCL, V33, P358, DOI 10.1080/15257770.2014.894197; Peters GJ, 2014, NUCLEOS NUCLEOT NUCL, V33, P403, DOI 10.1080/15257770.2014.894196; Peters GJ, 2013, INVEST NEW DRUG, V31, P1444, DOI 10.1007/s10637-013-0025-x; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Shimamoto Y, 2002, JPN J CANCER RES, V93, P825, DOI 10.1111/j.1349-7006.2002.tb01325.x; Sripayap P, 2014, EXP HEMATOL, V42, P294, DOI 10.1016/j.exphem.2013.12.004; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; Valencia A, 2014, LEUKEMIA, V28, P621, DOI 10.1038/leu.2013.330; van Kuilenburg ABP, 2016, BBA-MOL BASIS DIS, V1862, P1504, DOI 10.1016/j.bbadis.2016.05.012; Van Rompay AR, 2001, MOL PHARMACOL, V59, P1181, DOI 10.1124/mol.59.5.1181; Yang MY, 2014, ANTICANCER RES, V34, P6951	24	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162901	10.1371/journal.pone.0162901	http://dx.doi.org/10.1371/journal.pone.0162901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612203	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900184
J	Skare, JT; Shaw, DK; Trzeciakowski, JP; Hyde, JA				Skare, Jonathan T.; Shaw, Dana K.; Trzeciakowski, Jerome P.; Hyde, Jenny A.			In Vivo Imaging Demonstrates That Borrelia burgdorferi ospC Is Uniquely Expressed Temporally and Spatially throughout Experimental Infection	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; RESPONSE REGULATOR RRP2; LYME-DISEASE SPIROCHETE; GENE-EXPRESSION; BINDING-PROTEIN; CRYSTAL-STRUCTURE; VIRULENCE FACTOR; SENSU-STRICTO; RPOS; STRAINS	Borrelia burgdorferiis a spirochetal bacterium transmitted by the Ixodes tick that causes Lyme disease in humans due to its ability to evade the host immune response and disseminate to multiple immunoprotective tissues. The pathogen undergoes dynamic genetic alterations important for adaptation from the tick vector to the mammalian host, but little is known regarding the changes at the transcriptional level within the distal tissues they colonize. In this study, B. burgdorferiinfection and gene expression of the essential virulence determinant ospC was quantitatively monitored in a spatial and temporal manner utilizing reporter bioluminescent borrelial strains with in vivo and ex vivo imaging. Although expressed from a shuttle vector, the PospC-luc construct exhibited a similar expression pattern relative to native ospC. Bacterial burden in skin, inguinal lymph node, heart, bladder and tibiotarsal joint varied between tissues and fluctuated over the course of infection possibly in response to unique cues of each microenvironment. Expression of ospC, when normalized for changes in bacterial load, presented unique profiles in murine tissues at different time points. The inguinal lymph node was infected with a significant B. burgdorferi burden, but showed minimal ospC expression. B. burgdorferi infected skin and heart induced expression of ospC early during infection while the bladder and tibiotarsal joint continued to display P-ospC driven luminescence throughout the 21 day time course. Localized skin borrelial burden increased dramatically in the first 96 hours following inoculation, which was not paralleled with an increase in ospC expression, despite the requirement of ospC for dermal colonization. Quantitation of bioluminescence representing ospC expression in individual tissues was validated by qRT-PCR of the native ospC transcript. Taken together, the temporal regulation of ospC expression in distal tissues suggests a role for this virulence determinant beyond early infection.	[Skare, Jonathan T.; Shaw, Dana K.; Hyde, Jenny A.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Coll Med, Bryan College Stn, TX 77807 USA; [Trzeciakowski, Jerome P.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med Physiol, Bryan College Stn, TX USA; [Shaw, Dana K.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University System of Maryland; University of Maryland Baltimore	Hyde, JA (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Coll Med, Bryan College Stn, TX 77807 USA.	jshyde@medicine.tamhsc.edu			 [AI101740A]		This work was supported by AI101740A, https://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; Bacconi M, 2016, APPL MICROBIOL BIOT, V100, P3197, DOI 10.1007/s00253-015-7229-2; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Blevins JS, 2009, J BACTERIOL, V191, P2902, DOI 10.1128/JB.01721-08; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Bontemps-Gallo S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005791; Burns S M, 2001, Contrib Microbiol, V9, P71; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carrasco SE, 2015, INFECT IMMUN, V83, P4848, DOI 10.1128/IAI.01215-15; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Chan KF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129532; Chang MH, 2011, JOVE-J VIS EXP, DOI 10.3791/2547; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Drecktrah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068799; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Earnhart CG, 2014, PATHOG DIS, V70, P176, DOI 10.1111/2049-632X.12119; Earnhart CG, 2011, CLIN VACCINE IMMUNOL, V18, P901, DOI 10.1128/CVI.05004-11; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Gherardini F., 2010, BORRELIA MOL BIOL HO, P103; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Groshong AM, 2012, J BACTERIOL, V194, P3336, DOI 10.1128/JB.00253-12; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Hyde Jenny A, 2011, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c04s20; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Iyer R, 2015, MOL MICROBIOL, V95, P509, DOI 10.1111/mmi.12882; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Kong Y, 2011, CURR PROTOC MICROBIO, V2; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; La Rosa SL, 2013, APPL ENVIRON MICROB, V79, P3986, DOI 10.1128/AEM.00831-13; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, INFECT IMMUN; Lagal V, 2003, J CLIN MICROBIOL, V41, P5059, DOI 10.1128/JCM.41.11.5059-5065.2003; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Lin YP, 2015, CELL MICROBIOL, V17, P860, DOI 10.1111/cmi.12407; Lin YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004238; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Mendez J, 2013, ENV MICROBIOL REP, V5, P179, DOI 10.1111/1758-2229.12030; Obonyo M, 1999, J CLIN MICROBIOL, V37, P2137, DOI 10.1128/JCM.37.7.2137-2141.1999; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Ouyang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096917; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2010, J BACTERIOL, V192, P1965, DOI 10.1128/JB.01616-09; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthy R, 2001, INFECT IMMUN, V69, P2739, DOI 10.1128/IAI.69.4.2739-2742.2001; Rego ROM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101009; Rhee KJ, 2011, GUT MICROBES, V2, P34, DOI 10.4161/gmic.2.1.14882; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Samuels DS, 1995, ELECTROTRANSFORMATIO; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Seemanapalli SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015830; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Shapiro ED, 2014, NEW ENGL J MED, V370, P1724, DOI [10.1056/NEJMcp1314325, 10.1056/NEJMc1407264]; Shaw DK, 2012, MOL MICROBIOL, V83, P319, DOI 10.1111/j.1365-2958.2011.07932.x; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tilly K, 2013, MOL MICROBIOL, V89, P216, DOI 10.1111/mmi.12271; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00079; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Yin YP, 2016, J BACTERIOL, V198, P1543, DOI 10.1128/JB.01010-15; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	102	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162501	10.1371/journal.pone.0162501	http://dx.doi.org/10.1371/journal.pone.0162501			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611840	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900116
J	Yadav, A; Dhole, K; Sinha, H				Yadav, Anupama; Dhole, Kaustubh; Sinha, Himanshu			Genetic Regulation of Phenotypic Plasticity and Canalisation in Yeast Growth	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ENVIRONMENT; EVOLUTION; ASSIMILATION; POPULATIONS; ADAPTATION; MECHANISMS; CROSS	The ability of a genotype to show diverse phenotypes in different environments is called phenotypic plasticity. Phenotypic plasticity helps populations to evade extinctions in novel environments, facilitates adaptation and fuels evolution. However, most studies focus on understanding the genetic basis of phenotypic regulation in specific environments. As a result, while it's evolutionary relevance is well established, genetic mechanisms regulating phenotypic plasticity and their overlap with the environment specific regulators is not well understood. Saccharomyces cerevisiae is highly sensitive to the environment, which acts as not just external stimulus but also as signalling cue for this unicellular, sessile organism. We used a previously published dataset of a biparental yeast population grown in 34 diverse environments and mapped genetic loci regulating variation in phenotypic plasticity, plasticity QTL, and compared them with environment-specific QTL. Plasticity QTL is one whose one allele exhibits high plasticity whereas the other shows a relatively canalised behaviour. We mapped phenotypic plasticity using two parameters-environmental variance, an environmental order-independent parameter and reaction norm(slope), an environmental order-dependent parameter. Our results show a partial overlap between pleiotropic QTL and plasticity QTL such that while some plasticity QTL are also pleiotropic, others have a significant effect on phenotypic plasticity without being significant in any environment independently. Furthermore, while some plasticity QTL are revealed only in specific environmental orders, we identify large effect plasticity QTL, which are order-independent such that whatever the order of the environments, one allele is always plastic and the other is canalised. Finally, we show that the environments can be divided into two categories based on the phenotypic diversity of the population within them and the two categories have differential regulators of phenotypic plasticity. Our results highlight the importance of identifying genetic regulators of phenotypic plasticity to comprehensively understand the genotype-phenotype map.	[Yadav, Anupama; Dhole, Kaustubh; Sinha, Himanshu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India; [Sinha, Himanshu] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras, Tamil Nadu, India; [Sinha, Himanshu] Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Yadav, A; Sinha, H (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India.; Sinha, H (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras, Tamil Nadu, India.; Sinha, H (corresponding author), Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras, Tamil Nadu, India.	anupamayadav1990@gmail.com; sinha@iitm.ac.in	Sinha, Himanshu/AAT-7853-2021	Sinha, Himanshu/0000-0001-7031-0491; Yadav, Anupama/0000-0001-5338-0455	Tata Institute of Fundamental Research [12P-0120]	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	The authors were supported by an intramural grant (12P-0120) from Tata Institute of Fundamental Research to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Bhatia A, 2014, G3-GENES GENOM GENET, V4, P769, DOI 10.1534/g3.113.009142; Bloom JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9712; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Forsman A, 2015, HEREDITY, V115, P276, DOI 10.1038/hdy.2014.92; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kwan EX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002250; Lacaze X, 2009, HEREDITY, V102, P163, DOI 10.1038/hdy.2008.76; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Schlichting CD, 2008, ANN NY ACAD SCI, V1133, P187, DOI 10.1196/annals.1438.010; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; STEARNS SC, 1994, EVOLUTION, V48, P1438, DOI 10.1111/j.1558-5646.1994.tb02186.x; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; Taylor MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11669; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; Wu RL, 1998, EVOLUTION, V52, P967, DOI [10.2307/2411229, 10.1111/j.1558-5646.1998.tb01826.x]; Yadav A, 2016, 033621 BIORXIV, DOI [10.1101/033621, DOI 10.1101/033621]; Yadav A, 2015, G3-GENES GENOM GENET, V5, P699, DOI 10.1534/g3.115.017020	35	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162326	10.1371/journal.pone.0162326	http://dx.doi.org/10.1371/journal.pone.0162326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611930	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900077
J	Zeng, DY; Luo, JT; Li, ZL; Chen, G; Zhang, LQ; Ning, SZ; Yuan, ZW; Zheng, YL; Hao, M; Liu, DC				Zeng, Deying; Luo, Jiangtao; Li, Zenglin; Chen, Gang; Zhang, Lianquan; Ning, Shunzong; Yuan, Zhongwei; Zheng, Youliang; Hao, Ming; Liu, Dengcai			High Transferability of Homoeolog-Specific Markers between Bread Wheat and Newly Synthesized Hexaploid Wheat Lines	PLOS ONE			English	Article							ALLOHEXAPLOID WHEAT; AEGILOPS-TAUSCHII; DRAFT GENOME; IMPROVEMENT; ANEUPLOIDY; SEQUENCES; INSIGHTS	Bread wheat (Triticum aestivum, 2n = 6x = 42, AABBDD) has a complex allohexaploid genome, which makes it difficult to differentiate between the homoeologous sequences and assign them to the chromosome A, B, or D subgenomes. The chromosome-based draft genome sequence of the 'Chinese Spring' common wheat cultivar enables the large-scale development of polymerase chain reaction (PCR)-based markers specific for homoeologs. Based on high-confidence 'Chinese Spring' genes with known functions, we developed 183 putative homoeolog- specific markers for chromosomes 4B and 7B. These markers were used in PCR assays for the 4B and 7B nullisomes and their euploid synthetic hexaploid wheat (SHW) line that was newly generated from a hybridization between Triticum turgidum (AABB) and the wild diploid species Aegilops tauschii (DD). Up to 64% of the markers for chromosomes 4B or 7B in the SHW background were confirmedto be homoeolog-specific. Thus, these markers were highly transferable between the 'Chinese Spring' bread wheat and SHW lines. Homoeolog-specific markers designed using genes with known functions may be useful for genetic investigations involving homoeologous chromosome tracking and homoeolog expression and interaction analyses.	[Zeng, Deying; Li, Zenglin; Chen, Gang; Zhang, Lianquan; Ning, Shunzong; Yuan, Zhongwei; Zheng, Youliang; Hao, Ming; Liu, Dengcai] Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang 611130, Sichuan, Peoples R China; [Luo, Jiangtao] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu 610066, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS)	Hao, M; Liu, DC (corresponding author), Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang 611130, Sichuan, Peoples R China.	haomingluo@foxmail.com; dcliu7@yahoo.com	Hao, Ming/GXI-0243-2022; Hao, Ming/K-3216-2019	Liu, Dengcai/0000-0001-5508-1125	National key research and development program [2016YFD0102002]; National Natural Science Foundation of China (NSFC) [31271723]; Key Projects of Sichuan Provincial Department of Education [16ZA0028]; Youth Fund of the Sichuan Academy of Agricultural Sciences [2016QNJJ-008]	National key research and development program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Projects of Sichuan Provincial Department of Education; Youth Fund of the Sichuan Academy of Agricultural Sciences	This study was supported in part by National key research and development program (2016YFD0102002), National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/publish/portal1/) (31271723 to DL), The Key Projects of Sichuan Provincial Department of Education (16ZA0028 to MH), and The Youth Fund of the Sichuan Academy of Agricultural Sciences (2016QNJJ-008 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professors Long Mao and Aili Li from the Chinese Academy of Agricultural Sciences for their help with the bioinformatics analysis. This study was supported in part by National key research and development program (2016YFD0102002), National Natural Science Foundation of China (NSFC) (31271723), The Key Projects of Sichuan Provincial Department of Education (16ZA0028), and The Youth Fund of the Sichuan Academy of Agricultural Sciences (2016QNJJ-008).	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Barker GLA, 2009, PLANT BIOTECHNOL J, V7, P318, DOI 10.1111/j.1467-7652.2009.00412.x; Hao M, 2014, G3-GENES GENOM GENET, V4, P1943, DOI 10.1534/g3.114.013078; Hawkesford MJ, 2013, FOOD ENERGY SECUR, V2, P34, DOI 10.1002/fes3.15; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kihara H, 1944, AGR HORTIC, V19, P889; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Li AL, 2015, MOL PLANT, V8, P847, DOI 10.1016/j.molp.2015.02.016; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu D, 2016, POLYPLOIDY HYBRIDIZA, P27; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Mestiri I, 2010, NEW PHYTOL, V186, P86, DOI 10.1111/j.1469-8137.2010.03186.x; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Ogbonnaya FC, 2013, PL BRED RE, V37, P35; Poole R, 2007, FUNCT INTEGR GENOMIC, V7, P207, DOI 10.1007/s10142-007-0046-7; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wang Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1852-2; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhang LQ, 2010, EUPHYTICA, V172, P285, DOI 10.1007/s10681-009-0081-7; Zhang LQ, 2008, J GENET GENOMICS, V35, P617, DOI 10.1016/S1673-8527(08)60082-X	26	9	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162847	10.1371/journal.pone.0162847	http://dx.doi.org/10.1371/journal.pone.0162847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611704	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900179
J	Deconinck, H; Pesonen, A; Hallarou, M; Gerard, JC; Briend, A; Donnen, P; Macq, J				Deconinck, Hedwig; Pesonen, Anais; Hallarou, Mahaman; Gerard, Jean-Christophe; Briend, Andre; Donnen, Philippe; Macq, Jean			Challenges of Estimating the Annual Caseload of Severe Acute Malnutrition: The Case of Niger	PLOS ONE			English	Article							DURATION; CHILDREN; DISEASE; BURDEN	Introduction Reliable prospective estimates of annual severe acute malnutrition (SAM) caseloads for treatment are needed for policy decisions and planning of quality services in the context of competing public health priorities and limited resources. This paper compares the reliability of SAM caseloads of children 6-59 months of age in Niger estimated from prevalence at the start of the year and counted from incidence at the end of the year. Methods Secondary data from two health districts for 2012 and the country overall for 2013 were used to calculate annual caseload of SAM. Prevalence and coverage were extracted from survey reports, and incidence from weekly surveillance systems. Results The prospective caseload estimate derived from prevalence and duration of illness underestimated the true burden. Similar incidence was derived from two weekly surveillance systems, but differed from that obtained from the monthly system. Incidence conversion factors were two to five times higher than recommended. Discussion Obtaining reliable prospective caseloads was challenging because prevalence is unsuitable for estimating incidence of SAM. Different SAM indicators identified different SAM populations, and duration of illness, expected contact coverage and population figures were inaccurate. The quality of primary data measurement, recording and reporting affected incidence numbers from surveillance. Coverage estimated in population surveys was rarely available, and coverage obtained by comparing admissions with prospective caseload estimates was unrealistic or impractical. Conclusions Caseload estimates derived from prevalence are unreliable and should be used with caution. Policy and service decisions that depend on these numbers may weaken performance of service delivery. Niger may improve SAM surveillance by simplifying and improving primary data collection and methods using innovative information technologies for single data entry at the first contact with the health system. Lessons may be relevant for countries with a high burden of SAM, including for targeted emergency responses.	[Deconinck, Hedwig; Macq, Jean] Catholic Univ Louvain, Inst Rech Sante & Soc, Brussels, Belgium; [Pesonen, Anais] Catholic Univ Louvain, Ecole Med, Brussels, Belgium; [Hallarou, Mahaman; Donnen, Philippe] Catholic Univ Louvain, Ecole Sante Publ, Brussels, Belgium; [Gerard, Jean-Christophe] Save Children, Niamey, Niger; [Briend, Andre] Univ Tampere, Tampere Ctr Child Hlth Res, Tampere, Finland; [Briend, Andre] Tampere Univ Hosp, Tampere, Finland; [Briend, Andre] Univ Copenhagen, Dept Nutr Exercise & Sports, Fac Sci, Frederiksberg, Denmark	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Save the Children; Tampere University; Tampere University; Tampere University Hospital; University of Copenhagen	Deconinck, H (corresponding author), Catholic Univ Louvain, Inst Rech Sante & Soc, Brussels, Belgium.	hedwig.deconinck@gmail.com	Laivuori, Hannele/F-2953-2011	Laivuori, Hannele/0000-0003-3212-7826; Mahaman, Hallarou/0000-0003-0940-2105				Adam T, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czs084; Agyepong I, 2015, LANCET, V385, P1377, DOI 10.1016/S0140-6736(15)60024-1; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Crowe S, 2014, PEERJ, V2, DOI 10.7717/peerj.380; Deconinck H, 2014, REV INTEGRATED MANAG; Deconinck H, 2015, REPORT LIT REV; Deconinck H, 2016, HEALTH POLICY PLANN, V31, P1364, DOI [10.1093/heapol/czw073, 10.109]; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Emergency Nutrition Network, 2012, C GOV EXP COMM BAS M; Garenne M, 2009, PUBLIC HEALTH NUTR, V12, P1974, DOI 10.1017/S1368980009004972; Grellety E, 2015, PUBLIC HEALTH NUTR, V18, P2575, DOI 10.1017/S1368980015000737; Isanaka S, 2016, GETTING BETTER NUMBE; Isanaka S, 2011, AM J EPIDEMIOL, V173, P932, DOI 10.1093/aje/kwq436; Myatt M, 2012, COVERAGE TRAINING CO; Myatt M, 2012, SEMIQUANTITATIVE EVA; Pawson R, 2004, ENCY EVALUATION; Republique du Niger Institut national de la statistique, 2013, RAPP ENQ NUTR SURV E; Republique du Niger Institut national de la statistique, 2012, RAPP ENQ NUTR SURV E; Republique du Niger Ministere de la sante publique Direction des statistiques, 2014, SYST NAT INF SAN ANN; Republique du Niger Ministere de la sante publique Direction des statistiques, 2012, SCAL PRIS CHARG INT; Republique du Niger Ministere de la sante publique Direction des statistiques, 2012, MAL DECL OBL BAS DON; Republique du Niger Ministere de la sante publique Direction des statistiques, 2012, REPP MENS PRIS CHARG; Ribesse N, 2017, GLOB HEALTH PROMOT, V24, P43, DOI 10.1177/1757975915591684; Rogers E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128666; Save the Children Niger, 2012, RAPP ENQ NUTR SURV E; Save the Children Niger, 2010, EV SEM ACC COUV DIST; Save the Children Niger, 2012, EV SEM ACC COUV DIST; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; The Sphere Project, 2011, HUM CHART MIN STAND; The World Bank, WOLD BANK DAT BAS; United Nations Children's Fund, 2014, NUTRIDASH GLOB REP N; United Nations Children's Fund, 2015, MAN SEV AC MALN CHIL; United Nations Children's Fund World Health Organization, 2009, WHO CHILD GROWTH STA; United Nations Children's Fund  World Health Organization & World Bank, 2015, LEV TRENDS CHILD MAL; WHO, 2013, GUID UPD MAN SEV AC; Wurthwein R, 2001, INT J EPIDEMIOL, V30, P501, DOI 10.1093/ije/30.3.501	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162534	10.1371/journal.pone.0162534	http://dx.doi.org/10.1371/journal.pone.0162534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606677	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600059
J	Eckhard, LH; Houri-Haddad, Y; Sol, A; Zeharia, R; Shai, Y; Beyth, S; Domb, AJ; Bachrach, G; Beyth, N				Eckhard, Lea H.; Houri-Haddad, Yael; Sol, Asaf; Zeharia, Rotem; Shai, Yechiel; Beyth, Shaul; Domb, Abraham J.; Bachrach, Gilad; Beyth, Nurit			Sustained Release of Antibacterial Lipopeptides from Biodegradable Polymers against Oral Pathogens	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; IN-VITRO; RICINOLEIC ACID; BIOCOMPATIBILITY; FLUORESCAMINE; DAPTOMYCIN; PACLITAXEL; BACTERIA; MAGAININ; CARRIER	The development of antibacterial drugs to overcome various pathogenic species, which inhabit the oral cavity, faces several challenges, such as salivary flow and enzymatic activity that restrict dosage retention. Owing to their amphipathic nature, antimicrobial peptides (AMPs) serve as the first line of defense of the innate immune system. The ability to synthesize different types of AMPs enables exploitation of their advantages as alternatives to antibiotics. Sustained release of AMPs incorporated in biodegradable polymers can be advantageous in maintaining high levels of the peptides. In this study, four potent ultra-short lipopeptides, conjugated to an aliphatic acid chain (16C) were incorporated in two different biodegradable polymers: poly (lactic acid co castor oil) (PLACO) and ricinoleic acid-based poly (ester-anhydride) (P(SA-RA)) for sustained release. The lipopeptide and polymer formulations were tested for antibacterial activity during one week, by turbidometric measurements of bacterial outgrowth, anti-biofilm activity by live/dead staining, biocompatibility by hemolysis and XTT colorimetric assays, mode of action by fluorescence-activated cell sorting (FACS) and release profile by a fluorometric assay. The results show that an antibacterial and anti-biofilm effect, as well as membrane disruption, can be achieved by the use of a formulation of lipopeptide incorporated in biodegradable polymer.	[Eckhard, Lea H.; Houri-Haddad, Yael; Zeharia, Rotem; Beyth, Nurit] Hebrew Univ Jerusalem, Fac Med Dent, Dept Prosthodont, Jerusalem, Israel; [Sol, Asaf; Bachrach, Gilad] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Jerusalem, Israel; [Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel; [Beyth, Shaul] Hadassah Med Ctr, Dept Orthoped Surg, Jerusalem, Israel; [Domb, Abraham J.] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Sch Pharmacol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Beyth, N (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il		Sol, Asaf/0000-0002-8731-2490; Domb, Abraham J./0000-0002-2241-7726; Bachrach, Gilad/0000-0003-1350-2280	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation [1764/11]	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation	This work was supported by the Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (Grant No. 1764/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by The Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (Grant No. 1764/11). The authors would like to thank Ester Abtew for her help in preparing the polymers.	Al-Tahami Khaled, 2007, Recent Pat Drug Deliv Formul, V1, P65, DOI 10.2174/187221107779814113; ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; BESSALLE R, 1992, ANTIMICROB AGENTS CH, V36, P313, DOI 10.1128/AAC.36.2.313; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Blondelle SE, 1996, ANTIMICROB AGENTS CH, V40, P1067, DOI 10.1128/AAC.40.5.1067; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Carmona-Ribeiro AM, 2014, INT J MOL SCI, V15, P18040, DOI 10.3390/ijms151018040; Cully M, 2015, NAT REV DRUG DISCOV, V14, P750, DOI 10.1038/nrd4766; Davis RR, 2007, J BIOMED MATER RES B, V83B, P505, DOI 10.1002/jbm.b.30823; DE BERNARDO S, 1974, ARCH BIOCHEM BIOPHYS, V163, P390, DOI 10.1016/0003-9861(74)90490-1; Eckhard LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109413; Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x; Horn JN, 2013, BIOCHEMISTRY-US, V52, P5604, DOI 10.1021/bi400773q; Jain JP, 2008, POLYM REV, V48, P156, DOI 10.1080/15583720701834232; Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Phoenix D.A., 2013, ANTIMICROB PEPT, V8, P1, DOI [10.1002/9783527652853.ch1, DOI 10.1002/9783527652853.CH1]; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Rosier BT, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00092; Sampaio-Maia Benedita, 2014, Dent Res J (Isfahan), V11, P291; Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360; Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648+; Shikanov A, 2005, J CONTROL RELEASE, V105, P52, DOI 10.1016/j.jconrel.2005.02.018; Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101; SOREN L, 1995, J ANTIMICROB CHEMOTH, V35, P669, DOI 10.1093/jac/35.5.669; Spengler G, 2009, IN VIVO, V23, P81; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Steinberg D, 1999, CRIT REV THER DRUG, V16, P425; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Struzycka I, 2014, POL J MICROBIOL, V63, P127; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vaisman B, 2010, J BIOMED MATER RES A, V92A, P419, DOI 10.1002/jbm.a.32342	45	8	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162537	10.1371/journal.pone.0162537	http://dx.doi.org/10.1371/journal.pone.0162537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606830	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255600061
J	Stilianakis, NI; Syrris, V; Petroliagkis, T; Part, P; Gewehr, S; Kalaitzopoulou, S; Mourelatos, S; Baka, A; Pervanidou, D; Vontas, J; Hadjichristodoulou, C				Stilianakis, Nikolaos I.; Syrris, Vasileios; Petroliagkis, Thomas; Part, Peeter; Gewehr, Sandra; Kalaitzopoulou, Stella; Mourelatos, Spiros; Baka, Agoritsa; Pervanidou, Danai; Vontas, John; Hadjichristodoulou, Christos			Identification of Climatic Factors Affecting the Epidemiology of Human West Nile Virus Infections in Northern Greece	PLOS ONE			English	Article							DROUGHT-INDUCED AMPLIFICATION; UNITED-STATES; TRANSMISSION; DISEASE; MOSQUITOS; EUROPE; SURVEILLANCE; ENCEPHALITIS; TEMPERATURE; VARIABILITY	Climate can affect the geographic and seasonal patterns of vector-borne disease incidence such as West Nile Virus (WNV) infections. We explore the association between climatic factors and the occurrence of West Nile fever (WNF) or West Nile neuro-invasive disease (WNND) in humans in Northern Greece over the years 2010-2014. Time series over a period of 30 years (1979-2008) of climatic data of air temperature, relative humidity, soil temperature, volumetric soil water content, wind speed, and precipitation representing average climate were obtained utilising the ECMWF's (European Centre for Medium-Range-Weather Forecasts) Re-Analysis (ERA-Interim) system allowing for a homogeneous set of data in time and space. We analysed data of reported human cases of WNF/WNND and Culex mosquitoes in Northern Greece. Quantitative assessment resulted in identifying associations between the above climatic variables and reported human cases of WNF/WNND. A substantial fraction of the cases was linked to the upper percentiles of the distribution of air and soil temperature for the period 1979-2008 and the lower percentiles of relative humidity and soil water content. A statistically relevant relationship between the mean weekly value climatic anomalies of wind speed (negative association), relative humidity (negative association) and air temperature (positive association) over 30 years, and reported human cases of WNF/WNND during the period 2010-2014 could be shown. A negative association between the presence of WNV infected Culex mosquitoes and wind speed could be identified. The statistically significant associations could also be confirmed for the week the WNF/WNND human cases appear and when a time lag of up to three weeks was considered. Similar statistically significant associations were identified with the weekly anomalies of the maximum and minimum values of the above climatic factors. Utilising the ERA-Interim re-analysis methodology it could be shown that besides air temperature, climatic factors such as soil temperature, relative humidity, soil water content and wind speed may affect the epidemiology of WNV.	[Stilianakis, Nikolaos I.; Syrris, Vasileios; Petroliagkis, Thomas; Part, Peeter] European Commiss, Joint Res Ctr, Ispra, VA, Italy; [Stilianakis, Nikolaos I.] Univ Erlangen Nurnberg, Dept Biometry & Epidemiol, Erlangen, Germany; [Baka, Agoritsa; Pervanidou, Danai] Hellen Ctr Dis Control & Prevent KEELPNO, Athens, Greece; [Gewehr, Sandra; Kalaitzopoulou, Stella; Mourelatos, Spiros] EcoDev SA, Thessaloniki, Greece; [Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece	European Commission Joint Research Centre; EC JRC ISPRA Site; University of Erlangen Nuremberg; Foundation for Research & Technology - Hellas (FORTH); University of Thessaly	Stilianakis, NI (corresponding author), European Commiss, Joint Res Ctr, Ispra, VA, Italy.; Stilianakis, NI (corresponding author), Univ Erlangen Nurnberg, Dept Biometry & Epidemiol, Erlangen, Germany.	nikolaos.stilianakis@jrc.ec.europa.eu	Vontas, John/X-5112-2018	Vontas, John/0000-0002-8704-2574; Mourelatos, Spiros/0000-0001-9276-0135; KALAITZOPOULOU, STELLA/0000-0002-7932-3157; Gewehr, Sandra/0000-0001-5236-9537; Hadjichristodoulou, Christos/0000-0002-4769-8376	European Union Regional Development Fund	European Union Regional Development Fund(European Commission)	The epidemiological data acquisition was supported by the Operational Program entitled 'Human Resources Development of National Strategic Reference Framework' (NSRF) 2007-2013 co-funded by Greece and the European Union Regional Development Fund. There was no funding by Ecodevelopment S.A. that provided the entomological data. Members of Ecodevelopment S.A. (SG, SK, SM) collected, analyzed data and contributed to the interpretation of the data.	Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Berrisford P, 2009, ERA REP SER, P1; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cardenas R, 2008, ANN NY ACAD SCI, V1149, P326, DOI 10.1196/annals.1428.094; Chevalier V, 2014, INT J ENV RES PUB HE, V11, P67, DOI 10.3390/ijerph110100067; Chung WM, 2013, JAMA-J AM MED ASSOC, V310, P297, DOI 10.1001/jama.2013.8267; Coelho CAS, 2008, J CLIMATE, V21, P2072, DOI 10.1175/2007JCLI1781.1; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Crowder DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055006; Darsie RF, 1997, J AM MOSQUITO CONTR, V13, P247; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869; Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Johnson BJ, 2013, J MED ENTOMOL, V50, P195, DOI 10.1603/ME12035; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Mann BR, 2013, EMERG INFECT DIS, V19, P1418, DOI 10.3201/eid1909.130377; Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700; Marka A, 2013, INT J ENV RES PUB HE, V10, P6534, DOI 10.3390/ijerph10126534; Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5; National Oceanic and Atmospheric Administration USA, 2015, NCDC CLIM DAT ONL; Papa A, 2013, VECTOR-BORNE ZOONOT, V13, P682, DOI 10.1089/vbz.2012.1212; Papa A, 2013, PARASITOL RES, V112, P1551, DOI 10.1007/s00436-013-3302-x; Paz S, 2006, INT J ENVIRON HEAL R, V16, P1, DOI 10.1080/09603120500392400; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Takeda T, 2003, J AM MOSQUITO CONTR, V19, P179; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Wimberly MC, 2014, AM J TROP MED HYG, V91, P677, DOI 10.4269/ajtmh.14-0239; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	41	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161510	10.1371/journal.pone.0161510	http://dx.doi.org/10.1371/journal.pone.0161510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631082	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900019
J	Zhao, ZQ; Liu, XX; Xing, XM; Lu, Y; Sun, Y; Ou, XY; Su, XL; Jiang, J; Yang, YR; Chen, JL; Shen, BL; He, Y				Zhao, Zhiqiang; Liu, Xinxia; Xing, Xiumei; Lu, Yao; Sun, Yi; Ou, Xiaoyan; Su, Xiaolin; Jiang, Jun; Yang, Yarui; Chen, Jingli; Shen, Biling; He, Yun			The Activation Effects of Low Level Isopropyl Alcohol Exposure on Arterial Blood Pressures Are Associated with Decreased 5-Hydroxyindole Acetic Acid in Urine	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; CARDIOVASCULAR-DISEASE; DEVELOPMENTAL TOXICITY; INTOXICATION; INGESTION; SEROTONIN; HEALTH; METABOLISM; ABSORPTION; MECHANISMS	Purposes The objectives of this paper are to study the impact of low level isopropyl alcohol exposure on blood pressure and to explore its potential mechanism. Methods This cross-sectional study was based on a prospective occupational cohort in south China, which focusing on occupational risk factors related cardiovascular health problems. A total of 283 participants (200 low isopropyl alcohol exposed workers and 83 controls) was finally enrolled in this study. Linear regression models were used to analyze the relationship between arterial blood pressures and low level isopropyl alcohol exposure. We used mediation method to explore possible mediated roles of neurogenic factors. Results Systolic blood pressure (SBP, 123 +/- 10 vs. 118 +/- 11), diastolic blood pressure (DBP, 79 +/- 7 vs. 74 +/- 7) and mean blood pressure (MBP, 93 +/- 8 vs. 89 +/- 9) were different between the exposed group and the control group (p < 0.01). After adjusting for covariates, the difference was still significant. Besides, isopropyl alcohol and smoking had an interactive effect on DBP and MBP (p < 0.05). Furthermore, we observed a mediated effect of 5-hydroxyindole acetic acid (5-HIAA) on isopropyl alcohol exposure induced arterial blood pressure increase, which accounted for about 25%. Conclusions Our results suggest that low level isopropyl alcohol exposure is a potential risk factor for the increased arterial blood pressure and 5-HIAA partly mediates the association between low level isopropyl alcohol exposure and arterialblood pressures.	[Zhao, Zhiqiang; Xing, Xiumei; Lu, Yao; Sun, Yi; Ou, Xiaoyan; Su, Xiaolin; Jiang, Jun; Yang, Yarui; Chen, Jingli; Shen, Biling; He, Yun] Sun Yat Sen Univ, Guangzhou Key Lab Environm Pollut & Risk Assessme, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Xinxia] Zhongshan Ctr Dis Control & Prevent, Prevent & Control Ctr Occupat Dis, Zhongshan, Guangdong, Peoples R China	Sun Yat Sen University	He, Y (corresponding author), Sun Yat Sen Univ, Guangzhou Key Lab Environm Pollut & Risk Assessme, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	heyun_jane@163.com			Natural Science Foundation of China [81273097, 81472998]; One Hundred Talents Program of Sun Yat-sen University [18801031]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Talents Program of Sun Yat-sen University	This research was supported by the Natural Science Foundation of China (No. 81273097, 81472998) and by the One Hundred Talents Program of Sun Yat-sen University (No. 18801031).	ADELSON L, 1962, AM J CLIN PATHOL, V38, P144; Allen B, 1998, REGUL TOXICOL PHARM, V28, P38, DOI 10.1006/rtph.1998.1226; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Calabrese EJ, 2011, REGUL TOXICOL PHARM, V61, P73, DOI 10.1016/j.yrtph.2011.06.003; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Carignan D, 2012, TOXICOL SCI, V125, P144, DOI 10.1093/toxsci/kfr283; Carrasco G, 1998, LIFE SCI, V62, P1323, DOI 10.1016/S0024-3205(98)00066-6; Clark JD, 2010, J EMERG NURS, V36, P81, DOI 10.1016/j.jen.2009.10.006; Cosselman KE, 2015, NAT REV CARDIOL, V12, P627, DOI 10.1038/nrcardio.2015.152; Cote F, 2004, TRENDS MOL MED, V10, P232, DOI 10.1016/j.molmed.2004.03.007; DALZIEL K, 1966, BIOCHEM J, V100, P34, DOI 10.1042/bj1000034; DANIEL DR, 1981, J ANAL TOXICOL, V5, P110, DOI 10.1093/jat/5.3.110; Desy O, 2008, J IMMUNOL, V181, P2348, DOI 10.4049/jimmunol.181.4.2348; Emadi A, 2007, NEW ENGL J MED, V356, P530, DOI 10.1056/NEJMc063237; Faber WD, 2008, BIRTH DEFECTS RES B, V83, P459, DOI 10.1002/bdrb.20167; FILSHIE GM, 1992, BRIT MED J, V304, P1223, DOI 10.1136/bmj.304.6836.1223; FREIREICH AW, 1967, NEW ENGL J MED, V277, P699, DOI 10.1056/NEJM196709282771308; Grammer TB, 2013, EUR HEART J, V34, P1298, DOI 10.1093/eurheartj/eht001; GUJRATI VR, 1994, LIFE SCI, V55, P327, DOI 10.1016/0024-3205(94)00735-7; Hyland K, 2008, CLIN CHEM, V54, P633, DOI 10.1373/clinchem.2007.099986; Iavicoli I, 2007, G Ital Med Lav Ergon, V29, P271; JELEN I, 1979, BRIT J OBSTET GYNAEC, V86, P468, DOI 10.1111/j.1471-0528.1979.tb10791.x; Jiang Kaiyou, 2014, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V32, P140; Jones AW, 2000, J ANAL TOXICOL, V24, P8, DOI 10.1093/jat/24.1.8; Leeper SC, 2000, VET HUM TOXICOL, V42, P15; Leow MKS, 2015, HYPERTENS RES, V38, P299, DOI 10.1038/hr.2015.7; Lewis RJ, 2012, SAXS DANGEROUS PROPE, V1-5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Palermo AM, 2011, MUTAT RES-GEN TOX EN, V726, P215, DOI 10.1016/j.mrgentox.2011.09.016; MARTINEZ TT, 1986, VET HUM TOXICOL, V28, P233; Martz W, 2010, J ANAL TOXICOL, V34, P49, DOI 10.1093/jat/34.1.49; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Mueller-Kronast N, 2003, NEUROLOGY, V61, P1456, DOI 10.1212/01.WNL.0000094205.26168.43; Nascimento BR, 2014, HEART, V100, P1743, DOI 10.1136/heartjnl-2014-306026; NATOWICZ M, 1985, CLIN CHEM, V31, P326; NELSON BK, 1988, FOOD CHEM TOXICOL, V26, P247, DOI 10.1016/0278-6915(88)90126-3; NORDMANN R, 1973, LIFE SCI, V13, P919, DOI 10.1016/0024-3205(73)90082-9; Nwosu ME, 2009, J CHILD NEUROL, V24, P349, DOI 10.1177/0883073808322664; ONeil MJ, 2013, MERCK INDEX ENCY CHE, V15th; Peng LW, 2006, AM J MED, V119, pE9, DOI 10.1016/j.amjmed.2005.12.024; PERSSON B, 1988, J CARDIOVASC PHARM, V11, pS22; Rapisarda V, 2016, TOXICOL IND HEALTH, V32, P1729, DOI 10.1177/0748233715576616; Sethre T, 2000, INT ARCH OCC ENV HEA, V73, P528, DOI 10.1007/s004200000178; Sethre T, 2000, INT ARCH OCC ENV HEA, V73, P105, DOI 10.1007/s004200050015; Slaughter RJ, 2014, CLIN TOXICOL, V52, P470, DOI 10.3109/15563650.2014.914527; Stremski E, 2000, PEDIATR EMERG CARE, V16, P238, DOI 10.1097/00006565-200008000-00005; VICAS IMO, 1993, J TOXICOL-CLIN TOXIC, V31, P473, DOI 10.3109/15563659309000415; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Wood JN, 2007, J PERINATOL, V27, P183, DOI 10.1038/sj.jp.7211646; Zahra A, 2015, PUBLIC HEALTH, V129, P385, DOI 10.1016/j.puhe.2015.01.013	52	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162762	10.1371/journal.pone.0162762	http://dx.doi.org/10.1371/journal.pone.0162762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622502	gold, Green Submitted, Green Published			2022-12-27	WOS:000383681000053
J	Juon, HS; Strong, C; Kim, F; Park, E; Lee, SM				Juon, Hee-Soon; Strong, Carol; Kim, Frederic; Park, Eunmi; Lee, Sunmin			Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial	PLOS ONE			English	Article							TASK-FORCE RECOMMENDATION; VIRUS INFECTION; LIVER-CANCER; VIETNAMESE AMERICANS; COST-EFFECTIVENESS; CHINESE-AMERICANS; COMMUNITY; ADULTS; HBV; DISPARITIES	Background This study aimed to evaluate the effect of a lay health worker (LHW) telephone intervention on completing a series of hepatitis B virus (HBV) vaccinations among foreign-born Asian Americans in the Baltimore-Washington Metropolitan area. Methods During the period of April 2013 and March 2014, we recruited Asian Americans who were 18 years of age and older in the community-based organizations. Of the 645 eligible participants, 600 (201 Chinese, 198 Korean, 201 Vietnamese) completed a pretest survey and received hepatitis B screening. Based on the screening results, we conducted a randomized controlled trial among those unprotected (HBsAg-/HBsAB-) by assigning them either to an intervention group (n = 124) or control group (n = 108). The intervention group received a list of resources by mails for where to get free vaccinations as well as reminder calls for vaccinations from trained LHWs, while the control group received only list of resources by mail. Seven months after mailing the HBV screening results, trained LHWs followed up with all participantsby phone to ask how many of the recommended series of 3 vaccinations they had received: none, 1 or 2, or all 3 (complete). Their self-reported vaccinations were verified with the medical records. Multinomial logistic regressions were used to examine the effect of the LHW intervention. Process evaluation was conducted by asking study participants in the intervention group to evaluate the performance of the LHWs. Results After seven months, those in the intervention group were more likely to have 1 or more vaccines than the control group, compared to the no vaccination group (OR = 3.04, 95% CI, 1.16, 8.00). Also, those in the intervention group were more likely to complete a series of vaccinations than the control group, compared to the no vaccination group (OR = 7.29, 95% CI 3.39, 15.67). The most important barrier preventing them from seeking hepatitis B vaccinations was lack of time to get the vaccination. The most important promoters to getting vaccinations, among those who had vaccinations (n = 89), were our intervention program (70.8%) and self-motivation (49.4%). The majority of participants in the intervention group received the phone calls from LHWs (93%) and almost all of them got the reminder to receive vaccines (98%). Conclusion The LHW intervention was successful at increasing HBV vaccinations rates among foreign-born Asian Americans. This study suggests that this culturally integrated intervention program may be useful for reducing liver cancer disparities from chronic HBV infection in high risk Asian Americans.	[Juon, Hee-Soon; Kim, Frederic] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Strong, Carol] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Park, Eunmi] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Lee, Sunmin] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA	Jefferson University; National Cheng Kung University; National Cheng Kung University Hospital; Johns Hopkins University; University System of Maryland; University of Maryland College Park	Juon, HS (corresponding author), Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA.	hee-soon.juon@jefferson.edu	Strong, Carol/E-2127-2016; Strong, Carol/ABI-6992-2020	Strong, Carol/0000-0002-2934-5382; Strong, Carol/0000-0002-2934-5382; Lee, Sunmin/0000-0001-9652-9475	National Cancer Institute [R01CA163805]; Center for Strategic Scientific Initiatives, National Cancer Institute [5P30CA056036-17]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Strategic Scientific Initiatives, National Cancer Institute	This work was supported by the National Cancer Institute (R01CA163805) HJ, and Center for Strategic Scientific Initiatives, National Cancer Institute (5P30CA056036-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akosionu O, 2016, J IMMIGR MINOR HEALT, V18, P277, DOI 10.1007/s10903-015-0160-x; Bird JA, 1996, HEALTH EDUC BEHAV, V23, P104; Census, 2010, CENS PRES AAPI DAT; Census, 2004, FACTS FEAT AS PAC AM; Centers for Disease Control and Prevention, 2014, VIR HEP PREV SERV; Centers for Disease Control and Prevention, 2015, VIR HEP CDC REC SPEC; Chang ET, 2009, AM J HEALTH PROMOT, V23, P176, DOI 10.4278/ajhp.071025115; Chen MS, 2013, CANCER EPIDEM BIOMAR, V22, P782, DOI 10.1158/1055-9965.EPI-12-1399; Choe John H, 2006, J Immigr Minor Health, V8, P193, DOI 10.1007/s10903-006-9322-1; Chou R, 2014, ANN INTERN MED, V161, P31, DOI 10.7326/M13-2837; Chu D, 2013, GUT LIVER, V7, P450, DOI 10.5009/gnl.2013.7.4.450; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Coronado GD, 2007, J COMMUN HEALTH, V32, P379, DOI 10.1007/s10900-007-9060-x; Hsu CE, 2007, J NATL MED ASSOC, V99, P900; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Juon HS, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130258; Juon HS, 2013, PREV MED, V56, P53, DOI 10.1016/j.ypmed.2012.11.003; Kao JH, 2015, BEST PRACT RES CL GA, V29, P907, DOI 10.1016/j.bpg.2015.09.011; Nguyen K, 2015, J IMMIGR MINOR HEALT, V17, P13, DOI 10.1007/s10903-013-9975-5; Krieger J, 1999, AM J PUBLIC HEALTH, V89, P856, DOI 10.2105/AJPH.89.6.856; Kue J, 2013, J HEALTH CARE POOR U, V24, P566, DOI 10.1353/hpu.2013.0081; Lee H, 2013, J AM COLL HEALTH, V61, P67, DOI 10.1080/07448481.2012.753891; Lee SM, 2013, HEALTH EDUC BEHAV, V40, P694, DOI 10.1177/1090198112474003; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Ma GX, 2007, J HEALTH CARE POOR U, V18, P62, DOI 10.1353/hpu.2007.0013; Ma GX, 2012, PROG COMM HLTH PARTN, V6, P7, DOI 10.1353/cpr.2012.0002; Misra R, 2013, J INVEST MED, V61, P1121, DOI 10.2310/JIM.0b013e3182a70f10; Nelson A, 2002, J NATL MED ASSOC, V94, P666; Sarpel D, 2016, EXPERT REV ANTI-INFE, V14, P511, DOI 10.1586/14787210.2016.1174066; Strong C, 2012, J COMMUN HEALTH, V37, P1071, DOI 10.1007/s10900-012-9541-4; Taylor Vicky M, 2006, Asian Pac J Cancer Prev, V7, P313; Taylor VM, 2009, J COMMUN HEALTH, V34, P165, DOI 10.1007/s10900-008-9138-0; Taylor VM, 2013, J COMMUN HEALTH, V38, P546, DOI 10.1007/s10900-012-9649-6; Taylor VM, 2004, CANCER DETECT PREV, V28, P170, DOI 10.1016/j.cdp.2004.01.003	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162683	10.1371/journal.pone.0162683	http://dx.doi.org/10.1371/journal.pone.0162683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27617742	Green Submitted, gold, Green Published			2022-12-27	WOS:000383653100041
J	Kaseva, N; Pyhala, R; Pesonen, AK; Raikkonen, K; Jarvenpaa, AL; Andersson, S; Eriksson, JG; Hovi, P; Kajantie, E				Kaseva, Nina; Pyhala, Riikka; Pesonen, Anu-Katriina; Raikkonen, Katri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Eriksson, Johan G.; Hovi, Petteri; Kajantie, Eero			Diurnal Cortisol Patterns and Dexamethasone Suppression Test Responses in Healthy Young Adults Born Preterm at Very Low Birth Weight	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; CIRCADIAN-RHYTHM; INFANTS BORN; STRESS; DETERMINANTS; PROFILES; CHILDREN; BEHAVIOR; AGE	Background Early life stress, such as painful and stressful procedures during neonatal intensive care after pretermbirth, can permanently affect physiological, hormonal and neurobiological systems. This may contribute to altered programming of the hypothalamic-pituitary-adrenal axis (HPAA) and provoke changes in HPAA function with long-term health impacts. Previous studies suggest a lower HPAA response to stress in young adults born preterm compared with controls born at term. We assessed whether these differences in HPAA stress responsiveness are reflected in everyday life HPAA functioning, i.e. in diurnal salivary cortisol patterns, and reactivity to a low-dose dexamethasone suppression test (DST), in unimpaired young adults born preterm at very low birth weight (VLBW; <1500 g). Methods The participants were recruited from the Helsinki Study of Very Low Birth Weight Adults cohort study. At mean age 23.3 years (2.1 SD), 49 VLBW and 36 controls born at term participated in the study. For cortisol analyzes, saliva samples were collected on two consecutive days at 0, 15, 30 and 60 min after wake-up, at 12: 00 h, 17: 00 h and 22: 00 h. After the last salivary sample of the first study day the participants were instructed to take a 0.5 mg dexamethasone tablet. Results With mixed-effects model no difference was seen in overall diurnal salivary cortisol between VLBW and control groups [13.9% (95% CI: -11.6, 47.0), P = 0.31]. Salivary cortisol increased similarly after awakening in both VLBW and control participants[mean difference -2.9% (29.2, 33.0), P = 0.85]. Also reactivity to the low-dose DST (awakening cortisol ratio day2/day1) was similar between VLBW and control groups [-1.1% (-53.5, 103.8), P = 0.97)]. Conclusions Diurnal cortisol patterns and reactivity to a low-dose DST in young adulthood were not associated with preterm birth.	[Kaseva, Nina; Eriksson, Johan G.; Hovi, Petteri; Kajantie, Eero] Natl Inst Hlth & Welfare, Dept Hlth, Chron Dis Prevent Unit, Helsinki, Finland; [Pyhala, Riikka; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Pyhala, Riikka; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Jarvenpaa, Anna-Liisa; Andersson, Sture; Hovi, Petteri; Kajantie, Eero] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Jarvenpaa, Anna-Liisa; Andersson, Sture; Hovi, Petteri] Univ Helsinki, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Kajantie, Eero] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Grp, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; University of Oulu; University of Oulu	Kaseva, N (corresponding author), Natl Inst Hlth & Welfare, Dept Hlth, Chron Dis Prevent Unit, Helsinki, Finland.	nina.kaseva@fimnet.fi	Kaseva, Nina/O-7918-2019; Pyhälä, Riikka/AAG-1947-2021	Pesonen, Anu-Katriina/0000-0002-0662-6261; Raikkonen, Katri/0000-0003-3124-3470; Kaseva, Nina/0000-0003-4648-0022	Medical Societies of Finland; Finnish Foundation of Paediatric Research, Academy of Finland [127437, 129306, 130326, 134791, 263924]; Emil Aaltonen Foundation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Novo Nordisk Fonden [NNF12OC1016374, NNF15OC0016362] Funding Source: researchfish	Medical Societies of Finland; Finnish Foundation of Paediatric Research, Academy of Finland; Emil Aaltonen Foundation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Medical Societies of Finland (Duodecim and Finska Lakaresallskapet to NK), the Finnish Foundation of Paediatric Research (to EK), Academy of Finland (grants 127437, 129306, 130326, 134791 and 263924 to EK), the Emil Aaltonen Foundation (to EK), the Jalmari and Rauha Ahokas Foundation (to EK), the Juho Vainio Foundation, the Novo Nordisk Foundation, the Signe and Ane Gyllenberg Foundation (to NK), the Sigrid Juselius Foundation (to EK) and the Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelte S, 2011, DEV PSYCHOBIOL, V53, P184, DOI 10.1002/dev.20511; Buske-Kirschbaum A, 2007, J CLIN ENDOCR METAB, V92, P3429, DOI 10.1210/jc.2006-2223; de Graaf J, 2014, J PEDIATR-US, V165, P459, DOI 10.1016/j.jpeds.2014.05.047; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; de Weerth C, 2003, EARLY HUM DEV, V73, P39, DOI 10.1016/S0378-3782(03)00074-4; Grunau RE, 2007, J PEDIATR-US, V150, P151, DOI 10.1016/j.jpeds.2006.10.053; Grunau RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073926; Grunau RE, 2010, CLIN J PAIN, V26, P698, DOI 10.1097/AJP.0b013e3181e5bb00; Gustafsson PE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-346; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-57; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Kaseva N, 2014, CLIN ENDOCRINOL, V80, P101, DOI 10.1111/cen.12251; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Lee J, 2014, AM J HUM BIOL, V26, P598, DOI 10.1002/ajhb.22569; Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2; McEwen BS, 1998, NEW ENGL J MED, P338; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Pihkala J, 1989, Duodecim, V105, P1540; Raikkonen K, 2010, PSYCHONEUROENDOCRINO, V35, P1587, DOI 10.1016/j.psyneuen.2010.04.010; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1843, DOI 10.1016/j.psyneuen.2013.05.018; Rosmalen JGM, 2005, PSYCHONEUROENDOCRINO, V30, P483, DOI 10.1016/j.psyneuen.2004.12.007; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; Smith CM, 2011, CLIN ENDOCRINOL, V75, P443, DOI 10.1111/j.1365-2265.2011.04118.x; Tollenaar MS, 2010, EARLY HUM DEV, V86, P13, DOI 10.1016/j.earlhumdev.2009.12.003	27	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162650	10.1371/journal.pone.0162650	http://dx.doi.org/10.1371/journal.pone.0162650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618620	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100038
J	Tan, CW; Tee, HK; Lee, MHP; Sam, IC; Chan, YF				Tan, Chee Wah; Tee, Han Kang; Lee, Michelle Hui Pheng; Sam, I-Ching; Chan, Yoke Fun			Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool	PLOS ONE			English	Article							MESSENGER-RNA; IN-VITRO; CDNA-CLONES; INITIATES REPLICATION; CLINICAL-FEATURES; IMMUNE-RESPONSE; POLIOVIRUS CDNA; PLASMID DNA; HNRNP A1; VIRUS	Enterovirus A71 (EV-A71) causes major outbreaks of hand, foot and mouth disease, and is occasionally associated with neurological complications and death in children. Reverse genetics is widely used in the field of virology for functional study of viral genes. For EV-A71, such tools are limited to clones that are transcriptionally controlled by T7/SP6 bacteriophage promoter. This is often time-consuming and expensive. Here, we describe the development of infectious plasmid DNA-based EV-A71 clones, for which EV-A71 genome expression is under transcriptional control by the CMV-intermediate early promoter and SV40 transcriptional-termination signal. Transfection of this EV-A71 infectious DNA produces good virus yield similar to in vitro-transcribed EV-A71 infectious RNA, 6.4 and 5.8 log(10)PFU/ml, respectively. Infectious plasmid with enhanced green fluorescence protein and Nano luciferase reportergenes also produced good virus titers, with 4.3 and 5.0 log(10) PFU/ml, respectively. Another infectious plasmid with both CMV and T7 promoters was also developed for easy manipulation of in vitro transcription or direct plasmid transfection. Transfection with either dual-promoter infectious plasmid DNA or infectious RNA derived from this dual-promoter clone produced infectious viral particles. Incorporation of hepatitis delta virus ribozyme, which yields precise 3' ends of the DNA-launched EV-A71 genomic transcripts, increased infectious viral production. In contrast, the incorporation of hammerhead ribozyme in the DNA-launched EV-A71 resulted in lower virus yield, but improved the virus titers for T7 promoter-derived infectious RNA. This study describes rapid and robust reverse genetic tools for EV-A71.	[Tan, Chee Wah; Tee, Han Kang; Lee, Michelle Hui Pheng; Sam, I-Ching; Chan, Yoke Fun] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Tan, CW; Chan, YF (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.	tcwah@um.edu.my; chanyf@um.edu.my	Tee, Han Kang/GOK-1453-2022; Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010	Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510; Tan, Chee Wah/0000-0001-9837-1413; Tee, Han Kang/0000-0002-8975-0945	University of Malaya [UM.C/625/1/HIR/MOHE/MED/41, BK046-2015]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya High Impact Research Grant (UM.C/625/1/HIR/MOHE/MED/41) and University of Malaya Research Fund Assistance (BK046-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053; Chambers TJ, 2006, J GEN VIROL, V87, P3131, DOI 10.1099/vir.0.81909-0; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Du N, 2014, J VIROL, V88, P5816, DOI 10.1128/JVI.03826-13; Dubensky TW, 1996, J VIROL, V70, P508, DOI 10.1128/JVI.70.1.508-519.1996; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; Hayashi T, 2010, DEV DYNAM, V239, P2034, DOI 10.1002/dvdy.22344; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; KEAN KM, 1986, J VIROL, V59, P490, DOI 10.1128/JVI.59.2.490-493.1986; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KUHN RJ, 1987, VIROLOGY, V157, P560, DOI 10.1016/0042-6822(87)90302-3; Lazouskaya NV, 2014, J VIROL METHODS, V197, P67, DOI 10.1016/j.jviromet.2013.12.005; Lian KQ, 2015, VIRUS RES, V208, P73, DOI 10.1016/j.virusres.2015.06.008; Lilley DMJ, 2005, CURR OPIN STRUC BIOL, V15, P313, DOI 10.1016/j.sbi.2005.05.002; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-534; Liu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001066; Meng T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-238; Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9; Nishimura Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003511; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Pu SY, 2014, J GEN VIROL, V95, P1493, DOI 10.1099/vir.0.064915-0; RACANIELLO VR, 1981, P NATL ACAD SCI-BIOL, V78, P4887, DOI 10.1073/pnas.78.8.4887; RACANIELLO VR, 1981, SCIENCE, V214, P916, DOI 10.1126/science.6272391; SARNOW P, 1989, J VIROL, V63, P467, DOI 10.1128/JVI.63.1.467-470.1989; Shang BD, 2013, ANTIVIR RES, V97, P198, DOI 10.1016/j.antiviral.2012.12.010; Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Song YT, 2012, J VIROL, V86, P1999, DOI 10.1128/JVI.05871-11; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Tan CW, 2014, ANTIVIR RES, V107, P35, DOI 10.1016/j.antiviral.2014.04.004; Tan CW, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-14; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034589; Tretyakova I, 2014, VIROLOGY, V468, P28, DOI 10.1016/j.virol.2014.07.050; Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114; Tretyakova I, 2013, VACCINE, V31, P1019, DOI 10.1016/j.vaccine.2012.12.050; Usme-Ciro JA, 2014, VIRUS RES, V180, P12, DOI 10.1016/j.virusres.2013.12.001; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330; Varnavski AN, 2000, J VIROL, V74, P4394, DOI 10.1128/JVI.74.9.4394-4403.2000; Wickramasinghe VO, 2015, NAT REV MOL CELL BIO, V16, P431, DOI 10.1038/nrm4010; Xu LL, 2015, J VIROL METHODS, V219, P62, DOI 10.1016/j.jviromet.2015.03.020; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11; Yeh MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027082; ZHANG HC, 1995, VIROLOGY, V212, P686, DOI 10.1006/viro.1995.1526	59	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162771	10.1371/journal.pone.0162771	http://dx.doi.org/10.1371/journal.pone.0162771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617744	Green Published, Green Submitted, gold			2022-12-27	WOS:000383653100051
J	Hovorakova, M; Lochovska, K; Zahradnicek, O; Tibenska, KD; Dornhoferova, M; Horakova-Smrckova, L; Bodorikova, S				Hovorakova, Maria; Lochovska, Katerina; Zahradnicek, Oldrich; Domonkosova Tibenska, Kristina; Dornhoferova, Michaela; Horakova-Smrckova, Lucie; Bodorikova, Silvia			One OdontogenicCell-Population Contributes to the Development of the Mouse Incisors and of the Oral Vestibule	PLOS ONE			English	Article							DECIDUOUS DENTITION; TOOTH DEVELOPMENT; HUMAN EMBRYOS; STEM-CELLS; EXPRESSION; SOX2; ODONTOMA; MARKER; ADULT; CRE	The area of the oral vestibule is often a place where pathologies appear (e.g., peripheral odontomas). The origin of these pathologies is not fully understood. In the present study, we traced a cell population expressing Sonic hedgehog (Shh) from the beginning of tooth development using Cre-LoxP system in the lower jaw of wild-type (WT) mice. We focused on Shh expression in the area of the early appearing rudimentaryincisor germs located anteriorly to the prospective incisors. The localization of the labelled cells in the incisor germs and also in the inner epithelial layer of the vestibular anlage showed that the first very early developmental events in the lower incisor area are common to the vestibulum oris and the prospective incisor primordia in mice. Scanning electron microscopic analysis of human historical tooth-like structures found in the vestibular area of jaws confirmedtheir relation to teeth and thus the capability of the vestibular tissue to form teeth. The location of labelled cells descendant of the early appearing Shh expression domain related to the rudimentary incisor anlage not only in the rudimentary and functional incisor germs but also in the externally located anlage of the oral vestibule documented the odontogenic potential of the vestibular epithelium. This potential can be awakened under pathological conditions and become a source of pathologies in the vestibular area.	[Hovorakova, Maria; Lochovska, Katerina; Zahradnicek, Oldrich; Horakova-Smrckova, Lucie] Acad Sci Czech Republic, Inst Expt Med, Dept Teratol, Prague 14220 4, Czech Republic; [Lochovska, Katerina] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Domonkosova Tibenska, Kristina; Dornhoferova, Michaela; Bodorikova, Silvia] Comenius Univ, Fac Nat Sci, Dept Anthropol, Bratislava, Slovakia; [Horakova-Smrckova, Lucie] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Comenius University Bratislava; Charles University Prague	Hovorakova, M (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Teratol, Prague 14220 4, Czech Republic.	marhor@biomed.cas.cz	Hovořáková, Mária/AAD-5403-2022; Lochovska, Katerina/H-3831-2018	Hovořáková, Mária/0000-0002-6346-6671; Lochovska, Katerina/0000-0003-4142-4531; Bodorikova, Silvia/0000-0001-5090-8066; Dornhoferova, Michaela/0000-0002-5058-1021	Grant Agency of the Czech Republic [P305/12/1766]; Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0442/13]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Science, Research and Sport of the Slovak Republic	Funded by MH: Grant Agency of the Czech Republic (P305/12/1766) and SB: Ministry of Education, Science, Research and Sport of the Slovak Republic (VEGA 1/0442/13).; The authors would like to thank Martina Gregorovicova, Ivana Koppova, Zdenka Lisa and Dr. Simona Vojtechova for their technical assistance, and to Petr Velensky for the egg of a mangrove monitor lizard. The research was supported by Grant Agency of the Czech Republic (P305/12/1766), and Ministry of Education, Science, Research and Sport of the Slovak Republic (VEGA 1/0442/13). The authors declare that they have no competing interests.	Bernardes VDF., 2008, BRAZ J ORAL SCI, V7, P1624, DOI DOI 10.20396/BJ0S.V7I26.8642760; Bolk L., 1924, DEUT MONATSSCHR ZAHN, V7, P129; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; GIUNTA JL, 1990, ORAL SURG ORAL MED O, V69, P406, DOI 10.1016/0030-4220(90)90312-G; Hanemann JAC, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-15; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hattab F N, 1998, J Clin Pediatr Dent, V22, P159; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hovorakova M, 2005, ANAT EMBRYOL, V209, P303, DOI 10.1007/s00429-004-0441-y; Hovorakova M, 2007, EUR J ORAL SCI, V115, P280, DOI 10.1111/j.1600-0722.2007.00464.x; Hovorakova M, 2013, J EXP ZOOL PART B, V320, P455, DOI 10.1002/jez.b.22522; Hovorakova M, 2011, J EXP ZOOL PART B, V316B, P347, DOI 10.1002/jez.b.21408; Ide F, 2000, J PERIODONTOL, V71, P830, DOI 10.1902/jop.2000.71.5.830; Ide F, 2008, ORAL SURG ORAL MED O, V106, pE14, DOI 10.1016/j.tripleo.2008.05.064; Juuri E, 2013, EUR J ORAL SCI, V121, P509, DOI 10.1111/eos.12095; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; LedesmaMontes C, 1996, INT J ORAL MAX SURG, V25, P296, DOI 10.1016/S0901-5027(06)80061-5; Peterka M, 2002, CONNECT TISSUE RES, V43, P186, DOI 10.1080/03008200290000673; PETERKOVA R, 1985, J CRAN GENET DEV BIO, V5, P89; ROSE C, 1895, OSTERREICHISCH UNGAR, V2, P45; Schour I, 1929, J DENT RES, V9, P699, DOI [10.1177/00220345290090050801, DOI 10.1177/00220345290090050801]; Silva ARS, 2009, MED ORAL PATOL ORAL, V14, pE612, DOI 10.4317/medoral.14.e612; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tonkova M., 2010, ANTROPOLOGICKA ANALY; Tucker AS, 2010, FRONT ORAL BIOL, V14, P21, DOI 10.1159/000313705; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001	27	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162523	10.1371/journal.pone.0162523	http://dx.doi.org/10.1371/journal.pone.0162523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611193	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900122
J	Jousimo, J; Ovaskainen, O				Jousimo, Jussi; Ovaskainen, Otso			A Spatio-Temporally Explicit Random Encounter Model for Large-Scale Population Surveys	PLOS ONE			English	Article							WILDLIFE; EXTENSIONS; DESIGN	Random encounter models can be used to estimate population abundance from indirect data collected by non-invasive sampling methods, such as track counts or camera-trap data. The classical Formozov-Malyshev-Pereleshin (FMP) estimator converts track counts into an estimate of mean population density, assuming that data on the daily movement distances of the animals are available. We utilize generalized linear models with spatio-temporal error structures to extend the FMP estimator into a flexible Bayesian modelling approach that estimates not only total population size, but also spatio-temporal variation in population density. We also introduce a weighting scheme to estimate density on habitats that are not covered by survey transects, assuming that movement data on a subset of individuals is available. We test the performance of spatio-temporal and temporal approaches by a simulation study mimicking the Finnish winter track count survey. The results illustrate how the spatio-temporal modelling approach is able to borrow information from observations made on neighboring locations and times when estimating population density, and that spatio-temporal and temporal smoothing models can provide improved estimates of total population size compared to the FMP method.	[Jousimo, Jussi; Ovaskainen, Otso] Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, POB 65, FI-00014 Helsinki, Finland; [Ovaskainen, Otso] Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, N-7491 Trondheim, Norway	University of Helsinki; Norwegian University of Science & Technology (NTNU)	Jousimo, J (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, POB 65, FI-00014 Helsinki, Finland.	jussi.jousimo@helsinki.fi	Ovaskainen, Otso/D-9119-2012; Ovaskainen, Otso/AGN-4838-2022	Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421	LUOVA Doctoral Programme in Wildlife Biology Reseach; Academy of Finland [250444, 250243]; Research Council of Norway (Centres of Excellence funding scheme) [223257]	LUOVA Doctoral Programme in Wildlife Biology Reseach; Academy of Finland(Academy of Finland); Research Council of Norway (Centres of Excellence funding scheme)(Research Council of Norway)	This work is funded by the LUOVA Doctoral Programme in Wildlife Biology Reseach (to JJ, http://www.helsinki.fi/luova/), the Academy of Finland (grants nr 250444 and 250243 to OO, http://www.aka.fi/en/) and the Research Council of Norway (Centres of Excellence funding scheme, project number 223257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Harto Linden for insightful discussions and valuable comments and for access to the WTC data. Funding by the LUOVA Doctoral Programme in Wildlife Biology Reseach (to JJ), the Academy of Finland (grants nr 250444 and 250243 to OO) and the Research Council of Norway (Centres of Excellence funding scheme, project number 223257) is thankfully acknowledged.	Borchers D.L., 2002, ESTIMATING ANIMAL AB; Buckland S, 2011, BIOL DIVERSITY FRONT; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Gregoire TG, 1998, CAN J FOREST RES, V28, P1429, DOI 10.1139/cjfr-28-10-1429; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Haakana M, 2008, SPIE P REM SENS ENV; Hogmander Harri, 1996, Finnish Game Research, V49, P37; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Jaberg C, 2001, J APPL ECOL, V38, P1169, DOI 10.1046/j.0021-8901.2001.00668.x; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Keeping D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096598; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Linden Harto, 1996, Finnish Game Research, V49, P4; Lindgren F, 2015, J STAT SOFTW, V63, P1, DOI 10.18637/jss.v063.i19; Lomanov IK, 2000, ZOOL ZH, V79, P430; Long RA, 2008, NONINVASIVE SURVEY M; Lucas TCD, 2015, METHODS ECOL EVOL, V6, P500, DOI 10.1111/2041-210X.12346; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maunder M., 2008, MAXIMUM SUSTAINABLE; Morrison M.L., 2008, WILDLIFE STUDY DESIG; Pellikka J, 2005, ANN ZOOL FENN, V42, P123; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Priklonsky S.G., 1965, OTDEL BIOLOGII, V70, P5; R Core Development Team, 2014, LANG ENV STAT COMP; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Stephens PA, 2006, ANIM CONSERV, V9, P339, DOI 10.1111/j.1469-1795.2006.00044.x; Svensson L, 2014, VARG SKANDINAVIEN FI; Thomas L, 2012, ENCY ENV; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Williams B. K., 2002, ANAL MANAGEMENT ANIM	35	3	3	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162447	10.1371/journal.pone.0162447	http://dx.doi.org/10.1371/journal.pone.0162447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611683	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900100
J	Mayadevi, M; Lakshmi, K; Priya, SDS; John, S; Omkumar, RV				Mayadevi, Madhavan; Lakshmi, Kesavan; Priya, Sudarsana Devi Suma; John, Sebastian; Omkumar, Ramakrishnapillai V.			Protection of alpha-CaMKII from Dephosphorylation by GluN2B Subunit of NMDA Receptor Is Abolished by Mutation of Glu(96) or His(282) of alpha-CaMKII	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; POSTSYNAPTIC DENSITY; AUTOINHIBITORY DOMAIN; SYNAPTIC PLASTICITY; INHIBITOR-ALPHA; MEMORY SWITCH; NR2B SUBUNIT; FEAR MEMORY	Interaction of CaMKII and the GluN2B subunit of NMDA receptor is essential for synaptic plasticity events such as LTP. Synaptic targeting of CaMKII and regulation of its biochemical functions result from this interaction. GluN2B binding to the T-site of CaMKII leads to changes in substrate binding and catalytic parameters and inhibition of its own dephosphorylation. We find that CaMKIIN alpha, a natural inhibitor that binds to the T-site of CaMKII, also causes inhibition of dephosphorylation of CaMKII similar to GluN2B. Two residues on alpha-CaMKII, Glu(96) and His(282), are involved in the inhibition of CaMKII dephosphorylation exerted by binding of GluN2B. E96A-alpha-CaMKII is known to be defective in GluN2B-induced catalytic modulation. Data presented here show that, in both E96A and H282A mutants of alpha-CaMKII, GluN2B-induced inhibition of dephosphorylation is impaired.	[Mayadevi, Madhavan; Lakshmi, Kesavan; Priya, Sudarsana Devi Suma; John, Sebastian; Omkumar, Ramakrishnapillai V.] Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram 695014, Kerala, India; [Priya, Sudarsana Devi Suma] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Yale University	Omkumar, RV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram 695014, Kerala, India.	omkumar@rgcb.res.in		John, Sebastian/0000-0002-4488-1300	Council of Scientific and Industrial research, Government of India [18-12/2011(ii)EU-V]; UGC Award [F.2-56/2002/(II)EU-II]; Rajiv Gandhi Centre for Biotechnology, Intramural Funding; University Grants Commission, Government of India	Council of Scientific and Industrial research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC Award; Rajiv Gandhi Centre for Biotechnology, Intramural Funding; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by Council of Scientific and Industrial research, Government of India (http://www.csir.res.in/), Ref. No: 18-12/2011(ii)EU-V, KL; University Grants Commission, Government of India (http://www.ugc.ac.in/), UGC Award Letter No. F.2-56/2002/(II)EU-II, SDSP; and Rajiv Gandhi Centre for Biotechnology (www.rgcb.res.in), Intramural Funding, RVO, MM, SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcomb K, 2016, J BIOL CHEM, V291, P16082, DOI 10.1074/jbc.M116.734822; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Cheriyan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016495; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; DOSEMECI A, 1993, J NEUROCHEM, V61, P550; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Gouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049293; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lepicard EM, 2006, EUR J NEUROSCI, V23, P3063, DOI 10.1111/j.1460-9568.2006.04830.x; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lisman J, 2015, BRAIN RES, V1621, P51, DOI 10.1016/j.brainres.2014.12.010; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Praseeda M, 2004, BIOCHEM J, V378, P391, DOI 10.1042/BJ20030741; Radwanska K, 2010, GENES BRAIN BEHAV, V9, P648, DOI 10.1111/j.1601-183X.2010.00595.x; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Saha S, 2007, BRAIN RES, V1148, P38, DOI 10.1016/j.brainres.2007.02.018; Saha S, 2006, BIOCHEM BIOPH RES CO, V350, P444, DOI 10.1016/j.bbrc.2006.09.066; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urakubo H, 2014, BIOPHYS J, V106, P1414, DOI 10.1016/j.bpj.2014.01.026; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	52	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162011	10.1371/journal.pone.0162011	http://dx.doi.org/10.1371/journal.pone.0162011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610621	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900042
J	Taniguchi, T; Maruyama, N; Ogata, T; Kasahara, T; Nakanishi, N; Miyagawa, K; Naito, D; Hamaoka, T; Nishi, M; Matoba, S; Ueyama, T				Taniguchi, Takuya; Maruyama, Naoki; Ogata, Takehiro; Kasahara, Takeru; Nakanishi, Naohiko; Miyagawa, Kotaro; Naito, Daisuke; Hamaoka, Tetsuro; Nishi, Masahiro; Matoba, Satoaki; Ueyama, Tomomi			PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis	PLOS ONE			English	Article							LONG-QT SYNDROME; INFANT-DEATH-SYNDROME; COILED-COIL PROTEIN; LATE SODIUM CURRENT; KNOCKOUT MICE; GENERALIZED LIPODYSTROPHY; PTRF MUTATIONS; CAVEOLAE; MUSCLE; CAVIN	Mutations in the PTRF/Cavin-1 gene cause congenital generalized lipodystrophy type 4 (CGL4) associated with myopathy. Additionally, long-QT syndrome and fatal cardiac arrhythmia are observed in patients with CGL4 who have homozygous PTRF/Cavin-1 mutations. PTRF/Cavin-1 deficiency shows reductions of caveolae and caveolin-3 (Cav3) protein expression in skeletal muscle, and Cav3 deficiency in the heart causes cardiac hypertrophy with loss of caveolae. However, it remains unknown how loss of PTRF/Cavin-1 affects cardiac morphology and function. Here, we present a characterization of the hearts of PTRF/Cavin-1-null (PTRF-/-) mice. Electron microscopy revealed the reduction of caveolae in cardiomyocytes of PTRF-/- mice. PTRF-/- mice at 16 weeks of age developed a progressive cardiomyopathic phenotype with wall thickening of left ventricles and reduced fractional shortening evaluated by echocardiography. Electrocardiography revealed that PTRF-/- mice at 24 weeks of age had low voltages and wide QRS complexes in limb leads. Histological analysis showed cardiomyocyte hypertrophy accompanied by progressive interstitial/perivascular fibrosis. Hypertrophy-related fetal gene expression was also induced in PTRF-/- hearts. Western blotting analysis and quantitative RT-PCR revealed that Cav3 expression was suppressed in PTRF-/- hearts compared with that in wild-type (WT) ones. ERK1/2 was activated in PTRF-/- hearts compared with that in WT ones. These results suggest that loss of PTRF/Cavin-1 protein expression is sufficient to induce a molecular program leading to cardiomyocyte hypertrophy and cardiomyopathy, which is partly attributable to Cav3 reduction in the heart.	[Taniguchi, Takuya; Maruyama, Naoki; Ogata, Takehiro; Kasahara, Takeru; Nakanishi, Naohiko; Miyagawa, Kotaro; Naito, Daisuke; Hamaoka, Tetsuro; Nishi, Masahiro; Matoba, Satoaki; Ueyama, Tomomi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Ueyama, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan.	toueyama-circ@umin.ac.jp	Nishi, Masahiro/HDM-4433-2022; Taniguchi, Takuya/AAD-9103-2022		Japan Society for the Promotion of Science (JSPS) KAKENHI [26670407]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26670407, https://www.jsps.go.jp/index.html.	[Anonymous], 2014, BRAUNWALDS HEART DIS; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Berul CI, 2003, PHYSIOL GENOMICS, V13, P207, DOI 10.1152/physiolgenomics.00183.2002; Brenyo A, 2011, CARDIOL J, V18, P8; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Cronk LB, 2007, HEART RHYTHM, V4, P161, DOI 10.1016/j.hrthm.2006.11.030; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hayashi T, 2004, BIOCHEM BIOPH RES CO, V313, P178, DOI 10.1016/j.bbrc.2003.11.101; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hedley PL, 2013, CIRC-CARDIOVASC GENE, V6, P452, DOI 10.1161/CIRCGENETICS.113.000137; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Karbalaei MS, 2012, EUR J PHARMACOL, V689, P179, DOI 10.1016/j.ejphar.2012.05.023; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Ogata T, 2014, P NATL ACAD SCI USA, V111, P3811, DOI 10.1073/pnas.1315359111; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Pfleger C, 2012, HISTOCHEM CELL BIOL, V138, P231, DOI 10.1007/s00418-012-0961-0; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Satomi-Kobayashi S, 2009, HYPERTENSION, V54, P825, DOI 10.1161/HYPERTENSIONAHA.109.130443; Sellers SL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00280; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sward K., 2013, PHYSL REP, V1, DOI DOI 10.1002/PHY2.8; Sward K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092428; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	49	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162513	10.1371/journal.pone.0162513	http://dx.doi.org/10.1371/journal.pone.0162513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612189	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900119
J	Yan, F; Pang, JX; Peng, Y; Molina, JR; Yang, P; Liu, SJ				Yan, Fei; Pang, Jiuxia; Peng, Yong; Molina, Julian R.; Yang, Ping; Liu, Shujun			Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells	PLOS ONE			English	Article							TUMOR IMMUNE MICROENVIRONMENT; 2ND-LINE THERAPY; PD-1; ACTIVATION; MECHANISM; P53; EPIDEMIOLOGY; CHEMOTHERAPY; CHECKPOINTS; TOPOTECAN	Although small cell lung cancer (SCLC) is highly responsive to chemotherapies (e.g., cisplatin-etoposide doublet), virtually almost all responsive SCLC patients experience disease recurrence characterized by drug resistance. The mechanisms underlying cisplatin resistance remain elusive. Here we report that cell-intrinsic expression of PD1 and PD-L1, two immune checkpoints, is required for sustained expansion of SCLC cells under cisplatin selection. Indeed, PD1 and PD-L1 were expressed at a higher level in lung cancer cell lines, tumor tissues, and importantly, in SCLC cells resistant to cisplatin (H69R, H82R), when compared to respective controls. Genetic abrogation of PD1 and PD-L1 in H69R and H82R cells decreased their proliferation rate, and restored their sensitivity to cisplatin. Mechanistically, PD-L1 upregulation in H69R and H82R cells was attributed to the overexpression of DNA methyltransferase 1 (DNMT1) or receptor tyrosine kinase KIT, as knockdown of DNMT1 or KIT in H69R and H82R cells led to PD-L1 downregulation. Consequently, combined knockdown of PD-L1 with KIT or DNMT1 resulted in more pronounced inhibition of H69R and H82R cell growth. Thus, cell intrinsic PD1/PD-L1 signaling may be a predictor for poor efficacy of cisplatin treatment, and targeting the cellular PD1/PD-L1 axis may improve chemosensitization of aggressive SCLC.	[Yan, Fei; Pang, Jiuxia; Liu, Shujun] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Peng, Yong] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Dept Thorac Surg,State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Molina, Julian R.] Mayo Clin, Dept Med Oncol, 200 1st St SW, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Div Epidemiol, 200 1st St SW, Rochester, MN 55905 USA	University of Minnesota System; Sichuan University; Mayo Clinic; Mayo Clinic	Liu, SJ (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	sliu@hi.umn.edu	Yan, Fei/G-4941-2016	Yan, Fei/0000-0003-4750-1200	National Cancer Institute (Bethesda, MD) [R01CA149623, R21CA155915]; Hormel Institute Foundation [4592336]	National Cancer Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hormel Institute Foundation	This work was supported in part by National Cancer Institute (Bethesda, MD) grants R01CA149623 (SL), R21CA155915 (SL) and Hormel Institute Foundation 4592336 (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bauer JA, 2005, MOL CANCER THER, V4, P1096, DOI 10.1158/1535-7163.MCT-05-0081; Biswas SK, 2004, MOL CANCER THER, V3, P327; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chan BA, 2013, J THORAC DIS, V5, pS565, DOI 10.3978/j.issn.2072-1439.2013.07.43; Crivellari G, 2007, ONCOLOGIST, V12, P79, DOI 10.1634/theoncologist.12-1-79; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gao XN, 2015, LEUKEMIA, V29, P1730, DOI 10.1038/leu.2015.56; Giaccone G, 1998, J CLIN ONCOL, V16, P2133, DOI 10.1200/JCO.1998.16.6.2133; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hagmann R, 2015, J CANCER, V6, P1148, DOI 10.7150/jca.13080; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Itamochi H, 2014, INT J GYNECOL CANCER, V24, P61, DOI 10.1097/IGC.0000000000000014; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; O'Byrne Kenneth J, 2011, Cancers (Basel), V3, P1426, DOI 10.3390/cancers3011426; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pietanza MC, 2016, J CLIN ONCOL, V34, P1027, DOI 10.1200/JCO.2015.65.6462; Puglisi M, 2010, BRIT J CANCER, V102, P629, DOI 10.1038/sj.bjc.6605527; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Santarpia M, 2015, CANCER BIOL MED, V12, P74, DOI 10.7497/j.issn.2095-3941.2015.0022; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131; Tang CH, 2011, CANCER CHEMOTH PHARM, V67, P1389, DOI 10.1007/s00280-010-1435-5; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Wang M, 2013, J CHEMOTHERAPY, V25, P162, DOI 10.1179/1973947812Y.0000000056; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Wu W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-49; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.380; Yan F, 2015, J BIOL CHEM, V290, P18480, DOI 10.1074/jbc.M114.633693; Yu W, 2012, J NANOMATER, V2012, DOI 10.1155/2012/435873; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611	46	24	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162925	10.1371/journal.pone.0162925	http://dx.doi.org/10.1371/journal.pone.0162925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610620	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900185
J	Ohbuchi, K; Mori, Y; Ogawa, K; Warabi, E; Yamamoto, M; Hirokawa, T				Ohbuchi, Katsuya; Mori, Yoshikazu; Ogawa, Kazuo; Warabi, Eiji; Yamamoto, Masahiro; Hirokawa, Takatsugu			Detailed Analysis of the Binding Mode of Vanilloids to Transient Receptor Potential Vanilloid Type I (TRPV1) by a Mutational and Computational Study	PLOS ONE			English	Article							ION-CHANNEL; CAPSAICIN RECEPTOR; MOLECULAR-BASIS; ACTIVATION; RESINIFERATOXIN; SENSITIVITY; MECHANISMS; RESIDUES; INSIGHTS	Transient receptor potential vanilloid type 1 (TRPV1) is a non-selective cation channel and a multimodal sensor protein. Since the precise structure of TRPV1 was obtained by electron cryo-microscopy, the binding mode of representative agonists such as capsaicin and resiniferatoxin (RTX) has been extensively characterized; however, detailed information on the binding mode of other vanilloids remains lacking. In this study, mutational analysis of human TRPV1 was performed, and four agonists (capsaicin, RTX, [6]-shogaol and [6]-gingerol) were used to identify amino acid residues involved in ligand binding and/or modulation of proton sensitivity. The detailed binding mode of each ligand was then simulated by computational analysis. As a result, three amino acids (L518, F591 and L670) were newly identified as being involved in ligand binding and/or modulation of proton sensitivity. In addition, in silico docking simulation and a subsequent mutational study suggested that [6]-gingerol might bind to and activate TRPV1 in a unique manner. These results provide novel insights into the binding mode of various vanilloids to the channel and will be helpful in developing a TRPV1 modulator.	[Ohbuchi, Katsuya; Ogawa, Kazuo; Yamamoto, Masahiro] Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan; [Mori, Yoshikazu] Tsumura & Co, Analyt & Pharmaceut Technol Res Ctr, Ibaraki, Japan; [Warabi, Eiji] Univ Tsukuba, Environm Mol Biol Lab, Fac Med, Tsukuba, Ibaraki 305, Japan; [Hirokawa, Takatsugu] AIST, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 305, Japan	Tsumura & Company; Tsumura & Company; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Ohbuchi, K (corresponding author), Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan.; Hirokawa, T (corresponding author), AIST, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan.; Hirokawa, T (corresponding author), Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 305, Japan.	oobuchi_katsuya@mail.tsumura.co.jp; t-hirokawa@aist.go.jp		Ohbuchi, Katsuya/0000-0001-6756-3260	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and development (AMED); Tsumura Co.	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tsumura Co.(Tsumura & Company)	This research was partially supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and development (AMED). Tsumura & Co., provided support in the form of salaries for authors KOhbuchi, YM, KOgawa and MY. The specific roles of these authors are articulated in the 'author contributions' section. This study was funded by Tsumura & Co. Tsumura & Co. was responsible for the study design, and the collection, analysis and interpretation of data.; This research is partially supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and development (AMED).	Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; Bishnoi M, 2011, CURR PHARM BIOTECHNO, V12, P102, DOI 10.2174/138920111793937907; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Elokely K, 2016, P NATL ACAD SCI USA, V113, pE137, DOI 10.1073/pnas.1517288113; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Johnson DM, 2006, MOL PHARMACOL, V70, P1005, DOI 10.1124/mol.106.023945; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Lee JH, 2011, J COMPUT AID MOL DES, V25, P317, DOI 10.1007/s10822-011-9421-5; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meents JE, 2010, TRENDS MOL MED, V16, P153, DOI 10.1016/j.molmed.2010.02.004; Morita A, 2007, BIOSCI BIOTECH BIOCH, V71, P2304, DOI 10.1271/bbb.70187; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Szolcsanyi J, 2012, TRENDS PHARMACOL SCI, V33, P646, DOI 10.1016/j.tips.2012.09.002; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yang F, 2015, NAT CHEM BIOL, V12, P1, DOI DOI 10.1038/NCHEMBI0.1835	24	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162543	10.1371/journal.pone.0162543	http://dx.doi.org/10.1371/journal.pone.0162543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606946	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600062
J	Yashima, K; Sasaki, A				Yashima, Kenta; Sasaki, Akira			Spotting Epidemic Keystones by R-0 Sensitivity Analysis: High-Risk Stations in the Tokyo Metropolitan Area	PLOS ONE			English	Article							PANDEMIC INFLUENZA; IMMUNIZATION; STRATEGIES; NETWORKS; SPREAD; POPULATIONS; OUTBREAKS; MOVEMENT; MODEL	How can we identify the epidemiologically high-risk communities in a metapopulation network? The network centrality measure, which quantifies the relative importance of each location, is commonly utilized for this purpose. As the disease invasion condition is given from the basic reproductive ratio R-0, we have introduced a novel centrality measure based on the sensitivity analysis of this R-0 and shown its capability of revealing the characteristics that has been overlooked by the conventional centrality measures. The epidemic dynamics over the commute network of the Tokyo metropolitan area is theoretically analyzed by using this centrality measure. We found that, the impact of countermeasures at the largest station is more than 1,000 times stronger compare to that at the second largest station, even though the population sizes are only around 1.5 times larger. Furthermore, the effect of countermeasures at every station is strongly dependent on the existence and the number of commuters to this largest station. It is well known that the hubs are the most influential nodes, however, our analysis shows that only the largest among the network plays an extraordinary role. Lastly, we also found that, the location that is important for the prevention of disease invasion does not necessarily match the location that is important for reducing the number of infected.	[Yashima, Kenta; Sasaki, Akira] Grad Univ Adv Studies SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Yashima, Kenta] Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo, Japan; [Sasaki, Akira] Int Inst Appl Syst Anal, Evolut & Ecol Program, Laxenburg, Austria	Graduate University for Advanced Studies - Japan; International Institute for Applied Systems Analysis (IIASA)	Yashima, K (corresponding author), Grad Univ Adv Studies SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.; Yashima, K (corresponding author), Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo, Japan.	yashima_kenta@soken.ac.jp			MEXT [24115001]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by the MEXT Grant-in-Aid for Scientific Research on Innovative Areas 24115001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 2007, 10 URBAN TRANSPORTAT; Balcan D, 2012, J THEOR BIOL, V293, P87, DOI 10.1016/j.jtbi.2011.10.010; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Britton N, 2005, SPRINGER UNDERGRADUA; Caswell, 2000, MATRIX POPULATION MO; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Cui FQ, 2011, J EPIDEMIOL, V21, P271, DOI 10.2188/jea.JE20100119; Daley DJ, 1999, EPIDEMIC MODELING; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; ELLNER S. P., 2011, DYNAMIC MODELS BIOL; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Klemm K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00292; Kuramitsu M, 2005, EPIDEMIOL INFECT, V133, P1131, DOI 10.1017/S0950268805004139; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Madar N, 2004, EUR PHYS J B, V38, P269, DOI 10.1140/epjb/e2004-00119-8; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Mohr O, 2012, EUROSURVEILLANCE, V17, P12; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray J. D., 2002, MATH BIOL; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Ohkusa Yasushi, 2007, Journal of Infection and Chemotherapy, V13, P380, DOI 10.1007/s10156-007-0556-1; Ohkusa Y, 2009, JPN J INFECT DIS, V62, P98; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Saito MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072866; Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Yashima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098518; Yasuda H, 2009, EUROSURVEILLANCE, V14, P12; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162406	10.1371/journal.pone.0162406	http://dx.doi.org/10.1371/journal.pone.0162406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607239	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000383255600044
J	Buffarini, R; Restrepo-Mendez, MC; Silveira, VM; Miranda, JJ; Goncalves, HD; Oliveira, IO; Horta, BL; Gigante, DP; Menezes, AM; Assuncao, MCF				Buffarini, Romina; Restrepo-Mendez, Maria Clara; Silveira, Vera M.; Miranda, Jaime J.; Goncalves, Helen D.; Oliveira, Isabel O.; Horta, Bernardo L.; Gigante, Denise P.; Menezes, Ana Maria; Assuncao, Maria Cecilia F.			Distribution of Glycated Haemoglobin According to Early-Life and Contemporary Characteristics in Adolescents and Adults without Diabetes: The 1982 and 1993 Pelotas Birth Cohorts	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK-FACTORS; 3RD NATIONAL-HEALTH; BODY-MASS INDEX; NONDIABETIC INDIVIDUALS; ATHEROSCLEROSIS RISK; WAIST CIRCUMFERENCE; ETHNIC-DIFFERENCES; BLOOD-PRESSURE; GROWTH	Aim Glycated haemoglobin (HbA(1c)), a marker of glucose control in individuals with diabetes mellitus, is also related with the incidence of cardiometabolic risk in populations free of disease. The aim of this study was to describe the distribution of HbA(1c) levels according to early-life and contemporary factors in adolescents and adults without diabetes mellitus. Methods HbA(1c) was measured in adults aged 30 years and adolescents aged 18 years who are participants in the 1982 and 1993 Pelotas Birth Cohorts, respectively. Bivariate and multivariate analyses were performed to describe the HbA(1c) mean values according to early-life and contemporary characteristics collected prospectively since birth. Results The distribution of the HbA(1c) was approximately normal in both cohorts, with a mean (SD) 5.10% (0.43) in the 1982 cohort, and 4.89% (0.50) in the 1993 cohort. HbA(1c) mean levels were significantly higher in individuals self-reportedas black/brown skin color compared to those self-reportedas white in both cohorts. Parental history of diabetes was associated with higher HbA(1c) mean in adults, while stunting at one year old presented an inverse relation with the outcome in adolescents. No other early and contemporary factors were associated with HbA(1c) levels in adults or adolescents. Conclusions We found a consistent relationship between HbA1c and skin color in both cohorts. Further research is needed to understand the role of genomic ancestry on levels of HbA1c concentrations which may informpolicies and preventive actions for diabetes mellitus and cardiometabolic risk.	[Buffarini, Romina; Goncalves, Helen D.; Horta, Bernardo L.; Gigante, Denise P.; Menezes, Ana Maria] Univ Fed Pelotas, Postgrad Program Epidemiol, Marechal Deodoro 1160,3rd Floor, BR-96020220 Pelotas, Brazil; [Restrepo-Mendez, Maria Clara] Univ Fed Pelotas, Int Ctr Equity Hlth, Rua Marechal Deodoro,1160 3rd Floor, BR-96020220 Pelotas, Brazil; [Silveira, Vera M.] Univ Fed Pelotas, Fac Med, Dept Clin Med, Rua Felix Cunha 614, BR-96010000 Pelotas, Brazil; [Miranda, Jaime J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Oliveira, Isabel O.] Univ Fed Pelotas, Dept Physiol & Pharmacol, Campus Univ S-N, BR-96010900 Pelotas, Brazil; [Assuncao, Maria Cecilia F.] Univ Fed Pelotas, Sch Nutr, Dept Nutr, Campus Anglo,Gomes Carneiro 1, BR-96010900 Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidad Peruana Cayetano Heredia; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Buffarini, R (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Marechal Deodoro 1160,3rd Floor, BR-96020220 Pelotas, Brazil.	romibuffarini@gmail.com	Gonçalves, Helen/P-2381-2018; Horta, Bernardo/A-7604-2008; Menezes, Ana MB/G-7266-2012; Gonçalves, Helen/M-1603-2017	Horta, Bernardo/0000-0001-9843-412X; Menezes, Ana MB/0000-0002-2996-9427; Gonçalves, Helen/0000-0001-6470-3352; Reis, AlessanRSS/0000-0001-8486-7469; Restrepo-Mendez, Maria Clara/0000-0001-7714-7340	International Development Research Center (Canada); World Health Organization (WHO); Overseas Development Administration (U.K.); Brazilian Council for Scientific and Technological Development (CNPq); Rio Grande do Sul State Research Foundation (FAPERGS); Wellcome Trust [072403/Z/03/Z]; European Union; National Program for Centers of Excellence (Brazil); National Research Council (Brazil); Ministry of Health (Brazil)	International Development Research Center (Canada)(CGIAR); World Health Organization (WHO)(World Health Organization); Overseas Development Administration (U.K.); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio Grande do Sul State Research Foundation (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Wellcome Trust(Wellcome Trust); European Union(European Commission); National Program for Centers of Excellence (Brazil); National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (Brazil)	The 1982 cohort study, in its many stages, was supported by the International Development Research Center (Canada), the World Health Organization (WHO), the Overseas Development Administration (U.K.), the Brazilian Council for Scientific and Technological Development (CNPq), and the Rio Grande do Sul State Research Foundation (FAPERGS). The 1993 cohort study was supported by the Wellcome Trust initiative entitled 'Major Awards for Latin America on Health Consequences of Population Change' (process 072403/Z/03/Z). Earlier phases of the 1993 cohort study were funded by the European Union, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil), and the Ministry of Health (Brazil).	Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barros AJD, 2008, CAD SAUDE PUBLICA, V24, pS371, DOI 10.1590/S0102-311X2008001500002; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bleyer AJ, 2009, DIABETIC MED, V26, P128, DOI 10.1111/j.1464-5491.2008.02646.x; Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eskesen K, 2013, J INTERN MED, V273, P94, DOI 10.1111/j.1365-2796.2012.02594.x; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Forrester TE, 1996, BRIT MED J, V312, P156; Goncalves H, 2014, INT J EPIDEMIOL; Gulliford MC, 2001, EUR J CLIN NUTR, V55, P615, DOI 10.1038/sj.ejcn.1601233; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jorgensen L, 2004, CIRCULATION, V110, P466, DOI 10.1161/01.CIR.0000136809.55141.3B; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Meigs JB, 1996, J CLIN EPIDEMIOL, V49, P411, DOI 10.1016/0895-4356(95)00513-7; Nakanishi S, 2005, DIABETOLOGIA, V48, P230, DOI 10.1007/s00125-004-1643-9; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Nazmi A, 2007, EUR J CLIN NUTR, V61, P434, DOI 10.1038/sj.ejcn.1602535; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Nightingale CM, 2015, DIABETOLOGIA, V58, P474, DOI 10.1007/s00125-014-3474-7; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Saydah S, 2009, DIABETES CARE, V32, P1440, DOI 10.2337/dc09-0117; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; SIMON D, 1989, DIABETOLOGIA, V32, P864, DOI 10.1007/BF00297451; Syed IAA, 2011, J PAK MED ASSOC, V61, P690; Szostak-Wegierek Dorota, 2007, Pol Arch Med Wewn, V117, P13; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Victora CG, 1993, INT J EPIDEMIOL, V2008, P704, DOI DOI 10.1093/IJEIDYRN277; Vitelli LL, 1997, DIABETES CARE, V20, P1454, DOI 10.2337/diacare.20.9.1454; World Health Organization, 2010, Global recommendations on physical activity for health; Yoshida D, 2009, J ATHEROSCLER THROMB, V16, P431, DOI 10.5551/jat.No539	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162614	10.1371/journal.pone.0162614	http://dx.doi.org/10.1371/journal.pone.0162614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626274	Green Published, gold, Green Submitted			2022-12-27	WOS:000383680600046
J	Fan, LC; Jeng, YM; Lu, YT; Lien, HC				Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun			SPOCK1 Is a Novel Transforming Growth Factor-beta-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IMMUNOHISTOCHEMICAL ANALYSIS; TUMOR PROGRESSION; CELL-FATE; DIFFERENTIATION; EXPRESSION; CARCINOMA; IDENTIFICATION; MYOFIBROBLAST; PROMOTES	In addition to contraction, myoepithelia have diverse paracrine effects, including a tumor suppression effect. However, certain myoepithelial markers have been shown to contribute to tumor progression. Transforming growth factor-beta (TGF-beta) is involved in the transdifferentiation of fibroblasts to contractile myofibroblasts. We investigated whether TGF-beta can upregulate potential myoepithelial markers, which may have functional and clinicopathological significance in breast cancer. We found that TGF-beta induced SPOCK1 expression in MCF10A, MCF12A, and M10 breast cells and demonstrated SPOCK1 as a novel myoepithelial marker that was immunolocalized within or beneath myoepithelia lining ductolobular units. A functional study showed that overexpression of SPOCK1 enhanced invasiveness in mammary immortalized and cancer cells. To further determine the biological significance of SPOCK1 in breast cancer, we investigated the expression of SPOCK1 in 478 invasive ductal carcinoma (IDC) cases through immunohistochemistry and correlated the expression with clinicopathological characteristics. SPOCK1 expression was significantly correlated with high pathological tumor size (P = 0.012), high histological grade (P = 0.013), the triple-negative phenotype (P = 0.022), and the basal-like phenotype (P = 0.026) and was correlated with a significantly poorer overall survival on univariate analysis (P = 0.001, log-rank test). Multivariate Cox regression analysis demonstrated that SPOCK1 expression maintained an independent poor prognostic factor of overall survival. Analysis of SPOCK1 expression on various non-IDC carcinoma sub-types showed an enrichment of SPOCK1 expression in metaplastic carcinoma, which is pathogenetically closely related to epithelial-mesenchymal transition (EMT). In conclusion, we identified SPOCK1 as a novel TGF-beta-induced myoepithelial marker and furtherdemon-strated that SPOCK1 enhanced invasion in breast cancer cells and correlated with poor prognosis in breast cancer clinical samples. The enrichment of SPOCK1 expression in metaplastic carcinoma and the correlation between SPOCK1 expression and high histological grading and basal-like phenotypes in IDC evidence an association between SPOCK1 and EMT.	[Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lien, HC (corresponding author), Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan.; Lien, HC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan.	huangchunlien@ntu.edu.tw		LIEN, HUANG-CHUN/0000-0003-1472-1231; JENG, YUNG-MING/0000-0002-3878-4491	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Carter MR, 2006, AM J SURG PATHOL, V30, P300; Colin C, 2006, ONCOGENE, V25, P2818, DOI 10.1038/sj.onc.1209305; Dugina V, 2001, J CELL SCI, V114, P3285; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang FI, 2012, CARCINOGENESIS, V33, P1142, DOI 10.1093/carcin/bgs131; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kim HP, 2014, ONCOGENE, V33, P3334, DOI 10.1038/onc.2013.285; Lachapelle J, 2011, CURR ONCOL, V18, P161; Li Y, 2013, GASTROENTEROLOGY, V144, P179, DOI 10.1053/j.gastro.2012.09.042; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lien HC, 2014, HISTOPATHOLOGY, V65, P328, DOI 10.1111/his.12390; Miao LY, 2013, BIOCHEM BIOPH RES CO, V440, P792, DOI 10.1016/j.bbrc.2013.10.024; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; Pandey PR, 2010, FRONT BIOSCI-LANDMRK, V15, P226, DOI 10.2741/3617; Porter DA, 2001, CANCER RES, V61, P5697; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reis JS, 2006, HISTOPATHOLOGY, V49, P10, DOI 10.1111/j.1365-2559.2006.02467.x; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Schwartz TL, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-31; Shu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0276-y; Song XP, 2015, J MOL HISTOL, V46, P347, DOI 10.1007/s10735-015-9627-2; Yang C, 2015, TUMOR BIOL, V36, P9567, DOI 10.1007/s13277-015-3628-3	34	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162933	10.1371/journal.pone.0162933	http://dx.doi.org/10.1371/journal.pone.0162933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626636	Green Published, Green Submitted, gold			2022-12-27	WOS:000383680600065
J	Gao, C; Wang, Z; Li, XH; Zhang, ZL; Zeng, W				Gao, Chao; Wang, Zhen; Li, Xianghua; Zhang, Zili; Zeng, Wei			PR-Index: Using the h-Index and PageRank for Determining True Impact	PLOS ONE			English	Article							BIBLIOGRAPHIC NETWORKS; CITATION NETWORKS; ALGORITHM	Several technical indicators have been proposed to assess the impact of authors and institutions. Here, we combine the h-index and the PageRank algorithm to do away with some of the individual limitations of these two indices. Most importantly, we aim to take into account value differences between citations-evaluating the citation sources by defining the h-index using the PageRank score rather than with citations. The resulting PR-index is then constructed by evaluating source popularity as well as the source publication authority. Extensive tests on available collections data (i.e., Microsoft Academic Search and benchmarks on the SIGKDD innovation award) show that the PR-index provides a more balanced impact measure than many existing indices. Due to its simplicity and similarity to the popular h-index, the PR-index may thus become a welcome addition to the technical indices already in use. Moreover, growth dynamics prior to the SIGKDD innovation award indicate that the PR-index might have notable predictive power.	[Gao, Chao; Li, Xianghua; Zhang, Zili; Zeng, Wei] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Zhang, Zili] Deakin Univ, Sch Informat Technol, Locked Bag 20000, Geelong, Vic 3220, Australia	Southwest University - China; Kyushu University; Deakin University	Li, XH (corresponding author), Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China.; Wang, Z (corresponding author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan.	zhenwang0@gmail.com; li_xianghua@163.com			National Natural Science Foundation of China [61402379, 61403315]; Natural Science Foundation of Chongqing [cstc2013jcyjA40022]; Fundamental Research Funds for the Central Universities [XDJK2016A008, XDJK2016B029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (61402379, 61403315), Natural Science Foundation of Chongqing (cstc2013jcyjA40022), and Fundamental Research Funds for the Central Universities (XDJK2016A008, XDJK2016B029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartneck C, 2011, SCIENTOMETRICS, V87, P85, DOI 10.1007/s11192-010-0306-5; Batista PD, 2006, SCIENTOMETRICS, V68, P179, DOI 10.1007/s11192-006-0090-4; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Bornmann L, 2011, J INFORMETR, V5, P346, DOI 10.1016/j.joi.2011.01.006; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Ding Y, 2011, J AM SOC INF SCI TEC, V62, P236, DOI 10.1002/asi.21452; Fiala D, 2008, SCIENTOMETRICS, V76, P135, DOI 10.1007/s11192-007-1908-4; Fiala D, 2012, J INFORMETR, V6, P370, DOI 10.1016/j.joi.2012.02.002; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Liang LM, 2006, SCIENTOMETRICS, V69, P153, DOI 10.1007/s11192-006-0145-6; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; Liu XZ, 2012, J INFORMETR, V6, P557, DOI 10.1016/j.joi.2012.05.002; Ma N, 2008, INFORM PROCESS MANAG, V44, P800, DOI 10.1016/j.ipm.2007.06.006; Maslov S, 2008, J NEUROSCI, V28, P11103, DOI 10.1523/JNEUROSCI.0002-08.2008; Page Lawrence, 1999, 199966 STANF INFOLAB; Schreiber M, 2009, J AM SOC INF SCI TEC, V60, P1274, DOI 10.1002/asi.21057; Sidiropoulos A, 2006, J SYST SOFTWARE, V79, P1679, DOI 10.1016/j.jss.2006.01.011; Yan EJ, 2011, INFORM PROCESS MANAG, V47, P125, DOI 10.1016/j.ipm.2010.05.002; Zhang CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059912; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429	22	33	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161755	10.1371/journal.pone.0161755	http://dx.doi.org/10.1371/journal.pone.0161755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627767	gold, Green Published, Green Submitted			2022-12-27	WOS:000383680600008
J	Ishii, S; Chang, C; Tanaka, T; Kuroda, A; Tsuji, T; Akishita, M; Iijima, K				Ishii, Shinya; Chang, Chang; Tanaka, Tomoki; Kuroda, Aki; Tsuji, Tetsuo; Akishita, Masahiro; Iijima, Katsuya			The Association between Sarcopenic Obesity and Depressive Symptoms in Older Japanese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL PERFORMANCE; BLOOD-PRESSURE; MUSCLE MASS; MORTALITY; DISABILITY; LEPTIN; ONSET	The effects of sarcopenic obesity, the co-existence of sarcopenia and obesity, on mood disorders have not been studies extensively. Our objective was to examine the association of depressive symptoms with sarcopenia and obesity status in older Japanese adults. We analyzed data from 1731 functionally-independent, community-dwelling Japanese adults aged 65 years or older (875 men, 856 women) randomly selected from the resident register of Kashiwa city, Chiba, Japan in 2012. Sarcopenia was defined based on appendicular skeletal muscle mass, grip strength and usual gait speed. Obesity was defined as the highest sex-specific quintile of the percentage body fat. Depressive symptoms were defined as a Geriatric Depression Scale 15-item score >= 6. Multiple logistic regression was employed to examine the association of depressive symptoms with four groups defined by the presence/absence of sarcopenia and obesity. The prevalence of depressive symptoms was 10.1% and the proportions of sarcopenia/obesity, sarcopenia/non-obesity, non-sarcopenia/obesity, non-sarcopenia/non-obesity were 3.7%, 13.6%, 16.9% and 65.8%, respectively. After adjustment for potential confounders, sarcopenia/obesity was positively associated with depressive symptoms compared with non-sarcopenia/non-obesity, whereas either sarcopenia or obesity alone was not associated with depressive symptoms. The association was particularly pronounced in those aged 65 to 74 years in age-stratified analysis. We conclude that our findings suggest a synergistic impact exerted by sarcopenic obesity on the risk of depressive symptoms, particularly in those aged 65 to 74 years.	[Ishii, Shinya; Chang, Chang; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Tanaka, Tomoki; Kuroda, Aki; Tsuji, Tetsuo; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Tokyo, Japan	University of Tokyo; University of Tokyo	Iijima, K (corresponding author), Univ Tokyo, Inst Gerontol, Tokyo, Japan.	iijima@iog.u-tokyo.ac.jp		Ishii, Shinya/0000-0001-5762-4066	Ministry osf Health, Labor, and Welfare of Japan [H24-Choju-Ippan-002]	Ministry osf Health, Labor, and Welfare of Japan	KI received a Health and Labor Sciences Research Grant (H24-Choju-Ippan-002) from the Ministry osf Health, Labor, and Welfare of Japan http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h24/gaiyo/16.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Everson-Rose SA, 2005, PSYCHOSOM MED, V67, P609, DOI 10.1097/01.psy.0000170334.77508.35; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Forman-Hoffman VL, 2007, J GERONTOL B-PSYCHOL, V62, pS43, DOI 10.1093/geronb/62.1.S43; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Kawano Y, 2011, AM J HYPERTENS, V24, P1250, DOI 10.1038/ajh.2011.138; Kim JH, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/634289; Kim NH, 2011, J AM GERIATR SOC, V59, P2062, DOI 10.1111/j.1532-5415.2011.03664.x; Kurimoto Ayumi, 2011, Nihon Ronen Igakkai Zasshi, V48, P149; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Laudisio A, 2014, CLIN NUTR, V33, P626, DOI 10.1016/j.clnu.2013.08.005; Light JM, 1996, GERONTOLOGIST, V36, P165, DOI 10.1093/geront/36.2.165; Milaneschi Y, 2012, J CLIN PSYCHIAT, V73, P1205, DOI 10.4088/JCP.11m07552; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Nagasaki H, 1996, PERCEPT MOTOR SKILL, V82, P435, DOI 10.2466/pms.1996.82.2.435; Noh JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1663-z; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Wada T, 2004, ARCH GERONTOL GERIAT, V39, P15, DOI 10.1016/j.archger.2003.12.003; Waters DL, 2008, J GERONTOL A-BIOL, V63, P536, DOI 10.1093/gerona/63.5.536; World Health Organization,, 2015, OB OV; Xiang XL, 2015, J PSYCHOSOM RES, V78, P242, DOI 10.1016/j.jpsychores.2014.12.008; Yanagita M, 2006, AM J GERIAT PSYCHIAT, V14, P1060, DOI 10.1097/01.JGP.0000224364.70515.12	40	40	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162898	10.1371/journal.pone.0162898	http://dx.doi.org/10.1371/journal.pone.0162898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627756	Green Submitted, gold, Green Published			2022-12-27	WOS:000383680600062
J	Schroder, H; Gomez, SF; Ribas-Barba, L; Perez-Rodrigo, C; Bawaked, RA; Fito, M; Serra-Majem, L				Schroeder, Helmut; Gomez, Santiago F.; Ribas-Barba, Lourdes; Perez-Rodrigo, Carmen; Ahmed Bawaked, Rowaedh; Fito, Montserrat; Serra-Majem, Lluis			Monetary Diet Cost, Diet Quality, and Parental Socioeconomic Status in Spanish Youth	PLOS ONE			English	Article							MEDITERRANEAN DIET; CHILDREN; INDEX; SAMPLE; ADOLESCENTS; ADHERENCE; PATTERNS; HEALTH; SCORE	Background Using a food-based analysis, healthy dietary patterns in adults are more expensive than less healthy ones; studies are needed in youth. Therefore, the objective of the present study was to determine relationships between monetary daily diet cost, diet quality, and parental socioeconomic status. Design and Methods Data were obtained from a representative national sample of 3534 children and young people in Spain, aged 2 to 24 years. Dietary assessment was performed with a 24-hour recall. Mediterranean diet adherence was measured by the KIDMED questionnaire. Average food cost was calculated from official Spanish government data. Monetary daily diet cost was expressed as euros per day ((sic)/d) and euros per day standardized to a 1000kcal diet ((sic)/1000kcal/d). Results Mean monetary daily diet cost was 3.16 +/- 1.57(sic)/d (1.56 +/- 0.72(sic)/1000kcal/d). Socioeconomic status was positively associated with monetary daily diet cost and diet quality measured by the KIDMED index ((sic)/d and (sic)/1000kcal/d, p<0.019). High Mediterranean diet adherence (KIDMED score 8-12) was 0.71 (sic)/d (0.28(sic)/1000kcal/d) more expensive than low compliance (KIDMED score 0-3). Analysis for nonlinear association between the KIDMED index and monetary daily diet cost per1000kcal showed no further cost increases beyond a KIDMED score of 8 (linear p<0.001; nonlinear p = 0.010). Conclusion Higher monetary daily diet cost is associated with healthy eating in Spanish youth. Higher socioeconomic status is a determinant for higher monetary daily diet cost and quality.	[Schroeder, Helmut; Gomez, Santiago F.; Ahmed Bawaked, Rowaedh; Fito, Montserrat] IMIM Hosp del Mar Med Res Inst, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain; [Schroeder, Helmut] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Gomez, Santiago F.] Generalitat Catalunya, Dept Salut, AQuAS ASPCAT, Barcelona, Spain; [Gomez, Santiago F.] Univ Pompeu Fabra, PhD Programme Biomed, Barcelona, Spain; [Ribas-Barba, Lourdes; Serra-Majem, Lluis] Nutr Res Fdn, Barcelona, Spain; [Ribas-Barba, Lourdes; Fito, Montserrat; Serra-Majem, Lluis] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain; [Perez-Rodrigo, Carmen] Univ Basque Country, FIDEC Fdn, Bilbao, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Reseach Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Basque Country; Universidad de Las Palmas de Gran Canaria	Schroder, H (corresponding author), IMIM Hosp del Mar Med Res Inst, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain.; Schroder, H (corresponding author), Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	hschroeder@imim.es	Serra-Majem, Lluis/I-6708-2019; Bawaked, Rowaedh/AAX-6292-2020; Schroder, Helmut/G-2586-2015; Fito, Montserrat/C-1822-2012; Perez-Rodrigo, Carmen/N-3251-2018; Santos, Santiago Felipe Gómez/H-9478-2017	Serra-Majem, Lluis/0000-0002-9658-9061; Bawaked, Rowaedh/0000-0002-8161-0454; Schroder, Helmut/0000-0003-2231-5081; Fito, Montserrat/0000-0002-1817-483X; Santos, Santiago Felipe Gómez/0000-0003-3352-2510; Perez-Rodrigo, Carmen/0000-0002-4554-6184	Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain; Kellogg's Espana SA and Kellogg's Company; Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacio'n Nutricional; King Abdullah scholarship program [ID 2631]; Instituto de Salud Carlos III FEDER [CB06/02/0029]; AGAUR [2014 SGR 240]	Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain(Spanish Government); Kellogg's Espana SA and Kellogg's Company; Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacio'n Nutricional; King Abdullah scholarship program; Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos IIIEuropean Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by grants from the Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain; and Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria and the Fundacion para la Investigacio'n Nutricional and by King Abdullah scholarship program [2014, ID 2631], Instituto de Salud Carlos III FEDER (CB06/02/0029), AGAUR (2014 SGR 240). The CIBERESP and the CIBEROBN and the RETIC Predimed are initiatives of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy U, 2014, EUR J CLIN NUTR, V68, P1175, DOI 10.1038/ejcn.2014.101; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Carlson A, 2012, EIB96 USDA EC RES SE; Cunado J, 2012, SOC INDIC RES, V108, P185, DOI 10.1007/s11205-011-9874-x; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Frazao E, 2011, AM J CLIN NUTR, V93, P861, DOI 10.3945/ajcn.110.009639; French SA, 2003, J NUTR, V133, p841S, DOI 10.1093/jn/133.3.841S; Giannini C, 2014, NUTR METAB CARDIOVAS, V24, P75, DOI 10.1016/j.numecd.2013.04.005; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Kontogianni MD, 2008, J NUTR, V138, P1951, DOI 10.1093/jn/138.10.1951; Lydakis C, 2012, EUR J PEDIATR, V171, P1373, DOI 10.1007/s00431-012-1735-3; Monsivais P, 2012, J EPIDEMIOL COMMUN H, V66, P530, DOI 10.1136/jech.2010.122333; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110; OECD, 2015, INEQUALITY; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Ryden PJ, 2011, PUBLIC HEALTH NUTR, V14, P1680, DOI 10.1017/S1368980010003642; Sahingoz SA, 2011, APPETITE, V57, P272, DOI 10.1016/j.appet.2011.05.307; Santomauro F, 2014, NUTRITION, V30, P1379, DOI 10.1016/j.nut.2014.04.008; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Schroder H, 2006, INT J OBESITY, V30, P1574, DOI 10.1038/sj.ijo.0803308; Schroder H, 2007, J NUTR BIOCHEM, V18, P149, DOI 10.1016/j.jnutbio.2006.05.006; Schroder H, 2014, EUR J PEDIATR, V173, P1169, DOI 10.1007/s00431-014-2302-x; Schroder H, 2013, NUTRITION, V29, P1350, DOI 10.1016/j.nut.2013.05.019; Schroder H, 2010, INT J PEDIATR OBES, V5, P516, DOI 10.3109/17477161003777417; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Serra-Majem L, 2003, EUR J CLIN NUTR, V57, pS35, DOI 10.1038/sj.ejcn.1601812; Serra-Majem L, 2004, PUBLIC HEALTH NUTR, V7, P931, DOI 10.1079/PHN2004556; Steffen LM, 2014, BRIT J NUTR, V112, P1654, DOI 10.1017/S0007114514002633; Torun B, 1996, EUR J CLIN NUTR, V50, pS37	30	18	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161422	10.1371/journal.pone.0161422	http://dx.doi.org/10.1371/journal.pone.0161422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622518	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000005
J	Welsh, K; Milutinovic, S; Ardecky, RJ; Gonzalez-Lopez, M; Ganji, SR; Teriete, P; Finlay, D; Riedl, S; Matsuzawa, S; Pinilla, C; Houghten, R; Vuori, K; Reed, JC; Cosford, NDP				Welsh, Kate; Milutinovic, Snezana; Ardecky, Robert J.; Gonzalez-Lopez, Marcos; Ganji, Santhi Reddy; Teriete, Peter; Finlay, Darren; Riedl, Stefan; Matsuzawa, Shu-ichi; Pinilla, Clemencia; Houghten, Richard; Vuori, Kristiina; Reed, John C.; Cosford, Nicholas D. P.			Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ALPHA-DEPENDENT APOPTOSIS; MOLECULE IAP ANTAGONISTS; XIAP INHIBITS CASPASE-3; PROTEIN XIAP; BIR3 DOMAIN; SIGNALING COMPLEX; ML-IAP; CIAP1	Members of the Inhibitor of APoptosis (IAP) protein family suppress apoptosis within tumor cells, particularly in the context of immune cell-mediated killing by the tumor necrosis factor (TNF) superfamily cytokines. Most IAPs are opposed endogenously by the second mitochondrial activator of caspases (SMAC), which binds to selected baculovirus IAP repeat (BIR) domains of IAPs to displace interacting proteins. The development of SMAC mimetics as novel anticancer drugs has gained impetus, with several agents now in human clinical trials. To further understand the cellular mechanisms of SMAC mimetics, we focused on IAP family members cIAP1 and cIAP2, which are recruited to TNF receptor complexes where they support cell survival through NF-kappa B activation while suppressing apoptosis by preventing caspase activation. We established fluorescence polarization (FP) assays for the BIR2 and BIR3 domains of human cIAP1 and cIAP2 using fluorochrome-conjugated SMAC peptides as ligands. A library of SMAC mimetics was profiled using the FP assays to provide a unique structure activity relationship (SAR) analysis compared to previous assessments of binding to XIAP. Potent compounds displayed mean inhibitory binding constants (K-i) of 9 to 27 nM against the BIR3 domains of cIAP1 and cIAP2, respectively. Selected compounds were then characterized using cytotoxicity assays in which a cytokine-resistant human tumor cell line was sensitized to either TNF or lymphotoxin-alpha (LT-alpha). Cytotoxicity correlated closely with cIAP1 and cIAP2 BIR3 binding activity with the most potent compounds able to reduce cell viability by 50%. Further testing demonstrated that active compounds also inhibit RIP1 binding to BIR3 of cIAP1 and cIAP2 in vitro and reduce steady-state cIAP1 protein levels in cells. Altogether, these data inform the SAR for our SMAC mimetics with respect to cIAP1 and cIAP2, suggesting that these IAP family members play an important role in tumor cell resistance to cytotoxicity mediated by TNF and LT-alpha.	[Welsh, Kate; Milutinovic, Snezana; Ardecky, Robert J.; Gonzalez-Lopez, Marcos; Ganji, Santhi Reddy; Teriete, Peter; Finlay, Darren; Riedl, Stefan; Matsuzawa, Shu-ichi; Vuori, Kristiina; Reed, John C.; Cosford, Nicholas D. P.] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Pinilla, Clemencia; Houghten, Richard] Torrey Pines Inst Mol Studies, 3550 Gen Atomics Ct, San Diego, CA 92121 USA; [Pinilla, Clemencia; Houghten, Richard] 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA; [Gonzalez-Lopez, Marcos] Ignyta Inc, 11111 Flintkote Ave, San Diego, CA 92121 USA; [Reed, John C.] Hoffmann La Roche AG, Grenzacherstr 124, CH-4070 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; Torrey Pines Institute for Molecular Studies, California; Roche Holding	Cosford, NDP (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ncosford@sbpdiscovery.org		Cosford, Nic/0000-0001-7228-4709	National Institute of Health [CA163743, HG003916, CA195227]; NATIONAL CANCER INSTITUTE [R01CA195227, P30CA030199] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institute of Health: CA163743 (JCR), National Institute of Health: HG003916 (JCR), and National Institute of Health: CA195227 (NDPC).	Ardecky RJ, 2013, BIOORG MED CHEM LETT, V23, P4253, DOI 10.1016/j.bmcl.2013.04.096; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Benetatos CA, 2014, MOL CANCER THER, V13, P867, DOI 10.1158/1535-7163.MCT-13-0798; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Beug ST, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28541; Beug ST, 2014, NAT BIOTECHNOL, V32, P182, DOI 10.1038/nbt.2806; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Condon SM, 2014, J MED CHEM, V57, P3666, DOI 10.1021/jm500176w; Corrie JET, 2001, BIOCONJUGATE CHEM, V12, P186, DOI 10.1021/bc0000785; Cossu F, 2010, PROTEIN SCI, V19, P2418, DOI 10.1002/pro.523; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Etemadi N, 2013, FEBS J, V280, P5283, DOI 10.1111/febs.12419; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Finlay D, 2014, MOL CANCER THER, V13, P5, DOI 10.1158/1535-7163.MCT-13-0153; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gonzalez-Lopez M, 2011, BIOORG MED CHEM LETT, V21, P4332, DOI 10.1016/j.bmcl.2011.05.049; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kulathila R, 2009, ACTA CRYSTALLOGR D, V65, P58, DOI 10.1107/S0907444908039243; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lorusso D, 2012, BRIT J CANCER, V107, P37, DOI 10.1038/bjc.2012.233; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Ndubaku C, 2009, ACS CHEM BIOL, V4, P557, DOI 10.1021/cb900083m; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Samuel T, 2005, CANCER RES, V65, P210; Schilling R, 2014, METHOD ENZYMOL, V545, P83, DOI 10.1016/B978-0-12-801430-1.00004-4; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Son JK, 2010, CELL DEATH DIFFER, V17, P1288, DOI 10.1038/cdd.2010.9; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Vamos M, 2013, ACS CHEM BIOL, V8, P725, DOI 10.1021/cb3005512; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, BIOCHEM J, V447, P427, DOI 10.1042/BJ20121103; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2001, GENOME BIOL, V2; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046	61	15	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161952	10.1371/journal.pone.0161952	http://dx.doi.org/10.1371/journal.pone.0161952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617834	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100012
J	Asou, Y; Iwata, M; Ochi, H; Ailixiding, M; Aibibula, Z; Piao, JY; Jin, GW; Hara, Y; Okawa, A				Asou, Yoshinori; Iwata, Munetaka; Ochi, Hiroki; Ailixiding, Maierhaba; Aibibula, Zulipiya; Piao, Jinying; Jin, Guangwen; Hara, Yasushi; Okawa, Atsushi			Pleiotropic Functions of High Fat Diet in the Etiology of Osteoarthritis	PLOS ONE			English	Article							BONE-RESORPTION; INDUCED OBESITY; KNEE-JOINT; DEGRADATION; PAD; CHONDROCYTES; INFLAMMATION; OVERWEIGHT; APOPTOSIS; MOUSE	Obesity is a risk factor for osteoarthritis(OA). To investigate the roles of increased mechanical loading in the onset of obesity-induced OA, knee joints were histologically analyzed after applying a tail suspension (TS) model to a high-fat diet (HFD)-induced OA model. Mice were divided into four groups: normal diet (ND) with normal loading (NL) group; HFD with NL group; ND with TS group; and HFD with TS group. Whole knee joints were evaluated by immunohistological analysis. The infrapatellar fat pad (IPFP) was excised and mRNA expression profiles were compared by qPCR analysis. After twelve weeks of the diet, body weight was increased by HFD in both the NL group and TS group. Upon histological analysis, the irregularity of the surface layer of articular cartilage was observed only in the NL+HFD group. Osteophyte area increased as a result of HFD in both the NL and TS groups, although osteophyte area in the TS+HFD group was smaller than that of the NL+HFD group. In the evaluation of the IPFP by qPCR, adipokines and inflammatory cytokines also increased as a result of HFD. While TGF-beta increased as a result of HFD, the trend was slightly lower in the TS group, in parallel with osteophyte area. To detect apoptosis of articular chondrocytes, TUNEL staining was employed. TUNEL-positive cells were abundantly observed in the articular cartilage in the HFD mice regardless of mechanical loading. IPFP inflammation, enhanced chondrocyte apoptosis, and osteophyte formation were seen even in the TS group as a result of a HFD. In all, these data demonstrate that HFD contributed to osteophyte formation through mechanical loading dependent and independent mechanisms.	[Asou, Yoshinori; Aibibula, Zulipiya; Piao, Jinying; Jin, Guangwen; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Iwata, Munetaka; Hara, Yasushi] Nippon Vet & Life Sci Univ, Div Vet Surg, 1-7-1 Sakaiminamicho, Musashino, Tokyo 1808602, Japan; [Ochi, Hiroki] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Ailixiding, Maierhaba] Tokyo Med & Dent Univ, Grad Sch, Dept Rehabil Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU); Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Asou, Y (corresponding author), Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	aso.orth@tmd.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The supporter had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Andriacchi TP, 2004, PATHOMECHANICS OSTEO, P447; Bastiaansen-Jenniskens YM, 2012, ANN RHEUM DIS, V71, P288, DOI 10.1136/ard.2011.153858; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; CARMAN WJ, 1994, AM J EPIDEMIOL, V139, P119, DOI 10.1093/oxfordjournals.aje.a116974; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034; Distel E, 2009, ARTHRITIS RHEUM-US, V60, P3374, DOI 10.1002/art.24881; Doi T, 2002, OSTEOARTHR CARTILAGE, V10, P270, DOI 10.1053/joca.2001.0503; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Gabay O, 2008, JOINT BONE SPINE, V75, P675, DOI 10.1016/j.jbspin.2008.07.011; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hirose T, 2008, J APPL PHYSIOL, V104, P170, DOI 10.1152/japplphysiol.00463.2006; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Iwata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060706; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kamiya T, 2010, J BIOMED MATER RES A, V92A, P801, DOI 10.1002/jbm.a.32295; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Klein-Wieringa IR, 2011, ANN RHEUM DIS, V70, P851, DOI 10.1136/ard.2010.140046; Kwon OS, 2015, AM J PHYSIOL-ENDOC M, V309, pE11, DOI 10.1152/ajpendo.00124.2015; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Magliano Malgorzata, 2008, Menopause Int, V14, P149, DOI 10.1258/mi.2008.008018; Saamanen AMK, 2000, OSTEOARTHR CARTILAGE, V8, P248, DOI 10.1053/joca.2000.0298; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; SILBERBERG M, 1952, Exp Med Surg, V10, P76; SOKOLOFF L, 1960, AM J PHYSIOL, V198, P765, DOI 10.1152/ajplegacy.1960.198.4.765; Tomiya M, 2009, BONE, V44, P295, DOI 10.1016/j.bone.2008.10.038; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; WALTON M, 1979, J PATHOL, V127, P165, DOI 10.1002/path.1711270402; WILHELMI G, 1976, PHARMACOLOGY, V14, P289, DOI 10.1159/000136607; Won Y, 2016, ANN RHEUM DIS, V75, P2045, DOI 10.1136/annrheumdis-2015-208406; Yang S, 2015, ANN RHEUM DIS, V74, P595, DOI 10.1136/annrheumdis-2013-204355	38	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162794	10.1371/journal.pone.0162794	http://dx.doi.org/10.1371/journal.pone.0162794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611831	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900167
J	Galindo-Romero, C; Harun-Or-Rashid, M; Jimenez-Lopez, M; Vidal-Sanz, M; Agudo-Barriuso, M; Hallbook, F				Galindo-Romero, Caridad; Harun-Or-Rashid, Mohammad; Jimenez-Lopez, Manuel; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta; Hallbook, Finn			Neuroprotection by alpha 2-Adrenergic Receptor Stimulation after Excitotoxic Retinal Injury: A Study of the Total Population of Retinal Ganglion Cells and Their Distribution in the Chicken Retina	PLOS ONE			English	Article							CHRONIC OCULAR HYPERTENSION; QUANTITATIVE-ANALYSIS; SPATIAL-DISTRIBUTION; GROWTH-FACTOR; MULLER CELLS; COMPUTERIZED ANALYSIS; EMBRYONIC-DEVELOPMENT; EXPERIMENTAL GLAUCOMA; TRANSIENT ISCHEMIA; AMACRINE CELLS	We have studied the effect of alpha 2-adrenergic receptor stimulation on the total excitotoxically injured chicken retinal ganglion cell population. N-methyl-D-aspartate (NMDA) was intraocularly injected at embryonic day 18 and Brn3a positive retinal ganglion cells (Brn3a+ RGCs) were counted in flat-mounted retinas using automated routines. The number and distribution of the Brn3a+ RGCs were analyzed in series of normal retinas from embryonic day 8 to post-hatch day 11 retinas and in retinas 7 or 14 days post NMDA lesion. The total number of Brn3a+ RGCs in the post-hatch retina was approximately 1.9x10(6) with a density of approximately 9.2x10(3) cells/mm(2). The isodensity maps of normal retina showed that the density decreased with age as the retinal size increased. In contrast to previous studies, we did not find any specific region with increased RGC density, rather the Brn3a+ RGCs were homogeneously distributed over the central retina with decreasing density in the periphery and in the region of the pecten oculli. Injection of 5-10 mu g NMDA caused 30-50% loss of Brn3a+ cells and the loss was more severe in the dorsal than in the ventral retina. Pretreatment with brimonidine reduced the loss of Brn3a+ cells both 7 and 14 days post lesion and the protective effect was higher in the dorsal than in the ventral retina. We conclude that alpha 2-adrenergic receptor stimulation reduced the impact of the excitotoxic injury in chicken similarly to what has been shown in mammals. Furthermore, the data show that the RGCs are evenly distributed over in the retina, which challenges previous results that indicate the presence of specific high RGC-density regions of the chicken retina.	[Galindo-Romero, Caridad; Harun-Or-Rashid, Mohammad; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden; [Galindo-Romero, Caridad; Jimenez-Lopez, Manuel; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Univ Murcia, Inst Murciano Invest Biosanitaria, Hosp Virgen de la Arrixaca IMIB Virgen de la Arri, Murcia, Spain; [Galindo-Romero, Caridad; Jimenez-Lopez, Manuel; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain	Uppsala University; University of Murcia; University of Murcia	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden.	Finn.hallbook@neuro.uu.se	GALINDO-ROMERO, CARIDAD/AAF-8324-2021; Agudo-Barriuso, Marta/B-7100-2016	GALINDO-ROMERO, CARIDAD/0000-0001-9469-9868; Agudo-Barriuso, Marta/0000-0002-8566-9277; Hallbook, Finn/0000-0001-7552-187X	Spanish Ministry of Economy and Competitiveness [SAF-2012-38328]; ISCIII-FEDER "Una manera de hacer Europa'' [PI13/00643, PI13/01266]; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS) [RD12/0034/0014, RD12/0034/0010]; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade; Swedish Research Council [MH521.2013.3346]	Spanish Ministry of Economy and Competitiveness(Spanish Government); ISCIII-FEDER "Una manera de hacer Europa''; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS)(European Commission); Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Supported by grants from the Spanish Ministry of Economy and Competitiveness: SAF-2012-38328, MVS; ISCIII-FEDER "Una manera de hacer Europa'' PI13/00643 and PI13/01266; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS): RD12/0034/0014 and RD12/0034/0010; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade 34:2015, FH; and Swedish Research Council MH521.2013.3346, FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; BARRINGTON M, 1989, CURR EYE RES, V8, P781, DOI 10.3109/02713688909000868; Boije H, 2013, DIFFERENTIATION, V85, P11, DOI 10.1016/j.diff.2012.12.002; Boije H, 2013, J MOL NEUROSCI, V51, P615, DOI 10.1007/s12031-013-0034-4; Bruhn SL, 1996, J NEUROSCI, V16, P1430; Chen Y, 2004, ANAT HISTOL EMBRYOL, V33, P161, DOI 10.1111/j.1439-0264.2004.00528.x; Chen YX, 1999, BRAIN BEHAV EVOLUT, V53, P75, DOI 10.1159/000006584; Doh ST, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-8; Dong CJ, 2008, INVEST OPHTH VIS SCI, V49, P4515, DOI 10.1167/iovs.08-2078; Dong CJ, 2010, INVEST OPHTH VIS SCI, V51, P4174, DOI 10.1167/iovs.09-4613; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GALVEZ JMG, 1977, EXP NEUROL, V56, P151, DOI 10.1016/0014-4886(77)90145-5; Greenfield DS, 1997, J GLAUCOMA, V6, P250; Harun-Or-Rashid M, 2015, INVEST OPHTH VIS SCI, V56, P5933, DOI 10.1167/iovs.15-16816; Harun-Or-Rashid M, 2014, INVEST OPHTH VIS SCI, V55, P3385, DOI 10.1167/iovs.13-13823; Heidinger V, 1999, GLIA, V25, P229, DOI 10.1002/(SICI)1098-1136(19990201)25:3<229::AID-GLIA3>3.0.CO;2-C; Jung KI, 2015, EUR J PHARMACOL, V765, P274, DOI 10.1016/j.ejphar.2015.08.035; Karlsson M, 2001, DEVELOPMENT, V128, P471; Lafuente MP, 2002, EXP EYE RES, V74, P181, DOI 10.1006/exer.2001.1122; Lafuente MP, 2001, INVEST OPHTH VIS SCI, V42, P2074; LAYER PG, 1982, NEUROSCI LETT, V31, P99, DOI 10.1016/0304-3940(82)90099-4; Li XD, 2008, DEV DYNAM, V237, P3210, DOI 10.1002/dvdy.21744; Liu W, 2000, DEVELOPMENT, V127, P3237; Lonngren U, 2006, BRAIN RES BULL, V71, P208, DOI 10.1016/j.brainresbull.2006.09.005; Mayor-Torroglosa S, 2005, INVEST OPHTH VIS SCI, V46, P3825, DOI 10.1167/iovs.05-0392; Mayordomo R, 2003, EUR J NEUROSCI, V18, P1744, DOI 10.1046/j.1460-9568.2003.02891.x; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Naito Jumpei, 2004, Anatomical Science International, V79, P213, DOI 10.1111/j.1447-073x.2004.00084.x; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113798; RAGER G, 1978, EXP BRAIN RES, V33, P65, DOI 10.1007/BF00238795; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Seki M, 2005, NEUROCHEM RES, V30, P1163, DOI 10.1007/s11064-005-7936-7; SHIRAZI F, 2013, PLOS ONE, V0008; Stanke JJ, 2010, INVEST OPHTH VIS SCI, V51, P2208, DOI 10.1167/iovs.09-4447; Thangaraj G, 2012, J COMP NEUROL, V520, P3181, DOI 10.1002/cne.23083; TUNG NN, 1990, VISUAL NEUROSCI, V4, P217, DOI 10.1017/S0952523800003369; Vidal-Sanz M, 2015, PROG BRAIN RES, V220, P1, DOI 10.1016/bs.pbr.2015.04.008; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wen R, 1996, J NEUROSCI, V16, P5986; WILDSOET CF, 1988, INVEST OPHTH VIS SCI, V29, P311; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65; ZEEVALK GD, 1989, J NEUROCHEM, V53, P1610, DOI 10.1111/j.1471-4159.1989.tb08559.x; Zelinka CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044477	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161862	10.1371/journal.pone.0161862	http://dx.doi.org/10.1371/journal.pone.0161862			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611432	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900033
J	Hou, WC; Zhang, W; Chen, GD; Luo, YP				Hou, Wencheng; Zhang, Wei; Chen, Guode; Luo, Yanping			Optimization of Extraction Conditions for Maximal Phenolic, Flavonoid and Antioxidant Activity from Melaleuca bracteata Leaves Using the Response Surface Methodology	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; OCIMUM-GRATISSIMUM; ESSENTIAL OILS; L.; COMMON; CAPACITY; STRESS; FRUIT; SKIN	Melaleuca bracteata is a yellow-leaved tree belonging to the Melaleuca genus. Species from this genus are known to be good sources of natural antioxidants, for example, the "tea tree oil" derived from M. alternifolia is used in food processing to extend the shelf life of products. In order to determine whether M. bracteata contains novel natural antioxidants, the components of M. bracteata ethanol extracts were analyzed by gas chromatography-mass spectrometry. Total phenolic and flavonoid contents were extracted and the antioxidant activities of the extracts evaluated. Single-factor experiments, central composite rotatable design (CCRD) and response surface methodology (RSM) were used to optimize the extraction conditions for total phenolic content (TPC) and total flavonoid content (TFC). Ferric reducing power (FRP) and 1,1-Diphenyl-2-picrylhydrazyl radical (DPPH.) scavenging capacity were used as the evaluation indices of antioxidant activity. The results showed that the main components of M. bracteata ethanol extracts are methyl eugenol (86.86%) and trans-cinnamic acid methyl ester (6.41%). The single-factor experiments revealed that the ethanol concentration is the key factor determining the TPC, TFC, FRP and DPPH.scavenging capacity. RSM results indicated that the optimal condition of all four evaluation indices was achieved by extracting for 3.65 days at 53.26 degrees C in 34.81% ethanol. Under these conditions, the TPC, TFC, FRP and DPPH.scavenging capacity reached values of 88.6 +/- 1.3 mg GAE/g DW, 19.4 +/- 0.2 mg RE/g DW, 2.37 +/- 0.01 mMFe(2+)/g DW and 86.0 +/- 0.3%, respectively, which were higher than those of the positive control, methyl eugenol (FRP 0.97 +/- 0.02 mM, DPPH.scavenging capacity 58.6 +/- 0.7%) at comparable concentrations. Therefore, the extracts of M. bracteata leaves have higher antioxidant activity, which did not only attributed to the methyl eugenol. Further research could lead to the development of a potent new natural antioxidant.	[Hou, Wencheng; Luo, Yanping] Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Haikou 570228, Hainan, Peoples R China; [Hou, Wencheng; Luo, Yanping] Hainan Univ, Coll Environm & Plant Protect, Haikou 570228, Hainan, Peoples R China; [Zhang, Wei; Chen, Guode] Hainan Prov Forestry Sci Inst, Tongshen Branch Off, Wuzhishan 572200, Hainan, Peoples R China	Hainan University; Hainan University	Luo, YP (corresponding author), Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Haikou 570228, Hainan, Peoples R China.; Luo, YP (corresponding author), Hainan Univ, Coll Environm & Plant Protect, Haikou 570228, Hainan, Peoples R China.	yanpluo@126.com			National Natural Science Foundation of China [21162007, 21402059]; Opening Project of Shanghai Key Laboratory of Chemical Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Project of Shanghai Key Laboratory of Chemical Biology	We are grateful for financial support from the National Natural Science Foundation of China (No. 21162007, 21402059) and the Opening Project of Shanghai Key Laboratory of Chemical Biology (2015).	Ai XingMei, 2014, Journal of West China Forestry Science, V43, P29; Asoodeh A, 2012, J PEPT SCI, V18, P10, DOI 10.1002/psc.1409; Bouaziz M, 2009, FOOD CHEM TOXICOL, V47, P2755, DOI 10.1016/j.fct.2009.08.005; Budhiraja SS, 1999, J MANIP PHYSIOL THER, V22, P447, DOI 10.1016/S0161-4754(99)70033-3; Chamani J, 2006, J COLLOID INTERF SCI, V293, P52, DOI 10.1016/j.jcis.2005.06.015; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; COSGROVE D. J., 1948, BULL IMPERIAL INST [GR BRIT], V46, P46; Du B., 2014, BIOACTIVE CARBOHYDRA, V3, P11, DOI [10.1016/j.bcdf.2013.12.001, DOI 10.1016/J.BCDF.2013.12.001]; Garcia-Salas P, 2010, MOLECULES, V15, P8813, DOI 10.3390/molecules15128813; Gliwa J, 2011, J AGR FOOD CHEM, V59, P11473, DOI 10.1021/jf2023353; Gulluce M, 2007, FOOD CHEM, V103, P1449, DOI 10.1016/j.foodchem.2006.10.061; Halake K, 2016, J IND ENG CHEM, V35, P1, DOI 10.1016/j.jiec.2016.01.003; Han QX, 2003, PLANT PROTECTION, V30, P60; Hefnawy H. T. M., 2013, Asian Pacific Journal of Tropical Disease, V3, P277; Holetzi FB, 2003, ACTA PROTOZOOL, V42, P269; Hou Shuting, 2014, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V34, P2491, DOI 10.7606/j.issn.1000-4025.2014.12.2491; Ibrahim MM, 2015, SAUDI J BIOL SCI, V22, P168, DOI 10.1016/j.sjbs.2014.11.019; Juergens UR, 2003, RESP MED, V97, P250, DOI 10.1053/rmed.2003.1432; Kim SG, 2009, COLLOID SURFACE A, V348, P289, DOI 10.1016/j.colsurfa.2009.07.043; Kim SC, 2016, J IND ENG CHEM, V38, P93, DOI 10.1016/j.jiec.2016.04.010; Kumarappan CT, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.004; Kuppusamy S, 2016, PROCESS SAF ENVIRON, V100, P173, DOI 10.1016/j.psep.2016.01.009; Kuppusamy S, 2016, IND CROP PROD, V83, P630, DOI 10.1016/j.indcrop.2015.12.060; Lee LS, 2016, J CEREAL SCI, V68, P181, DOI 10.1016/j.jcs.2015.07.005; Lemos JD, 2005, MEM I OSWALDO CRUZ, V100, P55, DOI 10.1590/S0074-02762005000100011; [林晓红 Lin Xiaohong], 2015, [热带作物学报, Chinese Journal of Tropical Crops], V36, P991; Liu GL, 2010, J ANHUI AGR SCI, V38, P12062; Martins N, 2016, TRENDS FOOD SCI TECH, V48, P1, DOI 10.1016/j.tifs.2015.11.008; Mokrani A, 2016, SEP PURIF TECHNOL, V162, P68, DOI 10.1016/j.seppur.2016.01.043; Naczk M, 2006, J PHARMACEUT BIOMED, V41, P1523, DOI 10.1016/j.jpba.2006.04.002; Padalia RC, 2015, IND CROP PROD, V63, P264, DOI 10.1016/j.indcrop.2014.09.039; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P1690, DOI 10.1016/j.biortech.2007.04.005; Qu FX, 2011, NO HORTICULTURE, V8, P152; Saurav K, 2012, SAUDI J BIOL SCI, V19, P81, DOI 10.1016/j.sjbs.2011.07.003; Shim JY, 2010, TOXICOL APPL PHARM, V242, P318, DOI 10.1016/j.taap.2009.11.005; Silva CJ, 2010, QUIM NOVA, V33, P104, DOI 10.1590/S0100-40422010000100019; Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008; Singh M, 2014, EUR J MED CHEM, V84, P206, DOI 10.1016/j.ejmech.2014.07.013; Sokmen M, 2004, J AGR FOOD CHEM, V52, P3309, DOI 10.1021/jf049859g; Tang JC, 2016, APPL ENERG, V169, P696, DOI 10.1016/j.apenergy.2016.02.042; Tao Yan-Yan, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P145, DOI 10.3736/jcim20040223; Tchabo W, 2015, IND CROP PROD, V63, P214, DOI 10.1016/j.indcrop.2014.09.053; Wang LF, 2016, FOOD CHEM, V196, P509, DOI 10.1016/j.foodchem.2015.09.083; Wojtunik-Kulesza KA, 2016, BIOMED PHARMACOTHER, V78, P39, DOI 10.1016/j.biopha.2015.12.024; [吴丽君 Wu Lijun], 2010, [福建林学院学报, Journal of Fujian College of Forestry], V30, P314; Xu GH, 2007, J AGR FOOD CHEM, V55, P330, DOI 10.1021/jf062517l; Yang LiQiong, 2014, Guizhou Agricultural Sciences, V42, P150; [叶征美 Ye Zhengmei], 2014, [热带作物学报, Chinese Journal of Tropical Crops], V35, P992; Yoshimura M, 2008, PHYTOCHEMISTRY, V69, P3062, DOI 10.1016/j.phytochem.2008.04.004; ZHONG CY, 2009, FLAVOUR FRAGRANCE CO, V6, P8	50	27	28	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162139	10.1371/journal.pone.0162139	http://dx.doi.org/10.1371/journal.pone.0162139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611576	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900047
J	Miao, XY; Zhang, W; Huang, ZS; Li, NL				Miao, Xinyan; Zhang, Wei; Huang, Zhangsen; Li, Nailin			Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ALPHA-GRANULES; ACTIVATION; PROTEINS; RELEASE; THROMBOSPONDIN-1; MICROANGIOPATHY; MOBILIZATION; ADHESION; REVEALS	Type 2 diabetes mellitus (T2DM) is associated with platelet dysfunction and impaired angiogenesis. Aim of the study is to investigate if platelet dysfunction might hamper platelet angiogenic activities in T2DM patients. Sixteen T2DM patients and gender/age-matched non-diabetic controls were studied. Flow cytometry and endothelial colony forming cell (ECFC) tube formation on matrigelwere used to assess platelet reactivity and angiogenic activity, respectively. Thrombin receptor PAR1-activating peptide (PAR1-AP) induced higher platelet P-selectin expression, and evoked more rapid and intense platelet annexin V binding in T2DM patients, seen as a more rapid increase of annexin V+ platelets (24.3 +/- 6.4% vs 12.6 +/- 3.8% in control at 2 min) and a higher elevation (30.9 +/- 5.1% vs 24.3 +/- 3.0% at 8 min). However, PAR1-AP and PAR4-AP induced similar releases of angiogenic regulators from platelets, and both stimuli evoked platelet release of platelet angiogenic regulators to similar extents in T2DM and control subjects. Thus, PAR1-stimulated platelet releasate (PAR1-PR) and PAR4-PR similarly enhanced capillary-like network/tube formation of ECFCs, and the enhancements did not differ between T2DM and control subjects. Direct supplementation of platelets to ECFCs at the ratio of 1: 200 enhanced ECFC tube formation even more markedly, leading to approximately 100% increases of the total branch points of ECFC tube formation, for which the enhancements were also similar between patients and controls. In conclusion, platelets from T2DM subjects are hyperreactive. Platelet activation induced by high doses of PAR1-AP, however, results in similar releases of angiogenic regulators in mild T2DM and control subjects. Platelets from T2DM and control subjects also demonstrate similar enhancements on ECFC angiogenic activities.	[Miao, Xinyan; Zhang, Wei; Huang, Zhangsen; Li, Nailin] Karolinska Univ Hosp Solna, Clin Pharmacol, Dept Med Solna, Karolinska Inst, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Li, NL (corresponding author), Karolinska Univ Hosp Solna, Clin Pharmacol, Dept Med Solna, Karolinska Inst, S-17176 Stockholm, Sweden.	Nailin.Li@ki.se	Huang, Zhangsen/AAJ-5425-2021	Li, Nailin/0000-0002-3848-7251	Swedish Heart-Lung Foundation; Swedish Research Council; China Scholarship Council; Karolinska Institutet; Stockholm County Council	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The study was supported by grants from the Swedish Heart-Lung Foundation, the Swedish Research Council, the China Scholarship Council, Karolinska Institutet, and the Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bikfalvi A, 2004, SEMIN THROMB HEMOST, V30, P379, DOI 10.1055/s-2004-831051; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Cines DB, 1998, BLOOD, V91, P3527; Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferroni P, 2004, J THROMB HAEMOST, V2, P1282, DOI 10.1111/j.1538-7836.2004.00836.x; Fox CS, 2015, CIRCULATION, V132, P691, DOI 10.1161/CIR.0000000000000230; Gawaz M, 2013, BLOOD, V122, P2550, DOI 10.1182/blood-2013-05-468694; Hu H, 2004, J THROMB HAEMOST, V2, P58, DOI 10.1111/j.1538-7836.2003.00525.x; Huang Z, 2016, J THROMB HAEMOST, V14, P606, DOI 10.1111/jth.13248; Huang Z, 2015, J THROMB HAEMOST, V13, P465, DOI 10.1111/jth.12815; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kamykowski J, 2011, BLOOD, V118, P1370, DOI 10.1182/blood-2011-01-330910; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Li NL, 2003, THROMB RES, V111, P165, DOI 10.1016/j.thromres.2003.08.026; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Patzelt J, 2012, CURR VASC PHARMACOL, V10, P570, DOI 10.2174/157016112801784648; Razmara M, 2008, J THROMB HAEMOST, V6, P2186, DOI 10.1111/j.1538-7836.2008.03185.x; Redondo PC, 2005, BIOCHEM BIOPH RES CO, V333, P794, DOI 10.1016/j.bbrc.2005.05.178; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Santilli F, 2015, PROSTAG OTH LIPID M, V120, P28, DOI 10.1016/j.prostaglandins.2015.05.002; Schneider DJ, 2009, DIABETES CARE, V32, P525, DOI 10.2337/dc08-1865; Spinetti G, 2008, CARDIOVASC RES, V78, P265, DOI 10.1093/cvr/cvn039; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van Holten TC, 2014, CARDIOVASC RES, V103, P140, DOI 10.1093/cvr/cvu113; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Yngen M, 2004, DIABETOLOGIA, V47, P537, DOI 10.1007/s00125-004-1352-4; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162405	10.1371/journal.pone.0162405	http://dx.doi.org/10.1371/journal.pone.0162405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612088	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900091
J	Sankella, S; Garg, A; Agarwal, AK				Sankella, Shireesha; Garg, Abhimanyu; Agarwal, Anil K.			Characterization of the Mouse and Human Monoacylglycerol O-Acyltransferase 1 (Mogat1) Promoter in Human Kidney Proximal Tubule and Rat Liver Cells	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; INDUCED HEPATIC STEATOSIS; INSULIN-RESISTANCE; FATTY-ACIDS; LIPID-ACCUMULATION; GENOME TOPOLOGY; PPAR-GAMMA; MICE; GENE; DNA	Monoacylglycerol acyltransferase 1 (Mogat1) catalyzes the conversion of monoacylglycerols (MAG) to diacylglycerols (DAG), the precursor of several physiologically important lipids such as phosphatidylcholine, phosphatidylethanolamine and triacylglycerol (TAG). Expression of Mogat1 is tissue restricted and it is highly expressed in the kidney, stomach and adipose tissue but minimally in the normal adult liver. To understand the transcriptional regulation of Mogat1, we characterized the mouse and human Mogat1 promoters in human kidney proximal tubule-2 (HK-2) cells. In-silico analysis revealed several peroxisome proliferator response element (PPRE) binding sites in the promoters of both human and mouse Mogat1. These sites responded to all three peroxisome proliferator activated receptor (PPAR) isoforms such that their respective agonist or antagonist activated or inhibited the expression of Mogat1. PPRE site mutagenesis revealed that sites located at -592 and -2518 are very effective in decreasing luciferase reporter gene activity. Chromatin immunoprecipitation (ChIP) assay using PPARa antibody further confirmed the occupancy of these sites by PPARa. While these assays revealed the core promoter elements necessary for Mogat1 expression, there are additional elements required to regulate its tissue specific expression. Chromosome conformation capture (3C) assay revealed additional cis-elements located similar to 10-15 kb upstream which interact with the core promoter. These chromosomal regions are responsive to both PPARa agonist and antagonist.	[Agarwal, Anil K.] UT Southwestern Med Ctr, Div Nutr & Metab Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; UT Southwestern Med Ctr, Ctr Human Nutr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agarwal, AK (corresponding author), UT Southwestern Med Ctr, Div Nutr & Metab Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Anil.Agarwal@utsouthwestern.edu			National Institutes of Health [R01-DK54387]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from National Institutes of Health; R01-DK54387.; Authors thank Katie Tunison for copy editing. This work was supported by a grant from National Institutes of Health; R01-DK54387	Agarwal AK, 2016, J LIPID RES, V57, P616, DOI 10.1194/jlr.M065896; [Anonymous], 2005, NATURE METHODS, V2, P997; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; BARDOT O, 1995, FEBS LETT, V360, P183, DOI 10.1016/0014-5793(95)00097-S; Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Daguenet E, 2015, EMBO REPORTS, DOI 10.15252/embr.201541116; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.4; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; MOSTAFA N, 1993, BIOCHIM BIOPHYS ACTA, V1169, P189, DOI 10.1016/0005-2760(93)90205-N; Mudaliar Sunder, 2003, Endocr Pract, V9, P406; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; Sankella S, 2014, J BIOL CHEM, V289, P4762, DOI 10.1074/jbc.M113.530998; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Soufi N, 2014, J BIOL CHEM, V289, P30177, DOI 10.1074/jbc.M114.595850; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Yu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29352; Yu JH, 2015, BIOCHEM BIOPH RES CO, V460, P715, DOI 10.1016/j.bbrc.2015.03.095; Zhao XM, 2002, CELL, V108, P615, DOI 10.1016/S0092-8674(02)00648-7	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162504	10.1371/journal.pone.0162504	http://dx.doi.org/10.1371/journal.pone.0162504			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611931	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900117
J	Rath, D; Schaeffeler, E; Winter, S; Hewer, J; MuLler, K; Droppa, M; Stimpfle, F; Gawaz, M; Schwab, M; Geisler, T				Rath, Dominik; Schaeffeler, Elke; Winter, Stefan; Hewer, Jens; MueLler, Karin; Droppa, Michal; Stimpfle, Fabian; Gawaz, Meinrad; Schwab, Matthias; Geisler, Tobias			SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; MESENCHYMAL STEM-CELLS; I RECEPTORS CXCR4; CIRCULATING PLATELETS; HEART-DISEASE; EXPRESSION; GENE; ASSOCIATION; RECRUITMENT; GENOTYPE	Background SDF1 and its cognate receptors CXCR4 and CXCR7 are involved in myocardial repair and are associated with outcome in cardiovascular patients. Hence, we aimed to investigate clinically significant SDF1 SNPs for their prognostic impact in patients with cardiovascular disease. Methods and Results Genotyping for selected SDF1 variants (rs1065297, rs2839693, rs1801157, rs266087, rs266085 and rs266089 was performed in patients (n = 872) who underwent percutaneous coronary intervention. Carriers of variant rs2839693 and rs266089 showed significantly higher cumulative event-free survival compared with non-carriers. All other polymorphisms had no relevant influence on outcome. Multivariate Cox regression analysis showed a significant correlation of these SNPs with cardiovascular outcome after inclusion of clinical and prognostic relevant variables (hazard ratio (HR) 0.51 (95% CI 0.30-0.88), p = 0.015 and [ HR 0.51 (95% CI 0.30-0.88), p = 0.016, respectively). In addition, multivariate Cox regression with SDF1 haplotypes revealed a significantly reduced risk for the haplotype carrying the minor alleles of rs2839693 and rs266089 (HR 0.47 (95% CI 0.27-0.84), p = 0.011). Conclusion Distinct SDF1 polymorphisms are associated with improved cardiovascular prognosis in CAD patients. Further studies are warranted to validate these results and to better describe the endogenous regeneration potential in carriers of these SNPs. Targeted, genotype guided therapeutic approaches to foster myocardial regeneration and thus cardiovascular prognosis should be evaluated in future.	[Rath, Dominik; Hewer, Jens; MueLler, Karin; Droppa, Michal; Stimpfle, Fabian; Gawaz, Meinrad; Geisler, Tobias] Univ Hosp Tuebingen, Dept Cardiol, Otfried Mueller Str 10, Tubingen, Germany; [Schaeffeler, Elke; Winter, Stefan; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany; [Schwab, Matthias] Univ Hosp Tuebingen, Dept Clin Pharmacol, Morgenstelle 8, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Geisler, T (corresponding author), Univ Hosp Tuebingen, Dept Cardiol, Otfried Mueller Str 10, Tubingen, Germany.	tobias.geisler@med.uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020; Geisler, Tobias/AAO-4472-2020	Droppa, Michal/0000-0001-5807-7615	German Ministry of Education and Research; Deutsche Forschungsgemeinschaft [BO 3786/1-1]; Robert Bosch Stiftung Stuttgart; University of Tuebingen; Klinische Forschergruppe [KFO274, 2133-0-0, SCHW858/1-1/2]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Bosch Stiftung Stuttgart; University of Tuebingen; Klinische Forschergruppe	This work was supported in part by the German Ministry of Education and Research, the Deutsche Forschungsgemeinschaft (Grant Number: BO 3786/1-1), the Robert Bosch Stiftung Stuttgart, the Open Access Publishing Fund of the University of Tuebingen and the Klinische Forschergruppe KFO274 (Grant number 2133-0-0; SCHW858/1-1/2) 'Platelets-Basic Mechanisms and Translational Implications'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the German Ministry of Education and Research, the Deutsche Forschungsgemeinschaft (Grant Number: BO 3786/1-1), the Robert Bosch Stiftung Stuttgart, the Open Access Publishing Fund of the University of Tuebingen and the Klinische Forschergruppe KFO274 (Grant number 2133-0-0; SCHW858/1-1/2) 'Platelets-Basic Mechanisms and Translational Implications'. We gratefully acknowledge Monika Elbl, Andrea Jarmuth, and Heidi Kohler for excellent technical assistance. Furthermore we would like to thank L. Laptev, E. Tavlaki, D. Lombardi, A. Hoffmann, A. Valera, D. Eppler, D. Tschernow, J. Metzger, J. P. Schwille, K. Hey, M. Schmid, M. Haas, S. Breuning, C. Eick, and Christina Flaum for the excellent support in data collection.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; [Anonymous], 1997, Cardiovasc Res, V35, P2; [Anonymous], 2002, Med Etika Bioet, V9, P12; Feng L, 2014, INT J MOL SCI, V15, P11054, DOI 10.3390/ijms150611054; Geisler T, 2012, EUR J RADIOL, V81, pE486, DOI 10.1016/j.ejrad.2011.06.019; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; Gerli G, 2005, CLIN CHEM, V51, P2411, DOI 10.1373/clinchem.2005.057802; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Gu XL, 2014, BIOCHEM BIOPH RES CO, V443, P932, DOI 10.1016/j.bbrc.2013.12.065; Hayakawa Jun, 2009, Journal of Nippon Medical School, V76, P198; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; ICH Harmonised Tripartite Guideline, 2001, J POSTGRAD MED, V47, P45; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kimura R, 2005, HUM MOL GENET, V14, P1579, DOI 10.1093/hmg/ddi166; Ku FC, 2013, EUR J HAEMATOL, V90, P25, DOI 10.1111/ejh.12025; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Rath D, 2015, J THROMB HAEMOST, V13, P719, DOI 10.1111/jth.12870; Rath D, 2014, EUR HEART J, V35, P386, DOI 10.1093/eurheartj/eht448; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schesny MK, 2014, BIOMATERIALS, V35, P7180, DOI 10.1016/j.biomaterials.2014.04.116; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Secchiero P, 2000, ANAT REC, V260, P141, DOI 10.1002/1097-0185(20001001)260:2<141::AID-AR40>3.0.CO;2-I; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2011, ATHEROSCLEROSIS, V219, P913, DOI 10.1016/j.atherosclerosis.2011.09.022; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Verschuren JJW, 2012, EUR HEART J, V33, P165, DOI 10.1093/eurheartj/ehr239; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Wu N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11803; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Ziegler M, 2012, CIRCULATION, V125, P685, DOI 10.1161/CIRCULATIONAHA.111.070508	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161933	10.1371/journal.pone.0161933	http://dx.doi.org/10.1371/journal.pone.0161933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607427	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600015
J	Young, A; Dandekar, U; Pan, C; Sader, A; Zheng, JJ; Lewis, RA; Farber, DB				Young, Alejandra; Dandekar, Uma; Pan, Calvin; Sader, Avery; Zheng, Jie J.; Lewis, Richard A.; Farber, Debora B.			GNAI3: Another Candidate Gene to Screen in Persons with Ocular Albinism	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; RNA-BINDING PROTEINS; MISSENSE MUTATION; OA1 GENE; TYPE-1; CELLS; SEQUENCE; ELEMENTS; REVEALS; REGIONS	Ocular albinism type 1 (OA), caused by mutations in the OA1 gene, encodes a G-protein coupled receptor, OA1, localized in melanosomal membranes of the retinal pigment epithelium (RPE). This disorder is characterized by both RPE macro-melanosomes and abnormal decussation of ganglion cell axons at the brain's optic chiasm. We demonstrated previously that Oa1 specifically activates G alpha i3, which also signals in the Oa1 transduction pathway that regulates melanosomal biogenesis. In this study, we screened the human G alpha i3 gene, GNAI3, in DNA samples from 26 patients who had all clinical characteristics of OA but in whom a specific mutation in the OA1 gene had not been found, and in 6 normal control individuals. Using the Agilent HaloPlex Target Enrichment System and next-generation sequencing (NGS) on the Illumina MiSeq platform, we identified 518 variants after rigorous filtering. Many of these variants were corroborated by Sanger sequencing. Overall, 98.8% coverage of the GNAI3 gene was obtained by the HaloPlex amplicons. Of all variants, 6 non-synonymous and 3 synonymous were in exons, 41 in a non-coding exon embedded in the 3' untranslated region (UTR), 6 in the 5' UTR, and 462 in introns. These variants included novel SNVs, insertions, deletions, and a frameshift mutation. All were found in at least one patient but none in control samples. Using computational methods, we modeled the GNAI3 protein and its non-synonymous exonic mutations and determined that several of these may be the cause of disease in the patients studied. Thus, we have identified GNAI3 as a second gene possibly responsible for X-linked ocular albinism.	[Young, Alejandra; Sader, Avery; Zheng, Jie J.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Young, Alejandra; Sader, Avery; Zheng, Jie J.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Young, Alejandra; Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Dandekar, Uma; Pan, Calvin] Univ Calif Los Angeles, UCLA GenoSeq Core, Los Angeles, CA USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine	Farber, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.; Farber, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.; Farber, DB (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Farber, DB (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	farber@jsei.ucla.edu		Young, Alejandra/0000-0002-1855-0559; Farber, Debora/0000-0002-3207-697X; Zheng, Jie/0000-0001-6524-6800; Lewis, Richard/0000-0002-6644-6385	Vision of Children Foundation; NIH Core center [EY000331]; Research to Prevent Blindness; Genetic Resource Association of Texas (GReAT); NATIONAL EYE INSTITUTE [P30EY002520, P30EY000331, T32EY007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100909] Funding Source: NIH RePORTER	Vision of Children Foundation; NIH Core center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Genetic Resource Association of Texas (GReAT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by The Vision of Children Foundation, http://www.visionofchildren.org/(AY). Stein Eye Institute core facilities used (available to DBF) were supported by an NIH Core center grant (EY000331) and by a grant from Research to Prevent Blindness. RAL received partial support from the Genetic Resource Association of Texas (GReAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; Bassi MT, 2001, HUM GENET, V108, P51, DOI 10.1007/s004390000440; Bicknell AA, 2012, BIOESSAYS, V34, P1025, DOI 10.1002/bies.201200073; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cortese K, 2005, INVEST OPHTH VIS SCI, V46, P4358, DOI 10.1167/iovs.05-0834; Dainer E, 2008, HEMOGLOBIN, V32, P596, DOI 10.1080/03630260802507915; Eidinger O, 2015, MOL VIS, V21, P1295; Emmrich S, 2016, ONCOGENE, V35, P1822, DOI 10.1038/onc.2015.247; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Garcia TY, 2015, INVEST OPHTH VIS SCI, V56, P7480, DOI 10.1167/iovs.15-17251; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Hallsson JH, 2007, PIGM CELL RES, V20, P185, DOI 10.1111/j.1600-0749.2007.00373.x; HAUBENWALLNER S, 1993, GENOMICS, V18, P392, DOI 10.1006/geno.1993.1481; HERMANS MMP, 1993, BIOCHEM J, V289, P687, DOI 10.1042/bj2890687; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Huber RG, 2014, J CHEM INF MODEL, V54, P1371, DOI 10.1021/ci500183u; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LAZZARINO DA, 1988, J BIOL CHEM, V263, P10118; Lee EC, 2007, J PHYS CHEM A, V111, P3446, DOI 10.1021/jp068635t; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li CY, 2009, NUCLEIC ACIDS RES, V37, pD251, DOI 10.1093/nar/gkn568; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang TM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/679563; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; MARTINIUK F, 1991, DNA CELL BIOL, V10, P681, DOI 10.1089/dna.1991.10.681; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mirny LA, 1996, J MOL BIOL, V264, P1164, DOI 10.1006/jmbi.1996.0704; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; Owens CD, 2010, J VASC SURG, V52, P205, DOI 10.1016/j.jvs.2010.01.097; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Raghunath A, 2015, OPHTHALMIC RES, V53, P169, DOI 10.1159/000371853; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Sivasakthi V, 2013, CELL BIOCHEM BIOPHYS, V67, P853, DOI 10.1007/s12013-013-9573-0; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Vetrini F, 2006, HUM MUTAT, V27, P420, DOI 10.1002/humu.20303; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang LJ, 2006, BIOCHEMISTRY-US, V45, P13750, DOI 10.1021/bi0615689; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Young A, 2008, INVEST OPHTH VIS SCI, V49, P3245, DOI 10.1167/iovs.08-1806; Young A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076240; Young A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024376	66	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162273	10.1371/journal.pone.0162273	http://dx.doi.org/10.1371/journal.pone.0162273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607449	Green Published, gold			2022-12-27	WOS:000383255600035
J	Frejd, D; Dunaway, K; Hill, J; Van Maanen, J; Carlson, C				Frejd, Derek; Dunaway, Kiera; Hill, Jennifer; Van Maanen, Jesse; Carlson, Clayton			The Genomic and Morphological Effects of Bisphenol A on Arabidopsis thaliana	PLOS ONE			English	Article							GERMINATION	The environmental toxin bisphenol A (BPA) is a known mammalian hormone disrupter but its effects on plants have not been well established. The effect of BPA on gene expression in Arabidopsis thaliana was determined using microarray analysis and quantitative gene PCR. Many hormone responsive genes showed changes in expression after BPA treatment. BPA disrupted flowering by a mechanism that may involve disruption of auxin signaling. The results presented here indicate that BPA is a plant hormone disrupter.	[Frejd, Derek; Dunaway, Kiera; Hill, Jennifer; Van Maanen, Jesse; Carlson, Clayton] Trinity Christian Coll, Dept Biol, Palos Hts, IL USA; [Dunaway, Kiera] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Hill, Jennifer] Univ New Hampshire, Mol Cellular & Biomed Sci Dept, Durham, NH 03824 USA; [Van Maanen, Jesse] Univ South Dakota, Dept Surg, Sanford Sch Med, Vermillion, SD USA	University System Of New Hampshire; University of New Hampshire; University of South Dakota	Carlson, C (corresponding author), Trinity Christian Coll, Dept Biol, Palos Hts, IL USA.	clayton.carlson@trnty.edu			VanderVelde Research Fellowship; Trinity Christian College	VanderVelde Research Fellowship; Trinity Christian College	This work was supported by the VanderVelde Research Fellowship and the Trinity Summer Research Grant from Trinity Christian College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakis IDS, 2013, MUTAT RES-GEN TOX EN, V750, P111, DOI 10.1016/j.mrgentox.2012.10.012; Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jayasri K, 2016, ASIAN J WATER ENVIRO, V13, P107, DOI 10.3233/AJW-160021; KOPCEWICZ J, 1970, Acta Societatis Botanicorum Poloniae, V39, P339, DOI 10.5586/asbp.1970.026; Latorre A, 2003, CHROMATOGRAPHIA, V57, P111, DOI 10.1007/BF02497486; LEOPOLD AC, 1958, ANNU REV PLANT PHYS, V9, P281, DOI 10.1146/annurev.pp.09.060158.001433; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Mohapatra DP, 2011, J XENOBIOTICS, V1, P9, DOI 10.4081/xeno.2011.e3; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Speranza A, 2011, PLANT BIOLOGY, V13, P209, DOI 10.1111/j.1438-8677.2010.00330.x; Staples C, 2010, ENVIRON TOXICOL CHEM, V29, P467, DOI 10.1002/etc.49; Terouchi N, 2004, PLANT BIOTECHNOL, V21, P307, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.307; Terouchi N, 2010, PLANT BIOTECHNOL-NAR, V27, P115, DOI 10.5511/plantbiotechnology.27.115; Tian YS, 2014, J TOXICOL SCI, V39, P671, DOI 10.2131/jts.39.671; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; US Environmental Protection Agency, 2010, BISPH A ACT PLAN; US Environmental Protection Agency, 2014, BISPH A ALT THEM PAP; Williams SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055698	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163028	10.1371/journal.pone.0163028	http://dx.doi.org/10.1371/journal.pone.0163028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631104	gold, Green Submitted, Green Published			2022-12-27	WOS:000383706900119
J	Zhao, YZ; Liu, XY; Wang, WP				Zhao, Yuzhen; Liu, Xiyu; Wang, Wenping			Spiking Neural P Systems with Neuron Division and Dissolution	PLOS ONE			English	Article							PRE-COMPUTED RESOURCES; SOLVING SUBSET SUM; STRUCTURAL PLASTICITY; COMPUTATIONAL POWER; UNIFORM SOLUTIONS; SYNAPSES WORKING; RULES; STRATEGY; SPIKES; SAT	Spiking neural P systems are a new candidate in spiking neural network models. By using neuron division and budding, such systems can generate/produce exponential working space in linear computational steps, thus provide a way to solve computational hard problems in feasible (linear or polynomial) time with a "time-spacetrade-off" strategy. In this work, a new mechanism called neuron dissolution is introduced, by which redundant neurons produced during the computation can be removed. As applications, uniform solutions to two NP-hard problems: SAT problem and Subset Sum problem are constructed in linear time, working in a deterministic way. The neuron dissolution strategy is used to eliminate invalid solutions, and all answers to these two problems are encoded as indices of output neurons. Our results improve the one obtained in Science China Information Sciences, 2011, 1596-1607 by Pan et al.	[Zhao, Yuzhen; Liu, Xiyu; Wang, Wenping] Shandong Normal Univ, Sch Management Sci & Engn, Jinan, Peoples R China	Shandong Normal University	Liu, XY (corresponding author), Shandong Normal Univ, Sch Management Sci & Engn, Jinan, Peoples R China.	sdxyliu@163.com		Zhao, Yuzhen/0000-0003-4902-1120	National Natural Science Foundation of China [61472231, 61170038, 61402187, 61502283]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) 61472231 to XL, 61170038 to XL, 61402187 (not applicable) and 61502283 (not applicable). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, COMPUTERS INTRACTABI; Brown D., 2014, APOPTOSIS ENCY TOXIC, V3, P598; Cabarle F G C, 2012, THEORY PRACTICE COMP, V7, P82, DOI [10.1007/978-4-431-54436-4_6, DOI 10.1007/978-4-431-54436-4_6]; Cabarle F G C, 2012, S MATH ASPECTS COMPU, V12, P25; Cabarle FGC, 2016, NEURAL COMPUT APPL, V27, P1337, DOI 10.1007/s00521-015-1937-5; Cabarle FGC, 2015, LECT NOTES COMPUT SC, V9504, P106, DOI 10.1007/978-3-319-28475-0_8; Cabarle FGC, 2015, NEURAL COMPUT APPL, V26, P1905, DOI 10.1007/s00521-015-1857-4; Chen H., 2006, 4H BRAINSTORMING WEE, V1, P195; Diaz-Pernil D, 2013, PATTERN RECOGN LETT, V34, P846, DOI 10.1016/j.patrec.2012.10.014; Galli R, 2003, CIRC RES, V92, P598, DOI 10.1161/01.RES.0000065580.02404.F4; Ionescu M, 2006, FUND INFORM, V71, P279; Ishdorj Tseren-Onolt, 2008, Natural Computing, V7, P519, DOI 10.1007/s11047-008-9081-0; Leporati A, 2007, LECT NOTES COMPUT SC, V4860, P336; Leporati Alberto, 2009, Natural Computing, V8, P681, DOI 10.1007/s11047-008-9091-y; Leporati A, 2009, INT J UNCONV COMPUT, V5, P459; Leporati A, 2008, FUND INFORM, V87, P61; Pan LQ, 2016, THEOR COMPUT SCI, V623, P83, DOI 10.1016/j.tcs.2015.10.027; Pan LQ, 2012, NEURAL PROCESS LETT, V35, P13, DOI 10.1007/s11063-011-9201-1; Pan LQ, 2011, SCI CHINA INFORM SCI, V54, P1596, DOI 10.1007/s11432-011-4303-y; Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; Paun G, 2006, FUND INFORM, V73, P213; Pun G, 2010, OXFORD HDB ELEGY; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; Song T, 2015, NEURAL PROCESS LETT, V42, P633, DOI 10.1007/s11063-014-9378-1; Song T, 2015, IEEE T NANOBIOSCI, V14, P465, DOI 10.1109/TNB.2015.2402311; Song T, 2015, IEEE T NANOBIOSCI, V14, P38, DOI 10.1109/TNB.2014.2367506; Song T, 2015, NEURAL PROCESS LETT, V42, P199, DOI 10.1007/s11063-014-9352-y; Song T, 2015, NEUROCOMPUTING, V151, P1439, DOI 10.1016/j.neucom.2014.10.044; Song T, 2014, APPL MATH INFORM SCI, V8, P333; Song T, 2014, APPL MATH INFORM SCI, V8, P327; Tu M, 2014, CHINESE J ELECTRON, V23, P87; Wang J, 2011, MEMBRANE COMPUTING, P361; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Zeng XX, 2015, J COMPUT THEOR NANOS, V12, P2023, DOI 10.1166/jctn.2015.3981; Zhang XY, 2015, IEEE T NEUR NET LEAR, V26, P2816, DOI 10.1109/TNNLS.2015.2396940; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500038	38	28	28	0	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162882	10.1371/journal.pone.0162882	http://dx.doi.org/10.1371/journal.pone.0162882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627104	Green Submitted, Green Published, gold			2022-12-27	WOS:000383680600059
J	Ferrero, DM; Larson, J; Jacobsson, B; Di Renzo, GC; Norman, JE; Martin, JN; D'Alton, M; Castelazo, E; Howson, CP; Sengpiel, V; Bottai, M; Mayo, JA; Shaw, GM; Verdenik, I; Tul, N; Velebil, P; Cairns-Smith, S; Rushwan, H; Arulkumaran, S; Howse, JL; Simpson, JL				Ferrero, David M.; Larson, Jim; Jacobsson, Bo; Di Renzo, Gian Carlo; Norman, Jane E.; Martin, James N., Jr.; D'Alton, Mary; Castelazo, Ernesto; Howson, Chris P.; Sengpiel, Verena; Bottai, Matteo; Mayo, Jonathan A.; Shaw, Gary M.; Verdenik, Ivan; Tul, Natasa; Velebil, Petr; Cairns-Smith, Sarah; Rushwan, Hamid; Arulkumaran, Sabaratnam; Howse, Jennifer L.; Simpson, Joe Leigh			Cross-Country Individual Participant Analysis of 4.1 Million Singleton Births in 5 Countries with Very High Human Development Index Confirms Known Associations but Provides No Biologic Explanation for 2/3 of All Preterm Births	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; RISK-FACTORS; MATERNAL OBESITY; DELIVERY; INTERVENTIONS; WEIGHT; TRENDS; WOMEN; US	Background Preterm birth is the most common single cause of perinatal and infant mortality, affecting 15 million infants worldwide each year with global rates increasing. Understanding of risk factors remains poor, and preventive interventions have only limited benefit. Large differences exist in preterm birth rates across high income countries. We hypothesized that understanding the basis for these wide variations could lead to interventions that reduce preterm birth incidence in countries with high rates. We thus sought to assess the contributions of known risk factors for both spontaneous and provider-initiated preterm birth in selected high income countries, estimating also the potential impact of successful interventions due to advances in research, policy and public health, or clinical practice. Methods We analyzed individual patient-level data on 4.1 million singleton pregnancies from four countries with very high human development index (Czech Republic, New Zealand, Slovenia, Sweden) and one comparator U.S. state (California) to determine the specific contribution (adjusting for confounding effects) of 21 factors. Both individual and population-attributable preterm birth risks were determined, as were contributors to cross-country differences. We also assessed the ability to predict preterm birth given various sets of known risk factors. Findings Previous preterm birth and preeclampsia were the strongest individual risk factors of preterm birth in all datasets, with odds ratios of 4.6-6.0 and 2.8-5.7, respectively, for individual women having those characteristics. In contrast, on a population basis, nulliparity and male sex were the two risk factors with the highest impact on preterm birth rates, accounting for 25-50% and 11-16% of excess population attributable risk, respectively (p<0.001). The importance of nulliparity and male sex on population attributable risk was driven by high prevalence despite low odds ratios for individual women. More than 65% of the total aggregated risk of preterm birth within each country lacks a plausible biologic explanation, and 63% of difference between countries cannot be explained with known factors; thus, research is necessary to elucidate the underlying mechanisms of preterm birth and, hence, therapeutic intervention. Surprisingly, variation in prevalence of known risk factors accounted for less than 35% of the difference in preterm birth rates between countries. Known risk factors had an area under the curve of less than 0.7 in ROC analysis of preterm birth prediction within countries. These data suggest that other influences, as yet unidentified, are involved in preterm birth. Further research into biological mechanisms is warranted. Conclusions We have quantified the causes of variation in preterm birth rates among countries with very high human development index. The paucity of explicit and currently identified factors amenable to intervention illustrates the limited impact of changes possible through current clinical practice and policy interventions. Our research highlights the urgent need for research into underlying biological causes of preterm birth, which alone are likely to lead to innovative and efficacious interventions.	[Ferrero, David M.; Larson, Jim; Cairns-Smith, Sarah] Boston Consulting Grp Inc, Boston, MA USA; [Howson, Chris P.; Howse, Jennifer L.; Simpson, Joe Leigh] March Dimes Fdn, White Plains, NY 10605 USA; [Di Renzo, Gian Carlo; Castelazo, Ernesto; Rushwan, Hamid; Arulkumaran, Sabaratnam] Int Federat Gynecol & Obstet, London, England; [Jacobsson, Bo; Sengpiel, Verena] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Hlth Women & Children, Dept Obstet & Gynecol,Sahlgrenska Acad, Gothenburg, Sweden; [Mayo, Jonathan A.; Shaw, Gary M.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Martin, James N., Jr.] Univ Mississippi, Med Ctr, Div Maternal Fetal Med, Jackson, MS 39216 USA; [D'Alton, Mary] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Norman, Jane E.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, Tommys Ctr Fetal & Maternal Hlth,Med Res Council, Edinburgh, Midlothian, Scotland; [Bottai, Matteo] Karolinska Inst, IMM, Unit Biostat, Stockholm, Sweden; [Di Renzo, Gian Carlo] Univ Perugia, Dept Obstet & Gynecol, Perugia, Italy; [Verdenik, Ivan; Tul, Natasa] Univ Med Ctr Ljubljana, Div Obstet & Gynecol, Dept Perinatol, Ljubljana, Slovenia; [Velebil, Petr] Perinatal Ctr, Inst Care Mother & Child, Prague, Czech Republic; [Jacobsson, Bo] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway	Boston Consulting Group (BCG); Sahlgrenska University Hospital; University of Gothenburg; Stanford University; University of Mississippi; University of Mississippi Medical Center; Columbia University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; Karolinska Institutet; University of Perugia; University Medical Centre Ljubljana; Norwegian Institute of Public Health (NIPH)	Simpson, JL (corresponding author), March Dimes Fdn, White Plains, NY 10605 USA.	jsimposon@marchofdimes.org	Di Renzo, Gian C./P-3819-2017; Verdenik, Ivan/G-9618-2012; Jacobsson, Bo/O-8007-2014	Di Renzo, Gian C./0000-0003-4467-240X; Jacobsson, Bo/0000-0001-5079-2374; Shaw, Gary/0000-0001-7438-4914; Norman, Jane/0000-0001-6031-6953	March of Dimes Foundation; International Federation of Obstetrics and Gynecology (FIGO)	March of Dimes Foundation(March of Dimes); International Federation of Obstetrics and Gynecology (FIGO)	This study was funded by the March of Dimes Foundation and the International Federation of Obstetrics and Gynecology (FIGO). Individuals from these organizations were involved in analyzing the data and writing the paper. Authors from the Boston Consulting Group (DMF, JL, SCS) contributed to this work under contract with the March of Dimes Foundation and FIGO. The sponsoring agencies' financial management had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	[Anonymous], 2014, NZ MAT CLIN IND 2012; [Anonymous], 2002, NEW TOT POP REG SYST; Behrman RE, 2007, REPORTS FUNDED NATL; Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Chiavarini M, 2012, INT J PUBLIC HEALTH, V57, P261, DOI 10.1007/s00038-011-0311-3; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Delnord M, 2015, CURR OPIN OBSTET GYN, V27, P133, DOI 10.1097/GCO.0000000000000156; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Di Renzo GC, 2011, EUR J OBSTET GYN R B, V159, P342, DOI 10.1016/j.ejogrb.2011.09.024; Erickson K, 2001, J CLIN ENDOCR METAB, V86, P2544, DOI 10.1210/jc.86.6.2544; Euro Peristat, 2010, EUR PER HLTH REP HLT; Garn JV, 2015, MATERN CHILD HLTH J, V19, P811, DOI 10.1007/s10995-014-1576-y; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Gould JB, 2014, ACTA PAEDIATR, V103, P586, DOI 10.1111/apa.12616; Heaman M, 2013, PAEDIATR PERINAT EP, V27, P54, DOI 10.1111/ppe.12016; Herrchen B, 1997, COMPUT BIOMED RES, V30, P290, DOI 10.1006/cbmr.1997.1448; Hillemeier MM, 2007, J RURAL HEALTH, V23, P42, DOI 10.1111/j.1748-0361.2006.00066.x; Iams JD, 2014, NEW ENGL J MED, V370, P254, DOI 10.1056/NEJMcp1103640; Kistka ZA, 2008, AM J OBSTET GYNECOL, V199, pe1, DOI DOI 10.1016/J.AJ0G.2007.12.014; Kistka ZAF, 2007, AM J OBSTET GYNECOL, V196, P241, DOI [10.1016/j.ajog.2006.10.873, 10.1016/j.ajog.2006.06.093]; KRAMER MS, 1992, AM J EPIDEMIOL, V136, P574, DOI 10.1093/oxfordjournals.aje.a116535; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lucovnik M, 2014, J PERINATOL, V34, P673, DOI 10.1038/jp.2014.74; March of Dimes P Save the Children WHO, 2012, BORN TOO SOON GLOBAL; Martius JA, 1998, EUR J OBSTET GYN R B, V80, P183, DOI 10.1016/S0301-2115(98)00130-4; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Morken NH, 2014, PAEDIATR PERINAT EP, V28, P11, DOI 10.1111/ppe.12087; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Ofori BD, 2008, PHARMACOEPIDEM DR S, V17, P556, DOI 10.1002/pds.1575; OLSEN P, 1995, AM J EPIDEMIOL, V142, P1184, DOI 10.1093/oxfordjournals.aje.a117577; Rodrigues T, 2007, MATERN CHILD HLTH J, V11, P417, DOI 10.1007/s10995-007-0195-2; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce; Xu XK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0406-y; Zeitlin J, 2015, MATERN CHILD HLTH J, V19, P1107, DOI 10.1007/s10995-014-1602-0; Zhang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052780; ZWEIG MH, 1993, CLIN CHEM, V39, P561	44	94	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162506	10.1371/journal.pone.0162506	http://dx.doi.org/10.1371/journal.pone.0162506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622562	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000383681000035
J	Douglas, SM; Chubiz, LM; Harcombe, WR; Ytreberg, FM; Marx, CJ				Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Ytreberg, F. Marty; Marx, Christopher J.			Parallel Mutations Result in a Wide Range of Cooperation and Community Consequences in a Two-Species Bacterial Consortium	PLOS ONE			English	Article							LONG-TERM EXPERIMENT; ESCHERICHIA-COLI; METHIONINE BIOSYNTHESIS; SALMONELLA-TYPHIMURIUM; BENEFICIAL MUTATIONS; SPECIES INTERACTIONS; EVOLUTION; POPULATIONS; MUTANTS; EXPRESSION	Multi-species microbial communities play a critical role in human health, industry, and waste remediation. Recently, the evolution of synthetic consortia in the laboratory has enabled adaptation to be addressed in the context of interacting species. Using an engineered bacterial consortium, we repeatedly evolved cooperative genotypes and examined both the predictability of evolution and the phenotypes that determine community dynamics. Eight Salmonella enterica serovar Typhimurium strains evolved methionine excretion sufficient to support growth of an Escherichia coli methionine auxotroph, from whom they required excreted growth substrates.Non-synonymous mutations in metA, encoding homoserine trans-succinylase (HTS), were detected in each evolved S. enterica methionine cooperator and were shown to be necessary for cooperative consortia growth. Molecular modeling was used to predict that most of the non-synonymous mutations slightly increase the binding affinity for HTS homodimer formation. Despite this genetic parallelism and trend of increasing protein binding stability, these metA alleles gave rise to a wide range of phenotypic diversity in terms of individual versus group benefit. The cooperators with the highest methionine excretion permitted nearly two-fold faster consortia growth and supported the highest fraction of E. coli, yet also had the slowest individual growth rates compared to less cooperative strains. Thus, although the genetic basis of adaptation was quite similar across independent origins of cooperative phenotypes, quantitative measurements of metabolite production were required to predict either the individual-level growth consequences or how these propagate to community-level behavior.	[Douglas, Sarah M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA; [Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Ytreberg, F. Marty; Marx, Christopher J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Chubiz, Lon M.] Univ Missouri St Louis, Dept Biol, St Louis, MO USA; [Harcombe, William R.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Harvard University; Harvard University; Harvard University; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; University of Missouri System; University of Missouri Saint Louis; University of Minnesota System; University of Minnesota Twin Cities	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Marx, CJ (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.; Marx, CJ (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.	cmarx@uidaho.edu			NIH NRSA Award; DOE award [DE-SC0006731]	NIH NRSA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE award(United States Department of Energy (DOE))	This work was funded with an NIH (www.nih.gov) NRSA Award to WRH and a DOE (www.energy.gov) award to CJM (DE-SC0006731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Dominguez A, 2014, ISME J, V8, P1041, DOI 10.1038/ismej.2013.208; [Anonymous], PYMOL MOL GRAPHICS S; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Biran D, 2000, MOL MICROBIOL, V37, P1436, DOI 10.1046/j.1365-2958.2000.02097.x; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Chubiz L, 2014, METHODS MOL BIOL, V1151, P39, DOI 10.1007/978-1-4939-0554-6_3; Chubiz LM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00271; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delaney NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062957; Delaney NF, 2013, JALA-J LAB AUTOM, V18, P171, DOI 10.1177/2211068212460237; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; HOBSON AC, 1973, MOL GEN GENET, V126, P7, DOI 10.1007/BF00333477; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; KASCER H, 1973, S SOC EXP BIOL, V27, P65; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim W, 2014, P NATL ACAD SCI USA, V111, pE1639, DOI 10.1073/pnas.1323632111; Kinnersley M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004430; Kummerli R, 2015, J EVOLUTION BIOL, V28, P2264, DOI 10.1111/jeb.12751; LAWRENCE DA, 1968, GENETICS, V58, P473; LAWRENCE DA, 1972, J BACTERIOL, V109, P8, DOI 10.1128/JB.109.1.8-11.1972; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Liow LH, 2011, TRENDS ECOL EVOL, V26, P349, DOI 10.1016/j.tree.2011.03.016; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; MacLean RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000406; Marx CJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001487; Miller CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112988; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00230; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Paliwal V, 2012, APPL BIOCHEM BIOTECH, V166, P903, DOI 10.1007/s12010-011-9479-5; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shyu C, 2011, TOXICOL APPL PHARM, V250, P322, DOI 10.1016/j.taap.2010.11.005; Smid EJ, 2013, CURR OPIN BIOTECH, V24, P148, DOI 10.1016/j.copbio.2012.11.007; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Usuda Y, 2005, APPL ENVIRON MICROB, V71, P3228, DOI 10.1128/AEM.71.6.3228-3234.2005; Wagner M, 2002, ANTON LEEUW INT J G, V81, P665, DOI 10.1023/A:1020586312170; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhan YA, 2013, PROTEINS, V81, P1738, DOI 10.1002/prot.24310	55	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161837	10.1371/journal.pone.0161837	http://dx.doi.org/10.1371/journal.pone.0161837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617746	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100011
J	Bauer, PM; Zalis, MC; Abdshill, H; Deierborg, T; Johansson, F; Englund-Johansson, U				Bauer, Patrik Maximilian; Zalis, Marina Castro; Abdshill, Hodan; Deierborg, Tomas; Johansson, Fredrik; Englund-Johansson, Ulrica			Inflamed In Vitro Retina: Cytotoxic Neuroinflammationand Galectin-3 Expression	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MICROGLIAL CELL RESPONSES; NEURODEGENERATIVE DISEASES; ORGANOTYPIC CULTURES; MOUSE RETINA; MULLER CELLS; RAT RETINA; DEATH; INFLAMMATION; ACTIVATION	Background Disease progression in retinal neurodegeneration is strongly correlated to immune cell activation, which may have either a neuroprotective or neurotoxic effect. Increased knowledge about the immune response profile and retinal neurodegeneration may lead to candidate targets for treatments. Therefore, we have used the explanted retina as a model to explore the immune response and expression of the immune modulator galectin-3 (Gal-3), induced by the cultivation per se and after additional immune stimulation with lipopolysaccharide (LPS), and how this correlates with retinal neurotoxicity. Methods Post-natal mouse retinas were cultured in a defined medium. One group was stimulated with LPS (100 ng/ml, 24 h). Retinal architecture, apoptotic cell death, and micro-and macroglial activity were studied at the time of cultivation (0 days in vitro (DIV)) and at 3, 4 and 7 DIV using morphological staining, biochemical-and immunohistochemical techniques. Results Our results show that sustained activation of macro-and microglia, characterized by no detectable cytokine release and limited expression of Gal-3, is not further inducing apoptosis additional to the axotomy-induced apoptosis in innermost nuclear layer. An elevated immune response was detected after LPS stimulation, as demonstrated primarily by release of immune mediators (i.e. interleukin 2 (IL-2), IL-6, KC/GRO (also known as CLCX1) and tumour necrosis factor-alpha (TNF-alpha)), increased numbers of microglia displaying morphologies of late activation stages as well as Gal-3 expression. This was accompanied with increased apoptosis in the two additional nuclear layers, and damage to retinal gross architecture. Conclusion We demonstrate that an immune response characterized by sustained and increased release of cytokines, along with an increase in Gal-3 expression, is accompanied by significant increased neurotoxicity in the explanted retina. Further investigations using the current setting may lead to increased understanding on the mechanisms involved in neuronal loss in retinal neurodegenerations.	[Bauer, Patrik Maximilian; Johansson, Fredrik] Lund Univ, Dept Biol, Sect Funct Zool, Lund, Sweden; [Bauer, Patrik Maximilian; Zalis, Marina Castro; Abdshill, Hodan; Englund-Johansson, Ulrica] Lund Univ, Div Ophthalmol, Dept Clin Sci Lund, Lund, Sweden; [Deierborg, Tomas] Lund Univ, Dept Expt Med Sci, Expt Neuroinflammat Lab, Lund, Sweden	Lund University; Lund University; Lund University	Englund-Johansson, U (corresponding author), Lund Univ, Div Ophthalmol, Dept Clin Sci Lund, Lund, Sweden.	ulrica.englund_johansson@med.lu.se	Deierborg, Tomas/P-6345-2015	Deierborg, Tomas/0000-0002-3651-3444	Crafoord Foundation; Olle Engqvist Foundation; Olle and Edla Johansson Foundation; VELUX stiftung; Claes Groschinsky Foundation; Crown Princess Margaretas Fund for Vision Disabled; Fund for Vision disabled in Southern Sweden; Clas Groschinsky Foundation	Crafoord Foundation; Olle Engqvist Foundation; Olle and Edla Johansson Foundation; VELUX stiftung; Claes Groschinsky Foundation; Crown Princess Margaretas Fund for Vision Disabled; Fund for Vision disabled in Southern Sweden; Clas Groschinsky Foundation	This work was funded by The Crafoord Foundation, The Olle Engqvist Foundation, The Olle and Edla Johansson Foundation, The VELUX stiftung, The Claes Groschinsky Foundation, Crown Princess Margaretas Fund for visually disabled, and Fund for Vision disabled in Southern Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For funding we gratefully thank the Crafoord Foundation, VELUX stiftung, Olle Engqvist Foundation, Edla and Olle Johanssons Foundation, Clas Groschinsky Foundation, Crown Princess Margaretas Fund for Vision Disabled, Fund for vision disabled in Southern Sweden. We also thank Birgitta Stenstrom for excellent technical assistance, Dr Lars Raberg (Dept Biology, Lund University) for advice on the statistical analysis, and Dr Christopher Dunning for proof-reading the manuscript.	Ahl M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0618-3; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Boza-Serrano A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0156-0; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Burguillos M. A., 2015, CELL REPORTS; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Canning P, 2007, EXP DIABETES RES, DOI 10.1155/2007/51837; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; DUNLOP SA, 1987, J COMP NEUROL, V264, P14, DOI 10.1002/cne.902640103; Engelsberg K, 2004, GRAEF ARCH CLIN EXP, V242, P229, DOI 10.1007/s00417-003-0780-z; Fakhoury M, 2015, NEURODEGENER DIS, V15, P63, DOI 10.1159/000369933; Farinelli P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.512; Ferrer-Martin RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135238; Ferrer-Martin RM, 2014, EXP EYE RES, V121, P42, DOI 10.1016/j.exer.2014.02.015; GUERIN CJ, 1990, INVEST OPHTH VIS SCI, V31, P1474; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hakansson Gisela, 2010, J Ocul Biol Dis Infor, V3, P20, DOI 10.1007/s12177-010-9050-6; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jang S, 2007, NEUROCHEM RES, V32, P1, DOI 10.1007/s11064-006-9215-7; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim J, 2009, MOL VIS, V15, P1971; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; Liu GH, 2014, MICROCIRCULATION, V21, P478, DOI 10.1111/micc.12121; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Madeira MH, MEDIATORS INFLAMMATI; Manouchehrian O, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0312-x; McKernan DP, 2006, INVEST OPHTH VIS SCI, V47, P807, DOI 10.1167/iovs.05-0520; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Mertsch K, 2001, J COMP NEUROL, V431, P217; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036; Pajoohesh-Ganji A, 2012, BRAIN RES, V1475, P96, DOI 10.1016/j.brainres.2012.07.058; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Pfister F, 2013, PFLUG ARCH EUR J PHY, V465, P789, DOI 10.1007/s00424-013-1272-6; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SANYAL S, 1973, Z ANAT ENTWICKLUNGS, V142, P219, DOI 10.1007/BF00519723; SCHNITZER J, 1990, J COMP NEUROL, V302, P779, DOI 10.1002/cne.903020410; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Shin T, 2013, ACTA HISTOCHEM, V115, P407, DOI 10.1016/j.acthis.2012.11.010; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Smith SWMJ Richard S., 2001, SYSTEMATIC EVALUATIO, P195; Soderstjerna E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105359; Soto I, 2014, COLD SPRING HARB PER, V4; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Uehara F, 2001, INVEST OPHTH VIS SCI, V42, P2164; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/724648; Wilson GN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0399-0; Zhang FJ, 2015, NEUROPSYCH DIS TREAT, V11, P243, DOI 10.2147/NDT.S75546	72	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161723	10.1371/journal.pone.0161723	http://dx.doi.org/10.1371/journal.pone.0161723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612287	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900028
J	Bian, YQ; Deng, C; Li, WZ; Lei, ZJ; Li, YJ; Li, XY				Bian, Yongqian; Deng, Chen; Li, Wangzhou; Lei, Zhanjun; Li, Yuejun; Li, Xueyong			A Comparative Study on the Biological Characteristics of Human Adipose-Derived Stem Cells from Lipectomy and Liposuction	PLOS ONE			English	Article							LOCAL-ANESTHETICS; REGENERATIVE MEDICINE; TISSUE; APOPTOSIS; DIFFERENTIATION; RECONSTRUCTION; CYTOTOXICITY; TOXICITY	Purposes To compare the biological behaviors of human adipose-derived stem cells (ADSCs) isolated from adipose tissue by lipectomy and liposuction, with the purpose of providing the basis for clinical application. Methods The proliferation and apoptosis of ADSCs were analyzed by CCK-8 assay and flow cytometry. Cell migration was measured by a wound healing assay. An ELISA assay was used to evaluate paracrine functions. SOD and MDA were tested by xanthine oxidase and thiobarbituric acid reactions, respectively. In addition, we used a CCK-8, LDH assay and flow cytometry to analyze the proliferation and apoptosis of ADSCs treated with lidocaine or adrenaline. Results The viable ADSCs yield from liposuction was significantly lower than that from lipectomy, while the apoptosis of cells from liposuction was significantly higher than from lipectomy. The paracrine secretion of the two sources of ADSCs was highest when treated with 10(-7) mol/L insulin and 10 ng/mL TGF-alpha, but there were no significant differences in VEGF, IL-6, IL-8 or HGF levels. The ADSCs from lipectomy migrated faster than those from liposuction, and SOD in the lipectomy group was higher than in the liposuction group, whereas MDA of the lipectomy group was lower than that of the liposuction group. The proliferation ADSCs treated with lidocaine or adrenaline was greatly decreased, while apoptosis was significantly increased, and cytotoxicity of lidocaine or adrenaline to ADSCs was dose-dependent. Conclusions Compared with ADSCs from liposuction, the ADSCs from lipectomy have better biological characteristics. Lidocaine and adrenaline decreased the viability of ADSCs, and their cytotoxicity to ADSCs was dose-dependent.	[Bian, Yongqian; Deng, Chen; Li, Wangzhou; Lei, Zhanjun; Li, Yuejun; Li, Xueyong] Fourth Mil Med Univ, Tangdu Hosp, Dept Burn & Plast Surg, Xian, Shannxi, Peoples R China	Air Force Military Medical University	Li, YJ; Li, XY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Burn & Plast Surg, Xian, Shannxi, Peoples R China.	liyj@fmmu.edu.cn; yuyong@fmmu.edu.cn			National High Technology Research and Development Program of China [2015AA020313]; National Natural Foundation of China [81302377]; Military Medical Science and Technology for Youth Development Project [13QNP133]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Military Medical Science and Technology for Youth Development Project	This study was funded by National High Technology Research and Development Program of China (No. 2015AA020313, http://www.most.gov.cn, Xueyong Li received the funding), National Natural Foundation of China (No. 81302377, http://www.nsfc.gov.cn, Yongqian Bian received the funding), and Military Medical Science and Technology for Youth Development Project (No. 13QNP133, Yongqian Bian received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RW, 2010, AUTOLOGOUS FAT TRANSFER: ART, SCIENCE, AND CLINICAL PRACTICE, P445, DOI 10.1007/978-3-642-00473-5_58; Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115; Chang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089563; Chung MT, 2013, STEM CELL TRANSL MED, V2, P808, DOI 10.5966/sctm.2012-0183; Gause TM, 2014, ADIPOCYTE, V3, P273, DOI 10.4161/21623945.2014.957987; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Lei H, 2014, ANN PLAS SURG, V73, P225, DOI 10.1097/SAP.0b013e318271005f; Li KH, 2015, J MOL NEUROSCI, V56, P122, DOI 10.1007/s12031-014-0473-6; Livaoglu M, 2012, J CRANIOFAC SURG, V23, P1015, DOI 10.1097/SCS.0b013e31824e7302; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Serra-Renom JM, 2010, PLAST RECONSTR SURG, V125, P12, DOI 10.1097/PRS.0b013e3181c49458; Milena R, 2014, ACTA VET, V64, P281, DOI [10.2478/acve-2014-0027, DOI 10.2478/ACVE-2014-0027]; Naderi N, 2014, J PLAST RECONSTR AES, V67, P1726, DOI 10.1016/j.bjps.2014.08.013; Nagata H, 2016, STEM CELL TRANSL MED, V5, P141, DOI 10.5966/sctm.2015-0083; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Rahnama R, 2013, J BONE JOINT SURG AM, V95A, P132, DOI 10.2106/JBJS.K.01291; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Rubin JP, 2013, LANCET, V382, P1077, DOI 10.1016/S0140-6736(13)61744-4; Schreml S, 2009, CYTOTHERAPY, V11, P947, DOI 10.3109/14653240903204322; Stosich MS, 2007, PLAST RECONSTR SURG, V119, P71, DOI 10.1097/01.prs.0000244840.80661.e7; Tran AN, 2014, J DRUGS DERMATOL, V13, P1118; Uysal AC, 2009, PLAST RECONSTR SURG, V124, P804, DOI 10.1097/PRS.0b013e3181b17bb4; Walker SM, 2012, ANESTH ANALG, V115, P450, DOI 10.1213/ANE.0b013e3182501a09; Werdehausen R, 2009, BRIT J ANAESTH, V103, P711, DOI 10.1093/bja/aep236; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162343	10.1371/journal.pone.0162343	http://dx.doi.org/10.1371/journal.pone.0162343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610618	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900081
J	Emmert, S; Haenssle, HA; Zibert, JR; Schon, M; Hald, A; Hansen, MH; Litman, T; Schon, MP				Emmert, Steffen; Haenssle, Holger A.; Zibert, John R.; Schoen, Margarete; Hald, Andreas; Hansen, Maria H.; Litman, Thomas; Schoen, Michael P.			Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate	PLOS ONE			English	Article							PROTEIN-KINASE-C; SOLAR KERATOSIS; GENE-EXPRESSION; DOUBLE-BLIND; HUMAN SKIN; CARCINOMA; GEL; CANCER; PEP005; INGENOL-3-ANGELATE	The rapid and strong clinical efficacy of the first-in-class, ingenol mebutate, against actinic keratosis (AK) has resulted in its recent approval. We conducted the first comprehensive analysis of the cellular and molecular mode of action of topical ingenol mebutate 0.05% gel in both AK and uninvolved skin of 26 patients in a phase I, single-center, open-label, within-patient comparison. As early as 1 day after application, ingenol mebutate induced profound epidermal cell death, along with a strong infiltrate of CD4(+) and CD8(+) T-cells, neutrophils, and macrophages. Endothelial ICAM-1 activation became evident after 2 days. The reaction pattern was significantly more pronounced in AK compared with uninvolved skin, suggesting a tumor-preferential mode of action. Extensive molecular analyses and transcriptomic profiling of mRNAs and microRNAs demonstrated alterations in gene clusters functionally associated with epidermal development, inflammation, innate immunity, and response to wounding. Ingenol mebutate reveals a unique mode of action linking directly to anti-tumoral effects.	[Emmert, Steffen; Haenssle, Holger A.; Schoen, Margarete; Schoen, Michael P.] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Zibert, John R.; Hald, Andreas; Hansen, Maria H.; Litman, Thomas] LEO Pharma AS, Ballerup, Denmark; [Emmert, Steffen] Univ Med Ctr Rostock, Dept Dermatol, Rostock, Germany; [Haenssle, Holger A.] Univ Med Ctr Heidelberg, Dept Dermatol Venereol & Allergol, Heidelberg, Germany	University of Gottingen; LEO Pharma; University of Rostock; Ruprecht Karls University Heidelberg	Schon, MP (corresponding author), Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany.	michael.schoen@med.uni-goettingen.de	Zibert, John Robert/GRY-3584-2022	Litman, Thomas/0000-0002-6068-901X	LEO Pharma A/S	LEO Pharma A/S	This work was funded by LEO Pharma A/S. The funder provided support in the form of salaries for authors (JRZ, AH, MHH, TL). The funder was responsible for the study according to the law. LEO Pharma A/S did contribute to: the study design, the electronic case report system and analysis of the data, the monitoring according to GCP, preparation of the manuscript, and, in collaboration with the PI, the decision to publish the work. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Babilas R, 2003, HAUTARZT, V54, P551, DOI 10.1007/s00105-003-0543-0; Berman B, 2014, J DRUGS DERMATOL, V13, P741; Berman B, 2012, CLIN COSMET INVESTI, V5, P111, DOI 10.2147/CCID.S28905; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; Cockerell CJ, 2000, J AM ACAD DERMATOL, V42, pS11, DOI 10.1067/mjd.2000.103344; Cohen Joel L, 2010, J Clin Aesthet Dermatol, V3, P39; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; Czarnecki D, 2002, J CUTAN MED SURG, V6, P207, DOI 10.1007/s10227-001-0041-x; Dayem MA, 2003, COMP FUNCT GENOM, V4, P47, DOI 10.1002/cfg.239; Divekar AA, 2011, J IMMUNOL, V186, P924, DOI 10.4049/jimmunol.1002218; Einspahr JG, 2002, CRIT REV ONCOL HEMAT, V41, P269, DOI 10.1016/S1040-8428(01)00185-8; Esmann S, 2013, BRIT J DERMATOL, V168, P277, DOI 10.1111/bjd.12036; Fernandez-Figueras MT, 2015, J EUR ACAD DERMATOL, V29, P991, DOI 10.1111/jdv.12848; Flohil SC, 2013, J INVEST DERMATOL, V133, P1971, DOI 10.1038/jid.2013.134; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; Fu W, 2003, ARCH DERMATOL, V139, P66, DOI 10.1001/archderm.139.1.66; Gillespie SK, 2004, MOL CANCER THER, V3, P1651; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; HURWITZ RM, 1995, DERMATOL SURG, V21, P184, DOI 10.1111/j.1524-4725.1995.tb00141.x; Jorgensen L, 2013, SCIENCE, V341, P878, DOI 10.1126/science.1241606; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Le TTT, 2009, VACCINE, V27, P3053, DOI 10.1016/j.vaccine.2009.03.025; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Liang PF, 2012, BURNS, V38, P534, DOI 10.1016/j.burns.2011.10.014; Makino K, 2012, CLIN EXP DERMATOL, V37, P34, DOI 10.1111/j.1365-2230.2011.04158.x; Memon AA, 2000, BRIT J DERMATOL, V142, P1154, DOI 10.1046/j.1365-2133.2000.03541.x; Mittelbronn MA, 1998, INT J DERMATOL, V37, P677, DOI 10.1046/j.1365-4362.1998.00467.x; Nissan X, 2011, DEV BIOL, V356, P506, DOI 10.1016/j.ydbio.2011.06.004; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Olsnes AM, 2009, BRIT J HAEMATOL, V145, P761, DOI 10.1111/j.1365-2141.2009.07691.x; Ortonne JP, 2002, BRIT J DERMATOL, V146, P20, DOI 10.1046/j.1365-2133.146.s61.6.x; Padilla RS, 2010, ARCH DERMATOL, V146, P288, DOI 10.1001/archdermatol.2009.378; Ramsay JR, 2011, BRIT J DERMATOL, V164, P633, DOI 10.1111/j.1365-2133.2010.10184.x; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rosen RH, 2012, J AM ACAD DERMATOL, V66, P486, DOI 10.1016/j.jaad.2010.12.038; Rosen T, 2013, J AM ACAD DERMATOL, V68, pS2, DOI 10.1016/j.jaad.2012.09.052; Salvesen HG, 2002, ESSAYS BIOCHEM, V39, P9; Sanmartin O, 2008, NEW ENGL J MED, V358, pE21, DOI 10.1056/NEJMicm071130; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Siller G, 2009, AUSTRALAS J DERMATOL, V50, P16, DOI 10.1111/j.1440-0960.2008.00497.x; Stahlhut M, 2012, J DRUGS DERMATOL, V11, P1181; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004; Zidar N, 2011, DIS MARKERS, V31, P259, DOI [10.1155/2011/247654, 10.3233/DMA-2011-0827]	53	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160096	10.1371/journal.pone.0160096	http://dx.doi.org/10.1371/journal.pone.0160096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612149	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255900002
J	Esteban, C; Arostegui, I; Aburto, M; Moraza, J; Quintana, JM; Garcia-Loizaga, A; Basualdo, LV; Aramburu, A; Aizpiri, S; Uranga, A; Capelastegui, A				Esteban, Cristobal; Arostegui, Inmaculada; Aburto, Myriam; Moraza, Javier; Quintana, Jose M.; Garcia-Loizaga, Amaia; Basualdo, Luis V.; Aramburu, Amaia; Aizpiri, Susana; Uranga, Ane; Capelastegui, Alberto			Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CLINICAL PHENOTYPES; COPD; MORTALITY; IDENTIFICATION; COMORBIDITIES; RELIABILITY; STRENGTH; CLUSTERS; DYSPNEA	Background Although subtypes of chronic obstructive pulmonary disease are recognized, it is unknown what happens to these subtypes over time. Our objectives were to assess the stability of cluster-based subtypes in patients with stable disease and explore changes in clusters over 1 year. Methods Multiple correspondence and cluster analysis were used to evaluate data collected from 543 stable patients included consecutively from 5 respiratory outpatient clinics. Results Four subtypes were identified. Three of them, A, B, and C, had marked respiratory profiles with a continuum in severity of several variables, while the fourth, subtype D, had a more systemic profile with intermediate respiratory disease severity. Subtype A was associated with less dyspnea, better health-related quality of life and lower Charlson comorbidity scores, and subtype C with the most severe dyspnea, and poorer pulmonary function and quality of life, while subtype B was between subtypes A and C. Subtype D had higher rates of hospitalization the previous year, and comorbidities. After 1 year, all clusters remained stable. Generally, patients continued in the same subtype but 28% migrated to another cluster. Together with movement across clusters, patients showed changes in certain characteristics (especially exercise capacity, some variables of pulmonary function and physical activity) and changes in outcomes (quality of life, hospitalization and mortality) depending on the new cluster they belonged to. Conclusions Chronic obstructive pulmonary disease clusters remained stable over 1 year. Most patients stayed in their initial subtype cluster, but some moved to another subtype and accordingly had different outcomes.	[Esteban, Cristobal; Aburto, Myriam; Moraza, Javier; Garcia-Loizaga, Amaia; Basualdo, Luis V.; Aramburu, Amaia; Aizpiri, Susana; Uranga, Ane; Capelastegui, Alberto] Hosp Galdakao Usansolo, Resp Dept, Galdakao, Bizkaia, Spain; [Esteban, Cristobal; Arostegui, Inmaculada; Quintana, Jose M.] Hlth Serv Res Chron Patients Network REDISSEC, Galdakao, Bizkaia, Spain; [Arostegui, Inmaculada] Univ Basque Country UPV EHU, Dept Appl Math Stat & Operat Res, Leioa, Bizkaia, Spain; [Arostegui, Inmaculada] Basque Ctr Appl Math BCAM, Leioa, Bizkaia, Spain; [Quintana, Jose M.] Hosp Galdakao Usansolo, Res Unit, Galdakao, Bizkaia, Spain	Galdakao Hospital; University of Basque Country; Basque Center for Applied Mathematics (BCAM); Galdakao Hospital	Esteban, C (corresponding author), Hosp Galdakao Usansolo, Resp Dept, Galdakao, Bizkaia, Spain.; Esteban, C (corresponding author), Hlth Serv Res Chron Patients Network REDISSEC, Galdakao, Bizkaia, Spain.	cristobal.est@gmail.com	; AROSTEGUI, INMACULADA/G-5941-2014	Aburto, Myriam/0000-0001-8644-1015; AROSTEGUI, INMACULADA/0000-0002-6848-2240; Quintana, Jose M./0000-0003-2170-7876; ESTEBAN, CRISTOBAL/0000-0001-9878-7806	Fondo de Investigacion Sanitaria [PI020510]; Departamento de Sanidad del Gobierno Vasco Ministerio de Economia y Competitividad del Gobierno de Espana [200111002, MTM2013-40941-P]; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco [IT620-13]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Departamento de Sanidad del Gobierno Vasco Ministerio de Economia y Competitividad del Gobierno de Espana; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco	This work was supported by Fondo de Investigacion Sanitaria [grant number PI020510], and by Departamento de Sanidad del Gobierno Vasco [grant number 200111002] Ministerio de Economia y Competitividad del Gobierno de Espana (MTM2013-40941-P), Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco (IT620-13).	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2004, MANUAL SEPAR PROCEDI; Arostegui I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098580; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Benzecri J. P., 1969, Proceedings of the international conference on methodologies of pattern recognition, P35; Bohannon RW, 2009, ISOKINET EXERC SCI, V17, P169, DOI 10.3233/IES-2009-0349; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Burgel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051048; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; DORNHORST AC, 1955, LANCET, V1, P1185; Esteban C, 2010, EUR RESPIR J, V36, P292, DOI 10.1183/09031936.00021409; Esteban C, 2014, RESPIROLOGY, V19, P330, DOI 10.1111/resp.12239; Ferrer M, 1996, EUR RESPIR J, V9, P1160, DOI 10.1183/09031936.96.09061160; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Jambu M, 1978, CLASSIFICATION AUTOM, V1; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Mahler DA, 2009, CHEST, V136, P1473, DOI 10.1378/chest.09-0934; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Miravitiles M, 2013, EUR RESPIR J, V41, P1252, DOI 10.1183/09031936.00118912; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Schnohr P, 2003, AM J EPIDEMIOL, V158, P639, DOI 10.1093/aje/kwg207; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161710	10.1371/journal.pone.0161710	http://dx.doi.org/10.1371/journal.pone.0161710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611911	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900025
J	Gimenez-Lirola, LG; Mur, L; Rivera, B; Mogler, M; Sun, YX; Lizano, S; Goodell, C; Harris, DLH; Rowland, RRR; Gallardo, C; Sanchez-Vizcaino, JM; Zimmerman, J				Gimenez-Lirola, Luis G.; Mur, Lina; Rivera, Belen; Mogler, Mark; Sun, Yaxuan; Lizano, Sergio; Goodell, Christa; Harris, D. L. Hank; Rowland, Raymond R. R.; Gallardo, Carmina; Manuel Sanchez-Vizcaino, Jose; Zimmerman, Jeff			Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; HIGH-LEVEL EXPRESSION; POTENTIAL USE; SAMPLES; SERODIAGNOSIS; SURVEILLANCE; DIAGNOSIS; PRRSV; PIGS	In the absence of effective vaccine(s), control of African swine fever caused by African swine fever virus (ASFV) must be based on early, efficient, cost-effective detection and strict control and elimination strategies. For this purpose, we developed an indirect ELISA capable of detecting ASFV antibodies in either serum or oral fluid specimens. The recombinant protein used in the ELISA was selected by comparing the early serum antibody response of ASFV-infected pigs (NHV-p68 isolate) to three major recombinant polypeptides (p30, p54, p72) using a multiplex fluorescent microbead-based immunoassay (FMIA). Nonhazardous (non-infectious) antibody-positive serum for use as plate positive controls and for the calculation of sample-to-positive (S:P) ratios was produced by inoculating pigs with a replicon particle (RP) vaccine expressing the ASFV p30 gene. The optimized ELISA detected anti-p30 antibodies in serum and/or oral fluid samples from pigs inoculated with ASFV under experimental conditions beginning 8 to 12 days post inoculation. Tests on serum (n = 200) and oral fluid (n = 200) field samples from an ASFV-free population demonstrated that the assay was highly diagnostically specific. The convenience and diagnostic utility of oral fluid sampling combined with the flexibility to test either serum or oral fluid on the same platform suggests that this assay will be highly useful under the conditions for which OIE recommends ASFV antibody surveillance, i.e., in ASFV-endemic areas and for the detection of infections with ASFV isolates of low virulence.	[Gimenez-Lirola, Luis G.; Zimmerman, Jeff] Iowa State Univ, Coll Vet Med, Ames, IA 50011 USA; [Mur, Lina; Rivera, Belen; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, VISAVET Ctr, E-28040 Madrid, Spain; [Mur, Lina; Rivera, Belen; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Dept Anim Hlth, E-28040 Madrid, Spain; [Mogler, Mark; Harris, D. L. Hank] Harrisvaccines Inc, Ames, IA USA; [Sun, Yaxuan] Iowa State Univ, Coll Liberal Arts & Sci, Ames, IA USA; [Lizano, Sergio; Goodell, Christa] IDEXX Labs, Westbrook, ME USA; [Rowland, Raymond R. R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Gallardo, Carmina] CISA INIA, Madrid, Spain	Iowa State University; Complutense University of Madrid; Complutense University of Madrid; Iowa State University; Kansas State University	Gimenez-Lirola, LG (corresponding author), Iowa State Univ, Coll Vet Med, Ames, IA 50011 USA.	luisggl@iastate.edu	Zimmerman, Jeff/ABC-6361-2020; Gallardo+Frontaura, Carmina/ABE-6878-2021; Mur, Lina/AAC-8860-2022; gallardo, Carmina/AAB-2386-2019	Zimmerman, Jeff/0000-0002-8107-2422; gallardo, Carmina/0000-0003-3293-306X	Pork Checkoff funds through the National Pork Board, Des Moines, Iowa USA [13-048]; Iowa State University; Pork Checkoff funds through the National Pork Board (Des Moines, Iowa USA)	Pork Checkoff funds through the National Pork Board, Des Moines, Iowa USA; Iowa State University; Pork Checkoff funds through the National Pork Board (Des Moines, Iowa USA)	This work was supported by Pork Checkoff funds distributed through the National Pork Board (#13-048), Des Moines, Iowa USA 50306, and by internal funding through Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Pork Checkoff funds distributed through the National Pork Board (PO Box 9114, Des Moines, Iowa USA 50306).	Carrascosa Angel L, 2011, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2614s53; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cubillos C, 2013, VIRUS RES, V173, P159, DOI 10.1016/j.virusres.2012.10.021; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Dixon L.K., 2005, VIRUS TAXONOMY, P135, DOI DOI 10.1186/1743-422X-2-64; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4228; Gallardo C, 2006, J CLIN MICROBIOL, V44, P950, DOI 10.1128/JCM.44.3.950-956.2006; Gallardo C, 2013, VET MICROBIOL, V162, P32, DOI 10.1016/j.vetmic.2012.08.011; Gallardo C, 2009, CLIN VACCINE IMMUNOL, V16, P1012, DOI 10.1128/CVI.00408-08; Gimenez-Lirola LG, 2014, CLIN VACCINE IMMUNOL, V21, P85, DOI 10.1128/CVI.00451-13; Hooper JW, 2009, VACCINE, V28, P494, DOI 10.1016/j.vaccine.2009.09.133; Kamrud KI, 2007, VIROLOGY, V360, P376, DOI 10.1016/j.virol.2006.10.049; Kittawornrat A, 2014, VET MICROBIOL, V168, P331, DOI 10.1016/j.vetmic.2013.11.035; Kittawornrat A, 2012, J VET DIAGN INVEST, V24, P262, DOI 10.1177/1040638711435679; Kittawornrat A, 2010, VIRUS RES, V154, P170, DOI 10.1016/j.virusres.2010.07.025; MCVICAR JW, 1984, AM J VET RES, V45, P1535; Mur L, 2016, TRANSBOUND EMERG DIS, V63, pE436, DOI 10.1111/tbed.12304; Mur L, 2013, VET MICROBIOL, V165, P135, DOI 10.1016/j.vetmic.2012.12.034; Olsen C, 2013, J VET DIAGN INVEST, V25, P328, DOI 10.1177/1040638713481471; Oura CAL, 2012, MANUAL DIAGNOSTIC TE; Oviedo JM, 1997, J VIROL METHODS, V64, P27, DOI 10.1016/S0166-0934(96)02140-4; Pang S, 2005, J IMMUNOL METHODS, V302, P1, DOI 10.1016/j.jim.2005.04.007; Panyasing Y, 2016, TRANSBOUND EMERG DIS, V63, pE328, DOI 10.1111/tbed.12307; Perez-Filgueira DA, 2006, J CLIN MICROBIOL, V44, P3114, DOI 10.1128/JCM.00406-06; Prickett JR, 2011, TRANSBOUND EMERG DIS, V58, P121, DOI 10.1111/j.1865-1682.2010.01189.x; Prickett JR, 2008, J SWINE HEALTH PROD, V16, P86; Prickett John R., 2010, Animal Health Research Reviews, V11, P207, DOI 10.1017/S1466252310000010; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; Sanchez-Vizcaino M., 2012, DIS SWINE, P396; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4	32	43	55	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161230	10.1371/journal.pone.0161230	http://dx.doi.org/10.1371/journal.pone.0161230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611939	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900013
J	Kim, YW; Jeoung, JW; Girard, MJA; Mari, JM; Park, KH				Kim, Yong Woo; Jeoung, Jin Wook; Girard, Michael J. A.; Mari, Jean Martial; Park, Ki Ho			Positional and Curvature Difference of Lamina Cribrosa According to the Baseline Intraocular Pressure in Primary Open-Angle Glaucoma: A Swept-Source Optical Coherence Tomography (SS-OCT) Study	PLOS ONE			English	Article							RETINAL VESSEL TRUNK; NERVE HEAD; REGIONAL DIFFERENCES; NEURORETINAL RIM; VISUAL-FIELD; DISC; ENHANCEMENT; AGE; DISPLACEMENT; VISIBILITY	Purpose To investigate the variation of lamina cribrosa (LC) structure based on the baseline intraocular pressure (IOP) in eyes with primary open-angle glaucoma (POAG) and healthy individuals using swept-source optical coherence tomography. Methods A total of 108 eyes with POAG and 61 healthy eyes were recruited. Based on the baseline IOP, the POAG eyes were divided into higher-baseline IOP (HTG; baseline IOP > 21 mmHg, n = 38 eyes) and lower-baseline IOP (NTG; baseline IOP <= 21 mmHg, n = 70 eyes). The anterior laminar insertion depth (ALID), mean LC depth (mLCD), and the LC curvature index (mLCD-ALID) were measured, and compared among the three groups. The regional variation of LC structure was evaluated by vertical-horizontal ALID difference. Results The mLCD and LC curvature index were greatest in HTG eyes (520.3 +/- 123.0 and 80.9 +/- 30.7 mu m), followed by NTG (463.2 +/- 110.5 and 64.5 +/- 30.7 mu m) and healthy eyes (382.9 +/- 107.6 and 47.6 +/- 25.7 mu m, all P < 0.001). However, there were no significant difference in ALID between HTG and NTG eyes. The vertical-horizontal ALID difference was larger in NTG eyes (72.8 +/- 56.2 mu m) than in HTG (32.7 +/- 61.4 mu m, P = 0.004) and healthy eyes (25.5 +/- 34.8 mu m, P < 0.001). Conclusions Lamina cribrosa position and curvature differed in POAG eyes with low and high IOP. This would support the theory that IOP induced biomechanical effects on the optic play a role on glaucoma.	[Kim, Yong Woo] Armed Forces Capital Hosp, Dept Ophthalmol, Songnam, South Korea; [Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Girard, Michael J. A.] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Girard, Michael J. A.] Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ French Polynesia, Tahiti, France	Seoul National University (SNU); Seoul National University Hospital; National University of Singapore; National University of Singapore; Singapore National Eye Center	Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	kihopark@snu.ac.kr	Girard, Michael/F-9323-2015	Girard, Michael/0000-0003-4408-5918; Mari, Jean Martial/0000-0002-1169-6547	NUS Young Investigator Award [NUSYIA_FY13_P03, R-397-000-174-133]	NUS Young Investigator Award	This work was supported by a grant of NUS Young Investigator Award (NUSYIA_FY13_P03, R-397-000-174-133). The funding organizations had no role in the design or conduct of this research.	Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; Amini N, 2014, INVEST OPHTH VIS SCI, V55, P7332, DOI 10.1167/iovs.14-14962; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; DANDONA L, 1990, ARCH OPHTHALMOL-CHIC, V108, P393, DOI 10.1001/archopht.1990.01070050091039; Danthurebandara VM, 2015, INVEST OPHTH VIS SCI, V56, P98, DOI 10.1167/iovs.14-15375; Edwards ME, 2001, CURR EYE RES, V23, P215, DOI 10.1076/ceyr.23.3.215.5460; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Girard MJA, 2015, INVEST OPHTH VIS SCI, V56, P865, DOI 10.1167/iovs.14-14903; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; He L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092225; Huang HL, 2013, BRIT J OPHTHALMOL, V97, P96, DOI 10.1136/bjophthalmol-2012-302068; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P99, DOI 10.1136/bjo.78.2.99; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim YW, 2015, EYE, V29, P1368, DOI 10.1038/eye.2015.162; Kim YK, 2016, ACTA OPHTHALMOL, V94, pE468, DOI 10.1111/aos.12903; Kim YK, 2016, INVEST OPHTH VIS SCI, V57, P899, DOI 10.1167/iovs.15-18389; Kim YW J J, 2016, PLOS ONE IN PRESS; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Mwanza JC, 2016, AM J OPHTHALMOL, V161, P12, DOI 10.1016/j.ajo.2015.09.019; Nadler Z, 2014, INVEST OPHTH VIS SCI, V55, P6459, DOI 10.1167/iovs.14-15177; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P478; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Rho CR, 2012, CLIN EXP OPHTHALMOL, V40, pE183, DOI 10.1111/j.1442-9071.2011.02669.x; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Sigal IA, 2009, INVEST OPHTH VIS SCI, V50, P2785, DOI 10.1167/iovs.08-3095; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P85, DOI 10.1007/s10237-008-0120-7; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P99, DOI 10.1007/s10237-008-0119-0; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P2031, DOI 10.1167/iovs.14-15734	36	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162182	10.1371/journal.pone.0162182	http://dx.doi.org/10.1371/journal.pone.0162182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611970	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255900052
J	Ollberding, NJ; Volgyi, E; Macaluso, M; Kumar, R; Morrow, C; Tylavsky, FA; Piyathilake, CJ				Ollberding, Nicholas J.; Volgyi, Eszter; Macaluso, Maurizio; Kumar, Ranjit; Morrow, Casey; Tylavsky, Frances A.; Piyathilake, Chandrika J.			Urinary Microbiota Associated with Preterm Birth: Results from the Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) Study	PLOS ONE			English	Article							TRACT-INFECTION; SERRATIA-MARCESCENS; BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; AMNIOTIC-FLUID; PREGNANT-WOMEN; 16S RDNA; DIVERSITY; SEQUENCES; FLORA	Preterm birth (PTB) is the leading cause of infant morbidity and mortality. Genitourinary infection is implicated in the initiation of spontaneous PTB; however, examination of the urinary microbiota in relation to preterm delivery using next-generation sequencing technologies is lacking. In a case-control study nested within the Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) study, we examined associations between the urinary microbiota and PTB. A total of 49 cases (delivery < 37 weeks gestation) and 48 controls (delivery >= 37 weeks gestation) balanced on health insurance type were included in the present analysis. Illumina sequencing of the 16S rRNA gene V4 region was performed on urine samples collected during the second trimester. We observed no difference in taxa richness, evenness, or community composition between cases and controls or for gestational age modeled as a continuous variable. Operational taxonomic units (OTUs) classified to Prevotella, Sutterella, L. iners, Blautia, Kocuria, Lachnospiraceae, and S. marcescens were enriched among cases (FDR corrected p <= 0.05). A urinary microbiota clustering partition dominated by S. marcescens was also associated with PTB (OR = 3.97, 95% CI: 1.19-13.24). These data suggest a limited role for the urinary microbiota in PTB when measured during the second trimester by 16S rRNA gene sequencing. The enrichment among cases in several organisms previously reported to be associated with genitourinary pathology requires confirmation in future studies to rule out the potential for false positive findings.	[Ollberding, Nicholas J.; Macaluso, Maurizio] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Volgyi, Eszter] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN USA; [Volgyi, Eszter; Tylavsky, Frances A.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Kumar, Ranjit] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Morrow, Casey] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA	Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Piyathilake, CJ (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA.	piyathic@uab.edu			Urban Child Institute; Urban Child Institute, Memphis, TN; Microbiome Resource at the University of Alabama at Birmingham: School of Medicine, Comprehensive Cancer Center [P30AR050948]; Center for AIDS Research [5P30AI027767]; Center for Clinical Translational Science [UL1TR000165]; Heflin Center	Urban Child Institute; Urban Child Institute, Memphis, TN; Microbiome Resource at the University of Alabama at Birmingham: School of Medicine, Comprehensive Cancer Center; Center for AIDS Research; Center for Clinical Translational Science; Heflin Center	This project was supported by The Urban Child Institute (F.T.). The funding sources had no role in the design, implementation and interpretation or in the preparation of the manuscript. The CANDLE study (Director F.T.) was funded by the Urban Child Institute, Memphis, TN. The following are acknowledged for their support of the Microbiome Resource at the University of Alabama at Birmingham: School of Medicine, Comprehensive Cancer Center (P30AR050948), Center for AIDS Research (5P30AI027767), and Center for Clinical Translational Science (UL1TR000165) and Heflin Center.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Andrews S., 2010, FASTQC QUALITY CONTR; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; AVERBUCH B, 1995, EUR J OBSTET GYN R B, V62, P25, DOI 10.1016/0301-2115(95)02176-8; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Brook I, 2004, INT J UROL, V11, P133, DOI 10.1111/j.1442-2042.2003.00756.x; Brubaker L, 2015, AM J OBSTET GYNECOL, V213, P644, DOI 10.1016/j.ajog.2015.05.032; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Hay PE, 2002, POLYMICROBIAL DIS; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Honaker J, 2011, J STAT SOFTW, V45, P1; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Kacerovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126884; Kawecki D, 2011, TRANSPL P, V43, P2991, DOI 10.1016/j.transproceed.2011.09.002; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mysorekar IU, 2014, SEMIN REPROD MED, V32, P50, DOI 10.1055/s-0033-1361830; Nelson DB, 2016, AM J PERINAT, V33, P887, DOI 10.1055/s-0036-1581057; Oksanen J., 2019, R PACKAGE VERSION; Payne MS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00595; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Petricevic L, 2012, EUR J OBSTET GYN R B, V160, P93, DOI 10.1016/j.ejogrb.2011.10.002; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shannon CE, 1997, M D COMPUT, V14, P306; Siddiqui H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Stock I, 2003, INT J ANTIMICROB AG, V22, P35, DOI 10.1016/S0924-8579(02)00163-2; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Volgyi E, 2013, NUTRIENTS, V5, P1511, DOI 10.3390/nu5051511; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	70	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162302	10.1371/journal.pone.0162302	http://dx.doi.org/10.1371/journal.pone.0162302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611781	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900075
J	Yin, ZY; Chen, DY; Li, BF				Yin Zongyi; Chen Dongying; Li Baifeng			Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; KNOWLEDGE DOMAIN; EMERGING TRENDS; GRANZYME-B; SUPPRESSION; TH17; DIFFERENTIATION; AUTOIMMUNITY; MECHANISMS; GENERATION	We aimed to analyze the global scientific output of regulatoryT-cell (Treg) research and built a model to qualitatively and quantitatively evaluate publications from 2000 to 2015. Data were obtained from the Web of Science Core Collection (WoSCC) of Thomson Reuters on January 1, 2016. The bibliometric method and Citespace III were used to analyze authors, journals, publication outputs, institutions, countries, research areas, research hotspots, and trends. In total, we identified 35,741 publications on Treg research from 2000 to 2015, and observed that the annual publication rate increased with time. The Journal of Immunology published the highest number of articles, the leading country was the USA, and the leading institute was Harvard University. Sakaguchi, Hori, Fontenot, and Wang were the top authors in Treg research. Immunology accounted for the highest number of publications, followed by oncology, experimental medicine, cell biology, and hematology. Keyword analysis indicated that autoimmunity, inflammation, cytokine, gene expression, foxp3, and immunotherapy were the research hotspots, whereas autoimmune inflammation, gene therapy, granzyme B, ROR gamma t, and th17 were the frontiers of Treg research. This bibliometric analysis revealed that Treg-related studies are still research hotspots, and that Treg-related clinical therapies are the research frontiers; however, further study and collaborations are needed worldwide. Overall, our findings provide valuable information for the editors of immunology journals to identify new perspectives and shape future research directions.	[Yin Zongyi; Li Baifeng] China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China; [Chen Dongying] China Med Univ, Hosp 1, Dept Anesthesiol, Shenyang, Peoples R China	China Medical University; China Medical University	Li, BF (corresponding author), China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China.	bfli@cmu.edu.cn			National Natural Science Foundation of China [81370882]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81370882), Li Baifeng, http://www.nsfc.gov.cn/nsfc/cen/zc/09.htm.	Anz D, 2015, CANCER RES, V75, P4483, DOI 10.1158/0008-5472.CAN-14-3499; Asseman C, 2000, AM J RESP CRIT CARE, V162, pS185, DOI 10.1164/ajrccm.162.supplement_3.15tac9; Barbi J, 2014, IMMUNOL REV, V259, P115, DOI 10.1111/imr.12172; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bhela S, 2015, J IMMUNOL, V194, P2180, DOI 10.4049/jimmunol.1303257; Bouvy AP, 2014, NEPHROL DIAL TRANSPL, V29, P1587, DOI 10.1093/ndt/gfu079; Bradford S. C., 1934, ENGINEERING, P85; Carter CRD, 2013, J CLIN PATHOL, V66, P146, DOI 10.1136/jclinpath-2012-201046; Chen CM, 2014, EXPERT OPIN BIOL TH, V14, P1295, DOI 10.1517/14712598.2014.920813; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Golovina TN, 2010, CANCER J, V16, P342, DOI 10.1097/PPO.0b013e3181eb336d; Gregori S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00593; Hashizume H, 2016, J DERMATOL SCI, V81, P131, DOI 10.1016/j.jdermsci.2015.11.002; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CP, 2009, J CHIN MED ASSOC, V72, P6; Huang YF, 2015, J IMMUNOL, V195, P5572, DOI 10.4049/jimmunol.1501604; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Jarosz-Biej M, 2015, ARCH IMMUNOL THER EX, V63, P451, DOI 10.1007/s00005-015-0337-y; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim MG, 2014, KIDNEY INT, V85, P62, DOI 10.1038/ki.2013.277; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Klabusay M., 2015, KLIN ONKOL, V28, P23; Kurose K, 2015, CLIN CANCER RES, V21, P4327, DOI 10.1158/1078-0432.CCR-15-0357; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Leceta J, 2007, NEUROIMMUNOMODULAT, V14, P134, DOI 10.1159/000110636; Lee YC, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6010011; Li H, 2015, CYTOTHERAPY, V17, P1560, DOI 10.1016/j.jcyt.2015.07.018; Li JF, 2009, CROAT CHEM ACTA, V82, P695; Liao JY, 2016, CLIN IMMUNOL, V162, P74, DOI 10.1016/j.clim.2015.11.006; Lin KL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00473; Liu ZG, 2015, SCIENTOMETRICS, V103, P135, DOI 10.1007/s11192-014-1517-y; Lv Hong, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P493, DOI 10.3760/cma.j.issn.1007-3418.2014.07.004; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; Matino D, 2015, J CLIN INVEST, V125, P3766, DOI 10.1172/JCI81859; Merigo JM, 2010, J SYSTEMS ENG ELECT, V21, P10; Mittag D, 2010, J IMMUNOL, V184, P4708, DOI 10.4049/jimmunol.0901036; Montane J, 2015, CELL TRANSPLANT, V24, P2143, DOI 10.3727/096368914X685249; Nguyen MTJP, 2016, TRANSPLANTATION, V100, P314, DOI 10.1097/TP.0000000000000942; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Omenetti S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00639; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Richards DM, 2015, PROG MOL BIOL TRANSL, V136, P175, DOI 10.1016/bs.pmbts.2015.07.014; Rolland JM, 2010, CURR OPIN ALLERGY CL, V10, P559, DOI 10.1097/ACI.0b013e32833ff2b2; Rothstein DM, 2015, CURR OPIN ORGAN TRAN, V20, P376, DOI 10.1097/MOT.0000000000000212; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salvalaggio PRO, 2006, J IMMUNOL, V176, P2292, DOI 10.4049/jimmunol.176.4.2292; Serr I, 2014, BIODRUGS, V28, P7, DOI 10.1007/s40259-013-0060-3; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Spence A, 2015, CURR OPIN IMMUNOL, V37, P11, DOI 10.1016/j.coi.2015.09.002; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tang QZ, 2014, CURR OPIN ORGAN TRAN, V19, P616, DOI 10.1097/MOT.0000000000000132; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Wang Q. Y Y, 2014, SCI TOTAL ENVIRON, P473; Wei F., 2015, PROF GEOGR, V67, P1; Wei Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/340126; Whelan MC, 2010, CANCER GENE THER, V17, P501, DOI 10.1038/cgt.2010.8; White HD, 2003, J AM SOC INF SCI TEC, V54, P423, DOI 10.1002/asi.10228; Zhou XD, 2015, SCIENTOMETRICS, V105, P231, DOI 10.1007/s11192-015-1659-6; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	76	19	19	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162099	10.1371/journal.pone.0162099	http://dx.doi.org/10.1371/journal.pone.0162099			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611317	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900045
J	Nowak, M; Castellini, C				Nowak, Markus; Castellini, Claudio			The LET Procedure for Prosthetic Myocontrol: Towards Multi-DOF Control Using Single-DOF Activations	PLOS ONE			English	Article							MYOELECTRIC CONTROL; SURFACE EMG	Simultaneous and proportional myocontrol of dexterous hand prostheses is to a large extent still an open problem. With the advent of commercially and clinically available multi-fingered hand prostheses there are now more independent degrees of freedom (DOFs) in prostheses than can be effectively controlled using surface electromyography (sEMG), the current standard human-machine interface for hand amputees. In particular, it is uncertain, whether several DOFs can be controlled simultaneously and proportionally by exclusively calibrating the intended activation of single DOFs. The problem is currently solved by training on all required combinations. However, as the number of available DOFs grows, this approach becomes overly long and poses a high cognitive burden on the subject. In this paper we present a novel approach to overcome this problem. Multi-DOF activations are artificially modelled from single-DOF ones using a simple linear combination of sEMG signals, which are then added to the training set. This procedure, which we named LET (Linearly Enhanced Training), provides an augmented data set to any machine-learning-based intent detection system. In two experiments involving intact subjects, one offline and one online, we trained a standard machine learning approach using the full data set containing single-and multi-DOF activations as well as using the LET-augmented data set in order to evaluate the performance of the LET procedure. The results indicate that the machine trained on the latter data set obtains worse results in the offline experiment compared to the full data set. However, the online implementation enables the user to perform multi-DOF tasks with almost the same precision as single-DOF tasks without the need of explicitly training multi-DOF activations. Moreover, the parameters involved in the system are statistically uniform across subjects.	[Nowak, Markus; Castellini, Claudio] DLR German Aerosp Ctr, Robot & Mechatron Ctr, Wessling, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Nowak, M (corresponding author), DLR German Aerosp Ctr, Robot & Mechatron Ctr, Wessling, Germany.	markus.nowak@dlr.de	Castellini, Claudio/M-8555-2017	Castellini, Claudio/0000-0002-7346-2180	German Aerospace Center (DLR)	German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	The authors were funded by the basic funding of the German Aerospace Center (DLR). The funding provider had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsuss S., 2014, P MEC MYOEL CONTR S, P2; [Anonymous], 2013, TXB ES; Aszmann OC, 2015, LANCET, V385, P2183, DOI 10.1016/S0140-6736(14)61776-1; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Castellini C., 2014, P MEC MYOEL CONTR S, P45; Castellini C, 2014, FRONT NEUROROBOTICS, V8, P1, DOI 10.3389/fnbot.2014.00022; Christensen R, 2001, ADV LINEAR MODELING; Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020; Farina D, 2014, IEEE T NEUR SYS REH, V22, P797, DOI 10.1109/TNSRE.2014.2305111; Fougner A, 2012, IEEE T NEUR SYS REH, V20, P663, DOI 10.1109/TNSRE.2012.2196711; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Gijsberts A, 2014, FRONT NEUROROBOTICS, V8, P1, DOI 10.3389/fnbot.2014.00008; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hogg RV., 1987, ENG STAT; Ison M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/051001; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P549, DOI 10.1109/TNSRE.2013.2287383; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Koiva R, 2012, IEEE ENG MED BIO, P531, DOI 10.1109/EMBC.2012.6345985; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Kutner M. H., 2004, APPL LINEAR REGRESSI; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Micera Silvestro, 2010, IEEE Rev Biomed Eng, V3, P48, DOI 10.1109/RBME.2010.2085429; Nagata K, 2011, IEEE ENG MED BIO, P7865, DOI 10.1109/IEMBS.2011.6091938; Peerdeman B, 2011, J REHABIL RES DEV, V48, P719, DOI 10.1682/JRRD.2010.08.0161; Rahimi A., 2007, ADV NEURAL INFORM PR, V20, P1177, DOI DOI 10.5555/2981562.2981710; Rifkin R, 2003, NATO SCI SERIES 3, V190, P131, DOI DOI 10.1016/S0072-9752(06)80038-2; Rudolf M, 2008, BIOSTATISTIK EINFUHR; Yatsenko D, 2007, P ANN INT IEEE EMBS, P6134	30	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161678	10.1371/journal.pone.0161678	http://dx.doi.org/10.1371/journal.pone.0161678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606674	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000383255600009
J	Deschodt-Arsac, V; Arsac, L; Magat, J; Naulin, J; Quesson, B; Dos Santos, P				Deschodt-Arsac, Veronique; Arsac, Laurent; Magat, Julie; Naulin, Jerome; Quesson, Bruno; Dos Santos, Pierre			Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo P-31-MR Spectroscopy Follow-Up Study	PLOS ONE			English	Article							CARDIAC-FUNCTION; DILATED CARDIOMYOPATHY; HYPERTROPHIED HEARTS; VENTRICULAR MYOCYTES; PHOSPHATE-METABOLISM; RESPIRATORY CONTROL; OXYGEN-CONSUMPTION; BEATING HEART; FAILING HEART; ENERGETICS	Introduction Gradual alterations in cardiac energy balance, as assessed by the myocardial PCr/ATP-ratio, are frequently associated with the development of cardiac disease. Despite great interest for the follow-up of myocardial PCr and ATP content, cardiac MR-spectroscopy in rat models in vivo is challenged by sensitivity issues and cross-contamination from other organs. Methods Here we combined MR-Imaging and MR-Spectroscopy (Bruker BioSpec 9.4T) to follow-up for the first time in vivo the cardiac energy balance in the SHR, a genetic rat model of cardiac hypertrophy known to develop early disturbances in cytosolic calcium dynamics. Results We obtained consistent P-31-spectra with high signal/noise ratio from the left ventricle in vivo by using a double-tuned (P-31/H-1) surface coil. Reasonable acquisition time (< 3.2min) allowed assessing the PCr/ATP-ratio comparatively in SHR and age-matched control rats (WKY): i) weekly from 12 to 21 weeks of age; ii) in response to a bolus injection of the beta-adrenoreceptor agonist isoproterenol at age 21 weeks. Discussion Along weeks, the cardiac PCr/ATP-ratio was highly reproducible, steady and similar (2.35 +/- 0.06) in SHR and WKY, in spite of detectable ventricular hypertrophy in SHR. At the age 21 weeks, PCr/ATP dropped more markedly (-17.1%+/- 0.8% vs. -3,5%+/- 1.4%, P< 0.001) after isoproterenol injection in SHR and recovered slowly thereafter (time constant 21.2min vs. 6.6min, P< 0.05) despite similar profiles of tachycardia among rats. Conclusion The exacerbated PCr/ATP drop under beta-adrenergic stimulation indicates a defect in cardiac energy regulation possibly due to calcium-mediated abnormalities in the SHR heart. Of note, defects in energy regulation were present before detectable abnormalities in cardiac energy balance at rest.	[Deschodt-Arsac, Veronique; Arsac, Laurent; Magat, Julie; Naulin, Jerome; Quesson, Bruno; Dos Santos, Pierre] Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Pessac, France; [Deschodt-Arsac, Veronique; Arsac, Laurent; Magat, Julie; Naulin, Jerome; Quesson, Bruno; Dos Santos, Pierre] Univ Bordeaux, Inserm CRCTB U1045, Bordeaux, France; [Dos Santos, Pierre] CHU Bordeaux, Hop Cardiol Haut Leveque, Pessac, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Deschodt-Arsac, V (corresponding author), Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Pessac, France.; Deschodt-Arsac, V (corresponding author), Univ Bordeaux, Inserm CRCTB U1045, Bordeaux, France.	veronique.arsac@u-bordeaux.fr	NAULIN, Jérôme/AAP-4488-2021; Magat, Julie/ABC-5523-2021	NAULIN, Jérôme/0000-0002-9402-4200; Deschodt-Arsac, Veronique/0000-0002-9244-9862; quesson, bruno/0000-0001-6434-3684; Dos Santos, Pierre/0000-0002-0811-3099; Magat, Julie/0000-0002-0967-9625	ANR "Investissement d'Avenir" [ANR-10-IAHU-04]; "Investissement d'Avenir" Grant from French Government through Agence Nationale de la Recherche [ANR-10-IAHU-04]	ANR "Investissement d'Avenir"(French National Research Agency (ANR)); "Investissement d'Avenir" Grant from French Government through Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by ANR "Investissement d'Avenir": ANR-10-IAHU-04. The Liryc creation was supported by the "Investissement d'Avenir" Grant, ANR-10-IAHU-04 from the French Government through the Agence Nationale de la Recherche.	Atlante A, 2011, MECH AGEING DEV, V132, P488, DOI 10.1016/j.mad.2011.07.009; Bashir A, 2014, NMR BIOMED, V27, P663, DOI 10.1002/nbm.3103; Bollano E, 2007, INT J CARDIOL, V114, P195, DOI 10.1016/j.ijcard.2006.01.027; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3301, DOI 10.1152/ajpheart.00259.2007; Cui WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135000; DAS AM, 1990, AM J PHYSIOL, V259, pH1264, DOI 10.1152/ajpheart.1990.259.4.H1264; De Sousa E, 1999, CIRC RES, V85, P68; Deschodt-Arsac V, 2013, INT J BIOCHEM CELL B, V45, P4, DOI 10.1016/j.biocel.2012.07.007; Diolez P, 2007, AM J PHYSIOL-REG I, V293, pR13, DOI 10.1152/ajpregu.00189.2006; Diolez Philippe, 2015, Methods Mol Biol, V1264, P289, DOI 10.1007/978-1-4939-2257-4_26; Dupont S, 2012, AM J PHYSIOL-HEART C, V302, pH1524, DOI 10.1152/ajpheart.00955.2010; Endoh M, 2006, J PHARMACOL SCI, V100, P525, DOI 10.1254/jphs.CPJ06009X; Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Gupta A, 2009, AM J PHYSIOL-HEART C, V297, pH59, DOI 10.1152/ajpheart.00178.2009; Holloway CJ, 2012, HEART, V98, P1083, DOI 10.1136/heartjnl-2012-302145; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; Iemitsu M, 2008, AM J PHYSIOL-HEART C, V295, pH136, DOI 10.1152/ajpheart.01417.2006; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; INGWALL JS, 1985, NEW ENGL J MED, V313, P1050, DOI 10.1056/NEJM198510243131704; Jang A, 2016, MAGN RESON MED, V75, P1859, DOI 10.1002/mrm.26162; KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265; Korzeniewski B, 2008, BIOCHEM J, V413, P343, DOI 10.1042/BJ20080162; Kushmerick MJ, 2002, BIOCHEM SOC T, V30, P227, DOI 10.1042/bst0300227; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Nahrendorf M, 2003, AM J PHYSIOL-HEART C, V285, pH2712, DOI 10.1152/ajpheart.00233.2003; Naumova AV, 2003, AM J PHYSIOL-HEART C, V285, pH1976, DOI 10.1152/ajpheart.00474.2003; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 1999, J MOL CELL CARDIOL, V31, P1845, DOI 10.1006/jmcc.1999.1016; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; ORDIDGE RJ, 1988, MAGNET RESON MED, V8, P323, DOI 10.1002/mrm.1910080309; Perings SM, 2000, HEART VESSELS, V15, P197, DOI 10.1007/PL00007270; Portman MA, 2000, CIRCULATION, V102, P1323, DOI 10.1161/01.CIR.102.11.1323; Portman MA, 1997, AM J PHYSIOL-HEART C, V273, pH1977; SHIMAMOTO N, 1982, BASIC RES CARDIOL, V77, P359, DOI 10.1007/BF02005337; Vendelin M, 2010, J BIOL CHEM, V285, P37240, DOI 10.1074/jbc.M110.147116; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Whalen EJ, 1999, EUR J PHARMACOL, V382, P207, DOI 10.1016/S0014-2999(99)00631-7; WU ST, 1992, CELL CALCIUM, V13, P235, DOI 10.1016/0143-4160(92)90012-H; Xiong QA, 2011, CIRC RES, V108, P653, DOI 10.1161/CIRCRESAHA.110.231456	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162677	10.1371/journal.pone.0162677	http://dx.doi.org/10.1371/journal.pone.0162677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622548	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000045
J	Kim, DH; Hong, YK; Jeun, SS; Park, JS; Jung, KH; Kim, SW; Cho, JH; Park, YJ; Kang, YJ; Kim, SW				Kim, Do Hyun; Hong, Yong-Kil; Jeun, Sin-Soo; Park, Jae-Sung; Jung, Ki Hwan; Kim, Soo Whan; Cho, Jin Hee; Park, Yong Jin; Kang, Yun Jin; Kim, Sung Won			Invagination of the Sphenoid Sinus Mucosa after Endoscopic Endonasal Transsphenoidal Approach and Its Significance	PLOS ONE			English	Article							CEREBROSPINAL-FLUID LEAKS; PITUITARY MACROADENOMAS; GRADED REPAIR; RECONSTRUCTION; SURGERY; IMPLANTS; CLOSURE; SELLAR; FLAPS; PLATE	Objective To describe the clinical features of invagination of the sphenoid sinus mucosa (ISM) and compare them with other similar cases using a visual analog scale (VAS) to assess the various nasal symptoms and to discuss its clinical significance and means of prevention. Study Design Retrospective chart review at a tertiary referral center. Methods Between 2010 and 2015, 8 patients who had undergone EETSA surgery displayed postoperative ISM. The comparison group consisted of 147 patients who underwent the same surgical procedures and were diagnosed with the same diseases. Pre- or postoperative paranasal sinus computed tomography (PNS CT) and VAS were performed and subsequently analyzed. Results The clinical features of ISM of the sphenoid sinus showed sellar floor invagination and regenerated inverted ingrowing sphenoid mucosa on endoscopic imaging. PNS CT also showed a bony defect and invaginated air densities at the sellar turcica. Pre- and postoperative VAS scores revealed that the ISM group had much less of an improvement in headaches after surgery than that of the comparison group (p = 0.049). Conclusion ISM may occur because of a change in pressure, sphenoid mucosal status, or arachnoid membrane status. Moreover, ISM is related to improvements in headaches. Therefore, EETSA patients should avoid activities that cause rapid pressure changes during the healing process. In addition, sellar reconstruction that is resistant to physical pressure changes should be mandated despite the absence of an intraoperative CSF leak.	[Kim, Do Hyun; Jung, Ki Hwan; Kim, Soo Whan; Cho, Jin Hee; Park, Yong Jin; Kang, Yun Jin; Kim, Sung Won] Catholic Univ Korea, Seoul St Marys Hosp, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Hong, Yong-Kil; Jeun, Sin-Soo; Park, Jae-Sung] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	kswent@catholic.ac.kr	Kim, Do Hyun/AAA-2792-2021	Kim, Do Hyun/0000-0002-9248-5572; Park, Jae-Sung/0000-0002-9827-9913	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT, and Future Planning [2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT, and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT, and Future Planning (No. 2014R1A2A2A01004325) and the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare (HI14C3228). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2016, NEUROSURG REV, V39, P123, DOI 10.1007/s10143-015-0667-6; Arita K, 1999, J NEUROSURG, V91, P1055, DOI 10.3171/jns.1999.91.6.1055; Chen X, 2011, AM J NEURORADIOL, V32, P785, DOI 10.3174/ajnr.A2364; Couldwell William T, 2006, Neurosurg Focus, V20, pE11, DOI 10.3171/foc.2006.20.3.12; Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66; FREIDBERG SR, 1994, NEUROSURGERY, V35, P159, DOI 10.1227/00006123-199407000-00027; Balanzar GG, 2011, WORLD NEUROSURG, V75, P286, DOI 10.1016/j.wneu.2010.08.002; Kabuto M, 1998, J NEUROSURG, V88, P949, DOI 10.3171/jns.1998.88.6.0949; Kaptain GJ, 2001, NEUROSURGERY, V48, P232, DOI 10.1097/00006123-200101000-00048; Kelly DF, 2001, NEUROSURGERY, V49, P885, DOI 10.1097/00006123-200110000-00020; Kim BY, 2013, LARYNGOSCOPE, V123, P2605, DOI 10.1002/lary.24098; Kim do H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151531; KOBAYASHI S, 1987, NEUROSURGERY, V21, P751, DOI 10.1227/00006123-198711000-00032; Locatelli D, 2009, ACTA NEUROCHIR, V151, P1431, DOI 10.1007/s00701-009-0428-9; Mak HKF, 2015, PITUITARY, V18, P509, DOI 10.1007/s11102-014-0603-8; Park JH, 2015, J KOREAN NEUROSURG S, V58, P36, DOI 10.3340/jkns.2015.58.1.36; SPAZIANTE R, 1989, J NEUROSURG, V71, P864, DOI 10.3171/jns.1989.71.6.0864; Stadlbauer A, 2008, J NEUROSURG, V109, P306, DOI 10.3171/JNS/2008/109/8/0306; Yoon TM, 2008, ACTA OTO-LARYNGOL, V128, P785, DOI 10.1080/00016480701730752; Yu B, 2017, CEPHALALGIA, V37, P348, DOI 10.1177/0333102416648347	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162836	10.1371/journal.pone.0162836	http://dx.doi.org/10.1371/journal.pone.0162836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622454	Green Published, gold, Green Submitted			2022-12-27	WOS:000383681000062
J	Kwon, MY; Liu, R; Chien, LL				Kwon, MiYoung; Liu, Rong; Chien, Lillian			Compensation for Blur Requires Increase in Field of View and Viewing Time	PLOS ONE			English	Article							HIGH SPATIAL-FREQUENCIES; FACE RECOGNITION; LOW-VISION; MACULAR DEGENERATION; VISUAL RECOGNITION; READING SPEED; PERCEPTION; PSYCHOPHYSICS; CATEGORIZATION; SPAN	Spatial resolution is an important factor for human pattern recognition. In particular, low resolution (blur) is a defining characteristic of low vision. Here, we examined spatial (field of view) and temporal (stimulus duration) requirements for blurry object recognition. The spatial resolution of an image such as letter or face, was manipulated with a low-pass filter. In experiment 1, studying spatial requirement, observers viewed a fixed-size object through a window of varying sizes, which was repositioned until object identification (moving window paradigm). Field of view requirement, quantified as the number of "views" (window repositions) for correct recognition, was obtained for three blur levels, including no blur. In experiment 2, studying temporal requirement, we determined threshold viewing time, the stimulus duration yielding criterion recognition accuracy, at six blur levels, including no blur. For letter and face recognition, we found blur significantly increased the number of views, suggesting a larger field of view is required to recognize blurry objects. We also found blur significantly increased threshold viewing time, suggesting longer temporal integration is necessary to recognize blurry objects. The temporal integration reflects the tradeoff between stimulus intensity and time. While humans excel at recognizing blurry objects, our findings suggest compensating for blur requires increased field of view and viewing time. The need for larger spatial and longer temporal integration for recognizing blurry objects may further challenge object recognition in low vision. Thus, interactions between blur and field of view should be considered for developing low vision rehabilitation or assistive aids.	[Kwon, MiYoung; Liu, Rong; Chien, Lillian] Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Kwon, MY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35233 USA.	kwon@uab.edu			EyeSight Foundation of Alabama; Research to Prevent Blindness Inc.	EyeSight Foundation of Alabama; Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB))	This work was supported by the EyeSight Foundation of Alabama and Research to Prevent Blindness Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann T., 2016, PERCEPTION PIXELATED; Baugh LA, 2007, J NEUROSCI METH, V160, P128, DOI 10.1016/j.jneumeth.2006.09.002; Bethlehem RAI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100171; Bloch AM, 1885, PARIS SOC BIOL MEM, P493; Boucart M, 2008, VISUAL NEUROSCI, V25, P603, DOI 10.1017/S0952523808080656; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BULLIMORE MA, 1991, INVEST OPHTH VIS SCI, V32, P2020; Cheung OS, 2008, J EXP PSYCHOL HUMAN, V34, P1327, DOI 10.1037/a0011752; Chung STL, 2002, VISION RES, V42, P2137, DOI 10.1016/S0042-6989(02)00092-5; Collin CA, 2004, J EXP PSYCHOL HUMAN, V30, P975, DOI 10.1037/0096-1523.30.5.975; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; COSTEN NP, 1994, PERCEPTION, V23, P129, DOI 10.1068/p230129; DUYSENS J, 1991, VISION RES, V31, P1517, DOI 10.1016/0042-6989(91)90129-S; Fabre-Thorpe M, 2003, PHILOS T R SOC B, V358, P1215, DOI 10.1098/rstb.2003.1310; FIORENTINI A, 1983, PERCEPTION, V12, P195, DOI 10.1068/p120195; GERVAIS MJ, 1984, J EXP PSYCHOL HUMAN, V10, P655, DOI 10.1037/0096-1523.10.5.655; GINSBURG AP, 1980, P SID, V21, P219; Ginsburg AP, 1978, VISUAL INFORMATION P; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Grabowska A, 1996, PSYCHOL BULL, V120, P434, DOI 10.1037/0033-2909.120.3.434; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; HARMON LD, 1973, SCI AM, V229, P70, DOI 10.1038/scientificamerican1173-70; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; INUI T, 1984, PERCEPTION, V13, P49, DOI 10.1068/p130049; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Jansen AR, 2003, BEHAV RES METH INS C, V35, P57, DOI 10.3758/BF03195497; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; KAHNEMAN D, 1964, J EXP PSYCHOL, V68, P215, DOI 10.1037/h0046097; KELLY DH, 1981, J OPT SOC AM, V71, P1051, DOI 10.1364/JOSA.71.001051; KELLY DH, 1984, J OPT SOC AM A, V1, P107, DOI 10.1364/JOSAA.1.000107; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Kwon M, 2013, J VISION, V13, DOI 10.1167/13.1.13; Kwon M, 2012, VISION RES, V62, P139, DOI 10.1016/j.visres.2012.03.025; Kwon M, 2011, VISION RES, V51, P1995, DOI 10.1016/j.visres.2011.06.020; Leat SJ, 1999, OPTOMETRY VISION SCI, V76, P198, DOI 10.1097/00006324-199904000-00023; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; Legge GE, 1997, VISION RES, V37, P1999, DOI 10.1016/S0042-6989(97)00017-5; LEGGE GE, 1985, VISION RES, V25, P253, DOI 10.1016/0042-6989(85)90118-X; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Legge GE, 2011, J VISION, V11, DOI 10.1167/11.5.8; Lingnau A, 2008, J VISION, V8, DOI 10.1167/8.5.6; LOOMIS JM, 1990, J EXP PSYCHOL HUMAN, V16, P106, DOI 10.1037/0096-1523.16.1.1066; Loschky LC, 2002, J EXP PSYCHOL-APPL, V8, P99, DOI 10.1037/1076-898X.8.2.99; Majaj NJ, 2002, VISION RES, V42, P1165, DOI 10.1016/S0042-6989(02)00045-7; Mangione CM, 1999, AM J OPHTHALMOL, V128, P45, DOI 10.1016/S0002-9394(99)00169-5; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Morrison DJ, 2001, PSYCHON B REV, V8, P454, DOI 10.3758/BF03196180; Mulholland PJ, 2015, INVEST OPHTH VIS SCI, V56, P431, DOI 10.1167/iovs.14-15304; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Olds ES, 1998, VISION RES, V38, P2109, DOI 10.1016/S0042-6989(97)00393-3; Oruc I, 2010, J VISION, V10, DOI 10.1167/10.12.20; Oruc I, 2009, J VISION, V9, DOI 10.1167/9.9.4; Owsley C, 2009, ARCH OPHTHALMOL-CHIC, V127, P681, DOI 10.1001/archophthalmol.2009.55; PARISH DH, 1991, VISION RES, V31, P1399, DOI 10.1016/0042-6989(91)90060-I; Parker DM, 1999, CURR PSYCHOL, V18, P118, DOI 10.1007/s12144-999-1021-3; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.i; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; POULTON EC, 1962, BRIT J PSYCHOL, V53, P409, DOI 10.1111/j.2044-8295.1962.tb00846.x; REYNOLDS RI, 1981, PERCEPTION, V10, P107, DOI 10.1068/p100107; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Ruiz-Soler M, 2012, J NONVERBAL BEHAV, V36, P191, DOI 10.1007/s10919-012-0131-z; Sass SM, 2006, OPTOMETRY VISION SCI, V83, P166, DOI 10.1097/01.opx.0000204752.43520.17; Scharnowski F, 2007, VISION RES, V47, P2444, DOI 10.1016/j.visres.2007.05.004; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Schyns PG, 2003, PERCEPTION FACES OBJ, P120; SERGENT J, 1985, J EXP PSYCHOL HUMAN, V11, P846, DOI 10.1037/0096-1523.11.6.846; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Shahangian K, 2014, PERCEPTION, V43, P90, DOI 10.1068/p7436; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sinha P, 2002, NAT NEUROSCI, V5, P1093, DOI 10.1038/nn949; Smith ML, 2004, PSYCHOL SCI, V15, P753, DOI 10.1111/j.0956-7976.2004.00752.x; Smith ND, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/120528; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Tejeria L, 2002, BRIT J OPHTHALMOL, V86, P1019, DOI 10.1136/bjo.86.9.1019; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TOLHURST DJ, 1975, NATURE, V257, P674, DOI 10.1038/257674a0; Van der Stigchel S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00579; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	85	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162711	10.1371/journal.pone.0162711	http://dx.doi.org/10.1371/journal.pone.0162711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622710	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000049
J	Lu, Y; Wang, AH; Shi, P; Zhang, H; Li, ZS				Lu, Yang; Wang, Aihua; Shi, Peng; Zhang, Hui; Li, ZeSheng			Kinetic Reaction Mechanism of Sinapic Acid Scavenging NO2 and OH Radicals: A Theoretical Study	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; CHEMICAL-REACTION RATES; ANTIOXIDANT ACTIVITY; NITROGEN-DIOXIDE; FERULIC ACID; PHENOLIC-COMPOUNDS; RATE CONSTANTS; CAFFEIC ACID; GALLIC ACID; DERIVATIVES	The mechanism and kinetics underlying reactions between the naturally-occurring antioxidant sinapic acid (SA) and the very damaging center dot NO2 and center dot OH were investigated through the density functional theory (DFT). Two most possible reaction mechanisms were studied: hydrogen atom transfer (HAT) and radical adduct formation (RAF). Different reaction channels of neutral and anionic sinapic acid (SA-) scavenging radicals in both atmosphere and water medium were traced independently, and the thermodynamic and kinetic parameters were calculated. We find the most active site of SA/SA-scavenging center dot NO2 and center dot OH is the -OH group in benzene ring by HAT mechanism, while the RAF mechanism for SA/SA-scavenging center dot NO2 seems thermodynamically unfavorable. In water phase, at 298 K, the total rate constants of SA eliminating center dot NO2 and center dot OH are 1.30x108 and 9.20x109 M-1 S-1 respectively, indicating that sinapic acid is an efficient scavenger for both center dot NO2 and center dot OH.	[Lu, Yang; Wang, Aihua; Shi, Peng] Harbin Univ Sci & Technol, Coll Mat Sci & Engn, Harbin, Peoples R China; [Zhang, Hui] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Key Lab Cluster Sci, Minist Educ, Beijing, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Sch Chem, Beijing, Peoples R China	Harbin University of Science & Technology; Harbin University of Science & Technology; Beijing Institute of Technology; Beijing Institute of Technology	Zhang, H (corresponding author), Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin, Peoples R China.	hust_zhanghui11@hotmail.com						Agnihotri N, 2011, J PHYS CHEM A, V115, P14221, DOI 10.1021/jp209318f; Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758; Ardura D, 2005, J PHYS CHEM B, V109, P23618, DOI 10.1021/jp0540499; ARUOMA OI, 1993, J AGR FOOD CHEM, V41, P1880, DOI 10.1021/jf00035a014; Bakalbassis EG, 2001, LIPIDS, V36, P181, DOI 10.1007/s11745-001-0705-9; Black G, 2010, J COMPUT CHEM, V31, P1236, DOI 10.1002/jcc.21410; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Chen WJ, 2006, BIOORG MED CHEM LETT, V16, P3582, DOI 10.1016/j.bmcl.2006.03.091; Chen YZ, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0327-0; Cheng JC, 2007, FOOD CHEM, V104, P132, DOI 10.1016/j.foodchem.2006.11.012; CHISOLM GM, 1991, CLIN CARDIOL, V14, P25, DOI 10.1002/clc.4960141304; Chuang YY, 1998, INT J QUANTUM CHEM, V70, P887, DOI 10.1002/(SICI)1097-461X(1998)70:4/5<887::AID-QUA34>3.0.CO;2-W; Corchado J.C., 2007, POLYRATE VERSION 9 7; CSALLANY AS, 1978, ARCH ENVIRON HEALTH, V33, P285, DOI 10.1080/00039896.1978.10667349; CUVELIER ME, 1992, BIOSCI BIOTECH BIOCH, V56, P324, DOI 10.1271/bbb.56.324; Di Meo F, 2013, J PHYS CHEM A, V117, P2082, DOI 10.1021/jp3116319; Draganic I, 1971, RAD CHEM WATER; Filipovic M, 2015, CR CHIM, V18, P492, DOI 10.1016/j.crci.2014.09.001; FORNI LG, 1986, J CHEM SOC PERK T 2, P1, DOI 10.1039/p29860000001; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Furuncuoglu T, 2010, MACROMOLECULES, V43, P1823, DOI 10.1021/ma902803p; Galano A, 2013, J COMPUT CHEM, V34, P2430, DOI 10.1002/jcc.23409; Galano A, 2011, PHYS CHEM CHEM PHYS, V13, P11199, DOI 10.1039/c1cp20722a; Galano A, 2009, ORG LETT, V11, P5114, DOI 10.1021/ol901862h; Gao JY, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1108-z; GARRETT BC, 1980, J PHYS CHEM-US, V84, P805, DOI 10.1021/j100444a020; Garzon A, 2014, J AGR FOOD CHEM, V62, P9705, DOI 10.1021/jf5011148; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HERRMANN K, 1989, CRIT REV FOOD SCI, V28, P315, DOI 10.1080/10408398909527504; Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1; Leopoldini M, 2004, J PHYS CHEM A, V108, P92, DOI 10.1021/jp035901j; Leopoldini M, 2011, J CHEM THEORY COMPUT, V7, P4218, DOI 10.1021/ct200572p; LU DH, 1992, COMPUT PHYS COMMUN, V71, P235, DOI 10.1016/0010-4655(92)90012-N; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Marino T, 2014, J PHYS CHEM B, V118, P10380, DOI 10.1021/jp505589b; Mohajeri A, 2009, J MOL STRUCT, V930, P15, DOI 10.1016/j.molstruc.2009.04.031; Nenadis N, 2012, FOOD RES INT, V48, P538, DOI 10.1016/j.foodres.2012.05.014; Niwa T, 1999, FEBS LETT, V459, P43, DOI 10.1016/S0014-5793(99)01216-8; Okuno Y, 1997, CHEM-EUR J, V3, P212, DOI 10.1002/chem.19970030208; Perez-Gonzalez A, 2011, J PHYS CHEM B, V115, P1306, DOI 10.1021/jp110400t; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; PRYOR WA, 1981, SCIENCE, V214, P435, DOI 10.1126/science.214.4519.435; PRYOR WA, 1982, J AM CHEM SOC, V104, P6685, DOI 10.1021/ja00388a035; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Saqib M, 2016, INT J FOOD PROP, V19, P745, DOI 10.1080/10942912.2015.1042588; Saqib M, 2013, PAK J PHARM SCI, V26, P1209; SCOTT BC, 1993, FREE RADICAL RES COM, V19, P241, DOI 10.3109/10715769309056512; Silva FAM, 2000, J AGR FOOD CHEM, V48, P2122, DOI 10.1021/jf9913110; Smyk B, 2003, J FLUORESC, V13, P349, DOI 10.1023/A:1025334029406; SMYK B, 1989, ANALYST, V114, P723, DOI 10.1039/an9891400723; STREET DA, 1994, CIRCULATION, V90, P1154, DOI 10.1161/01.CIR.90.3.1154; Thiyam U, 2006, EUR J LIPID SCI TECH, V108, P239, DOI 10.1002/ejlt.200500292; Urbaniak A, 2012, CMST, V18, P1; Urbaniak A., 2012, COMPUT METHODS SCI T, V18, P117, DOI [DOI 10.12921/CMST.2012.18.02.117-128, 10.12921/cmst.2012.18.02.117-128]; Urbaniak A, 2013, COMPUT THEOR CHEM, V1012, P33, DOI 10.1016/j.comptc.2013.02.018; Valentao P, 2001, J AGR FOOD CHEM, V49, P3476, DOI 10.1021/jf001145s; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vallet V, 2001, J AM CHEM SOC, V123, P11999, DOI 10.1021/ja015935+; vanAcker SABE, 1996, CHEM RES TOXICOL, V9, P1305, DOI 10.1021/tx9600964; Vega-Rodriguez A, 2009, PHYS CHEM CHEM PHYS, V11, P7649, DOI 10.1039/b906692f; Velez E, 2009, J PHYS ORG CHEM, V22, P971, DOI 10.1002/poc.1547; WANG WF, 1993, RADIAT PHYS CHEM, V42, P985, DOI 10.1016/0969-806X(93)90417-S; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u; Yoon BH, 2007, LIFE SCI, V81, P234, DOI 10.1016/j.lfs.2007.05.007; Yun KJ, 2008, J AGR FOOD CHEM, V56, P10265, DOI 10.1021/jf802095g; Zavala-Oseguera C, 2009, J PHYS CHEM A, V113, P13913, DOI 10.1021/jp906144d; Zhang ZE, 1998, FREE RADICAL RES, V29, P13, DOI 10.1080/10715769800300021; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763; Zhao Y, 2008, J PHYS CHEM A, V112, P1095, DOI 10.1021/jp7109127; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n; Zou YN, 2002, J AGR FOOD CHEM, V50, P5884, DOI 10.1021/jf020496z	72	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162729	10.1371/journal.pone.0162729	http://dx.doi.org/10.1371/journal.pone.0162729			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622460	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000052
J	Thompson, S; Avent, T; Doughty, LS				Thompson, S.; Avent, T.; Doughty, L. S.			Range Analysis and Terrain Preference of Adult Southern White Rhinoceros (Ceratotherium simum) in a South African Private Game Reserve: Insights into Carrying Capacity and Future Management	PLOS ONE			English	Article							HOME-RANGE; MEGA-GRAZER; PATTERNS; FOOD; TERRITORIALITY; SELECTION; SIZE	The Southern white rhinoceros (Ceratotherium simum) is a threatened species, central to the tourism appeal of private game reserves in South Africa. Privately owned reserves in South Africa tend to be smaller than government run reserves such as Kruger National Park. Because of their relatively small size and the often heterogeneous nature of the landscape private game reserve managers benefit from detailed knowledge of white rhinoceros terrain selection preferences, which can be assessed from their ranging behaviours. We collected adult and sub-adult white rhinoceros distribution data over a 15 month period, calculating individual range size using kernel density estimation analysis within a GIS. From this, terrain selectivity was calculated using 50% and 95% kernels to extract terrain composition values. Jacob's correction of the Ivlev's selectivity index was subsequently applied to the terrain composition of each individual to identify trends in selectivity. Results reveal that adult males hold exclusive territories considerably smaller than those found in previous work conducted in "open" or large reserves. Similarly, results for the size of male versus female territories were also not in keeping with those from previous field studies, with males, rather than females, having the larger territory requirement. Terrain selection for both genders and age classes (adult and sub-adult) showed a strong preference for open grassland and avoidance of hill slope and riparian terrains. This research reveals white rhinoceros terrain selection preferences and how they influence range requirements in small, closed reserves. We conclude that this knowledge will be valuable in future white rhinoceros conservation management in small private game reserves, particularly in decisions surrounding removal of surplus individuals or augmentation of existing populations, calculation of reserve carrying capacity and future private reserve acquisition.	[Thompson, S.; Avent, T.; Doughty, L. S.] Oxford Brookes Univ, Spatial Ecol & Landuse Unit, Gipsy Lane, Oxford OX3 0BP, England; [Avent, T.] WWT, Conservat & Dev, Slimbridge, Glos, England	Oxford Brookes University	Thompson, S (corresponding author), Oxford Brookes Univ, Spatial Ecol & Landuse Unit, Gipsy Lane, Oxford OX3 0BP, England.	sthompson@brookes.ac.uk			Operation Wallacea & WEI: Provision of students; Welgevonden Game Reserve; Operation Wallacea	Operation Wallacea & WEI: Provision of students; Welgevonden Game Reserve; Operation Wallacea	This work was supported by Operation Wallacea & WEI: Provision of students to collect data.; We would like to thank the lodge owners of Welgevonden Game Reserve for access to their properties and for their support for this project. We are indebted to the conservation management staff of the reserve in general and Gerhardt Lorist in particular, for provision of on the ground knowledge of individual rhino identification and distribution. This study was supported by Operation Wallacea. We would like to thank their volunteers who assisted in the field.	Acocks J. P. H., 1988, VELD TYPES S AFRICA; Bro-Jorgensen J, 2008, ANIM BEHAV, V75, P1229, DOI 10.1016/j.anbehav.2007.06.010; Callaghan CC, 1993, GEOLOGY WATERBERG GR; Chytry M, 2008, VEGETATION S AFRICA; CONWAY AJ, 1989, BIOL CONSERV, V47, P109, DOI 10.1016/0006-3207(89)90094-3; Emslie RH, 1995, FINE TUNING RHINO MA; Environmental Systems Research Institute, 2011, ESRI ARCGIS DESKT RE; FRITZ H, 1994, P ROY SOC B-BIOL SCI, V256, P77, DOI 10.1098/rspb.1994.0052; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Hitchins PM, 1970, LAMMERGEYER, V12, P48; Hopcraft JGC, 2012, J ANIM ECOL, V81, P201, DOI 10.1111/j.1365-2656.2011.01885.x; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; IVIEV VS, 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Kettles R, 2009, S AFR J WILDL RES, V39, P23, DOI 10.3957/056.039.0103; Knight M, 2013, PACHYDERM, P7; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; McLeod SR, 1997, OIKOS, V79, P529, DOI 10.2307/3546897; MURRAY MG, 1982, AFR J ECOL, V20, P253, DOI 10.1111/j.1365-2028.1982.tb00301.x; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; Oudtshoorn FV, 2002, GUIDE GRASSES SO AFR; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith R.N., 1973, THESIS; OWENSMIT.N, 1971, NATURE, V231, P294, DOI 10.1038/231294a0; Perrin MR, 1999, S AFR J WILDL RES, V29, P72; Pienaar D. J., 1993, Koedoe, V36, P79; Pienaar D. J., 1992, Koedoe, V35, P1; PIENAAR DJ, 1993, J ZOOL, V229, P641, DOI 10.1111/j.1469-7998.1993.tb02661.x; Pienaar DJ, 1994, P S RHIN GAM RANCH A; Rachlow JL, 1999, AFR J ECOL, V37, P295, DOI 10.1046/j.1365-2028.1999.00175.x; Save the Rhino, 2016, POACH STAT; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sims-Castley R., 2005, PARKS, V15, P6; Slater K, 2012, OPERATION WALLACEA W; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Timko JA, 2009, BIOL CONSERV, V142, P676, DOI 10.1016/j.biocon.2008.11.022; Trollope W. S. W., 1998, Koedoe, V41, P103; US Geological Survey, 2016, LAND PROC DISTR ACT; van Aarde RJ, 2006, S AFR J SCI, V102, P385; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Wallgren M, 2009, AFR J ECOL, V47, P20, DOI 10.1111/j.1365-2028.2007.00904.x; White AM, 2007, ANIM BEHAV, V74, P349, DOI 10.1016/j.anbehav.2006.12.011; Wronski T, 2006, BEHAV ECOL SOCIOBIOL, V59, P819, DOI 10.1007/s00265-005-0128-2	44	7	7	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161724	10.1371/journal.pone.0161724	http://dx.doi.org/10.1371/journal.pone.0161724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622566	Green Published, Green Submitted, gold			2022-12-27	WOS:000383681000007
J	Yao, KZ; Wu, YY; Chen, Q; Zhang, ZH; Chen, X; Zhang, Y				Yao, Kezhen; Wu, Yongyan; Chen, Qi; Zhang, Zihan; Chen, Xin; Zhang, Yong			The Arginine/Lysine-Rich Element within the DNA-Binding Domain Is Essential for Nuclear Localization and Function of the Intracellular Pathogen Resistance 1	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; REGULATOR PROTEIN; TUBERCULOSIS; SP110; GENE; TRANSCRIPTION; SIGNALS; IMPORT; SUSCEPTIBILITY; IDENTIFICATION	The mouse intracellular pathogen resistance 1 (Ipr1) gene plays important roles in mediating host immunity and previous work showed that it enhances macrophage apoptosis upon mycobacterium infection. However, to date, little is known about the regulation pattern of Ipr1 action. Recent studies have investigated the protein-coding genes and microRNAs regulated by Ipr1 in mouse macrophages, but the structure and the functional motif of the Ipr1 protein have yet to be explored. In this study, we analyzed the domains and functional motif of the Ipr1 protein. The resulting data reveal that Ipr1 protein forms a homodimer and that the Sp100-like domain mediates the targeting of Ipr1 protein to nuclear dots (NDs). Moreover, we found that an Ipr1mutant lacking the classic nuclear localization signal (cNLS) also translocated into the nuclei, suggesting that the cNLS is not the only factor that directs Ipr1 nuclear localization. Additionally, mechanistic studies revealed that an arginine/lysinerich element within the DNA-binding domain (SAND domain) is critical for Ipr1 binding to the importin protein receptor NPI-1, demonstrating that this element plays an essential role in mediating the nuclear localization of Ipr1 protein. Furthermore, our results show that this arginine/lysine-rich element contributes to the transcriptional regulation and apoptotic activity of Ipr1. These findings highlight the structural foundations of Ipr1 action and provide new insights into the mechanism of Ipr1-mediated resistance to mycobacterium.	[Yao, Kezhen; Wu, Yongyan; Chen, Qi; Zhang, Zihan; Chen, Xin; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yao, Kezhen; Wu, Yongyan; Chen, Qi; Zhang, Zihan; Chen, Xin; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.; Zhang, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	yongzhlab@hotmail.com	chen, xiner/GVU-3933-2022; Wu, Yongyan/AAH-1471-2019	Wu, Yongyan/0000-0003-1669-3860	National Natural Science Foundation of China [31530075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 31530075).	Abhimanyu, 2011, HUM IMMUNOL, V72, P576, DOI 10.1016/j.humimm.2011.03.014; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cai L, 2010, MOL BIOL REP, V37, P3863, DOI 10.1007/s11033-010-0042-1; Christensen J, 1999, MOL CELL BIOL, V19, P7741; de la Fuente J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-110; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fox GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099496; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; He XN, 2011, SCAND J IMMUNOL, V74, P438, DOI 10.1111/j.1365-3083.2011.02596.x; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Li LZ, 2016, MOL GENET GENOMICS; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nicewonger J, 2004, J VIROL, V78, P9412, DOI 10.1128/JVI.78.17.9412-9422.2004; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ruiz-Larranaga O, 2010, J DAIRY SCI, V93, P5950, DOI 10.3168/jds.2010-3340; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Wu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22041	35	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162832	10.1371/journal.pone.0162832	http://dx.doi.org/10.1371/journal.pone.0162832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622275	Green Submitted, Green Published, gold			2022-12-27	WOS:000383681000061
J	Bosseler, AN; Teinonen, T; Tervaniemi, M; Huotilainen, M				Bosseler, Alexis N.; Teinonen, Tuomas; Tervaniemi, Mari; Huotilainen, Minna			Infant Directed Speech Enhances Statistical Learning in Newborn Infants: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; AUDITORY-EVOKED POTENTIALS; MISMATCH NEGATIVITY; CEREBRAL SPECIALIZATION; LANGUAGE EXPERIENCE; 9-MONTH-OLD INFANTS; BRAIN POTENTIALS; NATIVE-LANGUAGE; VISUAL-CORTEX; SEGMENTATION	Statistical learning and the social contexts of language addressed to infants are hypothesized to play important roles in early language development. Previous behavioral work has found that the exaggerated prosodic contours of infant-directed speech (IDS) facilitate statistical learning in 8-month-old infants. Here we examined the neural processes involved in on-line statistical learning and investigated whether the use of IDS facilitates statistical learning in sleeping newborns. Event-related potentials (ERPs) were recorded while newborns were exposed to 12 pseudo-words, six spoken with exaggerated pitch contours of IDS and six spoken without exaggerated pitch contours (ADS) in ten alternating blocks. We examined whether ERP amplitudes for syllable position within a pseudo-word (word-initial vs. word-medial vs. word-final, indicating statistical word learning) and speech register (ADS vs. IDS) would interact. The ADS and IDS registers elicited similar ERP patterns for syllable position in an early 0-100 ms component but elicited different ERP effects in both the polarity and topographical distribution at 200-400 ms and 450-650 ms. These results provide the first evidence that the exaggerated pitch contours of IDS result in differences in brain activity linked to on-line statistical learning in sleeping newborns.	[Bosseler, Alexis N.; Teinonen, Tuomas; Tervaniemi, Mari; Huotilainen, Minna] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Bosseler, Alexis N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Tervaniemi, Mari; Huotilainen, Minna] Univ Helsinki, Cicero Learning, Helsinki, Finland	University of Helsinki; University of Washington; University of Washington Seattle; University of Helsinki	Bosseler, AN (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.; Bosseler, AN (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	bosseler@u.washington.edu		Tervaniemi, Mari/0000-0002-9651-2929; Huotilainen, Minna/0000-0002-7251-6984	Erasmus Mundus Mobility Auditory Cognitive Neuroscience; Academy of Finland	Erasmus Mundus Mobility Auditory Cognitive Neuroscience; Academy of Finland(Academy of Finland)	This work was supported by Erasmus Mundus Mobility Auditory Cognitive Neuroscience, http://research.uni-leipzig.de/acn/ (ANB); and Academy of Finland, http://www.aka.fi/en/ (ANB).	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Best CC, 2003, LANG SPEECH, V46, P183, DOI 10.1177/00238309030460020701; Boersma P, PRAAT DONING PHONETI; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Bosseler AN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00690; Callan DE, 2004, NEUROIMAGE, V22, P1182, DOI 10.1016/j.neuroimage.2004.03.006; CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; Conboy BT, 2006, DEVELOPMENTAL SCI, V9, pF1, DOI 10.1111/j.1467-7687.2005.00453.x; Cunillera T, 2006, BRAIN RES, V1123, P168, DOI 10.1016/j.brainres.2006.09.046; Cunillera T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-23; de Gardelle V, 2013, CEREB CORTEX, V23, P2235, DOI 10.1093/cercor/bhs211; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; Friederici AD, 2007, CURR BIOL, V17, P1208, DOI 10.1016/j.cub.2007.06.011; Friedrich M, 2009, CORTEX, V45, P662, DOI 10.1016/j.cortex.2008.06.014; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garcia-Sierra A, 2011, J PHON, V39, P456; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; GOODSITT JV, 1993, J CHILD LANG, V20, P229, DOI 10.1017/S0305000900008266; Grimm S, 2007, RESTOR NEUROL NEUROS, V25, P241; Guenther FH, 2004, J SPEECH LANG HEAR R, V47, P46, DOI 10.1044/1092-4388(2004/005); Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hinojosa JA, 2005, NEUROSCI LETT, V378, P34, DOI 10.1016/j.neulet.2004.12.010; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kooijman V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00025; Kudo N, 2011, DEVELOPMENTAL SCI, V14, P1100, DOI 10.1111/j.1467-7687.2011.01056.x; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; MASSARO DW, 1983, PERCEPT PSYCHOPHYS, V34, P338, DOI 10.3758/BF03203046; Massaro DW, 1993, PERCEIVING TALKING F; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2008, DEVELOPMENTAL SCI, V11, P122, DOI 10.1111/j.1467-7687.2007.00653.x; Meyer MC, 2009, NAT LANG LINGUIST TH, V27, P139, DOI 10.1007/s11049-008-9060-2; Mills D L, 1997, Semin Pediatr Neurol, V4, P125, DOI 10.1016/S1071-9091(97)80029-0; MILLS DL, 1993, J COGNITIVE NEUROSCI, V5, P317, DOI 10.1162/jocn.1993.5.3.317; Mills DL, 2004, J COGNITIVE NEUROSCI, V16, P1452, DOI 10.1162/0898929042304697; Mills DL, 1997, DEV NEUROPSYCHOL, V13, P397, DOI 10.1080/87565649709540685; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Muller NG, 2013, CEREB CORTEX, V23, P315, DOI 10.1093/cercor/bhs009; Purdy SC, 2001, AUDIOL NEURO-OTOL, V6, P211, DOI 10.1159/000046835; Reinke KS, 2003, COGNITIVE BRAIN RES, V17, P781, DOI 10.1016/S0926-6410(03)00202-7; Rescorla R.A., 1966, PSYCHON SCI, V4, P383, DOI [10.3758/BF03342350, DOI 10.3758/BF03342350]; Rivera-Gaxiola M, 2005, NEUROREPORT, V16, P495, DOI 10.1097/00001756-200504040-00015; Saffran JR, 2001, COGNITION, V81, P149, DOI 10.1016/S0010-0277(01)00132-9; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2005, DEVELOPMENTAL SCI, V8, P1, DOI 10.1111/j.1467-7687.2005.00387.x; Saffran JR, 2002, J MEM LANG, V47, P172, DOI 10.1006/jmla.2001.2839; Saito Y, 2007, ARCH DIS CHILD-FETAL, V92, pF113, DOI 10.1136/adc.2006.097949; Saito Y, 2007, EARLY HUM DEV, V83, P225, DOI 10.1016/j.earlhumdev.2006.05.017; Sanders LD, 2002, NAT NEUROSCI, V5, P700, DOI 10.1038/nn873; Sanders LD, 2003, COGNITIVE BRAIN RES, V15, P214, DOI 10.1016/S0926-6410(02)00194-5; Santesso DL, 2007, BRAIN COGNITION, V65, P14, DOI 10.1016/j.bandc.2007.02.008; Shafer LV, 2011, J PHONETICS, V39, P527; Shahin A, 2003, J NEUROSCI, V23, P5545; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Teinonen T, 2012, J PSYCHOLINGUIST RES, V41, P71, DOI 10.1007/s10936-011-9182-2; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Tremblay P, 2013, NEUROIMAGE, V66, P318, DOI 10.1016/j.neuroimage.2012.10.055; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; WERKER JF, 1994, INFANT BEHAV DEV, V17, P323, DOI 10.1016/0163-6383(94)90012-4; Zangl R, 2007, INFANCY, V11, P31, DOI 10.1207/s15327078in1101_2; Zhang Y, 2005, NEUROIMAGE, V26, P703, DOI 10.1016/j.neuroimage.2005.02.040; Zhang Y, 2011, DEVELOPMENTAL SCI, V14, P566, DOI 10.1111/j.1467-7687.2010.01004.x; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	75	31	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162177	10.1371/journal.pone.0162177	http://dx.doi.org/10.1371/journal.pone.0162177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27617967	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100013
J	El Alaoui, S; Ljotsson, B; Hedman, E; Svanborg, C; Kaldo, V; Lindefors, N				El Alaoui, Samir; Ljotsson, Brjann; Hedman, Erik; Svanborg, Cecilia; Kaldo, Viktor; Lindefors, Nils			Predicting Outcome in Internet-Based Cognitive Behaviour Therapy for Major Depression: A Large Cohort Study of Adult Patients in Routine Psychiatric Care	PLOS ONE			English	Article							SOCIAL ANXIETY DISORDER; INSOMNIA SEVERITY INDEX; TO-MODERATE DEPRESSION; UNGUIDED SELF-HELP; IDENTIFICATION TEST; DSM-IV; VALIDATION; PHARMACOTHERAPY; COMORBIDITY; PREVALENCE	Background Although the effectiveness of therapist-guided internet-based cognitive behaviour therapy (ICBT) for treating depression has been well documented, knowledge of outcome predictors and risk factors associated with lower treatment response is limited, especially when the treatment has been conducted within a naturalistic clinical setting. Identification of such factors is important for clinicians when making treatment recommendations. Methods Data from a large cohort (N = 1738) of adult outpatients having been treated with ICBT for depression at an outpatient psychiatric clinic were analysed. A multilevel modelling approach was used to identify patient and treatment variables associated with the speed of recovery during treatment using weekly measurements of the Montgomery Asberg Depression Rating Scale Self-Rated (MADRS-S). Outcomes Adhering to the treatment, perceiving it as credible and working full-time emerged as predictors of a faster pace of recovery and were also associated with a lower level of depression at the end of treatment. Higher pre-treatment depression and sleep problems were associated with a greater improvement rate, but predicted higher depression after treatment. Having a history of psychotropic medication was associated with both slower improvement and higher post-treatment depression. Conclusion Perceived credibility of ICBT is a strong predictor of treatment response. Assessing patient beliefs and expectations may be a useful aid for clinicians when identifying those who are more or less likely to benefit from ICBT. Helping patients improve expectations prior to treatment may be an important goal for clinicians during the initial assessment phase.	[El Alaoui, Samir; Ljotsson, Brjann; Hedman, Erik; Svanborg, Cecilia; Kaldo, Viktor; Lindefors, Nils] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Hedman, Erik] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden; [Ljotsson, Brjann; Hedman, Erik] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	El Alaoui, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden.	samir.el.alaoui@ki.se	; El Alaoui, Samir/I-3504-2012	Hedman-Lagerlof, Erik/0000-0002-7939-9848; El Alaoui, Samir/0000-0002-6590-1606; Kaldo, Viktor/0000-0002-6443-5279	Stockholm County Council [ALF 20130413]	Stockholm County Council(Stockholm County Council)	This study was supported by a research grant (ALF 20130413, to Nils Lindefors) from Stockholm County Council, a public institution that had no role in study design, data collection, analysis, data interpretation, manuscript writing, or decision to submit for publication. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Allen JP, 2001, PREV MED, V33, P428, DOI 10.1006/pmed.2001.0910; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Andersson G, 2004, VERHALTENSTHERAPIE, V14, P185, DOI 10.1159/000080914; Andrews G, 2016, EVID-BASED MENT HEAL, V19, P43, DOI 10.1136/eb-2015-102293; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Aydos L, 2009, AUSTRALAS PSYCHIATRY, V17, P488, DOI 10.1080/10398560903284943; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Blom K, 2015, SLEEP, V38, P267, DOI 10.5665/sleep.4412; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cassell J, 2002, J MED ETHICS, V28, P315; Clark AM, 2004, NEW ENGL J MED, V351, P612; Davis LL, 2010, DRUG ALCOHOL DEPEN, V107, P161, DOI 10.1016/j.drugalcdep.2009.10.003; El Alaoui S, 2015, J CONSULT CLIN PSYCH, V83, P902, DOI 10.1037/a0039198; El Alaoui S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124258; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Gajecki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104615; Geraghty AWA, 2010, SOC SCI MED, V71, P30, DOI 10.1016/j.socscimed.2010.03.007; Gledhill J, 2011, SOC PSYCH PSYCH EPID, V46, P993, DOI 10.1007/s00127-010-0271-6; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Hallgren M, 2015, BRIT J PSYCHIAT, V207, P227, DOI 10.1192/bjp.bp.114.160101; Hamilton KE, 2002, CLIN PSYCHOL REV, V22, P875, DOI 10.1016/S0272-7358(02)00106-X; Hedman E, 2013, ACTA PSYCHIAT SCAND, V128, P457, DOI 10.1111/acps.12079; Hedman E, 2012, ACTA PSYCHIAT SCAND, V126, P126, DOI 10.1111/j.1600-0447.2012.01834.x; Hedman E, 2014, J AFFECT DISORDERS, V155, P49, DOI 10.1016/j.jad.2013.10.023; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Hilvert-Bruce Z, 2012, BEHAV RES THER, V50, P463, DOI 10.1016/j.brat.2012.04.001; HOBERMAN HM, 1988, J CONSULT CLIN PSYCH, V56, P393, DOI 10.1037/0022-006X.56.3.393; HOLLON SD, 1992, ARCH GEN PSYCHIAT, V49, P774; Howland RH, 2009, DRUG ALCOHOL DEPEN, V99, P248, DOI 10.1016/j.drugalcdep.2008.08.010; JARRETT RB, 1991, PSYCHIAT RES, V37, P245, DOI 10.1016/0165-1781(91)90061-S; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Nordgreen T, 2012, BEHAV RES THER, V50, P13, DOI 10.1016/j.brat.2011.10.009; Proudfoot J, 2003, PSYCHOL MED, V33, P217, DOI 10.1017/S0033291702007225; Rapee RM, 2007, BRIT J PSYCHIAT, V191, P246, DOI 10.1192/bjp.bp.106.028167; Rief W, 2009, J AFFECT DISORDERS, V118, P1, DOI 10.1016/j.jad.2009.01.029; Ruwaard Jeroen, 2009, Cognitive Behaviour Therapy, V38, P206, DOI 10.1080/16506070802408086; SHAPIRO DA, 1994, J CONSULT CLIN PSYCH, V62, P522, DOI 10.1037/0022-006X.62.3.522; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SIMONS AD, 1995, J CONSULT CLIN PSYCH, V63, P369, DOI 10.1037/0022-006X.63.3.369; Smits JAJ, 2013, J CONSULT CLIN PSYCH, V81, P1100, DOI 10.1037/a0034120; SOTSKY SM, 1991, AM J PSYCHIAT, V148, P997; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; THASE ME, 1991, AM J PSYCHIAT, V148, P784; Thorndike FP, 2011, BEHAV SLEEP MED, V9, P216, DOI 10.1080/15402002.2011.606766; Vuorilehto MS, 2009, PSYCHOL MED, V39, P1697, DOI 10.1017/S0033291709005182; Warmerdam L, 2013, PSYCHOTHER RES, V23, P559, DOI 10.1080/10503307.2013.807377; Watkins KE, 2006, AM J PSYCHIAT, V163, P125, DOI 10.1176/appi.ajp.163.1.125	54	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161191	10.1371/journal.pone.0161191	http://dx.doi.org/10.1371/journal.pone.0161191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618548	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100007
J	Grounta, A; Harizanis, P; Mylonakis, E; Nychas, GJE; Panagou, EZ				Grounta, Athena; Harizanis, Paschalis; Mylonakis, Eleftherios; Nychas, George-John E.; Panagou, Efstathios Z.			Investigating the Effect of Different Treatments with Lactic Acid Bacteria on the Fate of Listeria monocytogenes and Staphylococcus aureus Infection in Galleria mellonella Larvae	PLOS ONE			English	Article							IMMUNOGLOBULIN-E PRODUCTION; TABLE OLIVES; LACTOBACILLUS-PLANTARUM; CAENORHABDITIS-ELEGANS; CANDIDA-ALBICANS; IN-VITRO; BIOFILM FORMATION; FERMENTED OLIVES; IMMUNE-RESPONSES; STARTER CULTURES	The use of Galleria mellonella as a model host to elucidate microbial pathogenesis and search for novel drugs and therapies has been well appreciated over the past years. However, the effect of microorganisms with functional appeal in the specific host remains scarce. The present study investigates the effect of treatment with selected lactic acid bacteria (LAB) with probiotic potential, as potential protective agents by using live or heat-killed cells at 6 and 24 h prior to infection with Listeria monocytogenes and Staphylococcus aureus or as potential therapeutic agents by using cell-free supernatants (CFS) after infection with the same pathogens. The employed LAB strains were Lactobacillus pentosus B281 and Lactobacillus plantarum B282 (isolated from table olive fermentations) along with Lactobacillus rhamnosusGG (inhabitant of human intestinal tract). Kaplan-Meier survival curves were plotted while the pathogen's persistence in the larval hemolymph was determined by microbiological analysis. It was observed that the time (6 or 24 h) and type (live or heat-killed cells) of challenge period with LAB prior to infection greatly affected the survival of infected larvae. The highest decrease of L. monocytogenes population in the hemolymph was observed in groups challenged for 6 h with heat-killed cells by an average of 1.8 log units compared to non challenged larvae for strains B281 (p 0.0322), B282 (p 0.0325), and LGG (p 0.0356). In the case of S. aureus infection, the population of the pathogen decreased in the hemolymph by 1 log units at 8 h post infection in the groups challenged for 6 h with heat-killed cells of strains B281 (p 0.0161) and B282 (p 0.0096) and by 1.8 log units in groups challenged with heat-killed cells of LGG strain (p 0.0175). Further use of CFS of each LAB strain did not result in any significant prolonged survival but interestingly it resulted in pronounced decrease of L. monocytogenes in the hemolymph at 24 h and 48 h after infection by more than 1 log unit (p < 0.05) depending on the strain. The results of the present work support the broader use of G. mellonella larvae as a low cost in vivo tool for screening for probiotic properties.	[Grounta, Athena; Nychas, George-John E.; Panagou, Efstathios Z.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Microbiol & Biotechnol, Athens, Greece; [Harizanis, Paschalis] Agr Univ Athens, Fac Crop Sci, Lab Sericulture & Apiculture, Athens, Greece; [Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	Agricultural University of Athens; Agricultural University of Athens; Brown University	Panagou, EZ (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Microbiol & Biotechnol, Athens, Greece.	stathispanagou@aua.gr	Nychas, George/B-2734-2009; Panagou, Efstathios/I-6537-2019	Nychas, George/0000-0002-2673-6425; Panagou, Efstathios/0000-0002-0317-1177	EU [243471/FP7-SME-2008-2]	EU(European Commission)	The present study was funded by the EU project PROBIOLIVES (No 243471/FP7-SME-2008-2).	Abriouel H, 2012, FOOD MICROBIOL, V32, P308, DOI 10.1016/j.fm.2012.07.006; Andrejko M, 2009, COMP BIOCHEM PHYS B, V152, P118, DOI 10.1016/j.cbpb.2008.10.008; Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Bautista-Gallego J, 2013, FOOD RES INT, V50, P135, DOI 10.1016/j.foodres.2012.10.004; Bergin D, 2006, MICROBES INFECT, V8, P2105, DOI 10.1016/j.micinf.2006.03.005; Beristain-Bauza SC, 2016, FOOD CONTROL, V62, P44, DOI 10.1016/j.foodcont.2015.10.007; Bevilacqua A, 2010, J FOOD SCI, V75, pM536, DOI 10.1111/j.1750-3841.2010.01793.x; Blana VA, 2014, FOOD MICROBIOL, V38, P208, DOI 10.1016/j.fm.2013.09.007; Botta C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094457; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Commane D, 2005, MUTAT RES-FUND MOL M, V591, P276, DOI 10.1016/j.mrfmmm.2005.02.027; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Cross ML, 2002, FEMS IMMUNOL MED MIC, V34, P245, DOI 10.1111/j.1574-695X.2002.tb00632.x; Cytrynska M, 2007, PEPTIDES, V28, P533, DOI 10.1016/j.peptides.2006.11.010; De Bellis P, 2010, INT J FOOD MICROBIOL, V140, P6, DOI 10.1016/j.ijfoodmicro.2010.02.024; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Doulgeraki AI, 2013, ANTON LEEUW INT J G, V103, P821, DOI 10.1007/s10482-012-9864-2; Doulgeraki AI, 2013, LWT-FOOD SCI TECHNOL, V50, P353, DOI 10.1016/j.lwt.2012.07.003; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; FAO/WHO, 2002, PROB FOOD HLTH NUTR; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Gibreel TM, 2013, J ANTIMICROB CHEMOTH, V68, P2269, DOI 10.1093/jac/dkt195; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Grounta A, 2016, FOOD MICROBIOL, V56, P35, DOI 10.1016/j.fm.2015.12.002; Gupta S, 2012, CRIT REV FOOD SCI, V52, P183, DOI 10.1080/10408398.2010.499779; Ishikawa H, 2010, BIOSCI BIOTECH BIOCH, V74, P1338, DOI 10.1271/bbb.90871; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6; Latimer J, 2012, ANTIMICROB AGENTS CH, V56, P3092, DOI 10.1128/AAC.05904-11; Lavermicocca P, 2005, APPL ENVIRON MICROB, V71, P4233, DOI 10.1128/AEM.71.8.4233-4240.2005; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lin WH, 2007, J APPL MICROBIOL, V102, P22, DOI 10.1111/j.1365-2672.2006.03073.x; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; MATSUZAKI T, 1990, MED MICROBIOL IMMUN, V179, P161; Matsuzaki T, 1998, J DAIRY SCI, V81, P48, DOI 10.3168/jds.S0022-0302(98)75549-3; Michaux C, 2011, INFECT IMMUN, V79, P2638, DOI 10.1128/IAI.01132-10; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; Mukherjee K, 2011, APPL ENVIRON MICROB, V77, P4237, DOI 10.1128/AEM.02435-10; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Ramos AN, 2010, INT IMMUNOPHARMACOL, V10, P247, DOI 10.1016/j.intimp.2009.11.007; Salminen S, 1998, INT DAIRY J, V8, P563, DOI 10.1016/S0958-6946(98)00077-6; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Saxami G, 2016, J FUNCT FOODS, V24, P461, DOI 10.1016/j.jff.2016.04.036; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; Upadhyay A, 2016, J MED MICROBIOL, V65, P443, DOI 10.1099/jmm.0.000251; Vilela SFG, 2015, VIRULENCE, V6, P29, DOI 10.4161/21505594.2014.981486; Villena J, 2009, MICROBIOL IMMUNOL, V53, P636, DOI 10.1111/j.1348-0421.2009.00171.x; Vintini EO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-46; Wollowski I, 2001, AM J CLIN NUTR, V73, p451S, DOI 10.1093/ajcn/73.2.451s	60	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161263	10.1371/journal.pone.0161263	http://dx.doi.org/10.1371/journal.pone.0161263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618619	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100008
J	Shah, P; Lueschen, N; Ardestani, A; Oberholzer, J; Olerud, J; Carlsson, PO; Maedler, K				Shah, Payal; Lueschen, Navina; Ardestani, Amin; Oberholzer, Jose; Olerud, Johan; Carlsson, Per-Ola; Maedler, Kathrin			Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BETA-CELL APOPTOSIS; IN-VIVO; VEGF-A; EXTRACELLULAR-MATRIX; INSULIN-SECRETION; ANGIOPOIETIN-2; TIE2; RECEPTOR; VASCULARIZATION	Aims Changes in the islet vasculature have been implicated in the regulation of beta-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the beta-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex interplay of genetic and environmental factors (e.g. ongoing inflammation within the islets) and impaired vascular function. The Angiopoietin/Tie (Ang/Tie) angiogenic system maintains vasculature and is closely related to organ inflammation and angiogenesis. In this study we aimed to identify whether the vessel area within the islets changes in diabetes and whether such changes would be triggered by the Tie-antagonist Ang-2. Methods Immunohistochemical and qPCR analyses to follow islet vascularization and Ang/Tie levels were performed in human pancreatic autopsies and isolated human and mouse islets. The effect of Ang-2 was assessed in beta-cell-specific Ang-2 overexpressing mice during high fat diet (HFD) feeding. Results Islet vessel area was increased in autopsy pancreases from patients with T2D. The vessel markers Tie-1, Tie-2 and CD31 were upregulated in mouse islets upon HFD feeding from 8 to 24 weeks. Ang-2 was transiently upregulated in mouse islets at 8 weeks of HFD and under glucolipotoxic conditions (22.2mMglucose/0.5 mMpalmitate) in vitro in human and mouse islets, in contrast to its downregulation by cytokines (IL-1 beta, IFN-gamma and TNF-alpha). Ang-1 on the other hand was oppositely regulated, with a significant loss under glucolipotoxic condition, a trend to reduce in islets from patients with T2D and an upregulation by cytokines. Modulation of such changes in Ang-2 by its overexpression or the inhibition of its receptor Tie-2 impaired beta-cell function at basal conditions but protected islets from cytokine induced apoptosis. In vivo, beta-cell-specific Ang-2 overexpression in mice induced hypervascularization under normal diet but contrastingly led to hypovascularized islets in response to HFD together with increased apoptosis and reduced beta-cell mass. Conclusions Islet hypervascularization occurs in T2D. A balanced expression of the Ang1/Ang2 system is important for islet physiology. Ang-2 prevents beta-cell mass and islet vascular adaptation in response to HFD feeding with no major influence on glucose homeostasis.	[Shah, Payal; Lueschen, Navina; Ardestani, Amin; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, Bremen, Germany; [Oberholzer, Jose] Univ Illinois, Div Transplantat, Chicago, IL USA; [Olerud, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Carlsson, Per-Ola] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Maedler, Kathrin] Univ Bremen, German Ctr Diabet Res DZD Project Partner, Bremen, Germany	University of Bremen; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Uppsala University; Uppsala University; Uppsala University; University of Bremen	Maedler, K (corresponding author), Univ Bremen, Ctr Biomol Interact, Bremen, Germany.; Maedler, K (corresponding author), Univ Bremen, German Ctr Diabet Res DZD Project Partner, Bremen, Germany.	kmaedler@uni-bremen.de	Maedler, Kathrin/ABE-3022-2021	Maedler, Kathrin/0000-0002-7436-1197; Ardestani, Amin/0000-0002-0685-8564	European Research Council (ERC); German Research Foundation (DFG); German Diabetes Center grant (DZD) from the BMBF; EFSD; JDRF award [31-2008-413]; NIDDK; integrated islet distribution program (IIDP)	European Research Council (ERC)(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Diabetes Center grant (DZD) from the BMBF; EFSD; JDRF award; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); integrated islet distribution program (IIDP)	This work was supported by the European Research Council (ERC), the German Research Foundation (DFG), by the German Diabetes Center grant (DZD) from the BMBF (to KM) and by an Albert Renold travel grant from the EFSD (to PS). Human is lets were provided through the JDRF award 31-2008-413 (ECIT Islet for Basic Research program) and by the integrated islet distribution program (IIDP). Autopsy pancreases were provided by the National Disease Research Interchange NDRI, supported from the NIDDK.; We thank J. Kerr-Conte and Francois Pattou (European Genomic Institute for Diabetes, Lille) and ProdoLabs for the high quality human islet isolations, Marcella Brissova and Alvin C. Powers (Vanderbilt University, Nashville) for providing the RIP-rtTA<SUP>tg/tg</SUP> and Tet-O-Ang-2<SUP>tg/wt</SUP> mice, Katrischa Hennekens and Jennifer Bergemann for technical assistance, Wei He (all University of Bremen) for human islet RNA processing and Hellmut Augustin (Dkfz-Heidelberg) for the Ang2-adenovirus. Autopsy pancreases were provided by the National Disease Research Interchange NDRI, supported from the NIDDK. Human islets were provided through an approved protocol by the Integrated Islet Distribution Program (IIDP) for human islets for research.	Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Ardestani A, 2011, J BIOL CHEM, V286, P17144, DOI 10.1074/jbc.M110.210526; Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Bonner-Weir S, 2015, J HISTOCHEM CYTOCHEM, V63, P604, DOI 10.1369/0022155415570969; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Brissova M, 2015, J HISTOCHEM CYTOCHEM, V63, P637, DOI 10.1369/0022155415573324; Cai Q, 2012, DEV BIOL, V367, P40, DOI 10.1016/j.ydbio.2012.04.022; Calderari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029438; Dai CH, 2013, DIABETES, V62, P4144, DOI 10.2337/db12-1657; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Feng ZC, 2015, DIABETES, V64, P3852, DOI 10.2337/db15-0054; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Hasenstein JR, 2012, NEOPLASIA, V14, P131, DOI 10.1593/neo.111770; HENDERSON JR, 1985, Q J EXP PHYSIOL CMS, V70, P347, DOI 10.1113/expphysiol.1985.sp002920; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jabs N, 2008, EXP CLIN ENDOCR DIAB, V116, pS46, DOI 10.1055/s-2008-1081486; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; KAISER N, 1988, ENDOCRINOLOGY, V123, P834, DOI 10.1210/endo-123-2-834; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Manavski Y, 2014, CIRC RES, V114, P1077, DOI 10.1161/CIRCRESAHA.114.303452; Meyer A, 2015, DIABETES, V64, P2138, DOI 10.2337/db14-0864; Moldovan S, 2001, WORLD J SURG, V25, P468, DOI 10.1007/s002680020339; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; Rasul S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-55; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Scholz A, 2015, ANN NY ACAD SCI, V1347, P45, DOI 10.1111/nyas.12726; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Semones M, 2007, BIOORG MED CHEM LETT, V17, P4756, DOI 10.1016/j.bmcl.2007.06.068; Singh H, 2010, MICROVASC RES, V79, P121, DOI 10.1016/j.mvr.2010.01.005; Spelios MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072260; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Toyofuku Y, 2009, BIOCHEM BIOPH RES CO, V383, P303, DOI 10.1016/j.bbrc.2009.03.138; WEIR GC, 1990, J CLIN INVEST, V85, P983, DOI 10.1172/JCI114574; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161834	10.1371/journal.pone.0161834	http://dx.doi.org/10.1371/journal.pone.0161834			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617438	gold, Green Published, Green Submitted			2022-12-27	WOS:000383653100010
J	Wurtzler, EM; Wendell, D				Wurtzler, Elizabeth M.; Wendell, David			Selective Photocatalytic Disinfection by Coupling StrepMiniSog to the Antibody Catalyzed Water Oxidation Pathway	PLOS ONE			English	Article							TITANIUM-DIOXIDE; PSEUDOMONAS-AERUGINOSA; DRINKING-WATER; STAPHYLOCOCCUS-AUREUS; IN-VITRO; TIO2; INACTIVATION; PHOTOSENSITIZER; LIGHT; BACTERIOPHAGES	For several decades reactive oxygen species have been applied to water quality engineering and efficient disinfection strategies; however, these methods are limited by disinfection byproduct and catalyst-derived toxicity concerns which could be improved by selectively targeting contaminants of interest. Here we present a targeted photocatalytic system based on the fusion protein StrepMiniSOG that uses light within the visible spectrum to produce reactive oxygen species at a greater efficiency than current photosensitizers, allowing for shorter irradiation times from a fully biodegradable photocatalyst. The StrepMiniSOG photodisinfection system is unable to cross cell membranes and like other consumed proteins, can be degraded by endogenous digestive enzymes in the human gut, thereby reducing the consumption risks typically associated with other disinfection agents. We demonstrate specific, multi-log removal of Listeria monocytogenes from a mixed population of bacteria, establishing the StrepMiniSOG disinfection system as a valuable tool for targeted pathogen removal, while maintaining existing microbial biodiversity.	[Wurtzler, Elizabeth M.; Wendell, David] Univ Cincinnati, Coll Engn & Appl Sci, Dept Biol Chem & Environm Engn, Cincinnati, OH 45220 USA	University of Cincinnati	Wendell, D (corresponding author), Univ Cincinnati, Coll Engn & Appl Sci, Dept Biol Chem & Environm Engn, Cincinnati, OH 45220 USA.	wendeldw@uc.edu			National Science Foundation; Chemical, Bioengineering, Environmental, and Transport Systems Division; CBET [1552456, 1509022]; Div Of Chem, Bioeng, Env, & Transp Sys [1552456] Funding Source: National Science Foundation	National Science Foundation; Chemical, Bioengineering, Environmental, and Transport Systems Division; CBET; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation; Chemical, Bioengineering, Environmental, and Transport Systems Division; http://www.nsf.gov/div/index.jsp?div=CBET; CBET# 1552456; CBET# 1509022.	Abu-Yousif AO, 2012, CANCER LETT, V321, P120, DOI 10.1016/j.canlet.2012.01.014; Afaq F, 1998, J APPL TOXICOL, V18, P307, DOI 10.1002/(SICI)1099-1263(1998090)18:5<307::AID-JAT508>3.0.CO;2-K; Alrousan DMA, 2009, WATER RES, V43, P47, DOI 10.1016/j.watres.2008.10.015; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Babior BM, 2003, P NATL ACAD SCI USA, V100, P3031, DOI 10.1073/pnas.0530251100; Bertoloni G, 1984, PORPHYRINS TUMOR PHO, P177; Bhatti M, 2000, ANTIMICROB AGENTS CH, V44, P2615, DOI 10.1128/AAC.44.10.2615-2618.2000; Bruynoghe R, 1921, CR SOC BIOL, V85, P1120; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Centers for Disease Control and Prevention, 2015, MULT OUTBR LIST LINK; Centers for Disease Control and Prevention, 2012, MULT OUTBR LIST LINK; Chick H, 1908, J HYG-CAMBRIDGE, V8, P92, DOI 10.1017/S0022172400006987; Choi Y, 2006, CHEMMEDCHEM, V1, P458, DOI 10.1002/cmdc.200500036; Colombo MJ, 2011, IMMUNOL RES, V51, P249, DOI 10.1007/s12026-011-8260-8; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; De Gusseme B, 2010, APPL ENVIRON MICROB, V76, P1082, DOI 10.1128/AEM.02433-09; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Ede S, 2012, PHOTOCHEM PHOTOBIOL, V88, P728, DOI 10.1111/j.1751-1097.2012.01104.x; Embleton ML, 2005, ANTIMICROB AGENTS CH, V49, P3690, DOI 10.1128/AAC.49.9.3690-3696.2005; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Hope CK, 2009, J ANTIMICROB CHEMOTH, V64, P59, DOI 10.1093/jac/dkp157; Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Ibanez JA, 2003, J PHOTOCH PHOTOBIO A, V157, P81, DOI 10.1016/S1010-6030(03)00074-1; IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668, DOI 10.1128/AEM.59.5.1668-1670.1993; Kessel D., 1987, LASER MED SCI, V2, P95; Kuhn KP, 2003, CHEMOSPHERE, V53, P71, DOI 10.1016/S0045-6535(03)00362-X; Kuznetsova NA, 2007, J HAZARD MATER, V146, P487, DOI 10.1016/j.jhazmat.2007.04.064; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; LAOT N, 1999, J ADV OXID TECHNOL, V4, P97; Lee JH, 2004, WATER RES, V38, P713, DOI 10.1016/j.watres.2003.10.011; Liga MV, 2013, ENVIRON SCI TECHNOL, V47, P6463, DOI 10.1021/es400196p; Lin SH, 2013, WATER RES, V47, P3959, DOI 10.1016/j.watres.2012.09.005; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; MALIK Z, 1990, J PHOTOCH PHOTOBIO B, V5, P281, DOI 10.1016/1011-1344(90)85044-W; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; MERKEL PB, 1972, J AM CHEM SOC, V94, P7244, DOI 10.1021/ja00776a003; MEW D, 1985, CANCER RES, V45, P4380; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; Pal B., 2000, TOXICOL ENVIRON CHEM, V78, P233; Parthasarathy A, 2013, ACS APPL MATER INTER, V5, P4516, DOI 10.1021/am400282p; Pellieux C, 2000, METHOD ENZYMOL, V319, P197; Pilloni A., 2012, LASER MED SCI, V2, P1; Praetorius A, 2012, ENVIRON SCI TECHNOL, V46, P6705, DOI 10.1021/es204530n; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; RICCHELLI F, 1995, J PHOTOCH PHOTOBIO B, V29, P109, DOI 10.1016/1011-1344(95)07155-U; Rice TB, 1930, AM J MED SCI, V179, P345; Ryu H, 2008, WATER RES, V42, P1523, DOI 10.1016/j.watres.2007.10.037; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B; Schless RA, 1932, AM J DIS CHILD, V44, P813, DOI 10.1001/archpedi.1932.01950110115011; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sigstam T, 2013, APPL ENVIRON MICROB, V79, P3455, DOI 10.1128/AEM.00663-13; SJOGREN JC, 1994, APPL ENVIRON MICROB, V60, P344, DOI 10.1128/AEM.60.1.344-347.1994; Uehara Y, 2006, J INFECT DIS, V194, P98, DOI 10.1086/504439; Usacheva MN, 2001, LASER SURG MED, V29, P165, DOI 10.1002/lsm.1105; Waite GN, 2005, BIOCHEM BIOPH RES CO, V338, P1110, DOI 10.1016/j.bbrc.2005.10.037; WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Wurtzler EM, 2014, BIOMACROMOLECULES, V15, P228, DOI 10.1021/bm401511a; Xia DH, 2013, ENVIRON SCI TECHNOL, V47, P11166, DOI 10.1021/es402170b; Xie XM, 2010, J IMMUNOL, V184, P3725, DOI 10.4049/jimmunol.0902732; Yamashita K, 2008, P NATL ACAD SCI USA, V105, P16912, DOI 10.1073/pnas.0807952105; Zhang YY, 2013, WATER RES, V47, P4507, DOI 10.1016/j.watres.2013.05.014; Zhang YY, 2013, BIOTECHNOL BIOENG, V110, P286, DOI 10.1002/bit.24630; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu XY, 2004, P NATL ACAD SCI USA, V101, P2247, DOI 10.1073/pnas.0307311101	72	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162577	10.1371/journal.pone.0162577	http://dx.doi.org/10.1371/journal.pone.0162577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617441	Green Published, gold, Green Submitted			2022-12-27	WOS:000383653100030
J	Andrews, CJ; Kempf, M; Kimble, R; Cuttle, L				Andrews, Christine J.; Kempf, Margit; Kimble, Roy; Cuttle, Leila			Development of a Consistent and Reproducible Porcine Scald Burn Model	PLOS ONE			English	Article							THICKNESS BURN; HISTOPATHOLOGICAL EVALUATION; OPTIMAL DURATION; AID TREATMENT; DEPTH; TEMPERATURE; INJURY; PIG; PROGRESSION; VALIDATION	There are very few porcine burn models that replicate scald injuries similar to those encountered by children. We have developed a robust porcine burn model capable of creating reproducible scald burns for a wide range of burn conditions. The study was conducted with juvenile Large White pigs, creating replicates of burn combinations; 50 degrees C for 1, 2, 5 and 10 minutes and 60 degrees C, 70 degrees C, 80 degrees C and 90 degrees C for 5 seconds. Visual wound examination, biopsies and Laser Doppler Imaging were performed at 1, 24 hours and at 3 and 7 days post-burn. A consistent water temperature was maintained within the scald device for long durations (49.8 +/- 0.1 degrees C when set at 50 degrees C). The macroscopic and histologic appearance was consistent between replicates of burn conditions. For 50 degrees C water, 10 minute duration burns showed significantly deeper tissue injury than all shorter durations at 24 hours post-burn (p <= 0.0001), with damage seen to increase until day 3 post-burn. For 5 second duration burns, by day 7 post-burn the 80 degrees C and 90 degrees C scalds had damage detected significantly deeper in the tissue than the 70 degrees C scalds (p <= 0.001). A reliable and safe model of porcine scald burn injury has been successfully developed. The novel apparatus with continually refreshed water improves consistency of scald creation for long exposure times. This model allows the pathophysiology of scald burn wound creation and progression to be examined.	[Andrews, Christine J.; Kempf, Margit; Kimble, Roy] Univ Queensland, Ctr Childrens Burns & Trauma Res, Ctr Childrens Hlth Res, South Brisbane, Qld, Australia; [Cuttle, Leila] Queensland Univ Technol, Ctr Childrens Burns & Trauma Res, Sch Biomed Sci, Inst Hlth & Biomed Innovat,Ctr Childrens Hlth Res, South Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT)	Andrews, CJ (corresponding author), Univ Queensland, Ctr Childrens Burns & Trauma Res, Ctr Childrens Hlth Res, South Brisbane, Qld, Australia.	c.andrews@uq.edu.au	Andrews, Christine/J-4891-2015; Cuttle, Leila/U-9376-2017	Andrews, Christine/0000-0003-4513-1349; Cuttle, Leila/0000-0002-2282-4815	National Health and Medical Research Council [APP1035907]; Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant [50083]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant	This work was financially supported by the National Health and Medical Research Council (Fellowship for LC (APP1035907) and Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant funding (50083)).; The authors would like to acknowledge Dr Gael Phillips for her invaluable advice and providing training in dermatohistopathology. We would also like to thank Mr Blair McEwan for his technical assistance with the animal studies and Mr Anthony Smith for his input on early scald burn device prototypes. This work was financially supported by the National Health and Medical Research Council (Fellowship for LC (APP1035907) and Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant funding (50083)).	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Abraham JP, 2011, INT COMMUN HEAT MASS, V38, P1169, DOI 10.1016/j.icheatmasstransfer.2011.07.004; Abraham JP, 2016, INT J HYPERTHER, V32, P900, DOI 10.1080/02656736.2016.1211752; Abraham JP, 2016, BURNS, V42, P715, DOI 10.1016/j.burns.2016.01.003; Abraham JP, 2015, BURNS, V41, P1741, DOI 10.1016/j.burns.2015.06.002; Andrews CJ, 2016, INT J HEAT MASS TRAN, V101, P542, DOI 10.1016/j.ijheatmasstransfer.2016.05.070; Barker R, 2005, BURNS SCALDS QUEENSL; Bartlett N, 2008, J BURN CARE RES, V29, P828, DOI 10.1097/BCR.0b013e3181855c9a; Bourdon RT, 2016, AUSTIN J EMERGENCY C, V3, P1043; BRANS TA, 1994, BURNS, V20, pS48, DOI 10.1016/0305-4179(94)90090-6; Branski LK, 2008, BURNS, V34, P1119, DOI 10.1016/j.burns.2008.03.013; Braue EH, 2007, J BURN CARE RES, V28, P275, DOI 10.1097/BCR.0B013E318031A1A8; Cuttle L, 2008, WOUND REPAIR REGEN, V16, P626, DOI 10.1111/j.1524-475X.2008.00413.x; Cuttle L, 2006, BURNS, V32, P806, DOI 10.1016/j.burns.2006.02.023; Cuttle L, 2010, BURNS, V36, P673, DOI 10.1016/j.burns.2009.08.002; Dahiya P, 2009, FRONT BIOSCI, V14, P4962, DOI 10.2741/3580; Diller KR, 2011, J BURN CARE RES, V32, pE33, DOI 10.1097/BCR.0b013e31820ab159; Duke J, 2011, PEDIATRICS, V127, pE971, DOI 10.1542/peds.2010-3136; FELDMAN KW, 1978, PEDIATRICS, V62, P1; Fourman MS, 2015, BURNS, V41, P1043, DOI 10.1016/j.burns.2014.11.001; Fourman MS, BURNS; Gaines C, 2013, BURNS, V39, P311, DOI 10.1016/j.burns.2012.06.011; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Henze U, 1997, BURNS, V23, P473, DOI 10.1016/S0305-4179(97)00019-3; Hirth DA, 2012, WOUND REPAIR REGEN, V20, P918, DOI 10.1111/j.1524-475X.2012.00847.x; Hoeksema H, 2009, BURNS, V35, P36, DOI 10.1016/j.burns.2008.08.011; HOEKSTRA MJ, 1993, BRIT J PLAST SURG, V46, P585, DOI 10.1016/0007-1226(93)90111-N; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; Jandera V, 2000, BURNS, V26, P265, DOI 10.1016/S0305-4179(99)00133-3; Johnson N. N., 2011, Journal of Thermal Science and Engineering Applications, V3, DOI 10.1115/1.4003610; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kempf M, 2009, BURNS, V35, P454, DOI 10.1016/j.burns.2008.06.013; Kim JY, 2016, BURNS, V42, P384, DOI 10.1016/j.burns.2015.08.027; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7; MONTAGNA W, 1964, J INVEST DERMATOL, V43, P11, DOI 10.1038/jid.1964.5; MORITZ AR, 1947, AM J PATHOL, V23, P915; MORITZ AR, 1947, AM J PATHOL, V23, P695; O'Reilly T J, 1989, J Burn Care Rehabil, V10, P1, DOI 10.1097/00004630-198901000-00001; Papp A, 2004, BURNS, V30, P684, DOI 10.1016/j.burns.2004.03.021; Public Health Association Australia, 2012, HOT TAP WAT TEMP SCA; Radke A, 2000, CRIT CARE MED, V28, P3224, DOI 10.1097/00003246-200009000-00018; Rayner R, 2011, WOUND PRACT RES, V19, P39; Ring Lisa M, 2007, J Pediatr Health Care, V21, P192, DOI 10.1016/j.pedhc.2007.02.001; Sheu SY, 2014, BURNS, V40, P1679, DOI 10.1016/j.burns.2014.04.023; Singer AJ, 2011, J BURN CARE RES, V32, P638, DOI 10.1097/BCR.0b013e31822dc439; Singer AJ, 2009, AM J EMERG MED, V27, P285, DOI 10.1016/j.ajem.2008.02.019; Singer AJ, 2003, METH MOLEC MED, V78, P107; Stetinsky J, 2015, LASER SURG MED, V47, P196, DOI 10.1002/lsm.22291; Stockton KA, 2015, BURNS, V41, P476, DOI 10.1016/j.burns.2014.09.018; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Wang XQ, 2009, BURNS, V35, P264, DOI 10.1016/j.burns.2008.05.030; Watts AMI, 2001, BURNS, V27, P154, DOI 10.1016/S0305-4179(00)00079-6; Yuan J, 2007, J BURN CARE RES, V28, P514, DOI 10.1097/BCR.0B013E318053DB13	54	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162888	10.1371/journal.pone.0162888	http://dx.doi.org/10.1371/journal.pone.0162888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612153	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900183
J	Donley, DW; Olson, AR; Raisbeck, MF; Fox, JH; Gigley, JP				Donley, David W.; Olson, Andrew R.; Raisbeck, Merl F.; Fox, Jonathan H.; Gigley, Jason P.			Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+T-Cell Responses, and Premature Mortality	PLOS ONE			English	Article							INTERFERON-GAMMA; MICROGLIAL ACTIVATION; T-CELLS; REACTIVATION; DYSFUNCTION; ENZYME; BRAIN; MODEL; ONSET	Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a polyglutamine-repeat expansion in the huntingtin protein. Activation of the kynurenine pathway of tryptophan degradation is implicated in the pathogenesis of HD. Indoleamine-2,3-dioxygenase (IDO) catalyzes the oxidation of tryptophan to kynurenine, the first step in this pathway. The prevalent, neuroinvasive protozoal pathogen To xoplasma gondii (T. gondii) results in clinically silent life-long infection in immune-competent individuals. T. gondii infection results in activation of IDO which provides some protection against the parasite by depleting tryptophan which the parasite cannot synthesize. The kynurenine pathway may therefore represent a point of synergism between HD and T. gondii infection. We show here that IDO activity is elevated at least four-fold in frontal cortex and striata of non-infected N171-82Q HD mice at 14-weeks corresponding to early-advanced HD. T. gondii infection at 5 weeks resulted in elevation of cortical IDO activity in HD mice. HD-infected mice died significantly earlier than wild-type infected and HD control mice. Prior to death, infected HD mice demonstrated decreased CD8+ T-lymphocyte proliferation in brain and spleen compared to wild-type infected mice. We demonstrate for the first time that HD mice have an altered response to an infectious agent that is characterized by premature mortality, altered immune responses and early activation of IDO. Findings are relevant to understanding how T. gondii infection may interact with pathways mediating neurodegeneration in HD.	[Donley, David W.; Raisbeck, Merl F.; Fox, Jonathan H.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Donley, David W.; Fox, Jonathan H.] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Olson, Andrew R.] Univ Wyoming, Dept Psychol, Laramie, WY 82071 USA; [Gigley, Jason P.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming; University of Wyoming	Gigley, JP (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	jgigley@uwyo.edu			University of Wyoming Neuroscience Center [5P30GM103398-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103398] Funding Source: NIH RePORTER	University of Wyoming Neuroscience Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided as a pilot project from the University of Wyoming Neuroscience Center Grant 5P30GM103398-03. (https://www.nigms.nih.gov/Pages/default.aspx) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadra R, 2012, J INFECT DIS, V206, P125, DOI 10.1093/infdis/jis304; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boussicault L, 2016, BRAIN, V139, P953, DOI 10.1093/brain/awv384; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Celik T, 2010, SCAND J INFECT DIS, V42, P604, DOI 10.3109/00365541003716500; Chew WK, 2012, EXP PARASITOL, V130, P22, DOI 10.1016/j.exppara.2011.10.004; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Fujigaki S, 2002, INFECT IMMUN, V70, P779, DOI 10.1128/IAI.70.2.779-786.2002; Gigley JP, 2009, INFECT IMMUN, V77, P5380, DOI 10.1128/IAI.00649-09; Gigley JP, 2009, J IMMUNOL, V182, P1069, DOI 10.4049/jimmunol.182.2.1069; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; GUPTA SL, 1994, INFECT IMMUN, V62, P2277, DOI 10.1128/IAI.62.6.2277-2284.1994; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Khan IA, 1999, INFECT IMMUN, V67, P5869, DOI 10.1128/IAI.67.11.5869-5876.1999; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Lu Z, 2014, NEUROBIOL DIS, V71, P34, DOI 10.1016/j.nbd.2014.06.022; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacKenzie CR, 1999, ADV EXP MED BIOL, V467, P533; Mazarei G, 2013, J NEUROCHEM, V127, P852, DOI 10.1111/jnc.12350; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller JRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141793; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Perry CE, 2016, ALZ DIS ASSOC DIS, V30, P123, DOI 10.1097/WAD.0000000000000108; Politis M, 2015, NEUROBIOL DIS, V83, P115, DOI 10.1016/j.nbd.2015.08.011; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schilling G, 2004, EXP NEUROL, V187, P137, DOI 10.1016/j.expneurol.2004.01.003; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sutterland AL, 2015, ACTA PSYCHIAT SCAND, V132, P161, DOI 10.1111/acps.12423; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trager U, 2015, NEUROBIOL DIS, V73, P388, DOI 10.1016/j.nbd.2014.10.012; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	44	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162404	10.1371/journal.pone.0162404	http://dx.doi.org/10.1371/journal.pone.0162404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611938	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255900090
J	Hewawasam, RP; Liu, D; Casarotto, MG; Board, PG; Dulhunty, AF				Hewawasam, Ruwani P.; Liu, Dan; Casarotto, Marco G.; Board, Philip G.; Dulhunty, Angela F.			The GSTM2 C-Terminal Domain Depresses Contractility and Ca2+ Transients in Neonatal Rat Ventricular Cardiomyocytes	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASE GSTM2-2; RYANODINE RECEPTORS; MALEYLACETOACETATE ISOMERASE; STRIATED-MUSCLE; MYOCYTES; LOCATION; CHANNELS; RELEASE; SIGNALS; CULTURE	The cardiac ryanodine receptor (RyR2) is an intracellular ion channel that regulates Ca2+ release from the sarcoplasmic reticulum (SR) during excitation-contraction coupling in the heart. The glutathione transferases (GSTs) are a family of phase II detoxification enzymes with additional functions including the selective inhibition of RyR2, with therapeutic implications. The C-terminal half of GSTM2 (GSTM2C) is essential for RyR2 inhibition, and mutations F157A and Y160A within GSTM2C prevent the inhibitory action. Our objective in this investigation was to determine whether GSTM2C can enter cultured rat neonatal ventricular cardiomyocytes and influence contractility. We show that oregon green-tagged GSTM2C (at 1 mu M) is internalized into the myocytes and it reduces spontaneous contraction frequency and myocyte shortening. Field stimulation of myocytes evoked contraction in the same percentage of myocytes treated either with media alone or media plus 15 mu M GSTM2C. Myocyte shortening during contraction was significantly reduced by exposure to 15 mu MGSTM2C, but not 5 and 10 mu M GSTM2C and was unaffected by exposure to 15 mu M of the mutants Y160A or F157A. The amplitude of the Ca2+ transient in the 15 mu MGSTM2C-treatedmyocytes was significantly decreased, the rise time was significantly longer and the decay time was significantly shorter than in controlmyocytes. The Ca2+ transient was not altered by exposure to Y160A or F157A. The results are consistent with GSTM2C entering themyocytes and inhibiting RyR2, in a manner that indicates a possible therapeutic potential for treatment of arrhythmia in the neonatal heart.	[Hewawasam, Ruwani P.; Liu, Dan; Casarotto, Marco G.; Board, Philip G.; Dulhunty, Angela F.] Australian Natl Univ, John Curtin Sch Med Res, GPO Box 334, Canberra, ACT 2600, Australia; [Hewawasam, Ruwani P.] Univ Ruhuna, Fac Med, Dept Biochem, Labuduwa Rd, Galle, Sri Lanka	Australian National University; John Curtin School of Medical Research; University Ruhuna	Dulhunty, AF (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, GPO Box 334, Canberra, ACT 2600, Australia.	Angela.dulhunty@anu.edu.au	Hewawasam, Ruwani/ABF-2161-2020; Dulhunty, Angela/AAO-5421-2020	Casarotto, Marco/0000-0002-0571-7671; Hewawasam, Ruwani/0000-0001-6349-4755; Dulhunty, Angela/0000-0001-9493-4944	Australian National Health and Medical Research Council [471462, 1008477]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by The Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) APP #471462 to P. G. Board, A. F. Dulhunty, M. G. Casarotto and APP #1008477 to P. G. Board, A. F. Dulhunty, M. G. Casarotto and L. Arnolda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif Y, 2007, CELL CALCIUM, V41, P429, DOI 10.1016/j.ceca.2006.08.004; Aceto A, 1997, BIOCHEM J, V322, P229, DOI 10.1042/bj3220229; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Blackburn AC, 1998, CYTOGENET CELL GENET, V83, P109, DOI 10.1159/000015145; BOARD PG, 1988, BIOCHIM BIOPHYS ACTA, V953, P214, DOI 10.1016/0167-4838(88)90027-1; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Dulhunty AF, 2002, PROG BIOPHYS MOL BIO, V79, P45, DOI 10.1016/S0079-6107(02)00013-5; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Fernandez-Canon JM, 1999, GENOMICS, V58, P263, DOI 10.1006/geno.1999.5832; FIELD AC, 1988, J PHYSIOL-LONDON, V406, P277, DOI 10.1113/jphysiol.1988.sp017380; GOMEZ JP, 1994, CELL CALCIUM, V15, P265, DOI 10.1016/0143-4160(94)90066-3; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hewawasam R, 2010, BIOCHEM PHARMACOL, V80, P381, DOI 10.1016/j.bcp.2010.04.019; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Janowski E, 2010, AM J PHYSIOL-HEART C, V298, pH1939, DOI 10.1152/ajpheart.00607.2009; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; KOMIYAMA M, 1990, J MUSCLE RES CELL M, V11, P419, DOI 10.1007/BF01739762; Korhonen T, 2009, BIOPHYS J, V96, P1189, DOI 10.1016/j.bpj.2008.10.026; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Liu D, 2012, BIOCHEM PHARMACOL, V83, P1523, DOI 10.1016/j.bcp.2012.02.020; Liu D, 2009, BIOCHEM PHARMACOL, V77, P1181, DOI 10.1016/j.bcp.2008.12.024; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Maltsev VA, 2006, J PHARMACOL SCI, V100, P338, DOI 10.1254/jphs.CR0060018; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Morris MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017864; Morris MJ, 2009, BBA-BIOMEMBRANES, V1788, P676, DOI 10.1016/j.bbamem.2008.10.018; RAGHUNATHAN S, 1994, J MOL BIOL, V238, P815, DOI 10.1006/jmbi.1994.1336; Rapila R, 2008, J GEN PHYSIOL, V132, P397, DOI 10.1085/jgp.200809960; Samarasinghe K, 2015, BIOCHEM PHARMACOL, V97, P269, DOI 10.1016/j.bcp.2015.08.004; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Trafford AW, 2000, CELL CALCIUM, V28, P269, DOI 10.1054/ceca.2000.0156; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162415	10.1371/journal.pone.0162415	http://dx.doi.org/10.1371/journal.pone.0162415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612301	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900093
J	Muroya, S; Shibata, M; Hayashi, M; Oe, M; Ojima, K				Muroya, Susumu; Shibata, Masahiro; Hayashi, Masayuki; Oe, Mika; Ojima, Koichi			Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes	PLOS ONE			English	Article							MUSCLE-FIBER CHARACTERISTICS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; JAPANESE-BLACK; IDENTIFICATION; ADIPOGENESIS; BIOGENESIS; HOLSTEIN; ISOFORMS; PROFILIN	We aimed to understand the roles of miRNAs in the muscle tissue maturation and those of circulating microRNAs (c-miRNAs) in beef production of Japanese Black (JB) cattle (Wagyu), a breed with genetically background of superior intermuscular fat depot, by comparing different feeding conditions (indoor grain-feeding vs. grazing on pasture). The cattle at 18 months old were assigned to pasture feeding or conventional indoor grain feeding conditions for 5 months. Microarray analysis of c-miRNAs from the plasma extracellular vesicles led to the detection of a total of 202 bovine miRNAs in the plasma, including 15 miRNAs that differed between the feeding conditions. Validation of the microarray results by qPCR showed that the circulating miR-10b level in the grazing cattle was upregulated compared to that of the grain-fed cattle. In contrast, the levels of miR-17-5p, miR-19b, miR-29b, miR-30b-5p, miR-98, miR-142-5p, miR-301a, miR-374b, miR-425-5p, and miR-652 were lower in the grazing cattle than in the grain-fed cattle. Bioinformatic analysis indicated that the predicted target genes of those c-miRNAs were enriched in gene ontology terms associated with blood vessel morphogenesis, plasma membrane, focal adhesion, endocytosis, collagen, ECM-receptor interaction, and phosphorylation. In the grazing cattle, the elevation of miR-10b expression in the plasma was coincident with its elevation in the longissimus lumborum (LL) muscle. Expression of bovine-specific miR-2478, the most plasma-enriched miRNA, tended to be also upregulated in the muscle but not in the plasma. Furthermore, grazing caused the downregulated mRNA expression of predicted miR-10b and/or miR-2478 target genes, such as DNAJB2, PTEN, and SCD1. Thus, the feeding system used for JB cattle affected the c-miRNAs that could be indicators of grain feeding. Among these, miR-10b expression was especially associated with feeding-induced changes and with the expression of the potential target genes responsible for glucose homeo-stasis and intramuscular fat depot in the LL muscle of JB cattle.	[Muroya, Susumu; Oe, Mika; Ojima, Koichi] NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan; [Shibata, Masahiro] NARO Western Reg Agr Ctr, Livestock Prod & Wildlife Management Res Div, Ohda, Shimane, Japan; [Hayashi, Masayuki] NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Res Div, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Muroya, S (corresponding author), NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan.	muros@affrc.go.jp	MUROYA, Susumu/H-9604-2019	MUROYA, Susumu/0000-0002-2376-9352; Ojima, Koichi/0000-0002-5973-1073	Japan Society for the Promotion of Science [JP15K07775, JP15K14849]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/; JSPS KAKENHI JP15K07775 to SM and JP15K14849 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bai WL, 2014, EXP MOL PATHOL, V96, P426, DOI 10.1016/j.yexmp.2014.04.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Choi YM, 2009, LIVEST SCI, V122, P105, DOI 10.1016/j.livsci.2008.08.015; Chung KY, 2007, J ANIM SCI, V85, P380, DOI 10.2527/jas.2006-087; Claeys KG, 2010, AM J PATHOL, V176, P2901, DOI 10.2353/ajpath.2010.090663; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Endo K, 2013, BIOMED RES-TOKYO, V34, P289, DOI 10.2220/biomedres.34.289; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Horikawa A, 2015, ANIMAL SCI IN PRESS; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Kim JM, 2015, ANIM GENET, V46, P73, DOI 10.1111/age.12255; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; LAMBRECHTS A, 1995, EUR J BIOCHEM, V230, P281, DOI 10.1111/j.1432-1033.1995.0281i.x; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x; Liu JY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122788; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI 10.2527/jas.2014-7710; Moisa SJ, 2014, GENE REGUL SYST BIO, V8, P17, DOI 10.4137/GRSB.S11782; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; Muroya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136475; Muroya S, 2014, MEAT SCI, V98, P726, DOI 10.1016/j.meatsci.2014.07.018; Mussnich P, 2013, MOL ONCOL, V7, P531, DOI 10.1016/j.molonc.2013.01.002; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; Ortega FJ, 2015, J NUTR BIOCHEM, V26, P1095, DOI 10.1016/j.jnutbio.2015.05.001; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Romao JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-137; Romao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040605; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Sharples AP, 2013, GROWTH HORM IGF RES, V23, P53, DOI 10.1016/j.ghir.2013.03.004; Shen LY, 2016, MEAT SCI, V116, P201, DOI 10.1016/j.meatsci.2016.02.023; Shibata M., 2014, Open Journal of Animal Sciences, V4, P297; Shibata M, 2009, J ANIM SCI, V87, P2700, DOI 10.2527/jas.2008-1486; Shibata M, 2016, ANIM SCI J, V87, P929, DOI 10.1111/asj.12519; Shibata M, 2011, MEAT SCI, V89, P451, DOI 10.1016/j.meatsci.2011.05.006; Sun JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099299; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yamada T, 2012, MEAT SCI, V90, P807, DOI 10.1016/j.meatsci.2011.11.019; ZEMBAYASHI M, 1995, MEAT SCI, V40, P211, DOI 10.1016/0309-1740(94)00046-A; Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8	53	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162496	10.1371/journal.pone.0162496	http://dx.doi.org/10.1371/journal.pone.0162496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611783	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900115
J	Qiu, K; Qin, CF; Luo, M; Zhang, X; Sun, WJ; Jiao, N; Li, DF; Yin, JD				Qiu, Kai; Qin, Chun Fu.; Luo, Min; Zhang, Xin; Sun, Wen Juan; Jiao, Ning; Li, De Fa; Yin, Jing Dong			Protein Restriction with Amino Acid-Balanced Diets Shrinks Circulating Pool Size of Amino Acid by Decreasing Expression of Specific Transporters in the Small Intestine	PLOS ONE			English	Article							PEPTIDE TRANSPORTERS; CARCASS COMPOSITION; NITROGEN-EXCRETION; MESSENGER-RNA; PIGS; PERFORMANCE; METABOLISM; GROWTH; SUPPLEMENTATION; ARGININE	Dietary protein restriction is not only beneficial to health and longevity in humans, but also protects against air pollution and minimizes feeding cost in livestock production. However, its impact on amino acid (AA) absorption and metabolism is not quite understood. Therefore, the study aimed to explore the effect of protein restriction on nitrogen balance, circulating AA pool size, and AA absorption using a pig model. In Exp. 1, 72 gilts weighting 29.9 +/- 1.5 kg were allocated to 1 of the 3 diets containing 14, 16, or 18% CP for a 28-d trial. Growth (n = 24), nitrogen balance (n = 6), and the expression of small intestinal AA and peptide transporters (n = 6) were evaluated. In Exp. 2, 12 barrows weighting 22.7 +/- 1.3 kg were surgically fitted with catheters in the portal and jejunal veins as well as the carotid artery and assigned to a diet containing 14 or 18% CP. A series of blood samples were collected before and after feeding for determining the pool size of circulating AA and AA absorption in the portal vein, respectively. Protein restriction did not sacrifice body weight gain and protein retention, since nitrogen digestibility was increased as dietary protein content reduced. However, the pool size of circulating AA except for lysine and threonine, and most AA flux through the portal vein were reduced in pigs fed the low protein diet. Meanwhile, the expression of peptide transporter 1 (PepT-1) was stimulated, but the expression of the neutral and cationic AA transporter systems was depressed. These results evidenced that protein restriction with essential AA-balanced diets, decreased AA absorption and reduced circulating AA pool size. Increased expression of small intestinal peptide transporter PepT-1 could not compensate for the depressed expression of jejunal AA transporters for AA absorption.	[Qiu, Kai; Qin, Chun Fu.; Zhang, Xin; Sun, Wen Juan; Jiao, Ning; Li, De Fa; Yin, Jing Dong] China Agr Univ, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Qiu, Kai; Qin, Chun Fu.; Zhang, Xin; Sun, Wen Juan; Jiao, Ning; Li, De Fa; Yin, Jing Dong] China Agr Univ, Minist Agr, Feed Ind Ctr, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Luo, Min] Chongqing Acad Anim Sci, Chongqing 450023, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Yin, JD (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.; Yin, JD (corresponding author), China Agr Univ, Minist Agr, Feed Ind Ctr, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	yinjd@cau.edu.cn		Yin, Jingdong/0000-0003-4623-0568; Qiu, Kai/0000-0002-6575-5346	National Key Basic Research Program of China [2013CB127302, 2012CB124703]; National Natural Science Foundation of China [31272452]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of China (2013CB127302) received by JY; National Key Basic Research Program of China (2012CB124703) received by DL; and National Natural Science Foundation of China (31272452) received by JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2003, OFFICIAL METHODS ANA, V17th; Bauchart-Thevret C, 2011, J ANIM SCI, V89, P4093, DOI 10.2527/jas.2011-3944; Bergen WG, 2009, J NUTR, V139, P821, DOI 10.3945/jn.109.104497; BOYD CAR, 1981, BIOSCIENCE REP, V1, P851, DOI 10.1007/BF01114818; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Bunger L, 2015, ANIM PROD SCI, V55, P461, DOI 10.1071/AN13051; Burrin D. G., 2001, P75, DOI 10.1079/9780851995175.0075; Canh TT, 1998, LIVEST PROD SCI, V56, P181, DOI 10.1016/S0301-6226(98)00156-0; Chen LX, 2009, AMINO ACIDS, V37, P143, DOI 10.1007/s00726-009-0268-1; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Garcia-Launay F, 2014, LIVEST SCI, V161, P158, DOI 10.1016/j.livsci.2013.11.027; Garcia-Villalobos H, 2012, ARCH ANIM NUTR, V66, P257, DOI 10.1080/1745039X.2012.697351; GATEL F, 1992, LIVEST PROD SCI, V31, P109, DOI 10.1016/0301-6226(92)90059-D; Gloaguen M, 2014, J ANIM SCI, V92, P637, DOI 10.2527/jas.2013-6514; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; HARVEY RB, 1962, ANN NY ACAD SCI, V102, P46, DOI 10.1111/j.1749-6632.1962.tb13624.x; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Ihara T, 2000, DIGESTION, V61, P59, DOI 10.1159/000007736; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Lebret B, 2008, ANIMAL, V2, P1548, DOI 10.1017/S1751731108002796; Leibach FH, 1996, ANNU REV NUTR, V16, P99, DOI 10.1146/annurev.nu.16.070196.000531; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Li W, 2015, J ZHEJIANG UNIV-SC B, V16, P496, DOI [10.1631/jzus.B1400259, DOI 10.1631/JZUS.B1400259]; Liu LY, 2014, J ANIM PHYSIOL AN N, V98, P310, DOI 10.1111/jpn.12081; Liu XD, 2012, AMINO ACIDS, V42, P2111, DOI 10.1007/s00726-011-0948-5; Madara J.L., 1991, COMPR PHYSIOL, P83, DOI [10.1002/cphy.cp060403, DOI 10.1002/CPHY.CP060403]; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Morales A, 2015, J ANIM SCI, V93, P2154, DOI 10.2527/jas.2014-8834; MOUGHAN PJ, 1994, EAAP PUBLIC, P389; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Qin CF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0052-x; RERAT A, 1992, BRIT J NUTR, V68, P111, DOI 10.1079/BJN19920071; Sanayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06941; Schaart MW, 2005, J NUTR, V135, P765, DOI 10.1093/jn/135.4.765; Schiavon S, 2012, ANIM FEED SCI TECH, V174, P96, DOI 10.1016/j.anifeedsci.2012.02.011; SILK DBA, 1985, P NUTR SOC, V44, P63, DOI 10.1079/PNS19850011; Sirtori F, 2014, ANIMAL, V8, P1987, DOI 10.1017/S1751731114002006; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Troncone C, 2015, FARMECONOMIA, V16, P45, DOI 10.7175/fe.v16i2.1176; Wang WW, 2009, AMINO ACIDS, V37, P105, DOI 10.1007/s00726-008-0152-4; Whang KY, 2003, J ANIM SCI, V81, P705; Wood JD, 2013, MEAT SCI, V95, P123, DOI 10.1016/j.meatsci.2013.03.001; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2010, DYNAMICS IN ANIMAL NUTRITION, P69; Wu GY, 1996, AM J PHYSIOL-GASTR L, V271, pG913, DOI 10.1152/ajpgi.1996.271.5.G913; WU GY, 1995, AM J PHYSIOL-REG I, V268, pR334; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yen JT, 2004, J ANIM SCI, V82, P1079; YEN JT, 1987, J ANIM SCI, V64, P923, DOI 10.2527/jas1987.643923x; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yue LY, 2008, LIVEST SCI, V115, P144, DOI 10.1016/j.livsci.2007.06.018; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	64	22	24	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162475	10.1371/journal.pone.0162475	http://dx.doi.org/10.1371/journal.pone.0162475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611307	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900110
J	Zelenay, V; Arzt, ME; Bibow, S; Schwab, ME; Riek, R				Zelenay, Viviane; Arzt, Michael E.; Bibow, Stefan; Schwab, Martin E.; Riek, Roland			The Neurite Outgrowth Inhibitory Nogo-A-Delta 20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ISOTOPICALLY ENRICHED PROTEINS; RECEPTOR FAMILY-MEMBER; NOGO-A; NMR-SPECTROSCOPY; UNSTRUCTURED PROTEINS; SYNAPTIC PLASTICITY; AXONAL REGENERATION; BACKBONE DYNAMICS; SIGNALING COMPLEX	Functional recovery from central neurotrauma, such as spinal cord injury, is limited by myelin-associated inhibitory proteins. The most prominent example, Nogo-A, imposes an inhibitory cue for nerve fibre growth via two independent domains: Nogo-A-Delta 20 (residues 544725 of the rat Nogo-A sequence) and Nogo-66 (residues 1026-1091). Inhibitory signalling from these domains causes a collapse of the neuronal growth cone via individual receptor complexes, centred around sphingosine 1-phosphate receptor 2 (S1PR2) for Nogo-A-Delta 20 and Nogo receptor 1 (NgR1) for Nogo-66. Whereas the helical conformation of Nogo-66 has been studied extensively, only little structural information is available for the Nogo-A-Delta 20 region. We used nuclear magnetic resonance (NMR) spectroscopy to assess potential residual structural propensities of the intrinsically disordered Nogo-A-Delta 20. Using triple resonance experiments, we were able to assign 94% of the non-proline backbone residues. While secondary structure analysis and relaxation measurements highlighted the intrinsically disordered character of Nogo-A-Delta 20, three stretches comprising residues (561)EAI-QESL(567), (639)EAMNVALKALGT(650), and (693)SNYSEIAK(700) formtransient a-helical structures. Interestingly, (561)EAIQESL(567) is situated directly adjacent to one of the most conserved regions of Nogo-A-Delta 20 that contains a binding motif for beta 1-integrin. Likewise, 639EAMNVALKALGT650 partially overlaps with the epitope recognized by 11C7, a Nogo-A-neutralizing antibody that promotes functional recovery from spinal cord injury. Diffusion measurements by pulse-field gradient NMR spectroscopy suggest concentration-and oxidation state-dependent dimerisation of Nogo-A-Delta 20. Surprisingly, NMR and isothermal titration calorimetry (ITC) data could not validate previously shown binding of extracellular loops of S1PR2 to Nogo-A-Delta 20.	[Zelenay, Viviane; Bibow, Stefan; Riek, Roland] Swiss Fed Inst Technol, Dept Phys Chem, Zurich, Switzerland; [Arzt, Michael E.; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Arzt, Michael E.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Riek, R (corresponding author), Swiss Fed Inst Technol, Dept Phys Chem, Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch			Swiss National Science Foundation grant [31003A_149315]; ERC advanced grant 'Nogorise' [294115]	Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); ERC advanced grant 'Nogorise'	This work was supported by the Swiss National Science Foundation grant 31003A_149315 and the ERC advanced grant 294115 'Nogorise' to MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gal M, 2011, J BIOMOL NMR, V51, P497, DOI 10.1007/s10858-011-9580-7; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Li MF, 2004, EUR J BIOCHEM, V271, P3512, DOI 10.1111/j.0014-2956.2004.04286.x; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Novacek J, 2014, J MAGN RESON, V241, P41, DOI 10.1016/j.jmr.2013.12.008; Oertle T, 2003, J NEUROSCI, V23, P5393; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Permi P, 2000, J BIOMOL NMR, V16, P29, DOI 10.1023/A:1008343926502; Plaxco KW, 1997, J BIOMOL NMR, V10, P221, DOI 10.1023/A:1018340217891; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qin HN, 2008, BIOCHEMISTRY-US, V47, P13647, DOI 10.1021/bi8017976; Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093; Schmandke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078212; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shypitsyna A, 2011, MOL BIOL EVOL, V28, P1363, DOI 10.1093/molbev/msq313; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sumiyoshi K, 2010, NEUROPATHOLOGY, V30, P7, DOI 10.1111/j.1440-1789.2009.01035.x; Tews B, 2013, P NATL ACAD SCI USA, V110, P6583, DOI 10.1073/pnas.1217665110; Thiede-Stan NK, 2015, J CELL SCI, V128, P3583, DOI 10.1242/jcs.167981; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2003, J MOL STRUC-THEOCHEM, V666, P361, DOI 10.1016/j.theochem.2003.08.047; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Vasudevan SV, 2010, P NATL ACAD SCI USA, V107, P6847, DOI 10.1073/pnas.0911817107; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zander H, 2007, FEBS J, V274, P2603, DOI 10.1111/j.1742-4658.2007.05796.x; Zar J. H., 1999, BIOSTATISTICAL ANALY; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353; Zheng G, 2008, J MAGN RESON, V191, P159, DOI 10.1016/j.jmr.2007.12.001	68	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161813	10.1371/journal.pone.0161813	http://dx.doi.org/10.1371/journal.pone.0161813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611089	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000383255900030
J	Dutton, DG; Lane, RA; Koren, T; Bartholomew, K				Dutton, Donald G.; Lane, Rene A.; Koren, Tamara; Bartholomew, Kim			Secure Base Priming Diminishes Conflict-Based Anger and Anxiety	PLOS ONE			English	Article							ATTACHMENT THEORY; RELATIONAL SCHEMAS; ADULT ATTACHMENT; ABUSE; ACTIVATION; RESPONSES; EXPOSURE; INTIMACY; VIOLENCE; GENDER	This study examines the impact of a visual representation of a secure base (i.e. a secure base prime) on attenuating experimentally produced anger and anxiety. Specifically, we examined the assuaging of negative emotions through exposure to an image of a mother-infant embrace or a heterosexual couple embracing. Subjects seated at a computer terminal rated their affect (Pre Affect) using the Affect Adjective Checklist (AAC) then listened to two sets of intense two person conflicts. After the first conflict exposure they rated affect again (Post 1 AAC). Following the second exposure they saw a blank screen (control condition), pictures of everyday objects (distraction condition) or a photo of two people embracing (Secure Base Prime condition). They then reported emotions using the Post 2 AAC. Compared to either control or distraction subjects, Secure Base Prime (SBP) subjects reported significantly less anger and anxiety. These results were then replicated using an internet sample with control, SBP and two new controls: Smiling Man (to control for expression of positive affect) and Cold Mother (an unsmiling mother with infant). The SBP amelioration of anger and anxiety was replicated with the internet sample. No control groups produced this effect, which was generated only by a combination of positive affect in a physically embracing dyad. The results are discussed in terms of attachment theory and research on spreading activation.	[Dutton, Donald G.; Bartholomew, Kim] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Dutton, Donald G.; Koren, Tamara] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Lane, Rene A.] Univ British Columbia, Fac Med, Neurosci, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; University of British Columbia	Dutton, DG (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.; Dutton, DG (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	dondutton@shaw.ca			Social Sciences and Research Council of Canada [410-2008-0490]	Social Sciences and Research Council of Canada	This work was supported by the Social Sciences and Research Council of Canada, Grant No: 410-2008-0490, http://www.sshrc-crsh.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C. J., 2006, ROMANTIC LOVE ATTACH; [Anonymous], 2013, FULL CATASTROPHE LIV; BALDWIN MW, 1994, J SOC CLIN PSYCHOL, V13, P380, DOI 10.1521/jscp.1994.13.4.380; Bargh J., 1997, ADV SOCIAL COGNITION; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; BARTHOLOMEW K, 1990, J SOC PERS RELAT, V7, P147, DOI 10.1177/0265407590072001; Bartholomew K, 2008, VIOLENCE VICTIMS, V23, P344, DOI 10.1891/0886-6708.23.3.344; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; Bowlby J, 1988, SECURE BASE CLIN APP; Bowlby J, 1973, ATTACHMENT LOSS SEPA; Bowlby J., 1969, ATTACHMENT LOSS ATTA; Bowlby J., 1980, ATTACHMENT AND LOSS; Bradley M. M., 2007, HDB EMOTION ELICITAT; BRISCH KH, 2002, TREATING ATTACHMENT; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cohen J., 1983, APPL MULTIPLE REGRES; DODGE KA, 1995, J ABNORM PSYCHOL, V104, P632, DOI 10.1037/0021-843X.104.4.632; DUTTON DG, 1994, J APPL SOC PSYCHOL, V24, P1367, DOI 10.1111/j.1559-1816.1994.tb01554.x; DUTTON DG, 1994, CAN J BEHAV SCI, V26, P353, DOI 10.1037/0008-400X.26.3.353; Feeney JA, 2001, HDB FAMILY MEASUREME, V3; Follingstad Diane R, 2002, Violence Vict, V17, P35, DOI 10.1891/vivi.17.1.35.33639; FOLLINGSTAD DR, 1991, FAM RELAT, V40, P51, DOI 10.2307/585658; Fonagy P., 2002, AFFECT REGULATION ME; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Godbout N, 2009, PERS RELATIONSHIP, V16, P365, DOI 10.1111/j.1475-6811.2009.01228.x; Grady CL, 1998, P NATL ACAD SCI USA, V95, P2703, DOI 10.1073/pnas.95.5.2703; GREENWALD AG, 1989, MEM COGNITION, V17, P35, DOI 10.3758/BF03199555; Hardie E, 2007, AUST J EMERG TECH SO, V5, P34, DOI DOI 10.1016/S0092-6566(03)00046-1; Hazan C., 1994, ADV PERSONAL RELATIO, V5; JACK LA, 1995, CAN J BEHAV SCI, V27, P484, DOI 10.1037/0008-400X.27.4.484; Karpf F.B., 1970, PSYCHOL PSYCHOTHERAP; Klauer K. C., 2003, PSYCHOL EVALUATION A; Lyons-Ruth K, 1999, HDB ATTACHMENT THEOR, P520; Mauricio Anne Marie, 2007, Violence Vict, V22, P139, DOI 10.1891/088667007780477339; Mikulincer M, 1998, J PERS SOC PSYCHOL, V74, P513, DOI 10.1037/0022-3514.74.2.513; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P97, DOI 10.1037//0022-3514.81.1.97; Mikulincer M., 2004, ADULT ATTACHMENT THE, V1st; Neeley J., 1991, BASIC PROCESSING REA; Pierce T, 1998, J PERS SOC PSYCHOL, V75, P1441, DOI 10.1037/0022-3514.75.6.1441; Rottenberg J., 2007, HDB EMOTION ELICITAT; RUSSELL JA, 1974, J CONSULT CLIN PSYCH, V42, P79, DOI 10.1037/h0035915; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Shaver P. R., 2007, ATTACHMENT PATTERNS; Shaver Phillip R, 2002, Attach Hum Dev, V4, P133, DOI 10.1080/14616730210154171; Shaver PR, 2005, J RES PERS, V39, P22, DOI 10.1016/j.jrp.2004.09.002; SILVERMA.LH, 1969, J NERV MENT DIS, V148, P39, DOI 10.1097/00005053-196901000-00005; SILVERMAN LH, 1978, J CONSULT CLIN PSYCH, V46, P432, DOI 10.1037/0022-006X.46.3.432; SILVERMAN LH, 1985, AM PSYCHOL, V40, P1296, DOI 10.1037/0003-066X.40.12.1296; Sohlberg S, 2003, J PERS SOC PSYCHOL, V85, P302, DOI 10.1037/0022-3514.85.2.302; Sonkin D. J, 2005, CALIFORNIA THERAPIST, V17, P68; Starzomski A, 1994, THESIS; STRACHAN CE, 1992, J APPL SOC PSYCHOL, V22, P1721, DOI 10.1111/j.1559-1816.1992.tb00973.x; Thomas LA, 2004, J APPL SOC PSYCHOL, V34, P2166, DOI 10.1111/j.1559-1816.2004.tb02695.x; Trinke SJ, 1997, J SOC PERS RELAT, V14, P603, DOI 10.1177/0265407597145002; Van Kleef GA, 2008, HDB ANGER CONSTITUEN; Wellman B, 2001, AM BEHAV SCI, V45, P436, DOI 10.1177/00027640121957286	57	7	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162374	10.1371/journal.pone.0162374	http://dx.doi.org/10.1371/journal.pone.0162374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606897	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600042
J	Zhang, C; Chen, M; Wang, GZ; Fang, W; Ye, C; Hu, HH; Fa, ZZ; Yi, J; Liao, WQ				Zhang, Chao; Chen, Mei; Wang, Guizhen; Fang, Wei; Ye, Chen; Hu, Hanhua; Fa, Zhenzong; Yi, Jiu; Liao, Wan-qing			Pd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal Effect	PLOS ONE			English	Article							SILVER NANOPARTICLES; ANTIFUNGAL ACTIVITY; ESCHERICHIA-COLI; ANTIBACTERIAL; FLUCONAZOLE; RESISTANCE; MENINGITIS; EPIDEMIOLOGY; NEOFORMANS; AGENTS	Silver nanoparticles have received considerable interest as new "nanoantibiotics" with the potential to kill drug-resistant microorganisms. Recently, a class of new core-shell nanostructures, Pd@Ag nanosheets (Pd@Ag NSs), were created using deposition techniques and demonstrated excellent inhibitory effects on various bacteria in vitro. In this study, we evaluated the antifungal activity of Pd@Ag NSs against common invasive fungal pathogens. Among these organisms, Cryptococcus neoformans complex species was most susceptible to Pd@Ag NSs, which exhibited potent antifungal activity against various molecular types or sources of cryptococcal strains including fluconazole-resistant isolates. The anticryptococcal activity of Pd@Ag NSs was significantly greater than fluconazole and similar to that of amphotericin B (AmB). At relatively high concentrations, Pd@Ag NSs exhibited fungicidal activity against Cryptococcus spp., which can likely be attributed to the disruption of cell integrity, intracellular protein synthesis, and energy metabolism. Intriguingly, Pd@Ag NSs also exhibited strong synergistic anti-cryptococcal fungicidal effects at low concentrations in combination with AmB but exhibitedmuch better safety in erythrocytes than AmB, even at the minimal fungicidal concentration. Therefore, Pd@Ag NSs may be a promising adjunctive agent for treating cryptococcosis, and further investigation for clinical applications is required.	[Zhang, Chao; Yi, Jiu; Liao, Wan-qing] Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Zhang, Chao; Fang, Wei; Fa, Zhenzong] Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China; [Chen, Mei] Xiamen Univ, Coll Chem & Chem Engn, Collaborat Innovat Ctr Chem Energy Mat, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China; [Chen, Mei] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Wang, Guizhen] Urumuqi Army Gen Hosp, ICU Dept, Urumqi, Xinjiang, Peoples R China; [Ye, Chen] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Hu, Hanhua] Xinjiang Med Univ, UEM Dept, Urumqi, Xinjiang, Peoples R China	Naval Medical University; Naval Medical University; Xiamen University; Xiamen University; Naval Medical University; Xinjiang Medical University	Liao, WQ (corresponding author), Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.; Fang, W (corresponding author), Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China.	weifang081782@163.com; liaowanqing@sohu.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Key Basic Research Programs of China [2013CB531601]; National Natural Science Foundation of China [81401651, 81471926, 31170139]; Shanghai Municipal Natural Science Foundation [12JC1411000, 12ZR1454400, 14495800500]; Shanghai Key Laboratory of Molecular Medical Mycology [14DZ2272900]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Key Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Shanghai Key Laboratory of Molecular Medical Mycology; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by the National Key Basic Research Programs of China (2013CB531601), the National Natural Science Foundation of China (81401651, 81471926, and 31170139), the Shanghai Municipal Natural Science Foundation (12JC1411000, 12ZR1454400, and 14495800500), and the Shanghai Key Laboratory of Molecular Medical Mycology (14DZ2272900).	AbuSalah KM, 1996, BRIT J BIOMED SCI, V53, P122; Ajesh K, 2013, J APPL MICROBIOL, V115, P1287, DOI 10.1111/jam.12324; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; Despax B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/17/175101; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Fang WJ, 2012, SMALL, V8, P3816, DOI 10.1002/smll.201200962; Fang WJ, 2012, ADV FUNCT MATER, V22, P842, DOI 10.1002/adfm.201101960; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fortun J, 2011, ENFERM INFEC MICR CL, V29, P38, DOI 10.1016/S0213-005X(11)70042-8; Friese G, 2001, AIDS, V15, P2344, DOI 10.1097/00002030-200111230-00026; Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P316, DOI 10.1128/AAC.4.3.316; Huang XQ, 2011, ADV MATER, V23, P3420, DOI 10.1002/adma.201100905; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI 10.1038/NNANO.2010.235; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Ishida K, 2014, MEM I OSWALDO CRUZ, V109, P220, DOI 10.1590/0074-0276130269; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jebali A, 2014, MED MYCOL, V52, P65, DOI 10.3109/13693786.2013.822996; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103442; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Manfredi R, 2006, AIDS PATIENT CARE ST, V20, P227, DOI 10.1089/apc.2006.20.227; Mares D, 1998, MED MYCOL, V36, P379, DOI 10.1080/02681219880000601; Mdodo R, 2010, East Afr Med J, V87, P481; Mo SG, 2015, J MATER CHEM B, V3, P6255, DOI 10.1039/c5tb00830a; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Niazi JH, 2011, APPL BIOCHEM BIOTECH, V164, P1278, DOI 10.1007/s12010-011-9212-4; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Osumi M, 1998, MICRON, V29, P207; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Richardson M, 2008, CLIN MICROBIOL INFEC, V14, P5, DOI 10.1111/j.1469-0691.2008.01978.x; Roling EE, 2002, DIAGN MICR INFEC DIS, V43, P13, DOI 10.1016/S0732-8893(02)00361-9; Sar B, 2004, J ANTIMICROB CHEMOTH, V54, P563, DOI 10.1093/jac/dkh361; Selvaraj M, 2014, APPL BIOCHEM BIOTECH, V173, P55, DOI 10.1007/s12010-014-0782-9; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sifuentes-Osornio J, 2012, CURR FUNGAL INFECT R, V6, P23, DOI 10.1007/s12281-011-0081-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tang SH, 2014, SMALL, V10, P3139, DOI 10.1002/smll.201303631; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Xu Y, 2013, J OCUL PHARMACOL TH, V29, P270, DOI 10.1089/jop.2012.0155; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhao ZX, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/28/285701	69	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157000	10.1371/journal.pone.0157000	http://dx.doi.org/10.1371/journal.pone.0157000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27611217	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000058
J	Zhang, N; Becares, L; Chandola, T				Zhang, Nan; Becares, Laia; Chandola, Tarani			Patterns and Determinants of Double-Burden of Malnutrition among Rural Children: Evidence from China	PLOS ONE			English	Article							LEFT-BEHIND CHILDREN; DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; RISK-FACTORS; PARENTAL MIGRATION; PHYSICAL-ACTIVITY; GROWTH STANDARDS; OLDER CHILDREN; HEALTH-STATUS; LIFE-COURSE	Chinese children are facing dual burden of malnutrition-coexistence of under-and overnutrition. Little systematic evidence exists for explaining the simultaneous presence of under-and over-nutrition. This study aims to explore underlying mechanisms of under-and over-nutrition among children in rural China. This study used a nationwide longitudinal data-set of children (N = 5,017) from 9 provinces across China, with four exclusively categories of nutritional outcomes including under-nutrition (stunting and underweight), over-nutrition (overweight only including obesity), paradox (stunted overweight), with normal nutrition as reference. Multinomial logit models (Level-1: occasions; Level-2: children; Level-3: villages) were fitted which corrected for non-independence of observations due to geographic clustering and repeated observations of individuals. A mixture of risk factors at the individual, household and neighbourhood levels predicted under-and over-nutrition among children in rural China. Improved socioeconomic status and living in more urbanised villages reduced the risk of stunted overweight among rural children in China. Young girls appeared to have higher risk of under-nutrition, and the risk decreased with age more markedly than for boys up to age 5. From age 5 onwards, boys tended to have higher risk of under-nutrition than girls. Girls aged around 12 and older were less likely to suffer from under-nutrition, while boys' higher risk of under-nutrition persisted throughout adolescence. Children were less likely to suffer from over-nutrition compared to normal nutrition. Boys tended to have an even lower risk of over-nutrition than girls and the gender difference widened with age until adolescence. Our results have important policy implications that improving household economic status, in particular, maternal education and health insurance for children, and living environment are important to enhance rural children's nutritional status in China. Investments in early years of childhood can be effective to reduce gender inequality in nutritional health in rural China.	[Zhang, Nan; Becares, Laia; Chandola, Tarani] Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England; [Becares, Laia] Univ Manchester, Ctr Dynam Ethn CoDE, Sch Social Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Zhang, N (corresponding author), Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England.	nancytju@gmail.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	ESRC; National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre [5 R24 HD050924]; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R24 HD050924, R01-HD38700]; Fogarty International Centre, NIH; China-Japan Friendship Hospital, Ministry of Health; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital, Ministry of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supporting by an ESRC postgraduate scholarship to NZ. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an ESRC postgraduate scholarship to NZ. We use data from China Health and Nutrition Survey (CHNS), which is available for public use from http://www.cpc.unc.edu/projects/china/data. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009.	All-China Women's Federation, 2013, RES REP RUR LEFT CHI; [Anonymous], 2000, MODERNISATION SON PR; ASTRUP A, 1994, AM J PHYSIOL, V266, pE592, DOI 10.1152/ajpendo.1994.266.4.E592; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, MOTHERS BABIES HLTH; Berk LE., 2013, CHILD DEV; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Bredenkamp C, 2006, INCOME CHILD NUTR ST; Brown J, 2007, NUTR LIFE CYCLE; Browne W.J., 2015, MCMC ESTIMATION MLWI; Chang S, 2000, Wei Sheng Yan Jiu, V29, P270; Chang Suying, 2006, Wei Sheng Yan Jiu, V35, P768; Chen CM, 2011, BIOMED ENVIRON SCI, V24, P321, DOI 10.3967/0895-3988.2011.04.001; Dang SN, 2014, J CHILD HEALTH CARE, V18, P358, DOI 10.1177/1367493513496669; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Ge XJ, 2001, SOC PSYCHOL QUART, V64, P363, DOI 10.2307/3090160; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; He W, 2014, AM J PUBLIC HEALTH, V104, pE14, DOI 10.2105/AJPH.2013.301669; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hui L, 2003, HEALTH PLACE, V9, P371, DOI 10.1016/S1353-8292(03)00049-2; Jia X-y, 2012, CHINESE J PUBLIC HLT, V1; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Jiang Y, 2015, CHILD CARE HLTH DEV, V41, P45, DOI 10.1111/cch.12148; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li YP, 2009, BIOMED ENVIRON SCI, V22, P130, DOI 10.1016/S0895-3988(09)60035-0; Liu Y, 2007, ECON BULL, V15; Luo JY, 2008, PUBLIC HEALTH REP, V123, P382; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Morgan SL, 2000, CHINA J, V44, P1, DOI 10.2307/2667475; Mu R, 2015, J POPUL ECON, V28, P631, DOI 10.1007/s00148-015-0550-3; Na Zhang, 2015, 2015 Visual Communications and Image Processing (VCIP), P1, DOI 10.1109/VCIP.2015.7457813; Ning MX, 2013, AGR ECON-CZECH, V59, P467, DOI 10.17221/19/2013-AGRICECON; Pei LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-121; Piernas C, 2015, EUROPEAN J CLIN NUTR; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Poskitt EME, 2009, ANN TROP PAEDIATR, V29, P1, DOI 10.1179/146532809X401971; Rasbash J, 2013, MLWIN VERSION 2 28; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Ren WW, 2014, CHINA ECON REV, V31, P145, DOI 10.1016/j.chieco.2014.09.001; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Shen TF, 1996, NEW ENGL J MED, V335, P400, DOI 10.1056/NEJM199608083350606; Shetty P, 2013, INDIAN J PEDIATR, V80, pS21, DOI 10.1007/s12098-013-0971-5; Shi ZM, 2005, J ADOLESCENT HEALTH, V37, P313, DOI 10.1016/j.jadohealth.2004.10.013; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Strauss J, 1998, J ECON LIT, V36, P766; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tan C, 2010, PUBLIC HEALTH NUTR, V13, P1663, DOI 10.1017/S1368980010000078; Tassoni P., 2007, CHILD DEV 6 16 YEARS; United Nations Children's Fund, 1998, STAT WORLDS CHILDR 1; United Nations Children's Fund, 1990, STRAT IMPR NUTR STAT; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Wang Y, 1998, EUR J CLIN NUTR, V52, P908, DOI 10.1038/sj.ejcn.1600664; Wang Y., 2012, HDB ANTHROPOMETRY PH, V1, P29, DOI DOI 10.1007/978-1-4419-1788-1_2; Wang YF, 2003, PUBLIC HEALTH NUTR, V6, P549, DOI 10.1079/PHN2003470; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wei SG, 2011, AUSTRALAS MED J, V4, P123, DOI 10.4066/AMJ.2011.584; Zhang J, 2011, ASIA PAC J CLIN NUTR, V20, P584; Zhang N, 2016, PARENTAL MIGRATION I; Zhang N, 2015, APPETITE, V95, P484, DOI 10.1016/j.appet.2015.08.024; Zhang N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2296-y; Zhang YX, 2014, INT J CARDIOL, V176, P1212, DOI 10.1016/j.ijcard.2014.07.222; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	91	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158119	10.1371/journal.pone.0158119	http://dx.doi.org/10.1371/journal.pone.0158119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27611217	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400031
J	Zhang, MH; Xin, M				Zhang, Miaohui; Xin, Ming			Human Detection Using Random Color Similarity Feature and Random Ferns Classifier	PLOS ONE			English	Article								We explore a novel approach for human detection based on random color similarity feature (RCS) and random ferns classifier which is also known as semi-naive Bayesian classifier. In contrast to other existing features employed by human detection, color-based features are rarely used in vision-based human detection because of large intra-class variations. In this paper, we propose a novel color-based feature, RCS feature, which is yielded by simple color similarity computation between image cells randomly picked in still images, and can effectively characterize human appearances. In addition, a histogram of oriented gradient based local binary feature (HOG-LBF) is also introduced to enrich the human descriptor set. Furthermore, random ferns classifier is used in the proposed approach because of its faster speed in training and testing than traditional classifiers such as SupportVector Machine (SVM) classifier, without a loss in performance. Finally, the proposed method is conducted in public datasets and achieves competitive detection results.	[Zhang, Miaohui] Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China; [Xin, Ming] Beihang Univ, Sch Comp Sci & Engn, Beijing Key Lab Digital Media, Beijing, Peoples R China	Henan University; Beihang University	Zhang, MH (corresponding author), Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China.	zhmh@henu.edu.cn	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Natural Science Foundation of China [61305042, 61503250, 61503173]; Science and Technology Research Key Project of Education Department of Henan Province [152102210057]; Postdoctoral Science Fund of China [2015M582182]; Henan University Fund [2012YBZR005]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Key Project of Education Department of Henan Province; Postdoctoral Science Fund of China(China Postdoctoral Science Foundation); Henan University Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by the National Natural Science Foundation of China (No. 61305042, No. 61503250, No. 61503173), the Science and Technology Research Key Project of Education Department of Henan Province (No. 152102210057), the Postdoctoral Science Fund of China (No. 2015M582182), Henan University Fund (2012YBZR005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng WC, 2013, ENG APPL ARTIF INTEL, V26, P1016, DOI 10.1016/j.engappai.2012.08.013; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dalal N, 2006, LECT NOTES COMPUT SC, V3952, P428, DOI 10.1007/11744047_33; Everingham P. M., 2009, P INT C COMP VIS KYO; Kalal Z., 2010, P COMP VIS PATT REC; Kong KK, 2015, PATTERN RECOGN LETT, V68, P63, DOI 10.1016/j.patrec.2015.07.043; Laptev I, 2006, BMVC, V3, P949; Liu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142820; Luo P, 2014, IEEE C CVPR; Maji S, 2008, PROC CVPR IEEE, P2245; Mikolajczyk K, 2004, LECT NOTES COMPUT SC, V3021, P69; Mohan A, 2001, IEEE T PATTERN ANAL, V23, P349, DOI 10.1109/34.917571; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Schwartz W.R., 2009, P INT C COMP VIS KYO; Tuzel O., 2007, CVPR, V1; Villamizar M., 2010, CVPR; WALK S, 2010, PROC CVPR IEEE, P1030, DOI DOI 10.1109/CVPR.2010.5540102; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Winn J., 2006, CVPR; Wu B, 2005, IEEE I CONF COMP VIS, P90; Wu B., 2008, P IEEE COMP SOC C CO; Yao SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134242; Zhang M., 2011, OPTICAL ENG, V9; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhao Y, 2013, IEEE INTELLIGENT TRA, V7, P459	30	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162830	10.1371/journal.pone.0162830	http://dx.doi.org/10.1371/journal.pone.0162830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611217	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900174
J	Yang, FX; Mao, DQ; Zhou, H; Luo, Y				Yang, Fengxia; Mao, Daqing; Zhou, Hao; Luo, Yi			Prevalence and Fate of Carbapenemase Genes in a Wastewater Treatment Plant in Northern China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE ISOLATE; ANTIBIOTIC-RESISTANCE GENES; HYDROLYZING ENZYME KPC-2; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PLASMIDS; ENTEROBACTERIACEAE; DISSEMINATION; VIRULENCE	Carbapenemase-producing strains of bacteria, which were primarily found in the medical field, have increasingly been found in the environment, thus posing potential risks to public health. One possible way for carbapenemase genes to enter the environment is via wastewater. Therefore, the goal of this study was to determine the occurrence and fate of five high-risk carbapenemase genes in a wastewater treatment plant (WWTP) in northern China using real-time qPCR. Results showed that the bla(KPC-2), bla(GES-1), and bla(IMP-1) genes prevailed throughout all processing stages (even in the chlorination disinfection unit) in the WWTP, whereas the bla(VIM-2) and bla(OXA-48) genes were not detected in all samples. Worryingly, considerable amounts of carbapenemase genes ((1.54 +/- 0.61) x 10(3) copies/mL to (2.14 +/- 0.41) x 10(5) copies/mL) were detected in WWTP effluent samples, while the majority of the carbapenemase genes were transported to the dewatered sludge with concentrations from (6.51 +/- 0.14) x 10(9) copies/g to (6.18 +/- 0.63) x 10(10) copies/g dry weight. Furthermore, a total of 97 KPC-2-producing strains, belonging to 8 bacterial genera, were isolated from the WWTP. Sequencing of 16S rRNA revealed that most of KPC-2 producing isolates were opportunistic pathogens, including Klebsiella spp. (10.3%), Enterococcus spp. (11.3%), Acinetobacter spp. (19.6%), Escherichia spp. (12.4%), Shigella spp. (17.5%), Stenotrophomonas spp. (10.3%) and Wautersiella spp. (9.3%). Moreover, bla(KPC-2) genes were identified for the first time in Paenibacillus spp. isolates (an indigenous bacteria), indicating an increased risk of horizontal transfer between clinical pathogens and environmental bacteria. Indeed, a conjugation experiment demonstrated transfer of the bla(KPC-2) gene to an E. coli J53 strain from a Klebsiella strain isolated from the WWTP. To our knowledge, this is the first study to obtain Paenibacillus spp. isolates carrying the carbapenemase gene and to quantify the abundance of carbapenemase genes in the environment.	[Yang, Fengxia; Mao, Daqing] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China; [Yang, Fengxia; Zhou, Hao; Luo, Yi] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China	Tianjin University; Nankai University	Mao, DQ (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.; Luo, Y (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China.	mao@tju.edu.cn; luoy@nankai.edu.cn	Luo, Yi/C-2451-2018; Zhou, Hao/AFQ-5956-2022; Zhou, Hao/Q-2401-2018	Zhou, Hao/0000-0001-7131-3758; Zhou, Hao/0000-0001-7131-3758	National Natural Science Foundation of China [31470440, 21277075]; State Environmental Protection Commonweal Project [201309031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Environmental Protection Commonweal Project	This study was supported by the National Natural Science Foundation of China (31470440, 21277075), and the State Environmental Protection Commonweal Project (201309031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2009, J CLIN MICROBIOL, V47, P2670, DOI 10.1128/JCM.00362-09; Amos GCA, 2014, VET MICROBIOL, V171, P441, DOI 10.1016/j.vetmic.2014.02.017; Baughman Robert P, 2009, J Intensive Care Med, V24, P230, DOI 10.1177/0885066609335660; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Boyd EF, 1996, GENETICS, V143, P1091; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CALISTO F, 2011, BMC PROCEEDINGS, V5, P132, DOI DOI 10.1186/1753-6561-5-S6-P132; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, EMERG INFECT DIS, V7, P444, DOI 10.3201/eid0703.017314; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; CAVALLI LL, 1953, J GEN MICROBIOL, V8, P89, DOI 10.1099/00221287-8-1-89; Chen ZW, 2015, J QUANT SPECTROSC RA, V167, P1, DOI 10.1016/j.jqsrt.2015.07.018; CLSI, 2012, M100S22 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P796, DOI 10.1128/AAC.01180-07; Dallal MMS, 2008, INFECT DIS CLIN PRAC, V16, P41, DOI [10.1097/ipc.0b013e31815f6586, DOI 10.1097/IPC.0B013E31815F6586]; Desai P J, 2001, Indian J Med Microbiol, V19, P132; DEVRIESE LA, 1993, J APPL BACTERIOL, V75, P399, DOI 10.1111/j.1365-2672.1993.tb02794.x; Diallo AA, 2013, WATER RES, V47, P4719, DOI 10.1016/j.watres.2013.04.047; Fleurbaaij F, 2014, ANAL CHEM, V86, P9154, DOI 10.1021/ac502049p; Galler H, 2014, CLIN MICROBIOL INFEC, V20, pO132, DOI 10.1111/1469-0691.12336; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Gonullu N, 2008, J CLIN MICROBIOL, V46, P1110, DOI 10.1128/JCM.01974-07; Hays C, 2012, INT J ANTIMICROB AG, V39, P545, DOI 10.1016/j.ijantimicag.2012.03.002; Hopkins KL, 2006, ANTIMICROB AGENTS CH, V50, P3203, DOI 10.1128/AAC.00149-06; Hossain A, 2004, ANTIMICROB AGENTS CH, V48, P4438, DOI 10.1128/AAC.48.11.4438-4440.2004; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Insa R, 2007, J ANTIMICROB CHEMOTH, V59, P583, DOI 10.1093/jac/dkl496; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P243, DOI 10.1093/jac/dkr431; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lartigue MF, 2006, ANTIMICROB AGENTS CH, V50, P1282, DOI 10.1128/AAC.50.4.1282-1286.2006; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Manenzhe RI, 2015, J ANTIMICROB CHEMOTH, V53, P3396; Mao DQ, 2015, WATER RES, V85, P458, DOI 10.1016/j.watres.2015.09.010; Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428; Mavroidi A, 2012, INT J ANTIMICROB AG, V39, P247, DOI 10.1016/j.ijantimicag.2011.11.003; Montezzi LF, 2015, INT J ANTIMICROB AG, V45, P174, DOI 10.1016/j.ijantimicag.2014.10.016; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4933, DOI 10.1128/AAC.00719-11; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; Nicolau DP, 2008, EXPERT OPIN PHARMACO, V9, P23, DOI 10.1517/14656566.9.1.23; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Pan XH, 2014, BIOCHEMISTRY-US, V53, P5414, DOI 10.1021/bi401609h; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P3072, DOI 10.1128/AAC.00513-10; Potron A, 2011, FEMS MICROBIOL LETT, V324, P111, DOI 10.1111/j.1574-6968.2011.02392.x; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Siu LK, 2012, MICROB DRUG RESIST, V18, P380, DOI 10.1089/mdr.2011.0241; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Virgincar N, 2011, J HOSP INFECT, V78, P293, DOI 10.1016/j.jhin.2011.03.016; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang XJ, 2014, MICROB DRUG RESIST, V20, P144, DOI 10.1089/mdr.2013.0100; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zhang R, 2007, J ANTIMICROB CHEMOTH, V59, P574, DOI 10.1093/jac/dkl541; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	77	44	44	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156383	10.1371/journal.pone.0156383	http://dx.doi.org/10.1371/journal.pone.0156383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27607467	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500127
